PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Woolley, SMN; Fremouw, TE; Hsu, A; Theunissen, FE				Woolley, SMN; Fremouw, TE; Hsu, A; Theunissen, FE			Tuning for spectro-temporal modulations as a mechanism for auditory discrimination of natural sounds	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELDS; CONSPECIFIC SONG; ZEBRA FINCHES; NEURONS; CORTEX; RESPONSES; SPEECH; REPRESENTATION; MIDBRAIN; STIMULI	Vocal communicators discriminate conspecific vocalizations from other sounds and recognize the vocalizations of individuals. To identify neural mechanisms for the discrimination of such natural sounds, we compared the linear spectro-temporal tuning properties of auditory midbrain and forebrain neurons in zebra finches with the statistics of natural sounds, including song. Here, we demonstrate that ensembles of auditory neurons are tuned to auditory features that enhance the acoustic differences between classes of natural sounds, and among the songs of individual birds. Tuning specifically avoids the spectro-temporal modulations that are redundant across natural sounds and therefore provide little information; rather, it overlaps with the temporal modulations that differ most across sounds. By comparing the real tuning and a less selective model of spectro-temporal tuning, we found that the real modulation tuning increases the neural discrimination of different sounds. Additionally, auditory neurons discriminate among zebra finch song segments better than among synthetic sound segments.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Woolley, SMN (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	sw2277@columbia.edu		Theunissen, Frederic/0000-0001-8980-0650	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009810] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC009810] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSMANN PF, 1996, J ACOUST SOC AM, V10, P2680; Braaten RF, 1999, ANIM BEHAV, V58, P105, DOI 10.1006/anbe.1999.1134; Calhoun BM, 1998, EUR J NEUROSCI, V10, P926, DOI 10.1046/j.1460-9568.1998.00102.x; Chi TS, 1999, J ACOUST SOC AM, V106, P2719, DOI 10.1121/1.428100; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Eggermont JJ, 2002, J NEUROPHYSIOL, V87, P305, DOI 10.1152/jn.00490.2001; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; Gehr DD, 1999, NEUROREPORT, V10, P375, DOI 10.1097/00001756-199902050-00030; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Hsu A, 2004, J NEUROSCI, V24, P9201, DOI 10.1523/JNEUROSCI.2449-04.2004; Hsu A, 2004, NETWORK-COMP NEURAL, V15, P91, DOI 10.1088/0954-898X/15/2/002; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Lu T, 2004, J NEUROPHYSIOL, V91, P301, DOI 10.1152/jn.00022.2003; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; MARLER P, 1977, SCIENCE, V198, P519, DOI 10.1126/science.198.4316.519; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; NARINS PM, 1980, BRAIN BEHAV EVOLUT, V17, P48, DOI 10.1159/000121790; POLLAK GD, 1981, J NEUROPHYSIOL, V46, P605, DOI 10.1152/jn.1981.46.3.605; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Ringach DL, 2004, J PHYSIOL-LONDON, V558, P717, DOI 10.1113/jphysiol.2004.065771; ROSE G, 1983, SCIENCE, V219, P1087, DOI 10.1126/science.6600522; Sen K, 2001, J NEUROPHYSIOL, V86, P1445, DOI 10.1152/jn.2001.86.3.1445; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Suga N, 2002, NEURON, V36, P9, DOI 10.1016/S0896-6273(02)00933-9; SUGA N, 1965, J PHYSIOL-LONDON, V181, P671, DOI 10.1113/jphysiol.1965.sp007791; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Woolley SMN, 2005, J NEUROPHYSIOL, V94, P1143, DOI 10.1152/jn.01064.2004; Woolley SMN, 2004, J NEUROPHYSIOL, V91, P136, DOI 10.1152/jn.00633.2003; Woolley SMN, 1999, J NEUROSCI, V19, P358, DOI 10.1523/JNEUROSCI.19-01-00358.1999	37	198	199	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1371	1379		10.1038/nn1536	http://dx.doi.org/10.1038/nn1536			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16136039				2022-12-17	WOS:000232145900022
J	Schneider, P; Sluming, V; Roberts, N; Scherg, M; Goebel, R; Specht, HJ; Dosch, HG; Bleeck, S; Stippich, C; Rupp, A				Schneider, P; Sluming, V; Roberts, N; Scherg, M; Goebel, R; Specht, HJ; Dosch, HG; Bleeck, S; Stippich, C; Rupp, A			Structural and functional asymmetry of lateral Heschl's gyrus reflects pitch perception preference	NATURE NEUROSCIENCE			English	Article							HUMAN AUDITORY-CORTEX; HUMAN BRAIN; TEMPORAL REGULARITY; VOLUME MEASUREMENT; MUSICIANS; RESONANCE; REPRESENTATION; ORGANIZATION; SOUND; MORPHOMETRY	The relative pitch of harmonic complex sounds, such as instrumental sounds, may be perceived by decoding either the fundamental pitch (f(0)) or the spectral pitch (f(SP)) of the stimuli. We classified a large cohort of 420 subjects including symphony orchestra musicians to be either f(0) or fSP listeners, depending on the dominant perceptual mode. In a subgroup of 87 subjects, MRI ( magnetic resonance imaging) and magnetoencephalography studies demonstrated a strong neural basis for both types of pitch perception irrespective of musical aptitude. Compared with f(0) listeners, fSP listeners possessed a pronounced rightward, rather than leftward, asymmetry of gray matter volume and P50m activity within the pitch-sensitive lateral Heschl's gyrus. Our data link relative hemispheric lateralization with perceptual stimulus properties, whereas the absolute size of the Heschl's gyrus depends on musical aptitude.	Univ Heidelberg Hosp, Dept Neurol, D-69120 Heidelberg, Germany; Univ Liverpool, Sch Hlth Sci, Div Med Imaging, Liverpool L69 3GB, Merseyside, England; Univ Liverpool, MARIARC, Liverpool L69 3BX, Merseyside, England; Univ Maastricht, Fac Psychol, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; Univ Heidelberg, Dept Phys, D-69120 Heidelberg, Germany; Univ Southampton, Inst Sound & Vibrat Res, Southampton SO17 1BJ, Hants, England	Ruprecht Karls University Heidelberg; University of Liverpool; University of Liverpool; Maastricht University; Ruprecht Karls University Heidelberg; University of Southampton	Schneider, P (corresponding author), Univ Heidelberg Hosp, Dept Neurol, INF 400, D-69120 Heidelberg, Germany.	Peter.Schneider@med.uni-heidelberg.de	Sluming, Vanessa/P-2986-2015; Specht, Karsten/C-3762-2009	Sluming, Vanessa/0000-0001-5130-2090; Specht, Karsten/0000-0002-9946-3704; Stippich, Christoph/0000-0001-8815-7018; Schneider, Peter/0000-0002-1920-0438; Bleeck, Stefan/0000-0003-4378-3394; Goebel, Rainer/0000-0003-1780-2467				Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; Devlin JT, 2003, J NEUROSCI, V23, P11516; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; GALABURDA AM, 1978, SCIENCE, V199, P852, DOI 10.1126/science.341314; Galuske RAW, 2000, SCIENCE, V289, P1946, DOI 10.1126/science.289.5486.1946; Gaser C, 2003, J NEUROSCI, V23, P9240; Gordon Edwin E., 1998, INTRO RES PSYCHOL MU; Griffiths TD, 1998, NAT NEUROSCI, V1, P422, DOI 10.1038/1637; Griffiths TD, 2003, ANN NY ACAD SCI, V999, P40, DOI 10.1196/annals.1284.004; Griffiths TD, 2001, NAT NEUROSCI, V4, P633, DOI 10.1038/88459; Gutschalk A, 2002, NEUROIMAGE, V15, P207, DOI 10.1006/nimg.2001.0949; Hall DA, 2002, CEREB CORTEX, V12, P140, DOI 10.1093/cercor/12.2.140; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Joliveau E, 2004, NATURE, V427, P116, DOI 10.1038/427116a; Laguitton V, 1998, NEUROPSYCHOLOGIA, V36, P201, DOI 10.1016/S0028-3932(97)00122-X; LANGNER G, 1992, HEARING RES, V60, P115, DOI 10.1016/0378-5955(92)90015-F; Leonard CM, 1998, CEREB CORTEX, V8, P397, DOI 10.1093/cercor/8.5.397; MEYER A, 1977, MUSIC BRAIN, P225; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Munte TF, 2001, NATURE, V409, P580, DOI 10.1038/35054668; PANTEV C, 1989, SCIENCE, V246, P486, DOI 10.1126/science.2814476; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Penagos H, 2004, J NEUROSCI, V24, P6810, DOI 10.1523/JNEUROSCI.0383-04.2004; Penhune VB, 2003, NEUROIMAGE, V20, P1215, DOI 10.1016/S1053-8119(03)00373-2; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; PFEIFER RA, 1936, HDB NEUROLOGIE, V6, P533; Plomp R., 1976, ASPECTS TONE SENSATI; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; RITTER S, IN PRESS NEUROIMAGE; Rupp A, 2004, J NEUROPHYSIOL, V92, P2239, DOI 10.1152/jn.00163.2004; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Seifritz E, 2002, SCIENCE, V297, P1706, DOI 10.1126/science.1074355; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; SMOORENBURG GF, 1970, J ACOUST SOC AM, V48, P924, DOI 10.1121/1.1912232; Talairach J, 1988, CO PLANAR STEREOTAXI; TERHARDT E, 1974, J ACOUST SOC AM, V55, P1061, DOI 10.1121/1.1914648; Tervaniemi M, 2003, BRAIN RES REV, V43, P231, DOI 10.1016/j.brainresrev.2003.08.004; VONHELMHOLTZ HLF, 1985, SENSATIONS TONE; Wallace MN, 2002, EXP BRAIN RES, V143, P499, DOI 10.1007/s00221-002-1014-z; Warren JD, 2003, J NEUROSCI, V23, P5799; Warren JD, 2003, P NATL ACAD SCI USA, V100, P10038, DOI 10.1073/pnas.1730682100; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	50	198	201	0	42	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1241	1247		10.1038/nn1530	http://dx.doi.org/10.1038/nn1530			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116442				2022-12-17	WOS:000231483800025
J	Tissir, F; Bar, I; Jossin, Y; Goffinet, AM				Tissir, F; Bar, I; Jossin, Y; Goffinet, AM			Protocadherin Celsr3 is crucial in axonal tract development	NATURE NEUROSCIENCE			English	Article							7-PASS TRANSMEMBRANE CADHERIN; DROSOPHILA VISUAL-SYSTEM; NEURAL-TUBE DEFECTS; PLANAR POLARITY; MUTANT MICE; THALAMOCORTICAL DEVELOPMENT; LOOP-TAIL; MOUSE; FLAMINGO; GUIDANCE	In the embryonic CNS, the development of axonal tracts is required for the formation of connections and is regulated by multiple genetic and microenvironmental factors. Here we show that mice with inactivation of Celsr3, an ortholog of Drosophila melanogaster flamingo (fmi; also known as starry night, stan) that encodes a seven-pass protocadherin, have marked, selective anomalies of several major axonal fascicles, implicating protocadherins in axonal development in the mammalian CNS for the first time. In flies, fmi controls planar cell polarity (PCP) in a frizzled-dependent but wingless-independent manner. The neural phenotype in Celsr3 mutant mice is similar to that caused by inactivation of Fzd3, a member of the frizzled family. Celsr3 and Fzd3 are expressed together during brain development and may act in synergy. Thus, a genetic pathway analogous to the one that controls PCP is key in the development of the axonal blueprint.	Univ Louvain, Sch Med, Dev Neurobiol Unit, B-1200 Brussels, Belgium; Univ Namur, Sch Med, Mol Physiol Res Unit, B-5000 Namur, Belgium	Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Namur	Goffinet, AM (corresponding author), Univ Louvain, Sch Med, Dev Neurobiol Unit, 73 Ave Mounier,Box DENE7382, B-1200 Brussels, Belgium.	andre.goffinet@dene.ucl.ac.be	bar, isabelle/AAQ-7795-2020	Tissir, Fadel/0000-0002-9292-6622; Jossin, Yves/0000-0001-8466-7432				Adler PN, 2001, CURR OPIN CELL BIOL, V13, P635, DOI 10.1016/S0955-0674(00)00263-5; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Chae J, 1999, DEVELOPMENT, V126, P5421; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Finger JH, 2002, J NEUROSCI, V22, P10346; Formstone CJ, 2001, MECH DEVELOP, V109, P91, DOI 10.1016/S0925-4773(01)00515-9; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Garel S, 2002, DEVELOPMENT, V129, P5621, DOI 10.1242/dev.00166; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Hadjantonakis AK, 1997, GENOMICS, V45, P97, DOI 10.1006/geno.1997.4892; Hadjantonakis AK, 1998, MECH DEVELOP, V78, P91, DOI 10.1016/S0925-4773(98)00153-1; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; Jones L, 2002, DEVELOPMENT, V129, P5041; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Lu BW, 1999, CURR BIOL, V9, P1247, DOI 10.1016/S0960-9822(99)80505-3; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Metin C, 1996, J NEUROSCI, V16, P3219; Metin C, 1997, DEVELOPMENT, V124, P5063; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Molnar Z, 2003, CEREB CORTEX, V13, P661, DOI 10.1093/cercor/13.6.661; MOLNAR Z, 1991, NATURE, V351, P475, DOI 10.1038/351475a0; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Nakayama M, 1998, GENOMICS, V51, P27, DOI 10.1006/geno.1998.5341; Pratt T, 2002, J NEUROSCI, V22, P8523; RETHELYI M, 1972, BRAIN RES, V46, P203, DOI 10.1016/0006-8993(72)90016-9; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Shima Y, 2004, DEV CELL, V7, P205, DOI 10.1016/j.devcel.2004.07.007; Shima Y, 2002, DEV DYNAM, V223, P321, DOI 10.1002/dvdy.10054; SHOLL DA, 1953, J ANAT, V87, P387; Stoykova A, 2000, J NEUROSCI, V20, P8042; Tamamaki N, 1997, J NEUROSCI, V17, P8313; Tissir F, 2004, DEV BRAIN RES, V149, P63, DOI 10.1016/j.devbrainres.2004.01.002; Tissir F, 2002, MECH DEVELOP, V112, P157, DOI 10.1016/S0925-4773(01)00623-2; Tuttle R, 1999, DEVELOPMENT, V126, P1903; Uemura T, 2003, J BIOCHEM, V134, P625, DOI 10.1093/jb/mvg186; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Volynski KE, 2004, EMBO J, V23, P4423, DOI 10.1038/sj.emboj.7600443; Wang YS, 2002, J NEUROSCI, V22, P8563; Yoshida M, 1997, DEVELOPMENT, V124, P101; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	50	198	204	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					451	457		10.1038/nn1428	http://dx.doi.org/10.1038/nn1428			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15778712				2022-12-17	WOS:000228040400015
J	Kingsbury, MA; Rehen, SK; Contos, JJA; Higgins, CM; Chun, J				Kingsbury, MA; Rehen, SK; Contos, JJA; Higgins, CM; Chun, J			Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding	NATURE NEUROSCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; CENTRAL-NERVOUS-SYSTEM; PROGRAMMED CELL-DEATH; NEURAL STEM-CELLS; POSTMITOTIC REGIONS; DECREASED APOPTOSIS; LYSOPHOSPHOLIPASE-D; RECEPTOR GENE; CYCLE; EXPRESSION	Lysophosphatidic acid (LPA) is a phospholipid that has extracellular signaling properties mediated by G protein-coupled receptors. Two LPA receptors, LPA(1) and LPA(2), are expressed in the embryonic cerebral cortex, suggesting roles for LPA signaling in cortical formation. Here we report that intact cerebral cortices exposed to extracellular LPA ex vivo rapidly increased in width and produced folds resembling gyri, which are not normally present in mouse brains and are absent in LPA(1) LPA(2) double-null mice. Mechanistically, growth was not due to increased proliferation but rather to receptor-dependent reduced cell death and increased terminal mitosis of neural progenitor cells (NPCs). Our results implicate extracellular lipid signals as new influences on brain formation during embryonic development.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Neurosci Program, La Jolla, CA 92093 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Chun, J (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,ICND 118, La Jolla, CA 92037 USA.		Chun, Jerold/Y-4670-2019; Rehen, Stevens/J-5874-2012	Rehen, Stevens/0000-0003-4216-9501				Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; BARRON DH, 1950, J EXP ZOOL, V113, P553, DOI 10.1002/jez.1401130304; Blaschke AJ, 1996, DEVELOPMENT, V122, P1165; Blaschke AJ, 1998, J COMP NEUROL, V396, P39, DOI 10.1002/(SICI)1096-9861(19980622)396:1<39::AID-CNE4>3.0.CO;2-J; Brauer AU, 2003, NAT NEUROSCI, V6, P572, DOI 10.1038/nn1052; Cai L, 1997, J NEUROSCI, V17, P2079; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Contos JJA, 2001, GENE, V267, P243, DOI 10.1016/S0378-1119(01)00410-3; DRAGO J, 1991, P NATL ACAD SCI USA, V88, P2199, DOI 10.1073/pnas.88.6.2199; Dubin AE, 1999, J NEUROSCI, V19, P1371; Fukushima N, 2000, DEV BIOL, V228, P6, DOI 10.1006/dbio.2000.9930; Fukushima N, 2001, ANNU REV PHARMACOL, V41, P507, DOI 10.1146/annurev.pharmtox.41.1.507; Fukushima N, 2002, MOL CELL NEUROSCI, V20, P271, DOI 10.1006/mcne.2002.1123; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ghosh MM, 1995, BIOREMED SER, V3, P15; Haydar TF, 1999, CEREB CORTEX, V9, P621, DOI 10.1093/cercor/9.6.621; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Ishii I, 2000, MOL PHARMACOL, V58, P895, DOI 10.1124/mol.58.5.895; ISHII I, IN PRESS ANN REV BIO; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Le Gros Clark W.E., 1945, ESSAYS GROWTH FORM, P1, DOI DOI 10.1016/J.JPEDSURG.2010.11.028; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; McGiffert C, 2002, FEBS LETT, V531, P103, DOI 10.1016/S0014-5793(02)03404-X; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; MOOLENAAR WH, 1995, CURR OPIN CELL BIOL, V7, P203, DOI 10.1016/0955-0674(95)80029-8; Pompeiano M, 2000, J COMP NEUROL, V423, P1; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Rehen SK, 2002, BRAIN RES, V947, P78, DOI 10.1016/S0006-8993(02)02909-8; RICHMAN DP, 1975, SCIENCE, V189, P18, DOI 10.1126/science.1135626; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; SIDMAN RL, 1959, EXP NEUROL, V1, P322, DOI 10.1016/0014-4886(59)90024-X; Suh JH, 2001, NAT NEUROSCI, V4, P123, DOI 10.1038/83936; Takahashi T, 1996, J NEUROSCI, V16, P5762; TAKAHASHI T, 1993, J NEUROSCI, V13, P820; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; TEMPLE S, 1995, NEURON, V15, P249, DOI 10.1016/0896-6273(95)90030-6; Thomaidou D, 1997, J NEUROSCI, V17, P1075, DOI 10.1523/jneurosci.17-03-01075.1997; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Ye XQ, 2002, BBA-MOL CELL BIOL L, V1585, P108, DOI 10.1016/S1388-1981(02)00330-X	50	198	204	1	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1292	1299		10.1038/nn1157	http://dx.doi.org/10.1038/nn1157			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14625558				2022-12-17	WOS:000186725600014
J	Yasuda, R; Sabatini, BL; Svoboda, K				Yasuda, R; Sabatini, BL; Svoboda, K			Plasticity of calcium channels in dendritic spines	NATURE NEUROSCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; HIPPOCAMPAL CA1 NEURONS; CA2+ CHANNELS; PYRAMIDAL NEURONS; SYNAPTIC TRANSMISSION; POSTSYNAPTIC DENSITY; RECEPTOR; INACTIVATION; INHIBITOR	Voltage-sensitive Ca2+ channels (VSCCs) constitute a major source of calcium ions in dendritic spines, but their function is unknown. Here we show that R-type VSCCs in spines of rat CA1 pyramidal neurons are depressed for at least 30 min after brief trains of back-propagating action potentials. Populations of channels in single spines are depressed stochastically and synchronously, independent of channels in the parent dendrite and other spines, implying that depression is the result of signaling restricted to individual spines. Induction of VSCC depression blocks theta-burst-induced long-term potentiation (LTP), indicating that postsynaptic action potentials can modulate synaptic plasticity by tuning VSCCs. Induction of depression requires [Ca2+] elevations and activation of L-type VSCCs, which activate Ca2+/calmodulin-dependent kinase II (CaMKII) and a cyclic adenosine monophosphate (cAMP)-dependent pathway. Given that L-type VSCCs do not contribute measurably to Ca2+ influx in spines, they must activate downstream effectors either directly through voltage-dependent conformational changes or via [Ca2+] microdomains.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Yasuda, Ryohei/E-7726-2011	Yasuda, Ryohei/0000-0001-6263-9297				Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; BEAN BP, 1994, ION CHANNELS, P199; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Garaschuk O, 1997, J PHYSIOL-LONDON, V502, P13, DOI 10.1111/j.1469-7793.1997.013bl.x; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; ITO K, 1995, NEUROSCI LETT, V183, P112, DOI 10.1016/0304-3940(94)11127-5; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Kavalali ET, 1997, NEURON, V18, P651, DOI 10.1016/S0896-6273(00)80305-0; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Pologruto T. A., 2003, BIOMED ENG ONLINE, V2; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; Shirke AM, 1997, J NEUROPHYSIOL, V78, P2682, DOI 10.1152/jn.1997.78.5.2682; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; WESTCOTT KR, 1979, P NATL ACAD SCI USA, V76, P204, DOI 10.1073/pnas.76.1.204; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	49	198	201	0	13	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					948	955		10.1038/nn1112	http://dx.doi.org/10.1038/nn1112			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12937422				2022-12-17	WOS:000184970400013
J	Beaumont, V; Zucker, RS				Beaumont, V; Zucker, RS			Enhancement of synaptic transmission by cyclic AMP modulation of presynaptic I-h channels	NATURE NEUROSCIENCE			English	Article							CRAYFISH NEUROMUSCULAR-JUNCTION; ACTIVATED CATION CURRENT; SEROTONIN-INDUCED FACILITATION; TIME-DEPENDENT RECTIFICATION; PROTEIN-KINASE-C; TRANSMITTER RELEASE; INWARD RECTIFICATION; SINOATRIAL NODE; NERVE-TERMINALS; CENTRAL NEURONS	Presynaptic activation of adenylyl cyclase and subsequent generation of cAMP represent an important mechanism in the modulation of synaptic transmission. In many cases, short- to medium-term modulation of synaptic strength by cAMP is due to activation of protein kinase A and subsequent covalent modification of presynaptic ion channels or synaptic proteins. Here we show that presynaptic cAMP generation via serotonin receptor activation directly modulated hyperpolarization-activated cation channels (I-h channels) in axons. This modulation of I-h produced an increase in synaptic strength that could not be explained solely by depolarization of the presynaptic membrane. These studies identify a mechanism by which cAMP and I-h regulate synaptic plasticity.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Beaumont, V (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343; Beaumont, Vahri/0000-0002-6488-2175				Bal T, 1996, NEURON, V17, P297, DOI 10.1016/S0896-6273(00)80161-0; BIRCH BD, 1991, J NEUROPHYSIOL, V66, P719, DOI 10.1152/jn.1991.66.3.719; BOBKER DH, 1989, NEURON, V2, P1535, DOI 10.1016/0896-6273(89)90041-X; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; BOULIS NM, 1990, BRAIN RES, V525, P198, DOI 10.1016/0006-8993(90)90864-8; DEKIN MS, 1993, J NEUROPHYSIOL, V70, P590, DOI 10.1152/jn.1993.70.2.590; DELANEY K, 1991, J NEUROSCI, V11, P2631; DiFrancesco D, 1999, J PHYSIOL-LONDON, V515, P367, DOI 10.1111/j.1469-7793.1999.367ac.x; DIFRANCESCO D, 1994, J PHYSIOL-LONDON, V474, P473, DOI 10.1113/jphysiol.1994.sp020038; DIXON D, 1985, J NEUROBIOL, V16, P409, DOI 10.1002/neu.480160602; DIXON D, 1989, J NEUROPHYSIOL, V62, P239, DOI 10.1152/jn.1989.62.1.239; DIXON D, 1989, J NEUROPHYSIOL, V62, P1251, DOI 10.1152/jn.1989.62.6.1251; DUDEL, 1971, PFLUGERS ARCH, V324, P227; DUDEL J., 1965, ARCH EXP PATHOL PHARMAKOL [NAUNYN SCHMIEDEBERGS], V249, P515; ENG DL, 1990, J PHYSIOL-LONDON, V421, P185, DOI 10.1113/jphysiol.1990.sp017940; ENYEART J, 1981, J NEUROBIOL, V12, P505, DOI 10.1002/neu.480120509; FISCHER L, 1983, J EXP BIOL, V102, P187; GLUSMAN S, 1982, J PHYSIOL-LONDON, V325, P223, DOI 10.1113/jphysiol.1982.sp014147; GOLOWASCH J, 1992, J NEUROPHYSIOL, V67, P318, DOI 10.1152/jn.1992.67.2.318; GOY MF, 1989, J NEUROSCI, V9, P369; Grafe P, 1997, J NEUROPHYSIOL, V77, P421, DOI 10.1152/jn.1997.77.1.421; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Hori Y, 1996, J PHYSIOL-LONDON, V492, P867, DOI 10.1113/jphysiol.1996.sp021352; HUBBARD JI, 1962, J PHYSIOL-LONDON, V163, P115, DOI 10.1113/jphysiol.1962.sp006961; Ingram G I, 1979, Clin Lab Haematol, V1, P13; Ingram SL, 1996, J PHYSIOL-LONDON, V492, P97, DOI 10.1113/jphysiol.1996.sp021292; KIEHN O, 1992, J NEUROPHYSIOL, V68, P496, DOI 10.1152/jn.1992.68.2.496; LERESCHE N, 1991, J PHYSIOL-LONDON, V441, P155, DOI 10.1113/jphysiol.1991.sp018744; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; LUTHI A, NAT NEUROSCI, V2634, P99; MACCAFERRI G, 1993, J NEUROPHYSIOL, V69, P2129, DOI 10.1152/jn.1993.69.6.2129; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P319, DOI 10.1113/jphysiol.1990.sp018332; MINTZ I, 1991, J NEUROSCI, V11, P3359; MITOMA H, 1994, NEUROSCI LETT, V173, P127, DOI 10.1016/0304-3940(94)90165-1; PAPE HC, 1992, J PHYSIOL-LONDON, V447, P729, DOI 10.1113/jphysiol.1992.sp019026; PAPE HC, 1994, NEUROSCIENCE, V59, P363, DOI 10.1016/0306-4522(94)90602-5; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.physiol.58.1.299; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; QUICK J, 1992, BIOCHEM BIOPH RES CO, V187, P657, DOI 10.1016/0006-291X(92)91245-L; SCHUMAN EM, 1994, J NEUROSCI, V14, P1613, DOI 10.1523/JNEUROSCI.14-03-01613.1994; STAUBLI U, 1994, BRAIN RES, V643, P10, DOI 10.1016/0006-8993(94)90003-5; SUGITA S, 1992, J NEUROPHYSIOL, V68, P643, DOI 10.1152/jn.1992.68.2.643; Sun ZY, 1998, J NEUROSCI, V18, P3991; TOKIMASA T, 1990, J PHYSIOL-LONDON, V420, P409, DOI 10.1113/jphysiol.1990.sp017920; TRAVAGLI RA, 1994, J NEUROPHYSIOL, V71, P1308, DOI 10.1152/jn.1994.71.4.1308; Vyshedskiy A, 1998, J NEUROSCI, V18, P5160, DOI 10.1523/JNEUROSCI.18-14-05160.1998; Wang C, 1998, NEURON, V21, P155, DOI 10.1016/S0896-6273(00)80523-1; WOJTOWICZ JM, 1984, J NEUROPHYSIOL, V52, P99, DOI 10.1152/jn.1984.52.1.99	49	198	202	1	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					133	141		10.1038/72072	http://dx.doi.org/10.1038/72072			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649568				2022-12-17	WOS:000085810300010
J	Gottlieb, J; Goldberg, ME				Gottlieb, J; Goldberg, ME			Activity of neurons in the lateral intraparietal area of the monkey during an antisaccade task	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; SINGLE NEURONS; MOTOR PLAN; EYE FIELD; SACCADES; CONNECTIONS; INTENTION; PATTERNS; MACAQUE; LESIONS	The close relationship between saccadic eye movements and vision complicates the identification of neural responses associated with each function. Visual and saccade-related responses are especially closely intertwined in a subdivision of posterior parietal cortex, the lateral parietal area (LIP). We analyzed LIP neurons using an antisaccade task in which monkeys made saccades away from a salient visual cue. The vast majority of neurons reliably signaled the location of the visual cue. In contrast, most neurons had only weak, if any, saccade-related activity independent of visual stimulation. Thus, whereas the great majority of LIP neurons reliably encoded cue location, only a small minority encoded the direction of the upcoming saccade.	NEI, Lab Sensorimotor Res, Bethesda, MD 20892 USA; Georgetown Univ, Sch Med, Dept Neurol, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Georgetown University	Gottlieb, J (corresponding author), NEI, Lab Sensorimotor Res, Bethesda, MD 20892 USA.							Amador N, 1998, J NEUROPHYSIOL, V80, P1775, DOI 10.1152/jn.1998.80.4.1775; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; BAIZER JS, 1993, VISUAL NEUROSCI, V10, P59, DOI 10.1017/S0952523800003229; BARASH S, 1991, J NEUROPHYSIOL, V66, P1109, DOI 10.1152/jn.1991.66.3.1109; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; CHEEORTS MN, 1993, BIOL CYBERN, V69, P29, DOI 10.1007/BF00201406; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Everling S, 1999, J NEUROSCI, V19, P2740; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Gaymard B, 1998, EXP BRAIN RES, V123, P159, DOI 10.1007/s002210050557; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; GUITTON D, 1985, EXP BRAIN RES, V58, P455; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hays A., 1982, WESCON C P, V2, P1; Heide W, 1998, EXP BRAIN RES, V123, P164, DOI 10.1007/s002210050558; Mazzoni P, 1996, J NEUROPHYSIOL, V76, P1439, DOI 10.1152/jn.1996.76.3.1439; Pare M, 1997, J NEUROPHYSIOL, V78, P3493, DOI 10.1152/jn.1997.78.6.3493; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; RICHMOND BJ, 1990, J NEUROPHYSIOL, V64, P351, DOI 10.1152/jn.1990.64.2.351; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; SEGRAVES MA, 1987, J NEUROPHYSIOL, V58, P1387, DOI 10.1152/jn.1987.58.6.1387; Snyder LH, 1998, J NEUROPHYSIOL, V79, P2814, DOI 10.1152/jn.1998.79.5.2814; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; YANTIS S, 1996, ATTENTIONAL CAPTURE, P45	29	198	198	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					906	912		10.1038/13209	http://dx.doi.org/10.1038/13209			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FE	10491612				2022-12-17	WOS:000083883200017
J	Caccamo, A; Branca, C; Piras, IS; Ferreira, E; Huentelman, MJ; Liang, WS; Readhead, B; Dudley, JT; Spangenberg, EE; Green, KN; Belfiore, R; Winslow, W; Oddo, S				Caccamo, Antonella; Branca, Caterina; Piras, Ignazio S.; Ferreira, Eric; Huentelman, Matthew J.; Liang, Winnie S.; Readhead, Ben; Dudley, Joel T.; Spangenberg, Elizabeth E.; Green, Kim N.; Belfiore, Ramona; Winslow, Wendy; Oddo, Salvatore			Necroptosis activation in Alzheimer's disease	NATURE NEUROSCIENCE			English	Article							CELL-DEATH; MECHANISMS; EXPRESSION; BETA; PHOSPHORYLATION; MLKL; APOPTOSIS; PROGRAM	Alzheimer's disease (AD) is characterized by severe neuronal loss; however, the mechanisms by which neurons die remain elusive. Necroptosis, a programmed form of necrosis, is executed by the mixed lineage kinase domain-like (MLKL) protein, which is triggered by receptor-interactive protein kinases (RIPK) 1 and 3. We found that necroptosis was activated in postmortem human AD brains, positively correlated with Braak stage, and inversely correlated with brain weight and cognitive scores. In addition, we found that the set of genes regulated by RIPK1 overlapped significantly with multiple independent AD transcriptomic signatures, indicating that RIPK1 activity could explain a substantial portion of transcriptomic changes in AD. Furthermore, we observed that lowering necroptosis activation reduced cell loss in a mouse model of AD. We anticipate that our findings will spur a new area of research in the AD field focused on developing new therapeutic strategies aimed at blocking its activation.	[Caccamo, Antonella; Branca, Caterina; Ferreira, Eric; Belfiore, Ramona; Winslow, Wendy; Oddo, Salvatore] Arizona State Univ, Banner Neurodegenerat Dis Res Ctr, Biodesign Inst, Tempe, AZ 85281 USA; [Piras, Ignazio S.; Huentelman, Matthew J.] Translat Genom Res Inst, Phoenix, AZ USA; [Readhead, Ben; Dudley, Joel T.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Spangenberg, Elizabeth E.; Green, Kim N.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Belfiore, Ramona] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy; [Oddo, Salvatore] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Translational Genomics Research Institute; Icahn School of Medicine at Mount Sinai; University of California System; University of California Irvine; University of Catania; Arizona State University; Arizona State University-Tempe	Oddo, S (corresponding author), Arizona State Univ, Banner Neurodegenerat Dis Res Ctr, Biodesign Inst, Tempe, AZ 85281 USA.; Oddo, S (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ USA.	oddo@asu.edu		Piras, Ignazio/0000-0003-4024-3368	Arizona Alzheimer's Consortium; US National Institutes of Health [R01 AG037637, R01 NS083801, P50 AG016573]; US National Institute of Neurological Disorders and Stroke [U24 NS072026]; National Institute on Aging [P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083801] Funding Source: NIH RePORTER	Arizona Alzheimer's Consortium; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Reiman for discussion and assistance, P. Coleman for kindly providing access to his expressing data set. We thank A. Rodin and A. Tran for contributing to the editing of the manuscript. We thank D. Green for kindly providing the MLKL constructs. We are grateful to the Banner Sun Health Research Institute Brain and Body Donation Program of Sun City, Arizona for providing the human tissue. Data for the RIPK1 causal regulatory gene network were generated from postmortem brain tissue collected through the Mount Sinai VA Medical Center Brain Bank and were provided by E. Schadt. The computational resources and staff expertise provided by the Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai also contributed to this study. This work was supported by grants from the Arizona Alzheimer's Consortium and the US National Institutes of Health (R01 AG037637) to S.O., and R01 NS083801 and P50 AG016573 to K.N.G. The Brain and Body Donation Program is supported by the US National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium), and the Michael J. Fox Foundation for Parkinson's Research.	Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Arevalo-Rodriguez I, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010783.pub2; Bancher C, 1997, J NEURAL TRANSM-SUPP, P141; Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Caccamo A, 2017, MOL PSYCHIATR, V22, P865, DOI 10.1038/mp.2016.139; Caselli RJ, 2006, J CLIN PSYCHIAT, V67, P1784, DOI 10.4088/JCP.v67n1118; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI 10.1529/biophysi.103.038422; Cotman CW, 1996, BRAIN PATHOL, V6, P493, DOI 10.1111/j.1750-3639.1996.tb00878.x; Dickerson BC, 2011, NEUROLOGY, V76, P1395, DOI 10.1212/WNL.0b013e3182166e96; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Giacobini E, 2013, NAT REV NEUROL, V9, P677, DOI 10.1038/nrneurol.2013.223; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Hamosh A, 2000, HUM MUTAT, V15, P57, DOI 10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G; Hanson B, 2016, CANCER BIOL THER, V17, P899, DOI 10.1080/15384047.2016.1210732; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ito Y, 2016, SCIENCE, V353, P603, DOI 10.1126/science.aaf6803; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Khan SS, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00031; Lalaoui N, 2015, SEMIN CELL DEV BIOL, V39, P63, DOI 10.1016/j.semcdb.2015.02.003; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Liu Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.69; Liu-Seifert H, 2015, J ALZHEIMERS DIS, V43, P949, DOI 10.3233/JAD-140792; Millstein J, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-23; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Niikura T, 2006, CURR NEUROPHARMACOL, V4, P139, DOI 10.2174/157015906776359577; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051; Perry G, 1998, SCIENCE, V282, P1268; Popescu BO, 2004, J ALZHEIMERS DIS, V6, P123; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez DA, 2016, CELL DEATH DIFFER, V23, P76, DOI 10.1038/cdd.2015.70; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Snigdha S, 2012, NEUROSCI BULL, V28, P14, DOI 10.1007/s12264-012-1057-5; Stadelmann C, 1998, J NEUROPATH EXP NEUR, V57, P456, DOI 10.1097/00005072-199805000-00009; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Su LJ, 2014, STRUCTURE, V22, P1489, DOI 10.1016/j.str.2014.07.014; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vanden Berghe T, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975093; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Velazquez R, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0118-z; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Zahodne LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073645; Zheng C, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0054-4; Zhu Xiongwei, 2006, Current Alzheimer Research, V3, P393, DOI 10.2174/156720506778249470	74	197	205	8	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2017	20	9					1236	+		10.1038/nn.4608	http://dx.doi.org/10.1038/nn.4608			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FF0JJ	28758999				2022-12-17	WOS:000408587700010
J	Zhang, YJ; Gendron, TF; Grima, JC; Sasaguri, H; Jansen-West, K; Xu, YF; Katzman, RB; Gass, J; Murray, ME; Shinohara, M; Lin, WL; Garrett, A; Stankowski, JN; Daughrity, L; Tong, JM; Perkerson, EA; Yue, M; Chew, J; Castanedes-Casey, M; Kurti, A; Wang, ZZS; Liesinger, AM; Baker, JD; Jiang, J; Lagier-Tourenne, C; Edbauer, D; Cleveland, DW; Rademakers, R; Boylan, KB; Bu, GJ; Link, CD; Dickey, CA; Rothstein, JD; Dickson, DW; Fryer, JD; Petrucelli, L				Zhang, Yong-Jie; Gendron, Tania F.; Grima, Jonathan C.; Sasaguri, Hiroki; Jansen-West, Karen; Xu, Ya-Fei; Katzman, Rebecca B.; Gass, Jennifer; Murray, Melissa E.; Shinohara, Mitsuru; Lin, Wen-Lang; Garrett, Aliesha; Stankowski, Jeannette N.; Daughrity, Lillian; Tong, Jimei; Perkerson, Emilie A.; Yue, Mei; Chew, Jeannie; Castanedes-Casey, Monica; Kurti, Aishe; Wang, Zizhao S.; Liesinger, Amanda M.; Baker, Jeremy D.; Jiang, Jie; Lagier-Tourenne, Clotilde; Edbauer, Dieter; Cleveland, Don W.; Rademakers, Rosa; Boylan, Kevin B.; Bu, Guojun; Link, Christopher D.; Dickey, Chad A.; Rothstein, Jeffrey D.; Dickson, Dennis W.; Fryer, John D.; Petrucelli, Leonard			C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins	NATURE NEUROSCIENCE			English	Article							DIPEPTIDE-REPEAT PROTEINS; HEXANUCLEOTIDE REPEAT; DNA-REPAIR; RNA FOCI; ANTISENSE TRANSCRIPTS; SQSTM1 MUTATIONS; GGGGCC REPEAT; NEURONAL LOSS; MOUSE MODEL; EXPANSION	Neuronal inclusions of poly(GA), a protein unconventionally translated from G(4)C(2) repeat expansions in C9ORF72, are abundant in patients with frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) caused by this mutation. To investigate poly(GA) toxicity, we generated mice that exhibit poly(GA) pathology, neurodegeneration and behavioral abnormalities reminiscent of FTD and ALS. These phenotypes occurred in the absence of TDP-43 pathology and required poly(GA) aggregation. HR23 proteins involved in proteasomal degradation and proteins involved in nucleocytoplasmic transport were sequestered by poly(GA) in these mice. HR23A and HR23B similarly colocalized to poly(GA) inclusions in C9ORF72 expansion carriers. Sequestration was accompanied by an accumulation of ubiquitinated proteins and decreased xeroderma pigmentosum C (XPC) levels in mice, indicative of HR23A and HR23B dysfunction. Restoring HR23B levels attenuated poly(GA) aggregation and rescued poly(GA)-induced toxicity in neuronal cultures. These data demonstrate that sequestration and impairment of nuclear HR23 and nucleocytoplasmic transport proteins is an outcome of, and a contributor to, poly(GA) pathology.	[Zhang, Yong-Jie; Gendron, Tania F.; Sasaguri, Hiroki; Jansen-West, Karen; Xu, Ya-Fei; Katzman, Rebecca B.; Gass, Jennifer; Murray, Melissa E.; Shinohara, Mitsuru; Lin, Wen-Lang; Garrett, Aliesha; Stankowski, Jeannette N.; Daughrity, Lillian; Tong, Jimei; Perkerson, Emilie A.; Yue, Mei; Chew, Jeannie; Castanedes-Casey, Monica; Kurti, Aishe; Wang, Zizhao S.; Liesinger, Amanda M.; Rademakers, Rosa; Bu, Guojun; Dickson, Dennis W.; Fryer, John D.; Petrucelli, Leonard] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Grima, Jonathan C.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA; [Grima, Jonathan C.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Brain Sci Inst, Baltimore, MD 21218 USA; [Grima, Jonathan C.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA; [Chew, Jeannie; Fryer, John D.] Mayo Clin, Coll Med, Mayo Grad Sch, Neurobiol Dis Grad Program, Rochester, MN USA; [Baker, Jeremy D.; Dickey, Chad A.] Univ S Florida, Coll Med, Dept Mol Med, Byrd Alzheimers Inst, Tampa, FL USA; [Jiang, Jie; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst, La Jolla, CA 92093 USA; [Lagier-Tourenne, Clotilde] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Edbauer, Dieter] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Edbauer, Dieter] Univ Munich, Inst Metab Biochem, Munich, Germany; [Edbauer, Dieter] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Boylan, Kevin B.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Link, Christopher D.] Univ Colorado, Inst Behav Genet, Integrat Physiol, Boulder, CO 80309 USA	Mayo Clinic; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Mayo Clinic; State University System of Florida; University of South Florida; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Massachusetts General Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; University of California System; University of California San Diego; Mayo Clinic; University of Colorado System; University of Colorado Boulder	Petrucelli, L (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	petrucelli.leonard@mayo.edu	Edbauer, Dieter/M-9906-2019; Cleveland, Don/AAN-9783-2021; lagier-Tourenne, Clotilde/ABE-6303-2020; Jiang, Jie/AAT-1630-2020; Murray, Melissa E/C-2763-2015	Edbauer, Dieter/0000-0002-7186-4653; lagier-Tourenne, Clotilde/0000-0002-3058-8322; Murray, Melissa E/0000-0001-7379-2545; Cleveland, Don/0000-0002-1934-3682; O'Raw, Aliesha/0000-0002-6618-3036	US National Institutes of Health (NIH) National Institute on Aging [R01AG026251]; NIH National Institute of Neurological Disorders and Stroke [R21NS079807, R21NS089979, F32NS087842, R01NS080882, R01NS085207, U54NS091046, R01NS063964, R01NS077402, R21NS084528, P01NS084974, R01NS088689]; National Institute of Environmental Health Services [R01ES20395]; Department of Defense (ALSRP) [AL130125]; Mayo Clinic Foundation; Mayo Clinic Center for Individualized Medicine; Alzheimer's Association [NIRP-14-304425, NIRP-12-259289]; Amyotrophic Lateral Sclerosis Association; Robert Packard Center for ALS Research at Johns Hopkins; Target ALS; Brain Science Institute; Ludwig Institute for Cancer Research; European Union [617198]; National Science Foundation Graduate Research Fellowship Award; Thomas Shortman Training Fund Graduate Scholarship; Axol Science Scholarship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087227, R01NS063964, R01NS085207, P01NS084974, R21NS084528, R01NS080882, R01NS094239, R01NS093865, R21NS089979, F32NS087842, R21NS079807, R01NS088689, R01NS077402, U54NS091046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026251, P50AG005131] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Institute on Aging; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Environmental Health Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Defense (ALSRP)(United States Department of Defense); Mayo Clinic Foundation; Mayo Clinic Center for Individualized Medicine; Alzheimer's Association(Alzheimer's Association); Amyotrophic Lateral Sclerosis Association; Robert Packard Center for ALS Research at Johns Hopkins; Target ALS; Brain Science Institute; Ludwig Institute for Cancer Research; European Union(European Commission); National Science Foundation Graduate Research Fellowship Award(National Science Foundation (NSF)); Thomas Shortman Training Fund Graduate Scholarship; Axol Science Scholarship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to all patients who agreed to donate post-mortem tissue. This work was supported by the US National Institutes of Health (NIH) National Institute on Aging (R01AG026251 (L.P.)); NIH National Institute of Neurological Disorders and Stroke (R21NS079807 (Y.-J.Z. and J.D.F.); R21NS089979 (T.F.G. and K.B.B.); F32NS087842 (J.J.); R01NS080882 (R.R.); R01NS085207 (J.D.R.); U54NS091046 (J.D.R.); R01NS063964 (L.P.); R01NS077402 (L.P.), R21NS084528 (L.P.); P01NS084974 (L.P., D.D., K.B.B. and R.R.); R01NS088689 (L.P.)); National Institute of Environmental Health Services (R01ES20395 (L.P.); Department of Defense (ALSRP AL130125 (L.P.)); Mayo Clinic Foundation (L.P.); Mayo Clinic Center for Individualized Medicine (L.P. and K.B.B.); Alzheimer's Association (NIRP-14-304425 (Y.-J.Z.); NIRP-12-259289 (J.D.F.)); Amyotrophic Lateral Sclerosis Association (Y.-J.Z., T.F.G., K.B.B., D.W.C. and L.P.); Robert Packard Center for ALS Research at Johns Hopkins (J.D.R. and L.P.), Target ALS (C.L.-T., J.D.R. and L.P.); Brain Science Institute (J.D.R.); the Ludwig Institute for Cancer Research (D.W.C. and C.L.T.), and the European Union's Seventh Framework Programme (FP7/2014-2019 grant 617198 (D.E.)). J.C.G. is the recipient of a National Science Foundation Graduate Research Fellowship Award, a Thomas Shortman Training Fund Graduate Scholarship and an Axol Science Scholarship.	Antonin W, 2005, MOL CELL, V17, P83, DOI 10.1016/j.molcel.2004.12.010; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Belzil VV, 2013, ACTA NEUROPATHOL, V126, P895, DOI 10.1007/s00401-013-1199-1; Bergink S, 2006, NEUROBIOL DIS, V23, P708, DOI 10.1016/j.nbd.2006.06.005; Chakrabarty P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067680; Chew J, 2015, SCIENCE, V348, P1151, DOI 10.1126/science.aaa9344; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Cook C, 2014, NEUROBIOL AGING, V35, P1769, DOI 10.1016/j.neurobiolaging.2013.12.023; Cooper-Knock J, 2014, BRAIN, V137, P2040, DOI 10.1093/brain/awu120; Dantuma NP, 2009, DNA REPAIR, V8, P449, DOI 10.1016/j.dnarep.2009.01.005; Davidson Y, 2016, NEUROPATH APPL NEURO, V42, P242, DOI 10.1111/nan.12292; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Dougan L, 2009, P NATL ACAD SCI USA, V106, P12605, DOI 10.1073/pnas.0900678106; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Gendron TF, 2015, ACTA NEUROPATHOL, V130, P559, DOI 10.1007/s00401-015-1474-4; Gendron TF, 2014, ACTA NEUROPATHOL, V127, P359, DOI 10.1007/s00401-013-1237-z; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Jovicic A, 2015, NAT NEUROSCI, V18, P1226, DOI 10.1038/nn.4085; Kim JY, 2013, EUR J NEUROSCI, V37, P1203, DOI 10.1111/ejn.12126; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Le Ber I, 2013, JAMA NEUROL, V70, P1403, DOI 10.1001/jamaneurol.2013.3849; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Lin WL, 2011, J NEUROPATH EXP NEUR, V70, P779, DOI 10.1097/NEN.0b013e31822ac9c9; Liu EY, 2014, ACTA NEUROPATHOL, V128, P525, DOI 10.1007/s00401-014-1286-y; Mackenzie IRA, 2015, ACTA NEUROPATHOL, V130, P845, DOI 10.1007/s00401-015-1476-2; May S, 2014, ACTA NEUROPATHOL, V128, P485, DOI 10.1007/s00401-014-1329-4; Melis JPM, 2011, MUTAT RES-REV MUTAT, V728, P107, DOI 10.1016/j.mrrev.2011.07.001; Mitchell JM, 2010, J CELL BIOL, V191, P505, DOI 10.1083/jcb.201007098; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Mocanu MM, 2008, J NEUROSCI, V28, P737, DOI 10.1523/JNEUROSCI.2824-07.2008; Mori K, 2013, ACTA NEUROPATHOL, V126, P881, DOI 10.1007/s00401-013-1189-3; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Murray ME, 2012, J NEUROPATH EXP NEUR, V71, P1113, DOI 10.1097/NEN.0b013e318277387e; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Ng JMY, 2002, MOL CELL BIOL, V22, P1233, DOI 10.1128/MCB.22.4.1233-1245.2002; Pelassa I, 2014, HUM MOL GENET, V23, P3402, DOI 10.1093/hmg/ddu049; Popiel HA, 2004, BIOCHEM BIOPH RES CO, V317, P1200, DOI 10.1016/j.bbrc.2004.03.161; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Schludi MH, 2015, ACTA NEUROPATHOL, V130, P537, DOI 10.1007/s00401-015-1450-z; Shinohara M, 2013, ACTA NEUROPATHOL, V125, P535, DOI 10.1007/s00401-013-1086-9; Tao ZT, 2015, HUM MOL GENET, V24, P2426, DOI 10.1093/hmg/ddv005; Todd TW, 2013, MOL CELLS, V36, P185, DOI 10.1007/s10059-013-0167-x; van Blitterswijk M, 2015, ACTA NEUROPATHOL, V130, P863, DOI 10.1007/s00401-015-1480-6; Wen XM, 2014, NEURON, V84, P1213, DOI 10.1016/j.neuron.2014.12.010; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Xi ZR, 2013, AM J HUM GENET, V92, P981, DOI 10.1016/j.ajhg.2013.04.017; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yamakawa M, 2015, HUM MOL GENET, V24, P1630, DOI 10.1093/hmg/ddu576; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zhang Y, 2009, CURR GENOMICS, V10, P250, DOI 10.2174/138920209788488544; Zhang YJ, 2014, ACTA NEUROPATHOL, V128, P505, DOI 10.1007/s00401-014-1336-5; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	57	197	199	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2016	19	5					668	+		10.1038/nn.4272	http://dx.doi.org/10.1038/nn.4272			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK2RM	26998601	Green Accepted			2022-12-17	WOS:000374762100006
J	Sapolsky, RM				Sapolsky, Robert M.			Stress and the brain: individual variability and the inverted-U	NATURE NEUROSCIENCE			English	Article							MECHANISMS; GLUCOCORTICOIDS	It is a truism that the brain influences the body and that peripheral physiology influences the brain. Never is this clearer than during stress, where the subtlest emotions or the most abstract thoughts can initiate stress responses, with consequences throughout the body, and the endocrine transducers of stress alter cognition, affect and behavior. For a fervent materialist, few things in life bring more pleasure than contemplating the neurobiology of stress.	[Sapolsky, Robert M.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Sapolsky, Robert M.] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA; [Sapolsky, Robert M.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Sapolsky, RM (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	sapolsky@stanford.edu						Arnsten AFT, 2015, NAT NEUROSCI, V18, P1376, DOI 10.1038/nn.4087; Baldi Elisabetta, 2005, Nonlinearity in Biology Toxicology and Medicine, V3, P9, DOI 10.2201/nonlin.003.01.002; Calhoon GG, 2015, NAT NEUROSCI, V18, P1394, DOI 10.1038/nn.4101; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chattarji S, 2015, NAT NEUROSCI, V18, P1364, DOI 10.1038/nn.4115; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; DIAMOND DM, 1992, HIPPOCAMPUS, V2, P421, DOI 10.1002/hipo.450020409; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Hariri AR, 2015, NAT NEUROSCI, V18, P1347, DOI 10.1038/nn.4111; Hodes GE, 2015, NAT NEUROSCI, V18, P1386, DOI 10.1038/nn.4113; Hollon NG, 2015, NAT NEUROSCI, V18, P1405, DOI 10.1038/nn.4114; Luksys G, 2011, CURR OPIN NEUROBIOL, V21, P502, DOI 10.1016/j.conb.2011.03.003; McEwen BS, 2015, NAT NEUROSCI, V18, P1353, DOI 10.1038/nn.4086; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; Prager EM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.286re5; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sorrells SF, 2009, NEURON, V64, P33, DOI 10.1016/j.neuron.2009.09.032; Tost H, 2015, NAT NEUROSCI, V18, P1421, DOI 10.1038/nn.4108	20	197	203	7	145	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2015	18	10					1344	1346		10.1038/nn.4109	http://dx.doi.org/10.1038/nn.4109			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CS2OK	26404708				2022-12-17	WOS:000361910600002
J	Chang, SWC; Gariepy, JF; Platt, ML				Chang, Steve W. C.; Gariepy, Jean-Francois; Platt, Michael L.			Neuronal reference frames for social decisions in primate frontal cortex	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; MEDIAL PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; VENTRAL STRIATUM; NEURAL BASIS; CHARITABLE DONATION; VALUE COMPUTATIONS; REWARD; COGNITION; BEHAVIOR	Social decisions are crucial for the success of individuals and the groups that they comprise. Group members respond vicariously to benefits obtained by others, and impairments in this capacity contribute to neuropsychiatric disorders such as autism and sociopathy. We examined the manner in which neurons in three frontal cortical areas encoded the outcomes of social decisions as monkeys performed a reward-allocation task. Neurons in the orbitofrontal cortex (OFC) predominantly encoded rewards that were delivered to oneself. Neurons in the anterior cingulate gyrus (ACCg) encoded reward allocations to the other monkey, to oneself or to both. Neurons in the anterior cingulate sulcus (ACCs) signaled reward allocations to the other monkey or to no one. In this network of received (OFC) and foregone (ACCs) reward signaling, ACCg emerged as an important nexus for the computation of shared experience and social reward. Individual and species-specific variations in social decision-making might result from the relative activation and influence of these areas.	[Chang, Steve W. C.; Platt, Michael L.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27708 USA; [Chang, Steve W. C.; Gariepy, Jean-Francois; Platt, Michael L.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Platt, Michael L.] Duke Univ, Dept Psychol & Neurosci, Duke Inst Brain Sci, Durham, NC USA; [Platt, Michael L.] Duke Univ, Dept Evolutionary Anthropol, Duke Inst Brain Sci, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Chang, SWC (corresponding author), Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27708 USA.	steve.chang@duke.edu		Chang, Steve Wohn Chul/0000-0003-4160-7549	T32 Postdoctoral Training Grant on Fundamental and Translational Neuroscience [2T32NS051156-06]; Ruth K. Broad Biomedical Foundation Postdoctoral Grant; Canadian Institutes of Health Research Doctoral research award [84765]; National Institute of Mental Health [MH095894]; Department of Defense [W81XVVH-11-1-0584]; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH099093, R01MH086712, R01MH095894, R00MH099093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS051156] Funding Source: NIH RePORTER	T32 Postdoctoral Training Grant on Fundamental and Translational Neuroscience; Ruth K. Broad Biomedical Foundation Postdoctoral Grant; Canadian Institutes of Health Research Doctoral research award(Canadian Institutes of Health Research (CIHR)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J.M. Groh, J.M. Pearson, D.L. Barack, R.B. Ebitz, E.S. Bromberg-Martin, K.K. Watson and B.Y. Hayden for helpful discussions. We are very grateful to S.P. Wise and C. Padoa-Schioppa for insightful discussions and comments on earlier versions of the manuscript. We also thank M.L. Carlson for general technical assistance. This work was supported by a T32 Postdoctoral Training Grant on Fundamental and Translational Neuroscience (S.W.C.C., 2T32NS051156-06), a Ruth K. Broad Biomedical Foundation Postdoctoral Grant (S.W.C.C.), a Canadian Institutes of Health Research Doctoral research award (J.-F.G., 84765), the National Institute of Mental Health (M.L.P. and S.W.C.C., MH095894) and the Department of Defense (M.L.P. and S.W.C.C., W81XVVH-11-1-0584).	Abe H, 2011, NEURON, V70, P731, DOI 10.1016/j.neuron.2011.03.026; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Azzi JCB, 2012, P NATL ACAD SCI USA, V109, P2126, DOI 10.1073/pnas.1111715109; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Behrens TEJ, 2009, SCIENCE, V324, P1160, DOI 10.1126/science.1169694; BERGER SM, 1962, PSYCHOL REV, V69, P450, DOI 10.1037/h0046466; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; Burke CJ, 2010, P NATL ACAD SCI USA, V107, P14431, DOI 10.1073/pnas.1003111107; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Chang SWC, 2012, P NATL ACAD SCI USA, V109, P959, DOI 10.1073/pnas.1114621109; Chang SWC, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00027; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hampton AN, 2008, P NATL ACAD SCI USA, V105, P6741, DOI 10.1073/pnas.0711099105; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Hare TA, 2010, J NEUROSCI, V30, P583, DOI 10.1523/JNEUROSCI.4089-09.2010; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Izuma K, 2010, J COGNITIVE NEUROSCI, V22, P621, DOI 10.1162/jocn.2009.21228; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kuss K, 2013, SOC COGN AFFECT NEUR, V8, P216, DOI 10.1093/scan/nsr088; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Mobbs D, 2009, SCIENCE, V324, P900, DOI 10.1126/science.1170539; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Paxinos G., 2000, RHESUS MONKEY BRAIN; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Santos GS, 2012, SOC NEUROSCI-UK, V7, P42, DOI 10.1080/17470919.2011.578465; Sato M, 2002, J NEUROSCI, V22, P2363, DOI 10.1523/JNEUROSCI.22-06-02363.2002; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seo H, 2008, PHILOS T R SOC B, V363, P3845, DOI 10.1098/rstb.2008.0158; Shidara M, 1998, J NEUROSCI, V18, P2613; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Sohn J, 2006, NEURAL NETWORKS, V19, P1181, DOI 10.1016/j.neunet.2006.04.005; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tsujimoto S, 2009, J NEUROSCI, V29, P2569, DOI 10.1523/JNEUROSCI.5777-08.2009; Waytz A, 2012, J NEUROSCI, V32, P7646, DOI 10.1523/JNEUROSCI.6193-11.2012; Yoshida K, 2011, CURR BIOL, V21, P249, DOI 10.1016/j.cub.2011.01.004	50	197	199	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					243	250		10.1038/nn.3287	http://dx.doi.org/10.1038/nn.3287			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	080RE	23263442	Green Accepted			2022-12-17	WOS:000314260200022
J	Paterlini, M; Zakharenko, SS; Lai, WS; Qin, J; Zhang, H; Mukai, J; Westphal, KGC; Olivier, B; Sulzer, D; Pavlidis, P; Siegelbaum, SA; Karayiorgou, M; Gogos, JA				Paterlini, M; Zakharenko, SS; Lai, WS; Qin, J; Zhang, H; Mukai, J; Westphal, KGC; Olivier, B; Sulzer, D; Pavlidis, P; Siegelbaum, SA; Karayiorgou, M; Gogos, JA			Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice	NATURE NEUROSCIENCE			English	Article							GENETIC-VARIATION; NEUROBIOLOGICAL BASIS; DOPAMINE-RECEPTOR; LEARNING-DEFICITS; WORKING-MEMORY; PROLINE; PHENCYCLIDINE; EXPRESSION; GLUTAMATE; ASSOCIATION	Microdeletions of 22q11.2 represent one of the highest known genetic risk factors for schizophrenia. It is likely that more than one gene contributes to the marked risk associated with this locus. Two of the candidate risk genes encode the enzymes proline dehydrogenase (PRODH) and catechol-O-methyltransferase (COMT), which modulate the levels of a putative neuromodulator (L-proline) and the neurotransmitter dopamine, respectively. Mice that model the state of PRODH deficiency observed in humans with schizophrenia show increased neurotransmitter release at glutamatergic synapses as well as deficits in associative learning and response to psychomimetic drugs. Transcriptional profiling and pharmacological manipulations identified a transcriptional and behavioral interaction between the Prodh and Comt genes that is likely to represent a homeostatic response to enhanced dopaminergic signaling in the frontal cortex. This interaction modulates a number of schizophrenia-related phenotypes, providing a framework for understanding the high disease risk associated with this locus, the expression of the phenotype, or both.	Rockefeller Univ, Human Neurogenet Lab, New York, NY 10021 USA; Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Genome Ctr, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Biomed Informat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Univ Utrecht, Dept Pharmacol, NL-3584 CA Utrecht, Netherlands; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Dept Pharmacol, New York, NY 10032 USA	Rockefeller University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Utrecht University; Columbia University; Howard Hughes Medical Institute; Columbia University	Karayiorgou, M (corresponding author), Rockefeller Univ, Human Neurogenet Lab, 1230 York Ave, New York, NY 10021 USA.	karayim@rockefeller.edu; jag90@columbia.edu	Olivier, Berend/AAX-4412-2021; Zakharenko, Stanislav/D-3287-2013; Pavlidis, Paul/H-8406-2013	Zakharenko, Stanislav/0000-0001-8115-202X; Pavlidis, Paul/0000-0002-0426-5028; Mukai, Jun/0000-0003-2065-4784; Lai, Wen-Sung/0000-0001-6918-5531	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007418, R29DA007418, R55DA007418] Funding Source: NIH RePORTER; NIDA NIH HHS [DA07418] Funding Source: Medline; NIMH NIH HHS [MH67068] Funding Source: Medline; Telethon [GFP02011] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Telethon(Fondazione Telethon)		Anholt RRH, 2003, NAT GENET, V35, P180, DOI 10.1038/ng1240; Balla A, 2003, NEUROPSYCHOPHARMACOL, V28, P34, DOI 10.1038/sj.npp.1300019; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Bender HU, 2005, AM J HUM GENET, V76, P409, DOI 10.1086/428142; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Castner SA, 2004, PSYCHOPHARMACOLOGY, V174, P111, DOI 10.1007/s00213-003-1710-9; Cohen SM, 1997, DEV BRAIN RES, V100, P230, DOI 10.1016/S0165-3806(97)00045-X; Cohen SM, 1997, BRAIN RES, V761, P271, DOI 10.1016/S0006-8993(97)00352-1; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Gogos JA, 1999, NAT GENET, V21, P434, DOI 10.1038/7777; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Healy DJ, 1996, BRAIN RES, V708, P38, DOI 10.1016/0006-8993(95)01241-9; HENZI V, 1992, MOL PHARMACOL, V41, P793; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jacquet H, 2002, HUM MOL GENET, V11, P2243, DOI 10.1093/hmg/11.19.2243; Jacquet H, 2005, MOL PSYCHIATR, V10, P479, DOI 10.1038/sj.mp.4001597; Jentsch JD, 1997, NEUROPSYCHOPHARMACOL, V17, P92, DOI 10.1016/S0893-133X(97)00034-1; KAAKKOLA S, 1994, GEN PHARMACOL-VASC S, V25, P813, DOI 10.1016/0306-3623(94)90082-5; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Laruelle M, 2000, BRAIN RES REV, V31, P371, DOI 10.1016/S0165-0173(99)00054-5; Latysheva NV, 2003, PROG NEURO-PSYCHOPH, V27, P787, DOI 10.1016/S0278-5846(03)00110-6; Li T, 2004, AM J MED GENET B, V129B, P13, DOI 10.1002/ajmg.b.30049; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; Matsumoto M, 2003, NEUROSCIENCE, V116, P127, DOI 10.1016/S0306-4522(02)00556-0; Maynard TM, 2003, P NATL ACAD SCI USA, V100, P14433, DOI 10.1073/pnas.2235651100; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; O'Donnell J, 2003, SYNAPSE, V50, P171, DOI 10.1002/syn.10258; Pavlidis Paul, 2002, Pac Symp Biocomput, P474; Paxinos G., 1997, MOUSE BRAIN STEREOTA; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Renick SE, 1999, J NEUROSCI, V19, P21, DOI 10.1523/JNEUROSCI.19-01-00021.1999; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Stefani MR, 2002, BEHAV BRAIN RES, V134, P267, DOI 10.1016/S0166-4328(02)00040-2; Szeszko PR, 1999, BIOL PSYCHIAT, V45, P680, DOI 10.1016/S0006-3223(98)00258-3; VEZINA P, 1991, EUR J NEUROSCI, V3, P1001, DOI 10.1111/j.1460-9568.1991.tb00036.x; Yui K, 1999, MOL PSYCHIATR, V4, P512, DOI 10.1038/sj.mp.4000575; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9	45	197	206	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1586	1594		10.1038/nn1562	http://dx.doi.org/10.1038/nn1562			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16234811				2022-12-17	WOS:000232966600034
J	Anton, ES; Ghashghaei, HT; Weber, JL; McCann, C; Fischer, TM; Cheung, ID; Gassmann, M; Messing, A; Klein, R; Schwab, MH; Lloyd, KCK; Lai, C				Anton, ES; Ghashghaei, HT; Weber, JL; McCann, C; Fischer, TM; Cheung, ID; Gassmann, M; Messing, A; Klein, R; Schwab, MH; Lloyd, KCK; Lai, C			Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain	NATURE NEUROSCIENCE			English	Article							RADIAL GLIA; NEURONAL PRECURSORS; CHAIN-MIGRATION; CELL-MIGRATION; MICE LACKING; STEM-CELLS; NEUREGULIN; PROLIFERATION; EXPRESSION; BRAIN	Neural progenitor proliferation, differentiation and migration are continually active in the rostral migratory stream of the adult brain. Here, we show that the receptor tyrosine kinase ErbB4 is expressed prominently by the neuroblasts present in the subventricular zone and the rostral migratory stream. The neuregulins (NRG1-NRG3), which have been identified as ErbB4 ligands, are detected either in the stream or in adjacent regions. Mice deficient in ErbB4 expressed under the control of either the nestin or the hGFAP promoter have altered neuroblast chain organization and migration and deficits in the placement and differentiation of olfactory interneurons. These findings suggest that ErbB4 activation helps to regulate the organization of neural chains that form the rostral migratory stream and influences the differentiation of olfactory interneuronal precursors.	Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; Univ Basel, Biozentrum Pharmazentrum, Dept Physiol, CH-4056 Basel, Switzerland; Univ Wisconsin, Waisman Ctr Mental Retardat & Human Dev, Madison, WI 53705 USA; Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; Max Planck Inst Expt Med, D-37075 Gottingen, Germany; Univ Calif Davis, Sch Vet Med, Ctr Comparat Med, Davis, CA 95616 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Scripps Research Institute; University of Basel; University of Wisconsin System; University of Wisconsin Madison; Max Planck Society; Max Planck Society; University of California System; University of California Davis	Anton, ES (corresponding author), Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA.	anton@med.unc.edu	Klein, Ruediger/C-6147-2008	Klein, Ruediger/0000-0002-3109-0163; Gassmann, Martin/0000-0001-6201-3032	NIMH NIH HHS [F32 MH071013-01A1, F32 MH071013-02, F32 MH071013] Funding Source: Medline; NINDS NIH HHS [P30NS045892, NS39411] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH071013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039411, P30NS045892] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Anderson MF, 2002, DEV BRAIN RES, V134, P115; Anton ES, 1997, DEVELOPMENT, V124, P3501; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Chazal G, 2000, J NEUROSCI, V20, P1446; Chiu K, 1996, DEV BRAIN RES, V95, P28, DOI 10.1016/0165-3806(96)00055-7; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Emsley JG, 2003, EXP NEUROL, V183, P273, DOI 10.1016/S0014-4886(03)00209-7; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Golub MS, 2004, BEHAV BRAIN RES, V153, P159, DOI 10.1016/j.bbr.2003.11.010; Gongidi V, 2004, NEURON, V41, P57, DOI 10.1016/S0896-6273(03)00818-3; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Gregg C. T., 2001, S SOC EXP BIOL, V53, P1; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7; Jacques TS, 1998, DEVELOPMENT, V125, P3167; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Mason HA, 2001, J NEUROSCI, V21, P7654, DOI 10.1523/JNEUROSCI.21-19-07654.2001; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Murase S, 2002, J NEUROSCI, V22, P3568; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tropepe V, 1997, J NEUROSCI, V17, P7850; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; YEE KT, 2001, ABSTR SOC NEUR; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	49	197	205	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1319	1328		10.1038/nn1345	http://dx.doi.org/10.1038/nn1345			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15543145				2022-12-17	WOS:000225353900012
J	Song, MR; Ghosh, A				Song, MR; Ghosh, A			FGF2-induced chromatin remodeling regulates CNTF-mediated gene expression and astrocyte differentiation	NATURE NEUROSCIENCE			English	Article							RAT CEREBRAL-CORTEX; HISTONE H3 METHYLATION; CENTRAL-NERVOUS-SYSTEM; RNA-POLYMERASE-II; STEM-CELLS; RECOMBINANT RETROVIRUS; DEVELOPMENTAL-CHANGES; X-INACTIVATION; METHYLTRANSFERASE; TRANSCRIPTION	The generation of distinct cell types during development depends on the competence of progenitor populations to differentiate along specific lineages. Here we investigate the mechanisms that regulate competence of rodent cortical progenitors to differentiate into astrocytes in response to ciliary neurotrophic factor (CNTF). We found that fibroblast growth factor 2 (FGF2), which by itself does not induce astrocyte-specific gene expression, regulates the ability of CNTF to induce expression of glial fibrillary acidic protein (GFAP). FGF2 facilitates access of the STAT/CBP (signal transducer and activator of transcription/CRE binding protein) complex to the GFAP promoter by inducing Lys4 methylation and suppressing Lys9 methylation of histone H3 at the STAT binding site. Histone methylation at this site is specific to the cell's state of differentiation. In progenitors, the promoter is bound by Lys9-methylated histones, and in astrocytes, it is bound by Lys4-methylated histones, indicating that astrocyte differentiation in vivo involves this switch in chromatin state. Our observations indicate that extracellular signals can regulate access of transcription factors to genomic promoters by local chromatin modification, and thereby regulate developmental competence.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Ghosh, A (corresponding author), Univ Calif San Diego, Div Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	aghosh@ucsd.edu			NIAID NIH HHS [1P30AI42855] Funding Source: Medline; NINDS NIH HHS [NS36176] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036176] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kahn MA, 1997, J NEUROCHEM, V68, P1413; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Molne M, 2000, J NEUROSCI RES, V59, P301, DOI 10.1002/(SICI)1097-4547(20000201)59:3<301::AID-JNR3>3.0.CO;2-H; Morrow T, 2001, DEVELOPMENT, V128, P3585; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(01)00269-0; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; PRICE J, 1988, DEVELOPMENT, V104, P473; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Viti J, 2003, J NEUROSCI, V23, P3385; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200	39	197	204	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					229	235		10.1038/nn1192	http://dx.doi.org/10.1038/nn1192			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14770186				2022-12-17	WOS:000189197900012
J	Ramnani, N; Miall, RC				Ramnani, N; Miall, RC			A system in the human brain for predicting the actions of others	NATURE NEUROSCIENCE			English	Article							PREMOTOR CORTEX; CORTICAL MECHANISMS; PREFRONTAL CORTEX; BIOLOGICAL MOTION; NEURONAL-ACTIVITY; RHESUS-MONKEY; MIND; AREAS; PERCEPTION; MOVEMENT	The ability to attribute mental states to others, and therefore to predict others' behavior, is particularly advanced in humans. A controversial but untested idea is that this is achieved by simulating the other person's mental processes in one's own mind. If this is the case, then the same neural systems activated by a mental function should re-activate when one thinks about that function performed by another. Here, using functional magnetic resonance imaging (fMRI), we tested whether the neural processes involved in preparing one's own actions are also used for predicting the future actions of others. We provide compelling evidence that areas within the action control system of the human brain are indeed activated when predicting others' actions, but a different action sub-system is activated when preparing one's own actions.	Univ Oxford, John Radcliffe Hosp, Ctr FMRI Brain, Oxford OX3 9DU, England; Univ Oxford, Physiol Lab, Oxford OX1 3TP, England	University of Oxford; University of Oxford	Ramnani, N (corresponding author), Univ Oxford, John Radcliffe Hosp, Ctr FMRI Brain, Headley Way, Oxford OX3 9DU, England.		Miall, R. Chris/B-7449-2013	Miall, R. Chris/0000-0003-3002-1251; Ramnani, Narender/0000-0003-0425-203X				Abell F, 1999, NEUROREPORT, V10, P1647, DOI 10.1097/00001756-199906030-00005; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Barbas H, 1999, J COMP NEUROL, V410, P343, DOI 10.1002/(SICI)1096-9861(19990802)410:3<343::AID-CNE1>3.0.CO;2-1; BARBAS H, 1987, J COMP NEUROL, V256, P211, DOI 10.1002/cne.902560203; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; CARRUTHERS P, 1996, THEORIES THEORIES MI; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; CHEN CT, 1991, J CHEM ENG JPN, V24, P284, DOI 10.1252/jcej.24.284; Davies M., 1995, FOLK PSYCHOL THEORY; Davies M., 1995, FOLK PSYCHOL; Dennett D., 1987, INTENTIONAL STANCE; Duvernoy H. M., 1999, HUMAN BRAIN SURFACE; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GEFFEN GM, 1994, BEHAV BRAIN RES, V64, P131, DOI 10.1016/0166-4328(94)90125-2; Gerloff C, 1998, J PHYSIOL-LONDON, V510, P249, DOI 10.1111/j.1469-7793.1998.249bz.x; Grafton ST, 1998, J NEUROPHYSIOL, V79, P1092, DOI 10.1152/jn.1998.79.2.1092; Grezes J, 2001, NEUROIMAGE, V13, P775, DOI 10.1006/nimg.2000.0740; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Happe F, 1996, NEUROREPORT, V8, P197, DOI 10.1097/00001756-199612200-00040; Hoshi E, 2002, J NEUROPHYSIOL, V87, P1123, DOI 10.1152/jn.00496.2001; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; LU T, 1994, J COMP NEUROL, V341, P375; Luppino G, 2001, EUR J NEUROSCI, V14, P1035, DOI 10.1046/j.0953-816x.2001.01734.x; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Miall RC, 2003, NEUROREPORT, V14, P2135, DOI 10.1097/00001756-200312020-00001; MITZ AR, 1991, J NEUROSCI, V11, P1855; Passingham R., 1995, FRONTAL LOBES VOLUNT; Passingham RE, 1996, PHILOS T ROY SOC B, V351, P1473, DOI 10.1098/rstb.1996.0132; PASSINGHAM RE, 1986, BEHAV NEUROSCI, V100, P695, DOI 10.1037/0735-7044.100.5.695; PETRIDES M, 1985, BEHAV BRAIN RES, V16, P95, DOI 10.1016/0166-4328(85)90085-3; Petrides M, 1999, EUR J NEUROSCI, V11, P1011, DOI 10.1046/j.1460-9568.1999.00518.x; Ramnani N, 2003, CEREB CORTEX, V13, P318, DOI 10.1093/cercor/13.3.318; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Schmahmann J.D., 2000, MRI ATLAS HUMAN CERE; Stich S., 1992, MIND LANG, V7, P35, DOI [DOI 10.1111/J.1468-0017.1992.TB00196, DOI 10.1111/J.1468-0017.1992.TB00196.X]; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Wise SP, 1996, CAN J PHYSIOL PHARM, V74, P469, DOI 10.1139/cjpp-74-4-469	50	197	199	0	20	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					85	90		10.1038/nn1168	http://dx.doi.org/10.1038/nn1168			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699420				2022-12-17	WOS:000187636000018
J	Walters, RJ; Hadley, SH; Morris, KDW; Amin, J				Walters, RJ; Hadley, SH; Morris, KDW; Amin, J			Benzodiazepines act an GABA(A) receptors via two distinct and separable mechanisms	NATURE NEUROSCIENCE			English	Article							AMINOBUTYRIC ACID(A) RECEPTORS; SINGLE AMINO-ACID; CONFERS BARBITURATE SENSITIVITY; A-RECEPTOR; BINDING-SITE; ALPHA-SUBUNIT; C-RECEPTOR; XENOPUS OOCYTES; MODULATION; AGONIST	Benzodiazepines (BZs) act on gamma -aminobutyric acid type A (GABA(A)) receptors such as alpha (1)beta (2)gamma (2) through key residues within the N-terminal region of a subunits, to render their sedative and anxiolytic actions. However, the molecular mechanisms underlying the BZs' other clinical actions are not known. Here we show that, with low concentrations of GABA, diazepam produces a biphasic potentiation for the alpha (1)beta (2)gamma (2)-receptor channel, with distinct components in the nanomolar and micromolar concentration ranges. Mutations at equivalent residues within the second transmembrane domains (TM2) of alpha, beta and gamma subunits, proven important for the action of other anesthetics, abolish the micromolar, but not the nanomolar component. Converse mutation of the corresponding TM2 residue and a TM3 residue within rho (1) subunits confers diazepam sensitivity on homo-oligomeric rho (1)-receptor channels that are otherwise insensitive to BZs. Thus, specific and distinct residues contribute to a previously unresolved component (micromolar) of diazepam action, indicating that diazepam can modulate the GABA(A)-receptor channel through two separable mechanisms.	Univ S Florida, Dept Pharmacol & Therapeut Physiol & Biophys, Tampa, FL 33612 USA; Univ S Florida, Inst Biomol Sci, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Amin, J (corresponding author), Univ S Florida, Dept Pharmacol & Therapeut Physiol & Biophys, Tampa, FL 33612 USA.	jamin@hsc.usf.edu	Amin, Jahanshah/I-7174-2012		NEI NIH HHS [EY11531] Funding Source: Medline; NATIONAL EYE INSTITUTE [R29EY011531] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amin J, 1999, MOL PHARMACOL, V55, P411; Amin J, 1997, MOL PHARMACOL, V51, P833, DOI 10.1124/mol.51.5.833; Barnard EA, 1998, PHARMACOL REV, V50, P291; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Belelli D, 1999, BRIT J PHARMACOL, V127, P601, DOI 10.1038/sj.bjp.0702611; BOND AJ, 1977, BRIT J CLIN PHARMACO, V4, P51, DOI 10.1111/j.1365-2125.1977.tb00666.x; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Buhr A, 1997, MOL PHARMACOL, V52, P676, DOI 10.1124/mol.52.4.676; CASALOTTI SO, 1986, J BIOL CHEM, V261, P5013; DENG L, 1986, BIOCHEM BIOPH RES CO, V138, P1308, DOI 10.1016/S0006-291X(86)80425-9; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; Duncalfe LL, 1996, J BIOL CHEM, V271, P9209, DOI 10.1074/jbc.271.16.9209; Dunn SMJ, 1999, MOL PHARMACOL, V56, P768; Francis WL, 1998, LEGIS STUD QUART, V23, P1; GARATTINI A, 1973, BENZODIAZEPINES, P75; GREENBLATT DJ, 1983, BRIT J ANAESTH, V55, P985, DOI 10.1093/bja/55.10.985; HUNKELER W, 1981, NATURE, V290, P514, DOI 10.1038/290514a0; Lavoie AM, 1996, NEUROPHARMACOLOGY, V35, P1383, DOI 10.1016/S0028-3908(96)00077-9; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; McKernan RM, 1998, MOL PHARMACOL, V54, P33, DOI 10.1124/mol.54.1.33; MELLOR JR, 1996, J PHYSIOL-LONDON, V503, P359; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; MOHLER H, 1984, EUR J PHARMACOL, V102, P191, DOI 10.1016/0014-2999(84)90358-3; Morris KDW, 1999, MOL PHARMACOL, V56, P752; Olsen RW, 1998, TOXICOL LETT, V101, P193, DOI 10.1016/S0378-4274(98)00185-4; PRITCHETT DB, 1991, P NATL ACAD SCI USA, V88, P1421, DOI 10.1073/pnas.88.4.1421; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; REVES J.G., 2000, ANESTHESIA, P228; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; SHIMADA S, 1992, MOL PHARMACOL, V41, P683; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; SMART TG, 1991, BRIT J PHARMACOL, V103, P1837, DOI 10.1111/j.1476-5381.1991.tb12337.x; STEPHENSON FA, 1990, J BIOL CHEM, V265, P21160; TOSSMAN U, 1986, ACTA PHYSIOL SCAND, V127, P533, DOI 10.1111/j.1748-1716.1986.tb07938.x; TWYMAN RE, 1990, J PHYSIOL-LONDON, V423, P193, DOI 10.1113/jphysiol.1990.sp018018; Ueno S, 1999, BRIT J PHARMACOL, V127, P377, DOI 10.1038/sj.bjp.0702563; Wall MJ, 1998, NAT NEUROSCI, V1, P675, DOI 10.1038/3677; Whitesides J. F., 1995, Equine Athlete, V8, P9; WIELAND HA, 1992, J BIOL CHEM, V267, P1426; WINGROVE PB, 1994, P NATL ACAD SCI USA, V91, P4569, DOI 10.1073/pnas.91.10.4569; Wingrove PB, 1997, MOL PHARMACOL, V52, P874, DOI 10.1124/mol.52.5.874; Wisden W, 1999, NATURE, V401, P751, DOI 10.1038/44482	45	197	199	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1274	1281		10.1038/81800	http://dx.doi.org/10.1038/81800			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100148	Bronze			2022-12-17	WOS:000167177900013
J	Choi, S; Klingauf, J; Tsien, RW				Choi, S; Klingauf, J; Tsien, RW			Postfusional regulation of cleft glutamate concentration during LTP at 'silent synapses'	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; SYNAPTICALLY RELEASED GLUTAMATE; METHYL-D-ASPARTATE; TRANSPORTER CURRENTS; TRANSMITTER RELEASE; KAINATE RECEPTORS; FUSION PORE; TIME-COURSE; AMPA	'Silent synapses' show responses from high-affinity NMDA receptors (NMDARs) but not low-affinity AMPA receptors (AMPARs), but gain AMPAR responses upon long-term potentiation (LTP). Using the rapidly reversible NMDAR antagonist L-AP5 to assess cleft glutamate concentration ([glu](cleft)), we found that it peaked at <<170 mu M at silent neonatal synapses, but greatly increased after potentiation. Cyclothiazide (CTZ), a potentiator of AMPAR, revealed slowly rising AMPA EPSCs at silent synapses; LTP shortened their rise times. Thus, LTP at silent synapses increased rate-of-rise and peak amplitude of [glu](cleft). Release probability reported by NMDARs remained unchanged during LTP, implying that [glu](cleft) increases arose from immediately presynaptic terminals. Our data suggest that changes in the dynamics of fusion-pore opening contribute to LTP.	Stanford Univ, Sch Med, Beckman Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Tsien, RW (corresponding author), Stanford Univ, Sch Med, Beckman Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.							Bekkers JM, 1996, J NEUROPHYSIOL, V75, P1250, DOI 10.1152/jn.1996.75.3.1250; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Diamond JS, 1997, J NEUROSCI, V17, P4672; Diamond JS, 1998, NEURON, V21, P425, DOI 10.1016/S0896-6273(00)80551-6; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Dzubay JA, 1999, J NEUROSCI, V19, P5265; Glavinovic MI, 1998, PFLUG ARCH EUR J PHY, V435, P193; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kullmann DM, 1999, NATURE, V399, P111, DOI 10.1038/20089; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lollike K, 1998, BIOPHYS J, V75, P53, DOI 10.1016/S0006-3495(98)77494-6; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; OLVERMAN HJ, 1988, NEUROSCIENCE, V26, P17, DOI 10.1016/0306-4522(88)90124-8; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Pothos EN, 1998, J NEUROSCI, V18, P4106; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Rumpel S, 1998, J NEUROSCI, V18, P8863; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7	43	197	200	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					330	336		10.1038/73895	http://dx.doi.org/10.1038/73895			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725921				2022-12-17	WOS:000087945400012
J	Joshi, AU; Minhas, PS; Liddelow, SA; Haileselassie, B; Andreasson, KI; Dorn, GW; Mochly-Rosen, D				Joshi, Amit U.; Minhas, Paras S.; Liddelow, Shane A.; Haileselassie, Bereketeab; Andreasson, Katrin, I; Dorn, Gerald W., II; Mochly-Rosen, Daria			Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; EXTRACELLULAR MITOCHONDRIA; NEUROINFLAMMATION; INHIBITION; FISSION	In neurodegenerative diseases, debris of dead neurons are thought to trigger glia-mediated neuroinflammation, thus increasing neuronal death. Here we show that the expression of neurotoxic proteins associated with these diseases in microglia alone is sufficient to directly trigger death of naive neurons and to propagate neuronal death through activation of naive astrocytes to the A1 state. Injury propagation is mediated, in great part, by the release of fragmented and dysfunctional microglial mitochondria into the neuronal milieu. The amount of damaged mitochondria released from microglia relative to functional mitochondria and the consequent neuronal injury are determined by Fis1-mediated mitochondrial fragmentation within the glial cells. The propagation of the inflammatory response and neuronal cell death by extracellular dysfunctional mitochondria suggests a potential new intervention for neurodegeneration-one that inhibits mitochondrial fragmentation in microglia, thus inhibiting the release of dysfunctional mitochondria into the extracellular milieu of the brain, without affecting the release of healthy neuroprotective mitochondria.	[Joshi, Amit U.; Haileselassie, Bereketeab; Mochly-Rosen, Daria] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA; [Minhas, Paras S.; Andreasson, Katrin, I] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Liddelow, Shane A.] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Haileselassie, Bereketeab] Stanford Univ, Dept Pediat, Sch Med, Div Crit Care Med, Stanford, CA 94305 USA; [Dorn, Gerald W., II] Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA; [Liddelow, Shane A.] NYU, Langone Med Ctr, Dept Neurosci & Physiol, New York, NY USA; [Liddelow, Shane A.] NYU, Langone Med Ctr, Neurosci Inst, New York, NY USA; [Liddelow, Shane A.] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic, Australia	Stanford University; Stanford University; Stanford University; Stanford University; Washington University (WUSTL); New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; University of Melbourne	Mochly-Rosen, D (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA.	mochly@stanford.edu	Liddelow, Shane/ABE-6456-2020	Liddelow, Shane/0000-0002-0840-1437; Mochly-Rosen, Daria/0000-0002-6691-8733	Stanford Discovery Innovation Award; Paul & Daisy Soros Fellowship; Australian National Health and Medical Research Council [GNT1052961]; Glenn Foundation Glenn Award [RO1AG058047, R35 HL135736];  [R01 HL52141]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052141, R35HL135736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011147] Funding Source: NIH RePORTER	Stanford Discovery Innovation Award; Paul & Daisy Soros Fellowship; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Glenn Foundation Glenn Award; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	In memory of Ben Barres, whose advice and research inspired this study. This work was supported, in part, by a Stanford Discovery Innovation Award and R01 HL52141 to D.M.-R., a Paul & Daisy Soros Fellowship to P.S.M., a postdoctoral fellowship from the Australian National Health and Medical Research Council (GNT1052961) and the Glenn Foundation Glenn Award to S.A.L., RO1AG058047 to K.I.A., and R35 HL135736 to G.W.D. The authors thank N. Raju and S. Avolicino for assistance with immunohistochemistry and J. Perrino for technical support with electron microscopy.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Belanger Mireille, 2009, Dialogues Clin Neurosci, V11, P281; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chen ZH, 2016, J NEUROCHEM, V136, P10, DOI 10.1111/jnc.13062; Chou SHY, 2017, STROKE, V48, P2231, DOI 10.1161/STROKEAHA.117.017758; Crotti A, 2015, TRENDS IMMUNOL, V36, P364, DOI 10.1016/j.it.2015.04.007; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; Disatnik MH, 2016, J EXP MED, V213, P2655, DOI 10.1084/jem.20160776; Falchi AM, 2013, HISTOCHEM CELL BIOL, V139, P221, DOI 10.1007/s00418-012-1045-x; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Glebov K, 2015, GLIA, V63, P626, DOI 10.1002/glia.22772; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Grohm J, 2012, CELL DEATH DIFFER, V19, P1446, DOI 10.1038/cdd.2012.18; Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911; Hayakawa K, 2018, STEM CELLS, V36, P1404, DOI 10.1002/stem.2856; Hayakawa K, 2018, JAMA NEUROL, V75, P119, DOI 10.1001/jamaneurol.2017.3475; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hessvik NP, 2018, CELL MOL LIFE SCI, V75, P193, DOI 10.1007/s00018-017-2595-9; Hooper C, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-144; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; Joshi AU, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708166; Joshi Amit U, 2018, Oncotarget, V9, P6128, DOI 10.18632/oncotarget.23640; Khalil B, 2017, NEURAL REGEN RES, V12, P1052, DOI 10.4103/1673-5374.211179; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Kornfeld OS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32228-1; Labzin LI, 2018, ANNU REV MED, V69, P437, DOI 10.1146/annurev-med-050715-104343; Lai RC, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.29828; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01005; Liu Y, 2009, J BIOL CHEM, V284, P3691, DOI 10.1074/jbc.M804446200; Minhas PS, 2019, NAT IMMUNOL, V20, P50, DOI 10.1038/s41590-018-0255-3; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Reddy PH, 2014, DRUG DISCOV TODAY, V19, P951, DOI 10.1016/j.drudis.2014.03.020; Reddy PH, 2011, BRAIN RES REV, V67, P103, DOI 10.1016/j.brainresrev.2010.11.004; Ryan KJ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai7635; Sarkar S, 2017, NPJ PARKINSON DIS, V3, DOI 10.1038/s41531-017-0032-2; Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1; Stevens JC, 2010, PLOS ONE, V5, pA8, DOI 10.1371/journal.pone.0009541; Taylor AR, 2007, DEV NEUROBIOL, V67, P1815, DOI 10.1002/dneu.20559; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Wilkins HM, 2016, J NEUROIMMUNE PHARM, V11, P622, DOI 10.1007/s11481-016-9704-7; Yates D, 2015, NAT REV NEUROSCI, V16, P67, DOI 10.1038/nrn3908; Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z; Zussman B, 2018, NEUROSURGERY, V82, pN11, DOI 10.1093/neuros/nyx528	50	196	201	11	88	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2019	22	10					1635	+		10.1038/s41593-019-0486-0	http://dx.doi.org/10.1038/s41593-019-0486-0			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JI3VE	31551592	Green Accepted			2022-12-17	WOS:000493396200014
J	Yasuda, R; Harvey, CD; Zhong, HN; Sobczyk, A; van Aelst, L; Svoboda, K				Yasuda, R; Harvey, CD; Zhong, HN; Sobczyk, A; van Aelst, L; Svoboda, K			Supersensitive Ras activation in dendrites and spines revealed by two-photon fluorescence lifetime imaging	NATURE NEUROSCIENCE			English	Article							CALCIUM-CHANNELS; BINDING DOMAIN; ACTION-POTENTIALS; GROWTH-FACTOR; PROTEIN; FRET; LOCALIZATION; DEPENDENCE; EXCHANGE; VARIANT	To understand the biochemical signals regulated by neural activity, it is necessary to measure protein-protein interactions and enzymatic activity in neuronal microcompartments such as axons, dendrites and their spines. We combined two-photon excitation laser scanning with fluorescence lifetime imaging to measure fluorescence resonance energy transfer at high resolutions in brain slices. We also developed sensitive fluorescent protein-based sensors for the activation of the small GTPase protein Ras with slow ( FRas) and fast ( FRas-F) kinetics. Using FRas-F, we found in CA1 hippocampal neurons that trains of back-propagating action potentials rapidly and reversibly activated Ras in dendrites and spines. The relationship between firing rate and Ras activation was highly nonlinear ( Hill coefficient similar to 5). This steep dependence was caused by a highly cooperative interaction between calcium ions ( Ca2+) and Ras activators. The Ras pathway therefore functions as a supersensitive threshold detector for neural activity and Ca2+ concentration.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Phys, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Yasuda, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	yasuda@neuro.duke.edu	Yasuda, Ryohei/E-7726-2011	Zhong, Haining/0000-0002-7109-4724; Yasuda, Ryohei/0000-0001-6263-9297				Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bondeva T, 2002, MOL BIOL CELL, V13, P2323, DOI 10.1091/mbc.E02-01-0019; CALLAWAY JC, 1995, J NEUROPHYSIOL, V74, P1395, DOI 10.1152/jn.1995.74.4.1395; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Davis AJ, 1996, J BIOL CHEM, V271, P24333, DOI 10.1074/jbc.271.40.24333; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dudek SM, 2002, P NATL ACAD SCI USA, V99, P3962, DOI 10.1073/pnas.062510599; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Erickson MG, 2003, BIOPHYS J, V85, P599, DOI 10.1016/S0006-3495(03)74504-4; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gratton E, 2003, J BIOMED OPT, V8, P381, DOI 10.1117/1.1586704; Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Jaitner BK, 1997, J BIOL CHEM, V272, P29927, DOI 10.1074/jbc.272.47.29927; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Liu Q, 2005, J CELL BIOL, V170, P183, DOI 10.1083/jcb.200504167; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; MCALLISTER AK, 2000, SCI STKE, pPL1; MEDEMA RH, 1993, MOL CELL BIOL, V13, P155, DOI 10.1128/MCB.13.1.155; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; PISTON DW, 1992, TIME RESOLVED LASER, V3, P379; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; SHANER NC, 2004, NAT BIOTECHNOL; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Walker SA, 2004, EMBO J, V23, P1749, DOI 10.1038/sj.emboj.7600197; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; YASUDA R, 2004, SCI STKE, pPL5; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	50	196	202	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					283	291		10.1038/nn1635	http://dx.doi.org/10.1038/nn1635			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16429133				2022-12-17	WOS:000234990100025
J	Amedi, A; Floel, A; Knecht, S; Zohary, E; Cohen, LG				Amedi, A; Floel, A; Knecht, S; Zohary, E; Cohen, LG			Transcranial magnetic stimulation of the occipital pole interferes with verbal processing in blind subjects	NATURE NEUROSCIENCE			English	Article							INFERIOR PREFRONTAL CORTEX; VISUAL-CORTEX; ACTIVATION; MEMORY; BRAIN; ORGANIZATION; CONNECTIONS; DEPRIVATION; CORTICES; PEOPLE	Recent neuroimaging studies in blind persons show that the occipital cortex, including the primary visual cortex (V1), is active during language-related and verbal-memory tasks. No studies, however, have identified a causal link between early visual cortex activity and successful performance on such tasks. We show here that repetitive transcranial magnetic stimulation (rTMS) of the occipital pole reduces accuracy on a verb-generation task in blind subjects, but not in sighted controls. An analysis of error types revealed that the most common error produced by rTMS was semantic; phonological errors and interference with motor execution or articulation were rare. Thus, in blind persons, a transient 'virtual lesion' of the left occipital cortex interferes with high-level verbal processing.	NINDS, Human Cort Physiol Sect, NIH, Bethesda, MD 20892 USA; Hebrew Univ Jerusalem, Dept Neurobiol, Inst Life Sci, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Univ Munster, D-48148 Munster, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Munster	Cohen, LG (corresponding author), NINDS, Human Cort Physiol Sect, NIH, Bethesda, MD 20892 USA.	udiz@lobster.ls.huji.ac.il; cohenl@ninds.nih.gov	Floel, Agnes/A-9426-2017	Knecht, Stefan/0000-0003-1056-9228; Amedi, Amir/0000-0001-5042-2533				Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Boroojerdi B, 2000, CEREB CORTEX, V10, P529, DOI 10.1093/cercor/10.5.529; Buchel C, 2003, NAT NEUROSCI, V6, P657, DOI 10.1038/nn0703-657; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Burton H, 2003, J NEUROSCI, V23, P4005; Burton H, 2003, J NEUROPHYSIOL, V90, P1965, DOI 10.1152/jn.00279.2003; Burton H, 2002, J NEUROPHYSIOL, V88, P3359, DOI 10.1152/jn.00129.2002; Chouinard PA, 2003, J NEUROPHYSIOL, V90, P1071, DOI 10.1152/jn.01105.2002; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; DEHAY C, 1984, EXP BRAIN RES, V57, P208; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; DISTLER C, 1993, J COMP NEUROL, V334, P125, DOI 10.1002/cne.903340111; Floel A, 2004, CEREB CORTEX, V14, P404, DOI 10.1093/cercor/bhh002; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Korpilahti P, 2001, BRAIN LANG, V76, P332, DOI 10.1006/brln.2000.2426; KUCERA WN, 1967, COMPUTATIONAL ANAL P; Levelt WJM, 2001, P NATL ACAD SCI USA, V98, P13464, DOI 10.1073/pnas.231459498; Lisanby SH, 2001, BIOL PSYCHIAT, V49, P460, DOI 10.1016/S0006-3223(00)01110-0; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Noppeney U, 2003, BRAIN, V126, P1620, DOI 10.1093/brain/awg152; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; PascualLeone A, 1995, ANN NEUROL, V38, P910, DOI 10.1002/ana.410380611; Paus T, 1999, NEUROPSYCHOLOGIA, V37, P219; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Rempel-Clower NL, 2000, CEREB CORTEX, V10, P851, DOI 10.1093/cercor/10.9.851; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Shapiro KA, 2001, J COGNITIVE NEUROSCI, V13, P713, DOI 10.1162/08989290152541386; Stewart L, 2001, NEUROIMAGE, V13, P472, DOI 10.1006/nimg.2000.0701	35	196	199	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1266	1270		10.1038/nn1328	http://dx.doi.org/10.1038/nn1328			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15467719				2022-12-17	WOS:000224749400020
J	Bao, SW; Chang, EF; Woods, J; Merzenich, MM				Bao, SW; Chang, EF; Woods, J; Merzenich, MM			Temporal plasticity in the primary auditory cortex induced by operant perceptual learning	NATURE NEUROSCIENCE			English	Article							MODULATION TRANSFER-FUNCTIONS; IMPAIRED CHILDREN; RESPONSE PROPERTIES; MONGOLIAN GERBIL; NERVE FIBERS; REPRESENTATION; NEURONS; SPEECH; INFORMATION; TONES	Processing of rapidly successive acoustic stimuli can be markedly improved by sensory training. To investigate the cortical mechanisms underlying such temporal plasticity, we trained rats in a 'sound maze' in which navigation using only auditory cues led to a target location paired with food reward. In this task, the repetition rate of noise pulses increased as the distance between the rat and target location decreased. After training in the sound maze, neurons in the primary auditory cortex (A1) showed greater responses to high-rate noise pulses and stronger phase-locking of responses to the stimuli; they also showed shorter post-stimulation suppression and stronger rebound activation. These improved temporal dynamics transferred to trains of pure-tone pips. Control animals that received identical sound stimulation but were given free access to food showed the same results as naive rats. We conclude that this auditory perceptual learning results in improvements in temporal processing, which may be mediated by enhanced cortical response dynamics.	Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bao, SW (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	bao@phy.ucsf.edu			NINDS NIH HHS [NS-34835, NS-10414] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034835] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahissar E, 2001, P NATL ACAD SCI USA, V98, P13367, DOI 10.1073/pnas.201400998; BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Bao SW, 2003, J NEUROSCI, V23, P10765; Bao SW, 2003, P NATL ACAD SCI USA, V100, P1405, DOI 10.1073/pnas.0337527100; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Beitel RE, 2003, P NATL ACAD SCI USA, V100, P11070, DOI 10.1073/pnas.1334187100; Blake DT, 2002, P NATL ACAD SCI USA, V99, P10114, DOI 10.1073/pnas.092278099; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Eggermont JJ, 1999, J NEUROSCI, V19, P2780; Eggermont JJ, 2002, J NEUROPHYSIOL, V87, P305, DOI 10.1152/jn.00490.2001; Elhilali M, 2004, J NEUROSCI, V24, P1159, DOI 10.1523/JNEUROSCI.3825-03.2004; Frisina RD, 2001, HEARING RES, V158, P1, DOI 10.1016/S0378-5955(01)00296-9; Garabedian CE, 2003, J NEUROPHYSIOL, V90, P1379, DOI 10.1152/jn.01158.2002; Ji WQ, 2001, J NEUROPHYSIOL, V86, P211, DOI 10.1152/jn.2001.86.1.211; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; JORIS PX, 1992, J ACOUST SOC AM, V91, P215, DOI 10.1121/1.402757; KANWAL JS, 1994, J ACOUST SOC AM, V96, P1229, DOI 10.1121/1.410273; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Krukowski AE, 2001, NAT NEUROSCI, V4, P424, DOI 10.1038/86084; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; MARDIA K. V., 2009, DIRECTIONAL STAT; Merzenich MM, 1996, SCIENCE, V271, P77, DOI 10.1126/science.271.5245.77; MERZENICH MM, 1999, PERVASIVE DEV DISORD, P365; Nagarajan S, 1999, P NATL ACAD SCI USA, V96, P6483, DOI 10.1073/pnas.96.11.6483; Nagarajan SS, 2002, J NEUROPHYSIOL, V87, P1723, DOI 10.1152/jn.00632.2001; Ohl FW, 1996, EUR J NEUROSCI, V8, P1001, DOI 10.1111/j.1460-9568.1996.tb01587.x; Ponton CW, 1996, NEUROREPORT, V8, P61, DOI 10.1097/00001756-199612200-00013; Ponton CW, 1999, SCAND AUDIOL, V28, P13; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1071, DOI 10.1152/jn.1992.67.5.1071; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769, DOI 10.1152/jn.1967.30.4.769; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Schreiner CE, 1997, ACTA OTO-LARYNGOL, P54; Schulze H, 1997, J COMP PHYSIOL A, V181, P651, DOI 10.1007/s003590050147; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Shepherd RK, 1997, ACTA OTO-LARYNGOL, P28; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; Temple E, 2001, NEUROREPORT, V12, P299, DOI 10.1097/00001756-200102120-00024; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Wright BA, 1997, NATURE, V387, P176, DOI 10.1038/387176a0	42	196	200	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					974	981		10.1038/nn1293	http://dx.doi.org/10.1038/nn1293			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15286790				2022-12-17	WOS:000223546700017
J	Duguid, IC; Smart, TG				Duguid, IC; Smart, TG			Retrograde activation of presynaptic NMDA receptors enhances GABA release at cerebellar interneuron-Purkinje cell synapses	NATURE NEUROSCIENCE			English	Article							DEPOLARIZATION-INDUCED SUPPRESSION; ENDOGENOUS CANNABINOIDS; CLIMBING FIBER; RAT CEREBELLUM; CALCIUM STORES; REBOUND POTENTIATION; TRANSMITTER RELEASE; SYNAPTIC CURRENTS; INHIBITION; NEURONS	Synaptic inhibition is a vital component in the control of cell excitability within the brain. Here we report a newly identified form of inhibitory synaptic plasticity, termed depolarization-induced potentiation of inhibition, in rodents. This mechanism strongly potentiated synaptic transmission from interneurons to Purkinje cells after the termination of depolarization-induced suppression of inhibition. It was triggered by an elevation of Ca(2+) in Purkinje cells and the subsequent retrograde activation of presynaptic NMDA receptors. These glutamate receptors promoted the spontaneous release of Ca(2+) from presynaptic ryanodine-sensitive Ca(2+) stores. Thus, NMDA receptor-mediated facilitation of transmission at this synapse provides a regulatory mechanism that can dynamically alter the synaptic efficacy at inhibitory synapses.	UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Smart, TG (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	t.smart@ucl.ac.uk		Duguid, Ian/0000-0001-6966-2641	MRC [G9603438] Funding Source: UKRI; Medical Research Council [G9603438] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Brenowitz SD, 2003, J NEUROSCI, V23, P6373; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; DeBiasi S, 1996, NEUROREPORT, V7, P2773, DOI 10.1097/00001756-199611040-00073; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713; Galante M, 2003, J NEUROSCI, V23, P11229; Glitsch M, 1996, J PHYSIOL-LONDON, V497, P531, DOI 10.1113/jphysiol.1996.sp021786; Glitsch M, 1999, J NEUROSCI, V19, P511; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; Hashimoto T, 1996, J PHYSIOL-LONDON, V497, P611, DOI 10.1113/jphysiol.1996.sp021794; Ito M, 1984, CEREBELLUM NEURAL CO; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kano M, 1996, P NATL ACAD SCI USA, V93, P13351, DOI 10.1073/pnas.93.23.13351; Kim J, 2001, J NEUROSCI, V21, P9608, DOI 10.1523/JNEUROSCI.21-24-09608.2001; KNOPFEL T, 1991, EUR J NEUROSCI, V3, P343, DOI 10.1111/j.1460-9568.1991.tb00821.x; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; KUROBE N, 1992, J NEUROCHEM, V58, P128, DOI 10.1111/j.1471-4159.1992.tb09287.x; Levenes C, 2001, J PHYSIOL-LONDON, V537, P125, DOI 10.1111/j.1469-7793.2001.0125k.x; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Paquet M, 2000, J COMP NEUROL, V423, P330, DOI 10.1002/1096-9861(20000724)423:2<330::AID-CNE10>3.0.CO;2-9; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; PITLER TA, 1992, J NEUROSCI, V12, P4122; Pittman QJ, 2000, EXP PHYSIOL, V85, p139S, DOI 10.1111/j.1469-445X.2000.tb00017.x; Pouzat C, 1997, J NEUROSCI, V17, P9104; ROSEMUND C, 1992, J NEUROPHYSIOL, V68, P1901, DOI 10.1152/jn.1992.68.5.1901; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; SOTELO C, 1991, PHILOS T R SOC B, V331, P307, DOI 10.1098/rstb.1991.0022; Stephens GJ, 2001, EUR J NEUROSCI, V13, P1902, DOI 10.1046/j.0953-816x.2001.01566.x; Strata P, 1997, PROG BRAIN RES, V114, P263; Takahashi KA, 2000, J NEUROPHYSIOL, V83, P1167, DOI 10.1152/jn.2000.83.3.1167; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Yamada K, 2000, J COMP NEUROL, V418, P106; Yamada Keiko, 2002, Anatomical Science International, V77, P94, DOI 10.1046/j.0022-7722.2002.00021.x; Yoshida T, 2002, J NEUROSCI, V22, P1690, DOI 10.1523/JNEUROSCI.22-05-01690.2002; Yung WH, 2001, J NEUROSCI, V21, P7063, DOI 10.1523/JNEUROSCI.21-18-07063.2001; Zilberter Y, 2000, J PHYSIOL-LONDON, V528, P489, DOI 10.1111/j.1469-7793.2000.00489.x; Zilberter Y, 1999, NEURON, V24, P979, DOI 10.1016/S0896-6273(00)81044-2; ZIMANYI I, 1992, MOL PHARMACOL, V42, P1049; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	49	196	202	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					525	533		10.1038/nn1227	http://dx.doi.org/10.1038/nn1227			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15097992				2022-12-17	WOS:000221101300030
J	Webster, MA; Georgeson, MA; Webster, SM				Webster, MA; Georgeson, MA; Webster, SM			Neural adjustments to image blur	NATURE NEUROSCIENCE			English	Article							CONTRAST CONSTANCY; PERCEIVED CONTRAST; NATURAL SCENES; HUMAN-VISION; SENSITIVITY; STATISTICS; ADAPTATION; COLOR		Univ Nevada, Dept Psychol, Reno, NV 89557 USA; Aston Univ, Neurosci Res Inst, Birmingham B4 7ET, W Midlands, England	Nevada System of Higher Education (NSHE); University of Nevada Reno; Aston University	Webster, MA (corresponding author), Univ Nevada, Dept Psychol, Reno, NV 89557 USA.			Webster, Michael/0000-0001-8262-7525; Georgeson, Mark/0000-0002-8173-9522	NATIONAL EYE INSTITUTE [R29EY010834, R01EY010834] Funding Source: NIH RePORTER; NEI NIH HHS [EY10834, R01 EY010834] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BRADY N, 1995, VISION RES, V35, P739, DOI 10.1016/0042-6989(94)00172-I; BURTON GJ, 1987, APPL OPTICS, V26, P157, DOI 10.1364/AO.26.000157; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P9631, DOI 10.1073/pnas.86.23.9631; DeValois RL, 1988, SPATIAL VISION; Field DJ, 1997, VISION RES, V37, P3367, DOI 10.1016/S0042-6989(97)00181-8; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; GEORGESON MA, 1975, J PHYSIOL-LONDON, V252, P627, DOI 10.1113/jphysiol.1975.sp011162; Graham N., 1989, VISUAL PATTERN ANAL; Mon-Williams M, 1998, P ROY SOC B-BIOL SCI, V265, P71, DOI 10.1098/rspb.1998.0266; PESUDOVS K, 1993, OPTOMETRY VISION SCI, V70, P528, DOI 10.1097/00006324-199307000-00002; TADMOR Y, 1994, VISION RES, V34, P541, DOI 10.1016/0042-6989(94)90167-8; WATT RJ, 1987, PATTERN RECOGN LETT, V5, P139, DOI 10.1016/0167-8655(87)90035-3; Webster MA, 1996, NETWORK-COMP NEURAL, V7, P587, DOI 10.1088/0954-898X/7/4/002; Webster MA, 1999, P SOC PHOTO-OPT INS, V3644, P58, DOI 10.1117/12.348468	14	196	209	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					839	840		10.1038/nn906	http://dx.doi.org/10.1038/nn906			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195427				2022-12-17	WOS:000177656300011
J	Colbert, CM; Pan, EH				Colbert, CM; Pan, EH			Ion channel properties underlying axonal action potential initiation in pyramidal neurons	NATURE NEUROSCIENCE			English	Article							SODIUM-CHANNELS; SPIKE-INITIATION; RAT HIPPOCAMPUS; CELL DENDRITES; GANGLION-CELLS; PROPAGATION; CA1; SEGMENT; SITE; BACKPROPAGATION	A high density of Na+ channels in the axon hillock, or initial segment, is believed to determine the threshold for action potential initiation in neurons. Here we report evidence for an alternative mechanism that lowers the threshold in the axon. We investigated properties and distributions of ion channels in outside-out patches from axons and somata of layer 5 pyramidal neurons in rat neocortical slices. Na+ channels in axonal patches (>30 mum from the soma) were activated by 7 mV less depolarization than were somatic Na+ channels. A-type K+ channels, which were prominent in somatic and dendritic patches, were rarely seen in axonal patches. We incorporated these findings into numerical simulations which indicate that biophysical properties of axonal channels, rather than a high density of channels in the initial segment, are most likely to determine the lowest threshold for action potential initiation.	Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Houston System; University of Houston	Colbert, CM (corresponding author), Univ Houston, Dept Biol & Biochem, 4800 Calhoun Rd, Houston, TX 77204 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS036982] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36982] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams Paul R., 1992, Current Biology, V2, P625, DOI 10.1016/0960-9822(92)90093-P; Alessandri-Haber N, 1999, J PHYSIOL-LONDON, V518, P203, DOI 10.1111/j.1469-7793.1999.0203r.x; ANDREASEN M, 1995, J PHYSIOL-LONDON, V483, P421, DOI 10.1113/jphysiol.1995.sp020595; ANGELIDES KJ, 1988, J CELL BIOL, V106, P1911, DOI 10.1083/jcb.106.6.1911; [Anonymous], [No title captured]; Astman N, 1998, J NEUROPHYSIOL, V80, P1547, DOI 10.1152/jn.1998.80.3.1547; BUHL EH, 1994, J NEUROPHYSIOL, V71, P1289, DOI 10.1152/jn.1994.71.4.1289; CARRAS PL, 1992, J NEUROPHYSIOL, V67, P292, DOI 10.1152/jn.1992.67.2.292; CATTERALL WA, 1981, J NEUROSCI, V1, P777, DOI 10.1523/JNEUROSCI.01-07-00777.1981; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Colbert CM, 1996, J NEUROSCI, V16, P6676; DODGE FA, 1973, IBM J RES DEV, V17, P219, DOI 10.1147/rd.173.0219; EDWARDS C, 1958, J PHYSIOL-LONDON, V143, P138, DOI 10.1113/jphysiol.1958.sp006049; FARINAS I, 1991, J COMP NEUROL, V304, P70, DOI 10.1002/cne.903040106; GOGAN P, 1983, J PHYSIOL-LONDON, V335, P205, DOI 10.1113/jphysiol.1983.sp014529; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Hines M, 1993, NEURAL SYSTEMS ANAL, P127; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kloosterman F, 2001, J NEUROPHYSIOL, V86, P2435, DOI 10.1152/jn.2001.86.5.2435; Luscher HR, 1998, J NEUROPHYSIOL, V80, P715, DOI 10.1152/jn.1998.80.2.715; Magee JC, 1998, J NEUROSCI, V18, P7613; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; MATSUMOTO E, 1985, J NEUROCYTOL, V14, P731, DOI 10.1007/BF01170825; MEL BW, 1994, NEURAL COMPUT, V6, P1031, DOI 10.1162/neco.1994.6.6.1031; MOORE JW, 1983, J PHYSIOL-LONDON, V336, P301, DOI 10.1113/jphysiol.1983.sp014582; MOORE JW, 1983, J PHYSIOL-LONDON, V336, P285, DOI 10.1113/jphysiol.1983.sp014581; PALAY SL, 1968, J CELL BIOL, V38, P193, DOI 10.1083/jcb.38.1.193; Rapp M, 1996, P NATL ACAD SCI USA, V93, P11985, DOI 10.1073/pnas.93.21.11985; Rasband MN, 1999, J NEUROCYTOL, V28, P319, DOI 10.1023/A:1007057512576; REGEHR WG, 1994, CURR BIOL, V4, P436, DOI 10.1016/S0960-9822(00)00096-8; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TURNER RW, 1991, J NEUROSCI, V11, P2270; Zecevic D, 1996, NATURE, V381, P322, DOI 10.1038/381322a0	40	196	199	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					533	538		10.1038/nn857	http://dx.doi.org/10.1038/nn857			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992119				2022-12-17	WOS:000175874600012
J	von Schack, D; Casademunt, E; Schweigreiter, R; Meyer, M; Bibel, M; Dechant, G				von Schack, D; Casademunt, E; Schweigreiter, R; Meyer, M; Bibel, M; Dechant, G			Complete ablation of the neurotrophin receptor p75(NTR) causes defects both in the nervous and the vascular system	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR RECEPTOR; NGF; EXPRESSION; GENE; P75; RAT		Max Planck Inst Neurobiol, Dept Neurobiochem, D-82152 Martinsried, Germany; Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Max Planck Society; Friedrich Miescher Institute for Biomedical Research	Dechant, G (corresponding author), AGY Therapeut, 290 Utah Ave, S San Francisco, CA 94080 USA.							CHAPMAN BS, 1995, PROTEIN SCI, V4, P1696, DOI 10.1002/pro.5560040905; Donovan MJ, 1996, NAT GENET, V14, P210, DOI 10.1038/ng1096-210; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; HUBER LJ, 1995, J NEUROSCI RES, V40, P557, DOI 10.1002/jnr.490400415; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lin MI, 2000, DEV BIOL, V226, P180, DOI 10.1006/dbio.2000.9850; SCARISBRICK IA, 1993, J NEUROSCI, V13, P875; SEHGAL A, 1988, MOL CELL BIOL, V8, P3160, DOI 10.1128/MCB.8.8.3160; Silver L., 1998, MOUSE GENETICS CONCE; Wheeler EF, 1998, J COMP NEUROL, V391, P407	11	196	198	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					977	978		10.1038/nn730	http://dx.doi.org/10.1038/nn730			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478CR	11559852				2022-12-17	WOS:000171325800009
J	Vissel, B; Krupp, JJ; Heinemann, SE; Westbrook, GL				Vissel, B; Krupp, JJ; Heinemann, SE; Westbrook, GL			A use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; AMPA RECEPTOR; POSTSYNAPTIC DENSITY; SYNAPTIC TRANSMISSION; HIPPOCAMPAL-NEURONS; CHANNEL ACTIVITY; NR1 SUBUNIT; SH2 DOMAINS; PROTEIN; KINASE	Tyrosine phosphorylation can upregulate NMDA receptor activity during pathological and physiological alterations of synaptic strength. Here we describe downregulation of recombinant NR1/2A receptors by tyrosine dephosphorylation that requires agonist binding, but is independent of ion flux. The tyrosine residues involved in this new form of NMDA receptor modulation likely form a 'ring' adjacent to the last transmembrane domain. The downregulation was due to a reduction in the number of functional channels, and was blocked by co-expressing a dominant-negative mu2-subunit of the clathrin-adaptor protein AP-2. Our results provide a mechanism by which synaptic NMDA receptors can be modulated in a use-dependent manner even when the postsynaptic membrane is not sufficiently depolarized to relieve channel block by magnesium ions.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA	Oregon Health & Science University; Salk Institute	Krupp, JJ (corresponding author), Karolinska Inst, NOVUM, AstraZeneca R&D Sodertalje, Halsovagen 7, S-14157 Huddinge, Sweden.	johannes.krupp@astrazeneca.com		Vissel, Bryce/0000-0001-8860-8050	NIMH NIH HHS [MH46613] Funding Source: Medline; NINDS NIH HHS [NS28709] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH046613, R01MH046613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028709] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chen SJ, 1996, J NEUROCHEM, V67, P194; Colledge M, 1998, CURR OPIN NEUROBIOL, V8, P357, DOI 10.1016/S0959-4388(98)80061-5; Craven SE, 2000, J BIOL CHEM, V275, P20045, DOI 10.1074/jbc.M910153199; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dunah AW, 1998, J NEUROCHEM, V71, P1926; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Fadool DA, 1998, J NEUROSCI, V18, P6126; Gurd JW, 1997, J NEUROCHEM, V69, P623; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; ISHII T, 1993, J BIOL CHEM, V268, P2836; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kobayashi S, 1997, J BIOL CHEM, V272, P16262, DOI 10.1074/jbc.272.26.16262; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; LEGENDRE P, 1993, J NEUROSCI, V13, P674; Lin SY, 1999, MOL BRAIN RES, V70, P18, DOI 10.1016/S0169-328X(99)00122-9; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; STERN P, 1994, J PHYSIOL-LONDON, V476, P391, DOI 10.1113/jphysiol.1994.sp020140; SWOPE SL, 1994, J BIOL CHEM, V269, P29817; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Takagi N, 1999, J CEREBR BLOOD F MET, V19, P880, DOI 10.1097/00004647-199908000-00007; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; TONG G, 1994, J NEUROPHYSIOL, V72, P754, DOI 10.1152/jn.1994.72.2.754; Wang H, 1999, J NEUROSCI, V19, pU1; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wang YT, 1996, P NATL ACAD SCI USA, V93, P1721, DOI 10.1073/pnas.93.4.1721; Wang YZ, 1997, NATURE, V389, P502, DOI 10.1038/39062; Xiong ZG, 1999, J NEUROSCI, V19; Yu XM, 1998, NATURE, V396, P469, DOI 10.1038/24877; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zheng F, 1998, NAT NEUROSCI, V1, P185, DOI 10.1038/634; ZHOU SY, 1995, TRENDS BIOCHEM SCI, V20, P470	50	196	201	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					587	596		10.1038/88404	http://dx.doi.org/10.1038/88404			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369939				2022-12-17	WOS:000169061800011
J	van Turennout, M; Ellmore, T; Martin, A				van Turennout, M; Ellmore, T; Martin, A			Long-lasting cortical plasticity in the object naming system	NATURE NEUROSCIENCE			English	Article							EVENT-RELATED FMRI; PREFRONTAL CORTEX; MEMORY STORAGE; TERM-MEMORY; MECHANISMS; HUMANS; ACTIVATION; CIRCUITRY	A single exposure to an object can produce long-lasting behavioral change. Here, using event-related functional magnetic resonance imaging (fMRI), we provide evidence for long-lasting changes in cortical activity associated with perceiving and naming objects. In posterior regions, we observed an immediate (30-second) and long-lasting (3-day) decrease in neural activity after brief (200-ms) exposure to nameable and nonsense objects. In addition, slower-developing decreases in left inferior frontal activity were observed concurrently with increases in left insula activity, only for nameable objects. These time-dependent cortical changes may reflect two distinct learning mechanisms: the formation of sparser, yet more object-form-specific, representations in posterior regions, and experience-induced reorganization of the brain circuitry underlying lexical retrieval in anterior regions.	NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	van Turennout, M (corresponding author), Max Planck Inst Psycholinguist, Wundtlaan 1, NL-6525 XD Nijmegen, Netherlands.		Ellmore, Timothy M./I-3760-2019; martin, alex/B-6176-2009	Ellmore, Timothy M./0000-0001-6125-0044; 	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002588, Z01MH002588] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; CAVE CB, 1992, J EXP PSYCHOL LEARN, V18, P509, DOI 10.1037/0278-7393.18.3.509; Cave CB, 1997, PSYCHOL SCI, V8, P322, DOI 10.1111/j.1467-9280.1997.tb00446.x; DAMASIO H, 1980, BRAIN, V103, P337, DOI 10.1093/brain/103.2.337; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; LEVELT WJM, 1989, SPEAKING INTENTION A; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; MITCHELL DB, 1988, J EXP PSYCHOL LEARN, V14, P213, DOI 10.1037/0278-7393.14.2.213; Paulesu E, 1996, BRAIN, V119, P143, DOI 10.1093/brain/119.1.143; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; PRICE C, 1999, NEUROCOGNITION LANGU, P211; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; RECANZONE GH, 2000, NEW COGNITIVE NEUROS, P237; Ringo JL, 1996, BEHAV BRAIN RES, V76, P191, DOI 10.1016/0166-4328(95)00197-2; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Talairach I., 1988, COPLANAR STEREOTACTI; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; van Turennout M, 1998, SCIENCE, V280, P572, DOI 10.1126/science.280.5363.572; WHEELDON LR, 1992, Q J EXP PSYCHOL-A, V44, P723, DOI 10.1080/14640749208401307; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	32	196	198	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1329	1334		10.1038/81873	http://dx.doi.org/10.1038/81873			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100155	Bronze			2022-12-17	WOS:000167177900020
J	Serizawa, S; Ishii, T; Nakatani, H; Tsuboi, A; Nagawa, F; Asano, M; Sudo, K; Sakagami, J; Sakano, H; Ijiri, T; Matsuda, Y; Suzuki, M; Yamamori, T; Iwakura, Y; Sakano, H				Serizawa, S; Ishii, T; Nakatani, H; Tsuboi, A; Nagawa, F; Asano, M; Sudo, K; Sakagami, J; Sakano, H; Ijiri, T; Matsuda, Y; Suzuki, M; Yamamori, T; Iwakura, Y; Sakano, H			Mutually exclusive expression of odorant receptor transgenes	NATURE NEUROSCIENCE			English	Article							ORGANIZATION; INFORMATION; PROJECTIONS; NEURONS; FAMILY; GENES; MICE; MAP	To study the mutually exclusive expression of odorant receptor (OW) genes, we generated transgenic mice that carried the murine OR gene MOR28. Expression of the transgene and the endogenous MOR28 was distinguished by using two different markers, beta -galactosidase and green fluorescent protein (GFP), respectively. Double staining of the olfactory epithelium revealed that the two genes were rarely expressed simultaneously in individual olfactory neurons. A similar exclusion was also observed between differently tagged but identical transgenes integrated into the same locus of one particular chromosome. Although allelic inactivation has been reported for the choice between the maternal and paternal alleles, this is the first demonstration of mutually exclusive activation among non-allelic OR gene members with identical coding and regulatory sequences. Such an unusual mode of gene expression, monoallelic and mutually exclusive, has previously been shown only for the antigen-receptor genes of the immune system.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo 1088639, Japan; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Lab Cytogenet, Sapporo, Hokkaido 0600810, Japan; Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 8620976, Japan; Natl Inst Basic Biol, Div Speciat Mech 1, Okazaki, Aichi 4448585, Japan	University of Tokyo; University of Tokyo; University of California System; University of California Berkeley; Hokkaido University; Kumamoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Sakano, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	Yamamori, Tetsuo/N-6536-2015; Iwakura, Yoichiro/E-5457-2011; Tsuboi, Akio/R-6793-2019	Yamamori, Tetsuo/0000-0001-5016-0078; Iwakura, Yoichiro/0000-0002-9934-5775; Tsuboi, Akio/0000-0002-4790-4512; Sakano, Hitomi/0000-0002-7471-8352				Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; BORST P, 1991, IMMUNOL TODAY, V12, P29; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bungert J, 1995, GENE DEV, V9, P3083, DOI 10.1101/gad.9.24.3083; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Ebrahimi FAW, 2000, DEV DYNAM, V217, P225, DOI 10.1002/(SICI)1097-0177(200002)217:2<225::AID-DVDY9>3.0.CO;2-3; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Kraus L, 1998, J PHYS IV, V8, P95, DOI 10.1051/jp4:1998222; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Qasba P, 1998, J NEUROSCI, V18, P227; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Rouquier S, 1998, NAT GENET, V18, P243, DOI 10.1038/ng0398-243; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STRATHERN JN, 1982, CELL, V31, P183, DOI 10.1016/0092-8674(82)90418-4; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tsuboi A, 1999, J NEUROSCI, V19, P8409; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459	33	196	198	1	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					687	693		10.1038/76641	http://dx.doi.org/10.1038/76641			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862701				2022-12-17	WOS:000167177200015
J	Hill, RA; Li, AM; Grutzendler, J				Hill, Robert A.; Li, Alice M.; Grutzendler, Jaime			Lifelong cortical myelin plasticity and age-related degeneration in the live mammalian brain	NATURE NEUROSCIENCE			English	Article							AGING RHESUS-MONKEY; IN-VIVO; NG2 CELLS; CONDUCTION-VELOCITY; MULTIPLE-SCLEROSIS; TRANSGENIC MICE; WHITE-MATTER; PREFRONTAL CORTEX; CEREBRAL-CORTEX; NERVOUS-SYSTEM	Axonal myelin increases neural processing speed and efficiency. It is unknown whether patterns of myelin distribution are fixed or whether myelinating oligodendrocytes are continually generated in adulthood and maintain the capacity for structural remodeling. Using high-resolution, intravital label-free and fluorescence optical imaging in mouse cortex, we demonstrate lifelong oligodendrocyte generation occurring in parallel with structural plasticity of individual myelin internodes. Continuous internode formation occurred on both partially myelinated and unmyelinated axons, and the total myelin coverage along individual axons progressed up to two years of age. After peak myelination, gradual oligodendrocyte death and myelin degeneration in aging were associated with pronounced internode loss and myelin debris accumulation within microglia. Thus, cortical myelin remodeling is protracted throughout life, potentially playing critical roles in neuronal network homeostasis. The gradual loss of internodes and myelin degeneration in aging could contribute significantly to brain pathogenesis.	[Hill, Robert A.; Li, Alice M.; Grutzendler, Jaime] Yale Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Grutzendler, Jaime] Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA	Yale University; Yale University	Hill, RA; Grutzendler, J (corresponding author), Yale Sch Med, Dept Neurol, New Haven, CT 06510 USA.; Grutzendler, J (corresponding author), Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA.	robert.hill@yale.edu; jaime.grutzendler@yale.edu		Hill, Robert/0000-0001-6080-8712; Li, Alice/0000-0002-5669-8896	National Institutes of Health [R21NS087511, R21NS088411, R01NS089734, T32NS007224, T32GM007205, F32NS090820, K99NS099469]; National Multiple Sclerosis Society [RR-1602-07686]; New Vision Award through the Donors Cure Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089734, T32NS007224, R21NS087511, F32NS090820, R00NS099469, K99NS099469, R21NS088411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG047270, RF1AG058257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); New Vision Award through the Donors Cure Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Nishiyama (University of Connecticut) and F. Kirchhoff (University of Saarland) for sharing PLP-DsRed transgenic mice. This work was supported by the following grants from the National Institutes of Health: R21NS087511, R21NS088411 and R01NS089734 to J.G.; T32NS007224 and T32GM007205 to A.M.L.; and F32NS090820 and K99NS099469 to R.A.H. This work was also supported in part by a research grant from the National Multiple Sclerosis Society (# RR-1602-07686) to J.G. and a New Vision Award through the Donors Cure Foundation to R.A.H.	Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bartzokis G, 2010, NEUROBIOL AGING, V31, P1554, DOI 10.1016/j.neurobiolaging.2008.08.015; Bechler ME, 2015, CURR BIOL, V25, P2411, DOI 10.1016/j.cub.2015.07.056; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bennett M. L. V., 1970, A. Rev. Physiol., V32, P471, DOI 10.1146/annurev.ph.32.030170.002351; Deng YQ, 2014, GENESIS, V52, P341, DOI 10.1002/dvg.22751; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Etxeberria A, 2016, J NEUROSCI, V36, P6937, DOI 10.1523/JNEUROSCI.0908-16.2016; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fields RD, 2015, NAT REV NEUROSCI, V16, P756, DOI 10.1038/nrn4023; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Haroutunian V, 2014, GLIA, V62, P1856, DOI 10.1002/glia.22716; HESS A, 1949, NATURE, V164, P490, DOI 10.1038/164490a0; Hill RA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15837; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; Hill RA, 2014, NAT METHODS, V11, P1081, DOI 10.1038/nmeth.3140; Hill RA, 2014, NAT NEUROSCI, V17, P1518, DOI 10.1038/nn.3815; Hill RA, 2014, GLIA, V62, P1195, DOI 10.1002/glia.22664; Hill RA, 2013, J NEUROSCI, V33, P14558, DOI 10.1523/JNEUROSCI.2001-12.2013; Hines JH, 2015, NAT NEUROSCI, V18, P683, DOI 10.1038/nn.3992; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Howell OW, 2011, BRAIN, V134, P2755, DOI 10.1093/brain/awr182; Huang WH, 2014, GLIA, V62, P896, DOI 10.1002/glia.22648; HUTCHINSON NA, 1970, J PHYSIOL-LONDON, V208, P279, DOI 10.1113/jphysiol.1970.sp009119; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lasiene J, 2009, AGING CELL, V8, P201, DOI 10.1111/j.1474-9726.2009.00462.x; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Mensch S, 2015, NAT NEUROSCI, V18, P628, DOI 10.1038/nn.3991; Micheva KD, 2016, ELIFE, V5, DOI 10.7554/eLife.15784; Miller DJ, 2012, P NATL ACAD SCI USA, V109, P16480, DOI 10.1073/pnas.1117943109; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Peters A, 2002, J COMP NEUROL, V442, P277, DOI 10.1002/cne.10099; Peters A, 2008, GLIA, V56, P1151, DOI 10.1002/glia.20686; Peters A, 2012, NEUROBIOL AGING, V33, P2357, DOI 10.1016/j.neurobiolaging.2011.11.015; Powers BE, 2013, P NATL ACAD SCI USA, V110, P4075, DOI 10.1073/pnas.1210293110; Romanelli E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13275; Safaiyan S, 2016, NAT NEUROSCI, V19, P995, DOI 10.1038/nn.4325; Salami M, 2003, P NATL ACAD SCI USA, V100, P6174, DOI 10.1073/pnas.0937380100; Salzer JL, 2016, CURR BIOL, V26, pR971, DOI 10.1016/j.cub.2016.07.074; Schain AJ, 2014, NAT MED, V20, P443, DOI 10.1038/nm.3495; Seidl AH, 2010, J NEUROSCI, V30, P70, DOI 10.1523/JNEUROSCI.3464-09.2010; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; STURROCK RR, 1987, J ANAT, V150, P111; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Vigano F, 2013, NAT NEUROSCI, V16, P1370, DOI 10.1038/nn.3503; Waxman SG, 1997, CURR BIOL, V7, pR406, DOI 10.1016/S0960-9822(06)00203-X; Yeh FL, 2017, TRENDS MOL MED, V23, P512, DOI 10.1016/j.molmed.2017.03.008; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	58	195	196	5	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2018	21	5					683	+		10.1038/s41593-018-0120-6	http://dx.doi.org/10.1038/s41593-018-0120-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GE4EB	29556031	Green Accepted			2022-12-17	WOS:000431166100008
J	Moser, EI; Moser, MB; McNaughton, BL				Moser, Edvard I.; Moser, May-Britt; McNaughton, Bruce L.			Spatial representation in the hippocampal formation: a history	NATURE NEUROSCIENCE			English	Article							HEAD-DIRECTION CELLS; SINGLE UNIT-ACTIVITY; FREELY MOVING RATS; PLACE CELLS; GRID CELLS; PATH-INTEGRATION; FIRING PROPERTIES; CELLULAR-RESOLUTION; THETA OSCILLATIONS; PHASE PRECESSION	Since the first place cell was recorded and the cognitive-map theory was subsequently formulated, investigation of spatial representation in the hippocampal formation has evolved in stages. Early studies sought to verify the spatial nature of place cell activity and determine its sensory origin. A new epoch started with the discovery of head direction cells and the realization of the importance of angular and linear movement-integration in generating spatial maps. A third epoch began when investigators turned their attention to the entorhinal cortex, which led to the discovery of grid cells and border cells. This review will show how ideas about integration of self-motion cues have shaped our understanding of spatial representation in hippocampal-entorhinal systems from the 1970s until today. It is now possible to investigate how specialized cell types of these systems work together, and spatial mapping may become one of the first cognitive functions to be understood in mechanistic detail.	[Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Trondheim, Norway; [McNaughton, Bruce L.] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92717 USA; [McNaughton, Bruce L.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB, Canada	Norwegian University of Science & Technology (NTNU); University of California System; University of California Irvine; University of Lethbridge	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Trondheim, Norway.	edvard.moser@ntnu.no			European Research Council (GRIDCODE) [338865]; European Research Council (ENSEMBLE) [268598]; Centre of Excellence scheme of the Research Council of Norway (Centre for Neural Computation) [223262]; Kavli Foundation; National Science Foundation [1631465]	European Research Council (GRIDCODE); European Research Council (ENSEMBLE)(European Research Council (ERC)); Centre of Excellence scheme of the Research Council of Norway (Centre for Neural Computation); Kavli Foundation; National Science Foundation(National Science Foundation (NSF))	The work was supported by two Advanced Investigator Grants from the European Research Council (GRIDCODE - grant no. 338865 to E.I.M.; 'ENSEMBLE', Grant Agreement no. 268598, to M.-B.M.), and by the Centre of Excellence scheme of the Research Council of Norway (Centre for Neural Computation, grant number 223262 to M.-B.M. and E.I.M.), the Kavli Foundation (M.-B.M. and E.I.M.), and National Science Foundation Grant 1631465 to B.L.M.	Aghajan ZM, 2015, NAT NEUROSCI, V18, P121, DOI 10.1038/nn.3884; AINSWORTH A, 1969, Journal of Physiology (Cambridge), V202, p80P; Alme CB, 2014, P NATL ACAD SCI USA, V111, P18428, DOI 10.1073/pnas.1421056111; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; Anderson MI, 2003, J NEUROSCI, V23, P8827; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Aronov D, 2017, NATURE, V543, P719, DOI 10.1038/nature21692; Aronov D, 2014, NEURON, V84, P442, DOI 10.1016/j.neuron.2014.08.042; Balint R, 1909, MON PSYCHIATR NEUROL, V25, P51; BARLOW JS, 1964, J THEOR BIOL, V6, P76; Barnes CA, 1997, NATURE, V388, P272, DOI 10.1038/40859; BARNES CA, 1990, PROG BRAIN RES, V83, P287; Barry C, 2006, REV NEUROSCIENCE, V17, P71; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Barry C, 2012, P NATL ACAD SCI USA, V109, P17687, DOI 10.1073/pnas.1209918109; Bassett JP, 2001, J NEUROSCI, V21, P5740, DOI 10.1523/JNEUROSCI.21-15-05740.2001; Battaglia FP, 1998, NEURAL COMPUT, V10, P431, DOI 10.1162/089976698300017827; Battaglia FP, 2004, J NEUROSCI, V24, P4541, DOI 10.1523/JNEUROSCI.4896-03.2004; Bellmund JLS, 2016, ELIFE, V5, DOI 10.7554/eLife.17089; BERGER TW, 1976, SCIENCE, V192, P483, DOI 10.1126/science.1257783; Best P.J., 1975, SOC NEUR ABSTR, V1, P837; Bjerknes TL, 2014, NEURON, V82, P71, DOI 10.1016/j.neuron.2014.02.014; Blair HT, 2007, J NEUROSCI, V27, P3211, DOI 10.1523/JNEUROSCI.4724-06.2007; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Bower MR, 2005, J NEUROSCI, V25, P1313, DOI 10.1523/JNEUROSCI.2901-04.2005; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; BREESE CR, 1989, J NEUROSCI, V9, P1097; Brozovic M, 2007, J NEUROSCI, V27, P10588, DOI 10.1523/JNEUROSCI.2685-07.2007; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Carvalho M.M., 2016, SOC NEUR ABSTR, V183, P10; Chen GF, 2016, CURR BIOL, V26, P2335, DOI 10.1016/j.cub.2016.06.043; Chen GF, 2013, P NATL ACAD SCI USA, V110, P378, DOI 10.1073/pnas.1215834110; CHEN LL, 1994, EXP BRAIN RES, V101, P24, DOI 10.1007/BF00243213; Cheng K., 1984, P409; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Clark BJ, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00007; Cohen N.J., 1993, MEMORY AMNESIA HIPPO, DOI DOI 10.1136/JNNP.58.1.128-A; Colgin LL, 2010, J NEUROPHYSIOL, V104, P35, DOI 10.1152/jn.00202.2010; Colgin LL, 2016, NAT REV NEUROSCI, V17, P239, DOI 10.1038/nrn.2016.21; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Conklin J, 2005, J COMPUT NEUROSCI, V18, P183, DOI 10.1007/s10827-005-6558-z; Constantinescu AO, 2016, SCIENCE, V352, P1464, DOI 10.1126/science.aaf0941; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Czurko A., 1999, EUR J NEUROSCI, V11, P344; de Almeida L, 2009, J NEUROSCI, V29, P7504, DOI 10.1523/JNEUROSCI.6048-08.2009; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Deshmukh SS, 2013, HIPPOCAMPUS, V23, P253, DOI 10.1002/hipo.22101; Deshmukh SS, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00069; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Domnisoru C, 2013, NATURE, V495, P199, DOI 10.1038/nature11973; Donato F, 2017, SCIENCE, V355, DOI 10.1126/science.aai8178; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Dunn B, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004052; EICHENBAUM H, 1987, J NEUROSCI, V7, P716; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Eichenbaum H, 2017, ANNU REV PSYCHOL, V68, P19, DOI 10.1146/annurev-psych-010416-044131; Etienne AS, 2004, HIPPOCAMPUS, V14, P180, DOI 10.1002/hipo.10173; Evans T, 2016, J PHYSIOL-LONDON, V594, P6535, DOI 10.1113/JP270666; Fiete IR, 2008, J NEUROSCI, V28, P6858, DOI 10.1523/JNEUROSCI.5684-07.2008; Fiete IR, 2010, NEURON, V66, P331, DOI 10.1016/j.neuron.2010.04.040; Finkelstein A, 2015, NATURE, V517, P159, DOI 10.1038/nature14031; FOSTER TC, 1989, SCIENCE, V244, P1580, DOI 10.1126/science.2740902; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Fyhn M, 2008, HIPPOCAMPUS, V18, P1230, DOI 10.1002/hipo.20472; Gallistel CR, 1990, ORG LEARNING; Gardner R.J., 2017, PREPRINT; Gerrard J.L., 2001, SOC NEUR ABSTR, V643, P12; Geva-Sagiv M, 2015, NAT REV NEUROSCI, V16, P94, DOI 10.1038/nrn3888; Gothard KM, 1996, J NEUROSCI, V16, P8027; Gothard KM, 1996, J NEUROSCI, V16, P823; Green J, 2017, NATURE, V546, P101, DOI 10.1038/nature22343; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hales JB, 2014, CELL REP, V9, P893, DOI 10.1016/j.celrep.2014.10.009; HAMPSON RE, 1993, BEHAV NEUROSCI, V107, P715, DOI 10.1037/0735-7044.107.5.715; Hardcastle K, 2017, NEURON, V94, P375, DOI 10.1016/j.neuron.2017.03.025; Hardcastle K, 2015, NEURON, V86, P827, DOI 10.1016/j.neuron.2015.03.039; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Hayman R, 2014, NEURON, V82, P721, DOI 10.1016/j.neuron.2014.05.011; Hayman R, 2011, NAT NEUROSCI, V14, P1182, DOI 10.1038/nn.2892; Hayman RMA, 2015, FRONT PSYCHOL, V6, DOI [10.3389/fpg.2015.00925, 10.3389/fpsyg.2015.00925]; Heys JG, 2014, NEURON, V84, P1079, DOI 10.1016/j.neuron.2014.10.048; Hinman JR, 2016, NEURON, V91, P666, DOI 10.1016/j.neuron.2016.06.027; Hirase H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0003.2001; Hok V, 2007, J NEUROSCI, V27, P472, DOI 10.1523/JNEUROSCI.2864-06.2007; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Holmes G, 1919, Br Med J, V2, P230; Horner AJ, 2016, CURR BIOL, V26, P842, DOI 10.1016/j.cub.2016.01.042; Hoydal O.A., 2017, SOC NEUROSCI; Igarashi KM, 2014, NATURE, V510, P143, DOI 10.1038/nature13162; Jacobs J, 2013, NAT NEUROSCI, V16, P1188, DOI 10.1038/nn.3466; Jeffery KJ, 1997, EXP BRAIN RES, V117, P131, DOI 10.1007/s002210050206; Jeffery KJ, 1999, EXP BRAIN RES, V127, P151, DOI 10.1007/s002210050785; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Johnson A, 2007, CURR OPIN NEUROBIOL, V17, P692, DOI 10.1016/j.conb.2008.01.003; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; JUNG MW, 1994, J NEUROSCI, V14, P7347; Justus D, 2017, NAT NEUROSCI, V20, P16, DOI 10.1038/nn.4447; Kanter BR, 2017, NEURON, V93, P1480, DOI 10.1016/j.neuron.2017.03.001; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Killian NJ, 2012, NATURE, V491, P761, DOI 10.1038/nature11587; King C, 1998, EUR J NEUROSCI, V10, P464, DOI 10.1046/j.1460-9568.1998.00026.x; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Knierim JJ, 1998, J NEUROPHYSIOL, V80, P425, DOI 10.1152/jn.1998.80.1.425; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Knierim JJ, 2002, J NEUROSCI, V22, P6254; Knierim JJ, 2001, J NEUROPHYSIOL, V85, P105, DOI 10.1152/jn.2001.85.1.105; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Komorowski RW, 2009, J NEUROSCI, V29, P9918, DOI 10.1523/JNEUROSCI.1378-09.2009; Kraus BJ, 2015, NEURON, V88, P578, DOI 10.1016/j.neuron.2015.09.031; Kraus BJ, 2013, NEURON, V78, P1090, DOI 10.1016/j.neuron.2013.04.015; Kropff E, 2015, NATURE, V523, P419, DOI 10.1038/nature14622; Kropff E, 2008, HIPPOCAMPUS, V18, P1256, DOI 10.1002/hipo.20520; Krupic J, 2015, NATURE, V518, P232, DOI 10.1038/nature14153; Kubie J L, 1991, Hippocampus, V1, P240, DOI 10.1002/hipo.450010305; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Latuske P, 2015, J NEUROSCI, V35, P10963, DOI 10.1523/JNEUROSCI.0276-15.2015; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Li Y, 2012, NATURE, V486, P118, DOI 10.1038/nature11110; Lu L, 2015, NEURON, V87, P1078, DOI 10.1016/j.neuron.2015.07.007; Lu L, 2013, NAT NEUROSCI, V16, P1085, DOI 10.1038/nn.3462; MacDonald CJ, 2013, J NEUROSCI, V33, P14607, DOI 10.1523/JNEUROSCI.1537-13.2013; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Mankin EA, 2015, NEURON, V85, P190, DOI 10.1016/j.neuron.2014.12.001; Mankin EA, 2012, P NATL ACAD SCI USA, V109, P19462, DOI 10.1073/pnas.1214107109; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mathis A, 2012, NEURAL COMPUT, V24, P2280, DOI 10.1162/NECO_a_00319; Mathis A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.018103; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCNAUGHTON BL, 1991, J COGNITIVE NEUROSCI, V3, P192, DOI 10.1162/jocn.1991.3.2.190; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; McNaughton BL, 1996, J EXP BIOL, V199, P173; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; McNaughton BL, 1990, NEUROSCIENCE CONNECT, P1; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; McNaughton Bruce L., 1995, P585; McNaughton BL, 2010, ARTIF INTELL, V174, P205, DOI 10.1016/j.artint.2009.11.013; Miao CL, 2015, NEURON, V88, P590, DOI 10.1016/j.neuron.2015.09.051; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; MITTELSTAEDT ML, 1980, NATURWISSENSCHAFTEN, V67, P566, DOI 10.1007/BF00450672; MIZUMORI SJY, 1989, J NEUROSCI, V9, P3915; Monaco JD, 2011, J NEUROSCI, V31, P9414, DOI 10.1523/JNEUROSCI.1433-11.2011; Moser EI, 2014, NAT REV NEUROSCI, V15, P466, DOI 10.1038/nrn3766; Moser MB, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021808; Muessig L, 2015, NEURON, V86, P1167, DOI 10.1016/j.neuron.2015.05.011; Muller R. U., 1991, BRAIN SPACE, P296; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1994, J NEUROSCI, V14, P7235; MULLER RU, 1987, J NEUROSCI, V7, P1935; Navratilova Z, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00006; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Keefe J, 1977, Ciba Found Symp, P179; O'Keefe J, 1998, PHILOS T ROY SOC B, V353, P1333, DOI 10.1098/rstb.1998.0287; O'Keefe J., 2014, NOBEL LECT SPATIAL C; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Olypher AV, 2002, NEUROSCIENCE, V111, P553, DOI 10.1016/S0306-4522(01)00586-3; Ormond J, 2015, P NATL ACAD SCI USA, V112, P4116, DOI 10.1073/pnas.1421963112; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pastoll H, 2013, NEURON, V77, P141, DOI 10.1016/j.neuron.2012.11.032; Paz-Villagran V, 2004, EUR J NEUROSCI, V20, P1379, DOI 10.1111/j.1460-9568.2004.03570.x; Perez-Escobar JA, 2016, ELIFE, V5, DOI 10.7554/eLife.16937; Peyrache A, 2015, NAT NEUROSCI, V18, P569, DOI 10.1038/nn.3968; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Poucet B, 2004, REV NEUROSCIENCE, V15, P89; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Ranck J.B., 1985, ELECT ACTIVITY ARCHI, P217; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; RanckJr J.B., 2005, HEAD DIRECTION CELLS, pxi; Ravassard P, 2013, SCIENCE, V340, P1342, DOI 10.1126/science.1232655; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; Redish AD, 1996, NETWORK-COMP NEURAL, V7, P671, DOI 10.1088/0954-898X/7/4/004; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; Remme MWH, 2010, NEURON, V66, P429, DOI 10.1016/j.neuron.2010.04.027; Rich PD, 2014, SCIENCE, V345, P814, DOI 10.1126/science.1255635; Rivard B, 2004, J GEN PHYSIOL, V124, P9, DOI 10.1085/jgp.200409015; Rolls ET, 2006, NETWORK-COMP NEURAL, V17, P447, DOI 10.1080/09548980601064846; Rolls ET, 1995, HIPPOCAMPUS, V5, P409, DOI 10.1002/hipo.450050504; Rolls ET, 1997, EUR J NEUROSCI, V9, P1789, DOI 10.1111/j.1460-9568.1997.tb01538.x; Rowland D.C., 2015, SOC NEUROSCI; Russell NA, 2003, J NEUROSCI, V23, P6490; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Sarel A, 2017, SCIENCE, V355, P176, DOI 10.1126/science.aak9589; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Savelli F, 2010, J NEUROPHYSIOL, V103, P3167, DOI 10.1152/jn.00932.2009; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; Schmidt-Hieber C, 2013, NAT NEUROSCI, V16, P325, DOI 10.1038/nn.3340; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Seelig JD, 2015, NATURE, V521, P186, DOI 10.1038/nature14446; SEGAL M, 1972, J NEUROPHYSIOL, V35, P680, DOI 10.1152/jn.1972.35.5.680; SEGAL M, 1972, SCIENCE, V175, P792, DOI 10.1126/science.175.4023.792; Shapiro ML, 2006, CURR OPIN NEUROBIOL, V16, P701, DOI 10.1016/j.conb.2006.08.017; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.0.CO;2-E; SHARP PE, 1990, J NEUROSCI, V10, P3093; Sharp PE, 2006, BEHAV BRAIN RES, V166, P55, DOI 10.1016/j.bbr.2005.07.004; Sharp PE, 1997, BEHAV BRAIN RES, V85, P71, DOI 10.1016/S0166-4328(96)00165-9; SHARP PE, 1994, J NEUROSCI, V14, P2339; Sharp PE, 2001, BEHAV NEUROSCI, V115, P571, DOI 10.1037/0735-7044.115.3.571; Sharp PE, 1999, HIPPOCAMPUS, V9, P432, DOI 10.1002/(SICI)1098-1063(1999)9:4<432::AID-HIPO9>3.3.CO;2-G; Si BL, 2012, BIOL CYBERN, V106, P483, DOI 10.1007/s00422-012-0513-7; Skaggs W E, 1995, Adv Neural Inf Process Syst, V7, P173; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Spiers HJ, 2015, CEREB CORTEX, V25, P10, DOI 10.1093/cercor/bht198; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stackman RW, 2002, HIPPOCAMPUS, V12, P291, DOI 10.1002/hipo.1112; Stackman RW, 1998, J NEUROSCI, V18, P9020; STEIN JF, 1989, Q J EXP PHYSIOL CMS, V74, P583, DOI 10.1113/expphysiol.1989.sp003314; Stemmler M, 2015, SCI ADV, V1, DOI 10.1126/science.1500816; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; Stensola T, 2015, NATURE, V518, P207, DOI 10.1038/nature14151; Sun C, 2015, P NATL ACAD SCI USA, V112, P9466, DOI 10.1073/pnas.1511668112; Tang QS, 2014, NEURON, V84, P1191, DOI 10.1016/j.neuron.2014.11.009; Tanila H, 1997, HIPPOCAMPUS, V7, P613, DOI 10.1002/(SICI)1098-1063(1997)7:6<613::AID-HIPO4>3.0.CO;2-F; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Taube JS, 1995, HIPPOCAMPUS, V5, P569, DOI 10.1002/hipo.450050608; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1990, J NEUROSCI, V10, P436; Terrazas A, 2005, J NEUROSCI, V25, P8085, DOI 10.1523/JNEUROSCI.0693-05.2005; Terrazas A., 2003, THESIS; Teyler TJ, 2007, HIPPOCAMPUS, V17, P1158, DOI 10.1002/hipo.20350; TEYLER TJ, 1986, BEHAV NEUROSCI, V100, P147, DOI 10.1037/0735-7044.100.2.147; Tocker G, 2015, HIPPOCAMPUS, V25, P1599, DOI 10.1002/hipo.22481; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Touretzky DS, 1996, HIPPOCAMPUS, V6, P247; Trettel S.G., 2017, PREPRINT; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tsao A., 2017, SOC NEUROSCI; Tsao A, 2013, CURR BIOL, V23, P399, DOI 10.1016/j.cub.2013.01.036; Tsodyks M, 1995, INTERNATIONAL JOURNAL OF NEURAL SYSTEMS, SUPPLEMENTARY ISSUE, 1995, P81; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Welinder PE, 2008, HIPPOCAMPUS, V18, P1283, DOI 10.1002/hipo.20519; WIENER SI, 1989, J NEUROSCI, V9, P2737; Wilber AA, 2014, J NEUROSCI, V34, P5431, DOI 10.1523/JNEUROSCI.0511-14.2014; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Winter SS, 2015, CURR BIOL, V25, P2493, DOI 10.1016/j.cub.2015.08.034; Winter SS, 2015, SCIENCE, V347, P870, DOI 10.1126/science.1259591; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; WORDEN R, 1992, HIPPOCAMPUS, V2, P165, DOI 10.1002/hipo.450020208; Yartsev MM, 2013, SCIENCE, V340, P367, DOI 10.1126/science.1235338; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Ye J., 2016, SOC NEUR ABSTR, V183, P11; Yoder RM, 2011, TRENDS NEUROSCI, V34, P561, DOI 10.1016/j.tins.2011.08.004; Yoganarasimha D, 2006, J NEUROSCI, V26, P622, DOI 10.1523/JNEUROSCI.3885-05.2006; Yoon KJ, 2013, NAT NEUROSCI, V16, P1077, DOI 10.1038/nn.3450; YOUNG BJ, 1994, J NEUROSCI, V14, P6553; Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722; Zhang K, 1996, J NEUROSCI, V16, P2112; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	299	195	198	10	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2017	20	11					1448	1464		10.1038/nn.4653	http://dx.doi.org/10.1038/nn.4653			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL0QV	29073644	Green Published, Green Submitted			2022-12-17	WOS:000413916800004
J	Saygin, ZM; Osher, DE; Norton, ES; Youssoufian, DA; Beach, SD; Feather, J; Gaab, N; Gabrieli, JDE; Kanwisher, N				Saygin, Zeynep M.; Osher, David E.; Norton, Elizabeth S.; Youssoufian, Deanna A.; Beach, Sara D.; Feather, Jenelle; Gaab, Nadine; Gabrieli, John D. E.; Kanwisher, Nancy			Connectivity precedes function in the development of the visual word form area	NATURE NEUROSCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; REPRESENTATIONS; RECOGNITION; PROJECTIONS; SELECTIVITY; REVEALS; ORIGINS; PATHWAY; OBJECTS; FACES	What determines the cortical location at which a given functionally specific region will arise in development? We tested the hypothesis that functionally specific regions develop in their characteristic locations because of pre-existing differences in the extrinsic connectivity of that region to the rest of the brain. We exploited the visual word form area (VWFA) as a test case, scanning children with diffusion and functional imaging at age 5, before they learned to read, and at age 8, after they learned to read. We found the VWFA developed functionally in this interval and that its location in a particular child at age 8 could be predicted from that child's connectivity fingerprints (but not functional responses) at age 5. These results suggest that early connectivity instructs the functional development of the VWFA, possibly reflecting a general mechanism of cortical development.	[Saygin, Zeynep M.; Beach, Sara D.; Feather, Jenelle; Gabrieli, John D. E.; Kanwisher, Nancy] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Saygin, Zeynep M.; Beach, Sara D.; Gabrieli, John D. E.; Kanwisher, Nancy] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Osher, David E.] Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA; [Norton, Elizabeth S.] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL USA; [Youssoufian, Deanna A.] Columbia Univ, Dept Biol Sci, Barnard Coll, New York, NY 10027 USA; [Gaab, Nadine] Boston Childrens Hosp, Boston, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Boston University; Northwestern University; Columbia University; Harvard University; Boston Children's Hospital	Saygin, ZM (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Saygin, ZM (corresponding author), MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA.	zsaygin@mit.edu	Saygin, Zeynep M./AAV-4951-2020; Gabrieli, John/AAJ-2869-2020; Gaab, Nadine/AAD-9144-2022	Norton, Elizabeth/0000-0002-4023-8051; Gaab, Nadine/0000-0002-7548-413X	NICHD/NIH grant [F32HD079169]; NIH/NICHD [R01HD067312]; Ellison Medical Foundation [EY13455]; McGovern Institute for Brain Research MINT [1444913]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD079169, R01HD065762, R01HD067312] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013455] Funding Source: NIH RePORTER	NICHD/NIH grant; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ellison Medical Foundation(Lawrence Ellison Foundation); McGovern Institute for Brain Research MINT; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank B. Fischl and M. Reuter for their guidance and advice on longitudinal registration, S. Robinson and O. Ozernov-Palchik for assistance with participant coordination and A. Park for technical assistance. We thank the Athinoula A. Martinos Imaging Center at the McGovern Institute for Brain Research at the Massachusetts Institute of Technology and its staff. We also thank our READ Study research testers, school coordinators and principals, and participating families. This work was funded by NICHD/NIH grant F32HD079169 to Z.M.S., NIH/NICHD R01HD067312 to J.D.E.G. and N.G., Ellison Medical Foundation, EY13455 to N.K., and grant 1444913 from McGovern Institute for Brain Research MINT to N.K. and Z.M.S.	Baker CI, 2007, P NATL ACAD SCI USA, V104, P9087, DOI 10.1073/pnas.0703300104; Behrmann M, 2013, TRENDS COGN SCI, V17, P210, DOI 10.1016/j.tics.2013.03.007; Botthali F, 2014, J NEUROSCI, V34, P15402, DOI 10.1523/JNEUROSCI.4918-13.2014; Brodmann K., 1909, VERGLEICHENDE LOKALI; Cantlon JF, 2011, CEREB CORTEX, V21, P191, DOI 10.1093/cercor/bhq078; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; Glezer LS, 2015, J NEUROSCI, V35, P4965, DOI 10.1523/JNEUROSCI.4031-14.2015; Glezer LS, 2013, J NEUROSCI, V33, P11221, DOI 10.1523/JNEUROSCI.5002-12.2013; Glezer LS, 2009, NEURON, V62, P199, DOI 10.1016/j.neuron.2009.03.017; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Hannagan T, 2015, TRENDS COGN SCI, V19, P374, DOI 10.1016/j.tics.2015.05.006; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Horng S, 2009, J NEUROSCI, V29, P13672, DOI 10.1523/JNEUROSCI.2127-09.2009; Langer N., 2015, CEREB CORTEX; Lorenz S., 2015, CEREB CORTEX; Mahon BZ, 2011, TRENDS COGN SCI, V15, P97, DOI 10.1016/j.tics.2011.01.004; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; Osher DE, 2016, CEREB CORTEX, V26, P1668, DOI 10.1093/cercor/bhu303; ROE AW, 1990, SCIENCE, V250, P818, DOI 10.1126/science.2237432; ROE AW, 1992, J NEUROSCI, V12, P3651; Saygin ZM, 2013, J NEUROSCI, V33, P13251, DOI 10.1523/JNEUROSCI.4383-12.2013; Saygin ZM, 2012, NAT NEUROSCI, V15, P321, DOI 10.1038/nn.3001; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; Srihasam K, 2014, NAT NEUROSCI, V17, P1776, DOI 10.1038/nn.3855; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; Tavor I, 2016, SCIENCE, V352, P216, DOI 10.1126/science.aad8127; Yeatman JD, 2013, BRAIN LANG, V125, P146, DOI 10.1016/j.bandl.2012.04.010	29	195	198	5	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2016	19	9					1250	1255		10.1038/nn.4354	http://dx.doi.org/10.1038/nn.4354			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU5SA	27500407	Green Accepted, Green Published			2022-12-17	WOS:000382270400025
J	Kurita, M; Holloway, T; Garcia-Bea, A; Kozlenkov, A; Friedman, AK; Moreno, JL; Heshmati, M; Golden, SA; Kennedy, PJ; Takahashi, N; Dietz, DM; Mocci, G; Gabilondo, AM; Hanks, J; Umali, A; Callado, LF; Gallitano, AL; Neve, RL; Shen, L; Buxbaum, JD; Han, MH; Nestler, EJ; Meana, JJ; Russo, SJ; Gonzalez-Maeso, J				Kurita, Mitsumasa; Holloway, Terrell; Garcia-Bea, Aintzane; Kozlenkov, Alexey; Friedman, Allyson K.; Moreno, Jose L.; Heshmati, Mitra; Golden, Sam A.; Kennedy, Pamela J.; Takahashi, Nagahide; Dietz, David M.; Mocci, Giuseppe; Gabilondo, Ane M.; Hanks, James; Umali, Adrienne; Callado, Luis F.; Gallitano, Amelia L.; Neve, Rachael L.; Shen, Li; Buxbaum, Joseph D.; Han, Ming-Hu; Nestler, Eric J.; Meana, J. Javier; Russo, Scott J.; Gonzalez-Maeso, Javier			HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity	NATURE NEUROSCIENCE			English	Article							HISTONE DEACETYLASE; RECEPTOR AGONIST; ANIMAL-MODELS; SCHIZOPHRENIA; GLUTAMATE; ACTIVATION; CLOZAPINE; BRAIN; PHARMACOLOGY; DIVALPROEX	Histone deacetylases (HDACs) compact chromatin structure and repress gene transcription. In schizophrenia, clinical studies demonstrate that HDAC inhibitors are efficacious when given in combination with atypical antipsychotics. However, the molecular mechanism that integrates a better response to antipsychotics with changes in chromatin structure remains unknown. Here we found that chronic atypical antipsychotics downregulated the transcription of metabotropic glutamate 2 receptor (mGlu2, also known as Grm2), an effect that was associated with decreased histone acetylation at its promoter in mouse and human frontal cortex. This epigenetic change occurred in concert with a serotonin 5-HT2A receptor-dependent upregulation and increased binding of HDAC2 to the mGlu2 promoter. Virally mediated overexpression of HDAC2 in frontal cortex decreased mGlu2 transcription and its electrophysiological properties, thereby increasing psychosis-like behavior. Conversely, HDAC inhibitors prevented the repressive histone modifications induced at the mGlu2 promoter by atypical antipsychotics, and augmented their therapeutic-like effects. These observations support the view of HDAC2 as a promising new target for schizophrenia treatment.	[Kurita, Mitsumasa; Holloway, Terrell; Garcia-Bea, Aintzane; Kozlenkov, Alexey; Moreno, Jose L.; Heshmati, Mitra; Takahashi, Nagahide; Mocci, Giuseppe; Hanks, James; Umali, Adrienne; Buxbaum, Joseph D.; Nestler, Eric J.; Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Garcia-Bea, Aintzane; Gabilondo, Ane M.; Callado, Luis F.; Meana, J. Javier] Univ Basque Country UPV EHU, Dept Pharmacol, Leioa, Spain; [Garcia-Bea, Aintzane; Gabilondo, Ane M.; Callado, Luis F.; Meana, J. Javier] Ctr Invest Biomed Red Salud Mental CIBERSAM, Leioa, Spain; [Friedman, Allyson K.; Han, Ming-Hu; Nestler, Eric J.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY USA; [Golden, Sam A.; Kennedy, Pamela J.; Dietz, David M.; Han, Ming-Hu; Nestler, Eric J.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Gallitano, Amelia L.] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ USA; [Gallitano, Amelia L.] Univ Arizona, Coll Med, Dept Psychiat, Phoenix, AZ USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Buxbaum, Joseph D.; Han, Ming-Hu; Nestler, Eric J.; Russo, Scott J.; Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Dept Neurol, New York, NY USA	Icahn School of Medicine at Mount Sinai; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Arizona; University of Arizona; Massachusetts Institute of Technology (MIT); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Gonzalez-Maeso, J (corresponding author), Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA.	javier.maeso@mssm.edu	Russo, Scott/R-7107-2019; Callado, Luis F./A-7024-2008; Dietz, David/J-9458-2015; Gallitano, Amelia L./C-5591-2014; Moreno, Jose L/L-8981-2017; Gabilondo, Ane M./C-4417-2015; Han, Ming-Hu/G-8836-2012; Takahashi, Nagahide/AAR-6268-2020; Shen, Li/B-3562-2008; Dietz, David/AAW-4574-2021; Buxbaum, Joseph D/G-6001-2010	Russo, Scott/0000-0002-6470-1805; Callado, Luis F./0000-0001-9941-012X; Dietz, David/0000-0002-6927-9236; Gallitano, Amelia L./0000-0002-0544-7114; Gabilondo, Ane M./0000-0002-1892-3861; Takahashi, Nagahide/0000-0002-7711-0297; Shen, Li/0000-0002-5190-2851; Dietz, David/0000-0002-6927-9236; Buxbaum, Joseph/0000-0001-8898-8313; Golden, Sam/0000-0002-2104-2272; MEANA, JOSE JAVIER/0000-0002-7913-6714; CALLADO HERNANDO, LUIS FELIPE/0000-0002-5564-3447	US National Institutes of Health (NIH) [R01 MH084894]; Dainippon Sumitomo Pharma; NARSAD; Maltz Family Foundation; NIH [R01 MH090264, P50 MH090963, R01 MH092306, P50 MH066392, F32 MH096464]; MICINN [SAF2009-084609]; Basque Government [IT-199-07]; Ministerio de Ciencia e Innovacion; Consejo Superior de Investigaciones Cientificas (CSIC), Spain; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH096464, T32MH087004, R01MH084894, P50MH090963, P50MH096890, U01MH083545, R01MH092306, P50MH066392, R01MH090264] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); NARSAD(NARSAD); Maltz Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Basque Government(Basque Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejo Superior de Investigaciones Cientificas (CSIC), Spain; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to thank A. Chess, Y. Hurd, C. Alberini, P. Bos and J. Greally for critical review of the manuscript; M. Shapiro for help in working memory experiments; S. Morgello (Mount Sinai School of Medicine) and the Manhattan HIV Brain Bank for providing control brain cortex; P. Casaccia (Mount Sinai School of Medicine) for discussions and for providing the plasmid encoding mouse HDAC2; J. Gingrich (Columbia University) for his gift of 5HT2A<SUP>-/-</SUP> mice; V. Rayannavar for assistance with biochemical and behavioral assays; and the staff members of the Basque Institute of Legal Medicine for their cooperation in the study. US National Institutes of Health (NIH) R01 MH084894 (J.G.-M.), Dainippon Sumitomo Pharma (J.G.-M.), NARSAD (J.G.-M.), the Maltz Family Foundation (J.G.-M.), NIH R01 MH090264 (S. J. R.), MICINN SAF2009-084609 (J. J. M.), the Basque Government IT-199-07 (J. J. M.), NIH P50 MH090963 (E.J.N.), NIH R01 MH092306 (M.-H. H.) and NIH P50 MH066392 (J. D. B.) helped fund this study. A. K. F. was supported by NIH grant F32 MH096464. A.G.-B., J. L. M. and G. M. were recipients of predoctoral and postdoctoral fellowships from the Basque government, Ministerio de Ciencia e Innovacion, and Consejo Superior de Investigaciones Cientificas (CSIC), Spain.	Abdolmaleky HM, 2011, SCHIZOPHR RES, V129, P183, DOI 10.1016/j.schres.2011.04.007; Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Aghajanian GK, 2009, PSYCHOPHARMACOLOGY, V206, P575, DOI 10.1007/s00213-009-1484-9; Agid O, 2003, ARCH GEN PSYCHIAT, V60, P1228, DOI 10.1001/archpsyc.60.12.1228; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Benneyworth MA, 2007, MOL PHARMACOL, V72, P477, DOI 10.1124/mol.107.035170; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Chiechio S, 2009, MOL PHARMACOL, V75, P1014, DOI 10.1124/mol.108.054346; Citrome L, 2004, PSYCHIAT SERV, V55, P290, DOI 10.1176/appi.ps.55.3.290; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Dean B, 2003, J NEUROCHEM, V85, P1, DOI 10.1046/j.1471-4159.2003.01693.x; Dobbs D, 2010, NATURE, V468, P154, DOI 10.1038/468154a; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; Dong E, 2007, P NATL ACAD SCI USA, V104, P4676, DOI 10.1073/pnas.0700529104; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Fell MJ, 2008, J PHARMACOL EXP THER, V326, P209, DOI 10.1124/jpet.108.136861; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Geyer MA, 2008, TRENDS PHARMACOL SCI, V29, P445, DOI 10.1016/j.tips.2008.06.006; GOLDBERG TE, 1993, BRIT J PSYCHIAT, V162, P43, DOI 10.1192/bjp.162.1.43; Gonzalez-Maeso J, 2003, J NEUROSCI, V23, P8836; Gonzalez-Maeso J, 2002, MOL PSYCHIATR, V7, P755, DOI 10.1038/sj.mp.4001067; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Gonzalez-Maeso J, 2009, TRENDS NEUROSCI, V32, P225, DOI 10.1016/j.tins.2008.12.005; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Hof PR., 2000, COMP CYTOARCHITECTON; Huang HS, 2006, J NEUROSCI METH, V156, P284, DOI 10.1016/j.jneumeth.2006.02.018; Humphrey GW, 2008, DIFFERENTIATION, V76, P348, DOI 10.1111/j.1432-0436.2007.00232.x; Kelly DL, 2006, PSYCHIAT QUART, V77, P81, DOI 10.1007/s11126-006-7963-9; Kristiansen LV, 2007, CURR OPIN PHARMACOL, V7, P48, DOI 10.1016/j.coph.2006.08.013; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Liu W, 2012, PHARMACOGENOMICS J, V12, P246, DOI 10.1038/tpj.2010.90; Loscher W, 1999, PROG NEUROBIOL, V58, P31, DOI 10.1016/S0301-0082(98)00075-6; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; Marder E, 2011, NAT NEUROSCI, V14, P133, DOI 10.1038/nn.2735; MARTIN WR, 1963, PSYCHOPHARMACOLOGIA, V4, P247, DOI 10.1007/BF00408180; Matrisciano F, 2012, NEUROPSYCHOPHARMACOL, V37, P929, DOI 10.1038/npp.2011.274; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Moreno JL, 2011, J NEUROSCI, V31, P1863, DOI 10.1523/JNEUROSCI.4230-10.2011; Moreno JL, 2009, CELL MOL LIFE SCI, V66, P3777, DOI 10.1007/s00018-009-0130-3; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Peter CJ, 2011, TRENDS MOL MED, V17, P372, DOI 10.1016/j.molmed.2011.02.003; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Suzuki T, 2009, HUM PSYCHOPHARM CLIN, V24, P628, DOI 10.1002/hup.1073; Tamaru Y, 2001, NEUROSCIENCE, V106, P481, DOI 10.1016/S0306-4522(01)00305-0; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Van Sant SP, 2011, EXPERT OPIN PHARMACO, V12, P411, DOI 10.1517/14656566.2011.528200; Vollenweider FX, 1998, NEUROREPORT, V9, P3897, DOI 10.1097/00001756-199812010-00024; Woolley ML, 2008, PSYCHOPHARMACOLOGY, V196, P431, DOI 10.1007/s00213-007-0974-x; Zhai Y, 2003, NEUROPSYCHOPHARMACOL, V28, P45, DOI 10.1038/sj.npp.1300013	60	195	218	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1245	U109		10.1038/nn.3181	http://dx.doi.org/10.1038/nn.3181			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22864611	Green Accepted			2022-12-17	WOS:000308072600015
J	Gupta, AS; van der Meer, MAA; Touretzky, DS; Redish, AD				Gupta, Anoopum S.; van der Meer, Matthijs A. A.; Touretzky, David S.; Redish, A. David			Segmentation of spatial experience by hippocampal theta sequences	NATURE NEUROSCIENCE			English	Article							PHASE PRECESSION; PLACE CELLS; AWAKE STATE; MEMORY; DYNAMICS; NEURONS; FUTURE; REPLAY; INFORMATION; CA3	The encoding and storage of experience by the hippocampus is essential for the formation of episodic memories and the transformation of individual experiences into semantic structures such as maps and schemas. The rodent hippocampus compresses ongoing experience into repeating theta sequences, but the factors determining the content of theta sequences are not understood. Here we first show that the spatial paths represented by theta sequences in rats extend farther in front of the rat during acceleration and higher running speeds and begin farther behind the rat during deceleration. Second, the length of the path is directly related to the length of the theta cycle and the number of gamma cycles in it. Finally, theta sequences represent the environment in segments or 'chunks'. These results imply that information encoded in theta sequences is subject to powerful modulation by behavior and task variables. Furthermore, these findings suggest a potential mechanism for the cognitive 'chunking' of experience.	[Redish, A. David] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Gupta, Anoopum S.] Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA; [Gupta, Anoopum S.; Touretzky, David S.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Gupta, Anoopum S.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [van der Meer, Matthijs A. A.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [van der Meer, Matthijs A. A.] Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON N2L 3G1, Canada; [Touretzky, David S.] Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA	University of Minnesota System; University of Minnesota Twin Cities; Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Waterloo; University of Waterloo; Carnegie Mellon University	Redish, AD (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	redish@umn.edu		van der Meer, Matthijs/0000-0002-2206-4473	US National Institutes of Health [R01 MH-080318, F30 MH-091821]; Pennsylvania Department of Health; US National Science Foundation Integrative Graduate Education and Research Traineeship grant [DGE-0549352]; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH091821, R01MH080318] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; US National Science Foundation Integrative Graduate Education and Research Traineeship grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Boldt, K.D. Seeland and A.P. Steiner for technical assistance and A. Johnson and the members of the Redish lab for discussion. This work was supported by US National Institutes of Health grants (R01 MH-080318 and F30 MH-091821), the Pennsylvania Department of Health and a US National Science Foundation Integrative Graduate Education and Research Traineeship grant (DGE-0549352).	Battaglia FP, 2004, J NEUROSCI, V24, P4541, DOI 10.1523/JNEUROSCI.4896-03.2004; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Cohen N.J., 1993, MEMORY AMNESIA HIPPO, DOI DOI 10.1136/JNNP.58.1.128-A; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Foster DJ, 2007, HIPPOCAMPUS, V17, P1093, DOI 10.1002/hipo.20345; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Geisler C, 2010, P NATL ACAD SCI USA, V107, P7957, DOI 10.1073/pnas.0912478107; Gothard KM, 2001, J NEUROSCI, V21, P7284, DOI 10.1523/JNEUROSCI.21-18-07284.2001; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Gupta AS, 2011, THESIS CARNEGIE MELL; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hasselmo ME, 2005, BEHAV NEUROSCI, V119, P342, DOI 10.1037/0735-7044.119.1.342; Hasselmo ME, 2009, NEUROBIOL LEARN MEM, V92, P559, DOI 10.1016/j.nlm.2009.07.005; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Ji DY, 2008, J NEUROSCI, V28, P4679, DOI 10.1523/JNEUROSCI.4597-07.2008; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman J, 2009, PHILOS T R SOC B, V364, P1193, DOI 10.1098/rstb.2008.0316; Malhotra S, 2012, REV NEUROSCIENCE, V23, P39, DOI 10.1515/revneuro-2011-0064; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; Maurer AP, 2012, HIPPOCAMPUS, V22, P737, DOI 10.1002/hipo.20936; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/0033-295X.101.2.343; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Mulder AB, 2004, EUR J NEUROSCI, V19, P1923, DOI 10.1111/j.1460-9568.2004.03301.x; MULLER RU, 1989, J NEUROSCI, V9, P4101; Newell A., 1990, UNIFIED THEORIES COG; Newell A., 1972, HUMAN PROBLEM SOLVIN; O'Keefe J., 1993, HIPPOCAMPUS, V3, P317, DOI DOI 10.1002/HIP0.450030307); O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; Robbe D, 2009, J NEUROSCI, V29, P12597, DOI 10.1523/JNEUROSCI.2407-09.2009; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schmidt R, 2009, J NEUROSCI, V29, P13232, DOI 10.1523/JNEUROSCI.2270-09.2009; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; van der Meer MAA, 2011, J NEUROSCI, V31, P2843, DOI 10.1523/JNEUROSCI.4869-10.2011; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Yartsev MM, 2008, J NEUROSCI, V28, P8383, DOI 10.1523/JNEUROSCI.2442-08.2008	48	195	198	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					1032	1039		10.1038/nn.3138	http://dx.doi.org/10.1038/nn.3138			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22706269	Green Accepted			2022-12-17	WOS:000305819600022
J	Baumgartner, T; Knoch, D; Hotz, P; Eisenegger, C; Fehr, E				Baumgartner, Thomas; Knoch, Daria; Hotz, Philine; Eisenegger, Christoph; Fehr, Ernst			Dorsolateral and ventromedial prefrontal cortex orchestrate normative choice	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DECISION-MAKING; ORBITOFRONTAL CORTEX; COGNITIVE CONTROL; SOCIAL COGNITION; NEURAL CIRCUITRY; SELF-CONTROL; NEUROBIOLOGY; PREFERENCES; MODULATION	Humans are noted for their capacity to over-ride self-interest in favor of normatively valued goals. We examined the neural circuitry that is causally involved in normative, fairness-related decisions by generating a temporarily diminished capacity for costly normative behavior, a 'deviant' case, through non-invasive brain stimulation (repetitive transcranial magnetic stimulation) and compared normal subjects' functional magnetic resonance imaging signals with those of the deviant subjects. When fairness and economic self-interest were in conflict, normal subjects (who make costly normative decisions at a much higher frequency) displayed significantly higher activity in, and connectivity between, the right dorsolateral prefrontal cortex (DLPFC) and the posterior ventromedial prefrontal cortex (pVMPFC). In contrast, when there was no conflict between fairness and economic self-interest, both types of subjects displayed identical neural patterns and behaved identically. These findings suggest that a parsimonious prefrontal network, the activation of right DLPFC and pVMPFC, and the connectivity between them, facilitates subjects' willingness to incur the cost of normative decisions.	[Baumgartner, Thomas; Hotz, Philine; Eisenegger, Christoph; Fehr, Ernst] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland; [Baumgartner, Thomas; Knoch, Daria] Univ Basel, Dept Psychol, Lab Social & Affect Neurosci, Basel, Switzerland; [Eisenegger, Christoph] Univ Cambridge, Dept Expt Psychol, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England	University of Zurich; University of Basel; University of Cambridge	Baumgartner, T (corresponding author), Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland.	t.baumgartner@unibas.ch; daria.knoch@unibas.ch; ernst.fehr@econ.uzh.ch	Knoch, Daria/H-7324-2012	Baumgartner, Thomas/0000-0001-5966-7377	Neurochoice Project of SystemsX; Swiss Initiative for Systems Biology; Swiss National Science Foundation [PP00P1-123381]	Neurochoice Project of SystemsX; Swiss Initiative for Systems Biology; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank C. Ruff, K. E. Stephan and A. Rangel for their helpful comments. This study is a part of the project on the foundations of norm compliance in the National Center of Competence in Affective Sciences. E. F. also acknowledges support from the Neurochoice Project of SystemsX, the Swiss Initiative for Systems Biology. D. K. acknowledges support from the Swiss National Science Foundation (grant no. PP00P1-123381).	BAUMGARTNER T, 2011, HUM BRAIN MAPP  0513, DOI DOI 10.1002/HBM.21298; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Baumgartner T, 2009, NEURON, V64, P756, DOI 10.1016/j.neuron.2009.11.017; BLOUNT S, 1995, ORGAN BEHAV HUM DEC, V63, P131, DOI 10.1006/obhd.1995.1068; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Boyd R, 2005, ORIGIN EVOLUTION CUL; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Damasio A, 1995, DESCARTES ERROR EMOT; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Eisenegger C, 2008, NEUROIMAGE, V42, P379, DOI 10.1016/j.neuroimage.2008.04.172; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Griskova I, 2007, NEUROSCI LETT, V419, P162, DOI 10.1016/j.neulet.2007.04.030; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2010, J NEUROSCI, V30, P583, DOI 10.1523/JNEUROSCI.4089-09.2010; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Herwig U, 2007, NEUROIMAGE, V37, P652, DOI 10.1016/j.neuroimage.2007.05.023; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Knoch D, 2008, CEREB CORTEX, V18, P1987, DOI 10.1093/cercor/bhm237; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Knoch D, 2010, PSYCHOL SCI, V21, P337, DOI 10.1177/0956797609360750; Knoch D, 2009, P NATL ACAD SCI USA, V106, P20895, DOI 10.1073/pnas.0911619106; Koch G, 2005, NEUROIMAGE, V24, P34, DOI 10.1016/j.neuroimage.2004.09.042; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Miller BL, 1997, BRIT J PSYCHIAT, V170, P150, DOI 10.1192/bjp.170.2.150; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Smith DV, 2010, J NEUROSCI, V30, P2490, DOI 10.1523/JNEUROSCI.3319-09.2010; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Tricomi E, 2010, NATURE, V463, P1089, DOI 10.1038/nature08785; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14	50	195	204	6	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1468	U149		10.1038/nn.2933	http://dx.doi.org/10.1038/nn.2933			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21964488	Green Accepted, Green Published			2022-12-17	WOS:000296518600024
J	Mazzuca, M; Heurteaux, C; Alloui, A; Diochot, S; Baron, A; Voilley, N; Blondeau, N; Escoubas, P; Gelot, A; Cupo, A; Zimmer, A; Zimmer, AM; Eschalier, A; Lazdunski, M				Mazzuca, Michel; Heurteaux, Catherine; Alloui, Abdelkrim; Diochot, Sylvie; Baron, Anne; Voilley, Nicolas; Blondeau, Nicolas; Escoubas, Pierre; Gelot, Agnes; Cupo, Anny; Zimmer, Andreas; Zimmer, Anne M.; Eschalier, Alain; Lazdunski, Michel			A tarantula peptide against pain via ASIC1a channels and opioid mechanisms	NATURE NEUROSCIENCE			English	Article								Psalmotoxin 1, a peptide extracted from the South American tarantula Psalmopoeus cambridgei, has very potent analgesic properties against thermal, mechanical, chemical, inflammatory and neuropathic pain in rodents. It exerts its action by blocking acid-sensing ion channel 1a, and this blockade results in an activation of the endogenous enkephalin pathway. The analgesic properties of the peptide are suppressed by antagonists of the mu and delta-opioid receptors and are lost in Penk1(-/-) mice.	Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, Inst Paul Hamel, F-06560 Valbonne, France; CHU, Fac Med, INSERM, Unite Mixte Rech 766, Clermont Ferrand, France; Univ Bonn, Dept Mol Psychiat, D-53105 Bonn, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Bonn	Lazdunski, M (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, Inst Paul Hamel, 660 Route Lucioles, F-06560 Valbonne, France.	ipmc@ipmc.cnrs.fr	HEURTEAUX, Catherine/M-4947-2016; Blondeau, Nicolas/T-1136-2019; Zimmer, Andreas/B-8357-2009; BARON, Anne/N-5691-2016; Blondeau, Nicolas P/M-5002-2016; ESCHALIER, Alain/L-9957-2015; Diochot, Sylvie/ABG-5495-2020	HEURTEAUX, Catherine/0000-0002-9741-9777; BARON, Anne/0000-0002-8026-6380; Blondeau, Nicolas P/0000-0001-5954-4094; 				Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Ettaiche M, 2006, J NEUROSCI, V26, P5800, DOI 10.1523/JNEUROSCI.0344-06.2006; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Mamet J, 2002, J NEUROSCI, V22, P10662; Roumy M, 1998, EUR J PHARMACOL, V345, P1, DOI 10.1016/S0014-2999(97)01604-X; Sluka KA, 2007, PAIN, V129, P102, DOI 10.1016/j.pain.2006.09.038; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wood J N, 2007, Handb Exp Pharmacol, P329	15	195	204	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					943	945		10.1038/nn1940	http://dx.doi.org/10.1038/nn1940			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17632507				2022-12-17	WOS:000248357500006
J	Borrell, V; Marin, O				Borrell, Victor; Marin, Oscar			Meninges control tangential migration of hem-derived Cajal-Retzius cells via CXCL12/CXCR4 signaling	NATURE NEUROSCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; CHEMOKINE RECEPTOR CXCR4; STRUCTURAL ORGANIZATION; INTERNEURON MIGRATION; CORTICAL LAMINATION; NEURONAL MIGRATION; ONE CENTURY; LAYER-I; MOUSE; FOREBRAIN	Cajal-Retzius cells are critical in the development of the cerebral cortex, but little is known about the mechanisms controlling their development. Three focal sources of Cajal-Retzius cells have been identified in mice-the cortical hem, the ventral pallium and the septum-from where they migrate tangentially to populate the cortical surface. Using a variety of tissue culture assays and in vivo manipulations, we demonstrate that the tangential migration of cortical hem-derived Cajal-Retzius cells is controlled by the meninges. We show that the meningeal membranes are a necessary and sufficient substrate for the tangential migration of Cajal-Retzius cells. We also show that the chemokine CXCL12 secreted by the meninges enhances the dispersion of Cajal-Retzius cells along the cortical surface, while retaining them within the marginal zone in a CXCR4-dependent manner. Thus, the meningeal membranes are fundamental in the development of Cajal-Retzius cells and, hence, in the normal development of the cerebral cortex.	CSIC, Inst Neurociencias Alicante, Sant Joan Dalacant 03550, Spain; Univ Miguel Hernandez, Sant Joan Dalacant 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche	Marin, O (corresponding author), CSIC, Inst Neurociencias Alicante, Sant Joan Dalacant 03550, Spain.	o.marin@umh.es	Borrell, Victor/U-1802-2017; Marin, Oscar/F-3856-2012	Borrell, Victor/0000-0002-7833-3978; Marin, Oscar/0000-0001-6264-7027				Alcantara S, 1998, J NEUROSCI, V18, P7779; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bagri A, 2002, DEVELOPMENT, V129, P4249; Belmadani A, 2005, J NEUROSCI, V25, P3995, DOI 10.1523/JNEUROSCI.4631-04.2005; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Chalasani SH, 2003, J NEUROSCI, V23, P1360, DOI 10.1523/JNEUROSCI.23-04-01360.2003; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DELRIO JA, 1995, CEREB CORTEX, V5, P13, DOI 10.1093/cercor/5.1.13; DERER P, 1990, NEUROSCIENCE, V36, P839, DOI 10.1016/0306-4522(90)90027-2; Fairen A, 2002, PROG BRAIN RES, V136, P281; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Halfter W, 2002, J NEUROSCI, V22, P6029; Hartmann D, 1999, CURR BIOL, V9, P719, DOI 10.1016/S0960-9822(99)80331-5; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Knaut H, 2005, NEURON, V47, P653, DOI 10.1016/j.neuron.2005.07.014; Lazarini F, 2000, EUR J NEUROSCI, V12, P117, DOI 10.1046/j.1460-9568.2000.00894.x; Lieberam I, 2005, NEURON, V47, P667, DOI 10.1016/j.neuron.2005.08.011; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; MARINPADILLA M, 1990, J COMP NEUROL, V299, P89, DOI 10.1002/cne.902990107; MARINPADILLA M, 1982, ANAT EMBRYOL, V164, P161, DOI 10.1007/BF00318504; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Niewmierzycka A, 2005, J NEUROSCI, V25, P7022, DOI 10.1523/JNEUROSCI.1695-05.2005; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Reiss K, 2002, NEUROSCIENCE, V115, P295, DOI 10.1016/S0306-4522(02)00307-X; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Shinozaki K, 2002, DEVELOPMENT, V129, P3479; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; Stumm RK, 2003, J NEUROSCI, V23, P5123; Super H, 1997, DEV BRAIN RES, V98, P9, DOI 10.1016/S0165-3806(96)00154-X; Super H, 2000, CEREB CORTEX, V10, P602, DOI 10.1093/cercor/10.6.602; Super H, 1997, DEV BRAIN RES, V98, P15, DOI 10.1016/S0165-3806(96)00155-1; TACHMINTZIS J, 1994, BIOCONTROL SCI TECHN, V4, P591, DOI 10.1080/09583159409355372; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Tissir F, 2004, DEV BRAIN RES, V149, P63, DOI 10.1016/j.devbrainres.2004.01.002; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Wines-Samuelson M, 2005, DEV BIOL, V277, P332, DOI 10.1016/j.ydbio.2004.09.024; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yamazaki H, 2004, P NATL ACAD SCI USA, V101, P14509, DOI 10.1073/pnas.0406295101; Yoshida M, 2006, DEVELOPMENT, V133, P537, DOI 10.1242/dev.02209; Zhu Y, 2004, DEV BIOL, V267, P153, DOI 10.1016/j.ydbio.2003.10.037; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	50	195	204	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1284	1293		10.1038/nn1764	http://dx.doi.org/10.1038/nn1764			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16964252				2022-12-17	WOS:000241493900022
J	Bandell, M; Dubin, AE; Petrus, MJ; Orth, A; Mathur, J; Hwang, SW; Patapoutian, A				Bandell, M; Dubin, AE; Petrus, MJ; Orth, A; Mathur, J; Hwang, SW; Patapoutian, A			High-throughput random mutagenesis screen reveals TRPM8 residues specifically required for activation by menthol	NATURE NEUROSCIENCE			English	Article							NUCLEOTIDE-GATED CHANNELS; ION-CHANNEL; MOLECULAR MECHANISM; CAPSAICIN RECEPTOR; VANILLOID RECEPTOR; CRYSTAL-STRUCTURE; HCN CHANNELS; K+ CHANNEL; COLD; TRPA1	Menthol is a cooling compound derived from mint leaves and is extensively used as a flavoring chemical. Menthol activates transient receptor potential melastatin 8 (TRPM8), an ion channel also activated by cold, voltage and phosphatidylinositol-4,5-bisphosphate (PIP2). Here we investigated the mechanism by which menthol activates mouse TRPM8. Using a new high-throughput approach, we screened a random mutant library consisting of similar to 14,000 individual TRPM8 mutants for clones that are affected in their response to menthol while retaining channel function. We identified determinants of menthol sensitivity in two regions: putative transmembrane segment 2 (S2) and the C-terminal TRP domain. Analysis of these mutants indicated that activation by menthol involves a gating mechanism distinct and separable from gating by cold, voltage or PIP2. Notably, TRP domain mutations mainly attenuated menthol efficacy, suggesting that this domain influences events downstream of initial binding. In contrast, S2 mutations strongly shifted the concentration dependence of menthol activation, raising the possibility that S2 influences menthol binding.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Novartis; Scripps Research Institute	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	ardem@scripps.edu		Hwang, Sun Wook/0000-0001-8460-7480	PHS HHS [MS046303] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Jung J, 2002, J BIOL CHEM, V277, P44448, DOI 10.1074/jbc.M207103200; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rosenbaum T, 2004, NEURON, V42, P193, DOI 10.1016/S0896-6273(04)00199-0; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Taylor J. R., 1982, INTRO ERROR ANAL STU; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang T, 2005, J CELL BIOL, V171, P685, DOI 10.1083/jcb.200508030; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; YU FH, 2004, SCI STKE; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012	39	195	200	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					493	500		10.1038/nn1665	http://dx.doi.org/10.1038/nn1665			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16520735				2022-12-17	WOS:000236310700016
J	Subramaniam, JR; Lyons, WE; Liu, J; Bartnikas, TB; Rothstein, J; Price, DL; Cleveland, DW; Gitlin, JD; Wong, PC				Subramaniam, JR; Lyons, WE; Liu, J; Bartnikas, TB; Rothstein, J; Price, DL; Cleveland, DW; Gitlin, JD; Wong, PC			Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU,ZN SUPEROXIDE-DISMUTASE; CU,ZN-SUPEROXIDE DISMUTASE; HYDROGEN-PEROXIDE; MOUSE MODEL; CELL-DEATH; K-M; MICE; ALS; BINDING	Copper-mediated oxidative damage is proposed to play a critical role in the pathogenesis of Cu/Zn superoxide dismutase (SOD1)-linked familial amyotrophic lateral sclerosis (FALS). We tested this hypothesis by ablating the gene encoding the copper chaperone for SOD1 (CCS) in a series of FALS-linked SOD1 mutant mice. Metabolic Cu-64 labeling in SOD1-mutant mice lacking the CCS showed that the incorporation of copper into mutant SOD1 was significantly diminished in the absence of CCS. Motor neurons in CCS-/- mice showed increased rate of death after facial nerve axotomy, a response documented for SOD1(-/-) mice. Thus, CCS is necessary for the efficient incorporation of copper into SOD1 in motor neurons. Although the absence of CCS led to a significant reduction in the amount of copper-loaded mutant SOD1, however, it did not modify the onset and progression of motor neuron disease in SOD1-mutant mice. Hence, CCS-dependent copper loading of mutant SOD1 plays no role in the pathogenesis of motor neuron disease in these mouse models.	Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins University	Wong, PC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, 558 Ross Res Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	wong@jhmi.edu	Cleveland, Don/AAN-9783-2021; rothstein, jeffrey d/C-9470-2013	Cleveland, Don/0000-0002-1934-3682; Subramaniam, Jamuna R/0000-0003-0343-2469				Beaulieu JM, 2000, J NEUROSCI, V20, P5321, DOI 10.1523/JNEUROSCI.20-14-05321.2000; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Crapo J D, 1978, Methods Enzymol, V53, P382; Crow JP, 1997, J NEUROCHEM, V69, P1945; Culotta VC, 1999, ADV EXP MED BIOL, V448, P247; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Doroudchi MM, 2001, NEUROREPORT, V12, P1239, DOI 10.1097/00001756-200105080-00037; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Facchinetti F, 1999, NEUROSCIENCE, V90, P1483, DOI 10.1016/S0306-4522(98)00492-8; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Liu HB, 2000, BIOCHEMISTRY-US, V39, P8125, DOI 10.1021/bi000846f; LYONS WE, 1995, J NEUROSCI, V15, P2985; Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005; Mouton PR, 1998, NEUROBIOL AGING, V19, P371, DOI 10.1016/S0197-4580(98)00080-3; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; PROHASKA JR, 1993, J NUTR, V123, P1226, DOI 10.1093/jn/123.7.1226; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sankarapandi S, 1999, J BIOL CHEM, V274, P34576, DOI 10.1074/jbc.274.49.34576; Singh RJ, 1998, P NATL ACAD SCI USA, V95, P6675, DOI 10.1073/pnas.95.12.6675; SUNDERMAN FW, 1970, CLIN CHEM, V16, P903; Torres AS, 2001, J BIOL CHEM, V276, P38410, DOI 10.1074/jbc.M104790200; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Williamson T L, 2000, Science, V288, P399; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yim HS, 1997, J BIOL CHEM, V272, P8861; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709	42	195	207	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					301	307		10.1038/nn823	http://dx.doi.org/10.1038/nn823			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11889469				2022-12-17	WOS:000174606900009
J	Reinhart, RMG; Nguyen, JA				Reinhart, Robert M. G.; Nguyen, John A.			Working memory revived in older adults by synchronizing rhythmic brain circuits	NATURE NEUROSCIENCE			English	Article							ALTERNATING-CURRENT STIMULATION; MEDIAL TEMPORAL-LOBE; LONG-TERM-MEMORY; ELECTRICAL-STIMULATION; PHASE SYNCHRONIZATION; THETA OSCILLATIONS; NEURAL ACTIVITY; VISUAL-CORTEX; HEAD MODEL; EEG-DATA	Understanding normal brain aging and developing methods to maintain or improve cognition in older adults are major goals of fundamental and translational neuroscience. Here we show a core feature of cognitive decline-working-memory deficits-emerges from disconnected local and long-range circuits instantiated by theta-gamma phase-amplitude coupling in temporal cortex and theta phase synchronization across frontotemporal cortex. We developed a noninvasive stimulation procedure for modulating long-range theta interactions in adults aged 60-76 years. After 25 min of stimulation, frequency-tuned to individual brain network dynamics, we observed a preferential increase in neural synchronization patterns and the return of sender-receiver relationships of information flow within and between frontotemporal regions. The end result was rapid improvement in working-memory performance that outlasted a 50 min post-stimulation period. The results provide insight into the physiological foundations of age-related cognitive impairment and contribute to groundwork for future non-pharmacological interventions targeting aspects of cognitive decline.	[Reinhart, Robert M. G.; Nguyen, John A.] Boston Univ, Dept Psychol & Brain Sci, Ctr Res Sensory Commun & Emerging Neural Technol, Ctr Syst Neurosci,Cognit Neuroimaging Ctr, Boston, MA 02215 USA	Boston University	Reinhart, RMG (corresponding author), Boston Univ, Dept Psychol & Brain Sci, Ctr Res Sensory Commun & Emerging Neural Technol, Ctr Syst Neurosci,Cognit Neuroimaging Ctr, Boston, MA 02215 USA.	rmgr@bu.edu			National Institutes of Health [R01 MH 114877]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH114877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the National Institutes of Health (R01 MH 114877) awarded to R.M.G.R.	Alekseichuk I, 2016, CURR BIOL, V26, P1513, DOI 10.1016/j.cub.2016.04.035; Ali MM, 2013, J NEUROSCI, V33, P11262, DOI 10.1523/JNEUROSCI.5867-12.2013; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Axmacher N, 2008, J NEUROSCI, V28, P7304, DOI 10.1523/JNEUROSCI.1778-08.2008; Axmacher N, 2007, J NEUROSCI, V27, P7807, DOI 10.1523/JNEUROSCI.0962-07.2007; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Beck A.T., 1996, PSYCHOL ASSESSMENT, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bergmann TO, 2018, NEURON, V97, P10, DOI 10.1016/j.neuron.2017.12.023; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Brady TF, 2008, P NATL ACAD SCI USA, V105, P14325, DOI 10.1073/pnas.0803390105; Buchner H, 1997, ELECTROEN CLIN NEURO, V102, P267, DOI 10.1016/S0013-4694(96)95698-9; Cho JH, 2015, NEUROIMAGE, V110, P60, DOI 10.1016/j.neuroimage.2015.01.043; Cole SR, 2017, TRENDS COGN SCI, V21, P137, DOI 10.1016/j.tics.2016.12.008; Dannhauer M, 2011, HUM BRAIN MAPP, V32, P1383, DOI 10.1002/hbm.21114; Darvas F, 2004, NEUROIMAGE, V23, pS289, DOI 10.1016/j.neuroimage.2004.07.014; Daume J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12511-3; Daume J, 2017, J NEUROSCI, V37, P313, DOI [10.1523/JNEUROSCI.2130-16.2017, 10.1523/JNEUROSCI.2130-16.2016]; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Grundey J, 2017, ADDICT BEHAV, V74, P90, DOI 10.1016/j.addbeh.2017.05.017; Grundey J, 2015, PSYCHOPHARMACOLOGY, V232, P2491, DOI 10.1007/s00213-015-3880-7; Hayutin A., 2007, PREA Q           FAL, P46; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Helfrich RF, 2016, TRENDS COGN SCI, V20, P916, DOI 10.1016/j.tics.2016.09.007; Helfrich RF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002031; Henson R, 2005, Q J EXP PSYCHOL-B, V58, P340, DOI 10.1080/02724990444000113; Herrmann CS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00279; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Jiang HT, 2015, NEUROIMAGE, V118, P359, DOI 10.1016/j.neuroimage.2015.05.044; Jung TP, 2001, P IEEE, V89, P1107, DOI 10.1109/5.939827; Kanai R, 2008, CURR BIOL, V18, P1839, DOI 10.1016/j.cub.2008.10.027; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Konkle T, 2010, J EXP PSYCHOL GEN, V139, P558, DOI 10.1037/a0019165; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lara AH, 2014, NAT NEUROSCI, V17, P876, DOI 10.1038/nn.3702; Lew S, 2009, APPL NUMER MATH, V59, P1970, DOI 10.1016/j.apnum.2009.02.006; LUESCHOW A, 1994, CEREB CORTEX, V4, P523, DOI 10.1093/cercor/4.5.523; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Nguyen J, 2018, BRAIN STIMUL, V11, P723, DOI 10.1016/j.brs.2018.02.008; Nichols EA, 2006, HIPPOCAMPUS, V16, P604, DOI 10.1002/hipo.20190; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nolte G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.234101; Noury N, 2018, NEUROIMAGE, V167, P53, DOI 10.1016/j.neuroimage.2017.11.023; Noury N, 2016, NEUROIMAGE, V140, P99, DOI 10.1016/j.neuroimage.2016.03.065; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Park JY, 2013, NEUROSCI LETT, V532, P39, DOI 10.1016/j.neulet.2012.10.061; Paulus W, 2010, CLIN NEUROPHYSIOL, V121, P987, DOI 10.1016/j.clinph.2010.01.029; Plume A., 2014, SCI ENG ETHICS, V38, P16, DOI DOI 10.1016/J.TICS.2013.10.010; Polania R, 2012, CURR BIOL, V22, P1314, DOI 10.1016/j.cub.2012.05.021; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; Powell HWR, 2005, NEUROIMAGE, V27, P231, DOI 10.1016/j.neuroimage.2005.04.033; Ranganath C, 2001, NEURON, V31, P865, DOI 10.1016/S0896-6273(01)00411-1; Reinhart RMG, 2017, P NATL ACAD SCI USA, V114, P11542, DOI 10.1073/pnas.1710257114; Reinhart RMG, 2017, ATTEN PERCEPT PSYCHO, V79, P3, DOI 10.3758/s13414-016-1224-2; Reinhart RMG, 2016, CURR BIOL, V26, P1867, DOI 10.1016/j.cub.2016.05.019; Reinhart RMG, 2015, J NEUROSCI, V35, P12232, DOI 10.1523/JNEUROSCI.1717-15.2015; Reinhart RMG, 2015, P NATL ACAD SCI USA, V112, P9448, DOI 10.1073/pnas.1504196112; Reinhart RMG, 2015, P NATL ACAD SCI USA, V112, P625, DOI 10.1073/pnas.1417259112; Reinhart RMG, 2014, J NEUROSCI, V34, P4214, DOI 10.1523/JNEUROSCI.5421-13.2014; Sabia S, 2012, ARCH GEN PSYCHIAT, V69, P627, DOI 10.1001/archgenpsychiatry.2011.2016; Salthouse Timothy A., 1994, NEUROPSYCHOLOGY, V8, P535, DOI [DOI 10.1037/0894-4105.8.4.535, 10.1037/0894-4105.8.4.535]; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Scheffer-Teixeira R., 2016, ELIFE, V5, P423; Schutter DJLG, 2010, CLIN NEUROPHYSIOL, V121, P1080, DOI 10.1016/j.clinph.2009.10.038; Sekihara K, 2008, SER BIOMED ENG, P1; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Sreenivasan KK, 2014, TRENDS COGN SCI, V18, P82, DOI 10.1016/j.tics.2013.12.001; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Driel J, 2015, J NEUROSCI METH, V254, P60, DOI 10.1016/j.jneumeth.2015.07.014; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Violante IR, 2017, ELIFE, V6, DOI [10.7554/elife.22001.001, 10.7554/eLife.22001]; Vossen A, 2015, BRAIN STIMUL, V8, P499, DOI 10.1016/j.brs.2014.12.004; Voytek B, 2015, J NEUROSCI, V35, P13257, DOI 10.1523/JNEUROSCI.2332-14.2015; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wolinski N, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005348; Woloszyn L, 2009, J NEUROSCI, V29, P5494, DOI 10.1523/JNEUROSCI.5785-08.2009; Wolters CH, 2006, NEUROIMAGE, V30, P813, DOI 10.1016/j.neuroimage.2005.10.014; Wolters CH, 2004, INVERSE PROBL, V20, P1099, DOI 10.1088/0266-5611/20/4/007; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766	95	194	202	32	261	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2019	22	5					820	+		10.1038/s41593-019-0371-x	http://dx.doi.org/10.1038/s41593-019-0371-x			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HU8SN	30962628	Green Accepted			2022-12-17	WOS:000465560800019
J	Li, WH; Prazak, L; Chatterjee, N; Gruninger, S; Krug, L; Theodorou, D; Dubnau, J				Li, Wanhe; Prazak, Lisa; Chatterjee, Nabanita; Grueninger, Servan; Krug, Lisa; Theodorou, Delphine; Dubnau, Josh			Activation of transposable elements during aging and neuronal decline in Drosophila	NATURE NEUROSCIENCE			English	Article							L1 RETROTRANSPOSITION; OLFACTORY MEMORY; GYPSY	We found that several transposable elements were highly active in Drosophila brain during normal aging. In addition, we found that mutations in Drosophila Argonaute 2 (Ago2) resulted in exacerbated transposon expression in the brain, progressive and age-dependent memory impairment, and shortened lifespan. These findings suggest that transposon activation may contribute to age-dependent loss of neuronal function.	[Li, Wanhe; Prazak, Lisa; Chatterjee, Nabanita; Dubnau, Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Li, Wanhe] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA; [Grueninger, Servan] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; [Grueninger, Servan; Krug, Lisa; Dubnau, Josh] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Theodorou, Delphine] Univ Paris Diderot, Magistere Genet Grad Program, Paris, France	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Zurich; Cold Spring Harbor Laboratory; UDICE-French Research Universities; Universite Paris Cite	Dubnau, J (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	dubnau@cshl.edu		Dubnau, Josh/0000-0002-9285-7444; Gruninger, Servan/0000-0003-2900-1376	US National Institutes of Health [TR01(5R01NS067690-03)]; DART NeuroScience LLC award; Shakespeare Fellowship; Ernst Gohner Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067690] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DART NeuroScience LLC award; Shakespeare Fellowship; Ernst Gohner Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Czech and G. Hannon (Cold Spring Harbor Laboratory) for the Ago2<SUP>414</SUP> and loki RNAi fly lines, F.-B. Gao (University of Massachusetts Medical School) for the Ago2<SUP>51B</SUP> fly line, B. Dickson (Institute of Molecular Pathology) for the UAS::Ago2 transgenic fly line, M. Welte (University of Rochester) for the Ago2<SUP>454</SUP> fly line, T. Lee (Janelia Farm Research Campus) for the pTub-GAL80 in Casper4 plasmid, J. Boek (Johns Hopkins University School of Medicine) for the 7B3 hybridoma cell line, and C. Bautista at the Cold Spring Harbor Laboratory shared resources for ascites production. We thank T. Russel for technical assistance in construction of the gypsy reporter system. We also are grateful to S. Waddell, J. Beshel, M. Cressy, B. Czech, G. Hannon, K. Honegger, J. Huang, M. Kernan, R. Martienssen, H. Qin, C. Sandoval, Y. Shuai, G. Turner, T. Zador and Y. Zhong for helpful discussions or comments on the manuscript. This work was supported by US National Institutes of Health grant TR01(5R01NS067690-03) and DART NeuroScience LLC awarded to J.D. S.G. received additional support from the Shakespeare Fellowship and the Ernst Gohner Foundation.	Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Belancio VP, 2008, GENOME RES, V18, P343, DOI 10.1101/gr.5558208; Chen GX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000026; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Coufal NG, 2011, P NATL ACAD SCI USA, V108, P20382, DOI 10.1073/pnas.1100273108; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Douville R, 2011, ANN NEUROL, V69, P141, DOI 10.1002/ana.22149; Dubnau J, 2013, CURR OPIN NEUROBIOL, V23, P84, DOI 10.1016/j.conb.2012.09.006; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Jeong BH, 2010, J CLIN VIROL, V47, P136, DOI 10.1016/j.jcv.2009.11.016; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Labrador M, 2008, GENETICS, V180, P1367, DOI 10.1534/genetics.108.094318; Lathe R, 2009, J MOL BIOL, V392, P813, DOI 10.1016/j.jmb.2009.07.045; Li WD, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044230, 10.1371/journal.pone.0044099]; Lim DH, 2011, FEBS LETT, V585, P3079, DOI 10.1016/j.febslet.2011.08.034; Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Qin HT, 2012, CURR BIOL, V22, P608, DOI 10.1016/j.cub.2012.02.014; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; SONG SU, 1994, GENE DEV, V8, P2046, DOI 10.1101/gad.8.17.2046; Tan HP, 2012, HUM MOL GENET, V21, P57, DOI 10.1093/hmg/ddr437; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0	24	194	203	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					529	+		10.1038/nn.3368	http://dx.doi.org/10.1038/nn.3368			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23563579	Green Accepted			2022-12-17	WOS:000318029300008
J	Siegert, S; Cabuy, E; Scherf, BG; Kohler, H; Panda, S; Le, YZ; Fehling, HJ; Gaidatzis, D; Stadler, MB; Roska, B				Siegert, Sandra; Cabuy, Erik; Scherf, Brigitte Gross; Kohler, Hubertus; Panda, Satchidananda; Le, Yun-Zheng; Fehling, Hans Joerg; Gaidatzis, Dimos; Stadler, Michael B.; Roska, Botond			Transcriptional code and disease map for adult retinal cell types	NATURE NEUROSCIENCE			English	Article							MACULAR DEGENERATION; GENE-EXPRESSION; IN-VIVO; DOPAMINERGIC-NEURONS; ALZHEIMERS-DISEASE; HUMAN FIBROBLASTS; COMMON VARIANTS; AMACRINE CELLS; MOUSE; PHOTOTRANSDUCTION	Brain circuits are assembled from a large variety of morphologically and functionally diverse cell types. It is not known how the intermingled cell types of an individual adult brain region differ in their expressed genomes. Here we describe an atlas of cell type transcriptomes in one brain region, the mouse retina. We found that each adult cell type expressed a specific set of genes, including a unique set of transcription factors, forming a 'barcode' for cell identity. Cell type transcriptomes carried enough information to categorize cells into morphological classes and types. Several genes that were specifically expressed in particular retinal circuit elements, such as inhibitory neuron types, are associated with eye diseases. The resource described here allows gene expression to be compared across adult retinal cell types, experimenting with specific transcription factors to differentiate stem or somatic cells to retinal cell types, and predicting cellular targets of newly discovered disease-associated genes.	[Siegert, Sandra; Cabuy, Erik; Scherf, Brigitte Gross; Kohler, Hubertus; Gaidatzis, Dimos; Stadler, Michael B.; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland; [Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Oklahoma Diabet Ctr, Oklahoma City, OK USA; [Fehling, Hans Joerg] Univ Clin Ulm, Inst Immunol, Ulm, Germany; [Gaidatzis, Dimos; Stadler, Michael B.] Swiss Inst Bioinformat, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Salk Institute; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Ulm University; Swiss Institute of Bioinformatics	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland.	botond.roska@fmi.ch	Panda, Satchidananda/J-6891-2012; Roska, Botond/AAD-7268-2021; Siegert, Sandra/GWC-4507-2022	Siegert, Sandra/0000-0001-8635-0877	Friedrich Miescher Institute; Alcon award; National Center of Competence in Research; European Research Council; Swiss-Hungarian grant; European Union; NATIONAL EYE INSTITUTE [R01EY020900] Funding Source: NIH RePORTER	Friedrich Miescher Institute; Alcon award; National Center of Competence in Research(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); Swiss-Hungarian grant; European Union(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank S. Djaffer, J. Juttner, J. Hall and Y. Shimada for technical assistance, E. Oakeley for comments on the experimental design, D. Balya for providing help with programming, and K. Farrow, S. Rompani, K. Yonehara, V. Busskamp, S. Oakeley, P. King, A. Matus, S. Arber and F. Rijli for comments on the manuscript. We thank Z. Raics for making the webpage, and L. Kus and S. Gong (Rockefeller University) for help and for BACs from the GENSAT project. We thank I. Provencio (University of Virginia) for providing the melanopsin antibody. The study was supported by Friedrich Miescher Institute funds, Alcon award, a National Center of Competence in Research Genetics grant, a European Research Council grant, a Swiss-Hungarian grant, and RETICIRC, TREATRUSH, SEEBETTER and OPTONEURO grants from the European Union to B.R.	Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Arendt D, 2003, INT J DEV BIOL, V47, P563; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; Chen J, 2007, J CLIN INVEST, V117, P2758, DOI 10.1172/JCI33513; Cherry TJ, 2009, P NATL ACAD SCI USA, V106, P9495, DOI 10.1073/pnas.0903264106; Corbo JC, 2007, P NATL ACAD SCI USA, V104, P12069, DOI 10.1073/pnas.0705465104; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Geng RS, 2009, HUM MOL GENET, V18, P2748, DOI 10.1093/hmg/ddp210; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Hardie RC, 2001, J EXP BIOL, V204, P3403; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kay JN, 2011, NAT NEUROSCI, V14, P965, DOI 10.1038/nn.2859; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LEE YJ, 1994, NEURON, V13, P1143, DOI 10.1016/0896-6273(94)90052-3; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Morrow EM, 1998, J NEUROSCI, V18, P3738; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Okaty BW, 2011, J NEUROSCI, V31, P6939, DOI 10.1523/JNEUROSCI.0626-11.2011; Okaty BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016493; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Sekaran S, 2007, J NEUROSCI, V27, P3981, DOI 10.1523/JNEUROSCI.4716-06.2007; Shibuya E, 2008, INVEST OPHTH VIS SCI, V49, P4453, DOI 10.1167/iovs.07-1575; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tarpey P, 2006, NAT GENET, V38, P1242, DOI 10.1038/ng1893; TERAKITA A, 1993, FEBS LETT, V330, P197, DOI 10.1016/0014-5793(93)80272-V; Tezel G, 2008, PROG BRAIN RES, V173, P409, DOI 10.1016/S0079-6123(08)01128-X; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	50	194	204	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					487	U191		10.1038/nn.3032	http://dx.doi.org/10.1038/nn.3032			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22267162				2022-12-17	WOS:000300793100024
J	Saygin, ZM; Osher, DE; Koldewyn, K; Reynolds, G; Gabrieli, JDE; Saxe, RR				Saygin, Zeynep M.; Osher, David E.; Koldewyn, Kami; Reynolds, Gretchen; Gabrieli, John D. E.; Saxe, Rebecca R.			Anatomical connectivity patterns predict face selectivity in the fusiform gyrus	NATURE NEUROSCIENCE			English	Article							RHESUS-MONKEY; FUNCTIONAL LOCALIZATION; CORTICAL REGION; CORTEX; AREA; PERCEPTION; PROSOPAGNOSIA; MACAQUE; BRAIN; PROJECTIONS	A fundamental assumption in neuroscience is that brain structure determines function. Accordingly, functionally distinct regions of cortex should be structurally distinct in their connections to other areas. We tested this hypothesis in relation to face selectivity in the fusiform gyrus. By using only structural connectivity, as measured through diffusion-weighted imaging, we were able to predict functional activation to faces in the fusiform gyrus. These predictions outperformed two control models and a standard group-average benchmark. The structure function relationship discovered from the initial participants was highly robust in predicting activation in a second group of participants, despite differences in acquisition parameters and stimuli. This approach can thus reliably estimate activation in participants who cannot perform functional imaging tasks and is an alternative to group-activation maps. Additionally, we identified cortical regions whose connectivity was highly influential in predicting face selectivity within the fusiform, suggesting a possible mechanistic architecture underlying face processing in humans.	[Saygin, Zeynep M.; Osher, David E.; Koldewyn, Kami; Reynolds, Gretchen; Gabrieli, John D. E.; Saxe, Rebecca R.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Saygin, Zeynep M.; Osher, David E.; Koldewyn, Kami; Gabrieli, John D. E.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Gabrieli, John D. E.] MIT, Harvard MIT Hlth Sci & Technol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Saygin, ZM (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	zsaygin@mit.edu; dosher@mit.edu	Koldewyn, Kami/Q-6108-2019; Gabrieli, John/AAJ-2869-2020; Saygin, Zeynep M./AAV-4951-2020; Koldewyn, Kami/B-6434-2013	Koldewyn, Kami/0000-0003-3588-6449; /0000-0003-2377-1791	US Public Health Service [DA023427]; US National Institute of Mental Health [F32 MH084488]; US National Eye Institute [T32 EY013935]; Poitras Center for Affective Disorders Research; Simons Foundation; Ellison Medical Foundation; NATIONAL EYE INSTITUTE [T32EY013935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH084488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R90DA023427] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Poitras Center for Affective Disorders Research; Simons Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank N. Kanwisher, S. Ghosh, F. Polli and the Athinoula A. Martinos Imaging Center at McGovern Institute for Brain Research, Massachusetts Institute of Technology. This work was supported by US Public Health Service DA023427, US National Institute of Mental Health F32 MH084488, US National Eye Institute T32 EY013935, the Poitras Center for Affective Disorders Research, the Simons Foundation and the Ellison Medical Foundation.	Annese J, 2005, CEREB CORTEX, V15, P1044, DOI 10.1093/cercor/bhh205; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Dauguet J, 2007, NEUROIMAGE, V37, P530, DOI 10.1016/j.neuroimage.2007.04.067; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Gholipour A, 2007, IEEE T MED IMAGING, V26, P427, DOI 10.1109/TMI.2007.892508; GLICKSTEIN M, 1994, J COMP NEUROL, V349, P51, DOI 10.1002/cne.903490105; Gloor P., 1997, TEMPORAL LOBE LIMBIC; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Hastie T., 2009, SPRINGER, V2nd, DOI DOI 10.1007/978-0-387-21606-5; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Hilgetag CC, 2004, NEUROINFORMATICS, V2, P353, DOI 10.1385/NI:2:3:353; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Ishai A, 2008, NEUROIMAGE, V40, P415, DOI 10.1016/j.neuroimage.2007.10.040; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Kanwisher N, 1999, NEUROREPORT, V10, P183, DOI 10.1097/00001756-199901180-00035; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; LANDIS T, 1986, CORTEX, V22, P243, DOI 10.1016/S0010-9452(86)80048-X; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; MCNEIL JE, 1993, Q J EXP PSYCHOL-A, V46, P1, DOI 10.1080/14640749308401064; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Peled S., 2005, P I SOC MAGN RESON M, V13, P1323; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; Saxe R, 2006, SOC COGN AFFECT NEUR, V1, P229, DOI 10.1093/scan/nsl034; SCHMAHMANN JD, 1993, J COMP NEUROL, V337, P94, DOI 10.1002/cne.903370107; SCHMAHMANN JD, 1992, J COMP NEUROL, V326, P159, DOI 10.1002/cne.903260202; SELTZER B, 1994, J COMP NEUROL, V343, P445, DOI 10.1002/cne.903430308; Sewards TV, 2011, NEUROPSYCHOLOGIA, V49, P277, DOI 10.1016/j.neuropsychologia.2010.11.018; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Tsao DY, 2008, NAT NEUROSCI, V11, P877, DOI 10.1038/nn.2158; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983	41	194	199	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					321	327		10.1038/nn.3001	http://dx.doi.org/10.1038/nn.3001			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22197830	Green Submitted, Green Accepted			2022-12-17	WOS:000299603500025
J	Derdikman, D; Whitlock, JR; Tsao, A; Fyhn, M; Hafting, T; Moser, MB; Moser, EI				Derdikman, Dori; Whitlock, Jonathan R.; Tsao, Albert; Fyhn, Marianne; Hafting, Torkel; Moser, May-Britt; Moser, Edvard I.			Fragmentation of grid cell maps in a multicompartment environment	NATURE NEUROSCIENCE			English	Article							FREELY-MOVING RATS; HIPPOCAMPAL ENSEMBLE CODE; MEDIAL ENTORHINAL CORTEX; SPATIAL FIRING PATTERNS; HEAD DIRECTION SIGNAL; COMPLEX-SPIKE CELLS; PATH-INTEGRATION; PLACE CELLS; NEURAL ENSEMBLES; UNIT-ACTIVITY	To determine whether entorhinal spatial representations are continuous or fragmented, we recorded neural activity in grid cells while rats ran through a stack of interconnected, zig-zagged compartments of equal shape and orientation (a hairpin maze). The distribution of spatial firing fields was markedly similar across all compartments in which running occurred in the same direction, implying that the grid representation was fragmented into repeating submaps. Activity at neighboring positions was least correlated at the transitions between different arms, indicating that the map split regularly at the turning points. We saw similar discontinuities among place cells in the hippocampus. No fragmentation was observed when the rats followed similar trajectories in the absence of internal walls, implying that stereotypic behavior alone cannot explain the compartmentalization. These results indicate that spatial environments are represented in entorhinal cortex and hippocampus as a mosaic of discrete submaps that correspond to the geometric structure of the space.	[Derdikman, Dori; Whitlock, Jonathan R.; Tsao, Albert; Fyhn, Marianne; Hafting, Torkel; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, MTFS, N-7034 Trondheim, Norway; [Derdikman, Dori; Whitlock, Jonathan R.; Tsao, Albert; Fyhn, Marianne; Hafting, Torkel; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Biol Memory, MTFS, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, MTFS, N-7034 Trondheim, Norway.	edvard.moser@ntnu.no		Hafting, Torkel/0000-0002-0928-3487	Kavli Foundation; Norwegian Research Council	Kavli Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission)	We thank A. M. Amundgord, I. Hammer, K. Haugen, K. Jenssen, R. Skjerpeng and H. Waade for technical assistance and T. Bonnevie and G. Pfuhl for help with animal training. We thank A. D. Redish and members of the Kavli Institute for Systems Neuroscience and the Centre for the Biology of Memory for useful discussions. This work was supported by the Kavli Foundation and a Centre of Excellence grant from the Norwegian Research Council.	Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Biegler R, 2000, ANIM LEARN BEHAV, V28, P257, DOI 10.3758/BF03200260; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Gothard KM, 1996, J NEUROSCI, V16, P8027; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; HAMPSON RE, 1993, BEHAV NEUROSCI, V107, P715, DOI 10.1037/0735-7044.107.5.715; Hargreaves EL, 2007, HIPPOCAMPUS, V17, P826, DOI 10.1002/hipo.20316; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; Johnson A, 2005, HIPPOCAMPUS, V15, P86, DOI 10.1002/hipo.20033; Jones PM, 2007, BEHAV NEUROSCI, V121, P1258, DOI 10.1037/0735-7044.121.6.1258; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McGregor A, 2004, BEHAV NEUROSCI, V118, P1011, DOI 10.1037/0735-7044.118.5.1011; McNaughton BL, 1996, J EXP BIOL, V199, P173; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Moser EI, 2008, HIPPOCAMPUS, V18, P1142, DOI 10.1002/hipo.20483; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1987, J NEUROSCI, V7, P1935; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pearce JM, 2004, J EXP PSYCHOL ANIM B, V30, P135, DOI 10.1037/0097-7403.30.2.135; Ranck J.B., 1985, ELECT ACTIVITY ARCHI, P217; Redish AD, 2000, J NEUROSCI, V20, P9298; Redish AD, 2000, NEUROCOMPUTING, V32, P235, DOI 10.1016/S0925-2312(00)00169-7; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; Sharp PE, 1997, BEHAV BRAIN RES, V85, P71, DOI 10.1016/S0166-4328(96)00165-9; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1990, J NEUROSCI, V10, P436; Touretzky DS, 1996, HIPPOCAMPUS, V6, P247; Whishaw IQ, 1998, NEUROSCI BIOBEHAV R, V22, P209, DOI 10.1016/S0149-7634(97)00002-X; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Yoganarasimha D, 2006, J NEUROSCI, V26, P622, DOI 10.1523/JNEUROSCI.3885-05.2006; YOUNG BJ, 1994, J NEUROSCI, V14, P6553	50	194	195	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1325	U155		10.1038/nn.2396	http://dx.doi.org/10.1038/nn.2396			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19749749				2022-12-17	WOS:000270170200022
J	Wulff, P; Schonewille, M; Renzi, M; Viltono, L; Sassoe-Pognetto, M; Badura, A; Gao, ZY; Hoebeek, FE; van Dorp, S; Wisden, W; Farrant, M; De Zeeuw, CI				Wulff, Peer; Schonewille, Martijn; Renzi, Massimiliano; Viltono, Laura; Sassoe-Pognetto, Marco; Badura, Aleksandra; Gao, Zhenyu; Hoebeek, Freek E.; van Dorp, Stijn; Wisden, William; Farrant, Mark; De Zeeuw, Chris I.			Synaptic inhibition of Purkinje cells mediates consolidation of vestibulo-cerebellar motor learning	NATURE NEUROSCIENCE			English	Article							TEMPORAL FIDELITY; GABA(A) RECEPTORS; SPIKE OUTPUT; PLASTICITY; LTD; EXPRESSION; SYNAPSES; PATTERN; INPUT; INTERNEURONS	Although feedforward inhibition onto Purkinje cells was first documented 40 years ago, we understand little of how inhibitory interneurons contribute to cerebellar function in behaving animals. Using a mouse line (PC-Delta gamma 2) in which GABA(A) receptor mediated synaptic inhibition is selectively removed from Purkinje cells, we examined how feedforward inhibition from molecular layer interneurons regulates adaptation of the vestibulo-ocular reflex. Although impairment of baseline motor performance was relatively mild, the ability to adapt the phase of the vestibulo-ocular reflex and to consolidate gain adaptations was strongly compromised. Purkinje cells showed abnormal patterns of simple spikes, both during and in the absence of evoked compensatory eye movements. On the basis of modeling our experimental data, we propose that feedforward inhibition, by controlling the fine-scale patterns of Purkinje cell activity, enables the induction of plasticity in neurons of the cerebellar and vestibular nuclei.	[Badura, Aleksandra; Gao, Zhenyu; Hoebeek, Freek E.; De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Wulff, Peer; Wisden, William] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Renzi, Massimiliano; Farrant, Mark] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Viltono, Laura; Sassoe-Pognetto, Marco] Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy; [Viltono, Laura; Sassoe-Pognetto, Marco] Natl Inst Neurosci Italy, Turin, Italy; [van Dorp, Stijn; De Zeeuw, Chris I.] Royal Acad Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Wisden, William] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England	Erasmus University Rotterdam; Erasmus MC; University of Aberdeen; University of London; University College London; University of Turin; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Imperial College London	De Zeeuw, CI (corresponding author), Erasmus MC, Dept Neurosci, Rotterdam, Netherlands.	w.wisden@imperial.ac.uk; m.farrant@ucl.ac.uk; c.dezeeuw@erasmusmc.nl	Schonewille, Martijn/E-6170-2013; Wisden, William/A-4071-2011; Badura, Aleksandra/ABC-5427-2020; Sassoe-Pognetto, Marco/AAE-3536-2022	Wisden, William/0000-0003-4743-0334; Badura, Aleksandra/0000-0002-0119-5108; RENZI, MASSIMILIANO/0000-0001-6973-3569; Wulff, Peer/0000-0002-0282-7832; Farrant, Mark/0000-0002-9918-0376; Sassoe-Pognetto, Marco/0000-0001-8906-0613	Medical Research Council [G0800399]; Royal Society; Institute Pasteur-Fondazione Cenci Bolognetti; Wellcome Trust program; Regione Piemonte; Compagnia di San Paolo; Dutch Organization for Medical Sciences; Prinses Beatrix Fonds; SENSOPAC; European Community; Medical Research Council [G0601498] Funding Source: researchfish; MRC [G0800399, G0601498] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Institute Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Wellcome Trust program(Wellcome Trust); Regione Piemonte(Regione Piemonte); Compagnia di San Paolo(Compagnia di San Paolo); Dutch Organization for Medical Sciences; Prinses Beatrix Fonds; SENSOPAC; European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank L. Cheyne, D. Massie, M. Rutteman, R. Avila Freire, E. Dalm and J. v. d. Burg for their excellent technical assistance, and D. Andersson and L. Kelly for their participation in the initial electrophysiological studies. This work was supported by the J. Ernest Tait Estate Aberdeen (W. W.), a Medical Research Council program grant G0800399 (P. W. and W. W.), the Royal Society (P. W.), the Institute Pasteur-Fondazione Cenci Bolognetti (M. R.), a Wellcome Trust program grant (M. F.), Regione Piemonte (Ricerca Scientifica Applicata A218 and Ricerca Sanitaria Finalizzata 2006) and Compagnia di San Paolo (M. S.-P.), the Dutch Organization for Medical Sciences (C. I. D. Z.), Life Sciences (C. I. D. Z.), Senter (Neuro-Bsik, C. I. D. Z.), Prinses Beatrix Fonds (C. I. D. Z.), and the SENSOPAC (SENSOrimotor structuring of Perception and Action for Emerging Cognition) program of the European Community (C. I. D. Z.).	Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Blazquez PM, 2006, J NEUROPHYSIOL, V95, P1812, DOI 10.1152/jn.01061.2005; Boyden ES, 2006, NEURON, V51, P823, DOI 10.1016/j.neuron.2006.08.026; Brickley SG, 1999, J NEUROSCI, V19, P2960; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/S0896-6273(04)00528-8; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Davie JT, 2008, J NEUROSCI, V28, P7599, DOI 10.1523/JNEUROSCI.0559-08.2008; de Solages C, 2008, NEURON, V58, P775, DOI 10.1016/j.neuron.2008.05.008; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; Eccles JC, 1967, CEREBELLUM NEURONAL; Feil R, 2003, J CELL BIOL, V163, P295, DOI 10.1083/jcb.200306148; Gittis AH, 2006, CURR OPIN NEUROBIOL, V16, P385, DOI 10.1016/j.conb.2006.06.012; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; ITO M, 1993, NATURE, V363, P24, DOI 10.1038/363024b0; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kassardjian CD, 2005, J NEUROSCI, V25, P7979, DOI 10.1523/JNEUROSCI.2215-05.2005; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Lamsa K, 2005, NAT NEUROSCI, V8, P916, DOI 10.1038/nn1486; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Lisberger SG, 1998, CELL, V92, P701, DOI 10.1016/S0092-8674(00)81397-5; Lorez N, 2000, J PHYSIOL-LONDON, V527, P11; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Medina JF, 2008, NAT NEUROSCI, V11, P1185, DOI 10.1038/nn.2197; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Mittmann W, 2007, J NEUROSCI, V27, P5559, DOI 10.1523/JNEUROSCI.5117-06.2007; MIYASHITA Y, 1984, J PHYSIOL-LONDON, V351, P251, DOI 10.1113/jphysiol.1984.sp015243; Orduz D, 2007, P NATL ACAD SCI USA, V104, P17831, DOI 10.1073/pnas.0707489104; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Santamaria F, 2007, J NEUROPHYSIOL, V97, P248, DOI 10.1152/jn.01098.2005; Scelfo B, 2008, P NATL ACAD SCI USA, V105, P769, DOI 10.1073/pnas.0706342105; Schonewille M, 2006, J COMP NEUROL, V497, P670, DOI 10.1002/cne.21036; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Shin SL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000485; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; Smith SL, 2005, P NATL ACAD SCI USA, V102, P14901, DOI 10.1073/pnas.0505028102; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Steuber V, 2007, NEURON, V54, P121, DOI 10.1016/j.neuron.2007.03.015; Van Der Giessen RS, 2006, J COMP NEUROL, V495, P173, DOI 10.1002/cne.20873; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Watt AJ, 2009, NAT NEUROSCI, V12, P463, DOI 10.1038/nn.2285; Wulff P, 2007, NAT NEUROSCI, V10, P923, DOI 10.1038/nn1927	50	194	194	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1042	U118		10.1038/nn.2348	http://dx.doi.org/10.1038/nn.2348			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19578381	Green Accepted			2022-12-17	WOS:000268396300019
J	Ng, L; Bernard, A; Lau, C; Overly, CC; Dong, HW; Kuan, C; Pathak, S; Sunkin, SM; Dang, C; Bohland, JW; Bokil, H; Mitra, PP; Puelles, L; Hohmann, J; Anderson, DJ; Lein, ES; Jones, AR; Hawrylycz, M				Ng, Lydia; Bernard, Amy; Lau, Chris; Overly, Caroline C.; Dong, Hong-Wei; Kuan, Chihchau; Pathak, Sayan; Sunkin, Susan M.; Dang, Chinh; Bohland, Jason W.; Bokil, Hemant; Mitra, Partha P.; Puelles, Luis; Hohmann, John; Anderson, David J.; Lein, Ed S.; Jones, Allan R.; Hawrylycz, Michael			An anatomic gene expression atlas of the adult mouse brain	NATURE NEUROSCIENCE			English	Article							PARAFASCICULAR NUCLEUS; NEUROGENESIS; STRIATUM; PATTERNS; AREAS; CELLS; RAT	Studying gene expression provides a powerful means of understanding structure-function relationships in the nervous system. The availability of genome-scale in situ hybridization datasets enables new possibilities for understanding brain organization based on gene expression patterns. The Anatomic Gene Expression Atlas (AGEA) is a new relational atlas revealing the genetic architecture of the adult C57Bl/6J mouse brain based on spatial correlations across expression data for thousands of genes in the Allen Brain Atlas (ABA). The AGEA includes three discovery tools for examining neuroanatomical relationships and boundaries: (1) three-dimensional expression-based correlation maps, (2) a hierarchical transcriptome-based parcellation of the brain and (3) a facility to retrieve from the ABA specific genes showing enriched expression in local correlated domains. The utility of this atlas is illustrated by analysis of genetic organization in the thalamus, striatum and cerebral cortex. The AGEA is a publicly accessible online computational tool integrated with the ABA (http://mouse.brain-map.org/agea).	[Ng, Lydia; Bernard, Amy; Lau, Chris; Overly, Caroline C.; Kuan, Chihchau; Pathak, Sayan; Sunkin, Susan M.; Dang, Chinh; Hohmann, John; Lein, Ed S.; Jones, Allan R.; Hawrylycz, Michael] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Dong, Hong-Wei] Univ Calif Los Angeles, Lab NeuroImaging, Los Angeles, CA 90095 USA; [Bohland, Jason W.; Bokil, Hemant; Mitra, Partha P.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Puelles, Luis] Univ Murcia, Fac Med, Dept Human Anat & Psychobiol, Murcia, Spain; [Puelles, Luis] Univ Murcia, Fac Med, CIBER Enfermedades Raras, U736, Murcia, Spain; [Anderson, David J.] CALTECH, Div Biol, Pasadena, CA 91125 USA	Allen Institute for Brain Science; University of California System; University of California Los Angeles; Cold Spring Harbor Laboratory; University of Murcia; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Murcia; California Institute of Technology	Hawrylycz, M (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	mikeh@alleninstitute.org	Bohland, Jason/L-4807-2016	Bohland, Jason/0000-0002-6305-5848; Pathak, Shankar D/0000-0001-9689-7577; PUELLES, LUIS/0000-0002-9541-7073; Bernard, Amy/0000-0003-2540-1153; Mitra, Partha/0000-0001-8818-6804	Allen Institute for Brain Science	Allen Institute for Brain Science	This work was sponsored by the Allen Institute for Brain Science. The authors wish to thank the Allen Institute founders, P. G. Allen and J. Patton, for their vision, encouragement and support. The authors also thank D. Haynor of the University of Washington, Department of Neuroradiology, and C. Thompson of the Allen Institute.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Brodmann K., 1960, SOME PAPERS CEREBRAL, P201; DeGroot M.H., 2002, PROBABILITY STAT; Dong H. W., 2008, ALLEN REFERENCE ATLA; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; GEE CE, 1983, DNA-J MOLEC CELL BIO, V2, P157, DOI 10.1089/dna.1983.2.157; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P115, DOI 10.1007/BF02289694; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; MacKenzie-Graham A, 2004, J ANAT, V204, P93, DOI 10.1111/j.1469-7580.2004.00264.x; MacKenzie-Graham A, 2003, NEUROINFORMATICS, V1, P397, DOI 10.1385/NI:1:4:397; Marini G, 1996, NEUROSCI LETT, V203, P81, DOI 10.1016/0304-3940(95)12266-4; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; Nakamura Y, 2006, NEUROSCI RES, V56, P73, DOI 10.1016/j.neures.2006.05.009; Ng L, 2007, IEEE ACM T COMPUT BI, V4, P382, DOI 10.1109/TCBB.2007.1035; Paxinos G., 2019, PAXINOS FRANKLINS MO, DOI [10.3390/ijms20225729, DOI 10.3390/IJMS20225729]; Paxinos G, 1995, RAT NERVOUS SYSTEM; PRICE JL, 1995, RAT NERVOUS SYSTEMS, P632; SHERMAN SM, 2006, EXPLORING THALAMUS R; Sunkin SM, 2007, HUM MOL GENET, V16, pR209, DOI 10.1093/hmg/ddm183; Swanson L. W, 2004, STRUCTURE RAT BRAIN; Toga AW, 2006, NAT REV NEUROSCI, V7, P952, DOI 10.1038/nrn2012; TOGA AW, 2000, BRAIN MAPPING SYSTEM, P4; Van Essen DC, 1998, P NATL ACAD SCI USA, V95, P788, DOI 10.1073/pnas.95.3.788; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Yamamori T, 2006, NEUROSCI RES, V55, P11, DOI 10.1016/j.neures.2006.02.006; YUSHKEVICH PA, 2005, P INT SOC MAGN RES M, V13, P2809; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102	32	194	196	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2009	12	3					356	362		10.1038/nn.2281	http://dx.doi.org/10.1038/nn.2281			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	410LF	19219037				2022-12-17	WOS:000263577900022
J	Jia, YC; Zhou, J; Tai, YL; Wang, YZ				Jia, Yichang; Zhou, Jian; Tai, Yilin; Wang, Yizheng			TRPC channels promote cerebellar granule neuron survival	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH CONES; SIGNALING PATHWAY; CELL-DEATH; CREB PHOSPHORYLATION; TRANSCRIPTION FACTOR; NEUROTROPHIC FACTOR; CALCIUM-CHANNEL; GENE-EXPRESSION; CATION CHANNELS; KINASE PATHWAY	Channels formed by the transient receptor potential (TRP) family of proteins have a variety of physiological functions. Here we report that two members of the TRP cation channel (TRPC) subfamily, TRPC3 and 6, protected cerebellar granule neurons ( CGNs) against serum deprivation - induced cell death in cultures and promoted CGN survival in rat brain. In CGN cultures, blocking TRPC channels or downregulating TRPC3 or 6 suppressed brain- derived neurotrophic factor ( BDNF) - mediated protection, BDNF-triggered intracellular Ca2+ elevation and BDNF-induced CREB activation. By contrast, overexpressing TRPC3 or 6 increased CREB-dependent reporter gene transcription and prevented apoptosis in the neurons deprived of serum, and this protection was blocked by the dominant negative form of CREB. Furthermore, downregulating TRPC3 or 6 induced CGN apoptosis in neonatal rat cerebellum, and this effect was rescued by overexpressing either TRPC3 or 6. Thus, our findings provide in vitro and in vivo evidence that TRPC channels are important in promoting neuronal survival.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Key Lab Neurobiol,Lab Neural Signal Transduct, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Wang, YZ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Key Lab Neurobiol,Lab Neural Signal Transduct, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	yzwang@ion.ac.cn						Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Atabay C, 1996, J NEUROSCI RES, V43, P465; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cheng AW, 2003, J BIOL CHEM, V278, P7591, DOI 10.1074/jbc.M207232200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Egea J, 2001, J CELL BIOL, V154, P585, DOI 10.1083/jcb.200101023; Fahlman CS, 2002, BRAIN RES, V958, P43, DOI 10.1016/S0006-8993(02)03433-9; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Groschner K, 1998, FEBS LETT, V437, P101, DOI 10.1016/S0014-5793(98)01212-5; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; LEVI G, 1984, BRAIN RES, V290, P77, DOI 10.1016/0006-8993(84)90737-6; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; MINKE B, 1977, BIOPHYS STRUCT MECH, V3, P59, DOI 10.1007/BF00536455; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	49	194	205	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					559	567		10.1038/nn1870	http://dx.doi.org/10.1038/nn1870			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17396124				2022-12-17	WOS:000245948000012
J	Luders, E; Narr, KI; Thompson, PM; Rex, DE; Jancke, L; Steinmetz, H; Toga, AW				Luders, E; Narr, KI; Thompson, PM; Rex, DE; Jancke, L; Steinmetz, H; Toga, AW			Gender differences in cortical complexity	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; CEREBRAL-CORTEX; ATLASES; PATTERN; MATTER; WOMEN; GRAY	Cortical complexity, a measure that quantifies the spatial frequency of gyrification and fissuration of the brain surface, has not been thoroughly characterized with respect to gender differences in the human brain. Using a new three-dimensional (3D) analytic technique with magnetic resonance imaging, we found greater gyrification in women than men in frontal and parietal regions. Increased complexity implies more cortical surface area, which may offset gender differences in brain volume and account for behavioral gender differences.	Univ Calif Los Angeles, Sch Med, Lab Neuroimaging, Dept Neurol, Div Brain Mapping, Los Angeles, CA 90095 USA; Swiss Fed Inst Technol, Dept Neuropsychol, CH-8032 Zurich, Switzerland; Goethe Univ Frankfurt, Dept Neurol, D-60528 Frankfurt, Germany	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Swiss Federal Institutes of Technology Domain; ETH Zurich; Goethe University Frankfurt	Toga, AW (corresponding author), Univ Calif Los Angeles, Sch Med, Lab Neuroimaging, Dept Neurol, Div Brain Mapping, 710 Westwood Pl,4238 Reed, Los Angeles, CA 90095 USA.	toga@loni.ucla.edu	Thompson, Paul M/C-4194-2018; Jäncke, Lutz/C-3792-2009	Thompson, Paul M/0000-0002-4720-8867; Jäncke, Lutz/0000-0002-8115-4890	NCRR NIH HHS [R21RR19771, P41 RR013642, M01 RR000865] Funding Source: Medline; NIBIB NIH HHS [R21EB01561, P01 EB001955] Funding Source: Medline; NIMH NIH HHS [P20 MH065166, MH14584] Funding Source: Medline; NLM NIH HHS [R01 LM05639] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR019771, M01RR000865, P41RR013642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P01EB001955, R21EB001561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014584, P20MH065166] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM005639] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		[Anonymous], 1988, STAT POWER ANAL BEHA; Gur RC, 1999, J NEUROSCI, V19, P4065; MacDonald D, 1994, P SOC PHOTO-OPT INS, V2359, P160; Nopoulos P, 2000, PSYCHIAT RES-NEUROIM, V98, P1, DOI 10.1016/S0925-4927(99)00044-X; Rabinowicz T, 2002, J NEUROPATH EXP NEUR, V61, P46, DOI 10.1093/jnen/61.1.46; RICHMAN DP, 1975, SCIENCE, V189, P18, DOI 10.1126/science.1135626; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P458, DOI 10.1016/0166-2236(94)90131-7; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sowell ER, 2002, CEREB CORTEX, V12, P17, DOI 10.1093/cercor/12.1.17; Thompson PM, 1996, J NEUROSCI, V16, P4261; Thompson PM, 2000, HUM BRAIN MAPP, V9, P81, DOI 10.1002/(SICI)1097-0193(200002)9:2<81::AID-HBM3>3.0.CO;2-8; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; WITELSON SF, 1995, J NEUROSCI, V15, P3418; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028; ZILLES K, 1988, ANAT EMBRYOL, V179, P173, DOI 10.1007/BF00304699	15	194	199	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					799	800		10.1038/nn1277	http://dx.doi.org/10.1038/nn1277			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15338563				2022-12-17	WOS:000222930800021
J	Abe, K; Chisaka, O; van Roy, F; Takeichi, M				Abe, K; Chisaka, O; van Roy, F; Takeichi, M			Stability of dendritic spines and synaptic contacts is controlled by alpha N-catenin	NATURE NEUROSCIENCE			English	Article							ACTIN-BASED PLASTICITY; CULTURED HIPPOCAMPAL-NEURONS; BETA-CATENIN; IN-VIVO; POSTSYNAPTIC DENSITIES; ADHESION COMPLEX; NERVOUS-SYSTEM; SMALL GTPASES; ADULT CORTEX; CADHERIN	Morphological plasticity of dendritic spines and synapses is thought to be crucial for their physiological functions. Here we show that alphaN-catenin, a linker between cadherin adhesion receptors and the actin cytoskeleton, is essential for stabilizing dendritic spines in rodent hippocampal neurons in culture. In the absence of alphaN-catenin, spine heads were abnormally motile, actively protruding filopodia from their synaptic contact sites. Conversely, alphaN-catenin overexpression in dendrites reduced spine turnover, causing an increase in spine and synapse density. Tetrodotoxin (TTX), a neural activity blocker, suppressed the synaptic accumulation of alphaN-catenin, whereas bicuculline, a GABA antagonist, promoted it. Furthermore, excess alphaN-catenin rendered spines resistant to the TTX treatment. These results suggest that alphaN-catenin is a key regulator for the stability of synaptic contacts.	RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; VIB Ghent Univ, Dept Mol Biomed Res, B-9000 Ghent, Belgium	RIKEN; Kyoto University; Flanders Institute for Biotechnology (VIB); Ghent University	Takeichi, M (corresponding author), RIKEN, Ctr Dev Biol, Chuo Ku, 2-2-3 Minatojima, Kobe, Hyogo 6500047, Japan.	takeichi@cdb.riken.jp	Takeichi, Masatoshi/G-5903-2012; van Roy, Frans M/C-6123-2009; Abe, Kentaro/T-2247-2019; Abe, Kentaro/A-6197-2008	Takeichi, Masatoshi/0000-0002-9931-3378; van Roy, Frans M/0000-0003-4358-1039; Abe, Kentaro/0000-0002-3923-6323; 				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Bek S, 2002, J CELL SCI, V115, P4743, DOI 10.1242/jcs.00154; Benson DL, 1998, J NEUROSCI, V18, P6892; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Ebihara T, 2003, J NEUROSCI, V23, P2170; El-Hussein AE, 2000, SCIENCE, V290, P1364; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Huntley GW, 1999, J COMP NEUROL, V407, P453; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Korkotian E, 2001, J NEUROSCI, V21, P6115, DOI 10.1523/JNEUROSCI.21-16-06115.2001; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Provost E, 1999, CURR OPIN CELL BIOL, V11, P567, DOI 10.1016/S0955-0674(99)00015-0; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; UCHIDA N, 1994, DEV BIOL, V163, P75, DOI 10.1006/dbio.1994.1124; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	50	194	197	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					357	363		10.1038/nn1212	http://dx.doi.org/10.1038/nn1212			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034585				2022-12-17	WOS:000220482500014
J	Wolff, MJ; Jochim, J; Akyurek, EG; Stokes, MG				Wolff, Michael J.; Jochim, Janina; Akyurek, Elkan G.; Stokes, Mark G.			Dynamic hidden states underlying working-memory-guided behavior	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; SHORT-TERM-MEMORY; NEURAL MECHANISMS; ATTENTION; REPRESENTATIONS; EEG; ELECTROENCEPHALOGRAPHY; TOOLBOX; FOCUS	Recent theoretical models propose that working memory is mediated by rapid transitions in 'activity-silent' neural states (for example, short-term synaptic plasticity). According to the dynamic coding framework, such hidden state transitions flexibly configure memory networks for memory-guided behavior and dissolve them equally fast to allow forgetting. We developed a perturbation approach to measure mnemonic hidden states in an electroencephalogram. By 'pinging' the brain during maintenance, we show that memory-item-specific information is decodable from the impulse response, even in the absence of attention and lingering delay activity. Moreover, hidden memories are remarkably flexible: an instruction cue that directs people to forget one item is sufficient to wipe the corresponding trace from the hidden state. In contrast, temporarily unattended items remain robustly coded in the hidden state, decoupling attentional focus from cue-directed forgetting. Finally, the strength of hidden-state coding predicts the accuracy of working-memory-guided behavior, including memory precision.	[Wolff, Michael J.; Jochim, Janina; Stokes, Mark G.] Univ Oxford, Dept Expt Psychol, Oxford, England; [Wolff, Michael J.; Akyurek, Elkan G.] Univ Groningen, Dept Expt Psychol, Groningen, Netherlands	University of Oxford; University of Groningen	Stokes, MG (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford, England.	mark.stokes@psy.ox.ac.uk		Wolff, Michael/0000-0002-1225-2294; Akyurek, Elkan/0000-0001-9111-5847	Biotechnology and Biological Sciences Research Council [BB/M010732/1] Funding Source: Medline; BBSRC [BB/M010732/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Barak O, 2014, CURR OPIN NEUROBIOL, V25, P20, DOI 10.1016/j.conb.2013.10.008; Barak O, 2010, J NEUROSCI, V30, P9424, DOI 10.1523/JNEUROSCI.1875-10.2010; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Claessens PME, 2008, J VISION, V8, DOI 10.1167/8.7.33; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Fukasaku, 2007, DATA SCI J, V6, pOD4, DOI [10.2481/dsj.6.OD4, DOI 10.2481/DSJ.6.OD4]; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Griffin IC, 2003, J COGNITIVE NEUROSCI, V15, P1176, DOI 10.1162/089892903322598139; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Hempel CM, 2000, J NEUROPHYSIOL, V83, P3031, DOI 10.1152/jn.2000.83.5.3031; King JR, 2014, TRENDS COGN SCI, V18, P203, DOI 10.1016/j.tics.2014.01.002; Landman R, 2003, VISION RES, V43, P149, DOI 10.1016/S0042-6989(02)00402-9; LaRocque JJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00005; LaRocque JJ, 2013, J COGNITIVE NEUROSCI, V25, P127, DOI 10.1162/jocn_a_00305; Ledoit O, 2004, J PORTFOLIO MANAGE, V30, P110, DOI 10.3905/jpm.2004.110; Lewis-Peacock JA, 2012, J COGNITIVE NEUROSCI, V24, P61, DOI 10.1162/jocn_a_00140; Lundqvist M, 2016, NEURON, V90, P152, DOI 10.1016/j.neuron.2016.02.028; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Martinez-Garcia M, 2011, P NATL ACAD SCI USA, V108, P11626, DOI 10.1073/pnas.1108137108; Miller EK, 1996, J NEUROSCI, V16, P5154; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Murray AM, 2011, NEUROPSYCHOLOGIA, V49, P1458, DOI 10.1016/j.neuropsychologia.2011.02.016; Murray JD, 2017, P NATL ACAD SCI USA, V114, P394, DOI 10.1073/pnas.1619449114; Myers NE, 2015, ELIFE, V4, DOI 10.7554/eLife.09000; Olivers CNL, 2011, TRENDS COGN SCI, V15, P327, DOI 10.1016/j.tics.2011.05.004; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Rose NS, 2016, SCIENCE, V354, P1136, DOI 10.1126/science.aah7011; Saproo S, 2010, J NEUROPHYSIOL, V104, P885, DOI 10.1152/jn.00369.2010; Schneider D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21442; Souza AS, 2016, ATTEN PERCEPT PSYCHO, V78, P1839, DOI 10.3758/s13414-016-1108-5; Sprague TC, 2016, NEURON, V91, P694, DOI 10.1016/j.neuron.2016.07.006; Sreenivasan KK, 2014, TRENDS COGN SCI, V18, P82, DOI 10.1016/j.tics.2013.12.001; Stokes MG, 2015, TRENDS COGN SCI, V19, P394, DOI 10.1016/j.tics.2015.05.004; Stokes MG, 2013, NEURON, V78, P364, DOI 10.1016/j.neuron.2013.01.039; Sugase-Miyamoto Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000073; van Ede F, 2017, J NEUROSCI, V37, P437, DOI [10.1523/JNEUROSCI.2272-16.2017, 10.1523/JNEUROSCI.2272-16.2016]; Watanabe K, 2007, CEREB CORTEX, V17, pI88, DOI 10.1093/cercor/bhm102; Watanabe K, 2014, NAT NEUROSCI, V17, P601, DOI 10.1038/nn.3667; Wolff MJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00123; Worden MS, 2000, J NEUROSCI, V20; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	48	193	194	11	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2017	20	6					864	+		10.1038/nn.4546	http://dx.doi.org/10.1038/nn.4546			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EV8FU	28414333	Green Accepted, Green Published, Green Submitted			2022-12-17	WOS:000402016900016
J	Halder, R; Hennion, M; Vidal, RO; Shomroni, O; Rahman, RU; Rajput, A; Centeno, TP; van Bebber, F; Capece, V; Vizcaino, JCG; Schuetz, AL; Burkhardt, S; Benito, E; Sala, MN; Javan, SB; Haass, C; Schmid, B; Fischer, A; Bonn, S				Halder, Rashi; Hennion, Magali; Vidal, Ramon O.; Shomroni, Orr; Rahman, Raza-Ur; Rajput, Ashish; Centeno, Tonatiuh Pena; van Bebber, Frauke; Capece, Vincenzo; Vizcaino, Julio C. Garcia; Schuetz, Anna-Lena; Burkhardt, Susanne; Benito, Eva; Sala, Magdalena Navarro; Javan, Sanaz Bahari; Haass, Christian; Schmid, Bettina; Fischer, Andre; Bonn, Stefan			DNA methylation changes in plasticity genes accompany the formation and maintenance of memory	NATURE NEUROSCIENCE			English	Article							HISTONE ACETYLATION; EPIGENETIC REGULATION; SEQUENCING DATA; RNA; CHROMATIN; SAMPLES; TRANSCRIPTION; GENERATION; EXPRESSION; NEURONS	The ability to form memories is a prerequisite for an organism's behavioral adaptation to environmental changes. At the molecular level, the acquisition and maintenance of memory requires changes in chromatin modifications. In an effort to unravel the epigenetic network underlying both short- and long-term memory, we examined chromatin modification changes in two distinct mouse brain regions, two cell types and three time points before and after contextual learning. We found that histone modifications predominantly changed during memory acquisition and correlated surprisingly little with changes in gene expression. Although long-lasting changes were almost exclusive to neurons, learning-related histone modification and DNA methylation changes also occurred in non-neuronal cell types, suggesting a functional role for non-neuronal cells in epigenetic learning. Finally, our data provide evidence for a molecular framework of memory acquisition and maintenance, wherein DNA methylation could alter the expression and splicing of genes involved in functional plasticity and synaptic wiring.	[Halder, Rashi; Burkhardt, Susanne; Benito, Eva; Sala, Magdalena Navarro; Javan, Sanaz Bahari; Fischer, Andre] German Ctr Neurodegenerat Dis DZNE, Res Grp Epigenet Mech Dementia, Gottingen, Germany; [Hennion, Magali; Vidal, Ramon O.; Shomroni, Orr; Rahman, Raza-Ur; Rajput, Ashish; Centeno, Tonatiuh Pena; Capece, Vincenzo; Vizcaino, Julio C. Garcia; Schuetz, Anna-Lena; Bonn, Stefan] German Ctr Neurodegenerat Dis DZNE, Res Grp Computat Syst Biol, Gottingen, Germany; [van Bebber, Frauke; Haass, Christian; Schmid, Bettina] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Haass, Christian] Univ Munich, Biomed Ctr, Munich, Germany; [Haass, Christian; Schmid, Bettina] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Fischer, Andre] Univ Med Ctr, Dept Psychiat & Psychotherapy, Gottingen, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; University of Gottingen	Bonn, S (corresponding author), German Ctr Neurodegenerat Dis DZNE, Res Grp Computat Syst Biol, Gottingen, Germany.	andre.fischer@dzne.de; stefan.bonn@dzne.de	Benito, Eva/AAN-9604-2020; Fischer, Andre/AAU-7487-2021; HALDER, RASHI/G-6894-2015	HALDER, RASHI/0000-0002-1402-1254; Fischer, Andre/0000-0001-8546-1161; Rahman, Raza-Ur/0000-0002-7019-5486; Hennion, Magali/0000-0002-0352-2790; Rajput, Ashish/0000-0002-6741-8861; Benito, Eva/0000-0003-0094-0257; Bonn, Stefan/0000-0003-4366-5662	DFG [BO4224/4-1]; Network of Centres of Excellence in Neurodegeneration (CoEN) initiative; iMed - the Helmholtz Initiative on Personalized Medicine; EURYI Award of the ESF; Hans and Ilse Breuer Foundation; European Research Council under the European Union's Seventh Framework Program (FP7)/ERC Grant [321366-Amyloid]	DFG(German Research Foundation (DFG)); Network of Centres of Excellence in Neurodegeneration (CoEN) initiative; iMed - the Helmholtz Initiative on Personalized Medicine; EURYI Award of the ESF; Hans and Ilse Breuer Foundation; European Research Council under the European Union's Seventh Framework Program (FP7)/ERC Grant(European Research Council (ERC))	We would like to thank M. Boroomandi for help with the behavioral experiments. We would like to thank E.E. Furlong, A.G. Ladurner, C. Margulies, R.P. Zinzen and W. Jackson for critical reading of the manuscript. This work was supported by the DFG (BO4224/4-1) (S. Bonn), the Network of Centres of Excellence in Neurodegeneration (CoEN) initiative (S. Bonn and A.F.), iMed - the Helmholtz Initiative on Personalized Medicine (S. Bonn and A.F.), the EURYI Award of the ESF (A.F.), the Hans and Ilse Breuer Foundation (A.F.), and by the European Research Council under the European Union's Seventh Framework Program (FP7/20072013)/ERC Grant Agreement No. 321366-Amyloid (advanced grant to C.H.).	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Andrews S., 2010, FASTQC QUALITY CONTR; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bero AW, 2014, P NATL ACAD SCI USA, V111, P11852, DOI 10.1073/pnas.1408378111; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; Bonn S, 2012, NAT PROTOC, V7, P978, DOI 10.1038/nprot.2012.049; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Capece V, 2015, BIOINFORMATICS, V31, P2205, DOI 10.1093/bioinformatics/btv113; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Einarsson EO, 2012, LEARN MEMORY, V19, P449, DOI 10.1101/lm.027227.112; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Fischer A, 2014, EMBO J, V33, P945, DOI 10.1002/embj.201387637; Fosque BF, 2015, SCIENCE, V347, P755, DOI 10.1126/science.1260922; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Graff J, 2013, NAT REV NEUROSCI, V14, P97, DOI 10.1038/nrn3427; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Gupta S, 2010, J NEUROSCI, V30, P3589, DOI 10.1523/JNEUROSCI.3732-09.2010; Guzman-Karlsson MC, 2014, NEUROPHARMACOLOGY, V80, P3, DOI 10.1016/j.neuropharm.2014.01.001; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heyward FD, 2015, NEUROSCIENTIST, V21, P475, DOI 10.1177/1073858415579635; Jiang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-42; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kendziorski CM, 2003, BIOSTATISTICS, V4, P465, DOI 10.1093/biostatistics/4.3.465; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Ko Y, 2013, P NATL ACAD SCI USA, V110, P3095, DOI 10.1073/pnas.1222897110; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lesburgueres E, 2011, SCIENCE, V331, P924, DOI 10.1126/science.1196164; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lopez-Atalaya JP, 2014, TRENDS GENET, V30, P529, DOI 10.1016/j.tig.2014.09.003; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; Malik AN, 2014, NAT NEUROSCI, V17, P1330, DOI 10.1038/nn.3808; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Nakayama A, 2003, J BIOL CHEM, V278, P233, DOI 10.1074/jbc.M209574200; Park CS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-539; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Proudhon C, 2012, MOL CELL, V47, P909, DOI 10.1016/j.molcel.2012.07.010; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajagopal N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002968; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Reiprich S, 2015, CELL TISSUE RES, V359, P111, DOI 10.1007/s00441-014-1909-6; Runyan JD, 2004, J NEUROSCI, V24, P1288, DOI 10.1523/JNEUROSCI.4880-03.2004; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Song QA, 2011, BIOINFORMATICS, V27, P870, DOI 10.1093/bioinformatics/btr030; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sweatt JD, 2013, NEURON, V80, P624, DOI 10.1016/j.neuron.2013.10.023; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zovkic IB, 2013, LEARN MEMORY, V20, P61, DOI 10.1101/lm.026575.112	66	193	197	3	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2016	19	1					102	+		10.1038/nn.4194	http://dx.doi.org/10.1038/nn.4194			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ7BH	26656643				2022-12-17	WOS:000367254400018
J	Herrmann, K; Montaser-Kouhsari, L; Carrasco, M; Heeger, DJ				Herrmann, Katrin; Montaser-Kouhsari, Leila; Carrasco, Marisa; Heeger, David J.			When size matters: attention affects performance by contrast or response gain	NATURE NEUROSCIENCE			English	Article							HUMAN VISUAL-CORTEX; SPATIAL ATTENTION; COVERT ATTENTION; PHYSIOLOGICAL CORRELATE; SUSTAINED ATTENTION; ZOOM LENS; AREA V4; MECHANISMS; FMRI; SENSITIVITY	Covert attention, the selective processing of visual information in the absence of eye movements, improves behavioral performance. We found that attention, both exogenous (involuntary) and endogenous (voluntary), can affect performance by contrast or response gain changes, depending on the stimulus size and the relative size of the attention field. These two variables were manipulated in a cueing task while stimulus contrast was varied. We observed a change in behavioral performance consonant with a change in contrast gain for small stimuli paired with spatial uncertainty and a change in response gain for large stimuli presented at one location (no uncertainty) and surrounded by irrelevant flanking distracters. A complementary neuroimaging experiment revealed that observers' attention fields were wider with than without spatial uncertainty. Our results support important predictions of the normalization model of attention and reconcile previous, seemingly contradictory findings on the effects of visual attention.	[Herrmann, Katrin; Montaser-Kouhsari, Leila; Carrasco, Marisa; Heeger, David J.] NYU, Dept Psychol, New York, NY 10003 USA; [Carrasco, Marisa; Heeger, David J.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; New York University	Heeger, DJ (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	david.heeger@nyu.edu			US National Institutes of Health [R01-EY019693, R01-MH06980, R01-EY016200]; NATIONAL EYE INSTITUTE [R01EY016200, R01EY019693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069880] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Mike Landy and members of the Carrasco and Heeger laboratories for their helpful comments. The psychophysical experiments were presented at the Annual Meeting of the Vision Science Society (2009) and the European Conference on Visual Perception (2009). This work was supported by US National Institutes of Health grants R01-EY019693 (D.J.H. and M.C.), R01-MH06980 (D.J.H.) and R01-EY016200 (M.C.).	Bartels A, 2008, TRENDS NEUROSCI, V31, P444, DOI 10.1016/j.tins.2008.06.004; Belopolsky AV, 2007, PSYCHON B REV, V14, P934, DOI 10.3758/BF03194124; Boynton GM, 2009, VISION RES, V49, P1129, DOI 10.1016/j.visres.2008.11.001; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Buracas GT, 2007, J NEUROSCI, V27, P93, DOI 10.1523/JNEUROSCI.3162-06.2007; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Carrasco M, 2006, PROG BRAIN RES, V154, P33; CASTIELLO U, 1990, ACTA PSYCHOL, V73, P195, DOI 10.1016/0001-6918(90)90022-8; Datta R, 2009, VISION RES, V49, P1037, DOI 10.1016/j.visres.2009.01.014; DEAN AF, 1981, EXP BRAIN RES, V44, P437; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Donner TH, 2008, J NEUROSCI, V28, P10298, DOI 10.1523/JNEUROSCI.2371-08.2008; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Giordano AM, 2009, J VISION, V9, DOI 10.1167/9.3.30; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; HERNANDEZ M, ATTEN PERCEPT PSYCHO, V72, P963; Huang LQ, 2005, VISION RES, V45, P1201, DOI 10.1016/j.visres.2004.10.024; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; JONIDES J, 1981, COGNITION, V10, P145, DOI 10.1016/0010-0277(81)90038-X; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Katkov M, 2007, VISION RES, V47, P2855, DOI 10.1016/j.visres.2007.06.024; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Li X, 2008, P NATL ACAD SCI USA, V105, P6202, DOI 10.1073/pnas.0801390105; Ling S, 2006, VISION RES, V46, P1210, DOI 10.1016/j.visres.2005.05.008; Ling S, 2006, NAT NEUROSCI, V9, P1243, DOI 10.1038/nn1761; Liu TS, 2007, VISION RES, V47, P108, DOI 10.1016/j.visres.2006.09.017; Liu TS, 2005, NEURON, V45, P469, DOI 10.1016/j.neuron.2004.12.039; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Lu ZL, 2000, J EXP PSYCHOL HUMAN, V26, P1534, DOI 10.1037//0096-1523.26.5.1534; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Morrone MC, 2004, VISION RES, V44, P1389, DOI 10.1016/j.visres.2003.10.014; Morrone MC, 2002, CURR BIOL, V12, P1134, DOI 10.1016/S0960-9822(02)00921-1; Muller NG, 2003, J NEUROSCI, V23, P3561; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Pestilli F, 2005, VISION RES, V45, P1867, DOI 10.1016/j.visres.2005.01.019; Pestilli F, 2007, J VISION, V7, DOI 10.1167/7.7.9; Pestilli F, 2009, VISION RES, V49, P1144, DOI 10.1016/j.visres.2008.09.018; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Sperling G., 1986, HDB PERCEPTION PERFO, V1, P1; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; Yeshurun Y, 2008, VISION RES, V48, P80, DOI 10.1016/j.visres.2007.10.015	50	193	194	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1554	U149		10.1038/nn.2669	http://dx.doi.org/10.1038/nn.2669			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21057509	Green Accepted			2022-12-17	WOS:000284525800022
J	Atallah, HE; Lopez-Paniagua, D; Rudy, JW; O'Reilly, RC				Atallah, Hisham E.; Lopez-Paniagua, Dan; Rudy, Jerry W.; O'Reilly, Randall C.			Separate neural substrates for skill learning and performance in the ventral and dorsal striatum	NATURE NEUROSCIENCE			English	Article							CAUDATE-NUCLEUS LESIONS; BASAL GANGLIA; DORSOCENTRAL STRIATUM; DOUBLE DISSOCIATION; PREDICTION ERRORS; PREFRONTAL CORTEX; MAZE TASKS; REWARD; DOPAMINE; ORGANIZATION	It is widely accepted that the striatum of the basal ganglia is a primary substrate for the learning and performance of skills. We provide evidence that two regions of the rat striatum, ventral and dorsal, play distinct roles in instrumental conditioning ( skill learning), with the ventral striatum being critical for learning and the dorsal striatum being important for performance but, notably, not for learning. This implies an actor ( dorsal) versus director ( ventral) division of labor, which is a new variant of the widely discussed actor-critic architecture. Our results also imply that the successful performance of a skill can ultimately result in its establishment as a habit outside the basal ganglia.	Univ Colorado, Dept Psychiat, Boulder, CO 80309 USA; Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Atallah, HE (corresponding author), Univ Colorado, Dept Psychiat, 345 UCB, Boulder, CO 80309 USA.	hisham.atallah@colorado.edu; randy.oreilly@colorado.edu	O'Reilly, Randall/A-5819-2008	O'Reilly, Randall/0000-0003-0322-4600	NIMH NIH HHS [MH069597-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069597] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Andrzejewski ME, 2004, BEHAV NEUROSCI, V118, P715, DOI 10.1037/0735-7044.118.4.715; Atallah HE, 2004, NEUROBIOL LEARN MEM, V82, P253, DOI 10.1016/j.nlm.2004.06.004; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Cheatwood JL, 2005, BRAIN RES, V1036, P90, DOI 10.1016/j.brainres.2004.12.049; Corbit LH, 2005, J NEUROSCI, V25, P962, DOI 10.1523/JNEUROSCI.4507-04.2005; Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001; Corlett PR, 2004, NEURON, V44, P877, DOI 10.1016/j.neuron.2004.11.022; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; DICKINSON A, 1995, ANIM LEARN BEHAV, V23, P197, DOI 10.3758/BF03199935; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Featherstone RE, 2004, BEHAV BRAIN RES, V150, P15, DOI 10.1016/S0166-4328(03)00218-3; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Haber SN, 2000, J NEUROSCI, V20, P2369; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Han JS, 1997, J NEUROSCI, V17, P3913; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Hernandez PJ, 2006, LEARN MEMORY, V13, P599, DOI 10.1101/lm.335006; Hernandez PJ, 2002, NAT NEUROSCI, V5, P1327, DOI 10.1038/nn973; Holland PC, 2004, J EXP PSYCHOL-ANIM B, V30, P104, DOI 10.1037/0097-7403.30.2.104; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; JOEL D, 1994, NEUROSCIENCE, V63, P363, DOI 10.1016/0306-4522(94)90536-3; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; JOEL D, 2000, CONC ADV BRAIN RES, V1, P209; Kantak KM, 2001, BEHAV NEUROSCI, V115, P589, DOI 10.1037//0735-7044.115.3.589; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; PACKARD MG, 1992, BEHAV NEUROSCI, V106, P439, DOI 10.1037/0735-7044.106.3.439; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Poldrack RA, 1999, NEUROPSYCHOLOGY, V13, P564, DOI 10.1037/0894-4105.13.4.564; Reep RL, 2003, J COMP NEUROL, V467, P271, DOI 10.1002/cne.10868; Rodriguez PF, 2006, HUM BRAIN MAPP, V27, P306, DOI 10.1002/hbm.20186; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Seger CA, 2005, J NEUROSCI, V25, P2941, DOI 10.1523/JNEUROSCI.3401-04.2005; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Williams ZM, 2006, NAT NEUROSCI, V9, P562, DOI 10.1038/nn1662; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	47	193	195	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					126	131		10.1038/nn1817	http://dx.doi.org/10.1038/nn1817			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17187065				2022-12-17	WOS:000243096100024
J	Fine, I; Wade, AR; Brewer, AA; May, MG; Goodman, DF; Boynton, GM; Wandell, BA; MacLeod, DIA				Fine, I; Wade, AR; Brewer, AA; May, MG; Goodman, DF; Boynton, GM; Wandell, BA; MacLeod, DIA			Long-term deprivation affects visual perception and cortex	NATURE NEUROSCIENCE			English	Article							EARLY BLINDNESS; REHABILITATION; NEURONS; AREA		Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA; Stanford Univ, Dept Neurosci, Stanford, CA 94305 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Sendero Grp LLC, Concord, CA 94520 USA; Calif Pacific Med Ctr, San Francisco, CA 94109 USA; Salk Inst Biol Studies, La Jolla, CA 93037 USA	University of California System; University of California San Diego; The Smith-Kettlewell Eye Research Institute; Stanford University; Stanford University; California Pacific Medical Center; Salk Institute	Fine, I (corresponding author), Univ Calif San Diego, Dept Psychol, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Wade, Alex/B-5473-2010	Wade, Alexander Robert/0000-0003-4871-2747	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS044759] Funding Source: NIH RePORTER; NINDS NIH HHS [F30 NS044759] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACKROYD C, 1974, Q J EXP PSYCHOL, V26, P114, DOI 10.1080/14640747408400393; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; CARLSON S, 1983, ACTA OPHTHALMOL, V61, P701; CARLSON S, 1986, BRIT J OPHTHALMOL, V70, P607, DOI 10.1136/bjo.70.8.607; CHESELDEN W, 1728, PHILOS T, V402, P447; Collins CE, 2003, J NEUROSCI, V23, P2251; GREGORY RL, 1963, EXP PSYCHOL SOC MONO, V2; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; Lewis TL, 2002, VISION RES, V42, P939, DOI 10.1016/S0042-6989(02)00041-X; MAYER DL, 1982, VISION RES, V22, P1141, DOI 10.1016/0042-6989(82)90079-7; Morgan MichaelJ., 1977, MOLYNEUXS QUESTION V; PASTERNAK T, 1981, NATURE, V292, P834, DOI 10.1038/292834a0; SACKS O., 1995, ANTHR MARS, P108; VAEGAN TD, 1979, T OPHTHAL SOC UK, V99, P432; Valvo A., 1971, SIGHT RESTORATION LO	15	193	194	1	31	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					915	916		10.1038/nn1102	http://dx.doi.org/10.1038/nn1102			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12937420				2022-12-17	WOS:000184970400008
J	Zhu, Y; Yu, T; Zhang, XC; Nagasawa, T; Wu, JY; Rao, Y				Zhu, Y; Yu, T; Zhang, XC; Nagasawa, T; Wu, JY; Rao, Y			Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons	NATURE NEUROSCIENCE			English	Article							RECEPTOR CXCR4; LYMPHOPOIESIS; MYELOPOIESIS; MIGRATION; PROTEIN; MICE; SLIT; CNS		Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Osaka Med Ctr Maternal & Child Hlth, Res Inst, Dept Mol & Cellular Immunol, Osaka 5901101, Japan	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wu, JY (corresponding author), Washington Univ, Sch Med, Dept Pediat, Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.			Nagasawa, Takashi/0000-0002-1085-0960	NATIONAL CANCER INSTITUTE [R01CA114197] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070967] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA114197-01A2, R01 CA114197] Funding Source: Medline; NEI NIH HHS [R01 EY014576, R01 EY014576-03] Funding Source: Medline; NIGMS NIH HHS [R01 GM070967-02, R01 GM070967] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Jazin EE, 1997, J NEUROIMMUNOL, V79, P148, DOI 10.1016/S0165-5728(97)00117-3; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mennicken F, 1999, TRENDS PHARMACOL SCI, V20, P73, DOI 10.1016/S0165-6147(99)01308-5; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	13	193	201	1	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					719	720		10.1038/nn881	http://dx.doi.org/10.1038/nn881			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12080344	Green Accepted			2022-12-17	WOS:000177088900009
J	Kros, CJ; Marcotti, W; van Netten, SM; Self, TJ; Libby, RT; Brown, SDM; Richardson, GP; Steel, KP				Kros, CJ; Marcotti, W; van Netten, SM; Self, TJ; Libby, RT; Brown, SDM; Richardson, GP; Steel, KP			Reduced climbing and increased slipping adaptation in cochlear hair cells of mice with Myo7a mutations	NATURE NEUROSCIENCE			English	Article							MYOSIN-VIIA; MECHANOELECTRICAL TRANSDUCTION; AMINOGLYCOSIDE ACCUMULATION; MEMBRANE; DEAFNESS; CADHERIN; CURRENTS; MODEL; CHANNELS; PROTEIN	Mutations in Myo7a cause hereditary deafness in mice and humans. We describe the effects of two mutations, Myo7a(6J) and Myo7a(4626SB). on mechano-electrical transduction in cochlear hair cells. Both mutations result in two major functional abnormalities that would interfere with sound transduction. The hair bundles need to be displaced beyond their physiological operating range for mechanotransducer channels to open. Transducer currents also adapt more strongly than normal to excitatory stimuli. We conclude that myosin VIIA participates in anchoring and holding membrane-bound elements to the actin core of the stereocilium. Myosin VIIA is therefore required for the normal gating of transducer channels.	Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; Univ Bristol, Sch Med Sci, Dept Physiol, Bristol BS8 1TD, Avon, England; Univ Groningen, Dept Neurobiophys, NL-9747 AG Groningen, Netherlands; Univ Nottingham, MRC, Inst Hearing Res, Nottingham NG7 2RD, England; MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England	University of Sussex; University of Bristol; University of Groningen; University of Nottingham; MRC Harwell	Kros, CJ (corresponding author), Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England.	c.j.kros@sussex.ac.uk	Libby, Richard/Q-6720-2019	Libby, Richard/0000-0003-2844-7632				ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; ASSAD JA, 1992, J NEUROSCI, V12, P3291; BARR E, 1994, GENE THER, V1, P51; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; DENK W, 1992, J NEUROPHYSIOL, V68, P927, DOI 10.1152/jn.1992.68.3.927; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Garcia JA, 1998, J NEUROSCI, V18, P8637; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; Gillespie PG, 1997, NEURON, V19, P955, DOI 10.1016/S0896-6273(00)80387-6; GOODNO CC, 1982, P NATL ACAD SCI-BIOL, V79, P21, DOI 10.1073/pnas.79.1.21; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Holt JR, 2000, P NATL ACAD SCI USA, V97, P11730, DOI 10.1073/pnas.97.22.11730; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; Kros C. J., 1995, ACTIVE HEARING, P113; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Lord EM, 1929, AM NAT, V63, P435, DOI 10.1086/280276; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Mburu Philomena, 1997, Genes and Function, V1, P191; OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189, DOI 10.1113/jphysiol.1985.sp015581; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; RHODE WS, 1967, J ACOUST SOC AM, V42, P185, DOI 10.1121/1.1910547; Richardson GP, 1997, J NEUROSCI, V17, P9506; Richardson GP, 1999, ANN NY ACAD SCI, V884, P110; Ruggero MA, 1997, J ACOUST SOC AM, V101, P2151, DOI 10.1121/1.418265; RUSSELL IJ, 1987, HEARING RES, V31, P9, DOI 10.1016/0378-5955(87)90210-3; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Self T, 1998, DEVELOPMENT, V125, P557; SHEPHERD GMG, 1994, J NEUROSCI, V14, P6217; van Netten SM, 2000, P ROY SOC B-BIOL SCI, V267, P1915, DOI 10.1098/rspb.2000.1230; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Yamoah EN, 1998, J NEUROSCI, V18, P610; Yamoah EN, 1996, NEURON, V17, P523, DOI 10.1016/S0896-6273(00)80184-1	47	193	200	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					41	47		10.1038/nn784	http://dx.doi.org/10.1038/nn784			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753415				2022-12-17	WOS:000173031800013
J	Maina, F; Klein, R				Maina, F; Klein, R			Hepatocyte growth factor, a versatile signal for developing neurons	NATURE NEUROSCIENCE			English	Review							FACTOR-SCATTER FACTOR; RECEPTOR TYROSINE KINASE; C-MET RECEPTOR; NEUROTROPHIC FACTORS; NEURAL INDUCTION; AXONAL GROWTH; IN-VITRO; EXPRESSION; SURVIVAL; CELLS	Here we summarize recent findings on the biology of hepatocyte growth factor (HGF, also known as scatter factor), focusing on its effects on developing neurons. HGF is both a chemoattractant and a survival factor for embryonic motor neurons. In addition, sensory and sympathetic neurons and their precursors respond to HGF with increased differentiation, survival and axonal outgrowth. The broad spectrum of HGF activities and its observed synergy with other neurotrophic factors suggest that the major role of HGF is to potentiate the response of developing neurons to specific signals.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Maina, F (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Maina, Flavio/J-9962-2019; Klein, Ruediger/C-6147-2008	Maina, Flavio/0000-0001-6100-4695; Klein, Ruediger/0000-0002-3109-0163				Achim CL, 1997, DEV BRAIN RES, V102, P299, DOI 10.1016/S0165-3806(97)00108-9; ALLEN RE, 1995, J CELL PHYSIOL, V165, P307, DOI 10.1002/jcp.1041650211; APFEL SC, 1991, ANN NEUROL, V29, P87, DOI 10.1002/ana.410290115; APFEL SC, 1994, BRAIN RES, V634, P7, DOI 10.1016/0006-8993(94)90252-6; BARINAGA M, 1994, SCIENCE, V264, P772, DOI 10.1126/science.8171331; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Birchmeier W, 1997, CIBA F SYMP, V212, P230; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Chen HC, 1998, J BIOL CHEM, V273, P25777, DOI 10.1074/jbc.273.40.25777; DIRENZO MF, 1993, ONCOGENE, V8, P219; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Fagan AM, 1996, J NEUROSCI, V16, P6208; Hamanoue M, 1996, J NEUROSCI RES, V43, P554, DOI 10.1002/(SICI)1097-4547(19960301)43:5<554::AID-JNR5>3.0.CO;2-H; HARTMANN G, 1994, J BIOL CHEM, V269, P21936; Jeffers M, 1996, J MOL MED-JMM, V74, P505, DOI 10.1007/BF00204976; JUNG W, 1994, J CELL BIOL, V126, P485, DOI 10.1083/jcb.126.2.485; Kochhar KS, 1996, CANCER LETT, V104, P163, DOI 10.1016/0304-3835(96)04244-9; KRASNOSELSKY A, 1994, J NEUROSCI, V14, P7284; Lindvall Olle, 1994, Current Opinion in Neurobiology, V4, P752, DOI 10.1016/0959-4388(94)90019-1; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; Maina F, 1998, NEURON, V20, P835, DOI 10.1016/S0896-6273(00)80466-3; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; MARTINEZSERRANO A, 1995, NEURON, V15, P473, DOI 10.1016/0896-6273(95)90051-9; MONARD D, 1988, TRENDS NEUROSCI, V11, P541, DOI 10.1016/0166-2236(88)90182-8; Nguyen L, 1997, J BIOL CHEM, V272, P20811, DOI 10.1074/jbc.272.33.20811; NISHI R, 1994, SCIENCE, V265, P1052, DOI 10.1126/science.8066443; Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8; PITTMAN RN, 1989, DEV NEUROSCI-BASEL, V11, P361, DOI 10.1159/000111912; Ponzetto C, 1996, J BIOL CHEM, V271, P14119, DOI 10.1074/jbc.271.24.14119; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Rodrigues GA, 1997, EMBO J, V16, P2634, DOI 10.1093/emboj/16.10.2634; RONG S, 1993, CELL GROWTH DIFFER, V4, P563; ROYAL I, 1995, J BIOL CHEM, V270, P27780, DOI 10.1074/jbc.270.46.27780; SCHATZL HM, 1995, TRENDS NEUROSCI, V18, P463, DOI 10.1016/0166-2236(95)90044-6; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; SHIOTA G, 1994, HEPATOLOGY, V19, P962, DOI 10.1016/0270-9139(94)90297-6; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; STREIT A, 1995, DEVELOPMENT, V121, P813; Streit A, 1997, DEVELOPMENT, V124, P1191; Thewke DP, 1996, J NEUROSCI, V16, P6933; Tuszynski MH, 1996, GENE THER, V3, P305; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Wong VV, 1997, J BIOL CHEM, V272, P5187, DOI 10.1074/jbc.272.8.5187; Wyatt S, 1997, EMBO J, V16, P3115, DOI 10.1093/emboj/16.11.3115; Yamamoto Y, 1997, DEVELOPMENT, V124, P2903; Yang XM, 1998, J NEUROSCI, V18, P8369	50	193	204	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					213	217		10.1038/6310	http://dx.doi.org/10.1038/6310			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195212				2022-12-17	WOS:000081684500007
J	Ng, B; White, CC; Klein, HU; Sieberts, SK; McCabe, C; Patrick, E; Xu, JS; Yu, L; Gaiteri, C; Bennett, DA; Mostafavi, S; De Jager, PL				Ng, Bernard; White, Charles C.; Klein, Hans-Ulrich; Sieberts, Solveig K.; McCabe, Cristin; Patrick, Ellis; Xu, Jishu; Yu, Lei; Gaiteri, Chris; Bennett, David A.; Mostafavi, Sara; De Jager, Philip L.			An xQTL map integrates the genetic architecture of the human brain's transcriptome and epigenome	NATURE NEUROSCIENCE			English	Article							GENOME-WIDE ASSOCIATION; AUTISM SPECTRUM DISORDER; SUSCEPTIBILITY LOCI; ALZHEIMERS-DISEASE; DNA METHYLATION; BINDING PROTEIN; RISK LOCI; EXPRESSION; VARIANTS; SCHIZOPHRENIA	We report a multi-omic resource generated by applying quantitative trait locus (xQTL) analyses to RNA sequence, DNA methylation and histone acetylation data from the dorsolateral prefrontal cortex of 411 older adults who have all three data types. We identify SNPs significantly associated with gene expression, DNA methylation and histone modification levels. Many of these SNPs influence multiple molecular features, and we demonstrate that SNP effects on RNA expression are fully mediated by epigenetic features in 9% of these loci. Further, we illustrate the utility of our new resource, xQTL Serve, by using it to prioritize the cell type(s) most affected by an xQTL. We also reanalyze published genome wide association studies using an xQTL-weighted analysis approach and identify 18 new schizophrenia and 2 new bipolar susceptibility variants, which is more than double the number of loci that can be discovered with a larger blood-based expression eQTL resource.	[Ng, Bernard; Mostafavi, Sara] Univ British Columbia, Dept Stat, Vancouver, BC, Canada; [Ng, Bernard; Mostafavi, Sara] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Ng, Bernard; Mostafavi, Sara] Ctr Mol Med & Therapeut, Vancouver, BC, Canada; [White, Charles C.; Klein, Hans-Ulrich; McCabe, Cristin; Patrick, Ellis; Xu, Jishu; De Jager, Philip L.] Broad Inst, Cambridge, MA 02142 USA; [Klein, Hans-Ulrich; De Jager, Philip L.] Columbia Univ, Med Ctr, Dept Neurol, Ctr Translat & Syst Neuroimmunol, New York, NY 10032 USA; [Sieberts, Solveig K.] Sage Bionetworks, Seattle, WA USA; [Yu, Lei; Gaiteri, Chris; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Mostafavi, Sara] Canadian Inst Adv Res, CIFAR Program Child & Brain Dev, Toronto, ON, Canada	University of British Columbia; University of British Columbia; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Columbia University; Rush University; Canadian Institute for Advanced Research (CIFAR)	Mostafavi, S (corresponding author), Univ British Columbia, Dept Stat, Vancouver, BC, Canada.; Mostafavi, S (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.; Mostafavi, S (corresponding author), Ctr Mol Med & Therapeut, Vancouver, BC, Canada.; De Jager, PL (corresponding author), Broad Inst, Cambridge, MA 02142 USA.; De Jager, PL (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, Ctr Translat & Syst Neuroimmunol, New York, NY 10032 USA.; Mostafavi, S (corresponding author), Canadian Inst Adv Res, CIFAR Program Child & Brain Dev, Toronto, ON, Canada.	saram@stat.ubc.ca; pld2115@cumc.columbia.edu	Yu, Lei/AAT-3685-2020; Klein, Hans-Ulrich/O-5118-2019; Patrick, Ellis/B-1763-2013	Klein, Hans-Ulrich/0000-0002-6382-9428; Patrick, Ellis/0000-0002-5253-4747; Gaiteri, Chris/0000-0001-7838-8664	National Institute of Health (NIH) [P330AG10161, U01 AG046152, R01AG16042, R01 AG036836, R01 AG015819, R01 AG017917, R01 AG036547]; AMP-AD Target Discovery and Preclinical Validation Consortium, a program of the National Institute of Aging [U01 AG046152]; Foundation of the NIH [U01 AG046152]; NATIONAL INSTITUTE ON AGING [RF1AG015819, P30AG010161, RF1AG036042, R01AG017917] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AMP-AD Target Discovery and Preclinical Validation Consortium, a program of the National Institute of Aging; Foundation of the NIH; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the participants of ROS and MAP for their essential contributions and gift to these projects. This work has been supported by National Institute of Health (NIH) grants P330AG10161, U01 AG046152, R01AG16042, R01 AG036836, R01 AG015819, R01 AG017917 and R01 AG036547. The U01 AG046152 grant (to P.L.D.J. and D.A.B.) is a component of the AMP-AD Target Discovery and Preclinical Validation Consortium, a program of the National Institute of Aging and the Foundation of the NIH.	Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Banovich NE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004663; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Bestman JE, 2008, P NATL ACAD SCI USA, V105, P20494, DOI 10.1073/pnas.0806296105; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Cai N, 2015, NATURE, V523, P588, DOI 10.1038/nature14659; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; De Jager PL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.033; Del Villar K, 2004, P NATL ACAD SCI USA, V101, P4210, DOI 10.1073/pnas.0307349101; Do C, 2016, AM J HUM GENET, V98, P934, DOI 10.1016/j.ajhg.2016.03.027; Dourlen P, 2017, MOL PSYCHIATR, V22, P874, DOI 10.1038/mp.2016.59; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Gaulton KJ, 2015, NAT GENET, V47, P1415, DOI 10.1038/ng.3437; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Hannon E, 2016, NAT NEUROSCI, V19, P48, DOI 10.1038/nn.4182; Huang L, 2013, SCHIZOPHR RES, V150, P588, DOI 10.1016/j.schres.2013.07.023; Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Johnson AD, 2008, PHARMACOGENET GENOM, V18, P781, DOI 10.1097/FPC.0b013e3283050107; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Karch CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148717; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim ASP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14931; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Mecham BH, 2010, BIOINFORMATICS, V26, P1308, DOI 10.1093/bioinformatics/btq118; Millstein J, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-23; Mostafavi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068141; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P884, DOI 10.1016/j.jaac.2010.06.008; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nishida H, 2006, CHROMOSOME RES, V14, P203, DOI 10.1007/s10577-006-1036-7; Otowa T, 2016, MOL PSYCHIATR, V21, P1391, DOI 10.1038/mp.2015.197; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pontillo A, 2012, ALZ DIS ASSOC DIS, V26, P277, DOI 10.1097/WAD.0b013e318231a8ac; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Robinson EB, 2016, NAT GENET, V48, P552, DOI 10.1038/ng.3529; Roeder K, 2007, GENET EPIDEMIOL, V31, P741, DOI 10.1002/gepi.20237; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Ruderfer DM, 2014, MOL PSYCHIATR, V19, P1017, DOI 10.1038/mp.2013.138; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Shulha HP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001427; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun WJ, 2016, CELL, V167, P1385, DOI 10.1016/j.cell.2016.10.031; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005223; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	78	192	193	6	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2017	20	10					1418	+		10.1038/nn.4632	http://dx.doi.org/10.1038/nn.4632			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FI1IM	28869584	Green Accepted			2022-12-17	WOS:000411686400016
J	Roth, MM; Dahmen, JC; Muir, DR; Imhof, F; Martini, FJ; Hofer, SB				Roth, Morgane M.; Dahmen, Johannes C.; Muir, Dylan R.; Imhof, Fabia; Martini, Francisco J.; Hofer, Sonja B.			Thalamic nuclei convey diverse contextual information to layer 1 of visual cortex	NATURE NEUROSCIENCE			English	Article							ORIENTATION SELECTIVITY; RESPONSE PROPERTIES; CORTICAL AREAS; PULVINAR; LOCOMOTION; ATTENTION; DORSAL; REPRESENTATIONS; MODULATION; PARALLEL	Sensory perception depends on the context in which a stimulus occurs. Prevailing models emphasize cortical feedback as the source of contextual modulation. However, higher order thalamic nuclei, such as the pulvinar, interconnect with many cortical and subcortical areas, suggesting a role for the thalamus in providing sensory and behavioral context. Yet the nature of the signals conveyed to cortex by higher order thalamus remains poorly understood. Here we use axonal calcium imaging to measure information provided to visual cortex by the pulvinar equivalent in mice, the lateral posterior nucleus (LP), as well as the dorsolateral geniculate nucleus (dLGN). We found that dLGN conveys retinotopically precise visual signals, while LP provides distributed information from the visual scene. Both LP and dLGN projections carry locomotion signals. However, while dLGN inputs often respond to positive combinations of running and visual flow speed, LP signals discrepancies between self-generated and external visual motion. This higher order thalamic nucleus therefore conveys diverse contextual signals that inform visual cortex about visual scene changes not predicted by the animal's own actions.	[Roth, Morgane M.; Muir, Dylan R.; Imhof, Fabia; Martini, Francisco J.; Hofer, Sonja B.] Univ Basel, Biozentrum, Basel, Switzerland; [Dahmen, Johannes C.; Hofer, Sonja B.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Dahmen, Johannes C.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Basel; University of London; University College London; University of Oxford	Hofer, SB (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.; Hofer, SB (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	sonja.hofer@unibas.ch	Martini, Francisco J/L-7997-2014; Muir, Dylan/E-1910-2011	Martini, Francisco J/0000-0002-4584-718X; Dahmen, Johannes/0000-0001-9889-8303; Muir, Dylan/0000-0003-3856-826X; Roth, Morgane/0000-0002-5714-6719; Hofer, Sonja/0000-0003-4921-8521	European Research Council [337797]; Wellcome Trust [095853, 076508]	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank J. Poort and A.G. Khan for generous help, software and hardware for the behavioral experiments, data acquisition and analysis, H. Ko for analysis software, M. Pachitariu for related preliminary analysis, A. Nemri for building the intrinsic imaging setup, G.B. Keller and his group (Friedrich Miescher Institute, Basel) for analysis software and AAV vectors, and I. Orsolic for an earlier version of the schematic in Figure 5a. We thank P. Znamensky, J. Poort, A. Blot, A. J. Keller and G.B. Keller for comments on earlier versions of the manuscript, the Hofer and Mrsic-Flogel laboratory for discussions and T.D. Mrsic-Flogel for support, comments and discussions. We thank the Biozentrum Imaging Core Facility (IMCF; Basel) for providing access and maintenance of confocal microscopes, as well as analysis support. We thank the GENIE Program, Janelia Farm Research Campus and Howard Hughes Medical Institute for making GCaMP5 and GCaMP6 material available. This work was supported by the European Research Council (S.B.H., HigherVision 337797) and the Wellcome Trust (S.B.H., 095853; J.C.D., 076508).	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Baldwin MKL, 2011, J COMP NEUROL, V519, P1071, DOI 10.1002/cne.22552; BENDER DB, 1982, J NEUROPHYSIOL, V48, P1, DOI 10.1152/jn.1982.48.1.1; Bickford ME, 2015, J NEUROSCI, V35, P10523, DOI 10.1523/JNEUROSCI.3375-14.2015; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cruz-Martin A, 2014, NATURE, V507, P358, DOI 10.1038/nature12989; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Dyer EL, 2013, I IEEE EMBS C NEUR E, P593, DOI 10.1109/NER.2013.6696004; Erisken S, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.10.045; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Gale SD, 2014, J NEUROSCI, V34, P13458, DOI 10.1523/JNEUROSCI.2768-14.2014; Gandy A, 2014, SCAND J STAT, V41, P1083, DOI 10.1111/sjos.12085; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; Gilbert CD, 2013, NAT REV NEUROSCI, V14, P350, DOI 10.1038/nrn3476; Grieve KL, 2000, TRENDS NEUROSCI, V23, P35, DOI 10.1016/S0166-2236(99)01482-4; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; Guillery RW, 2011, BRAIN RES REV, V66, P205, DOI 10.1016/j.brainresrev.2010.08.001; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Kaas JH, 2007, BRAIN RES REV, V55, P285, DOI 10.1016/j.brainresrev.2007.02.008; Kamishina H, 2009, BRAIN RES, V1264, P39, DOI 10.1016/j.brainres.2009.01.024; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Kropff E, 2015, NATURE, V523, P419, DOI 10.1038/nature14622; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Lee AM, 2014, NEURON, V83, P455, DOI 10.1016/j.neuron.2014.06.031; Leinweber M, 2014, JOVE-J VIS EXP, DOI 10.3791/50885; Liang FX, 2015, NEURON, V86, P755, DOI 10.1016/j.neuron.2015.03.048; Makino H, 2015, NAT NEUROSCI, V18, P1116, DOI 10.1038/nn.4061; Marshel JH, 2012, NEURON, V76, P713, DOI 10.1016/j.neuron.2012.09.021; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Poort J, 2015, NEURON, V86, P1478, DOI 10.1016/j.neuron.2015.05.037; Purushothaman G, 2012, NAT NEUROSCI, V15, P905, DOI 10.1038/nn.3106; RACZKOWSKI D, 1983, J NEUROSCI, V3, P1912; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Rubio-Garrido P, 2009, CEREB CORTEX, V19, P2380, DOI 10.1093/cercor/bhn259; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Saalmann YB, 2011, NEURON, V71, P209, DOI 10.1016/j.neuron.2011.06.027; Saleem AB, 2013, NAT NEUROSCI, V16, P1864, DOI 10.1038/nn.3567; Scholl B, 2013, J NEUROSCI, V33, P10616, DOI 10.1523/JNEUROSCI.0404-13.2013; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Shipp S, 2003, PHILOS T R SOC B, V358, P1605, DOI 10.1098/rstb.2002.1213; Sillito AM, 2006, TRENDS NEUROSCI, V29, P307, DOI 10.1016/j.tins.2006.05.001; Smith SL, 2010, NAT NEUROSCI, V13, P1144, DOI 10.1038/nn.2620; Tohmi M, 2014, CURR BIOL, V24, P587, DOI 10.1016/j.cub.2014.01.061; Williamson RS, 2015, CURR BIOL, V25, P1885, DOI 10.1016/j.cub.2015.05.045; Wurtz RH, 2011, TRENDS COGN SCI, V15, P177, DOI 10.1016/j.tics.2011.02.004; Zhang SY, 2014, SCIENCE, V345, P660, DOI 10.1126/science.1254126; Zhao XY, 2013, J NEUROSCI, V33, P12751, DOI 10.1523/JNEUROSCI.0095-13.2013	62	192	192	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2016	19	2					299	+		10.1038/nn.4197	http://dx.doi.org/10.1038/nn.4197			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DC4EG	26691828	Green Submitted, Green Accepted			2022-12-17	WOS:000369172600018
J	Womelsdorf, T; Valiante, TA; Sahin, NT; Miller, KJ; Tiesinga, P				Womelsdorf, Thilo; Valiante, Taufik A.; Sahin, Ned T.; Miller, Kai J.; Tiesinga, Paul			Dynamic circuit motifs underlying rhythmic gain control, gating and integration	NATURE NEUROSCIENCE			English	Review							MEMBRANE-POTENTIAL OSCILLATIONS; GAMMA-BAND SYNCHRONIZATION; NETWORK OSCILLATIONS; INHIBITORY INTERNEURONS; ATTENTIONAL MODULATION; FEEDFORWARD INHIBITION; FREQUENCY OSCILLATIONS; NEURAL ACTIVITY; VISUAL-CORTEX; MOTOR CORTEX	Brain circuitry processes information by rapidly and selectively engaging functional neuronal networks. The dynamic formation of networks is often evident in rhythmically synchronized neuronal activity and tightly correlates with perceptual, cognitive and motor performances. But how synchronized neuronal activity contributes to network formation and how it relates to the computation of behaviorally relevant information has remained difficult to discern. Here we structure recent empirical advances that link synchronized activity to the activation of so-called dynamic circuit motifs. These motifs explicitly relate (1) synaptic and cellular properties of circuits to (2) identified timescales of rhythmic activation and to (3) canonical circuit computations implemented by rhythmically synchronized circuits. We survey the ubiquitous evidence of specific cell and circuit properties underlying synchronized activity across theta, alpha, beta and gamma frequency bands and show that their activation likely implements gain control, context-dependent gating and state-specific integration of synaptic inputs. This evidence gives rise to the dynamic circuit motifs hypothesis of synchronized activation states, with its core assertion that activation states are linked to uniquely identifiable local circuit structures that are recruited during the formation of functional networks to perform specific computational operations.	[Womelsdorf, Thilo] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Womelsdorf, Thilo] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada; [Valiante, Taufik A.] Toronto Western Res Inst, Div Fundamental Neurobiol, Toronto, ON, Canada; [Valiante, Taufik A.] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Sahin, Ned T.] Brain Power LLC, Boston, MA USA; [Sahin, Ned T.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Miller, Kai J.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Miller, Kai J.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Tiesinga, Paul] Radboud Univ Nijmegen, Donders Inst Brain Behav & Cognit, NL-6525 ED Nijmegen, Netherlands	York University - Canada; York University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Harvard University; University of Washington; University of Washington Seattle; Stanford University; Radboud University Nijmegen	Womelsdorf, T (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	thiwom@yorku.ca	Tiesinga, Paul/D-1901-2010; Valiante, Taufik A/C-3285-2015; Womelsdorf, Thilo/C-3096-2015	Valiante, Taufik A/0000-0002-3443-3790; Womelsdorf, Thilo/0000-0001-6921-4187	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Ontario Ministry of Economic Development and Innovation (MEDI); CIHR; US National Institutes of Health (NIH) [NS18741, NS44623, HD 18381]; NIH Institutional Training Grant [T32 MH070328]; US National Center for Research Resources [P41 RR14075]; Netherlands Organization for Scientific Research (NWO) Computational Lifesciences program; Neuroseeker [600925]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018381] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH070328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018741, R01NS044623] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Economic Development and Innovation (MEDI); CIHR(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Netherlands Organization for Scientific Research (NWO) Computational Lifesciences program(Netherlands Organization for Scientific Research (NWO)); Neuroseeker; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the speakers of two workshops held at the Computational and Systems Neuroscience (cosyne.org) meetings on The Consequences of Brain Rhythms in the Organization of Neuronal Computation (2009) and Developing Simplified Algebras to Describe Large-Scale Brain Dynamics (2011) for numerous discussions. We thank T. Donner, C. Eliasmith, B. Hansen and M. Vinck for discussions and comments on an earlier version of the manuscript. T.W. was supported by grants from the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Ontario Ministry of Economic Development and Innovation (MEDI). T.A.V. was supported by grants from the CIHR. N.T.S. was supported by US National Institutes of Health (NIH) R01 grants NS18741, NS44623 and grant HD 18381, NIH Institutional Training Grant T32 MH070328, and the US National Center for Research Resources (P41 RR14075). P.T. was supported by a grant from the Netherlands Organization for Scientific Research (NWO) Computational Lifesciences program and by Neuroseeker (FP7 grant agreement 600925).	Akam T, 2014, NAT REV NEUROSCI, V15, P111, DOI 10.1038/nrn3668; Akam T, 2010, NEURON, V67, P308, DOI 10.1016/j.neuron.2010.06.019; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Bazhenov I., 2012, JASPERS BASIC MECH E; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Berger TK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000473; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Boehlen A, 2013, J NEUROPHYSIOL, V109, P445, DOI 10.1152/jn.00743.2011; Bollimunta A, 2011, J NEUROSCI, V31, P4935, DOI 10.1523/JNEUROSCI.5580-10.2011; Borgers C, 2008, P NATL ACAD SCI USA, V105, P18023, DOI 10.1073/pnas.0809511105; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; Brumberg JC, 2000, J NEUROSCI, V20, P4829; Bruno RM, 2011, CURR OPIN NEUROBIOL, V21, P701, DOI 10.1016/j.conb.2011.06.003; Buffalo EA, 2011, P NATL ACAD SCI USA, V108, P11262, DOI 10.1073/pnas.1011284108; Buzsaki G, 2013, NEURON, V80, P751, DOI 10.1016/j.neuron.2013.10.002; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Capogna M, 2011, TRENDS NEUROSCI, V34, P101, DOI 10.1016/j.tins.2010.10.005; Cardin JA, 2005, J NEUROSCI, V25, P5339, DOI 10.1523/JNEUROSCI.0374-05.2005; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carracedo LM, 2013, J NEUROSCI, V33, P10750, DOI 10.1523/JNEUROSCI.0735-13.2013; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V541, P319, DOI 10.1113/jphysiol.2002.016857; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V542, P567, DOI 10.1113/jphysiol.2002.019059; Castro-Alamancos MA, 2007, J PHYSIOL-LONDON, V578, P173, DOI 10.1113/jphysiol.2006.119016; Castro-Alamancos MA, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00021; Chapman CA, 1999, J NEUROPHYSIOL, V81, P1296, DOI 10.1152/jn.1999.81.3.1296; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Constantinople CM, 2013, SCIENCE, V340, P1591, DOI 10.1126/science.1236425; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Cunningham MO, 2004, P NATL ACAD SCI USA, V101, P7152, DOI 10.1073/pnas.0402060101; de Almeida L, 2009, J NEUROSCI, V29, P7504, DOI 10.1523/JNEUROSCI.6048-08.2009; Drion G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002050; English DF, 2012, NAT NEUROSCI, V15, P123, DOI 10.1038/nn.2984; Fanselow EE, 2008, J NEUROPHYSIOL, V100, P2640, DOI 10.1152/jn.90691.2008; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fischer I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.123902; Flint AC, 1996, J NEUROPHYSIOL, V75, P951, DOI 10.1152/jn.1996.75.2.951; Florez CM, 2015, CEREB CORTEX, V25, P578, DOI 10.1093/cercor/bht235; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Glasgow SD, 2008, J NEUROPHYSIOL, V100, P2746, DOI 10.1152/jn.90351.2008; Gloveli T, 2005, J PHYSIOL-LONDON, V562, P131, DOI 10.1113/jphysiol.2004.073007; Gregoriou GG, 2012, NEURON, V73, P581, DOI 10.1016/j.neuron.2011.12.019; Grillner S, 2005, TRENDS NEUROSCI, V28, P525, DOI 10.1016/j.tins.2005.08.003; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Helfrich RF, 2014, CURR BIOL, V24, P333, DOI 10.1016/j.cub.2013.12.041; Hentschke H, 2009, J NEUROPHYSIOL, V102, P3643, DOI 10.1152/jn.00651.2009; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Hu H, 2011, J NEUROSCI, V31, P3351, DOI 10.1523/JNEUROSCI.4881-10.2011; Hughes SW, 2008, BRAIN RES, V1235, P12, DOI 10.1016/j.brainres.2008.06.029; Hughes SW, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00193; Hughes SW, 2004, NEURON, V42, P253, DOI 10.1016/S0896-6273(04)00191-6; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Karameh FN, 2006, BIOL CYBERN, V95, P289, DOI 10.1007/s00422-006-0090-8; Karnani MM, 2014, CURR OPIN NEUROBIOL, V26, P96, DOI 10.1016/j.conb.2013.12.015; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Knoblich U, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00185; Kopell N, 2011, P NATL ACAD SCI USA, V108, P3779, DOI 10.1073/pnas.1019676108; Kramer MA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000169; Kremkow J, 2010, J NEUROSCI, V30, P15760, DOI 10.1523/JNEUROSCI.3874-10.2010; Kremkow J, 2010, J COMPUT NEUROSCI, V28, P579, DOI 10.1007/s10827-010-0240-9; Kumar A, 2013, TRENDS NEUROSCI, V36, P579, DOI 10.1016/j.tins.2013.06.005; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Lawrence JJ, 2008, TRENDS NEUROSCI, V31, P317, DOI 10.1016/j.tins.2008.03.008; Leao RN, 2012, NAT NEUROSCI, V15, P1524, DOI 10.1038/nn.3235; Lee AT, 2014, NEURON, V81, P61, DOI 10.1016/j.neuron.2013.10.031; Lee SH, 2014, NATURE, V508, pE1, DOI 10.1038/nature13128; Li XM, 2013, J NEUROPHYSIOL, V109, P2739, DOI 10.1152/jn.00397.2012; Lipsman N, 2014, NEUROIMAGE, V85, P769, DOI 10.1016/j.neuroimage.2013.05.104; Lorincz ML, 2009, NEURON, V63, P683, DOI 10.1016/j.neuron.2009.08.012; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Mancilla JG, 2007, J NEUROSCI, V27, P2058, DOI 10.1523/JNEUROSCI.2715-06.2007; Metherate R, 1999, EXP BRAIN RES, V126, P160, DOI 10.1007/s002210050726; Moca VV, 2014, CEREB CORTEX, V24, P119, DOI 10.1093/cercor/bhs293; Molyneaux BJ, 2002, J NEUROPHYSIOL, V87, P1196, DOI 10.1152/jn.00077.2001; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Otte S, 2010, J NEUROSCI, V30, P2150, DOI 10.1523/JNEUROSCI.4818-09.2010; Palmer L, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00026; Patel M, 2013, J THEOR BIOL, V334, P13, DOI 10.1016/j.jtbi.2013.05.022; Petersen CCH, 2013, NEURON, V78, P28, DOI 10.1016/j.neuron.2013.03.020; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Robbe D, 2009, J NEUROSCI, V29, P12597, DOI 10.1523/JNEUROSCI.2407-09.2009; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Roopun AK, 2008, FRONT CELL NEUROSCI, V2, DOI 10.3389/neuro.03.001.2008; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Saalmann YB, 2011, NEURON, V71, P209, DOI 10.1016/j.neuron.2011.06.027; Salazar RF, 2012, SCIENCE, V338, P1097, DOI 10.1126/science.1224000; Sherman S.M., 2006, EXPLORING THALAMUS I, V2nd; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; Silver RA, 2010, NAT REV NEUROSCI, V11, P474, DOI 10.1038/nrn2864; Sippy T, 2013, J NEUROSCI, V33, P9813, DOI 10.1523/JNEUROSCI.4579-12.2013; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Spaak E, 2012, CURR BIOL, V22, P2313, DOI 10.1016/j.cub.2012.10.020; Stark E, 2013, NEURON, V80, P1263, DOI 10.1016/j.neuron.2013.09.033; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Tetzlaff T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002596; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Thut G, 2012, CURR BIOL, V22, pR658, DOI 10.1016/j.cub.2012.06.061; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Tiesinga P, 2009, NEURON, V63, P727, DOI 10.1016/j.neuron.2009.09.009; Tiesinga PH, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00196; Varga C, 2012, P NATL ACAD SCI USA, V109, pE2726, DOI 10.1073/pnas.1210929109; Vinck M, 2013, NEURON, V80, P1077, DOI 10.1016/j.neuron.2013.08.019; Vinck M, 2010, J NEUROSCI, V30, P1250, DOI 10.1523/JNEUROSCI.1623-09.2010; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wang XJ, 1999, NEUROSCIENCE, V89, P347, DOI 10.1016/S0306-4522(98)00315-7; Wang XJ, 2004, P NATL ACAD SCI USA, V101, P1368, DOI 10.1073/pnas.0305337101; White JA, 2000, P NATL ACAD SCI USA, V97, P8128, DOI 10.1073/pnas.100124097; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Womelsdorf T, 2012, P NATL ACAD SCI USA, V109, P4302, DOI 10.1073/pnas.1114223109; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zemankovics R, 2013, J NEUROSCI, V33, P12337, DOI 10.1523/JNEUROSCI.3680-12.2013	120	192	194	2	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2014	17	8					1031	1039		10.1038/nn.3764	http://dx.doi.org/10.1038/nn.3764			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AM1XA	25065440				2022-12-17	WOS:000339641400007
J	Seif, T; Chang, SJ; Simms, JA; Gibb, SL; Dadgar, J; Chen, BT; Harvey, BK; Ron, D; Messing, RO; Bonci, A; Hopf, FW				Seif, Taban; Chang, Shao-Ju; Simms, Jeffrey A.; Gibb, Stuart L.; Dadgar, Jahan; Chen, Billy T.; Harvey, Brandon K.; Ron, Dorit; Messing, Robert O.; Bonci, Antonello; Hopf, F. Woodward			Cortical activation of accumbens hyperpolarization-active NMDARs mediates aversion-resistant alcohol intake	NATURE NEUROSCIENCE			English	Article							CUE-INDUCED REINSTATEMENT; COCAINE-SEEKING BEHAVIOR; NUCLEUS-ACCUMBENS; PREFRONTAL CORTEX; GABA(A) RECEPTORS; ETHANOL-CONSUMPTION; ANIMAL-MODEL; RATS; CORE; ADDICTION	Compulsive drinking despite serious adverse medical, social and economic consequences is a characteristic of alcohol use disorders in humans. Although frontal cortical areas have been implicated in alcohol use disorders, little is known about the molecular mechanisms and pathways that sustain aversion-resistant intake. Here, we show that nucleus accumbens core (NAcore) NMDA-type glutamate receptors and medial prefrontal (mPFC) and insula glutamatergic inputs to the NAcore are necessary for aversion-resistant alcohol consumption in rats. Aversion-resistant intake was associated with a new type of NMDA receptor adaptation, in which hyperpolarization-active NMDA receptors were present at mPFC and insula but not amygdalar inputs in the NAcore. Accordingly, inhibition of Grin2c NMDA receptor subunits in the NAcore reduced aversion-resistant alcohol intake. None of these manipulations altered intake when alcohol was not paired with an aversive consequence. Our results identify a mechanism by which hyperpolarization-active NMDA receptors under mPFC- and insula-to-NAcore inputs sustain aversion-resistant alcohol intake.	[Seif, Taban; Chang, Shao-Ju; Simms, Jeffrey A.; Gibb, Stuart L.; Dadgar, Jahan; Ron, Dorit; Messing, Robert O.; Hopf, F. Woodward] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA; [Chen, Billy T.; Harvey, Brandon K.; Bonci, Antonello] Natl Inst Drug Abuse, Intramural Res Program, Baltimore, MD USA; [Ron, Dorit; Messing, Robert O.; Bonci, Antonello; Hopf, F. Woodward] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA USA; [Bonci, Antonello] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of California System; University of California San Francisco; Johns Hopkins University	Hopf, FW (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA.	antonello.bonci@nih.gov; woody@gallo.ucsf.edu	Harvey, Brandon Keith/AAY-4080-2021; Messing, Robert/D-3642-2015	Harvey, Brandon Keith/0000-0002-4036-1383; Messing, Robert/0000-0002-5345-4431	NIAAA [RO1AA015358]; National Institute on Drug Abuse [F32DA028065]; NIAAA/NIH [RO1A/MH13438]; State of California for medical research for alcohol substance abuse through the University of California San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015358, P50AA017072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZICDA000555, F32DA028065, ZIADA000526, ZIADA000579] Funding Source: NIH RePORTER	NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); State of California for medical research for alcohol substance abuse through the University of California San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank V. Kharazia and the Gallo Center P50 National Institute on Alcohol Abuse and Alcoholism (NIAAA) AA017072 Histology Core for assistance with histology and R. Maiya for shRNA assistance. Supported by NIAAA RO1AA015358 (F.W.H.), National Institute on Drug Abuse F32DA028065 (T.S.), NIAAA/NIH RO1A/MH13438 (D.R.) and funds provided by the State of California for medical research for alcohol substance abuse through the University of California San Francisco (D.R., A.B., R.O.M.).	Backstrom P, 2007, PSYCHOPHARMACOLOGY, V192, P571, DOI 10.1007/s00213-007-0753-8; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Bassareo V, 2002, J NEUROSCI, V22, P4709, DOI 10.1523/JNEUROSCI.22-11-04709.2002; Belin D, 2011, NEUROPSYCHOPHARMACOL, V36, P569, DOI 10.1038/npp.2010.188; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Breese GR, 2011, PHARMACOL THERAPEUT, V129, P149, DOI 10.1016/j.pharmthera.2010.09.007; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Chaudhri N, 2009, PSYCHOPHARMACOLOGY, V207, P303, DOI 10.1007/s00213-009-1657-6; Chen BT, 2013, NATURE, V496, P359, DOI 10.1038/nature12024; Cooper A, 2007, PSYCHOPHARMACOLOGY, V194, P117, DOI 10.1007/s00213-007-0827-7; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; da Cunha IC, 2008, BEHAV BRAIN RES, V188, P91, DOI 10.1016/j.bbr.2007.10.023; de Visser L, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00109, 10.3389/fnins.2011.00102]; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Di Ciano P, 2001, NEUROPSYCHOPHARMACOL, V25, P341, DOI 10.1016/S0893-133X(01)00235-4; Di Pietro NC, 2006, EUR J NEUROSCI, V24, P3285, DOI 10.1111/j.1460-9568.2006.05193.x; Filbey FM, 2008, NEUROPSYCHOPHARMACOL, V33, P1391, DOI 10.1038/sj.npp.1301513; Gerfen C.R., 2004, RAT NERVOUS SYSTEM, P455, DOI DOI 10.1016/B978-012547638-6/50019-5; Gibb SL, 2011, J NEUROSCI, V31, P2180, DOI 10.1523/JNEUROSCI.5540-10.2011; Gremel CM, 2009, NEUROPSYCHOPHARMACOL, V34, P1443, DOI 10.1038/npp.2008.179; Hagino Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013722; Hodge CW, 1998, PSYCHOPHARMACOLOGY, V139, P95, DOI 10.1007/s002130050694; Hopf FW, 2010, NEURON, V65, P682, DOI 10.1016/j.neuron.2010.02.015; Hopf FW, 2010, ALCOHOL CLIN EXP RES, V34, P1565, DOI 10.1111/j.1530-0277.2010.01241.x; June HL, 2001, J NEUROSCI, V21, P2166, DOI 10.1523/JNEUROSCI.21-06-02166.2001; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; LaLumiere RT, 2008, J NEUROSCI, V28, P3170, DOI 10.1523/JNEUROSCI.5129-07.2008; Lasek AW, 2007, GENES BRAIN BEHAV, V6, P728, DOI 10.1111/j.1601-183X.2007.00303.x; Li J, 2011, ADDICT BIOL, V16, P600, DOI 10.1111/j.1369-1600.2011.00344.x; Low CM, 2010, MOL PHARMACOL, V78, P1, DOI 10.1124/mol.110.064006; MALDONADOIRIZARRY CS, 1994, PSYCHOPHARMACOLOGY, V116, P65, DOI 10.1007/BF02244872; McFarland K, 2004, J NEUROSCI, V24, P1551, DOI 10.1523/JNEUROSCI.4177-03.2004; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Obiang P, 2012, J NEUROSCI, V32, P12726, DOI 10.1523/JNEUROSCI.6202-11.2012; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Raeder H, 2008, DRUG ALCOHOL DEPEN, V96, P16, DOI 10.1016/j.drugalcdep.2007.12.013; RASSNICK S, 1992, PSYCHOPHARMACOLOGY, V109, P92, DOI 10.1007/BF02245485; Rhodes JS, 2007, GENES BRAIN BEHAV, V6, P1, DOI 10.1111/j.1601-183X.2006.00210.x; Roberts AJ, 1996, ALCOHOL CLIN EXP RES, V20, P1289, DOI 10.1111/j.1530-0277.1996.tb01125.x; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shi MM, 2011, NEUROREPORT, V22, P762, DOI 10.1097/WNR.0b013e32834ae32e; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Sinclair CM, 2012, PHARMACOL BIOCHEM BE, V101, P329, DOI 10.1016/j.pbb.2012.01.014; Singh T, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00126; Spanagel R, 2009, PHYSIOL REV, V89, P649, DOI 10.1152/physrev.00013.2008; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Stefanik MT, 2013, ADDICT BIOL, V18, P50, DOI 10.1111/j.1369-1600.2012.00479.x; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tiffany ST, 2000, ADDICTION, V95, pS145, DOI 10.1046/j.1360-0443.95.8s2.3.x; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Wang J, 2007, J NEUROSCI, V27, P3593, DOI 10.1523/JNEUROSCI.4749-06.2007; Wenzel A, 1995, NEUROREPORT, V7, P45, DOI 10.1097/00001756-199512290-00010; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Wolffgramm J, 2000, J NEURAL TRANSM, V107, P649, DOI 10.1007/s007020070067; Yamamoto T, 2006, ARCH HISTOL CYTOL, V69, P243, DOI 10.1679/aohc.69.243; Zahm DS, 1999, ANN NY ACAD SCI, V877, P113, DOI 10.1111/j.1749-6632.1999.tb09264.x; Zhang YC, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.020.2009	60	192	196	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1094	U162		10.1038/nn.3445	http://dx.doi.org/10.1038/nn.3445			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23817545	Green Accepted			2022-12-17	WOS:000322323000020
J	Berniker, M; Kording, K				Berniker, Max; Kording, Konrad			Estimating the sources of motor errors for adaptation and generalization	NATURE NEUROSCIENCE			English	Article							CORIOLIS-FORCE PERTURBATIONS; REACHING MOVEMENTS; INTERLIMB TRANSFER; LIMB DYNAMICS; BAYESIAN-INFERENCE; NONDOMINANT ARM; DOMINANT; MODELS; REPRESENTATIONS; INFORMATION	Motor adaptation is usually defined as the process by which our nervous system produces accurate movements while the properties of our bodies and our environment continuously change. Many experimental and theoretical studies have characterized this process by assuming that the nervous system uses internal models to compensate for motor errors. Here we extend these approaches and construct a probabilistic model that not only compensates for motor errors but estimates the sources of these errors. These estimates dictate how the nervous system should generalize. For example, estimated changes of limb properties will affect movements across the workspace but not movements with the other limb. We provide evidence that many movement-generalization phenomena emerge from a strategy by which the nervous system estimates the sources of our motor errors.	[Berniker, Max; Kording, Konrad] Northwestern Univ, Dept Phys Med & Rehabil, Rehabil Inst Chicago, Chicago, IL 60611 USA	Northwestern University; Shirley Ryan AbilityLab	Berniker, M (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Rehabil Inst Chicago, 345 E Super St,ONT 931, Chicago, IL 60611 USA.	mbernike@northwestern.edu	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499	US National Institutes of Health [RO1 NS057814-01]; Falk Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007418] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057814] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Falk Trust(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank S. Mussa-Ivaldi, J. Patton, R. Shadmehr and C. Ghez for helpful discussions. This work has been supported by the US National Institutes of Health (grant RO1 NS057814-01) and by the Falk Trust.	Ahmed AA, 2008, CURR BIOL, V18, P763, DOI 10.1016/j.cub.2008.04.061; Bagesteiro LB, 2002, J NEUROPHYSIOL, V88, P2408, DOI 10.1152/jn.00901.2001; BOCK O, 1993, BEHAV BRAIN RES, V55, P61, DOI 10.1016/0166-4328(93)90007-D; Burgess JK, 2007, IEEE T NEUR SYS REH, V15, P347, DOI 10.1109/TNSRE.2007.903908; Chib VS, 2006, J NEUROPHYSIOL, V95, P1068, DOI 10.1152/jn.00610.2005; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; Cothros N, 2006, EXP BRAIN RES, V173, P689, DOI 10.1007/s00221-006-0411-0; Criscimagna-Hemminger SE, 2003, J NEUROPHYSIOL, V89, P168, DOI 10.1152/jn.00622.2002; DIZIO P, 1995, J NEUROPHYSIOL, V74, P1787, DOI 10.1152/jn.1995.74.4.1787; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; HOGAN N, 1984, J NEUROSCI, V4, P2745; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kording KP, 2007, NAT NEUROSCI, V10, P779, DOI 10.1038/nn1901; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Lackner JR, 2005, CURR OPIN NEUROBIOL, V15, P653, DOI 10.1016/j.conb.2005.10.012; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Lackner JR, 1998, J NEUROPHYSIOL, V80, P546, DOI 10.1152/jn.1998.80.2.546; LASZLO JI, 1970, J MOTOR BEHAV, V2, P261, DOI 10.1080/00222895.1970.10734884; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Malfait N, 2002, J NEUROSCI, V22, P9656; Malfait N, 2004, J NEUROSCI, V24, P8084, DOI 10.1523/JNEUROSCI.1742-04.2004; Malfait N, 2005, J NEUROPHYSIOL, V93, P3327, DOI 10.1152/jn.00883.2004; Sainburg RL, 2000, J NEUROPHYSIOL, V83, P2661, DOI 10.1152/jn.2000.83.5.2661; Sainburg RL, 2002, EXP BRAIN RES, V142, P241, DOI 10.1007/s00221-001-0913-8; Schaal S, 2005, CURR OPIN NEUROBIOL, V15, P675, DOI 10.1016/j.conb.2005.10.009; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 2000, J NEUROSCI, V20, P7807; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tong C, 2002, J NEUROSCI, V22, P1108, DOI 10.1523/JNEUROSCI.22-03-01108.2002; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Wang JS, 2004, J NEUROPHYSIOL, V92, P349, DOI 10.1152/jn.00960.2003; Wang JS, 2004, EXP BRAIN RES, V155, P1, DOI 10.1007/s00221-003-1691-2; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Yuille A, 2006, TRENDS COGN SCI, V10, P301, DOI 10.1016/j.tics.2006.05.002	44	192	192	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2008	11	12					1454	1461		10.1038/nn.2229	http://dx.doi.org/10.1038/nn.2229			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	375JF	19011624	Green Accepted			2022-12-17	WOS:000261109300019
J	Medina, JF; Lisberger, SG				Medina, Javier F.; Lisberger, Stephen G.			Links from complex spikes to local plasticity and motor learning in the cerebellum of awake-behaving monkeys	NATURE NEUROSCIENCE			English	Article							PURSUIT EYE-MOVEMENTS; PURKINJE-CELLS; VESTIBULOOCULAR REFLEX; SYNAPTIC PLASTICITY; VESTIBULAR SIGNALS; VISUAL RESPONSES; FLOCCULUS; DYNAMICS; MECHANISMS; PATHWAYS	The hypothesis of cerebellar learning proposes that complex spikes in Purkinje cells engage mechanisms of plasticity in the cerebellar cortex; in turn, changes in the cerebellum depress the simple-spike response of Purkinje cells to a given stimulus and cause the adaptive modification of a motor behavior. Although many elements of this hypothesis have been supported by prior experiments, the links between complex spikes, simple-spike plasticity and behavior have not yet been examined simultaneously during the learning process. We carried out a trial-by-trial analysis of Purkinje cell responses in awake-behaving monkeys and found evidence for a causal role for complex spikes in the induction of cerebellar plasticity during a simple motor learning task. We found that the presence of a complex spike on one learning trial was linked to a substantial depression of simple-spike responses on the subsequent trial, at a time when behavioral learning was expressed.	[Lisberger, Stephen G.] Univ Calif San Francisco, Howard Hughes Med Inst, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Lisberger, Stephen G.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Medina, Javier F.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania	Lisberger, SG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, WM Keck Fdn Ctr Integrat Neurosci, 513 Parnassus Ave, San Francisco, CA 94143 USA.	sgl@phy.ucsf.edu		Medina, Javier/0000-0001-8708-5315	Howard Hughes Medical Institute; US National Institutes of Health [P50 MH77970]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Howard Hughes Medical Institute and by US National Institutes of Health grant P50 MH77970.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Blazquez PM, 2006, J NEUROPHYSIOL, V95, P1812, DOI 10.1152/jn.01061.2005; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; Carey MR, 2002, NEURON, V35, P223, DOI 10.1016/S0896-6273(02)00771-7; Cheng S, 2007, J NEUROPHYSIOL, V97, P3057, DOI 10.1152/jn.00897.2006; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; Doi T, 2005, J NEUROSCI, V25, P950, DOI 10.1523/JNEUROSCI.2727-04.2005; Eccles JC, 1967, CEREBELLUM NEURONAL; Fine MS, 2007, J NEUROPHYSIOL, V98, P1392, DOI 10.1152/jn.00196.2007; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; HIGHSTEIN SM, 1973, EXP BRAIN RES, V17, P301; Houk JC, 1996, BEHAV BRAIN SCI, V19, P457, DOI 10.1017/S0140525X00081735; ITO M, 1972, BRAIN RES, V40, P81, DOI 10.1016/0006-8993(72)90110-2; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Ito M, 2000, BRAIN RES, V886, P237, DOI 10.1016/S0006-8993(00)03142-5; Ito M, 1984, CEREBELLUM NEURAL CO; Jirenhed DA, 2007, J NEUROSCI, V27, P2493, DOI 10.1523/JNEUROSCI.4202-06.2007; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Kahlon M, 2000, J NEUROPHYSIOL, V84, P2945, DOI 10.1152/jn.2000.84.6.2945; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Krauzlis RJ, 2000, NEUROREPORT, V11, P1045, DOI 10.1097/00001756-200004070-00029; KRAUZLIS RJ, 1994, J NEUROPHYSIOL, V72, P2045, DOI 10.1152/jn.1994.72.4.2045; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; LISBERGER SG, 1986, J NEUROSCI, V6, P346; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P764, DOI 10.1152/jn.1978.41.3.764; LISBERGER SG, 1994, J NEUROPHYSIOL, V72, P974, DOI 10.1152/jn.1994.72.2.974; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Medina JF, 2007, J NEUROSCI, V27, P6832, DOI 10.1523/JNEUROSCI.1323-07.2007; Medina JF, 2005, NEURON, V45, P157, DOI 10.1016/j.neuron.2004.12.017; Medina JF, 2000, CURR OPIN NEUROBIOL, V10, P717, DOI 10.1016/S0959-4388(00)00154-9; MILES FA, 1980, J NEUROPHYSIOL, V43, P1437, DOI 10.1152/jn.1980.43.5.1437; Mittmann W, 2007, J NEUROSCI, V27, P5559, DOI 10.1523/JNEUROSCI.5117-06.2007; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; Ramachandran R, 2006, J NEUROPHYSIOL, V96, P1061, DOI 10.1152/jn.00281.2006; Raymond JL, 1998, J NEUROSCI, V18, P9112; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Robinson FR, 2001, ANNU REV NEUROSCI, V24, P981, DOI 10.1146/annurev.neuro.24.1.981; RON S, 1973, J NEUROPHYSIOL, V36, P1004, DOI 10.1152/jn.1973.36.6.1004; SATO Y, 1992, J NEUROPHYSIOL, V68, P2051, DOI 10.1152/jn.1992.68.6.2051; SHIDARA M, 1993, NATURE, V365, P50, DOI 10.1038/365050a0; Simpson JI, 1996, BEHAV BRAIN SCI, V19, P384, DOI 10.1017/S0140525X00081486; STONE LS, 1986, NEUROSCI LETT, V72, P163, DOI 10.1016/0304-3940(86)90073-X; STONE LS, 1990, J NEUROPHYSIOL, V63, P1241, DOI 10.1152/jn.1990.63.5.1241; STONE LS, 1990, J NEUROPHYSIOL, V63, P1262, DOI 10.1152/jn.1990.63.5.1262; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wolpert DM, 2002, HDB BRAIN THEORY NEU, P1020	50	192	192	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2008	11	10					1185	1192		10.1038/nn.2197	http://dx.doi.org/10.1038/nn.2197			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	352WQ	18806784	Green Accepted, Green Submitted			2022-12-17	WOS:000259528500016
J	Groc, L; Choquet, D; Chaouloff, F				Groc, Laurent; Choquet, Daniel; Chaouloff, Francis			The stress hormone corticosterone conditions AMPAR surface trafficking and synaptic potentiation	NATURE NEUROSCIENCE			English	Article							RECEPTOR TRAFFICKING; NMDA RECEPTORS; BRAIN; TRANSMISSION; HIPPOCAMPUS; ADAPTATION; PLASTICITY	Corticosterone facilitates hippocampal glutamate transmission, but the cellular pathways by which AMPA receptor (AMPAR) signaling is adjusted remain elusive. Single quantum-dot imaging in live rat hippocampal neurons revealed that corticosterone triggers, via distinct corticosteroid receptors, time-dependent increases in GluR2-AMPAR surface mobility and synaptic surface GluR2 content. Furthermore, corticosterone potentiates the increase of synaptic surface GluR2 contents by a chemical long-term potentiation stimulus, revealing the influence that corticosterone has on AMPAR trafficking.	[Groc, Laurent; Choquet, Daniel] Univ Bordeaux 2, CNRS, UMR 5091, F-33077 Bordeaux, France; [Chaouloff, Francis] Univ Bordeaux 2, INSERM, U862, Equipe AVENIR Mecan Mol Adaptat, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Groc, L (corresponding author), Univ Bordeaux 2, CNRS, UMR 5091, F-33077 Bordeaux, France.	laurent.groc@u-bordeaux2.fr	Choquet, Daniel/E-4203-2013; Choquet, Daniel/K-7893-2018; Choquet, Daniel/GOJ-8825-2022; Chaouloff, Francis/N-7003-2017	Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763; Chaouloff, Francis/0000-0001-9036-4067				de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Joels M, 2006, TRENDS PHARMACOL SCI, V27, P244, DOI 10.1016/j.tips.2006.03.007; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2005, J NEUROPHYSIOL, V94, P3479, DOI 10.1152/jn.00143.2005; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Wiegert O, 2006, LEARN MEMORY, V13, P110, DOI 10.1101/lm.87706	13	192	194	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					868	870		10.1038/nn.2150	http://dx.doi.org/10.1038/nn.2150			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18622402				2022-12-17	WOS:000257969100007
J	Correia, SS; Bassani, S; Brown, TC; Lise, MF; Backos, DS; El-Husseini, A; Passafaro, M; Esteban, JA				Correia, Susana S.; Bassani, Silvia; Brown, Tyler C.; Lise, Marie-France; Backos, Donald S.; El-Husseini, Alaa; Passafaro, Maria; Esteban, Jose A.			Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation	NATURE NEUROSCIENCE			English	Article							MYOSIN-VA; SYNAPTIC-TRANSMISSION; DENDRITIC SPINES; RECYCLING ENDOSOMES; GRISCELLI-DISEASE; ACTIN-FILAMENTS; TRAFFICKING; PLASTICITY; SYNAPSES; NEURONS	The regulated trafficking of neurotransmitter receptors at synapses is critical for synaptic function and plasticity. However, the molecular machinery that controls active transport of receptors into synapses is largely unknown. We found that, in rat hippocampus, the insertion of AMPA receptors (AMPARs) into spines during synaptic plasticity requires a specific motor protein, which we identified as myosin Va. We found that myosin Va associates with AMPARs through its cargo binding domain. This interaction was enhanced by active, GTP-bound Rab11, which is also transported by the motor protein. Myosin Va mediated the CaMKII-triggered translocation of GluR1 receptors from the dendritic shaft into spines, but it was not required for constitutive GluR2 trafficking. Accordingly, myosin Va was specifically required for long-term potentiation, but not for basal synaptic transmission. In summary, we identified the specific motor protein and organelle acceptor that catalyze the directional transport of AMPARs into spines during activity-dependent synaptic plasticity.	[Correia, Susana S.; Brown, Tyler C.; Backos, Donald S.; Esteban, Jose A.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Bassani, Silvia; Passafaro, Maria] Univ Milan, Dept Pharmacol, Dulbecco Telethon Inst, Consiglio Nazl Ric Inst Neurosci, I-20129 Milan, Italy; [Brown, Tyler C.; Esteban, Jose A.] Univ Michigan, Sch Med, Neurosci Program, Ann Arbor, MI 48109 USA; [Lise, Marie-France; El-Husseini, Alaa] Univ British Columbia, Dept Psychiat, Brain Res Ctr, Fac Med, Vancouver, BC V6T 1Z3, Canada	University of Michigan System; University of Michigan; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Milan; University of Michigan System; University of Michigan; University of British Columbia	Esteban, JA (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	estebanj@umich.edu	Backos, Donald/Q-4791-2018; Bassani, Silvia/A-7241-2012; Esteban, Jose/L-4944-2014; Backos, Donald/N-5265-2019	Backos, Donald/0000-0001-6735-6210; Bassani, Silvia/0000-0003-0553-7168; Esteban, Jose/0000-0002-3759-3300; Backos, Donald/0000-0001-6735-6210; Brown, Tyler/0000-0001-9543-8555	NIMH NIH HHS [F31-MH070205, MH070417] Funding Source: Medline; Telethon [TCR07006] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH070205, R01MH070417] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Barral DC, 2002, J CLIN INVEST, V110, P247, DOI 10.1172/JCI200215058; Brown JR, 2001, BIOL BULL, V201, P240, DOI 10.2307/1543343; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Cao TT, 2004, MOL BIOL CELL, V15, P151, DOI 10.1091/mbc.E03-07-0504; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Gerges NZ, 2005, METHOD ENZYMOL, V403, P153, DOI 10.1016/S0076-6879(05)03013-2; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Petralia RS, 2001, EUR J NEUROSCI, V13, P1722, DOI 10.1046/j.0953-816x.2001.01553.x; Piccini A, 2002, J NEUROSCI, V22, P5387; Rodriguez OC, 2002, J CELL SCI, V115, P991; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Sanal O, 2000, J NEUROL, V247, P570, DOI 10.1007/s004150070162; Schnell E, 2001, J NEUROPHYSIOL, V85, P1498, DOI 10.1152/jn.2001.85.4.1498; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Tabb JS, 1998, J CELL SCI, V111, P3221; Takagishi Y, 1996, NEUROSCI LETT, V215, P169, DOI 10.1016/S0304-3940(96)12967-0; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	50	192	196	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					457	466		10.1038/nn2063	http://dx.doi.org/10.1038/nn2063			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18311135	Green Submitted			2022-12-17	WOS:000254359300018
J	Wu, Q; Zhao, ZW; Shen, P				Wu, Q; Zhao, ZW; Shen, P			Regulation of aversion to noxious food by Drosophila neuropeptide Y- and insulin-like systems	NATURE NEUROSCIENCE			English	Article							SIGNALING PATHWAY; GROWTH-CONTROL; CELL-GROWTH; S6 KINASE; RECEPTOR; EXPRESSION; TRANSPORT; BEHAVIOR; DYNAMIN; PROTEIN	Omnivores, including humans, have an inborn tendency to avoid noxious or unfamiliar foods. Such defensive foraging behaviors are modifiable, however, in response to physiological needs. Here we describe a method for assessing risk-sensitive food acquisition in Drosophila melanogaster. Food-deprived fly larvae become more likely to feed on noxious foods ( adulterated with quinine) as the duration of deprivation increases. The neuropeptide F receptor NPFR1, a mammalian neuropeptide Y (NPY) receptor homolog, centrally regulates the response to noxious food in D. melanogaster. Overexpression of NPFR1 was sufficient to cause nondeprived larvae to more readily take in noxious food, whereas loss of NPFR1 signaling led to the opposite phenotype. Moreover, NPFR1 neuronal activity may be directly regulated by the insulin-like signaling pathway. Upregulation of insulin-like receptor signaling in NPFR1 cells suppressed the feeding response to noxious food. Our results suggest that the coordinated activities of the conserved NPY- and insulin-like receptor signaling systems are essential for the dynamic regulation of noxious food intake according to the animal's energy state.	Univ Georgia, Dept Cellular Biol & Biomed, Athens, GA 30602 USA; Univ Georgia, Hlth Sci Inst, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Shen, P (corresponding author), Univ Georgia, Dept Cellular Biol & Biomed, 724 Biol Sci Bldg, Athens, GA 30602 USA.	pshen@cellmate.cb.uga.edu		Shen, Ping/0000-0001-5024-3893	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058348] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-58348] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bannon AW, 2000, BRAIN RES, V868, P79, DOI 10.1016/S0006-8993(00)02285-X; Barcelo H, 2002, GENESIS, V34, P83, DOI 10.1002/gene.10132; Bateson M, 2002, P NUTR SOC, V61, P509, DOI 10.1079/PNS2002181; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Cao H, 2000, J CELL SCI, V113, P1993; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Garczynski SF, 2002, PEPTIDES, V23, P773, DOI 10.1016/S0196-9781(01)00647-7; HAASS M, 1989, N-S ARCH PHARMACOL, V340, P509; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kimball SR, 2001, CURR OPIN CLIN NUTR, V4, P39, DOI 10.1097/00075197-200101000-00008; Kitamoto T, 2002, J NEUROGENET, V16, P205, DOI 10.1080/01677060216295; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Kyriaki G, 2003, CELL MOL NEUROBIOL, V23, P1, DOI 10.1023/A:1022598900246; Larhammar D, 1996, REGUL PEPTIDES, V62, P1, DOI 10.1016/0167-0115(95)00169-7; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Levine AS, 2004, PEPTIDES, V25, P505, DOI 10.1016/j.peptides.2004.01.005; Levine AS, 2003, J NUTR, V133, p831S, DOI 10.1093/jn/133.3.831S; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; MOORE P, 2003, J BIOL, V2; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Rao S, 2001, J NEUROBIOL, V49, P159, DOI 10.1002/neu.1072; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Segal-Lieberman G, 2003, AM J PHYSIOL-ENDOC M, V284, pE1131, DOI 10.1152/ajpendo.00491.2002; Shen P, 2001, J NEUROBIOL, V47, P16, DOI 10.1002/neu.1012; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Stricker E. M., 1990, NEUROBIOLOGY FOOD FL; Thomas G, 2002, BIOL RES, V35, P305, DOI 10.4067/S0716-97602002000200022; Thorsell A, 2002, NEUROPEPTIDES, V36, P182, DOI 10.1054/npep.2002.0897; Thorsell A, 2000, P NATL ACAD SCI USA, V97, P12852, DOI 10.1073/pnas.220232997; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9	41	192	197	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1350	1355		10.1038/nn1540	http://dx.doi.org/10.1038/nn1540			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16172603				2022-12-17	WOS:000232145900019
J	Chase, DL; Pepper, JS; Koelle, MR				Chase, DL; Pepper, JS; Koelle, MR			Mechanism of extrasynaptic dopamine signaling in Caenorhabditis elegans	NATURE NEUROSCIENCE			English	Article							C-ELEGANS; NERVOUS-SYSTEM; LOCOMOTOR-ACTIVITY; SYNAPTIC-TRANSMISSION; ACETYLCHOLINE-RELEASE; MULTIPLE ASPECTS; RAT STRIATUM; RECEPTORS; PROTEIN; G(Q)ALPHA	D1-like and D2-like dopamine receptors have synergistic and antagonistic effects on behavior. To understand the mechanisms underlying these effects, we studied dopamine signaling genetically in Caenorhabditis elegans. Knocking out a D2-like receptor, DOP-3, caused locomotion defects similar to those observed in animals lacking dopamine. Knocking out a D1-like receptor, DOP-1, reversed the defects of the DOP-3 knockout. DOP-3 and DOP-1 have their antagonistic effects on locomotion by acting in the same motor neurons, which coexpress the receptors and which are not postsynaptic to dopaminergic neurons. In a screen for mutants unable to respond to dopamine, we identified four genes that encode components of the antagonistic Galpha(o) and Galpha(q) signaling pathways, including Galpha(o) itself and two subunits of the regulator of G protein signaling (RGS) complex that inhibits Galpha(q). Our results indicate that extrasynaptic dopamine regulates C. elegans locomotion through D1- and D2-like receptors that activate the antagonistic Galpha(q) and Galpha(o) signaling pathways, respectively.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Chase, DL (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	daniel.chase@yale.edu						Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; AVERY L, 1993, GENETICS, V133, P897; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; Caille I, 1996, BRAIN RES, V730, P17, DOI 10.1016/0006-8993(96)00424-6; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chase DL, 2001, CURR BIOL, V11, P222, DOI 10.1016/S0960-9822(01)00071-9; Corvol JC, 2001, J NEUROCHEM, V76, P1585, DOI 10.1046/j.1471-4159.2001.00201.x; Eastman C, 1999, J NEUROSCI, V19, P6225; GIRAULT JA, 1986, NEUROSCIENCE, V19, P1109, DOI 10.1016/0306-4522(86)90127-2; Gong W, 1999, NEUROSCIENCE, V93, P1349, DOI 10.1016/S0306-4522(99)00235-3; Gonon F, 1997, J NEUROSCI, V17, P5972; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hallam S, 2000, DEVELOPMENT, V127, P4239; Ikarashi Y, 1997, BRAIN RES BULL, V43, P107, DOI 10.1016/S0361-9230(96)00351-6; Jiang MS, 2001, P NATL ACAD SCI USA, V98, P3577, DOI 10.1073/pnas.051632598; Kelly MA, 1998, J NEUROSCI, V18, P3470; KIMURA K, 1995, J BIOL CHEM, V270, P14672, DOI 10.1074/jbc.270.24.14672; Knable MB, 1997, J PSYCHOPHARMACOL, V11, P123, DOI 10.1177/026988119701100205; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; Lints R, 1999, DEVELOPMENT, V126, P5819; LIU YF, 1994, J BIOL CHEM, V269, P13880; LOCHRIE MA, 1991, CELL REGUL, V2, P135, DOI 10.1091/mbc.2.2.135; McNamara FN, 2003, NEUROPSYCHOPHARMACOL, V28, P86, DOI 10.1038/sj.npp.1300008; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Nass R, 2003, ANNU REV PHARMACOL, V43, P521, DOI 10.1146/annurev.pharmtox.43.100901.135934; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; PLAZNIK A, 1989, PSYCHOPHARMACOLOGY, V99, P558, DOI 10.1007/BF00589908; Robatzek M, 2000, GENETICS, V156, P1069; Robatzek M, 2001, CURR BIOL, V11, P288, DOI 10.1016/S0960-9822(01)00074-4; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; SENOGLES SE, 1994, J BIOL CHEM, V269, P23120; Suo S, 2003, J NEUROCHEM, V86, P869, DOI 10.1046/j.1471-4159.2003.01896.x; Suo S, 2002, NEUROSCI LETT, V319, P13, DOI 10.1016/S0304-3940(01)02477-6; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; van der Linden AM, 2001, GENETICS, V158, P221; Wang HY, 1995, MOL PHARMACOL, V48, P988; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wintle RF, 2001, PARKINSONISM RELAT D, V7, P177, DOI 10.1016/S1353-8020(00)00055-9; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	50	192	224	1	25	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1096	1103		10.1038/nn1316	http://dx.doi.org/10.1038/nn1316			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15378064				2022-12-17	WOS:000224156900019
J	Washbourne, P; Bennett, JE; McAllister, AK				Washbourne, P; Bennett, JE; McAllister, AK			Rapid recruitment of NMDA receptor transport packets to nascent synapses	NATURE NEUROSCIENCE			English	Article							INDIVIDUAL EXCITATORY SYNAPSES; CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; AMPA RECEPTORS; GLUTAMATE RECEPTORS; SILENT SYNAPSES; SPINE FORMATION; SYNAPTOGENESIS; DYNAMICS; VESICLE	Although many of the molecules involved in synaptogenesis have been identified, the sequence and kinetics of synapse assembly in the central nervous system (CNS) remain largely unknown. We used simultaneous time-lapse imaging of fluorescent glutamate receptor subunits and presynaptic proteins in rat cortical neurons in vitro to determine the dynamics and time course of N-methyl-D-aspartate receptor (NMDAR) recruitment to nascent synapses. We found that both NMDA and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) subunits are present in mobile transport packets in neurons before and during synaptogenesis. NMDAR transport packets are more mobile than AMPAR subunits, moving along microtubules at about 4 mum/min, and are recruited to sites of axodendritic contact within minutes. Whereas NMDAR recruitment to new synapses can be either concurrent with or independent of the protein PSD-95, AMPARs are recruited with a slower time course. Thus, glutamatergic synapses can form rapidly by the sequential delivery of modular transport packets containing glutamate receptors.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	University of California System; University of California Davis	McAllister, AK (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Ct, Davis, CA 95616 USA.			McAllister, A. Kimberley/0000-0001-9177-9889	NATIONAL EYE INSTITUTE [R01EY013584] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY13584] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aarts LHJ, 1998, MOL BIOL CELL, V9, P1279, DOI 10.1091/mbc.9.6.1279; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Benson DL, 1998, J NEUROSCI, V18, P6892; Benson DL, 1996, J NEUROSCI, V16, P6424; Bresler T, 2001, MOL CELL NEUROSCI, V18, P149, DOI 10.1006/mcne.2001.1012; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; COOPER MW, 1992, J NEUROBIOL, V23, P814, DOI 10.1002/neu.480230704; Cottrell JR, 2000, J NEUROPHYSIOL, V84, P1573, DOI 10.1152/jn.2000.84.3.1573; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Dai ZS, 1996, MOL CELL NEUROSCI, V7, P443, DOI 10.1006/mcne.1996.0032; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Mammen AL, 1997, J NEUROSCI, V17, P7351; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Niethammer M, 1996, J NEUROSCI, V16, P2157; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Prange O, 2001, J NEUROSCI, V21, P9325, DOI 10.1523/JNEUROSCI.21-23-09325.2001; Rao A, 1998, J NEUROSCI, V18, P1217; Rumpel S, 1998, J NEUROSCI, V18, P8863; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; VERDERIO C, 1994, J CELL BIOL, V126, P1527, DOI 10.1083/jcb.126.6.1527; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Ziv NE, 2001, CURR OPIN NEUROBIOL, V11, P536, DOI 10.1016/S0959-4388(00)00246-4	50	192	204	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					751	759		10.1038/nn883	http://dx.doi.org/10.1038/nn883			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12089529				2022-12-17	WOS:000177088900018
J	Lee, I; Kesner, RP				Lee, I; Kesner, RP			Differential contribution of NMDA receptors in hippocampal subregions to spatial working memory	NATURE NEUROSCIENCE			English	Article							ANTAGONIST; BLOCKADE; ENVIRONMENT; IMPAIRMENT; INDUCTION; SYNAPSES; INFUSION; NEURONS; CONTEXT; RATS	N-methyl-D-aspartate (NMDA) receptor-dependent synaptic plasticity in the mammalian hippocampus is essential for learning and memory. Although computational models and anatomical studies have emphasized functional differences among hippocampal subregions, subregional specificity of NMDA receptor function is largely unknown. Here we present evidence that NMDA receptors in CA3 are required in a situation in which spatial representation needs to be reorganized, whereas the NMDA receptors in CA1 and/or the dentate gyrus are more involved in acquiring memory that needs to be retrieved after a delay period exceeding a short-term range. Our data, with data from CA1-specific knockout mice, suggest the possibility of heterogeneous mnemonic function of NMDA receptors in different subregions of the hippocampus.	Univ Utah, Med Ctr, Program Neurosci, Salt Lake City, UT 84132 USA; Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kesner, RP (corresponding author), Univ Utah, Med Ctr, Program Neurosci, 50 N Med Dr, Salt Lake City, UT 84132 USA.	rpkesner@behsci.utah.edu						Adams MM, 2001, J COMP NEUROL, V432, P230, DOI 10.1002/cne.1099; Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; BAWIN SM, 1993, EPILEPSY RES, V15, P7, DOI 10.1016/0920-1211(93)90003-P; BOLHUIS JJ, 1992, BEHAV BRAIN RES, V47, P151, DOI 10.1016/S0166-4328(05)80121-4; Borroni AM, 2000, J NEUROSCI, V20, P9272; CARAMANOS Z, 1994, BEHAV NEUROSCI, V108, P30, DOI 10.1037/0735-7044.108.1.30; Cassel JC, 1998, NEUROBIOL LEARN MEM, V69, P22, DOI 10.1006/nlme.1997.3807; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; DERRICK BE, 1991, BRAIN RES BULL, V27, P219, DOI 10.1016/0361-9230(91)90071-Q; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Granger R, 1996, HIPPOCAMPUS, V6, P567, DOI 10.1002/(SICI)1098-1063(1996)6:6<567::AID-HIPO2>3.0.CO;2-E; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Hetherington PA, 1997, BEHAV NEUROSCI, V111, P20, DOI 10.1037/0735-7044.111.1.20; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; Kawabe K, 1998, BRAIN RES, V781, P300, DOI 10.1016/S0006-8993(97)01256-0; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kesner RP, 2000, CURR OPIN NEUROBIOL, V10, P260, DOI 10.1016/S0959-4388(00)00067-2; Kesner RP, 2001, HIPPOCAMPUS, V11, P240, DOI 10.1002/hipo.1040; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Mizumori SJY, 1999, HIPPOCAMPUS, V9, P444, DOI 10.1002/(SICI)1098-1063(1999)9:4<444::AID-HIPO10>3.0.CO;2-Z; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Moser MB, 1998, J NEUROSCI, V18, P7535; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; MULLER RU, 1987, J NEUROSCI, V7, P1951; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Paxinos G., 1998, RAT BRAIN STEROTAXIC; PEINADOMANZANO MA, 1990, BEHAV BRAIN RES, V38, P117, DOI 10.1016/0166-4328(90)90010-C; RAWLINS JNP, 1983, BEHAV BRAIN RES, V10, P233, DOI 10.1016/0166-4328(83)90033-5; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Wiebe SP, 1997, HIPPOCAMPUS, V7, P656, DOI 10.1002/(SICI)1098-1063(1997)7:6<656::AID-HIPO7>3.0.CO;2-C; YOUNG SL, 1994, BEHAV NEUROSCI, V108, P19, DOI 10.1037/0735-7044.108.1.19	38	192	204	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					162	168		10.1038/nn790	http://dx.doi.org/10.1038/nn790			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11780144				2022-12-17	WOS:000173558400019
J	Jones, SR; Gainetdinov, RR; Hu, XT; Cooper, DC; Wightman, RM; White, FJ; Caron, MG				Jones, SR; Gainetdinov, RR; Hu, XT; Cooper, DC; Wightman, RM; White, FJ; Caron, MG			Loss of autoreceptor functions in mice lacking the dopamine transporter	NATURE NEUROSCIENCE			English	Article							RECEPTOR MUTANT MICE; SUSTAINED ACTIVATION; CONSCIOUS RATS; IN-VIVO; NEURONS; D-2; RELEASE; COCAINE; AGONISTS; SYSTEM	Autoreceptors provide an important inhibitory feedback mechanism for dopamine neurons by altering neuronal functions in response to changes in extracellular levels of dopamine. Elevated dopamine may be a component of several neuropsychiatric disorders. However, evidence concerning the state of autoreceptors in such conditions has remained elusive. The function of dopamine autoreceptors was assessed in mice lacking the dopamine transporter (DAT). Genetic deletion of the DAT gene in mice results in a persistent elevation in levels of extracellular dopamine. Direct assessment of impulse-, synthesis- and release-regulating autoreceptors in these mice reveals a nearly complete loss of function. These findings may provide insight into the neurochemical consequences of hyperdopaminergia.	Duke Univ, Med Ctr, Dept Cell Biol, Howard Hughes Med Inst, Durham, NC 27710 USA; Finch Univ Hlth Sci Chicago Med Sch, N Chicago, IL 60064 USA; Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA	Duke University; Howard Hughes Medical Institute; Chicago Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Howard Hughes Med Inst, Box 3287,487 CARL Bldg, Durham, NC 27710 USA.		Jones, Sara R/K-4816-2014; Gainetdinov, Raul R/G-5875-2011	Jones, Sara R/0000-0002-3424-7576; Gainetdinov, Raul R/0000-0003-2951-6038	NIDA NIH HHS [F31 DA005794] Funding Source: Medline; NINDS NIH HHS [NS 19576] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA005794] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BANNON MJ, 1983, PHARMACOL REV, V35, P53; BATESON G, 1955, Psychiatr Res Rep Am Psychiatr Assoc, P39; Bosse R, 1997, NEURON, V19, P127, DOI 10.1016/S0896-6273(00)80353-0; BOYSON SJ, 1986, J NEUROSCI, V6, P3177; BURRIS KD, 1995, NEUROPSYCHOPHARMACOL, V12, P335, DOI 10.1038/sj.npp.1380268; COOK EH, 1995, AM J HUM GENET, V56, P993; Cragg SJ, 1997, J NEUROSCI, V17, P5738; DRUKARCH B, 1990, LIFE SCI, V47, P361, DOI 10.1016/0024-3205(90)90293-Z; DRUKARCH B, 1991, EUR J PHARMACOL, V196, P209, DOI 10.1016/0014-2999(91)90431-O; ELSWORTH JD, 1997, DOPAMINE RECEPTORS, P223; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Gainetdinov RR, 1997, J NEUROCHEM, V69, P1322; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; GAINETDINOV RR, 1994, EUR J PHARMACOL, V261, P327, DOI 10.1016/0014-2999(94)90125-2; Gill M, 1997, MOL PSYCHIATR, V2, P311, DOI 10.1038/sj.mp.4000290; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Henry DJ, 1998, PSYCHOPHARMACOLOGY, V140, P233, DOI 10.1007/s002130050762; IVINS KJ, 1991, MOL PHARMACOL, V39, P531; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; JONES SR, 1995, J NEUROCHEM, V64, P2581; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; KENNEDY RT, 1992, J NEUROCHEM, V59, P449, DOI 10.1111/j.1471-4159.1992.tb09391.x; Koeltzow TE, 1998, J NEUROSCI, V18, P2231; Mercuri NB, 1997, NEUROSCIENCE, V79, P323; Paxinos G., 1997, MOUSE BRAIN STEREOTA; PITTS DK, 1995, J PHARMACOL EXP THER, V275, P412; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SterneMarr R, 1995, VITAM HORM, V51, P193, DOI 10.1016/S0083-6729(08)61039-0; Tepper JM, 1997, J NEUROSCI, V17, P2519; TIMMERMAN W, 1990, N-S ARCH PHARMACOL, V342, P650, DOI 10.1007/BF00175707; VANMUISWINKEL FL, 1994, EXP NEUROL, V125, P218, DOI 10.1006/exnr.1994.1025; Waldman ID, 1998, AM J HUM GENET, V63, P1767, DOI 10.1086/302132; WALTERS JR, 1976, N-S ARCH PHARMACOL, V296, P5, DOI 10.1007/BF00498834; WESTERINK BHC, 1990, J NEUROCHEM, V54, P381, DOI 10.1111/j.1471-4159.1990.tb01884.x; WHITE FJ, 1983, LIFE SCI, V32, P983, DOI 10.1016/0024-3205(83)90929-3; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; White FJ, 1996, ANNU REV NEUROSCI, V19, P405, DOI 10.1146/annurev.ne.19.030196.002201; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445; WOOLVERTON WL, 1992, TRENDS PHARMACOL SCI, V13, P193, DOI 10.1016/0165-6147(92)90063-C; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; Zoli M, 1998, BRAIN RES REV, V26, P136, DOI 10.1016/S0165-0173(97)00048-9	41	192	202	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					649	655		10.1038/10204	http://dx.doi.org/10.1038/10204			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10404198				2022-12-17	WOS:000083882600016
J	Dan, Y; Alonso, JM; Usrey, WM; Reid, RC				Dan, Y; Alonso, JM; Usrey, WM; Reid, RC			Coding of visual information by precisely correlated spikes in the lateral geniculate nucleus	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; CROSS-CORRELATION ANALYSIS; BEHAVING MONKEYS; CAT RETINA; X-CELL; Y-CELL; CORTEX; NEURONS; SYNCHRONIZATION; OSCILLATIONS	Correlated firing among neurons is widespread in the nervous system. Precisely correlated spiking, occurring on a millisecond time scale, has recently been observed among neurons in the lateral geniculate nucleus with overlapping receptive fields. We have used an information-theoretic analysis to examine the role of these correlations in visual coding. Considerably more information can be extracted from two cells if temporal correlations between them are considered. The percentage increase in information depends on the degree of correlation; the average increase is approximately 20% for strongly correlated pairs. Thus, precise temporal correlation could be used as an additional information channel from thalamus to visual cortex.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Rockefeller Univ, Neurobiol Lab, New York, NY 10021 USA	Harvard University; Harvard Medical School; Rockefeller University	Reid, RC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	clay_reid@hms.harvard.edu		Dan, Yang/0000-0002-3818-877X	NATIONAL EYE INSTITUTE [R01EY010115, R37EY005253, R01EY005253] Funding Source: NIH RePORTER; NEI NIH HHS [EY10115, EY06604, EY05253] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; Adrian E.D., 1928, BASIS SENSATION; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; CLELAND BG, 1971, NATURE-NEW BIOL, V231, P191, DOI 10.1038/newbio231191a0; CLELAND BG, 1986, VISUAL NEUROSCI, P111; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; GHOSE GM, 1994, J NEUROPHYSIOL, V71, P330, DOI 10.1152/jn.1994.71.1.330; GUIDO W, 1995, VISUAL NEUROSCI, V12, P723, DOI 10.1017/S0952523800008993; HUBEL DH, 1961, J PHYSIOL-LONDON, V155, P385, DOI 10.1113/jphysiol.1961.sp006635; KAPLAN E, 1987, J PHYSIOL-LONDON, V391, P267, DOI 10.1113/jphysiol.1987.sp016737; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P325, DOI 10.1152/jn.1983.49.2.325; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P350, DOI 10.1152/jn.1983.49.2.350; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; NELSON JI, 1992, VISUAL NEUROSCI, V9, P21, DOI 10.1017/S0952523800006349; Neuenschwander S, 1996, NATURE, V379, P728, DOI 10.1038/379728a0; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; RODIECK RW, 1967, J NEUROPHYSIOL, V30, P1043, DOI 10.1152/jn.1967.30.5.1043; Shannon E.R., 1963, MATH THEORY COMMUNIC; Sherman SM, 1996, VISUAL NEUROSCI, V13, P205, DOI 10.1017/S0952523800007446; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Sutter E.E., 1987, ADV METHODS PHYSIOLO, V1, P303; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P191, DOI 10.1152/jn.1981.46.2.191; TSO DY, 1986, J NEUROSCI, V6, P1160; USREY WM, IN PRESS NATURE; USREY WM, IN PRESS ANN REV PHY, V61	36	192	195	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					501	507		10.1038/2217	http://dx.doi.org/10.1038/2217			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196548				2022-12-17	WOS:000076406900015
J	Ga, L; Cookson, MR; Petrucelli, L; La Spade, AR				Ga, Li; Cookson, Mark R.; Petrucelli, Leonard; La Spade, Albert R.			Converging pathways in neurodegeneration, from genetics to mechanisms	NATURE NEUROSCIENCE			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; GENOME-WIDE ASSOCIATION; PROGRESSIVE SUPRANUCLEAR PALSY; STRESS GRANULE DYNAMICS; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; HUNTINGTONS-DISEASE; FRONTOTEMPORAL DEMENTIA; AMYLOID-BETA; MUTANT HUNTINGTIN	Neurodegenerative diseases cause progressive loss of cognitive and/or motor function and pose major challenges for societies with rapidly aging populations. Human genetics studies have shown that disease-causing rare mutations and risk-associated common alleles overlap in different neurodegenerative disorders. Here we review the intricate genotype-phenotype relationships and common cellular pathways emerging from recent genetic and mechanistic studies. Shared pathological mechanisms include defective protein quality-control and degradation pathways, dysfunctional mitochondrial homeostasis, stress granules, and maladaptive innate immune responses. Research efforts have started to bear fruit, as shown by recent treatment successes and an encouraging therapeutic outlook.	[Ga, Li] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA; [Ga, Li] Weill Cornell Med, Fell Family Brain & Mind Res Inst, New York, NY 10065 USA; [Cookson, Mark R.] NIA, Cell Biol & Gene Express Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Petrucelli, Leonard] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [La Spade, Albert R.] Duke Univ, Sch Med, Dept Neurol, Durham, NC USA; [La Spade, Albert R.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC USA; [La Spade, Albert R.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC USA; [La Spade, Albert R.] Duke Univ, Sch Med, Duke Ctr Neurodegenerat & Neurotherapeut, Durham, NC USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Mayo Clinic; Duke University; Duke University; Duke University; Duke University	Ga, L (corresponding author), Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA.; Ga, L (corresponding author), Weill Cornell Med, Fell Family Brain & Mind Res Inst, New York, NY 10065 USA.	lig2033@med.cornell.edu	Cookson, Mark/AAW-2516-2021	Cookson, Mark/0000-0002-1058-3831; Gan, Li/0000-0003-4600-275X	Intramural NIH HHS [Z99 AG999999] Funding Source: Medline; NIA NIH HHS [R01 AG033082] Funding Source: Medline; NINDS NIH HHS [R01 NS041648] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG033082] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abeliovich A, 2016, NATURE, V539, P207, DOI 10.1038/nature20414; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Apicco DJ, 2018, NAT NEUROSCI, V21, P72, DOI 10.1038/s41593-017-0022-z; Ashkenazi A, 2017, NATURE, V545, P108, DOI 10.1038/nature22078; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Barnes SJ, 2017, NEURON, V96, P871, DOI 10.1016/j.neuron.2017.09.052; Batlevi Y, 2011, NEUROBIOL DIS, V43, P46, DOI 10.1016/j.nbd.2010.09.009; Batra R, 2017, CELL, V170, P899, DOI 10.1016/j.cell.2017.07.010; BEAL MF, 1993, J NEUROSCI, V13, P4181; Blank T, 2016, IMMUNITY, V44, P901, DOI 10.1016/j.immuni.2016.04.005; Boeynaems S, 2017, MOL CELL, V65, P1044, DOI 10.1016/j.molcel.2017.02.013; Boeynaems S, 2016, ACTA NEUROPATHOL, V132, P159, DOI 10.1007/s00401-016-1586-5; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bras J, 2014, HUM MOL GENET, V23, P6139, DOI 10.1093/hmg/ddu334; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Burbulla LF, 2017, SCIENCE, V357, P1255, DOI 10.1126/science.aam9080; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Chang D, 2017, NAT GENET, V49, P1511, DOI 10.1038/ng.3955; Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243; Cho SH, 2015, J NEUROSCI, V35, P807, DOI 10.1523/JNEUROSCI.2939-14.2015; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cortes CJ, 2014, NAT NEUROSCI, V17, P1180, DOI 10.1038/nn.3787; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; Cruts Marc, 2006, Current Alzheimer Research, V3, P485, DOI 10.2174/156720506779025251; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; De Biase LM, 2017, NEURON, V95, P341, DOI 10.1016/j.neuron.2017.06.020; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dickey AS, 2016, NAT MED, V22, P37, DOI 10.1038/nm.4003; Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Gao FB, 2017, CELL, V171, P994, DOI 10.1016/j.cell.2017.10.042; Garre JM, 2017, NAT MED, V23, P714, DOI 10.1038/nm.4340; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Golpich M, 2017, CNS NEUROSCI THER, V23, P5, DOI 10.1111/cns.12655; Gomez-Pastor R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14405; Gopal PP, 2017, P NATL ACAD SCI USA, V114, pE2466, DOI 10.1073/pnas.1614462114; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Gowers IR, 2011, CYTOKINE, V56, P792, DOI 10.1016/j.cyto.2011.09.009; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Guerreiro R, 2018, LANCET NEUROL, V17, P64, DOI 10.1016/S1474-4422(17)30400-3; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hardy J, 2006, J NEUROCHEM, V97, P1690, DOI 10.1111/j.1471-4159.2006.03979.x; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Holmans P, 2013, HUM MOL GENET, V22, P1039, DOI 10.1093/hmg/dds492; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Huang YD, 2014, NEUROBIOL DIS, V72, P3, DOI 10.1016/j.nbd.2014.08.025; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; Jiang BC, 2017, MECH AGEING DEV, V161, P130, DOI 10.1016/j.mad.2016.07.009; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kalia LV, 2015, JAMA NEUROL, V72, P100, DOI 10.1001/jamaneurol.2014.2704; Kawai T, 2004, MOL CELL BIOL, V24, P6773, DOI 10.1128/MCB.24.15.6773-6787.2004; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Kouri N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8247; Krabbe G, 2017, P NATL ACAD SCI USA, V114, P5029, DOI 10.1073/pnas.1700477114; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lackie RE, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00254; Lee JM, 2015, CELL, V162, P516, DOI 10.1016/j.cell.2015.07.003; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lin Y, 2016, CELL, V167, P789, DOI 10.1016/j.cell.2016.10.003; Lindberg I, 2015, J NEUROSCI, V35, P13853, DOI 10.1523/JNEUROSCI.2600-15.2015; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Lu XH, 2012, NEURON, V74, P964, DOI 10.1016/j.neuron.2012.06.001; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; Mackenzie IR, 2017, NEURON, V95, P808, DOI 10.1016/j.neuron.2017.07.025; Martinez T, 2013, HUM GENET, V132, P481, DOI 10.1007/s00439-013-1288-1; MASLIAH E, 1991, ACTA NEUROPATHOL, V81, P428, DOI 10.1007/BF00293464; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.e06-12-1079; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Minami SS, 2014, NAT MED, V20, P1157, DOI 10.1038/nm.3672; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Moskvina V, 2013, JAMA NEUROL, V70, P1268, DOI 10.1001/jamaneurol.2013.448; Mustonen EK, 2017, REGUL TOXICOL PHARM, V90, P328, DOI 10.1016/j.yrtph.2017.09.028; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Noormohammadi A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13649; O'Rourke JG, 2016, SCIENCE, V351, P1324, DOI 10.1126/science.aaf1064; Oakes JA, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0287-x; Ochaba J, 2014, P NATL ACAD SCI USA, V111, P16889, DOI 10.1073/pnas.1420103111; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Ossenkoppele R, 2016, BRAIN, V139, P1551, DOI 10.1093/brain/aww027; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Park H, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/125273; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pinto BS, 2017, MOL CELL, V68, P479, DOI 10.1016/j.molcel.2017.09.033; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Reiman EM, 2016, NATURE, V537, P36, DOI 10.1038/537036a; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Robak LA, 2017, BRAIN, V140, P3191, DOI 10.1093/brain/awx285; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SCHOLS L, 2015, BRAIN 11, V138, DOI DOI 10.1093/BRAIN/AWV255; Scholz SW, 2009, ANN NEUROL, V65, P610, DOI 10.1002/ana.21685; Seguin SJ, 2014, CELL DEATH DIFFER, V21, P1838, DOI 10.1038/cdd.2014.103; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Shorter J, 2016, MOL BIOL CELL, V27, P1556, DOI 10.1091/mbc.E15-10-0693; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sontag EM, 2013, P NATL ACAD SCI USA, V110, P3077, DOI 10.1073/pnas.1222663110; Sorrentino V, 2017, NATURE, V552, P187, DOI 10.1038/nature25143; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104; Sulzer D, 2017, NATURE, V546, P656, DOI 10.1038/nature22815; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tracy TE, 2016, NEURON, V90, P245, DOI 10.1016/j.neuron.2016.03.005; Ulrich JD, 2017, NEURON, V94, P237, DOI 10.1016/j.neuron.2017.02.042; Vanderweyde T, 2016, CELL REP, V15, P1455, DOI 10.1016/j.celrep.2016.04.045; Vanderweyde T, 2012, J NEUROSCI, V32, P8270, DOI 10.1523/JNEUROSCI.1592-12.2012; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wang C, 2018, CURR OPIN NEUROBIOL, V48, P52, DOI 10.1016/j.conb.2017.09.005; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Weishaupt JH, 2016, TRENDS MOL MED, V22, P769, DOI 10.1016/j.molmed.2016.07.005; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhao XH, 2016, NAT MED, V22, P1268, DOI 10.1038/nm.4199; Zhao YJ, 2015, NEURON, V87, P963, DOI 10.1016/j.neuron.2015.08.020; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	150	191	193	2	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2018	21	10					1300	1309		10.1038/s41593-018-0237-7	http://dx.doi.org/10.1038/s41593-018-0237-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU9FY	30258237	Green Accepted			2022-12-17	WOS:000445651600005
J	Sussillo, D; Churchland, MM; Kaufman, MT; Shenoy, KV				Sussillo, David; Churchland, Mark M.; Kaufman, Matthew T.; Shenoy, Krishna V.			A neural network that finds a naturalistic solution for the production of muscle activity	NATURE NEUROSCIENCE			English	Article							MOTOR CORTEX NEURONS; OPTIMAL FEEDBACK-CONTROL; ARM MOVEMENTS; PREMOTOR CORTEX; LIMB BIOMECHANICS; CORTICAL CONTROL; DYNAMICS; MONKEY; REPRESENTATION; DIRECTION	It remains an open question how neural responses in motor cortex relate to movement. We explored the hypothesis that motor cortex reflects dynamics appropriate for generating temporally patterned outgoing commands. To formalize this hypothesis, we trained recurrent neural networks to reproduce the muscle activity of reaching monkeys. Models had to infer dynamics that could transform simple inputs into temporally and spatially complex patterns of muscle activity. Analysis of trained models revealed that the natural dynamical solution was a low-dimensional oscillator that generated the necessary multiphasic commands. This solution closely resembled, at both the single-neuron and population levels, what was observed in neural recordings from the same monkeys. Notably, data and simulations agreed only when models were optimized to find simple solutions. An appealing interpretation is that the empirically observed dynamics of motor cortex may reflect a simple solution to the problem of generating temporally patterned descending commands.	[Sussillo, David; Kaufman, Matthew T.; Shenoy, Krishna V.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Sussillo, David; Kaufman, Matthew T.; Shenoy, Krishna V.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Churchland, Mark M.] Columbia Univ, Med Ctr, Kavli Inst Brain Sci,David Mahoney Ctr Brain & Be, Dept Neurosci,Grossman Ctr Stat Mind, New York, NY USA; [Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford Neurosci Inst, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Dept Neurobiol, Stanford Neurosci Inst, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Bio X Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Columbia University; Stanford University; Stanford University; Stanford University	Sussillo, D (corresponding author), Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.	sussillo@stanford.edu	Kaufman, Matthew/AAK-2860-2020	Kaufman, Matthew/0000-0002-8072-023X; Sussillo, David/0000-0003-1620-1264	Searle Scholars Program; Sloan Foundation; McKnight Foundation; Grossman Charitable Trust; US National Institutes of Health (NIH) Director's New Innovator Award [DP2 NS083037]; NIH [R01 MH93338-02, R01NS076460, 8DP1HD075623]; Burroughs Wellcome Fund Career Awards in the Biomedical Sciences; National Science Foundation; DARPA REPAIR Award [N66001-10-C-2010]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076460, DP2NS083037] Funding Source: NIH RePORTER	Searle Scholars Program; Sloan Foundation(Alfred P. Sloan Foundation); McKnight Foundation; Grossman Charitable Trust; US National Institutes of Health (NIH) Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Awards in the Biomedical Sciences(Burroughs Wellcome Fund); National Science Foundation(National Science Foundation (NSF)); DARPA REPAIR Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Abbott and S. Ganguli for insightful conversations. We thank S. I. Ryu for electrode array implantation surgical assistance, M. Mazariegos and J. Aguayo for surgical assistance and veterinary care, B. Otskotsky for IT support, and S. Eisensee, B. Davis and E. Castaneda for administrative assistance. This work was supported by The Searle Scholars Program (M.M.C.), The Sloan Foundation (M.M.C.), The McKnight Foundation (M.M.C.), The Grossman Charitable Trust (M.M.C.), US National Institutes of Health (NIH) Director's New Innovator Award DP2 NS083037 (M.M.C.), an NIH R01 MH93338-02 grant (M.M.C.), Burroughs Wellcome Fund Career Awards in the Biomedical Sciences (M.M.C., K.V.S.), a National Science Foundation graduate research fellowship (M.T.K.), an NIH T-RO1 Award R01NS076460 (K.V.S.), an NIH Director's Pioneer Award 8DP1HD075623 (K.V.S.) and a DARPA REPAIR Award N66001-10-C-2010 (K.V.S.).	Aflalo TN, 2007, J NEUROSCI, V27, P2760, DOI 10.1523/JNEUROSCI.3147-06.2007; Ajemian R, 2008, NEURON, V58, P414, DOI 10.1016/j.neuron.2008.02.033; BUYS EJ, 1986, J PHYSIOL-LONDON, V381, P529, DOI 10.1113/jphysiol.1986.sp016342; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Churchland MM, 2014, COLD SH Q B, V79, P67, DOI 10.1101/sqb.2014.79.024703; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; DOYA K, 1992, 1992 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS 1-6, P2777, DOI 10.1109/ISCAS.1992.230622; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Fetz E E, 1993, Curr Opin Neurobiol, V3, P932, DOI 10.1016/0959-4388(93)90165-U; FETZ EE, 1992, BEHAV BRAIN SCI, V15, P679; FETZ EE, 1980, J NEUROPHYSIOL, V44, P751, DOI 10.1152/jn.1980.44.4.751; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Hatsopoulos NG, 2005, J NEUROPHYSIOL, V94, P2261, DOI 10.1152/jn.00533.2005; Hennequin G, 2014, NEURON, V82, P1394, DOI 10.1016/j.neuron.2014.04.045; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Kalaska JF, 2009, ADV EXP MED BIOL, V629, P139, DOI 10.1007/978-0-387-77064-2_8; Kaufman MT, 2014, NAT NEUROSCI, V17, P440, DOI 10.1038/nn.3643; Kaufman MT, 2013, J NEUROPHYSIOL, V110, P817, DOI 10.1152/jn.00892.2011; Kaufman MT, 2010, J NEUROPHYSIOL, V104, P799, DOI 10.1152/jn.00231.2009; Laje R, 2013, NAT NEUROSCI, V16, P925, DOI 10.1038/nn.3405; Lillicrap TP, 2013, NEURON, V77, P168, DOI 10.1016/j.neuron.2012.10.041; Maass W, 2007, PLOS COMPUT BIOL, V3, P15, DOI 10.1371/journal.pcbi.0020165; Maier MA, 2005, J COMPUT NEUROSCI, V19, P125, DOI 10.1007/s10827-005-0899-5; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Martens J., 2011, P 28 INT C MACH LEAR, P1033; Morrow MM, 2003, J NEUROPHYSIOL, V89, P2279, DOI 10.1152/jn.00632.2002; MUSSAIVALDI FA, 1988, NEUROSCI LETT, V91, P106, DOI 10.1016/0304-3940(88)90257-1; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Pearce TM, 2012, SCIENCE, V337, P984, DOI 10.1126/science.1220642; Pruszynski JA, 2014, J NEUROSCI, V34, P4608, DOI 10.1523/JNEUROSCI.4520-13.2014; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Rifai S., 2011, PREPRINT; Rokni U, 2012, NEURAL COMPUT, V24, P289, DOI 10.1162/NECO_a_00223; SANGER TD, 1994, NEURAL COMPUT, V6, P29, DOI 10.1162/neco.1994.6.1.29; Schieber MH, 2007, J NEUROPHYSIOL, V97, P70, DOI 10.1152/jn.00544.2006; SCHWARTZ AB, 1994, SCIENCE, V265, P540, DOI 10.1126/science.8036499; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Scott SH, 2008, J PHYSIOL-LONDON, V586, P1217, DOI 10.1113/jphysiol.2007.146068; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; Sussillo D, 2013, NEURAL COMPUT, V25, P626, DOI 10.1162/NECO_a_00409; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Tanaka H, 2013, J NEUROPHYSIOL, V109, P1182, DOI 10.1152/jn.00279.2012; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Todorov E, 2002, NEURAL COMPUT, V14, P1233, DOI 10.1162/089976602753712918; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; WEINRICH M, 1984, BRAIN, V107, P385, DOI 10.1093/brain/107.2.385	50	191	192	3	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2015	18	7					1025	+		10.1038/nn.4042	http://dx.doi.org/10.1038/nn.4042			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CL3QU	26075643	Green Accepted			2022-12-17	WOS:000356866200018
J	Lovejoy, LP; Krauzlis, RJ				Lovejoy, Lee P.; Krauzlis, Richard J.			Inactivation of primate superior colliculus impairs covert selection of signals for perceptual judgments	NATURE NEUROSCIENCE			English	Article							SPATIAL ATTENTION; REVERSIBLE INACTIVATION; NEURONAL RESPONSES; NEURAL MECHANISMS; VISUAL-ATTENTION; TARGET SELECTION; EYE-MOVEMENTS; NEGLECT; DEFICITS; MACAQUE	Primates base perceptual judgments on some sensory inputs while ignoring others. The covert selection of sensory information for perception is often thought to be accomplished mostly by the cerebral cortex, whereas the overt orienting toward relevant stimuli involves various additional structures such as the superior colliculus, a subcortical region involved in the control of eye movements. Contrary to this view, we show that the superior colliculus is necessary for determining which stimuli will inform perceptual judgments, even in the absence of orienting movements. Reversible inactivation of the superior colliculus in monkeys performing a motion discrimination task caused profound inattention for stimuli in the affected visual field, but only when distracters containing counterinformative signals appeared in the unaffected field. When distracting stimuli contained no information, discrimination performance was largely unaffected. Thus, the superior colliculus is a bottleneck in the covert selection of signals for perceptual judgments.	[Lovejoy, Lee P.; Krauzlis, Richard J.] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Lovejoy, Lee P.] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Lovejoy, LP (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	lovejoy@salk.edu		Richard, Krauzlis/0000-0002-1826-0447	Simons Foundation; Institute for Neural Computation; Aginsky Scholars Award; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020002] Funding Source: NIH RePORTER	Simons Foundation; Institute for Neural Computation; Aginsky Scholars Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank E. Boehle and N. Dill for technical assistance. This work was supported by the Simons Foundation (R.J.K.), the Institute for Neural Computation (L.P.L.) and an Aginsky Scholars Award (L.P.L.).	Berman RA, 2008, PROG BRAIN RES, V171, P467, DOI 10.1016/S0079-6123(08)00668-7; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Carello CD, 2004, NEURON, V43, P575, DOI 10.1016/j.neuron.2004.07.026; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Chen LTL, 2001, J NEUROSCI METH, V107, P81, DOI 10.1016/S0165-0270(01)00354-5; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; De Weerd P, 2003, EUR J NEUROSCI, V18, P1671, DOI 10.1046/j.1460-9568.2003.02862.x; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Dosher BA, 2000, VISION RES, V40, P1269, DOI 10.1016/S0042-6989(00)00019-5; Driver J, 1998, NAT NEUROSCI, V1, P17, DOI 10.1038/217; Fecteau JH, 2004, J NEUROPHYSIOL, V92, P1728, DOI 10.1152/jn.00184.2004; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; Hafed ZM, 2008, J NEUROSCI, V28, P8124, DOI 10.1523/JNEUROSCI.1317-08.2008; HALLIGAN PW, 1994, COGNITIVE NEUROPSYCH, V11, P167, DOI 10.1080/02643299408251973; Heilman KM, 2004, FRONT BIOSCI-LANDMRK, V9, P694, DOI 10.2741/1261; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; JOANETTE Y, 1984, BRAIN COGNITION, V3, P152, DOI 10.1016/0278-2626(84)90014-9; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MCCULLAH P, 1990, GEN LINEAR MODELS; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Quaia C, 1998, J NEUROPHYSIOL, V79, P2097, DOI 10.1152/jn.1998.79.4.2097; RAFAL RD, 1994, CURR OPIN NEUROBIOL, V4, P231, DOI 10.1016/0959-4388(94)90078-7; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; RODMAN HR, 1990, J NEUROSCI, V10, P1154; Rossi AF, 2007, J NEUROSCI, V27, P11306, DOI 10.1523/JNEUROSCI.2939-07.2007; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Sparks DL, 1999, CURR OPIN NEUROBIOL, V9, P698, DOI 10.1016/S0959-4388(99)00039-2; SPRAGUE JM, 1966, SCIENCE, V153, P1544, DOI 10.1126/science.153.3743.1544; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	45	191	191	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					261	U153		10.1038/nn.2470	http://dx.doi.org/10.1038/nn.2470			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20023651	Green Accepted			2022-12-17	WOS:000273985800023
J	Huntwork, S; Littleton, JT				Huntwork, Sarah; Littleton, J. Troy			A complexin fusion clamp regulates spontaneous neurotransmitter release and synaptic growth	NATURE NEUROSCIENCE			English	Article							VESICLE EXOCYTOSIS; PROTEINS; EVENTS	Neuronal signaling occurs through both action potential triggered synaptic vesicle fusion and spontaneous release, although the fusion clamp machinery that prevents premature exocytosis of synaptic vesicles in the absence of calcium is unknown. Here we demonstrate that spontaneous release at synapses is regulated by complexin, a SNARE complex-binding protein. Analysis of Drosophila melanogaster complexin null mutants showed a marked increase in spontaneous fusion and a profound overgrowth of synapses, suggesting that complexin functions as the fusion clamp in vivo and may modulate structural remodeling of neuronal connections by controlling the rate of spontaneous release.	MIT, Dept Biol, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT)	Littleton, JT (corresponding author), MIT, Dept Biol, Picower Inst Learning & Memory, Bldg 46,Room 3243, Cambridge, MA 02139 USA.	troy@mit.edu		Littleton, J. Troy/0000-0001-5576-2887	NINDS NIH HHS [R01 NS040296, R01 NS040296-07] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040296] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Guan Z, 2005, NEURON, V48, P91, DOI 10.1016/j.neuron.2005.08.036; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Sawada K, 2005, ARCH GEN PSYCHIAT, V62, P263, DOI 10.1001/archpsyc.62.3.263; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541	15	191	192	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1235	1237		10.1038/nn1980	http://dx.doi.org/10.1038/nn1980			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17873870				2022-12-17	WOS:000249720800006
J	Kuhl, BA; Dudukovic, NM; Kahn, I; Wagner, AD				Kuhl, Brice A.; Dudukovic, Nicole M.; Kahn, Itamar; Wagner, Anthony D.			Decreased demands on cognitive control reveal the neural processing benefits of forgetting	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; INFERIOR FRONTAL GYRUS; PREFRONTAL CORTEX; RECOGNITION MEMORY; CONFLICT; MECHANISMS; RETRIEVAL; ACTIVATION; INHIBITION; RECOLLECTION	Remembering often requires the selection of goal-relevant memories in the face of competition from irrelevant memories. Although there is a cost of selecting target memories over competing memories (increased forgetting of the competing memories), here we report neural evidence for the adaptive benefits of forgetting-namely, reduced demands on cognitive control during future acts of remembering. Functional magnetic resonance imaging during selective retrieval showed that repeated retrieval of target memories was accompanied by dynamic reductions in the engagement of functionally coupled cognitive control mechanisms that detect (anterior cingulate cortex) and resolve (dorsolateral and ventrolateral prefrontal cortex) mnemonic competition. Strikingly, regression analyses revealed that this prefrontal disengagement tracked the extent to which competing memories were forgotten; greater forgetting of competing memories was associated with a greater decline in demands on prefrontal cortex during target remembering. These findings indicate that, although forgetting can be frustrating, memory might be adaptive because forgetting confers neural processing benefits.	Stanford Univ, Dept Psychol, Neurosci Program, Stanford, CA 94305 USA	Stanford University	Kuhl, BA (corresponding author), Stanford Univ, Dept Psychol, Neurosci Program, Jordan Hall,Bldg 420,450 Serra Mall, Stanford, CA 94305 USA.	bkuhl@stanford.edu		Kahn, Itamar/0000-0002-1895-8677	NIMH NIH HHS [1R01MH080309-01, R01 MH080309] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080309] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Anderson MC, 2003, J MEM LANG, V49, P415, DOI 10.1016/j.jml.2003.08.006; ANDERSON MC, 1995, PSYCHOL REV, V102, P68, DOI 10.1037/0033-295X.102.1.68; ANDERSON MC, 1994, J EXP PSYCHOL LEARN, V20, P1063, DOI 10.1037/0278-7393.20.5.1063; Anderson MC, 2000, PSYCHON B REV, V7, P522, DOI 10.3758/BF03214366; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Bjork RA., 1989, VARIETIES MEMORY CON, P309; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; Bunge SA, 2004, BRAIN COGNITION, V56, P141, DOI 10.1016/j.bandc.2003.08.001; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Chikazoe J, 2007, J COGNITIVE NEUROSCI, V19, P69, DOI 10.1162/jocn.2007.19.1.69; Cohen N.J., 1993, MEMORY AMNESIA HIPPO, DOI DOI 10.1136/JNNP.58.1.128-A; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.3.CO;2-N; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Dobbins IG, 2003, NEUROPSYCHOLOGIA, V41, P318, DOI 10.1016/S0028-3932(02)00164-1; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Gates A. I., 1917, ARCH PSYCHOL, V40, P1; Giovanello KS, 2004, HIPPOCAMPUS, V14, P5; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Hazeltine E, 2000, J COGNITIVE NEUROSCI, V12, P118, DOI 10.1162/089892900563984; Henson RNA, 2000, J COGNITIVE NEUROSCI, V12, P913, DOI 10.1162/08989290051137468; Kahn I, 2004, J NEUROSCI, V24, P4172, DOI 10.1523/JNEUROSCI.0624-04.2004; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kirwan CB, 2004, HIPPOCAMPUS, V14, P919, DOI 10.1002/hipo.20014; Levy BJ, 2002, TRENDS COGN SCI, V6, P299, DOI 10.1016/S1364-6613(02)01923-X; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McDermott KB, 2000, J COGNITIVE NEUROSCI, V12, P965, DOI 10.1162/08989290051137503; MENSINK GJ, 1988, PSYCHOL REV, V95, P434, DOI 10.1037/0033-295X.95.4.434; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Raye CL, 2002, NEUROIMAGE, V15, P447, DOI 10.1006/nimg.2001.0983; ROEDIGER HL, 1974, MEM COGNITION, V2, P261, DOI 10.3758/BF03208993; Roediger HL, 2000, CURR DIR PSYCHOL SCI, V9, P123, DOI 10.1111/1467-8721.00075; Roediger HL, 2006, PSYCHOL SCI, V17, P249, DOI 10.1111/j.1467-9280.2006.01693.x; Rugg MD, 2003, TRENDS COGN SCI, V7, P313, DOI 10.1016/S1364-6613(03)00131-1; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; Schacter DL, 1999, AM PSYCHOL, V54, P182, DOI 10.1037/0003-066X.54.3.182; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Thompson-Schill SL, 2006, PSYCHON B REV, V13, P402, DOI 10.3758/BF03193860; van Veen V, 2005, NEUROIMAGE, V27, P497, DOI 10.1016/j.neuroimage.2005.04.042; Weissman DH, 2004, J NEUROSCI, V24, P10941, DOI 10.1523/JNEUROSCI.3669-04.2004; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005	50	191	195	3	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					908	914		10.1038/nn1918	http://dx.doi.org/10.1038/nn1918			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17558403				2022-12-17	WOS:000247560200022
J	Bonnin, A; Torii, M; Wang, L; Rakic, P; Levitt, P				Bonnin, Alexandre; Torii, Masaaki; Wang, Lilly; Rakic, Pasko; Levitt, Pat			Serotonin modulates the response of embryonic thalamocortical axons to netrin-1	NATURE NEUROSCIENCE			English	Article							THALAMIC NEURONS; CORTICAL DEVELOPMENT; EXPRESSION PATTERNS; PROTEIN-KINASE; MUTANT MICE; GROWTH; PROJECTIONS; RECEPTOR; RAT; ACTIVATION	Modifying serotonin ( 5- HT) abundance in the embryonic mouse brain disrupts the precision of sensory maps formed by thalamocortical axons ( TCAs), suggesting that 5- HT influences their growth. We investigated the mechanism by which 5- HT influences TCAs during development. 5- HT1B and 5- HT1D receptor expression in the fetal forebrain overlaps with that of the axon guidance receptors DCC and Unc5c. In coculture assays, axons originating from anterior and posterior halves of the embryonic day 14.5 dorsal thalamus responded differently to netrin- 1, reflecting the patterns of DCC and Unc5c expression. 5- HT converts the attraction exerted by netrin- 1 on posterior TCAs to repulsion. Pharmacological manipulation of 5- HT1B/1D receptors and intracellular cAMP showed the signaling cascade through which this modulation occurs. An in vivo correlate of altered TCA pathfinding was obtained by transient manipulation of 5- HT1B/1D receptor expression abundance in the dorsal thalamus by in utero electroporation. These data demonstrate that serotonergic signaling has a previously unrecognized role in the modulation of axonal responsiveness to a classic guidance cue.	Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37203 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Yale University; Yale University; Vanderbilt University	Levitt, P (corresponding author), Vanderbilt Univ, Dept Pharmacol, 465 21st Ave S, Nashville, TN 37232 USA.	pat.levitt@vanderbilt.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NICHD NIH HHS [P30HD15052] Funding Source: Medline; NIMH NIH HHS [MH65299] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADHAM N, 1992, MOL PHARMACOL, V41, P1; AITKEN AR, 1988, J COMP NEUROL, V274, P32, DOI 10.1002/cne.902740105; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Bonnin A, 2006, NEUROSCIENCE, V141, P781, DOI 10.1016/j.neuroscience.2006.04.036; Bouchard JF, 2004, J NEUROSCI, V24, P3040, DOI 10.1523/JNEUROSCI.4934-03.2004; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; CRANDALL JE, 1984, J COMP NEUROL, V228, P542, DOI 10.1002/cne.902280407; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; Gad JM, 1997, DEV BIOL, V192, P258, DOI 10.1006/dbio.1997.8756; Garel S, 2004, TRENDS NEUROSCI, V27, P533, DOI 10.1016/j.tins.2004.06.014; Garel S, 2002, DEVELOPMENT, V129, P5621, DOI 10.1242/dev.00166; Geerts IS, 1999, BRIT J PHARMACOL, V127, P1327, DOI 10.1038/sj.bjp.0702684; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; HAMBLIN MW, 1991, MOL PHARMACOL, V40, P143; HAYDON PG, 1984, SCIENCE, V226, P561, DOI 10.1126/science.6093252; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Janusonis S, 2004, J NEUROSCI, V24, P1652, DOI 10.1523/JNEUROSCI.4651-03.2004; Kreibich TA, 2004, J NEUROSCI, V24, P7085, DOI 10.1523/JNEUROSCI.0349-04.2004; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Lotto B, 1999, NEUROSCI LETT, V269, P87, DOI 10.1016/S0304-3940(99)00422-X; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; Molnar Z, 1998, J NEUROSCI, V18, P5723; Nakashiba T, 2000, J NEUROSCI, V20, P6540, DOI 10.1523/JNEUROSCI.20-17-06540.2000; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Persico AM, 2001, J NEUROSCI, V21, P6862, DOI 10.1523/JNEUROSCI.21-17-06862.2001; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Persico AM, 2006, BRAIN RES, V1095, P17, DOI 10.1016/j.brainres.2006.04.006; Price GW, 1997, N-S ARCH PHARMACOL, V356, P312, DOI 10.1007/PL00005056; Przyborski SA, 1998, DEVELOPMENT, V125, P41; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Rehn AE, 2005, CLIN EXP PHARMACOL P, V32, P687, DOI 10.1111/j.1440-1681.2005.04257.x; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Torii M, 2005, NEURON, V48, P563, DOI 10.1016/j.neuron.2005.09.021; Vanderhaeghen P, 2004, TRENDS NEUROSCI, V27, P384, DOI 10.1016/j.tins.2004.05.009; Vitalis T, 2003, DEV NEUROSCI-BASEL, V25, P245, DOI 10.1159/000072272; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19; Wiencken-Barger AE, 2004, CEREB CORTEX, V14, P121, DOI 10.1093/cercor/bhg110	49	191	194	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					588	597		10.1038/nn1896	http://dx.doi.org/10.1038/nn1896			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17450135				2022-12-17	WOS:000245948000015
J	Choi, DS; Cascini, MG; Mailliard, W; Young, H; Paredes, P; McMahon, T; Diamond, I; Bonci, A; Messing, RO				Choi, DS; Cascini, MG; Mailliard, W; Young, H; Paredes, P; McMahon, T; Diamond, I; Bonci, A; Messing, RO			The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; INDUCED MOTOR INCOORDINATION; ADENOSINE A(2A) RECEPTORS; RAT NUCLEUS-ACCUMBENS; EXTRACELLULAR ADENOSINE; PRESYNAPTIC INHIBITION; SEEKING BEHAVIOR; PROTEIN-KINASE; CALCIUM INFLUX; A(1) RECEPTORS	Adenosine is an important mediator of ethanol intoxication. In vitro, ethanol stimulates adenosine signaling by inhibiting the type 1 equilibrative nucleoside transporter (ENT1), whereas chronic ethanol exposure downregulates ENT1. It is not known, however, whether ENT1 is important for ethanol intoxication or consumption in vivo. Here we report that ENT1-null mice show reduced hypnotic and ataxic responses to ethanol and greater consumption of alcohol as compared with their wild-type littermates. These features are associated with a decrease in adenosine tone, as measured indirectly as a reduction in A(1)receptor- mediated inhibition of glutamate excitatory postsynaptic currents (EPSCs) in the nucleus accumbens, leading to increased phosphorylation of CRE-binding protein (CREB) in the striatum. Treatment with an A(1) receptor agonist decreases EPSC amplitude and reduces ethanol consumption in ENT1-null mice. Our results indicate that ENT1 has a physiological role in ethanol-mediated behaviors and suggest that decreased A(1) adenosine receptor function promotes alcohol consumption.	Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Messing, RO (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, Emeryville, CA 94608 USA.	romes@itsa.ucsf.edu	Choi, Doo-Sup/G-9474-2012; Messing, Robert/D-3642-2015	Choi, Doo-Sup/0000-0002-6796-9938; Messing, Robert/0000-0002-5345-4431	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA013588, R01AA013588] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA013588] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Anderson CM, 1999, J NEUROCHEM, V73, P867, DOI 10.1046/j.1471-4159.1999.0730867.x; Backstrom P, 2004, ALCOHOL CLIN EXP RES, V28, P558, DOI 10.1097/01.ALC.0000122101.13164.21; Backstrom P, 2004, NEUROPSYCHOPHARMACOL, V29, P921, DOI 10.1038/sj.npp.1300381; Baldwin SA, 1999, MOL MED TODAY, V5, P216, DOI 10.1016/S1357-4310(99)01459-8; BALLARIN M, 1991, ACTA PHYSIOL SCAND, V142, P97, DOI 10.1111/j.1748-1716.1991.tb09133.x; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Bowers BJ, 2000, ALCOHOL RES HEALTH, V24, P175; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; CARMICHAEL FJ, 1991, J PHARMACOL EXP THER, V259, P403; Choi DS, 2002, J NEUROSCI, V22, P9905; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; Dar MS, 2001, BRAIN RES BULL, V55, P513, DOI 10.1016/S0361-9230(01)00552-4; Dar MS, 1997, BRAIN RES, V749, P263, DOI 10.1016/S0006-8993(96)01263-2; Diao LH, 1996, J PHARMACOL EXP THER, V278, P542; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; El Yacoubi M, 2000, PSYCHOPHARMACOLOGY, V148, P153; Florio C, 1998, PSYCHOPHARMACOLOGY, V136, P311, DOI 10.1007/s002130050572; GEIGER JD, 1984, BRAIN RES BULL, V13, P657, DOI 10.1016/0361-9230(84)90198-9; Harvey J, 1997, J NEUROSCI, V17, P5271; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Jennings LL, 2001, NEUROPHARMACOLOGY, V40, P722, DOI 10.1016/S0028-3908(00)00207-0; LI TK, 1993, BEHAV GENET, V23, P163, DOI 10.1007/BF01067421; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Marston HM, 1998, J PHARMACOL EXP THER, V285, P1023; Naassila M, 2002, J NEUROSCI, V22, P10487; Nagel J, 2002, BEHAV BRAIN RES, V134, P485, DOI 10.1016/S0166-4328(02)00062-1; NAGY LE, 1989, MOL PHARMACOL, V36, P744; NAGY LE, 1990, J BIOL CHEM, V265, P1946; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; SANDERSON G, 1986, PFLUG ARCH EUR J PHY, V406, P25, DOI 10.1007/BF00582948; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; Schuckit MA, 1998, J STUD ALCOHOL, V59, P485, DOI 10.15288/jsa.1998.59.485; Self DW, 1998, J NEUROSCI, V18, P1848; Shaw-Lutchman TZ, 2003, SYNAPSE, V48, P10, DOI 10.1002/syn.10172; Svenningsson P, 1999, PROG NEUROBIOL, V59, P355, DOI 10.1016/S0301-0082(99)00011-8; Svenningsson P, 2002, P NATL ACAD SCI USA, V99, P3182, DOI 10.1073/pnas.052712799; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2	39	191	197	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					855	861		10.1038/nn1288	http://dx.doi.org/10.1038/nn1288			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15258586				2022-12-17	WOS:000222930800016
J	Friedrich, RW; Habermann, CJ; Laurent, G				Friedrich, RW; Habermann, CJ; Laurent, G			Multiplexing using synchrony in the zebrafish olfactory bulb	NATURE NEUROSCIENCE			English	Article							ODORANT REPRESENTATIONS; NEURONAL SYNCHRONY; OSCILLATIONS; DYNAMICS; SYSTEM; CORTEX; BRAIN; DISCRIMINATION; ORGANIZATION; RAT	In the olfactory bulb (OB) of zebrafish and other species, odors evoke fast oscillatory population activity and specific firing rate patterns across mitral cells (MCs). This activity evolves over a few hundred milliseconds from the onset of the odor stimulus. Action potentials of odor-specific MC subsets phase-lock to the oscillation, defining small and distributed ensembles within the MC population output. We found that oscillatory field potentials in the zebrafish OB propagate across the OB in waves. Phase-locked MC action potentials, however, were synchronized without a time lag. Firing rate patterns across MCs analyzed with low temporal resolution were informative about odor identity. When the sensitivity for phase-locked spiking was increased, activity patterns became progressively more informative about odor category. Hence, information about complementary stimulus features is conveyed simultaneously by the same population of neurons and can be retrieved selectively by biologically plausible mechanisms, indicating that seemingly alternative coding strategies operating on different time scales may coexist.	Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany; CALTECH, Div Biol, Pasadena, CA 91125 USA	Max Planck Society; California Institute of Technology	Friedrich, RW (corresponding author), Max Planck Inst Med Res, Dept Biomed Opt, Jahnstr 29, D-69120 Heidelberg, Germany.	Rainer.Friedrich@mpimf-heidelberg.mpg.de	Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Friedrich, Rainer/0000-0001-9107-0482				BAIER H, 1994, J NEUROSCI, V14, P219; BYRD CA, 1995, J COMP NEUROL, V358, P247, DOI 10.1002/cne.903580207; Carr W.E.S., 1988, P3; Cleland TA, 2002, BEHAV NEUROSCI, V116, P222, DOI 10.1037//0735-7044.116.2.222; ECKHORN R, 1994, PROG BRAIN RES, V102, P405; Edwards JG, 2002, J COMP NEUROL, V454, P294, DOI 10.1002/cne.10445; EECKMAN FH, 1990, BRAIN RES, V528, P238, DOI 10.1016/0006-8993(90)91663-2; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; FLUHLER E, 1985, BIOCHEMISTRY-US, V24, P5749, DOI 10.1021/bi00342a010; FREEMAN WJ, 1985, BRAIN RES REV, V10, P147, DOI 10.1016/0165-0173(85)90022-0; Friedman D, 2003, J NEUROPHYSIOL, V89, P2601, DOI 10.1152/jn.00887.2002; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; GOLDBERG SJ, 1987, EXP NEUROL, V96, P430, DOI 10.1016/0014-4886(87)90060-4; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Haberly LB, 1998, SYNAPTIC ORG BRAIN, P377; HASEGAWA T, 1994, COMP BIOCHEM PHYS A, V108, P17, DOI 10.1016/0300-9629(94)90048-5; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P695, DOI 10.1113/jphysiol.1974.sp010772; Kuhn B, 2003, J PHYS CHEM B, V107, P7903, DOI 10.1021/jp0345811; Lam YW, 2003, EUR J NEUROSCI, V17, P436, DOI 10.1046/j.1460-9568.2003.02457.x; Lam YW, 2000, J NEUROSCI, V20, P749, DOI 10.1523/JNEUROSCI.20-02-00749.2000; Lamme VAF, 1998, NATURE, V396, P362, DOI 10.1038/24608; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; LAURENT G, 1994, J NEUROSCI; LEVINE RL, 1985, J COMP NEUROL, V237, P427, DOI 10.1002/cne.902370402; Lledo PM, 2003, NEUROREPORT, V14, P1655, DOI 10.1097/00001756-200309150-00001; MATHIESON WB, 1988, J COMP PHYSIOL A, V163, P489, DOI 10.1007/BF00604903; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; Reyment R.A., 1996, APPL FACTOR ANAL NAT; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; SATOU M, 1990, PROG NEUROBIOL, V34, P115, DOI 10.1016/0301-0082(90)90004-Z; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Valentincic T, 2000, CHEM SENSES, V25, P21, DOI 10.1093/chemse/25.1.21; VANESSEN DC, 1994, NEURON, V13, P1, DOI 10.1016/0896-6273(94)90455-3; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wise PM, 2000, CHEM SENSES, V25, P247, DOI 10.1093/chemse/25.3.247; [No title captured]	50	191	191	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					862	871		10.1038/nn1292	http://dx.doi.org/10.1038/nn1292			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15273692				2022-12-17	WOS:000222930800017
J	Weimer, RM; Richmond, JE; Davis, WS; Hadwiger, G; Nonet, ML; Jorgensen, EM				Weimer, RM; Richmond, JE; Davis, WS; Hadwiger, G; Nonet, ML; Jorgensen, EM			Defects in synaptic vesicle docking in unc-18 mutants	NATURE NEUROSCIENCE			English	Article							NEUROTRANSMITTER RELEASE; SYNAPTOTAGMIN MUTANTS; LOCUS ENCODES; SYNTAXIN 1A; PROTEIN; FUSION; ROP; SYNAPTOBREVIN; EXOCYTOSIS; INTERACTS	Sec1-related proteins function in most, if not all, membrane trafficking pathways in eukaryotic cells. The Sec1-related protein required in neurons for synaptic vesicle exocytosis is UNC-18. Several models for UNC-18 function during vesicle exocytosis are under consideration. We have tested these models by characterizing unc-18 mutants of the nematode Caenorhabditis elegans. In the absence of UNC-18, the size of the readily releasable pool is severely reduced. Our results show that the near absence of fusion-competent vesicles is not caused by a reduction in syntaxin levels, by a mislocalization of syntaxin, by a defect in fusion or by a failure to open syntaxin during priming. Rather, we found a reduction of docked vesicles at the active zone in unc-18 mutants, suggesting that UNC-18 functions, directly or indirectly, as a facilitator of vesicle docking.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Utah System of Higher Education; University of Utah; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Washington University (WUSTL)	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041477] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS041477-01A1, R01 NS041477] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamber BA, 1999, J NEUROSCI, V19, P5348; BEKKERS JM, 1969, PRACTICAL ELECT METH, P150; BRENNER S, 1974, GENETICS, V77, P71; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Bryant NJ, 2001, EMBO J, V20, P3380, DOI 10.1093/emboj/20.13.3380; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; GENGYOANDO K, 1993, NEURON, V11, P703, DOI 10.1016/0896-6273(93)90080-B; Grote E, 2000, J CELL BIOL, V151, P439, DOI 10.1083/jcb.151.2.439; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KOENIG JH, 1989, J NEUROSCI, V9, P1937; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Li J, 1999, PHILOS T ROY SOC B, V354, P299, DOI 10.1098/rstb.1999.0381; Lickteig KM, 2001, J NEUROSCI, V21, P2001, DOI 10.1523/JNEUROSCI.21-06-02001.2001; Lonart G, 2000, J BIOL CHEM, V275, P27703; Marsal J, 1997, P NATL ACAD SCI USA, V94, P14871, DOI 10.1073/pnas.94.26.14871; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1998, J NEUROSCI, V18, P70; OConnor V, 1997, P NATL ACAD SCI USA, V94, P12186, DOI 10.1073/pnas.94.22.12186; Ogawa H, 1998, J BIOL CHEM, V273, P2192, DOI 10.1074/jbc.273.4.2192; OSSIG R, 1991, MOL CELL BIOL, V11, P2980, DOI 10.1128/MCB.11.6.2980; Peng RW, 2002, J CELL BIOL, V157, P645, DOI 10.1083/jcb.200202006; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Reist NE, 1998, J NEUROSCI, V18, P7662; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Robinson LJ, 1998, CURR OPIN CELL BIOL, V10, P483, DOI 10.1016/S0955-0674(98)80063-X; Rowe J, 2001, J CELL SCI, V114, P3323; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Sassa T, 1999, J NEUROSCI, V19, P4772; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, J CELL SCI, V116, P3661, DOI 10.1242/jcs.00687; Wu MN, 2001, EUR J CELL BIOL, V80, P196, DOI 10.1078/0171-9335-00143; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	49	191	203	0	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1023	1030		10.1038/nn1118	http://dx.doi.org/10.1038/nn1118			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12973353	Green Accepted			2022-12-17	WOS:000185633600013
J	Hoshi, N; Zhang, JS; Omaki, M; Takeuchi, T; Yokoyama, S; Wanaverbecq, N; Langeberg, LK; Yoneda, Y; Scott, JD; Brown, DA; Higashida, H				Hoshi, N; Zhang, JS; Omaki, M; Takeuchi, T; Yokoyama, S; Wanaverbecq, N; Langeberg, LK; Yoneda, Y; Scott, JD; Brown, DA; Higashida, H			AKAP150 signaling complex promotes suppression of the M-current by muscarinic agonists	NATURE NEUROSCIENCE			English	Article							RAT SYMPATHETIC NEURONS; PROTEIN-KINASE-C; POTASSIUM CHANNEL SUBUNITS; M-CURRENT INHIBITION; ANCHORING PROTEIN; K+ CHANNELS; LINOPIRDINE DUP-996; CA2+ CHANNELS; MODULATION; RECEPTORS	M-type (KCNQ2/3) potassium channels are suppressed by activation of G(q/11)-coupled receptors, thereby increasing neuronal excitability. We show here that rat KCNQ2 can bind directly to the multivalent A-kinase-anchoring protein AKAP150. Peptides that block AKAP150 binding to the KCNQ2 channel complex antagonize the muscarinic inhibition of the currents. A mutant form of AKAP150, AKAP(DeltaA), which is unable to bind protein kinase C (PKC), also attenuates the agonist-induced current suppression. Analysis of recombinant KCNQ2 channels suggests that targeting of PKC through association with AKAP150 is important for the inhibition. Phosphorylation of KCNQ2 channels was increased by muscarinic stimulation; this was prevented either by coexpression with AKAP(DeltaA) or pretreatment with PKC inhibitors that compete with diacylglycerol. These inhibitors also reduced muscarinic inhibition of M-current. Our data indicate that AKAP150-bound PKC participates in receptor-induced inhibition of the M-current.	Kanazawa Univ, Grad Sch Med, Dept Biophys Genet, Kanazawa, Ishikawa 9208640, Japan; Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Kanazawa Univ, Fac Pharmaceut Sci, Dept Mol Pharmacol, Kanazawa, Ishikawa 9200934, Japan; UCL, Dept Pharmacol, London WC1E 6BT, England	Kanazawa University; Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University; Kanazawa University; University of London; University College London	Hoshi, N (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Biophys Genet, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	hoshin@ohsu.edu	Yoneda, Yukio/ABI-1864-2020; Brown, David A/J-9019-2012; higashida, haruhiro/L-3773-2015	Yoneda, Yukio/0000-0002-4624-177X; higashida, haruhiro/0000-0002-1779-0606; Wanaverbecq, Nicolas/0000-0001-5486-2771	NIGMS NIH HHS [R37 GM048231, GM48231, R01 GM048231] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048231, R37GM048231] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIKEN SP, 1995, BRIT J PHARMACOL, V115, P1163, DOI 10.1111/j.1476-5381.1995.tb15019.x; Bofill-Cardona E, 2000, MOL PHARMACOL, V57, P1165; Brown BS, 2000, PROG BIOPHYS MOL BIO, V73, P135, DOI 10.1016/S0079-6107(00)00004-3; Brown D A, 1988, Ion Channels, V1, P55; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Cooper EC, 2000, P NATL ACAD SCI USA, V97, P4914, DOI 10.1073/pnas.090092797; Cruzblanca H, 1998, P NATL ACAD SCI USA, V95, P7151, DOI 10.1073/pnas.95.12.7151; del Rio E, 1999, J PHYSIOL-LONDON, V520, P101, DOI 10.1111/j.1469-7793.1999.00101.x; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Delmas P, 1998, J PHYSIOL-LONDON, V506, P319, DOI 10.1111/j.1469-7793.1998.319bw.x; DORJE F, 1991, J PHARMACOL EXP THER, V256, P727; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Haley JE, 1998, J NEUROSCI, V18, P4521; Haley JE, 2000, J NEUROSCI, V20; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; HIGASHIDA H, 1986, NATURE, V323, P333, DOI 10.1038/323333a0; Hoshi N, 1998, J BIOL CHEM, V273, P23080, DOI 10.1074/jbc.273.36.23080; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; JOHNSON BD, 1994, P NATL ACAD SCI USA, V91, P11492, DOI 10.1073/pnas.91.24.11492; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Lamas JA, 1997, EUR J NEUROSCI, V9, P605, DOI 10.1111/j.1460-9568.1997.tb01637.x; Marrion NV, 1996, NEURON, V16, P163, DOI 10.1016/S0896-6273(00)80033-1; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; MARRION NV, 1994, PFLUG ARCH EUR J PHY, V426, P296, DOI 10.1007/BF00374785; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; ROBBINS J, 1993, J PHYSIOL-LONDON, V469, P153, DOI 10.1113/jphysiol.1993.sp019809; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; Rundfeldt C, 2000, NEUROSCI LETT, V282, P73, DOI 10.1016/S0304-3940(00)00866-1; SACHS CW, 1995, J BIOL CHEM, V270, P26639, DOI 10.1074/jbc.270.44.26639; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; SELYANKO AA, 1992, P ROY SOC B-BIOL SCI, V250, P119, DOI 10.1098/rspb.1992.0139; Selyanko AA, 1996, NEURON, V16, P151, DOI 10.1016/S0896-6273(00)80032-X; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Sik A, 2000, EUR J NEUROSCI, V12, P1155, DOI 10.1046/j.1460-9568.2000.00002.x; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Takahashi Y, 1999, J PHYSIOL-LONDON, V521, P567, DOI 10.1111/j.1469-7793.1999.00567.x; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93	50	191	195	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					564	571		10.1038/nn1062	http://dx.doi.org/10.1038/nn1062			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12754513	Green Accepted			2022-12-17	WOS:000183140400012
J	Bottcher, C; Schlickeiser, S; Sneeboer, MAM; Kunkel, D; Knop, A; Paza, E; Fidzinski, P; Kraus, L; Snijders, GJL; Kahn, RS; Schulz, AR; Mei, HE; Hol, EM; Siegmund, B; Glauben, R; Spruth, EJ; de Witte, LD; Priller, J				Boettcher, Chotima; Schlickeiser, Stephan; Sneeboer, Marjolein A. M.; Kunkel, Desiree; Knop, Anniki; Paza, Evdokia; Fidzinski, Pawel; Kraus, Larissa; Snijders, Gijsje J. L.; Kahn, Rene S.; Schulz, Axel R.; Mei, Henrik E.; Hol, Elly M.; Siegmund, Britta; Glauben, Rainer; Spruth, Eike J.; de Witte, Lot D.; Priller, Josef		NBB-Psy	Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometry	NATURE NEUROSCIENCE			English	Article							REVEALS; EXPRESSION; MACROPHAGES; RECEPTOR; DISCOVERY; SUBSETS; SYSTEM; MOUSE; AGE; HIV	Microglia, the specialized innate immune cells of the CNS, play crucial roles in neural development and function. Different phenotypes and functions have been ascribed to rodent microglia, but little is known about human microglia (huMG) heterogeneity. Difficulties in procuring huMG and their susceptibility to cryopreservation damage have limited large-scale studies. Here we applied multiplexed mass cytometry for a comprehensive characterization of postmortem huMG (10(3) - 10(4) cells). We determined expression levels of 57 markers on huMG isolated from up to five different brain regions of nine donors. We identified the phenotypic signature of huMG, which was distinct from peripheral myeloid cells but was comparable to fresh huMG. We detected microglia regional heterogeneity using a hybrid workflow combining Cytobank and R/Bioconductor for multidimensional data analysis. Together, these methodologies allowed us to perform high-dimensional, large-scale immunophenotyping of huMG at the single-cell level, which facilitates their unambiguous profiling in health and disease.	[Boettcher, Chotima; Knop, Anniki; Paza, Evdokia; Spruth, Eike J.; Priller, Josef] Charite Univ Med Berlin, Dept Neuropsychiat, Berlin, Germany; [Boettcher, Chotima; Knop, Anniki; Paza, Evdokia; Spruth, Eike J.; Priller, Josef] Charite Univ Med Berlin, Lab Mol Psychiat, Berlin, Germany; [Schlickeiser, Stephan; Kunkel, Desiree] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Sneeboer, Marjolein A. M.; Snijders, Gijsje J. L.; Hol, Elly M.; de Witte, Lot D.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Psychiat, Utrecht, Netherlands; [Fidzinski, Pawel; Kraus, Larissa] Charite Univ Med Berlin, Epilepsy Ctr Berlin Brandenburg, Dept Neurol, Berlin, Germany; [Kraus, Larissa; Priller, Josef] Berlin Inst Hlth, Berlin, Germany; [Kahn, Rene S.; de Witte, Lot D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Schulz, Axel R.; Mei, Henrik E.] German Rheumatism Res Ctr, Berlin, Germany; [NBB-Psy] Netherlands Brain Bank, Amsterdam, Netherlands; [Hol, Elly M.] Inst Royal Acad Arts & Sci, Netherlands Inst Neurosci, Dept Neuroimmunol, Amsterdam, Netherlands; [Siegmund, Britta; Glauben, Rainer] Charite Univ Med Berlin, Med Dept Gastroenterol, Div Gastroenterol Infectiol & Rheumatol, Berlin, Germany; [Spruth, Eike J.; Priller, Josef] DZNE, Berlin, Germany; [Priller, Josef] Cluster Excellence NeuroCure, Berlin, Germany; [Priller, Josef] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Priller, Josef] UK Dementia Res Inst, Edinburgh, Midlothian, Scotland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Utrecht University; Utrecht University Medical Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Icahn School of Medicine at Mount Sinai; Deutsches Rheuma-Forschungszentrum (DRFZ); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Edinburgh	Bottcher, C; Priller, J (corresponding author), Charite Univ Med Berlin, Dept Neuropsychiat, Berlin, Germany.; Bottcher, C; Priller, J (corresponding author), Charite Univ Med Berlin, Lab Mol Psychiat, Berlin, Germany.; Priller, J (corresponding author), Berlin Inst Hlth, Berlin, Germany.; Priller, J (corresponding author), DZNE, Berlin, Germany.; Priller, J (corresponding author), Cluster Excellence NeuroCure, Berlin, Germany.; Priller, J (corresponding author), Univ Edinburgh, Edinburgh, Midlothian, Scotland.; Priller, J (corresponding author), UK Dementia Res Inst, Edinburgh, Midlothian, Scotland.	chotima.boettcher@charite.de; josef.priller@charite.de	Priller, Josef/ABW-3835-2022; Hol, Elly M/F-1891-2013; Fidzinski, Pawel/AAM-8884-2020; de Witte, Lot/GZG-9717-2022; Siegmund, Britta/E-6929-2018	Hol, Elly M/0000-0001-5604-2603; Fidzinski, Pawel/0000-0001-6373-4763; de Witte, Lot/0000-0002-7235-9958; Paza, Evdokia/0000-0002-4297-8598; Schulz, Axel Ronald/0000-0002-5106-0148; Siegmund, Britta/0000-0002-0055-958X; Schlickeiser, Stephan/0000-0003-3142-2890; Knop, Anniki/0000-0001-8994-606X; Kraus, Larissa/0000-0003-2615-7009; Priller, Josef/0000-0001-7596-0979; Bottcher, Chotima/0000-0002-6226-586X	German Research Foundation [SI 749/9-1, 749/10-1, CRC-TRR 241, 70112011, SFB TRR167]; Berlin Institute of Health [CRG2aSP6]; UK DRI (Momentum Award); NeuroMac School [SFB TRR167]; Cluster of Excellence NeuroCure; EU-H2020 project PACE [733006]; Deutsche Krebhilfe [70112011]; Brain & Behavior Research Foundation; Virgo Consortium - Dutch government [FES0908]; Netherlands Organization for Scientific Research (NWO);  [Me3644/5-1]; MRC [MC_PC_16031] Funding Source: UKRI	German Research Foundation(German Research Foundation (DFG)); Berlin Institute of Health; UK DRI (Momentum Award); NeuroMac School; Cluster of Excellence NeuroCure; EU-H2020 project PACE; Deutsche Krebhilfe; Brain & Behavior Research Foundation(NARSAD); Virgo Consortium - Dutch government; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Bottcher for excellent technical assistance with FACS analysis. We also acknowledge the assistance of the BCRT Flow Cytometry Lab (Charite -Universitatsmedizin Berlin, Germany). C.B. and J.P. were supported by the German Research Foundation (SFB TRR167, B05 & B07). J.P. received additional funding from the Berlin Institute of Health (CRG2aSP6) and the UK DRI (Momentum Award). S.S. was partially funded by the EU-H2020 project PACE (grant agreement number 733006). A.K. and E.P. were supported by stipends from the NeuroMac School (SFB TRR167, IRTG). A.K. received additional funding from the Cluster of Excellence NeuroCure. H.E.M. and A.R.S. were supported through grant Me3644/5-1. B.S. was supported by the German Research Foundation (SI 749/9-1, 749/10-1, CRC-TRR 241). B.S. and R.G. were supported by the Deutsche Krebhilfe (70112011). M.A.M.S. was supported by a 2014 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation and L.D.D.W. by the Virgo Consortium, funded by the Dutch government, project number FES0908. The psychiatric donor program of the Netherlands Brain Bank (NBB-Psy) is financially supported by the Netherlands Organization for Scientific Research (NWO). We acknowledge the Leibniz Science Campus for Chronic Inflammation for general support.	Aghaeepour N, 2012, CYTOM PART A, V81A, P1022, DOI 10.1002/cyto.a.22209; Aghaeepour N, 2012, BIOINFORMATICS, V28, P1009, DOI 10.1093/bioinformatics/bts082; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1111/j.1442-9993.2001.01070.pp.x; Askew K, 2017, CELL REP, V18, P391, DOI 10.1016/j.celrep.2016.12.041; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bianchin MM, 2004, CELL MOL NEUROBIOL, V24, P1, DOI 10.1023/B:CEMN.0000012721.08168.ee; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chatfield M, 2009, STATA J, V9, P299, DOI 10.1177/1536867X0900900208; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Cohen M, 2017, J NEUROSCI, V37, P972, DOI 10.1523/JNEUROSCI.2199-16.2016; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Diggins KE, 2017, NAT METHODS, V14, P275, DOI [10.1038/NMETH.4149, 10.1038/nmeth.4149]; Duong T, 2007, J STAT SOFTW, V21, P1, DOI 10.18637/jss.v021.i07; Durafourt Bryce A, 2013, Methods Mol Biol, V1041, P199, DOI 10.1007/978-1-62703-520-0_19; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Finak G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003806; Galatro TF, 2017, NAT NEUROSCI, V20, P1162, DOI 10.1038/nn.4597; Gaudilliere B, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009701; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Hamann J, 2007, EUR J IMMUNOL, V37, P2797, DOI 10.1002/eji.200737553; HODGES JL, 1963, ANN MATH STAT, V34, P598, DOI 10.1214/aoms/1177704172; Holder GE, 2014, J NEUROIMMUNE PHARM, V9, P716, DOI 10.1007/s11481-014-9564-y; Japp AS, 2017, CYTOM PART A, V91A, P85, DOI 10.1002/cyto.a.22906; Jiang M., 2016, CYTOML GATINGML INTE; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Klegeris A, 2005, NEUROBIOL AGING, V26, P673, DOI 10.1016/j.neurobiolaging.2004.06.012; Korin B, 2017, NAT NEUROSCI, V20, P1300, DOI 10.1038/nn.4610; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Lambert C, 2010, BRAIN BEHAV IMMUN, V24, P1241, DOI 10.1016/j.bbi.2010.02.010; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lun ATL, 2017, NAT METHODS, V14, P707, DOI 10.1038/nmeth.4295; Mei HE, 2015, J IMMUNOL, V194, P2022, DOI 10.4049/jimmunol.1402661; Melief J, 2016, GLIA, V64, P1857, DOI 10.1002/glia.23023; Melief J, 2013, GLIA, V61, P1848, DOI 10.1002/glia.22562; Mildner A, 2017, GLIA, V65, P375, DOI 10.1002/glia.23097; Mizee MR, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0418-8; Moore CS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000080; Naumann U, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-44; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Neill K, 2014, BIOINFORMATICS, V30, P1329, DOI 10.1093/bioinformatics/btt770; Oksanen J., 2008, COMMUNITY ECOL PACKA; Olah M, 2012, GLIA, V60, P96, DOI 10.1002/glia.21251; Orlova DY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151859; Orre M, 2014, NEUROBIOL AGING, V35, P2746, DOI 10.1016/j.neurobiolaging.2014.06.004; Orre M, 2014, NEUROBIOL AGING, V35, P1, DOI 10.1016/j.neurobiolaging.2013.07.008; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Prinz M, 2017, NAT NEUROSCI, V20, P136, DOI 10.1038/nn.4475; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; RCore Team, 2014, R LANG ENV STAT COMP; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roederer M, 2001, CYTOMETRY, V45, P37, DOI 10.1002/1097-0320(20010901)45:1<37::AID-CYTO1142>3.0.CO;2-E; Rogers Wade T., 2009, Advances in Bioinformatics, V2009, P193947, DOI 10.1155/2009/193947; Rousseeuw P., 1992, L1 STAT ANAL RELATED, P77; Rustenhoven J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19371; Samusik N, 2016, NAT METHODS, V13, P493, DOI [10.1038/NMETH.3863, 10.1038/nmeth.3863]; Schughart K, 2013, EUR J HUM GENET, V21, P1191, DOI 10.1038/ejhg.2013.79; Shekhar K, 2014, P NATL ACAD SCI USA, V111, P202, DOI 10.1073/pnas.1321405111; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Smith AM, 2014, TRENDS NEUROSCI, V37, P125, DOI 10.1016/j.tins.2013.12.001; Spidlen J, 2008, CYTOM PART A, V73A, P1151, DOI 10.1002/cyto.a.20637; Szulzewsky F, 2016, GLIA, V64, P1416, DOI 10.1002/glia.23014; Duong T, 2012, P NATL ACAD SCI USA, V109, P8382, DOI 10.1073/pnas.1117796109; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van Dongen S., 2012, PREPRINT	75	190	191	3	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2019	22	1					78	+		10.1038/s41593-018-0290-2	http://dx.doi.org/10.1038/s41593-018-0290-2			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE5CJ	30559476	Green Submitted			2022-12-17	WOS:000453388700011
J	Goncalves, JT; Anstey, JE; Golshani, P; Portera-Cailliau, C				Goncalves, J. Tiago; Anstey, James E.; Golshani, Peyman; Portera-Cailliau, Carlos			Circuit level defects in the developing neocortex of Fragile X mice	NATURE NEUROSCIENCE			English	Article							CRITICAL PERIOD PLASTICITY; BARREL CORTEX; MOUSE MODEL; MENTAL-RETARDATION; GABA(A) RECEPTOR; VISUAL-CORTEX; STATES; NETWORK; NEURONS; SLEEP	Subtle alterations in how cortical network dynamics are modulated by different behavioral states could disrupt normal brain function and underlie symptoms of neuropsychiatric disorders, including Fragile X syndrome (FXS). Using two-photon calcium imaging and electrophysiology, we recorded spontaneous neuronal ensemble activity in mouse somatosensory cortex. Unanesthetized Fmr1(-/-) mice exhibited abnormally high synchrony of neocortical network activity, especially during the first two postnatal weeks. Neuronal firing rates were threefold higher in Fmr1(-/-) mice than in wild-type mice during whole-cell recordings manifesting Up/Down states (slow-wave sleep, quiet wakefulness), probably as a result of a higher firing probability during Up states. Combined electroencephalography and calcium imaging experiments confirmed that neurons in mutant mice had abnormally high firing and synchrony during sleep. We conclude that cortical networks in FXS are hyperexcitable in a brain state-dependent manner during a critical period for experience-dependent plasticity. These state-dependent network defects could explain the intellectual, sleep and sensory integration dysfunctions associated with FXS.	[Goncalves, J. Tiago; Anstey, James E.; Golshani, Peyman; Portera-Cailliau, Carlos] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Portera-Cailliau, Carlos] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Portera-Cailliau, C (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	cpcailliau@mednet.ucla.edu		Anstey, James/0000-0001-6422-0086; Goncalves, J. Tiago/0000-0003-2303-1822	National Institute of Child Health and Human Development [R01HD054453]; National Institute of Neurological Disorders and Stroke [RC1NS068093]; FRAXA Research Foundation; Dana Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD054453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068093] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); FRAXA Research Foundation; Dana Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Buonomano, C. Houser, I. Mody and R. Mostany, as well as D. Cantu for helpful discussions and/or valuable comments on the manuscript. We also thank A. Bragin and M. Blumberg for help with EEG recordings and interpretation, J. Gornbein and D. Markovich for help with statistical analyses, and W. Greenough for providing the Fmr1<SUP>-/-</SUP> mice. This work was supported by grants from the National Institute of Child Health and Human Development (R01HD054453), the National Institute of Neurological Disorders and Stroke (RC1NS068093), the FRAXA Research Foundation and the Dana Foundation.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BAKKER CE, 1994, CELL, V78, P23; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bureau I, 2008, J NEUROSCI, V28, P5178, DOI 10.1523/JNEUROSCI.1076-08.2008; Bushey D, 2009, J NEUROSCI, V29, P1948, DOI 10.1523/JNEUROSCI.4830-08.2009; Castro-Alamancos MA, 2009, NEUROSCIENTIST, V15, P625, DOI 10.1177/1073858409333074; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; Curia G, 2009, CEREB CORTEX, V19, P1515, DOI 10.1093/cercor/bhn159; D'Hulst C, 2007, TRENDS NEUROSCI, V30, P425, DOI 10.1016/j.tins.2007.06.003; El Idrissi A, 2005, NEUROSCI LETT, V377, P141, DOI 10.1016/j.neulet.2004.11.087; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Golshani Peyman, 2008, J Vis Exp, DOI 10.3791/681; Golshani P, 2009, J NEUROSCI, V29, P10890, DOI 10.1523/JNEUROSCI.2012-09.2009; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hagerman R, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-12; Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024; Hays SA, 2011, J NEUROSCI, V31, P14223, DOI 10.1523/JNEUROSCI.3157-11.2011; He CX, 2013, NEUROSCIENCE, V251, P120, DOI 10.1016/j.neuroscience.2012.03.049; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kronk R, 2010, SLEEP, V33, P679, DOI 10.1093/sleep/33.5.679; LeBlanc JJ, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/921680; Li CYT, 2009, SCIENCE, V324, P643, DOI 10.1126/science.1169957; Markram K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00224; Meredith RM, 2012, TRENDS NEUROSCI, V35, P335, DOI 10.1016/j.tins.2012.03.005; Miller LJ, 1999, AM J MED GENET, V83, P268, DOI 10.1002/(SICI)1096-8628(19990402)83:4<268::AID-AJMG7>3.3.CO;2-B; Mitra P., 2008, OBSERVED BRAIN DYNAM; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; Olmos-Serrano JL, 2010, J NEUROSCI, V30, P9929, DOI 10.1523/JNEUROSCI.1714-10.2010; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Portera-Cailliau C, 2012, NEUROSCIENTIST, V18, P28, DOI 10.1177/1073858410395322; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Rapin I, 1998, ANN NEUROL, V43, P7, DOI 10.1002/ana.410430106; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; Selby L, 2007, NEUROSCI LETT, V412, P227, DOI 10.1016/j.neulet.2006.11.062; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; TANELIAN DL, 1993, ANESTHESIOLOGY, V78, P757, DOI 10.1097/00000542-199304000-00020; Testa-Silva G, 2012, CEREB CORTEX, V22, P1333, DOI 10.1093/cercor/bhr224; Van der Molen MJW, 2013, BIOL PSYCHOL, V92, P216, DOI 10.1016/j.biopsycho.2012.11.013; Veasey SC, 2000, SLEEP, V23, P1025; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Zhang J, 2008, AM J HUM GENET, V83, P43, DOI 10.1016/j.ajhg.2008.06.003; Zhang L, 2008, HIPPOCAMPUS, V18, P294, DOI 10.1002/hipo.20389	56	190	193	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					903	U166		10.1038/nn.3415	http://dx.doi.org/10.1038/nn.3415			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23727819	Green Accepted, Green Submitted			2022-12-17	WOS:000321180900024
J	Schapiro, AC; Rogers, TT; Cordova, NI; Turk-Browne, NB; Botvinick, MM				Schapiro, Anna C.; Rogers, Timothy T.; Cordova, Natalia I.; Turk-Browne, Nicholas B.; Botvinick, Matthew M.			Neural representations of events arise from temporal community structure	NATURE NEUROSCIENCE			English	Article							SEGMENTATION; REPETITION; LANGUAGE; MODEL; INFORMATION; HIERARCHIES; PERCEPTION; CORTEX; COMMON; BRAIN	Our experience of the world seems to divide naturally into discrete, temporally extended events, yet the mechanisms underlying the learning and identification of events are poorly understood. Research on event perception has focused on transient elevations in predictive uncertainty or surprise as the primary signal driving event segmentation. We present human behavioral and functional magnetic resonance imaging (fMRI) evidence in favor of a different account, in which event representations coalesce around clusters or 'communities' of mutually predicting stimuli. Through parsing behavior, fMRI adaptation and multivoxel pattern analysis, we demonstrate the emergence of event representations in a domain containing such community structure, but in which transition probabilities (the basis of uncertainty and surprise) are uniform. We present a computational account of how the relevant representations might arise, proposing a direct connection between event learning and the learning of semantic categories.	[Schapiro, Anna C.; Cordova, Natalia I.; Turk-Browne, Nicholas B.; Botvinick, Matthew M.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Schapiro, Anna C.; Cordova, Natalia I.; Turk-Browne, Nicholas B.; Botvinick, Matthew M.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Rogers, Timothy T.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	Princeton University; Princeton University; University of Wisconsin System; University of Wisconsin Madison	Schapiro, AC (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	schapiro@princeton.edu		Schapiro, Anna/0000-0001-8086-0331	John Templeton Foundation; US National Science Foundation [DGE-0646086, IIS-1207833]; US National Institutes of Health [R01-EY021755]; James S. McDonnell Foundation; NATIONAL EYE INSTITUTE [R01EY021755] Funding Source: NIH RePORTER	John Templeton Foundation; US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank M. Arcaro, J. McGuire, K. Norman, F. Pereira and M. Todd for helpful discussions. This project was made possible through the support of a grant from the John Templeton Foundation. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. This work was also supported by US National Science Foundation Graduate Research Fellowship DGE-0646086 to A.C.S., US National Institutes of Health grant R01-EY021755 to N.B.T.-B., and US National Science Foundation grant IIS-1207833 and a James S. McDonnell Foundation grant to M.M.B.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; AVRAHAMI J, 1994, COGNITION, V53, P239, DOI 10.1016/0010-0277(94)90050-7; Baird J.A., 2001, INTENTIONS INTENTION, P193; Baldwin D, 2008, COGNITION, V106, P1382, DOI 10.1016/j.cognition.2007.07.005; Bar M, 2007, HIPPOCAMPUS, V17, P420, DOI 10.1002/hipo.20287; Bornkessel I, 2005, NEUROIMAGE, V26, P221, DOI 10.1016/j.neuroimage.2005.01.032; Botvinick M, 2004, PSYCHOL REV, V111, P395, DOI 10.1037/0033-295X.111.2.395; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Ezzyat Y, 2011, PSYCHOL SCI, V22, P243, DOI 10.1177/0956797610393742; Fiser J, 2002, J EXP PSYCHOL LEARN, V28, P458, DOI 10.1037//0278-7393.28.3.458; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gelfand JR, 2003, NEURON, V38, P831, DOI 10.1016/S0896-6273(03)00285-X; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Griffiths TL, 2007, PSYCHOL REV, V114, P211, DOI 10.1037/0033-295X.114.2.211; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Homae F, 2002, NEUROIMAGE, V16, P883, DOI 10.1006/nimg.2002.1138; Howard MW, 2011, TOP COGN SCI, V3, P48, DOI 10.1111/j.1756-8765.2010.01112.x; James TW, 2006, HUM BRAIN MAPP, V27, P37, DOI 10.1002/hbm.20165; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Krueger F, 2009, NEUROREPORT, V20, P1093, DOI 10.1097/WNR.0b013e32832e7ea5; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; MEDIN DL, 1978, PSYCHOL REV, V85, P207, DOI 10.1037/0033-295X.85.3.207; Moss HE, 2005, CEREB CORTEX, V15, P1723, DOI 10.1093/cercor/bhi049; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; NEWTSON D, 1973, J PERS SOC PSYCHOL, V28, P28, DOI 10.1037/h0035584; Pereira F, 2011, NEUROIMAGE, V56, P476, DOI 10.1016/j.neuroimage.2010.05.026; Perruchet P, 2002, Q J EXP PSYCHOL-A, V55, P485, DOI 10.1080/02724980143000451; Perruchet P, 1998, J MEM LANG, V39, P246, DOI 10.1006/jmla.1998.2576; Petersson KM, 2004, COGNITIVE SCI, V28, P383, DOI 10.1016/j.cogsci.2003.12.003; Pothos EM, 2007, PSYCHOL BULL, V133, P227, DOI 10.1037/0033-2909.133.2.227; Press C, 2012, NEUROIMAGE, V60, P1671, DOI 10.1016/j.neuroimage.2012.01.118; Remillard G, 2010, MEM COGNITION, V38, P905, DOI 10.3758/MC.38.7.905; Reynolds JR, 2007, COGNITIVE SCI, V31, P613, DOI 10.1080/15326900701399913; Rogers T. T., 2004, SEMANTIC COGNITION P; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Schapiro AC, 2012, CURR BIOL, V22, P1622, DOI 10.1016/j.cub.2012.06.056; Speer NK, 2003, COGN AFFECT BEHAV NE, V3, P335, DOI 10.3758/CABN.3.4.335; Sridharan D, 2007, NEURON, V55, P521, DOI 10.1016/j.neuron.2007.07.003; Thompson-Schill SL, 2003, NEUROPSYCHOLOGIA, V41, P280, DOI 10.1016/S0028-3932(02)00161-6; Turk-Browne NB, 2007, CEREB CORTEX, V17, P425, DOI 10.1093/cercor/bhj159; Turk-Browne NB, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.016.2008; Ueno T, 2011, NEURON, V72, P385, DOI 10.1016/j.neuron.2011.09.013; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Wood JN, 2005, CEREB CORTEX, V15, P1155, DOI 10.1093/cercor/bhh215; Zacks JM, 2011, J COGNITIVE NEUROSCI, V23, P4057, DOI 10.1162/jocn_a_00078; Zacks JM, 2001, NAT NEUROSCI, V4, P651, DOI 10.1038/88486	51	190	189	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					486	U161		10.1038/nn.3331	http://dx.doi.org/10.1038/nn.3331			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	114EM	23416451	Green Accepted			2022-12-17	WOS:000316723700020
J	Karnezis, T; Mandemakers, W; McQualter, JL; Zheng, BH; Ho, PP; Jordan, KA; Murray, BM; Barres, B; Tessier-Lavigne, M; Bernard, CCA				Karnezis, T; Mandemakers, W; McQualter, JL; Zheng, BH; Ho, PP; Jordan, KA; Murray, BM; Barres, B; Tessier-Lavigne, M; Bernard, CCA			The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD-INJURY; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; RETINAL GANGLION-CELLS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; ADULT-RAT; AXON REGENERATION; FUNCTIONAL RECOVERY; BRAIN-LESIONS; T-CELLS	Inhibitors associated with CNS myelin are thought to be important in the failure of axons to regenerate after spinal cord injury and in other neurodegenerative disorders. Here we show that targeting the CNS-specific inhibitor of neurite outgrowth Nogo A by active immunization blunts clinical signs, demyelination and axonal damage associated with experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis (MS). Mice vaccinated against Nogo A produce Nogo-specific antibodies that block the neurite outgrowth inhibitory activity associated with CNS myelin in vitro. Passive immunization with anti-Nogo IgGs also suppresses EAE. Our results identify Nogo A as an important determinant of the development of EAE and suggest that its blockade may help to maintain and/or to restore the neuronal integrity of the CNS after autoimmune insult in diseases such as MS. Our finding that Nogo A is involved in CNS autoimmune demyelination indicates that this molecule may have a far more complex role than has been previously anticipated.	La Trobe Univ, Sch Mol Sci, Dept Biochem, Neuroimmunol Lab, Bundoora, Vic 3086, Australia; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	La Trobe University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Bernard, CCA (corresponding author), La Trobe Univ, Sch Mol Sci, Dept Biochem, Neuroimmunol Lab, Bundoora, Vic 3086, Australia.	c.bernard@latrobe.edu.au	Murray, Belinda/B-9426-2008	Mandemakers, Wim/0000-0003-2673-5972; McQualter, Jonathan/0000-0002-3844-8009; /0000-0002-6848-318X	NEI NIH HHS [R01 EY10257] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010257] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; ACHIRON A, 1994, J CLIN INVEST, V93, P600, DOI 10.1172/JCI117012; Ahmed Z, 2001, AM J PATHOL, V158, P2127, DOI 10.1016/S0002-9440(10)64684-6; BANDTLOW C, 1990, J NEUROSCI, V10, P3837, DOI 10.1523/JNEUROSCI.10-12-03837.1990; Baranzini SE, 1999, J IMMUNOL, V163, P5133; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Berger T, 2003, NEW ENGL J MED, V349, P139, DOI 10.1056/NEJMoa022328; Bernard CCA, 1997, J MOL MED-JMM, V75, P77, DOI 10.1007/s001090050092; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Bettelli E, 1998, J IMMUNOL, V161, P3299; Brosamle C, 2000, J NEUROSCI, V20, P8061; Buffo A, 2000, J NEUROSCI, V20, P2275; Buffo A, 2003, EUR J NEUROSCI, V18, P2146, DOI 10.1046/j.1460-9568.2003.02940.x; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; Hauben E, 2001, P NATL ACAD SCI USA, V98, P15173, DOI 10.1073/pnas.011585298; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Huber AB, 2002, J NEUROSCI, V22, P3553; Karim F, 2001, BRAIN RES REV, V36, P204, DOI 10.1016/S0165-0173(01)00096-0; Kawakami N, 2004, J EXP MED, V199, P185, DOI 10.1084/jem.20031064; Keegan BM, 2002, ANNU REV MED, V53, P285, DOI 10.1146/annurev.med.53.082901.103909; LININGTON C, 1992, J NEUROIMMUNOL, V40, P219, DOI 10.1016/0165-5728(92)90136-9; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Marusic S, 1997, J EXP MED, V186, P507, DOI 10.1084/jem.186.4.507; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Merkler D, 2003, FASEB J, V17, P2275, DOI 10.1096/fj.02-1203fje; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Miller DJ, 1997, J NEUROIMMUNOL, V75, P204, DOI 10.1016/S0165-5728(97)00027-1; MISTUNAGA Y, 2002, FASEB J, V16, P1325; Nicholson LB, 1996, CURR OPIN IMMUNOL, V8, P837, DOI 10.1016/S0952-7915(96)80013-6; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Okuda Y, 2002, J NEUROIMMUNOL, V131, P115, DOI 10.1016/S0165-5728(02)00267-9; Onuki I, 2001, MICROSC RES TECHNIQ, V52, P731; Reindl M, 2003, J NEUROIMMUNOL, V145, P139, DOI 10.1016/j.jneuroim.2003.09.010; Robinson WH, 2003, NAT BIOTECHNOL, V21, P1033, DOI 10.1038/nbt859; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; Sicotte M, 2003, MOL CELL NEUROSCI, V23, P251, DOI 10.1016/S1044-7431(03)00053-8; Slavin A, 1998, AUTOIMMUNITY, V28, P109, DOI 10.3109/08916939809003872; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Weiner HL, 2001, MICROBES INFECT, V3, P947, DOI 10.1016/S1286-4579(01)01456-3; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3	50	190	222	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					736	744		10.1038/nn1261	http://dx.doi.org/10.1038/nn1261			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15184901				2022-12-17	WOS:000222274400015
J	Chambers, CD; Payne, JM; Stokes, MG; Mattingley, JB				Chambers, CD; Payne, JM; Stokes, MG; Mattingley, JB			Fast and slow parietal pathways mediate spatial attention	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTEX	Mechanisms of selective attention are vital for guiding human behavior. The parietal cortex has long been recognized as a neural substrate of spatial attention, but the unique role of distinct parietal subregions has remained unclear. Using single-pulse transcranial magnetic stimulation, we found that the angular gyrus of the right parietal cortex mediates spatial orienting during two distinct time periods after the onset of a behaviorally relevant event. The biphasic involvement of the angular gyrus suggests that both fast and slow visual pathways are necessary for orienting spatial attention.	Univ Melbourne, Dept Psychol, Cognit Neurosci Lab, Melbourne, Vic 3010, Australia	University of Melbourne	Chambers, CD (corresponding author), Univ Melbourne, Dept Psychol, Cognit Neurosci Lab, Melbourne, Vic 3010, Australia.	c.chambers@psych.unimelb.edu.au	Mattingley, Jason/J-1537-2014; Chambers, Chris/E-7827-2010	Mattingley, Jason/0000-0003-0929-9216; Payne, Jonathan/0000-0001-9565-3845; Chambers, Chris/0000-0001-6058-4114				Ashbridge E, 1997, NEUROPSYCHOLOGIA, V35, P1121, DOI 10.1016/S0028-3932(97)00003-1; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Muri RM, 2002, EXP BRAIN RES, V143, P426, DOI 10.1007/s00221-002-1009-9; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P698, DOI 10.1152/jn.1995.74.2.698; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; WRIGHT MJ, 1995, BIOL PSYCHOL, V41, P183, DOI 10.1016/0301-0511(95)05128-7	11	190	192	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					217	218		10.1038/nn1203	http://dx.doi.org/10.1038/nn1203			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14983182				2022-12-17	WOS:000189197900009
J	Nemeroff, CB; Owens, MJ				Nemeroff, CB; Owens, MJ			Treatment of mood disorders	NATURE NEUROSCIENCE			English	Review							SEROTONIN REUPTAKE INHIBITORS; NATIONAL-COMORBIDITY-SURVEY; MAJOR DEPRESSIVE DISORDER; ANTIDEPRESSANT TREATMENT; MYOCARDIAL-INFARCTION; REMISSION RATES; PHARMACOLOGY; VENLAFAXINE; PREVALENCE; RECEPTOR	Depression is a leading cause of morbidity and mortality, and its treatment includes a high percentage of the medications prescribed by physicians. Available antidepressant drugs are safe and effective, but less than half of all patients attain complete remission after therapy with a single antidepressant. Others exhibit partial, refractory or intolerant responses to treatment, emphasizing the need to discover new antidepressants. The mechanisms of action of available medications are directing the field toward new research avenues. This review highlights those areas we believe will influence the field and soon lead to better treatment.	Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Lab Neuropsychopharmacol, Atlanta, GA 30322 USA	Emory University	Nemeroff, CB (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Lab Neuropsychopharmacol, 1639 Pierce Dr,Suite 4000, Atlanta, GA 30322 USA.		Owens, Michael J/G-5191-2012	Nemeroff, Charles/0000-0001-7867-1160	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058922, R01MH042088] Funding Source: NIH RePORTER; NIMH NIH HHS [MH42088, MH58922] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson IM, 2000, J AFFECT DISORDERS, V58, P19, DOI 10.1016/S0165-0327(99)00092-0; Belanoff JK, 2001, J CLIN PSYCHOPHARM, V21, P516, DOI 10.1097/00004714-200110000-00009; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Blier P, 2001, J CLIN PSYCHIAT, V62, P12; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Entsuah AR, 2001, J CLIN PSYCHIAT, V62, P869, DOI 10.4088/JCP.v62n1106; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; FRASURESMITH N, 1995, CIRCULATION, V91, P999, DOI 10.1161/01.CIR.91.4.999; GILMOR ML, IN PRESS AM J PSYCHI; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; KLERMAN GL, 1985, ARCH GEN PSYCHIAT, V42, P689; Kramer MS, 1998, SCIENCE, V281, P1640, DOI 10.1126/science.281.5383.1640; Meyer JH, 2001, NEUROREPORT, V12, P4121, DOI 10.1097/00001756-200112210-00052; Meyer JH, 2001, AM J PSYCHIAT, V158, P1843, DOI 10.1176/appi.ajp.158.11.1843; MURAY CJL, 1996, GLOBAL BURDEN DIS; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Owens M J, 1998, Depress Anxiety, V8 Suppl 1, P5, DOI 10.1002/(SICI)1520-6394(1998)8:1+<5::AID-DA2>3.0.CO;2-I; OWENS MJ, 1991, PHARMACOL REV, V43, P425; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; Rabiner EA, 2001, AM J PSYCHIAT, V158, P2080, DOI 10.1176/appi.ajp.158.12.2080; Ressler KJ, 1999, BIOL PSYCHIAT, V46, P1219, DOI 10.1016/S0006-3223(99)00127-4; Reul JMHM, 2002, CURR OPIN PHARMACOL, V2, P23, DOI 10.1016/S1471-4892(01)00117-5; Sanders A. R., 1999, NEUROBIOLOGY MENTAL, P299; Stout SC, 2001, ANNU REV PHARMACOL, V41, P877, DOI 10.1146/annurev.pharmtox.41.1.877; Thase ME, 2001, BRIT J PSYCHIAT, V178, P234, DOI 10.1192/bjp.178.3.234; Thome J, 2000, J NEUROSCI, V20, P4030; Zobel AW, 2000, J PSYCHIATR RES, V34, P171, DOI 10.1016/S0022-3956(00)00016-9	27	190	201	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1068	1070		10.1038/nn943	http://dx.doi.org/10.1038/nn943			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403988				2022-12-17	WOS:000179041300016
J	Op de Beeck, H; Wagemans, J; Vogels, R				Op de Beeck, H; Wagemans, J; Vogels, R			Inferotemporal neurons represent low-dimensional configurations of parameterized shapes	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL NEURONS; SIMILARITY; RECOGNITION; SENSITIVITY; COMPONENTS; NETWORK; CORTEX; CELLS	Behavioral studies with parameterized shapes have shown that the similarities among these complex stimuli can be represented using a low number of dimensions. Using psychophysical measurements and single-cell recordings in macaque inferotemporal (IT) cortex, we found an agreement between low-dimensional parametric configurations of shapes and the representation of shape similarity at the behavioral and neuronal level. The shape configurations, computed from both the perceived and neuron-based similarities, revealed a low number of dimensions and contained the same stimulus order as the parametric configurations. However, at a metric level, the behavioral and neural representations deviated consistently from the parametric configurations. These findings suggest an ordinally faithful but metrically biased representation of shape similarity in IT.	Katholieke Univ Leuven, Neuro & Psychofysiol Lab, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Expt Psychol Lab, B-3000 Louvain, Belgium	KU Leuven; KU Leuven	Vogels, R (corresponding author), Katholieke Univ Leuven, Neuro & Psychofysiol Lab, Campus Gasthuisberg,Herestr 49, B-3000 Louvain, Belgium.	rufin.vogels@med.kuleuven.ac.be	Wagemans, Johan/M-3878-2019; Rohlf, F J/A-8710-2008	Wagemans, Johan/0000-0002-7970-1541; Op de Beeck, Hans/0000-0002-2250-212X				Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; ASHBY FG, 1988, PSYCHOL REV, V95, P124, DOI 10.1037/0033-295X.95.1.124; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; BORG I, 1985, MULTIVAR BEHAV RES, V20, P325, DOI 10.1207/s15327906mbr2003_6; Cortese JM, 1996, J EXP PSYCHOL HUMAN, V22, P133, DOI 10.1037/0096-1523.22.1.133; CORTESE JM, 1992, PERCEPTUAL SIMILARIT; Cutzu F, 1998, VISION RES, V38, P2229, DOI 10.1016/S0042-6989(97)00186-7; DEAN P, 1976, PSYCHOL BULL, V83, P41, DOI 10.1037/0033-2909.83.1.41; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Edelman GM., 1987, BASIC BOOKS; Edelman S, 1998, BEHAV BRAIN SCI, V21, P449, DOI 10.1017/S0140525X98001253; Edelman S., 1999, REPRESENTATION RECOG; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; GOCHIN PM, 1994, J NEUROPHYSIOL, V71, P2325, DOI 10.1152/jn.1994.71.6.2325; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Gross CG, 1990, P INT C FUZZ LOG NEU, P375; Kirk R.E., 1968, EXPT DESIGN PROCEDUR; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Marr D., 1982, VISION COMPUTATIONAL; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; NOSOFSKY RM, 1984, J EXP PSYCHOL LEARN, V10, P104, DOI 10.1037/0278-7393.10.1.104; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; POGGIO T, 1990, SCIENCE, V247, P978, DOI 10.1126/science.247.4945.978; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Rieke F., 1997, SPIKES EXPLORING NEU; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; SANDS SF, 1982, J EXP PSYCHOL GEN, V111, P369, DOI 10.1037/0096-3445.111.4.369; SHEPARD RN, 1980, SCIENCE, V210, P390, DOI 10.1126/science.210.4468.390; SHEPARD RN, 1973, COGNITIVE PSYCHOL, V4, P351, DOI 10.1016/0010-0285(73)90018-2; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; Smith E. E., 1981, CATEGORIES CONCEPTS; Sugihara T, 1998, BIOL CYBERN, V78, P1, DOI 10.1007/s004220050407; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Vogels R, 2001, J COGNITIVE NEUROSCI, V13, P444, DOI 10.1162/08989290152001871; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wilkinson F, 1998, VISION RES, V38, P3555, DOI 10.1016/S0042-6989(98)00039-X; Wise SP, 1999, HIPPOCAMPUS, V9, P101, DOI 10.1002/(SICI)1098-1063(1999)9:2<101::AID-HIPO3>3.0.CO;2-L; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; ZAHN CT, 1972, IEEE T COMPUT, VC 21, P269, DOI 10.1109/TC.1972.5008949	46	190	191	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1244	1252		10.1038/nn767	http://dx.doi.org/10.1038/nn767			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	498RV	11713468	Green Published			2022-12-17	WOS:000172525000022
J	Watrous, AJ; Tandon, N; Conner, CR; Pieters, T; Ekstrom, AD				Watrous, Andrew J.; Tandon, Nitin; Conner, Chris R.; Pieters, Thomas; Ekstrom, Arne D.			Frequency-specific network connectivity increases underlie accurate spatiotemporal memory retrieval	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; COMPLEMENTARY-LEARNING-SYSTEMS; HUMAN NEOCORTICAL OSCILLATIONS; THETA OSCILLATIONS; PARIETAL CORTEX; PREFRONTAL CORTEX; EPISODIC MEMORY; WORKING-MEMORY; PHASE-LOCKING; HIPPOCAMPAL	The medial temporal lobes, prefrontal cortex and parts of parietal cortex form the neural underpinnings of episodic memory, which includes remembering both where and when an event occurred. However, the manner in which these three regions interact during retrieval of spatial and temporal context remains untested. We employed simultaneous electrocorticographical recordings across multilobular regions in patients undergoing seizure monitoring while they retrieved spatial and temporal context associated with an episode, and we used phase synchronization as a measure of network connectivity. Successful memory retrieval was characterized by greater global connectivity compared with incorrect retrieval, with the medial temporal lobe acting as a hub for these interactions. Spatial versus temporal context retrieval resulted in prominent differences in both the spectral and temporal patterns of network interactions. These results emphasize dynamic network interactions as being central to episodic memory retrieval, providing insight into how multiple contexts underlying a single event can be recreated in the same network.	[Watrous, Andrew J.; Ekstrom, Arne D.] Univ Calif Davis, Neurosci Grad Grp, Davis, CA 95616 USA; [Watrous, Andrew J.; Ekstrom, Arne D.] Univ Calif, Ctr Neurosci, Davis, CA USA; [Tandon, Nitin; Conner, Chris R.; Pieters, Thomas] Univ Texas Houston, Sch Med, Dept Neurosurg, Houston, TX USA; [Tandon, Nitin] Memorial Hermann Hosp, Texas Med Ctr, Houston, TX USA; [Ekstrom, Arne D.] Univ Calif, Dept Psychol, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Davis	Ekstrom, AD (corresponding author), Univ Calif Davis, Neurosci Grad Grp, Davis, CA 95616 USA.	adekstrom@ucdavis.edu	Ekstrom, Arne/A-1329-2013	Ekstrom, Arne/0000-0002-6812-2368; Tandon, Nitin/0000-0002-2752-2365; Conner, Christopher R/0000-0003-0176-9025	Sloan Foundation; Hellman Young Investigator Award; National Institute of Neurological Disorders and Stroke [RO1NS076856]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076856] Funding Source: NIH RePORTER	Sloan Foundation(Alfred P. Sloan Foundation); Hellman Young Investigator Award; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Ranganath and A. Yonelinas, as well as members of their laboratories, for helpful comments on this manuscript. This work was supported by the Sloan Foundation, a Hellman Young Investigator Award and National Institute of Neurological Disorders and Stroke grant RO1NS076856.	Anderson KL, 2010, CEREB CORTEX, V20, P1604, DOI 10.1093/cercor/bhp223; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Duarte A, 2005, J NEUROSCI, V25, P8333, DOI 10.1523/JNEUROSCI.1392-05.2005; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Ekstrom AD, 2011, NEUROIMAGE, V56, P1803, DOI 10.1016/j.neuroimage.2011.02.033; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Howard MW, 2002, J MATH PSYCHOL, V46, P269, DOI 10.1006/jmps.2001.1388; Hutchinson JB, 2009, LEARN MEMORY, V16, P343, DOI 10.1101/lm.919109; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.0.CO;2-5; Lega BC, 2012, HIPPOCAMPUS, V22, P748, DOI 10.1002/hipo.20937; Libby LA, 2012, J NEUROSCI, V32, P6550, DOI 10.1523/JNEUROSCI.3711-11.2012; Maris E, 2011, NEUROIMAGE, V54, P836, DOI 10.1016/j.neuroimage.2010.09.029; Marshuetz C, 2006, NEUROSCIENCE, V139, P311, DOI 10.1016/j.neuroscience.2005.04.071; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Mitchell KJ, 2009, PSYCHOL BULL, V135, P638, DOI 10.1037/a0015849; Mormann F, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.003.2008; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Rizzuto DS, 2006, NEUROIMAGE, V31, P1352, DOI 10.1016/j.neuroimage.2006.01.009; Rizzuto DS, 2003, P NATL ACAD SCI USA, V100, P7931, DOI 10.1073/pnas.0732061100; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; Spiers HJ, 2001, BRAIN, V124, P2476, DOI 10.1093/brain/124.12.2476; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; TEYLER TJ, 1986, BEHAV NEUROSCI, V100, P147, DOI 10.1037/0735-7044.100.2.147; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; van der Meij R, 2012, J NEUROSCI, V32, P111, DOI 10.1523/JNEUROSCI.4816-11.2012; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Watrous AJ, 2011, J NEUROPHYSIOL, V105, P1747, DOI 10.1152/jn.00921.2010; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; Zhang H, 2013, HUM BRAIN MAPP, V34, P1070, DOI 10.1002/hbm.21494	47	189	193	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					349	356		10.1038/nn.3315	http://dx.doi.org/10.1038/nn.3315			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23354333	Green Accepted, Green Submitted			2022-12-17	WOS:000315474800018
J	Koya, E; Golden, SA; Harvey, BK; Guez-Barber, DH; Berkow, A; Simmons, DE; Bossert, JM; Nair, SG; Uejima, JL; Marin, MT; Mitchell, TB; Farquhar, D; Ghosh, SC; Mattson, BJ; Hope, BT				Koya, Eisuke; Golden, Sam A.; Harvey, Brandon K.; Guez-Barber, Danielle H.; Berkow, Alexander; Simmons, Danielle E.; Bossert, Jennifer M.; Nair, Sunila G.; Uejima, Jamie L.; Marin, Marcelo T.; Mitchell, Timothy B.; Farquhar, David; Ghosh, Sukhen C.; Mattson, Brandi J.; Hope, Bruce T.			Targeted disruption of cocaine-activated nucleus accumbens neurons prevents context-specific sensitization	NATURE NEUROSCIENCE			English	Article							INDUCED LOCOMOTOR-ACTIVITY; FOS EXPRESSION; DRUG-ADDICTION; SEEKING; GENE; DOPAMINE; WITHDRAWAL; ENSEMBLES; MORPHINE; HABITS	Learned associations between effects of abused drugs and the drug administration environment are important in drug addiction. Histochemical and electrophysiological studies suggest that these associations are encoded in sparsely distributed nucleus accumbens neurons that are selectively activated by drugs and drug-associated cues. Although correlations have been observed between nucleus accumbens neuronal activity and responsivity to drugs and drug cues, no technique exists for selectively manipulating these activated neurons and establishing their causal role in behavioral effects of drugs and drug cues. Here we describe a new approach, which we term the 'Daun02 inactivation method', that selectively inactivates a minority of neurons previously activated by cocaine in an environment repeatedly paired with cocaine to demonstrate a causal role for these activated neurons in context-specific cocaine-induced psychomotor sensitization in rats. This method provides a new tool for studying the causal roles of selectively activated neurons in behavioral effects of drugs and drug cues and in other learned behaviors.	[Koya, Eisuke; Golden, Sam A.; Harvey, Brandon K.; Guez-Barber, Danielle H.; Berkow, Alexander; Simmons, Danielle E.; Bossert, Jennifer M.; Nair, Sunila G.; Uejima, Jamie L.; Marin, Marcelo T.; Mitchell, Timothy B.; Mattson, Brandi J.; Hope, Bruce T.] Natl Inst Drug Abuse, Behav Neurosci Branch, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD USA; [Farquhar, David; Ghosh, Sukhen C.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); University of Texas System; UTMD Anderson Cancer Center	Hope, BT (corresponding author), Natl Inst Drug Abuse, Behav Neurosci Branch, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD USA.	bhope@intra.nida.nih.gov	Hope, Bruce T/A-9223-2010; Marin, Marcelo T/K-3256-2013; Marin, Marcelo/J-3026-2012; Harvey, Brandon K/A-5559-2010; Nair, Sunila/AAW-7600-2020; Harvey, Brandon Keith/AAY-4080-2021; Marin, Marcelo Tadeu/AGZ-1077-2022	Hope, Bruce T/0000-0001-5804-7061; Marin, Marcelo T/0000-0002-0522-2839; Harvey, Brandon Keith/0000-0002-4036-1383; Koya, Eisuke/0000-0002-5039-4875; Mitchell, Timothy/0000-0002-1503-4049; Barber, Danielle/0000-0002-1086-8001; Golden, Sam/0000-0002-2104-2272	Intramural Research Program of the National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000467, F30DA024931, ZIADA000526] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Intramural Research Program of the National Institute on Drug Abuse. We thank E. Wentzell for her excellent editorial assistance, K. Knestaut for breeding the cfos-lacZ rats and T. Adams-Deutsch, C. Pickens and K. Wihbey for technical assistance. We are especially thankful to Y. Shaham for his comments over the years and for his help in writing this manuscript, and to R. Wise for providing the inspiration for this study.	Anagnostaras SG, 1996, BEHAV NEUROSCI, V110, P1397, DOI 10.1037/0735-7044.110.6.1397; Badiani A, 2004, BEHAV PHARMACOL, V15, P327, DOI 10.1097/00008877-200409000-00004; BERRETTA S, 1993, PROG BRAIN RES, V99, P201; Bossert JM, 2007, J NEUROSCI, V27, P12655, DOI 10.1523/JNEUROSCI.3926-07.2007; Canales JJ, 2000, ANN NEUROL, V47, pS53; Carelli RM, 2004, CURR OPIN NEUROBIOL, V14, P763, DOI 10.1016/j.conb.2004.10.001; Carelli RM, 2000, SYNAPSE, V35, P238, DOI 10.1002/(SICI)1098-2396(20000301)35:3<238::AID-SYN10>3.0.CO;2-Y; Crombag HS, 2008, PHILOS T R SOC B, V363, P3233, DOI 10.1098/rstb.2008.0090; Crombag HS, 2002, BEHAV BRAIN RES, V136, P455, DOI 10.1016/S0166-4328(02)00196-1; Crombag HS, 2002, BEHAV NEUROSCI, V116, P169, DOI 10.1037//0735-7044.116.1.169; DELFS JM, 1990, J NEUROSCI, V10, P303; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Farquhar D, 2002, CANCER CHEMOTH PHARM, V50, P65, DOI 10.1007/s00280-002-0438-2; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hollander JA, 2007, J NEUROSCI, V27, P3535, DOI 10.1523/JNEUROSCI.3667-06.2007; Hope BT, 2006, EUR J NEUROSCI, V24, P867, DOI 10.1111/j.1460-9568.2006.04969.x; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; KASOF GM, 1995, J NEUROSCI, V15, P4238; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; Lu L, 2004, NEUROPHARMACOLOGY, V47, P214, DOI 10.1016/j.neuropharm.2004.06.027; Mattson BJ, 2008, EUR J NEUROSCI, V27, P202, DOI 10.1111/j.1460-9568.2007.05984.x; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Moser EI, 2001, CURR OPIN NEUROBIOL, V11, P745, DOI 10.1016/S0959-4388(01)00279-3; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Rademacher DJ, 2007, EUR J NEUROSCI, V26, P2661, DOI 10.1111/j.1460-9568.2007.05895.x; ROBERTS DCS, 1977, PHARMACOL BIOCHEM BE, V6, P615, DOI 10.1016/0091-3057(77)90084-3; ROBINSON TE, 1986, BRAIN RES REV, V11, P157, DOI 10.1016/0165-0173(86)90002-0; SANTONE KS, 1986, CANCER RES, V46, P2659; SCHILLING K, 1991, P NATL ACAD SCI USA, V88, P5665, DOI 10.1073/pnas.88.13.5665; Sgambato V, 1997, NEUROSCIENCE, V81, P93, DOI 10.1016/S0306-4522(97)00179-6; SIEGEL S, 1976, SCIENCE, V193, P323, DOI 10.1126/science.935870; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; Todtenkopf MS, 2002, NEUROSCIENCE, V114, P1061, DOI 10.1016/S0306-4522(02)00272-5; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; VEZINA P, 1989, PHARMACOL BIOCHEM BE, V32, P581, DOI 10.1016/0091-3057(89)90201-3; Vezina P, 2009, NEUROPHARMACOLOGY, V56, P160, DOI 10.1016/j.neuropharm.2008.06.070; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	40	189	193	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1069	U152		10.1038/nn.2364	http://dx.doi.org/10.1038/nn.2364			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19620976	Green Accepted			2022-12-17	WOS:000268396300023
J	Howard, JD; Plailly, J; Grueschow, M; Haynes, JD; Gottfried, JA				Howard, James D.; Plailly, Jane; Grueschow, Marcus; Haynes, John-Dylan; Gottfried, Jay A.			Odor quality coding and categorization in human posterior piriform cortex	NATURE NEUROSCIENCE			English	Article							OLFACTORY-BULB; ORBITOFRONTAL CORTEX; INFEROTEMPORAL CORTEX; ASSOCIATIVE MEMORY; VISUAL-CORTEX; HUMAN BRAIN; RECOGNITION; INFORMATION; MODEL; REPRESENTATIONS	Efficient recognition of odorous objects universally shapes animal behavior and is crucial for survival. To distinguish kin from nonkin, mate from nonmate and food from nonfood, organisms must be able to create meaningful perceptual representations of odor qualities and categories. It is currently unknown where and in what form the brain encodes information about odor quality. By combining functional magnetic resonance imaging (fMRI) with multivariate (pattern-based) techniques, we found that spatially distributed ensemble activity in human posterior piriform cortex (PPC) coincides with perceptual ratings of odor quality, such that odorants with more (or less) similar fMRI patterns were perceived as more (or less) alike. We did not observe these effects in anterior piriform cortex, amygdala or orbitofrontal cortex, indicating that ensemble coding of odor categorical perception is regionally specific for PPC. These findings substantiate theoretical models emphasizing the importance of distributed piriform templates for the perceptual reconstruction of odor object quality.	[Howard, James D.; Gottfried, Jay A.] Northwestern Univ, Feinberg Sch Med, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA; [Plailly, Jane] Univ Lyon 1, Lab Neurosci & Syst Sensoriels, F-69365 Lyon, France; [Grueschow, Marcus; Haynes, John-Dylan] Charite, Bernstein Ctr Computat Neurosci, D-13353 Berlin, Germany; [Grueschow, Marcus; Haynes, John-Dylan] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Grueschow, Marcus] Otto von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Gottfried, Jay A.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Gottfried, Jay A.] Northwestern Univ, Dept Psychol, Weinberg Coll Arts & Sci, Evanston, IL USA	Northwestern University; Feinberg School of Medicine; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Otto von Guericke University; Northwestern University; Feinberg School of Medicine; Northwestern University	Gottfried, JA (corresponding author), Northwestern Univ, Feinberg Sch Med, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA.	j-gottfried@northwestern.edu	Haynes, John-Dylan/Q-1148-2016; Plailly, Jane/G-8417-2017	Haynes, John-Dylan/0000-0003-1786-6954; Plailly, Jane/0000-0003-4189-1631	National Institute on Deafness and Other Communication Disorders [K08-DC007653, R01-DC010014]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC007653, R01DC010014] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank T. Egner, W. Li, J.- P. Mague and T. Parrish for helpful suggestions. This work was supported by grants from the National Institute on Deafness and Other Communication Disorders to J. A. G. (K08-DC007653 and R01-DC010014).	BARKAI E, 1994, J NEUROPHYSIOL, V72, P659, DOI 10.1152/jn.1994.72.2.659; BORG I., 2005, MODERN MULTIDIMENSIO, P207; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; Cleland TA, 2002, BEHAV NEUROSCI, V116, P222, DOI 10.1037//0735-7044.116.2.222; Dravnieks A., 1985, ATLAS ODOR CHARACTER; FREEMAN WJ, 1979, BIOL CYBERN, V35, P221, DOI 10.1007/BF00344205; Gottfried JA, 2006, NEURON, V49, P467, DOI 10.1016/j.neuron.2006.01.007; Gottfried JA, 2005, BRAIN RES REV, V50, P287, DOI 10.1016/j.brainresrev.2005.08.004; Guerrieri FJ, 2008, J EXP BIOL, V211, P1109, DOI 10.1242/jeb.008508; HABERLY LB, 1989, TRENDS NEUROSCI, V12, P258, DOI 10.1016/0166-2236(89)90025-8; HABERLY LB, 1985, CHEM SENSES, V10, P219, DOI 10.1093/chemse/10.2.219; Haddad R, 2008, NAT METHODS, V5, P425, DOI 10.1038/NMETH.1197; HASSELMO ME, 1990, COLD SPRING HARB SYM, V55, P599; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; Kadohisa M, 2006, P NATL ACAD SCI USA, V103, P15206, DOI 10.1073/pnas.0604313103; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kayaert G, 2005, CEREB CORTEX, V15, P1308, DOI 10.1093/cercor/bhi014; Kendrick KM, 1997, BRAIN RES BULL, V44, P383, DOI 10.1016/S0361-9230(97)00218-9; KENT PF, 1995, J NEUROPHYSIOL, V74, P1777, DOI 10.1152/jn.1995.74.4.1777; Kriegeskorte N, 2007, NEUROIMAGE, V38, P649, DOI 10.1016/j.neuroimage.2007.02.022; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Li W, 2006, NEURON, V52, P1097, DOI 10.1016/j.neuron.2006.10.026; Linster C, 2001, J NEUROSCI, V21, P9837, DOI 10.1523/JNEUROSCI.21-24-09837.2001; Linster C, 2002, J NEUROSCI, V22, P6842; Mai JK, 2004, ATLAS HUMAN BRAIN; Miller EK, 2003, CURR OPIN NEUROBIOL, V13, P198, DOI 10.1016/S0959-4388(03)00037-0; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Op de Beeck H, 2001, NAT NEUROSCI, V4, P1244, DOI 10.1038/nn767; Plailly J, 2008, J NEUROSCI, V28, P5257, DOI 10.1523/JNEUROSCI.5607-07.2008; Reddy L, 2006, CURR OPIN NEUROBIOL, V16, P408, DOI 10.1016/j.conb.2006.06.004; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1982, DOI 10.1152/jn.1996.75.5.1982; Rosch E., 1978, CONCEPTS CORE READIN, DOI DOI 10.1037/0012-1649.16.5.391; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; SHARP FR, 1977, J NEUROPHYSIOL, V40, P800, DOI 10.1152/jn.1977.40.4.800; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Stevenson RJ, 2007, PERCEPTION, V36, P1821, DOI 10.1068/p5563; Stevenson RJ, 2001, LEARN MOTIV, V32, P154, DOI 10.1006/lmot.2000.1070; TANABE T, 1975, J NEUROPHYSIOL, V38, P1284, DOI 10.1152/jn.1975.38.5.1284; Todrank J, 1998, ANIM BEHAV, V55, P377, DOI 10.1006/anbe.1997.0611; Tootell RBH, 1997, J NEUROSCI, V17, P7060; WILSON M, 1992, J NEUROPHYSIOL, V67, P981, DOI 10.1152/jn.1992.67.4.981; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; Youngentob SL, 2006, BEHAV NEUROSCI, V120, P1337, DOI 10.1037/0735-7044.120.6.1337; Zelano C, 2005, NEURON, V48, P431, DOI 10.1016/j.neuron.2005.10.009	50	189	195	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2009	12	7					932	U158		10.1038/nn.2324	http://dx.doi.org/10.1038/nn.2324			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	462OA	19483688	Green Accepted, Green Submitted			2022-12-17	WOS:000267362900022
J	Faber, ESL; Delaney, AJ; Sah, P				Faber, ESL; Delaney, AJ; Sah, P			SK channels regulate excitatory synaptic transmission and plasticity in the lateral amygdala	NATURE NEUROSCIENCE			English	Article							CA2+-ACTIVATED K+ CHANNELS; HIPPOCAMPAL PYRAMIDAL NEURONS; LONG-TERM POTENTIATION; ACTIVATED POTASSIUM CURRENTS; NMDA-RECEPTOR ACTIVATION; DENDRITIC SPINES; LESIONED MICE; HAIR-CELLS; IN-VITRO; CALCIUM	At glutamatergic synapses, calcium influx through NMDA receptors (NMDARs) is required for long-term potentiation (LTP); this is a proposed cellular mechanism underlying memory and learning. Here we show that in lateral amygdala pyramidal neurons, SK channels are also activated by calcium influx through synaptically activated NMDARs, resulting in depression of the synaptic potential. Thus, blockade of SK channels by apamin potentiates fast glutamatergic synaptic potentials. This potentiation is blocked by the NMDAR antagonist AP5 (D(-)-2-amino-5-phosphono-valeric acid) or by buffering cytosolic calcium with BAPTA. Blockade of SK channels greatly enhances LTP of cortical inputs to lateral amygdala pyramidal neurons. These results show that NMDARs and SK channels are colocalized at glutamatergic synapses in the lateral amygdala. Calcium influx through NMDARs activates SK channels and shunts the resultant excitatory postsynaptic potential. These results demonstrate a new role for SK channels as postsynaptic regulators of synaptic efficacy.	Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia	University of Queensland	Sah, P (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	pankaj.sah@uq.edu.au	Delaney, Andrew/H-4238-2018; Sah, Pankaj/C-8175-2009	Delaney, Andrew/0000-0001-8972-4870; Sah, Pankaj/0000-0001-5063-1589; Faber, Luli/0000-0001-9015-9805				Behnisch T, 1998, NEUROSCI LETT, V253, P91, DOI 10.1016/S0304-3940(98)00612-0; BELCADIABBASSI W, 1995, NEUROREPORT, V6, P1293, DOI 10.1097/00001756-199506090-00016; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Cangiano L, 2002, J NEUROPHYSIOL, V88, P289, DOI 10.1152/jn.2002.88.1.289; CASTLE NA, 1989, TRENDS NEUROSCI, V12, P59, DOI 10.1016/0166-2236(89)90137-9; Faber ESL, 2002, J NEUROSCI, V22, P1618, DOI 10.1523/JNEUROSCI.22-05-01618.2002; Faber ESL, 2001, J NEUROPHYSIOL, V85, P714, DOI 10.1152/jn.2001.85.2.714; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Grillner S, 2001, J PHYSIOL-LONDON, V533, P23, DOI 10.1111/j.1469-7793.2001.0023b.x; Hirschberg B, 1998, J GEN PHYSIOL, V111, P565, DOI 10.1085/jgp.111.4.565; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Ikonen S, 1999, EUR J PHARMACOL, V382, P151, DOI 10.1016/S0014-2999(99)00616-0; Ikonen S, 1998, EUR J PHARMACOL, V347, P13, DOI 10.1016/S0014-2999(98)00075-2; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; Mahanty NK, 1999, EUR J NEUROSCI, V11, P1217, DOI 10.1046/j.1460-9568.1999.00528.x; Neher E., 1986, CALCIUM ELECTROGENES, V14, P80; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Obermair GJ, 2003, EUR J NEUROSCI, V17, P721, DOI 10.1046/j.1460-9568.2003.02488.x; Oliver D, 2000, NEURON, V26, P595, DOI 10.1016/S0896-6273(00)81197-6; Pedarzani P, 2001, J BIOL CHEM, V276, P9762, DOI 10.1074/jbc.M010001200; Power JM, 2002, J NEUROSCI, V22, P3454; ROMEY G, 1984, J PHYSIOL-PARIS, V79, P259; Roncarati R, 2001, NEUROSCIENCE, V104, P253, DOI 10.1016/S0306-4522(01)00066-5; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sah P, 1996, J NEUROSCI, V16, P4537; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Sailer CA, 2002, J NEUROSCI, V22, P9698; Shah MM, 2002, J NEUROPHYSIOL, V87, P2983, DOI 10.1152/jn.2002.87.6.2983; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Tsay D, 2004, TRENDS NEUROSCI, V27, P77, DOI 10.1016/j.tins.2003.11.008; van der Staay FJ, 1999, NEUROSCI BIOBEHAV R, V23, P1087, DOI 10.1016/S0149-7634(99)00043-3; Villalobos C, 2004, J NEUROSCI, V24, P3537, DOI 10.1523/JNEUROSCI.0380-04.2004; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Weisskopf MG, 1999, J NEUROPHYSIOL, V81, P930, DOI 10.1152/jn.1999.81.2.930; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yamada SI, 2004, J NEUROPHYSIOL, V91, P2322, DOI 10.1152/jn.01049.2003; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	45	189	192	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					635	641		10.1038/nn1450	http://dx.doi.org/10.1038/nn1450			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852010				2022-12-17	WOS:000228895100024
J	Kennedy, HJ; Evans, MG; Crawford, AC; Fettiplace, R				Kennedy, HJ; Evans, MG; Crawford, AC; Fettiplace, R			Fast adaptation of mechanoelectrical transducer channels in mammalian cochlear hair cells	NATURE NEUROSCIENCE			English	Article							POSTNATAL-DEVELOPMENT; BUNDLE MOVEMENTS; CURRENTS; CALCIUM; EXPRESSION; INNER; RAT; ELECTROMOTILITY; STIMULI; PRESTIN	Outer hair cells are centrally involved in the amplification and frequency tuning of the mammalian cochlea, but evidence about their transducing properties in animals with fully developed hearing is lacking. Here we describe measurements of mechanoelectrical transducer currents in outer hair cells of rats between postnatal days 5 and 18, before and after the onset of hearing. Deflection of hair bundles using a new rapid piezoelectric stimulator evoked transducer currents with ultra-fast activation and adaptation kinetics. Fast adaptation resembled the same process in turtle hair cells, where it is regulated by changes in stereociliary calcium. It is argued that sub-millisecond transducer adaptation can operate in outer hair cells under the ionic, driving force and temperature conditions that prevail in the intact mammalian cochlea.	Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; Univ Bristol, Sch Med Sci, Dept Physiol, Bristol BS8 1TD, Avon, England; Univ Keele, Sch Life Sci, MacKay Inst Commun & Neurosci, Keele ST5 5BG, Staffs, England; Univ Cambridge, Dept Physiol, Cambridge CB2 3EG, England	University of Wisconsin System; University of Wisconsin Madison; University of Bristol; Keele University; University of Cambridge	Fettiplace, R (corresponding author), Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA.	fettiplace@physiology.wisc.edu	Evans, Michael/C-4980-2009	Evans, Michael/0000-0002-8755-0034	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001362] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC 01362] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASHMORE JF, 1993, BIOPHYSICS HAIR CELL, P151; ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; Benser ME, 1996, J NEUROSCI, V16, P5629; BLATCHLEY BJ, 1987, DEV BRAIN RES, V32, P75, DOI 10.1016/0165-3806(87)90140-4; BOSHER SK, 1978, NATURE, V273, P377, DOI 10.1038/273377a0; BOSHER SK, 1971, J PHYSIOL-LONDON, V212, P739, DOI 10.1113/jphysiol.1971.sp009354; COREY DP, 1983, J NEUROSCI, V3, P962; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; CROWLEY DE, 1966, J COMP PHYSIOL PSYCH, V62, P427, DOI 10.1037/h0023953; DALLOS P, 1986, HEARING RES, V22, P185, DOI 10.1016/0378-5955(86)90095-X; DALLOS P, 1992, J NEUROSCI, V12, P4575; Eatock RA, 2000, ANNU REV NEUROSCI, V23, P285, DOI 10.1146/annurev.neuro.23.1.285; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Fettiplace R, 2003, BIOPHYSICS OF THE COCHLEA: FROM MOLECULES TO MODELS, P65, DOI 10.1142/9789812704931_0007; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Hille B., 2001, ION CHANNELS EXCITAB; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Holt JR, 2000, P NATL ACAD SCI USA, V97, P11730, DOI 10.1073/pnas.97.22.11730; HOUSLEY GD, 1992, J PHYSIOL-LONDON, V448, P73, DOI 10.1113/jphysiol.1992.sp019030; Hudspeth AJ, 1997, CURR OPIN NEUROBIOL, V7, P480, DOI 10.1016/S0959-4388(97)80026-8; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kikuchi T, 2000, BRAIN RES REV, V32, P163, DOI 10.1016/S0165-0173(99)00076-4; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Mammano F, 1996, J PHYSIOL-LONDON, V496, P639, DOI 10.1113/jphysiol.1996.sp021715; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Meyer J, 1998, J NEUROSCI, V18, P6748; MULLER M, 1991, HEARING RES, V51, P247, DOI 10.1016/0378-5955(91)90041-7; Nenov AP, 1997, HEARING RES, V105, P146, DOI 10.1016/S0378-5955(96)00207-9; Nobili R, 1998, TRENDS NEUROSCI, V21, P159, DOI 10.1016/S0166-2236(97)01192-2; Nobili R, 1996, J ACOUST SOC AM, V99, P2244, DOI 10.1121/1.415412; Oliver D, 1999, J PHYSIOL-LONDON, V519, P791, DOI 10.1111/j.1469-7793.1999.0791n.x; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Ricci AJ, 1998, J PHYSIOL-LONDON, V506, P159, DOI 10.1111/j.1469-7793.1998.159bx.x; Ricci AJ, 1998, J NEUROSCI, V18, P8261; Ricci AJ, 1997, J PHYSIOL-LONDON, V501, P111, DOI 10.1111/j.1469-7793.1997.111bo.x; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; ROTH B, 1992, ANAT EMBRYOL, V185, P571, DOI 10.1007/BF00185616; RUSSELL IJ, 1986, HEARING RES, V22, P199, DOI 10.1016/0378-5955(86)90096-1; UZIEL A, 1981, AUDIOLOGY, V20, P89; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; YATES GK, 1992, TRENDS NEUROSCI, V15, P57, DOI 10.1016/0166-2236(92)90027-6; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	50	189	194	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					832	836		10.1038/nn1089	http://dx.doi.org/10.1038/nn1089			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12872124				2022-12-17	WOS:000184413700012
J	Maguire, EA; Valentine, ER; Wilding, JM; Kapur, N				Maguire, EA; Valentine, ER; Wilding, JM; Kapur, N			Routes to remembering: the brains behind superior memory	NATURE NEUROSCIENCE			English	Article							HUMAN NAVIGATION; MORPHOMETRY; HANDEDNESS; MNEMONICS; ASYMMETRY; IMAGERY	Why do some people have superior memory capabilities? We addressed this age-old question by examining individuals renowned for outstanding memory feats in forums such as the World Memory Championships. Using neuropsychological measures, as well as structural and functional brain imaging, we found that superior memory was not driven by exceptional intellectual ability or structural brain differences. Rather, we found that superior memorizers; used a spatial learning strategy, engaging brain regions such as the hippocampus that are critical for memory and for spatial memory in particular. These results illustrate how functional neuroimaging might prove valuable in delineating the neural substrates of mnemonic techniques, which could broaden the scope for memory improvement in the general population and the memory-impaired.	UCL, Neurol Inst, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Univ London, Royal Holloway & Bedford New Coll, Dept Psychol, Egham TW20 0EX, Surrey, England; Southampton Gen Hosp, Wessex Neurol Ctr, Dept Clin Neuropsychol, Southampton SO16 6YD, Hants, England; Univ Southampton, Dept Psychol, Southampton SO16 6YD, Hants, England	University of London; University College London; University of London; Royal Holloway University London; University of Southampton; University of Southampton	Maguire, EA (corresponding author), UCL, Neurol Inst, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	e.maguire@fil.ion.ucl.ac.uk	Valentine, Elizabeth/AAY-1032-2021		Wellcome Trust [071173] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Amidzic O, 2001, NATURE, V412, P603, DOI 10.1038/35088119; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BELLEZZA FS, 1981, REV EDUC RES, V51, P247, DOI 10.2307/1170198; BENDER BG, 1978, J EDUC PSYCHOL, V70, P583, DOI 10.1037/0022-0663.70.4.583; BENNETTLEVY J, 1980, CORTEX, V16, P543, DOI 10.1016/S0010-9452(80)80002-5; Bentley W. A., 1962, SNOW CRYSTALS; BOWER GH, 1970, AM SCI, V58, P496; BROWN E, 1975, J HIST BEHAV SCI, V11, P342, DOI 10.1002/1520-6696(197510)11:4<342::AID-JHBS2300110404>3.0.CO;2-D; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Butcher J, 2000, LANCET, V356, P836; Chase W.G., 1982, PSYCHOL LEARN MOTIV, V16, P1, DOI [10.1016/S0079-7421(08)60546-0, DOI 10.1016/S0079-7421(08)60546-0]; COUGHLAN AK, 1985, ADULT MEMORY INFORMA; Deichmann R, 2000, NEUROIMAGE, V12, P112, DOI 10.1006/nimg.2000.0601; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; Gadian DG, 2000, BRAIN, V123, P499, DOI 10.1093/brain/123.3.499; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Luria A.R., 1975, MIND MNEMONIST; Maguire EA, 2001, BRAIN, V124, P1156, DOI 10.1093/brain/124.6.1156; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maguire EA, 2001, SCAND J PSYCHOL, V42, P225, DOI 10.1111/1467-9450.00233; MCMILLAN TM, 1984, CORTEX, V20, P333, DOI 10.1016/S0010-9452(84)80002-7; NEISSER U, 1982, MEMORY OBSERVED REME, P377; Nelson H. E., 1991, NATL ADULT READING T; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Pesenti M, 2001, NAT NEUROSCI, V4, P103, DOI 10.1038/82831; *PSYCH CORP, 1986, WECHSL AD INT SCAL R; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RICHARDSON JTE, 1995, NEUROPSYCHOLOGIA, V33, P1345, DOI 10.1016/0028-3932(95)00068-E; ROEDIGER HL, 1980, J EXP PSYCHOL-HUM L, V6, P558, DOI 10.1037/0278-7393.6.5.558; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Tomaiuolo F, 1999, EUR J NEUROSCI, V11, P3033, DOI 10.1046/j.1460-9568.1999.00718.x; Toni I, 1999, EXP BRAIN RES, V127, P19, DOI 10.1007/s002210050770; Verhaeghen P, 1996, PSYCHOL AGING, V11, P164, DOI 10.1037/0882-7974.11.1.164; Wilding J. M., 1997, SUPERIOR MEMORY; Wilson B. A., 2002, NEUROPSYCHOLOGY MEMO, P263; Yates F. A., 1966, ART MEMORY	41	189	193	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					90	95		10.1038/nn988	http://dx.doi.org/10.1038/nn988			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	630CE	12483214				2022-12-17	WOS:000180089300020
J	Lewohl, JM; Wilson, WR; Mayfield, RD; Brozowski, SJ; Morrisett, RA; Harris, RA				Lewohl, JM; Wilson, WR; Mayfield, RD; Brozowski, SJ; Morrisett, RA; Harris, RA			G-protein-coupled inwardly rectifying potassium channels are targets of alcohol action	NATURE NEUROSCIENCE			English	Article							GAMMA-AMINOBUTYRIC-ACID; LONG-CHAIN ALCOHOLS; GATED K+ CHANNEL; G-BETA-GAMMA; GLUTAMATE RECEPTORS; GENERAL-ANESTHESIA; CHLORIDE CURRENTS; XENOPUS OOCYTES; NEURONAL SODIUM; RAT-BRAIN	C-protein-coupled inwardly rectifying potassium channels (GIRKs) are important for regulation of synaptic transmission and neuronal firing rates. Because of their key role in brain function, we asked if these potassium channels are targets of alcohol action. Ethanol enhanced function of cerebellar granule cell GIRKs coupled to GABA(B) receptors. Enhancement of GIRK function by ethanol was studied in detail using Xenopus oocytes expressing homomeric or heteromeric channels. Function of all GIRK channels was enhanced by intoxicating concentrations of ethanol, but other, related inwardly rectifying potassium channels were not affected. GIRK2/IRK1 chimeras and GIRK2 truncation mutants were used to identify a region of 43 amino acids in the carboxyl (C) terminus that is critical for the action of ethanol on these channels.	Univ Texas, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; Univ Texas, Neurobiol Sect, Austin, TX 78712 USA; Univ Texas, Coll Pharm, Dept Pharmacol & Toxicol, Austin, TX 78712 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Lewohl, JM (corresponding author), Univ Texas, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA.	lewohlj@mail.utexas.edu	Lewohl, Joanne/D-6163-2011		NIAAA NIH HHS [AA03527, AA06399] Funding Source: Medline; NIGMS NIH HHS [GM47818] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA003527, R37AA006399, R01AA006399] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ALIFIMOFF JK, 1989, BRIT J PHARMACOL, V96, P9, DOI 10.1111/j.1476-5381.1989.tb11777.x; ANANTHARAM V, 1992, MOL PHARMACOL, V42, P499; Brodie MS, 1998, ALCOHOL CLIN EXP RES, V22, P236, DOI 10.1111/j.1530-0277.1998.tb03644.x; Coe IR, 1996, J BIOL CHEM, V271, P29468, DOI 10.1074/jbc.271.46.29468; COVARRUBIAS M, 1995, J BIOL CHEM, V270, P19408, DOI 10.1074/jbc.270.33.19408; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; DildyMayfield JE, 1996, BRIT J PHARMACOL, V118, P378, DOI 10.1111/j.1476-5381.1996.tb15413.x; DILDYMAYFIELD JE, 1992, J PHARMACOL EXP THER, V262, P487; Dopico AM, 1996, MOL PHARMACOL, V49, P40; ELLIOTT JR, 1992, GEN PHARMACOL, V23, P1005, DOI 10.1016/0306-3623(92)90278-R; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Herlitze X, 1999, J PHYSIOL-LONDON, V517, P341, DOI 10.1111/j.1469-7793.1999.0341t.x; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Hille B., 1992, IONIC CHANNELS EXCIT, V2 ed, P115; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; INANOBE A, 1995, BIOCHEM BIOPH RES CO, V212, P1022, DOI 10.1006/bbrc.1995.2072; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Karschin C, 1996, J NEUROSCI, V16, P3559; KIM JY, 1994, J BIOL CHEM, V269, P28724; Korn SJ., 1991, J NEUROSCI METH, V4, P264; KOVOOR A, 1995, J BIOL CHEM, V270, P589, DOI 10.1074/jbc.270.2.589; Krapivinsky G, 1998, J BIOL CHEM, V273, P16946, DOI 10.1074/jbc.273.27.16946; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; Leonoudakis D, 1998, J NEUROSCI, V18, P868; LEVIN LR, 1995, J BIOL CHEM, V270, P7573, DOI 10.1074/jbc.270.13.7573; LI CY, 1994, P NATL ACAD SCI USA, V91, P8200, DOI 10.1073/pnas.91.17.8200; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Mascia MP, 1996, BRIT J PHARMACOL, V119, P1331, DOI 10.1111/j.1476-5381.1996.tb16042.x; MIHIC SJ, 1994, MOL PHARMACOL, V46, P851; Minami K, 1998, MOL PHARMACOL, V53, P148, DOI 10.1124/mol.53.1.148; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13, DOI 10.1111/j.1476-5381.1989.tb16855.x; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Plapp B V, 1993, Adv Exp Med Biol, V328, P391; Ponce A, 1996, J NEUROSCI, V16, P1990; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Sonders MS, 1997, J NEUROSCI, V17, P960; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; TAKAO K, 1994, NEURON, V13, P747, DOI 10.1016/0896-6273(94)90041-8; URBAN BW, 1993, BRIT J ANAESTH, V71, P25, DOI 10.1093/bja/71.1.25; WAFFORD KA, 1989, BRAIN RES, V505, P215, DOI 10.1016/0006-8993(89)91445-5; WANN KT, 1993, BRIT J ANAESTH, V71, P2, DOI 10.1093/bja/71.1.2; Wick MJ, 1998, P NATL ACAD SCI USA, V95, P6504, DOI 10.1073/pnas.95.11.6504; Yost CS, 1999, ANESTHESIOLOGY, V90, P1186, DOI 10.1097/00000542-199904000-00035	46	189	196	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1084	1090		10.1038/16012	http://dx.doi.org/10.1038/16012			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570485				2022-12-17	WOS:000085810100012
J	Haring, M; Zeisel, A; Hochgerner, H; Rinwa, P; Jakobsson, JET; Lonnerberg, P; La Manno, G; Sharma, N; Borgius, L; Kiehn, O; Lagerstrom, MC; Linnarsson, S; Ernfors, P				Haring, Martin; Zeisel, Amit; Hochgerner, Hannah; Rinwa, Puneet; Jakobsson, Jon E. T.; Lonnerberg, Peter; La Manno, Gioele; Sharma, Nilesh; Borgius, Lotta; Kiehn, Ole; Lagerstrom, Malin C.; Linnarsson, Sten; Ernfors, Patrik			Neuronal atlas of the dorsal horn defines its architecture and links sensory input to transcriptional cell types	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD INTERNEURONS; EXCITATORY INTERNEURONS; MECHANICAL PAIN; ITCH SENSATION; LAMINAE I; MOUSE; CIRCUITS; IDENTIFICATION; TOUCH; GATE	The dorsal horn of the spinal cord is critical to processing distinct modalities of noxious and innocuous sensation, but little is known of the neuronal subtypes involved, hampering efforts to deduce principles governing somatic sensation. Here we used single-cell RNA sequencing to classify sensory neurons in the mouse dorsal horn. We identified 15 inhibitory and 15 excitatory molecular subtypes of neurons, equaling the complexity in cerebral cortex. Validating our classification scheme in vivo and matching cell types to anatomy of the dorsal horn by spatial transcriptomics reveals laminar enrichment for each of the cell types. Neuron types, when combined, define a multilayered organization with like neurons layered together. Employing our scheme, we find that heat and cold stimuli activate discrete sets of both excitatory and inhibitory neuron types. This work provides a systematic and comprehensive molecular classification of spinal cord sensory neurons, enabling functional interrogation of sensory processing.	[Haring, Martin; Zeisel, Amit; Hochgerner, Hannah; Rinwa, Puneet; Lonnerberg, Peter; La Manno, Gioele; Sharma, Nilesh; Linnarsson, Sten; Ernfors, Patrik] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, Stockholm, Sweden; [Jakobsson, Jon E. T.; Lagerstrom, Malin C.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Borgius, Lotta; Kiehn, Ole] Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, Stockholm, Sweden; [Kiehn, Ole] Univ Copenhagen, Dept Neurosci, Copenhagen, Denmark	Karolinska Institutet; Uppsala University; Karolinska Institutet; University of Copenhagen	Linnarsson, S; Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, Stockholm, Sweden.	sten.linnarsson@ki.se; patrik.ernfors@ki.se	Linnarsson, Sten/HCH-3909-2022; kiehn, ole/AAB-1262-2019; La Manno, Gioele/AAC-7968-2022; kiehn, ole/AAT-7881-2021	La Manno, Gioele/0000-0003-1428-8757; Kiehn, Ole/0000-0002-5954-469X; Hochgerner, Hannah/0000-0002-7739-666X	Swedish Research Council; Uppsala Multidisciplinary Center for Advanced Computational Science; Swedish Medical Research Council; Knut and Alice Wallenbergs Foundation; SFO grant (StratNeuro); Wellcome Trust (Pain Consortium); European Research Council advanced grant [PainCells 740491]; Karolinska Institutet; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation [2015.0041]; Ragnar Soderberg Foundation; Brain Foundation; Human Frontier Science Program	Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala Multidisciplinary Center for Advanced Computational Science; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Knut and Alice Wallenbergs Foundation(Knut & Alice Wallenberg Foundation); SFO grant (StratNeuro); Wellcome Trust (Pain Consortium)(Wellcome Trust); European Research Council advanced grant(European Research Council (ERC)); Karolinska Institutet(Karolinska Institutet); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ragnar Soderberg Foundation; Brain Foundation; Human Frontier Science Program(Human Frontier Science Program)	We thank Science for Life Laboratory, the National Genomics Infrastructure funded by the Swedish Research Council, and Uppsala Multidisciplinary Center for Advanced Computational Science for providing assistance in massively parallel sequencing and access to the UPPMAX computational infrastructure. This work was supported by the Swedish Medical Research Council, Knut and Alice Wallenbergs Foundation (Wallenberg Scholar and Wallenberg project grant), SFO grant (StratNeuro), Wellcome Trust (Pain Consortium), European Research Council advanced grant (PainCells 740491) and Karolinska Institutet (to P.E.); Swedish Foundation for Strategic Research, Knut and Alice Wallenberg Foundation (2015.0041) (to S.L.); Ragnar Soderberg Foundation and the Brain Foundation (to M.C.L.). A.Z. was supported by the Human Frontier Science Program.	Abraira VE, 2017, CELL, V168, P295, DOI 10.1016/j.cell.2016.12.010; Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Al-Khater KM, 2009, J COMP NEUROL, V515, P629, DOI 10.1002/cne.22081; Aresh B, 2017, PAIN, V158, P945, DOI 10.1097/j.pain.0000000000000861; Borgius L, 2010, MOL CELL NEUROSCI, V45, P245, DOI 10.1016/j.mcn.2010.06.016; Bourane S, 2015, SCIENCE, V350, P550, DOI 10.1126/science.aac8653; Bourane S, 2015, CELL, V160, P503, DOI 10.1016/j.cell.2015.01.011; Caldeira V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41369; Cameron D, 2015, PAIN, V156, P2061, DOI 10.1097/j.pain.0000000000000270; Christensen AJ, 2016, CELL REP, V17, P1699, DOI 10.1016/j.celrep.2016.10.010; Coggeshall RE, 2005, PROG NEUROBIOL, V77, P299, DOI 10.1016/j.pneurobio.2005.11.002; Cui L, 2016, NEURON, V91, P1413, DOI 10.1016/j.neuron.2016.09.010; Duan B, 2018, NEUROSCI BULL, V34, P186, DOI 10.1007/s12264-017-0136-z; Duan B, 2014, CELL, V159, P1417, DOI 10.1016/j.cell.2014.11.003; Foster E, 2015, NEURON, V85, P1289, DOI 10.1016/j.neuron.2015.02.028; Graham BA, 2007, J NEUROPHYSIOL, V98, P1057, DOI 10.1152/jn.00581.2007; Hu HJ, 2006, NEURON, V50, P89, DOI 10.1016/j.neuron.2006.03.010; Huang HY, 2005, EUR J NEUROSCI, V22, P1149, DOI 10.1111/j.1460-9568.2005.04283.x; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Kardon AP, 2014, NEURON, V82, P573, DOI 10.1016/j.neuron.2014.02.046; La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027; Lai HC, 2016, DEVELOPMENT, V143, P3434, DOI 10.1242/dev.139592; Lallemend F, 2012, TRENDS NEUROSCI, V35, P373, DOI 10.1016/j.tins.2012.03.006; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; Li CL, 2016, CELL RES, V26, P83, DOI 10.1038/cr.2015.149; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Liu Y, 2011, CURR OPIN NEUROBIOL, V21, P52, DOI 10.1016/j.conb.2010.09.003; Ma QF, 2012, NEUROSCI BULL, V28, P91, DOI 10.1007/s12264-012-1201-2; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; Peirs C, 2016, SCIENCE, V354, P578, DOI 10.1126/science.aaf8933; Peirs C, 2015, NEURON, V87, P797, DOI 10.1016/j.neuron.2015.07.029; Petitjean H, 2015, CELL REP, V13, P1246, DOI 10.1016/j.celrep.2015.09.080; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Polgar E, 1999, BRAIN RES, V833, P71, DOI 10.1016/S0006-8993(99)01500-0; Prescott SA, 2014, NAT NEUROSCI, V17, P183, DOI 10.1038/nn.3629; REXED B, 1954, J COMP NEUROL, V100, P297, DOI 10.1002/cne.901000205; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; Romanov RA, 2017, NAT NEUROSCI, V20, P176, DOI 10.1038/nn.4462; Ross SE, 2012, NEURON, V73, P292, DOI 10.1016/j.neuron.2011.09.035; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Sathyamurthy A, 2018, CELL REP, V22, P2216, DOI 10.1016/j.celrep.2018.02.003; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Todd AJ, 2017, MOL PAIN, V13, P1, DOI 10.1177/1744806917693003; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zheng JH, 2010, J PHYSIOL-LONDON, V588, P2065, DOI 10.1113/jphysiol.2010.188052	54	188	187	4	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2018	21	6					869	+		10.1038/s41593-018-0141-1	http://dx.doi.org/10.1038/s41593-018-0141-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GH2LE	29686262				2022-12-17	WOS:000433232600016
J	Fuger, P; Hefendehl, JK; Veeraraghavalu, K; Wendeln, AC; Schlosser, C; Obermuller, U; Wegenast-Braun, BM; Neher, JJ; Martus, P; Kohsaka, S; Thunemann, M; Feil, R; Sisodia, SS; Skodras, A; Jucker, M				Fueger, Petra; Hefendehl, Jasmin K.; Veeraraghavalu, Karthik; Wendeln, Ann-Christin; Schlosser, Christine; Obermueller, Ulrike; Wegenast-Braun, Bettina M.; Neher, Jonas J.; Martus, Peter; Kohsaka, Shinichi; Thunemann, Martin; Feil, Robert; Sisodia, Sangram S.; Skodras, Angelos; Jucker, Mathias			Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging	NATURE NEUROSCIENCE			English	Article							REVEALS; MACROPHAGES; AGE; PROLIFERATION; NEUROGENESIS; MAINTAIN; MICE	To clarify the role of microglia in brain homeostasis and disease, an understanding of their maintenance, proliferation and turnover is essential. The lifespan of brain microglia, however, remains uncertain, and reflects confounding factors in earlier assessments that were largely indirect. We genetically labeled single resident microglia in living mice and then used multiphoton microscopy to monitor these cells over time. Under homeostatic conditions, we found that neocortical resident microglia were long-lived, with a median lifetime of well over 15 months; thus, approximately half of these cells survive the entire mouse lifespan. While proliferation of resident neocortical microglia under homeostatic conditions was low, microglial proliferation in a mouse model of Alzheimer's beta-amyloidosis was increased threefold. The persistence of individual microglia throughout the mouse lifespan provides an explanation for how microglial priming early in life can induce lasting functional changes and how microglial senescence may contribute to age-related neurodegenerative diseases.	[Fueger, Petra; Hefendehl, Jasmin K.; Wendeln, Ann-Christin; Schlosser, Christine; Obermueller, Ulrike; Wegenast-Braun, Bettina M.; Neher, Jonas J.; Skodras, Angelos; Jucker, Mathias] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Tubingen, Germany; [Fueger, Petra; Hefendehl, Jasmin K.; Wendeln, Ann-Christin; Obermueller, Ulrike; Wegenast-Braun, Bettina M.; Neher, Jonas J.; Skodras, Angelos; Jucker, Mathias] DZNE German Ctr Neurodegenerat Dis, Tubingen, Germany; [Veeraraghavalu, Karthik; Sisodia, Sangram S.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Wendeln, Ann-Christin] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, Tubingen, Germany; [Martus, Peter] Univ Tubingen, Inst Med Biometry, Tubingen, Germany; [Kohsaka, Shinichi] Natl Inst Neurosci, Dept Neurochem, Kodaira, Tokyo, Japan; [Thunemann, Martin; Feil, Robert] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Chicago; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; National Center for Neurology & Psychiatry - Japan; Eberhard Karls University of Tubingen	Skodras, A; Jucker, M (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Tubingen, Germany.; Skodras, A; Jucker, M (corresponding author), DZNE German Ctr Neurodegenerat Dis, Tubingen, Germany.	angelos.skodras@medizin.uni-tuebingen.de; mathias.jucker@uni-tuebingen.de	Neher, Jonas/AAQ-4927-2021; Hefendehl, Jasmin/AAM-1598-2020; Feil, Robert/B-8918-2014	Feil, Robert/0000-0002-7335-4841; Neher, Jonas/0000-0003-1346-8924; Thunemann, Martin/0000-0003-4139-079X; Wendeln, Ann-Christin/0000-0003-4586-6281; Hefendehl, Jasmin/0000-0001-8994-2536	Ministry of Science, Research and the Arts, Baden-Wuerttemberg; Studienstiftung des Deutschen Volkes; National Institute of Health [AG021494, AG027854]; Cure Alzheimer's Fund	Ministry of Science, Research and the Arts, Baden-Wuerttemberg; Studienstiftung des Deutschen Volkes; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund	We thank L. Walker, G. Kempermann and M. Staufenbiel, as well as all other laboratory members, for help and comments on the manuscript, and P. Nilsson (Linkoping University) for providing the LCO amyloid dye. This work was supported by internal institutional funds from the Ministry of Science, Research and the Arts, Baden-Wuerttemberg (M.J.), by a Ph.D. fellowship of the Studienstiftung des Deutschen Volkes (A.-C.W.), by National Institute of Health grants AG021494 and AG027854 (S.S.S., K.V.) and by the Cure Alzheimer's Fund (S.S.S.).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Askew K, 2017, CELL REP, V18, P391, DOI 10.1016/j.celrep.2016.12.041; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Collet D., 2003, MODELLING SURVIVAL D; Crotti A, 2016, IMMUNITY, V44, P505, DOI 10.1016/j.immuni.2016.02.013; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Frisen J, 2016, ANNU REV CELL DEV BI, V32, P127, DOI 10.1146/annurev-cellbio-111315-124953; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Graeber MB, 1998, BRAIN RES, V813, P241, DOI 10.1016/S0006-8993(98)00859-2; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hefendehl JK, 2014, AGING CELL, V13, P60, DOI 10.1111/acel.12149; Hefendehl JK, 2012, J NEUROSCI METH, V205, P357, DOI 10.1016/j.jneumeth.2011.10.029; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hirasawa T, 2005, J NEUROSCI RES, V81, P357, DOI 10.1002/jnr.20480; Hoeijmakers L, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00398; Jucker M, 1997, BEHAV BRAIN RES, V85, P1, DOI 10.1016/S0166-4328(96)02243-7; Klingstedt T, 2011, ORG BIOMOL CHEM, V9, P8356, DOI 10.1039/c1ob05637a; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mahler J, 2012, THESIS; Moores DL, 2017, TRENDS CELL BIOL, V27, P82, DOI 10.1016/j.tcb.2016.09.007; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nowakowski R S, 2000, Science, V288, P771; Pelvig DP, 2008, NEUROBIOL AGING, V29, P1754, DOI 10.1016/j.neurobiolaging.2007.04.013; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Rakic P, 2002, PROG BRAIN RES, V138, P3, DOI 10.1016/S0079-6123(02)38067-1; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016; Sierra A, 2016, GLIA, V64, P1801, DOI 10.1002/glia.23046; Streit WJ, 2004, GLIA, V45, P208, DOI 10.1002/glia.10319; Streit WJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0142-6; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Wegenast-Braun BM, 2012, AM J PATHOL, V181, P1953, DOI 10.1016/j.ajpath.2012.08.031	39	188	189	4	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2017	20	10					1371	+		10.1038/nn.4631	http://dx.doi.org/10.1038/nn.4631			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FI1IM	28846081				2022-12-17	WOS:000411686400010
J	Ma, T; Wang, CM; Wang, L; Zhou, X; Tian, M; Zhang, QQ; Zhang, Y; Li, JW; Liu, ZD; Cai, YQ; Liu, F; You, Y; Chen, C; Campbell, K; Song, HJ; Ma, L; Rubenstein, JL; Yang, ZG				Ma, Tong; Wang, Congmin; Wang, Lei; Zhou, Xing; Tian, Miao; Zhang, Qiangqiang; Zhang, Yue; Li, Jiwen; Liu, Zhidong; Cai, Yuqun; Liu, Fang; You, Yan; Chen, Chao; Campbell, Kenneth; Song, Hongjun; Ma, Lan; Rubenstein, John L.; Yang, Zhengang			Subcortical origins of human and monkey neocortical interneurons	NATURE NEUROSCIENCE			English	Article							LATERAL/CAUDAL GANGLIONIC EMINENCE; COUP-TFII; CORTICAL INTERNEURONS; SUBVENTRICULAR ZONE; GABAERGIC NEURONS; RADIAL GLIA; EXPRESSION; SUBPOPULATION; DIVERSITY; NKX2-1	Cortical GABAergic inhibitory interneurons have crucial roles in the development and function of the cerebral cortex. In rodents, nearly all neocortical interneurons are generated from the subcortical ganglionic eminences. In humans and nonhuman primates, however, the developmental origin of neocortical GABAergic interneurons remains unclear. Here we show that the expression patterns of several key transcription factors in the developing primate telencephalon are very similar to those in rodents, delineating the three main subcortical progenitor domains (the medial, lateral and caudal ganglionic eminences) and the interneurons tangentially migrating from them. On the basis of the continuity of Sox6, COUP-TFII and Sp8 transcription factor expression and evidence from cell migration and cell fate analyses, we propose that the majority of primate neocortical GABAergic interneurons originate from ganglionic eminences of the ventral telencephalon. Our findings reveal that the mammalian neocortex shares basic rules for interneuron development, substantially reshaping our understanding of the origin and classification of primate neocortical interneurons.	[Ma, Tong; Wang, Congmin; Wang, Lei; Zhou, Xing; Tian, Miao; Zhang, Qiangqiang; Zhang, Yue; Li, Jiwen; Liu, Zhidong; Cai, Yuqun; Liu, Fang; You, Yan; Ma, Lan; Yang, Zhengang] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Ma, Tong; Wang, Congmin; Wang, Lei; Zhou, Xing; Tian, Miao; Zhang, Qiangqiang; Zhang, Yue; Li, Jiwen; Liu, Zhidong; Cai, Yuqun; Liu, Fang; You, Yan; Ma, Lan; Yang, Zhengang] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Wang, Lei] Hebei Med Univ, Dept Human Anat, Shijiazhuang, Hebei, Peoples R China; [Chen, Chao] Fudan Univ, Childrens Hosp, Dept Neonatol, Shanghai 200433, Peoples R China; [Campbell, Kenneth] Univ Cincinnati, Med Ctr, Coll Med, Childrens Hosp,Div Dev Biol, Cincinnati, OH 45267 USA; [Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA; [Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Rubenstein, John L.] Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA USA	Fudan University; Fudan University; Hebei Medical University; Fudan University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco	Yang, ZG (corresponding author), Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China.	yangz@fudan.edu.cn	Campbell, Kenneth/ABC-3570-2021; Ma, Lan/B-9295-2009	Wang, Lei/0000-0003-0741-8170; Ma, Lan/0000-0001-9034-5472; Li, Jiwen/0000-0002-1332-4763	National Basic Research Program of China [2011CB504400, 2010CB945500]; National Natural Science Foundation of China [30990261, 31028009, 31121061, 91232723]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2011CB504400 and 2010CB945500) and the National Natural Science Foundation of China (30990261, 31028009, 31121061 and 91232723). We thank the staff at the Chinese Brain Bank Center, Wuhan, China and the Red Cross Society of China, Shanghai Branch at Fudan University for providing access to donated adult human brains.	Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Bayer SA, 2005, HUMAN BRAIN 2 TRIMES; Borello U, 2014, CEREB CORTEX, V24, P1409, DOI 10.1093/cercor/bhs412; Britz O, 2006, CEREB CORTEX, V16, pI138, DOI 10.1093/cercor/bhj168; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Cai YQ, 2013, STEM CELLS, V31, P1193, DOI 10.1002/stem.1363; Cai YQ, 2013, J COMP NEUROL, V521, P479, DOI 10.1002/cne.23186; Fertuzinhos S, 2009, CEREB CORTEX, V19, P2196, DOI 10.1093/cercor/bhp009; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Flandin P, 2010, J NEUROSCI, V30, P2812, DOI 10.1523/JNEUROSCI.4228-09.2010; Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Guerrero-Cazares H, 2011, J COMP NEUROL, V519, P1165, DOI 10.1002/cne.22566; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Jakovcevski I, 2011, CEREB CORTEX, V21, P1771, DOI 10.1093/cercor/bhq245; Kanatani S, 2008, J NEUROSCI, V28, P13582, DOI 10.1523/JNEUROSCI.2132-08.2008; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Long JE, 2009, CEREB CORTEX S1, V19, P196; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Ma T, 2012, CEREB CORTEX, V22, P2120, DOI 10.1093/cercor/bhr296; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; McKinsey GL, 2013, NEURON, V77, P83, DOI 10.1016/j.neuron.2012.11.035; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Molnar Z, 2012, PROG BRAIN RES, V195, P45, DOI 10.1016/B978-0-444-53860-4.00003-9; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Nobrega-Pereira S, 2008, NEURON, V59, P733, DOI 10.1016/j.neuron.2008.07.024; Pei ZL, 2011, P NATL ACAD SCI USA, V108, P1675, DOI 10.1073/pnas.1008824108; Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Reinchisi G, 2012, CEREB CORTEX, V22, P2820, DOI 10.1093/cercor/bhr359; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Sahara S, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-10; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Stenman J, 2003, J NEUROSCI, V23, P167; Sussel L, 1999, DEVELOPMENT, V126, P3359; Taniguchi H, 2013, SCIENCE, V339, P70, DOI 10.1126/science.1227622; Waclaw RR, 2006, NEURON, V49, P503, DOI 10.1016/j.neuron.2006.01.018; Wang B, 2013, J COMP NEUROL, V521, P1561, DOI 10.1002/cne.23242; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Yu XJ, 2011, J NEUROSCI, V31, P2413, DOI 10.1523/JNEUROSCI.5249-10.2011; Zecevic N, 2011, DEV NEUROBIOL, V71, P18, DOI 10.1002/dneu.20812; Zembrzycki A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-8; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052	50	188	189	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1588	1597		10.1038/nn.3536	http://dx.doi.org/10.1038/nn.3536			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24097041				2022-12-17	WOS:000326205700016
J	Nithianantharajah, J; Komiyama, NH; McKechanie, A; Johnstone, M; Blackwood, DH; St Clair, D; Emes, RD; van de Lagemaat, LN; Saksida, LM; Bussey, TJ; Grant, SGN				Nithianantharajah, Jess; Komiyama, Noboru H.; McKechanie, Andrew; Johnstone, Mandy; Blackwood, Douglas H.; St Clair, David; Emes, Richard D.; van de Lagemaat, Louie N.; Saksida, Lisa M.; Bussey, Timothy J.; Grant, Seth G. N.			Synaptic scaffold evolution generated components of vertebrate cognitive complexity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; GENOME DUPLICATION; NMDA RECEPTOR; MICE; GENE; SCHIZOPHRENIA; IMPAIRMENTS; MUTATIONS; ATTENTION; CINGULATE	The origins and evolution of higher cognitive functions, including complex forms of learning, attention and executive functions, are unknown. A potential mechanism driving the evolution of vertebrate cognition early in the vertebrate lineage (550 million years ago) was genome duplication and subsequent diversification of postsynaptic genes. Here we report, to our knowledge, the first genetic analysis of a vertebrate gene family in cognitive functions measured using computerized touchscreens. Comparison of mice carrying mutations in each of the four Dlg paralogs showed that simple associative learning required Dlg4, whereas Dlg2 and Dlg3 diversified to have opposing functions in complex cognitive processes. Exploiting the translational utility of touchscreens in humans and mice, testing Dlg2 mutations in both species showed that Dlg2's role in complex learning, cognitive flexibility and attention has been highly conserved over 100 million years. Dlg-family mutations underlie psychiatric disorders, suggesting that genome evolution expanded the complexity of vertebrate cognition at the cost of susceptibility to mental illness.	[Nithianantharajah, Jess; Komiyama, Noboru H.; van de Lagemaat, Louie N.; Grant, Seth G. N.] Univ Edinburgh, Ctr Clin Brain Sci, Genes Cognit Programme, Edinburgh, Midlothian, Scotland; [Nithianantharajah, Jess; Komiyama, Noboru H.; van de Lagemaat, Louie N.; Grant, Seth G. N.] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland; [Nithianantharajah, Jess; Komiyama, Noboru H.; van de Lagemaat, Louie N.; Grant, Seth G. N.] Wellcome Trust Sanger Inst, Genes Cognit Programme, Hinxton, England; [McKechanie, Andrew; Johnstone, Mandy; Blackwood, Douglas H.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh, Midlothian, Scotland; [McKechanie, Andrew] Univ Edinburgh, Patrick Wild Ctr, Edinburgh, Midlothian, Scotland; [St Clair, David] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Emes, Richard D.] Univ Nottingham, Sch Vet Med & Sci, Loughborough, England; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, MRC, Cambridge, England; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England	University of Edinburgh; University of Edinburgh; Wellcome Trust Sanger Institute; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; University of Aberdeen; University of Nottingham; University of Cambridge; University of Cambridge; University of Cambridge	Grant, SGN (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Genes Cognit Programme, Edinburgh, Midlothian, Scotland.	seth.grant@ed.ac.uk	blackwood, douglas/AIB-8874-2022; Saksida, Lisa M/M-2753-2016; Johnstone, Mandy/AAI-1952-2019; Bussey, Timothy J/M-2758-2016; Emes, Richard D/C-5341-2008; Nithianantharajah, Jess/AAF-2347-2019; St Clair, David/AAN-2412-2021	Saksida, Lisa M/0000-0002-8416-8171; Johnstone, Mandy/0000-0002-8398-0862; Bussey, Timothy J/0000-0001-7518-4041; Emes, Richard D/0000-0001-6855-5481; Nithianantharajah, Jess/0000-0002-3501-1143; McKechanie, Andrew/0000-0003-4273-9906; Grant, Seth/0000-0001-8732-8735	Wellcome Trust; Genes to Cognition Program; Medical Research Council (MRC); European Union [241995, 242498, 242167]; RS Macdonald Charitable Trust; Academy of Medical Sciences/The Wellcome Trust; Medical Research Council [G0001354B, G0001354, G1000183B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Genes to Cognition Program; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); RS Macdonald Charitable Trust; Academy of Medical Sciences/The Wellcome Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank K. Elsegood and D. Fricker for mouse husbandry and genotyping, T. W. Robbins for advice on CANTAB, J. Barnett for assistance with CANTAB control data and T. W. Robbins and T. J. O'Dell for comments on the manuscript. Figure illustration contribution by D. J. Maizels. J.N., N.H.K., L.N.L. and S.G.N.G. was supported by The Wellcome Trust, Genes to Cognition Program, The Medical Research Council (MRC) and European Union programs (Project GENCODYS no. 241995, Project EUROSPIN no. 242498 and Project SYNSYS no. 242167). M. J. was supported by grants from RS Macdonald Charitable Trust and Academy of Medical Sciences/The Wellcome Trust.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Barnett JH, 2010, NEUROSCI BIOBEHAV R, V34, P1161, DOI 10.1016/j.neubiorev.2010.01.012; Barnett JH, 2005, PSYCHOL MED, V35, P1031, DOI 10.1017/S0033291704004301; Bartko SJ, 2011, NEUROPHARMACOLOGY, V61, P1366, DOI 10.1016/j.neuropharm.2011.08.023; Bartko SJ, 2011, PSYCHOPHARMACOLOGY, V214, P537, DOI 10.1007/s00213-010-2050-1; Bayes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046683; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Bossinger O, 2001, DEV BIOL, V230, P29, DOI 10.1006/dbio.2000.0113; Brigman JL, 2008, LEARN MEMORY, V15, P50, DOI 10.1101/lm.777308; Bussey TJ, 2012, NEUROPHARMACOLOGY, V62, P1191, DOI 10.1016/j.neuropharm.2011.04.011; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P908, DOI 10.1037/0735-7044.111.5.908; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P920, DOI 10.1037/0735-7044.111.5.920; Carlisle HJ, 2008, J PHYSIOL-LONDON, V586, P5885, DOI 10.1113/jphysiol.2008.163469; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Caruana G, 2001, MOL CELL BIOL, V21, P1475, DOI 10.1128/MCB.21.5.1475-1483.2001; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Emes RD, 2008, NAT NEUROSCI, V11, P799, DOI 10.1038/nn.2135; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Fray PJ, 1996, NEUROTOXICOL TERATOL, V18, P499, DOI 10.1016/0892-0362(96)00027-X; Grant SGN, 2009, COLD SH Q B, V74, P249, DOI 10.1101/sqb.2009.74.033; Gregory Richard L., 1987, OXFORD COMPANION MIN, DOI 10.1007/978-1-4939-2236-9_11; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Holt DJ, 2009, BIOL PSYCHIAT, V65, P455, DOI 10.1016/j.biopsych.2008.09.017; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; Leeson VC, 2009, BIOL PSYCHIAT, V66, P586, DOI 10.1016/j.biopsych.2009.05.016; Luck SJ, 2008, BIOL PSYCHIAT, V64, P34, DOI 10.1016/j.biopsych.2008.02.014; McGee AW, 2001, J NEUROSCI, V21, P3085, DOI 10.1523/JNEUROSCI.21-09-03085.2001; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Moore BR, 2004, BIOL REV, V79, P301, DOI 10.1017/S1464793103006225; Morton AJ, 2006, NAT METHODS, V3, P767, DOI 10.1038/nmeth1006-767; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Robbins TW, 2012, BEHAV BRAIN RES, V231, P337, DOI 10.1016/j.bbr.2012.03.005; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Romberg C, 2011, J NEUROSCI, V31, P3500, DOI 10.1523/JNEUROSCI.5242-10.2011; Ryan TJ, 2013, NAT NEUROSCI, V16, P25, DOI 10.1038/nn.3277; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Suls A, 2006, HUM MUTAT, V27, P914, DOI 10.1002/humu.20350; Talpos JC, 2009, PSYCHOPHARMACOLOGY, V205, P157, DOI 10.1007/s00213-009-1526-3; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703; van de Lagemaat LN, 2010, NEURON, V67, P8, DOI 10.1016/j.neuron.2010.06.026; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Waltz JA, 2007, SCHIZOPHR RES, V93, P296, DOI 10.1016/j.schres.2007.03.010; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162	52	188	188	2	59	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					16	U37		10.1038/nn.3276	http://dx.doi.org/10.1038/nn.3276			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23201973	Green Accepted, Green Published			2022-12-17	WOS:000312633900008
J	Maret, S; Faraguna, U; Nelson, AB; Cirelli, C; Tononi, G				Maret, Stephanie; Faraguna, Ugo; Nelson, Aaron B.; Cirelli, Chiara; Tononi, Giulio			Sleep and waking modulate spine turnover in the adolescent mouse cortex	NATURE NEUROSCIENCE			English	Article							SYNAPTIC HOMEOSTASIS; PLASTICITY; INCREASES; WAKE	Cortical development involves synaptic formation and elimination. Although synaptogenesis predominates in the early stages and pruning in the later stages, the two processes are thought to happen concurrently. In adults, synaptic strength is modulated by behavioral state, and we asked whether synaptic remodeling may be affected by sleep and waking states. Using two-photon microscopy in adolescent mice, we found that waking results in a net increase in cortical spines, whereas sleep is associated with net spine loss.	[Maret, Stephanie; Faraguna, Ugo; Nelson, Aaron B.; Cirelli, Chiara; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Nelson, Aaron B.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Cirelli, C (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA.	ccirelli@wisc.edu; gtononi@wisc.edu	Faraguna, Ugo/J-6805-2012	Faraguna, Ugo/0000-0002-4814-7218	US National Institutes of Health; National Institute of Mental Health [1R01MH091326]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091326] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a US National Institutes of Health Director's Pioneer award (to G. T.) and the National Institute of Mental Health (1R01MH091326 to G. T. and C. C.).	Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Cirelli C, 2006, J NEUROCHEM, V98, P1632, DOI 10.1111/j.1471-4159.2006.04058.x; DASH MB, 2009, NEUROSCIENCE, V29, P620; DeFelipe J, 1997, CEREB CORTEX, V7, P619, DOI 10.1093/cercor/7.7.619; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Liu ZW, 2010, J NEUROSCI, V30, P8671, DOI 10.1523/JNEUROSCI.1409-10.2010; Nikonova EV, 2010, SLEEP, V33, P889, DOI 10.1093/sleep/33.7.889; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; RAKIC P, 1994, PROG BRAIN RES, V102, P227; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yu XZ, 2011, CURR OPIN NEUROBIOL, V21, P169, DOI 10.1016/j.conb.2010.07.010	15	188	189	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1418	1420		10.1038/nn.2934	http://dx.doi.org/10.1038/nn.2934			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21983682	Green Accepted			2022-12-17	WOS:000296518600017
J	Halassa, MM; Siegle, JH; Ritt, JT; Ting, JT; Feng, GP; Moore, CI				Halassa, Michael M.; Siegle, Joshua H.; Ritt, Jason T.; Ting, Jonathan T.; Feng, Guoping; Moore, Christopher I.			Selective optical drive of thalamic reticular nucleus generates thalamic bursts and cortical spindles	NATURE NEUROSCIENCE			English	Article							SLEEP; OSCILLATIONS; PATTERNS; CORTEX; SLOW	The thalamic reticular nucleus (TRN) is hypothesized to regulate neocortical rhythms and behavioral states. Using optogenetics and multi-electrode recording in behaving mice, we found that brief selective drive of TRN switched the thalamocortical firing mode from tonic to bursting and generated state-dependent neocortical spindles. These findings provide causal support for the involvement of the TRN in state regulation in vivo and introduce a new model for addressing the role of this structure in behavior.	[Halassa, Michael M.; Siegle, Joshua H.; Ting, Jonathan T.; Feng, Guoping] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Halassa, Michael M.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Ritt, Jason T.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Moore, Christopher I.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Boston University; Brown University	Feng, GP (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	fengg@mit.edu; cim@mit.edu	Feng, Guoping/Y-2827-2019	Moore, Christopher/0000-0003-4534-1602; Ting, Jonathan/0000-0001-8266-0392	US National Institutes of Health [R01 NS045130-05]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045130] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by a US National Institutes of Health award (R01 NS045130-05) to C.I.M.	Bezdudnaya T, 2006, NEURON, V49, P421, DOI 10.1016/j.neuron.2006.01.010; Contreras D, 1997, J NEUROSCI, V17, P1179; Dang-Vu TT, 2010, CURR BIOL, V20, pR626, DOI 10.1016/j.cub.2010.06.032; Espinosa F, 2008, J NEUROSCI, V28, P5570, DOI 10.1523/JNEUROSCI.0747-08.2008; Ferrarelli F, 2010, AM J PSYCHIAT, V167, P1339, DOI 10.1176/appi.ajp.2010.09121731; Lesica NA, 2006, PLOS BIOL, V4, P1201, DOI 10.1371/journal.pbio.0040209; Li B, 1999, J PHYSIOL-LONDON, V514, P857, DOI 10.1111/j.1469-7793.1999.857ad.x; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Sherman SM, 2001, NAT NEUROSCI, V4, P344, DOI 10.1038/85973; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sohal VS, 2006, J NEUROSCI, V26, P4247, DOI 10.1523/JNEUROSCI.3812-05.2006; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; Steriade M, 2001, NAT NEUROSCI, V4, P671, DOI 10.1038/89434	15	188	194	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1118	1120		10.1038/nn.2880	http://dx.doi.org/10.1038/nn.2880			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21785436	Green Accepted			2022-12-17	WOS:000294284900010
J	Lee, HHC; Deeb, TZ; Walker, JA; Davies, PA; Moss, SJ				Lee, Henry H. C.; Deeb, Tarek Z.; Walker, Joshua A.; Davies, Paul A.; Moss, Stephen J.			NMDA receptor activity downregulates KCC2 resulting in depolarizing GABA(A) receptor-mediated currents	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; K-CL COTRANSPORTER; CATION-CHLORIDE COTRANSPORTERS; NEURONAL-SPECIFIC ISOFORM; POSTNATAL RAT BRAINS; SPINAL-CORD-INJURY; HIPPOCAMPAL SLICE; NEUROPATHIC PAIN; GLUTAMATE; PHOSPHORYLATION	KCC2 is a neuron-specific K+-Cl- co-transporter that maintains a low intracellular Cl-concentration that is essential for hyperpolarizing inhibition mediated by GABA(A) receptors. Deficits in KCC2 activity occur in disease states associated with pathophysiological glutamate release. However, the mechanisms by which elevated glutamate alters KCC2 function are unknown. The phosphorylation of KCC2 residue Ser940 is known to regulate its surface activity. We found that NMDA receptor activity and Ca2+ influx caused the dephosphorylation of Ser940 in dissociated rat neurons, leading to a loss of KCC2 function that lasted longer than 20 min. Protein phosphatase 1 mediated the dephosphorylation events of Ser940 that coincided with a deficit in hyperpolarizing GABAergic inhibition resulting from the loss of KCC2 activity. Blocking dephosphorylation of Ser940 reduced the glutamate-induced downregulation of KCC2 and substantially improved the maintenance of hyperpolarizing GABAergic inhibition. Reducing the downregulation of KCC2 therefore has therapeutic potential in the treatment of neurological disorders.	[Lee, Henry H. C.; Deeb, Tarek Z.; Walker, Joshua A.; Davies, Paul A.; Moss, Stephen J.] Tufts Univ, Dept Neurosci, Boston, MA 02111 USA; [Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London, England	Tufts University; University of London; University College London	Moss, SJ (corresponding author), Tufts Univ, Dept Neurosci, Boston, MA 02111 USA.	stephen.moss@tufts.edu	Davies, Paul A/P-4595-2017	Davies, Paul A/0000-0002-3973-3143; Lee, Henry/0000-0003-4975-7330	US National Institutes of Health/National Institute of Neurological Disorders and Stroke [NS036296, NS047478, NS048045, NS054900]; American Heart Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS036296, R01NS047478, R01NS036296, R01NS081986, R21NS080064, P01NS054900, R01NS048045, R01NS051195] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Haydon and L.K. Chau for critical comments on the manuscript and H. Tang and L. Silayeva for providing technical assistance. The work was supported in part by US National Institutes of Health/National Institute of Neurological Disorders and Stroke grants NS036296, NS047478, NS048045 and NS054900. H.H.C.L. is supported by a Postdoctoral Fellowship from the American Heart Association.	Banke TG, 2008, J PHYSIOL-LONDON, V586, P4925, DOI 10.1113/jphysiol.2008.157024; Banke TG, 2006, J NEUROSCI, V26, P11720, DOI 10.1523/JNEUROSCI.2887-06.2006; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Cavus I, 2008, EPILEPSIA, V49, P1358, DOI 10.1111/j.1528-1167.2008.01603.x; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Cramer SW, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-36; DURING MJ, 1993, LANCET, V341, P1607; Foldy C, 2010, NAT NEUROSCI, V13, P1047, DOI 10.1038/nn.2609; Galeffi F, 2004, J NEUROSCI, V24, P4478, DOI 10.1523/JNEUROSCI.0755-04.2004; Garrett MC, 2009, J CRIT CARE, V24, P335, DOI 10.1016/j.jcrc.2008.10.015; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Jaenisch N, 2010, STROKE, V41, pE151, DOI 10.1161/STROKEAHA.109.570424; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Kitamura A, 2008, NEUROSCI RES, V62, P270, DOI 10.1016/j.neures.2008.09.002; Kristensen BW, 2003, BRAIN RES, V973, P303, DOI 10.1016/S0006-8993(03)02550-2; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lee HHC, 2010, MOL CELL NEUROSCI, V45, P173, DOI 10.1016/j.mcn.2010.06.008; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Lu Y, 2008, J PHYSIOL-LONDON, V586, P5701, DOI 10.1113/jphysiol.2008.152348; Nabekura J, 2002, J NEUROSCI, V22, P4412, DOI 10.1523/JNEUROSCI.22-11-04412.2002; Palma E, 2006, P NATL ACAD SCI USA, V103, P8465, DOI 10.1073/pnas.0602979103; Papp E, 2008, NEUROSCIENCE, V154, P677, DOI 10.1016/j.neuroscience.2008.03.072; Pathak HR, 2007, J NEUROSCI, V27, P14012, DOI 10.1523/JNEUROSCI.4390-07.2007; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Staley K, 1996, NEURON, V17, P543, DOI 10.1016/S0896-6273(00)80186-5; Stephen LJ, 2001, EPILEPSIA, V42, P357, DOI 10.1046/j.1528-1157.2001.29000.x; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; Toyoda H, 2003, J NEUROPHYSIOL, V89, P1353, DOI 10.1152/jn.00721.2002; Vargova L, 2001, J CEREBR BLOOD F MET, V21, P1077, DOI 10.1097/00004647-200109000-00005; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007; Watanabe M, 2009, J BIOL CHEM, V284, P27980, DOI 10.1074/jbc.M109.043620; Wu LA, 2009, NEUROSCI LETT, V457, P36, DOI 10.1016/j.neulet.2009.03.107	49	188	192	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					736	U390		10.1038/nn.2806	http://dx.doi.org/10.1038/nn.2806			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21532577	Green Accepted			2022-12-17	WOS:000290958000016
J	Schwarzkopf, DS; Song, C; Rees, G				Schwarzkopf, D. Samuel; Song, Chen; Rees, Geraint			The surface area of human V1 predicts the subjective experience of object size	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; EBBINGHAUS ILLUSION; REPRESENTATION; CONNECTIONS	The surface area of human primary visual cortex (V1) varies substantially between individuals for unknown reasons. We found that this variability was strongly and negatively correlated with the magnitude of two common visual illusions, where two physically identical objects appear different in size as a result of their context. Because such illusions dissociate conscious perception from physical stimulation, our findings indicate that the surface area of V1 predicts variability in conscious experience.	[Schwarzkopf, D. Samuel; Song, Chen; Rees, Geraint] UCL, Inst Cognit Neurosci, London, England; [Schwarzkopf, D. Samuel; Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimaging, London, England	University of London; University College London; University of London; University College London	Schwarzkopf, DS (corresponding author), UCL, Inst Cognit Neurosci, London, England.	s.schwarzkopf@fil.ion.ucl.ac.uk	Rees, Geraint/C-1493-2008; Song, Chen/B-3269-2008; Song, Chen/ABC-2033-2021; Schwarzkopf, D. Sam/F-5285-2012	Rees, Geraint/0000-0002-9623-7007; Song, Chen/0000-0002-5418-5747; Schwarzkopf, D. Sam/0000-0003-3686-1622	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank F. Sengpiel for comments on the manuscript. This work was supported by the Wellcome Trust.	Adams DL, 2007, J NEUROSCI, V27, P10391, DOI 10.1523/JNEUROSCI.2923-07.2007; Bosking WH, 1997, J NEUROSCI, V17, P2112; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; de Fockert J, 2007, J EXP PSYCHOL HUMAN, V33, P738, DOI 10.1037/0096-1523.33.3.738; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; Edden RAE, 2009, J NEUROSCI, V29, P15721, DOI 10.1523/JNEUROSCI.4426-09.2009; Fang F, 2008, CURR BIOL, V18, P1707, DOI 10.1016/j.cub.2008.09.025; FISHER GH, 1967, NATURE, V215, P553, DOI 10.1038/215553a0; Frith C, 1999, TRENDS COGN SCI, V3, P105, DOI 10.1016/S1364-6613(99)01281-4; GILBERT CD, 1989, J NEUROSCI, V9, P2432; MASSARO DW, 1971, J EXP PSYCHOL, V89, P147, DOI 10.1037/h0031158; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376	14	188	189	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					28	30		10.1038/nn.2706	http://dx.doi.org/10.1038/nn.2706			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21131954	Green Accepted			2022-12-17	WOS:000285684900010
J	Cohen, JR; Asarnow, RF; Sabb, FW; Bilder, RM; Bookheimer, SY; Knowlton, BJ; Poldrack, RA				Cohen, Jessica R.; Asarnow, Robert F.; Sabb, Fred W.; Bilder, Robert M.; Bookheimer, Susan Y.; Knowlton, Barbara J.; Poldrack, Russell A.			A unique adolescent response to reward prediction errors	NATURE NEUROSCIENCE			English	Article							ORBITOFRONTAL CORTEX; DECISION; BRAIN; RISK; ACCUMBENS; STRIATUM; VALUES; ADULTS	Previous work has shown that human adolescents may be hypersensitive to rewards, but it is not known which aspect of reward processing is responsible for this. We separated decision value and prediction error signals and found that neural prediction error signals in the striatum peaked in adolescence, whereas neural decision value signals varied depending on how value was modeled. This suggests that heightened dopaminergic prediction error responsivity contributes to adolescent reward seeking.	[Asarnow, Robert F.; Sabb, Fred W.; Bilder, Robert M.; Bookheimer, Susan Y.; Poldrack, Russell A.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Sabb, Fred W.; Bilder, Robert M.; Bookheimer, Susan Y.; Knowlton, Barbara J.; Poldrack, Russell A.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Cohen, Jessica R.; Bilder, Robert M.; Bookheimer, Susan Y.; Knowlton, Barbara J.; Poldrack, Russell A.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Cohen, JR (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	jrcohen@berkeley.edu	Bilder, Robert M/A-8894-2008	Bilder, Robert M/0000-0001-5085-7852; Bookheimer, Susan/0000-0002-3417-5891; Poldrack, Russell/0000-0001-6755-0259	National Institute of Mental Health [(5R24 MH072697]; National Institute of Drug Abuse [5F31 DA024534]; James S. McDonnell Foundation; Della Martin Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH072697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA024534] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); James S. McDonnell Foundation; Della Martin Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the National Institute of Mental Health (5R24 MH072697), the National Institute of Drug Abuse (5F31 DA024534), the James S. McDonnell Foundation and the Della Martin Foundation.	Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; Casey BJ, 2008, DEV REV, V28, P62, DOI [10.1016/j.dr.2007.08.003, 10.1196/annals.1440.010]; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Ernst M, 2005, NEUROIMAGE, V25, P1279, DOI 10.1016/j.neuroimage.2004.12.038; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; May JC, 2004, BIOL PSYCHIAT, V55, P359, DOI 10.1016/j.biopsych.2003.11.008; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239	15	188	188	3	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					669	671		10.1038/nn.2558	http://dx.doi.org/10.1038/nn.2558			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	600QY	20473290	Green Accepted, Green Submitted			2022-12-17	WOS:000278003300010
J	Mita, A; Mushiake, H; Shima, K; Matsuzaka, Y; Tanji, J				Mita, Akihisa; Mushiake, Hajime; Shima, Keisetsu; Matsuzaka, Yoshiya; Tanji, Jun			Interval time coding by neurons in the presupplementary and supplementary motor areas	NATURE NEUROSCIENCE			English	Article							MEDIAL FRONTAL-CORTEX; PREFRONTAL CORTEX; MULTIPLE MOVEMENTS; TEMPORAL ORGANIZATION; ELAPSED TIME; MONKEY; REPRESENTATION; MACAQUE; PERCEPTION; PREMOTOR	Interval timing is an essential guiding force of behavior. Previous reports have implicated the prefrontal and parietal cortex as being involved in time perception and in temporal decision making. We found that neurons in the medial motor areas, in particular the presupplementary motor area, participate in interval timing in the range of seconds. Monkeys were trained to perform an interval-generation task that required them to determine waiting periods of three different durations. Neuronal activity contributed to the process of retrieving time instructions from visual cues, signaled the initiation of action in a time-selective manner, and developed activity to represent the passage of time. These results specify how medial motor areas take part in initiating actions on the basis of self-generated time estimates.	[Mita, Akihisa; Mushiake, Hajime; Shima, Keisetsu; Matsuzaka, Yoshiya; Tanji, Jun] Tohoku Univ, Sch Med, Dept Physiol, Sendai, Miyagi 980, Japan; [Tanji, Jun] Tamagawa Univ, Brain Res Inst, Tokyo, Japan	Tohoku University	Tanji, J (corresponding author), Tohoku Univ, Sch Med, Dept Physiol, Sendai, Miyagi 980, Japan.	tanji@lab.tamagawa.ac.jp		Mushiake, Hajime/0000-0002-5130-4720				Akkal D, 2004, NEUROREPORT, V15, P1283, DOI 10.1097/01.wnr.0000127347.87552.87; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; CHURCH RM, 1994, J EXP PSYCHOL ANIM B, V20, P135, DOI 10.1037/0097-7403.20.2.135; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Fujii N, 2002, J NEUROPHYSIOL, V87, P2158, DOI 10.1152/jn.00867.2001; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; Gallistel CR, 1993, ORG LEARNING LEARNIN; Genovesio A, 2006, J NEUROPHYSIOL, V95, P3281, DOI 10.1152/jn.01011.2005; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; Gibbon J., 1984, TIMING TIME PERCEPTI; Harrington DL, 2004, COGNITIVE BRAIN RES, V21, P193, DOI 10.1016/j.cogbrainres.2004.01.010; Hinton SC, 1997, ENDEAVOUR, V21, P3, DOI 10.1016/S0160-9327(96)10022-3; Isoda M, 2004, J NEUROPHYSIOL, V92, P653, DOI 10.1152/jn.01201.2003; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Ivry RB, 2002, BRAIN COGNITION, V48, P117, DOI 10.1006/brcg.2001.1308; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Jones CRG, 2004, EXP BRAIN RES, V158, P366, DOI 10.1007/s00221-004-1912-3; Koch G, 2002, NEUROLOGY, V59, P1658, DOI 10.1212/01.WNL.0000032504.45792.8F; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; LU MT, 1994, J COMP NEUROL, V341, P375, DOI 10.1002/cne.903410308; Lucchetti C, 2001, EXP BRAIN RES, V141, P254, DOI 10.1007/s002210100818; Macar F, 1999, EXP BRAIN RES, V125, P271, DOI 10.1007/s002210050683; Macar Francoise, 2006, Cogn Process, V7, P89, DOI 10.1007/s10339-005-0025-7; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Matell MS, 2003, BEHAV NEUROSCI, V117, P760, DOI 10.1037/0735-7044.117.4.760; Matsuzaka Y, 1996, J NEUROPHYSIOL, V76, P2327, DOI 10.1152/jn.1996.76.4.2327; MATSUZAKA Y, 1992, J NEUROPHYSIOL, V68, P653, DOI 10.1152/jn.1992.68.3.653; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; MECK WH, 1984, ANN NY ACAD SCI, V423, P528, DOI 10.1111/j.1749-6632.1984.tb23457.x; MUSHIAKE H, 1991, J NEUROPHYSIOL, V66, P705, DOI 10.1152/jn.1991.66.3.705; Nachev P, 2007, NEUROIMAGE, V36, pT155, DOI 10.1016/j.neuroimage.2007.03.034; Nakamura K, 1999, J NEUROPHYSIOL, V82, P1063, DOI 10.1152/jn.1999.82.2.1063; OKANO K, 1987, EXP BRAIN RES, V66, P155; Onoe H, 2001, NEUROIMAGE, V13, P37, DOI 10.1006/nimg.2000.0670; Oshio KI, 2006, EUR J NEUROSCI, V23, P2779, DOI 10.1111/j.1460-9568.2006.04781.x; Pouthas V, 2005, HUM BRAIN MAPP, V25, P433, DOI 10.1002/hbm.20126; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Reutimann J, 2004, J NEUROSCI, V24, P3295, DOI 10.1523/JNEUROSCI.4098-03.2004; Sakurai Y, 2001, LEARN MEMORY, V8, P309, DOI 10.1101/lm.43901; Shima K, 1996, P NATL ACAD SCI USA, V93, P8694, DOI 10.1073/pnas.93.16.8694; Shima K, 1998, J NEUROPHYSIOL, V80, P3247, DOI 10.1152/jn.1998.80.6.3247; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Sohn JW, 2007, J NEUROSCI, V27, P13655, DOI 10.1523/JNEUROSCI.2982-07.2007; Staddon JER, 2005, TRENDS COGN SCI, V9, P312, DOI 10.1016/j.tics.2005.05.013; Sumner P, 2007, NEURON, V54, P697, DOI 10.1016/j.neuron.2007.05.016; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Tanne J, 1995, NEUROREPORT, V7, P267, DOI 10.1097/00001756-199512000-00064	50	188	190	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2009	12	4					502	507		10.1038/nn.2272	http://dx.doi.org/10.1038/nn.2272			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	424JN	19252498				2022-12-17	WOS:000264563100025
J	Chen, G; Sima, J; Jin, M; Wang, KY; Xue, XJ; Zheng, W; Ding, YQ; Yuan, XB				Chen, Gang; Sima, Jian; Jin, Ming; Wang, Kai-yu; Xue, Xiao-jing; Zheng, Wang; Ding, Yu-qiang; Yuan, Xiao-bing			Semaphorin-3A guides radial migration of cortical neurons during development	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; CEREBRAL-CORTEX; GROWTH CONES; RECEPTOR; NEUROPILIN; PROTEIN; REELIN; BRAIN; NEOCORTEX	Postmitotic neurons in the developing cortex migrate along radial glial fibers to their proper location in the cortical plate and form the layered structure. Here we report that the radial migration of rat layer II/III cortical neurons requires guidance by the extracellular diffusible factor Semaphorin-3A (Sema3A). This factor is expressed in a descending gradient across the cortical layers, whereas its receptor neuropilin-1 (NP1) is highly expressed in migrating neurons. Downregulation or conditional knockout of NP1 in newborn cortical neurons impedes their radial migration by disrupting their radial orientation during migration without altering their cell fate. Studies in cultured cortical slices further show that the endogenous gradient of Sema3A is required for the proper migration of newborn neurons. In addition, transwell chemotaxis assays show that isolated newborn neurons are attracted by Sema3A. Thus, Sema3A may function as a chemoattractive guidance signal for the radial migration of newborn cortical neurons toward upper layers.	[Chen, Gang; Sima, Jian; Jin, Ming; Wang, Kai-yu; Xue, Xiao-jing; Zheng, Wang; Ding, Yu-qiang; Yuan, Xiao-bing] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Chen, Gang; Sima, Jian; Jin, Ming; Wang, Kai-yu; Xue, Xiao-jing; Zheng, Wang; Ding, Yu-qiang; Yuan, Xiao-bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Key State Lab Neurobiol, Shanghai 200031, Peoples R China; [Chen, Gang; Sima, Jian; Wang, Kai-yu; Xue, Xiao-jing; Zheng, Wang] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Yuan, XB (corresponding author), Chinese Acad Sci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	yuanxb@ion.ac.cn		Yuan, Xiaobing/0000-0002-1632-8460; Sima, Jian/0000-0002-4127-1638; Ding, Yu-Qiang/0000-0003-1202-4635; Zheng, Wang/0000-0002-7050-6133				Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Behar TN, 2001, CEREB CORTEX, V11, P744, DOI 10.1093/cercor/11.8.744; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; FISHELL G, 1991, DEVELOPMENT, V113, P755; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; GUIARRO P, 2006, MOL CELL NEUROSCI, V33, P389; Gupta A, 2003, NEUROSIGNALS, V12, P173, DOI 10.1159/000074618; Gupta A, 2003, NAT NEUROSCI, V6, P1284, DOI 10.1038/nn1151; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Jossin Y, 2003, J NEUROSCI, V23, P9953; Khaibullina AA, 2004, DEV BRAIN RES, V148, P59, DOI 10.1016/j.devbrainres.2003.09.022; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kuo G, 2005, J NEUROSCI, V25, P8578, DOI 10.1523/JNEUROSCI.1656-05.2005; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Liebl DJ, 2003, J NEUROSCI RES, V71, P7, DOI 10.1002/jnr.10457; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Magdaleno S, 2002, NEURON, V33, P573, DOI 10.1016/S0896-6273(02)00582-2; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Murakami Y, 2001, DEV DYNAM, V220, P246, DOI 10.1002/1097-0177(20010301)220:3<246::AID-DVDY1112>3.0.CO;2-2; Petreanu L, 2002, J NEUROSCI, V22, P6106; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rakic P, 1998, J AM ACAD CHILD PSY, V37, P116, DOI 10.1097/00004583-199801000-00026; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Sun W, 2002, MOL BRAIN RES, V103, P36, DOI 10.1016/S0169-328X(02)00168-7; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Suto F, 2003, MECH DEVELOP, V120, P385, DOI 10.1016/S0925-4773(02)00421-5; Tabata H, 2002, J NEUROSCI RES, V69, P723, DOI 10.1002/jnr.10345; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Van Der Zwaag B, 2002, DEV DYNAM, V225, P336, DOI 10.1002/dvdy.10159; Whitaker GB, 2001, J BIOL CHEM, V276, P25520, DOI 10.1074/jbc.M102315200; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xu HT, 2004, P NATL ACAD SCI USA, V101, P4296, DOI 10.1073/pnas.0303893101; Yamashita N, 2006, J NEUROSCI, V26, P13357, DOI 10.1523/JNEUROSCI.4276-06.2006; Yoneshima H, 2006, NEUROSCIENCE, V137, P401, DOI 10.1016/j.neuroscience.2005.08.075	50	188	192	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					36	44		10.1038/nn2018	http://dx.doi.org/10.1038/nn2018			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18059265				2022-12-17	WOS:000252117900010
J	Keleman, K; Kruttner, S; Alenius, M; Dickson, BJ				Keleman, Krystyna; Kruettner, Sebastian; Alenius, Mattias; Dickson, Barry J.			Function of the Drosophila CPEB protein Orb2 in long-term courtship memory	NATURE NEUROSCIENCE			English	Article							CYTOPLASMIC POLYADENYLATION; CONSOLIDATED MEMORY; SYNAPTIC PLASTICITY; NEURONAL ISOFORM; NEURAL CIRCUITRY; MESSENGER-RNA; BEHAVIOR; GENE; SEX; LOCALIZATION	Both long-term behavioral memory and synaptic plasticity require protein synthesis, some of which may occur locally at specific synapses. Cytoplasmic polyadenylation element-binding (CPEB) proteins are thought to contribute to the local protein synthesis that underlies long-term changes in synaptic efficacy, but a role has not been established for them in the formation of long-term behavioral memory. We found that the Drosophila melanogaster CPEB protein Orb2 is acutely required for long-term conditioning of male courtship behavior. Deletion of the N-terminal glutamine-rich region of Orb2 resulted in flies that were impaired in their ability to form long-term, but not short-term, memory. Memory was restored by expressing Orb2 selectively in fruitless (fru)positive c neurons of the mushroom bodies and by providing Orb2 function in mushroom bodies only during and shortly after training. Our data thus demonstrate that a CPEB protein is important in long-term memory and map the molecular, spatial and temporal requirements for its function in memory formation.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Keleman, K (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	keleman@imp.ac.at; dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X				Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; Berger-Sweeney J, 2006, LEARN MEMORY, V13, P4, DOI 10.1101/lm.73706; Chang JS, 1999, DEV BIOL, V215, P91, DOI 10.1006/dbio.1999.9444; Chang JS, 2001, DEVELOPMENT, V128, P3169; CHRISTERSON LB, 1994, GENE DEV, V8, P614, DOI 10.1101/gad.8.5.614; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dukas R, 2005, ANIM BEHAV, V69, P1203, DOI 10.1016/j.anbehav.2004.08.012; Dukas R, 2006, ANIM BIOL, V56, P125, DOI 10.1163/157075606777304258; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GAILEY DA, 1985, GENETICS, V111, P795; GAILEY DA, 1984, GENETICS, V106, P613; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Kamyshev NG, 1999, LEARN MEMORY, V6, P1; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; LANTZ V, 1992, DEVELOPMENT, V115, P75; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Mehren JE, 2004, CURR OPIN NEUROBIOL, V14, P745, DOI 10.1016/j.conb.2004.10.012; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mery F, 2005, SCIENCE, V308, P1148, DOI 10.1126/science.1111331; Reif M, 2002, ANIM BEHAV, V63, P143, DOI 10.1006/anbe.2001.1876; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schlote, 1984, DROS INFORM SERV, V60, P210; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Sitnik N A, 2003, Neurosci Behav Physiol, V33, P67, DOI 10.1023/A:1021131415653; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tuite MF, 2000, CELL, V100, P289, DOI 10.1016/S0092-8674(00)80663-7; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; VANNATEERS WV, 2007, DROSOPHILA CURR BIOL, V17, P606; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	50	188	192	0	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1587	1593		10.1038/nn1996	http://dx.doi.org/10.1038/nn1996			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17965711				2022-12-17	WOS:000251172900016
J	Chhatwal, JP; Stanek-Rattiner, L; Davis, M; Ressler, KJ				Chhatwal, Jasmeer P.; Stanek-Rattiner, Lisa; Davis, Michael; Ressler, Kerry J.			Amygdala BDNF signaling is required for consolidation but not encoding of extinction	NATURE NEUROSCIENCE			English	Article							FEAR-POTENTIATED STARTLE; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; TYROSINE KINASE; D-CYCLOSERINE; FACILITATION; MEMORY; TRKB	Brain-derived neurotrophic factor ( BDNF) acting through the tyrosine kinase B receptor ( TrkB) is thought to be a critical mediator of learning. As there are no available selective antagonists of TrkB, we used a lentivirus encoding a dominant-negative TrkB ( TrkB.t1) to antagonize BDNF signaling during extinction of conditioned fear. Whereas TrkB. t1-infected rats showed normal within-session extinction, their retention of extinction was impaired, suggesting that amygdala TrkB activation is required for the consolidation of stable extinction memories.	Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; Yerkes Res Ctr, Ctr Behav Neurosci, Atlanta, GA 30329 USA	Emory University	Ressler, KJ (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, 1639 Pierce Dr,Suite 4000, Atlanta, GA 30322 USA.	kressle@emory.edu	Ressler, Kerry J/N-8741-2018	Ressler, Kerry J/0000-0002-5158-1103	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH047840, F30MH070218, K01MH069884, R37MH047840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019624] Funding Source: NIH RePORTER; NCRR NIH HHS [P51RR000165, P51 RR000165-460189, P51 RR000165-457288, P51 RR000165, P51 RR000165-450216] Funding Source: Medline; NIDA NIH HHS [R01 DA019624, R01 DA019624-01A2] Funding Source: Medline; NIGMS NIH HHS [T32 GM008169] Funding Source: Medline; NIMH NIH HHS [K01 MH069884-01, R01 MH047840, K01 MH069884-03, R37 MH047840, MH47840, MH069884, K01 MH069884, F30 MH070218, MH070218, K01 MH069884-02] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Cain CK, 2002, J NEUROSCI, V22, P9113; Cannistraro Paul A, 2003, Psychopharmacol Bull, V37, P8; FALLS WA, 1992, J NEUROSCI, V12, P854; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Ressler KJ, 2002, J NEUROSCI, V22, P7892; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Schroeder JP, 2004, LEARN MEMORY, V11, P641, DOI 10.1101/lm.78504; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002	15	188	193	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					870	872		10.1038/nn1718	http://dx.doi.org/10.1038/nn1718			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16783370	Green Accepted			2022-12-17	WOS:000238590800009
J	Dunah, AW; Hueske, E; Wyszynski, M; Hoogenraad, CC; Jaworski, J; Pak, DT; Simonetta, A; Liu, GS; Sheng, M				Dunah, AW; Hueske, E; Wyszynski, M; Hoogenraad, CC; Jaworski, J; Pak, DT; Simonetta, A; Liu, GS; Sheng, M			LAR receptor protein tyrosine phosphatases in the development and maintenance of excitatory synapses	NATURE NEUROSCIENCE			English	Article							CADHERIN-CATENIN COMPLEX; CELL-ADHESION; AMPA RECEPTORS; PTP-SIGMA; ALPHA-CATENIN; LIPRIN-ALPHA; RAT-BRAIN; ASSOCIATION; EXPRESSION; TRAFFICKING	Leukocyte common antigen - related (LAR) family receptor protein tyrosine phosphatases (LAR-RPTP) bind to liprin-alpha (SYD2) and are implicated in axon guidance. We report that LAR-RPTP is concentrated in mature synapses in cultured rat hippocampal neurons, and is important for the development and maintenance of excitatory synapses in hippocampal neurons. RNA interference (RNAi) knockdown of LAR or dominant-negative disruption of LAR function results in loss of excitatory synapses and dendritic spines, reduction of surface AMPA receptors, impairment of dendritic targeting of the cadherin - beta-catenin complex, and reduction in the amplitude and frequency of miniature excitatory postsynaptic currents (mEPSCs). Cadherin, beta-catenin and GluR2/3 are tyrosine phosphoproteins that coimmunoprecipitate with liprin-alpha and GRIP from rat brain extracts. We propose that the cadherin-beta-catenin complex is cotransported with AMPA receptors to synapses and dendritic spines by a mechanism that involves binding of liprin-alpha to LAR-RPTP and tyrosine dephosphorylation by LAR-RPTP.	MIT, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sheng, M (corresponding author), MIT, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msheng@mit.edu	Hoogenraad, Casper/B-8866-2011	Hoogenraad, Casper/0000-0002-2666-0758; Jaworski, Jacek/0000-0001-8760-7865; Sheng, Morgan/0000-0002-8703-5366				Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Aicher B, 1997, J CELL BIOL, V138, P681, DOI 10.1083/jcb.138.3.681; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Goda Y, 2002, NEURON, V35, P1, DOI 10.1016/S0896-6273(02)00765-1; HARRIS MI, 1997, INT TXB DIABETES MEL, V1, P9; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Lee SH, 2001, NEUROPHARMACOLOGY, V41, P680, DOI 10.1016/S0028-3908(01)00124-1; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; McGee AW, 2003, CURR OPIN NEUROBIOL, V13, P111, DOI 10.1016/S0959-4388(03)00008-4; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; PULIDO R, 1995, J BIOL CHEM, V270, P6722, DOI 10.1074/jbc.270.12.6722; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Schaapveld RQJ, 1998, MECH DEVELOP, V77, P59, DOI 10.1016/S0925-4773(98)00119-1; Schikorski T, 1997, J NEUROSCI, V17, P5858; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; SERRAPAGES C, 1994, J BIOL CHEM, V269, P23632; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shin H, 2003, J BIOL CHEM, V278, P11393, DOI 10.1074/jbc.M211874200; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; STREULI M, 1992, EMBO J, V11, P897, DOI 10.1002/j.1460-2075.1992.tb05128.x; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Tsujikawa K, 2001, MOL ENDOCRINOL, V15, P271, DOI 10.1210/me.15.2.271; Wallace MJ, 1998, MOL CELL BIOL, V18, P2608, DOI 10.1128/MCB.18.5.2608; WANG YH, 1995, J NEUROCHEM, V65, P176; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Wyszynski M, 1998, NEUROPHARMACOLOGY, V37, P1335, DOI 10.1016/S0028-3908(98)00120-8; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yagi T, 2000, GENE DEV, V14, P1169; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	50	188	193	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					458	467		10.1038/nn1416	http://dx.doi.org/10.1038/nn1416			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15750591				2022-12-17	WOS:000228040400016
J	McDonald, BJ; Amato, A; Connolly, CN; Benke, D; Moss, SJ; Smart, TG				McDonald, BJ; Amato, A; Connolly, CN; Benke, D; Moss, SJ; Smart, TG			Adjacent phosphorylation sites on GABA(A) receptor beta subunits determine regulation by cAMP-dependent protein kinase	NATURE NEUROSCIENCE			English	Article							A RECEPTOR; INTRACELLULAR DOMAINS; REBOUND POTENTIATION; MEDIATED CURRENTS; CYCLIC-AMP; ACTIVATION; EXPRESSION; MODULATION; CHANNELS	Activation of cAMP-dependent protein kinase (PKA) can enhance or reduce the function of neuronal GABA, receptors, the major sites of fast synaptic inhibition in the brain. This differential regulation depends on PKA-induced phosphorylation of adjacent conserved sites in the receptor beta subunits. Phosphorylation of beta 3 subunit-containing receptors at S408 and S409 enhanced the GABA-activated response, whereas selectively mutating S408 to alanine converted the potentiation into an inhibition, comparable to that of beta 1 subunits, which are phosphorylated solely on S409. These distinct modes of regulation were interconvertible between beta 1 and beta 3 subunits and depended upon the presence of S408 in either subunit, In contrast, beta 2 subunit-containing receptors were not phosphorylated or affected by PKA. Differential regulation by PKA of postsynaptic GABA(A) receptors containing different beta subunits may have profound effects on neuronal excitability.	Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; Univ London Univ Coll, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; Univ London Univ Coll, Dept Pharmacol, London WC1E 6BT, England; Univ Zurich, Inst Pharmacol, CH-8057 Zurich, Switzerland	University of London; University College London; University of London School of Pharmacy; University of London; University College London; University of London; University College London; University of Zurich	Smart, TG (corresponding author), Univ London, Sch Pharm, Dept Pharmacol, 29-39 Brunswick Sq, London WC1N 1AX, England.	steve.moss@ucl.ac.uk; tsmart@ulsop.ac.uk		Connolly, Christopher/0000-0002-0445-8874	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANGELOTTI TP, 1993, MOL PHARMACOL, V44, P1202; BENKE D, 1994, J BIOL CHEM, V269, P27100; BULLER AL, 1994, MOL PHARMACOL, V46, P858; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1996, P NATL ACAD SCI USA, V93, P9899, DOI 10.1073/pnas.93.18.9899; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FEIGENSPAN A, 1994, P NATL ACAD SCI USA, V91, P10893, DOI 10.1073/pnas.91.23.10893; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; KANO M, 1992, NEUROREPORT, V3, P563, DOI 10.1097/00001756-199207000-00004; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kano M, 1996, P NATL ACAD SCI USA, V93, P13351, DOI 10.1073/pnas.93.23.13351; Kapur J, 1996, J NEUROPHYSIOL, V76, P2626, DOI 10.1152/jn.1996.76.4.2626; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.ne.17.030194.003033; McDonald BJ, 1997, NEUROPHARMACOLOGY, V36, P1377, DOI 10.1016/S0028-3908(97)00111-1; MOSS SJ, 1995, NATURE, V377, P344, DOI 10.1038/377344a0; MOSS SJ, 1992, J BIOL CHEM, V267, P14470; MOSS SJ, 1992, SCIENCE, V257, P661, DOI 10.1126/science.1323140; Moss SJ, 1996, INT REV NEUROBIOL, V39, P1, DOI 10.1016/S0074-7742(08)60662-5; NAYEEM N, 1994, J NEUROCHEM, V62, P815; PORTER NM, 1990, NEURON, V5, P789, DOI 10.1016/0896-6273(90)90338-G; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; VERUKI ML, 1994, VISUAL NEUROSCI, V11, P899, DOI 10.1017/S0952523800003850; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x	27	188	193	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					23	28		10.1038/223	http://dx.doi.org/10.1038/223			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195104				2022-12-17	WOS:000076361000013
J	Voss, U; Holzmann, R; Hobson, A; Pauluss, W; Koppehele-Gossel, J; Klimke, A; Nitsche, MA				Voss, Ursula; Holzmann, Romain; Hobson, Allan; Pauluss, Walter; Koppehele-Gossel, Judith; Klimke, Ansgar; Nitsche, Michael A.			Induction of self awareness in dreams through frontal low current stimulation of gamma activity	NATURE NEUROSCIENCE			English	Article							REM-SLEEP; CONSCIOUSNESS; SCHIZOPHRENIA; OSCILLATIONS; SYNCHRONIZATION; FRAMEWORK; LUCIDITY; NETWORKS; STATE	Recent findings link fronto-temporal gamma electroencephalographic (EEG) activity to conscious awareness in dreams, but a causal relationship has not yet been established. We found that current stimulation in the lower gamma band during REM sleep influences ongoing brain activity and induces self-reflective awareness in dreams. Other stimulation frequencies were not effective, suggesting that higher order consciousness is indeed related to synchronous oscillations around 25 and 40 Hz.	[Voss, Ursula] Goethe Univ Frankfurt, Dept Psychol, D-60054 Frankfurt, Germany; [Voss, Ursula; Klimke, Ansgar] VITOS Hochtaunus Klin, Dept Clin Sleep Res, Friedrichsdorf, Germany; [Holzmann, Romain] GSI Helmholtzzentrum Schwerionenforsch, Darmstadt, Germany; [Hobson, Allan] Harvard Univ, Sch Med, Boston, MA USA; [Pauluss, Walter; Nitsche, Michael A.] Univ Med Ctr, Dept Clin Neurophysiol, Gottingen, Germany; [Koppehele-Gossel, Judith] Univ Bonn, Dept Psychol, Bonn, Germany; [Klimke, Ansgar] Univ Dusseldorf, Dept Psychiat, Dusseldorf, Germany	Goethe University Frankfurt; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Harvard University; Harvard Medical School; University of Gottingen; University of Bonn; Heinrich Heine University Dusseldorf	Voss, U (corresponding author), Goethe Univ Frankfurt, Dept Psychol, D-60054 Frankfurt, Germany.	voss@psych.uni-frankfurt.de	Nitsche, Michael A/B-6755-2012; Paulus, Walter/A-3544-2009	Paulus, Walter/0000-0001-5549-8377; Klimke, Ansgar/0000-0002-1160-5270; Voss, Ursula/0000-0003-1272-9934	German Science Foundation [DFG Vo 650/5-1]	German Science Foundation(German Research Foundation (DFG))	We thank A. Antal and C. Stephani for technical advice, S. Weyn Banningh for data collection, J. Windt for helpful discussions, K. Schermelleh-Engel for advice on statistical procedures, C. Frenzel for technical assistance during preliminary work, and A. Melnikova and C. Naefgen for help with data acquisition of pilot data. This work was supported by the German Science Foundation (DFG Vo 650/5-1).	Anticevic A, 2014, BIOL PSYCHIAT, V75, P595, DOI 10.1016/j.biopsych.2013.10.021; Bojak I, 2007, NEUROCOMPUTING, V70, P2085, DOI 10.1016/j.neucom.2006.10.087; Brown RE, 2012, LIBR J, V137, P92; Brunelin J, 2012, AM J PSYCHIAT, V169, P719, DOI 10.1176/appi.ajp.2012.11071091; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cordes J, 2006, NEUROPSYCHOBIOLOGY, V54, P87, DOI 10.1159/000096990; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; Dresler M, 2012, SLEEP, V35, P1017, DOI 10.5665/sleep.1974; Edelman GM, 2003, P NATL ACAD SCI USA, V100, P5520, DOI 10.1073/pnas.0931349100; Ferrarelli F, 2012, ARCH GEN PSYCHIAT, V69, P766, DOI 10.1001/archgenpsychiatry.2012.147; Hobson A, 2011, CONSCIOUS COGN, V20, P993, DOI 10.1016/j.concog.2010.09.018; Hobson JA, 2009, NAT REV NEUROSCI, V10, P803, DOI 10.1038/nrn2716; Kanai R, 2010, CLIN NEUROPHYSIOL, V121, P1551, DOI 10.1016/j.clinph.2010.03.022; Kortelainen J, 2012, BRIT J ANAESTH, V109, P782, DOI 10.1093/bja/aes265; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Steriade M, 1996, J NEUROSCI, V16, P2788; Voss U, 2013, CONSCIOUS COGN, V22, P8, DOI 10.1016/j.concog.2012.11.001; Voss U, 2009, SLEEP, V32, P1191, DOI 10.1093/sleep/32.9.1191	19	187	201	0	121	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2014	17	6					810	812		10.1038/nn.3719	http://dx.doi.org/10.1038/nn.3719			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI1TO	24816141				2022-12-17	WOS:000336638000016
J	Chang, MC; Park, JM; Pelkey, KA; Grabenstatter, HL; Xu, DS; Linden, DJ; Sutula, TP; McBain, CJ; Worley, PF				Chang, Michael C.; Park, Joo Min; Pelkey, Kenneth A.; Grabenstatter, Heidi L.; Xu, Desheng; Linden, David J.; Sutula, Thomas P.; McBain, Chris J.; Worley, Paul F.			Narp regulates homeostatic scaling of excitatory synapses on parvalbumin-expressing interneurons	NATURE NEUROSCIENCE			English	Article							FAST-SPIKING CELLS; AMPA RECEPTORS; MESSENGER-RNAS; PLASTICITY; NEURONS; PENTRAXIN; SUBUNIT; AGGREGATION; INHIBITION; INTERACTS	Homeostatic synaptic scaling alters the strength of synapses to compensate for prolonged changes in network activity and involves both excitatory and inhibitory neurons. The immediate-early gene Narp (neuronal activity-regulated pentraxin) encodes a secreted synaptic protein that can bind to and induce clustering of AMPA receptors (AMPARs). We found that Narp prominently accumulated at excitatory synapses on parvalbumin-expressing interneurons (PV-INs). Increasing network activity resulted in a homeostatic increase of excitatory synaptic strength onto PV-INs that increased inhibitory drive and this response was absent in neurons cultured from Narp(-/-) mice. Activity-dependent changes in the strength of excitatory inputs on PV-INs in acute hippocampal slices were also dependent on Narp and Narp(-/-) mice had increased sensitivity to kindling-induced seizures. We propose that Narp recruits AMPARs at excitatory synapses onto PV-INs to rebalance network excitation/inhibition dynamics following episodes of increased circuit activity.	[Chang, Michael C.; Park, Joo Min; Xu, Desheng; Linden, David J.; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Pelkey, Kenneth A.; McBain, Chris J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD USA; [Grabenstatter, Heidi L.; Sutula, Thomas P.] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	pworley@jhmi.edu			US National Institutes of Health [PAR-02-059, NS 39156]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039156] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M.S. Perin for the Narp<SUP>-/-</SUP> mouse, R.L. Huganir (Johns Hopkins University) for antibodies to GluR1, M. Dehoff and P. Chuang for animal care, M. Papapavlou for administrative assistance and X. Yuan and B. Jeffries for technical assistance. Work in the laboratory of C.J.M. is supported by a US National Institutes of Health intramural award. Work in the laboratory of P.F.W. is supported by US National Institutes of Health grants PAR-02-059 and NS 39156.	Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; BEKENSTEIN JW, 1993, SCIENCE, V259, P97, DOI 10.1126/science.8093417; Berke JD, 1998, J NEUROSCI, V18, P5301, DOI 10.1523/JNEUROSCI.18-14-05301.1998; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Bruckner G, 1998, EXP BRAIN RES, V121, P300, DOI 10.1007/s002210050463; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; COLE AJ, 1990, J NEUROCHEM, V55, P1920, DOI 10.1111/j.1471-4159.1990.tb05777.x; Dodds DC, 1997, J BIOL CHEM, V272, P21488, DOI 10.1074/jbc.272.34.21488; Doyle S, 2010, J BIOL CHEM, V285, P14366, DOI 10.1074/jbc.M109.080069; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; HARTIG W, 1992, NEUROREPORT, V3, P869; Hartig W, 1999, BRAIN RES, V842, P15, DOI 10.1016/S0006-8993(99)01784-9; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; KAWAGUCHI Y, 1987, BRAIN RES, V416, P369, DOI 10.1016/0006-8993(87)90921-8; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; KOH DS, 1995, J PHYSIOL-LONDON, V485, P383, DOI 10.1113/jphysiol.1995.sp020737; KOSAKA T, 1989, BRAIN RES, V483, P158, DOI 10.1016/0006-8993(89)90048-6; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Mi RF, 2002, J NEUROSCI, V22, P7606; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Nissen W, 2010, J NEUROSCI, V30, P1337, DOI 10.1523/JNEUROSCI.3481-09.2010; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Reti IM, 2000, NEUROPSYCHOPHARMACOL, V23, P439, DOI 10.1016/S0893-133X(00)00120-2; Sayin U, 2003, J NEUROSCI, V23, P2759; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Sia GM, 2007, NEURON, V55, P87, DOI 10.1016/j.neuron.2007.06.020; Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106; Tsui CC, 1996, J NEUROSCI, V16, P2463; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X	46	187	192	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1090	U83		10.1038/nn.2621	http://dx.doi.org/10.1038/nn.2621			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20729843	Green Accepted			2022-12-17	WOS:000281332600014
J	Talavera, K; Gees, M; Karashima, Y; Meseguer, VM; Vanoirbeek, JAJ; Damann, N; Everaerts, W; Benoit, M; Janssens, A; Vennekens, R; Viana, F; Nemery, B; Nilius, B; Voets, T				Talavera, Karel; Gees, Maarten; Karashima, Yuji; Meseguer, Victor M.; Vanoirbeek, Jeroen A. J.; Damann, Nils; Everaerts, Wouter; Benoit, Melissa; Janssens, Annelies; Vennekens, Rudi; Viana, Felix; Nemery, Benoit; Nilius, Bernd; Voets, Thomas			Nicotine activates the chemosensory cation channel TRPA1	NATURE NEUROSCIENCE			English	Article							TRIGEMINAL SUBNUCLEUS CAUDALIS; CROSS-DESENSITIZATION; MENTHOL; NEURONS; COLD; MECAMYLAMINE; RESPONSES; SENSITIZES; RECEPTORS; TARGETS	Topical application of nicotine, as used in nicotine replacement therapies, causes irritation of the mucosa and skin. This reaction has been attributed to activation of nicotinic acetylcholine receptors (nAChRs) in chemosensory neurons. In contrast with this view, we found that the chemosensory cation channel transient receptor potential A1 (TRPA1) is crucially involved in nicotine-induced irritation. We found that micromolar concentrations of nicotine activated heterologously expressed mouse and human TRPA1. Nicotine acted in a membrane-delimited manner, stabilizing the open state(s) and destabilizing the closed state(s) of the channel. In the presence of the general nAChR blocker hexamethonium, nociceptive neurons showed nicotine-induced responses that were strongly reduced in TRPA1-deficient mice. Finally, TRPA1 mediated the mouse airway constriction reflex to nasal instillation of nicotine. The identification of TRPA1 as a nicotine target suggests that existing models of nicotine-induced irritation should be revised and may facilitate the development of smoking cessation therapies with less adverse effects.	[Talavera, Karel; Gees, Maarten; Karashima, Yuji; Damann, Nils; Everaerts, Wouter; Benoit, Melissa; Janssens, Annelies; Vennekens, Rudi; Nilius, Bernd; Voets, Thomas] Katholieke Univ Leuven, Lab Ion Channel Res, Dept Mol Cell Biol, Leuven, Belgium; [Meseguer, Victor M.; Viana, Felix] Univ Miguel Hernandez, Inst Neurociencias Alicante, Consejo Super Invest Cient, Alacant, Spain; [Vanoirbeek, Jeroen A. J.; Nemery, Benoit] Katholieke Univ Leuven, Lab Lung Toxicol, Leuven, Belgium; [Everaerts, Wouter] Katholieke Univ Leuven, Dept Surg, Lab Expt Urol, Leuven, Belgium	KU Leuven; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); KU Leuven; KU Leuven	Talavera, K (corresponding author), Katholieke Univ Leuven, Lab Ion Channel Res, Dept Mol Cell Biol, Leuven, Belgium.	karel.talavera@med.kuleuven.be	Nemery, Benoit/D-1224-2013; Talavera, Karel/K-7990-2014; gees, maarten/H-4185-2011; Vanoirbeek, Jeroen/D-5183-2016; Viana, Felix/U-8533-2017; Nemery, Benoit/N-3155-2019; Voets, Thomas/E-2466-2012; Everaerts, Wouter/A-3153-2019; Karashima, Yuji/AGY-5391-2022; Voets, Thomas/AAD-4389-2019; Vennekens, Rudi/AAQ-1664-2020	Talavera, Karel/0000-0002-3124-138X; Vanoirbeek, Jeroen/0000-0001-5508-3518; Viana, Felix/0000-0003-1439-949X; Nemery, Benoit/0000-0003-0571-4689; Voets, Thomas/0000-0001-5526-5821; Everaerts, Wouter/0000-0002-3157-7115; Karashima, Yuji/0000-0002-2866-8999; Voets, Thomas/0000-0001-5526-5821; Vennekens, Rudi/0000-0002-2564-5150; Janssens, Annelies/0000-0002-6735-8248	Spanish CONSOLIDERINGENIO; Inter- university Attraction Poles Programme [P6/ 28]; FWO [G. 0172.03, G. 0565.07]; Research Council of the KU Leuven [GOA 2004/ 07]; Flemish Government [EF/ 95/ 010]	Spanish CONSOLIDERINGENIO(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Inter- university Attraction Poles Programme(Belgian Federal Science Policy Office); FWO(FWO); Research Council of the KU Leuven(KU Leuven); Flemish Government(European Commission)	We are grateful to K. Y. Kwan for providing us with the Trpa1 knockout mice, M. R. Sep lveda for helpful discussions, and V. De Vooght and P. Hoet for help in some plethysmography experiments. The expert technical assistance of J. Prenen is greatly acknowledged. The mTRPA1 CHO cell line was kindly provided by A. Patapoutian. K. T. and J. A. J. V. were supported by a postdoctoral mandate from KU Leuven and are currently postdoctoral fellows of the Research Foundation Flanders ( Fonds voor Wetenschappelijk Onderzoek, FWO). M. G. and W. E. are doctoral FWO fellows. V. M. M was supported by Spanish CONSOLIDERINGENIO 2010 CSD2007- 00023. This work was supported by grants from Inter- university Attraction Poles Programme ( Belgian Science Policy, P6/ 28), FWO ( G. 0172.03 and G. 0565.07), the Research Council of the KU Leuven ( GOA 2004/ 07) and the Flemish Government ( Excellentiefinanciering, EF/ 95/ 010).	Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; BALDWIN IT, 1993, J CHEM ECOL, V19, P1143, DOI 10.1007/BF00987376; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Carstens E, 1998, J NEUROPHYSIOL, V80, P465, DOI 10.1152/jn.1998.80.2.465; Carstens E, 2007, CHEM SENSES, V32, P811, DOI 10.1093/chemse/bjm048; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Dessirier JM, 2001, PHYSIOL BEHAV, V73, P25, DOI 10.1016/S0031-9384(01)00431-0; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dhar P, 2004, J PHARMACEUT BIOMED, V35, P155, DOI 10.1016/j.jpba.2004.01.009; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Dussor GO, 2003, EUR J NEUROSCI, V18, P2515, DOI 10.1046/j.1460-9568.2003.02935.x; Fajardo O, 2008, CHANNELS, V2, P429, DOI 10.4161/chan.2.6.7126; Fucile S, 2005, J PHYSIOL-LONDON, V565, P219, DOI 10.1113/jphysiol.2005.084871; Haberberger RV, 2004, AUTON NEUROSCI-BASIC, V113, P32, DOI 10.1016/j.autneu.2004.05.008; Hajek P, 1999, ARCH INTERN MED, V159, P2033, DOI 10.1001/archinte.159.17.2033; Hatsukami DK, 2008, LANCET, V371, P2027, DOI 10.1016/S0140-6736(08)60871-5; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kreslake JM, 2008, NICOTINE TOB RES, V10, P705, DOI 10.1080/14622200801979134; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lee L. -Y., 2009, V187, P77, DOI 10.1007/978-3-540-79842-2_5; Liu L, 2004, J NEUROPHYSIOL, V91, P1482, DOI 10.1152/jn.00922.2003; Liu L, 1996, AM J PHYSIOL-CELL PH, V270, pC1807, DOI 10.1152/ajpcell.1996.270.6.C1807; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Meseguer V, 2008, J NEUROSCI, V28, P576, DOI 10.1523/JNEUROSCI.4772-07.2008; Nides M, 2008, AM J MED, V121, pS20, DOI 10.1016/j.amjmed.2008.01.016; Papke RL, 2001, J PHARMACOL EXP THER, V297, P646; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; Simons CT, 2006, J NEUROPHYSIOL, V96, P1877, DOI 10.1152/jn.00345.2006; Simons CT, 2003, BRAIN RES, V991, P249, DOI 10.1016/S0006-8993(03)03539-X; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Talavera K, 2003, J GEN PHYSIOL, V121, P511, DOI 10.1085/jgp.200308793; Talavera K, 2008, TRENDS NEUROSCI, V31, P287, DOI 10.1016/j.tins.2008.03.002; Thuerauf N, 2006, NEUROPSYCHOPHARMACOL, V31, P450, DOI 10.1038/sj.npp.1300842; Togias A, 1999, ALLERGY, V54, P94, DOI 10.1111/j.1398-9995.1999.tb04410.x; Vanoirbeek JAJ, 2004, TOXICOL SCI, V80, P310, DOI 10.1093/toxsci/kfh155; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Widdicombe J, 2006, J APPL PHYSIOL, V101, P628, DOI 10.1152/japplphysiol.00155.2006; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Zanotto KL, 2007, J NEUROPHYSIOL, V97, P966, DOI 10.1152/jn.00996.2006; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	50	187	198	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1293	U14		10.1038/nn.2379	http://dx.doi.org/10.1038/nn.2379			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19749751	Green Submitted, Green Published			2022-12-17	WOS:000270170200018
J	Mukai, J; Dhilla, A; Drew, LJ; Stark, KL; Cao, L; MacDermott, AB; Karayiorgou, M; Gogos, JA				Mukai, Jun; Dhilla, Alefiya; Drew, Liam J.; Stark, Kimberly L.; Cao, Luxiang; MacDermott, Amy B.; Karayiorgou, Maria; Gogos, Joseph A.			Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion	NATURE NEUROSCIENCE			English	Article							DENSITY PROTEIN PSD-95; CARDIO-FACIAL SYNDROME; DELETION SYNDROME; HIPPOCAMPAL-NEURONS; SCHIZOPHRENIA; ASSOCIATION; MICE; TRAFFICKING; ZDHHC8; CONTRIBUTES	Individuals with 22q11.2 microdeletions have cognitive deficits and a high risk of developing schizophrenia. Here we provide evidence that primary hippocampal neurons from a mouse model of 22q11.2 deletion (Df(16)A(+/-) mice) have decreased density of dendritic spines and glutamatergic synapses, as well as impaired dendritic growth. These deficits were prevented by introduction of the enzymatically active ZDHHC8 palmitoyltransferase encoded by a gene in the 22q11.2 locus, and they were also observed in primary cultures from Zdhhc8-deficient mice. Many of these deficits were also present in the hippocampi of adult Df(16)A(+/-) and Zdhhc8-deficient mice. Finally, we provide evidence that PSD95 is one of the substrates of ZDHHC8. Our analysis reveals that 22q11.2 microdeletion results in deficits in neuronal development and suggests that impaired neuronal protein palmitoylation contributes to many of these deficits.	[Stark, Kimberly L.; Karayiorgou, Maria] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [MacDermott, Amy B.; Gogos, Joseph A.] Columbia Univ, Dept Neurosci, Coll Phys & Surg, New York, NY 10032 USA; [Mukai, Jun; Drew, Liam J.; Cao, Luxiang; MacDermott, Amy B.; Gogos, Joseph A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Dhilla, Alefiya] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Karayiorgou, M (corresponding author), Columbia Univ, Dept Psychiat, 1051 Riverside Dr, New York, NY 10032 USA.	mk2758@columbia.edu; jag90@columbia.edu		Albers, Alefiya/0000-0003-2660-6927; Mukai, Jun/0000-0003-2065-4784	US National Institutes of Health [MH67068, MH077235]; McKnight Brain Disorders Award; EJLB Scholar award; NARSAD awards; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067068, R01MH077235] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Brain Disorders Award; EJLB Scholar award; NARSAD awards(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Sribour, A. Abrams-Downey, A. Garcia-Williams and D. Swor for technical support and assistance with the mouse colony; and G. Feng (Duke University) and P. Scheiffele (Columbia University) for constructs. This research was supported in part by the US National Institutes of Health (MH67068 to M. K. and J.A.G. and MH077235 to J.A.G.), a McKnight Brain Disorders Award, an EJLB Scholar award (to J.A.G.) and two NARSAD awards (to J.A.G. and J.M.).	Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Bearden CE, 2001, J CLIN EXP NEUROPSYC, V23, P447, DOI 10.1076/jcen.23.4.447.1228; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Chakravarthy S, 2006, P NATL ACAD SCI USA, V103, P1071, DOI 10.1073/pnas.0506305103; Charych EI, 2006, J NEUROSCI, V26, P10164, DOI 10.1523/JNEUROSCI.2379-06.2006; Chen WY, 2004, HUM MOL GENET, V13, P2991, DOI 10.1093/hmg/ddh322; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Chow EWC, 2006, SCHIZOPHR RES, V87, P270, DOI 10.1016/j.schres.2006.04.007; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Firestein BL, 2000, NEUROREPORT, V11, P3479, DOI 10.1097/00001756-200011090-00016; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gauthier-Campbell C, 2004, MOL BIOL CELL, V15, P2205, DOI 10.1091/mbc.E03-07-0493; Glaser B, 2005, BIOL PSYCHIAT, V58, P78, DOI 10.1016/j.biopsych.2005.03.017; Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Kanaani J, 2004, J CELL SCI, V117, P2001, DOI 10.1242/jcs.01030; Kang RJ, 2004, J BIOL CHEM, V279, P50524, DOI 10.1074/jbc.M404981200; Karayiorgou M, 2004, MOL BRAIN RES, V132, P95, DOI 10.1016/j.molbrainres.2004.09.029; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Linder ME, 2004, J CELL SCI, V117, P521, DOI 10.1242/jcs.00989; McDonald-McGinn DM, 2001, GENET MED, V3, P23, DOI 10.1097/00125817-200101000-00006; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Puech A, 1997, P NATL ACAD SCI USA, V94, P14608, DOI 10.1073/pnas.94.26.14608; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Raux G, 2007, HUM MOL GENET, V16, P83, DOI 10.1093/hmg/ddl443; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Sobin C, 2005, CHILD NEUROPSYCHOL, V11, P39, DOI 10.1080/09297040590911167; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Vessey JP, 2007, J NEUROCHEM, V102, P324, DOI 10.1111/j.1471-4159.2007.04662.x; Washbourne P, 2001, BIOCHEM J, V357, P625, DOI 10.1042/0264-6021:3570625; Woodin M, 2001, GENET MED, V3, P34, DOI 10.1097/00125817-200101000-00008; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162	50	187	191	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2008	11	11					1302	1310		10.1038/nn.2204	http://dx.doi.org/10.1038/nn.2204			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	366HZ	18836441	Green Accepted			2022-12-17	WOS:000260472700019
J	Ward, A; Liu, J; Feng, ZY; Xu, XZS				Ward, Alex; Liu, Jie; Feng, Zhaoyang; Xu, X. Z. Shawn			Light-sensitive neurons and channels mediate phototaxis in C-elegans	NATURE NEUROSCIENCE			English	Article							NUCLEOTIDE-GATED CHANNEL; CAENORHABDITIS-ELEGANS; TOUCH SENSITIVITY; GUANYLYL CYCLASE; CYCLIC-GMP; PHOTOTRANSDUCTION; BEHAVIOR; NEMATODE; EYE; PHOTORECEPTORS	Phototaxis behavior is commonly observed in animals with light-sensing organs. C. elegans, however, is generally believed to lack phototaxis, as this animal lives in darkness ( soil) and does not possess eyes. Here, we found that light stimuli elicited negative phototaxis in C. elegans and that this behavior is important for survival. We identified a group of ciliary sensory neurons as candidate photoreceptor cells for mediating phototaxis. Furthermore, we found that light excited photoreceptor cells by evoking a depolarizing conductance carried by cyclic guanosine monophosphate (cGMP)-sensitive cyclic nucleotide-gated (CNG) channels, revealing a conservation in phototransduction between worms and vertebrates. These results identify a new sensory modality in C. elegans and suggest that animals living in dark environments without light-sensing organs may not be presumed to be light insensitive. We propose that urbilaterians, the last common ancestor of bilaterians, might have already evolved a visual system that employs CNG channels and the second messenger cGMP for phototransduction.	[Ward, Alex; Liu, Jie; Feng, Zhaoyang; Xu, X. Z. Shawn] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Ward, Alex; Xu, X. Z. Shawn] Univ Michigan, Grad Program Neurosci, Ann Arbor, MI 48109 USA; [Xu, X. Z. Shawn] Univ Michigan, Dept Mol & Integrat Phys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, XZS (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	shawnxu@umich.edu	liu, jie/B-4901-2011	liu, jie/0000-0002-1215-5814	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083241, R01GM078276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS076401] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adoutte A, 1999, TRENDS GENET, V15, P104, DOI 10.1016/S0168-9525(98)01671-0; Arendt D, 2002, DEVELOPMENT, V129, P1143; Bargmann C.I., 2006, CHEMOSENSATION C ELE, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Bounoutas A, 2007, PFLUG ARCH EUR J PHY, V454, P691, DOI 10.1007/s00424-006-0187-x; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; BURR AH, 1985, PHOTOCHEM PHOTOBIOL, V41, P577, DOI 10.1111/j.1751-1097.1985.tb03529.x; CHALFIE M, 1985, J NEUROSCI, V5, P956; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; CHITWOOD B. G., 1964, TRANS AMER MICROSCOP SOC, V83, P311, DOI 10.2307/3224742; Cho SW, 2005, MOL CELLS, V19, P149; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; CROLL NA, 1966, NEMATOLOGICA, V12, P610, DOI 10.1163/187529266X00464; DANZIGER RS, 1993, BIOCHEM BIOPH RES CO, V195, P958, DOI 10.1006/bbrc.1993.2137; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; Finn JT, 1997, NATURE, V385, P815, DOI 10.1038/385815a0; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Gabel CV, 2007, J NEUROSCI, V27, P7586, DOI 10.1523/JNEUROSCI.0775-07.2007; Gehring WJ, 2005, J HERED, V96, P171, DOI 10.1093/jhered/esi027; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; HARRIS WA, 1976, J PHYSIOL-LONDON, V256, P415; KANDEL ER, 2000, PRINCIPLES NEURAL SC, P5; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Komatsu H, 1999, BRAIN RES, V821, P160, DOI 10.1016/S0006-8993(99)01111-7; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Miranda-Vizuete A, 2006, FEBS LETT, V580, P484, DOI 10.1016/j.febslet.2005.12.046; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MULSCH A, 1989, N-S ARCH PHARMACOL, V340, P119; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; STERN JH, 1986, P NATL ACAD SCI USA, V83, P1163, DOI 10.1073/pnas.83.4.1163; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	43	187	192	1	63	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					916	922		10.1038/nn.2155	http://dx.doi.org/10.1038/nn.2155			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18604203	Green Accepted			2022-12-17	WOS:000257969100017
J	Shen, H; Gong, QH; Aoki, C; Yuan, ML; Ruderman, Y; Dattilo, M; Williams, K; Smith, SS				Shen, Hui; Gong, Qi Hua; Aoki, Chiye; Yuan, Maoli; Ruderman, Yevgeniy; Dattilo, Michael; Williams, Keith; Smith, Sheryl S.			Reversal of neurosteroid effects at alpha 4 beta 2 delta GABA(A) receptors triggers anxiety at puberty	NATURE NEUROSCIENCE			English	Article							TONIC INHIBITION; ALLOPREGNANOLONE LEVELS; NEURONS; BRAIN; STEROIDS; CHANNEL; METABOLITES; MODULATION; WITHDRAWAL; NUCLEUS	Puberty is characterized by mood swings and anxiety, which are often produced by stress. Here we show that THP ( allopregnanolone), a steroid that is released as a result of stress, increases anxiety in pubertal female mice, in contrast to its anxiety-reducing effect in adults. Anxiety is regulated by GABAergic inhibition in limbic circuits. Although this inhibition is increased by THP administration before puberty and in adults, during puberty THP reduces the tonic inhibition of pyramidal cells in hippocampal region CA1, leading to increased excitability. This paradoxical effect of THP results from inhibition of alpha 4 beta delta GABA(A) receptors. These receptors are normally expressed at very low levels, but at puberty, their expression is increased in hippocampal area CA1, where they generate outward currents. THP also decreases the outward current at recombinant alpha 4 beta 2 delta receptors, and this effect depends on arginine 353 in the alpha 4 subunit, a putative site for modulation by Cl-. Therefore, inhibition of alpha 4 beta 2 delta GABA(A) receptors by THP provides a mechanism for the generation of anxiety at puberty.	Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University	Smith, SS (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	sheryl.smith@downstate.edu	Aoki, Chiye/T-9405-2019	Aoki, Chiye/0000-0003-4010-9425; Smith, Sheryl/0000-0003-4308-3267	NATIONAL EYE INSTITUTE [R01EY013145, P30EY013079, R01EY008055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009618] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY013145, R01 EY013145-04, P30 EY013079-079003, R01 EY008055-09, P30 EY013079] Funding Source: Medline; NIAAA NIH HHS [R01 AA012958] Funding Source: Medline; NIDA NIH HHS [R01 DA009618] Funding Source: Medline; NINDS NIH HHS [R01 NS041091-04, R25 NS080686, R01 NS041091] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agis-Balboa RC, 2006, P NATL ACAD SCI USA, V103, P14602, DOI 10.1073/pnas.0606544103; ALGER BE, 1982, J PHYSIOL-LONDON, V328, P125, DOI 10.1113/jphysiol.1982.sp014256; Andreen L, 2005, PSYCHONEUROENDOCRINO, V30, P212, DOI 10.1016/j.psyneuen.2004.07.003; Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Belelli D, 2005, J NEUROSCI, V25, P11513, DOI 10.1523/JNEUROSCI.2679-05.2005; Belelli D, 2002, NEUROPHARMACOLOGY, V43, P651, DOI 10.1016/S0028-3908(02)00172-7; Bianchi MT, 2002, NEUROPHARMACOLOGY, V43, P492, DOI 10.1016/S0028-3908(02)00163-6; Bitran D, 1999, BRAIN RES, V850, P217, DOI 10.1016/S0006-8993(99)02150-2; BUCHANAN CM, 1992, PSYCHOL BULL, V111, P62, DOI 10.1037/0033-2909.111.1.62; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Chang YC, 1996, J NEUROSCI, V16, P5415; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; Corpechot C, 1997, BRAIN RES, V766, P276, DOI 10.1016/S0006-8993(97)00749-X; Fadalti M, 1999, PEDIATR RES, V46, P323, DOI 10.1203/00006450-199909000-00013; Freeman EW, 2002, J CLIN PSYCHOPHARM, V22, P516, DOI 10.1097/00004714-200210000-00013; FREEMAN EW, 1993, NEUROENDOCRINOLOGY, V58, P478, DOI 10.1159/000126579; Girdler SS, 2006, PSYCHOPHYSIOLOGY, V43, P331, DOI 10.1111/j.1469-8986.2006.00410.x; Haas KF, 1999, J PHYSIOL-LONDON, V514, P27, DOI 10.1111/j.1469-7793.1999.027af.x; Hayward C, 2002, J ADOLESCENT HEALTH, V30, P49, DOI 10.1016/S1054-139X(02)00336-1; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; LAMBERT NA, 1991, J NEUROPHYSIOL, V66, P1538, DOI 10.1152/jn.1991.66.5.1538; Lundgren P, 2003, BRAIN RES, V982, P45, DOI 10.1016/S0006-8993(03)02939-1; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; McEwen BS, 2005, J PSYCHIATR NEUROSCI, V30, P315; Mele P, 2004, J NEUROCHEM, V89, P1471, DOI 10.1111/j.1471-4159.2004.02444.x; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; MODESTI PA, 1994, ANGIOLOGY, V45, P443, DOI 10.1177/000331979404500605; OLSEN RW, 1982, J NEUROSCI, V2, P1812; Perkins KL, 2006, J NEUROSCI METH, V154, P1, DOI 10.1016/j.jneumeth.2006.02.010; Prescott SA, 2003, P NATL ACAD SCI USA, V100, P2076, DOI 10.1073/pnas.0337591100; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Romeo RD, 2005, VITAM HORM, V71, P1, DOI 10.1016/S0083-6729(05)71001-3; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Schmidt PJ, 1998, NEW ENGL J MED, V338, P209, DOI 10.1056/NEJM199801223380401; Smith SS, 2006, PSYCHOPHARMACOLOGY, V186, P323, DOI 10.1007/s00213-005-0168-3; Smith SS, 1998, NATURE, V392, P926, DOI 10.1038/31948; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Turner JH, 2005, J BIOL CHEM, V280, P30741, DOI 10.1074/jbc.M501696200; Ulrich D, 1997, J NEUROSCI, V17, P2348; Wei WZ, 2003, J NEUROSCI, V23, P10650; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002; Wu YM, 2001, J NEUROSCI, V21, P2630, DOI 10.1523/JNEUROSCI.21-08-02630.2001	50	187	191	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					469	477		10.1038/nn1868	http://dx.doi.org/10.1038/nn1868			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17351635	Green Accepted			2022-12-17	WOS:000245228600018
J	Rogers, C; Reale, V; Kim, K; Chatwin, H; Li, C; Evans, P; de Bono, M				Rogers, C; Reale, V; Kim, K; Chatwin, H; Li, C; Evans, P; de Bono, M			Inhibition of Caenorhabditis elegans social feeding by FMRFamide-related peptide activation of NPR-1	NATURE NEUROSCIENCE			English	Article							NEUROPEPTIDE-Y RECEPTOR; NEMATODE ASCARIS-SUUM; C-ELEGANS; DROSOPHILA-MELANOGASTER; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; NATURAL VARIATION; NERVOUS-SYSTEM; GENE; NEURONS	Social and solitary feeding in natural Caenorhabditis elegans isolates are associated with two alleles of the orphan G-protein-coupled receptor (GPCR) NPR-1: social feeders contain NPR-1 215F, whereas solitary feeders contain NPR-1 215V. Here we identify FMRFamide-related neuropeptides (FaRPs) encoded by the flp-18 and flp-21 genes as NPR-1 ligands and show that these peptides can differentially activate the NPR-1 215F and NPR-1 215V receptors. Multicopy overexpression of flp-21 transformed wild social animals into solitary feeders. Conversely, a flp-21 deletion partially phenocopied the npr-1(null) phenotype, which is consistent with NPR-1 activation by FLP-21 in vivo but also implicates other ligands for NPR-1. Phylogenetic studies indicate that the dominant npr-1 215V allele likely arose from an ancestral npr-1 215F gene in C. elegans. Our data suggest a model in which solitary feeding evolved in an ancestral social strain of C. elegans by a gain-of-function mutation that modified the response of NPR-1 to FLP-18 and FLP-21 ligands.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Babraham Inst, Signalling Programme, Cambridge CB2 4AT, England; Boston Univ, Dept Biol, Boston, MA 02215 USA	MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Boston University	de Bono, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	debono@mrc-lmb.cam.ac.uk		de Bono, Mario/0000-0001-8347-0443				AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; Avery L, 1995, CAENORHABDITIS ELEGA, P251; Bargmann C. I., 1997, C ELEGANS, P717; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BLUML K, 1994, J BIOL CHEM, V269, P11537; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHEUNG AH, 1992, MOL PHARMACOL, V41, P1061; Choe JC, 1997, EVOLUTION SOCIAL BEH; CLARK SG, 1994, GENETICS, V137, P987; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; COWDEN C, 1995, PEPTIDES, V16, P491, DOI 10.1016/0196-9781(94)00211-N; Davis MW, 1995, J NEUROSCI, V15, P8408; Davis RE, 1996, PARASITOLOGY, V113, pS97, DOI 10.1017/S0031182000077921; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Denver DR, 2003, MOL BIOL EVOL, V20, P393, DOI 10.1093/molbev/msg044; DRISCOLL M, 1997, C ELEGANS, V2, P645; Edison AS, 1997, PEPTIDES, V18, P929, DOI 10.1016/S0196-9781(97)00047-8; Feng GP, 2003, EUR J NEUROSCI, V18, P227, DOI 10.1046/j.1460-9568.2003.02719.x; Feng GP, 1996, J NEUROSCI, V16, P3925; FITCH DHA, 1997, C ELEGANS, V0002, P00815; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; Hodgkin J, 1997, GENETICS, V146, P149; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Koch R, 2000, GENOME RES, V10, P1690, DOI 10.1101/gr.GR-1471R; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Kubiak TM, 2003, J BIOL CHEM, V278, P33724, DOI 10.1074/jbc.M304861200; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Marks NJ, 2001, BIOCHEM BIOPH RES CO, V286, P1170, DOI 10.1006/bbrc.2001.5524; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Milligan G, 1996, TRENDS PHARMACOL SCI, V17, P235, DOI 10.1016/0165-6147(96)10026-2; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; OKKEMA PG, 1993, GENETICS, V135, P385; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; RAJPARA SM, 1992, NEURON, V9, P505, DOI 10.1016/0896-6273(92)90188-J; Sambongi Y, 1999, NEUROREPORT, V10, P753, DOI 10.1097/00001756-199903170-00017; Silverman SK, 1996, J BIOL CHEM, V271, P30524, DOI 10.1074/jbc.271.48.30524; Sulston J.E., 1988, NEMATODE CAENORHABDI, P587; Sun LJ, 1998, J PHARMACOL EXP THER, V284, P625; Tensen CP, 1998, EUR J NEUROSCI, V10, P3409, DOI 10.1046/j.1460-9568.1998.00350.x; VANRENTERGHEM C, 1987, BRAIN RES, V388, P21; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wilson E.O., 1975, P1; Young LJ, 2001, HORM BEHAV, V40, P133, DOI 10.1006/hbeh.2001.1691	50	187	200	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1178	1185		10.1038/nn1140	http://dx.doi.org/10.1038/nn1140			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14555955				2022-12-17	WOS:000186229200017
J	Handy, TC; Grafton, ST; Shroff, NM; Ketay, S; Gazzaniga, MS				Handy, TC; Grafton, ST; Shroff, NM; Ketay, S; Gazzaniga, MS			Graspable objects grab attention when the potential for action is recognized	NATURE NEUROSCIENCE			English	Article							ACTION-DEFINED TEMPLATES; EYE-HAND COORDINATION; ELECTROPHYSIOLOGICAL EVIDENCE; NEUROPSYCHOLOGICAL EVIDENCE; NEURAL MECHANISMS; PARIETAL CORTEX; LATERALIZATION; REPRESENTATION; LOCALIZATION; PERCEPTION	Visually guided grasping movements require a rapid transformation of visual representations into object-specific motor programs. Here we report that graspable objects may facilitate these visuomotor transformations by automatically grabbing visual spatial attention. Human subjects viewed two task-irrelevant objects-one was a 'tool', the other a 'non-tool'-while waiting for a target to be presented in one of the two object locations. Using event-related potentials (ERPs), we found that spatial attention was systematically drawn to tools in the right and lower visual fields, the hemifields that are dominant for visuomotor processing. Using event-related fMRI, we confirmed that tools grabbed spatial attention only when they also activated dorsal regions of premotor and prefrontal cortices, regions associated with visually guided actions and their planning. Although it is widely accepted that visual sensory gain aids perception, our results suggest that it may also have consequences for object-directed actions.	Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA; Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Dartmouth Coll, Dartmouth Brain Imaging Ctr, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College	Handy, TC (corresponding author), Dartmouth Coll, Ctr Cognit Neurosci, 6162 Moore Hall, Hanover, NH 03755 USA.	todd.c.handy@dartmouth.edu						Batista AP, 2001, J NEUROPHYSIOL, V85, P539, DOI 10.1152/jn.2001.85.2.539; Battaglia-Mayer A, 2001, CEREB CORTEX, V11, P528, DOI 10.1093/cercor/11.6.528; BOLES DB, 1994, BRAIN COGNITION, V24, P184, DOI 10.1006/brcg.1994.1010; Bonfiglioli C, 2002, VIS COGN, V9, P458, DOI 10.1080/13506280143000539; Carey DP, 2000, CURR BIOL, V10, pR416, DOI 10.1016/S0960-9822(00)00508-X; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Colby CL, 1998, NEURON, V20, P15, DOI 10.1016/S0896-6273(00)80429-8; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Craighero L, 1999, J EXP PSYCHOL HUMAN, V25, P1673, DOI 10.1037/0096-1523.25.6.1673; Craighero L, 1996, NEUROREPORT, V8, P347, DOI 10.1097/00001756-199612200-00068; Danckert J, 2001, EXP BRAIN RES, V137, P303; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Duncan J, 1997, CURR OPIN NEUROBIOL, V7, P255, DOI 10.1016/S0959-4388(97)80014-1; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Haaland KY, 1996, CURR OPIN NEUROBIOL, V6, P796, DOI 10.1016/S0959-4388(96)80030-4; Handy TC, 2001, J EXP PSYCHOL HUMAN, V27, P303, DOI 10.1037/0096-1523.27.2.303; Handy TC, 2001, PSYCHOL SCI, V12, P213, DOI 10.1111/1467-9280.00338; Handy TC, 2000, PERCEPT PSYCHOPHYS, V62, P175, DOI 10.3758/BF03212070; HILLYARD SA, 1999, ATTENTION SPACE ACTI, P311; Hodges JR, 1999, P NATL ACAD SCI USA, V96, P9444, DOI 10.1073/pnas.96.16.9444; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Hopfinger JB, 1998, PSYCHOL SCI, V9, P441, DOI 10.1111/1467-9280.00083; Humphreys GW, 2001, NAT NEUROSCI, V4, P84, DOI 10.1038/82940; Humphreys GW, 2001, BEHAV NEUROL, V13, P75; Ivry R.B., 1998, 2 SIDES PERCEPTION; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Kenemans JL, 2000, CLIN NEUROPHYSIOL, V111, P1113, DOI 10.1016/S1388-2457(00)00270-4; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; MANGUN GR, 1988, ELECTROEN CLIN NEURO, V70, P417, DOI 10.1016/0013-4694(88)90019-3; Marconi B, 2001, CEREB CORTEX, V11, P513, DOI 10.1093/cercor/11.6.513; Marotta JJ, 2001, J COGNITIVE NEUROSCI, V13, P8, DOI 10.1162/089892901564135; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Milner A. D., 1995, VISUAL BRAIN ACTION; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Riddoch MJ, 2003, NAT NEUROSCI, V6, P82, DOI 10.1038/nn984; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; Rushworth MFS, 2001, J COGNITIVE NEUROSCI, V13, P698, DOI 10.1162/089892901750363244; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Talairach J., 1988, COPLANAR STEREOTAXIC; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; VANVOORHIS S, 1977, PERCEPT PSYCHOPHYS, V23, P146; WARD R, 1999, ATTENTION SPACE ACTI, P311; Zani A, 1997, J PSYCHOPHYSIOL, V11, P21	50	187	191	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					421	427		10.1038/nn1031	http://dx.doi.org/10.1038/nn1031			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12640459				2022-12-17	WOS:000181833100021
J	Allen, CB; Celikel, T; Feldman, DE				Allen, CB; Celikel, T; Feldman, DE			Long-term depression induced by sensory deprivation during cortical map plasticity in vivo	NATURE NEUROSCIENCE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; RAT BARREL CORTEX; OCULAR DOMINANCE PLASTICITY; SYNAPTIC PLASTICITY; CRITICAL PERIOD; MONOCULAR DEPRIVATION; ALPHA-CAMKII; AREA CA1; POTENTIATION; LTP	Cortical map plasticity is thought to involve long-term depression (LTD) of cortical synapses, but direct evidence for LTD during plasticity or learning in vivo is lacking. One putative role for LTD is in the reduction of cortical responsiveness to behaviorally irrelevant or unused sensory stimuli, a common feature of map plasticity. Here we show that whisker deprivation, a manipulation that drives map plasticity in rat somatosensory cortex (S1), induces detectable LTD-like depression at intracortical excitatory synapses between cortical layer 4 (L4) and L2/3 pyramidal neurons. This synaptic depression occluded further LTD, enhanced LTP, was column specific, and was driven in part by competition between active and inactive whiskers. The synaptic locus of LTD and these properties suggest that LTD underlies the reduction of cortical responses to deprived whiskers, a major component of S1 map plasticity.	Univ Calif San Diego, Program Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Feldman, DE (corresponding author), Univ Calif San Diego, Program Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dfeldman@ucsd.edu	Celikel, Tansu/P-4235-2018		NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER; NCRR NIH HHS [P41-RR09754] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Finnerty GT, 2000, P NATL ACAD SCI USA, V97, P12864, DOI 10.1073/pnas.230175697; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; FOX K, 1992, J NEUROSCI, V12, P1826; Froc DJ, 2000, J NEUROSCI, V20, P438, DOI 10.1523/JNEUROSCI.20-01-00438.2000; GERSTEIN GL, 1969, SCIENCE, V164, P828, DOI 10.1126/science.164.3881.828; Glazewski S, 1998, EUR J NEUROSCI, V10, P2107, DOI 10.1046/j.1460-9568.1998.00222.x; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; Glazewski S, 2000, NAT NEUROSCI, V3, P911, DOI 10.1038/78820; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Hensch TK, 1996, SCIENCE, V272, P554, DOI 10.1126/science.272.5261.554; Heynen AJ, 1996, NATURE, V381, P163, DOI 10.1038/381163a0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lebel D, 2001, CEREB CORTEX, V11, P485, DOI 10.1093/cercor/11.6.485; LI XR, 1995, J COMP NEUROL, V357, P465, DOI 10.1002/cne.903570310; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Rema V, 1998, J NEUROSCI, V18, P10196; Renger JJ, 2002, P NATL ACAD SCI USA, V99, P1041, DOI 10.1073/pnas.022618799; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Walcott EC, 2002, NEUROSCIENCE, V112, P815, DOI 10.1016/S0306-4522(02)00131-8; Wallace H, 2001, J NEUROSCI, V21, P3881, DOI 10.1523/JNEUROSCI.21-11-03881.2001; Wallace H, 1999, SOMATOSENS MOT RES, V16, P122; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029	50	187	191	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					291	299		10.1038/nn1012	http://dx.doi.org/10.1038/nn1012			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12577061				2022-12-17	WOS:000181178300018
J	Kobayashi, T; Ikeda, K; Kojima, H; Niki, H; Yano, R; Yoshioka, T; Kumanishi, T				Kobayashi, T; Ikeda, K; Kojima, H; Niki, H; Yano, R; Yoshioka, T; Kumanishi, T			Ethanol opens G-protein-activated inwardly rectifying K+ channels	NATURE NEUROSCIENCE			English	Article							GAMMA-AMINOBUTYRIC-ACID; KAPPA-OPIOID RECEPTORS; POTASSIUM CHANNEL; FUNCTIONAL COUPLINGS; ALCOHOL-INTOXICATION; GLYCINE RECEPTORS; XENOPUS-OOCYTES; MESSENGER-RNAS; BETA-SUBUNIT; MICE LACKING	Ethanol affects many functions of the brain and peripheral organs. Here we show that ethanol opens G-protein-activated, inwardly rectifying K+ (GIRK) channels, which has important implications for inhibitory regulation of neuronal excitability and heart rate. At pharmacologically relevant concentrations, ethanol activated both brain-type GIRK1/2 and cardiac-type GIRK1/4 channels without interaction with G proteins or second messengers. Moreover, weaver mutant mice, which have a missense mutation in the GIRK2 channel, showed a loss of ethanol-induced analgesia. These results suggest that the GIRK channels in the brain and heart are important target sites for ethanol.	Niigata Univ, Inst Brain Res, Dept Mol Neuropathol, Niigata 9518585, Japan; Niigata Univ, Sch Med, Dept Psychiat, Niigata 9518510, Japan; RIKEN, Brain Sci Inst, Lab Neurobiol Emot, Wako, Saitama 3510198, Japan; RIKEN, Brain Sci Inst, Lab Cellular Informat Proc, Wako, Saitama 3510198, Japan; Waseda Univ, Adv Res Inst Sci & Engn, Tokyo 1698555, Japan; Waseda Univ, Sch Human Sci, Dept Mol Neurobiol, Tokorozawa, Saitama 3591164, Japan	Niigata University; Niigata University; RIKEN; RIKEN; Waseda University; Waseda University	Kobayashi, T (corresponding author), Niigata Univ, Inst Brain Res, Dept Mol Neuropathol, 1-757 Asahimachi, Niigata 9518585, Japan.		Ikeda, Kazutaka/I-4694-2013	Ikeda, Kazutaka/0000-0001-8342-0278				BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; CARLEN PL, 1982, SCIENCE, V215, P306, DOI 10.1126/science.7053581; COVARRUBIAS M, 1993, P NATL ACAD SCI USA, V90, P6957, DOI 10.1073/pnas.90.15.6957; Covernton PJO, 1997, BRIT J PHARMACOL, V122, P1661, DOI 10.1038/sj.bjp.0701568; Devic E, 1996, MECH DEVELOP, V59, P141, DOI 10.1016/0925-4773(96)00588-6; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRIS RA, 1995, P NATL ACAD SCI USA, V92, P3658, DOI 10.1073/pnas.92.9.3658; HOBBS WR, 1996, GOODMAN GILMANS PHAR, P361; Ikeda K, 1999, NEUROSCI RES, V34, P149, DOI 10.1016/S0168-0102(99)00047-4; IKEDA K, 1995, MOL BRAIN RES, V33, P61, DOI 10.1016/0169-328X(95)00107-4; Ikeda K, 1996, ANN NY ACAD SCI, V801, P95, DOI 10.1111/j.1749-6632.1996.tb17434.x; IKEDA K, 1995, BIOCHEM BIOPH RES CO, V208, P302, DOI 10.1006/bbrc.1995.1338; Ikeda K, 1997, MOL BRAIN RES, V45, P117, DOI 10.1016/S0169-328X(96)00252-5; Karschin C, 1996, J NEUROSCI, V16, P3559; Kobayashi T, 1998, BRIT J PHARMACOL, V123, P421, DOI 10.1038/sj.bjp.0701621; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Lakhlani PP, 1997, P NATL ACAD SCI USA, V94, P9950, DOI 10.1073/pnas.94.18.9950; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LI CY, 1994, P NATL ACAD SCI USA, V91, P8200, DOI 10.1073/pnas.91.17.8200; Liao YJ, 1996, J NEUROSCI, V16, P7137; LOVINGER DM, 1991, MOL PHARMACOL, V40, P263; LYON RC, 1981, J PHARMACOL EXP THER, V218, P669; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13, DOI 10.1111/j.1476-5381.1989.tb16855.x; OSMANOVIC SS, 1994, J PHARMACOL EXP THER, V271, P334; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; PENNA M, 1985, ALCOHOL, V2, P603, DOI 10.1016/0741-8329(85)90087-4; PEOPLES RW, 1995, P NATL ACAD SCI USA, V92, P2825, DOI 10.1073/pnas.92.7.2825; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; SHEFNER SA, 1985, ALCOHOL, V2, P239, DOI 10.1016/0741-8329(85)90052-7; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Slesinger PA, 1997, P NATL ACAD SCI USA, V94, P12210, DOI 10.1073/pnas.94.22.12210; TREISTMAN SN, 1991, ANN NY ACAD SCI, V625, P249, DOI 10.1111/j.1749-6632.1991.tb33844.x; Wick MJ, 1998, P NATL ACAD SCI USA, V95, P6504, DOI 10.1073/pnas.95.11.6504; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; Wickman K, 1997, GENOMICS, V40, P395, DOI 10.1006/geno.1997.4599; Yan K, 1996, J BIOL CHEM, V271, P17597, DOI 10.1074/jbc.271.30.17597	40	187	200	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1091	1097		10.1038/16019	http://dx.doi.org/10.1038/16019			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570486				2022-12-17	WOS:000085810100013
J	Poulin, JF; Tasic, B; Hjerling-Leffler, J; Trimarchi, JM; Awatramani, R				Poulin, Jean-Francois; Tasic, Bosiljka; Hjerling-Leffler, Jens; Trimarchi, Jeffrey M.; Awatramani, Rajeshwar			Disentangling neural cell diversity using single-cell transcriptomics	NATURE NEUROSCIENCE			English	Review							MESSENGER-RNA-SEQ; GENE-EXPRESSION; RETINAL GANGLION; COMPUTATIONAL ANALYSIS; STEM-CELLS; GENOME; HETEROGENEITY; NEURONS; INTERNEURONS; MICE	Cellular specialization is particularly prominent in mammalian nervous systems, which are composed of millions to billions of neurons that appear in thousands of different 'flavors' and contribute to a variety of functions. Even in a single brain region, individual neurons differ greatly in their morphology, connectivity and electrophysiological properties. Systematic classification of all mammalian neurons is a key goal towards deconstructing the nervous system into its basic components. With the recent advances in single-cell gene expression profiling technologies, it is now possible to undertake the enormous task of disentangling neuronal heterogeneity. High-throughput single-cell RNA sequencing and multiplexed quantitative RT-PCR have become more accessible, and these technologies enable systematic categorization of individual neurons into groups with similar molecular properties. Here we provide a conceptual and practical guide to classification of neural cell types using single-cell gene expression profiling technologies.	[Poulin, Jean-Francois; Awatramani, Rajeshwar] Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA; [Tasic, Bosiljka] Allen Inst Brain Sci, Dept Mol Genet, Seattle, WA USA; [Hjerling-Leffler, Jens] Karolinska Inst, Div Mol Neurobiol, Dept Med Biochem & Biophys, Stockholm, Sweden; [Trimarchi, Jeffrey M.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA	Northwestern University; Allen Institute for Brain Science; Karolinska Institutet; Iowa State University	Awatramani, R (corresponding author), Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA.	r-awatramani@northwestern.edu	; Hjerling Leffler, Jens/E-3775-2012	Poulin, Jean-Francois/0000-0002-1039-4985; Trimarchi, Jeffrey/0000-0001-7923-1538; Hjerling Leffler, Jens/0000-0002-4539-1776; Tasic, Bosiljka/0000-0002-6861-4506	FRSQ; CIHR; Paul Ruby Foundation; NARSAD; NIH [R21NS092034-01A1, R01 NS096240-01]; Allen Institute for Brain Science; Swedish Research Council (VR); StratNeuro; Hjarnfonden; EU FP7/Marie Curie Actions; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS096240, R21NS092034] Funding Source: NIH RePORTER	FRSQ(Fonds de la Recherche en Sante du Quebec); CIHR(Canadian Institutes of Health Research (CIHR)); Paul Ruby Foundation; NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allen Institute for Brain Science; Swedish Research Council (VR)(Swedish Research Council); StratNeuro; Hjarnfonden; EU FP7/Marie Curie Actions; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank L. Laboissonniere, R. Chowdhury, N. Skene, V. Menon and G. Caronia-Brown for comments on the manuscript. J.-F.P. is supported by FRSQ and CIHR. R.A. is supported by the Paul Ruby Foundation, NARSAD, NIH R21NS092034-01A1 and R01 NS096240-01. B.T. is supported by the Allen Institute for Brain Science. J.H.-L. is supported by Swedish Research Council (VR), StratNeuro, Hjarnfonden, and EU FP7/Marie Curie Actions.	Ahmed ZM, 2008, MOL VIS, V14, P2227; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Bacher R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0927-y; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Beier KT, 2011, P NATL ACAD SCI USA, V108, P15414, DOI 10.1073/pnas.1110854108; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bheda P, 2014, TRENDS CELL BIOL, V24, P712, DOI 10.1016/j.tcb.2014.08.010; Bikoff JB, 2016, CELL, V165, P207, DOI 10.1016/j.cell.2016.01.027; Bota M, 2007, BRAIN RES REV, V56, P79, DOI 10.1016/j.brainresrev.2007.05.005; BRADY G, 1990, Methods in Molecular and Cellular Biology, V2, P17; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/NMETH.2645, 10.1038/nmeth.2645]; Brichta L, 2015, NAT NEUROSCI, V18, P1325, DOI 10.1038/nn.4070; Brichta L, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00152; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Cadwell CR, 2016, NAT BIOTECHNOL, V34, P199, DOI 10.1038/nbt.3445; Callaway EM, 2015, J NEUROSCI, V35, P8979, DOI 10.1523/JNEUROSCI.0409-15.2015; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Cangelosi R, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-2; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Cherry TJ, 2009, P NATL ACAD SCI USA, V106, P9495, DOI 10.1073/pnas.0903264106; Chiu IM, 2014, ELIFE, V3, DOI 10.7554/eLife.04660; Crosetto N, 2015, NAT REV GENET, V16, P57, DOI 10.1038/nrg3832; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Deneris ES, 2014, NAT NEUROSCI, V17, P899, DOI 10.1038/nn.3731; Dey SS, 2015, NAT BIOTECHNOL, V33, P285, DOI 10.1038/nbt.3129; Diaz A, 2016, BIOINFORMATICS, V32, P2219, DOI 10.1093/bioinformatics/btw201; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Fan J, 2016, NAT METHODS, V13, P241, DOI [10.1038/NMETH.3734, 10.1038/nmeth.3734]; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]; Ferguson JM, 2001, J CLIN PSYCHIAT, V62, P22; Fishell G, 2013, NEURON, V80, P602, DOI 10.1016/j.neuron.2013.10.035; Fuccillo MV, 2015, NEURON, V87, P326, DOI 10.1016/j.neuron.2015.06.028; Fuzik J, 2016, NAT BIOTECHNOL, V34, P175, DOI 10.1038/nbt.3443; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Grimm J, 2004, P NATL ACAD SCI USA, V101, P13891, DOI 10.1073/pnas.0405340101; Grun D, 2015, CELL, V163, P799, DOI 10.1016/j.cell.2015.10.039; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Guo MZ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004575; Hanchate NK, 2015, SCIENCE, V350, P1251, DOI 10.1126/science.aad2456; Handley A, 2015, MOL CELL, V58, P621, DOI 10.1016/j.molcel.2015.04.024; Harris JA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00076; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Heimberg G, 2016, CELL SYST, V2, P239, DOI 10.1016/j.cels.2016.04.001; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Holmberg J, 2012, NAT REV GENET, V13, P429, DOI 10.1038/nrg3209; Hu YJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0950-z; Huang ZJ, 2013, ANNU REV NEUROSCI, V36, P183, DOI 10.1146/annurev-neuro-062012-170307; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Johnson MB, 2015, NAT NEUROSCI, V18, P637, DOI 10.1038/nn.3980; Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Klein CA, 2002, NAT BIOTECHNOL, V20, P387, DOI 10.1038/nbt0402-387; Kolodziejczyk AA, 2015, MOL CELL, V58, P610, DOI 10.1016/j.molcel.2015.04.005; Lacar B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11022; LANDIS SC, 1990, TRENDS NEUROSCI, V13, P344, DOI 10.1016/0166-2236(90)90147-3; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li CL, 2016, CELL RES, V26, P83, DOI 10.1038/cr.2015.149; Liu GX, 2014, J CLIN INVEST, V124, P3032, DOI 10.1172/JCI72176; Lodato MA, 2015, SCIENCE, V350, P94, DOI 10.1126/science.aab1785; Lodato S, 2015, ANNU REV CELL DEV BI, V31, P699, DOI 10.1146/annurev-cellbio-100814-125353; Lovatt D, 2015, COLD SPRING HARB PRO, V2015; Lovatt D, 2014, NAT METHODS, V11, P190, DOI [10.1038/NMETH.2804, 10.1038/nmeth.2804]; Lubeck E, 2014, NAT METHODS, V11, P360, DOI 10.1038/nmeth.2892; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Macaulay IC, 2015, NAT METHODS, V12, P519, DOI 10.1038/nmeth.3370; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Niederkofler V, 2015, ACS CHEM NEUROSCI, V6, P1055, DOI 10.1021/acschemneuro.5b00021; O'Leary T, 2015, CURR OPIN NEUROBIOL, V32, P87, DOI 10.1016/j.conb.2015.01.006; Okaty BW, 2015, NEURON, V88, P774, DOI 10.1016/j.neuron.2015.10.007; Okaty BW, 2011, J NEUROSCI, V31, P6939, DOI 10.1523/JNEUROSCI.0626-11.2011; Okaty BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016493; Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pierson E, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0805-z; Plummer NW, 2015, DEVELOPMENT, V142, P4385, DOI 10.1242/dev.129981; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Poulin JF, 2014, CELL REP, V9, P930, DOI 10.1016/j.celrep.2014.10.008; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rajasethupathy P, 2015, NATURE, V526, P653, DOI 10.1038/nature15389; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Roeper J, 2013, TRENDS NEUROSCI, V36, P336, DOI 10.1016/j.tins.2013.03.003; Rossier J, 2015, MOL PSYCHIATR, V20, P154, DOI 10.1038/mp.2014.162; ROWE MH, 1977, BRAIN BEHAV EVOLUT, V14, P185, DOI 10.1159/000125660; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Sasagawa Y, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r31; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Spaethling JM, 2014, FASEB J, V28, P771, DOI 10.1096/fj.13-240267; Spitzer NC, 2015, NEURON, V86, P1131, DOI 10.1016/j.neuron.2015.05.028; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Steinbeck JA, 2015, NEURON, V86, P187, DOI 10.1016/j.neuron.2015.03.002; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Sternson SM, 2014, ANNU REV NEUROSCI, V37, DOI 10.1146/annurev-neuro-071013-014048; Subkhankulova T, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00010; Sulzer D, 2013, MOVEMENT DISORD, V28, P715, DOI 10.1002/mds.25187; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tang JCY, 2015, NAT NEUROSCI, V18, P1334, DOI 10.1038/nn.4081; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Thomsen ER, 2016, NAT METHODS, V13, P87, DOI [10.1038/NMETH.3629, 10.1038/nmeth.3629]; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Trapnell C, 2015, GENOME RES, V25, P1491, DOI 10.1101/gr.190595.115; Treutlein B, 2016, NATURE, V534, P391, DOI 10.1038/nature18323; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Tsafrir D, 2005, BIOINFORMATICS, V21, P2301, DOI 10.1093/bioinformatics/bti329; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vallejos CA, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0930-3; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Xu C, 2015, BIOINFORMATICS, V31, P1974, DOI 10.1093/bioinformatics/btv088; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Ye ZL, 2015, NEURON, V88, P475, DOI 10.1016/j.neuron.2015.10.006; Zador AM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001411; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	150	186	191	3	116	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2016	19	9					1131	1141		10.1038/nn.4366	http://dx.doi.org/10.1038/nn.4366			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU5SA	27571192				2022-12-17	WOS:000382270400009
J	Schmidt-Hieber, C; Hausser, M				Schmidt-Hieber, Christoph; Haeusser, Michael			Cellular mechanisms of spatial navigation in the medial entorhinal cortex	NATURE NEUROSCIENCE			English	Article							GRID CELLS; STELLATE CELLS; SUBTHRESHOLD OSCILLATIONS; PHASE PRECESSION; PATH-INTEGRATION; LAYER-II; THETA; INTERFERENCE; ORGANIZATION; FREQUENCY	Neurons in the medial entorhinal cortex exhibit a grid-like spatial pattern of spike rates that has been proposed to represent a neural code for path integration. To understand how grid cell firing arises from the combination of intrinsic conductances and synaptic input in medial entorhinal stellate cells, we performed patch-clamp recordings in mice navigating in a virtual-reality environment. We found that the membrane potential signature of stellate cells during firing field crossings consisted of a slow depolarization driving spike output. This was best predicted by network models in which neurons receive sustained depolarizing synaptic input during a field crossing, such as continuous attractor network models of grid cell firing. Another key feature of the data, phase precession of intracellular theta oscillations and spiking with respect to extracellular theta oscillations, was best captured by an oscillatory interference model. Thus, these findings provide crucial new information for a quantitative understanding of the cellular basis of spatial navigation in the entorhinal cortex.	[Schmidt-Hieber, Christoph; Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London, England; [Schmidt-Hieber, Christoph; Haeusser, Michael] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London; University of London; University College London	Schmidt-Hieber, C (corresponding author), UCL, Wolfson Inst Biomed Res, London, England.	c.schmidt-hieber@ucl.ac.uk; m.hausser@ucl.ac.uk	Hausser, Michael/AAW-6827-2020	Hausser, Michael/0000-0002-2673-8957; Schmidt-Hieber, Christoph/0000-0002-5328-9704	Wellcome Trust; European Research Council; Gatsby Charitable Foundation; Alexander von Humboldt Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Gatsby Charitable Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We are grateful to N. Burgess, B. Clark, P. Dayan, K. Harris, P. Latham, J. O'Keefe, A. Packer, A. Roth, S. Turaga and C. Wilms for helpful discussions and for comments on the manuscript, and to A. Naeem for assistance with histology. This work was supported by grants from the Wellcome Trust, European Research Council and Gatsby Charitable Foundation, and by a fellowship to C. S.-H. from the Alexander von Humboldt Foundation.	ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; Barry C, 2012, FRONT NEURAL CIRCUIT, V6, DOI [10.3389/fncir.2012.00005, 10.3389/fncir.2012.00030]; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2011, CURR OPIN NEUROBIOL, V21, P734, DOI 10.1016/j.conb.2011.07.002; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Dodson PD, 2011, J PHYSIOL-LONDON, V589, P2993, DOI 10.1113/jphysiol.2011.205021; Fernandez FR, 2008, J NEUROSCI, V28, P3790, DOI 10.1523/JNEUROSCI.5658-07.2008; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2008, HIPPOCAMPUS, V18, P1230, DOI 10.1002/hipo.20472; Garden DLF, 2008, NEURON, V60, P875, DOI 10.1016/j.neuron.2008.10.044; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Haas JS, 2002, J NEUROPHYSIOL, V88, P2422, DOI 10.1152/jn.00598.2002; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Kropff E, 2008, HIPPOCAMPUS, V18, P1256, DOI 10.1002/hipo.20520; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Navratilova Z, 2012, HIPPOCAMPUS, V22, P772, DOI 10.1002/hipo.20939; Nolan MF, 2007, J NEUROSCI, V27, P12440, DOI 10.1523/JNEUROSCI.2358-07.2007; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pastoll H, 2013, NEURON, V77, P141, DOI 10.1016/j.neuron.2012.11.032; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; Reifenstein ET, 2012, P NATL ACAD SCI USA, V109, P6301, DOI 10.1073/pnas.1109599109; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Welday AC, 2011, J NEUROSCI, V31, P16157, DOI 10.1523/JNEUROSCI.0712-11.2011; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Zilli EA, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00016; Zilli EA, 2010, J NEUROSCI, V30, P13850, DOI 10.1523/JNEUROSCI.0547-10.2010	36	186	188	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					325	331		10.1038/nn.3340	http://dx.doi.org/10.1038/nn.3340			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23396102				2022-12-17	WOS:000315474800015
J	Ronesi, JA; Collins, KA; Hays, SA; Tsai, NP; Guo, WR; Birnbaum, SG; Hu, JH; Worley, PF; Gibson, JR; Huber, KM				Ronesi, Jennifer A.; Collins, Katie A.; Hays, Seth A.; Tsai, Nien-Pei; Guo, Weirui; Birnbaum, Shari G.; Hu, Jia-Hua; Worley, Paul F.; Gibson, Jay R.; Huber, Kimberly M.			Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM DEPRESSION; PROTEIN-SYNTHESIS; SELECT BEHAVIORS; MESSENGER-RNAS; TRANSLATION; PHOSPHORYLATION; ACTIVATION; INHIBITION; MECHANISMS	Enhanced metabotropic glutamate receptor subunit 5 (mGluR5) function is causally associated with the pathophysiology of fragile X syndrome, a leading inherited cause of intellectual disability and autism. Here we provide evidence that altered mGluR5-Homer scaffolds contribute to mGluR5 dysfunction and phenotypes in the fragile X syndrome mouse model, Fmr1 knockout (Fmr1(-/y)). In Fmr1(-/y) mice, mGluR5 was less associated with long Homer isoforms but more associated with the short Homer1a. Genetic deletion of Homer1a restored mGluR5-long Homer scaffolds and corrected several phenotypes in Fmr1(-/y) mice, including altered mGluR5 signaling, neocortical circuit dysfunction and behavior. Acute, peptide-mediated disruption of mGluR5-Homer scaffolds in wild-type mice mimicked many Fmr1(-/y) phenotypes. In contrast, Homer1a deletion did not rescue altered mGluR-dependent long-term synaptic depression or translational control of target mRNAs of fragile X mental retardation protein, the gene product of Fmr1. Our findings reveal new functions for mGluR5-Homer interactions in the brain and delineate distinct mechanisms of mGluR5 dysfunction in a mouse model of cognitive dysfunction and autism.	[Ronesi, Jennifer A.; Collins, Katie A.; Hays, Seth A.; Tsai, Nien-Pei; Guo, Weirui; Gibson, Jay R.; Huber, Kimberly M.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Birnbaum, Shari G.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Hu, Jia-Hua; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University	Huber, KM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	kimberly.huber@utsouthwestern.edu	Huber, Kimberly/X-5534-2019; Hays, Seth/U-4701-2019; Guo, Weirui/G-2868-2015	Hays, Seth/0000-0003-4225-241X; 	US National Institutes of Health [NS045711, HD052731, HD056370, GM008203]; Autism Speaks; FRAXA Research Foundation; The Hartwell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056370, R01HD052731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045711] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks; FRAXA Research Foundation; The Hartwell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank L. Ormazabal and N. Cabalo for technical assistance. This research was supported by the grants from the US National Institutes of Health NS045711, HD052731 (K.M.H.), HD056370 (J.R.G.), GM008203 (S.A.H.), Autism Speaks (K.M.H.), FRAXA Research Foundation and The Hartwell Foundation (J.A.R.).	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; BAKKER CE, 1994, CELL, V78, P23; Bangash MA, 2011, CELL, V145, P758, DOI 10.1016/j.cell.2011.03.052; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berry-Kravis E, 2002, DEV MED CHILD NEUROL, V44, P724; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Brown MR, 2010, NAT NEUROSCI, V13, P819, DOI 10.1038/nn.2563; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dolen G, 2010, PHARMACOL THERAPEUT, V127, P78, DOI 10.1016/j.pharmthera.2010.02.008; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Giuffrida R, 2005, J NEUROSCI, V25, P8908, DOI 10.1523/JNEUROSCI.0932-05.2005; Gross C, 2010, J NEUROSCI, V30, P10624, DOI 10.1523/JNEUROSCI.0402-10.2010; Hagerman RJ, 2002, FRAGILE X SYNDROME D, P3; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hays SA, 2011, J NEUROSCI, V31, P14223, DOI 10.1523/JNEUROSCI.3157-11.2011; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Huang GN, 2008, SCIENCE, V319, P476, DOI 10.1126/science.1151227; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Liu ZH, 2009, NEUROSCI LETT, V454, P62, DOI 10.1016/j.neulet.2009.02.066; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Mackiewicz M, 2008, PHYSIOL GENOMICS, V33, P91, DOI 10.1152/physiolgenomics.00189.2007; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Mizutani A, 2008, J NEUROSCI, V28, P5369, DOI 10.1523/JNEUROSCI.4738-07.2008; Muddashetty RS, 2011, MOL CELL, V42, P673, DOI 10.1016/j.molcel.2011.05.006; Orlando LR, 2009, J NEUROCHEM, V110, P557, DOI 10.1111/j.1471-4159.2009.06139.x; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Potschka H, 2002, EUR J NEUROSCI, V16, P2157, DOI 10.1046/j.1460-9568.2002.02265.x; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Ronesi JA, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.15pe6; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; Thomas AM, 2012, PSYCHOPHARMACOLOGY, V219, P47, DOI 10.1007/s00213-011-2375-4; Thomas AM, 2011, BEHAV BRAIN RES, V223, P310, DOI 10.1016/j.bbr.2011.04.049; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5	50	186	188	6	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					431	U122		10.1038/nn.3033	http://dx.doi.org/10.1038/nn.3033			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22267161	Green Accepted			2022-12-17	WOS:000300793100017
J	Nie, D; Di Nardo, A; Han, JM; Baharanyi, H; Kramvis, I; Huynh, T; Dabora, S; Codeluppi, S; Pandolfi, PP; Pasquale, EB; Sahin, M				Nie, Duyu; Di Nardo, Alessia; Han, Juliette M.; Baharanyi, Hasani; Kramvis, Ioannis; Huynh, ThanhThao; Dabora, Sandra; Codeluppi, Simone; Pandolfi, Pier Paolo; Pasquale, Elena B.; Sahin, Mustafa			Tsc2-Rheb signaling regulates EphA-mediated axon guidance	NATURE NEUROSCIENCE			English	Article							TUBEROUS SCLEROSIS COMPLEX; PATTERNED RETINAL ACTIVITY; LOCAL PROTEIN-SYNTHESIS; EPHRIN-AS; TRANSLATION; MECHANISMS; RESPONSES; AUTISM; TSC2; PHOSPHORYLATION	Tuberous sclerosis complex is a disease caused by mutations in the TSC1 or TSC2 genes, which encode a protein complex that inhibits mTOR kinase signaling by inactivating the Rheb GTPase. Activation of mTOR promotes the formation of benign tumors in various organs and the mechanisms underlying the neurological symptoms of the disease remain largely unknown. We found that Tsc2 haploinsufficiency in mice caused aberrant retinogeniculate projections that suggest defects in EphA receptor-dependent axon guidance. We also found that EphA receptor activation by ephrin-A ligands in neurons led to inhibition of extracellular signal-regulated kinase 1/2 (ERK1/2) activity and decreased inhibition of Tsc2 by ERK1/2. Thus, ephrin stimulation inactivates the mTOR pathway by enhancing Tsc2 activity. Furthermore, Tsc2 deficiency and hyperactive Rheb constitutively activated mTOR and inhibited ephrin-induced growth cone collapse. Our results indicate that TSC2-Rheb-mTOR signaling cooperates with the ephrin-Eph receptor system to control axon guidance in the visual system.	[Nie, Duyu; Di Nardo, Alessia; Han, Juliette M.; Baharanyi, Hasani; Kramvis, Ioannis; Huynh, ThanhThao; Sahin, Mustafa] Harvard Univ, Sch Med, Childrens Hosp Boston, FM Kirby Neurobiol Ctr,Dept Neurol, Boston, MA 02115 USA; [Dabora, Sandra] Brigham & Womens Hosp, Dept Med, Translat Med Div, Boston, MA 02115 USA; [Codeluppi, Simone; Pasquale, Elena B.] Burnham Inst Med Res, La Jolla, CA USA; [Codeluppi, Simone; Pasquale, Elena B.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Med, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA USA; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Sahin, M (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, FM Kirby Neurobiol Ctr,Dept Neurol, Boston, MA 02115 USA.	mustafa.sahin@childrens.harvard.edu	codeluppi, simone/I-4143-2012; SAHIN, MUSTAFA/I-8653-2019; Nie, Duyu A./AAR-6211-2020	codeluppi, simone/0000-0002-7053-0520; SAHIN, MUSTAFA/0000-0001-7044-2953; Nie, Duyu A./0000-0002-4280-6956; Di Nardo, Alessia/0000-0002-0025-7290	US National Institutes of Health [NS58956, HD025938]; John Merck Scholars Fund; Tuberous Sclerosis Alliance; Manton Foundation; Children's Hospital Boston Translational Research Program; Children's Hospital Boston Mental Retardation and Developmental Disabilities Research Center [P01 HD18655]; Mentor Based Postdoctoral Fellowship; Hearst Foundation; Howard Hughes Medical Institute Research Training Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058956] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Merck Scholars Fund; Tuberous Sclerosis Alliance; Manton Foundation; Children's Hospital Boston Translational Research Program; Children's Hospital Boston Mental Retardation and Developmental Disabilities Research Center; Mentor Based Postdoctoral Fellowship; Hearst Foundation; Howard Hughes Medical Institute Research Training Fellowship(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Stevens and D. Shafer for assistance with multi-threshold LGN analysis, J.Twiss and T.Merianda for assistance with fluorescence recovery after photobleaching and M. Bear, E. Osterweil and D. Krueger for assistance with metabolic labeling experiments. The Tsc2<SUP>loxP/loxP</SUP> mice were a gift from M. Gambello, and the Tsc1<SUP>loxP/loxP</SUP> mice were gift of D. Kwiatkowski. We are also grateful to B. Stevens, C. Chen, Z. He and members of the Sahin laboratory for critical reading of the manuscript and to L. Mariani, A. Sadowski and S. Goldman for technical assistance. This work was supported in part by grants from the US National Institutes of Health (NS58956 to M. S. and HD025938 to E. B. P.), the John Merck Scholars Fund, Tuberous Sclerosis Alliance, the Manton Foundation and Children's Hospital Boston Translational Research Program to M.S. and the Children's Hospital Boston Mental Retardation and Developmental Disabilities Research Center (P01 HD18655). D.N. is supported by a Mentor Based Postdoctoral Fellowship from Autism Speaks. A.D.N. is supported by a grant from the Hearst Foundation. H.B. is supported by an Howard Hughes Medical Institute Research Training Fellowship for Medical Students.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Bolton PF, 2002, BRAIN, V125, P1247, DOI 10.1093/brain/awf124; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Di Nardo A, 2009, J NEUROSCI, V29, P5926, DOI 10.1523/JNEUROSCI.0778-09.2009; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Ellsworth CA, 2005, J COMP NEUROL, V488, P140, DOI 10.1002/cne.20602; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; Henske EP, 1996, AM J HUM GENET, V59, P400; Hernandez O, 2007, GENESIS, V45, P101, DOI 10.1002/dvg.20271; Huberman AD, 2005, NAT NEUROSCI, V8, P1013, DOI 10.1038/nn1505; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Roche FK, 2009, J NEUROSCI, V29, P638, DOI 10.1523/JNEUROSCI.3845-08.2009; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Torii M, 2009, NATURE, V461, P524, DOI 10.1038/nature08362; VOLPE JJ, 2001, NEUROLOGY NEWBORN, P45; Weber AM, 2000, J AUTISM DEV DISORD, V30, P511, DOI 10.1023/A:1005679108529; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wong M, 2008, EPILEPSIA, V49, P8, DOI 10.1111/j.1528-1167.2007.01270.x; Wong V, 2006, J CHILD NEUROL, V21, P99, DOI 10.1177/08830738060210020901; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029	50	186	188	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					163	U43		10.1038/nn.2477	http://dx.doi.org/10.1038/nn.2477			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20062052	Green Accepted			2022-12-17	WOS:000273985800011
J	Morin, X; Jaouen, F; Durbec, P				Morin, Xavier; Jaouen, Florence; Durbec, Pascale			Control of planar divisions by the G-protein regulator LGN maintains progenitors in the chick neuroepithelium	NATURE NEUROSCIENCE			English	Article							HETEROTRIMERIC G-PROTEINS; ASYMMETRIC CELL DIVISIONS; DROSOPHILA NEUROBLAST; SPINDLE ORIENTATION; PLASMA-MEMBRANE; SIGNALING PATHWAYS; MAMMALIAN-CELLS; CEREBRAL-CORTEX; SIZE ASYMMETRY; GOLOCO MOTIF	The spatio-temporal regulation of symmetrical as opposed to asymmetric cell divisions directs the fate and location of cells in the developing CNS. In invertebrates, G-protein regulators control spindle orientation in asymmetric divisions, which generate progeny with different identities. We investigated the role of the G-protein regulator LGN (also called Gpsm2) in spindle orientation and cell-fate determination in the spinal cord neuroepithelium of the developing chick embryo. We show that LGN is located at the cell cortex and spindle poles of neural progenitors, and that it regulates spindle movements and orientation. LGN promotes planar divisions in the early spinal cord. Interfering with LGN function randomizes the plane of division. Notably, this does not affect cell fate, but frequently leads one daughter of proliferative symmetric divisions to exit the neuroepithelium prematurely and to proliferate aberrantly in the mantle zone. Hence, tight control of planar spindle orientation maintains neural progenitors in the neuroepithelium, and regulates the proper development of the nervous system.	Univ Aix Marseille 2, Marseille, France; CNRS, Inst Dev Biol, UMR6216, F-13288 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Morin, X (corresponding author), Univ Aix Marseille 2, Marseille, France.	morin@ibdml.univ-mrs.fr	morin, xavier/AAI-3306-2020	Morin, Xavier/0000-0001-9999-0355				Adams RJ, 1996, J NEUROSCI, V16, P7610; Bellaiche Y, 2005, CURR OPIN CELL BIOL, V17, P658, DOI 10.1016/j.ceb.2005.10.002; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Blumer JB, 2006, EUR J CELL BIOL, V85, P1233, DOI 10.1016/j.ejcb.2006.08.002; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Hilgers V, 2005, DEV BIOL, V284, P292, DOI 10.1016/j.ydbio.2005.05.021; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Kaushik R, 2003, MOL BIOL CELL, V14, P3144, DOI 10.1091/mbc.E03-04-0212; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Roszko I, 2006, DEV BIOL, V298, P212, DOI 10.1016/j.ydbio.2006.06.031; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Voronina E, 2006, DEV GROWTH DIFFER, V48, P549, DOI 10.1111/j.1440-169x.2006.00895.x; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Wilcock AC, 2007, DEVELOPMENT, V134, P1943, DOI 10.1242/dev.002519; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016; Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL SCI, V116, P887, DOI 10.1242/jcs.00297; Yu FW, 2002, MOL CELL BIOL, V22, P4230, DOI 10.1128/MCB.22.12.4230-4240.2002; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030	50	186	188	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1440	1448		10.1038/nn1984	http://dx.doi.org/10.1038/nn1984			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17934458				2022-12-17	WOS:000250508400022
J	Felsen, G; Dan, Y				Felsen, G; Dan, Y			A natural approach to studying vision	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; RECEPTIVE-FIELD PROPERTIES; SPATIAL-FREQUENCY; V1 NEURONS; INDEPENDENT COMPONENTS; SIMPLE CELLS; SCENES; STATISTICS; RESPONSES	An ultimate goal of systems neuroscience is to understand how sensory stimuli encountered in the natural environment are processed by neural circuits. Achieving this goal requires knowledge of both the characteristics of natural stimuli and the response properties of sensory neurons under natural stimulation. Most of our current notions of sensory processing have come from experiments using simple, parametric stimulus sets. However, a growing number of researchers have begun to question whether this approach alone is sufficient for understanding the real-life sensory tasks performed by the organism. Here, focusing on the early visual pathway, we argue that the use of natural stimuli is vital for advancing our understanding of sensory processing.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Cold Spring Harbor Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Felsen, G (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	ydan@berkeley.edu		Dan, Yang/0000-0002-3818-877X	NEI NIH HHS [R01 EY12561] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012561] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI 10.3109/0954898X.2011.638888; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H., 1961, SENSORY COMMUNICATIO, P217; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bredfeldt CE, 2002, J NEUROSCI, V22, P1976, DOI 10.1523/JNEUROSCI.22-05-01976.2002; Caywood MS, 2004, J NEUROPHYSIOL, V91, P2859, DOI 10.1152/jn.00775.2003; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; Dan Y, 1996, J NEUROSCI, V16, P3351; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P159, DOI 10.1088/0954-898X/6/2/003; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; Felsen G, 2002, NEURON, V36, P945, DOI 10.1016/S0896-6273(02)01011-5; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Hartline HK, 1940, AM J PHYSIOL, V130, P0690, DOI 10.1152/ajplegacy.1940.130.4.690; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1961, J PHYSIOL-LONDON, V155, P385, DOI 10.1113/jphysiol.1961.sp006635; Hyvarinen A, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-12; Karklin Y, 2003, NETWORK-COMP NEURAL, V14, P483, DOI 10.1088/0954-898X/14/3/306; Kayser C, 2003, NEUROCOMPUTING, V52-4, P117, DOI 10.1016/S0925-2312(02)00789-0; Lei YL, 2004, J NEUROSCI METH, V135, P35, DOI 10.1016/j.jneumeth.2003.11.014; Lewen GD, 2001, NETWORK-COMP NEURAL, V12, P317, DOI 10.1088/0954-898X/12/3/305; Lipton P, 2005, SCIENCE, V307, P219, DOI 10.1126/science.1103024; Marmarelis P.Z., 1978, ANAL PHYSL SYSTEMS W; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; Mechler F, 2002, J NEUROSCI, V22, P6129; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; OPPENHEIM AV, 1981, P IEEE, V69, P529, DOI 10.1109/PROC.1981.12022; Passaglia C, 1997, P NATL ACAD SCI USA, V94, P12649, DOI 10.1073/pnas.94.23.12649; Prenger R, 2004, NEURAL NETWORKS, V17, P663, DOI 10.1016/j.neunet.2004.03.008; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Smyth D, 2003, J NEUROSCI, V23, P4746; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Thomson MGA, 2001, NETWORK-COMP NEURAL, V12, P271, DOI 10.1088/0954-898X/12/3/303; Touryan J, 2005, NEURON, V45, P781, DOI 10.1016/j.neuron.2005.01.029; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; WANG Z, 2003, ADV NEURAL INFORM PR, V16; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536	49	186	190	1	31	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1643	1646		10.1038/nn1608	http://dx.doi.org/10.1038/nn1608			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16306891				2022-12-17	WOS:000233576200008
J	Adelsberger, H; Garaschuk, O; Konnerth, A				Adelsberger, H; Garaschuk, O; Konnerth, A			Cortical calcium waves in resting newborn mice	NATURE NEUROSCIENCE			English	Article							ELECTRICAL-ACTIVITY; IN-VIVO; NETWORKS; DIFFERENTIATION; PLASTICITY; SPIKES; CORTEX	Using a new optical fiber - based approach, we demonstrate the presence of recurrent Ca2+ transients in cortical neurons of non-anesthetized newborn mice in vivo. These Ca2+ waves reflect the correlated activity of thousands of cells and were detected only in resting, but not in moving pups. Our results suggest that Ca2+-dependent cortical maturation occurs predominantly during the intermittent sleep-like resting periods that are characteristic for the first days of postnatal life.	Univ Munich, Inst Physiol, D-80336 Munich, Germany	University of Munich	Konnerth, A (corresponding author), Univ Munich, Inst Physiol, Pettenkoferstr 12, D-80336 Munich, Germany.	konnerth@lrz.uni-muenchen.de	Garaschuk, Olga/G-5633-2015					Buonanno A, 1999, CURR OPIN NEUROBIOL, V9, P110, DOI 10.1016/S0959-4388(99)80014-2; Corlew R, 2004, J PHYSIOL-LONDON, V560, P377, DOI 10.1113/jphysiol.2004.071621; DASZUTA A, 1985, BRAIN RES, V354, P39; Feller MB, 2005, CURR OPIN NEUROBIOL, V15, P94, DOI 10.1016/j.conb.2005.01.012; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; GU XN, 1994, J NEUROSCI, V14, P6325; Jouvet-Mounier D, 1970, Dev Psychobiol, V2, P216; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; Spitzer NC, 2004, TRENDS NEUROSCI, V27, P415, DOI 10.1016/j.tins.2004.05.003; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; UYLINGS HBM, 1990, CEREBRAL CORTEX RAT, P36; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0	15	186	195	3	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					988	990		10.1038/nn1502	http://dx.doi.org/10.1038/nn1502			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16007081				2022-12-17	WOS:000230760200008
J	Tagawa, Y; Kanold, PO; Majdan, M; Shatz, CJ				Tagawa, Y; Kanold, PO; Majdan, M; Shatz, CJ			Multiple periods of functional ocular dominance plasticity in mouse visual cortex	NATURE NEUROSCIENCE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; POSTNATAL-DEVELOPMENT; NERVOUS-SYSTEM; COLUMNS; EYE; RETINOGENICULATE; PROJECTIONS; EXPRESSION; GENE; RAT	The precise period when experience shapes neural circuits in the mouse visual system is unknown. We used Arc induction to monitor the functional pattern of ipsilateral eye representation in cortex during normal development and after visual deprivation. After monocular deprivation during the critical period, Arc induction reflects ocular dominance (OD) shifts within the binocular zone. Arc induction also reports faithfully expected OD shifts in cat. Shifts towards the open eye and weakening of the deprived eye were seen in layer 4 after the critical period ends and also before it begins. These shifts include an unexpected spatial expansion of Arc induction into the monocular zone. However, this plasticity is not present in adult layer 6. Thus, functionally assessed OD can be altered in cortex by ocular imbalances substantially earlier and far later than expected.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Shatz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	carla_shatz@hms.harvard.edu		Kanold, Patrick/0000-0002-7529-5435	NEI NIH HHS [R01 EY02858, F32 EY013526-01, F32 EY013526, F32 EY1352] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002858, F32EY013526] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Antonini A, 1999, J NEUROSCI, V19, P4388; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; CAVINESS VS, 1975, J COMP NEUROL, V164, P247, DOI 10.1002/cne.901640207; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; DRAGER UC, 1978, J NEUROPHYSIOL, V41, P28, DOI 10.1152/jn.1978.41.1.28; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; DRAGER UC, 1974, BRAIN RES, V82, P284, DOI 10.1016/0006-8993(74)90607-6; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Gordon JA, 1996, NEURON, V17, P491, DOI 10.1016/S0896-6273(00)80181-6; Gordon JA, 1996, J NEUROSCI, V16, P3274; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hensch TK, 2003, NEUROSCI RES, V47, P17, DOI 10.1016/S0168-0102(03)00164-0; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Hubener M, 2003, CURR OPIN NEUROBIOL, V13, P413, DOI 10.1016/S0959-4388(03)00102-8; Kaczmarek L, 1997, BRAIN RES REV, V23, P237, DOI 10.1016/S0165-0173(97)00005-2; KAGEYAMA GH, 1993, J COMP NEUROL, V335, P123, DOI 10.1002/cne.903350109; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Lein ES, 2000, J NEUROSCI, V20, P1470; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Liu X, 1996, Chin Med Sci J, V11, P93; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Pham TA, 2001, NEURON, V31, P409, DOI 10.1016/S0896-6273(01)00381-6; PHAM TA, 2004, LEARN MEMORY, V11, P1; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Schaeren-Wiemers N, 1997, EUR J NEUROSCI, V9, P2687, DOI 10.1111/j.1460-9568.1997.tb01698.x; Schuett S, 2002, J NEUROSCI, V22, P6549; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2	43	186	193	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					380	388		10.1038/nn1410	http://dx.doi.org/10.1038/nn1410			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15723060				2022-12-17	WOS:000227354600024
J	Kinouchi, R; Takeda, M; Yang, L; Wilhelmsson, U; Lundkvist, A; Pekny, M; Chen, DF				Kinouchi, R; Takeda, M; Yang, L; Wilhelmsson, U; Lundkvist, A; Pekny, M; Chen, DF			Robust neural integration from retinal transplants in mice deficient in GFAP and vimentin	NATURE NEUROSCIENCE			English	Article							FIBRILLARY ACIDIC PROTEIN; STEM-CELLS; PROGENITOR CELLS; INTERMEDIATE-FILAMENTS; NEURONAL SURVIVAL; NEURITE OUTGROWTH; SPINAL-CORD; ASTROCYTES; DIFFERENTIATION; DEVELOP	With recent progress in neuroscience and stem-cell research, neural transplantation has emerged as a promising therapy for treating CNS diseases. The success of transplantation has been limited, however, by the restricted ability of neural implants to survive and establish neuronal connections with the host. Little is known about the mechanisms responsible for this failure. Neural implantation triggers reactive gliosis, a process accompanied by upregulation of intermediate filaments in astrocytes and formation of astroglial scar tissue. Here we show that the retinas of adult mice deficient in glial fibrillary acidic protein and vimentin, and consequently lacking intermediate filaments in reactive astrocytes and Muller cells, provide a permissive environment for grafted neurons to migrate and extend neurites. The transplanted cells integrated robustly into the host retina with distinct neuronal identity and appropriate neuronal projections. Our results indicate an essential role for reactive astroglial cells in preventing neural graft integration after transplantation.	Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Program Neurosci, Boston, MA 02114 USA; Univ Gothenburg, Dept Med Biochem, SE-41390 Gothenburg, Sweden; Asahikawa Med Coll, Dept Ophthalmol, Asahikawa, Hokkaido 0788510, Japan	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; University of Gothenburg; Asahikawa Medical College	Pekny, M (corresponding author), Harvard Univ, Sch Med, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	Milos.Pekny@medkem.gu.se; dfchen@vision.eri.harvard.edu	Kinouchi, Reiko/R-6833-2019; Chen, Dong/AAJ-2444-2020	Chen, Dong/0000-0001-6283-8843; Wilhelmsson, Ulrika/0000-0003-3227-2687; kinouchi, reiko/0000-0003-1344-1641	NATIONAL EYE INSTITUTE [R01EY012983] Funding Source: NIH RePORTER; NEI NIH HHS [EY012983] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Barker RA, 1996, EXP NEUROL, V141, P79, DOI 10.1006/exnr.1996.0141; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; Berson EL, 1999, OPHTHALMOLOGY, V106, P445, DOI 10.1016/S0161-6420(99)90134-3; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Dunnett SB, 1999, NEUROPATH APPL NEURO, V25, P351; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Ghosh F, 2002, GLIA, V40, P78, DOI 10.1002/glia.10121; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; GOURAS P, 1994, INVEST OPHTH VIS SCI, V35, P3145; Kurimoto Y, 2001, NEUROSCI LETT, V306, P57, DOI 10.1016/S0304-3940(01)01857-2; Lu B, 2002, BRAIN RES, V943, P292, DOI 10.1016/S0006-8993(02)02906-2; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Menet V, 2000, GLIA, V31, P267, DOI 10.1002/1098-1136(200009)31:3<267::AID-GLIA80>3.0.CO;2-N; Menet V, 2001, J NEUROSCI, V21, P6147; Nishida A, 2000, INVEST OPHTH VIS SCI, V41, P4268; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Pekny M, 1998, EXP CELL RES, V239, P332, DOI 10.1006/excr.1997.3922; Pekny M, 2001, Prog Brain Res, V132, P23; Qiu J, 2000, GLIA, V29, P166, DOI 10.1002/(SICI)1098-1136(20000115)29:2<166::AID-GLIA10>3.0.CO;2-G; SEILER M, 1988, DEV BRAIN RES, V43, P111, DOI 10.1016/0165-3806(88)90156-3; SMITHTHOMAS LC, 1994, J CELL SCI, V107, P1687; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Svendsen CN, 2001, NAT REV NEUROSCI, V2, P831, DOI 10.1038/35097581; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Van Hoffelen SJ, 2003, INVEST OPHTH VIS SCI, V44, P426, DOI 10.1167/iovs.02-0269; Wang X, 1997, EXP NEUROL, V148, P568, DOI 10.1006/exnr.1997.6702; Xu KX, 1999, GLIA, V25, P390, DOI 10.1002/(SICI)1098-1136(19990215)25:4<390::AID-GLIA8>3.0.CO;2-7; Young MJ, 2000, MOL CELL NEUROSCI, V16, P197, DOI 10.1006/mcne.2000.0869; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zhang YQ, 2003, INVEST OPHTH VIS SCI, V44, P324, DOI 10.1167/iovs.02-0132	39	186	189	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					863	868		10.1038/nn1088	http://dx.doi.org/10.1038/nn1088			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12845328				2022-12-17	WOS:000184413700016
J	Wei, F; Qiu, CS; Liauw, J; Robinson, DA; Ho, N; Chatila, T; Zhuo, M				Wei, F; Qiu, CS; Liauw, J; Robinson, DA; Ho, N; Chatila, T; Zhuo, M			Calcium-calmodulin-dependent protein kinase IV is required for fear memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; CAMP-RESPONSIVE ELEMENT; CREB PHOSPHORYLATION; GENETIC ENHANCEMENT; LATE-PHASE; POTENTIATION; AMYGDALA; NUCLEUS; CONSOLIDATION; TRANSCRIPTION	The ability to remember potential dangers in an environment is necessary to the survival of animals and humans. The cyclic AMP-responsive element binding protein (CREB) is a key transcription factor in synaptic plasticity and memory consolidation. We have found that in CaMKIV-/- mice-which are deficient in a component of the calcium-calmodulin-dependent protein kinase (CaMK) pathway, a major pathway of CREB activation-fear memory, but not persistent pain, was significantly reduced. CREB activation by fear conditioning and synaptic potentiation in the amygdala and cortical areas was reduced or blocked. We propose that cognitive memory related to a noxious shock can be disassociated from behavioral responses to tissue injury and inflammation.	Washington Univ, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Pain Ctr, Dept Anat, St Louis, MO 63110 USA; Washington Univ, Pain Ctr, Dept Neurobiol, St Louis, MO 63110 USA; Washington Univ, Pain Ctr, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Zhuo, M (corresponding author), Washington Univ, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA.	zhuom@morpheus.wustl.edu	Zhuo, Min/A-2072-2008	Zhuo, Min/0000-0001-9062-3241; Chatila, Talal/0000-0001-7439-2762; Robinson, Daphne/0000-0002-8817-6937	PHS HHS [10833, 38680] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; BARTON O, 1979, COMPREHENSIVE ORGANI, V2, P83; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.ne.15.030192.002033; Davis M, 1997, PHILOS T ROY SOC B, V352, P1675, DOI 10.1098/rstb.1997.0149; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Falls WA, 2000, BEHAV NEUROSCI, V114, P998, DOI 10.1037//0735-7044.114.5.998; FOSTER JL, 1984, J BIOL CHEM, V259, P3049; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kerchner GA, 2001, NAT NEUROSCI, V4, P453, DOI 10.1038/87396; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liao BR, 1999, P NATL ACAD SCI USA, V96, P6217, DOI 10.1073/pnas.96.11.6217; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; NAKAMURA Y, 1995, NEUROSCIENCE, V68, P181, DOI 10.1016/0306-4522(95)00092-W; Paxinos G., 1997, MOUSE BRAIN STEREOTA; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SAH P, 1991, J PHYSIOL-LONDON, V433, P615, DOI 10.1113/jphysiol.1991.sp018446; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 2000, J NEUROSCI, V20, P8177; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Teruel MN, 2000, CURR BIOL, V10, P86, DOI 10.1016/S0960-9822(00)00295-5; Wei F, 2001, NAT NEUROSCI, V4, P164, DOI 10.1038/83993; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	50	186	201	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					573	579		10.1038/nn0602-855	http://dx.doi.org/10.1038/nn0602-855			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12006982				2022-12-17	WOS:000175874600018
J	Bedford, FK; Kittler, JT; Muller, E; Thomas, P; Uren, JM; Merlo, D; Wisden, W; Triller, A; Smart, TG; Moss, SJ				Bedford, FK; Kittler, JT; Muller, E; Thomas, P; Uren, JM; Merlo, D; Wisden, W; Triller, A; Smart, TG; Moss, SJ			GABA(A) receptor cell surface number and subunit stability are regulated by the ubiquitin-like protein Plic-1	NATURE NEUROSCIENCE			English	Article							GAMMA-2 SUBUNIT; HIPPOCAMPAL-NEURONS; IDENTIFICATION; SYNAPSES; GLYCINE; LOCALIZATION; ENDOCYTOSIS; EXPRESSION; GEPHYRIN; RESIDUES	Controlling the number of functional gamma -aminobutyric acid A (GABA(A)) receptors in neuronal membranes is a crucial factor for the efficacy of inhibitory neurotransmission. Here we describe the direct interaction of GABA(A) receptors with the ubiquitin-like protein Plic-1. Furthermore, Plic-1 is enriched at inhibitory synapses and is associated with subsynaptic membranes. Functionally, Plic-1 facilitates GABA(A) receptor cell surface expression without affecting the rate of receptor internalization. Plic-1 also enhances the stability of intracellular GABA(A) receptor subunits, increasing the number of receptors available for insertion into the plasma membrane. Our study identifies a previously unknown role for Plic-1, a modulation of GABA(A) receptor cell surface number, which suggests that Plic-1 facilitates accumulation of these receptors in dendritic membranes.	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Dept Pharmacol, London WC1E 6BT, England; INSERM, U497, Dept Biol, Lab Biol Cellulaire Synapse, F-75005 Paris, France; Univ London Sch Pharm, Dept Pharmacol, London WC1E 1AX, England; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of London; University College London; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); University of London; University College London; University of London School of Pharmacy; MRC Laboratory Molecular Biology	Moss, SJ (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	steve.moss@ucl.ac.uk	Wisden, William/A-4071-2011; Kittler, Josef T/E-9113-2010; Merlo, Daniela/K-7986-2016; Kittler, Josef/N-7589-2019	Wisden, William/0000-0003-4743-0334; Kittler, Josef T/0000-0002-3437-9456; Merlo, Daniela/0000-0003-4240-5762; Kittler, Josef/0000-0002-3437-9456; TRILLER, Antoine/0000-0002-7530-1233				BENKE D, 1994, J BIOL CHEM, V269, P27100; Bonnert TP, 1999, P NATL ACAD SCI USA, V96, P9891, DOI 10.1073/pnas.96.17.9891; Colin I, 1998, J COMP NEUROL, V398, P359; Connolly CN, 1999, MOL CELL NEUROSCI, V13, P259, DOI 10.1006/mcne.1999.0746; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Funakoshi M, 1999, EMBO J, V18, P5009, DOI 10.1093/emboj/18.18.5009; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Gorrie GH, 1997, J NEUROSCI, V17, P6587; Hanley JG, 1999, NATURE, V397, P66, DOI 10.1038/16258; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/S0968-0004(96)30015-7; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Kittler JT, 2000, MOL CELL NEUROSCI, V16, P440, DOI 10.1006/mcne.2000.0882; Kittler JT, 2001, MOL CELL NEUROSCI, V18, P13, DOI 10.1006/mcne.2001.1005; Kittler JT, 2000, J NEUROSCI, V20, P7972; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.ne.17.030194.003033; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Taylor PM, 2000, J NEUROSCI, V20, P1297; Taylor PM, 1999, J NEUROSCI, V19, P6360; Todd AJ, 1996, J NEUROSCI, V16, P974; TRILLER A, 1986, P101; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; UNWIN N, 1993, CELL, V72, P31, DOI 10.1016/S0092-8674(05)80026-1; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Williams EJ, 1997, J BIOL CHEM, V272, P22349, DOI 10.1074/jbc.272.35.22349; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x; Wu AL, 1999, MOL CELL, V4, P619, DOI 10.1016/S1097-2765(00)80212-9	43	186	205	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					908	916		10.1038/nn0901-908	http://dx.doi.org/10.1038/nn0901-908			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528422				2022-12-17	WOS:000170698600017
J	Giraux, P; Sirigu, A; Schneider, F; Dubernard, JM				Giraux, P; Sirigu, A; Schneider, F; Dubernard, JM			Cortical reorganization in motor cortex after graft of both hands	NATURE NEUROSCIENCE			English	Article									CNRS, Inst Cognit Sci, F-69675 Bron, France; BD Pasteur, CHU, Dept Phys Med, St Etienne, France; BD Pasteur, CHU, Dept Radiol, St Etienne, France; E Herriot Hosp, Dept Surg Transplant, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CHU de St Etienne; CHU de St Etienne; CHU Lyon	Sirigu, A (corresponding author), CNRS, Inst Cognit Sci, 67 Bd Pinel, F-69675 Bron, France.	sirigu@isc.cnrs.fr	Schneider, Fabien c/G-2086-2015; Giraux, Pascal/D-8105-2018; Sirigu, Angela/L-4683-2017	Schneider, Fabien c/0000-0002-4033-0683; Giraux, Pascal/0000-0002-8581-1472; 				Dubernard JM, 1999, LANCET, V353, P1315, DOI 10.1016/S0140-6736(99)02062-0; KAAS JH, 1981, ORG CEREBRAL CORTEX, P223; Penfield W, 1950, CEREBRAL CORTEX MAN, DOI DOI 10.1001/JAMA.1950.02920160086033; RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826; Roricht S, 1999, NEUROLOGY, V53, P106, DOI 10.1212/WNL.53.1.106; Wu CWH, 2000, NEURON, V28, P967, DOI 10.1016/S0896-6273(00)00167-7; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	7	186	190	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					691	692		10.1038/89472	http://dx.doi.org/10.1038/89472			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	448HK	11426223				2022-12-17	WOS:000169621300012
J	Nobre, AC; Coull, JT; Frith, CD; Mesulam, MM				Nobre, AC; Coull, JT; Frith, CD; Mesulam, MM			Orbitofrontal cortex is activated during breaches of expectation in tasks of visual attention	NATURE NEUROSCIENCE			English	Article							PET		Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Inst Neurol, Wellcome Dept Cognit Neurol, Funct Imaging Lab, London WC1N 3BG, England; Northwestern Univ, Sch Med, Dept Neurol, Chicago, IL 60611 USA	University of Oxford; University of London; University College London; Northwestern University	Nobre, AC (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.		Frith, Chris D/A-2171-2009; Coull, Jennifer T/M-4243-2015	Frith, Chris D/0000-0002-8665-0690; Coull, Jennifer T/0000-0002-8790-5835; Nobre, Anna Christina/0000-0001-5762-2802	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Baker SC, 1997, PSYCHOL MED, V27, P565, DOI 10.1017/S0033291797004856; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, J NEUROSCI, V18, P7426; Craighero L., 1998, ADV PSYCHOL SCI, V2; Damasio AR, 1979, CLIN NEUROPSYCHOLOGY, P360; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Freedman M, 1998, CEREB CORTEX, V8, P18, DOI 10.1093/cercor/8.1.18; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Kawashima R, 1996, BRAIN RES, V728, P79, DOI 10.1016/0006-8993(96)00389-7; Krams M, 1998, EXP BRAIN RES, V120, P386, DOI 10.1007/s002210050412; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; MORECRAFT RJ, 1992, J COMP NEUROL, V323, P341, DOI 10.1002/cne.903230304; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124	15	186	187	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					11	12		10.1038/4513	http://dx.doi.org/10.1038/4513			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195173				2022-12-17	WOS:000078409300006
J	Cai, RY; Pan, CC; Ghasemigharagoz, A; Todorov, MI; Forstera, B; Zhao, S; Bhatia, HS; Parra-Damas, A; Mrowka, L; Theodorou, D; Rempfler, M; Xavier, ALR; Kress, BT; Benakis, C; Steinke, H; Liebscher, S; Bechmann, I; Liesz, A; Menze, B; Kerschensteiner, M; Nedergaard, M; Erturk, A				Cai, Ruiyao; Pan, Chenchen; Ghasemigharagoz, Alireza; Todorov, Mihail Ivilinov; Foerstera, Benjamin; Zhao, Shan; Bhatia, Harsharan S.; Parra-Damas, Arnaldo; Mrowka, Leander; Theodorou, Delphine; Rempfler, Markus; Xavier, Anna L. R.; Kress, Benjamin T.; Benakis, Corinne; Steinke, Hanno; Liebscher, Sabine; Bechmann, Ingo; Liesz, Arthur; Menze, Bjoern; Kerschensteiner, Martin; Nedergaard, Maiken; Ertuerk, Ali			Panoptic imaging of transparent mice reveals whole-body neuronal projections and skull-meninges connections	NATURE NEUROSCIENCE			English	Article							SINGLE-CELL RESOLUTION; CLEARING AGENT; TISSUE; SYSTEM; STABILIZATION; VISUALIZATION; VARIANTS; INJURY; ORGANS; MODEL	Analysis of entire transparent rodent bodies after clearing could provide holistic biological information in health and disease, but reliable imaging and quantification of fluorescent protein signals deep inside the tissues has remained a challenge. Here, we developed vDISCO, a pressure-driven, nanobody-based whole-body immunolabeling technology to enhance the signal of fluorescent proteins by up to two orders of magnitude. This allowed us to image and quantify subcellular details through bones, skin and highly autofluorescent tissues of intact transparent mice. For the first time, we visualized whole-body neuronal projections in adult mice. We assessed CNS trauma effects in the whole body and found degeneration of peripheral nerve terminals in the torso. Furthermore, vDISCO revealed short vascular connections between skull marrow and brain meninges, which were filled with immune cells upon stroke. Thus, our new approach enables unbiased comprehensive studies of the interactions between the nervous system and the rest of the body.	[Cai, Ruiyao; Pan, Chenchen; Ghasemigharagoz, Alireza; Todorov, Mihail Ivilinov; Foerstera, Benjamin; Zhao, Shan; Bhatia, Harsharan S.; Parra-Damas, Arnaldo; Mrowka, Leander; Benakis, Corinne; Liesz, Arthur; Ertuerk, Ali] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Cai, Ruiyao; Pan, Chenchen; Todorov, Mihail Ivilinov; Liesz, Arthur; Ertuerk, Ali] Grad Sch Syst Neurosci Munich, Munich, Germany; [Theodorou, Delphine; Liebscher, Sabine; Kerschensteiner, Martin] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Inst Clin Neuroimmunol, Munich, Germany; [Theodorou, Delphine; Liebscher, Sabine; Kerschensteiner, Martin] Ludwig Maximilians Univ Munchen, Biomed Ctr, Munich, Germany; [Rempfler, Markus; Menze, Bjoern] Tech Univ Munich, Dept Comp Sci, Munich, Germany; [Rempfler, Markus; Menze, Bjoern] Tech Univ Munich, Inst Adv Study, Munich, Germany; [Xavier, Anna L. R.; Kress, Benjamin T.; Nedergaard, Maiken] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Translat Neuromed, Copenhagen, Denmark; [Kress, Benjamin T.; Nedergaard, Maiken] Univ Rochester, Ctr Translat Neuromed, New York, NY USA; [Steinke, Hanno; Bechmann, Ingo] Univ Leipzig, Anat Inst, Leipzig, Germany; [Liebscher, Sabine; Liesz, Arthur; Kerschensteiner, Martin; Ertuerk, Ali] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of Munich; University of Munich; University of Munich; Technical University of Munich; Technical University of Munich; University of Copenhagen; University of Rochester; Leipzig University; University of Munich	Erturk, A (corresponding author), Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany.; Erturk, A (corresponding author), Grad Sch Syst Neurosci Munich, Munich, Germany.; Erturk, A (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.	ali.ertuerk@med.uni-muenchen.de	Parra-Damas, Arnaldo/A-8629-2018; Bhatia, Harsharan singh/AAR-4628-2021; Liesz, Arthur/AAT-7147-2021	Parra-Damas, Arnaldo/0000-0001-5683-060X; Liesz, Arthur/0000-0002-9069-2594; Bhatia, Harsharan Singh/0000-0001-9912-8263; zhao, shan/0000-0002-1778-9381; Steinke, Hanno/0000-0002-7117-9330; Ribeiro Xavier, Anna Lenice/0000-0001-5143-6531; Menze, Bjoern/0000-0003-4136-5690	Vascular Dementia Research Foundation; Synergy Excellence Cluster Munich (SyNergy) [EXC 1010]; ERA-Net Neuron [01EW1501A]; Fritz Thyssen Stiftung [10.17.1.019]; DFG [ER 810/2-1]; National Institutes of Health; Helmholtz ICEMED Alliance; Novo Nordisk Foundation; Howard Hughes Medical Institute; Lundbeck Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RF1NS110049, R01NS100366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048769, RF1AG057575] Funding Source: NIH RePORTER	Vascular Dementia Research Foundation; Synergy Excellence Cluster Munich (SyNergy); ERA-Net Neuron; Fritz Thyssen Stiftung; DFG(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmholtz ICEMED Alliance; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Vascular Dementia Research Foundation, Synergy Excellence Cluster Munich (SyNergy; EXC 1010), ERA-Net Neuron (01EW1501A; A.E.), Fritz Thyssen Stiftung (reference 10.17.1.019MN; A.E.), DFG (reference ER 810/2-1; A.E.), National Institutes of Health (A.E. and M.N.), Helmholtz ICEMED Alliance (A.E.), the Novo Nordisk Foundation (M.N.), the Howard Hughes Medical Institute (B.T.K.) and the Lundbeck Foundation (A.L.R.X. and M.N.). We thank A. Weingart for illustrations, F. Hellal for technical advice and critical reading of the manuscript, and F. P. Quacquarelli and G. Locatelli for help during initial optimization. A.E, C.P., R.C., A.L. and M.I.T. are members of the Graduate School of Systemic Neurosciences at the Ludwig Maximilian University of Munich.	ANDRES KH, 1987, ANAT EMBRYOL, V175, P289, DOI 10.1007/BF00309843; Belle M, 2017, CELL, V169, DOI 10.1016/j.cell.2017.03.008; Belle M, 2014, CELL REP, V9, P1191, DOI 10.1016/j.celrep.2014.10.037; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Choi I, 2011, BLOOD, V117, P362, DOI 10.1182/blood-2010-07-298562; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Costantini I, 2015, SCI REP-UK, V5, DOI 10.1038/srep09808; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Evans TM, 2015, NEUROSCIENCE, V298, P410, DOI 10.1016/j.neuroscience.2015.04.041; Faust N, 2000, BLOOD, V96, P719; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Frei K, 2017, J NEUROL SCI, V379, P183, DOI 10.1016/j.jns.2017.05.040; Gage Gregory J, 2012, J Vis Exp, DOI 10.3791/3564; Gimenez-Arnau A, 2016, CURR PROBL DERMATOL, V49, P123, DOI 10.1159/000441588; Greenbaum A, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6518; Haeryfar SMM, 2004, J IMMUNOL, V173, P3581, DOI 10.4049/jimmunol.173.6.3581; Hama H, 2015, NAT NEUROSCI, V18, P1518, DOI 10.1038/nn.4107; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Herisson F, 2018, NAT NEUROSCI, V21, P1209, DOI 10.1038/s41593-018-0213-2; Hong GS, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0010; Iqbal AJ, 2014, BLOOD, V124, pE33, DOI 10.1182/blood-2014-04-568691; Jing D, 2018, CELL RES, V28, P803, DOI 10.1038/s41422-018-0049-z; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kubota SI, 2017, CELL REP, V20, P236, DOI 10.1016/j.celrep.2017.06.010; Leijnse JN, 2016, J ANAT, V229, P384, DOI 10.1111/joa.12493; Leslie M, 2018, SCIENCE, V360, P593, DOI 10.1126/science.360.6389.594; Llovera G, 2017, ACTA NEUROPATHOL, V134, P851, DOI 10.1007/s00401-017-1758-y; Louveau A, 2017, J CLIN INVEST, V127, P3210, DOI 10.1172/JCI90603; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Murray E, 2015, CELL, V163, P1500, DOI 10.1016/j.cell.2015.11.025; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Noristani HN, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00090; Pan CC, 2016, NAT METHODS, V13, P859, DOI 10.1038/nmeth.3964; Quan TW, 2016, NAT METHODS, V13, P51, DOI [10.1038/NMETH.3662, 10.1038/nmeth.3662]; Renier N, 2016, CELL, V165, P1789, DOI 10.1016/j.cell.2016.05.007; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Treweek JB, 2015, NAT PROTOC, V10, P1860, DOI 10.1038/nprot.2015.122; Tuchin V. V, 2016, OPTICAL METHODS BIOM; Tuchin V. V., 2007, TISSUE OPTICS LIGHT; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Williams G, 2013, BRAIN INJURY, V27, P434, DOI 10.3109/02699052.2012.750754; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017	53	185	189	8	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2019	22	2					317	+		10.1038/s41593-018-0301-3	http://dx.doi.org/10.1038/s41593-018-0301-3			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HI9BQ	30598527	Green Submitted, Green Accepted			2022-12-17	WOS:000456750100018
J	Jucker, M; Walker, LC				Jucker, Mathias; Walker, Lary C.			Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases	NATURE NEUROSCIENCE			English	Review							PATHOLOGICAL ALPHA-SYNUCLEIN; PRION-LIKE PROPAGATION; A-BETA SEEDS; CREUTZFELDT-JAKOB-DISEASE; SYNTHETIC TAU FIBRILS; SOLUBLE AMYLOID-BETA; ALZHEIMERS-DISEASE; UNCONVENTIONAL SECRETION; NEUROFIBRILLARY TANGLES; REGIONAL VULNERABILITY	Many neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis, are characterized by the progressive appearance of abnormal proteinaceous assemblies in the nervous system. Studies in experimental systems indicate that the assemblies originate from the prion-like seeded aggregation of specific misfolded proteins that proliferate and amass to form the intracellular and/or extracellular lesions typical of each disorder. The host in which the proteopathic seeds arise provides the biochemical and physiological environment that either supports or restricts their emergence, proliferation, self-assembly, and spread. Multiple mechanisms influence the spatiotemporal spread of seeds and the nature of the resulting lesions, one of which is the cellular uptake, release, and transport of seeds along neural pathways and networks. The characteristics of cells and regions in the affected network govern their vulnerability and thereby influence the neuropathological and clinical attributes of the disease. The propagation of pathogenic protein assemblies within the nervous system is thus determined by the interaction of the proteopathic agent and the host milieu.	[Jucker, Mathias] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Tubingen, Germany; [Jucker, Mathias] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Walker, Lary C.] Emory Univ, Dept Neurol, Atlanta, GA USA; [Walker, Lary C.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Emory University; Emory University	Jucker, M (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Tubingen, Germany.; Jucker, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany.	rnathias.juckera@uni-tuebingen.de; lary.walker@emory.edu	Walker, L C/J-6541-2015	Walker, L C/0000-0001-9166-3261; Jucker, Mathias/0000-0001-9045-1072	EC Joint Programme on Neurodegenerative Diseases under the Grant JPND-NewTargets; EC Joint Programme on Neurodegenerative Diseases under the Grant JPND-REfrAME; Horizon 2020 IMPRiND; National Institutes of Health (NIH) [P50 AG025688, ORIP/OD P51OD011132]; Alexander von Humboldt Foundation; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	EC Joint Programme on Neurodegenerative Diseases under the Grant JPND-NewTargets; EC Joint Programme on Neurodegenerative Diseases under the Grant JPND-REfrAME; Horizon 2020 IMPRiND; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Rasmussen, M. Bacioglu, and the members of our laboratories for critical discussions and comments. The help of A. Apel and G. Rose with the manuscript and figures is gratefully acknowledged. Supported by the EC Joint Programme on Neurodegenerative Diseases under the Grants JPND-NewTargets and JPND-REfrAME (M.J.), Horizon 2020 IMPRiND (M.J.), National Institutes of Health (NIH) grants P50 AG025688 and ORIP/OD P51OD011132, and by the Alexander von Humboldt Foundation (L.C.W.).	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Ayers JI, 2017, J VIROL, V91, DOI 10.1128/JVI.02095-16; Ayers JI, 2014, ACTA NEUROPATHOL, V128, P791, DOI 10.1007/s00401-014-1342-7; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Bolmont T, 2007, AM J PATHOL, V171, P2012, DOI 10.2353/ajpath.2007.070403; Boluda S, 2015, ACTA NEUROPATHOL, V129, P221, DOI 10.1007/s00401-014-1373-0; Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brahic M, 2016, ACTA NEUROPATHOL, V131, P539, DOI 10.1007/s00401-016-1538-0; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Brown P, 2012, EMERG INFECT DIS, V18, P901, DOI 10.3201/eid1806.120116; Burwinkel M, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0511-7; Busche MA, 2012, P NATL ACAD SCI USA, V109, P8740, DOI 10.1073/pnas.1206171109; Cali I, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-017-0503-z; Cicchetti F, 2014, ANN NEUROL, V76, P31, DOI 10.1002/ana.24174; Clavaguera F, 2014, ACTA NEUROPATHOL, V127, P299, DOI 10.1007/s00401-013-1231-5; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cohen ML, 2015, BRAIN, V138, P1009, DOI 10.1093/brain/awv006; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collinge J, 2016, NATURE, V539, P217, DOI 10.1038/nature20415; Condello C, 2018, P NATL ACAD SCI USA, V115, pE782, DOI 10.1073/pnas.1714966115; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; DEARMOND SJ, 1995, AM J PATHOL, V146, P785; Del Tredici K, 2016, NEUROPATH APPL NEURO, V42, P33, DOI 10.1111/nan.12298; DeVos SL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00267; Di Fede G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21641-1; Diack AB, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010082; Domert J, 2014, NEUROBIOL DIS, V65, P82, DOI 10.1016/j.nbd.2013.12.019; Dubois B, 2016, ALZHEIMERS DEMENT, V12, P292, DOI 10.1016/j.jalz.2016.02.002; Duyckaerts C, 2018, ACTA NEUROPATHOL, V135, P201, DOI 10.1007/s00401-017-1791-x; Eisele YS, 2014, J NEUROSCI, V34, P10264, DOI 10.1523/JNEUROSCI.1608-14.2014; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Freer R, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600947; Fritschi SK, 2014, BRAIN, V137, P2909, DOI 10.1093/brain/awu255; Fritschi SK, 2014, ACTA NEUROPATHOL, V128, P477, DOI 10.1007/s00401-014-1339-2; Frontzek K, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14287; Gerson J, 2016, J NEUROTRAUM, V33, P2034, DOI 10.1089/neu.2015.4262; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gremer L, 2017, SCIENCE, V358, P116, DOI 10.1126/science.aao2825; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Hamaguchi T, 2016, ACTA NEUROPATHOL, V132, P313, DOI 10.1007/s00401-016-1588-3; Hamaguchi T, 2012, ACTA NEUROPATHOL, V123, P31, DOI 10.1007/s00401-011-0912-1; He ZH, 2018, NAT MED, V24, P29, DOI 10.1038/nm.4443; Heilbronner G, 2013, EMBO REP, V14, P1017, DOI 10.1038/embor.2013.137; Herve D, 2018, ACTA NEUROPATHOL, V135, P801, DOI 10.1007/s00401-018-1828-9; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Hu PP, 2016, J BIOL CHEM, V291, P12880, DOI 10.1074/jbc.M115.681791; Iba M, 2015, ACTA NEUROPATHOL, V130, P349, DOI 10.1007/s00401-015-1458-4; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Imran M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-559; Imran M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-493; Irwin DJ, 2016, ANN NEUROL, V79, P272, DOI 10.1002/ana.24559; Irwin DJ, 2013, JAMA NEUROL, V70, P462, DOI 10.1001/jamaneurol.2013.1933; Iturria-Medina Y, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00090; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jackson SJ, 2016, J NEUROSCI, V36, P762, DOI 10.1523/JNEUROSCI.3542-15.2016; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jeon I, 2016, ACTA NEUROPATHOL, V132, P577, DOI 10.1007/s00401-016-1582-9; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Katsinelos T, 2018, CELL REP, V23, P2039, DOI 10.1016/j.celrep.2018.04.056; Kaufman SK, 2018, ACTA NEUROPATHOL, V136, P57, DOI 10.1007/s00401-018-1855-6; Kaufman SK, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0442-8; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kim C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002835; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P911, DOI 10.1007/s00401-016-1565-x; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Li T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12082; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luna E, 2018, ACTA NEUROPATHOL, V135, P855, DOI 10.1007/s00401-018-1829-8; Mao XB, 2016, SCIENCE, V353, DOI 10.1126/science.aah3374; Marzesco AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28125; Masuda-Suzukake M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0088-8; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Mattsson N, 2016, J NEUROL NEUROSUR PS, V87, P1000, DOI 10.1136/jnnp-2015-311321; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mead S, 2015, NAT REV NEUROL, V11, P90, DOI 10.1038/nrneurol.2014.263; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Mezias C, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00653; Mirbaha H, 2015, J BIOL CHEM, V290, P14893, DOI 10.1074/jbc.M115.652693; Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; Novotny R, 2016, J NEUROSCI, V36, P5084, DOI 10.1523/JNEUROSCI.0258-16.2016; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Palmqvist S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01150-x; Parkinson J, 2002, J NEUROPSYCH CLIN N, V14, P223, DOI 10.1176/appi.neuropsych.14.2.223; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Peng C, 2018, NATURE, V557, P558, DOI 10.1038/s41586-018-0104-4; Phinney AL, 1999, J NEUROSCI, V19, P8552; Pooler AM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0199-x; Porta Y.X., NAT COMMUN; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Qiang W, 2017, NATURE, V541, P217, DOI 10.1038/nature20814; Rangel A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-8; Rasmussen J, 2018, ACTA NEUROPATHOL, V135, P965, DOI 10.1007/s00401-018-1848-5; Rasmussen J, 2017, P NATL ACAD SCI USA, V114, P13018, DOI 10.1073/pnas.1713215114; Recasens A, 2014, ANN NEUROL, V75, P351, DOI 10.1002/ana.24066; Rey NL, 2016, J EXP MED, V213, P1759, DOI 10.1084/jem.20160368; Ritchie DL, 2017, ACTA NEUROPATHOL, V134, P221, DOI 10.1007/s00401-017-1703-0; Ruiz-Riquelme A, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0529-x; Sacino AN, 2014, P NATL ACAD SCI USA, V111, P10732, DOI 10.1073/pnas.1321785111; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; SAPER CB, 1987, NEUROSCIENCE, V23, P389, DOI 10.1016/0306-4522(87)90063-7; Sargent D, 2017, J NEUROCHEM, V143, P126, DOI 10.1111/jnc.14139; Schweighauser M, 2015, ACTA NEUROPATHOL, V129, P157, DOI 10.1007/s00401-014-1360-5; Shen MM, 2015, NATURE, V520, P298, DOI 10.1038/nature14377; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Stancu IC, 2015, ACTA NEUROPATHOL, V129, P875, DOI 10.1007/s00401-015-1413-4; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Supattapone S, 2014, J BIOL CHEM, V289, P19850, DOI 10.1074/jbc.R113.511329; Surmeier J, 2017, J NEUROSCI, V37, P9799, DOI 10.1523/JNEUROSCI.1787-16.2017; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Vasconcelos B, 2016, ACTA NEUROPATHOL, V131, P549, DOI 10.1007/s00401-015-1525-x; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Walker LC, 2015, ANNU REV NEUROSCI, V38, P87, DOI 10.1146/annurev-neuro-071714-033828; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Will RG, 2003, BRIT MED BULL, V66, P255, DOI 10.1093/bmb/66.1.255; Wille H, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7010020; Woerman AL, 2018, P NATL ACAD SCI USA, V115, P409, DOI 10.1073/pnas.1719369115; Woerman AL, 2018, ACTA NEUROPATHOL, V135, P49, DOI 10.1007/s00401-017-1762-2; Wu JW, 2016, NAT NEUROSCI, V19, P1085, DOI 10.1038/nn.4328; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yamada K, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0241-0; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Ye L, 2017, EMBO REP, V18, P1536, DOI 10.15252/embr.201744067; Ye L, 2015, NAT NEUROSCI, V18, P1559, DOI 10.1038/nn.4117; Ye L, 2015, BRAIN PATHOL, V25, P743, DOI 10.1111/bpa.12252; Yetman MJ, 2016, BRAIN STRUCT FUNCT, V221, P2231, DOI 10.1007/s00429-015-1040-9; Zhou QH, 2017, EMBO MOL MED, V9, P687, DOI 10.15252/emmm.201607054	152	185	187	10	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2018	21	10					1341	1349		10.1038/s41593-018-0238-6	http://dx.doi.org/10.1038/s41593-018-0238-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU9FY	30258241	Green Accepted			2022-12-17	WOS:000445651600009
J	Dajas-Bailador, F; Bonev, B; Garcez, P; Stanley, P; Guillemot, F; Papalopulu, N				Dajas-Bailador, Federico; Bonev, Boyan; Garcez, Patricia; Stanley, Peter; Guillemot, Francois; Papalopulu, Nancy			microRNA-9 regulates axon extension and branching by targeting Map1b in mouse cortical neurons	NATURE NEUROSCIENCE			English	Article							LOCAL TRANSLATION; BDNF; POLARITY; PROTEIN	The capacity of neurons to develop a long axon and multiple dendrites defines neuron connectivity in the CNS. The highly conserved microRNA-9 (miR-9) is expressed in both neuronal precursors and some post-mitotic neurons, and we detected miR-9 expression in the axons of primary cortical neurons. We found that miR-9 controlled axonal extension and branching by regulating the levels of Map1b, an important protein for microtubule stability. Following microfluidic separation of the axon and the soma, we found that miR-9 repressed Map1b translation and was a functional target for the BDNF-dependent control of axon extension and branching. We propose that miR-9 links regulatory signaling processes with dynamic translation mechanisms, controlling Map 1b protein levels and axon development.	[Dajas-Bailador, Federico; Bonev, Boyan; Stanley, Peter; Papalopulu, Nancy] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Garcez, Patricia; Guillemot, Francois] Natl Inst Med Res, Div Mol Neurobiol, London NW7 1AA, England	University of Manchester; MRC National Institute for Medical Research	Dajas-Bailador, F (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg, Manchester, Lancs, England.	f.dajas-bailador@manchester.ac.uk; nancy.papalopulu@manchester.ac.uk	Garcez, Patricia/F-8026-2012; Guillemot, Francois/AAV-1482-2021; Neurociencia, Inct/I-1011-2013	Garcez, Patricia/0000-0002-9107-1335; Papalopulu, Nancy/0000-0001-6992-6870; Dajas-Bailador, Federico/0000-0002-2212-1482; Bonev, Boyan/0000-0002-7502-9399	Wellcome Trust [090868, GR083272]; Medical Research Council [G0900584]; Medical Research Council [MC_U117570528] Funding Source: researchfish; MRC [G0900584, MC_U117570528] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Wellcome Trust (090868, NP.; GR083272, B.B.), and Medical Research Council (grant G0900584, F.D.-B., P.S. and NP.; institutional funds, PG., PG.) funded this work.	Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Baudet ML, 2012, NAT NEUROSCI, V15, P29, DOI 10.1038/nn.2979; BLACK MM, 1994, J NEUROSCI, V14, P857; Bouquet C, 2004, J NEUROSCI, V24, P7204, DOI 10.1523/JNEUROSCI.2254-04.2004; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Gibson DA, 2011, DEVELOPMENT, V138, P183, DOI 10.1242/dev.046441; Hengst U, 2009, NAT CELL BIOL, V11, P1024, DOI 10.1038/ncb1916; Hoshino N, 2010, DEV NEUROSCI-BASEL, V32, P184, DOI 10.1159/000313902; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Montenegro-Venegas C, 2010, MOL BIOL CELL, V21, P3518, DOI 10.1091/mbc.E09-08-0709; Natera-Naranjo O, 2010, RNA, V16, P1516, DOI 10.1261/rna.1833310; Olsson-Carter K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001054; Panagiotaki N, 2010, DEVELOPMENT, V137, P4005, DOI 10.1242/dev.053173; Santos AR, 2010, PROG NEUROBIOL, V92, P505, DOI 10.1016/j.pneurobio.2010.08.004	15	185	186	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					697	699		10.1038/nn.3082	http://dx.doi.org/10.1038/nn.3082			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22484572				2022-12-17	WOS:000303270200012
J	McCall, C; Singer, T				McCall, Cade; Singer, Tania			The animal and human neuroendocrinology of social cognition, motivation and behavior	NATURE NEUROSCIENCE			English	Review							OXYTOCIN RECEPTOR DENSITY; EXOGENOUS TESTOSTERONE; ARGININE-VASOPRESSIN; INTRANASAL OXYTOCIN; AGGRESSIVE-BEHAVIOR; PATERNAL BEHAVIOR; NUCLEUS-ACCUMBENS; STRESS RESPONSES; NEURAL CIRCUITRY; INCREASES TRUST	Extensive animal and recent human research have helped inform neuroendocrinological models of social cognition, motivation and behavior. In this review, we first summarize important findings regarding oxytocin, arginine vasopressin and testosterone in the domains of affiliation, social cognition, aggression and stress/anxiety. We then suggest ways in which human research can continue to profit from animal research, particularly by exploring the interactive nature of neuromodulatory effects at neurochemical, organismic and contextual levels. We further propose methods inspired by the animal literature for the ecologically valid assessment of affiliative behavior in humans. We conclude with suggestions for how human research could advance by directly assessing specific social cognitive and motivational mechanisms as intermediate variables. We advocate a more comprehensive look at the distinct networks identified by social neuroscience and the importance of a motivational state, in addition to approach and avoidance, associated with quiescence and homeostatic regulation.	[McCall, Cade; Singer, Tania] Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany	Max Planck Society	Singer, T (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany.	singer@cbs.mpg.de	Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378; McCall, Cade/0000-0003-0746-8899				Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; Amico JA, 2004, J NEUROENDOCRINOL, V16, P319, DOI 10.1111/j.0953-8194.2004.01161.x; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1111/1469-7610.00715; Baron-Cohen S., 1997, MINDBLINDNESS ESSAY; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Bos PA, 2012, FRONT NEUROENDOCRIN, V33, P17, DOI 10.1016/j.yfrne.2011.01.002; Bos PA, 2010, P NATL ACAD SCI USA, V107, P9991, DOI 10.1073/pnas.0911700107; Bosch OJ, 2010, EUR J NEUROSCI, V31, P883, DOI 10.1111/j.1460-9568.2010.07115.x; Brown CH, 2000, NEUROSCI RES, V36, P97, DOI 10.1016/S0168-0102(99)00121-2; Burgdorf J, 2006, NEUROSCI BIOBEHAV R, V30, P173, DOI 10.1016/j.neubiorev.2005.06.001; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Carter CS, 2009, DEV NEUROSCI-BASEL, V31, P332, DOI 10.1159/000216544; Chen FS, 2011, P NATL ACAD SCI USA, V108, pE45, DOI 10.1073/pnas.1101633108; CSIFFARY A, 1992, NEUROENDOCRINOLOGY, V56, P429, DOI 10.1159/000126259; Cushing BS, 2003, J NEUROENDOCRINOL, V15, P1021, DOI 10.1046/j.1365-2826.2003.01097.x; D'Cunha TM, 2011, HORM BEHAV, V59, P14, DOI 10.1016/j.yhbeh.2010.09.007; De Dreu CKW, 2011, P NATL ACAD SCI USA, V108, P1262, DOI 10.1073/pnas.1015316108; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Declerck CH, 2010, HORM BEHAV, V57, P368, DOI 10.1016/j.yhbeh.2010.01.006; Depue RA, 2005, BEHAV BRAIN SCI, V28, P313; Detillion CE, 2004, PSYCHONEUROENDOCRINO, V29, P1004, DOI 10.1016/j.psyneuen.2003.10.003; Ditzen B, 2009, BIOL PSYCHIAT, V65, P728, DOI 10.1016/j.biopsych.2008.10.011; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Domes G, 2010, PSYCHONEUROENDOCRINO, V35, P83, DOI 10.1016/j.psyneuen.2009.06.016; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Eisenegger C, 2010, NATURE, V463, P356, DOI 10.1038/nature08711; Eisenegger C, 2011, TRENDS COGN SCI, V15, P263, DOI 10.1016/j.tics.2011.04.008; Engelmann M, 2004, FRONT NEUROENDOCRIN, V25, P132, DOI 10.1016/j.yfrne.2004.09.001; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; FERRIS CF, 1992, ANN NY ACAD SCI, V652, P456, DOI 10.1111/j.1749-6632.1992.tb34382.x; Frye CA, 2001, COGN AFFECT BEHAV NE, V1, P371, DOI 10.3758/CABN.1.4.371; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gamer M, 2010, P NATL ACAD SCI USA, V107, P9400, DOI 10.1073/pnas.1000985107; Gordon I, 2011, DEV COGN NEUROS-NETH, V1, P471, DOI 10.1016/j.dcn.2011.07.007; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Guastella AJ, 2011, PSYCHONEUROENDOCRINO, V36, P294, DOI 10.1016/j.psyneuen.2010.07.023; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P1220, DOI 10.1016/j.biopsych.2010.03.014; HANDA RJ, 1994, HORM BEHAV, V28, P464, DOI 10.1006/hbeh.1994.1044; Heim C, 2009, MOL PSYCHIATR, V14, P954, DOI 10.1038/mp.2008.112; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Heinrichs M, 2008, PROG BRAIN RES, V170, P337, DOI 10.1016/S0079-6123(08)00428-7; Hermans EJ, 2006, BIOL PSYCHIAT, V59, P872, DOI 10.1016/j.biopsych.2005.11.015; Hermans EJ, 2008, BIOL PSYCHIAT, V63, P263, DOI 10.1016/j.biopsych.2007.05.013; Hermans EJ, 2007, PSYCHONEUROENDOCRINO, V32, P1052, DOI 10.1016/j.psyneuen.2007.08.006; Hermans EJ, 2010, NEUROIMAGE, V52, P277, DOI 10.1016/j.neuroimage.2010.04.019; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Keri S, 2009, COGN AFFECT BEHAV NE, V9, P237, DOI 10.3758/CABN.9.3.237; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; KOOLHAAS JM, 1990, AGGRESSIVE BEHAV, V16, P223; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lim MM, 2004, NEUROSCIENCE, V125, P35, DOI 10.1016/j.neuroscience.2003.12.008; McCall C, 2009, SOC INFLUENCE, V4, P138, DOI 10.1080/15534510802517418; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Mikolajczak M, 2010, BIOL PSYCHOL, V85, P182, DOI 10.1016/j.biopsycho.2010.05.010; Mitchell JP, 2009, PHILOS T R SOC B, V364, P1309, DOI 10.1098/rstb.2008.0318; Muller MN, 2004, ANIM BEHAV, V67, P113, DOI 10.1016/j.anbehav.2003.03.013; Naber F, 2010, PSYCHONEUROENDOCRINO, V35, P1583, DOI 10.1016/j.psyneuen.2010.04.007; Nelson EE, 1998, NEUROSCI BIOBEHAV R, V22, P437, DOI 10.1016/S0149-7634(97)00052-3; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Olazabal DE, 2006, HORM BEHAV, V49, P681, DOI 10.1016/j.yhbeh.2005.12.010; Pace TWW, 2009, PSYCHONEUROENDOCRINO, V34, P87, DOI 10.1016/j.psyneuen.2008.08.011; Petrovic P, 2008, J NEUROSCI, V28, P6607, DOI 10.1523/JNEUROSCI.4572-07.2008; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Riem MME, 2011, BIOL PSYCHIAT, V70, P291, DOI 10.1016/j.biopsych.2011.02.006; Rimmele U, 2009, J NEUROSCI, V29, P38, DOI 10.1523/JNEUROSCI.4260-08.2009; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rockliff H, 2011, EMOTION, V11, P1388, DOI 10.1037/a0023861; Ross HE, 2009, NEUROSCIENCE, V162, P892, DOI 10.1016/j.neuroscience.2009.05.055; Ross HE, 2009, J NEUROSCI, V29, P1312, DOI 10.1523/JNEUROSCI.5039-08.2009; Savaskan E, 2008, PSYCHONEUROENDOCRINO, V33, P368, DOI 10.1016/j.psyneuen.2007.12.004; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Shalev I, 2011, HORM BEHAV, V60, P121, DOI 10.1016/j.yhbeh.2011.04.005; Shamay-Tsoory SG, 2009, BIOL PSYCHIAT, V66, P864, DOI 10.1016/j.biopsych.2009.06.009; Singer T, 2008, EMOTION, V8, P781, DOI 10.1037/a0014195; Theodoridou A, 2009, HORM BEHAV, V56, P128, DOI 10.1016/j.yhbeh.2009.03.019; Thompson RR, 2006, P NATL ACAD SCI USA, V103, P7889, DOI 10.1073/pnas.0600406103; Trainor BC, 2002, P ROY SOC B-BIOL SCI, V269, P823, DOI 10.1098/rspb.2001.1954; Unkelbach C, 2008, PSYCHOL SCI, V19, P1092, DOI 10.1111/j.1467-9280.2008.02206.x; van Anders SM, 2011, PSYCHONEUROENDOCRINO, V36, P1265, DOI 10.1016/j.psyneuen.2011.06.001; van Honk J, 2004, PSYCHONEUROENDOCRINO, V29, P937, DOI 10.1016/j.psyneuen.2003.08.007; van Ijzendoorn MH, 2012, PSYCHONEUROENDOCRINO, V37, P438, DOI 10.1016/j.psyneuen.2011.07.008; WANG ZX, 1994, P NATL ACAD SCI USA, V91, P400, DOI 10.1073/pnas.91.1.400; Wersinger SR, 2007, GENES BRAIN BEHAV, V6, P653, DOI 10.1111/j.1601-183X.2006.00294.x; WILLIAMS JR, 1992, HORM BEHAV, V26, P339, DOI 10.1016/0018-506X(92)90004-F; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Winslow JT, 2003, NEUROPSYCHOPHARMACOL, V28, P910, DOI 10.1038/sj.npp.1300128; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128; Zink CF, 2010, J NEUROSCI, V30, P7017, DOI 10.1523/JNEUROSCI.4899-09.2010	100	185	192	3	118	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					681	688		10.1038/nn.3084	http://dx.doi.org/10.1038/nn.3084			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22504348				2022-12-17	WOS:000303270200010
J	Chesler, EJ; Wilson, SG; Lariviere, WR; Rodriguez-Sas, S; Mogil, JS				Chesler, EJ; Wilson, SG; Lariviere, WR; Rodriguez-Sas, S; Mogil, JS			Influences of laboratory environment on behavior	NATURE NEUROSCIENCE			English	Letter							MOUSE BEHAVIOR; PAIN		Univ Illinois, Dept Psychol, Champaign, IL 61820 USA; Univ Illinois, Dept Anim Sci, Champaign, IL 61820 USA; McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; McGill University	Chesler, EJ (corresponding author), Univ Illinois, Dept Psychol, 603 E Daniel St, Champaign, IL 61820 USA.		Mogil, Jeffrey/AAA-9611-2019; Chesler, Elissa/K-4641-2019	Mogil, Jeffrey/0000-0003-1359-5720; Chesler, Elissa/0000-0002-5642-5062; Rodriguez-Zas, Sandra/0000-0003-1122-4758				Berkley KJ, 1997, BEHAV BRAIN SCI, V20, P371, DOI 10.1017/S0140525X97221485; Breiman L., 1984, CLASSIFICATION REGRE, DOI DOI 10.1201/9781315139470; Cabib S, 2000, SCIENCE, V289, P463, DOI 10.1126/science.289.5478.463; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; JORUM E, 1988, PAIN, V32, P341, DOI 10.1016/0304-3959(88)90046-2; Mogil JS, 1999, P NATL ACAD SCI USA, V96, P7744, DOI 10.1073/pnas.96.14.7744; Mogil JS, 2001, METH NE FRO NEUROSCI, P11; Paigen K, 2000, MAMM GENOME, V11, P715, DOI 10.1007/s003350010152; PLOMIN R, 1990, SCIENCE, V248, P183, DOI 10.1126/science.2183351; Wahlsten D, 2001, PHYSIOL BEHAV, V73, P695, DOI 10.1016/S0031-9384(01)00527-3	10	185	187	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1101	1102		10.1038/nn1102-1101	http://dx.doi.org/10.1038/nn1102-1101			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12403996				2022-12-17	WOS:000178884600002
J	Bolshakov, VY; Carboni, L; Cobb, MH; Siegelbaum, SA; Belardetti, F				Bolshakov, VY; Carboni, L; Cobb, MH; Siegelbaum, SA; Belardetti, F			Dual MAP kinase pathways mediate opposing forms of long-term plasticity at CA3-CA1 synapses	NATURE NEUROSCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; METABOTROPIC GLUTAMATE-RECEPTOR; ARACHIDONIC-ACID; RAT HIPPOCAMPUS; AREA CA1; DEPRESSION; INDUCTION; PHOSPHORYLATION; POTENTIATION; INVOLVEMENT	Although the function of the p42/p44 mitogen-activated protein (MAP) kinase pathway in longterm potentiation at hippocampal CA3-CA1 synapses has been well described, relatively little is known about the importance of the p38 MAP kinase pathway in synaptic plasticity. Here we show that the p38 MAP kinase pathway, a parallel signaling cascade activated by distinct upstream kinases, mediates the induction of metabotropic glutamate receptor-dependent long-term depression at CA3-CA1 synapses. Thus, two parallel MAP kinase pathways contribute to opposing forms of long-term plasticity at a central synapse.	Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, Dept Pharmacol, New York, NY 10032 USA; Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat, Belmont, MA 02478 USA; Glaxo Wellcome Med Res Ctr, Dept Biol, I-37135 Verona, Italy; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA	Columbia University; Howard Hughes Medical Institute; Harvard University; McLean Hospital; GlaxoSmithKline; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Siegelbaum, SA (corresponding author), Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, Dept Pharmacol, 722 W 168 St, New York, NY 10032 USA.	sas8@columbia.edu	Carboni, Lucia/AAY-9824-2021	Carboni, Lucia/0000-0001-9335-3312; Cobb, Melanie/0000-0003-0833-5473	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034128, R37DK034128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS029832] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK34128] Funding Source: Medline; NINDS NIH HHS [NS29832] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAUDRY M, 1981, DEV BRAIN RES, V1, P37, DOI 10.1016/0165-3806(81)90092-4; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BOLSHAKOV VY, 1995, NEUROPHARMACOLOGY, V34, P1581, DOI 10.1016/0028-3908(95)00127-R; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BorschHaubold AG, 1997, EUR J BIOCHEM, V245, P751, DOI 10.1111/j.1432-1033.1997.t01-1-00751.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Christie BR, 1997, J NEUROPHYSIOL, V77, P1651, DOI 10.1152/jn.1997.77.3.1651; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Ferraguti F, 1998, J COMP NEUROL, V400, P391; Fitzjohn SM, 1999, NEUROPHARMACOLOGY, V38, P1577, DOI 10.1016/S0028-3908(99)00123-9; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Goda Y, 1996, CURR BIOL, V6, P375, DOI 10.1016/S0960-9822(02)00499-2; Hii CST, 1998, J BIOL CHEM, V273, P19277, DOI 10.1074/jbc.273.30.19277; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Normandin M, 1996, BRAIN RES, V730, P40; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Otani S, 1998, J PHYSIOL-LONDON, V511, P761, DOI 10.1111/j.1469-7793.1998.761bg.x; Overstreet LS, 1997, NEUROPHARMACOLOGY, V36, P831, DOI 10.1016/S0028-3908(97)00031-2; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Wilk-Blaszczak MA, 1998, J NEUROSCI, V18, P112; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	39	185	189	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1107	1112		10.1038/80624	http://dx.doi.org/10.1038/80624			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036267				2022-12-17	WOS:000167177600015
J	Zhou, M; Liang, FX; Xiong, XRR; Li, L; Li, HF; Xiao, ZJ; Tao, HZW; Zhang, LI				Zhou, Mu; Liang, Feixue; Xiong, Xiaorui R.; Li, Lu; Li, Haifu; Xiao, Zhongju; Tao, Huizhong W.; Zhang, Li I.			Scaling down of balanced excitation and inhibition by active behavioral states in auditory cortex	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; BARREL CORTEX; GABAERGIC NEURONS; MODULATION; MECHANISMS; RESPONSES; CIRCUITS; INTERNEURONS; ORGANIZATION; ORIENTATION	Cortical sensory processing is modulated by behavioral and cognitive states. How this modulation is achieved by changing synaptic circuits remains largely unknown. In awake mouse auditory cortex, we found that sensory-evoked spike responses of layer 2/3 (L213) excitatory cells were scaled down with preserved sensory tuning when mice transitioned from quiescence to active behaviors, including locomotion, whereas L4 and thalamic responses were unchanged. Whole-cell voltage-clamp recordings revealed that tone-evoked synaptic excitation and inhibition exhibited a robust functional balance. The change to active states caused scaling down of excitation and inhibition at approximately equal levels in L213 cells, but resulted in no synaptic changes in L4 cells. This lamina-specific gain control could be attributed to an enhancement of L1-mediated inhibitory tone, with L213 parvalbumin inhibitory neurons also being suppressed. Thus, L213 circuits can adjust the salience of output in accordance with momentary behavioral demands while maintaining the sensitivity and quality of sensory processing.	[Zhou, Mu; Liang, Feixue; Xiong, Xiaorui R.; Tao, Huizhong W.; Zhang, Li I.] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Zhou, Mu; Zhang, Li I.] Univ So Calif, Dept Physiol & Biophys, Los Angeles, CA 90089 USA; [Zhou, Mu; Xiong, Xiaorui R.] Univ So Calif, Keck Sch Med, Grad Programs, Los Angeles, CA 90033 USA; [Liang, Feixue; Li, Lu; Li, Haifu; Xiao, Zhongju] Southern Med Univ, Sch Basic Med Sci, Dept Physiol, Guangzhou, Guangdong, Peoples R China; [Tao, Huizhong W.] Univ So Calif, Dept Cell & Neurobiol, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; Southern Medical University - China; University of Southern California	Zhang, LI (corresponding author), Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA.	xiaozj@fimmu.com; htao@usc.edu; liizhang@usc.edu	Zhou, Mu/K-8137-2016; Li, Haifu/AAI-5869-2020; Tao, Huizhong W/HDM-9767-2022	Zhou, Mu/0000-0001-5326-4884; 	US National Institutes of Health [R01DC008983, R01EY019049]; David and Lucile Packard Foundation; National Natural Science Foundation of China [U1301225, 31228013, 31200831]; 973 program [2014CB943002]; NATIONAL EYE INSTITUTE [R01EY019049, R21EY022478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008983] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank B. Zingg and L.Y. Li for the help on viral injection and Nissl staining. This work was supported by grants to L.I.Z. from the US National Institutes of Health (R01DC008983) and the David and Lucile Packard Foundation (Packard Fellowships for Science and Engineering). H.W.T. was supported by US National Institutes of Health grant R01EY019049. Z.X., L.I.Z. and F.L. were supported by grants from the National Natural Science Foundation of China (U1301225, 31228013, 31200831) and a 973 program (2014CB943002).	Bennett C, 2013, NEURON, V80, P350, DOI 10.1016/j.neuron.2013.08.007; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Cauller LJ, 1998, J COMP NEUROL, V390, P297; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Glickfeld LL, 2013, J NEUROSCI, V33, P19416, DOI 10.1523/JNEUROSCI.3560-13.2013; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Gonchar Y, 2003, J NEUROSCI, V23, P10904; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Harris KD, 2013, NEURON, V79, P408, DOI 10.1016/j.neuron.2013.07.034; Hestrin S, 1996, J NEUROSCI, V16, P5290; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Lee S, 2008, NAT NEUROSCI, V11, P1430, DOI 10.1038/nn.2227; Li LY, 2015, CEREB CORTEX, V25, P1782, DOI 10.1093/cercor/bht417; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Nelson A, 2013, J NEUROSCI, V33, P14342, DOI 10.1523/JNEUROSCI.2275-13.2013; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Oswald AMM, 2006, CURR OPIN NEUROBIOL, V16, P371, DOI 10.1016/j.conb.2006.06.015; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Petersen CCH, 2013, NEURON, V78, P28, DOI 10.1016/j.neuron.2013.03.020; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Poulet JFA, 2012, NAT NEUROSCI, V15, P370, DOI 10.1038/nn.3035; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Sakata S, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00109; Shlosberg D, 2006, J NEUROPHYSIOL, V96, P3170, DOI 10.1152/jn.00520.2006; Sun YJ, 2010, NATURE, V465, P927, DOI 10.1038/nature09079; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WINER JA, 1989, NEUROSCIENCE, V33, P499, DOI 10.1016/0306-4522(89)90402-8; Wozny C, 2011, CEREB CORTEX, V21, P1818, DOI 10.1093/cercor/bhq257; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Wu GY, 2006, NEURON, V52, P705, DOI 10.1016/j.neuron.2006.10.009; Wu GYK, 2011, NEUROSCI BIOBEHAV R, V35, P2094, DOI 10.1016/j.neubiorev.2011.05.004; Xiong XRR, 2013, NEURON, V79, P738, DOI 10.1016/j.neuron.2013.06.012; Zagha E, 2013, NEURON, V79, P567, DOI 10.1016/j.neuron.2013.06.008; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhou Y, 2012, J NEUROSCI, V32, P9969, DOI 10.1523/JNEUROSCI.1384-12.2012; Zhou Y, 2010, NEURON, V65, P706, DOI 10.1016/j.neuron.2010.02.021	50	184	187	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2014	17	6					841	850		10.1038/nn.3701	http://dx.doi.org/10.1038/nn.3701			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI1TO	24747575	Green Accepted			2022-12-17	WOS:000336638000020
J	Hansen, DV; Lui, JH; Flandin, P; Yoshikawa, K; Rubenstein, JL; Alvarez-Buylla, A; Kriegstein, AR				Hansen, David V.; Lui, Jan H.; Flandin, Pierre; Yoshikawa, Kazuaki; Rubenstein, John L.; Alvarez-Buylla, Arturo; Kriegstein, Arnold R.			Non-epithelial stem cells and cortical interneuron production in the human ganglionic eminences	NATURE NEUROSCIENCE			English	Article							FATE MAPPING REVEALS; GABAERGIC NEURONS; NEOCORTICAL INTERNEURONS; MOLECULAR SPECIFICATION; SUBVENTRICULAR ZONE; GLOBUS-PALLIDUS; VISUAL-CORTEX; RADIAL GLIA; MIGRATION; ORIGINS	GABAergic cortical interneurons underlie the complexity of neural circuits and are particularly numerous and diverse in humans. In rodents, cortical interneurons originate in the subpallial ganglionic eminences, but their developmental origins in humans are controversial. We characterized the developing human ganglionic eminences and found that the subventricular zone (SVZ) expanded massively during the early second trimester, becoming densely populated with neural stem cells and intermediate progenitor cells. In contrast with the cortex, most stem cells in the ganglionic eminence SVZ did not maintain radial fibers or orientation. The medial ganglionic eminence exhibited unique patterns of progenitor cell organization and clustering, and markers revealed that the caudal ganglionic eminence generated a greater proportion of cortical interneurons in humans than in rodents. On the basis of labeling of newborn neurons in slice culture and mapping of proliferating interneuron progenitors, we conclude that the vast majority of human cortical interneurons are produced in the ganglionic eminences, including an enormous contribution from non-epithelial SVZ stem cells.	[Hansen, David V.; Lui, Jan H.; Rubenstein, John L.; Alvarez-Buylla, Arturo; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Hansen, David V.; Lui, Jan H.; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Flandin, Pierre; Rubenstein, John L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Yoshikawa, Kazuaki] Osaka Univ, Inst Prot Res, Lab Regulat Neuronal Dev, Suita, Osaka 565, Japan; [Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Osaka University; University of California System; University of California San Francisco	Kriegstein, AR (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	john.rubenstein@ucsf.edu; abuylla@stemcell.ucsf.edu; kriegsteina@stemcell.ucsf.edu		Hansen, David/0000-0001-9679-7189; Alvarez-Buylla, Arturo/0000-0003-4426-8925	National Institute of Neurological Disorders and Stroke of the US National Institutes of Health; National Institute of Mental Health of the US National Institutes of Health; California Institute for Regenerative Medicine; John G. Bowes Research Fund; Bernard Osher; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021223] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); John G. Bowes Research Fund; Bernard Osher; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the staff at San Francisco General Hospital Women's Options Center for their consideration in allowing access to donated human fetal tissue. We thank S. Davis and co-workers at the California National Primate Research Center for providing fixed brain tissue from fetal macaques. We also thank W Walantus, K. Wang, S. Wang, Y. Wang and other University of California at San Francisco personnel for technical and administrative support. We are very grateful to J. Kohtz (Northwestern University) for sharing her final aliquot of pan-Dlx antibody. The NKX2-2 antibody developed by T. Jessell and S. Brenner-Morton was obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the National Institute of Child Health and Human Development and maintained by the University of Iowa Department of Biology. This work was supported by grants from the National Institute of Neurological Disorders and Stroke and the National Institute of Mental Health of the US National Institutes of Health, California Institute for Regenerative Medicine, John G. Bowes Research Fund and from Bernard Osher.	Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Battista D, 2010, J NEUROSCI, V30, P3995, DOI 10.1523/JNEUROSCI.4382-09.2010; Brown KN, 2011, SCIENCE, V334, P480, DOI 10.1126/science.1208884; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Cai YQ, 2013, J COMP NEUROL, V521, P479, DOI 10.1002/cne.23186; Carney RSE, 2006, J NEUROSCI, V26, P11562, DOI 10.1523/JNEUROSCI.3092-06.2006; CONNOR JR, 1984, NEUROSCIENCE, V12, P1027, DOI 10.1016/0306-4522(84)90002-2; DEACON TW, 1994, BRAIN RES, V668, P211, DOI 10.1016/0006-8993(94)90526-6; delRio MR, 1997, J CHEM NEUROANAT, V13, P243, DOI 10.1016/S0891-0618(97)00050-1; FELDMAN ML, 1978, J COMP NEUROL, V179, P761, DOI 10.1002/cne.901790406; Fertuzinhos S, 2009, CEREB CORTEX, V19, P2196, DOI 10.1093/cercor/bhp009; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Flandin P, 2010, J NEUROSCI, V30, P2812, DOI 10.1523/JNEUROSCI.4228-09.2010; Gelman D, 2011, J NEUROSCI, V31, P16570, DOI 10.1523/JNEUROSCI.4068-11.2011; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Inta D, 2008, P NATL ACAD SCI USA, V105, P20994, DOI 10.1073/pnas.0807059105; Jakovcevski I, 2011, CEREB CORTEX, V21, P1771, DOI 10.1093/cercor/bhq245; Jones EG, 2009, CEREB CORTEX, V19, P1953, DOI 10.1093/cercor/bhp088; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kanatani S, 2008, J NEUROSCI, V28, P13582, DOI 10.1523/JNEUROSCI.2132-08.2008; Kawaguchi Y, 1996, J NEUROSCI, V16, P2701; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Ma T, 2012, CEREB CORTEX, V22, P2120, DOI 10.1093/cercor/bhr296; Marin O, 2000, J NEUROSCI, V20, P6063; Menezes JRL, 1995, MOL CELL NEUROSCI, V6, P496, DOI 10.1006/mcne.1995.0002; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Nadarajah B, 2002, NAT NEUROSCI, V5, P218, DOI 10.1038/nn813; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Nobrega-Pereira S, 2010, J NEUROSCI, V30, P2824, DOI 10.1523/JNEUROSCI.4023-09.2010; OLSSON M, 1995, NEUROSCIENCE, V69, P1169, DOI 10.1016/0306-4522(95)00325-D; Petanjek Z, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.026.2009; Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Riccio O, 2012, CEREB CORTEX, V22, P86, DOI 10.1093/cercor/bhr086; SOMOGYI P, 1981, J COMP NEUROL, V195, P547, DOI 10.1002/cne.901950402; Sussel L, 1999, DEVELOPMENT, V126, P3359; Ventura RE, 2007, J NEUROSCI, V27, P4297, DOI 10.1523/JNEUROSCI.0399-07.2007; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Wu SX, 2011, DEVELOPMENT, V138, P2499, DOI 10.1242/dev.063032; Xu Q, 2003, CEREB CORTEX, V13, P670, DOI 10.1093/cercor/13.6.670; Xu Q, 2010, NEURON, V65, P328, DOI 10.1016/j.neuron.2010.01.004; Yu XJ, 2011, J NEUROSCI, V31, P2413, DOI 10.1523/JNEUROSCI.5249-10.2011; Yun K, 2002, DEVELOPMENT, V129, P5029; Zecevic N, 2005, J COMP NEUROL, V491, P109, DOI 10.1002/cne.20714; Zecevic N, 2011, DEV NEUROBIOL, V71, P18, DOI 10.1002/dneu.20812	50	184	185	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1576	1587		10.1038/nn.3541	http://dx.doi.org/10.1038/nn.3541			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24097039	Green Accepted			2022-12-17	WOS:000326205700015
J	Baig, SM; Koschak, A; Lieb, A; Gebhart, M; Dafinger, C; Nurnberg, G; Ali, A; Ahmad, I; Sinnegger-Brauns, MJ; Brandt, N; Engel, J; Mangoni, ME; Farooq, M; Khan, HU; Nurnberg, P; Striessnig, J; Bolz, HJ				Baig, Shahid M.; Koschak, Alexandra; Lieb, Andreas; Gebhart, Mathias; Dafinger, Claudia; Nuernberg, Gudrun; Ali, Amjad; Ahmad, Ilyas; Sinnegger-Brauns, Martina J.; Brandt, Niels; Engel, Jutta; Mangoni, Matteo E.; Farooq, Muhammad; Khan, Habib U.; Nuernberg, Peter; Striessnig, Joerg; Bolz, Hanno J.			Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness	NATURE NEUROSCIENCE			English	Article							CA2+ CHANNELS; CALCIUM-CHANNELS; POTASSIUM CHANNEL; GATING CURRENT; IONIC CURRENT; GENE; CELL; MODULATION; MUTATION; JERVELL	Deafness is genetically very heterogeneous and forms part of several syndromes. So far, delayed rectifier potassium channels have been linked to human deafness associated with prolongation of the QT interval on electrocardiograms and ventricular arrhythmia in Jervell and Lange-Nielsen syndrome. Ca(v)1.3 voltage-gated L-type calcium channels (LTCCs) translate sound-induced depolarization into neurotransmitter release in auditory hair cells and control diastolic depolarization in the mouse sinoatrial node (SAN). Human deafness has not previously been linked to defects in LTCCs. We used positional cloning to identify a mutation in CACNA1D, which encodes the pore-forming alpha 1 subunit of Ca(v)1.3 LTCCs, in two consanguineous families with deafness. All deaf subjects showed pronounced SAN dysfunction at rest. The insertion of a glycine residue in a highly conserved, alternatively spliced region near the channel pore resulted in nonconducting calcium channels that had abnormal voltage-dependent gating. We describe a human channelopathy (termed SANDD syndrome, sinoatrial node dysfunction and deafness) with a cardiac and auditory phenotype that closely resembles that of Cacna1d(-/-) mice.	[Dafinger, Claudia; Bolz, Hanno J.] Univ Hosp Cologne, Inst Human Genet, Cologne, Germany; [Baig, Shahid M.; Ali, Amjad; Ahmad, Ilyas; Farooq, Muhammad] Natl Inst Biotechnol & Genet Engn, Human Mol Genet Lab, Hlth Biotechnol Div, Faisalabad, Pakistan; [Koschak, Alexandra; Lieb, Andreas; Gebhart, Mathias; Sinnegger-Brauns, Martina J.; Striessnig, Joerg] Univ Innsbruck, Ctr Mol Biosci, Inst Pharm, A-6020 Innsbruck, Austria; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Inst Genet, Cologne, Germany; [Brandt, Niels; Engel, Jutta] Univ Tubingen, Inst Physiol 2, Tubingen, Germany; [Brandt, Niels; Engel, Jutta] Univ Tubingen, Tubingen Hearing Res Ctr, Tubingen, Germany; [Brandt, Niels; Engel, Jutta] Univ Saarland, Dept Biophys, D-6650 Homburg, Germany; [Mangoni, Matteo E.] Univ Montpellier 1 & 2, CNRS, Inst Genom Fonct,Dept Physiol,UMR 5203,U661, Montpellier, France; [Khan, Habib U.] Khyber Teaching Hosp, Dept Pathol, Peshawar, Pakistan; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Bolz, Hanno J.] Bioscientia, Ctr Human Genet, Ingelheim, Germany	University of Cologne; Pakistan Institute of Engineering & Applied Science; University of Innsbruck; University of Cologne; University of Cologne; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Saarland University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Cologne	Bolz, HJ (corresponding author), Univ Hosp Cologne, Inst Human Genet, Cologne, Germany.	joerg.striessnig@uibk.ac.at; hanno.bolz@uk-koeln.de	Ali, Amjad/AAG-4441-2021; Baig, Shahid Mahmood/I-7309-2015; Tuluc, Petronel/C-2527-2011; BAig, Shahid Mahmood/AAS-8365-2020; Mangoni, Matteo E/E-6025-2015; Striessnig, Joerg/S-9334-2017; Ahmad, Ilyas/AAT-6577-2021	Ali, Amjad/0000-0002-0486-4661; Mangoni, Matteo E/0000-0002-8892-3373; Striessnig, Joerg/0000-0002-9406-7120; Ahmad, Ilyas/0000-0003-4845-9227; Brauns, Martina/0000-0002-0547-2731; Lieb, Andreas/0000-0001-9567-649X	Geers-Stiftung, Bonn; Imhoff-Stiftung, Koln; Koln Fortune, University Hospital of Cologne, Deutsche Forschungsgemeinschaft [BO2954/1-2]; Forschung contra Blindheit: Initiative Usher-Syndrom e.V.; Austrian Science Fund [P-20670]; Agence Nationale pour la Recherche [ANR-06-PHYSIO-004-01]; Fondation de France; Marie Curie Research Training Network CavNET [MRTN-CT-2006-035367]; University of Innsbruck; Austrian Science Fund (FWF) [P 20670] Funding Source: researchfish	Geers-Stiftung, Bonn; Imhoff-Stiftung, Koln; Koln Fortune, University Hospital of Cologne, Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschung contra Blindheit: Initiative Usher-Syndrom e.V.; Austrian Science Fund(Austrian Science Fund (FWF)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation de France(Fondation de France); Marie Curie Research Training Network CavNET(European Commission); University of Innsbruck; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank the families who have participated in this study, K. Beam and W. Sandtner for discussion on gating currents, M. Thoenes, K. Zimmermann, S. Blick, G. Gajic and S. Kasperek for technical assistance, B. Ali for help with ECG recordings, K. Boss for discussion of the manuscript and C. Striessnig for artwork. This work was supported by the Geers-Stiftung, Bonn; Imhoff-Stiftung, Koln; Koln Fortune, University Hospital of Cologne, Deutsche Forschungsgemeinschaft (BO2954/1-2); Forschung contra Blindheit: Initiative Usher-Syndrom e.V. (to H.J.B.); the Austrian Science Fund (P-20670); the Agence Nationale pour la Recherche (ANR-06-PHYSIO-004-01 to M.E.M.); the Fondation de France; the Marie Curie Research Training Network CavNET (MRTN-CT-2006-035367); and the University of Innsbruck (to J.S. and A.K.).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Bangalore R, 1996, AM J PHYSIOL-HEART C, V270, pH1521, DOI 10.1152/ajpheart.1996.270.5.H1521; Bitner-Glindzicz M, 2000, ADV OTO-RHINO-LARYNG, V56, P45; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Brandt N, 2007, J NEUROSCI, V27, P3174, DOI 10.1523/JNEUROSCI.3965-06.2007; Busquet P, 2010, INT J NEUROPSYCHOPH, V13, P499, DOI 10.1017/S1461145709990368; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Cohen M, 2007, INT J AUDIOL, V46, P82, DOI 10.1080/14992020600975279; Dou HV, 2004, JARO-J ASSOC RES OTO, V5, P215, DOI 10.1007/s10162-003-4020-3; FUKUSHIMA K, 1995, GENOME RES, V5, P305, DOI 10.1101/gr.5.3.305; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Hoda JC, 2005, J NEUROSCI, V25, P252, DOI 10.1523/JNEUROSCI.3054-04.2005; Jones LP, 1997, J PHYSIOL-LONDON, V498, P601, DOI 10.1113/jphysiol.1997.sp021886; Kamp TJ, 1996, J PHYSIOL-LONDON, V492, P89, DOI 10.1113/jphysiol.1996.sp021291; Knirsch M, 2007, J NEUROSCI, V27, P6442, DOI 10.1523/JNEUROSCI.5364-06.2007; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; McDonough SI, 2005, BIOPHYS J, V88, P211, DOI 10.1529/biophysj.104.051714; McKinney BC, 2006, LEARN MEMORY, V13, P584, DOI 10.1101/lm.279006; Naz S, 2002, AM J HUM GENET, V71, P632, DOI 10.1086/342193; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Raybaud A, 2006, J BIOL CHEM, V281, P39424, DOI 10.1074/jbc.M607405200; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Safayhi H, 1997, MOL ENDOCRINOL, V11, P619, DOI 10.1210/me.11.5.619; SEINO S, 1992, P NATL ACAD SCI USA, V89, P584, DOI 10.1073/pnas.89.2.584; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Sinnegger-Brauns MJ, 2004, J CLIN INVEST, V113, P1430, DOI 10.1172/JCI200420208; Splawski I, 1997, NEW ENGL J MED, V336, P1562, DOI 10.1056/NEJM199705293362204; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Stary A, 2008, CHANNELS, V2, P210, DOI 10.4161/chan.2.3.6158; Striessnig J, 2008, CHANNELS, V2, P233, DOI 10.4161/chan.2.4.5847; Striessnig J, 2010, PFLUG ARCH EUR J PHY, V460, P361, DOI 10.1007/s00424-010-0800-x; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875	46	184	193	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					77	U107		10.1038/nn.2694	http://dx.doi.org/10.1038/nn.2694			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21131953				2022-12-17	WOS:000285684900017
J	Johansen, JP; Tarpley, JW; LeDoux, JE; Blair, HT				Johansen, Joshua P.; Tarpley, Jason W.; LeDoux, Joseph E.; Blair, Hugh T.			Neural substrates for expectation-modulated fear learning in the amygdala and periaqueductal gray	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; LATERAL AMYGDALA; POTENTIATED STARTLE; SYNAPTIC PLASTICITY; CONDITIONED FEAR; RAT; PROJECTIONS; RESPONSES; NUCLEUS; NEURONS	A form of aversively motivated learning called fear conditioning occurs when a neutral conditioned stimulus is paired with an aversive unconditioned stimulus (UCS). UCS-evoked depolarization of amygdala neurons may instruct Hebbian plasticity that stores memories of the conditioned stimulus-unconditioned stimulus association, but the origin of UCS inputs to the amygdala is unknown. Theory and evidence suggest that instructive UCS inputs to the amygdala will be inhibited when the UCS is expected, but this has not been found during fear conditioning. We investigated neural pathways that relay information about the UCS to the amygdala by recording neurons in the amygdala and periaqueductal gray (PAG) of rats during fear conditioning. UCS-evoked responses in both amygdala and PAG were inhibited by expectation. Pharmacological inactivation of the PAG attenuated UCS-evoked responses in the amygdala and impaired acquisition of fear conditioning, indicating that PAG may be an important part of the pathway that relays instructive signals to the amygdala.	[Johansen, Joshua P.; Tarpley, Jason W.; Blair, Hugh T.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Johansen, Joshua P.; Tarpley, Jason W.] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA USA; [LeDoux, Joseph E.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [LeDoux, Joseph E.] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; New York University; Nathan Kline Institute for Psychiatric Research	Blair, HT (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA.	jtarpley@ucla.edu; blair@psych.ucla.edu	Johansen, Joshua/N-8010-2015	Johansen, Joshua/0000-0003-4240-1550; Blair, Hugh/0000-0001-8256-5109	National Science Foundation; National Alliance for Research on Schizophrenia and Depression; US National Institutes of Health [R01 MH073700-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073700] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Alliance for Research on Schizophrenia and Depression(NARSAD); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to S. Nicola and A. Welday for comments on an earlier version of the manuscript and M. Fanselow, D. Buonomano, R. Thompson, D. Schiller and Y. Niv for valuable discussions. This work was supported by a National Science Foundation Graduate Research Fellowship to J.P.J. and a National Alliance for Research on Schizophrenia and Depression Young Investigator Award and US National Institutes of Health grant (R01 MH073700-01) to H. T. B.	ASTONJONES G, 1991, PROG BRAIN RES, V88, P47; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Blair HT, 2005, J NEUROSCI, V25, P4198, DOI 10.1523/JNEUROSCI.0674-05.2005; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; Borszcz GS, 2006, PAIN, V123, P155, DOI 10.1016/j.pain.2006.02.026; Brunzell DH, 2001, BEHAV NEUROSCI, V115, P365, DOI 10.1037//0735-7044.115.2.365; CASSELL MD, 1986, BRAIN RES BULL, V17, P321, DOI 10.1016/0361-9230(86)90237-6; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; DISCALA G, 1987, PHYSIOL BEHAV, V40, P55, DOI 10.1016/0031-9384(87)90185-5; ENNIS M, 1991, J COMP NEUROL, V306, P480, DOI 10.1002/cne.903060311; Fanselow M.S., 1991, MIDBRAIN PERIAQUEDUC; Fanselow MS, 1998, NEURON, V20, P625, DOI 10.1016/S0896-6273(00)81002-8; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Gauriau C, 2004, J COMP NEUROL, V468, P24, DOI 10.1002/cne.10873; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; HELMSTETTER FJ, 1994, J NEUROSCI, V14, P7099; Helmstetter FJ, 2008, NEUROBIOL LEARN MEM, V89, P324, DOI 10.1016/j.nlm.2007.09.002; HERRERO MT, 1991, BRAIN RES, V543, P201, DOI 10.1016/0006-8993(91)90029-U; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; Kamin L. J., 1968, MIAMI S PREDICTION B, P9; Keay KA, 1997, J COMP NEUROL, V385, P207, DOI 10.1002/(SICI)1096-9861(19970825)385:2<207::AID-CNE3>3.0.CO;2-5; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; Lanuza E, 2004, NEUROSCIENCE, V125, P305, DOI 10.1016/j.neuroscience.2003.12.034; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McNally GP, 2006, LEARN MEMORY, V13, P245, DOI 10.1101/lm.196606; McNally GP, 2006, BEHAV NEUROSCI, V120, P313, DOI 10.1037/0735-7044.120.2.313; OTTERSEN OP, 1981, J COMP NEUROL, V202, P335, DOI 10.1002/cne.902020304; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rescorla R. A., 1972, CLASSICAL CONDITIONI; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shi CJ, 1999, J NEUROSCI, V19, P420, DOI 10.1523/JNEUROSCI.19-01-00420.1999; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tang JR, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-6; Thompson RF, 1998, NEUROBIOL LEARN MEM, V70, P150, DOI 10.1006/nlme.1998.3845; UWANO T, 1995, NEUROSCIENCE, V68, P339, DOI 10.1016/0306-4522(95)00125-3; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006; YOUNG SL, 1992, J EXP PSYCHOL ANIM B, V18, P400, DOI 10.1037/0097-7403.18.4.400; Zhao ZW, 2004, J NEUROSCI, V24, P10326, DOI 10.1523/JNEUROSCI.2758-04.2004	50	184	184	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					979	U102		10.1038/nn.2594	http://dx.doi.org/10.1038/nn.2594			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	632DK	20601946	Green Accepted			2022-12-17	WOS:000280400600017
J	Williams, ZM; Eskandar, EN				Williams, ZM; Eskandar, EN			Selective enhancement of associative learning by microstimulation of the anterior caudate	NATURE NEUROSCIENCE			English	Article							BASAL GANGLIA; NEURONAL-ACTIVITY; PRIMATE STRIATUM; MONKEY STRIATUM; DOPAMINE; REPRESENTATIONS; ORGANIZATION; STIMULATION; EXPECTATION; SIGNAL	Primates have the remarkable ability to rapidly adjust or modify associations between visual cues and specific motor responses. Whereas little is known as to how such adjustments in behavioral policy are implemented, recent learning models suggest that the anterior striatum is optimally positioned to have a role in this process. We recorded from single units and delivered microstimulation in the striatum of rhesus monkeys performing an associative learning task. Caudate activity during reinforcement was closely correlated with the rate of learning and peaked during the steepest portion of the learning curve when new associations were being acquired. Moreover, delivering microstimulation in the caudate during the reinforcement period significantly increased the rate of learning without altering the monkeys' ultimate performance. These findings suggest that the caudate is responsible for implementing selective adjustments to the 'associative weights' between sensory cues and motor responses during learning, thus enhancing the likelihood of selecting profitable actions.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Eskandar, EN (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA.	eeskandar@partners.org						ALEXANDER GE, 1985, J NEUROPHYSIOL, V53, P1417, DOI 10.1152/jn.1985.53.6.1417; ALEXANDER GE, 1994, J CLIN NEUROPHYSIOL, V11, P420, DOI 10.1097/00004691-199407000-00004; AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; Borland LM, 2005, J NEUROSCI METH, V146, P149, DOI 10.1016/j.jneumeth.2005.02.002; Cohen MR, 2004, CURR OPIN NEUROBIOL, V14, P169, DOI 10.1016/j.conb.2004.03.016; Cragg SJ, 2000, J NEUROSCI, V20, P8209; FIBIGER HC, 1987, J NEUROSCI, V7, P3888; FLAHERTY AW, 1994, J NEUROSCI, V14, P599; Hadj-Bouziane F, 2003, EXP BRAIN RES, V153, P190, DOI 10.1007/s00221-003-1592-4; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Hollerman JR, 1998, J NEUROPHYSIOL, V80, P947, DOI 10.1152/jn.1998.80.2.947; HOOVER JE, 1993, SCIENCE, V259, P819, DOI 10.1126/science.7679223; HOUK J, 1995, MODELS INFORMATION P; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Miyachi S, 1997, EXP BRAIN RES, V115, P1, DOI 10.1007/PL00005669; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Press WH., 2002, NUMERICAL RECIPES C, V2; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Schraudolph NN, 2002, NEURAL COMPUT, V14, P1723, DOI 10.1162/08997660260028683; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324	29	184	184	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					562	568		10.1038/nn1662	http://dx.doi.org/10.1038/nn1662			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16501567				2022-12-17	WOS:000236310700024
J	Kim, J; Alger, BE				Kim, J; Alger, BE			Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus	NATURE NEUROSCIENCE			English	Article							ACID AMIDE HYDROLASE; ANANDAMIDE; NEURONS; ENZYME	In hippocampal pyramidal cells, a rise in Ca2+ releases endocannabinoids that activate the presynaptic cannabinoid receptor (CB1R) and transiently reduce GABAergic transmission-a process called depolarization-induced suppression of inhibition (DSI). The mechanism that limits the duration of endocannabinoid action in intact cells is unknown. Here we show that inhibition of cyclooxygenase-2 (COX-2), not fatty acid amide hydrolase (FAAH), prolongs DSI, suggesting that COX-2 limits endocannabinoid action.	Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Alger, BE (corresponding author), Univ Maryland, Sch Med, Program Neurosci, 655 W Baltimore St, Baltimore, MD 21201 USA.	balger@umaryland.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014725] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA14725] Funding Source: Medline; NINDS NIH HHS [R01 NS30219] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alger BE, 2002, PROG NEUROBIOL, V68, P247; Chen C, 2002, J NEUROPHYSIOL, V87, P2851, DOI 10.1152/jn.2002.87.6.2851; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Fowler CJ, 1997, J PHARMACOL EXP THER, V283, P729; Goparaju SK, 1999, BIOCHEM PHARMACOL, V57, P417, DOI 10.1016/S0006-2952(98)00314-1; Guhring H, 2002, EUR J PHARMACOL, V454, P153, DOI 10.1016/S0014-2999(02)02485-8; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Lichtman AH, 2002, J PHARMACOL EXP THER, V302, P73, DOI 10.1124/jpet.302.1.73; Tsou K, 1998, NEUROSCI LETT, V254, P137, DOI 10.1016/S0304-3940(98)00700-9; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181	14	184	192	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					697	698		10.1038/nn1262	http://dx.doi.org/10.1038/nn1262			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15184902				2022-12-17	WOS:000222274400007
J	Xiang, Y; Li, Y; Zhang, Z; Cui, K; Wang, S; Yuan, XB; Wu, CP; Poo, MM; Duan, SM				Xiang, Y; Li, Y; Zhang, Z; Cui, K; Wang, S; Yuan, XB; Wu, CP; Poo, MM; Duan, SM			Nerve growth cone guidance mediated by G protein-coupled receptors	NATURE NEUROSCIENCE			English	Article							LYMPHOCYTE CHEMOATTRACTANT; PHOSPHOINOSITIDE 3-KINASE; NEURONAL MIGRATION; MOLECULAR-BIOLOGY; CHEMOKINE; CHEMOTAXIS; SYSTEM; CELLS; PROLIFERATION; ATTRACTION	Growing axons navigate by responding to chemical guidance cues. Here we report that growth cones of rat cerebellar axons in culture turned away from a gradient of SDF-1, a chemokine that attracts migrating leukocytes and cerebellar granule cells via a G protein-coupled receptor (GPCR). Similarly, Xenopus spinal growth cones turned away from a gradient of baclofen, an agonist of the GABA(B) receptor. This response was mediated by G(i) and subsequent activation of phospholipase C (PLC), which triggered two pathways: protein kinase C (PKC) led to repulsion, and inositol 1,4,5-triphosphate (IP3) receptor activation led to attractive turning. Under normal culture conditions, PKC-dependent repulsion dominated, but the repulsion could be converted to attraction by inhibiting PKC or by elevating cytosolic cGMP. Thus, GPCRs can mediate both repulsive and attractive axon guidance in vitro, and chemokines may serve as guidance cues for axon pathfinding.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Univ Calif Berkeley, Dept Cell & Mol Biol, Div Neurobiol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California Berkeley	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	shumin@ion.ac.cn	Zhang, Zhe/C-2685-2011; wang, sheng/B-1969-2010	Yuan, Xiaobing/0000-0002-1632-8460				BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cellbio.4.1.649; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hesselgesser J, 1999, J NEUROVIROL, V5, P13, DOI 10.3109/13550289909029741; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; IGARASHI M, 1993, SCIENCE, V259, P77, DOI 10.1126/science.8418498; Klein RS, 2001, DEVELOPMENT, V128, P1971; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Mennicken F, 1999, TRENDS PHARMACOL SCI, V20, P73, DOI 10.1016/S0165-6147(99)01308-5; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; OBERLEY LW, 1982, SUPEROXIDE DISMUTASE, V1, P1; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang JF, 2000, BLOOD, V95, P2505, DOI 10.1182/blood.V95.8.2505.008k24_2505_2513; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xia MQ, 1999, J NEUROVIROL, V5, P32, DOI 10.3109/13550289909029743; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Zhou FQ, 2001, J CELL BIOL, V153, P1071, DOI 10.1083/jcb.153.5.1071; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	43	184	192	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					843	848		10.1038/nn899	http://dx.doi.org/10.1038/nn899			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12161754				2022-12-17	WOS:000177656300013
J	Jagota, A; de la Iglesia, HO; Schwartz, WJ				Jagota, A; de la Iglesia, HO; Schwartz, WJ			Morning and evening circadian oscillations in the suprachiasmatic nucleus in vitro	NATURE NEUROSCIENCE			English	Article							LONG-TERM MULTIUNIT; GOLDEN-HAMSTER; IN-VITRO; N-ACETYLTRANSFERASE; ACTIVITY RECORDINGS; NEURONAL-ACTIVITY; SYRIAN-HAMSTER; CLOCK; RHYTHMS; PHASE	Daily biological rhythms are governed by an innate timekeeping mechanism, or 'circadian clock'. In mammals, a clock in the suprachiasmatic nucleus (SCN) comprises multiple autonomous single-cell oscillators, but it is unclear how SCN cells interact to form a tissue with coherent metabolic and electrical rhythms that might account for circadian animal behaviors. Here we demonstrate that the circadian rhythm of SCN electrophysiological activity, recorded as a single daytime peak in hamster hypothalamic coronal slices, shows two distinct peaks when slices are cut in the horizontal plane. Substantiating an idea initially derived from behavioral observations, the properties of these two peaks indicate functional organization of SCN tissue as a clock with two oscillating components.	Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Schwartz, WJ (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, 55 Lake Ave N, Worcester, MA 01655 USA.							BOUSKILA Y, 1993, P NATL ACAD SCI USA, V90, P3207, DOI 10.1073/pnas.90.8.3207; DAAN S, 1978, J THEOR BIOL, V70, P297, DOI 10.1016/0022-5193(78)90378-8; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Ebling FJP, 1996, PROG NEUROBIOL, V50, P109, DOI 10.1016/S0301-0082(96)00032-9; ELLIOTT JA, 1994, J COMP PHYSIOL A, V174, P469; Franken P, 1999, BRAIN RES, V818, P34, DOI 10.1016/S0006-8993(98)01261-X; GILLETTE MU, 1995, CIRCADIAN CLOCKS THE, P134; Gribkoff VK, 1998, J NEUROSCI, V18, P3014; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; HONMA K, 1985, JPN J PHYSIOL, V35, P643, DOI 10.2170/jjphysiol.35.643; Honma S, 1998, NEUROSCI LETT, V250, P157, DOI 10.1016/S0304-3940(98)00464-9; ILLNEROVA H, 1985, J PINEAL RES, V2, P67, DOI 10.1111/j.1600-079X.1985.tb00628.x; ILLNEROVA H, 1982, J COMP PHYSIOL, V145, P539, DOI 10.1007/BF00612819; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; KALSBEEK A, 1993, J COMP NEUROL, V332, P293, DOI 10.1002/cne.903320304; Liu C, 1997, NEURON, V19, P91, DOI 10.1016/S0896-6273(00)80350-5; MASON R, 1991, NEUROSCI LETT, V123, P160, DOI 10.1016/0304-3940(91)90920-O; MEIJER JH, 1995, J BIOL RHYTHM, V10, P4, DOI 10.1177/074873049501000101; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Meijer JH, 1998, J NEUROSCI, V18, P9078; MORIN LP, 1994, NEUROSCIENCE, V61, P391, DOI 10.1016/0306-4522(94)90240-2; MRUGALA MM, IN PRESS AM J PHYSL; PICKARD GE, 1982, J COMP NEUROL, V211, P65, DOI 10.1002/cne.902110107; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Prosser RA, 1998, J BIOL RHYTHM, V13, P30, DOI 10.1177/074873098128999899; SHINOHARA K, 1995, P NATL ACAD SCI USA, V92, P7396, DOI 10.1073/pnas.92.16.7396; SUMOVA A, 1995, P NATL ACAD SCI USA, V92, P7754, DOI 10.1073/pnas.92.17.7754; Tcheng TK, 1996, J NEUROSCI METH, V69, P163, DOI 10.1016/S0165-0270(96)00039-8; Vuillez P, 1996, NEUROSCI LETT, V208, P37, DOI 10.1016/0304-3940(96)12535-0; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamazaki S, 1998, J NEUROSCI, V18, P10709; ZLOMANCZUK P, 1991, BRAIN RES, V559, P94, DOI 10.1016/0006-8993(91)90291-3	32	184	189	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					372	376		10.1038/73943	http://dx.doi.org/10.1038/73943			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725927				2022-12-17	WOS:000087945400018
J	Kaas, JH; Hackett, TA				Kaas, JH; Hackett, TA			'What' and 'where' processing in auditory cortex	NATURE NEUROSCIENCE			English	News Item							PRIMATE PREFRONTAL CORTEX; MONKEYS	Tracing of auditory cortical connections suggests that the primate auditory system, like the visual and somatosensory systems, may be organized into 'what' and 'where' pathways.	Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; Vanderbilt Univ, Dept Speech & Hearing Sci, Nashville, TN 37240 USA	Vanderbilt University; Vanderbilt University	Kaas, JH (corresponding author), Vanderbilt Univ, Dept Psychol, 301 Wilson Hall, Nashville, TN 37240 USA.							DEYOE EA, 1994, NATURE, V371, P151, DOI 10.1038/371151a0; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; GUNERLEIDER LG, 1982, ANAL VISUAL BEHAV, P549; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Hackett TA, 1999, BRAIN RES, V817, P45, DOI 10.1016/S0006-8993(98)01182-2; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; KRUBITZER L, 1990, VISUAL NEUROSCI, V5, P609, DOI 10.1017/S0952523800000778; MISHKIN M, 1979, NEUROPSYCHOLOGIA, V17, P139, DOI 10.1016/0028-3932(79)90005-8; MOREL A, 1990, VISUAL NEUROSCI, V4, P555, DOI 10.1017/S0952523800005769; MURRAY EA, 1984, J NEUROSCI, V4, P2565; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Romanski LM, 1999, J COMP NEUROL, V403, P141, DOI 10.1002/(SICI)1096-9861(19990111)403:2<141::AID-CNE1>3.0.CO;2-V; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	15	184	184	2	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1045	1047		10.1038/15967	http://dx.doi.org/10.1038/15967			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570476				2022-12-17	WOS:000085810100004
J	Schiller, J; Schiller, Y; Clapham, DE				Schiller, J; Schiller, Y; Clapham, DE			NMDA receptors amplify calcium influx into dendritic spines during associative pre- and postsynaptic activation	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; LONG-TERM POTENTIATION; CA2+ CHANNELS; INTEGRATION; TRANSIENTS; SIGNAL; SOMA	Long-term potentiation (LTP) of synaptic strength can be induced by synchronous pre- and postsynaptic activation, and a rise in postsynaptic calcium is essential for induction of LTP. Calcium can enter through both voltage-dependent Ca2+ channels and NMDA-type glutamate receptors, but the relative contributions of these pathways is not known. We have examined this issue in layer V cortical pyramidal neurons, using focal flash photolysis of caged glutamate to mimic synaptic input and two-photon, laser-scanning microscopy to measure calcium levels in dendritic spines. Most of the calcium entry in response to glutamate alone was via voltage-dependent Ca2+ channels, and NMDA receptors accounted for less than 20% of total Ca2+ entry. When glutamate was paired with postsynaptic action potentials, however, the NMDA-receptor-dependent component was selectively amplified. The same is likely to occur during paired physiological pre- and postsynaptic activation, providing a mechanism for the input specificity and Hebbian behavior of LTP.	Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Pharmacol, Rochester, MN 55905 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Mayo Clinic; Mayo Clinic	Clapham, DE (corresponding author), Childrens Hosp, Howard Hughes Med Inst, 1309 Enders Bldg,320 Longwood Ave, Boston, MA 02115 USA.	clapham@rascal.med.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428				[Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Eilers J, 1997, CURR OPIN NEUROBIOL, V7, P385, DOI 10.1016/S0959-4388(97)80067-0; EILERS J, 1995, NATURE, V373, P107; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kirkwood Alfredo, 1995, Biological Research, V28, P73; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; REGEHR WG, 1990, NATURE, V345, P807, DOI 10.1038/345807a0; SCHILLER J, 1995, J PHYSIOL-LONDON, V487, P583, DOI 10.1113/jphysiol.1995.sp020902; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schuman EM, 1997, NEURON, V18, P339, DOI 10.1016/S0896-6273(00)81234-9; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	29	184	186	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					114	118		10.1038/363	http://dx.doi.org/10.1038/363			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QB	10195125				2022-12-17	WOS:000076361100011
J	Glickfeld, LL; Andermann, ML; Bonin, V; Reid, RC				Glickfeld, Lindsey L.; Andermann, Mark L.; Bonin, Vincent; Reid, R. Clay			Cortico-cortical projections in mouse visual cortex are functionally target specific	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELD PROPERTIES; EFFERENT CONNECTIONS; NEURONS; AREA; ORGANIZATION; STRIATE; STREAMS; CELLS; V2; SPECIALIZATION	Neurons in primary sensory cortex have diverse response properties, whereas higher cortical areas are specialized. Specific connectivity may be important for areal specialization, particularly in the mouse, where neighboring neurons are functionally diverse. To examine whether higher visual areas receive functionally specific input from primary visual cortex (V1), we used two-photon calcium imaging to measure responses of axons from V1 arborizing in three areas with distinct spatial and temporal frequency preferences. We found that visual preferences of presynaptic boutons in each area were distinct and matched the average preferences of recipient neurons. This specificity could not be explained by organization within V1 and instead was due to both a greater density and greater response amplitude of functionally matched boutons. Projections from a single layer (layer 5) and from secondary visual cortex were also matched to their target areas. Thus, transmission of specific information to downstream targets may be a general feature of cortico-cortical communication.	[Glickfeld, Lindsey L.; Andermann, Mark L.; Bonin, Vincent; Reid, R. Clay] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Reid, RC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	clay_reid@hms.harvard.edu	Bonin, Vincent/AAQ-3833-2020	Bonin, Vincent/0000-0002-9437-8092	US National Institutes of Health [R01 EY018742, R01 EY010115]; Helen Hay Whitney Foundation; Ludcke Foundation; Pierce Charitable Trust; NATIONAL EYE INSTITUTE [R01EY018742, R01EY010115] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; Ludcke Foundation; Pierce Charitable Trust; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank A. Caiado, G. Goldey, M. Kirk, C. Mazur and D. Roumis for surgical assistance; J. Curry, A. Moffa and W. Wray for behavioral habituation of mice; S. Yurgenson for technical contributions to visual stimulation and eye-tracking software; and A. Vagodny for technical assistance. We also thank V. Berezovskii, R. Born, S. Chatterjee, M. Histed, C. Hull, A. Kerlin, W. Lee, J. Maunsell and W. Regehr for advice and discussion at all stages of the project. This work was supported by the US National Institutes of Health (R01 EY018742 and R01 EY010115) and by fellowships from the Helen Hay Whitney Foundation (L.L.G. and M.L.A.) and the Ludcke Foundation and Pierce Charitable Trust (M.L.A.).	Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; Berezovskii VK, 2011, J COMP NEUROL, V519, P3672, DOI 10.1002/cne.22675; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; Bosking WH, 1997, J NEUROSCI, V17, P2112; Brenowitz SD, 2007, J NEUROSCI, V27, P7888, DOI 10.1523/JNEUROSCI.1064-07.2007; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Churchland AK, 2005, J NEUROPHYSIOL, V94, P1084, DOI 10.1152/jn.00196.2005; COOGAN TA, 1993, J NEUROSCI, V13, P3749; DEYOE EA, 1985, NATURE, V317, P58, DOI 10.1038/317058a0; Dong HW, 2004, VISION RES, V44, P3389, DOI 10.1016/j.visres.2004.09.007; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; Gao EQ, 2010, J NEUROSCI, V30, P5912, DOI 10.1523/JNEUROSCI.6456-09.2010; Hata Y, 1999, NEURON, V22, P375, DOI 10.1016/S0896-6273(00)81097-1; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Jarosiewicz B, 2012, CURR BIOL, V22, P269, DOI 10.1016/j.cub.2012.01.011; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Johnson RR, 1997, J NEUROSCI, V17, P7129; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3371; LIVINGSTONE MS, 1983, NATURE, V304, P531, DOI 10.1038/304531a0; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; Morishima M, 2006, J NEUROSCI, V26, P4394, DOI 10.1523/JNEUROSCI.0252-06.2006; Movshon JA, 1996, J NEUROSCI, V16, P7733; Nassi JJ, 2007, NEURON, V55, P799, DOI 10.1016/j.neuron.2007.07.037; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Nikolaou N, 2012, NEURON, V76, P317, DOI 10.1016/j.neuron.2012.08.040; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Roth MM, 2012, J NEUROSCI, V32, P9716, DOI 10.1523/JNEUROSCI.0110-12.2012; Sato TR, 2010, J NEUROSCI, V30, P4256, DOI 10.1523/JNEUROSCI.3774-09.2010; SHIPP S, 1989, EUR J NEUROSCI, V1, P333, DOI 10.1111/j.1460-9568.1989.tb00799.x; SIMMONS PA, 1982, J COMP NEUROL, V211, P295, DOI 10.1002/cne.902110308; Sincich LC, 2003, J NEUROSCI, V23, P5684; Swadlow HA, 1998, J NEUROSCI METH, V79, P131, DOI 10.1016/S0165-0270(97)00176-3; SWADLOW HA, 1981, J COMP NEUROL, V203, P799, DOI 10.1002/cne.902030415; Van den Bergh G, 2010, J COMP NEUROL, V518, P2051, DOI 10.1002/cne.22321; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Wang QX, 2012, J NEUROSCI, V32, P4386, DOI 10.1523/JNEUROSCI.6063-11.2012; Wang QX, 2011, J NEUROSCI, V31, P1905, DOI 10.1523/JNEUROSCI.3488-10.2011; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zhao CJ, 2011, J NEUROSCI, V31, P7492, DOI 10.1523/JNEUROSCI.6636-10.2011	50	183	185	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					219	226		10.1038/nn.3300	http://dx.doi.org/10.1038/nn.3300			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23292681	Green Accepted, Green Published			2022-12-17	WOS:000314260200019
J	Stoianov, I; Zorzi, M				Stoianov, Ivilin; Zorzi, Marco			Emergence of a 'visual number sense' in hierarchical generative models	NATURE NEUROSCIENCE			English	Article							REPRESENTATION; NUMEROSITY; CORTEX	Numerosity estimation is phylogenetically ancient and foundational to human mathematical learning, but its computational bases remain controversial. Here we show that visual numerosity emerges as a statistical property of images in 'deep networks' that learn a hierarchical generative model of the sensory input. Emergent numerosity detectors had response profiles resembling those of monkey parietal neurons and supported numerosity estimation with the same behavioral signature shown by humans and animals.	[Stoianov, Ivilin; Zorzi, Marco] Univ Padua, Dipartimento Psicol Gen, I-35100 Padua, Italy; [Zorzi, Marco] Univ Padua, Ctr Cognit Sci, I-35100 Padua, Italy	University of Padua; University of Padua	Zorzi, M (corresponding author), Univ Padua, Dipartimento Psicol Gen, I-35100 Padua, Italy.	marco.zorzi@unipd.it	Stoianov, Ivilin/AAX-8528-2020; Stoianov, Ivilin/G-5904-2011; Zorzi, Marco/B-7863-2008	Stoianov, Ivilin/0000-0003-0642-259X; Zorzi, Marco/0000-0002-4651-6390	European Research Council [210922]	European Research Council(European Research Council (ERC)European Commission)	This study was supported by the European Research Council (grant no. 210922 to M.Z.)	ALLIK J, 1991, PERCEPT PSYCHOPHYS, V49, P303, DOI 10.3758/BF03205986; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Durgin FH, 2008, CURR BIOL, V18, pR855, DOI 10.1016/j.cub.2008.07.053; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2007, TRENDS COGN SCI, V11, P428, DOI 10.1016/j.tics.2007.09.004; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2010, COGNITION, V116, P33, DOI 10.1016/j.cognition.2010.03.012; Roitman JD, 2007, PLOS BIOL, V5, P1672, DOI 10.1371/journal.pbio.0050208; Santens S, 2010, CEREB CORTEX, V20, P77, DOI 10.1093/cercor/bhp080; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497	15	183	185	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					194	196		10.1038/nn.2996	http://dx.doi.org/10.1038/nn.2996			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22231428				2022-12-17	WOS:000299603500009
J	Bernacchia, A; Seo, H; Lee, D; Wang, XJ				Bernacchia, Alberto; Seo, Hyojung; Lee, Daeyeol; Wang, Xiao-Jing			A reservoir of time constants for memory traces in cortical neurons	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; MIXED-STRATEGY GAME; PRIMATE PREFRONTAL CORTEX; DECISION-MAKING; WORKING-MEMORY; COMPETITIVE GAME; DOPAMINE NEURONS; NEURAL-NETWORKS; RHESUS-MONKEYS; REWARD SIGNALS	According to reinforcement learning theory of decision making, reward expectation is computed by integrating past rewards with a fixed timescale. In contrast, we found that a wide range of time constants is available across cortical neurons recorded from monkeys performing a competitive game task. By recognizing that reward modulates neural activity multiplicatively, we found that one or two time constants of reward memory can be extracted for each neuron in prefrontal, cingulate and parietal cortex. These timescales ranged from hundreds of milliseconds to tens of seconds, according to a power law distribution, which is consistent across areas and reproduced by a 'reservoir' neural network model. These neuronal memory timescales were weakly, but significantly, correlated with those of monkey's decisions. Our findings suggest a flexible memory system in which neural subpopulations with distinct sets of long or short memory timescales may be selectively deployed according to the task demands.	[Wang, Xiao-Jing] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT USA	Yale University; Yale University	Wang, XJ (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA.	xjwang@yale.edu	Lee, Daeyeol/A-6794-2008; Seo, Hyojung/A-6860-2008; Wang, Xiao-Jing/D-2722-2009	Lee, Daeyeol/0000-0003-3474-019X; 	US National Institutes of Health [R01 MH062349, R01 MH073246, DA029330]; Swartz Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062349, R01MH073246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029330] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swartz Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Mazer and M. W. Jung for comments on an earlier version of the manuscript, and R. Chaudhuri, M. Harre and J. Murray for discussions. This work was supported by the US National Institutes of Health grant R01 MH062349 and the Swartz Foundation (A. B. and X.-J.W.), and by US National Institutes of Health grants R01 MH073246 (X.-J.W. and D. L.) and DA029330 (D.L.).	Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Bromberg-Martin ES, 2010, NEURON, V67, P499, DOI 10.1016/j.neuron.2010.06.031; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/S0896-6273(04)00528-8; Corrado GS, 2005, J EXP ANAL BEHAV, V84, P581, DOI 10.1901/jeab.2005.23-05; Curtis CE, 2010, TRENDS COGN SCI, V14, P216, DOI 10.1016/j.tics.2010.03.006; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Ganguli S, 2008, NEURON, V58, P15, DOI 10.1016/j.neuron.2008.01.038; Ganguli S, 2008, P NATL ACAD SCI USA, V105, P18970, DOI 10.1073/pnas.0804451105; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; Jaegera H, 2007, NEURAL NETWORKS, V20, P335, DOI 10.1016/j.neunet.2007.04.016; Jin DZZ, 2009, P NATL ACAD SCI USA, V106, P19156, DOI 10.1073/pnas.0909881106; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kim S, 2009, NEURAL NETWORKS, V22, P294, DOI 10.1016/j.neunet.2009.03.010; LANGTON CG, 1990, PHYSICA D, V42, P12, DOI 10.1016/0167-2789(90)90064-V; Lapish CC, 2008, P NATL ACAD SCI USA, V105, P11963, DOI 10.1073/pnas.0804045105; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Lebedev MA, 2004, PLOS BIOL, V2, P1919, DOI 10.1371/journal.pbio.0020365; Lee D, 2004, COGNITIVE BRAIN RES, V22, P45, DOI 10.1016/j.cogbrainres.2004.07.007; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Machens CK, 2010, J NEUROSCI, V30, P350, DOI 10.1523/JNEUROSCI.3276-09.2010; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Passingham D, 2004, CURR OPIN NEUROBIOL, V14, P163, DOI 10.1016/j.conb.2004.03.003; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rainer G, 1999, J NEUROSCI, V19, P5493; Rainer G, 2002, EUR J NEUROSCI, V15, P1244, DOI 10.1046/j.1460-9568.2002.01958.x; Rigotti M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00024; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Seo H, 2007, CEREB CORTEX, V17, pI110, DOI 10.1093/cercor/bhm064; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Seo H, 2009, J NEUROSCI, V29, P7278, DOI 10.1523/JNEUROSCI.1479-09.2009; Shafi M, 2007, NEUROSCIENCE, V146, P1082, DOI 10.1016/j.neuroscience.2006.12.072; Sigala N, 2008, P NATL ACAD SCI USA, V105, P11969, DOI 10.1073/pnas.0802569105; Soltani A, 2006, NEURAL NETWORKS, V19, P1075, DOI 10.1016/j.neunet.2006.05.044; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Trefethen LN., 2005, SPECTRA PSEUDOSPECTR, DOI 10.1515/9780691213101; Verstraeten D, 2007, NEURAL NETWORKS, V20, P391, DOI 10.1016/j.neunet.2007.04.003; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034	50	183	183	3	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					366	372		10.1038/nn.2752	http://dx.doi.org/10.1038/nn.2752			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21317906	Green Accepted			2022-12-17	WOS:000287650100018
J	McLean, DL; Masino, MA; Koh, IYY; Lindquist, WB; Fetcho, JR				McLean, David L.; Masino, Mark A.; Koh, Ingrid Y. Y.; Lindquist, W. Brent; Fetcho, Joseph R.			Continuous shifts in the active set of spinal interneurons during changes in locomotor speed	NATURE NEUROSCIENCE			English	Article							LARVAL ZEBRAFISH; FUNCTIONAL SIGNIFICANCE; MOTOR PATTERNS; SIZE PRINCIPLE; NEURAL-CONTROL; RECRUITMENT; CORD; MOTONEURONS; CIRCUITS; INVITRO	The classic 'size principle' of motor control describes how increasingly forceful movements arise by the recruitment of motoneurons of progressively larger size and force output into the active pool. We explored the activity of pools of spinal interneurons in larval zebrafish and found that increases in swimming speed were not associated with the simple addition of cells to the active pool. Instead, the recruitment of interneurons at faster speeds was accompanied by the silencing of those driving movements at slower speeds. This silencing occurred both between and within classes of rhythmically active premotor excitatory interneurons. Thus, unlike motoneurons, there is a continuous shift in the set of cells driving the behavior, even though changes in the speed of the movements and the frequency of the motor pattern appear to be smoothly graded. We conclude that fundamentally different principles may underlie the recruitment of motoneuron and interneuron pools.	[McLean, David L.; Masino, Mark A.; Fetcho, Joseph R.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Koh, Ingrid Y. Y.; Lindquist, W. Brent] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA	Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Fetcho, JR (corresponding author), Cornell Univ, Dept Neurobiol & Behav, W103 Mudd Hall, Ithaca, NY 14853 USA.	jrf49@cornell.edu			US National Institutes of Health [NS44728, NS44758, NS26539]; National Science Foundation [DMS-0107893]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS044758, R29NS026539, R37NS026539, F32NS044728, R01NS026539] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are extremely grateful to S. Higashijima for providing us with the alx-gfp transgenic fish. We also thank L. Heller for fish care and M. Koyama for comments on the manuscript. This work was supported by fellowships from the US National Institutes of Health (NS44728 to D. L. M. and NS44758 to M. A. M.) and grants from the National Science Foundation (DMS-0107893 to W. B. L.) and US National Institutes of Health (NS26539 to J.R.F.).	Berkowitz A, 2007, J NEUROSCI, V27, P4634, DOI 10.1523/JNEUROSCI.5602-06.2007; Bhatt DH, 2004, SCIENCE, V305, P254, DOI 10.1126/science.1098439; Bhatt DH, 2007, NEURON, V53, P91, DOI 10.1016/j.neuron.2006.11.011; Budick SA, 2000, J EXP BIOL, V203, P2565; COHEN AH, 1980, EXP BRAIN RES, V41, P11; Cope TC, 1995, NEWS PHYSIOL SCI, V10, P280, DOI 10.1152/physiologyonline.1995.10.6.280; Cope TC, 1999, J PHYSIOL-PARIS, V93, P81, DOI 10.1016/S0928-4257(99)80138-7; DAVIS WJ, 1971, J NEUROPHYSIOL, V34, P274, DOI 10.1152/jn.1971.34.2.274; Drapeau P, 1999, J NEUROSCI METH, V88, P1, DOI 10.1016/S0165-0270(99)00008-4; FAN J, 2005, SOC NEUR ABSTR; FETCHO JR, 1988, J NEUROSCI, V8, P4192; FETCHO JR, 1990, J COMP NEUROL, V299, P283, DOI 10.1002/cne.902990303; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Gabriel JP, 2008, J NEUROPHYSIOL, V99, P37, DOI 10.1152/jn.00785.2007; Gabriel JP, 2003, J NEUROBIOL, V56, P237, DOI 10.1002/neu.10237; GRILLNER S, 1981, ACTA PHYSIOL SCAND, V113, P549, DOI 10.1111/j.1748-1716.1981.tb06937.x; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Hale ME, 2001, J COMP NEUROL, V437, P1, DOI 10.1002/cne.1266; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; Higashijima S, 2004, J COMP NEUROL, V480, P19, DOI 10.1002/cne.20279; Higashijima S, 2004, J NEUROSCI, V24, P5827, DOI 10.1523/JNEUROSCI.5342-03.2004; Hill AAV, 2008, J EXP BIOL, V211, P613, DOI 10.1242/jeb.006270; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kimura Y, 2006, J NEUROSCI, V26, P5684, DOI 10.1523/JNEUROSCI.4993-05.2006; KOH IYY, 2001, AUTOMATED RECOGNITIO; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Li WC, 2007, J NEUROSCI, V27, P12267, DOI 10.1523/JNEUROSCI.3694-07.2007; LIU DW, 1988, J PHYSIOL-LONDON, V403, P73, DOI 10.1113/jphysiol.1988.sp017239; Masino MA, 2005, J NEUROPHYSIOL, V93, P3177, DOI 10.1152/jn.01248.2004; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; Mendell LM, 2005, J NEUROPHYSIOL, V93, P3024, DOI 10.1152/classicessays.00025.2005; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; ROBERTS A, 1981, SCIENCE, V213, P1032, DOI 10.1126/science.7196599; Roberts A, 1998, ANN NY ACAD SCI, V860, P19, DOI 10.1111/j.1749-6632.1998.tb09036.x; SILLAR KT, 1993, J PHYSIOL-LONDON, V472, P557, DOI 10.1113/jphysiol.1993.sp019962; SMITH JC, 1987, J NEUROSCI METH, V21, P321, DOI 10.1016/0165-0270(87)90126-9; Stein PSG, 1998, ANN NY ACAD SCI, V860, P142, DOI 10.1111/j.1749-6632.1998.tb09045.x; Svoboda KR, 1996, J NEUROSCI, V16, P843; Thorsen DH, 2004, J EXP BIOL, V207, P4175, DOI 10.1242/jeb.01285; ZAJAC FE, 1985, J NEUROPHYSIOL, V53, P1303, DOI 10.1152/jn.1985.53.5.1303	41	183	183	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2008	11	12					1419	1429		10.1038/nn.2225	http://dx.doi.org/10.1038/nn.2225			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	375JF	18997790	Green Accepted			2022-12-17	WOS:000261109300015
J	Behrens, CJ; van den Boom, LP; de Hoz, L; Friedman, A; Heinemann, U				Behrens, CJ; van den Boom, LP; de Hoz, L; Friedman, A; Heinemann, U			Induction of sharp wave-ripple complexes in vitro and reorganization of hippocampal networks	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; HIGH-FREQUENCY OSCILLATIONS; RAT HIPPOCAMPUS; SYNAPTIC TRANSMISSION; MEMORY CONSOLIDATION; NEURONS; SLICES; DEPRESSION; PLASTICITY; SLEEP	Hippocampal sharp wave-ripple complexes (SPW-Rs) occur during slow-wave sleep and behavioral immobility and are thought to represent stored information that is transferred to the neocortex during memory consolidation. Here we show that stimuli that induce long-term potentiation (LTP), a neurophysiological correlate of learning and memory, can lead to the generation of SPW-Rs in rat hippocampal slices. The induced SPW-Rs have properties that are identical to spontaneously generated SPW-Rs: they originate in CA3, propagate to CA1 and subiculum and require AMPA/kainate receptors. Their induction is dependent on NMDA receptors and involves changes in interactions between clusters of neurons in the CA3 network. Their expression is blocked by low-frequency stimulation but not by NMDA receptor antagonists. These data indicate that induction of LTP in the recurrent CA3 network may facilitate the generation of SPW-Rs.	Charite Univ Med Berlin, Inst Neurophysiol, D-10117 Berlin, Germany; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Dept Neurosurg, IL-84105 Beer Sheva, Israel; Soroka Med Ctr, IL-84105 Beer Sheva, Israel	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Heinemann, U (corresponding author), Charite Univ Med Berlin, Inst Neurophysiol, Tucholskystr 2, D-10117 Berlin, Germany.	uwe.heinemann@charite.de		de Hoz, Livia/0000-0002-5782-1120				Amaral David G., 1995, P443; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; ASHTON D, 1989, BRAIN RES, V487, P368, DOI 10.1016/0006-8993(89)90842-1; Axmacher N, 2004, J PHYSIOL-LONDON, V555, P713, DOI 10.1113/jphysiol.2003.052225; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRAGDON AC, 1986, BRAIN RES, V378, P169, DOI 10.1016/0006-8993(86)90300-8; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; BUZSAKI G, 1984, BRAIN RES, V300, P179, DOI 10.1016/0006-8993(84)91356-8; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Buzsaki G, 2002, CEREB CORTEX, V12, P893, DOI 10.1093/cercor/12.9.893; BUZSAKI G, 1987, BRAIN RES, V435, P331, DOI 10.1016/0006-8993(87)91618-0; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Colgin LL, 2005, NEUROSCI LETT, V385, P46, DOI 10.1016/j.neulet.2005.05.005; Colgin LL, 2004, J PHYSIOL-LONDON, V558, P953, DOI 10.1113/jphysiol.2004.068080; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Dudek F E, 1986, Adv Neurol, V44, P593; DUDEK SM, 1993, J NEUROSCI, V13, P2910; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; Heinemann U., 1992, P206; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; JOHNSTON D, 1984, ANN NEUROL, V16, pS65, DOI 10.1002/ana.410160711; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kann O, 2003, NEUROSCIENCE, V119, P87, DOI 10.1016/S0306-4522(03)00026-5; King C, 1999, J PHYSIOL-LONDON, V521, P159, DOI 10.1111/j.1469-7793.1999.00159.x; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; MILES R, 1987, NATURE, V329, P724, DOI 10.1038/329724a0; Moser MB, 2000, NEURON, V26, P559, DOI 10.1016/S0896-6273(00)81192-7; Nadel L, 1998, NEUROPHARMACOLOGY, V37, P431, DOI 10.1016/S0028-3908(98)00057-4; Papatheodoropoulos C, 2002, BRAIN RES BULL, V57, P187, DOI 10.1016/S0361-9230(01)00738-9; Ponomarenko AA, 2003, NEUROSCIENCE, V121, P759, DOI 10.1016/S0306-4522(03)00524-4; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Windmuller O, 2005, BRAIN, V128, P2042, DOI 10.1093/brain/awh545; Wong R K, 1986, Adv Neurol, V44, P583; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	49	183	187	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1560	1567		10.1038/nn1571	http://dx.doi.org/10.1038/nn1571			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16222227				2022-12-17	WOS:000232966600031
J	Da Silva, JS; Hasegawa, T; Miyagi, T; Dotti, CG; Abad-Rodriguez, J				Da Silva, JS; Hasegawa, T; Miyagi, T; Dotti, CG; Abad-Rodriguez, J			Asymmetric membrane ganglioside sialidase activity specifies axonal fate	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; CULTURED HIPPOCAMPAL-NEURONS; GM1 GANGLIOSIDE; CELL POLARITY; ACTIN FLOW; RHOA; 3-KINASE; GTPASES; RAC1; CONE	Axon specification triggers the polarization of neurons and requires the localized destabilization of filamentous actin. Here we show that plasma membrane ganglioside sialidase (PMGS) asymmetrically accumulates at the tip of one neurite of the unpolarized rat neuron, inducing actin instability. Suppressing PMGS activity blocks axonal generation, whereas stimulating it accelerates the formation of a single (not several) axon. PMGS induces axon specification by enhancing TrkA activity locally, which triggers phosphatidylinositol-3-kinase (PI3K)- and Rac1-dependent inhibition of RhoA signaling and the consequent actin depolymerization in one neurite only. Thus, spatial restriction of an actin-regulating molecular machinery, in this case a membrane enzymatic activity, before polarization is enough to determine axonal fate.	Univ Turin, Cavalieri Ottolenghi Sci Inst, I-10043 Turin, Italy; Miyagi Prefectural Canc Ctr, Div Biochem, Natori, Miyagi 9811293, Japan; Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol, B-3000 Louvain, Belgium	University of Turin; Universite Catholique Louvain	Abad-Rodriguez, J (corresponding author), Univ Turin, Cavalieri Ottolenghi Sci Inst, I-10043 Turin, Italy.	carlos.dotti@unito.it; jose.abad@unito.it	Dotti, Carlos G/I-5533-2015; Hasegawa, Takafumi/I-6668-2017; Abad-Rodríguez, José/L-8274-2014	Dotti, Carlos G/0000-0003-4052-1719; Abad-Rodríguez, José/0000-0002-0350-500X				Baas PW, 2001, TRENDS CELL BIOL, V11, P244, DOI 10.1016/S0962-8924(01)02005-0; Banker G., 1991, CULTURING NERVE CELL; BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; BARTLETT WP, 1984, J NEUROSCI, V4, P1954; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Bradke F, 2000, MICROSC RES TECHNIQ, V48, P3, DOI 10.1002/(SICI)1097-0029(20000101)48:1<3::AID-JEMT2>3.0.CO;2-O; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Da Silva JS, 2004, MOL CELL NEUROSCI, V27, P1, DOI 10.1016/j.men.2004.03.008; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Duchemin AM, 1998, ANN NY ACAD SCI, V845, P406, DOI 10.1111/j.1749-6632.1998.tb09696.x; Hasegawa T, 2000, J BIOL CHEM, V275, P14778; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Kalka D, 2001, BIOCHEM BIOPH RES CO, V283, P989, DOI 10.1006/bbrc.2001.4864; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; Kopitz J, 1997, EUR J CELL BIOL, V73, P1; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kranenburg O, 1997, J CELL SCI, V110, P2417; Ledesma MD, 2003, INT REV CYTOL, V227, P183, DOI 10.1016/S0074-7696(03)01010-6; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Nusser N, 2002, J BIOL CHEM, V277, P35840, DOI 10.1074/jbc.M203617200; Pfenninger KH, 2003, J CELL SCI, V116, P1209, DOI 10.1242/jcs.00285; RABIN SJ, 1995, J NEUROCHEM, V65, P347; Rodriguez JA, 2001, J NEUROSCI, V21, P8387, DOI 10.1523/JNEUROSCI.21-21-08387.2001; SCHNAAR RL, 1994, METHOD ENZYMOL, V230, P371; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; UI M, 1995, TRENDS BIOCHEM SCI, V20, P303, DOI 10.1016/S0968-0004(00)89056-8; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; Zhang XF, 2003, NEURON, V40, P931, DOI 10.1016/S0896-6273(03)00754-2	45	183	187	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					606	615		10.1038/nn1442	http://dx.doi.org/10.1038/nn1442			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15834419				2022-12-17	WOS:000228895100021
J	Wang, JX; Kurth-Nelson, Z; Kumaran, D; Tirumala, D; Soyer, H; Leibo, JZ; Hassabis, D; Botvinick, M				Wang, Jane X.; Kurth-Nelson, Zeb; Kumaran, Dharshan; Tirumala, Dhruva; Soyer, Hubert; Leibo, Joel Z.; Hassabis, Demis; Botvinick, Matthew			Prefrontal cortex as a meta-reinforcement learning system	NATURE NEUROSCIENCE			English	Article							ACTION SELECTION; DECISION-MAKING; WORKING-MEMORY; DOPAMINE; NEURONS; SIGNALS; MODEL; UNCERTAINTY; HUMANS; CHOICE	Over the past 20 years, neuroscience research on reward-based learning has converged on a canonical model, under which the neurotransmitter dopamine 'stamps in' associations between situations, actions and rewards by modulating the strength of synaptic connections between neurons. However, a growing number of recent findings have placed this standard model under strain. We now draw on recent advances in artificial intelligence to introduce a new theory of reward-based learning. Here, the dopamine system trains another part of the brain, the prefrontal cortex, to operate as its own free-standing learning system. This new perspective accommodates the findings that motivated the standard model, but also deals gracefully with a wider range of observations, providing a fresh foundation for future research.	[Wang, Jane X.; Kurth-Nelson, Zeb; Kumaran, Dharshan; Tirumala, Dhruva; Soyer, Hubert; Leibo, Joel Z.; Hassabis, Demis; Botvinick, Matthew] DeepMind, London, England; [Kurth-Nelson, Zeb] UCL, Max Planck UCL Ctr Computat Psychiat & Ageing Res, London, England; [Kumaran, Dharshan] UCL, Inst Cognit Neurosci, London, England; [Hassabis, Demis; Botvinick, Matthew] UCL, Gatsby Computat Neurosci Unit, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Botvinick, M (corresponding author), DeepMind, London, England.; Botvinick, M (corresponding author), UCL, Gatsby Computat Neurosci Unit, London, England.	botvinick@google.com		Wang, Jane/0000-0003-1339-5040; Leibo, Joel/0000-0002-3153-916X				Acuna DE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001003; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bromberg-Martin ES, 2010, J NEUROPHYSIOL, V104, P1068, DOI 10.1152/jn.00158.2010; Chan SCY, 2016, J NEUROSCI, V36, P7817, DOI 10.1523/JNEUROSCI.0659-16.2016; Chang CY, 2016, NAT NEUROSCI, V19, P111, DOI 10.1038/nn.4191; Chatham CH, 2015, CURR OPIN BEHAV SCI, V1, P23, DOI 10.1016/j.cobeha.2014.08.001; Collins AGE, 2012, EUR J NEUROSCI, V35, P1024, DOI 10.1111/j.1460-9568.2011.07980.x; Collins AGE, 2016, COGNITION, V152, P160, DOI 10.1016/j.cognition.2016.04.002; Daw N. D., 2014, NEUROECONOMICS, P283, DOI [10.1016/B978-0-12-416008-8.00015-2, DOI 10.1016/B978-0-12-416008-8.00015-2]; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Duan Y, 2016, PREPRINT; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Gershman SJ, 2017, ANNU REV PSYCHOL, V68, P101, DOI 10.1146/annurev-psych-122414-033625; Graves A, 2013, 2013 IEEE WORKSHOP ON AUTOMATIC SPEECH RECOGNITION AND UNDERSTANDING (ASRU), P273, DOI 10.1109/ASRU.2013.6707742; Haber SN, 2014, NEUROSCIENCE, V282, P248, DOI 10.1016/j.neuroscience.2014.10.008; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Hochreiter S, 1997, STUD COMPUT INTELL, V8, P1735, DOI DOI 10.1007/978-3-642-24797-2; Houk JC, 1995, MODELS INFORM PROCES, P249; Iigaya K, 2016, ELIFE, V5, DOI 10.7554/eLife.18073; Ishii S, 2002, NEURAL NETWORKS, V15, P665, DOI 10.1016/S0893-6080(02)00056-4; Khamassi M, 2013, PROG BRAIN RES, V202, P441, DOI 10.1016/B978-0-444-62604-2.00022-8; Kim H, 2013, J NEUROSCI, V33, P52, DOI 10.1523/JNEUROSCI.2422-12.2013; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Leibo J. Z., 2018, PREPRINT; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Miller KJ, 2017, NAT NEUROSCI, V20, P1269, DOI 10.1038/nn.4613; Mnih V., 2016, INT C MACH LEARN, DOI DOI 10.5555/3045390.3045594; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nakahara H, 2012, NEUROSCI RES, V74, P177, DOI 10.1016/j.neures.2012.09.007; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Redish AD, 2007, PSYCHOL REV, V114, P784, DOI 10.1037/0033-295X.114.3.784; Rougier NP, 2005, P NATL ACAD SCI USA, V102, P7338, DOI 10.1073/pnas.0502455102; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Sadacca BF, 2016, ELIFE, V5, DOI 10.7554/eLife.13665; Schmidhuber J., 1996, SIMPLE PRINCIPLES ME; Schuck NW, 2016, NEURON, V91, P1402, DOI 10.1016/j.neuron.2016.08.019; Schweighofer N, 2003, NEURAL NETWORKS, V16, P5, DOI 10.1016/S0893-6080(02)00228-9; Seo H, 2008, PHILOS T R SOC B, V363, P3845, DOI 10.1098/rstb.2008.0158; Seo M, 2012, NEURON, V74, P947, DOI 10.1016/j.neuron.2012.03.037; Song HF, 2017, ELIFE, V6, DOI [10.7554/elife.21492, 10.7554/eLife.21492]; Stopper CM, 2014, NEURON, V84, P177, DOI 10.1016/j.neuron.2014.08.033; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Takahashi YK, 2011, NAT NEUROSCI, V14, P1590, DOI 10.1038/nn.2957; Thrun Sebastian, 2012, LEARNING LEARN; Trujillo-Pisanty I., 2016, SOC NEUROSCI ANN M 6; Tsutsui KI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12554; Wang J., 2016, PREPRINT; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3	55	182	185	15	120	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2018	21	6					860	+		10.1038/s41593-018-0147-8	http://dx.doi.org/10.1038/s41593-018-0147-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GH2LE	29760527	Green Submitted			2022-12-17	WOS:000433232600015
J	Rich, EL; Wallis, JD				Rich, Erin L.; Wallis, Jonathan D.			Decoding subjective decisions from orbitofrontal cortex	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; VALUE-GUIDED CHOICE; FRONTAL-CORTEX; ECONOMIC DECISIONS; MACAQUE MONKEYS; MODEL; REPRESENTATION; MECHANISMS; MEMORIES; BEHAVIOR	When making a subjective choice, the brain must compute a value for each option and compare those values to make a decision. The orbitofrontal cortex (OFC) is critically involved in this process, but the neural mechanisms remain obscure, in part due to limitations in our ability to measure and control the internal deliberations that can alter the dynamics of the decision process. Here we tracked these dynamics by recovering temporally precise neural states from multidimensional data in OFC. During individual choices, OFC alternated between states associated with the value of two available options, with dynamics that predicted whether a subject would decide quickly or vacillate between the two alternatives. Ensembles of value-encoding neurons contributed to these states, with individual neurons shifting activity patterns as the network evaluated each option. Thus, the mechanism of subjective decision-making involves the dynamic activation of OFC states associated with each choice alternative.	[Rich, Erin L.; Wallis, Jonathan D.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Wallis, Jonathan D.] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rich, EL (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	erin.rich@berkeley.edu		Rich, Erin/0000-0002-7153-6027; Wallis, Joni/0000-0001-7262-7417	NIDA [R01 DA19028, K08 DA039051]; NIMH [R01 MH097990]; Hilda and Preston Davis Foundation; Defense Advanced Research Projects Agency (DARPA) [W911NF-14-2-0043]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019028, K08DA039351] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Hilda and Preston Davis Foundation; Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank M. Rangel-Gomez for comments on the manuscript. This work was funded by NIDA R01 DA19028 and NIMH R01 MH097990 (to J.D.W.) and by the Hilda and Preston Davis Foundation and NIDA K08 DA039051 to (E.L.R.). This research was partially funded by the Defense Advanced Research Projects Agency (DARPA) under Cooperative Agreement Number W911NF-14-2-0043, issued by the Army Research Office contracting office in support of DARPA'S SUBNETS program. The views, opinions, and/or findings expressed are those of the author(s) and should not be interpreted as representing the official views or policies of the Department of Defense or the U.S. Government.	Barron HC, 2013, NAT NEUROSCI, V16, P1492, DOI 10.1038/nn.3515; Bouret S, 2010, J NEUROSCI, V30, P8591, DOI 10.1523/JNEUROSCI.0049-10.2010; Buesing L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002211; Cai XY, 2014, NEURON, V81, P1140, DOI 10.1016/j.neuron.2014.01.008; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; Dai JY, 2014, J EXP PSYCHOL GEN, V143, P1489, DOI 10.1037/a0035976; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Farovik A, 2015, J NEUROSCI, V35, P8333, DOI 10.1523/JNEUROSCI.0134-15.2015; Fellows LK, 2011, ANN NY ACAD SCI, V1239, P51, DOI 10.1111/j.1749-6632.2011.06229.x; Fukushima M, 2014, J NEUROSCI, V34, P4665, DOI 10.1523/JNEUROSCI.3969-13.2014; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Grattan LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112750; Habenschuss S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003311; Hosokawa T, 2013, J NEUROSCI, V33, P17385, DOI 10.1523/JNEUROSCI.2221-13.2013; Hunt LT, 2015, ELIFE, V4, DOI 10.7554/eLife.11945; Hunt LT, 2012, NAT NEUROSCI, V15, P470, DOI 10.1038/nn.3017; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Jocham G, 2012, NAT NEUROSCI, V15, P960, DOI 10.1038/nn.3140; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Jones JL, 2012, SCIENCE, V338, P953, DOI 10.1126/science.1227489; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Lak A, 2014, NEURON, V84, P190, DOI 10.1016/j.neuron.2014.08.039; Lara AH, 2014, NAT NEUROSCI, V17, P876, DOI 10.1038/nn.3702; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Luk CH, 2013, J NEUROSCI, V33, P1864, DOI 10.1523/JNEUROSCI.4920-12.2013; McDannald MA, 2012, EUR J NEUROSCI, V35, P991, DOI 10.1111/j.1460-9568.2011.07982.x; McKenzie S, 2014, NEURON, V83, P202, DOI 10.1016/j.neuron.2014.05.019; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2013, NEURON, V80, P1322, DOI 10.1016/j.neuron.2013.09.013; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rich EL, 2014, J COGNITIVE NEUROSCI, V26, P1347, DOI 10.1162/jocn_a_00573; Rudebeck PH, 2014, NEURON, V84, P1143, DOI 10.1016/j.neuron.2014.10.049; Rushworth MFS, 2009, CURR OPIN NEUROBIOL, V19, P75, DOI 10.1016/j.conb.2009.02.005; Rustichini A, 2015, J NEUROPHYSIOL, V114, P1382, DOI 10.1152/jn.00184.2015; Schoenbaum G, 2011, ANN NY ACAD SCI, V1239, P87, DOI 10.1111/j.1749-6632.2011.06210.x; Seidemann E, 1996, J NEUROSCI, V16, P752; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Strait CE, 2016, J NEUROPHYSIOL, V115, P1098, DOI 10.1152/jn.00325.2015; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Takahashi YK, 2013, NEURON, V80, P507, DOI 10.1016/j.neuron.2013.08.008; Tremblay S, 2015, NEURON, V85, P202, DOI 10.1016/j.neuron.2014.11.021; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wallis JD, 2012, NAT NEUROSCI, V15, P13, DOI 10.1038/nn.2956; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Willett FR, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026011; Wilson RC, 2014, NEURON, V81, P267, DOI 10.1016/j.neuron.2013.11.005	50	182	182	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2016	19	7					973	980		10.1038/nn.4320	http://dx.doi.org/10.1038/nn.4320			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DP8PH	27273768	Green Accepted			2022-12-17	WOS:000378759600017
J	Lomniczi, A; Loche, A; Castellano, JM; Ronnekleiv, OK; Bosch, M; Kaidar, G; Knoll, JG; Wright, H; Pfeifer, GP; Ojeda, SR				Lomniczi, Alejandro; Loche, Alberto; Castellano, Juan Manuel; Ronnekleiv, Oline K.; Bosch, Martha; Kaidar, Gabi; Knoll, J. Gabriel; Wright, Hollis; Pfeifer, Gerd P.; Ojeda, Sergio R.			Epigenetic control of female puberty	NATURE NEUROSCIENCE			English	Article							ARCUATE NUCLEUS; HORMONE NEURONS; HYPOGONADOTROPIC HYPOGONADISM; NEUROKININ B; LIFE-SPAN; CHROMATIN; KISSPEPTIN; COMPLEX; GENE; MECHANISMS	The timing of puberty is controlled by many genes. The elements coordinating this process have not, however, been identified. Here we show that an epigenetic mechanism of transcriptional repression times the initiation of female puberty in rats. We identify silencers of the Polycomb group (PcG) as principal contributors to this mechanism and show that PcG proteins repress Kiss1, a puberty-activating gene. Hypothalamic expression of two key PcG genes, Eed and Cbx7, decreased and methylation of their promoters increased before puberty. Inhibiting DNA methylation blocked both events and resulted in pubertal failure. The pubertal increase in Kiss1 expression was accompanied by EED loss from the Kiss1 promoter and enrichment of histone H3 modifications associated with gene activation. Preventing the eviction of EED from the Kiss1 promoter disrupted pulsatile gonadotropin-releasing hormone release, delayed puberty and compromised fecundity. Our results identify epigenetic silencing as a mechanism underlying the neuroendocrine control of female puberty.	[Lomniczi, Alejandro; Loche, Alberto; Castellano, Juan Manuel; Ronnekleiv, Oline K.; Kaidar, Gabi; Knoll, J. Gabriel; Wright, Hollis; Ojeda, Sergio R.] Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR USA; [Ronnekleiv, Oline K.; Bosch, Martha] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Pfeifer, Gerd P.] City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; City of Hope; Beckman Research Institute of City of Hope	Lomniczi, A (corresponding author), Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR USA.	lomniczi@ohsu.edu; ojedas@ohsu.edu	Castellano, Juan Manuel/AAI-2052-2019	Castellano, Juan Manuel/0000-0003-3981-6683; Lomniczi, Alejandro/0000-0003-4535-0103; Loche, Alberto/0000-0001-5974-6008	US National Institute of Health (NIH) [HD025123-ARRA, 8P51OD011092]; US National Science Foundation [IOS1121691]; NIH [NS43330, DK68098]; European Community; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007133] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043330] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M.E. Costa for technical assistance with the in situ hybridization procedures and the preparation of ovaries for morphological observation. This work was supported by US National Institute of Health (NIH; HD025123-ARRA and 8P51OD011092) and US National Science Foundation (IOS1121691) grants to S.R.O. and by NIH grants NS43330 and DK68098 to O.K.R., and by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (FP7-PEOPLE-2010-IOF) to J.M.C.	Bedecarrats GY, 2007, SEMIN REPROD MED, V25, P368, DOI 10.1055/s-2007-984743; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bilger M, 2001, ENDOCRINOLOGY, V142, P2102, DOI 10.1210/en.142.5.2102; BROADWELL RD, 1976, J COMP NEUROL, V166, P257, DOI 10.1002/cne.901660302; Christian CA, 2009, BIOL REPROD, V80, P1128, DOI 10.1095/biolreprod.108.075077; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Ghoshal K, 2007, DRUG TODAY, V43, P395, DOI 10.1358/dot.2007.43.6.1062666; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gottsch ML, 2011, ENDOCRINOLOGY, V152, P4298, DOI 10.1210/en.2011-1521; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Herbison AE, 2011, J NEUROENDOCRINOL, V23, P557, DOI 10.1111/j.1365-2826.2011.02145.x; Herde MK, 2011, ENDOCRINOLOGY, V152, P3832, DOI 10.1210/en.2011-1228; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Iremonger KJ, 2010, BRAIN RES, V1364, P35, DOI 10.1016/j.brainres.2010.08.071; Komashko Vitalina M, 2010, Epigenetics, V5, P229; Krewson TD, 2004, ENDOCRINOLOGY, V145, P4447, DOI 10.1210/en.2004-0543; Kurian JR, 2010, ENDOCRINOLOGY, V151, P5359, DOI 10.1210/en.2010-0555; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Lehman MN, 2010, ENDOCRINOLOGY, V151, P3479, DOI 10.1210/en.2010-0022; Meng S, 2010, J BIOL CHEM, V285, P33219, DOI 10.1074/jbc.M110.133686; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Neill JD, 1994, PHYSL REPRODUCTION, V1, P1621; NOWAK KW, 1995, LIFE SCI, V57, P833, DOI 10.1016/0024-3205(95)02015-B; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Ojeda SR, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2061; Ojeda SR, 2010, EUR J NEUROSCI, V32, P2003, DOI 10.1111/j.1460-9568.2010.07515.x; Ojeda SR, 2010, BRAIN RES, V1364, P164, DOI 10.1016/j.brainres.2010.09.039; Ojeda SR, 2006, ENDOCRINOLOGY, V147, P1166, DOI 10.1210/en.2005-1136; Otte AP, 2003, CURR OPIN GENET DEV, V13, P448, DOI 10.1016/S0959-437X(03)00108-4; Plant TM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2177; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sawarkar R, 2010, DEV CELL, V19, P651, DOI 10.1016/j.devcel.2010.10.012; Schaefer M, 2009, CANCER RES, V69, P8127, DOI 10.1158/0008-5472.CAN-09-0458; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Seminara SB, 2001, ENDOCRINOLOGY, V142, P2173, DOI 10.1210/en.142.6.2173; SHRIVASTAVA A, 1994, NUCLEIC ACIDS RES, V22, P5151, DOI 10.1093/nar/22.24.5151; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Suter KJ, 2004, NEUROSCIENCE, V128, P443, DOI 10.1016/j.neuroscience.2004.06.044; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416	50	182	188	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					281	289		10.1038/nn.3319	http://dx.doi.org/10.1038/nn.3319			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23354331	Green Accepted			2022-12-17	WOS:000315474800010
J	Ueno, T; Tomita, J; Tanimoto, H; Endo, K; Ito, K; Kume, S; Kume, K				Ueno, Taro; Tomita, Jun; Tanimoto, Hiromu; Endo, Keita; Ito, Kei; Kume, Shoen; Kume, Kazuhiko			Identification of a dopamine pathway that regulates sleep and arousal in Drosophila	NATURE NEUROSCIENCE			English	Article							MUSHROOM BODIES; OLFACTORY MEMORY; CENTRAL COMPLEX; NEURAL CIRCUIT; FRUIT-FLY; RECEPTOR; NEURONS; MELANOGASTER; BODY; WAKEFULNESS	Sleep is required to maintain physiological functions, including memory, and is regulated by monoamines across species. Enhancement of dopamine signals by a mutation in the dopamine transporter (DAT) decreases sleep, but the underlying dopamine circuit responsible for this remains unknown. We found that the D1 dopamine receptor (DA1) in the dorsal fan-shaped body (dFSB) mediates the arousal effect of dopamine in Drosophila. The short sleep phenotype of the DAT mutant was completely rescued by an additional mutation in the DA1 (also known as DopR) gene, but expression of wild-type DA1 in the dFSB restored the short sleep phenotype. We found anatomical and physiological connections between dopamine neurons and the dFSB neuron. Finally, we used mosaic analysis with a repressive marker and found that a single dopamine neuron projecting to the FSB activated arousal. These results suggest that a local dopamine pathway regulates sleep.	[Ueno, Taro; Tomita, Jun; Kume, Shoen; Kume, Kazuhiko] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto, Japan; [Tanimoto, Hiromu] Max Planck Inst Neurobiol, Martinsried, Germany; [Endo, Keita; Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Kume, Shoen] Kumamoto Univ, Global Ctr Excellence, Kumamoto, Japan	Kumamoto University; Max Planck Society; University of Tokyo; Kumamoto University	Kume, K (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto, Japan.	kkume@kumamoto-u.ac.jp	Kume, Shoen/M-4356-2016; Ueno, Taro/AAN-7260-2021; Tanimoto, Hiromu/J-6810-2016	Kume, Shoen/0000-0002-4292-205X; Ueno, Taro/0000-0003-3697-4301; Kume, Kazuhiko/0000-0003-4232-1657	Japanese Society for the Promotion of Science (JSPS) [22300132]	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank M. Wu and Q. Liu for sharing unpublished results, K. Ueno, T. Sakai and S. Sato for encouraging advice, M. Yamazaki, A. Miyoshi, Y. Kawahara and W Honghang for technical assistance, F.W. Wolf for the kind gift of an antibody, R. Jackson and the members of Kume laboratory for discussion and critical reading of the manuscript, and P. Garrity, D. Armstrong, J. Hirsh, K. Scott, the Kyoto Drosophila Genetic Resource Center and the Bloomington Stock Center for fly stocks. This work was supported by a grant (22300132) from the Japanese Society for the Promotion of Science (JSPS). T.U. is a JSPS fellow. S.K. is a member of the Global COE Program (Cell Fate Regulation Research and Education Unit).	Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Andretic R, 2008, P NATL ACAD SCI USA, V105, P20392, DOI 10.1073/pnas.0806776105; Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Draper I, 2007, DEV NEUROBIOL, V67, P378, DOI 10.1002/dneu.20355; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Kume K., 2006, SLEEP BIOL RHYTHMS, V4, P263, DOI DOI 10.1111/J.1479-8425.2006.00225.X; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li XJ, 2009, SLEEP, V32, P1417, DOI 10.1093/sleep/32.11.1417; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Seugnet L, 2008, CURR BIOL, V18, P1110, DOI 10.1016/j.cub.2008.07.028; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Shang YH, 2011, NAT NEUROSCI, V14, P889, DOI 10.1038/nn.2860; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shinomiya K, 2011, J COMP NEUROL, V519, P807, DOI 10.1002/cne.22540; SUGAMORI KS, 1995, FEBS LETT, V362, P131, DOI 10.1016/0014-5793(95)00224-W; Tomita J, 2011, J NEUROSCI, V31, P13137, DOI 10.1523/JNEUROSCI.5860-10.2011; Ueno T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032007; Ueno T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031513; Van Swinderen B, 2011, P ROY SOC B-BIOL SCI, V278, P906, DOI 10.1098/rspb.2010.2564; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284; Yuan N, 2007, EUR J NEUROSCI, V26, P2417, DOI 10.1111/j.1460-9568.2007.05870.x; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Zhang S, 2008, BIOCHEM BIOPH RES CO, V370, P82, DOI 10.1016/j.bbrc.2008.03.015	50	182	188	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1516	1523		10.1038/nn.3238	http://dx.doi.org/10.1038/nn.3238			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23064381				2022-12-17	WOS:000310424900011
J	Oliveira, AMM; Hemstedt, TJ; Bading, H				Oliveira, Ana M. M.; Hemstedt, Thekla J.; Bading, Hilmar			Rescue of aging-associated decline in Dnmt3a2 expression restores cognitive abilities	NATURE NEUROSCIENCE			English	Article							DNA METHYLATION; AGE; 5-METHYLCYTOSINE; RATS	Cognitive abilities decline in normal aging, yet the underlying molecular mechanisms are poorly understood. We found that aging was associated with a decrease in the expression of the DNA methyltransferase Dnmt3a2 in the hippocampus and that rescuing Dnmt3a2 levels restored cognitive functions. Moreover, we found that Dnmt3a2 is an activity-regulated immediate early gene that is partly dependent on nuclear calcium signaling and that hippocampal Dnmt3a2 levels determine cognitive abilities in both young adult and aged mice.	[Oliveira, Ana M. M.; Hemstedt, Thekla J.; Bading, Hilmar] Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci IZN, D-6900 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Bading, H (corresponding author), Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci IZN, D-6900 Heidelberg, Germany.	hilmar.bading@uni-hd.de	Oliveira, Ana M.M./AFF-2561-2022	Oliveira, Ana M.M./0000-0002-2729-9036	Alexander von Humboldt Foundation; ERC; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich (SFB) 488, SFB 636]; Foundation for Science and Technology, Portugal	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); ERC(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Foundation for Science and Technology, Portugal(Portuguese Foundation for Science and Technology)	We thank I. Bunzli-Ehret for her help with the preparation of hippocampal cultures and U. Weiss for the western blot experiments. We thank D. Tkachev and M. Klugmann for their contributions at the initial stages of this project and the tools that they provided. We thank A. M. Hagenston for comments on the manuscript. This work was supported by the Alexander von Humboldt Foundation (Wolfgang Paul Prize to H. B.), an ERC Advanced Grant (to H. B.), the Sonderforschungsbereich (SFB) 488 and SFB 636 of the Deutsche Forschungsgemeinschaft. H. B. is a member of the Excellence Cluster CellNetworks at Heidelberg University. A.M.M.O. is recipient of a Postdoctoral Fellowship by the Foundation for Science and Technology, Portugal.	BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Erickson CA, 2003, EXP GERONTOL, V38, P61, DOI 10.1016/S0531-5565(02)00160-2; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Kang YK, 2001, FEBS LETT, V498, P1, DOI 10.1016/S0014-5793(01)02472-3; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Kotini AG, 2011, MOL CELL BIOL, V31, P1577, DOI 10.1128/MCB.01093-10; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Monsey MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019958; SHOLL DA, 1953, J ANAT, V87, P387; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; VANYUSHI.BF, 1973, GERONTOLOGY, V19, P138, DOI 10.1159/000211967; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	19	182	190	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1111	+		10.1038/nn.3151	http://dx.doi.org/10.1038/nn.3151			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22751036				2022-12-17	WOS:000306844500015
J	Kristensen, AS; Jenkins, MA; Banke, TG; Schousboe, A; Makino, Y; Johnson, RC; Huganir, R; Traynelis, SF				Kristensen, Anders S.; Jenkins, Meagan A.; Banke, Tue G.; Schousboe, Arne; Makino, Yuichi; Johnson, Richard C.; Huganir, Richard; Traynelis, Stephen F.			Mechanism of Ca2+/calmodulin-dependent kinase II regulation of AMPA receptor gating	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; BIDIRECTIONAL SYNAPTIC PLASTICITY; LIGAND-BINDING CORE; PROTEIN-KINASE; PHOSPHORYLATION SITE; GLUTAMATE RECEPTORS; GLUR1 SUBUNIT; UNITARY CONDUCTANCE; STRUCTURAL BASIS; TRAFFICKING	The function, trafficking and synaptic signaling of AMPA receptors are tightly regulated by phosphorylation. Ca2+/calmodulin-dependent kinase II (CaMKII) phosphorylates the GluA1 AMPA receptor subunit at Ser831 to increase single-channel conductance. We show that CaMKII increases the conductance of native heteromeric AMPA receptors in mouse hippocampal neurons through phosphorylation of Ser831. In addition, co-expression of transmembrane AMPA receptor regulatory proteins (TARPs) with recombinant receptors is required for phospho-Ser831 to increase conductance of heteromeric GluA1-GluA2 receptors. Finally, phosphorylation of Ser831 increases the efficiency with which each subunit can activate, independent of agonist efficacy, thereby increasing the likelihood that more receptor subunits will be simultaneously activated during gating. This underlies the observation that phospho-Ser831 increases the frequency of openings to larger conductances rather than altering unitary conductance. Together, these findings suggest that CaMKII phosphorylation of GluA1-Ser831 decreases the activation energy for an intrasubunit conformational change that regulates the conductance of the receptor when the channel pore opens.	[Kristensen, Anders S.; Jenkins, Meagan A.; Banke, Tue G.; Traynelis, Stephen F.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Kristensen, Anders S.] Univ Copenhagen, Dept Med Chem, Copenhagen, Denmark; [Schousboe, Arne] Univ Copenhagen, Dept Pharmacol & Pharmacotherapy, Copenhagen, Denmark; [Makino, Yuichi; Johnson, Richard C.; Huganir, Richard] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Makino, Yuichi; Johnson, Richard C.; Huganir, Richard] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Emory University; University of Copenhagen; University of Copenhagen; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Traynelis, SF (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.	strayne@emory.edu	Kristensen, Anders Skov/B-4414-2009	Kristensen, Anders Skov/0000-0001-8955-6790; Banke, Tue/0000-0001-8417-4400; Schousboe, Arne/0000-0001-9600-402X	US National Institutes of Health [NS068464, NS036654]; Howard Hughes Medical Institute; Alfred Benzon Foundation; Lundbeck Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036654, R01NS068464, R37NS036654] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Alfred Benzon Foundation; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank V. Derkach and J. Howe for comments on the manuscript. We thank D. Colquhoun (University College London) for providing software for time course fitting and single channel dwell time and amplitude analysis (SCAN, EKDIST). GluA1 and GluA2 cDNA was provided by P. Seeburg (Max-Planck-Institut fur medizinische Forschung) and gamma 8 cDNA by R. Nicoll (University of California, San Francisco). This work was supported by the US National Institutes of Health (NS068464, NS036654; S.F.T.), the Howard Hughes Medical Institute (R.H.), the Alfred Benzon Foundation (A.S.K., T.G.B.) and the Lundbeck Foundation (A.S.).	Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Delgado JY, 2007, J NEUROSCI, V27, P13210, DOI 10.1523/JNEUROSCI.3056-07.2007; Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Derkach VA, 2003, BIOPHYS J, V84, P1701, DOI 10.1016/S0006-3495(03)74978-9; Frandsen A, 2005, MOL PHARMACOL, V67, P703, DOI 10.1124/mol.104.002931; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hogner A, 2002, J MOL BIOL, V322, P93, DOI 10.1016/S0022-2836(02)00650-2; Holmes WR, 2006, J NEUROPHYSIOL, V96, P1478, DOI 10.1152/jn.00248.2006; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Lamsa K, 2007, J PHYSIOL-LONDON, V584, P885, DOI 10.1113/jphysiol.2007.137380; Lee HK, 2007, MOL CELL NEUROSCI, V36, P86, DOI 10.1016/j.mcn.2007.06.003; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lisman J., 2006, SCI STKE, V2006, pr; Luthi A, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-44; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Milstein AD, 2009, P NATL ACAD SCI USA, V106, P11348, DOI 10.1073/pnas.0905570106; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Palmer MJ, 2004, J NEUROSCI, V24, P4903, DOI 10.1523/JNEUROSCI.0170-04.2004; Poncer JC, 2002, J NEUROSCI, V22, P4406, DOI 10.1523/JNEUROSCI.22-11-04406.2002; Poon K, 2010, BIOPHYS J, V99, P1437, DOI 10.1016/j.bpj.2010.06.058; Prieto ML, 2010, J NEUROSCI, V30, P4449, DOI 10.1523/JNEUROSCI.5613-09.2010; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; Traynelis SF, 1998, TRENDS NEUROSCI, V21, P137, DOI 10.1016/S0166-2236(98)01238-7; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Wenthold RJ, 1996, J NEUROSCI, V16, P1982	50	182	187	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					727	U327		10.1038/nn.2804	http://dx.doi.org/10.1038/nn.2804			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21516102	Green Accepted			2022-12-17	WOS:000290958000015
J	Higley, MJ; Sabatini, BL				Higley, Michael J.; Sabatini, Bernardo L.			Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors	NATURE NEUROSCIENCE			English	Article							MEDIUM SPINY NEURONS; DENDRITIC SPINES; NMDA RECEPTOR; BASAL GANGLIA; CALCIUM PERMEABILITY; ANTIPSYCHOTIC-DRUGS; CORTICAL AFFERENTS; DORSAL STRIATUM; DISEASE MODELS; MODULATION	Striatal D2-type dopamine receptors (D2Rs) have been implicated in the pathophysiology of neuropsychiatric disorders, including Parkinson's disease and schizophrenia. Although these receptors regulate striatal synaptic plasticity, the mechanisms underlying dopaminergic modulation of glutamatergic synapses are unclear. We combined optogenetics, two-photon microscopy and glutamate uncaging to examine D2R-dependent modulation of glutamatergic synaptic transmission in mouse striatopallidal neurons. We found that D2R activation reduces corticostriatal glutamate release and attenuates both synaptic-and action potential-evoked Ca2+ influx into dendritic spines by approximately 50%. Modulation of Ca2+ signaling was mediated by a protein kinase A (PKA)-dependent regulation of Ca2+ entry through NMDA-type glutamate receptors that was inhibited by D2Rs and enhanced by activation of 2A-type adenosine receptors (A2ARs). D2Rs also produced a PKA- and A2AR-independent reduction in Ca2+ influx through R-type voltage-gated Ca2+ channels. These findings reveal that dopamine regulates spine Ca2+ by multiple pathways and that competitive modulation of PKA controls NMDAR-mediated Ca2+ signaling in the striatum.	[Higley, Michael J.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu			Parkinson's Disease Foundation; National Institute of Neurological Disorders and Stroke [NS063663, NS046579]; National Alliance for Research on Schizophrenia and Depression; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS063663, R01NS046579] Funding Source: NIH RePORTER	Parkinson's Disease Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Alliance for Research on Schizophrenia and Depression(NARSAD); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank members of the Sabatini laboratory and J.A. Cardin for helpful comments during the preparation of this manuscript. We thank K. Deisseroth and V. Gradinaru for assistance with the ChR2 experiments. The work was funded by grants from the Parkinson's Disease Foundation (Postdoctoral Fellowship) and the National Institute of Neurological Disorders and Stroke (NS063663) to M.J.H. and grants from the National Institute of Neurological Disorders and Stroke (NS046579) and the National Alliance for Research on Schizophrenia and Depression (Independent Investigator Award) to B. L. S.	Bamford NS, 2004, J NEUROSCI, V24, P9541, DOI 10.1523/JNEUROSCI.2891-04.2004; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bonci A, 2005, NEURON, V47, P335, DOI 10.1016/j.neuron.2005.07.015; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Busetto G, 2008, J PHYSIOL-LONDON, V586, P1519, DOI 10.1113/jphysiol.2007.149336; Calabresi P, 1997, J NEUROSCI, V17, P4536; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Carter AG, 2007, J NEUROSCI, V27, P8967, DOI 10.1523/JNEUROSCI.2798-07.2007; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Day M, 2008, J NEUROSCI, V28, P11603, DOI 10.1523/JNEUROSCI.1840-08.2008; Drew MR, 2007, J NEUROSCI, V27, P7731, DOI 10.1523/JNEUROSCI.1736-07.2007; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Furukawa T, 2009, EUR J PHARMACOL, V613, P100, DOI 10.1016/j.ejphar.2009.04.036; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Hakansson K, 2006, J NEUROCHEM, V96, P482, DOI 10.1111/j.1471-4159.2005.03558.x; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; HERSCH SM, 1995, J NEUROSCI, V15, P5222; Higley MJ, 2008, NEURON, V59, P902, DOI 10.1016/j.neuron.2008.08.020; Higley MJ, 2009, NAT NEUROSCI, V12, P1121, DOI 10.1038/nn.2368; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; LOPEZ SH, 2000, J NEUROSCI, V20, P8987; Mahon S, 2001, CEREB CORTEX, V11, P360, DOI 10.1093/cercor/11.4.360; Meltzer HY, 2004, CURR OPIN PHARMACOL, V4, P53, DOI 10.1016/j.coph.2003.09.010; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ronesi J, 2005, J PHYSIOL-LONDON, V562, P245, DOI 10.1113/jphysiol.2004.068460; Salgado H, 2005, J NEUROPHYSIOL, V94, P3771, DOI 10.1152/jn.00455.2005; Schiffmann SN, 2007, PROG NEUROBIOL, V83, P277, DOI 10.1016/j.pneurobio.2007.05.001; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Wang H, 2002, J COMP NEUROL, V442, P392, DOI 10.1002/cne.10086; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495; Yin HH, 2006, P NATL ACAD SCI USA, V103, P8251, DOI 10.1073/pnas.0510797103	49	182	184	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					958	U77		10.1038/nn.2592	http://dx.doi.org/10.1038/nn.2592			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20601948	Green Accepted			2022-12-17	WOS:000280400600014
J	Hagglund, M; Borgius, L; Dougherty, KJ; Kiehn, O				Hagglund, Martin; Borgius, Lotta; Dougherty, Kimberly J.; Kiehn, Ole			Activation of groups of excitatory neurons in the mammalian spinal cord or hindbrain evokes locomotion	NATURE NEUROSCIENCE			English	Article							VITRO NEONATAL-RAT; IN-VITRO; TRANSGENIC MICE; COMMISSURAL INTERNEURONS; VENTROLATERAL FUNICULUS; NEURAL CIRCUITRY; RHYTHM; SPEED; MOUSE; CHANNELRHODOPSIN-2	Central pattern generators (CPGs) are spinal neuronal networks required for locomotion. Glutamatergic neurons have been implicated as being important for intrinsic rhythm generation in the CPG and for the command signal for initiating locomotion, although this has not been demonstrated directly. We used a newly generated vesicular glutamate transporter 2-channelrhodopsin2-yellow fluorescent protein (Vglut2-ChR2-YFP) mouse to directly examine the functional role of glutamatergic neurons in rhythm generation and initiation of locomotion. This mouse line expressed ChR2-YFP in the spinal cord and hindbrain. ChR2-YFP was reliably expressed in Vglut2-positive cells and YFP-expressing cells could be activated by light. Photo-stimulation of either the lumbar spinal cord or the caudal hindbrain was sufficient to both initiate and maintain locomotor-like activity. Our results indicate that glutamatergic neurons in the spinal cord are critical for initiating or maintaining the rhythm and that activation of hindbrain areas containing the locomotor command regions is sufficient to directly activate the spinal locomotor network.	[Hagglund, Martin; Borgius, Lotta; Dougherty, Kimberly J.; Kiehn, Ole] Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, Stockholm, Sweden	Karolinska Institutet	Kiehn, O (corresponding author), Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, Stockholm, Sweden.	o.kiehn@ki.se	kiehn, ole/AAT-7881-2021; kiehn, ole/AAB-1262-2019	Hagglund, Martin/0000-0003-1921-8563; Dougherty, Kimberly/0000-0002-0807-574X; Kiehn, Ole/0000-0002-5954-469X	US National Institutes of Health [R01NS040795-08]; European Union; National Science Foundation [0701166]; Swedish Medical Research Council; Karolinska Institutet's foundation; Soderbergs Foundation; Friends of Karolinska Intitutet; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040795] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); National Science Foundation(National Science Foundation (NSF)); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institutet's foundation; Soderbergs Foundation; Friends of Karolinska Intitutet; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Deisseroth for providing us with the ChR2 construct, D. Engblom for technical assistance with BAC cloning and the Karolinska Center for Transgenic Technologies for pronuclear injection. This work was supported by grants from the US National Institutes of Health (R01NS040795-08), the European Union (SPINAL CORD REPAIR), the National Science Foundation (0701166 to K.J.D.), and by the Swedish Medical Research Council, the Karolinska Institutet's foundation for support of graduate students (M.H.) and postdocs (L.B.), Soderbergs Foundation, and Friends of Karolinska Intitutet.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bonnot A, 2002, BRAIN RES REV, V40, P141, DOI 10.1016/S0165-0173(02)00197-2; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bracci E, 1996, J NEUROPHYSIOL, V75, P640, DOI 10.1152/jn.1996.75.2.640; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Clarac F, 2004, J COMP PHYSIOL A, V190, P343, DOI 10.1007/s00359-004-0499-2; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; Crone SA, 2009, J NEUROSCI, V29, P7098, DOI 10.1523/JNEUROSCI.1206-09.2009; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Dubuc R, 2008, BRAIN RES REV, V57, P172, DOI 10.1016/j.brainresrev.2007.07.016; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; Kiehn O, 2000, BRAIN RES BULL, V53, P649, DOI 10.1016/S0361-9230(00)00398-1; Kiehn O, 1998, ANN NY ACAD SCI, V860, P110, DOI 10.1111/j.1749-6632.1998.tb09043.x; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Liu J, 2005, J NEUROPHYSIOL, V94, P1392, DOI 10.1152/jn.00136.2005; Lundfald L, 2007, EUR J NEUROSCI, V26, P2989, DOI 10.1111/j.1460-9568.2007.05906.x; Magnuson DSK, 1997, J NEUROPHYSIOL, V77, P200, DOI 10.1152/jn.1997.77.1.200; Marchetti C, 2001, J PHYSIOL-LONDON, V530, P105, DOI 10.1111/j.1469-7793.2001.0105m.x; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nishimaru H, 2000, BRAIN RES BULL, V53, P661, DOI 10.1016/S0361-9230(00)00399-3; Parkitna Jan Rodriguez, 2009, V530, P325, DOI 10.1007/978-1-59745-471-1_17; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Reed WR, 2008, NEUROSCIENCE, V151, P505, DOI 10.1016/j.neuroscience.2007.10.025; Restrepo CE, 2009, J COMP NEUROL, V517, P177, DOI 10.1002/cne.22144; Roberts A, 1998, ANN NY ACAD SCI, V860, P19, DOI 10.1111/j.1749-6632.1998.tb09036.x; Schmidt BJ, 2000, BRAIN RES BULL, V53, P689, DOI 10.1016/S0361-9230(00)00402-0; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stornetta RL, 2002, J COMP NEUROL, V444, P191, DOI 10.1002/cne.10141; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wilson JM, 2005, J NEUROSCI, V25, P5710, DOI 10.1523/JNEUROSCI.0274-05.2005; Zaporozhets E, 2006, J PHYSIOL-LONDON, V572, P443, DOI 10.1113/jphysiol.2005.102376; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zhong GS, 2006, J NEUROPHYSIOL, V95, P1545, DOI 10.1152/jn.01103.2005	50	182	187	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					246	U143		10.1038/nn.2482	http://dx.doi.org/10.1038/nn.2482			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20081850				2022-12-17	WOS:000273985800021
J	Jensen, P; Farago, AF; Awatramani, RB; Scott, MM; Deneris, ES; Dymecki, SM				Jensen, Patricia; Farago, Anna F.; Awatramani, Rajeshwar B.; Scott, Michael M.; Deneris, Evan S.; Dymecki, Susan M.			Redefining the serotonergic system by genetic lineage	NATURE NEUROSCIENCE			English	Article							NEURON DEVELOPMENT; HINDBRAIN; BRAIN; BOUNDARIES; FATE; RAT	Central serotonin-producing neurons are heterogeneous differing in location, morphology, neurotoxin sensitivity and associated clinical disorders - but the underpinnings of this heterogeneity are largely unknown, as are the markers that distinguish physiological subtypes of serotonergic neurons. Here we redefined serotonergic subtypes on the basis of genetic programs that are differentially enacted in progenitor cells. We uncovered a molecular framework for the serotonergic system that, having genetic lineages as its basis, is likely to have physiological relevance and will permit access to genetically defined subtypes for manipulation.	[Jensen, Patricia; Farago, Anna F.; Dymecki, Susan M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Awatramani, Rajeshwar B.] Northwestern Univ, Feinberg Med Sch, Dept Neurol, Chicago, IL 60611 USA; [Awatramani, Rajeshwar B.] Northwestern Univ, Feinberg Med Sch, Ctr Genet Med, Chicago, IL 60611 USA; [Jensen, Patricia; Farago, Anna F.; Awatramani, Rajeshwar B.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Harvard University; Harvard Medical School; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Case Western Reserve University	Dymecki, SM (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dymecki@genetics.med.harvard.edu	Jensen, Patricia/Z-1523-2018	Jensen, Patricia/0000-0001-6459-7289	NICHD NIH HHS [P01 HD036379-130007, P01 HD036379, P01 HD036379-120007] Funding Source: Medline; NIDA NIH HHS [R21 DA023643-01, R21 DA023643, R21 DA023643-02] Funding Source: Medline; NIDDK NIH HHS [R01 DK067826-04, R01 DK067826, R01 DK 067826] Funding Source: Medline; NIMH NIH HHS [R01 MH62723, R01 MH062723] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD036379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023643] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Cordes SP, 2005, CLIN GENET, V68, P487, DOI 10.1111/j.1399-0004.2005.00534.x; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Kimmel RA, 2000, GENE DEV, V14, P1377; LIDOV HGW, 1982, BRAIN RES BULL, V8, P389, DOI 10.1016/0361-9230(82)90077-6; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Riikonen RS, 2005, BIOL PSYCHIAT, V57, P1565, DOI 10.1016/j.biopsych.2005.01.029; Scott MM, 2005, J NEUROSCI, V25, P2628, DOI 10.1523/JNEUROSCI.4979-04.2005; Simon HH, 2005, MOL CELL NEUROSCI, V28, P96, DOI 10.1016/j.mcn.2004.08.016; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; WALLACE JA, 1982, BRAIN RES BULL, V9, P117, DOI 10.1016/0361-9230(82)90127-7; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	15	182	183	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					417	419		10.1038/nn2050	http://dx.doi.org/10.1038/nn2050			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344997	Green Accepted			2022-12-17	WOS:000254359300011
J	Shepherd, GMG; Stepanyants, A; Bureau, I; Chklovskii, D; Svoboda, K				Shepherd, GMG; Stepanyants, A; Bureau, I; Chklovskii, D; Svoboda, K			Geometric and functional organization of cortical circuits	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; PYRAMIDAL NEURONS; QUANTITATIVE-ANALYSIS; SOMATOSENSORY CORTEX; LAYER 4; RAT; PLASTICITY; CELLS; CONNECTIVITY; PROJECTION	Can neuronal morphology predict functional synaptic circuits? In the rat barrel cortex, 'barrels' and 'septa' delineate an orderly matrix of cortical columns. Using quantitative laser scanning photostimulation we measured the strength of excitatory projections from layer 4 (L4) and L5A to L2/3 pyramidal cells in barrel- and septum-related columns. From morphological reconstructions of excitatory neurons we computed the geometric circuit predicted by axodendritic overlap. Within most individual projections, functional inputs were predicted by geometry and a single scale factor, the synaptic strength per potential synapse. This factor, however, varied between projections and, in one case, even within a projection, up to 20-fold. Relationships between geometric overlap and synaptic strength thus depend on the laminar and columnar locations of both the pre- and postsynaptic neurons, even for neurons of the same type. A large plasticity potential appears to be incorporated into these circuits, allowing for functional 'tuning' with fixed axonal and dendritic arbor geometry.	Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Northeastern Univ, Dept Phys, Boston, MA 02115 USA; Northeastern Univ, Ctr Interdisciplinary Res Complex Syst, Boston, MA 02115 USA	Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; Northeastern University; Northeastern University	Svoboda, K (corresponding author), Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.edu	Shepherd, Gordon/F-2679-2010; Bureau, Ingrid/O-3941-2016	Bureau, Ingrid/0000-0001-9166-2250	NINDS NIH HHS [K25 NS047138] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K25NS047138] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bender KJ, 2003, J NEUROSCI, V23, P8759; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg VB, 1998, CORTEX STAT GEOMETRY; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; BURKHALTER A, 1989, J COMP NEUROL, V279, P171, DOI 10.1002/cne.902790202; CAJAL SRY, 1891, CELLULE, V7, P125; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Canepari M, 2001, J NEUROSCI METH, V112, P29, DOI 10.1016/S0165-0270(01)00451-4; CHMIELOWSKA J, 1989, J COMP NEUROL, V285, P325, DOI 10.1002/cne.902850304; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Gottlieb JP, 1997, EXP BRAIN RES, V115, P47, DOI 10.1007/PL00005684; GRACE AA, 1985, NEUROSCIENCE, V16, P461, DOI 10.1016/0306-4522(85)90018-1; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Ichinohe N, 2003, J NEUROSCI, V23, P1372, DOI 10.1523/JNEUROSCI.23-04-01372.2003; Kaas J, 1998, NAT NEUROSCI, V1, P341, DOI 10.1038/1546; Kalisman N, 2005, P NATL ACAD SCI USA, V102, P880, DOI 10.1073/pnas.0407088102; Kalisman N, 2003, BIOL CYBERN, V88, P210, DOI 10.1007/s00422-002-0377-3; Keller A, 1999, J COMP NEUROL, V412, P83, DOI 10.1002/(SICI)1096-9861(19990913)412:1<83::AID-CNE6>3.0.CO;2-7; Kim U, 1999, J COMP NEUROL, V408, P489; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Linkenhoker BA, 2002, NATURE, V419, P293, DOI 10.1038/nature01002; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; PETERS A, 1979, TRENDS NEUROSCI, V2, P183, DOI 10.1016/0166-2236(79)90074-2; PETERS A, 1976, J NEUROCYTOL, V5, P63, DOI 10.1007/BF01176183; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Petersen CCH, 2000, J NEUROSCI, V20, P7579; REN JQ, 1992, EXP BRAIN RES, V92, P1; Sawatari A, 2000, NEURON, V25, P459, DOI 10.1016/S0896-6273(00)80908-3; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Schubert D, 2003, J NEUROSCI, V23, P2961; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; SHEPHERD GMG, IN PRESS J NEUROSCI; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; STAIGER JF, 2004, CEREB CORTEX; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stepanyants A, 2004, NEURON, V43, P251, DOI 10.1016/j.neuron.2004.06.013; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; UTTLEY AM, 1955, PROC R SOC SER B-BIO, V144, P229, DOI 10.1098/rspb.1955.0054; White E.L., 1989, CORTICAL CIRCUITS, DOI [10.1007/978-1-4684-8721-3, DOI 10.1007/978-1-4684-8721-3]; Yabuta NH, 2001, SCIENCE, V292, P297, DOI 10.1126/science.1057916; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zhang ZW, 1997, J NEUROSCI, V17, P6365	50	182	187	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					782	790		10.1038/nn1447	http://dx.doi.org/10.1038/nn1447			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880111				2022-12-17	WOS:000229345300019
J	Zhao, AZ; Huan, JN; Gupta, S; Pal, R; Sahu, A				Zhao, AZ; Huan, JN; Gupta, S; Pal, R; Sahu, A			A phosphatidylinositol 3kinase-phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on feeding	NATURE NEUROSCIENCE			English	Article							CONCENTRATING HORMONE MCH; NEUROPEPTIDE-Y NPY; GALANIN GAL; FOOD-INTAKE; PHOSPHODIESTERASE; RAT		Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sahu, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, 3550 Terrace St, Pittsburgh, PA 15261 USA.				NIDDK NIH HHS [DK 52844] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052844] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Ahmad M, 2000, CELL SIGNAL, V12, P541, DOI 10.1016/S0898-6568(00)00093-0; AKABAYASHI A, 1994, BRAIN RES, V660, P323, DOI 10.1016/0006-8993(94)91306-4; BEAVO JA, 1990, TRENDS PHARMACOL SCI, V11, P150, DOI 10.1016/0165-6147(90)90066-H; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gillard ER, 1998, J NEUROSCI, V18, P2646; RAHN T, 1994, FEBS LETT, V350, P314, DOI 10.1016/0014-5793(94)00797-7; Sahu A, 1998, ENDOCRINOLOGY, V139, P4739, DOI 10.1210/en.139.11.4739; SAHU A, 1993, TRENDS ENDOCRIN MET, V4, P217, DOI 10.1016/1043-2760(93)90125-X; Sahu A, 1998, ENDOCRINOLOGY, V139, P795, DOI 10.1210/en.139.2.795; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sheriff S, 1997, MOL PHARMACOL, V51, P597, DOI 10.1124/mol.51.4.597; SHITNIZUALBERGI.M, 2001, J NEUROSCI, V21, P1238; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348	14	182	193	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					727	728		10.1038/nn885	http://dx.doi.org/10.1038/nn885			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12101402				2022-12-17	WOS:000177088900013
J	Han, ZS; Zhang, ET; Craig, AD				Han, ZS; Zhang, ET; Craig, AD			Nociceptive and thermoreceptive lamina I neurons are anatomically distinct	NATURE NEUROSCIENCE			English	Article							SUPERFICIAL DORSAL HORN; RAT SPINAL-CORD; TRIGEMINAL-NUCLEUS-CAUDALIS; SPINOTHALAMIC TRACT NEURONS; MARGINAL ZONE; SUBSTANCE-P; MORPHOLOGICAL CHARACTERIZATION; AXONAL CONTACTS; RAPHE MAGNUS; CAT	Pain and temperature stimuli activate neurons of lamina I within the dorsal horn of the spinal cord, and although these neurons can be classified into three basic morphological types and three major physiological classes, earlier studies did not establish a structure/function correlation between their morphology and their physiological responses. We recorded and intracellularly labeled 38 cat lamina I neurons. All 12 fusiform cells were nociceptive-specific, responsive only to pinch and/or heat. All 11 pyramidal cells were thermoreceptive-specific, responsive only to innocuous cooling. Of ten multipolar cells, six were polymodal, responsive to heat, pinch and cold, and four were nociceptive-specific. Five unclassified cells had features consistent with this pattern. These results support the view that central pain and temperature pathways contain anatomically discrete sets of modality-selective neurons.	Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA; Barrow Neurol Inst, Div Neurosurg, Phoenix, AZ 85013 USA	Barrow Neurological Institute; Barrow Neurological Institute	Craig, AD (corresponding author), Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.				NIDA NIH HHS [DA 07402] Funding Source: Medline; NINDS NIH HHS [NS 25616] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007402] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BENNETT GJ, 1981, BRAIN RES, V209, P421, DOI 10.1016/0006-8993(81)90164-5; BROWN JL, 1995, J COMP NEUROL, V356, P327, DOI 10.1002/cne.903560302; CERVERO F, 1987, J PHYSL, V383, P383; CHRISTENSEN BN, 1970, J NEUROPHYSIOL, V33, P293, DOI 10.1152/jn.1970.33.2.293; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Craig A. D, 1996, SOMESTHESIS NEUROBIO, P27; CRAIG AD, 1993, J COMP NEUROL, V331, P517, DOI 10.1002/cne.903310407; CRAIG AD, 1994, NATURE, V372, P770, DOI 10.1038/372770a0; CRAIG AD, 1995, J COMP NEUROL, V361, P225, DOI 10.1002/cne.903610204; CRAIG AD, 1985, J PHYSIOL-LONDON, V365, P197, DOI 10.1113/jphysiol.1985.sp015767; CRAIG AD, 1994, BRAIN RES, V636, P233, DOI 10.1016/0006-8993(94)91022-7; CRAIG AD, 1991, BRAIN RES, V558, P93, DOI 10.1016/0006-8993(91)90719-C; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0; DE KONINCK Y, 1991, P NATL ACAD SCI USA, V88, P11344, DOI 10.1073/pnas.88.24.11344; DOSTROVSKY JO, 1983, J NEUROPHYSIOL, V49, P948, DOI 10.1152/jn.1983.49.4.948; Dostrovsky JO, 1996, J NEUROPHYSIOL, V76, P3656, DOI 10.1152/jn.1996.76.6.3656; FERRINGTON DG, 1987, J PHYSIOL-LONDON, V388, P681, DOI 10.1113/jphysiol.1987.sp016638; GOBEL S, 1978, J COMP NEUROL, V180, P375, DOI 10.1002/cne.901800212; HOFFERT MJ, 1983, BRAIN RES, V267, P361, DOI 10.1016/0006-8993(83)90890-9; HYLDEN JLK, 1986, J COMP NEUROL, V247, P505, DOI 10.1002/cne.902470410; LIGHT AR, 1993, SOMATOSENS MOT RES, V10, P309, DOI 10.3109/08990229309028840; LIGHT AR, 1979, J COMP NEUROL, V186, P151, DOI 10.1002/cne.901860204; LIMA D, 1986, J COMP NEUROL, V244, P53, DOI 10.1002/cne.902440105; LIMA D, 1993, J CHEM NEUROANAT, V6, P43, DOI 10.1016/0891-0618(93)90006-P; LOPEZGARCIA JA, 1994, EUR J NEUROSCI, V6, P998, DOI 10.1111/j.1460-9568.1994.tb00594.x; MACIVER MB, 1992, ANESTHESIOLOGY, V76, P617; Marshall GE, 1996, NEUROSCIENCE, V72, P255, DOI 10.1016/0306-4522(95)00558-7; Menendez L, 1996, J NEUROPHYSIOL, V75, P2099, DOI 10.1152/jn.1996.75.5.2099; MILETIC V, 1984, J COMP NEUROL, V228, P129, DOI 10.1002/cne.902280112; MOKHA SS, 1987, EXP BRAIN RES, V65, P427; MOLONY V, 1981, Q J EXP PHYSIOL CMS, V66, P211, DOI 10.1113/expphysiol.1981.sp002551; MOSCHOVAKIS AK, 1991, J COMP NEUROL, V311, P531, DOI 10.1002/cne.903110408; Perl E. R., 1984, HDB PHYSL 2 1, VIII, P915; PICKAR JG, 1994, J NEUROPHYSIOL, V71, P753, DOI 10.1152/jn.1994.71.2.753; PRICE DD, 1978, J NEUROPHYSIOL, V41, P933, DOI 10.1152/jn.1978.41.4.933; Schmelz M, 1997, J NEUROSCI, V17, P8003; STEEDMAN WM, 1985, EXP BRAIN RES, V58, P171; SUN MK, 1991, J PHYSIOL-LONDON, V436, P685, DOI 10.1113/jphysiol.1991.sp018573; TAMAMAKI N, 1995, J COMP NEUROL, V354, P583, DOI 10.1002/cne.903540408; WALL PD, 1995, PAIN, V62, P389, DOI 10.1016/0304-3959(95)00130-K; Willis William D., 1985, PAIN SYSTEM; WOOLF CJ, 1994, PAIN, V58, P141, DOI 10.1016/0304-3959(94)90195-3; WOOLF CJ, 1983, J COMP NEUROL, V221, P313, DOI 10.1002/cne.902210307; Zhang ET, 1996, J COMP NEUROL, V367, P537; Zhang ET, 1997, J NEUROSCI, V17, P3274	46	182	187	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					218	225		10.1038/665	http://dx.doi.org/10.1038/665			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195146				2022-12-17	WOS:000076361200012
J	Karalis, N; Dejean, C; Chaudun, F; Khoder, S; Rozeske, RR; Wurtz, H; Bagur, S; Benchenane, K; Sirota, A; Courtin, J; Herry, C				Karalis, Nikolaos; Dejean, Cyril; Chaudun, Fabrice; Khoder, Suzana; Rozeske, Robert R.; Wurtz, Helene; Bagur, Sophie; Benchenane, Karim; Sirota, Anton; Courtin, Julien; Herry, Cyril			4-Hz oscillations synchronize prefrontal-amygdala circuits during fear behavior	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL THETA-RHYTHM; CAT VISUAL-CORTEX; RESPIRATION; RESPONSES; NEURONS; MOUSE; MOTOR; RETRIEVAL; ATTENTION; MEMORIES	Fear expression relies on the coordinated activity of prefrontal and amygdala circuits, yet the mechanisms allowing long-range network synchronization during fear remain unknown. Using a combination of extracellular recordings, pharmacological and optogenetic manipulations, we found that freezing, a behavioral expression of fear, temporally coincided with the development of sustained, internally generated 4-Hz oscillations in prefrontal-amygdala circuits. 4-Hz oscillations predict freezing onset and offset and synchronize prefrontal-amygdala circuits. Optogenetic induction of prefrontal 4-Hz oscillations coordinates prefrontal-amygdala activity and elicits fear behavior. These results unravel a sustained oscillatory mechanism mediating prefrontal-amygdala coupling during fear behavior.	[Karalis, Nikolaos; Dejean, Cyril; Chaudun, Fabrice; Khoder, Suzana; Rozeske, Robert R.; Wurtz, Helene; Courtin, Julien; Herry, Cyril] INSERM, U862, Neuroctr Magendie, Bordeaux, France; [Karalis, Nikolaos; Dejean, Cyril; Chaudun, Fabrice; Khoder, Suzana; Rozeske, Robert R.; Wurtz, Helene; Courtin, Julien; Herry, Cyril] Univ Bordeaux, U862, Neuroctr Magendie, Bordeaux, France; [Karalis, Nikolaos; Sirota, Anton] Ludwig Maximilians Univ Munchen, Fac Med, Bernstein Ctr Computat Neurosci Munich, Munich Cluster Syst Neurol SyNergy, Planegg Martinsried, Germany; [Bagur, Sophie; Benchenane, Karim] Ecole Super Phys & Chim Ind Ville Paris, CNRS UMR 8249, ESPCI ParisTech, Team Memory Oscillat & Brain States MOBs,Brain Pl, Paris, France; [Courtin, Julien] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Munich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Friedrich Miescher Institute for Biomedical Research	Karalis, N; Herry, C (corresponding author), INSERM, U862, Neuroctr Magendie, Bordeaux, France.; Karalis, N; Herry, C (corresponding author), Univ Bordeaux, U862, Neuroctr Magendie, Bordeaux, France.; Karalis, N (corresponding author), Ludwig Maximilians Univ Munchen, Fac Med, Bernstein Ctr Computat Neurosci Munich, Munich Cluster Syst Neurol SyNergy, Planegg Martinsried, Germany.	karalis@bio.lmu.de; cyril.herry@inserm.fr	Herry, Cyril/AAP-9902-2020; courtin, julien/AAH-2380-2022; courtin, julien/AEN-1402-2022; Karalis, Nikolaos/U-4987-2017; benchenane, karim/D-8023-2015	Herry, Cyril/0000-0003-2973-0843; courtin, julien/0000-0002-6454-3245; courtin, julien/0000-0002-6454-3245; Karalis, Nikolaos/0000-0002-1804-9756; benchenane, karim/0000-0001-7118-0748	French National Research Agency [ANR-2010-BLAN-1442-01, ANR-10-EQPX-08, ANR 10-LABX-43, ANR 10-LABX-57, ANR-10-LABX-54, ANR-11-IDEX-0001-02]; European Research Council (ERC) under the European Union's Seventh Framework Program [281168]; Conseil Regional d'Aquitaine; Fondation pour la Recherche Medicale (FRM); CNRS ATIP program; city of Paris; Munich Cluster for Systems Neurology (SyNergy) [EXC 1010]; Deutsche Forschungsgemeinschaft [1665, 1392]; Bundesministerium fur Bildung und Forschung [01GQ0440]; Erasmus Mundus program Neurasmus	French National Research Agency(French National Research Agency (ANR)); European Research Council (ERC) under the European Union's Seventh Framework Program(European Research Council (ERC)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); CNRS ATIP program; city of Paris(Region Ile-de-France); Munich Cluster for Systems Neurology (SyNergy); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Erasmus Mundus program Neurasmus	We thank the members of the Herry laboratory for discussions and comments on the manuscript and K. Deisseroth (Stanford University) and E. Boyden (Massachusetts Institute of Technology) for generously sharing material. This work was supported by grants from the French National Research Agency (ANR-2010-BLAN-1442-01; ANR-10-EQPX-08 OPTOPATH; LABEX BRAIN ANR 10-LABX-43, LABEX TRAIL ANR 10-LABX-57), the European Research Council (ERC) under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement no. 281168, the Conseil Regional d'Aquitaine (C.H.), the Fondation pour la Recherche Medicale (FRM) (F.C.), the CNRS ATIP program (2014) and the city of Paris (Grant Emergence 2014), the French National Research Agency (ANR-10-LABX-54 MEMO LIFE; ANR-11-IDEX-0001-02 PSL) (K. B.), Munich Cluster for Systems Neurology (SyNergy, EXC 1010), Deutsche Forschungsgemeinschaft Priority Program 1665 and 1392 and Bundesministerium fur Bildung und Forschung via grant no. 01GQ0440 (Bernstein Centre for Computational Neuroscience Munich) (A.S.) and a scholarship from the Erasmus Mundus program Neurasmus (N.K.).	Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Barnett L, 2014, J NEUROSCI METH, V223, P50, DOI 10.1016/j.jneumeth.2013.10.018; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bishop, 2016, PATTERN RECOGN; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; ENGEL AK, 1990, EUR J NEUROSCI, V2, P588, DOI 10.1111/j.1460-9568.1990.tb00449.x; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Fujisawa S, 2011, NEURON, V72, P153, DOI 10.1016/j.neuron.2011.08.018; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Holstege G, 2014, PROG BRAIN RES, V209, P379, DOI 10.1016/B978-0-444-63274-6.00020-5; Ito J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4572; Lesting J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021714; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; Livneh U, 2012, NEURON, V75, P133, DOI 10.1016/j.neuron.2012.05.016; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez P.L., 2006, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Siegle JH, 2014, ELIFE, V3, DOI 10.7554/eLife.03061; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Stark E, 2013, NEURON, V80, P1263, DOI 10.1016/j.neuron.2013.09.033; Steenland HW, 2012, J NEUROSCI, V32, P1082, DOI 10.1523/JNEUROSCI.5566-11.2012; Steenland HW, 2009, J NEUROSCI METH, V177, P355, DOI 10.1016/j.jneumeth.2008.10.020; Stujenske JM, 2014, NEURON, V83, P919, DOI 10.1016/j.neuron.2014.07.026; Subramanian HH, 2008, J NEUROSCI, V28, P12274, DOI 10.1523/JNEUROSCI.4168-08.2008; Vaidya SP, 2013, NAT NEUROSCI, V16, P1812, DOI 10.1038/nn.3562; Vianna DML, 2001, NEUROSCI BIOBEHAV R, V25, P711, DOI 10.1016/S0149-7634(01)00052-5; Vinck M, 2010, NEUROIMAGE, V51, P112, DOI 10.1016/j.neuroimage.2010.01.073; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062; YOUNG MP, 1992, J NEUROPHYSIOL, V67, P1464, DOI 10.1152/jn.1992.67.6.1464	42	181	182	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2016	19	4					605	+		10.1038/nn.4251	http://dx.doi.org/10.1038/nn.4251			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH6OI	26878674	Green Accepted			2022-12-17	WOS:000372909800018
J	Furutachi, S; Miya, H; Watanabe, T; Kawai, H; Yamasaki, N; Harada, Y; Imayoshi, I; Nelson, M; Nakayama, KI; Hirabayashi, Y; Gotoh, Y				Furutachi, Shohei; Miya, Hiroaki; Watanabe, Tomoyuki; Kawai, Hiroki; Yamasaki, Norihiko; Harada, Yujin; Imayoshi, Itaru; Nelson, Mark; Nakayama, Keiichi I.; Hirabayashi, Yusuke; Gotoh, Yukiko			Slowly dividing neural progenitors are an embryonic origin of adult neural stem cells	NATURE NEUROSCIENCE			English	Article							SUBVENTRICULAR ZONE; MAMMALIAN BRAIN; NEURONAL DIFFERENTIATION; OLFACTORY-BULB; SELF-RENEWAL; RADIAL GLIA; NEUROGENESIS; QUIESCENCE; CYCLE; MAINTENANCE	The mechanism by which adult neural stem cells (NSCs) are established during development is unclear. In this study, analysis of cell cycle progression by examining retention of a histone 2B (H2B)-GFP fusion protein revealed that, in a subset of mouse embryonic neural progenitor cells (NPCs), the cell cycle slows between embryonic day (E) 13.5 and E15.5 while other embryonic NPCs continue to divide rapidly. By allowing H2B-GFP expressed at E9.5 to become diluted in dividing cells until the young adult stage, we determined that a majority of NSCs in the young adult subependymal zone (SEZ) originated from these slowly dividing embryonic NPCs. The cyclin-dependent kinase inhibitor p57 is highly expressed in this embryonic subpopulation, and the deletion of p57 impairs the emergence of adult NSCs. Our results suggest that a substantial fraction of adult SEZ NSCs is derived from a slowly dividing subpopulation of embryonic NPCs and identify p57 as a key factor in generating this embryonic origin of adult SEZ NSCs.	[Furutachi, Shohei; Miya, Hiroaki; Watanabe, Tomoyuki; Kawai, Hiroki; Yamasaki, Norihiko; Harada, Yujin; Hirabayashi, Yusuke; Gotoh, Yukiko] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Imayoshi, Itaru] Kyoto Univ, Inst Virus Res, Hakubi Ctr, Kyoto 606, Japan; [Nelson, Mark] Echelon Biosci, Salt Lake City, UT USA; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 812, Japan	University of Tokyo; Kyoto University; Kyushu University	Gotoh, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan.	ygotoh@mol.f.u-tokyo.ac.jp		Hirabayashi, Yusuke/0000-0003-3950-6781; Kawai, Hiroki/0000-0002-7129-2384	Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [15K15086, 25891008] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Tyssowski for editing the manuscript, F. Calegari (Center for Regenerative Therapies Dresden (CRTD)) for reagents, H. Sugizaki, C. Koga and J. Takeuchi for FACS analysis, A Shitamukai, F. Matsuzaki and Y. Sasai for comments and members of the Gotoh laboratory for discussion. This work was supported by Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency.	Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Bowman AN, 2013, P NATL ACAD SCI USA, V110, P7324, DOI 10.1073/pnas.1305411110; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Furutachi S, 2013, EMBO J, V32, P970, DOI 10.1038/emboj.2013.50; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Isaka F, 1999, EUR J NEUROSCI, V11, P2582, DOI 10.1046/j.1460-9568.1999.00699.x; Joseph B, 2003, P NATL ACAD SCI USA, V100, P15619, DOI 10.1073/pnas.2635658100; Joseph B, 2009, CELL DEATH DIFFER, V16, P1256, DOI 10.1038/cdd.2009.72; Kageyama R, 2012, BEHAV BRAIN RES, V227, P459, DOI 10.1016/j.bbr.2011.04.038; Kawaguchi D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2895; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Lopez-Juarez A, 2013, GENE DEV, V27, P1272, DOI 10.1101/gad.217539.113; Matsumoto A, 2011, MOL CELL BIOL, V31, P4176, DOI 10.1128/MCB.05370-11; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Nonaka-Kinoshita M, 2013, EMBO J, V32, P1817, DOI 10.1038/emboj.2013.96; Pateras IS, 2009, MOL CANCER RES, V7, P1902, DOI 10.1158/1541-7786.MCR-09-0317; Porlan E, 2013, NAT NEUROSCI, V16, P1567, DOI 10.1038/nn.3545; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Tran V, 2012, SCIENCE, V338, P679, DOI 10.1126/science.1226028; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007	47	181	183	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2015	18	5					657	+		10.1038/nn.3989	http://dx.doi.org/10.1038/nn.3989			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG9LN	25821910				2022-12-17	WOS:000353636900012
J	Yeo, GSH; Heisler, LK				Yeo, Giles S. H.; Heisler, Lora K.			Unraveling the brain regulation of appetite: lessons from genetics	NATURE NEUROSCIENCE			English	Review							AGOUTI-RELATED PROTEIN; BODY-MASS INDEX; CONGENITAL LEPTIN DEFICIENCY; NUCLEUS-TRACTUS-SOLITARIUS; EARLY-ONSET OBESITY; ENERGY-BALANCE; FOOD-INTAKE; MELANOCORTIN-4 RECEPTOR; NEUROTROPHIC FACTOR; NEUROPEPTIDE-Y	Over the past 20 years, genetic studies have illuminated critical pathways in the hypothalamus and brainstem mediating energy homeostasis, such as the melanocortin, leptin, 5-hydroxytryptamine and brain-derived neurotrophic factor signaling axes. The identification of these pathways necessary for appropriate appetitive responses to energy state has yielded insight into normal homeostatic processes. Although monogenic alterations in each of these axes result in severe obesity, such cases remain rare. The major burden of disease is carried by those with common obesity, which has so far resisted yielding meaningful biological insights. Recent progress into the etiology of common obesity has been made with genome-wide association studies. Such studies now reveal more than 32 different candidate obesity genes, most of which are highly expressed or known to act in the CNS, emphasizing, as in rare monogenic forms of obesity, the role of the brain in predisposition to obesity.	[Yeo, Giles S. H.] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England; [Heisler, Lora K.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Yeo, GSH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England.	gshy2@cam.ac.uk; lkh30@medschl.cam.ac.uk		Heisler, Lora/0000-0002-7731-1419; Yeo, Giles See How/0000-0001-8823-3615	UK Medical Research Council Centre for Obesity and Related Metabolic Disorders (MRC-CORD); European Union [FP7-HEALTH-2009-241592 EurOCHIP, FP7-HEALTH-266408 Full4Health]; Wellcome Trust [WT081713, WT090812]; Medical Research Council [G0600717B, G0600717] Funding Source: researchfish; MRC [G0600717] Funding Source: UKRI	UK Medical Research Council Centre for Obesity and Related Metabolic Disorders (MRC-CORD)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	G.S.H.Y. is supported by the UK Medical Research Council Centre for Obesity and Related Metabolic Disorders (MRC-CORD) and the European Union (FP7-HEALTH-2009-241592 EurOCHIP and FP7-HEALTH-266408 Full4Health). L.K.H. is supported by the Wellcome Trust (WT081713; WT090812).	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B; Bariohay B, 2009, ENDOCRINOLOGY, V150, P2646, DOI 10.1210/en.2008-1184; BERTAGNA X, 1994, ENDOCRIN METAB CLIN, V23, P467, DOI 10.1016/S0889-8529(18)30079-3; Bewick GA, 2005, FASEB J, V19, P1680, DOI 10.1096/fj.04-3434fje; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Castro MG, 1997, CRIT REV NEUROBIOL, V11, P35; Challis BG, 2004, P NATL ACAD SCI USA, V101, P4695, DOI 10.1073/pnas.0306931101; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; de Luca C, 2005, J CLIN INVEST, V115, P3484, DOI 10.1172/JCI24059; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Fidler MC, 2011, J CLIN ENDOCR METAB, V96, P3067, DOI 10.1210/jc.2011-1256; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Funatsu N, 1999, J BIOL CHEM, V274, P8224, DOI 10.1074/jbc.274.12.8224; Garfield AS, 2009, J PHYSIOL-LONDON, V587, P49, DOI 10.1113/jphysiol.2008.164152; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Godar R, 2011, NEUROSCIENCE, V194, P36, DOI 10.1016/j.neuroscience.2011.07.079; Gray J, 2006, DANCING TIMES, V96, P55; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Hayes MR, 2010, CELL METAB, V11, P77, DOI 10.1016/j.cmet.2009.10.009; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jurvansuu JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025317; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Komori T, 2006, NEUROSCIENCE, V139, P1107, DOI 10.1016/j.neuroscience.2005.12.066; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lam DD, 2011, CELL METAB, V13, P584, DOI 10.1016/j.cmet.2011.03.016; Lam Daniel D., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000245; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Morris HV, 2008, PHARMACOL BIOCHEM BE, V90, P9, DOI 10.1016/j.pbb.2008.02.010; Nicholson JR, 2007, J NEUROENDOCRINOL, V19, P974, DOI 10.1111/j.1365-2826.2007.01610.x; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Sohn JW, 2011, NEURON, V71, P488, DOI 10.1016/j.neuron.2011.06.012; Spaeth AM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1252, DOI 10.1152/ajpendo.00025.2012; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Suviolahti E, 2003, J CLIN INVEST, V112, P1762, DOI 10.1172/JCI200317491; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tran PV, 2006, J COMP NEUROL, V498, P637, DOI 10.1002/cne.21070; Tung YCL, 2011, ANN NY ACAD SCI, V1220, P162, DOI 10.1111/j.1749-6632.2010.05903.x; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Vimaleswaran KS, 2010, INT J OBESITY, V34, P1028, DOI 10.1038/ijo.2009.292; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wortley KE, 2005, CELL METAB, V2, P421, DOI 10.1016/j.cmet.2005.11.004; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Xu Y, 2010, J NEUROSCI, V30, P14630, DOI 10.1523/JNEUROSCI.5412-09.2010; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	88	181	188	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1343	1349		10.1038/nn.3211	http://dx.doi.org/10.1038/nn.3211			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	23007189				2022-12-17	WOS:000309335300009
J	Xu, J; Pang, ZPP; Shin, OH; Sudhof, TC				Xu, Jun; Pang, Zhiping P.; Shin, Ok-Ho; Suedhof, Thomas C.			Synaptotagmin-1 functions as a Ca2+ sensor for spontaneous release	NATURE NEUROSCIENCE			English	Article							GABAERGIC SYNAPTIC-TRANSMISSION; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; ASYNCHRONOUS RELEASE; CALCIUM-DEPENDENCE; GLUTAMATE RELEASE; HIPPOCAMPAL-NEURONS; RECEPTORS; VESICLES; BINDING	Spontaneous 'mini' release occurs at all synapses, but its nature remains enigmatic. We found that > 95% of spontaneous release in murine cortical neurons was induced by Ca2+-binding to synaptotagmin-1 (Syt1), the Ca2+ sensor for fast synchronous neurotransmitter release. Thus, spontaneous and evoked release used the same Ca2+-dependent release mechanism. As a consequence, Syt1 mutations that altered its Ca2+ affinity altered spontaneous and evoked release correspondingly. Paradoxically, Syt1 deletions (as opposed to point mutations) massively increased spontaneous release. This increased spontaneous release remained Ca2+ dependent but was activated at lower Ca2+ concentrations and with a lower Ca2+ cooperativity than synaptotagmin-driven spontaneous release. Thus, in addition to serving as a Ca2+ sensor for spontaneous and evoked release, Syt1 clamped a second, more sensitive Ca2+ sensor for spontaneous release that resembles the Ca2+ sensor for evoked asynchronous release. These data suggest that Syt1 controls both evoked and spontaneous release at a synapse as a simultaneous Ca2+-dependent activator and clamp of exocytosis.	[Xu, Jun; Pang, Zhiping P.; Suedhof, Thomas C.] Stanford Univ, Dept Cellular & Mol Physiol, Palo Alto, CA 94304 USA; [Xu, Jun; Pang, Zhiping P.; Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA; [Xu, Jun; Pang, Zhiping P.; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Xu, Jun; Pang, Zhiping P.; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Palo Alto, CA 94304 USA.	tcs1@stanford.edu	Pang, Zhiping/AAF-5757-2020	Pang, Zhiping/0000-0002-6183-1233	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Atasoy D, 2008, J NEUROSCI, V28, P10151, DOI 10.1523/JNEUROSCI.2432-08.2008; Barazangi N, 2001, J NEUROPHYSIOL, V86, P463, DOI 10.1152/jn.2001.86.1.463; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Chung CH, 2006, NAT NEUROSCI, V9, P989, DOI 10.1038/nn0806-989; Deitcher DL, 1998, J NEUROSCI, V18, P2028; Delgado-Martinez I, 2007, J NEUROSCI, V27, P9380, DOI 10.1523/JNEUROSCI.5092-06.2007; ELMQVIST D, 1965, J PHYSIOL-LONDON, V181, P487, DOI 10.1113/jphysiol.1965.sp007777; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Glitsch MD, 2008, CELL CALCIUM, V43, P9, DOI 10.1016/j.ceca.2007.02.008; Grillner P, 2000, NEUROSCIENCE, V96, P299, DOI 10.1016/S0306-4522(99)00579-5; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Han WP, 2004, NEURON, V41, P85, DOI 10.1016/S0896-6273(03)00820-1; Lambe EK, 2003, NEUROPSYCHOPHARMACOL, V28, P216, DOI 10.1038/sj.npp.1300032; LENA C, 1993, J NEUROSCI, V13, P2680, DOI 10.1523/JNEUROSCI.13-06-02680.1993; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Pang ZPP, 2006, J NEUROSCI, V26, P12556, DOI 10.1523/JNEUROSCI.3804-06.2006; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; PRESTWICH SA, 1987, BRAIN RES, V405, P130, DOI 10.1016/0006-8993(87)90997-8; Radcliffe KA, 1999, ANN NY ACAD SCI, V868, P591, DOI 10.1111/j.1749-6632.1999.tb11332.x; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Simkus CRL, 2002, J PHYSIOL-LONDON, V545, P521, DOI 10.1113/jphysiol.2002.022103; Sollner TH, 2003, MOL MEMBR BIOL, V20, P209, DOI 10.1080/0968768031000104953; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Yoshihara M, 2003, CURR OPIN NEUROBIOL, V13, P315, DOI 10.1016/S0959-4388(03)00063-1	46	181	185	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2009	12	6					759	U111		10.1038/nn.2320	http://dx.doi.org/10.1038/nn.2320			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	450DJ	19412166	Green Accepted			2022-12-17	WOS:000266380900020
J	Glickfeld, LL; Roberts, JD; Somogyi, P; Scanziani, M				Glickfeld, Lindsey L.; Roberts, J. David; Somogyi, Peter; Scanziani, Massimo			Interneurons hyperpolarize pyramidal cells along their entire somatodendritic axis	NATURE NEUROSCIENCE			English	Article							RAT HIPPOCAMPUS; GABA; INHIBITION; EXCITATION; RECEPTORS; RESPONSES	Although GABAergic interneurons are the main source of synaptic inhibition in the cortex, activation of GABA(A) receptors has been shown to depolarize specific neuronal compartments, resulting in excitation. By using a noninvasive approach to monitor the effect of individual interneurons on the pyramidal cell population, we found that rat hippocampal interneurons hyperpolarized pyramidal cells irrespective of the location of their synapses along the somato-dendritic axis.	[Glickfeld, Lindsey L.; Scanziani, Massimo] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; [Glickfeld, Lindsey L.] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; [Roberts, J. David; Somogyi, Peter] Univ Oxford, Anat Neuropharmacol Unit, MRC, Oxford OX1 3TH, England	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Oxford	Scanziani, M (corresponding author), Univ Calif San Diego, Dept Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	massimo@ucsd.edu			US National Institutes of Health [MH71401, NS056529]; Medical Research Council [MC_U138197107] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS056529] Funding Source: NIH RePORTER; MRC [MC_U138197107] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Park for assistance in reconstructing the neurons; K. Detzner and W. Y. Suen for some tissue processing; J. Isaacson for his insightful comments and suggestions during the entire course of the project and for critically reading the manuscript; and all the members of the Scanziani and Isaacson laboratories for their input and support. This work was funded by the US National Institutes of Health (MH71401 and NS056529).	ALGER BE, 1979, NATURE, V281, P315, DOI 10.1038/281315a0; ANDERSEN P, 1980, J PHYSIOL-LONDON, V305, P279, DOI 10.1113/jphysiol.1980.sp013363; ARAKI T, 1960, J PHYSIOL-LONDON, V154, P354, DOI 10.1113/jphysiol.1960.sp006584; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; GLOOR P, 1963, NATURE, V199, P699, DOI 10.1038/199699a0; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; LAMBERT NA, 1991, J NEUROPHYSIOL, V66, P1538, DOI 10.1152/jn.1991.66.5.1538; Perkins KL, 1996, J NEUROPHYSIOL, V76, P3886, DOI 10.1152/jn.1996.76.6.3886; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P347, DOI 10.1113/jphysiol.1992.sp019168; Verheugen JAH, 1999, J NEUROSCI, V19, P2546; Woodruff AR, 2006, J NEUROSCI, V26, P11881, DOI 10.1523/JNEUROSCI.3389-06.2006	15	181	182	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2009	12	1					21	23		10.1038/nn.2230	http://dx.doi.org/10.1038/nn.2230			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	388HL	19029887	Green Accepted			2022-12-17	WOS:000262010800008
J	O'Neill, J; Senior, TJ; Allen, K; Huxter, JR; Csicsvari, J				O'Neill, Joseph; Senior, Timothy J.; Allen, Kevin; Huxter, John R.; Csicsvari, Jozsef			Reactivation of experience-dependent cell assembly patterns in the hippocampus	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SUBSEQUENT SLEEP EPISODES; CA1 PYRAMIDAL CELLS; SHARP WAVES; SYNAPTIC PLASTICITY; BEHAVING RAT; SEQUENTIAL EXPERIENCE; AWAKE STATE; MEMORY; NEURONS	The hippocampus is thought to be involved in episodic memory formation by reactivating traces of waking experience during sleep. Indeed, the joint firing of spatially tuned pyramidal cells encoding nearby places recur during sleep. We found that the sleep cofiring of rat CA1 pyramidal cells encoding similar places increased relative to the sleep session before exploration. This cofiring increase depended on the number of times that cells fired together with short latencies ( < 50 ms) during exploration, and was strongest between cells representing the most visited places. This is indicative of a Hebbian learning rule in which changes in firing associations between cells are determined by the number of waking coincident firing events. In contrast, cells encoding different locations reduced their cofiring in proportion to the number of times that they fired independently. Together these data indicate that reactivated patterns are shaped by both positive and negative changes in cofiring, which are determined by recent behavior.	[O'Neill, Joseph; Senior, Timothy J.; Allen, Kevin; Huxter, John R.; Csicsvari, Jozsef] Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England	University of Oxford	Csicsvari, J (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Mansfield Rd, Oxford OX1 3TH, England.	jozsef.csicsvari@pharm.ox.ac.uk		Allen, Kevin/0000-0001-5319-3721	Medical Research Council [MC_U138169944] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MC_U138169944] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Battaglia FP, 2005, NEURAL NETWORKS, V18, P1280, DOI 10.1016/j.neunet.2005.08.011; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Brun VH, 2001, J NEUROSCI, V21, P356, DOI 10.1523/JNEUROSCI.21-01-00356.2001; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CASTRO CA, 1989, NATURE, V342, P545, DOI 10.1038/342545a0; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Csicsvari J, 2007, EUR J NEUROSCI, V26, P704, DOI 10.1111/j.1460-9568.2007.05684.x; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Giovannini MG, 2001, NEUROSCIENCE, V106, P43, DOI 10.1016/S0306-4522(01)00266-4; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Jackson JC, 2006, J NEUROSCI, V26, P12415, DOI 10.1523/JNEUROSCI.4118-06.2006; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; MULLER RU, 1987, J NEUROSCI, V7, P1951; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nitz D, 2004, J NEUROPHYSIOL, V91, P863, DOI 10.1152/jn.00614.2003; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Shen B, 1996, HIPPOCAMPUS, V6, P685; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; YLINEN A, 1995, J NEUROSCI, V15, P30	46	181	181	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					209	215		10.1038/nn2037	http://dx.doi.org/10.1038/nn2037			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18193040				2022-12-17	WOS:000252712100015
J	Shen, W; Tian, X; Day, M; Ulrich, S; Tkatch, T; Nathanson, NM; Surmeier, DJ				Shen, Weixing; Tian, Xinyong; Day, Michelle; Ulrich, Sasha; Tkatch, Tatiana; Nathanson, Neil M.; Surmeier, D. James			Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons	NATURE NEUROSCIENCE			English	Article							MEDIUM SPINY NEURONS; RECTIFYING POTASSIUM CHANNELS; RECTIFIER K+ CHANNEL; MUSCARINIC RECEPTORS; PARKINSONS-DISEASE; BASAL GANGLIA; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; STRIATAL NEURONS; MESSENGER-RNAS; RAT STRIATUM	Dopamine-depleting lesions of the striatum that mimic Parkinson's disease induce a profound pruning of spines and glutamatergic synapses in striatopallidal medium spiny neurons, leaving striatonigral medium spiny neurons intact. The mechanisms that underlie this cell type-specific loss of connectivity are poorly understood. The Kir2 K+ channel is an important determinant of dendritic excitability in these cells. Here we show that opening of these channels is potently reduced by signaling through M1 muscarinic receptors in striatopallidal neurons, but not in striatonigral neurons. This asymmetry could be attributed to differences in the subunit composition of Kir2 channels. Dopamine depletion alters the subunit composition further, rendering Kir2 channels in striatopallidal neurons even more susceptible to modulation. Reduced opening of Kir2 channels enhances dendritic excitability and synaptic integration. This cell type-specific enhancement of dendritic excitability is an essential trigger for synaptic pruning after dopamine depletion, as pruning was prevented by genetic deletion of M1 muscarinic receptors.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Inst Neurosci, Chicago, IL 60611 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu		Nathanson, Neil/0000-0002-9216-121X; Tkatch, Tatiana/0000-0001-6626-7435	NINDS NIH HHS [NS 34696] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034696, R37NS034696] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ANDERSON JJ, 1994, J PHARMACOL EXP THER, V269, P1144; BARBEAU A, 1962, CAN MED ASSOC J, V87, P802; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Calabresi P, 1998, EUR J NEUROSCI, V10, P3020, DOI 10.1046/j.1460-9568.1998.00348.x; Calabresi P, 1999, NEUROPHARMACOLOGY, V38, P323, DOI 10.1016/S0028-3908(98)00199-3; Chuang HH, 1997, CELL, V89, P1121, DOI 10.1016/S0092-8674(00)80299-8; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Delmas P, 2004, TRENDS NEUROSCI, V27, P41, DOI 10.1016/j.tins.2003.10.013; Ding J, 2006, NAT NEUROSCI, V9, P832, DOI 10.1038/nn1700; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Figueroa A, 2002, SYNAPSE, V46, P215, DOI 10.1002/syn.10114; Galarraga E, 1999, J NEUROSCI, V19, P3629, DOI 10.1523/jneurosci.19-09-03629.1999; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; HERSCH SM, 1994, J NEUROSCI, V14, P3351; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HOWE AR, 1995, J NEUROSCI, V15, P458; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Inanobe A, 2002, AM J PHYSIOL-CELL PH, V282, pC1396, DOI 10.1152/ajpcell.00615.2001; Johnston D, 2000, J PHYSIOL-LONDON, V525, P75, DOI 10.1111/j.1469-7793.2000.00075.x; Karschin C, 1996, J NEUROSCI, V16, P3559; KOCH C, 1993, J NEUROSCI, V13, P413; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; MANDEL RJ, 1994, BRAIN RES, V653, P57, DOI 10.1016/0006-8993(94)90372-7; MCNEILL TH, 1988, BRAIN RES, V455, P148, DOI 10.1016/0006-8993(88)90124-2; Mermelstein PG, 1998, J NEUROSCI, V18, P6650; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Pruss H, 2005, MOL BRAIN RES, V139, P63, DOI 10.1016/j.molbrainres.2005.05.006; Pruss H, 2003, MOL BRAIN RES, V110, P203, DOI 10.1016/S0169-328X(02)00649-6; Rakhilin SV, 2004, SCIENCE, V306, P698, DOI 10.1126/science.1099961; ROBERTSON GS, 1992, EUR J PHARMACOL, V219, P323, DOI 10.1016/0014-2999(92)90313-S; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Segal M, 2003, EUR J NEUROSCI, V17, P2573, DOI 10.1046/j.1460-9568.2003.02696.x; Shen WX, 2005, J NEUROSCI, V25, P7449, DOI 10.1523/JNEUROSCI.1381-05.2005; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Tillerson JL, 2001, J NEUROSCI, V21, P4427, DOI 10.1523/JNEUROSCI.21-12-04427.2001; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; Topert C, 1998, J NEUROSCI, V18, P4096; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; WILSON CJ, 2004, SYNAPTIC ORG BRAIN, P361, DOI DOI 10.1093/ACPROF:0S0/9780195159561.003.0009; WOOTEN G, 1990, NEUROBIOLOGY DIS; Yan Z, 2001, NEUROSCIENCE, V103, P1017, DOI 10.1016/S0306-4522(01)00039-2	50	181	185	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1458	1466		10.1038/nn1972	http://dx.doi.org/10.1038/nn1972			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17906621				2022-12-17	WOS:000250508400024
J	Foltenyi, K; Greenspan, RJ; Newport, JW				Foltenyi, Krisztina; Greenspan, Ralph J.; Newport, John W.			Activation of EGFR and ERK by rhomboid signaling regulates the consolidation and maintenance of sleep in Drosophila	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR RECEPTOR; CIRCADIAN-RHYTHMS; CORPUS CARDIACUM; PROTEIN-KINASES; MUSHROOM BODIES; DOWN-REGULATION; PATHWAY; MELANOGASTER; COMPONENTS; BRAIN	Epidermal growth factor receptor ( EGFR) signaling in the mammalian hypothalamus is important in the circadian regulation of activity. We have examined the role of this pathway in the regulation of sleep in Drosophila melanogaster. Our results demonstrate that rhomboid ( Rho)- and Star-mediated activation of EGFR and ERK signaling increases sleep in a dose-dependent manner, and that blockade of rhomboid ( rho) expression in the nervous system decreases sleep. The requirement of rho for sleep localized to the pars intercerebralis, a part of the fly brain that is developmentally and functionally analogous to the hypothalamus in vertebrates. These results suggest that sleep and its regulation by EGFR signaling may be ancestral to insects and mammals.	Inst Neurosci, San Diego, CA 92121 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Greenspan, RJ (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.	greenspan@nsi.edu						Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Basyuk E, 2000, Nucleic Acids Res, V28, pE46, DOI 10.1093/nar/28.10.e46; Botella JA, 2003, MOL BIOL CELL, V14, P241, DOI 10.1091/mbc.E02-05-0297; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; De Velasco B, 2004, DEV BIOL, V274, P280, DOI 10.1016/j.ydbio.2004.07.015; de Velasco B, 2007, DEV BIOL, V302, P309, DOI 10.1016/j.ydbio.2006.09.035; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Guichard A, 2002, P NATL ACAD SCI USA, V99, P3752, DOI 10.1073/pnas.052028699; Guichard A, 1999, DEVELOPMENT, V126, P2663; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hoeffer CA, 2003, J NEUROSCI, V23, P6362; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kilduff TS, 2000, TRENDS NEUROSCI, V23, P359, DOI 10.1016/S0166-2236(00)01594-0; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kushikata T, 1998, AM J PHYSIOL-REG I, V275, pR509, DOI 10.1152/ajpregu.1998.275.2.R509; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Mignot E, 2002, NAT NEUROSCI, V5, P1071, DOI 10.1038/nn944; Ng DCH, 2000, J BIOL CHEM, V275, P40856, DOI 10.1074/jbc.M004639200; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; RAJASHEKHAR KP, 1994, J COMP NEUROL, V349, P633, DOI 10.1002/cne.903490410; Roenneberg T, 2000, METHOD ENZYMOL, V305, P104; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; SCHEJTER ED, 1986, CELL, V46, P1091, DOI 10.1016/0092-8674(86)90709-9; Schrader LA, 2006, AM J PHYSIOL-CELL PH, V290, pC852, DOI 10.1152/ajpcell.00358.2005; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Sokal R. R., 1995, BIOMETRY PRINCIPLES; STURTEVANT MA, 1994, DEVELOPMENT, V120, P2593; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; Suzuki T, 1999, BRAIN RES, V840, P36, DOI 10.1016/S0006-8993(99)01762-X; SUZUKI T, 1995, NEUROSCI RES, V22, P277, DOI 10.1016/0168-0102(95)00902-6; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Veelaert D, 1998, INT REV CYTOL, V182, P249, DOI 10.1016/S0074-7696(08)62171-3; WELSH JB, 1991, J CELL BIOL, V114, P533, DOI 10.1083/jcb.114.3.533; WILEY HS, 1991, J BIOL CHEM, V266, P11083; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	50	181	182	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1160	1167		10.1038/nn1957	http://dx.doi.org/10.1038/nn1957			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17694052				2022-12-17	WOS:000249144000018
J	Ding, J; Guzman, JN; Tkatch, T; Chen, SH; Goldberg, JA; Ebert, PJ; Levitt, P; Wilson, CJ; Hamm, HE; Surmeier, DJ				Ding, Jun; Guzman, Jaime N.; Tkatch, Tatiana; Chen, Songhai; Goldberg, Joshua A.; Ebert, Philip J.; Levitt, Pat; Wilson, Charles J.; Hamm, Heidi E.; Surmeier, D. James			RGS4-dependent attenuation of M-4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion	NATURE NEUROSCIENCE			English	Article							RGS MESSENGER-RNAS; REDUCE N-TYPE; BASAL GANGLIA; RECEPTOR SUPERSENSITIVITY; ACETYLCHOLINE-RELEASE; PARKINSONS-DISEASE; SYNTHETIC PEPTIDES; ALPHA-SUBUNITS; CA2+ CURRENTS; RAT STRIATUM	Parkinson disease is a neurodegenerative disorder whose symptoms are caused by the loss of dopaminergic neurons innervating the striatum. As striatal dopamine levels fall, striatal acetylcholine release rises, exacerbating motor symptoms. This adaptation is commonly attributed to the loss of interneuronal regulation by inhibitory D-2 dopamine receptors. Our results point to a completely different, new mechanism. After striatal dopamine depletion, D2 dopamine receptor modulation of calcium (Ca2+) channels controlling vesicular acetylcholine release in interneurons was unchanged, but M-4 muscarinic autoreceptor coupling to these same channels was markedly attenuated. This adaptation was attributable to the upregulation of RGS4-an autoreceptor-associated, GTPase-accelerating protein. This specific signaling adaptation extended to a broader loss of autoreceptor control of interneuron spiking. These observations suggest that RGS4-dependent attenuation of interneuronal autoreceptor signaling is a major factor in the elevation of striatal acetylcholine release in Parkinson disease.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Inst Neurosci, Chicago, IL 60611 USA; Univ Texas, Dept Biol, San Antonio, TX 78249 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Texas System; Vanderbilt University; Vanderbilt University	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Wilson, Charles/D-2529-2011; Ding, Jun/B-2513-2009; Hamm, Heidi E/G-2374-2014; Goldberg, Joshua/B-3398-2009	Wilson, Charles/0000-0002-9004-2145; Ding, Jun/0000-0003-0690-1312; chen, songhai/0000-0001-7316-7125; Goldberg, Joshua/0000-0002-5740-4087; Ebert, Philip/0000-0002-8945-2948; Tkatch, Tatiana/0000-0001-6626-7435	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH045156, T32MH065215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS050900, R01NS034696, R37NS037760, R37NS034696, R01NS037760] Funding Source: NIH RePORTER; NICHD NIH HHS [HD15052] Funding Source: Medline; NIMH NIH HHS [MH065215, MH45156, T32 MH065215] Funding Source: Medline; NINDS NIH HHS [NS 37760, 32 NS 050900, NS 34696] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; [Anonymous], 1996, BIOCH BASIS NEUROPHA; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; BARBEAU A, 1962, CAN MED ASSOC J, V87, P802; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Calabresi P, 1998, J PHYSIOL-LONDON, V510, P421, DOI 10.1111/j.1469-7793.1998.421bk.x; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; DeBoer P, 1996, EUR J PHARMACOL, V317, P257, DOI 10.1016/S0014-2999(96)00761-3; DOLEZAL V, 1990, J PHARMACOL EXP THER, V252, P739; Esaki T, 2005, P NATL ACAD SCI USA, V102, P5582, DOI 10.1073/pnas.0501509102; FREUND TF, 1985, J NEUROSCI, V5, P603; Geurts M, 2003, BIOCHEM PHARMACOL, V66, P1163, DOI 10.1016/S0006-2952(03)00447-7; Geurts M, 2002, NEUROSCI LETT, V333, P146, DOI 10.1016/S0304-3940(02)01004-2; GOLARD A, 1993, J NEUROSCI, V13, P3884; Goldberg JA, 2005, J NEUROSCI, V25, P10230, DOI 10.1523/JNEUROSCI.2734-05.2005; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; HU XT, 1990, J NEUROSCI, V10, P2318; Inanobe A, 2001, J PHYSIOL-LONDON, V535, P133, DOI 10.1111/j.1469-7793.2001.t01-1-00133.x; JOYCE JN, 1991, EXP NEUROL, V113, P277, DOI 10.1016/0014-4886(91)90017-7; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; LAHOSTE GJ, 1993, P NATL ACAD SCI USA, V90, P7451, DOI 10.1073/pnas.90.16.7451; MACKENZIE RG, 1989, EUR J PHARMACOL, V168, P43, DOI 10.1016/0014-2999(89)90631-6; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; MILESON BE, 1991, BRAIN RES, V561, P1, DOI 10.1016/0006-8993(91)90742-E; NASTUK MA, 1985, J COMP NEUROL, V237, P176, DOI 10.1002/cne.902370204; Ni YG, 1999, J NEUROSCI, V19, P3674; Pepperl DJ, 1998, BIOCHEM BIOPH RES CO, V243, P52, DOI 10.1006/bbrc.1997.8056; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; RASENICK MM, 1994, J BIOL CHEM, V269, P21519; Raz A, 1996, J NEUROPHYSIOL, V76, P2083, DOI 10.1152/jn.1996.76.3.2083; Reid CA, 2003, TRENDS NEUROSCI, V26, P683, DOI 10.1016/j.tins.2003.10.003; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; UEDA H, 1995, BIOMED PHARMACOTHER, V49, P169, DOI 10.1016/0753-3322(96)82617-5; WICHMANN T, 1988, N-S ARCH PHARMACOL, V338, P623, DOI 10.1007/BF00165626; WOOTEN GF, 1990, NEUROBIOL DIS, P454; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Yan Z, 1996, J NEUROSCI, V16, P2592; Yan Z, 1997, J NEUROPHYSIOL, V77, P1003, DOI 10.1152/jn.1997.77.2.1003; Zamponi GW, 1998, P NATL ACAD SCI USA, V95, P4035, DOI 10.1073/pnas.95.7.4035; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687; ZHANG W, 2000, J NEUROSCI, V22, P1709	49	181	184	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					832	842		10.1038/nn1700	http://dx.doi.org/10.1038/nn1700			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699510				2022-12-17	WOS:000237895200024
J	Lisman, J; Spruston, N				Lisman, J; Spruston, N			Postsynaptic depolarization requirements for LTP and LTD: a critique of spike timing-dependent plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CA1 PYRAMIDAL NEURONS; BACKPROPAGATING ACTION-POTENTIALS; SYNAPTIC PLASTICITY; AREA CA1; HIPPOCAMPAL-NEURONS; DENDRITIC SPIKES; NMDA RECEPTORS; VISUAL-CORTEX; BARREL CORTEX	Long-term potentiation and long-term depression require postsynaptic depolarization, which many current models attribute to backpropagating action potentials. New experimental work suggests, however, that other mechanisms can lead to dendritic depolarization, and that backpropagating action potentials may be neither necessary nor sufficient for synaptic plasticity in vivo.	Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02454 USA; Northwestern Univ, Inst Neurosci, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Brandeis University; Northwestern University	Lisman, J (corresponding author), Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, 415 South St, Waltham, MA 02454 USA.	Lisman@brandeis.edu		Spruston, Nelson/0000-0003-3118-1636				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bradshaw JM, 2003, P NATL ACAD SCI USA, V100, P10512, DOI 10.1073/pnas.1932759100; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; CALLAWAY JC, 1995, J NEUROPHYSIOL, V74, P1395, DOI 10.1152/jn.1995.74.4.1395; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Goldberg J, 2002, TRENDS NEUROSCI, V25, P433, DOI 10.1016/S0166-2236(02)02200-2; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 2001, J NEUROPHYSIOL, V86, P2998, DOI 10.1152/jn.2001.86.6.2998; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Holscher C, 1997, J NEUROSCI, V17, P6470; Holthoff K, 2004, J PHYSIOL-LONDON, V560, P27, DOI 10.1113/jphysiol.2004.072678; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Hyman JM, 2003, J NEUROSCI, V23, P11725; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kampa BM, 2004, J PHYSIOL-LONDON, V556, P337, DOI 10.1113/jphysiol.2003.058842; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Nevian T, 2004, J NEUROSCI, V24, P1689, DOI 10.1523/JNEUROSCI.3332-03.2004; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Sjostrom PJ, 2004, J NEUROPHYSIOL, V92, P3338, DOI 10.1152/jn.00376.2004; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/s0896-6273(01)00542-6; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Staubli UV, 1996, BRAIN RES, V714, P169, DOI 10.1016/0006-8993(95)01523-X; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Thomas MJ, 1998, J NEUROSCI, V18, P7118, DOI 10.1523/jneurosci.18-18-07118.1998; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Vargas-Caballero M, 2004, J NEUROSCI, V24, P6171, DOI 10.1523/JNEUROSCI.1380-04.2004; Vargas-Caballero M, 2003, J NEUROPHYSIOL, V89, P2778, DOI 10.1152/jn.01038.2002; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Waters J, 2005, PROG BIOPHYS MOL BIO, V87, P145, DOI 10.1016/j.pbiomolbio.2004.06.009; WESTPATAT V, 2004, J NEUROSCI, V24, P9067; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305	57	181	183	1	24	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					839	841		10.1038/nn0705-839	http://dx.doi.org/10.1038/nn0705-839			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	16136666				2022-12-17	WOS:000230137100002
J	Bourikas, D; Pekarik, V; Baeriswyl, T; Grunditz, A; Sadhu, R; Nardo, M; Stoeckli, ET				Bourikas, D; Pekarik, V; Baeriswyl, T; Grunditz, A; Sadhu, R; Nardo, M; Stoeckli, ET			Sonic hedgehog guides commissural axons along the longitudinal axis of the spinal cord	NATURE NEUROSCIENCE			English	Article							FLOOR-PLATE; NEURONAL IDENTITY; CHICK DEVELOPMENT; NEURAL-TUBE; IN-VIVO; GUIDANCE; GENE; SPECIFICATION; RECEPTOR; PROTEIN	Dorsal commissural axons in the developing spinal cord cross the floor plate, then turn rostrally and grow along the longitudinal axis, close to the floor plate. We used a subtractive hybridization approach to identify guidance cues responsible for the rostral turn in chicken embryos. One of the candidates was the morphogen Sonic hedgehog (Shh). Silencing of the gene SHH (which encodes Shh) by in ovo RNAi during commissural axon navigation demonstrated a repulsive role in post-commissural axon guidance. This effect of Shh was not mediated by Patched (Ptc) and Smoothened (Smo), the receptors that mediate effects of Shh in morphogenesis and commissural axon growth toward the floor plate. Rather, functional in vivo studies showed that the repulsive effect of Shh on postcommissural axons was mediated by Hedgehog interacting protein (Hip).	Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland; Friedrich Miescher Inst, CH-4058 Basel, Switzerland	University of Zurich; Friedrich Miescher Institute for Biomedical Research	Stoeckli, ET (corresponding author), Univ Zurich, Inst Zool, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	esther.stoeckli@zool.unizh.ch	Pekarik, Vladimir/I-5816-2014	Pekarik, Vladimir/0000-0001-6362-9007; Stoeckli, Esther/0000-0002-8485-0648				Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Baranski M, 2000, DEV BIOL, V217, P25, DOI 10.1006/dbio.1999.9516; Bourikas D, 2003, OLIGONUCLEOTIDES, V13, P411, DOI 10.1089/154545703322617096; BOVOLENTA P, 1991, DEVELOPMENT, V113, P625; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Chuang PT, 2000, CURR OPIN GENET DEV, V10, P515, DOI 10.1016/S0959-437X(00)00121-0; CLARKE JDW, 1991, DEVELOPMENT, V112, P499; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; GREENSPOON S, 1995, J NEUROSCI, V15, P5956; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; Ladher RK, 2000, DEV BIOL, V218, P183, DOI 10.1006/dbio.1999.9586; Lee CS, 2000, DEVELOPMENT, V127, P109; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Leonardo ED, 1997, COLD SPRING HARB SYM, V62, P467; Livesey FJ, 1999, CELL MOL LIFE SCI, V56, P62, DOI 10.1007/s000180050006; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Matise MP, 1999, DEVELOPMENT, V126, P3649; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Pekarik V, 2003, NAT BIOTECHNOL, V21, P93, DOI 10.1038/nbt770; Perrin FE, 2000, MICROSC RES TECHNIQ, V48, P25, DOI 10.1002/(SICI)1097-0029(20000101)48:1<25::AID-JEMT4>3.0.CO;2-F; Perrin JM, 2001, AMBUL PEDIATR, V1, P1; PLACZEK M, 1995, CURR OPIN GENET DEV, V5, P499, DOI 10.1016/0959-437X(95)90055-L; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Stoeckli Esther T., 2003, P297; Stoeckli ET, 1998, CURR OPIN NEUROBIOL, V8, P73, DOI 10.1016/S0959-4388(98)80010-X; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; Stoeckli ET, 1997, NEURON, V18, P209, DOI 10.1016/S0896-6273(00)80262-7; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Trousse F, 2001, DEVELOPMENT, V128, P3927; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; VANSTRAATEN HWM, 1991, ANAT EMBRYOL, V184, P55; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	45	181	185	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					297	304		10.1038/nn1396	http://dx.doi.org/10.1038/nn1396			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15746914				2022-12-17	WOS:000227354600014
J	Maro, GS; Vermeren, M; Voiculescu, O; Melton, L; Cohen, J; Charnay, P; Topilko, P				Maro, GS; Vermeren, M; Voiculescu, O; Melton, L; Cohen, J; Charnay, P; Topilko, P			Neural crest boundary cap cells constitute a source of neuronal and glial cells of the PNS	NATURE NEUROSCIENCE			English	Article							PERIPHERAL NERVOUS-SYSTEM; DORSAL-ROOT-GANGLIA; SPINAL-CORD; DEVELOPING HINDBRAIN; SENSORY NEURONS; EXIT POINTS; STEM-CELLS; EXPRESSION; SPECIFICATION; NEUROGENESIS	Boundary cap ( BC) cells are neural crest derivatives that form clusters at the surface of the neural tube, at entry and exit points of peripheral nerve roots. Using various knock-in alleles of the mouse gene Egr2 ( also known as Krox20), the expression of which, in trunk regions, is initially restricted to BC cells, we were able to trace BC cell progeny during development and analyze their fate. Trunk BC-derived cells migrated along peripheral axons and colonized spinal nerve roots and dorsal root ganglia (DRG). All Schwann cell precursors occupying the dorsal roots were derived from BC cells. In the DRG, BC-derived cells were the progenitors of both neurons, mainly nociceptive afferents, and satellite cells. These data indicate that BC cells constitute a source of peripheral nervous system (PNS) components that, after the major neural crest ventrolateral migratory stream, feeds a secondary wave of migration to the PNS.	Ecole Normale Super, INSERM, U368, F-75230 Paris 05, France; MRC, Ctr Dev Neurobiol, London SE1 1UL, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Charnay, P (corresponding author), Ecole Normale Super, INSERM, U368, 46 Rue Ulm, F-75230 Paris 05, France.	charnay@wotan.ens.fr	Voiculescu, Octavian/C-3543-2008; Voiculescu, Octavian/A-7571-2010	Voiculescu, Octavian/0000-0003-0714-1482; Vermeren, Matthieu/0000-0003-3584-0387; Melton, Lisa/0000-0002-6314-359X; Charnay, Patrick/0000-0002-3847-6042				ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; ALTMAN J, 1982, ADV ANAT EMBRYOL CEL, V74, P1; Anderson DJ, 1999, CURR OPIN NEUROBIOL, V9, P517, DOI 10.1016/S0959-4388(99)00015-X; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Farinas I, 2002, BRAIN RES BULL, V57, P809, DOI 10.1016/S0361-9230(01)00767-5; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; Golding JP, 1997, MOL CELL NEUROSCI, V9, P381, DOI 10.1006/mcne.1997.0647; Hagedorn L, 1999, DEVELOPMENT, V126, P3781; HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q; Itasaki N, 1999, NAT CELL BIOL, V1, pE203, DOI 10.1038/70231; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; LAWSON SN, 1979, J NEUROCYTOL, V8, P265, DOI 10.1007/BF01236122; Le Douarin NM, 1999, NEURAL CREST; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Meyer D, 1997, DEVELOPMENT, V124, P3575; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Morrison SJ, 2001, CURR OPIN CELL BIOL, V13, P666, DOI 10.1016/S0955-0674(00)00269-6; MU XJ, 1993, J NEUROSCI, V13, P4029; Murphy P, 1996, DEVELOPMENT, V122, P2847; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; Niederlander C, 1996, DEVELOPMENT, V122, P2367; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Rosario CM, 1997, DEVELOPMENT, V124, P4213; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; SHARMA K, 1995, NEURON, V14, P143, DOI 10.1016/0896-6273(95)90248-1; Snider WD, 1996, NEURON, V16, P229, DOI 10.1016/S0896-6273(00)80039-2; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Sonnabend DH, 2001, J SHOULDER ELB SURG, V10, P109, DOI 10.1067/mse.2001.112882; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Vermeren M, 2003, NEURON, V37, P403, DOI 10.1016/S0896-6273(02)01188-1; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Voiculescu O, 2001, DEVELOPMENT, V128, P4967; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811; WEIS J, 1991, J CELL BIOL, V113, P1385, DOI 10.1083/jcb.113.6.1385; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538	44	181	183	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					930	938		10.1038/nn1299	http://dx.doi.org/10.1038/nn1299			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15322547				2022-12-17	WOS:000223546700011
J	Miall, RC; Reckess, GZ; Imamizu, H				Miall, RC; Reckess, GZ; Imamizu, H			The cerebellum coordinates eye and hand tracking movements	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; DELAYED VISUAL FEEDBACK; FUNCTIONAL-ANATOMY; MANUAL TRACKING; BRAIN ACTIVITY; MOTOR CONTROL; ACTIVATION; TASK; PURSUIT; MEMORY	The cerebellum is thought to help coordinate movement. We tested this using functional magnetic resonance imaging (fMRI) of the human brain during visually guided tracking tasks requiring varying degrees of eye-hand coordination. The cerebellum was more active during independent rather than coordinated eye and hand tracking. However, in three further tasks, we also found parametric increases in cerebellar blood oxygenation signal (BOLD) as eye-hand coordination increased. Thus, the cerebellar BOLD signal has a non-monotonic relationship to tracking performance, with high activity during both coordinated and independent conditions. These data provide the most direct evidence from functional imaging that the cerebellum supports motor coordination. Its activity is consistent with roles in coordinating and learning to coordinate eye and hand movement.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Dept Expt Psychol, Oxford OX1 3UD, England; JST, ERATO, Kawato Dynam Brain Project, Sora Ku, Kyoto 6190288, Japan	University of Oxford; Japan Science & Technology Agency (JST)	Miall, RC (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.		Imamizu, Hiroshi/AAK-6059-2020; Miall, R. Chris/B-7449-2013	Imamizu, Hiroshi/0000-0003-1024-0051; Miall, R. Chris/0000-0003-3002-1251				ABRAMS RA, 1990, J EXP PSYCHOL HUMAN, V16, P248, DOI 10.1037/0096-1523.16.2.248; Allen G, 1997, SCIENCE, V275, P1940, DOI 10.1126/science.275.5308.1940; Bastian AJ, 1996, J NEUROPHYSIOL, V76, P492, DOI 10.1152/jn.1996.76.1.492; Berman RA, 1999, HUM BRAIN MAPP, V8, P209, DOI 10.1002/(SICI)1097-0193(1999)8:4<209::AID-HBM5>3.0.CO;2-0; BIGUER B, 1984, EXP BRAIN RES, V55, P462; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; Ferraina S, 1997, EUR J NEUROSCI, V9, P1090, DOI 10.1111/j.1460-9568.1997.tb01460.x; Flament D, 1996, HUM BRAIN MAPP, V4, P210, DOI 10.1002/hbm.460040302; Fletcher PC, 1996, BRAIN, V119, P1587, DOI 10.1093/brain/119.5.1587; Flourens P, 1968, HUMAN BRAIN SPINAL C, P657; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; Ghaem O, 1997, NEUROREPORT, V8, P739, DOI 10.1097/00001756-199702100-00032; GRAFTON ST, 1992, BRAIN, V115, P565, DOI 10.1093/brain/115.2.565; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Ivry R, 1997, INT REV NEUROBIOL, V41, P555; Jenkins IH, 1997, J NEUROL SCI, V151, P195, DOI 10.1016/S0022-510X(97)00145-7; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Jueptner M, 1996, EXP BRAIN RES, V112, P462; KOKEN PW, 1992, EXP BRAIN RES, V88, P657; Lewis RF, 1998, J NEUROPHYSIOL, V80, P1605, DOI 10.1152/jn.1998.80.3.1605; Marple-Horvat DE, 1998, J PHYSIOL-LONDON, V506, P489, DOI 10.1111/j.1469-7793.1998.489bw.x; Miall RC, 2000, EXP BRAIN RES, V135, P22, DOI 10.1007/s002210000491; Miall RC, 1998, NOVART FDN SYMP, V218, P272; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; MIALL RC, 1985, NEUROSCIENCE, V16, P511, DOI 10.1016/0306-4522(85)90189-7; MULLER F, 1994, EXP BRAIN RES, V101, P485; Nishitani N, 1999, J NEUROSCI, V19, P2647; PELISSON D, 1986, EXP BRAIN RES, V62, P303; Petit L, 1999, J NEUROPHYSIOL, V82, P463, DOI 10.1152/jn.1999.82.1.463; POULTON EC, 1974, TRACKIN SKILL MANUAL; ROLAND PE, 1995, CEREB CORTEX, V5, P79, DOI 10.1093/cercor/5.1.79; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Serrien DJ, 2000, NEUROPSYCHOLOGIA, V38, P558, DOI 10.1016/S0028-3932(99)00116-5; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Talairach J., 1988, COPLANAR STEREOTAXIC; Tamada T, 1999, NEUROREPORT, V10, P325, DOI 10.1097/00001756-199902050-00022; Turner RS, 1998, J NEUROPHYSIOL, V80, P2162, DOI 10.1152/jn.1998.80.4.2162; VANDONKELAAR P, 1994, J NEUROPHYSIOL, V72, P1674, DOI 10.1152/jn.1994.72.4.1674; VANDONKELAAR P, 1994, EXP BRAIN RES, V99, P155, DOI 10.1007/BF00241420; VanMeter JW, 1995, NEUROIMAGE, V2, P273, DOI 10.1006/nimg.1995.1035; Vercher JL, 1996, J NEUROPHYSIOL, V76, P1133, DOI 10.1152/jn.1996.76.2.1133; VERCHER JL, 1988, EXP BRAIN RES, V73, P155, DOI 10.1007/BF00279669; VERCHER JL, 1992, EXP BRAIN RES, V90, P599; VERCHER JL, 1994, EXP BRAIN RES, V99, P507; Waldvogel D, 1999, J CEREBR BLOOD F MET, V19, P1209, DOI 10.1097/00004647-199911000-00004; Winstein CJ, 1997, J NEUROPHYSIOL, V77, P1581, DOI 10.1152/jn.1997.77.3.1581; Witney AG, 1999, J NEUROPHYSIOL, V82, P2039, DOI 10.1152/jn.1999.82.5.2039; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Woods R.P., 1998, J COMPUT ASSIST TOMO, V22, P141	49	181	182	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					638	644		10.1038/88465	http://dx.doi.org/10.1038/88465			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369946				2022-12-17	WOS:000169061800018
J	Mott, DD; Doherty, JJ; Zhang, SN; Washburn, MS; Fendley, MJ; Lyuboslavsky, P; Traynelis, SF; Dingledine, R				Mott, DD; Doherty, JJ; Zhang, SN; Washburn, MS; Fendley, MJ; Lyuboslavsky, P; Traynelis, SF; Dingledine, R			Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition	NATURE NEUROSCIENCE			English	Article							D-ASPARTATE RECEPTOR; CEREBELLAR GRANULE NEURONS; CULTURED CORTICAL-NEURONS; ANTI-ISCHEMIC AGENTS; AMINO-ACID; PHARMACOLOGICAL PROPERTIES; GLUTAMATE-RECEPTOR; CEREBRAL-ISCHEMIA; XENOPUS OOCYTES; CA2+ CHANNELS	The phenylethanolamines, ifenprodil and CP-101,606, are NMDA receptor antagonists with promising neuroprotective properties. In recombinant NMDA receptors expressed in Xenopus oocytes, we found that these drugs inhibit NMDA receptors through a unique mechanism, making the receptor more sensitive to inhibition by protons, an endogenous negative modulator. These findings support a critical role for the proton sensor in gating the NMDA receptor and point the way to identifying a context-dependent NMDA receptor antagonist that is inactive at physiological pH, but is a potent inhibitor during the acidic conditions that arise during epilepsy, ischemia and brain trauma.	Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Mott, DD (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Rollins Res Bldg,1510 Clifton Rd, Atlanta, GA 30322 USA.		dingledine, Ray/F-5173-2011	Dingledine, Ray/0000-0001-7128-4520; Mott, David/0000-0003-0758-8006				Bath CP, 1996, EUR J PHARMACOL, V299, P103, DOI 10.1016/0014-2999(95)00846-2; Biton B, 1997, EUR J PHARMACOL, V323, P277, DOI 10.1016/S0014-2999(97)00141-6; Blahos J, 1996, J BIOL CHEM, V271, P15669, DOI 10.1074/jbc.271.26.15669; CARTER C, 1988, J PHARMACOL EXP THER, V247, P1222; CARTER CJ, 1990, J PHARMACOL EXP THER, V253, P475; CHENARD BL, 1995, J MED CHEM, V38, P3138, DOI 10.1021/jm00016a017; CHENARD BL, 1991, J MED CHEM, V34, P3085, DOI 10.1021/jm00114a018; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Davis SM, 1997, LANCET, V349, P32, DOI 10.1016/S0140-6736(05)62166-6; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; DINGLEDINE R, 1990, TRENDS PHARMACOL SCI, V11, P334, DOI 10.1016/0165-6147(90)90238-4; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Gallagher MJ, 1996, J BIOL CHEM, V271, P9603, DOI 10.1074/jbc.271.16.9603; GIFFARD RG, 1990, BRAIN RES, V506, P339, DOI 10.1016/0006-8993(90)91276-M; GOTTI B, 1988, J PHARMACOL EXP THER, V247, P1211; GRAHAM D, 1992, EUR J PHARM-MOLEC PH, V226, P373, DOI 10.1016/0922-4106(92)90056-2; HOCH DB, 1986, DEV BRAIN RES, V25, P53, DOI 10.1016/0165-3806(86)90151-3; KAKU DA, 1993, SCIENCE, V260, P1516, DOI 10.1126/science.8389056; Kashiwagi K, 1996, MOL PHARMACOL, V49, P1131; Kew JNC, 1996, J PHYSIOL-LONDON, V497, P761, DOI 10.1113/jphysiol.1996.sp021807; Kew JNC, 1998, BRIT J PHARMACOL, V123, P463, DOI 10.1038/sj.bjp.0701634; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Lees KR, 1997, NEUROLOGY, V49, pS66, DOI 10.1212/WNL.49.5_Suppl_4.S66; LEGENDRE P, 1991, MOL PHARMACOL, V40, P289; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; MCCOOL BA, 1995, NEUROPHARMACOLOGY, V34, P621, DOI 10.1016/0028-3908(95)00030-A; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Menniti F, 1997, EUR J PHARMACOL, V331, P117, DOI 10.1016/S0014-2999(97)10092-9; Pahk AJ, 1997, NEUROSCI LETT, V225, P29, DOI 10.1016/S0304-3940(97)00176-6; Pasternack M, 1996, NEUROPHARMACOLOGY, V35, P1279, DOI 10.1016/S0028-3908(96)00075-5; REYNOLDS IJ, 1989, MOL PHARMACOL, V36, P758; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; SIESJO BK, 1985, PROG BRAIN RES, V63, P121; SILVER IA, 1992, J CEREBR BLOOD F MET, V12, P759, DOI 10.1038/jcbfm.1992.107; SULLIVAN JM, 1994, NEURON, V13, P929, DOI 10.1016/0896-6273(94)90258-5; TAMURA Y, 1993, J PHARMACOL EXP THER, V265, P1017; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; TRAYNELIS SF, 1991, J PHYSIOL-LONDON, V433, P727, DOI 10.1113/jphysiol.1991.sp018453; Traynelis SF, 1998, J NEUROSCI, V18, P6163; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; TRAYNELIS SF, 1998, PH BRAIN FUNCTION, P407; VYKLICKY L, 1990, J PHYSIOL-LONDON, V430, P497, DOI 10.1113/jphysiol.1990.sp018304; Williams K, 1995, MOL PHARMACOL, V48, P1087; WILLIAMS K, 1995, NEUROSCI LETT, V184, P181, DOI 10.1016/0304-3940(94)11201-S; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851	48	181	190	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					659	667		10.1038/3661	http://dx.doi.org/10.1038/3661			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196581				2022-12-17	WOS:000077323400009
J	Burt, JB; Demirtas, M; Eckner, WJ; Navejar, NM; Ji, JL; Martin, WJ; Bernacchia, A; Anticevic, A; Murray, JD				Burt, Joshua B.; Demirtas, Murat; Eckner, William J.; Navejar, Natasha M.; Ji, Jie Lisa; Martin, William J.; Bernacchia, Alberto; Anticevic, Alan; Murray, John D.			Hierarchy of transcriptomic specialization across human cortex captured by structural neuroimaging topography	NATURE NEUROSCIENCE			English	Article							TEMPORAL RECEPTIVE WINDOWS; HUMAN CONNECTOME PROJECT; LOCAL CIRCUIT NEURONS; HUMAN CEREBRAL-CORTEX; ADULT HUMAN BRAIN; MACAQUE MONKEY; CORTICAL ORGANIZATION; PREFRONTAL CORTEX; PYRAMIDAL NEURONS; GENE-EXPRESSION	Hierarchy provides a unifying principle for the macroscale organization of anatomical and functional properties across primate cortex, yet microscale bases of specialization across human cortex are poorly understood. Anatomical hierarchy is conventionally informed by invasive tract-tracing measurements, creating a need for a principled proxy measure in humans. Moreover, cortex exhibits marked interareal variation in gene expression, yet organizing principles of cortical transcription remain unclear. We hypothesized that specialization of cortical microcircuitry involves hierarchical gradients of gene expression. We found that a noninvasive neuroimaging measure-MRI-derived T1-weighted/T2-weighted (T1w/T2w) mapping-reliably indexes anatomical hierarchy, and it captures the dominant pattern of transcriptional variation across human cortex. We found hierarchical gradients in expression profiles of genes related to microcircuit function, consistent with monkey microanatomy, and implicated in neuropsychiatric disorders. Our findings identify a hierarchical axis linking cortical transcription and anatomy, along which gradients of microscale properties may contribute to the macroscale specialization of cortical function.	[Burt, Joshua B.; Eckner, William J.; Murray, John D.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Demirtas, Murat; Anticevic, Alan; Murray, John D.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Navejar, Natasha M.] Tulane Univ, Neurosci Program, New Orleans, LA 70118 USA; [Ji, Jie Lisa] Yale Univ, Interdept Neurosci Program, New Haven, CT USA; [Martin, William J.] BlackThorn Therapeut, San Francisco, CA USA; [Bernacchia, Alberto] Univ Cambridge, Dept Engn, Cambridge, England	Yale University; Yale University; Tulane University; Yale University; University of Cambridge	Murray, JD (corresponding author), Yale Univ, Dept Phys, New Haven, CT 06520 USA.; Murray, JD (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	john.murray@yale.edu	Burt, Joshua/AAM-5751-2020; Martin, William J/L-9033-2017	Martin, William J/0000-0002-2749-3365; Demirtas, Murat/0000-0002-6035-7752	NIH [R01MH112746, R01MH108590, TL1TR000141]; BlackThorn Therapeutics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001864, TL1TR000141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH108590, R01MH112189, R01MH112746] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BlackThorn Therapeutics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B.D. Fulcher, X.-J. Wang, R. Chaudhuri, and D.C. Glahn for useful discussions. This research was supported by NIH grants R01MH112746 (J.D.M.), R01MH108590 (A.A.), and TL1TR000141 (J.D.M.), and by BlackThorn Therapeutics (J.D.M., A.A.).	Anselin L., 2001, COMPANION THEOR EC, P310, DOI [10.1002/9780470996249.ch15, DOI 10.1002/9780470996249.CH15]; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Bakken TE, 2016, NATURE, V535, P367, DOI 10.1038/nature18637; Barbas H, 1997, CEREB CORTEX, V7, P635, DOI 10.1093/cercor/7.7.635; Bras J, 2014, HUM MOL GENET, V23, P6139, DOI 10.1093/hmg/ddu334; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carey D., 2017, NEUROIMAGE S, P31012; Chaudhuri R, 2015, NEURON, V88, P419, DOI 10.1016/j.neuron.2015.09.008; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; CONDE F, 1994, J COMP NEUROL, V341, P95, DOI 10.1002/cne.903410109; Davison AC, 1997, BOOTSTRAP METHODS TH; Dombrowski SM, 2001, CEREB CORTEX, V11, P975, DOI 10.1093/cercor/11.10.975; Donahue CJ, 2016, J NEUROSCI, V36, P6758, DOI 10.1523/JNEUROSCI.0493-16.2016; Elston GN, 1997, CEREB CORTEX, V7, P432, DOI 10.1093/cercor/7.5.432; Elston GN, 2003, CEREB CORTEX, V13, P1124, DOI 10.1093/cercor/bhg093; Elston GN, 2005, CEREB CORTEX, V15, P64, DOI 10.1093/cercor/bhh109; Elston GN, 2002, CEREB CORTEX, V12, P1071, DOI 10.1093/cercor/12.10.1071; Elston GN, 1999, P ROY SOC B-BIOL SCI, V266, P1367, DOI 10.1098/rspb.1999.0789; Elston GN, 1998, CEREB CORTEX, V8, P278, DOI 10.1093/cercor/8.3.278; Elston GN, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00042; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fischer M.M., 2010, HDB APPL SPATIAL ANA; Fulcher BD, 2016, P NATL ACAD SCI USA, V113, P1435, DOI 10.1073/pnas.1513302113; Gabbott PLA, 1996, J COMP NEUROL, V364, P609; Genovese G, 2016, NAT NEUROSCI, V19, P1433, DOI 10.1038/nn.4402; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Glasser MF, 2014, NEUROIMAGE, V93, P165, DOI 10.1016/j.neuroimage.2013.03.060; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Gomez J, 2017, SCIENCE, V355, P68, DOI 10.1126/science.aag0311; Hasson U, 2008, J NEUROSCI, V28, P2539, DOI 10.1523/JNEUROSCI.5487-07.2008; Hawrylycz M, 2015, NAT NEUROSCI, V18, P1832, DOI 10.1038/nn.4171; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hilgetag CC, 2016, NEUROIMAGE, V134, P685, DOI 10.1016/j.neuroimage.2016.04.017; Honey CJ, 2012, NEURON, V76, P423, DOI 10.1016/j.neuron.2012.08.011; Huntenburg JM, 2018, TRENDS COGN SCI, V22, P21, DOI 10.1016/j.tics.2017.11.002; Ito T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01000-w; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kondo H, 1999, EUR J NEUROSCI, V11, P4197, DOI 10.1046/j.1460-9568.1999.00844.x; Krienen FM, 2016, P NATL ACAD SCI USA, V113, pE469, DOI 10.1073/pnas.1510903113; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Lein ES, 2017, ANNU REV NEUROSCI, V40, P629, DOI 10.1146/annurev-neuro-070815-013858; Lennie P, 1998, PERCEPTION, V27, P889, DOI 10.1068/p270889; Lerner Y, 2011, J NEUROSCI, V31, P2906, DOI 10.1523/JNEUROSCI.3684-10.2011; Lorio S, 2016, HUM BRAIN MAPP, V37, P1801, DOI 10.1002/hbm.23137; Lutti A, 2014, NEUROIMAGE, V93, P176, DOI 10.1016/j.neuroimage.2013.06.005; Margulies DS, 2016, P NATL ACAD SCI USA, V113, P12574, DOI 10.1073/pnas.1608282113; Markov NT, 2014, CEREB CORTEX, V24, P17, DOI 10.1093/cercor/bhs270; Markov NT, 2014, J COMP NEUROL, V522, P225, DOI 10.1002/cne.23458; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Murray JD, 2017, J NEUROSCI, V37, P12167, DOI 10.1523/JNEUROSCI.0343-17.2017; Murray JD, 2014, NAT NEUROSCI, V17, P1661, DOI 10.1038/nn.3862; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Pirooznia M, 2012, BIOINFORMATICS, V28, P897, DOI 10.1093/bioinformatics/bts040; Richiardi J, 2015, SCIENCE, V348, P1241, DOI 10.1126/science.1255905; Robinson EC, 2014, NEUROIMAGE, V100, P414, DOI 10.1016/j.neuroimage.2014.05.069; Romme IAC, 2017, BIOL PSYCHIAT, V81, P495, DOI 10.1016/j.biopsych.2016.07.012; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Sereno MI, 2013, CEREB CORTEX, V23, P2261, DOI 10.1093/cercor/bhs213; Stuber C, 2014, NEUROIMAGE, V93, P95, DOI 10.1016/j.neuroimage.2014.02.026; Timmerman ME, 2007, BRIT J MATH STAT PSY, V60, P295, DOI 10.1348/000711006X109636; TUKEY JW, 1958, ANN MATH STAT, V29, P614; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Wagstyl K, 2015, NEUROIMAGE, V111, P241, DOI 10.1016/j.neuroimage.2015.02.036; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wang GZ, 2015, NEURON, V88, P659, DOI 10.1016/j.neuron.2015.10.022; Wang HX, 2008, P NATL ACAD SCI USA, V105, P16791, DOI 10.1073/pnas.0804318105; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Whitaker KJ, 2016, P NATL ACAD SCI USA, V113, P9105, DOI 10.1073/pnas.1601745113; Yang GR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12815; Yeatman JD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5932; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052	74	180	182	10	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2018	21	9					1251	+		10.1038/s41593-018-0195-0	http://dx.doi.org/10.1038/s41593-018-0195-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GS0DU	30082915	Green Accepted, Green Submitted			2022-12-17	WOS:000443157700014
J	Ostojic, S				Ostojic, Srdjan			Two types of asynchronous activity in networks of excitatory and inhibitory spiking neurons	NATURE NEUROSCIENCE			English	Article							CONNECTED NETWORKS; TRANSIENT DYNAMICS; MODEL; VARIABILITY; PATTERNS; CHAOS; REPRESENTATION; NOISE; RATES; STATE	Asynchronous activity in balanced networks of excitatory and inhibitory neurons is believed to constitute the primary medium for the propagation and transformation of information in the neocortex. Here we show that an unstructured, sparsely connected network of model spiking neurons can display two fundamentally different types of asynchronous activity that imply vastly different computational properties. For weak synaptic couplings, the network at rest is in the well-studied asynchronous state, in which individual neurons fire irregularly at constant rates. In this state, an external input leads to a highly redundant response of different neurons that favors information transmission but hinders more complex computations. For strong couplings, we find that the network at rest displays rich internal dynamics, in which the firing rates of individual neurons fluctuate strongly in time and across neurons. In this regime, the internal dynamics interact with incoming stimuli to provide a substrate for complex information processing and learning.	Ecole Normale Super, Grp Neural Theory, Lab Neurosci Cognit, INSERM,U960, F-75231 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Ostojic, S (corresponding author), Ecole Normale Super, Grp Neural Theory, Lab Neurosci Cognit, INSERM,U960, 24 Rue Lhomond, F-75231 Paris, France.	srdjan.ostojic@ens.fr		Ostojic, Srdjan/0000-0002-7473-1223	France's Agence Nationale de la Recherche [ANR-11-0001-02 PSL, ANR-10-LABX-0087]	France's Agence Nationale de la Recherche(French National Research Agency (ANR))	The author is grateful to N. Brunel, V. Hakim, D. Mart and M. Stern for discussions and feedback on the manuscript. This work was supported by France's Agence Nationale de la Recherche ANR-11-0001-02 PSL<SUP>star</SUP> and ANR-10-LABX-0087.	AMIT DJ, 1991, NETWORK-COMP NEURAL, V2, P259, DOI 10.1088/0954-898X/2/3/003; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; Churchland MM, 2012, NAT NEUROSCI, V15, P1472, DOI 10.1038/nn.3247; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Dayan P., 2001, THEORETICAL NEUROSCI; GERSTNER W, 1995, PHYS REV E, V51, P738, DOI 10.1103/PhysRevE.51.738; Gerstner W, 2000, NEURAL COMPUT, V12, P43, DOI 10.1162/089976600300015899; GINZBURG I, 1994, PHYS REV E, V50, P3171, DOI 10.1103/PhysRevE.50.3171; Helias M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000929; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Laje R, 2013, NAT NEUROSCI, V16, P925, DOI 10.1038/nn.3405; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Monteforte M, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041007; Monteforte M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.268104; Ostojic S, 2011, J NEUROPHYSIOL, V106, P361, DOI 10.1152/jn.00830.2010; Ostojic S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001056; Rajan K., 2010, ADV NEURAL INFORM PR, P1975; Rajan K, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188104; Rajan K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011903; Rangan AV, 2013, J COMPUT NEUROSCI, V35, P155, DOI 10.1007/s10827-013-0445-9; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Rigotti M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00024; Roxin A, 2011, J NEUROSCI, V31, P16217, DOI 10.1523/JNEUROSCI.1677-11.2011; Schaffer ES, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003301; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SOMPOLINSKY H, 1988, PHYS REV LETT, V61, P259, DOI 10.1103/PhysRevLett.61.259; Sussillo D, 2013, NEURAL COMPUT, V25, P626, DOI 10.1162/NECO_a_00409; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Tetzlaff T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002596; Timme M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.074101; Toyoizumi T, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051908; Troyer TW, 1997, NEURAL COMPUT, V9, P971, DOI 10.1162/neco.1997.9.5.971; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Wainrib G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.118101; Wallace E, 2013, NEURAL COMPUT, V25, P1408, DOI 10.1162/NECO_a_00449; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006	49	180	182	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2014	17	4					594	U155		10.1038/nn.3658	http://dx.doi.org/10.1038/nn.3658			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AD6XR	24561997				2022-12-17	WOS:000333405300020
J	Mainland, JD; Keller, A; Li, YR; Zhou, T; Trimmer, C; Snyder, LL; Moberly, AH; Adipietro, KA; Liu, WLL; Zhuang, HY; Zhan, SM; Lee, SS; Lin, A; Matsunami, H				Mainland, Joel D.; Keller, Andreas; Li, Yun R.; Zhou, Ting; Trimmer, Casey; Snyder, Lindsey L.; Moberly, Andrew H.; Adipietro, Kaylin A.; Liu, Wen Ling L.; Zhuang, Hanyi; Zhan, Senmiao; Lee, Somin S.; Lin, Abigail; Matsunami, Hiroaki			The missense of smell: functional variability in the human odorant receptor repertoire	NATURE NEUROSCIENCE			English	Article							HUMAN OLFACTORY RECEPTORS; GENETIC-VARIATION; HUMAN GENOME; EXPRESSION; SENSITIVITY; IDENTIFICATION; SPECIFICITY; POPULATION; PERCEPTION; CELLS	Humans have similar to 400 intact odorant receptors, but each individual has a unique set of genetic variations that lead to variation in olfactory perception. We used a heterologous assay to determine how often genetic polymorphisms in odorant receptors alter receptor function. We identified agonists for 18 odorant receptors and found that 63% of the odorant receptors we examined had polymorphisms that altered in vitro function. On average, two individuals have functional differences at over 30% of their odorant receptor alleles. To show that these in vitro results are relevant to olfactory perception, we verified that variations in OR10G4 genotype explain over 15% of the observed variation in perceived intensity and over 10% of the observed variation in perceived valence for the high-affinity in vitro agonist guaiacol but do not explain phenotype variation for the lower-affinity agonists vanillin and ethyl vanillin.	[Mainland, Joel D.; Trimmer, Casey; Snyder, Lindsey L.; Moberly, Andrew H.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Mainland, Joel D.; Li, Yun R.; Zhou, Ting; Adipietro, Kaylin A.; Liu, Wen Ling L.; Zhuang, Hanyi; Zhan, Senmiao; Lee, Somin S.; Lin, Abigail; Matsunami, Hiroaki] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Mainland, Joel D.; Moberly, Andrew H.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Keller, Andreas] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10021 USA; [Matsunami, Hiroaki] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Matsunami, Hiroaki] Duke Univ, Med Ctr, Duke Inst Brain Sci, Durham, NC 27710 USA	Monell Chemical Senses Center; Duke University; University of Pennsylvania; Rockefeller University; Duke University; Duke University	Mainland, JD (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	joel.mainland@gmail.com	Lee, Somin/V-4703-2018; Mainland, Joel/C-5171-2009	Lee, Somin/0000-0002-3957-5181; Mainland, Joel/0000-0002-5056-4598; Li, Yun Rose/0000-0002-8077-4975	National Research Service Award postdoctoral fellowship [F32 DC008932]; US National Institutes of Health NIDCD Core [P30 DC011735];  [R01 DC005782];  [R01 DC012095];  [R03 DC011373];  [R01 DC013339];  [T32 DC000014]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013339, P30DC011735, T32DC000014, R01DC005782, R03DC011373, R01DC012095, F32DC008932] Funding Source: NIH RePORTER	National Research Service Award postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health NIDCD Core; ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by R01 DC005782, R01 DC012095, R03 DC011373, R01 DC013339, T32 DC000014 and a National Research Service Award postdoctoral fellowship F32 DC008932 to J.D.M. A portion of the work was performed using the Monell Chemosensory Receptor Signaling Core and Genotyping and DNA/RNA Analysis Core, which are supported, in part, by funding from the US National Institutes of Health NIDCD Core Grant P30 DC011735. A portion of the work was supported by the Defense Advanced Research Project Agency RealNose Project. Collection of psychophysical data was supported by grant # UL1 TR000043 from the Clinical and Translational Science Award program at the National Center for Advancing Translational Sciences. The FACS analysis was performed using the Duke Cancer Institute Flow Cytometry Core. We thank D. Marchuk for sharing equipment, LB. Vosshall for supervising the collection of psychophysical data and DNA samples by A.K. in her laboratory, and R. Molday (University of British Columbia Centre for Macular Research) for 4D2 anti-rhodopsin antibody.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; AMOORE JE, 1977, CHEM SENS FLAV, V2, P267, DOI 10.1093/chemse/2.3.267; Ayabe-Kanamura S, 1998, CHEM SENSES, V23, P31, DOI 10.1093/chemse/23.1.31; Eriksson N., 2012, ARXIV12092096; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Fushan AA, 2009, CURR BIOL, V19, P1288, DOI 10.1016/j.cub.2009.06.015; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hasin-Brumshtein Y, 2009, TRENDS GENET, V25, P178, DOI 10.1016/j.tig.2009.02.002; Hayden S, 2010, GENOME RES, V20, P1, DOI 10.1101/gr.099416.109; Jacquier V, 2006, J NEUROCHEM, V97, P537, DOI 10.1111/j.1471-4159.2006.03771.x; Jaeger SR, 2013, CURR BIOL, V23, P1601, DOI 10.1016/j.cub.2013.07.030; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Keller A, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-122; Matarazzo V, 2005, CHEM SENSES, V30, P195, DOI 10.1093/chemse/bji015; McRae JF, 2013, CURR BIOL, V23, P1596, DOI 10.1016/j.cub.2013.07.031; Mcrae JF, 2012, CHEM SENSES, V37, P585, DOI 10.1093/chemse/bjs049; Menashe I, 2003, NAT GENET, V34, P143, DOI 10.1038/ng1160; Menashe I, 2007, PLOS BIOL, V5, P2462, DOI 10.1371/journal.pbio.0050284; Neuhaus EM, 2006, CHEM SENSES, V31, P445, DOI 10.1093/chemse/bjj049; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P20421, DOI 10.1073/pnas.0709956104; Olender T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-414; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Waszak SM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000988; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120	30	180	184	4	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					114	120		10.1038/nn.3598	http://dx.doi.org/10.1038/nn.3598			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24316890	Green Accepted, Green Submitted			2022-12-17	WOS:000329080000021
J	Buckholtz, JW; Marois, R				Buckholtz, Joshua W.; Marois, Rene			The roots of modern justice: cognitive and neural foundations of social norms and their enforcement	NATURE NEUROSCIENCE			English	Article							ALTRUISTIC PUNISHMENT; EVOLUTION; COOPERATION; RECIPROCITY; MECHANISMS; FAIRNESS; REWARD; BLAME; BRAIN	Among animals, Homo sapiens is unique in its capacity for widespread cooperation and prosocial behavior among large and genetically heterogeneous groups of individuals. This ultra-sociality figures largely in our success as a species. It is also an enduring evolutionary mystery. There is considerable support for the hypothesis that this facility is a function of our ability to establish, and enforce through sanctions, social norms. Third-party punishment of norm violations ("I punish you because you harmed him") seems especially crucial for the evolutionary stability of cooperation and is the cornerstone of modern systems of criminal justice. In this commentary, we outline some potential cognitive and neural processes that may underlie the ability to learn norms, to follow norms and to enforce norms through third-party punishment. We propose that such processes depend on several domain-general cognitive functions that have been repurposed, through evolution's thrift, to perform these roles.	[Buckholtz, Joshua W.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Buckholtz, Joshua W.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Buckholtz, Joshua W.] Massachusetts Gen Hosp, Dept Psychiat, Div Psychiat Neuroimaging, Boston, MA 02114 USA; [Marois, Rene] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Marois, Rene] Vanderbilt Univ, Ctr Integrated & Cognit Neurosci, Nashville, TN USA	Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Vanderbilt University; Vanderbilt University	Buckholtz, JW (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	joshuabuckholtz@fas.harvard.edu; rene.marois@vanderbilt.edu	Buckholtz, Joshua/E-7299-2010; Carroll, Joseph/D-1158-2011	Buckholtz, Joshua/0000-0002-9418-8686; Carroll, Joseph/0000-0003-2656-1378	MacArthur Foundation Research Network on Law and Neuroscience [KK9127, KK1031]	MacArthur Foundation Research Network on Law and Neuroscience	We thank K. Jan for literature research and O. Jones for comments on an earlier draft of this manuscript, and the MacArthur Foundation Research Network on Law and Neuroscience for support (KK9127 and KK1031).	Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bendor J, 2001, AM J SOCIOL, V106, P1493, DOI 10.1086/321298; Bicchieri C., 2006, GRAMMAR SOC NATURE D, DOI DOI 10.1017/CBO9780511616037; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; Boyd R, 2011, P NATL ACAD SCI USA, V108, P10918, DOI 10.1073/pnas.1100290108; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Bright DA, 2006, LAW HUMAN BEHAV, V30, P183, DOI 10.1007/s10979-006-9027-y; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Burke CJ, 2010, P NATL ACAD SCI USA, V107, P14431, DOI 10.1073/pnas.1003111107; Churchland PS, 2011, BRAINTRUST: WHAT NEUROSCIENCE TELLS US ABOUT MORALITY, P27; Crockett MJ, 2010, EMOTION, V10, P855, DOI 10.1037/a0019861; Cushman F, 2012, SOC NEUROSCI-UK, V7, P269, DOI 10.1080/17470919.2011.614000; Darley JM, 2009, ANNU REV LAW SOC SCI, V5, P1, DOI 10.1146/annurev.lawsocsci.4.110707.172335; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Feigenson N, 2006, LAW HUMAN BEHAV, V30, P143, DOI 10.1007/s10979-006-9026-z; Gospic K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001054; Haidt J, 2003, SER AFFECTIVE SCI, P852; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Heekeren HR, 2005, NEUROIMAGE, V24, P887, DOI 10.1016/j.neuroimage.2004.09.026; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Jensen K, 2007, P NATL ACAD SCI USA, V104, P13046, DOI 10.1073/pnas.0705555104; Kitcher P, 2011, ETHICAL PROJECT; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Knoch D, 2009, P NATL ACAD SCI USA, V106, P20895, DOI 10.1073/pnas.0911619106; Koenigs M, 2010, NEUROPSYCHOLOGIA, V48, P2198, DOI 10.1016/j.neuropsychologia.2010.04.012; Krajbich I, 2009, J NEUROSCI, V29, P2188, DOI 10.1523/JNEUROSCI.5086-08.2009; LAFAVE WR, 2003, CRIMINAL LAW; Marlowe FW, 2011, P ROY SOC B-BIOL SCI, V278, P2159, DOI 10.1098/rspb.2010.2342; Mikhail J, 2007, TRENDS COGN SCI, V11, P143, DOI 10.1016/j.tics.2006.12.007; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Oswald ME, 2005, J APPL SOC PSYCHOL, V35, P718, DOI 10.1111/j.1559-1816.2005.tb02143.x; Pinker S., 2011, BETTER ANGELS OUR NA; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Reidl K., 2010, INT J PRIM ABSTR, V314; Robinson PH, 2007, VANDERBILT LAW REV, V60, P1633; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Seymour B, 2007, NAT REV NEUROSCI, V8, P300, DOI 10.1038/nrn2119; Shen FX, 2011, NEW YORK U LAW REV, V86, P1306; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Waytz A, 2011, CURR DIR PSYCHOL SCI, V20, P197, DOI 10.1177/0963721411409007; Young L, 2010, P NATL ACAD SCI USA, V107, P6753, DOI 10.1073/pnas.0914826107	50	180	193	8	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					655	661		10.1038/nn.3087	http://dx.doi.org/10.1038/nn.3087			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	932DI	22534578				2022-12-17	WOS:000303270200006
J	Anderson, CT; Sheets, PL; Kiritani, T; Shepherd, GMG				Anderson, Charles T.; Sheets, Patrick L.; Kiritani, Taro; Shepherd, Gordon M. G.			Sublayer-specific microcircuits of corticospinal and corticostriatal neurons in motor cortex	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; PYRAMIDAL NEURONS; FLAVOPROTEIN AUTOFLUORESCENCE; CALLOSAL PROJECTIONS; RAT; CONNECTIONS; ORGANIZATION; MORPHOLOGY; NEOCORTEX; CIRCUITS	The mammalian motor system is organized around distinct subcortical subsystems, suggesting that the intracortical circuits immediately upstream of spinal cord and basal ganglia might be functionally differentiated as well. We found that the main excitatory pathway in mouse motor cortex, layer 2/3 -> 5, is fractionated into distinct pathways targeting corticospinal and corticostriatal neurons, which are involved in motor control. However, connections were selective for neurons in certain sublayers: corticospinal neurons in upper layer 5B and corticostriatal neurons in lower 5A. A simple structural combinatorial principle accounts for this highly specific functional circuit architecture: potential connectivity is established by neuronal sublayer positioning and actual connectivity in this framework is determined by long-range axonal projection targets. Thus, intracortical circuits of these pyramidal neurons are specified not only by their long-range axonal targets or their layer or sublayer positions, but by both, in specific combinations.	[Anderson, Charles T.; Sheets, Patrick L.; Kiritani, Taro; Shepherd, Gordon M. G.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Shepherd, GMG (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	g-shepherd@northwestern.edu	Shepherd, Gordon/F-2679-2010	Anderson, Charles/0000-0003-3353-0182	Whitehall Foundation; National Institute of Neurological Disorders and Stroke at the US National Institutes of Health [NS061963]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061963] Funding Source: NIH RePORTER	Whitehall Foundation; National Institute of Neurological Disorders and Stroke at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Petreanu and K. Svoboda (Howard Hughes Medical Institute) for plasmids and comments, and D. Buxton for advice on retrograde labeling methods. The work was funded by grants from the Whitehall Foundation and the National Institute of Neurological Disorders and Stroke at the US National Institutes of Health (NS061963).	Alstermark B, 2004, J NEUROPHYSIOL, V92, P1958, DOI 10.1152/jn.00092.2004; Alstermark B, 2004, J NEUROPHYSIOL, V91, P1832, DOI 10.1152/jn.00820.2003; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Ballion B, 2008, EUR J NEUROSCI, V27, P2313, DOI 10.1111/j.1460-9568.2008.06192.x; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Binzegger T, 2009, NEURAL NETWORKS, V22, P1071, DOI 10.1016/j.neunet.2009.07.011; Brown SP, 2009, CURR OPIN NEUROBIOL, V19, P415, DOI 10.1016/j.conb.2009.07.011; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Cheatwood JL, 2005, BRAIN RES, V1036, P90, DOI 10.1016/j.brainres.2004.12.049; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Gao WJ, 2004, J COMP NEUROL, V476, P174, DOI 10.1002/cne.20224; GERFEN CR, 1989, SCIENCE, V246, P385, DOI 10.1126/science.2799392; Grinevich V, 2005, J NEUROSCI, V25, P8250, DOI 10.1523/JNEUROSCI.2235-05.2005; Groh A, 2010, CEREB CORTEX, V20, P826, DOI 10.1093/cercor/bhp152; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Kaneko T, 2000, J COMP NEUROL, V423, P52, DOI 10.1002/1096-9861(20000717)423:1<52::AID-CNE5>3.0.CO;2-F; Larsen DD, 2008, FRONT NEURAL CIRCUIT, V1, DOI 10.3389/neuro.04.005.2007; Levesque M, 1996, BRAIN RES, V709, P311, DOI 10.1016/0006-8993(95)01333-4; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Llano DA, 2009, J NEUROPHYSIOL, V101, P3325, DOI 10.1152/jn.91291.2008; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Miller MN, 2008, J NEUROSCI, V28, P13716, DOI 10.1523/JNEUROSCI.2940-08.2008; Mizuno H, 2007, J NEUROSCI, V27, P6760, DOI 10.1523/JNEUROSCI.1215-07.2007; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Morishima M, 2006, J NEUROSCI, V26, P4394, DOI 10.1523/JNEUROSCI.0252-06.2006; Nelson Sacha B., 2002, Neuron, V36, P19, DOI 10.1016/S0896-6273(02)00944-3; Otsuka T, 2008, J NEUROSCI, V28, P11186, DOI 10.1523/JNEUROSCI.1921-08.2008; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Phillips C.G., 1977, MONOGR PHYSL SOC, V34; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Reiner A, 2003, J COMP NEUROL, V457, P420, DOI 10.1002/cne.10541; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shepherd GMG, 2009, FRONT NEUROSCI-SWITZ, V3, P337, DOI 10.3389/neuro.01.030.2009; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stepanyants A, 2008, CEREB CORTEX, V18, P13, DOI 10.1093/cercor/bhm027; Stevens CF, 1998, CURR BIOL, V8, pR708, DOI 10.1016/S0960-9822(98)70454-3; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408; Wood L, 2009, J NEUROSCI, V29, P12440, DOI 10.1523/JNEUROSCI.3321-09.2009; Yu JN, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.006.2008; Zarrinpar A, 2006, J NEUROPHYSIOL, V95, P1751, DOI 10.1152/jn.00974.2005	50	180	182	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					739	U116		10.1038/nn.2538	http://dx.doi.org/10.1038/nn.2538			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20436481	Green Accepted			2022-12-17	WOS:000278003300019
J	Morfini, GA; You, YM; Pollema, SL; Kaminska, A; Liu, K; Yoshioka, K; Bjorkblom, B; Coffey, ET; Bagnato, C; Han, D; Huang, CF; Banker, G; Pigino, G; Brady, ST				Morfini, Gerardo A.; You, Yi-Mei; Pollema, Sarah L.; Kaminska, Agnieszka; Liu, Katherine; Yoshioka, Katsuji; Bjorkblom, Benny; Coffey, Eleanor T.; Bagnato, Carolina; Han, David; Huang, Chun-Fang; Banker, Gary; Pigino, Gustavo; Brady, Scott T.			Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin	NATURE NEUROSCIENCE			English	Article							NUCLEAR-LOCALIZATION; ANDROGEN RECEPTOR; STRIATAL NEURONS; LIGHT-CHAIN; IN-VIVO; DISEASE; PROTEINS; KINASE; STRESS; TRAFFICKING	Selected vulnerability of neurons in Huntington's disease suggests that alterations occur in a cellular process that is particularly critical for neuronal function. Supporting this idea, pathogenic Htt (polyQ-Htt) inhibits fast axonal transport (FAT) in various cellular and animal models of Huntington's disease (mouse and squid), but the molecular basis of this effect remains unknown. We found that polyQ-Htt inhibited FAT through a mechanism involving activation of axonal cJun N-terminal kinase (JNK). Accordingly, we observed increased activation of JNK in vivo in cellular and mouse models of Huntington's disease. Additional experiments indicated that the effects of polyQ-Htt on FAT were mediated by neuron-specific JNK3 and not by ubiquitously expressed JNK1, providing a molecular basis for neuron-specific pathology in Huntington's disease. Mass spectrometry identified a residue in the kinesin-1 motor domain that was phosphorylated by JNK3 and this modification reduced kinesin-1 binding to microtubules. These data identify JNK3 as a critical mediator of polyQ-Htt toxicity and provide a molecular basis for polyQ-Htt-induced inhibition of FAT.	[Morfini, Gerardo A.; You, Yi-Mei; Pollema, Sarah L.; Kaminska, Agnieszka; Pigino, Gustavo; Brady, Scott T.] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60607 USA; [Morfini, Gerardo A.; Pollema, Sarah L.; Liu, Katherine; Pigino, Gustavo; Brady, Scott T.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Yoshioka, Katsuji] Kanazawa Univ, Canc Res Inst, Div Mol Cell Signaling, Kanazawa, Ishikawa 920, Japan; [Bjorkblom, Benny; Coffey, Eleanor T.] Abo Akad & Turku Univ, Turku Ctr Biotechnol, Turku, Finland; [Bagnato, Carolina; Han, David] Univ Connecticut, Ctr Vasc Biol, Farmington, CT USA; [Huang, Chun-Fang; Banker, Gary] Oregon Hlth & Sci Univ, Jungers Ctr Neurosci Res, Portland, OR 97201 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Marine Biological Laboratory - Woods Hole; Kanazawa University; University of Turku; University of Connecticut; Oregon Health & Science University	Morfini, GA (corresponding author), Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60607 USA.	gmorfini@uic.edu; stbrady@uic.edu	Pigino, Gustavo/L-7002-2019; Liu, Katherine/GQA-3751-2022	Coffey, Eleanor/0000-0002-9717-5610	Marine Biological Laboratory; Huntington's Disease Society of America; US National Institutes of Health [MH066179, NS23868, NS23320, NS41170]; Amyotropic Lateral Sclerosis Association; Muscular Dystrophy Association; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023868, R01NS023320, R01NS041170, R56NS023868] Funding Source: NIH RePORTER	Marine Biological Laboratory; Huntington's Disease Society of America; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amyotropic Lateral Sclerosis Association; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank M. MacDonald and M. DiFiglia for knock- in mice and huntingtin constructs, respectively, and B. Wang for excellent technical assistance. This work was supported by a 2007/2008 Marine Biological Laboratory summer fellowship to G. A. M., an Huntington's Disease Society of America grant to G. A. M., US National Institutes of Health grants MH066179 to G. B., and Amyotropic Lateral Sclerosis Association, Muscular Dystrophy Association and US National Institutes of Health (NS23868, NS23320, NS41170) grants to S. T. B.	Apostol BL, 2006, HUM MOL GENET, V15, P273, DOI 10.1093/hmg/ddi443; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Bjorkblom B, 2008, J BIOL CHEM, V283, P19704, DOI 10.1074/jbc.M707744200; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; Brill LB, 2000, METHODS, V22, P307, DOI 10.1006/meth.2000.1083; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Coffey ET, 2000, J NEUROSCI, V20, P7602; Colin E, 2005, EUR J NEUROSCI, V21, P1478, DOI 10.1111/j.1460-9568.2005.03985.x; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; DeBoer SR, 2008, BIOCHEMISTRY-US, V47, P4535, DOI 10.1021/bi702445j; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Donelan MJ, 2002, J BIOL CHEM, V277, P24232, DOI 10.1074/jbc.M203345200; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Garcia M, 2004, NEUROSCIENCE, V127, P859, DOI 10.1016/j.neuroscience.2004.05.054; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Ito M, 2000, GENE, V255, P229, DOI 10.1016/S0378-1119(00)00335-8; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Kozikowski AP, 2007, J MED CHEM, V50, P3054, DOI 10.1021/jm070178x; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Liu YF, 1998, J BIOL CHEM, V273, P28873, DOI 10.1074/jbc.273.44.28873; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Merienne K, 2003, J BIOL CHEM, V278, P16957, DOI 10.1074/jbc.M212049200; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2005, TRENDS MOL MED, V11, P64, DOI 10.1016/j.molmed.2004.12.002; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Nuhse TS, 2003, MOL CELL PROTEOMICS, V2, P1234, DOI 10.1074/mcp.T300006-MCP200; Okun MS, 2003, NEUROLOGIST, V9, P175, DOI 10.1097/01.nrl.0000080952.78533.1f; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pigino G, 2003, J NEUROSCI, V23, P4499; Qin ZH, 2004, J NEUROSCI, V24, P269, DOI 10.1523/JNEUROSCI.1409-03.2004; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Sack S, 1997, BIOCHEMISTRY-US, V36, P16155, DOI 10.1021/bi9722498; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Thomas GM, 2008, EMBO J, V27, P361, DOI 10.1038/sj.emboj.7601969; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899	50	180	187	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2009	12	7					864	U74		10.1038/nn.2346	http://dx.doi.org/10.1038/nn.2346			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	462OA	19525941	Green Accepted, Green Submitted			2022-12-17	WOS:000267362900013
J	Law, CT; Gold, JI				Law, Chi-Tat; Gold, Joshua I.			Reinforcement learning can account for associative and perceptual learning on a visual-decision task	NATURE NEUROSCIENCE			English	Article							PARIETAL CORTEX; AREA MT; PSYCHOPHYSICAL PERFORMANCE; MOTION DISCRIMINATION; NEURAL BASIS; MACAQUE MT; NEURONS; RESPONSES; SIGNALS; REWARD	We recently showed that improved perceptual performance on a visual motion direction-discrimination task corresponds to changes in how an unmodified sensory representation in the brain is interpreted to form a decision that guides behavior. Here we found that these changes can be accounted for using a reinforcement-learning rule to shape functional connectivity between the sensory and decision neurons. We modeled performance on the basis of the readout of simulated responses of direction-selective sensory neurons in the middle temporal area (MT) of monkey cortex. A reward prediction error guided changes in connections between these sensory neurons and the decision process, first establishing the association between motion direction and response direction, and then gradually improving perceptual sensitivity by selectively strengthening the connections from the most sensitive neurons in the sensory population. The results suggest a common, feedback-driven mechanism for some forms of associative and perceptual learning.	[Law, Chi-Tat; Gold, Joshua I.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Gold, JI (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	jigold@mail.med.upenn.edu			Sloan Foundation; McKnight Foundation; Burroughs-Wellcome Fund; US National Institutes of Health [R01-EY015260, T32-EY007035]; NATIONAL EYE INSTITUTE [R01EY015260, T32EY007035] Funding Source: NIH RePORTER	Sloan Foundation(Alfred P. Sloan Foundation); McKnight Foundation; Burroughs-Wellcome Fund(Burroughs Wellcome Fund); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank L. Ding, M. Nassar, B. Heasley, R. Kalwani, C.-L. Teng, S. Bennur and M. Todd for helpful comments on this manuscript and J. Zweigle for expert technical assistance. This work was supported by the Sloan Foundation, the McKnight Foundation, the Burroughs-Wellcome Fund, and US National Institutes of Health grants R01-EY015260 and T32-EY007035.	Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BARTO AG, 1985, IEEE T SYST MAN CYB, V15, P360, DOI 10.1109/TSMC.1985.6313371; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Connolly PM, 2009, J NEUROSCI, V29, P2136, DOI 10.1523/JNEUROSCI.3962-08.2009; Dayan P, 2008, COGN AFFECT BEHAV NE, V8, P429, DOI 10.3758/CABN.8.4.429; Dosher BA, 1999, VISION RES, V39, P3197, DOI 10.1016/S0042-6989(99)00059-0; Fahle M, 2005, CURR OPIN NEUROBIOL, V15, P154, DOI 10.1016/j.conb.2005.03.010; GIBSON EJ, 1963, ANNU REV PSYCHOL, V14, P29, DOI 10.1146/annurev.ps.14.020163.000333; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Gold JI, 2003, J NEUROSCI, V23, P632, DOI 10.1523/JNEUROSCI.23-02-00632.2003; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Hol K, 2001, VISION RES, V41, P685, DOI 10.1016/S0042-6989(00)00314-X; Jazayeri M, 2007, NATURE, V446, P912, DOI 10.1038/nature05739; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Loewenstein Y, 2006, P NATL ACAD SCI USA, V103, P15224, DOI 10.1073/pnas.0505220103; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Mukai I, 2007, J NEUROSCI, V27, P11401, DOI 10.1523/JNEUROSCI.3002-07.2007; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Redgrave P, 2008, BRAIN RES REV, V58, P322, DOI 10.1016/j.brainresrev.2007.10.007; Roitman JD, 2002, J NEUROSCI, V22, P9475; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Shadlen MN, 1996, J NEUROSCI, V16, P1486; SHAMIR M, 2002, ADV NEURAL INFORM PR; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; SPIEGELHALTER DJ, 1990, NETWORKS, V20, P579, DOI 10.1002/net.3230200507; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; van Veen V, 2006, CLIN EEG NEUROSCI, V37, P330, DOI 10.1177/155005940603700411; WILLIAMS RJ, 1992, MACH LEARN, V8, P229, DOI 10.1007/BF00992696; Yoon H., 1998, P 11 INT C NEUR INF, V11, P167; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	50	180	182	4	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2009	12	5					655	663		10.1038/nn.2304	http://dx.doi.org/10.1038/nn.2304			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	438SJ	19377473	Green Accepted			2022-12-17	WOS:000265575400023
J	Lin, WS; Popko, B				Lin, Wensheng; Popko, Brian			Endoplasmic reticulum stress in disorders of myelinating cells	NATURE NEUROSCIENCE			English	Review							UNFOLDED PROTEIN RESPONSE; CENTRAL-NERVOUS-SYSTEM; PELIZAEUS-MERZBACHER-DISEASE; MULTIPLE-SCLEROSIS; ER-STRESS; PROTEOLIPID PROTEIN; INTERFERON-GAMMA; OLIGODENDROCYTE APOPTOSIS; CHILDHOOD ATAXIA; TRANSGENIC MICE	Myelinating cells, oligodendrocytes in the CNS and Schwann cells in the peripheral nervous system produce an enormous amount of plasma membrane during the myelination process, making them particularly susceptible to disruptions of the secretory pathway. Endoplasmic reticulum stress, initiated by the accumulation of unfolded or misfolded proteins, activates the unfolded protein response, which adapts cells to the stress. If this adaptive response is insufficient, the unfolded protein response activates an apoptotic program to eliminate the affected cells. Recent observations suggest that endoplasmic reticulum stress in myelinating cells is important in the pathogenesis of various disorders of myelin, including Charcot-Marie-Tooth disease, Pelizaeus- Merzbacher disease and Vanishing White Matter Disease, as well as in the most common myelin disorder, multiple sclerosis. A better understanding of endoplasmic reticulum stress in myelinating cells has laid the groundwork for the design of new therapeutic strategies for promoting myelinating cell survival in these disorders.	[Lin, Wensheng] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA; [Popko, Brian] Univ Chicago, Dept Neurol, Jack Miller Ctr Peripheral Neuropathy, Chicago, IL 60637 USA	University of South Alabama; University of Chicago	Lin, WS (corresponding author), Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA.	wlin@usoutha.edu; bpopko@uchicago.edu	Lin, Wensheng/J-2661-2019	Lin, Wensheng/0000-0003-4931-7642; Popko, Brian/0000-0001-9948-2553	National Multiple Sclerosis Society [TA 3026-A-1]; US National Institutes of Health [NS34939, 027336]; Myelin Repair Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034939, R01NS027336, R29NS027336] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Myelin Repair Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Douglas for critical comments on the manuscript. W. L. is supported by a National Multiple Sclerosis Society Career Transition Fellowship grant (TA 3026-A-1). B. P. is supported by grants from the US National Institutes of Health (NS34939 and 027336) and the Myelin Repair Foundation.	Anitei M, 2006, CURR BIOL, V16, pR418, DOI 10.1016/j.cub.2006.05.010; Bauer J, 2002, J NEUROPATH EXP NEUR, V61, P12, DOI 10.1093/jnen/61.1.12; Berger P, 2006, GLIA, V54, P243, DOI 10.1002/glia.20386; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Bruck W, 2003, J NEUROL SCI, V206, P181, DOI 10.1016/s0022-510x(02)00191-0; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chakrabarty A, 2005, J NEUROSCI METH, V144, P227, DOI 10.1016/j.jneumeth.2004.11.010; Chakrabarty A, 2004, J NEUROSCI RES, V76, P822, DOI 10.1002/jnr.20125; Colby J, 2000, NEUROBIOL DIS, V7, P561, DOI 10.1006/nbdi.2000.0323; Corbin JG, 1996, MOL CELL NEUROSCI, V7, P354, DOI 10.1006/mcne.1996.0026; Cwiklinska H, 2003, INT IMMUNOL, V15, P241, DOI 10.1093/intimm/dxg022; Dhaunchak AS, 2007, P NATL ACAD SCI USA, V104, P17813, DOI 10.1073/pnas.0704975104; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; Faitova J, 2006, CELL MOL BIOL LETT, V11, P488, DOI 10.2478/s11658-006-0040-4; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Garbern JY, 2007, CELL MOL LIFE SCI, V64, P50, DOI 10.1007/s00018-006-6182-8; Gow A, 1998, J CELL BIOL, V140, P925, DOI 10.1083/jcb.140.4.925; Gow A, 1996, NAT GENET, V13, P422, DOI 10.1038/ng0896-422; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Imitola J, 2005, PHARMACOL THERAPEUT, V106, P163, DOI 10.1016/j.pharmthera.2004.11.007; Ji C, 2008, J GASTROEN HEPATOL, V23, pS16, DOI 10.1111/j.1440-1746.2007.05276.x; Kantor L, 2005, HUM GENET, V118, P99, DOI 10.1007/s00439-005-0024-x; Kantor L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003783; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Khajavi M, 2007, AM J HUM GENET, V81, P438, DOI 10.1086/519926; KOEPPEN AH, 1988, J NEUROL SCI, V84, P315, DOI 10.1016/0022-510X(88)90135-9; LaFerla FM, 2000, J MOL NEUROSCI, V15, P45, DOI 10.1385/JMN:15:1:45; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Lees JR, 2007, J CLIN INVEST, V117, P297, DOI 10.1172/JCI31254; Lin WS, 2008, AM J PATHOL, V173, P1508, DOI 10.2353/ajpath.2008.080449; Lin WS, 2007, J CLIN INVEST, V117, P448, DOI 10.1172/JCI29571; Lin WS, 2006, BRAIN, V129, P1306, DOI 10.1093/brain/awl044; Lin WS, 2005, J CELL BIOL, V169, P603, DOI 10.1083/jcb.200502086; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lupski JR, 2005, PERIPHERAL NEUROPATH, P1659, DOI DOI 10.1016/B978-0-7216-9491-7.50073-9; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; McLaughlin M, 2007, NEUROCHEM RES, V32, P167, DOI 10.1007/s11064-006-9122-y; Mhaille AN, 2008, J NEUROPATH EXP NEUR, V67, P200, DOI 10.1097/NEN.0b013e318165b239; Mohammad-Qureshi SS, 2008, BIOCHEM SOC T, V36, P658, DOI 10.1042/BST0360658; Morell Pierre, 1999, P69; Mycko MP, 2004, CLIN NEUROL NEUROSUR, V106, P223, DOI 10.1016/j.clineuro.2004.02.019; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; PANITCH HS, 1987, NEUROLOGY, V37, P1097, DOI 10.1212/WNL.37.7.1097; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Renno T, 1998, MOL CELL NEUROSCI, V12, P376, DOI 10.1006/mcne.1998.0725; Ron D, 2000, COLD SPRING HARBOR M, V39, P547; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; ROUSSEL G, 1987, J NEUROCYTOL, V16, P195, DOI 10.1007/BF01795303; Rutkowski DT, 2003, DEV CELL, V4, P442, DOI 10.1016/S1534-5807(03)00100-X; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schiffmann R, 2006, MOL GENET METAB, V88, P7, DOI 10.1016/j.ymgme.2005.10.019; Schroder M, 2006, CURR MOL MED, V6, P5, DOI 10.2174/156652406775574569; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Sereda MW, 2006, NEUROMOL MED, V8, P205, DOI 10.1385/NMM:8:1:205; Sharma R, 2007, J NEUROCHEM, V102, P1703, DOI 10.1111/j.1471-4159.2007.04646.x; Sharma R, 2007, J NEUROCHEM, V101, P889, DOI 10.1111/j.1471-4159.2007.04541.x; Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003; SKRE H, 1974, CLIN GENET, V6, P98; Snipes GJ, 1999, ANN NY ACAD SCI, V883, P143, DOI 10.1111/j.1749-6632.1999.tb08577.x; Southwood C, 2001, MICROSC RES TECHNIQ, V52, P700, DOI 10.1002/jemt.1054; Southwood CM, 2002, NEURON, V36, P585, DOI 10.1016/S0896-6273(02)01045-0; Su QZ, 2007, EMBO REP, V8, P265, DOI 10.1038/sj.embor.7400891; Swanton E, 2005, P NATL ACAD SCI USA, V102, P4342, DOI 10.1073/pnas.0407287102; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Takano K, 2007, AM J PHYSIOL-CELL PH, V293, pC1884, DOI 10.1152/ajpcell.00305.2007; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; van der Knapp MS, 2006, LANCET NEUROL, V5, P413, DOI 10.1016/S1474-4422(06)70440-9; van der Voorn JP, 2005, J NEUROPATH EXP NEUR, V64, P770, DOI 10.1097/01.jnen.0000178446.41595.3a; Van Haren K, 2004, J NEUROPATH EXP NEUR, V63, P618, DOI 10.1093/jnen/63.6.618; van Kollenburg B, 2006, J NEUROPATH EXP NEUR, V65, P707, DOI 10.1097/01.jnen.0000228201.27539.50; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Wong K, 2000, ACTA NEUROPATHOL, V100, P635, DOI 10.1007/s004010000234; Wrabetz L, 2006, J NEUROSCI, V26, P2358, DOI 10.1523/JNEUROSCI.3819-05.2006; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	90	180	190	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2009	12	4					379	385		10.1038/nn.2273	http://dx.doi.org/10.1038/nn.2273			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	424JN	19287390	Green Accepted			2022-12-17	WOS:000264563100009
J	Makara, JK; Mor, M; Fegley, D; Szabo, SI; Kathuria, S; Astarita, G; Duranti, A; Tontini, A; Tarzia, G; Rivara, S; Freund, TF; Piomelli, D				Makara, JK; Mor, M; Fegley, D; Szabo, SI; Kathuria, S; Astarita, G; Duranti, A; Tontini, A; Tarzia, G; Rivara, S; Freund, TF; Piomelli, D			Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus	NATURE NEUROSCIENCE			English	Article							ENDOGENOUS CANNABINOIDS; SYNAPSES	The functions of 2-arachidonoylglycerol (2-AG), the most abundant endocannabinoid found in the brain, remain largely unknown. Here we show that two previously unknown inhibitors of monoacylglycerol lipase, a presynaptic enzyme that hydrolyzes 2-AG, increase 2-AG levels and enhance retrograde signaling from pyramidal neurons to GABAergic terminals in the hippocampus. These results establish a role for 2-AG in synaptic plasticity and point to monoacylglycerol lipase as a possible drug target.	Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Univ Urbino, Inst Med Chem, I-61029 Urbino, Italy; Hungarian Acad Sci, Inst Expt Med, H-1083 Budapest, Hungary; Univ Parma, Dept Pharmaceut, I-43100 Parma, Italy; Univ Calif Irvine, Ctr Drug Discovery, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of Urbino; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Parma; University of California System; University of California Irvine	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.	freund@koki.hu; piomelli@uci.edu	Rivara, Silvia/K-8104-2017; Astarita, Giuseppe/AAD-1239-2019; Mor, Marco/D-2394-2009; Astarita, Giuseppe/N-7346-2014	Rivara, Silvia/0000-0001-8058-4250; Mor, Marco/0000-0003-0199-1849; Astarita, Giuseppe/0000-0001-6700-301X				Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; HODSON HF, 2000, Patent No. [0040247, 040247]; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; Huang CC, 2002, MOL PHARMACOL, V61, P578, DOI 10.1124/mol.61.3.578; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; KRANTZ A, 1990, J MED CHEM, V33, P464, DOI 10.1021/jm00164a002; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Porter AC, 2002, J PHARMACOL EXP THER, V301, P1020, DOI 10.1124/jpet.301.3.1020; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	14	180	189	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1139	1141		10.1038/nn1521	http://dx.doi.org/10.1038/nn1521			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116451	Green Submitted			2022-12-17	WOS:000231483800010
J	Svoboda, K; Helmchen, F; Denk, W; Tank, DW				Svoboda, K; Helmchen, F; Denk, W; Tank, DW			Spread of dendritic excitation in layer 2/3 pyramidal neurons in rat barrel cortex in vivo	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL-NEURONS; ACTION-POTENTIALS; NUCLEUS BASALIS; SPIKE BACKPROPAGATION; NEOCORTICAL NEURONS; EXCITABLE DENDRITES; APICAL DENDRITES; FIRING PATTERNS; CELL DENDRITES; AREA CA1	In layer 2/3 pyramidal neurons of barrel cortex in vivo, calcium ion concentration ([Ca2+]) transients in apical dendrites evoked by sodium action potentials are limited to regions close to the soma. To study the mechanisms underlying this restricted pattern of calcium influx, we combined two-photon imaging of dendritic [Ca2+] dynamics with dendritic membrane potential measurements. We found that sodium action potentials attenuated and broadened rapidly with distance from the soma. However, dendrites of layer 2/3 cells were electrically excitable, and direct current injections could evoke large [Ca2+] transients. The restricted pattern of dendritic [Ca2+] transients is therefore due to a failure of sodium action-potential propagation into dendrites. Also, stimulating subcortical activating systems by tail pinch can enhance dendritic [Ca2+] influx induced by a sensory stimulus by increasing cellular excitability, consistent with the importance of these systems in plasticity and learning.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Lucent Technol, Bell Labs, Biol Computat Res Dept, Murray Hill, NJ 07974 USA	Cold Spring Harbor Laboratory; Alcatel-Lucent; Lucent Technologies; AT&T	Svoboda, K (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.org	denk, winfried/I-6627-2012; Helmchen, Fritjof/A-6255-2008	Helmchen, Fritjof/0000-0002-8867-9569				ANDREASEN M, 1993, J NEUROPHYSIOL, V69, P1966, DOI 10.1152/jn.1993.69.6.1966; ANDREASEN M, 1995, J PHYSIOL-LONDON, V483, P421, DOI 10.1113/jphysiol.1995.sp020595; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; CALLAWAY JC, 1995, J NEUROPHYSIOL, V74, P1395, DOI 10.1152/jn.1995.74.4.1395; Cauller LJ, 1992, SINGLE NEURON COMPUT, P199; Colbert CM, 1997, J NEUROSCI, V17, P6512; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Contreras D, 1997, NEUROSCIENCE, V76, P11; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Crevier DW, 1998, J NEUROPHYSIOL, V79, P1869, DOI 10.1152/jn.1998.79.4.1869; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; DETARI L, 1987, BRAIN RES, V437, P1, DOI 10.1016/0006-8993(87)91521-6; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Holscher C, 1997, J NEUROSCI, V17, P6470; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Juliano S. L., 1995, BARREL CORTEX RODENT, P411; Jung HY, 1997, J NEUROSCI, V17, P6639; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; KIM HG, 1995, J NEUROPHYSIOL, V74, P1810, DOI 10.1152/jn.1995.74.4.1810; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; METHERATE R, 1992, J NEUROSCI, V12, P4701; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; MULLER W, 1991, NEURON, V6, P901, DOI 10.1016/0896-6273(91)90230-W; MULLIN WJ, 1975, J PHYSIOL-LONDON, V244, P741, DOI 10.1113/jphysiol.1975.sp010823; Pare D, 1998, NEUROSCIENCE, V84, P377, DOI 10.1016/S0306-4522(97)00530-7; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Rapp M, 1996, P NATL ACAD SCI USA, V93, P11985, DOI 10.1073/pnas.93.21.11985; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Sloan TB, 1998, J CLIN NEUROPHYSIOL, V15, P217, DOI 10.1097/00004691-199805000-00005; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Tsubokawa H, 1997, J NEUROSCI, V17, P5782; TURNER RW, 1991, J NEUROSCI, V11, P2270; White E.L., 1989, CORTICAL CIRCUITS, DOI [10.1007/978-1-4684-8721-3, DOI 10.1007/978-1-4684-8721-3]; WINKLER J, 1995, NATURE, V375, P484, DOI 10.1038/375484a0; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	50	180	181	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					65	73		10.1038/4569	http://dx.doi.org/10.1038/4569			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195182				2022-12-17	WOS:000078409300015
J	King, M; Hernandez-Castillo, CR; Poldrack, RA; Ivry, RB; Diedrichsen, J				King, Maedbh; Hernandez-Castillo, Carlos R.; Poldrack, Russell A.; Ivry, Richard B.; Diedrichsen, Jorn			Functional boundaries in the human cerebellum revealed by a multi-domain task battery	NATURE NEUROSCIENCE			English	Article							INDIVIDUAL-DIFFERENCES; ORGANIZATION; MOTOR; CORTEX; TOPOGRAPHY; ACTIVATION	There is compelling evidence that the human cerebellum is engaged in a wide array of motor and cognitive tasks. A fundamental question centers on whether the cerebellum is organized into distinct functional subregions. To address this question, we employed a rich task battery designed to tap into a broad range of cognitive processes. During four functional MRI sessions, participants performed a battery of 26 diverse tasks comprising 47 unique conditions. Using the data from this multi-domain task battery, we derived a comprehensive functional parcellation of the cerebellar cortex and evaluated it by predicting functional boundaries in a novel set of tasks. The new parcellation successfully identified distinct functional subregions, providing significant improvements over existing parcellations derived from task-free data. Lobular boundaries, commonly used to summarize functional data, did not coincide with functional subdivisions. The new parcellation provides a functional atlas to guide future neuroimaging studies.	[King, Maedbh; Ivry, Richard B.] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA; [King, Maedbh; Hernandez-Castillo, Carlos R.; Diedrichsen, Jorn] Western Univ, Brain & Mind Inst, London, ON, Canada; [Poldrack, Russell A.] Stanford Univ, Dept Psychol, Stanford, CA USA; [Diedrichsen, Jorn] Western Univ, Dept Stat & Actuarial Sci, London, ON, Canada; [Diedrichsen, Jorn] Western Univ, Dept Comp Sci, London, ON, Canada	University of California System; University of California Berkeley; Western University (University of Western Ontario); Stanford University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Diedrichsen, J (corresponding author), Western Univ, Brain & Mind Inst, London, ON, Canada.; Diedrichsen, J (corresponding author), Western Univ, Dept Stat & Actuarial Sci, London, ON, Canada.; Diedrichsen, J (corresponding author), Western Univ, Dept Comp Sci, London, ON, Canada.	jdiedric@uwo.ca	Diedrichsen, Jörn/AAQ-2242-2020	Diedrichsen, Jörn/0000-0003-0264-8532; Poldrack, Russell/0000-0001-6755-0259	James S. McDonnell Foundation; Canadian Institutes of Health Research [PJT 159520]; Brain Canada; Canada First Research Excellence Fund (BrainsCAN); National Science Foundation [OAC-1649658]; National Institute of Health [NS092079, NS105839]; 16 National Institutes of Health (NIH) institutes and centers [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University	James S. McDonnell Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Brain Canada; Canada First Research Excellence Fund (BrainsCAN); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 16 National Institutes of Health (NIH) institutes and centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Center for Systems Neuroscience at Washington University	This work was supported by the James S. McDonnell Foundation (Scholar award to J.D.), the Canadian Institutes of Health Research (no. PJT 159520 to J.D.), a Platform Support Grant from Brain Canada and the Canada First Research Excellence Fund (BrainsCAN to Western University), the National Science Foundation (no. OAC-1649658 to R.A.P.) and the National Institute of Health (nos. NS092079 and NS105839 to R.B.I.). Data from the Human Connectome Project were analyzed by the Washington University-University of Minnesota Consortium (principal investigators: D. Van Essen and K. Ugurbil; no. 1U54MH091657) funded by the 16 National Institutes of Health (NIH) institutes and centers that support the NIH Blueprint for Neuroscience Research and by the McDonnell Center for Systems Neuroscience at Washington University. Thanks to J. Walters for assistance in task annotation.	Airey DC, 2001, J NEUROSCI, V21, P5099, DOI 10.1523/JNEUROSCI.21-14-05099.2001; Allen G, 1997, SCIENCE, V275, P1940, DOI 10.1126/science.275.5308.1940; Andreasen NC, 2008, BIOL PSYCHIAT, V64, P81, DOI 10.1016/j.biopsych.2008.01.003; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Ashburner J., 2019, SPM12 MANUAL; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Diedrichsen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133402; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056; Diedrichsen J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005508; Ding C, 2010, IEEE T PATTERN ANAL, V32, P45, DOI 10.1109/TPAMI.2008.277; Guell X, 2018, ELIFE, V7, DOI 10.7554/eLife.36652; Hawkes R, 1997, ACTA ANAT, V158, P205; HORAK FB, 1994, J NEUROPHYSIOL, V72, P479, DOI 10.1152/jn.1994.72.2.479; Ivry R B, 1992, Curr Opin Neurobiol, V2, P212, DOI 10.1016/0959-4388(92)90015-D; Ji JL, 2019, NEUROIMAGE, V185, P35, DOI 10.1016/j.neuroimage.2018.10.006; Kelly RM, 2003, J NEUROSCI, V23, P8432; LARSELL O, 1947, J COMP NEUROL, V87, P85, DOI 10.1002/cne.900870203; Lauritzen M, 2001, J CEREBR BLOOD F MET, V21, P1367, DOI 10.1097/00004647-200112000-00001; LECLERC N, 1990, BRAIN RES, V506, P70, DOI 10.1016/0006-8993(90)91200-Z; Marek S, 2018, NEURON, V100, P977, DOI 10.1016/j.neuron.2018.10.010; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; Moberget T, 2018, MOL PSYCHIATR, V23, P1512, DOI 10.1038/mp.2017.106; Nitschke MF, 2004, HUM BRAIN MAPP, V22, P155, DOI 10.1002/hbm.20025; OHTSUKA K, 1995, J NEUROPHYSIOL, V74, P1828, DOI 10.1152/jn.1995.74.5.1828; Oosterhof NN, 2011, NEUROIMAGE, V56, P593, DOI 10.1016/j.neuroimage.2010.04.270; Poldrack Russell A, 2011, Front Neuroinform, V5, P17, DOI 10.3389/fninf.2011.00017; Sereno M. I., 2014, RECONSTRUCTION UNFOL; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Sugihara I, 2004, J NEUROSCI, V24, P8771, DOI 10.1523/JNEUROSCI.1961-04.2004; Tavor I, 2016, SCIENCE, V352, P216, DOI 10.1126/science.aad8127; Van Essen DC, 2012, NEUROIMAGE, V62, P757, DOI 10.1016/j.neuroimage.2011.10.077; Nguyen VT, 2017, CEREB CORTEX, V27, P5652, DOI 10.1093/cercor/bhw334; Walther A, 2016, NEUROIMAGE, V137, P188, DOI 10.1016/j.neuroimage.2015.12.012; Wiestler T, 2011, J NEUROPHYSIOL, V105, P3042, DOI 10.1152/jn.00106.2011	39	179	182	7	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2019	22	8					1371	+		10.1038/s41593-019-0436-x	http://dx.doi.org/10.1038/s41593-019-0436-x			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IL1MZ	31285616	Green Accepted, Green Submitted			2022-12-17	WOS:000477065500019
J	Owen, SF; Liu, MH; Kreitzer, AC				Owen, Scott F.; Liu, Max H.; Kreitzer, Anatol C.			Thermal constraints on in vivo optogenetic manipulations	NATURE NEUROSCIENCE			English	Article							TEMPERATURE; INTERNEURONS; DYNAMICS	A key assumption of optogenetics is that light only affects opsin-expressing neurons. However, illumination invariably heats tissue, and many physiological processes are temperature-sensitive. Commonly used illumination protocols increased the temperature by 0.2-2 degrees C and suppressed spiking in multiple brain regions. In the striatum, light delivery activated an inwardly rectifying potassium conductance and biased rotational behavior. Thus, careful consideration of light-delivery parameters is required, as even modest introcranial heating can confound interpretation of optogenetic experiments.	[Owen, Scott F.; Kreitzer, Anatol C.] Gladstone Inst, San Francisco, CA 94158 USA; [Liu, Max H.] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Liu, Max H.; Kreitzer, Anatol C.] UCSF, Neurosci Grad Program, San Francisco, CA 94143 USA; [Kreitzer, Anatol C.] UCSF, Dept Neurol, San Francisco, CA 94143 USA; [Kreitzer, Anatol C.] UCSF, UCSF Weill Inst Neurosci, San Francisco, CA 94143 USA; [Kreitzer, Anatol C.] UCSF, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kreitzer, AC (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.; Kreitzer, AC (corresponding author), UCSF, Neurosci Grad Program, San Francisco, CA 94143 USA.; Kreitzer, AC (corresponding author), UCSF, Dept Neurol, San Francisco, CA 94143 USA.; Kreitzer, AC (corresponding author), UCSF, UCSF Weill Inst Neurosci, San Francisco, CA 94143 USA.; Kreitzer, AC (corresponding author), UCSF, Dept Physiol, San Francisco, CA 94143 USA.	anatol.kreitzer@gladstone.ucsf.edu		Liu, Max/0000-0002-4614-8807; Owen, Scott/0000-0001-6294-7513	NIH [R01 NS078435, RF1 AG047655]; NARSAD Young Investigator Award [F32 NS083369, K99 MH110597, RR018928]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064984] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Young Investigator Award(NARSAD); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank B. Margolin for assistance with genotyping, histology, and microscopy, and members of A.C.K.'s laboratory for comments on the manuscript. This work was funded by NIH R01 NS078435 and RF1 AG047655 (to A.C.K.), a NARSAD Young Investigator Award (to S.F.O.), F32 NS083369 (to S.F.O.) and K99 MH110597 (to S.F.O.), and RR018928 (to the Gladstone Institutes).	Allen BD, 2015, LEARN MEMORY, V22, P232, DOI 10.1101/lm.038026.114; Arias-Gil Gonzalo, 2016, Neurophotonics, V3, P045007, DOI 10.1117/1.NPh.3.4.045007; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/NMETH.1808, 10.1038/nmeth.1808]; MOSER E, 1993, SCIENCE, V259, P1324, DOI 10.1126/science.8446900; Ouares KA, 2019, EUR J NEUROSCI, V49, P6, DOI 10.1111/ejn.14251; Owen SF, 2018, CELL, V172, P683, DOI 10.1016/j.cell.2018.01.005; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Pisanello F, 2017, NAT NEUROSCI, V20, P1180, DOI 10.1038/nn.4591; Podgorski K, 2016, J NEUROPHYSIOL, V116, P1012, DOI 10.1152/jn.00275.2016; Pruss H, 2005, MOL BRAIN RES, V139, P63, DOI 10.1016/j.molbrainres.2005.05.006; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Steude A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600061; Stujenske JM, 2015, CELL REP, V12, P525, DOI 10.1016/j.celrep.2015.06.036; Yang F, 2014, ELIFE, V3, DOI 10.7554/eLife.03255; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	21	179	179	7	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2019	22	7					1061	+		10.1038/s41593-019-0422-3	http://dx.doi.org/10.1038/s41593-019-0422-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IE8GO	31209378	Green Accepted, Green Submitted			2022-12-17	WOS:000472612100007
J	Rothschild, G; Eban, E; Frank, LM				Rothschild, Gideon; Eban, Elad; Frank, Loren M.			A cortical-hippocampal-cortical loop of information processing during memory consolidation	NATURE NEUROSCIENCE			English	Article							SHARP-WAVE-RIPPLE; SENSORY RESPONSES; ENTORHINAL CORTEX; SLOW OSCILLATIONS; SLEEP; REPLAY; REACTIVATION; PLASTICITY; SPINDLES; RAT	Hippocampal replay during sharp-wave ripple events (SWRs) is thought to drive memory consolidation in hippocampal and cortical circuits. Changes in neocortical activity can precede SWR events, but whether and how these changes influence the content of replay remains unknown. Here we show that during sleep there is a rapid cortical hippocampal cortical loop of information flow around the times of SWRs. We recorded neural activity in auditory cortex (AC) and hippocampus of rats as they learned a sound-guided task and during sleep. We found that patterned activation in AC precedes and predicts the subsequent content of hippocampal activity during SWRs, while hippocampal patterns during SWRs predict subsequent AC activity. Delivering sounds during sleep biased AC activity patterns, and sound-biased AC patterns predicted subsequent hippocampal activity. These findings suggest that activation of specific cortical representations during sleep influences the identity of the memories that are consolidated into long-term stores.	[Rothschild, Gideon; Frank, Loren M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Rothschild, Gideon; Frank, Loren M.] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA; [Eban, Elad] Google Inc, Mountain View, CA USA; [Frank, Loren M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Google Incorporated; Howard Hughes Medical Institute	Frank, LM (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.; Frank, LM (corresponding author), Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA.; Frank, LM (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	loren@phy.ucsf.edu		Frank, Loren/0000-0002-1752-5677	Howard Hughes Medical Institute, an NIH grant [R01 MH090188]; EMBO; ELSC; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105174, R01MH090188] Funding Source: NIH RePORTER	Howard Hughes Medical Institute, an NIH grant(Howard Hughes Medical Institute); EMBO(European Molecular Biology Organization (EMBO)); ELSC; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank L. Tian, K. Kay, J. Yu, E. Anderson, M. Sosa, A. Eban-Rothschild, M. Karlsson and C. Schreiner for discussion and suggestions, and L. Tian, I. Grossrubatscher and S. Harris for technical assistance. This work was supported by the Howard Hughes Medical Institute, an NIH grant (R01 MH090188) to L.M.F. and an EMBO long-term postdoctoral fellowship and an ELSC postdoctoral fellowship to G.R.	Bendor D, 2012, NAT NEUROSCI, V15, P1439, DOI 10.1038/nn.3203; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Clemens Z, 2007, BRAIN, V130, P2868, DOI 10.1093/brain/awm146; Cowansage KK, 2014, NEURON, V84, P432, DOI 10.1016/j.neuron.2014.09.022; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eschenko O, 2008, LEARN MEMORY, V15, P222, DOI 10.1101/lm.726008; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Furtak SC, 2007, HIPPOCAMPUS, V17, P709, DOI 10.1002/hipo.20314; Girardeau G, 2011, CURR OPIN NEUROBIOL, V21, P452, DOI 10.1016/j.conb.2011.02.005; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Inostroza M, 2013, ANNU REV NEUROSCI, V36, P79, DOI 10.1146/annurev-neuro-062012-170429; Insausti R, 1997, HIPPOCAMPUS, V7, P146, DOI 10.1002/(SICI)1098-1063(1997)7:2<146::AID-HIPO4>3.0.CO;2-L; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Issa EB, 2008, J NEUROSCI, V28, P14467, DOI 10.1523/JNEUROSCI.3086-08.2008; Jadhav SP, 2016, NEURON, V90, P113, DOI 10.1016/j.neuron.2016.02.010; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; Lesburgueres E, 2011, SCIENCE, V331, P924, DOI 10.1126/science.1196164; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Lisman J, 2001, NATURE, V411, P248, DOI 10.1038/35077185; Logothetis NK, 2012, NATURE, V491, P547, DOI 10.1038/nature11618; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Maingret N, 2016, NAT NEUROSCI, V19, P959, DOI 10.1038/nn.4304; Nelken I, 2014, BIOL CYBERN, V108, P655, DOI 10.1007/s00422-014-0585-7; Oliva A, 2016, NEURON, V91, P1342, DOI 10.1016/j.neuron.2016.08.008; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Rothschild G, 2015, ANNU REV NEUROSCI, V38, P247, DOI 10.1146/annurev-neuro-071013-014038; Rothschild G, 2013, J NEUROSCI, V33, P12851, DOI 10.1523/JNEUROSCI.4656-12.2013; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; Sadowski JHLP, 2016, CELL REP, V14, P1916, DOI 10.1016/j.celrep.2016.01.061; Schreiner T, 2015, CEREB CORTEX, V25, P4169, DOI 10.1093/cercor/bhu139; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Staresina BP, 2015, NAT NEUROSCI, V18, P1679, DOI 10.1038/nn.4119; SUZUKI SS, 1988, ELECTROEN CLIN NEURO, V70, P73, DOI 10.1016/0013-4694(88)90197-6; SWANSON LW, 1986, J NEUROSCI, V6, P3010; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	50	179	180	5	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2017	20	2					251	259		10.1038/nn.4457	http://dx.doi.org/10.1038/nn.4457			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ5PU	27941790	Green Accepted			2022-12-17	WOS:000393271000019
J	Kim, J; Pignatelli, M; Xu, SY; Itohara, S; Tonegawa, S				Kim, Joshua; Pignatelli, Michele; Xu, Sangyu; Itohara, Shigeyoshi; Tonegawa, Susumu			Antagonistic negative and positive neurons of the basolateral amygdala	NATURE NEUROSCIENCE			English	Article							CONDITIONED BEHAVIOR; SEEKING BEHAVIOR; REWARD-SEEKING; MESSENGER-RNA; RAT; FEAR; NUCLEUS; COMPLEX; INNATE; MEMORY	The basolateral amygdala (BLA) is a site of convergence of negative and positive stimuli and is critical for emotional behaviors and associations. However, the neural substrate for negative and positive behaviors and relationship between negative and positive representations in the basolateral amygdala are unknown. Here we identify two genetically distinct, spatially segregated populations of excitatory neurons in the mouse BLA that participate in valence-specific behaviors and are connected through mutual inhibition. These results identify a genetically defined neural circuit for the antagonistic control of emotional behaviors and memories.	[Kim, Joshua; Pignatelli, Michele; Xu, Sangyu; Tonegawa, Susumu] MIT, RIKEN MIT Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kim, Joshua; Pignatelli, Michele; Xu, Sangyu; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Itohara, Shigeyoshi; Tonegawa, Susumu] RIKEN, Brain Sci Inst, Saitama, Japan; [Tonegawa, Susumu] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Tonegawa, S (corresponding author), MIT, RIKEN MIT Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Tonegawa, S (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Tonegawa, S (corresponding author), RIKEN, Brain Sci Inst, Saitama, Japan.; Tonegawa, S (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	tonegawa@mit.edu	Itohara, Shigeyoshi/I-8769-2012	Itohara, Shigeyoshi/0000-0002-2410-9989; Xu, Sangyu/0000-0002-4927-9204; Pignatelli, Michele/0000-0002-4918-2066; Pignatelli, Michele/0000-0003-1380-5329	NIH Pre-Doctoral Training Grant [T32GM007287]; RIKEN Brain Science Institute; Howard Hughes Medical Institute; JPB Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	NIH Pre-Doctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RIKEN Brain Science Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); JPB Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge A. Wagatsuma and R.L. Redondo for help designing behavioral apparatuses, the MIT BioMicroCenter for support collecting the RNA array data, X. Liu for cloning the Fos-tTA plasmid, T.J. Ryan and D.S. Roy for comments on the manuscript, and all the members of the Tonegawa laboratory for their support. This work is supported in part by NIH Pre-Doctoral Training Grant T32GM007287 (to J.K.) and by the RIKEN Brain Science Institute, the Howard Hughes Medical Institute and the JPB Foundation (to S.T.).	Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04580; CADOR M, 1989, NEUROSCIENCE, V30, P77, DOI 10.1016/0306-4522(89)90354-0; Cai HJ, 2014, NAT NEUROSCI, V17, P1240, DOI 10.1038/nn.3767; CARLSEN J, 1988, BRAIN RES, V441, P377, DOI 10.1016/0006-8993(88)91418-7; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Cohn R, 2015, CELL, V163, P1742, DOI 10.1016/j.cell.2015.11.019; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; Duvarci S, 2007, J NEUROSCI, V27, P4482, DOI 10.1523/JNEUROSCI.0680-07.2007; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; GALLAGHER M, 1990, J NEUROSCI, V10, P1906; Gay L, 2013, GENE DEV, V27, P98, DOI 10.1101/gad.205278.112; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Gore F, 2015, CELL, V162, P134, DOI 10.1016/j.cell.2015.06.027; HALL E, 1972, Z ZELLFORSCH MIK ANA, V134, P439, DOI 10.1007/BF00307668; Han S, 2015, CELL, V162, P363, DOI 10.1016/j.cell.2015.05.057; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Herry C, 2014, NAT NEUROSCI, V17, P1644, DOI 10.1038/nn.3869; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Kantak KM, 2002, J NEUROSCI, V22, P1126, DOI 10.1523/JNEUROSCI.22-03-01126.2002; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; Knapska E, 2006, LEARN MEMORY, V13, P192, DOI 10.1101/lm.54706; Knapska E, 2007, PHYSIOL REV, V87, P1113, DOI 10.1152/physrev.00037.2006; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Mascagni F, 2007, NEUROSCIENCE, V144, P1015, DOI 10.1016/j.neuroscience.2006.10.044; MCDONALD AJ, 1984, J COMP NEUROL, V222, P589, DOI 10.1002/cne.902220410; McDonald AJ, 2002, J COMP NEUROL, V446, P199, DOI 10.1002/cne.10204; MCDONALD AJ, 1982, J COMP NEUROL, V212, P293, DOI 10.1002/cne.902120307; Namburi P, 2015, NATURE, V520, P675, DOI 10.1038/nature14366; Parkinson JA, 2000, EUR J NEUROSCI, V12, P405, DOI 10.1046/j.1460-9568.2000.00960.x; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Peng YQ, 2015, NATURE, V527, P512, DOI 10.1038/nature15763; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Redondo RL, 2014, NATURE, V513, P426, DOI 10.1038/nature13725; Root CM, 2014, NATURE, V515, P269, DOI 10.1038/nature13897; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; SAVANDER V, 1995, J COMP NEUROL, V361, P345, DOI 10.1002/cne.903610211; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Yang ZY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni149; Zirlinger M, 2001, P NATL ACAD SCI USA, V98, P5270, DOI 10.1073/pnas.091094698	44	179	181	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2016	19	12					1636	1646		10.1038/nn.4414	http://dx.doi.org/10.1038/nn.4414			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED7BY	27749826	Green Published, Green Accepted			2022-12-17	WOS:000389011900023
J	Jaramillo, S; Zador, AM				Jaramillo, Santiago; Zador, Anthony M.			The auditory cortex mediates the perceptual effects of acoustic temporal expectation	NATURE NEUROSCIENCE			English	Article							ATTENTION; RESPONSES; NEURONS; TIME; DISCRIMINATION; CONTEXT; RAT	When events occur at predictable instants, anticipation improves performance. Knowledge of event timing modulates motor circuits and thereby improves response speed. By contrast, the neuronal mechanisms that underlie changes in sensory perception resulting from expectation are not well understood. We developed a behavioral procedure for rats in which we manipulated expectations about sound timing. Valid expectations improved both the speed and the accuracy of the subjects' performance, indicating not only improved motor preparedness but also enhanced perception. Single-neuron recordings in primary auditory cortex showed enhanced representation of sounds during periods of heightened expectation. Furthermore, we found that activity in auditory cortex was causally linked to the performance of the task and that changes in the neuronal representation of sounds predicted performance on a trial-by-trial basis. Our results indicate that changes in neuronal representation as early as primary sensory cortex mediate the perceptual advantage conferred by temporal expectation.	[Jaramillo, Santiago; Zador, Anthony M.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Zador, AM (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zador@cshl.edu		Zador, Anthony/0000-0002-8431-9136	Swartz Foundation; US National Institutes of Health; Marie Robertson Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005415] Funding Source: NIH RePORTER	Swartz Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Robertson Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank G. H. Otazu, A. E. Baker, J.M. Abolafia and B.J. Burbach for assistance with preliminary studies. This research was supported by a postdoctoral fellowship from the Swartz Foundation and by grants from the Swartz Foundation, the US National Institutes of Health and the Marie Robertson Fund.	Anderson B, 2008, NEUROPSYCHOLOGIA, V46, P947, DOI 10.1016/j.neuropsychologia.2007.11.025; Asari H, 2009, J NEUROPHYSIOL, V102, P2638, DOI 10.1152/jn.00577.2009; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Bialek W., 1996, SPIKES EXPLORING NEU; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; Correa A, 2006, BRAIN RES, V1076, P116, DOI 10.1016/j.brainres.2005.11.074; Correa A, 2005, PSYCHON B REV, V12, P328, DOI 10.3758/BF03196380; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Haykin S., 2001, ADAPTIVE FILTER THEO, V4th ed.; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Lange K, 2003, PSYCHOPHYSIOLOGY, V40, P806, DOI 10.1111/1469-8986.00081; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Nobre AC, 2001, NEUROPSYCHOLOGIA, V39, P1317; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; Ohl FW, 1999, LEARN MEMORY, V6, P347; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Paxinos G, 2005, RAT BRAIN STEREOTAXI, DOI 10.1016/c2009-0-63235-9; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Syka J, 2002, HEARING RES, V172, P151, DOI 10.1016/S0378-5955(02)00578-6; TAI L, 2008, NATURE PRECEDINGS; Talwar SK, 2001, J NEUROPHYSIOL, V85, P2350, DOI 10.1152/jn.2001.85.6.2350; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003	38	179	183	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					246	U340		10.1038/nn.2688	http://dx.doi.org/10.1038/nn.2688			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	711MJ	21170056	Green Accepted			2022-12-17	WOS:000286595400023
J	Koizumi, H; Higginbotham, H; Poon, T; Tanaka, T; Brinkman, BC; Gleeson, JG				Koizumi, Hiroyuki; Higginbotham, Holden; Poon, Tiffany; Tanaka, Teruyuki; Brinkman, Brendan C.; Gleeson, Joseph G.			Doublecortin maintains bipolar shape and nuclear translocation during migration in the adult forebrain	NATURE NEUROSCIENCE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; RAT OLFACTORY-BULB; NEURONAL MIGRATION; DIRECTIONAL GUIDANCE; CELL-MIGRATION; SUBVENTRICULAR ZONE; RADIAL MIGRATION; GRANULE NEURONS; CHAIN-MIGRATION; MAMMALIAN BRAIN	The ability of the mature mammalian nervous system to continually produce neuronal precursors is of considerable importance, as manipulation of this process might one day permit the replacement of cells lost as a result of injury or disease. In mammals, the anterior subventricular zone (SVZa) region is one of the primary sites of adult neurogenesis. Here we show that doublecortin (DCX), a widely used marker for newly generated neurons, when deleted in mice results in a severe morphological defect in the rostral migratory stream and delayed neuronal migration that is independent of direction or responsiveness to Slit chemorepulsion. DCX is required for nuclear translocation and maintenance of bipolar morphology during migration of these cells. Our data identifies a critical function for DCX in the movement of newly generated neurons in the adult brain.	Univ Calif San Diego, Dept Neurosci, Neurogenet Lab, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, Neurogenet Lab, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu			NINDS NIH HHS [NS02331, R01 NS041537, R01 NS04387, R01 NS47101] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041537] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; BRINON JG, 1992, CELL TISSUE RES, V269, P289, DOI 10.1007/BF00319620; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chazal G, 2000, J NEUROSCI, V20, P1446; Corbo JC, 2002, J NEUROSCI, V22, P7548; Del Rio JA, 2004, CURR BIOL, V14, P840, DOI 10.1016/j.cub.2004.04.046; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GREGORY WA, 1988, J NEUROSCI, V8, P1728; Gupta A, 2003, NAT NEUROSCI, V6, P1284, DOI 10.1038/nn1151; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; KOSAKA K, 1995, NEUROSCI RES, V23, P73, DOI 10.1016/0168-0102(95)00930-R; Liu GF, 2003, J NEUROSCI, V23, P6651; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; McManus MF, 2004, AM J PATHOL, V165, P775, DOI 10.1016/S0002-9440(10)63340-8; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Murase S, 2002, J NEUROSCI, V22, P3568; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; Petreanu L, 2002, J NEUROSCI, V22, P6106; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Sanada K, 2004, NEURON, V42, P197, DOI 10.1016/S0896-6273(04)00222-3; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Ward M, 2003, J NEUROSCI, V23, P5170; Ward ME, 2005, MOL CELL NEUROSCI, V30, P378, DOI 10.1016/j.mcn.2005.08.002; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yoshihara S, 2005, DEVELOPMENT, V132, P751, DOI 10.1242/dev.01619	49	179	185	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					779	786		10.1038/nn1704	http://dx.doi.org/10.1038/nn1704			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699506	Green Submitted			2022-12-17	WOS:000237895200018
J	Volkow, N; Li, TK				Volkow, N; Li, TK			The neuroscience of addiction	NATURE NEUROSCIENCE			English	Editorial Material							DRUG-USE; DEPENDENCE; ALCOHOL; ASSOCIATION; DOPAMINE; SEEKING; CORTEX; ONSET; ABUSE; RISK								NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000550, ZIAAA000550] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Adriani W, 2004, BEHAV PHARMACOL, V15, P341, DOI 10.1097/00008877-200409000-00005; Baumeister SE, 2005, EUR ADDICT RES, V11, P92, DOI 10.1159/000083038; Belluzzi JD, 2004, PSYCHOPHARMACOLOGY, V174, P389, DOI 10.1007/s00213-003-1758-6; BREESE GR, ALCOHOL CLIN EXP RES, V29, P185; Brook DW, 2002, ARCH GEN PSYCHIAT, V59, P1039, DOI 10.1001/archpsyc.59.11.1039; Crabbe JC, 2002, ANNU REV PSYCHOL, V53, P435, DOI 10.1146/annurev.psych.53.100901.135142; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Hiroi N, 2005, MOL PSYCHIATR, V10, P336, DOI 10.1038/sj.mp.4001622; Kelley AE, 2004, ANN NY ACAD SCI, V1021, P27, DOI 10.1196/annals.1308.003; Kosten TA, 1997, BRAIN RES, V778, P418, DOI 10.1016/S0006-8993(97)01205-5; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; Pistis M, 2004, BIOL PSYCHIAT, V56, P86, DOI 10.1016/j.biopsych.2004.05.006; Ranaldi R, 2001, BEHAV PHARMACOL, V12, P527, DOI 10.1097/00008877-200111000-00014; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; VOLKOW N, IN PRESS PHARM THER; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Wang B, 2005, J NEUROSCI, V25, P5389, DOI 10.1523/JNEUROSCI.0955-05.2005	19	179	183	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1429	1430		10.1038/nn1105-1429	http://dx.doi.org/10.1038/nn1105-1429			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	979TB	16251981	Green Submitted			2022-12-17	WOS:000232966600009
J	Lee, SH; Blake, R; Heeger, DJ				Lee, SH; Blake, R; Heeger, DJ			Traveling waves of activity in primary visual cortex during binocular rivalry	NATURE NEUROSCIENCE			English	Article							NEURONAL-ACTIVITY; PERCEPTION; DYNAMICS	When the two eyes view large, dissimilar patterns that induce binocular rivalry, alternating waves of visibility are experienced as one pattern sweeps the other out of conscious awareness. Here we combine psychophysics with functional magnetic resonance imaging to show tight linkage between dynamics of perceptual waves during rivalry and neural events in human primary visual cortex (V1).	NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA; Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA	New York University; New York University; Vanderbilt University	Heeger, DJ (corresponding author), NYU, Dept Psychol, 6 Washington Pl,8th Floor, New York, NY 10003 USA.	david.heeger@nyu.edu	Lee, Sang-Hun/B-9898-2008		NEI NIH HHS [EY14437, R03 EY014437, EY12741] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012741, R03EY014437] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; HUGHES JR, 1995, CLIN ELECTROENCEPHAL, V26, P1, DOI 10.1177/155005949502600103; Lee SH, 2002, J VISION, V2, P618, DOI 10.1167/2.9.4; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Wheatstone C, 1838, PHILOS T R SOC LOND, V128, P371; Wilson HR, 2001, NATURE, V412, P907, DOI 10.1038/35091066; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0	15	179	181	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					22	23		10.1038/nn1365	http://dx.doi.org/10.1038/nn1365			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15580269	Green Accepted			2022-12-17	WOS:000225967600010
J	Perrone, JA; Thiele, A				Perrone, JA; Thiele, A			Speed skills: measuring the visual speed analyzing properties of primate MT neurons	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELD PROPERTIES; AREA MT; MACAQUE MONKEY; DIRECTION SELECTIVITY; MOTION ANALYSIS; TEMPORAL AREA; SELF-MOTION; VELOCITY; CORTEX; MODEL	Knowing the direction and speed of moving objects is often critical for survival. However, it is poorly understood how cortical neurons process the speed of image movement. Here we tested Mi neurons using moving sine-wave gratings of different spatial and temporal frequencies, and mapped out the neurons' spatiotemporal frequency response profiles, The maps typically had oriented ridges of peak sensitivity as expected for speed-tuned neurons. The preferred speed estimate, derived from the orientation of the maps, corresponded well to the preferred speed when moving bars were presented. Thus, our data demonstrate that MT neurons are truly sensitive to the object speed. These findings indicate that MT is not only a key structure in the analysis of direction of motion and depth perception, but also in the analysis of object speed.	Univ Waikato, Dept Psychol, Hamilton, New Zealand; Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of Waikato; Salk Institute	Perrone, JA (corresponding author), Univ Waikato, Dept Psychol, Private Bag 3105, Hamilton, New Zealand.			Thiele, Alexander/0000-0003-4894-0213				ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; BRACEWELL RN, 1978, FOURIER TRANSFORM IT; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Del Viva MM, 1998, VISION RES, V38, P3633, DOI 10.1016/S0042-6989(98)00022-4; DOBKINS KR, 1994, J NEUROSCI, V14, P4854; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; FAHLE M, 1981, PROC R SOC SER B-BIO, V213, P451, DOI 10.1098/rspb.1981.0075; FELLEMAN DJ, 1984, J NEUROPHYSIOL, V52, P488, DOI 10.1152/jn.1984.52.3.488; FOSTER KH, 1985, J PHYSIOL-LONDON, V365, P331, DOI 10.1113/jphysiol.1985.sp015776; Gibson J.J., 1950, PERCEPTION VISUAL WO; KOENDERINK JJ, 1975, OPT ACTA, V22, P773, DOI 10.1080/713819112; LAGAE L, 1993, J NEUROPHYSIOL, V69, P19, DOI 10.1152/jn.1993.69.1.19; Lisberger SG, 1999, J NEUROSCI, V19, P2224; LONGUETHIGGINS HC, 1980, PROC R SOC SER B-BIO, V208, P385, DOI 10.1098/rspb.1980.0057; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; MOVSHON JA, 1975, J PHYSIOL-LONDON, V249, P445, DOI 10.1113/jphysiol.1975.sp011025; NAKAAMA K, 1984, VISION RES, V25, P625; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; NEWSOME WT, 1985, J NEUROSCI, V5, P825; ORBAN GA, 1986, J NEUROPHYSIOL, V56, P462, DOI 10.1152/jn.1986.56.2.462; Perrone JA, 1998, J NEUROSCI, V18, P5958; PERRONE JA, 1994, VISION RES, V34, P2917, DOI 10.1016/0042-6989(94)90060-4; PERRONE JA, 1992, J OPT SOC AM A, V9, P177, DOI 10.1364/JOSAA.9.000177; RODMAN HR, 1987, VISION RES, V27, P2035, DOI 10.1016/0042-6989(87)90118-0; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; Thiele A, 1999, EUR J NEUROSCI, V11, P2044, DOI 10.1046/j.1460-9568.1999.00630.x; Thiele A, 1999, J NEUROSCI, V19, P6571; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; Watson A.B, 1983, MOTION PERCEPTION RE, P1; WATSON AB, 1986, J OPT SOC AM A, V3, P300, DOI 10.1364/JOSAA.3.000300; WATSON AB, 1986, BEHAV RES METH INSTR, V18, P587, DOI 10.3758/BF03201433; [No title captured]	35	179	180	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					526	532		10.1038/87480	http://dx.doi.org/10.1038/87480			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319562				2022-12-17	WOS:000168412600017
J	Alonso, JM; Martinez, LM				Alonso, JM; Martinez, LM			Functional connectivity between simple cells and complex cells in cat striate cortex	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELD PROPERTIES; LATERAL GENICULATE-NUCLEUS; CROSS-CORRELATION ANALYSIS; PRIMARY VISUAL-CORTEX; ORIENTATION SELECTIVITY; PYRAMIDAL NEURONS; RAT NEOCORTEX; AREA 17; ORGANIZATION; PROJECTIONS	In the cat primary visual cortex, neurons are classified into the two main categories of simple cells and complex cells based on their response properties. According to the hierarchical model, complex receptive fields derive from convergent inputs of simple cells with similar orientation preferences. This model received strong support from anatomical studies showing that many complex cells lie within the range of layer IV simple-cell axons but outside the range of most thalamic axons. Physiological evidence for the model, however, has remained elusive. Here we demonstrate that layer IV simple cells and layer II and III complex cells show correlated firing consistent with monosynaptic connections. As expected from the hierarchical model, all connections were in the direction from the simple cell to the complex cell, most frequently between cells with similar orientation preferences.	Rockefeller Univ, Neurobiol Lab, New York, NY 10021 USA	Rockefeller University	Alonso, JM (corresponding author), Rockefeller Univ, Neurobiol Lab, 1230 York Ave, New York, NY 10021 USA.	alonsoj@rockvax.rockefeller.edu						ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; BULLIER J, 1979, J NEUROPHYSIOL, V42, P1271, DOI 10.1152/jn.1979.42.5.1271; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; DEUCHARS J, 1994, J PHYSIOL-LONDON, V478, P423, DOI 10.1113/jphysiol.1994.sp020262; ECKHORN R, 1993, J NEUROSCI METH, V49, P175, DOI 10.1016/0165-0270(93)90121-7; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; FERSTER D, 1985, J PHYSIOL-LONDON, V367, P233, DOI 10.1113/jphysiol.1985.sp015822; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FETZ EE, 1983, J PHYSIOL-LONDON, V341, P387, DOI 10.1113/jphysiol.1983.sp014812; Fitzpatrick D, 1996, CEREB CORTEX, V6, P329, DOI 10.1093/cercor/6.3.329; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; GHOSE GM, 1994, J NEUROPHYSIOL, V72, P1290, DOI 10.1152/jn.1994.72.3.1290; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; HAMMOND P, 1977, EXP BRAIN RES, V30, P275; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HEGGELUND P, 1981, EXP BRAIN RES, V42, P99; HIRSCH JA, 1995, NATURE, V378, P612, DOI 10.1038/378612a0; HOFFMANN KP, 1971, BRAIN RES, V32, P460, DOI 10.1016/0006-8993(71)90340-4; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUMPHREY AL, 1985, J COMP NEUROL, V233, P159, DOI 10.1002/cne.902330203; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; KIRKWOOD PA, 1979, J NEUROSCI METH, V1, P107, DOI 10.1016/0165-0270(79)90009-8; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; MALPELI JG, 1983, J NEUROPHYSIOL, V49, P595, DOI 10.1152/jn.1983.49.3.595; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; MASON A, 1991, J NEUROSCI, V11, P72; Matsumura M, 1996, J NEUROSCI, V16, P7757; Mel BW, 1998, J NEUROSCI, V18, P4325; MOORE GP, 1970, BIOPHYS J, V10, P876, DOI 10.1016/S0006-3495(70)86341-X; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Orban GA, 1984, STUDIES BRAIN FUNCTI; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; SILLITO AM, 1977, J PHYSIOL-LONDON, V271, P699, DOI 10.1113/jphysiol.1977.sp012021; SINGER W, 1975, J NEUROPHYSIOL, V38, P1080, DOI 10.1152/jn.1975.38.5.1080; SNODDERLY DM, 1995, J NEUROPHYSIOL, V74, P2100, DOI 10.1152/jn.1995.74.5.2100; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; SURMEIER DJ, 1985, BRAIN RES, V331, P180, DOI 10.1016/0006-8993(85)90732-2; Sutter E.E., 1987, ADV METHODS PHYSIOLO, V1, P303; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P202, DOI 10.1152/jn.1981.46.2.202; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P191, DOI 10.1152/jn.1981.46.2.191; TSO DY, 1986, J NEUROSCI, V6, P1160	50	179	184	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					395	403		10.1038/1609	http://dx.doi.org/10.1038/1609			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196530				2022-12-17	WOS:000076361400018
J	Dale, PS; Simonoff, E; Bishop, DVM; Eley, TC; Oliver, B; Price, TS; Purcell, S; Stevenson, J; Plomin, R				Dale, PS; Simonoff, E; Bishop, DVM; Eley, TC; Oliver, B; Price, TS; Purcell, S; Stevenson, J; Plomin, R			Genetic influence on language delay in two-year-old children	NATURE NEUROSCIENCE			English	Article							MULTIPLE-REGRESSION ANALYSIS; TWIN DATA; DEVELOPMENTAL SPEECH; DISORDERS; AGE	Previous work suggests that most clinically significant language difficulties in children do not result from acquired brain lesions or adverse environmental experiences but from genetic factors that presumably influence early brain development. We conducted the first twin study of language delay to evaluate whether genetic and environmental factors at the lower extreme of delayed language are different from those operating in the normal range. Vocabulary at age two was assessed for more than 3000 pairs of twins. Group differences heritability for the lowest 5% of subjects was estimated as 73% in model-fitting analyses, significantly greater than the individual differences heritability for the entire sample (25%). This supports the view of early language delay as a distinct disorder. Shared environment was only a quarter as important for the language-delayed sample (18%) as for the entire sample (69%).	Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, London SE5 8AF, England; Univ Washington, Dept Psychol, Seattle, WA 98195 USA; MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England; Univ Southampton, Ctr Res Psychol Dev, Southampton SO17 1BJ, Hants, England	University of London; King's College London; University of Washington; University of Washington Seattle; University of Southampton	Plomin, R (corresponding author), Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, London SE5 8AF, England.	r.plomin@iop.bpmf.ac.uk	Plomin, Robert/B-8911-2008; Dale, Philip S/A-2254-2009; Eley, Thalia C/D-4811-2011; Oliver, Bonamy R./AAT-2758-2020; Price, Thomas S./B-7372-2008; Simonoff, Emily A/B-7593-2011; Oliver, Bonamy/D-4798-2011	Dale, Philip S/0000-0002-7697-8510; Eley, Thalia C/0000-0001-6458-0700; Oliver, Bonamy R./0000-0002-8145-5482; Price, Thomas S./0000-0001-7356-2109; Plomin, Robert/0000-0002-0756-3629; Bishop, Dorothy/0000-0002-2448-4033; Simonoff, Emily/0000-0002-5450-0823				Bates E., 1996, RETHINKING INNATENES; Bates E, 1995, HDB CHILD LANGUAGE, P96; Beitchman J.H., 1996, LANGUAGE LEARNING BE; Bishop D., 1994, CHILD ADOLESCENT PSY, P546; BISHOP DVM, 1995, DEV MED CHILD NEUROL, V37, P56; BISHOP DVM, 1997, UNCOMMON UNDERSTANDI; CHRISTENSEN K, 1995, BRIT MED J, V310, P432, DOI 10.1136/bmj.310.6977.432; DEFRIES JC, 1988, ACTA GENET MED GEMEL, V37, P205, DOI 10.1017/S0001566000003810; DEFRIES JC, 1985, BEHAV GENET, V15, P467, DOI 10.1007/BF01066239; DEFRIES JC, 1993, NATURE NURTURE PSYCH, P121; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Felsenfeld S, 1997, J SPEECH LANG HEAR R, V40, P778, DOI 10.1044/jslhr.4004.778; FENSON L, 1994, MONOGR SOC RES CHILD, V59, pR5; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; Freeman B, 1997, BEHAV GENET, V27, P251, DOI 10.1023/A:1025614231190; GOLDSMITH HH, 1991, BEHAV GENET, V21, P257; HAMPSON J, 1993, J CHILD LANG, V20, P313, DOI 10.1017/S0305000900008308; Hart B., 1995, MEANINGFUL DIFFERENC; HART H, 1981, ARCH DIS CHILD, V56, P440, DOI 10.1136/adc.56.6.440; HUTTENLOCHER J, 1991, DEV PSYCHOL, V27, P236, DOI 10.1037/0012-1649.27.2.236; LEWIS BA, 1992, J SPEECH HEAR RES, V35, P1086, DOI 10.1044/jshr.3505.1086; LYTTON H, 1980, PARENT CHILD INTERAC; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; MARTIN NG, 1978, HEREDITY, V40, P97, DOI 10.1038/hdy.1978.10; MCGUE M, 1984, BEHAV GENET, V14, P325, DOI 10.1007/BF01080045; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; PHILLIPS DIW, 1993, LANCET, V341, P1008, DOI 10.1016/0140-6736(93)91086-2; Pinker S., 1994, LANGUAGE INSTINCT; Plomin R., 1997, BEHAV GENET; Rescorla L, 1997, J SPEECH LANG HEAR R, V40, P556, DOI 10.1044/jslhr.4003.556; Reznick JS, 1997, MONOGR SOC RES CHILD, V62, pR5, DOI 10.2307/1166193; Rosenberg S., 1987, ADV APPLIED PSYCHOLI, V1, P1, DOI DOI 10.1017/CBO9780511571374.002; RUTTER M, 1991, J CHILD PSYCHOL PSYC, V32, P885, DOI 10.1111/j.1469-7610.1991.tb01916.x; SAUDINO KJ, 1994, INTELLIGENCE, V19, P359, DOI 10.1016/0160-2896(94)90007-8; SMITH C, 1974, AM J HUM GENET, V26, P454; THAL DJ, 1997, ASSESSMENT COMMUNICA, P1; Tomblin JB, 1998, J SPEECH LANG HEAR R, V41, P188, DOI 10.1044/jslhr.4101.188	37	179	185	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					324	328		10.1038/1142	http://dx.doi.org/10.1038/1142			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	127QD	10195167				2022-12-17	WOS:000076361300017
J	Mendez-Bertolo, C; Moratti, S; Toledano, R; Lopez-Sosa, F; Martinez-Alvarez, R; Mah, YH; Vuilleumier, P; Gil-Nagel, A; Strange, BA				Mendez-Bertolo, Constantino; Moratti, Stephan; Toledano, Rafael; Lopez-Sosa, Fernando; Martinez-Alvarez, Roberto; Mah, Yee H.; Vuilleumier, Patrik; Gil-Nagel, Antonio; Strange, Bryan A.			A fast pathway for fear in human amygdala	NATURE NEUROSCIENCE			English	Article							EMOTIONAL FACES; SPATIAL-FREQUENCY; VISUAL-STIMULI; MONKEY AMYGDALA; FACIAL STIMULI; MEG-DATA; RESPONSES; CORTEX; PERCEPTION; ATTENTION	A fast, subcortical pathway to the amygdala is thought to have evolved to enable rapid detection of threat. This pathway's existence is fundamental for understanding nonconscious emotional responses, but has been challenged as a result of a lack of evidence for short-latency fear-related responses in primate amygdala, including humans. We recorded human intracranial electrophysiological data and found fast amygdala responses, beginning 74-ms post-stimulus onset, to fearful, but not neutral or happy, facial expressions. These responses had considerably shorter latency than fear responses that we observed in visual cortex. Notably, fast amygdala responses were limited to low spatial frequency components of fearful faces, as predicted by magnocellular inputs to amygdala. Furthermore, fast amygdala responses were not evoked by photographs of arousing scenes, which is indicative of selective early reactivity to socially relevant visual information conveyed by fearful faces. These data therefore support the existence of a phylogenetically old subcortical pathway providing fast, but coarse, threat-related signals to human amygdala.	[Mendez-Bertolo, Constantino; Moratti, Stephan; Lopez-Sosa, Fernando; Strange, Bryan A.] Tech Univ Madrid, Ctr Biomed Technol, Lab Clin Neurosci, Madrid, Spain; [Mendez-Bertolo, Constantino] UCM UPM, CEI Campus Moncloa, Madrid, Spain; [Moratti, Stephan] Univ Complutense Madrid, Dept Basic Psychol 1, Madrid, Spain; [Moratti, Stephan] Tech Univ Madrid, Lab Cognit & Computat Neurosci, Ctr Biomed Technol, Madrid, Spain; [Toledano, Rafael; Gil-Nagel, Antonio] Hosp Ruber Int, Dept Neurol, Epilepsy Unit, Madrid, Spain; [Martinez-Alvarez, Roberto] Hosp Ruber Int, Dept Neurosurg, Madrid, Spain; [Mah, Yee H.] St Georges Univ London, Neurosci Res Ctr, Cardiovasc & Cell Sci Inst, London, England; [Vuilleumier, Patrik] Univ Geneva, Lab Neurol & Imaging Cognit, Dept Neurosci & Neurol, Univ Hosp, Geneva, Switzerland; [Vuilleumier, Patrik] Univ Geneva, Sch Med, Geneva, Switzerland; [Strange, Bryan A.] Reina Sofia Ctr Alzheimers Res, Dept Neuroimaging, Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Complutense University of Madrid; Universidad Politecnica de Madrid; St Georges University London; University of London; King's College London; University of Geneva; University of Geneva	Strange, BA (corresponding author), Tech Univ Madrid, Ctr Biomed Technol, Lab Clin Neurosci, Madrid, Spain.; Strange, BA (corresponding author), Reina Sofia Ctr Alzheimers Res, Dept Neuroimaging, Madrid, Spain.	bryan.strange@upm.es	Strange, Bryan A/L-9466-2014; Méndez-Bértolo, Constantino/R-3803-2018; Vuilleumier, Patrik/AAJ-1839-2021; Strange, Bryan/AAF-3805-2019; Moratti, Stephan/A-5605-2019; Lopez Sosa, Fernando/H-4961-2017	Strange, Bryan A/0000-0001-6476-4091; Vuilleumier, Patrik/0000-0002-8198-9214; Strange, Bryan/0000-0001-6476-4091; Moratti, Stephan/0000-0003-0824-8759; Lopez Sosa, Fernando/0000-0002-0601-9103	Spanish Ministry of Science and Education [SAF2011-27766]; Marie Curie Career Integration Fellowship [FP7-PEOPLE-2011-CIG 304248]; PICATA fellowship of CEI Moncloa (UCM-UPM); Ramon y Cajal fellowship [RYC-2009-04974]; Spanish Ministry of Science and Education, Marie Curie Career Integration Fellowship [SAF2011-27766, FP7-PEOPLE-2011-CIG 304248]; BIAL Foundation [119/12]	Spanish Ministry of Science and Education(Spanish Government); Marie Curie Career Integration Fellowship; PICATA fellowship of CEI Moncloa (UCM-UPM); Ramon y Cajal fellowship(Spanish Government); Spanish Ministry of Science and Education, Marie Curie Career Integration Fellowship; BIAL Foundation(Bial Foundation)	We thank the electroencephalography technicians at the Hospital Ruber Internacional. This work was supported by Project grant SAF2011-27766 from the Spanish Ministry of Science and Education and Marie Curie Career Integration Fellowship (FP7-PEOPLE-2011-CIG 304248) to B.A.S., a PICATA fellowship of CEI Moncloa (UCM-UPM) to C.M.-B., and a Ramon y Cajal fellowship (RYC-2009-04974) to S.M. This work was supported by Project grant SAF2011-27766 from the Spanish Ministry of Science and Education, Marie Curie Career Integration Fellowship (FP7-PEOPLE-2011-CIG 304248), and BIAL Foundation Grant 119/12 to B.A.S.	AGGLETON JP, 1980, BRAIN RES, V190, P347, DOI 10.1016/0006-8993(80)90279-6; Ahrens J, 2005, VISUALIZATION HDB, V717, DOI [10.1016/B978-012387582-2/50038-1, DOI 10.1016/B978-012387582-2/50038-1]; AMARAL DG, 1992, EXP BRAIN RES, V88, P375, DOI 10.1007/BF02259113; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Anderson AK, 2003, J NEUROSCI, V23, P5627; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; BERSON DM, 1988, PROG BRAIN RES, V75, P17; Brazdil M, 2009, NEUROIMAGE, V47, P376, DOI 10.1016/j.neuroimage.2009.03.081; Carretie L, 2007, NEUROPSYCHOLOGIA, V45, P1187, DOI 10.1016/j.neuropsychologia.2006.10.013; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Day-Brown JD, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00143; Dimberg U, 1996, MOTIV EMOTION, V20, P149, DOI 10.1007/BF02253869; Eimer M, 2011, OXFORD HDB FACE PERC, P329, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0017; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Garrido MI, 2012, CURR BIOL, V22, P129, DOI 10.1016/j.cub.2011.11.056; Gothard KM, 2007, J NEUROPHYSIOL, V97, P1671, DOI 10.1152/jn.00714.2006; Gramfort A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-45; Hauk O, 2004, NEUROIMAGE, V21, P1612, DOI 10.1016/j.neuroimage.2003.12.018; Inagaki M, 2011, J NEUROSCI, V31, P10371, DOI 10.1523/JNEUROSCI.1114-11.2011; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; KLING A S, 1992, P353; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; Kveraga K, 2007, J NEUROSCI, V27, P13232, DOI 10.1523/JNEUROSCI.3481-07.2007; Lachaux JP, 2003, J PHYSIOLOGY-PARIS, V97, P613, DOI 10.1016/j.jphysparis.2004.01.018; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; LeDoux J. E., 1996, EMOTIONAL BRAIN; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Lundqvist D., 1998, KAROLINSKA DIRECTED; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Merzagora AR, 2014, NEUROIMAGE, V85, P844, DOI 10.1016/j.neuroimage.2013.07.006; Nguyen MN, 2013, EUR J NEUROSCI, V37, P35, DOI 10.1111/ejn.12020; Moors A, 2006, PSYCHOL BULL, V132, P297, DOI 10.1037/0033-2909.132.2.297; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Naccache L, 2005, P NATL ACAD SCI USA, V102, P7713, DOI 10.1073/pnas.0500542102; Ohman A, 2002, CURR DIR PSYCHOL SCI, V11, P62, DOI 10.1111/1467-8721.00169; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Olszanowski M, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01516; Oya H, 2002, J NEUROSCI, V22, P9502; Pegna AJ, 2005, NAT NEUROSCI, V8, P24, DOI 10.1038/nn1364; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Pourtois G, 2010, COGN AFFECT BEHAV NE, V10, P83, DOI 10.3758/CABN.10.1.83; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Sato W, 2011, NEUROPSYCHOLOGIA, V49, P612, DOI 10.1016/j.neuropsychologia.2010.12.025; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; SELIGMAN ME, 1971, BEHAV THER, V2, P307, DOI 10.1016/S0005-7894(71)80064-3; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Stefanacci L, 2000, J COMP NEUROL, V421, P52, DOI 10.1002/(SICI)1096-9861(20000522)421:1<52::AID-CNE4>3.0.CO;2-O; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tamietto M, 2012, CURR BIOL, V22, P1449, DOI 10.1016/j.cub.2012.06.006; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tanner D, 2015, PSYCHOPHYSIOLOGY, V52, P997, DOI 10.1111/psyp.12437; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wang S, 2014, P NATL ACAD SCI USA, V111, pE3110, DOI 10.1073/pnas.1323342111; Whalen PJ, 1998, J NEUROSCI, V18, P411	62	178	181	4	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2016	19	8					1041	+		10.1038/nn.4324	http://dx.doi.org/10.1038/nn.4324			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DS4TB	27294508				2022-12-17	WOS:000380773200013
J	Ohshiro, T; Angelaki, DE; DeAngelis, GC				Ohshiro, Tomokazu; Angelaki, Dora E.; DeAngelis, Gregory C.			A normalization model of multisensory integration	NATURE NEUROSCIENCE			English	Article							SUPERIOR COLLICULUS NEURONS; NEURAL-NETWORK MODEL; CAT STRIATE CORTEX; VISUAL-CORTEX; UNISENSORY INTEGRATION; POPULATION ACTIVITY; HEADING PERCEPTION; RECEPTIVE-FIELDS; SIMPLE CELLS; MST NEURONS	Responses of neurons that integrate multiple sensory inputs are traditionally characterized in terms of a set of empirical principles. However, a simple computational framework that accounts for these empirical features of multisensory integration has not been established. We propose that divisive normalization, acting at the stage of multisensory integration, can account for many of the empirical principles of multisensory integration shown by single neurons, such as the principle of inverse effectiveness and the spatial principle. This model, which uses a simple functional operation (normalization) for which there is considerable experimental support, also accounts for the recent observation that the mathematical rule by which multisensory neurons combine their inputs changes with cue reliability. The normalization model, which makes a strong testable prediction regarding cross-modal suppression, may therefore provide a simple unifying computational account of the important features of multisensory integration by neurons.	[Ohshiro, Tomokazu; DeAngelis, Gregory C.] Univ Rochester, Ctr Visual Sci, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Angelaki, Dora E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of Rochester; Washington University (WUSTL)	DeAngelis, GC (corresponding author), Univ Rochester, Ctr Visual Sci, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	gdeangelis@cvs.rochester.edu		DeAngelis, Gregory/0000-0002-1635-1273	US National Institutes of Health [EY016178, EY019087]; NATIONAL EYE INSTITUTE [R01EY019087, R01EY016178] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank R. Jacobs, A. Pouget, J. Drugowitsch, D. Barany, A. Anzai, T. Sanada, R. Sasaki and H. Kim for helpful discussions and comments on the manuscript. This work was supported by US National Institutes of Health R01 grants EY016178 to G.C.D. and EY019087 to D.E.A.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Alvarado JC, 2007, J NEUROPHYSIOL, V97, P3193, DOI 10.1152/jn.00018.2007; Alvarado JC, 2008, BRAIN RES, V1242, P13, DOI 10.1016/j.brainres.2008.03.074; Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Britten KH, 1999, J NEUROSCI, V19, P5074; Britten KH, 1998, J NEUROPHYSIOL, V80, P762, DOI 10.1152/jn.1998.80.2.762; Busse L, 2009, NEURON, V64, P931, DOI 10.1016/j.neuron.2009.11.004; Carandini M, 1997, J NEUROSCI, V17, P8621; Alvarado JC, 2009, J NEUROSCI, V29, P6580, DOI 10.1523/JNEUROSCI.0525-09.2009; Cuppini C, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00006; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Heuer HW, 2007, J NEUROPHYSIOL, V98, P1115, DOI 10.1152/jn.00083.2007; Jiang W, 2001, J NEUROPHYSIOL, V85, P506, DOI 10.1152/jn.2001.85.2.506; Kadunce DC, 1997, J NEUROPHYSIOL, V78, P2834, DOI 10.1152/jn.1997.78.6.2834; Kouh M, 2008, NEURAL COMPUT, V20, P1427, DOI 10.1162/neco.2008.02-07-466; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Magosso E, 2008, NEURAL NETWORKS, V21, P817, DOI 10.1016/j.neunet.2008.06.003; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; MEREDITH MA, 1986, BRAIN RES, V365, P350; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Morgan ML, 2008, NEURON, V59, P662, DOI 10.1016/j.neuron.2008.06.024; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Patton PE, 2003, NEURAL COMPUT, V15, P783, DOI 10.1162/08997660360581903; Perrault TJ, 2005, J NEUROPHYSIOL, V93, P2575, DOI 10.1152/jn.00926.2004; Perrault TJ, 2003, J NEUROPHYSIOL, V90, P4022, DOI 10.1152/jn.00494.2003; Priebe NJ, 2006, NAT NEUROSCI, V9, P552, DOI 10.1038/nn1660; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Recanzone GH, 1997, J NEUROPHYSIOL, V78, P2904, DOI 10.1152/jn.1997.78.6.2904; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rowland BA, 2007, PERCEPTION, V36, P1431, DOI 10.1068/p5842; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Stanford TR, 2005, J NEUROSCI, V25, P6499, DOI 10.1523/JNEUROSCI.5095-04.2005; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; Tolhurst DJ, 1997, VISUAL NEUROSCI, V14, P293, DOI 10.1017/S0952523800011433; Ursino M, 2009, J COMPUT NEUROSCI, V26, P55, DOI 10.1007/s10827-008-0096-4; WALLACE MT, 1994, J NEUROPHYSIOL, V71, P429, DOI 10.1152/jn.1994.71.1.429	50	178	178	3	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					775	U281		10.1038/nn.2815	http://dx.doi.org/10.1038/nn.2815			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21552274	Green Accepted			2022-12-17	WOS:000290958000022
J	Goutagny, R; Jackson, J; Williams, S				Goutagny, Romain; Jackson, Jesse; Williams, Sylvain			Self-generated theta oscillations in the hippocampus	NATURE NEUROSCIENCE			English	Article							RAT; INTERNEURONS; RHYTHM; URETHANE; CA1	Hippocampal theta rhythm is crucial for spatial memory and is thought to be generated by extrinsic inputs. In contrast, using a complete rat hippocampus in vitro, we found several intrinsic, atropine-resistant theta generators in CA1. These oscillators were organized along the septotemporal axis and arose independently from CA3. Our results suggest that CA1 theta rhythm can emerge from the coupling of multiple autonomous hippocampal theta oscillators.	[Goutagny, Romain; Jackson, Jesse; Williams, Sylvain] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University	Williams, S (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	sylvain.williams@douglas.mcgill.ca	goutagny, romain/C-1461-2018	goutagny, romain/0000-0002-1268-533X	Natural Sciences and Engineering Research Council of Canada; Fonds de la recherche en sante du Quebec chercheur boursier "senior."	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la recherche en sante du Quebec chercheur boursier "senior."	We thank M. Danik, G. Ducharme, C. K. Young, C. T. Dickson and G. Buzsaki for their comments on the manuscript. This work was supported by the Canadian Institute of Health Research, the Natural Sciences and Engineering Research Council of Canada and the Fonds de la Recherche en Sante du Quebec. R. G. was supported by the Conrad F. Harrington post-doctoral fellowship from the McGill Faculty of Medicine. J. J. received a Canadian Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada and S. W. is a Fonds de la recherche en sante du Quebec chercheur boursier "senior."	AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; ANDERSEN P, 1962, NATURE, V196, P645, DOI 10.1038/196645a0; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Crepel V, 1997, J NEUROPHYSIOL, V77, P2071, DOI 10.1152/jn.1997.77.4.2071; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; FOX SE, 1986, EXP BRAIN RES, V62, P495; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; KRAMIS R, 1975, EXP NEUROL, V49, P58, DOI 10.1016/0014-4886(75)90195-8; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; TRAUB RD, 1989, SCIENCE, V243, P1319, DOI 10.1126/science.2646715; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; White JA, 2000, P NATL ACAD SCI USA, V97, P8128, DOI 10.1073/pnas.100124097	15	178	180	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1491	1493		10.1038/nn.2440	http://dx.doi.org/10.1038/nn.2440			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19881503				2022-12-17	WOS:000272065600007
J	Nissant, A; Bardy, C; Katagiri, H; Murray, K; Lledo, PM				Nissant, Antoine; Bardy, Cedric; Katagiri, Hiroyuki; Murray, Kerren; Lledo, Pierre-Marie			Adult neurogenesis promotes synaptic plasticity in the olfactory bulb	NATURE NEUROSCIENCE			English	Article							NEWLY GENERATED NEURONS; GRANULE CELLS; CORTEX; MICE	To explore the functional consequences of adult neurogenesis in the mouse olfactory bulb, we investigated plasticity at glutamatergic synapses onto GABAergic interneurons. We found that one subset of excitatory synapses onto adult-born granule cells showed long-term potentiation shortly after their arrival in the bulb. This property faded as the newborn neurons matured. These results indicate that recently generated adult-born olfactory interneurons undergo different experience-dependent synaptic modifications compared with their pre-existing mature neighbors and provide a possible substrate for adult neurogenesis-dependent olfactory learning.	[Nissant, Antoine; Bardy, Cedric; Katagiri, Hiroyuki; Murray, Kerren; Lledo, Pierre-Marie] Inst Pasteur, CNRS, URA 2182, Lab Percept & Memory, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Lledo, PM (corresponding author), Inst Pasteur, CNRS, URA 2182, Lab Percept & Memory, Paris, France.	pmlledo@pasteur.fr	Bardy, Cedric/F-1182-2019	Bardy, Cedric/0000-0001-8321-0852	Fondation pour la Recherche Medicale; Agence Nationale de la Recherche [ANR-05-Neur-028-01]; Ecole des Neurosciences de Paris; Groupe Ionis; Network of European Neuroscience Institutes [LSHM-CT-2005-019063]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ecole des Neurosciences de Paris; Groupe Ionis(French National Research Agency (ANR)); Network of European Neuroscience Institutes	We thank M. Alonso for technical help with viral injections and M. Grubb for insightful comments on the manuscript. A. N. was supported by the Pasteur Institute; and P.- M. L., by the Fondation pour la Recherche Medicale "Equipe FRM,'' Agence Nationale de la Recherche (ANR-05-Neur-028-01), Ecole des Neurosciences de Paris and the Groupe Ionis. The Lledo laboratory is a member of the Network of European Neuroscience Institutes (LSHM-CT-2005-019063).	ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Balu R, 2007, J NEUROSCI, V27, P5621, DOI 10.1523/JNEUROSCI.4630-06.2007; DAVIS BJ, 1981, J COMP NEUROL, V203, P475, DOI 10.1002/cne.902030310; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kitazawa H, 1998, J NEUROPHYSIOL, V79, P137, DOI 10.1152/jn.1998.79.1.137; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Magavi SSP, 2005, J NEUROSCI, V25, P10729, DOI 10.1523/JNEUROSCI.2250-05.2005; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; PATNEAU DK, 1992, BRAIN RES, V585, P219, DOI 10.1016/0006-8993(92)91210-6; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shepherd G. M., 2004, SYNAPTIC ORG BRAIN	15	178	186	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2009	12	6					728	730		10.1038/nn.2298	http://dx.doi.org/10.1038/nn.2298			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	450DJ	19412168				2022-12-17	WOS:000266380900015
J	Custer, SK; Garden, GA; Gill, N; Rueb, U; Libby, RT; Schultz, C; Guyenet, SJ; Deller, T; Westrum, LE; Sopher, BL; La Spada, AR				Custer, Sara K.; Garden, Gwenn A.; Gill, Nishi; Rueb, Udo; Libby, Randell T.; Schultz, Christian; Guyenet, Stephan J.; Deller, Thomas; Westrum, Lesnick E.; Sopher, Bryce L.; La Spada, Albert R.			Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport	NATURE NEUROSCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; ASTROCYTE-SPECIFIC EXPRESSION; TRANSGENIC MICE; MOUSE MODEL; HUNTINGTONS-DISEASE; MUTANT HUNTINGTIN; NERVOUS-SYSTEM; DEGENERATION; SUBTYPES; NEURONS	Non-neuronal cells may be pivotal in neurodegenerative disease, but the mechanistic basis of this effect remains ill-defined. In the polyglutamine disease spinocerebellar ataxia type 7 (SCA7), Purkinje cells undergo non-cell-autonomous degeneration in transgenic mice. We considered the possibility that glial dysfunction leads to Purkinje cell degeneration, and generated mice that express ataxin-7 in Bergmann glia of the cerebellum with the Gfa2 promoter. Bergmann glia-specific expression of mutant ataxin-7 was sufficient to produce ataxia and neurodegeneration. Expression of the Bergmann glia-specific glutamate transporter GLAST was reduced in Gfa2-SCA7 mice and was associated with impaired glutamate transport in cultured Bergmann glia, cerebellar slices and cerebellar synaptosomes. Ultrastructural analysis of Purkinje cells revealed findings of dark cell degeneration consistent with excitotoxic injury. Our studies indicate that impairment of glutamate transport secondary to glial dysfunction contributes to SCA7 neurodegeneration, and suggest a similar role for glial dysfunction in other polyglutamine diseases and SCAs.	Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Neurol Neurogenet, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Ctr Neurogenet & Neurotherapeut, Seattle, WA 98195 USA; Goethe Univ Frankfurt, Dept Clin Neuroanat, D-60590 Frankfurt, Germany; Univ Washington, Med Ctr, Dept Neurosurg, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Med Med Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Goethe University Frankfurt; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	La Spada, AR (corresponding author), Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA.	laspada@u.washington.edu	La Spada, Albert/AAG-8809-2020; Garden, Gwenn/CAF-9344-2022	Garden, Gwenn/0000-0002-8753-6515	NATIONAL EYE INSTITUTE [R01EY014061] Funding Source: NIH RePORTER; NEI NIH HHS [EY14061] Funding Source: Medline; NICHD NIH HHS [P30 HD02774] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Brenner Michael, 1996, Methods (Orlando), V10, P351, DOI 10.1006/meth.1996.0113; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cui W, 2001, GLIA, V34, P272, DOI 10.1002/glia.1061; Dehnes Y, 1998, J NEUROSCI, V18, P3606; Duan SM, 1999, J NEUROSCI, V19, P10193; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Forman MS, 2005, J NEUROSCI, V25, P3539, DOI 10.1523/JNEUROSCI.0081-05.2005; Furuta A, 1997, J NEUROSCI, V17, P8363; Garden GA, 2002, J NEUROSCI, V22, P4897, DOI 10.1523/JNEUROSCI.22-12-04897.2002; Gegelashvili G, 1996, NEUROREPORT, V8, P261, DOI 10.1097/00001756-199612200-00052; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Gu XF, 2005, NEURON, V46, P433, DOI 10.1016/j.neuron.2005.03.025; Helmlinger D, 2004, HUM MOL GENET, V13, P1257, DOI 10.1093/hmg/ddh139; Huang H, 2004, J NEUROSCI, V24, P5659, DOI 10.1523/JNEUROSCI.1338-04.2004; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; KONIGSMARK BW, 1970, MEDICINE, V49, P227, DOI 10.1097/00005792-197005000-00003; La Spada AR, 2003, NEURON, V38, P681, DOI 10.1016/S0896-6273(03)00328-3; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; LERANTH C, 1970, ACTA BIOL ACAD SCI H, V21, P405; Lievens JC, 2001, NEUROBIOL DIS, V8, P807, DOI 10.1006/nbdi.2001.0430; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; ORTEGA A, 1991, NEUROSCIENCE, V41, P335, DOI 10.1016/0306-4522(91)90331-H; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Probst-Cousin S, 2004, J NEUROL NEUROSUR PS, V75, P503, DOI 10.1136/jnnp.2003.011825; Raeber AJ, 1997, EMBO J, V16, P6057, DOI 10.1093/emboj/16.20.6057; Robinson M B, 1997, Adv Pharmacol, V37, P69; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Serra HG, 2004, HUM MOL GENET, V13, P2535, DOI 10.1093/hmg/ddh268; Shimada F, 1999, EUR J PHARMACOL, V386, P263, DOI 10.1016/S0014-2999(99)00735-9; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Strahlendorf JC, 1998, NEUROCHEM RES, V23, P1355, DOI 10.1023/A:1020742404945; Strahlendorf JC, 1999, NEUROSCI RES, V33, P155, DOI 10.1016/S0168-0102(98)00126-6; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Yamada K, 2000, J COMP NEUROL, V418, P106; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X; Yvert G, 2000, HUM MOL GENET, V9, P2491, DOI 10.1093/hmg/9.17.2491; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	49	178	179	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1302	1311		10.1038/nn1750	http://dx.doi.org/10.1038/nn1750			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16936724				2022-12-17	WOS:000241493900024
J	Meredith, AL; Wiler, SW; Miller, BH; Takahashi, JS; Fodor, AA; Ruby, NF; Aldrich, RW				Meredith, Andrea L.; Wiler, Steven W.; Miller, Brooke H.; Takahashi, Joseph S.; Fodor, Anthony A.; Ruby, Norman F.; Aldrich, Richard W.			BK calcium-activated potassium channels regulate circadian behavioral rhythms and pacemaker output	NATURE NEUROSCIENCE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; CA2+-ACTIVATED K+ CHANNEL; VPAC(2) RECEPTOR; EXPLANTS INVITRO; CLOCK MUTATION; SCN NEURONS; FIRING RATE; IN-VITRO; PERIOD; MOUSE	Spontaneous action potentials in the suprachiasmatic nucleus (SCN) are necessary for normal circadian timing of behavior in mammals. The SCN exhibits a daily oscillation in spontaneous firing rate (SFR), but the ionic conductances controlling SFR and the relationship of SFR to subsequent circadian behavioral rhythms are not understood. We show that daily expression of the large conductance Ca2+ activated K+ channel (BK) in the SCN is controlled by the intrinsic circadian clock. BK channel-null mice (Kcnma1(-/-)) have increased SFRs in SCN neurons selectively at night and weak circadian amplitudes in multiple behaviors timed by the SCN. Kcnma1(-/-) mice show normal expression of clock genes such as Arnt1 (Bmal1), indicating a role for BK channels in SCN pacemaker output, rather than in intrinsic time- keeping. Our findings implicate BK channels as important regulators of the SFR and suggest that the SCN pacemaker governs the expression of circadian behavioral rhythms through SFR modulation.	Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Northwestern University; Howard Hughes Medical Institute; Northwestern University; Stanford University	Meredith, AL (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.	ameredith@som.umaryland.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Meredith, Andrea/0000-0003-1061-2302	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060385] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL102758, R01 HL102758-01] Funding Source: Medline; NIMH NIH HHS [MH-60385] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Antle MC, 2005, DEV BRAIN RES, V157, P8, DOI 10.1016/j.devbrainres.2005.02.017; Aton SJ, 2005, NEURON, V48, P531, DOI 10.1016/j.neuron.2005.11.001; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Cloues RK, 2003, J NEUROSCI, V23, P1593; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; de Jeu M, 1998, NEUROREPORT, V9, P3725, DOI 10.1097/00001756-199811160-00028; EARNEST DJ, 1991, BRAIN RES BULL, V26, P677, DOI 10.1016/0361-9230(91)90160-L; EARNEST DJ, 1986, BRAIN RES, V382, P129, DOI 10.1016/0006-8993(86)90119-8; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; GROOS G, 1982, NEUROSCI LETT, V34, P283, DOI 10.1016/0304-3940(82)90189-6; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Itri JN, 2005, NAT NEUROSCI, V8, P650, DOI 10.1038/nn1448; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kuhlman SJ, 2004, EUR J NEUROSCI, V20, P1113, DOI 10.1111/j.1460-9568.2004.03555.x; Kuhlman SJ, 2003, J NEUROSCI, V23, P1441, DOI 10.1523/JNEUROSCI.23-04-01441.2003; Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X; Lundkvist GB, 2005, METHOD ENZYMOL, V393, P623, DOI 10.1016/S0076-6879(05)93033-4; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Misonou H, 2006, J COMP NEUROL, V496, P289, DOI 10.1002/cne.20931; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Nakamura W, 2002, NAT NEUROSCI, V5, P399, DOI 10.1038/nn843; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Nitabach MN, 2005, J NEUROBIOL, V62, P1, DOI 10.1002/neu.20053; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pennartz CMA, 1998, J PHYSIOL-LONDON, V506, P775, DOI 10.1111/j.1469-7793.1998.775bv.x; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Pitts GR, 2006, BRAIN RES, V1071, P54, DOI 10.1016/j.brainres.2005.11.078; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; RATTRAY M, 1998, IN SITU HYBRIDISATIO, P23; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; Shinohara K, 1998, NEUROREPORT, V9, P137, DOI 10.1097/00001756-199801050-00027; Siepka SM, 2005, METHOD ENZYMOL, V393, P230, DOI 10.1016/S0076-6879(05)93008-5; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; VANDENPOL AN, 1985, NEUROSCIENCE, V15, P1049, DOI 10.1016/0306-4522(85)90254-4; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 1998, J NEUROSCI, V18, P10709; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	50	178	179	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1041	1049		10.1038/nn1740	http://dx.doi.org/10.1038/nn1740			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16845385	Green Accepted			2022-12-17	WOS:000240080300017
J	He, W; Lam, TKT; Obici, S; Rossetti, L				He, W; Lam, TKT; Obici, S; Rossetti, L			Molecular disruption of hypothalamic nutrient sensing induces obesity	NATURE NEUROSCIENCE			English	Article							HEPATIC GLUCOSE-PRODUCTION; FOOD-INTAKE; MALONYL-COA; LEPTIN RECEPTOR; BODY-WEIGHT; INSULIN-RESISTANCE; FATTY-ACIDS; AMP-KINASE; RATS; GENE	The sensing of circulating nutrients within the mediobasal hypothalamus may be critical for energy homeostasis. To induce a sustained impairment in hypothalamic nutrient sensing, adeno-associated viruses ( AAV) expressing malonyl-coenzyme A decarboxylase ( MCD; an enzyme involved in the degradation of malonyl coenzyme A) were injected bilaterally into the mediobasal hypothalamus of rats. MCD overexpression led to decreased abundance of long-chain fatty acyl-coenzyme A in the mediobasal hypothalamus and blunted the hypothalamic responses to increased lipid availability. The enhanced expression of MCD within this hypothalamic region induced a rapid increase in food intake and progressive weight gain. Obesity was sustained for at least 4 months and occurred despite increased plasma concentrations of leptin and insulin. These findings indicate that nutritional modulation of the hypothalamic abundance of malonyl-coenzyme A is required to restrain food intake and that a primary impairment in this central nutrient-sensing pathway is sufficient to disrupt energy homeostasis and induce obesity.	Albert Einstein Coll Med, Ctr Diabet Res, Dept Med, Bronx, NY 10461 USA; Albert Einstein Coll Med, Ctr Diabet Res, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Rossetti, L (corresponding author), Albert Einstein Coll Med, Ctr Diabet Res, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	rossetti@aecom.yu.edu						Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HOSOKAWA Y, 1986, ANAL BIOCHEM, V153, P45, DOI 10.1016/0003-2697(86)90058-8; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MCGARRY JD, 1978, J BIOL CHEM, V253, P8291; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; ROSSETTI L, 1987, J CLIN INVEST, V80, P1037, DOI 10.1172/JCI113157; ROSSETTI L, 1993, J CLIN INVEST, V92, P1126, DOI 10.1172/JCI116681; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	31	178	183	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					227	233		10.1038/nn1626	http://dx.doi.org/10.1038/nn1626			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415870				2022-12-17	WOS:000234990100018
J	Horvath, TL				Horvath, TL			The hardship of obesity: a soft-wired hypothalamus	NATURE NEUROSCIENCE			English	Article							BODY-WEIGHT; RAT HYPOTHALAMUS; ARCUATE NUCLEUS; MELANOCORTIN RECEPTORS; HYPOCRETIN NEURONS; FEEDING-BEHAVIOR; LEPTIN RECEPTOR; ENERGY-BALANCE; POMC NEURONS; FOOD-INTAKE	Food intake and energy expenditure are determinants of metabolic phenotype and are regulated by the CNS. Although humans have a well-balanced homeostatic feedback loop, obesity and metabolic disorders are spreading rapidly and carry a heavy toll of morbidity and mortality. The past decade has witnessed major advances in the understanding of basic metabolic processes, the brain circuitry that determines appropriate and, but, inappropriate behavioral and humoral responses to changing metabolic cues remains largely ill defined. This review summarizes current knowledge of the brain anatomy that supports food intake and energy expenditure and discusses cellular mechanisms such as synaptic plasticity that may provide clues toward the development of successful central therapies to combat metabolic disorders, including obesity and diabetes.	Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University; Yale University	Horvath, TL (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, 333 Cedar St, New Haven, CT 06510 USA.	tamas.horvath@yale.edu			NCRR NIH HHS [RR-014451] Funding Source: Medline; NIDDK NIH HHS [DK-060711] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR014451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060711] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cannon WB, 1912, AM J PHYSIOL, V29, P441, DOI 10.1152/ajplegacy.1912.29.5.441; Carlson A, 1916, CONTROL HUNGER HLTH; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cooke Sam F, 2005, Curr Opin Investig Drugs, V6, P25; Cowley MA, 2003, EUR J PHARMACOL, V480, P3, DOI 10.1016/j.ejphar.2003.08.087; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Flier JS, 2004, ANN INTERN MED, V141, P885, DOI 10.7326/0003-4819-141-11-200412070-00014; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GARCIASEGURA LM, 1986, BRAIN RES, V366, P131, DOI 10.1016/0006-8993(86)91287-4; Grill HJ, 2002, FRONT NEUROENDOCRIN, V23, P2, DOI 10.1006/frne.2001.0224; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Horvath TL, 2005, CELL METAB, V1, P279, DOI 10.1016/j.cmet.2005.03.003; Horvath TL, 2004, NAT REV NEUROSCI, V5, P662, DOI 10.1038/nrn1479; HORVATH TL, 1992, ENDOCRINOLOGY, V131, P2461, DOI 10.1210/en.131.5.2461; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; MEZEY E, 1985, BRAIN RES, V328, P341, DOI 10.1016/0006-8993(85)91046-7; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; PELLETIER G, 1977, AM J ANAT, V150, P201, DOI 10.1002/aja.1001500115; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; PFAFF DW, 1994, RECENT PROG HORM RES, V49, P1; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; SCHALLY AV, 1973, J REPROD FERTIL, P119; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Shepherd G. M., 2004, SYNAPTIC ORG BRAIN; SHERRINGTON CS, 1900, TXB PHYSL, P920; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; THEODOSIS DT, 1984, NEUROSCIENCE, V11, P183, DOI 10.1016/0306-4522(84)90222-7; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	49	178	180	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					561	565		10.1038/nn1453	http://dx.doi.org/10.1038/nn1453			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15856063				2022-12-17	WOS:000228895100013
J	Zelano, C; Bensafi, M; Porter, J; Mainland, J; Johnson, B; Bremner, E; Telles, C; Khan, R; Sobel, N				Zelano, C; Bensafi, M; Porter, J; Mainland, J; Johnson, B; Bremner, E; Telles, C; Khan, R; Sobel, N			Attentional modulation in human primary olfactory cortex	NATURE NEUROSCIENCE			English	Article							ANTERIOR PIRIFORM CORTEX; PRIMARY VISUAL-CORTEX; ORBITOFRONTAL CORTEX; FUNCTIONAL-HETEROGENEITY; SELECTIVE ATTENTION; SPATIAL ATTENTION; NEURONAL-ACTIVITY; CELL-ACTIVITY; BRAIN; FMRI	Central to the concept of attention is the fact that identical stimuli can be processed in different ways. In olfaction, attention may designate the identical flow of air through the nose as either respiration or olfactory exploration. Here we have used functional magnetic resonance imaging (fMRI) to probe this attentional mechanism in primary olfactory cortex (POC). We report a dissociation in POC that revealed attention-dependent and attention-independent subregions. Whereas a temporal subregion comprising temporal piriform cortex (PirT) responded equally across conditions, a frontal subregion comprising frontal piriform cortex (PirF) and the olfactory tubercle responded preferentially to attended sniffs as opposed to unattended sniffs. In addition, a task-specific anticipatory response occurred in the attention-dependent region only. This dissociation was consistent across two experimental designs: one focusing on sniffs of clean air, the other focusing on odor-laden sniffs. Our findings highlight the role of attention at the earliest cortical levels of olfactory processing.	Univ Calif Berkeley, Program Biophys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Program Bioengn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Wheeler Brain Imaging Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Zelano, C (corresponding author), Univ Calif Berkeley, Program Biophys, Berkeley, CA 94720 USA.	zelano@socrates.berkeley.edu; nsobel@socrates.berkeley.edu	Mainland, Joel/C-5171-2009; Bensafi, Moustafa/H-6618-2017	Mainland, Joel/0000-0002-5056-4598; Bensafi, Moustafa/0000-0002-2991-3036; Sobel, Noam/0000-0002-3232-9391	NIDCD NIH HHS [R01 DC005958] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005958] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; [Anonymous], 1997, ATLAS HUMAN BRAIN; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; BRESSLER SL, 1987, BRAIN RES, V409, P294, DOI 10.1016/0006-8993(87)90714-1; Bullmore ET, 2000, NEUROIMAGE, V11, P289, DOI 10.1006/nimg.2000.0544; Carlsson K, 2000, J COGNITIVE NEUROSCI, V12, P691, DOI 10.1162/089892900562318; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; Courchesne E, 1997, LEARN MEMORY, V4, P1, DOI 10.1101/lm.4.1.1; Effron B, 1993, INTRO BOOTSTRAP; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Fontanini A, 2003, J NEUROSCI, V23, P7993; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Geisler MW, 2000, INT J PSYCHOPHYSIOL, V37, P309, DOI 10.1016/S0167-8760(00)00111-2; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; GRAY CM, 1988, EXP BRAIN RES, V69, P378; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Johnson BN, 2003, J NEUROPHYSIOL, V90, P1084, DOI 10.1152/jn.00115.2003; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kareken DA, 2004, NEUROIMAGE, V22, P456, DOI 10.1016/j.neuroimage.2004.01.008; Kay LM, 1998, BEHAV NEUROSCI, V112, P541, DOI 10.1037/0735-7044.112.3.541; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Krauel K, 1998, CHEM SENSES, V23, P423, DOI 10.1093/chemse/23.4.423; Litaudon P, 2003, EUR J NEUROSCI, V17, P2457, DOI 10.1046/j.1460-9568.2003.02654.x; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; ODOHERTY J, 2000, NEUROREPORT, V11, P983; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Price JL, 1990, HUMAN NERVOUS SYSTEM, P979; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; Savic I, 2002, CURR OPIN NEUROBIOL, V12, P455, DOI 10.1016/S0959-4388(02)00346-X; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; Spence C, 2001, EXP BRAIN RES, V138, P432, DOI 10.1007/s002210100713; Spence C, 2000, PERCEPT PSYCHOPHYS, V62, P1265, DOI 10.3758/BF03212128; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Wandell BA, 2003, NEUROL CLIN, V21, P417, DOI 10.1016/S0733-8619(03)00003-3; Wilson DA, 2003, J NEUROPHYSIOL, V90, P65, DOI 10.1152/jn.00133.2003; Wilson JL, 2002, MAGNET RESON MED, V48, P906, DOI 10.1002/mrm.10298; Yu YQ, 2004, J NEUROSCI, V24, P3060, DOI 10.1523/JNEUROSCI.4897-03.2004; Zinyuk LE, 2001, BEHAV BRAIN RES, V124, P29, DOI 10.1016/S0166-4328(01)00212-1	44	178	183	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					114	120		10.1038/nn1368	http://dx.doi.org/10.1038/nn1368			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608635				2022-12-17	WOS:000225967600024
J	Ren, XR; Ming, GL; Xie, Y; Hong, Y; Sun, DM; Zhao, ZQ; Feng, Z; Wang, Q; Shim, S; Chen, ZF; Song, HJ; Mei, L; Xiong, WC				Ren, XR; Ming, GL; Xie, Y; Hong, Y; Sun, DM; Zhao, ZQ; Feng, Z; Wang, Q; Shim, S; Chen, ZF; Song, HJ; Mei, L; Xiong, WC			Focal adhesion kinase in netrin-1 signaling	NATURE NEUROSCIENCE			English	Article							GROWTH-CONE ATTRACTION; PHOSPHOLIPASE C-GAMMA; COLORECTAL-CANCER; TYROSINE PHOSPHORYLATION; AXON OUTGROWTH; DCC; GUIDANCE; RECEPTOR; PROTEIN; SRC	Netrins are a family of secreted molecules that are important for axonal outgrowth and guidance in the developing nervous system. However, the signaling mechanisms that lie immediately downstream of netrin receptors remain poorly understood. Here we report that the netrin receptor DCC (deleted in colorectal cancer) interacts with the focal adhesion kinase (FAK), a kinase implicated in regulating cell adhesion and migration. FAK was expressed in developing brains and was localized with DCC in cultured neurons. Netrin-1 induced FAK and DCC tyrosine phosphorylation. Disruption of FAK signaling abolished netrin-1-induced neurite outgrowth and attractive growth cone turning. Taken together, these results indicate a new signaling mechanism for DCC, in which FAK is activated upon netrin-1 stimulation and mediates netrin-1 function; they also identify a critical role for FAK in axon navigation.	Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; Washington Univ, Sch Med Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med Pain Ctr, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med Pain Ctr, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA; Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Johns Hopkins University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Xiong, WC (corresponding author), Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.	wxiong@mcg.edu	Ming, Guo-li/J-7880-2013; Mei, Lin/G-8755-2012	Ming, Guo-li/0000-0002-2517-6075	NIGMS NIH HHS [R01 GM063861] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Bouchard JF, 2004, J NEUROSCI, V24, P3040, DOI 10.1523/JNEUROSCI.4934-03.2004; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Cary LA, 1996, J CELL SCI, V109, P1787; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Finger JH, 2002, J NEUROSCI, V22, P10346; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Girault JA, 1999, TRENDS NEUROSCI, V22, P257, DOI 10.1016/S0166-2236(98)01358-7; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Livesey FJ, 1999, CELL MOL LIFE SCI, V56, P62, DOI 10.1007/s000180050006; Metin C, 1997, DEVELOPMENT, V124, P5063; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Rodriguez-Fernandez JL, 1999, BIOESSAYS, V21, P1069, DOI 10.1002/(SICI)1521-1878(199912)22:1<1069::AID-BIES13>3.0.CO;2-C; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Yebra M, 2003, DEV CELL, V5, P695, DOI 10.1016/S1534-5807(03)00330-7; Zhang X, 1999, P NATL ACAD SCI USA, V96, P9021, DOI 10.1073/pnas.96.16.9021	50	178	186	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1204	1212		10.1038/nn1330	http://dx.doi.org/10.1038/nn1330			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494733				2022-12-17	WOS:000224749400013
J	Wu, P; Tarasenko, YI; Gu, YP; Huang, LYM; Coggeshall, RE; Yu, YJ				Wu, P; Tarasenko, YI; Gu, YP; Huang, LYM; Coggeshall, RE; Yu, YJ			Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat	NATURE NEUROSCIENCE			English	Article							PROGENITOR CELLS; IN-VITRO; NERVOUS-SYSTEM; SPINAL-CORD; HUMAN BRAIN; HUMAN CNS; TRANSPLANTATION; GROWTH; DIFFERENTIATION; ESTABLISHMENT	Pluripotent or multipotent stem cells isolated from human embryos or adult central nervous system (CNS) may provide new neurons to ameliorate neural disorders. A major obstacle, however, is that the majority of such cells do not differentiate into neurons when grafted into non-neurogenic areas of the adult CNS. Here we report a new in vitro priming procedure that generates a nearly pure population of neurons from fetal human neural stem cells (hNSCs) transplanted into adult rat CNS. Furthermore, the grafted cells differentiated by acquiring a cholinergic phenotype in a region-specific manner. This technology may advance stem cell-based therapy to replace lost neurons in neural injury or neurodegenerative disorders.	Univ Texas, Med Branch, Dept Anat & Neurosci, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Physiol & Biophys, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Radiat Oncol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Inst Marine Biomed, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Wu, P (corresponding author), Univ Texas, Med Branch, Dept Anat & Neurosci, Galveston, TX 77555 USA.	piwu@utmb.edu	wu, Ping/G-8958-2011					Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Bonfanti L, 2001, CONT NEUROS, P49; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Fannon M, 2000, BIOCHEMISTRY-US, V39, P1434, DOI 10.1021/bi991895z; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Isacson O, 1997, TRENDS NEUROSCI, V20, P477, DOI 10.1016/S0166-2236(97)01081-3; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; Messam CA, 2000, EXP NEUROL, V161, P585, DOI 10.1006/exnr.1999.7319; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Roy NS, 2000, NAT MED, V6, P271; Schmitz HD, 2001, HISTOCHEM CELL BIOL, V116, P89; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Sheen VL, 1999, EXP NEUROL, V158, P47, DOI 10.1006/exnr.1999.7104; Shihabuddin LS, 1999, ARCH NEUROL-CHICAGO, V56, P29, DOI 10.1001/archneur.56.1.29; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237; Whittemore SR, 1999, EXP CELL RES, V252, P75, DOI 10.1006/excr.1999.4621; Wu P, 2002, GENE THER, V9, P245, DOI 10.1038/sj.gt.3301646; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	38	178	207	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1271	1278		10.1038/nn974	http://dx.doi.org/10.1038/nn974			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12426573				2022-12-17	WOS:000179447500009
J	Lawrence, CB; Celsi, F; Brennand, J; Luckman, SM				Lawrence, CB; Celsi, F; Brennand, J; Luckman, SM			Alternative role for prolactin-releasing peptide in the regulation of food intake	NATURE NEUROSCIENCE			English	Article							BODY-WEIGHT; RAT-BRAIN; EXPRESSION; LEPTIN		Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; AstraZeneca, Alderley Edge SK10 4TQ, Cheshire, England	University of Manchester; AstraZeneca	Luckman, SM (corresponding author), Univ Manchester, Sch Biol Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.		Celsi, Fulvio/H-5134-2013; Celsi, Fulvio/H-2775-2019	Celsi, Fulvio/0000-0002-9760-8463; Lawrence, Catherine/0000-0002-2372-2968; Luckman, Simon/0000-0001-5318-5473				Bhatnagar S, 1999, BRAIN RES, V851, P66, DOI 10.1016/S0006-8993(99)02108-3; BRADY LS, 1990, NEUROENDOCRINOLOGY, V52, P441, DOI 10.1159/000125626; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; Iijima N, 1999, NEUROREPORT, V10, P1713, DOI 10.1097/00001756-199906030-00016; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Maruyama M, 1999, ENDOCRINOLOGY, V140, P2326, DOI 10.1210/en.140.5.2326; Matsumoto H, 1999, BIOCHEM BIOPH RES CO, V259, P321, DOI 10.1006/bbrc.1999.0789; Ritter RC, 1999, NEUROPEPTIDES, V33, P387, DOI 10.1054/npep.1999.0051; Roland BL, 1999, ENDOCRINOLOGY, V140, P5736, DOI 10.1210/en.140.12.5736; Samson WK, 1998, ENDOCRINE, V9, P289, DOI 10.1385/ENDO:9:3:289; Seeley RJ, 2000, J NEUROSCI, V20, P1616; Tokita R, 1999, NEUROSCI LETT, V276, P103, DOI 10.1016/S0304-3940(99)00796-X; Yamakawa K, 1999, NEUROSCI LETT, V267, P113, DOI 10.1016/S0304-3940(99)00346-8	14	178	187	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					645	646		10.1038/76597	http://dx.doi.org/10.1038/76597			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862694				2022-12-17	WOS:000167177200008
J	Schnider, A; Ptak, R				Schnider, A; Ptak, R			Spontaneous confabulators fail to suppress currently irrelevant memory traces	NATURE NEUROSCIENCE			English	Article							ANTERIOR COMMUNICATING ARTERY; FRONTAL-LOBE; AMNESIC PATIENTS; TEMPORAL CONTEXT; LESIONS; RECOLLECTION; RECOGNITION; FAMILIARITY; DYSFUNCTION; ANTEROGRADE	Human actions require integration of past experiences, ongoing percepts and future concepts. To adapt behavior to reality, the brain must identify mental representations of current relevance. Occasional amnesic subjects act according to invented stories ('spontaneous confabulations'), disregarding present reality. We used repeated runs of a continuous recognition task to measure the ability to distinguish currently relevant from previously encountered but currently irrelevant information. Spontaneous confabulators detected target items as accurately as nonconfabulating amnesics, but increasingly failed to suppress false-positive responses, confusing presentation in previous runs with presentation in the current run. Lesions involved the anterior limbic system: medial orbitofrontal cortex, basal forebrain, amygdala and perirhinal cortex or medial hypothalamus. We suggest that the anterior limbic system represents 'now' in human thinking by suppressing currently irrelevant mental associations.	Univ Hosp Bern, Dept Neurol, Div Neuropsychol Rehabil, CH-3010 Bern, Switzerland; Hop Cantonal Geneva, Clin Reeduc, CH-1211 Geneva 14, Switzerland	University of Bern; University Hospital of Bern; University of Geneva	Schnider, A (corresponding author), Univ Hosp Bern, Dept Neurol, Div Neuropsychol Rehabil, CH-3010 Bern, Switzerland.	armin.schnider@hcuge.ch	Ptak, Radek/A-8661-2010	Ptak, Radek/0000-0003-4708-9201				Benson DF, 1996, NEUROLOGY, V46, P1239, DOI 10.1212/WNL.46.5.1239; BERLYNE N, 1972, BRIT J PSYCHIAT, V120, P31, DOI 10.1192/bjp.120.554.31; BOWERS D, 1988, BRAIN COGNITION, V8, P47, DOI 10.1016/0278-2626(88)90038-3; Burgess PW, 1996, MEMORY, V4, P359, DOI 10.1080/096582196388906; Cunningham JM, 1997, J CLIN EXP NEUROPSYC, V19, P867, DOI 10.1080/01688639708403767; DALLABARBA G, 1993, CORTEX, V29, P567, DOI 10.1016/S0010-9452(13)80281-X; DALLABARBA G, 1993, COGN NEUROPSYCHOL, V10, P1; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; Damasio H., 1989, LESION ANAL NEUROPSY; DELIS D, 1987, CALIFORNIA VERBAL LE; DELUCA J, 1991, CORTEX, V27, P417, DOI 10.1016/S0010-9452(13)80036-6; FISCHER RS, 1995, J CLIN EXP NEUROPSYC, V17, P20, DOI 10.1080/13803399508406577; Fuster JM, 1995, MEMORY CEREBRAL CORT; HANLEY JR, 1994, COGNITIVE NEUROPSYCH, V11, P543, DOI 10.1080/02643299408251985; HUPPERT FA, 1976, CORTEX, V12, P3, DOI 10.1016/S0010-9452(76)80024-X; Hurst W, 1982, Brain Cogn, V1, P294; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; Johnson M. K., 1991, AWARENESS DEFICIT BR, P176; Johnson MK, 1997, BRAIN COGNITION, V34, P189, DOI 10.1006/brcg.1997.0873; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; KAPUR N, 1980, J NEUROL NEUROSUR PS, V43, P461, DOI 10.1136/jnnp.43.5.461; KESNER RP, 1994, NEUROPSYCHOLOGIA, V32, P881, DOI 10.1016/0028-3932(94)90040-X; Kinsbourne Marcel, 1995, P1321; Kopelman MD, 1997, NEUROPSYCHOLOGIA, V35, P1533, DOI 10.1016/S0028-3932(97)00076-6; Kopelman MD, 1997, COGNITIVE NEUROPSYCH, V14, P683, DOI 10.1080/026432997381411; KOPELMAN MD, 1987, J NEUROL NEUROSUR PS, V50, P1482, DOI 10.1136/jnnp.50.11.1482; MERCER B, 1977, ARCH NEUROL-CHICAGO, V34, P429, DOI 10.1001/archneur.1977.00500190063009; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; Moscovitch M., 1989, VARIETIES MEMORY CON, P133; PARKIN AJ, 1993, CORTEX, V29, P267, DOI 10.1016/S0010-9452(13)80180-3; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; Schacter DL, 1998, ANNU REV PSYCHOL, V49, P289, DOI 10.1146/annurev.psych.49.1.289; SCHACTER DL, 1984, J VERB LEARN VERB BE, V23, P593, DOI 10.1016/S0022-5371(84)90373-6; Schnider A, 1994, Behav Neurol, V7, P87, DOI 10.3233/BEN-1994-7207; Schnider A, 1996, J NEUROL NEUROSUR PS, V61, P186, DOI 10.1136/jnnp.61.2.186; Schnider A, 1996, BRAIN, V119, P1365, DOI 10.1093/brain/119.4.1365; Schnider A, 1996, BRAIN, V119, P1627, DOI 10.1093/brain/119.5.1627; SCHNIDER A, 1997, J INT NEUROPSYCH SOC, V4, P61; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SHAPIRO BE, 1981, NEUROLOGY, V31, P1070, DOI 10.1212/WNL.31.9.1070; SHIMAMURA AP, 1991, PSYCHOBIOLOGY, V19, P1; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; SQUIRE LR, 1981, NEUROPSYCHOLOGIA, V19, P141, DOI 10.1016/0028-3932(81)90054-3; SQUIRE LR, 1986, BEHAV NEUROSCI, V100, P866, DOI 10.1037/0735-7044.100.6.866; STUSS DT, 1978, NEUROLOGY, V28, P1166, DOI 10.1212/WNL.28.11.1166; Thurstone L. L., 1963, CHICAGO TEST PRIMARY	49	178	182	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					677	681		10.1038/10236	http://dx.doi.org/10.1038/10236			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	259EY	10404203				2022-12-17	WOS:000083882600021
J	Alagarsamy, S; Marino, MJ; Rouse, ST; Gereau, RW; Heinemann, SF; Conn, PJ				Alagarsamy, S; Marino, MJ; Rouse, ST; Gereau, RW; Heinemann, SF; Conn, PJ			Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; PROTEIN-KINASE-C; RAT HIPPOCAMPAL SLICES; PHOSPHATIDYLINOSITOL TURNOVER; CEREBRAL-CORTEX; STRIATAL SLICES; MICE LACKING; RESPONSES; BRAIN	The metabotropic glutamate receptor, mGluR5, has a critical role in induction of NMDA-receptor-dependent forms of synaptic plasticity and excitotoxicity. This is likely mediated by a reciprocal positive-feedback interaction between these two glutamate receptor subtypes in which activation of mGluR5 potentiates NMDA receptor currents and NMDA receptor activation potentiates mGluR5-mediated responses. We have investigated the mechanism by which NMDA receptor activation modulates mGluR5 function and find evidence that this response is mediated by activation of a protein phosphatase and a resultant dephosphorylation of protein kinase C phosphorylation sites on mGluR5. This form of neuromodulation may be important in a number of normal and pathological processes that involve activation of the NMDA receptor.	Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Emory University; Baylor College of Medicine; Salk Institute	Conn, PJ (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	jconn@pharm.emory.edu	Conn, Peter/D-7848-2012					Angenstein F, 1997, PROG NEURO-PSYCHOPH, V21, P427, DOI 10.1016/S0278-5846(97)00012-2; ANIKSZTEJN L, 1992, EUR J NEUROSCI, V4, P500, DOI 10.1111/j.1460-9568.1992.tb00900.x; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; BORTOLOTTO ZA, 1995, J NEUROSCI METH, V59, P19, DOI 10.1016/0165-0270(94)00189-N; BRODIN L, 1994, ACTA PHYSIOL SCAND, V150, P1, DOI 10.1111/j.1748-1716.1994.tb09653.x; BRUNO V, 1995, NEUROPHARMACOLOGY, V34, P1089, DOI 10.1016/0028-3908(95)00077-J; CHALLISS RAJ, 1994, BRIT J PHARMACOL, V112, P231, DOI 10.1111/j.1476-5381.1994.tb13057.x; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; COLLINS DR, 1995, BRAIN RES, V684, P165, DOI 10.1016/0006-8993(95)00410-R; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Doherty AJ, 1997, NEUROPHARMACOLOGY, V36, P265, DOI 10.1016/S0028-3908(97)00001-4; ENAN E, 1992, BIOCHEM PHARMACOL, V43, P1777, DOI 10.1016/0006-2952(92)90710-Z; Fitzjohn SM, 1996, NEUROSCI LETT, V203, P211, DOI 10.1016/0304-3940(96)12301-6; Gereau RW, 1998, NEURON, V20, P143, DOI 10.1016/S0896-6273(00)80442-0; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; HALPAIN S, 1990, NEURON, V5, P237, DOI 10.1016/0896-6273(90)90161-8; HARVEY J, 1993, BRIT J PHARMACOL, V109, P1085, DOI 10.1111/j.1476-5381.1993.tb13733.x; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Kawabata S, 1996, NATURE, V383, P89, DOI 10.1038/383089a0; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lu YM, 1997, J NEUROSCI, V17, P5196; LUTHI A, 1994, PFLUG ARCH EUR J PHY, V427, P197, DOI 10.1007/BF00585965; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MORARI M, 1991, BRAIN RES, V553, P14, DOI 10.1016/0006-8993(91)90223-I; MORARI M, 1994, NEUROCHEM INT, V24, P191, DOI 10.1016/0197-0186(94)90106-6; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; PALMER E, 1988, MOL BRAIN RES, V4, P161, DOI 10.1016/0169-328X(88)90008-3; Roberson ED, 1996, LEARN MEMORY, V3, P1, DOI 10.1101/lm.3.1.1; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; SACAAN AI, 1992, NEUROSCI LETT, V139, P77, DOI 10.1016/0304-3940(92)90862-2; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; WANG JH, 1994, NEUROREPORT, V5, P2377, DOI 10.1097/00001756-199411000-00041; Yakel JL, 1997, TRENDS PHARMACOL SCI, V18, P124, DOI 10.1016/S0165-6147(97)01046-8	39	178	181	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					234	240		10.1038/6338	http://dx.doi.org/10.1038/6338			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195215				2022-12-17	WOS:000081684500010
J	Ilardi, JM; Mochida, S; Sheng, ZH				Ilardi, JM; Mochida, S; Sheng, ZH			Snapin: a SNARE-associated protein implicated in synaptic transmission	NATURE NEUROSCIENCE			English	Article							RAT SYMPATHETIC NEURONS; NEUROTRANSMITTER RELEASE; MEMBRANE-PROTEIN; SYNTAXIN; IDENTIFICATION; INHIBITION; PEPTIDES; FUSION; SYNAPTOTAGMIN; EXOCYTOSIS	Synaptic vesicle docking and fusion are mediated by the assembly of a stable SNARE core complex of proteins, which include the synaptic vesicle membrane protein VAMP/synaptobrevin and the plasmalemmal proteins syntaxin and SNAP-25. We have now identified another SNAP-25-binding protein, called Snapin. Snapin was enriched in neurons and exclusively located on synaptic vesicle membranes. It associated with the SNARE complex through direct interaction with SNAP-25. Binding of recombinant Snapin-CT to SNAP-25 blocked the association of the SNARE complex with synaptotagmin. Introduction of Snapin-CT and peptides containing the SNAP-25 binding sequence into presynaptic superior cervical ganglion neurons in culture reversibly inhibited synaptic transmission. These results suggest that Snapin is an important component of the neurotransmitter release process through its modulation of the sequential interactions between the SNAREs and synaptotagmin.	NINDS, Synapt Funct Unit, NIH, Bethesda, MD 20892 USA; Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Tokyo Medical University	Sheng, ZH (corresponding author), NINDS, Synapt Funct Unit, NIH, Bldg 36,Room 5A23,9000 Rockville Pike, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002946, ZIANS002946] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAJJALIEH SM, 1995, J BIOL CHEM, V270, P1971, DOI 10.1074/jbc.270.5.1971; Bean AJ, 1997, NATURE, V385, P826, DOI 10.1038/385826a0; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CORNILLE F, 1995, J BIOL CHEM, V270, P16826, DOI 10.1074/jbc.270.28.16826; Doussau F, 1998, J NEUROSCI, V18, P3147; DUNKLEY PR, 1988, BRAIN RES, V441, P59, DOI 10.1016/0006-8993(88)91383-2; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; Hunter J. S., 1994, HDB STAT, V12, P1, DOI [10.1016/S0169-7161(05)80003-3, DOI 10.1016/S0169-7161(05)80003-3]; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; MOCHIDA S, 1995, NEUROSCIENCE, V65, P905, DOI 10.1016/0306-4522(94)00508-3; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; WAKSHULL E, 1979, J NEUROPHYSIOL, V42, P1410, DOI 10.1152/jn.1979.42.5.1410; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925	31	178	195	1	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					119	124		10.1038/5673	http://dx.doi.org/10.1038/5673			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195194				2022-12-17	WOS:000078231600009
J	Debettencourt, MT; Cohen, JD; Lee, RF; Norman, KA; Turk-Browne, NB				Debettencourt, Megan T.; Cohen, Jonathan D.; Lee, Ray F.; Norman, Kenneth A.; Turk-Browne, Nicholas B.			Closed-loop training of attention with real-time brain imaging	NATURE NEUROSCIENCE			English	Article							BASAL GANGLIA; TOP-DOWN; SUSTAINED ATTENTION; COMPUTATIONAL MODEL; FMRI NEUROFEEDBACK; PREFRONTAL CORTEX; NEURAL MECHANISMS; PATTERN-ANALYSIS; PERFORMANCE; OBJECTS	Lapses of attention can have negative consequences, including accidents and lost productivity. Here we used closed-loop neurofeedback to improve sustained attention abilities and reduce the frequency of lapses. During a sustained attention task, the focus of attention was monitored in real time with multivariate pattern analysis of whole-brain neuroimaging data. When indicators of an attentional lapse were detected in the brain, we gave human participants feedback by making the task more difficult. Behavioral performance improved after one training session, relative to control participants who received feedback from other participants' brains. This improvement was largest when feedback carried information from a frontoparietal attention network. A neural consequence of training was that the basal ganglia and ventral temporal cortex came to represent attentional states more distinctively. These findings suggest that attentional failures do not reflect an upper limit on cognitive potential and that attention can be trained with appropriate feedback about neural signals.	[Debettencourt, Megan T.; Cohen, Jonathan D.; Lee, Ray F.; Norman, Kenneth A.; Turk-Browne, Nicholas B.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Cohen, Jonathan D.; Norman, Kenneth A.; Turk-Browne, Nicholas B.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Turk-Browne, NB (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	ntb@princeton.edu			US National Institutes of Health grant [R01EY021755]; US National Science Foundation (NSF) grant [BCS1229597]; NSF fellowship [DGE1148900]; John Templeton Foundation; NATIONAL EYE INSTITUTE [R01EY021755] Funding Source: NIH RePORTER	US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation (NSF) grant; NSF fellowship(National Science Foundation (NSF)); John Templeton Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by US National Institutes of Health grant R01EY021755, US National Science Foundation (NSF) grant BCS1229597, NSF fellowship DGE1148900 and the John Templeton Foundation. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of these funding agencies.	Al-Aidroos N, 2012, P NATL ACAD SCI USA, V109, P14675, DOI 10.1073/pnas.1202095109; Baldauf D, 2014, SCIENCE, V344, P424, DOI 10.1126/science.1247003; Biggs AT, 2014, Q J EXP PSYCHOL, V67, P1335, DOI 10.1080/17470218.2013.859715; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Czeisler CA, 2005, NEW ENGL J MED, V353, P476, DOI 10.1056/NEJMoa041292; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008; Foerde K, 2011, NEUROBIOL LEARN MEM, V96, P624, DOI 10.1016/j.nlm.2011.08.006; Frank MJ, 2012, CEREB CORTEX, V22, P509, DOI 10.1093/cercor/bhr114; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hinds O, 2013, J NEUROPHYSIOL, V109, P1250, DOI 10.1152/jn.00533.2011; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P2234, DOI 10.1016/j.neuropsychologia.2007.02.019; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; LaConte SM, 2011, NEUROIMAGE, V56, P440, DOI 10.1016/j.neuroimage.2010.06.052; Leber AB, 2008, P NATL ACAD SCI USA, V105, P13592, DOI 10.1073/pnas.0805423105; Mackworth NH, 1948, Q J EXP PSYCHOL, V1, P6, DOI 10.1080/17470214808416738; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Noudoost B, 2010, CURR OPIN NEUROBIOL, V20, P183, DOI 10.1016/j.conb.2010.02.003; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Reddy L, 2009, P NATL ACAD SCI USA, V106, P21447, DOI 10.1073/pnas.0907330106; Redelmeier DA, 1997, NEW ENGL J MED, V336, P453, DOI 10.1056/NEJM199702133360701; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rosenberg M, 2013, ATTEN PERCEPT PSYCHO, V75, P426, DOI 10.3758/s13414-012-0413-x; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Shallice T, 2002, DEV NEUROPSYCHOL, V21, P43, DOI 10.1207/S15326942DN2101_3; Shibata K, 2011, SCIENCE, V334, P1413, DOI 10.1126/science.1212003; Sulzer J, 2013, NEUROIMAGE, V76, P386, DOI 10.1016/j.neuroimage.2013.03.033; Todd MT, 2013, NEUROIMAGE, V77, P157, DOI 10.1016/j.neuroimage.2013.03.039; Turk-Browne NB, 2013, SCIENCE, V342, P580, DOI 10.1126/science.1238409; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wiecki TV, 2013, PSYCHOL REV, V120, P329, DOI 10.1037/a0031542; Wolfe JM, 2005, NATURE, V435, P439, DOI 10.1038/435439a; Woolgar A, 2011, J NEUROSCI, V31, P14592, DOI 10.1523/JNEUROSCI.2616-11.2011; Yoo JJ, 2012, NEUROIMAGE, V59, P846, DOI 10.1016/j.neuroimage.2011.07.063; YOSS RE, 1970, NEUROLOGY, V20, P545, DOI 10.1212/WNL.20.6.545	40	177	183	4	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2015	18	3					470	165		10.1038/nn.3940	http://dx.doi.org/10.1038/nn.3940			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC2SO	25664913	Green Accepted			2022-12-17	WOS:000350195100028
J	Narayanan, NS; Cavanagh, JF; Frank, MJ; Laubach, M				Narayanan, Nandakumar S.; Cavanagh, James F.; Frank, Michael J.; Laubach, Mark			Common medial frontal mechanisms of adaptive control in humans and rodents	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; DORSOMEDIAL PREFRONTAL CORTEX; COGNITIVE CONTROL; MOTOR CORTEX; RAT; INACTIVATIONS; SCHIZOPHRENIA; STIMULATION; MODULATION; ENSEMBLES	In this report we describe how common brain networks within the medial frontal cortex (MFC) facilitate adaptive behavioral control in rodents and humans. We demonstrate that after errors, low-frequency oscillations below 12 Hz are modulated over the midfrontal cortex in humans and within the prelimbic and anterior cingulate regions of the MFC in rats. These oscillations were phase locked between the MFC and motor areas in both rats and humans. In rats, single neurons that encoded prior behavioral outcomes were phase coherent with low-frequency field oscillations, particularly after errors. Inactivating the medial frontal regions in rats led to impaired behavioral adjustments after errors, eliminated the differential expression of low-frequency oscillations after errors and increased low-frequency spike-field coupling within the motor cortex. Our results describe a new mechanism for behavioral adaptation through low-frequency oscillations and elucidate how medial frontal networks synchronize brain activity to guide performance.	[Narayanan, Nandakumar S.] Univ Iowa, Dept Neurol, Carver Coll Med, Iowa City, IA 52242 USA; [Cavanagh, James F.; Frank, Michael J.] Brown Univ, Providence, RI 02912 USA; [Frank, Michael J.] Brown Univ, Dept Psychiat, Providence, RI 02912 USA; [Frank, Michael J.] Brown Univ, Brown Inst Brain Sci, Providence, RI 02912 USA; [Laubach, Mark] Yale Univ, Sch Med, John B Pierce Lab, New Haven, CT 06520 USA; [Laubach, Mark] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	University of Iowa; Brown University; Brown University; Brown University; Yale University; The John B Pierce Laboratory, Inc; Yale University	Laubach, M (corresponding author), Yale Univ, Sch Med, John B Pierce Lab, New Haven, CT 06520 USA.	mlaubach@jbpierce.org	Cavanagh, James F/I-5222-2015	Laubach, Mark/0000-0002-2403-4497; Narayanan, Nandakumar/0000-0002-0427-0003	National Institute of Neurological Disorders and Stroke [K08 NS078100]; US National Institutes of Health (NIH) [MH080066-01]; National Science Foundation (NSF) [1125788]; NIH [P0I-AG030004-01A1]; NSF [1121147]; Division Of Integrative Organismal Systems [1121147] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS078100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG030004] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S Masters for help with human data acquisition, N. Horst for technical editing and G.R. Yang for help with spike-field coherence code and simulations. This work was funded by National Institute of Neurological Disorders and Stroke grant K08 NS078100 to N.S.N., US National Institutes of Health (NIH) grant MH080066-01 and National Science Foundation (NSF) grant 1125788 to M.J.F., and NIH grant P0I-AG030004-01A1 and NSF grant 1121147 to M.L.	Allen TA, 2008, J NEUROSCI METH, V171, P30, DOI 10.1016/j.jneumeth.2008.01.033; Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; BELLMAN R, 1959, P NATL ACAD SCI USA, V45, P1288, DOI 10.1073/pnas.45.8.1288; Buzsaki G, 2011, RHYTHMS BRAIN; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cavanagh JF, 2012, PSYCHOPHYSIOLOGY, V49, P220, DOI 10.1111/j.1469-8986.2011.01293.x; Cavanagh JF, 2011, NAT NEUROSCI, V14, P1462, DOI 10.1038/nn.2925; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Danielmeier C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00233; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Dutilh G, 2012, ATTEN PERCEPT PSYCHO, V74, P454, DOI 10.3758/s13414-011-0243-2; Dzirasa K, 2010, J NEUROSCI, V30, P6387, DOI 10.1523/JNEUROSCI.0764-10.2010; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Hampson RE, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056012; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; KORNBLUM S, 1973, PERCEPT PSYCHOPHYS, V13, P108, DOI 10.3758/BF03207243; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; Lee TG, 2012, J NEUROSCI, V32, P15458, DOI 10.1523/JNEUROSCI.0627-12.2012; McClintock SM, 2011, BIOL PSYCHIAT, V70, P19, DOI 10.1016/j.biopsych.2011.02.031; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Modirrousta M, 2008, J NEUROSCI, V28, P14000, DOI 10.1523/JNEUROSCI.4450-08.2008; Narayanan NS, 2006, NEUROSCIENCE, V139, P865, DOI 10.1016/j.neuroscience.2005.11.072; Narayanan NS, 2008, J NEUROPHYSIOL, V100, P520, DOI 10.1152/jn.00035.2008; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; Narayanan NS, 2005, J NEUROSCI, V25, P4207, DOI 10.1523/JNEUROSCI.4697-04.2005; Newman EL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00024; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Robbins TW, 2007, PHILOS T R SOC B, V362, P917, DOI 10.1098/rstb.2007.2097; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Sheth SA, 2012, NATURE, V488, P218, DOI 10.1038/nature11239; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; van Meel CS, 2007, PSYCHIAT RES, V151, P211, DOI 10.1016/j.psychres.2006.05.011; Velligan DI, 2002, PSYCHIAT RES, V113, P227, DOI 10.1016/S0165-1781(02)00264-0; Vertes RP, 2006, J COMP NEUROL, V499, P768, DOI 10.1002/cne.21135; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Womelsdorf T, 2010, P NATL ACAD SCI USA, V107, P5248, DOI 10.1073/pnas.0906194107	40	177	177	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1888	1895		10.1038/nn.3549	http://dx.doi.org/10.1038/nn.3549			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24141310	Green Accepted			2022-12-17	WOS:000327416800028
J	Stassart, RM; Fledrich, R; Velanac, V; Brinkmann, BG; Schwab, MH; Meijer, D; Sereda, MW; Nave, KA				Stassart, Ruth M.; Fledrich, Robert; Velanac, Viktorija; Brinkmann, Bastian G.; Schwab, Markus H.; Meijer, Dies; Sereda, Michael W.; Nave, Klaus-Armin			A role for Schwann cell-derived neuregulin-1 in remyelination	NATURE NEUROSCIENCE			English	Article							PERIPHERAL-NERVE REGENERATION; MYELIN SHEATH THICKNESS; GROWTH; EXPRESSION; RECEPTORS; INJURY; PROLIFERATION; ENSHEATHMENT; MAINTENANCE; MECHANISMS	After peripheral nerve injury, axons regenerate and become remyelinated by resident Schwann cells. However, myelin repair never results in the original myelin thickness, suggesting insufficient stimulation by neuronal growth factors. Upon testing this hypothesis, we found that axonal neuregulin-1 NRG1) type III and, unexpectedly, also NRG1 type I restored normal myelination when overexpressed in transgenic mice. This led to the observation that Wallerian degeneration induced de novo NRG1 type I expression in Schwann cells themselves. Mutant mice lacking a functional Nrg1 gene in Schwann cells are fully myelinated but exhibit impaired remyelination in adult life. We suggest a model in which loss of axonal contact triggers denervated Schwann cells to transiently express NRG1 as an autocrine/paracrine signal that promotes Schwann cell differentiation and remyelination.	[Stassart, Ruth M.; Fledrich, Robert; Velanac, Viktorija; Brinkmann, Bastian G.; Schwab, Markus H.; Sereda, Michael W.; Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, D-3400 Gottingen, Germany; [Stassart, Ruth M.] Univ Gottingen, Dept Neuropathol, Gottingen, Germany; [Velanac, Viktorija] German Ctr Neurodegenerat Dis, Bonn, Germany; [Brinkmann, Bastian G.] Charite, Dept Neurosurg, D-13353 Berlin, Germany; [Meijer, Dies] Erasmus MC, Dept Genet, Rotterdam, Netherlands; [Sereda, Michael W.] Univ Gottingen, Dept Clin Neurophysiol, Gottingen, Germany	Max Planck Society; University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Erasmus University Rotterdam; Erasmus MC; University of Gottingen	Sereda, MW (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-3400 Gottingen, Germany.	sereda@em.mpg.de; nave@em.mpg.de	Stassart, Ruth M/T-7093-2019; Fledrich, Robert/AAF-1590-2020; Fledrich, Robert/M-1911-2019; Meijer, Dies/C-7786-2012	Meijer, Dies/0000-0002-8461-6341	Deutsche Forschungsgemeinschaft Research Center Molecular Physiology of the Brain; European Commission [FP7-201535]; Association Francaise contre Les Myopathies [15037]; German Ministry of Education and Research (BMBF) [FKZ: 01ES0812]; Deutsche Forschungsgemeinschaft; European Research Council	Deutsche Forschungsgemeinschaft Research Center Molecular Physiology of the Brain(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Association Francaise contre Les Myopathies(Association Francaise contre les Myopathies); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	We thank C. Birchmeier (Max Delbruck Center, Berlin) for providing NRG1 'floxed' mice, L. Role (Stony Brook University) for providing NRG1 type III mutants, and A. Fahrenholz for help with immunohistochemistry. This work was supported by grants from Deutsche Forschungsgemeinschaft Research Center Molecular Physiology of the Brain, European Commission FP7-201535 (Ngidd) to K.-A.N. and by the Association Francaise contre Les Myopathies (15037 to M. W. S.). M. W. S. and R. F. were supported by the German Ministry of Education and Research (BMBF, FKZ: 01ES0812 to M. W. S.). M. W. S. is funded through a Deutsche Forschungsgemeinschaft Heisenberg professorship. K.-A.N. is funded through a European Research Council Advanced Investigator grant.	Atanasoski S, 2006, J NEUROSCI, V26, P2124, DOI 10.1523/JNEUROSCI.4594-05.2006; Bermingham-McDonogh O, 1997, MOL CELL NEUROSCI, V10, P184, DOI 10.1006/mcne.1997.0654; Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; Bosse F, 2012, CELL TISSUE RES, V349, P5, DOI 10.1007/s00441-012-1389-5; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; CAMPENOT RB, 1982, DEV BIOL, V93, P1, DOI 10.1016/0012-1606(82)90232-9; Carroll SL, 1997, J NEUROSCI, V17, P1642; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Falls DL, 2003, J NEUROCYTOL, V32, P619, DOI 10.1023/B:NEUR.0000020614.83883.be; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Fricker FR, 2011, FUTUR NEUROL, V6, P809, DOI 10.2217/FNL.11.45; Fricker FR, 2011, J NEUROSCI, V31, P3225, DOI 10.1523/JNEUROSCI.2568-10.2011; Ghazvini M, 2002, EMBO J, V21, P4612, DOI 10.1093/emboj/cdf475; Hoke A, 2006, NAT CLIN PRACT NEURO, V2, P448, DOI 10.1038/ncpneuro0262; Inserra MM, 1998, MICROSURG, V18, P119, DOI 10.1002/(SICI)1098-2752(1998)18:2<119::AID-MICR10>3.0.CO;2-0; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Kleitman N., 1998, CULTURING NERVE CELL, P545; Li L, 2002, ONCOGENE, V21, P4900, DOI 10.1038/sj.onc.1205634; Loeb JA, 1999, DEVELOPMENT, V126, P781; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Myers RR, 2003, EXP NEUROL, V184, P606, DOI 10.1016/S0014-4886(03)00297-8; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Pertusa M, 2007, J BIOL CHEM, V282, P28768, DOI 10.1074/jbc.M701878200; Rosenbaum C, 1997, EXP NEUROL, V148, P604, DOI 10.1006/exnr.1997.6696; SCHRODER JM, 1972, BRAIN RES, V45, P49, DOI 10.1016/0006-8993(72)90215-6; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; Stonecypher MS, 2006, J NEUROPATH EXP NEUR, V65, P162, DOI 10.1097/01.jnen.0000199575.93794.2f; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Velanac V, 2012, GLIA, V60, P203, DOI 10.1002/glia.21255; WELCHER AA, 1991, PHILOS T R SOC B, V331, P295, DOI 10.1098/rstb.1991.0020; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9	38	177	186	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					48	U76		10.1038/nn.3281	http://dx.doi.org/10.1038/nn.3281			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23222914				2022-12-17	WOS:000312633900012
J	Antony, JW; Gobel, EW; O'Hare, JK; Reber, PJ; Paller, KA				Antony, James W.; Gobel, Eric W.; O'Hare, Justin K.; Reber, Paul J.; Paller, Ken A.			Cued memory reactivation during sleep influences skill learning	NATURE NEUROSCIENCE			English	Article							AUDITORY-STIMULATION; PREMOTOR CORTEX; SLOW WAVES; CONSOLIDATION; INTEGRATION; SPINDLES; RECOGNITION; IMPROVEMENT; NETWORK; HUMANS	Information acquired during waking can be reactivated during sleep, promoting memory stabilization. After people learned to produce two melodies in time with moving visual symbols, we enhanced relative performance by presenting one melody during an afternoon nap. Electrophysiological signs of memory processing during sleep corroborated the notion that appropriate auditory stimulation that does not disrupt sleep can nevertheless bias memory consolidation in relevant brain circuitry.	[Antony, James W.; Gobel, Eric W.; Reber, Paul J.; Paller, Ken A.] Northwestern Univ, Interdept Neurosci Program, Evanston, IL 60208 USA; [O'Hare, Justin K.; Reber, Paul J.; Paller, Ken A.] Northwestern Univ, Dept Psychol, Evanston, IL USA	Northwestern University; Northwestern University	Paller, KA (corresponding author), Northwestern Univ, Interdept Neurosci Program, Evanston, IL 60208 USA.	kap@northwestern.edu	Paller, Ken/M-2676-2019	O'Hare, Justin/0000-0002-7363-6064; Paller, Ken/0000-0003-4415-4143	National Science Foundation [BCS1025697]; National Institute of Aging [T32-AG020418]; National Institute of Neurological Diseases and Stroke [T32-NS047987]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS047987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020506, T32AG020418] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank B. Mander, J. Saletin, S. Greer and D. Oudiette for technical help. This material is based on work supported by National Science Foundation grant BCS1025697, National Institute of Aging grant T32-AG020418 and National Institute of Neurological Diseases and Stroke grant T32-NS047987.	Baumann S, 2005, ANN NY ACAD SCI, V1060, P186, DOI 10.1196/annals.1360.038; Brawn TP, 2008, LEARN MEMORY, V15, P815, DOI 10.1101/lm.1180908; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Diekelmann S, 2011, NAT NEUROSCI, V14, P381, DOI 10.1038/nn.2744; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Ferrarelli F, 2007, AM J PSYCHIAT, V164, P483, DOI 10.1176/appi.ajp.164.3.483; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gobel EW, 2011, J EXP PSYCHOL LEARN, V37, P994, DOI 10.1037/a0022959; GUERRIEN A, 1989, PHYSIOL BEHAV, V45, P947, DOI 10.1016/0031-9384(89)90219-9; HARS B, 1985, BEHAV BRAIN RES, V18, P241, DOI 10.1016/0166-4328(85)90032-4; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Landsness EC, 2009, SLEEP, V32, P1273; Mander BA, 2011, CURR BIOL, V21, pR183, DOI 10.1016/j.cub.2011.01.019; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Sanchez DJ, 2010, PSYCHON B REV, V17, P790, DOI 10.3758/PBR.17.6.790; Shank SS, 2009, NATURE, V458, P73, DOI 10.1038/nature07615; SMITH C, 1990, PSYCHIAT J U OTTAWA, V15, P85; Tamaki M, 2009, CLIN NEUROPHYSIOL, V120, P878, DOI 10.1016/j.clinph.2009.03.006; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	25	177	181	2	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1114	+		10.1038/nn.3152	http://dx.doi.org/10.1038/nn.3152			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22751035	Green Accepted			2022-12-17	WOS:000306844500016
J	Altimus, CM; Guler, AD; Alam, NM; Arman, AC; Prusky, GT; Sampath, AP; Hattar, S				Altimus, Cara M.; Gueler, Ali D.; Alam, Nazia M.; Arman, A. Cyrus; Prusky, Glen T.; Sampath, Alapakkam P.; Hattar, Samer			Rod photoreceptors drive circadian photoentrainment across a wide range of light intensities	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; SPECTRAL SENSITIVITY; VISUAL FUNCTIONS; NON-CONE; MELANOPSIN; MOUSE; RESPONSES; PHASE; MICE; RHYTHMS	In mammals, synchronization of the circadian pacemaker in the hypothalamus is achieved through direct input from the eyes conveyed by intrinsically photosensitive retinal ganglion cells (ipRGCs). Circadian photoentrainment can be maintained by rod and cone photoreceptors, but their functional contributions and their retinal circuits that impinge on ipRGCs are not well understood. Using mice that lack functional rods or in which rods are the only functional photoreceptors, we found that rods were solely responsible for photoentrainment at scotopic light intensities. Rods were also capable of driving circadian photoentrainment at photopic intensities at which they were incapable of supporting a visually guided behavior. Using mice in which cone photoreceptors were ablated, we found that rods signal through cones at high light intensities, but not at low light intensities. Thus, rods use two distinct retinal circuits to drive ipRGC function to support circadian photoentrainment across a wide range of light intensities.	[Altimus, Cara M.; Gueler, Ali D.; Hattar, Samer] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Alam, Nazia M.; Prusky, Glen T.] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Arman, A. Cyrus; Sampath, Alapakkam P.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Hattar, Samer] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; Cornell University; University of Southern California; Johns Hopkins University	Hattar, S (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	asampath@usc.edu; shattar@jhu.edu	Hattar, Samer/W-6927-2019	Guler, Ali Deniz/0000-0001-8218-850X	Johns Hopkins University Mouse Tri-Lab; US National Institutes of Health [GM076430, EY017606]; David and Lucile Packard Foundation; Alfred P. Sloan Foundation; McKnight Endowment Fund for Neurosciences; NATIONAL EYE INSTITUTE [R01EY017606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076430] Funding Source: NIH RePORTER	Johns Hopkins University Mouse Tri-Lab; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); McKnight Endowment Fund for Neurosciences; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank J. Nathans for the h. red DTA mice. We also want to thank R. Kuruvilla, H. Zhao and M. Halpern for their careful reading of the manuscript and helpful suggestions and the Johns Hopkins University Mouse Tri-Lab for its support. This work was supported by US National Institutes of Health grants GM076430 (S.H.) and EY017606 (A.P.S.), the David and Lucile Packard Foundation (S.H.), the Alfred P. Sloan Foundation (S.H.) and the McKnight Endowment Fund for Neurosciences (A.P.S.).	Armstrong-Gold CE, 2003, J NEUROSCI, V23, P3796; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Brainard GC, 2001, J NEUROSCI, V21, P6405; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chang B, 2006, INVEST OPHTH VIS SCI, V47, P5017, DOI 10.1167/iovs.05-1468; CORNWALL MC, 1994, J PHYSIOL-LONDON, V480, P261, DOI 10.1113/jphysiol.1994.sp020358; CORNWALL MC, 1990, J GEN PHYSIOL, V96, P345, DOI 10.1085/jgp.96.2.345; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DACHEUX RF, 1986, J NEUROSCI, V6, P331; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Doyle SE, 2006, P NATL ACAD SCI USA, V103, P10432, DOI 10.1073/pnas.0600934103; EBIHARA S, 1980, PHYSIOL BEHAV, V24, P523, DOI 10.1016/0031-9384(80)90246-2; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Gooley JJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000741; Guler AD, 2007, COLD SPRING HARB SYM, V72, P509, DOI 10.1101/sqb.2007.72.074; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hack I, 1999, P NATL ACAD SCI USA, V96, P14130, DOI 10.1073/pnas.96.24.14130; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; IBUKA N, 1977, BRAIN RES, V122, P33, DOI 10.1016/0006-8993(77)90660-6; Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 2001, BEHAV BRAIN RES, V125, P97, DOI 10.1016/S0166-4328(01)00274-1; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Mrosovsky N, 2005, J COMP PHYSIOL A, V191, P1011, DOI 10.1007/s00359-005-0017-1; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mrosovsky N, 2003, J COMP PHYSIOL A, V189, P69, DOI 10.1007/s00359-002-0378-7; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Protti DA, 2005, J NEUROPHYSIOL, V93, P3479, DOI 10.1152/jn.00839.2004; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Sampath AP, 2005, NEURON, V46, P413, DOI 10.1016/j.neuron.2005.04.006; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; SMITH RG, 1986, J NEUROSCI, V6, P3505; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Wright HR, 2004, J PINEAL RES, V36, P140, DOI 10.1046/j.1600-079X.2003.00108.x; Xin DY, 1999, VISUAL NEUROSCI, V16, P653, DOI 10.1017/S0952523899164058; Yoshimura T, 1996, J COMP PHYSIOL A, V178, P797	50	177	180	3	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1107	U102		10.1038/nn.2617	http://dx.doi.org/10.1038/nn.2617			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20711184	Green Accepted, Green Submitted			2022-12-17	WOS:000281332600016
J	Gan, JO; Walton, ME; Phillips, PEM				Gan, Jerylin O.; Walton, Mark E.; Phillips, Paul E. M.			Dissociable cost and benefit encoding of future rewards by mesolimbic dopamine	NATURE NEUROSCIENCE			English	Article							UTILITY	Reward-predicting cues evoke activity in midbrain dopamine neurons that encodes fundamental attributes of economic value, including reward magnitude, delay and uncertainty. We found that dopamine release in rat nucleus accumbens encodes anticipated benefits, but not effort-based response costs unless they are atypically low. This neural separation of costs and benefits indicates that mesolimbic dopamine scales with the value of pending rewards, but does not encode the net utility of the action to obtain them.	[Gan, Jerylin O.; Walton, Mark E.; Phillips, Paul E. M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Gan, Jerylin O.; Phillips, Paul E. M.] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; [Walton, Mark E.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Phillips, Paul E. M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Oxford; University of Washington; University of Washington Seattle	Phillips, PEM (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	pemp@uw.edu	Phillips, Paul/E-7813-2013; Phillips, Paul E. M./A-4463-2008	Phillips, Paul/0000-0002-8749-7026; Phillips, Paul E. M./0000-0002-8749-7026	National Institutes of Health [R01-MH079292, R21-AG030775]; Wellcome Trust; National Institute of General Medical Sciences [T32-GM007270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG030775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank S. Ng-Evans for invaluable technical support, C. Akers and S. Barnes for assistance, and J. Clark, S. Sandberg and M. Wanat for helpful comments. This work was funded by the National Institutes of Health (R01-MH079292 and R21-AG030775 to P. E. M. P.) and a Wellcome Trust Advanced Training Fellowship ( M. E. W.). J.O.G. was supported by the National Institute of General Medical Sciences (T32-GM007270, Kimelman).	Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Floresco SB, 2008, COGN AFFECT BEHAV NE, V8, P375, DOI 10.3758/CABN.8.4.375; Glimcher PW, 2005, GAME ECON BEHAV, V52, P213, DOI 10.1016/j.geb.2004.06.011; Knutson B, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P389, DOI 10.1016/B978-0-12-374176-9.00025-7; Kobayashi S, 2008, J NEUROSCI, V28, P7837, DOI 10.1523/JNEUROSCI.1600-08.2008; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Phillips PEM, 2007, PSYCHOPHARMACOLOGY, V191, P483, DOI 10.1007/s00213-006-0626-6; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Stephens D.W., 1986, pi; Walton ME, 2006, NEURAL NETWORKS, V19, P1302, DOI 10.1016/j.neunet.2006.03.005	13	177	177	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					25	27		10.1038/nn.2460	http://dx.doi.org/10.1038/nn.2460			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	19904261	Green Accepted, Green Submitted			2022-12-17	WOS:000273056300009
J	Goaillard, JM; Taylor, AL; Schulz, DJ; Marder, E				Goaillard, Jean-Marc; Taylor, Adam L.; Schulz, David J.; Marder, Eve			Functional consequences of animal-to-animal variation in circuit parameters	NATURE NEUROSCIENCE			English	Article							LOBSTER STOMATOGASTRIC GANGLION; ELECTRICALLY COUPLED NEURONS; RHYTHMICALLY ACTIVE NEURONS; TRANSIENT POTASSIUM CURRENT; PREMOTOR SYNAPTIC INPUT; HEART MOTOR-NEURONS; PATTERN GENERATOR; PYLORIC NEURONS; PHASE-SHIFTS; ALTERNATIVE OUTPUTS	How different are the neuronal circuits for a given behavior across individual animals? To address this question, we measured multiple cellular and synaptic parameters in individual preparations to see how they correlated with circuit function, using neurons and synapses in the pyloric circuit of the stomatogastric ganglion of the crab Cancer borealis. There was considerable preparation-to-preparation variability in the strength of two identified synapses, in the amplitude of a modulator-evoked current and in the expression of six ion channel genes. Nonetheless, we found strong correlations across preparations among these parameters and attributes of circuit performance. These data illustrate the importance of making multidimensional measurements from single preparations for understanding how variability in circuit output is related to the variability of multiple circuit parameters.	[Goaillard, Jean-Marc; Taylor, Adam L.; Marder, Eve] Brandeis Univ, Volen Ctr, Waltham, MA USA; [Goaillard, Jean-Marc; Taylor, Adam L.; Marder, Eve] Brandeis Univ, Dept Biol, Waltham, MA USA; [Schulz, David J.] Univ Missouri, Columbia, MO USA	Brandeis University; Brandeis University; University of Missouri System; University of Missouri Columbia	Goaillard, JM (corresponding author), Univ Aix Marseille 2, Fac Med Secteur Nord, INSERM, UMR 641, Marseille, France.	goaillard@univmed.fr	Marder, Eve/A-5713-2012	Schulz, David/0000-0003-4532-5362	US National Institutes of Health [NS17813, MH46742, NS50928]; James S. McDonnell Foundation [220020065]; National Science Foundation [IOB-0615160]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH046742, R01MH046742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS050928, R01NS017813, R37NS017813] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. R. Pulver and L. S. Tang for contributing data. This work was supported by US National Institutes of Health grants NS17813 (E. M.), MH46742 (E. M.) and NS50928 (A. L. T.), James S. McDonnell Foundation grant 220020065 (E. M.) and National Science Foundation grant IOB-0615160 (D. J. S.).	Achard P, 2006, PLOS COMPUT BIOL, V2, P794, DOI 10.1371/journal.pcbi.0020094; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; BUCHHOLTZ F, 1992, J NEUROPHYSIOL, V67, P332, DOI 10.1152/jn.1992.67.2.332; Chouard T, 2008, NATURE, V456, P300, DOI 10.1038/456300a; EISEN JS, 1982, J NEUROPHYSIOL, V48, P1392, DOI 10.1152/jn.1982.48.6.1392; EISEN JS, 1984, J NEUROPHYSIOL, V51, P1375, DOI 10.1152/jn.1984.51.6.1375; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; GOLOWASCH J, 1992, J NEUROPHYSIOL, V67, P318, DOI 10.1152/jn.1992.67.2.318; GOLOWASCH J, 1992, J NEUROSCI, V12, P810; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; Greenspan RJ, 2001, NAT REV GENET, V2, P383, DOI 10.1038/35072018; HARRISWARRICK RM, 1995, J NEUROSCI, V15, P342; HARRISWARRICK RM, 1995, J NEUROPHYSIOL, V74, P1404, DOI 10.1152/jn.1995.74.4.1404; HOOPER SL, 1987, J NEUROSCI, V7, P2097; HOOPER SL, 1986, J COMP PHYSIOL A, V159, P227, DOI 10.1007/BF00612305; Lien CC, 2003, J NEUROSCI, V23, P2058; Liss B, 2004, TRENDS NEUROSCI, V27, P475, DOI 10.1016/j.tins.2004.06.007; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; MARDER E, 1984, J NEUROPHYSIOL, V51, P1345, DOI 10.1152/jn.1984.51.6.1345; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Miller J.P., 1987, P109; Nadim F, 1999, P NATL ACAD SCI USA, V96, P8206, DOI 10.1073/pnas.96.14.8206; Norris BJ, 2007, J NEUROPHYSIOL, V98, P2992, DOI 10.1152/jn.00877.2007; Norris BJ, 2007, J NEUROPHYSIOL, V98, P2983, DOI 10.1152/jn.00407.2007; Nusbaum MP, 2001, TRENDS NEUROSCI, V24, P146, DOI 10.1016/S0166-2236(00)01723-9; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Prinz AA, 2003, J NEUROSCI, V23, P943; Rabbah P, 2007, J NEUROPHYSIOL, V97, P2239, DOI 10.1152/jn.01161.2006; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Swensen AM, 2005, J NEUROSCI, V25, P3509, DOI 10.1523/JNEUROSCI.3929-04.2005; Swensen AM, 2001, J NEUROSCI, V21, P4050, DOI 10.1523/JNEUROSCI.21-11-04050.2001; Swensen AM, 2000, J NEUROSCI, V20, P6752, DOI 10.1523/JNEUROSCI.20-18-06752.2000; Taylor AL, 2009, J NEUROSCI, V29, P5573, DOI 10.1523/JNEUROSCI.4438-08.2009; Thirumalai V, 2006, J NEUROPHYSIOL, V95, P1762, DOI 10.1152/jn.00764.2005; Thuma JB, 2007, J COMP PHYSIOL A, V193, P1101, DOI 10.1007/s00359-007-0261-7; TIERNEY AJ, 1992, J NEUROPHYSIOL, V67, P599, DOI 10.1152/jn.1992.67.3.599; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Weimann JM, 1997, J NEUROSCI, V17, P1748; WEIMANN JM, 1991, J NEUROPHYSIOL, V65, P111, DOI 10.1152/jn.1991.65.1.111	44	177	177	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1424	1430		10.1038/nn.2404	http://dx.doi.org/10.1038/nn.2404			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19838180	Green Submitted, Green Accepted			2022-12-17	WOS:000271194100015
J	Burr, D; Tozzi, A; Morrone, MC				Burr, David; Tozzi, Arianna; Morrone, M. Concetta			Neural mechanisms for timing visual events are spatially selective in real-world coordinates	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; PARIETAL CORTEX; TIME; NEURONS; REPRESENTATION; ADAPTATION; MACAQUE; SPACE	It is generally assumed that perceptual events are timed by a centralized supramodal clock. This study challenges this notion in humans by providing clear evidence that visual events of subsecond duration are timed by visual neural mechanisms with spatially circumscribed receptive fields, localized in real-world, rather than retinal, coordinates.	Univ Florence, Dept Psychol, Florence, Italy; Univ Western Australia, Nedlands, WA 6009, Australia; CNR, Ist Neurosci, I-56100 Pisa, Italy; Univ Vita & Salute San Rafaele, Fac Psicol, Milan, Italy	University of Florence; University of Western Australia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Vita-Salute San Raffaele University	Burr, D (corresponding author), Univ Florence, Dept Psychol, Via S Nicolo 89, Florence, Italy.	dave@in.cnr.it	Morrone, Maria Concetta/C-6756-2014	Morrone, Maria Concetta/0000-0002-1025-0316; Burr, David/0000-0003-1541-8832				BUETI D, 2006, J COGN NEUROSCI F, V58, P335; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; d'Avossa G, 2007, NAT NEUROSCI, V10, P249, DOI 10.1038/nn1824; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Macknik SL, 2004, J COGNITIVE NEUROSCI, V16, P1049, DOI 10.1162/0898929041502788; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; MORGAN MJ, 2006, J VIS, V6, P1012; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; THOMPSON P, 1981, VISION RES, V21, P337, DOI 10.1016/0042-6989(81)90161-9	15	177	180	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					423	425		10.1038/nn1874	http://dx.doi.org/10.1038/nn1874			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17369824				2022-12-17	WOS:000245228600012
J	Kim, S; Burette, A; Chung, HS; Kwon, SK; Woo, J; Lee, HW; Kim, K; Kim, H; Weinberg, RJ; Kim, E				Kim, Seho; Burette, Alain; Chung, Hye Sun; Kwon, Seok-Kyu; Woo, Jooyeon; Lee, Hyun Woo; Kim, Karam; Kim, Hyun; Weinberg, Richard J.; Kim, Eunjoon			NGL family PSD-95-interacting adhesion molecules regulate excitatory synapse formation	NATURE NEUROSCIENCE			English	Article							CELL-ADHESION; INHIBITORY SYNAPSES; NEUROLIGIN; BINDING; GENES; NEUREXINS; NETRIN-G1; PSD-95; MUTATION; LIGAND	Synaptic cell adhesion molecules (CAMs) regulate synapse formation through their trans-synaptic and heterophilic adhesion. Here we show that postsynaptic netrin-G ligand (NGL)CAMs associate with netrin-G CAMs in an isoform-specific manner and, through their cytosolic tail, with the abundant postsynaptic scaffold postsynaptic density-95 (PSD-95). Overexpression of NGL-2 in cultured rat neurons increased the number of PSD-95-positive dendritic protrusions. NGL-2 located on heterologous cells or beads induced functional presynaptic differentiation in contacting neurites. Direct aggregation of NGL-2 on the surface membrane of dendrites induced the clustering of excitatory postsynaptic proteins. Competitive inhibition by soluble NGL-2 reduced the number of excitatory synapses. NGL-2 knockdown reduced excitatory, but not inhibitory, synapse numbers and currents. These results suggest that NGL regulates the formation of excitatory synapses.	Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Synaptogenesis, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Korea Univ, Dept Anat, Coll Med, Seoul 136705, South Korea; Korea Univ, Div Brain Korea 21, Coll Med, Seoul 136705, South Korea; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); University of North Carolina; University of North Carolina Chapel Hill; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); University of North Carolina; University of North Carolina Chapel Hill	Kim, E (corresponding author), Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Synaptogenesis, Taejon 305701, South Korea.	kime@kaist.ac.kr	Weinberg, Richard/AAC-1898-2020; Kim, Karam/K-1412-2018; Kim, Eunjoon/C-1566-2011	Kim, Karam/0000-0002-1886-5163; Weinberg, Richard/0000-0001-9689-7278; Kwon, Seok-Kyu/0000-0002-7280-9867; Kim, Hyun/0000-0002-7210-5798	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039444] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-39444] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akins MR, 2006, CURR OPIN NEUROBIOL, V16, P83, DOI 10.1016/j.conb.2006.01.009; Aoki-Suzuki M, 2005, BIOL PSYCHIAT, V57, P382, DOI 10.1016/j.biopsych.2004.11.022; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Christopherson KS, 2003, J CELL SCI, V116, P3213, DOI 10.1242/jcs.00617; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Hata Y, 1996, J NEUROSCI, V16, P2488; Horejsi V, 1999, IMMUNOL TODAY, V20, P356, DOI 10.1016/S0167-5699(99)01489-9; Hsueh YP, 1999, J BIOL CHEM, V274, P532, DOI 10.1074/jbc.274.1.532; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Lin JC, 2003, NAT NEUROSCI, V6, P1270, DOI 10.1038/nn1148; Meerabux JMA, 2005, GENOMICS, V86, P112, DOI 10.1016/j.ygeno.2005.04.004; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; Nakashiba T, 2000, J NEUROSCI, V20, P6540, DOI 10.1523/JNEUROSCI.20-17-06540.2000; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Yin Y, 2002, MOL CELL NEUROSCI, V19, P344, DOI 10.1006/mcne.2001.1089	50	177	190	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1294	1301		10.1038/nn1763	http://dx.doi.org/10.1038/nn1763			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16980967				2022-12-17	WOS:000241493900023
J	Boschat, C; Pelofi, C; Randin, O; Roppolo, D; Luscher, C; Broillet, MC; Rodriguez, I				Boschat, C; Pelofi, C; Randin, O; Roppolo, D; Luscher, C; Broillet, MC; Rodriguez, I			Pheromone detection mediated by a V1r vomeronasal receptor	NATURE NEUROSCIENCE			English	Article							MULTIGENE FAMILY; MAMMALS; NEURONS; SYSTEM; MOUSE		Univ Geneva, Dep Zool & Anim Biol, CH-1211 Geneva, Switzerland; Univ Lausanne, Inst Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; Univ Geneva, Dept Physiol & Neurol, CH-1211 Geneva, Switzerland	University of Geneva; University of Lausanne; University of Geneva	Rodriguez, I (corresponding author), Univ Geneva, Dep Zool & Anim Biol, CH-1211 Geneva, Switzerland.		Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Broillet, Marie-Christine/0000-0002-0487-6638; rodriguez, ivan/0000-0002-6468-0565				Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; JEMIOLO B, 1989, PHYSIOL BEHAV, V46, P293, DOI 10.1016/0031-9384(89)90270-9; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Rodriguez I, 2000, NAT GENET, V26, P18, DOI 10.1038/79124; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137	14	177	182	0	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1261	1262		10.1038/nn978	http://dx.doi.org/10.1038/nn978			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12436115				2022-12-17	WOS:000179447500006
J	Fischer, AJ; McGuire, JJ; Schaeffel, F; Stell, WK				Fischer, AJ; McGuire, JJ; Schaeffel, F; Stell, WK			Light- and focus-dependent expression of the transcription factor ZENK in the chick retina	NATURE NEUROSCIENCE			English	Article							FORM-DEPRIVATION MYOPIA; ASPARTATE-INDUCED EXCITOTOXICITY; FOS MESSENGER-RNA; C-FOS; BIPOLAR CELLS; AMACRINE CELLS; RAT RETINA; GROWTH; NEURONS; NERVE	Ocular growth and refraction are regulated by visual processing in the retina. We identified candidate regulatory neurons by immunocytochemistry for immediate-early gene products, ZENK (zif268, Egr-1) and Fos, after appropriate visual stimulation. ZENK synthesis was enhanced by conditions that suppress ocular elongation (plus defocus, termination of form deprivation) and suppressed by conditions that enhance ocular elongation (minus defocus, form deprivation), particularly in glucagon-containing amacrine cells. Fos synthesis was enhanced by termination of visual deprivation, but not by defocus and not in glucagon-containing amacrine cells. We conclude that glucagon-containing amacrine cells respond differentially to the sign of defocus and may mediate lens-induced changes in ocular growth and refraction.	Univ Calgary, Fac Med, Dept Anat & Cell Biol, Neurosci Res Grp, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Lions Sight Ctr, Calgary, AB T2N 4N1, Canada; Univ Tubingen, Hosp Eye, Div Expt Ophthalmol, D-72076 Tubingen, Germany	University of Calgary; University of Calgary; Eberhard Karls University of Tubingen	Fischer, AJ (corresponding author), Univ Washington, Sch Med, Dept Biol Struct, Hlth Sci Ctr, PO 357420, Seattle, WA 98195 USA.		Fischer, Andrew J/E-3061-2011; Fischer, Andy J./AAE-9817-2022; Fischer, Andy J./AFF-1827-2022	Fischer, Andy J./0000-0001-6123-7405; Fischer, Andy J./0000-0001-6123-7405				Araki CM, 1998, BRAIN RES, V794, P333, DOI 10.1016/S0006-8993(98)00307-2; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; BRANDSTATTER JH, 1994, EUR J NEUROSCI, V6, P1100, DOI 10.1111/j.1460-9568.1994.tb00607.x; CAJAL SR, 1972, STRUCTURE RETINA, P76; Chaudhuri A, 1997, NEUROREPORT, V8, pR3, DOI 10.1097/00001756-199709080-00002; CROSSLAND WJ, 1978, BRAIN RES, V145, P239, DOI 10.1016/0006-8993(78)90860-0; CURTIN BJ, 1985, MYOPIAS BASIC SCI CL; DELAVILLA P, 1995, J NEUROSCI, V15, P3571; Dowling J.E., 1987, RETINA APPROACHABLE; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Fischer AJ, 1999, J COMP NEUROL, V405, P1, DOI 10.1002/(SICI)1096-9861(19990301)405:1<1::AID-CNE1>3.0.CO;2-U; Fischer AJ, 1999, VISION RES, V39, P685, DOI 10.1016/S0042-6989(98)00178-3; Fischer AJ, 1998, J COMP NEUROL, V393, P1; Fischer AJ, 1998, BRAIN RES, V794, P48, DOI 10.1016/S0006-8993(98)00188-7; Fischer AJ, 1997, CAN J OPHTHALMOL, V32, P373; FISCHER AJ, 1998, VISUAL NEUROSCI, V15, P685; GRUNERT U, 1994, J COMP NEUROL, V348, P607, DOI 10.1002/cne.903480410; GUDEHITHLU KP, 1993, BRAIN RES, V631, P77, DOI 10.1016/0006-8993(93)91189-Y; HARTVEIT E, 1994, J COMP NEUROL, V348, P570, DOI 10.1002/cne.903480407; KOISTINAHO J, 1994, NEUROSCI LETT, V177, P15, DOI 10.1016/0304-3940(94)90033-7; KOLB H, 1993, VISUAL NEUROSCI, V10, P341, DOI 10.1017/S0952523800003734; KUWAYAMA Y, 1982, INVEST OPHTH VIS SCI, V22, P681; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; Long KD, 1998, MOL BIOL EVOL, V15, P284, DOI 10.1093/oxfordjournals.molbev.a025925; Masana MI, 1996, MOL BRAIN RES, V42, P193, DOI 10.1016/S0169-328X(96)00031-9; MCBRIEN NA, 1995, VISION RES, V35, P1141, DOI 10.1016/0042-6989(94)00237-G; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; OWUSUYAW V, 1992, BRAIN RES, V576, P220, DOI 10.1016/0006-8993(92)90684-2; ROHRER B, 1993, VISUAL NEUROSCI, V10, P447, DOI 10.1017/S0952523800004673; ROHRER B, 1995, BRAIN RES, V686, P169, DOI 10.1016/0006-8993(95)00370-6; SAGAR SM, 1990, MOL BRAIN RES, V7, P17, DOI 10.1016/0169-328X(90)90068-O; Schaeffel F, 1999, VISION RES, V39, P1585, DOI 10.1016/S0042-6989(98)00304-6; Schmid KL, 1996, VISION RES, V36, P1023, DOI 10.1016/0042-6989(95)00191-3; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; UCHIYAMA H, 1993, NEUROSCI LETT, V154, P35, DOI 10.1016/0304-3940(93)90165-H; Ueda Y, 1997, J NEUROSCI, V17, P3014; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; VANEY DI, 1994, PROG RETIN EYE RES, V13, P301, DOI 10.1016/1350-9462(94)90014-0; WALLMAN J, 1993, PROG RETIN RES, V12, P133, DOI 10.1016/0278-4327(93)90007-G; WALLMAN J, 1994, NATURE, V371, P201, DOI 10.1038/371201a0; WILDSOET C, 1995, VISION RES, V35, P1175, DOI 10.1016/0042-6989(94)00233-C; WILDSOET CF, 1988, INVEST OPHTH VIS SCI, V29, P311; YAQUB A, 1995, J COMP NEUROL, V354, P481, DOI 10.1002/cne.903540402; YOSHIDA K, 1993, NEURON, V10, P1049, DOI 10.1016/0896-6273(93)90053-T	44	177	183	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1999	2	8					706	712		10.1038/11167	http://dx.doi.org/10.1038/11167			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FA	10412059				2022-12-17	WOS:000083882800009
J	Lawson, RP; Mathys, C; Rees, G				Lawson, Rebecca P.; Mathys, Christoph; Rees, Geraint			Adults with autism overestimate the volatility of the sensory environment	NATURE NEUROSCIENCE			English	Article							SPECTRUM QUOTIENT AQ; LOCUS-COERULEUS; PREDICTION ERRORS; CLINICAL-PRACTICE; AUDITORY-CORTEX; PUPIL-DILATION; VISUAL-CORTEX; DISORDERS; NOREPINEPHRINE; SUPPRESSION	Insistence on sameness and intolerance of change are among the diagnostic criteria for autism spectrum disorder (ASD), but little research has addressed how people with ASD represent and respond to environmental change. Here, behavioral and pupillometric measurements indicated that adults with ASD are less surprised than neurotypical adults when their expectations are violated, and decreased surprise is predictive of greater symptom severity. A hierarchical Bayesian model of learning suggested that in ASD, a tendency to overlearn about volatility in the face of environmental change drives a corresponding reduction in learning about probabilistically aberrant events, thus putatively rendering these events less surprising. Participant-specific modeled estimates of surprise about environmental conditions were linked to pupil size in the ASD group, thus suggesting heightened noradrenergic responsivity in line with compromised neural gain. This study offers insights into the behavioral, algorithmic and physiological mechanisms underlying responses to environmental volatility in ASD.	[Lawson, Rebecca P.; Mathys, Christoph; Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Lawson, Rebecca P.; Rees, Geraint] UCL, Inst Cognit Neurosci, London, England; [Lawson, Rebecca P.] Univ Cambridge, Dept Psychol, Cambridge, England; [Mathys, Christoph] SISSA, Trieste, Italy; [Mathys, Christoph] UCL, Max Planck UCL Ctr Computat Psychiat & Ageing, London, England; [Mathys, Christoph] Univ Zurich, Inst Biomed Engn, Translat Neuromodeling Unit, Zurich, Switzerland; [Mathys, Christoph] ETH, Zurich, Switzerland	University of London; University College London; University of London; University College London; University of Cambridge; International School for Advanced Studies (SISSA); University of London; University College London; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Lawson, RP (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.; Lawson, RP (corresponding author), UCL, Inst Cognit Neurosci, London, England.; Lawson, RP (corresponding author), Univ Cambridge, Dept Psychol, Cambridge, England.	rebecca.lawson@ucl.ac.uk	Mathys, Christoph/D-5661-2014; Rees, Geraint/C-1493-2008	Mathys, Christoph/0000-0003-4079-5453; Rees, Geraint/0000-0002-9623-7007; Lawson, Rebecca/0000-0003-1228-1244	Wellcome Trust [100227]; Wellcome Trust [100227/Z/12/Z] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Senior Clinical Research Fellowship (100227: G.R.). We thank all the participants who gave their time to take part in this research and M. Browning for helpful comments on an earlier poster presentation of these data.	American Psychiatric Association, 2000, DIAGN STAT MAN TEXT; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Balsters JH, 2017, BRAIN, V140, P235, DOI 10.1093/brain/aww287; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bonnet C, 2008, PSICOTHEMA, V20, P43; Brown J, 2010, Q J EXP PSYCHOL, V63, P1789, DOI 10.1080/17470210903536910; Browning M, 2015, NAT NEUROSCI, V18, P590, DOI 10.1038/nn.3961; Corlett PR, 2014, LANCET PSYCHIAT, V1, P399, DOI 10.1016/S2215-0366(14)70298-6; Costa VD, 2016, NEURON, V89, P8, DOI 10.1016/j.neuron.2015.12.031; COURCHESNE E, 1984, ELECTROEN CLIN NEURO, V59, P238, DOI 10.1016/0168-5597(84)90063-7; Daluwatte C, 2013, J AUTISM DEV DISORD, V43, P1910, DOI 10.1007/s10803-012-1741-3; de Berker AO, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10996; Van de Cruys S, 2014, PSYCHOL REV, V121, P649, DOI 10.1037/a0037665; den Ouden HEM, 2010, J NEUROSCI, V30, P3210, DOI 10.1523/JNEUROSCI.4458-09.2010; Ewbank MP, 2015, CEREB CORTEX, V25, P3381, DOI 10.1093/cercor/bhu149; Falck-Ytter T, 2011, PROG BRAIN RES, V189, P209, DOI 10.1016/B978-0-444-53884-0.00026-9; Friston KJ, 2013, TRENDS COGN SCI, V17, P1, DOI 10.1016/j.tics.2012.11.003; Gomot M, 2011, J AUTISM DEV DISORD, V41, P705, DOI 10.1007/s10803-010-1091-y; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Haker H, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00107; Happe FG, 2016, J AUTISM DEV DISORD, V46, P3469, DOI 10.1007/s10803-016-2886-2; Hasselmo ME, 1997, J NEUROPHYSIOL, V77, P3326, DOI 10.1152/jn.1997.77.6.3326; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Hirata A, 2006, J NEUROSCI, V26, P4426, DOI 10.1523/JNEUROSCI.5298-05.2006; Hosmer D, 2004, APPL LOGISTIC REGRES; Iglesias S, 2013, NEURON, V80, P519, DOI 10.1016/j.neuron.2013.09.009; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Jackson I, 2009, DEVELOPMENTAL SCI, V12, P670, DOI 10.1111/j.1467-7687.2008.00805.x; Jeste SS, 2015, DEVELOPMENTAL SCI, V18, P90, DOI 10.1111/desc.12188; Kang O, 2015, CONSCIOUS COGN, V35, P128, DOI 10.1016/j.concog.2015.05.001; Kenny L, 2016, AUTISM, V20, P442, DOI 10.1177/1362361315588200; KINNEALEY M, 1995, AM J OCCUP THER, V49, P444, DOI 10.5014/ajot.49.5.444; Kleinhans NM, 2009, AM J PSYCHIAT, V166, P467, DOI 10.1176/appi.ajp.2008.07101681; Knapen T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155574; Kobayashi M, 2000, EUR J NEUROSCI, V12, P264, DOI 10.1046/j.1460-9568.2000.00917.x; Lam KSL, 2006, RES DEV DISABIL, V27, P254, DOI 10.1016/j.ridd.2005.03.003; Lawson RP, 2015, SCI REP-UK, V5, DOI 10.1038/srep16157; Lawson RP, 2015, P NATL ACAD SCI USA, V112, pE5226, DOI 10.1073/pnas.1514212112; Lawson RP, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00302; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Manning C., 2016, DEV SCI; Marshall L, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002575; Martins ARO, 2015, NAT NEUROSCI, V18, P1483, DOI 10.1038/nn.4090; Mathys C, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00039; Mathys CD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00825; Nemeth D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011731; Palmer CJ, 2017, PSYCHOL BULL, V143, P521, DOI 10.1037/bul0000097; Pellicano E, 2012, TRENDS COGN SCI, V16, P504, DOI 10.1016/j.tics.2012.08.009; Ratcliff R, 2016, TRENDS COGN SCI, V20, P260, DOI 10.1016/j.tics.2016.01.007; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; Rigoux L, 2014, NEUROIMAGE, V84, P971, DOI 10.1016/j.neuroimage.2013.08.065; Ruzich E, 2015, MOL AUTISM, V6, DOI [10.1186/s13229-015-0038-8, 10.1186/2040-2392-6-2]; Schwarzkopf DS, 2014, J NEUROSCI, V34, P2713, DOI 10.1523/JNEUROSCI.4416-13.2014; Sevgi M, 2016, BIOL PSYCHIAT, V80, P112, DOI 10.1016/j.biopsych.2015.11.025; Shepard KN, 2015, J NEUROSCI, V35, P2432, DOI 10.1523/JNEUROSCI.0532-14.2015; Solomon M, 2011, AUTISM RES, V4, P109, DOI 10.1002/aur.177; South M, 2012, AUTISM RES, V5, P398, DOI 10.1002/aur.1255; Teufel C, 2016, BRAIN, V139, P2600, DOI 10.1093/brain/aww209; Vossel S, 2014, CEREB CORTEX, V24, P1436, DOI 10.1093/cercor/bhs418; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Wiecki TV, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00014; Willenbockel V, 2010, BEHAV RES METHODS, V42, P671, DOI 10.3758/BRM.42.3.671; Woodbury-Smith MR, 2005, J AUTISM DEV DISORD, V35, P331, DOI 10.1007/s10803-005-3300-7; World Health Organization, 2012, INT CLASS DIS ICD 10; Yu A, 2003, ADV NEURAL INF PROCE, P173; Yu AJ, 2012, NAT NEUROSCI, V15, P933, DOI 10.1038/nn.3150	69	176	178	7	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2017	20	9					1293	+		10.1038/nn.4615	http://dx.doi.org/10.1038/nn.4615			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FF0JJ	28758996	Green Submitted, Green Accepted			2022-12-17	WOS:000408587700017
J	Johnson, MB; Wang, PP; Atabay, KD; Murphy, EA; Doan, RN; Hecht, JL; Walsh, CA				Johnson, Matthew B.; Wang, Peter P.; Atabay, Kutay D.; Murphy, Elisabeth A.; Doan, Ryan N.; Hecht, Jonathan L.; Walsh, Christopher A.			Single-cell analysis reveals transcriptional heterogeneity of neural progenitors in human cortex	NATURE NEUROSCIENCE			English	Article							OUTER SUBVENTRICULAR ZONE; RADIAL GLIA; NONCODING RNAS; PROJECTION NEURONS; BRAIN-DEVELOPMENT; NERVOUS-SYSTEM; EXPRESSION; FERRET; GENE; NEOCORTEX	The human cerebral cortex depends for its normal development and size on a precisely controlled balance between self-renewal and differentiation of diverse neural progenitor cells. Specialized progenitors that are common in humans but virtually absent in rodents, called outer radial glia (ORG), have been suggested to be crucial to the evolutionary expansion of the human cortex. We combined progenitor subtype-specific sorting with transcriptome-wide RNA sequencing to identify genes enriched in human ORG, which included targets of the transcription factor neurogenin and previously uncharacterized, evolutionarily dynamic long noncoding RNAs. Activating the neurogenin pathway in ferret progenitors promoted delamination and outward migration. Finally, single-cell transcriptional profiling in human, ferret and mouse revealed more cells coexpressing proneural neurogenin targets in human than in other species, suggesting greater neuronal lineage commitment and differentiation of self-renewing progenitors. Thus, we find that the abundance of human ORG is paralleled by increased transcriptional heterogeneity of cortical progenitors.	[Johnson, Matthew B.; Wang, Peter P.; Atabay, Kutay D.; Murphy, Elisabeth A.; Doan, Ryan N.; Walsh, Christopher A.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Johnson, Matthew B.; Wang, Peter P.; Atabay, Kutay D.; Murphy, Elisabeth A.; Doan, Ryan N.; Walsh, Christopher A.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA USA; [Johnson, Matthew B.; Wang, Peter P.; Atabay, Kutay D.; Murphy, Elisabeth A.; Doan, Ryan N.; Walsh, Christopher A.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA USA; [Hecht, Jonathan L.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Hecht, Jonathan L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Walsh, Christopher A.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Walsh, CA (corresponding author), Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu	wang, peter/AAD-5851-2020	Walsh, Christopher/0000-0002-0156-2238	US National Institutes of Neurological Disease and Stroke [R01 NS032457]; Paul G. Allen Family Foundation; Nancy Lurie Marks Family Foundation; Stuart H.Q. & Victoria Quan Fellowship at Harvard Medical School; US National Institutes of Health [NCRR 1S10RR028832-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032457] Funding Source: NIH RePORTER	US National Institutes of Neurological Disease and Stroke; Paul G. Allen Family Foundation; Nancy Lurie Marks Family Foundation; Stuart H.Q. & Victoria Quan Fellowship at Harvard Medical School; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Partlow for coordinating human tissue protocols, D. Gonzalez for animal protocol and technical experimental assistance, S. Lazo-Kallanian for single-cell FACS assistance and all members of the Walsh laboratory for comments and discussion. The Neurog2-VP16 construct was a generous gift from C. Schuurmans (University of Calgary). This work was supported by grants to C.A.W. from the US National Institutes of Neurological Disease and Stroke (R01 NS032457) and the Paul G. Allen Family Foundation. M.B.J. was supported by a fellowship from the Nancy Lurie Marks Family Foundation. P.P.W. was supported by the Stuart H.Q. & Victoria Quan Fellowship at Harvard Medical School. Single-cell expression profiling experiments were performed at the Molecular Genetics Core at Boston Children's Hospital (BCH IDDRC, P30 HD18655). Transcriptome analysis was performed using Harvard Medical School's Orchestra high-performance computing cluster, which is partially supported by US National Institutes of Health grant NCRR 1S10RR028832-01. C.A.W. is an Investigator of the Howard Hughes Medical Institute.	Aprea J, 2013, EMBO J, V32, P3145, DOI 10.1038/emboj.2013.245; Betizeau M, 2013, NEURON, V80, P442, DOI 10.1016/j.neuron.2013.09.032; Borrell V, 2010, J NEUROSCI METH, V186, P186, DOI 10.1016/j.jneumeth.2009.11.016; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571; Franco SJ, 2012, SCIENCE, V337, P746, DOI 10.1126/science.1223616; Gertz CC, 2014, J NEUROSCI, V34, P2559, DOI 10.1523/JNEUROSCI.2645-13.2014; Gohlke JM, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-15; Gorski JA, 2002, J NEUROSCI, V22, P6309; Guo C, 2013, NEURON, V80, P1167, DOI 10.1016/j.neuron.2013.09.037; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hiller M, 2012, CELL REP, V2, P817, DOI 10.1016/j.celrep.2012.08.032; Hu P, 2014, CELL SIGNAL, V26, P83, DOI 10.1016/j.cellsig.2013.10.001; Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; JACKSON CA, 1989, J NEUROSCI, V9, P1242; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kawaguchi A, 2004, J NEUROSCI RES, V78, P784, DOI 10.1002/jnr.20347; Kawaguchi A, 2008, DEVELOPMENT, V135, P3113, DOI 10.1242/dev.022616; Kelava I, 2012, CEREB CORTEX, V22, P469, DOI 10.1093/cercor/bhr301; Kovach C, 2013, CEREB CORTEX, V23, P1884, DOI 10.1093/cercor/bhs176; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Lewitus E, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002000; Lui JH, 2014, NATURE, V515, P264, DOI 10.1038/nature13973; Martinez-Cerdeno V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041386, 10.1371/journal.pone.0030178]; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Mo ZC, 2007, J NEUROSCI, V27, P4132, DOI 10.1523/JNEUROSCI.0111-07.2007; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; Ng SY, 2013, MOL CELL, V51, P349, DOI 10.1016/j.molcel.2013.07.017; Noctor SC, 1997, J COMP NEUROL, V387, P179; Ochiai W, 2009, MOL CELL NEUROSCI, V40, P225, DOI 10.1016/j.mcn.2008.10.007; Reid CB, 1997, DEVELOPMENT, V124, P2441; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rousso DL, 2012, NEURON, V74, P314, DOI 10.1016/j.neuron.2012.02.024; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Shibata T, 1997, J NEUROSCI, V17, P9212; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Ware ML, 1999, CEREB CORTEX, V9, P636, DOI 10.1093/cercor/9.6.636; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425	51	176	184	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2015	18	5					637	+		10.1038/nn.3980	http://dx.doi.org/10.1038/nn.3980			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG9LN	25734491	Green Accepted			2022-12-17	WOS:000353636900010
J	Galea, JM; Mallia, E; Rothwell, J; Diedrichsen, J				Galea, Joseph M.; Mallia, Elizabeth; Rothwell, John; Diedrichsen, Joern			The dissociable effects of punishment and reward on motor learning	NATURE NEUROSCIENCE			English	Article							VISUOMOTOR ROTATION; SKILL ACQUISITION; PROSPECT-THEORY; BASAL GANGLIA; CORTEX; ADAPTATION; CEREBELLUM; DOPAMINE; REINFORCEMENT; SEROTONIN	A common assumption regarding error-based motor learning (motor adaptation) in humans is that its underlying mechanism is automatic and insensitive to reward- or punishment-based feedback. Contrary to this hypothesis, we show in a double dissociation that the two have independent effects on the learning and retention components of motor adaptation. Negative feedback, whether graded or binary, accelerated learning. While it was not necessary for the negative feedback to be coupled to monetary loss, it had to be clearly related to the actual performance on the preceding movement. Positive feedback did not speed up learning, but it increased retention of the motor memory when performance feedback was withdrawn. These findings reinforce the view that independent mechanisms underpin learning and retention in motor adaptation, reject the assumption that motor adaptation is independent of motivational feedback, and raise new questions regarding the neural basis of negative and positive motivational feedback in motor learning.	[Galea, Joseph M.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Mallia, Elizabeth; Rothwell, John] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Diedrichsen, Joern] UCL, Insititute Cognit Neurosci, London, England	University of Birmingham; University of London; University College London; University of London; University College London	Galea, JM (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	j.galea@bham.ac.uk	Diedrichsen, Jörn/A-7789-2010; Galea, Joseph M/ABA-4042-2021; Diedrichsen, Jörn/AAQ-2242-2020	Diedrichsen, Jörn/0000-0003-0264-8532; Galea, Joseph M/0000-0002-0009-4049; Diedrichsen, Jörn/0000-0003-0264-8532; Rothwell, John/0000-0003-1367-6467; Mallia, Elizabeth/0000-0003-1967-8922	Birmingham Fellow research fellowship; MRC [MR/K00414X/1] Funding Source: UKRI; Medical Research Council [MR/K00414X/1] Funding Source: researchfish	Birmingham Fellow research fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Birmingham Fellow research fellowship (J.M.G.). We thank P. Celnik for comments on a previous version of the manuscript.	Abe M, 2011, CURR BIOL, V21, P557, DOI 10.1016/j.cub.2011.02.030; Awenowicz PW, 2002, J NEUROPHYSIOL, V88, P3439, DOI 10.1152/jn.00078.2002; Beierholm U, 2013, NEUROPSYCHOPHARMACOL, V38, P1495, DOI 10.1038/npp.2013.48; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dayan E, 2014, LEARN MEMORY, V21, P140, DOI 10.1101/lm.032417.113; Dayan P, 2008, COGN AFFECT BEHAV NE, V8, P429, DOI 10.3758/CABN.8.4.429; De Martino B, 2010, P NATL ACAD SCI USA, V107, P3788, DOI 10.1073/pnas.0910230107; de Xivry JJO, 2011, CEREB CORTEX, V21, P1475, DOI 10.1093/cercor/bhq192; den Ouden HEM, 2013, NEURON, V80, P1090, DOI 10.1016/j.neuron.2013.08.030; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Donchin O, 2003, J NEUROSCI, V23, P9032; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Ernst M, 2002, NEUROPSYCHOPHARMACOL, V26, P682, DOI 10.1016/S0893-133X(01)00414-6; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Galea JM, 2010, EXP BRAIN RES, V202, P473, DOI 10.1007/s00221-010-2158-x; Galea JM, 2013, J NEUROSCI, V33, P3981, DOI 10.1523/JNEUROSCI.1294-12.2013; Galea JM, 2011, CEREB CORTEX, V21, P1761, DOI 10.1093/cercor/bhq246; Hadipour-Niktarash A, 2007, J NEUROSCI, V27, P13413, DOI 10.1523/JNEUROSCI.2570-07.2007; Haith AM, 2013, ADV EXP MED BIOL, V782, P1, DOI 10.1007/978-1-4614-5465-6_1; Hester R, 2010, J NEUROSCI, V30, P15600, DOI 10.1523/JNEUROSCI.2565-10.2010; Hosp JA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00145; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; Huang VS, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-5; Ingram JN, 2013, CURR BIOL, V23, P1107, DOI 10.1016/j.cub.2013.04.079; Izawa J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002012; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Krakauer JW, 2009, ADV EXP MED BIOL, V629, P405, DOI 10.1007/978-0-387-77064-2_21; Krakauer JW, 2006, CURR OPIN NEUROL, V19, P84, DOI 10.1097/01.wco.0000200544.29915.cc; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; Mercer J, 2005, ANNU REV POLIT SCI, V8, P1, DOI 10.1146/annurev.polisci.8.082103.104911; Moulton EA, 2011, J NEUROSCI, V31, P3795, DOI 10.1523/JNEUROSCI.6709-10.2011; Nichols RA, 2011, J PHYSIOL-LONDON, V589, P5019, DOI 10.1113/jphysiol.2011.219782; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Patton JL, 2004, IEEE T BIO-MED ENG, V51, P636, DOI 10.1109/TBME.2003.821035; Rabe K, 2009, J NEUROPHYSIOL, V101, P1961, DOI 10.1152/jn.91069.2008; Richardson AG, 2006, J NEUROSCI, V26, P12466, DOI 10.1523/JNEUROSCI.1139-06.2006; Robinson OJ, 2010, NEUROIMAGE, V51, P1459, DOI 10.1016/j.neuroimage.2010.03.036; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shmuelof L, 2012, J NEUROSCI, V32, P14617, DOI 10.1523/JNEUROSCI.2184-12.2012; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Tanaka H, 2009, J NEUROPHYSIOL, V102, P2921, DOI 10.1152/jn.90834.2008; Taylor JA, 2012, ANN NY ACAD SCI, V1251, P1, DOI 10.1111/j.1749-6632.2011.06430.x; Thabit MN, 2011, CLIN NEUROPHYSIOL, V122, P1764, DOI 10.1016/j.clinph.2011.02.021; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Wachter T, 2009, J NEUROSCI, V29, P436, DOI 10.1523/JNEUROSCI.4132-08.2009; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Wu HG, 2014, NAT NEUROSCI, V17, P312, DOI 10.1038/nn.3616	53	176	178	2	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2015	18	4					597	+		10.1038/nn.3956	http://dx.doi.org/10.1038/nn.3956			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CE4DL	25706473	Green Published			2022-12-17	WOS:000351780900024
J	Staley, K				Staley, Kevin			Molecular mechanisms of epilepsy	NATURE NEUROSCIENCE			English	Review							TEMPORAL-LOBE EPILEPSY; CA1 HIPPOCAMPAL REGION; SYNAPTIC-TRANSMISSION; STATUS EPILEPTICUS; MOUSE MODEL; POSTTRAUMATIC EPILEPSY; SEIZURE FREQUENCY; ENTORHINAL CORTEX; GABA(A) RECEPTORS; DRAVET SYNDROME	Decades of experimental work have established an imbalance of excitation and inhibition as the leading mechanism of the transition from normal brain function to seizure. In epilepsy, these transitions are rare and abrupt. Transition processes incorporating positive feedback, such as activity-dependent disinhibition, could provide these uncommon timing features. A rapidly expanding array of genetic etiologies will help delineate the molecular mechanism(s). This delineation will entail quite a bit of cell biology. The genes discovered so far are more remarkable for their diversity than their similarities.	[Staley, Kevin] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Staley, Kevin] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Staley, K (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.	staley.kevin@mgh.harvard.edu			US National Institutes of Health [NS034700, NS040109]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH106013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034700, R01NS034700, R01NS040109, R01NS034360] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by US National Institutes of Health grants NS034700 and NS040109.	Albensi BC, 2007, EXP NEUROL, V204, P1, DOI 10.1016/j.expneurol.2006.12.009; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Berdichevsky Y, 2013, J NEUROSCI, V33, P9056, DOI 10.1523/JNEUROSCI.3870-12.2013; Bertram E, 2007, EPILEPSIA, V48, P65, DOI 10.1111/j.1528-1167.2007.01068.x; Boison Detlev, 2011, Handb Exp Pharmacol, P251, DOI 10.1007/978-3-642-13443-2_9; Bracci E, 2001, J NEUROPHYSIOL, V85, P2412, DOI 10.1152/jn.2001.85.6.2412; Buckmaster PS, 2014, ADV EXP MED BIOL, V813, P161, DOI 10.1007/978-94-017-8914-1_13; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Carvill GL, 2014, NEUROLOGY, V82, P1245, DOI 10.1212/WNL.0000000000000291; Carvill GL, 2013, NAT GENET, V45, P1073, DOI 10.1038/ng.2727; Casillas-Espinosa PM, 2012, EPILEPSIA, V53, P41, DOI 10.1111/epi.12034; Chabrol B, 2013, HAND CLINIC, V113, P1701, DOI 10.1016/B978-0-444-59565-2.00038-1; Chang P, 2014, NEUROBIOL DIS, V62, P296, DOI 10.1016/j.nbd.2013.10.017; CROUCHER MJ, 1982, SCIENCE, V216, P899, DOI 10.1126/science.7079744; da Silva FL, 2003, EPILEPSIA, V44, P72, DOI 10.1111/j.0013-9580.2003.12005.x; Deng H, 2014, MOL NEUROBIOL, V49, P352, DOI 10.1007/s12035-013-8523-6; Ferini-Strambi L, 2012, NEUROLOGIST, V18, P343, DOI 10.1097/NRL.0b013e31826a99b8; Fernandez E, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00191; FISHER RS, 1976, ARCH NEUROL-CHICAGO, V33, P76, DOI 10.1001/archneur.1976.00500020004002; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Gardiner J, 2010, NEUROSCIENTIST, V16, P28, DOI 10.1177/1073858409334422; Girard JM, 2013, HAND CLINIC, V113, P1731, DOI 10.1016/B978-0-444-59565-2.00043-5; Goodkin HP, 2008, J NEUROSCI, V28, P2527, DOI 10.1523/JNEUROSCI.3426-07.2008; Guerrini R, 2014, LANCET NEUROL, V13, P710, DOI 10.1016/S1474-4422(14)70040-7; Heinemann U, 1986, Adv Neurol, V44, P641; Heinzen EL, 2014, LANCET NEUROL, V13, P503, DOI 10.1016/S1474-4422(14)70011-0; Herzog AG, 2008, SEIZURE-EUR J EPILEP, V17, P151, DOI 10.1016/j.seizure.2007.11.014; Jane DE, 2009, NEUROPHARMACOLOGY, V56, P90, DOI 10.1016/j.neuropharm.2008.08.023; Jett DA, 2012, NEUROTOXICOLOGY, V33, P1473, DOI 10.1016/j.neuro.2012.10.005; Jirsa VK, 2014, BRAIN, V137, P2210, DOI 10.1093/brain/awu133; Kaeser PS, 2014, ANNU REV PHYSIOL, V76, P333, DOI 10.1146/annurev-physiol-021113-170338; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kato M, 2005, J CHILD NEUROL, V20, P392, DOI 10.1177/08830738050200042001; Kovacs R, 2005, J NEUROSCI, V25, P4260, DOI 10.1523/JNEUROSCI.4000-04.2005; Kovacs R, 2009, J NEUROSCI, V29, P8565, DOI 10.1523/JNEUROSCI.5698-08.2009; Larsen BR, 2014, GLIA, V62, P608, DOI 10.1002/glia.22629; LaSarge CL, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00018, 10.3389/fnmol.2014.00018]; Lazarevic V, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00244; Le Duigou C, 2011, NEUROPHARMACOLOGY, V60, P748, DOI 10.1016/j.neuropharm.2010.12.015; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Lillis KP, 2012, NEUROBIOL DIS, V47, P358, DOI 10.1016/j.nbd.2012.05.016; Liu Y, 2013, ANN NEUROL, V74, P128, DOI 10.1002/ana.23897; Macdonald RL, 2012, EPILEPSIA, V53, P59, DOI 10.1111/epi.12035; Macdonald RL, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P257; Marsh E.D., 2012, JASPERS BASIC MECH E, P813; MATSUMOTO H, 1964, SCIENCE, V144, P193, DOI 10.1126/science.144.3615.193; McNamara James O, 2006, Sci STKE, V2006, pre12, DOI 10.1126/stke.3562006re12; Meier J, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00164; Mendez P, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/976856; Mirzaa GM, 2014, AM J MED GENET C, V166, P156, DOI 10.1002/ajmg.c.31401; Moran NF, 2004, SEIZURE-EUR J EPILEP, V13, P425, DOI 10.1016/j.seizure.2003.10.002; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Na ES, 2013, NEUROPSYCHOPHARMACOL, V38, P212, DOI 10.1038/npp.2012.116; Naylor DE, 2013, NEUROBIOL DIS, V54, P225, DOI 10.1016/j.nbd.2012.12.015; O'Leary T, 2011, J PHYSIOL-LONDON, V589, P4811, DOI 10.1113/jphysiol.2011.210179; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Patenaude C, 2005, EUR J NEUROSCI, V22, P179, DOI 10.1111/j.1460-9568.2005.04207.x; Prince D.A., 2012, JASPERS BASIC MECH E, P315; PRINCE DA, 1967, ARCH NEUROL-CHICAGO, V16, P194, DOI 10.1001/archneur.1967.00470200082007; Raimondo JV, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00202; Rajakulendran S, 2012, NAT REV NEUROL, V8, P86, DOI 10.1038/nrneurol.2011.228; Ran X, 2015, NUCLEIC ACIDS RES, V43, pD893, DOI 10.1093/nar/gku943; Ransom CB, 2000, J PHYSIOL-LONDON, V522, P427, DOI 10.1111/j.1469-7793.2000.00427.x; Scharfman HE, 2007, CURR NEUROL NEUROSCI, V7, P348, DOI 10.1007/s11910-007-0053-z; Southwell DG, 2014, SCIENCE, V344, P167, DOI 10.1126/science.1240622; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Sutula TP, 2007, PROG BRAIN RES, V163, P541, DOI 10.1016/S0079-6123(07)63029-5; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Vaillend C, 2002, J NEUROPHYSIOL, V88, P2963, DOI 10.1152/jn.00244.2002; VALENTINE M, 1968, BRIT J PSYCHIAT, V114, P989, DOI 10.1192/bjp.114.513.989; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Volman V, 2011, P NATL ACAD SCI USA, V108, P15402, DOI 10.1073/pnas.1112066108; WALTHER H, 1986, NEUROSCI LETT, V69, P156, DOI 10.1016/0304-3940(86)90595-1; Weckhuysen S, 2013, NEUROLOGY, V81, P1697, DOI 10.1212/01.wnl.0000435296.72400.a1; Wester JC, 2014, CURR OPIN NEUROBIOL, V29, P118, DOI 10.1016/j.conb.2014.07.007; WIECHERT P, 1966, J NEUROCHEM, V13, P59, DOI 10.1111/j.1471-4159.1966.tb03332.x; Wong M, 2013, EXPERT REV NEUROTHER, V13, P657, DOI [10.1586/ern.13.48, 10.1586/ERN.13.48]; Yokoi N, 2012, INT REV CEL MOL BIO, V297, P1, DOI 10.1016/B978-0-12-394308-8.00001-7; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zhang W, 2009, J NEUROSCI, V29, P14247, DOI 10.1523/JNEUROSCI.3842-09.2009	82	176	178	2	247	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2015	18	3					367	372		10.1038/nn.3947	http://dx.doi.org/10.1038/nn.3947			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC2SO	25710839	Green Accepted			2022-12-17	WOS:000350195100014
J	Murphy-Royal, C; Dupuis, JP; Varela, JA; Panatier, A; Pinson, B; Baufreton, J; Groc, L; Oliet, SHR				Murphy-Royal, Ciaran; Dupuis, Julien P.; Varela, Juan A.; Panatier, Aude; Pinson, Benoit; Baufreton, Jerome; Groc, Laurent; Oliet, Stephane H. R.			Surface diffusion of astrocytic glutamate transporters shapes synaptic transmission	NATURE NEUROSCIENCE			English	Article							RELEASED GLUTAMATE; TIME-COURSE; AMPA; TRAFFICKING; CLEARANCE; RECEPTORS; SYNAPSES; GLT-1; NMDA; LOCALIZATION	Control of the glutamate time course in the synapse is crucial for excitatory transmission. This process is mainly ensured by astrocytic transporters, high expression of which is essential to compensate for their slow transport cycle. Although molecular mechanisms regulating transporter intracellular trafficking have been identified, the relationship between surface transporter dynamics and synaptic function remains unexplored. We found that GLT-1 transporters were highly mobile on rat astrocytes. Surface diffusion of GLT-1 was sensitive to neuronal and glial activities and was strongly reduced in the vicinity of glutamatergic synapses, favoring transporter retention. Notably, glutamate uncaging at synaptic sites increased GLT-1 diffusion, displacing transporters away from this compartment. Functionally, impairing GLT-1 membrane diffusion through cross-linking in vitro and in vivo slowed the kinetics of excitatory postsynaptic currents, indicative of a prolonged time course of synaptic glutamate. These data provide, to the best of our knowledge, the first evidence for a physiological role of GLT-1 surface diffusion in shaping synaptic transmission.	[Murphy-Royal, Ciaran; Panatier, Aude; Oliet, Stephane H. R.] Inserm U862, Neuroctr Magendie, Bordeaux, France; [Murphy-Royal, Ciaran; Dupuis, Julien P.; Varela, Juan A.; Panatier, Aude; Pinson, Benoit; Baufreton, Jerome; Groc, Laurent; Oliet, Stephane H. R.] Univ Bordeaux, Bordeaux, France; [Murphy-Royal, Ciaran; Dupuis, Julien P.; Varela, Juan A.; Groc, Laurent] Interdisciplinary Inst Neurosci, CNRS UMR 5297, Bordeaux, France; [Pinson, Benoit] Inst Biochem & Cellular Genet, CNRS, UMR 5095, Bordeaux, France; [Baufreton, Jerome] Inst Neurodegenerat Dis, CNRS, UMR 5293, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Groc, L (corresponding author), Univ Bordeaux, Bordeaux, France.	laurent.groc@u-bordeaux2.fr; stephane.oliet@inserm.fr	Dupuis, Julien/M-7092-2017	Baufreton, Jerome/0000-0002-2623-6375; Pinson, Benoit/0000-0003-2936-9058; Dupuis, Julien P./0000-0003-1660-7782; Panatier, Aude/0000-0002-6107-4463; Varela, Juan Alberto/0000-0003-1901-1378; Oliet, Stephane/0000-0003-0595-9029; Murphy-Royal, Ciaran/0000-0001-7545-593X	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Conseil Regional d'Aquitaine; Agence National de la Recherche; Fondation de la Recherche Medicale; LABEX BRAIN [ANR-10-LABX-43]; Marie Curie 'Edu-GLIA' [PITN-GA-2009-237]; Marie Curie 'deepNMDAR' fellowship - European Commission under the Seventh Framework Programme	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Agence National de la Recherche(French National Research Agency (ANR)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); LABEX BRAIN; Marie Curie 'Edu-GLIA'; Marie Curie 'deepNMDAR' fellowship - European Commission under the Seventh Framework Programme	We thank M. Rattray (University of Bradford) for the generous gift of GLT-1<SUP>flag</SUP> construct, U. Gether (University of Copenhagen) for the generous gift of DAT<SUP>flag</SUP> construct and M. Goillandeau (CNRS) who developed the software for the detection and analysis of synaptic events. We thank D. Bouchet (IINS CNRS), A. Ledantec (TINS CNRS) and N. Cassagno (INSERM) for cell cultures. We thank the Bordeaux Imaging Center, C. Poujol and D. Choquet for technical support. We thank our laboratory members for critical discussions. This work was supported by Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, Conseil Regional d'Aquitaine, Agence National de la Recherche, Fondation de la Recherche Medicale, LABEX BRAIN ANR-10-LABX-43, Marie Curie 'Edu-GLIA' (PITN-GA-2009-237, an Initial Training Network) and Marie Curie 'deepNMDAR' fellowship funded by the European Commission under the Seventh Framework Programme.	Arizono M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002498; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Benediktsson AM, 2012, GLIA, V60, P175, DOI 10.1002/glia.21249; Bergles DE, 1998, J NEUROSCI, V18, P7709; Choquet D, 2013, NEURON, V80, P691, DOI 10.1016/j.neuron.2013.10.013; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Diamond JS, 1997, J NEUROSCI, V17, P4672; Diamond JS, 2000, J NEUROPHYSIOL, V83, P2835, DOI 10.1152/jn.2000.83.5.2835; Dupuis JP, 2014, EMBO J, V33, P842, DOI 10.1002/embj.201386356; Foran E, 2014, GLIA, V62, P1241, DOI 10.1002/glia.22677; Genoud C, 2006, PLOS BIOL, V4, P2057, DOI 10.1371/journal.pbio.0040343; Gonzalez MI, 2004, CURR OPIN PHARMACOL, V4, P30, DOI 10.1016/j.coph.2003.09.004; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Groc L, 2008, MOL MEMBR BIOL, V25, P344, DOI 10.1080/09687680801958364; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Huang YHH, 2004, CURR OPIN NEUROBIOL, V14, P346, DOI 10.1016/j.conb.2004.05.007; Kalandadze A, 2002, J BIOL CHEM, V277, P45741, DOI 10.1074/jbc.M203771200; Krugers HJ, 2010, NAT REV NEUROSCI, V11, P675, DOI 10.1038/nrn2913; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Lievens JC, 2001, NEUROBIOL DIS, V8, P807, DOI 10.1006/nbdi.2001.0430; Marcaggi P, 2003, J PHYSIOL-LONDON, V552, P89, DOI 10.1113/jphysiol.2003.044263; Massie A, 2010, NEUROCHEM INT, V57, P572, DOI 10.1016/j.neuint.2010.07.004; Melone M, 2009, GLIA, V57, P108, DOI 10.1002/glia.20744; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Mikasova L, 2012, BRAIN, V135, P1606, DOI 10.1093/brain/aws092; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Omrani A, 2009, J PHYSIOL-LONDON, V587, P4575, DOI 10.1113/jphysiol.2009.177881; Overstreet LS, 1999, J NEUROSCI, V19, P9663; Pannasch U, 2014, NAT NEUROSCI, V17, P549, DOI 10.1038/nn.3662; RIVEROS N, 1986, BRAIN RES, V386, P405, DOI 10.1016/0006-8993(86)90181-2; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Scimemi A, 2013, J NEUROSCI, V33, P5312, DOI 10.1523/JNEUROSCI.5274-12.2013; Stenovec M, 2008, MOL MEMBR BIOL, V25, P203, DOI 10.1080/09687680701790925; Takeda H, 2002, N-S ARCH PHARMACOL, V366, P620, DOI 10.1007/s00210-002-0640-0; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; Toulme E, 2012, J BIOL CHEM, V287, P14734, DOI 10.1074/jbc.M111.329334; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	50	176	178	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2015	18	2					219	226		10.1038/nn.3901	http://dx.doi.org/10.1038/nn.3901			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CA0UM	25581361				2022-12-17	WOS:000348631800012
J	Krey, JF; Pasca, SP; Shcheglovitov, A; Yazawa, M; Schwemberger, R; Rasmusson, R; Dolmetsch, RE				Krey, Jocelyn F.; Pasca, Sergiu P.; Shcheglovitov, Aleksandr; Yazawa, Masayuki; Schwemberger, Rachel; Rasmusson, Randall; Dolmetsch, Ricardo E.			Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons	NATURE NEUROSCIENCE			English	Article							CA2+ CHANNEL; CALCIUM-CHANNEL; DISTINCT ROLES; BETA-SUBUNITS; RHO-KINASE; CELL-SHAPE; AUTISM; PROTEINS; GROWTH; MUTATIONS	L-type voltage gated calcium channels have an important role in neuronal development by promoting dendritic growth and arborization. A point mutation in the gene encoding Ca(V)1.2 causes Timothy syndrome, a neurodevelopmental disorder associated with autism spectrum disorders (ASDs). We report that channels with the Timothy syndrome alteration cause activity-dependent dendrite retraction in rat and mouse neurons and in induced pluripotent stem cell (iPSC)-derived neurons from individuals with Timothy syndrome. Dendrite retraction was independent of calcium permeation through the mutant channel, was associated with ectopic activation of RhoA and was inhibited by overexpression of the channel-associated GTPase Gem. These results suggest that Ca(V)1.2 can activate RhoA signaling independently of Ca2+ and provide insights into the cellular basis of Timothy syndrome and other ASDs.	[Krey, Jocelyn F.; Pasca, Sergiu P.; Shcheglovitov, Aleksandr; Yazawa, Masayuki; Schwemberger, Rachel; Dolmetsch, Ricardo E.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Rasmusson, Randall] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; [Dolmetsch, Ricardo E.] Allen Inst Brain Sci, Seattle, WA USA	Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Allen Institute for Brain Science	Dolmetsch, RE (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu	Pasca, Sergiu/AAY-3949-2021	Pasca, Sergiu/0000-0002-3216-3248	National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the National Institute of Neurological Disorders and Stroke [F31 NS055549-03]; US National Institutes of Health; Simons Foundation; International Brain Research Organization; Tashia and John Morgridge Endowed Fellowship; Japan Society of the Promotion for Science; American Heart Association; California Institute for Regenerative Medicine Postdoctoral Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099904, T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS055549] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003889] Funding Source: NIH RePORTER	National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the National Institute of Neurological Disorders and Stroke; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; International Brain Research Organization; Tashia and John Morgridge Endowed Fellowship; Japan Society of the Promotion for Science; American Heart Association(American Heart Association); California Institute for Regenerative Medicine Postdoctoral Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Timothy and the individuals with Timothy syndrome who participated in this study, J. Bernstein and J. Hallmayer for recruiting the subjects for this study, and E. Nigh for critical reading of the manuscript. J.F.K. was supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award (F31 NS055549-03) from the National Institute of Neurological Disorders and Stroke. Financial support was provided by a US National Institutes of Health Director's Pioneer Award and a Simons Foundation Grant to R.E.D.; the International Brain Research Organization Outstanding Research Fellowship and the Tashia and John Morgridge Endowed Fellowship to S.P.P.; a Japan Society of the Promotion for Science Postdoctoral Fellowship for Research Abroad and American Heart Association Western States to MY.; and a California Institute for Regenerative Medicine Postdoctoral Fellowship to O.S. We are grateful for funding from B. and F. Horowitz, M. McCafferey, B. and J. Packard, P. Kwan and K. Wang.	Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Aresta S, 2002, BIOCHEM J, V367, P57, DOI 10.1042/BJ20020829; Bader PL, 2011, P NATL ACAD SCI USA, V108, P15432, DOI 10.1073/pnas.1112667108; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Beguin P, 2005, J CELL SCI, V118, P1923, DOI 10.1242/jcs.02321; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Beguin P, 2007, J BIOL CHEM, V282, P11509, DOI 10.1074/jbc.M606423200; Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Casanova MF, 2006, ACTA NEUROPATHOL, V112, P287, DOI 10.1007/s00401-006-0085-5; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cohen-Kutner M, 2010, CHANNELS, V4, P266, DOI 10.4161/chan.4.4.12130; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034; Dolmetsch Ricardo, 2003, Sci STKE, V2003, pPE4; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Finlin BS, 2006, J BIOL CHEM, V281, P23557, DOI 10.1074/jbc.M604867200; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hoda JC, 2006, J NEUROCHEM, V96, P1648, DOI 10.1111/j.1471-4159.2006.03678.x; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Lohmann C, 2005, CELL CALCIUM, V37, P403, DOI 10.1016/j.ceca.2005.01.008; Mahalakshmi RN, 2007, TRAFFIC, V8, P1164, DOI 10.1111/j.1600-0854.2007.00599.x; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Nyegaard M, 2010, MOL PSYCHIATR, V15, P119, DOI 10.1038/mp.2009.69; Oyama F, 2004, J BIOL CHEM, V279, P27272, DOI 10.1074/jbc.M401634200; Parent L, 1995, BIOPHYS J, V69, P1801, DOI 10.1016/S0006-3495(95)80050-0; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Pravettoni E, 2000, DEV BIOL, V227, P581, DOI 10.1006/dbio.2000.9872; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Splawski I, 2006, J BIOL CHEM, V281, P22085, DOI 10.1074/jbc.M603316200; Swetman CA, 2002, EUR J IMMUNOL, V32, P2074, DOI 10.1002/1521-4141(200207)32:7<2074::AID-IMMU2074>3.0.CO;2-S; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; Tonelli A, 2006, J NEUROL SCI, V241, P13, DOI 10.1016/j.jns.2005.10.007; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Tottene A, 2002, P NATL ACAD SCI USA, V99, P13284, DOI 10.1073/pnas.192242399; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Ward Y, 2002, J CELL BIOL, V157, P291, DOI 10.1083/jcb.200111026; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855	50	176	183	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					201	209		10.1038/nn.3307	http://dx.doi.org/10.1038/nn.3307			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23313911	Green Accepted			2022-12-17	WOS:000314260200017
J	Takahashi, YK; Roesch, MR; Wilson, RC; Toreson, K; O'Donnell, P; Niv, Y; Schoenbaum, G				Takahashi, Yuji K.; Roesch, Matthew R.; Wilson, Robert C.; Toreson, Kathy; O'Donnell, Patricio; Niv, Yael; Schoenbaum, Geoffrey			Expectancy-related changes in firing of dopamine neurons depend on orbitofrontal cortex	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; ORBITAL PREFRONTAL CORTEX; ENCODES RESPONSE; DECISION-MAKING; FRONTAL-CORTEX; REWARD VALUE; MODEL-FREE; RAT; PREDICTION; STRIATUM	The orbitofrontal cortex has been hypothesized to carry information regarding the value of expected rewards. Such information is essential for associative learning, which relies on comparisons between expected and obtained reward for generating instructive error signals. These error signals are thought to be conveyed by dopamine neurons. To test whether orbitofrontal cortex contributes to these error signals, we recorded from dopamine neurons in orbitofrontal-lesioned rats performing a reward learning task. Lesions caused marked changes in dopaminergic error signaling. However, the effect of lesions was not consistent with a simple loss of information regarding expected value. Instead, without orbitofrontal input, dopaminergic error signals failed to reflect internal information about the impending response that distinguished externally similar states leading to differently valued future rewards. These results are consistent with current conceptualizations of orbitofrontal cortex as supporting model-based behavior and suggest an unexpected role for this information in dopaminergic error signaling.	[Takahashi, Yuji K.; Toreson, Kathy; Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Roesch, Matthew R.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Roesch, Matthew R.] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA; [Wilson, Robert C.; Niv, Yael] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Wilson, Robert C.; Niv, Yael] Princeton Univ, Inst Neurosci, Princeton, NJ 08544 USA; [O'Donnell, Patricio; Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Schoenbaum, Geoffrey] NIDA, Intramural Res Program, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Princeton University; Princeton University; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Takahashi, YK (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	ytaka001@umaryland.edu; schoenbg@schoenbaumlab.org		O'Donnell, Patricio/0000-0001-7788-624X	US National Institute on Drug Abuse; US National Institute on Mental Health; Binational United States-Israel Science Foundation; Sloan Research Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH083940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000587, R01DA031695, K01DA021609, R01DA015718] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute on Mental Health; Binational United States-Israel Science Foundation; Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the US National Institute on Drug Abuse to G.S. and M.R. and from the US National Institute on Mental Health to Y.K.T., a Sloan Research Fellowship to Y.N. and a Binational United States-Israel Science Foundation grant to Y.N. and R.C.W.	Abe H, 2011, NEURON, V70, P731, DOI 10.1016/j.neuron.2011.03.026; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Bromberg-Martin ES, 2010, J NEUROPHYSIOL, V104, P1068, DOI 10.1152/jn.00158.2010; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; DAW ND, NEURON IN PRESS; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Furuyashiki T, 2008, J NEUROSCI, V28, P5127, DOI 10.1523/JNEUROSCI.0319-08.2008; Gershman SJ, 2010, CURR OPIN NEUROBIOL, V20, P251, DOI 10.1016/j.conb.2010.02.008; Gershman SJ, 2010, PSYCHOL REV, V117, P197, DOI 10.1037/a0017808; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; GRACE AA, 1984, J NEUROSCI, V4, P2877; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Lodge DJ, 2011, NEUROPSYCHOPHARMACOL, V36, P1227, DOI 10.1038/npp.2011.7; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; McDannald MA, 2011, J NEUROSCI, V31, P2700, DOI 10.1523/JNEUROSCI.5499-10.2011; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Niv Y, 2006, NAT NEUROSCI, V9, P987, DOI 10.1038/nn0806-987; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Ostlund SB, 2007, J NEUROSCI, V27, P4819, DOI 10.1523/JNEUROSCI.5443-06.2007; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Pickens CL, 2003, J NEUROSCI, V23, P11078; Ramus SJ, 2000, J NEUROSCI, V20, P8199, DOI 10.1523/jneurosci.20-21-08199.2000; Redish AD, 2007, PSYCHOL REV, V114, P784, DOI 10.1037/0033-295X.114.3.784; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SIMON DA, J NEUROSCI IN PRESS; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; Tsuchida A, 2010, J NEUROSCI, V30, P16868, DOI 10.1523/JNEUROSCI.1958-10.2010; Tsujimoto S, 2009, J NEUROSCI, V29, P2569, DOI 10.1523/JNEUROSCI.5777-08.2009; van Duuren E, 2008, J NEUROSCI, V28, P8590, DOI 10.1523/JNEUROSCI.5549-07.2008; van Duuren E, 2009, J NEUROSCI, V29, P8965, DOI 10.1523/JNEUROSCI.0005-09.2009; Vazquez-Borsetti P, 2009, CEREB CORTEX, V19, P1678, DOI 10.1093/cercor/bhn204; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Young JJ, 2011, J NEUROSCI, V31, P5989, DOI 10.1523/JNEUROSCI.5436-10.2011	50	176	178	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1590	U129		10.1038/nn.2957	http://dx.doi.org/10.1038/nn.2957			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22037501	Green Accepted			2022-12-17	WOS:000297546300020
J	Chan, DK; Hudspeth, AJ				Chan, DK; Hudspeth, AJ			Ca2+ current-driven nonlinear amplification by the mammalian cochlea in vitro	NATURE NEUROSCIENCE			English	Article							OUTER HAIR-CELLS; GUINEA-PIG COCHLEA; MECHANOELECTRICAL-TRANSDUCTION CHANNELS; BASILAR-MEMBRANE; MECHANICAL RESPONSES; TECTORIAL MEMBRANE; BUNDLE MOVEMENTS; GERBIL COCHLEA; NERVE-FIBERS; ADAPTATION	An active process in the inner ear expends energy to enhance the sensitivity and frequency selectivity of hearing. Two mechanisms have been proposed to underlie this process in the mammalian cochlea: receptor potential-based electromotility and Ca2+-driven active hair-bundle motility. To link the phenomenology of the cochlear amplifier with these cellular mechanisms, we developed an in vitro cochlear preparation from Meriones unguiculatus that affords optical access to the sensory epithelium while mimicking its in vivo environment. Acoustic and electrical stimulation elicited microphonic potentials and electrically evoked hair-bundle movement, demonstrating intact forward and reverse mechanotransduction. The mechanical responses of hair bundles from inner hair cells revealed a characteristic resonance and a compressive nonlinearity diagnostic of the active process. Blocking transduction with amiloride abolished nonlinear amplification, whereas eliminating all but the Ca2+ component of the transduction current did not. These results suggest that the Ca2+ current drives the cochlear active process, and they support the hypothesis that active hair-bundle motility underlies cochlear amplification.	Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Hudspeth, AJ (corresponding author), Rockefeller Univ, Lab Sensory Neurosci, 1230 York Ave, New York, NY 10021 USA.	hudspaj@rockefeller.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000241, F32DC000241] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDCD NIH HHS [F32 DC000241, R01 DC000241-26, DC00241, R01 DC000241] Funding Source: Medline; NIGMS NIH HHS [T32 GM007739, GM07739] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Bozovic D, 2003, P NATL ACAD SCI USA, V100, P958, DOI 10.1073/pnas.0337433100; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Choe Y, 1998, P NATL ACAD SCI USA, V95, P15321, DOI 10.1073/pnas.95.26.15321; COOPER NP, 1994, HEARING RES, V78, P221, DOI 10.1016/0378-5955(94)90028-0; Cooper NP, 1997, J NEUROPHYSIOL, V78, P261, DOI 10.1152/jn.1997.78.1.261; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; DALLOS P, 1982, SCIENCE, V218, P582, DOI 10.1126/science.7123260; Eguiluz VM, 2000, PHYS REV LETT, V84, P5232, DOI 10.1103/PhysRevLett.84.5232; Fettiplace R, 2003, CURR OPIN NEUROBIOL, V13, P446, DOI 10.1016/S0959-4388(03)00094-1; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; Freeman DM, 2003, HEARING RES, V180, P11, DOI 10.1016/S0378-5955(03)00072-8; He DZZ, 2004, NATURE, V429, P766, DOI 10.1038/nature02591; Holt JR, 1997, J NEUROSCI, V17, P8739; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Hu XT, 1999, J NEUROPHYSIOL, V82, P2798, DOI 10.1152/jn.1999.82.5.2798; Hudspeth AJ, 2000, P NATL ACAD SCI USA, V97, P11765, DOI 10.1073/pnas.97.22.11765; JORGENSEN F, 1988, J PHYSIOL-LONDON, V403, P577, DOI 10.1113/jphysiol.1988.sp017265; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; KIM DO, 1986, HEARING RES, V22, P105, DOI 10.1016/0378-5955(86)90088-2; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Lumpkin EA, 1997, P NATL ACAD SCI USA, V94, P10997, DOI 10.1073/pnas.94.20.10997; Magnasco MO, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.058101; Manley GA, 2001, J NEUROPHYSIOL, V86, P541, DOI 10.1152/jn.2001.86.2.541; Martin P, 2000, P NATL ACAD SCI USA, V97, P12026, DOI 10.1073/pnas.210389497; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Martin P, 2003, J NEUROSCI, V23, P4533; Muller M, 1996, HEARING RES, V94, P148, DOI 10.1016/0378-5955(95)00230-8; Murugasu E, 1996, J NEUROSCI, V16, P325; Naidu RC, 1998, HEARING RES, V124, P124, DOI 10.1016/S0378-5955(98)00133-6; OHLEMILLER KK, 1992, HEARING RES, V63, P79, DOI 10.1016/0378-5955(92)90076-Y; Overstreet EH, 2002, JARO-J ASSOC RES OTO, V3, P351, DOI 10.1007/s101620020023; Ren TY, 2001, HEARING RES, V151, P48, DOI 10.1016/S0378-5955(00)00211-2; RHODE WS, 1967, J ACOUST SOC AM, V42, P185, DOI 10.1121/1.1910547; Ricci Anthony, 2003, J Am Acad Audiol, V14, P325; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; RUGGERO MA, 1991, J NEUROSCI, V11, P1057; Ruggero MA, 1997, J ACOUST SOC AM, V101, P2151, DOI 10.1121/1.418265; RUSSELL IJ, 1986, HEARING RES, V22, P199, DOI 10.1016/0378-5955(86)90096-1; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; Santos-Sacchi J, 2003, CURR OPIN NEUROBIOL, V13, P459, DOI 10.1016/S0959-4388(03)00100-4; SELLICK PM, 1982, J ACOUST SOC AM, V72, P131, DOI 10.1121/1.387996; SEWELL WF, 1984, J PHYSIOL-LONDON, V347, P685, DOI 10.1113/jphysiol.1984.sp015090; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; Ulfendahl M, 1998, CURR OPIN NEUROBIOL, V8, P475, DOI 10.1016/S0959-4388(98)80034-2; Vilfan A, 2003, BIOPHYS J, V85, P191, DOI 10.1016/S0006-3495(03)74465-8; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	47	176	187	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					149	155		10.1038/nn1385	http://dx.doi.org/10.1038/nn1385			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15643426	Green Accepted			2022-12-17	WOS:000226638200013
J	Li, WQ; Lee, J; Vikis, HG; Lee, SH; Liu, GF; Aurandt, J; Shen, TL; Fearon, ER; Guan, JL; Han, M; Rao, Y; Hong, KS; Guan, KL				Li, WQ; Lee, J; Vikis, HG; Lee, SH; Liu, GF; Aurandt, J; Shen, TL; Fearon, ER; Guan, JL; Han, M; Rao, Y; Hong, KS; Guan, KL			Activation of FAK and Src are receptor-proximal events required for netrin signaling	NATURE NEUROSCIENCE			English	Article							FOCAL ADHESION KINASE; GROWTH CONE GUIDANCE; COLORECTAL-CANCER; C-ELEGANS; TYROSINE PHOSPHORYLATION; FAMILY KINASES; TERMINAL DOMAIN; AXON GUIDANCE; DCC; CELL	The axon guidance cue netrin is importantly involved in neuronal development. DCC (deleted in colorectal cancer) is a functional receptor for netrin and mediates axon outgrowth and the steering response. Here we show that different regions of the intracellular domain of DCC directly interacted with the tyrosine kinases Src and focal adhesion kinase (FAK). Netrin activated both FAK and Src and stimulated tyrosine phosphorylation of DCC. Inhibition of Src family kinases reduced DCC tyrosine phosphorylation and blocked both axon attraction and outgrowth of neurons in response to netrin. Mutation of the tyrosine phosphorylation residue in DCC abolished its function of mediating netrin-induced axon attraction. On the basis of our observations, we suggest a model in which DCC functions as a kinase-coupled receptor, and FAK and Src act immediately downstream of DCC in netrin signaling.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Colorado, Howard Hughes Med Inst, Dept Mol Cellular Dev Biol, Boulder, CO 80309 USA; Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; New York University; Washington University (WUSTL); Cornell University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Michigan System; University of Michigan	Guan, KL (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	kunliang@umich.edu	Guan, Kun-Liang/ADK-7088-2022; Lee, Seung-Hee/J-5971-2013; Li, Weiquan/B-4897-2011	Shen, Tang-Long/0000-0001-6264-3608	NCI NIH HHS [R01 CA107193, R01 CA107193-03] Funding Source: Medline; NIGMS NIH HHS [GM07767] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA107193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOCKHOLT SM, 1995, CELL ADHES COMMUN, V3, P91, DOI 10.3109/15419069509081279; CALALB MB, 1995, MOL CELL BIOL, V15, P954; CARY LA, 1999, FRONT BIOSCI, V4, P102; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chang C, 2004, SCIENCE, V305, P103, DOI 10.1126/science.1096983; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Sperber BR, 2001, J NEUROSCI, V21, P2039, DOI 10.1523/JNEUROSCI.21-06-02039.2001; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Tabti N., 1991, CULTURING NERVE CELL, P137; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tong JF, 2001, J BIOL CHEM, V276, P40917, DOI 10.1074/jbc.M103872200	42	176	187	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1213	1221		10.1038/nn1329	http://dx.doi.org/10.1038/nn1329			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494734	Green Accepted, Green Submitted			2022-12-17	WOS:000224749400014
J	Brown, SP; Brenowitz, SD; Regehr, WG				Brown, SP; Brenowitz, SD; Regehr, WG			Brief presynaptic bursts evoke synapse-specific retrograde inhibition mediated by endogenous cannabinoids	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; CEREBELLAR PURKINJE-CELLS; PARALLEL FIBER; CALCIUM TRANSIENTS; DEPRESSION; RELEASE; SPINES; SIGNAL; ENDOCANNABINOIDS; DENDRITES	Many types of neurons can release endocannabinoids that act as retrograde signals to inhibit neurotransmitter release from presynaptic terminals. Little is known, however, about the properties or role of such inhibition under physiological conditions. Here we report that brief bursts of presynaptic activity evoked endocannabinoid release, which strongly inhibited parallel fiber-to-Purkinje cell synapses in rat cerebellar slices. This retrograde inhibition was triggered by activation of either postsynaptic metabotropic or ionotropic glutamate receptors and was restricted to synapses activated with high-frequency bursts. Thus, endocannabinoids allow neurons to inhibit specific synaptic inputs in response to a burst, thereby dynamically fine-tuning the properties of synaptic integration.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	wade_regehr@hms.harvard.edu	Brown, Solange/H-1615-2012		NINDS NIH HHS [R01 NS 32405, 5 T32 NS07484-02, R01 NS 44396] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032405, R01NS044396, T32NS007484] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alger BE, 2002, PROG NEUROBIOL, V68, P247; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; Eccles JC, 1967, CEREBELLUM NEURONAL; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; KASE M, 1980, J PHYSIOL-LONDON, V300, P539, DOI 10.1113/jphysiol.1980.sp013178; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; LEVENES C, 1998, J PHYSL, V510, P876; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; MERRILL EG, 1978, J PHYSIOL-LONDON, V284, P127, DOI 10.1113/jphysiol.1978.sp012531; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Neale SA, 2001, EUR J NEUROSCI, V14, P1313, DOI 10.1046/j.0953-816x.2001.01769.x; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Palay S.L., 1974, CEREBELLAR CORTEX; PITLER TA, 1992, J NEUROSCI, V12, P4122; REGEHR WG, 2000, IMAGING NEURONS LAB; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Takahashi KA, 2000, J NEUROPHYSIOL, V83, P1167, DOI 10.1152/jn.2000.83.3.1167; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; TANABE Y, 1993, J NEUROSCI, V13, P1372; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	50	176	184	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1048	1057		10.1038/nn1126	http://dx.doi.org/10.1038/nn1126			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14502290				2022-12-17	WOS:000185633600016
J	Banke, TG; Traynelis, SF				Banke, TG; Traynelis, SF			Activation of NR1/NR2B NMDA receptors	NATURE NEUROSCIENCE			English	Article							GLUTAMATE-RECEPTOR; OPEN PROBABILITY; PROTEIN-KINASE; BINDING-SITE; CHANNEL; PATCH; DEPENDENCE; KINETICS; NUMBER; MUTANT	N-methyl-D-aspartate (NMDA) receptors are highly expressed in the central nervous system and are involved in excitatory synaptic transmission as well as synaptic plasticity. Despite considerable structural and biophysical research, the mechanism behind activation of the NMDA receptor is still poorly understood. By analyzing patch clamp recordings of one channel activated by glutamate, we determined the burst structure and open probability for recombinant rat NR1/NR2B receptors. We used partial agonists at the glutamate and glycine binding sites to show that at least two kinetically distinct subunit-associated conformational changes link co-agonist binding to the opening of the NMDA receptor pore. These data suggest that NR1 and NR2B subunits, respectively, undergo a fast and slow agonist-dependent conformational change that precedes opening of the pore. We propose a new working model of receptor activation that can account for macroscopic as well as microscopic NMDA receptor properties.	Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Banke, TG (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	tbanke@pharm.emory.edu		Banke, Tue/0000-0001-8417-4400	NINDS NIH HHS [NS36654] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036654, R37NS036654] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akk G, 1999, BIOPHYS J, V76, P207, DOI 10.1016/S0006-3495(99)77190-0; Anson LC, 2000, J PHYSIOL-LONDON, V527, P225, DOI 10.1111/j.1469-7793.2000.00225.x; ANTOINE R, 2001, J NEUROSCI, V21, P5574; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; BENVENISTE M, 1995, J PHYSIOL-LONDON, V483, P367, DOI 10.1113/jphysiol.1995.sp020591; CAREAGA CL, 1995, BIOCHEMISTRY-US, V34, P3048, DOI 10.1021/bi00009a036; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; COLQUHOUN D, 1990, PROC R SOC SER B-BIO, V240, P453, DOI 10.1098/rspb.1990.0048; Colquhoun David, 1995, P483; Dingledine R, 1999, PHARMACOL REV, V51, P7; EDMONDS B, 1992, P ROY SOC B-BIOL SCI, V250, P279, DOI 10.1098/rspb.1992.0160; GIBB AJ, 1992, J PHYSIOL-LONDON, V456, P143, DOI 10.1113/jphysiol.1992.sp019331; HORN R, 1991, BIOPHYS J, V60, P433, DOI 10.1016/S0006-3495(91)82069-0; JAHR CE, 1992, SCIENCE, V255, P470, DOI 10.1126/science.1346477; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jones KS, 2002, J NEUROSCI, V22, P2044, DOI 10.1523/JNEUROSCI.22-06-02044.2002; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LESTER RAJ, 1992, J NEUROSCI, V12, P635; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Perozo E, 2002, STRUCTURE, V10, P1027, DOI 10.1016/S0969-2126(02)00812-2; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Premkumar LS, 1997, J GEN PHYSIOL, V109, P181, DOI 10.1085/jgp.109.2.181; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; Schneggenburger R, 1997, NEURON, V18, P167, DOI 10.1016/S0896-6273(01)80055-6; Sobolevsky AI, 2002, NEURON, V33, P75, DOI 10.1016/S0896-6273(01)00560-8; Sobolevsky AI, 2002, BIOPHYS J, V83, P3304, DOI 10.1016/S0006-3495(02)75331-9; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978	34	176	179	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					144	152		10.1038/nn1000	http://dx.doi.org/10.1038/nn1000			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12524545	Green Published			2022-12-17	WOS:000180669100014
J	Crowley, JC; Katz, LC				Crowley, JC; Katz, LC			Development of ocular dominance columns in the absence of retinal input	NATURE NEUROSCIENCE			English	Article							DORSAL LATERAL GENICULATE; BINOCULAR IMPULSE BLOCKADE; FERRET VISUAL-CORTEX; STRIATE CORTEX; BILATERAL ENUCLEATION; POSTNATAL-DEVELOPMENT; MAMMALIAN RETINA; GANGLION-CELLS; NUCLEUS; MONKEY	The initial establishment of ocular dominance columns in visual cortex is believed to involve the segregation of overlapping geniculocortical axons into eye-specific patches based on patterns of correlated activity. However, we found that total removal of retinal influence early in visual development did not prevent segregation of geniculocortical axons into alternating stripes with periodicity normal for ocular dominance columns. Because the patterning of geniculocortical afferents resists this dramatic change in the level, source and pattern of spontaneous activity, we propose that formation of ocular dominance columns relies on molecular cues present on thalamic axons, cortical cells or both.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Crowley, JC (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 3209, Durham, NC 27710 USA.				NATIONAL EYE INSTITUTE [R01EY007960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH012359] Funding Source: NIH RePORTER; NEI NIH HHS [EYO7960] Funding Source: Medline; NIMH NIH HHS [MH12359] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; ANTONINI A, 1993, J NEUROSCI, V13, P3549; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; BRUNSOBECHTOLD JK, 1981, NEUROSCIENCE, V6, P2579, DOI 10.1016/0306-4522(81)90103-2; Cook PM, 1999, VISUAL NEUROSCI, V16, P491, DOI 10.1017/S0952523899163107; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Dehay C, 1996, J COMP NEUROL, V367, P70, DOI 10.1002/(SICI)1096-9861(19960325)367:1<70::AID-CNE6>3.0.CO;2-G; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Donoghue MJ, 1999, J NEUROSCI, V19, P5967, DOI 10.1523/JNEUROSCI.19-14-05967.1999; Erwin E, 1998, J NEUROSCI, V18, P9870; Finney EM, 1998, J NEUROSCI, V18, P8826; FITZPATRICK D, 1983, J NEUROSCI, V3, P673; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; GUILLERY RW, 1985, J NEUROSCI, V5, P1370; HENDRY SHC, 1994, SCIENCE, V264, P575, DOI 10.1126/science.8160015; Horton JC, 1996, J NEUROSCI, V16, P7228; Horton JC, 1996, J NEUROSCI, V16, P1791; HORTON JC, 1981, NATURE, V292, P762, DOI 10.1038/292762a0; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; JACKSON CA, 1989, J NEUROSCI, V9, P1242; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; KIM U, 1995, J NEUROPHYSIOL, V74, P1301, DOI 10.1152/jn.1995.74.3.1301; KULJIS RO, 1990, P NATL ACAD SCI USA, V87, P5303, DOI 10.1073/pnas.87.14.5303; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MCCORMICK DA, 1995, J NEUROSCI, V15, P5739; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; REDIES C, 1990, J NEUROSCI, V10, P2791; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; White LE, 1999, J NEUROSCI, V19, P7089, DOI 10.1523/JNEUROSCI.19-16-07089.1999; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; ZAHS KR, 1988, J NEUROPHYSIOL, V59, P1410, DOI 10.1152/jn.1988.59.5.1410	50	176	179	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1125	1130		10.1038/16051	http://dx.doi.org/10.1038/16051			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570491				2022-12-17	WOS:000085810100018
J	Chen, CH; Fremont, R; Arteaga-Bracho, EE; Khodakhah, K				Chen, Christopher H.; Fremont, Rachel; Arteaga-Bracho, Eduardo E.; Khodakhah, Kamran			Short latency cerebellar modulation of the basal ganglia	NATURE NEUROSCIENCE			English	Article							ONSET DYSTONIA-PARKINSONISM; LONG-TERM POTENTIATION; NEURONAL-ACTIVITY; STRIATAL NEURONS; DEPENDENT PLASTICITY; SYNAPTIC PLASTICITY; SUBSTANTIA NIGRAE; DOPAMINE RELEASE; THALAMIC NEURONS; CAUDATE NUCLEI	The graceful, purposeful motion of our body is an engineering feat that remains unparalleled in robotic devices using advanced artificial intelligence. Much of the information required for complex movements is generated by the cerebellum and the basal ganglia in conjunction with the cortex. Cerebellum and basal ganglia have been thought to communicate with each other only through slow, multi-synaptic cortical loops, begging the question as to how they coordinate their outputs in real time. We found that the cerebellum rapidly modulates the activity of the striatum via a disynaptic pathway in mice. Under physiological conditions, this short latency pathway was capable of facilitating optimal motor control by allowing the basal ganglia to incorporate time-sensitive cerebellar information and by guiding the sign of cortico-striatal plasticity. Conversely, under pathological condition, this pathway relayed aberrant cerebellar activity to the basal ganglia to cause dystonia.	[Chen, Christopher H.; Fremont, Rachel; Arteaga-Bracho, Eduardo E.; Khodakhah, Kamran] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Khodakhah, K (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	k.khodakhah@einstein.yu.edu	Core, Vector/CAF-4832-2022	Fremont, Rachel/0000-0001-5285-7899; Arteaga-Bracho, Eduardo/0000-0002-3996-9981	US National Institutes of Health [NS050808, NS079750, NS071665]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079750, R01NS050808, F30NS071665] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the members of the Khodakhah laboratory for invaluable discussions and comments on the manuscript. This work was supported by grants from the US National Institutes of Health (NS050808, NS079750 and NS071665).	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Bostan AC, 2010, P NATL ACAD SCI USA, V107, P8452, DOI 10.1073/pnas.1000496107; CALABRESI P, 1992, J NEUROSCI, V12, P4224; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; Calderon DP, 2011, NAT NEUROSCI, V14, P357, DOI 10.1038/nn.2753; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; Cooper I S, 1965, J Neurol Sci, V2, P520, DOI 10.1016/0022-510X(65)90002-X; Doya K, 1999, NEURAL NETWORKS, V12, P961, DOI 10.1016/S0893-6080(99)00046-5; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; Horisawa S, 2013, ANN NEUROL, V74, P648, DOI 10.1002/ana.23877; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Houlden H, 2010, NEUROLOGY, V74, P846, DOI 10.1212/WNL.0b013e3181d5276d; Ichinohe N, 2000, BRAIN RES, V880, P191, DOI 10.1016/S0006-8993(00)02744-X; Ito M, 1984, CEREBELLUM NEURAL CO; Jeljeli M, 2000, NEUROSCI RES, V38, P155, DOI 10.1016/S0168-0102(00)00152-8; Koralek AC, 2012, NATURE, V483, P331, DOI 10.1038/nature10845; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Lacey CJ, 2007, J NEUROSCI, V27, P4374, DOI 10.1523/JNEUROSCI.5519-06.2007; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Martella G, 2009, BRAIN, V132, P2336, DOI 10.1093/brain/awp194; Medina JF, 2011, CURR OPIN NEUROBIOL, V21, P616, DOI 10.1016/j.conb.2011.05.025; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; NIEOULLON A, 1980, NEUROSCI LETT, V17, P167, DOI 10.1016/0304-3940(80)90079-8; NIEOULLON A, 1978, BRAIN RES, V148, P143, DOI 10.1016/0006-8993(78)90384-0; Paille V, 2013, J NEUROSCI, V33, P9353, DOI 10.1523/JNEUROSCI.5796-12.2013; Proville RD, 2014, NAT NEUROSCI, V17, P1233, DOI 10.1038/nn.3773; RATCHESON RA, 1969, EXP NEUROL, V25, P268, DOI 10.1016/0014-4886(69)90050-8; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Rossi S, 2008, RESTOR NEUROL NEUROS, V26, P475; Schwingenschuh P, 2010, MOVEMENT DISORD, V25, P560, DOI 10.1002/mds.23019; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Starr PA, 2005, J NEUROPHYSIOL, V93, P3165, DOI 10.1152/jn.00971.2004; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Vitek JL, 1999, ANN NEUROL, V46, P22, DOI 10.1002/1531-8249(199907)46:1<22::AID-ANA6>3.0.CO;2-Z	44	175	177	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2014	17	12					1767	1775		10.1038/nn.3868	http://dx.doi.org/10.1038/nn.3868			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU2ZY	25402853	Green Accepted			2022-12-17	WOS:000345484000025
J	Altier, C; Garcia-Caballero, A; Simms, B; You, HT; Chen, LN; Walcher, J; Tedford, HW; Hermosilla, T; Zamponi, GW				Altier, Christophe; Garcia-Caballero, Agustin; Simms, Brett; You, Haitao; Chen, Lina; Walcher, Jan; Tedford, H. William; Hermosilla, Tamara; Zamponi, Gerald W.			The Cav beta subunit prevents RFP2-mediated ubiquitination and proteasomal degradation of L-type channels	NATURE NEUROSCIENCE			English	Article							CALCIUM-CHANNEL; ENDOPLASMIC-RETICULUM; RETRO-TRANSLOCATION; ALPHA(1) SUBUNIT; GENE RFP2; COMPLEX; TRAFFICKING; CONTRACTION; EXPRESSION; PROTEINS	It is well established that the auxiliary Cav beta subunit regulates calcium channel density in the plasma membrane, but the cellular mechanism by which this occurs has remained unclear. We found that the Cav beta subunit increased membrane expression of Cav1.2 channels by preventing the entry of the channels into the endoplasmic reticulum-associated protein degradation (ERAD) complex. Without Cav beta, Cav1.2 channels underwent robust ubiquitination by the RFP2 ubiquitin ligase and interacted with the ERAD complex proteins derlin-1 and p97, culminating in targeting of the channels to the proteasome for degradation. On treatment with the proteasomal inhibitor MG132, Cav beta-free channels were rescued from degradation and trafficked to the plasma membrane. The coexpression of Cav beta interfered with ubiquitination and targeting of the channel to the ERAD complex, thereby facilitating export from the endoplasmic reticulum and promoting expression on the cell surface. Thus, Cav beta regulates the ubiquitination and stability of the calcium channel complex.	[Altier, Christophe; Garcia-Caballero, Agustin; Simms, Brett; You, Haitao; Chen, Lina; Walcher, Jan; Tedford, H. William; Hermosilla, Tamara; Zamponi, Gerald W.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary	Zamponi, GW (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.	zamponi@ucalgary.ca		Zamponi, Gerald W./0000-0002-0644-9066	Heart and Stroke Foundation of Alberta; Northwest Territories and Nunavut; Canadian Institutes for Health Research; AFHMR; AHFMR	Heart and Stroke Foundation of Alberta; Northwest Territories and Nunavut; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); AFHMR; AHFMR(Alberta Heritage Foundation for Medical Research)	We thank J. Striessnig, S. Ferguson, J. Stutts, B. Schwappach, E. Bourinet and T. Snutch for cDNA constructs, and E. Stanley for help with the ICQ colocalization analysis. This work was supported by operating grants to G. W. Z. from the Heart and Stroke Foundation of Alberta, the Northwest Territories and Nunavut, and the Canadian Institutes for Health Research. G. W. Z. is a Scientist of the Alberta Heritage Foundation for Medical Research (AHFMR) and a Canada Research Chair in Molecular Neurobiology. H.Y. is supported by an AFHMR fellowship and B. S. is supported by an AHFMR studentship.	Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Altier C, 2006, NAT NEUROSCI, V9, P31, DOI 10.1038/nn1605; Baranova A, 2003, GENE, V321, P103, DOI 10.1016/j.gene.2003.08.007; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Birnbaumer L, 1998, J BIOENERG BIOMEMBR, V30, P357, DOI 10.1023/A:1021989622656; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Corcoran MM, 2004, GENE CHROMOSOME CANC, V40, P285, DOI 10.1002/gcc.20046; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Hidalgo P, 2007, CELL CALCIUM, V42, P389, DOI 10.1016/j.ceca.2007.05.009; Hullin R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000292; Kisilevsky AE, 2008, NEURON, V58, P557, DOI 10.1016/j.neuron.2008.03.002; Lerner M, 2007, MOL BIOL CELL, V18, P1670, DOI 10.1091/mbc.E06-03-0248; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lie AA, 1999, NEUROSCIENCE, V93, P449, DOI 10.1016/S0306-4522(99)00162-1; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Maltez JM, 2005, NAT STRUCT MOL BIOL, V12, P372, DOI 10.1038/nsmb909; Obermair GJ, 2010, J BIOL CHEM, V285, P5776, DOI 10.1074/jbc.M109.044271; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Vance CL, 1998, J BIOL CHEM, V273, P14495, DOI 10.1074/jbc.273.23.14495; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Weissgerber P, 2006, CIRC RES, V99, P749, DOI 10.1161/01.RES.0000243978.15182.c1; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198	40	175	177	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					173	U252		10.1038/nn.2712	http://dx.doi.org/10.1038/nn.2712			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21186355	Green Published			2022-12-17	WOS:000286595400014
J	Koenigs, M; Huey, ED; Raymont, V; Cheon, B; Solomon, J; Wassermann, EM; Grafman, J				Koenigs, Michael; Huey, Edward D.; Raymont, Vanessa; Cheon, Bobby; Solomon, Jeffrey; Wassermann, Eric M.; Grafman, Jordan			Focal brain damage protects against post-traumatic stress disorder in combat veterans	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; DOUBLE-BLIND; AMYGDALA; VIETNAM; ACTIVATION; PTSD	Post-traumatic stress disorder ( PTSD) is an often debilitating mental illness that is characterized by recurrent distressing memories of traumatic events. PTSD is associated with hypoactivity in the ventromedial prefrontal cortex ( vmPFC), hyperactivity in the amygdala and reduced volume in the hippocampus, but it is unknown whether these neuroimaging findings reflect the underlying cause or a secondary effect of the disorder. To investigate the causal contribution of specific brain areas to PTSD symptoms, we studied a unique sample of Vietnam War veterans who suffered brain injury and emotionally traumatic events. We found a substantially reduced occurrence of PTSD among those individuals with damage to one of two regions of the brain: the vmPFC and an anterior temporal area that included the amygdala. These results suggest that the vmPFC and amygdala are critically involved in the pathogenesis of PTSD.	[Koenigs, Michael; Huey, Edward D.; Raymont, Vanessa; Wassermann, Eric M.; Grafman, Jordan] Natl Inst Neurol Disorders & Stroke, Cognit Neurosci Sect, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Raymont, Vanessa; Cheon, Bobby] Natl Naval Med Ctr, Henry M Jackson Fdn, Vietnam Head Injury Study, Bethesda, MD 20889 USA; [Solomon, Jeffrey] Med Numer, Germantown, MD 20876 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed National Military Medical Center	Grafman, J (corresponding author), Natl Inst Neurol Disorders & Stroke, Cognit Neurosci Sect, US Natl Inst Hlth, 10 Ctr Dr,MSC 1440, Bethesda, MD 20892 USA.	grafmanj@ninds.nih.gov	Wassermann, Eric M./AAC-9064-2020	Wassermann, Eric M./0000-0003-0628-0210; Koenigs, Michael/0000-0002-5799-4881; Cheon, Bobby/0000-0001-6815-619X; Grafman, Jordan H./0000-0001-8645-4457	Intramural NIH HHS [Z01 NS003024-01, Z01 NS002792-19] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002977, ZIANS003024, ZIANS002792] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGGLETON JP, 1980, BRAIN RES, V190, P347, DOI 10.1016/0006-8993(80)90279-6; Aggleton JP., 2000, AMYGDALA FUNCTIONAL; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ayuso-Mateos JL., 2002, GLOBAL BURDEN POST T; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Cohen H, 2004, AM J PSYCHIAT, V161, P515, DOI 10.1176/appi.ajp.161.3.515; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsych.2007.05.008; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Driessen M, 2004, BIOL PSYCHIAT, V55, P603, DOI 10.1016/j.biopsych.2003.08.018; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; First M.B., 2002, STRUCTURED CLIN INTE; Fitzgerald PB, 2003, ARCH GEN PSYCHIAT, V60, P1002, DOI 10.1001/archpsyc.60.9.1002; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2384, DOI 10.1038/sj.npp.1301165; Hendler T, 2003, NEUROIMAGE, V19, P587, DOI 10.1016/S1053-8119(03)00141-1; Henry TR, 2002, NEUROLOGY, V59, pS3, DOI 10.1212/WNL.59.6_suppl_4.S3; Herskovits EH, 2002, RADIOLOGY, V224, P345, DOI 10.1148/radiol.2242011439; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 2003, NEUROREPORT, V14, P913, DOI 10.1097/01.wnr.0000071767.24455.10; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Talairach J., 1988, COPLANAR STEREOTAXIC; Tranel D, 2005, BRAIN, V128, P2872, DOI 10.1093/brain/awh643; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wassermann EM, 2005, TRENDS COGN SCI, V9, P503, DOI 10.1016/j.tics.2005.09.001; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033	38	175	183	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					232	237		10.1038/nn2032	http://dx.doi.org/10.1038/nn2032			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18157125	Green Accepted, Green Published			2022-12-17	WOS:000252712100018
J	Stuphorn, V; Schall, JD				Stuphorn, Veit; Schall, Jeffrey D.			Executive control of countermanding saccades by the supplementary eye field	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; ELECTRICAL-STIMULATION; INTRACORTICAL MICROSTIMULATION; COGNITIVE CONTROL; GUIDED SACCADES; MACAQUE MONKEY; MOVEMENTS; CONNECTIONS; PROJECTIONS; INITIATION	The supplementary eye field registers the occurrence of conflict, errors and reward in macaque monkeys performing a saccade-countermanding task. Using intracortical microstimulation, we determined whether the supplementary eye field only monitors or can actually influence performance. Weak microstimulation of many sites in the supplementary eye field improved monkeys' performance on a 'stop signal' task by delaying saccade initiation. This effect depended on the context of the task because simple visually guided saccades were not delayed by the same stimulation. These results demonstrate that the supplementary eye field can exert contextual executive control over saccade generation.	Vanderbilt Univ, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Dept Psychol, Nashville, TN 37203 USA; Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA	Vanderbilt University; Johns Hopkins University; Johns Hopkins University	Stuphorn, V (corresponding author), Vanderbilt Univ, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Dept Psychol, Wilson Hall,111 21st Ave S, Nashville, TN 37203 USA.	veit@jhu.edu			NEI NIH HHS [P30-EY08126] Funding Source: Medline; NICHD NIH HHS [P30-HD015052] Funding Source: Medline; NIMH NIH HHS [R01-MH55806] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055806] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Cavina-Pratesi C, 2001, J EXP PSYCHOL HUMAN, V27, P932, DOI 10.1037//0096-1523.27.4.932; Dobson A.J., 1990, INTRO GEN LINEAR MOD; Efron B., 1993, INTRO BOOTSTRAP, P436, DOI [10.1007/978-1-4899-4541-9, DOI 10.1007/978-1-4899-4541-9]; FALKENSTEIN M, 1995, PERSPECTIVES EVENT S, V44, P287; FRIED I, 1991, J NEUROSCI, V11, P3656; Fujii N, 1995, NEUROREPORT, V6, P2565, DOI 10.1097/00001756-199512150-00028; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; HANES DP, 1995, VISUAL NEUROSCI, V12, P929, DOI 10.1017/S0952523800009482; Hanes DP, 1998, J NEUROPHYSIOL, V79, P817, DOI 10.1152/jn.1998.79.2.817; HUERTA MF, 1990, J COMP NEUROL, V293, P299, DOI 10.1002/cne.902930211; Isoda M, 2005, J NEUROPHYSIOL, V93, P3016, DOI 10.1152/jn.01176.2004; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Izawa Y, 2004, J NEUROPHYSIOL, V92, P2248, DOI 10.1152/jn.01021.2003; KEATING EG, 1983, BRAIN RES, V269, P145, DOI 10.1016/0006-8993(83)90971-X; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; LIM SH, 1994, ELECTROEN CLIN NEURO, V91, P179, DOI 10.1016/0013-4694(94)90068-X; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Luppino G, 2003, EUR J NEUROSCI, V17, P559, DOI 10.1046/j.1460-9568.2003.02476.x; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Martinez-Trujillo JC, 2004, NEURON, V44, P1057, DOI 10.1016/j.neuron.2004.12.004; PARTHASARATHY HB, 1992, J NEUROSCI, V12, P4468; PENFIELD W, 1951, AMA ARCH NEUROL PSY, V66, P289, DOI 10.1001/archneurpsyc.1951.02320090038004; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Russo GS, 2000, J NEUROPHYSIOL, V84, P2605, DOI 10.1152/jn.2000.84.5.2605; Schacht J, 2006, AUDIOL NEURO-OTOL, V11, P1, DOI 10.1159/000088850; SCHALL JD, 1993, VISUAL NEUROSCI, V10, P385, DOI 10.1017/S0952523800003771; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; SCHALL JD, 1991, J NEUROPHYSIOL, V66, P559, DOI 10.1152/jn.1991.66.2.559; SCHILLER PH, 1980, J NEUROPHYSIOL, V44, P1175, DOI 10.1152/jn.1980.44.6.1175; SCHILLER PH, 1977, BRAIN RES, V122, P154, DOI 10.1016/0006-8993(77)90672-2; SCHLAG J, 1987, J NEUROPHYSIOL, V57, P179, DOI 10.1152/jn.1987.57.1.179; Schlag J, 1998, J NEUROPHYSIOL, V79, P64, DOI 10.1152/jn.1998.79.1.64; SHOOK BL, 1990, J COMP NEUROL, V301, P618, DOI 10.1002/cne.903010410; STONEY SD, 1968, J NEUROPHYSIOL, V31, P659, DOI 10.1152/jn.1968.31.5.659; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; Tehovnik EJ, 2003, EUR J NEUROSCI, V17, P870, DOI 10.1046/j.1460-9568.2003.02489.x; WAGMAN IH, 1958, J COMP NEUROL, V109, P169, DOI 10.1002/cne.901090203; WALKER EA, 1940, J NEUROPHYSIOL, V3, P369	41	175	177	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					925	931		10.1038/nn1714	http://dx.doi.org/10.1038/nn1714			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16732274				2022-12-17	WOS:000238590800019
J	Revest, JM; Di Blasi, F; Kitchener, P; Rouge-Pont, F; Desmedt, A; Turiault, M; Tronche, F; Piazza, PV				Revest, JM; Di Blasi, F; Kitchener, P; Rouge-Pont, F; Desmedt, A; Turiault, M; Tronche, F; Piazza, PV			The MAPK pathway and Egr-1 mediate stress-related behavioral effects of glucocorticoids	NATURE NEUROSCIENCE			English	Article							EARLY GENE ZIF268; RECOGNITION MEMORY; NERVOUS-SYSTEM; KINASE CASCADE; SPATIAL MEMORY; FEAR MEMORY; DNA-BINDING; RECEPTOR; EXPRESSION; HIPPOCAMPUS	Many of the behavioral consequences of stress are mediated by the activation of the glucocorticoid receptor by stress-induced high levels of glucocorticoid hormones. To explore the molecular mechanisms of these effects, we combined in vivo and in vitro approaches. We analyzed mice carrying a brain-specific mutation (GR(NesCre)) in the glucocorticoid receptor gene (GR, also called Nr3c1) and cell lines that either express endogenous glucocorticoid receptor or carry a constitutively active form of the receptor (Delta GR) that can be transiently induced. In the hippocampus of the mutant mice after stress, as well as in the cell lines, activation of glucocorticoid receptors greatly increased the expression and enzymatic activity of proteins in the MAPK signaling pathway and led to an increase in the levels of both Egr-1 mRNA and protein. In parallel, inhibition of the MAPK pathway within the hippocampus abolished the increase in contextual fear conditioning induced by glucocorticoids. The present results provide a molecular mechanism for the stress-related effects of glucocorticoids on fear memories.	Univ Bordeaux 2, Bordeaux Inst Neurosci, Lab Physiopathol Comportement, INSERM,U588, F-33077 Bordeaux, France; Cognit Neurosci Lab, CNRS, UMR5106, F-33405 Talence, France; Coll France, Inst Biol, CNRS, FRE2401, F-75231 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Universite Paris Cite	Piazza, PV (corresponding author), Univ Bordeaux 2, Bordeaux Inst Neurosci, Lab Physiopathol Comportement, INSERM,U588, Domaine Carreire,146 Rue Leo Saignat, F-33077 Bordeaux, France.	piazza@bordeaux.inserm.fr	TRONCHE, François/F-3895-2011	Desmedt, aline/0000-0002-1179-7161; Di Blasi, Francesco/0000-0001-8085-7538				Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Blum S, 1999, J NEUROSCI, V19, P3535; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Cella N, 1998, MOL CELL BIOL, V18, P1783, DOI 10.1128/MCB.18.4.1783; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; de Kloet E Ronald, 2003, Endocr Regul, V37, P51; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; Deroche-Gamonet V, 2003, J NEUROSCI, V23, P4785; Desmedt A, 1998, J NEUROSCI, V18, P480; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FUNDER JW, 1992, J STEROID BIOCHEM, V43, P389, DOI 10.1016/0960-0760(92)90074-S; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Jouvert P, 2002, NEUROMOL MED, V1, P137, DOI 10.1385/NMM:1:2:137; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kelly A, 2003, J NEUROSCI, V23, P5354; Kitchener P, 2004, EUR J NEUROSCI, V19, P1837, DOI 10.1111/j.1460-9568.2004.03267.x; Lee JE, 1996, ONCOGENE, V12, P1669; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Marais R, 1996, CANCER SURV, V27, P101; Marinelli M, 2002, EUR J NEUROSCI, V16, P387, DOI 10.1046/j.1460-9568.2002.02089.x; MCEWEN BS, 1986, PHYSIOL REV, V66, P1121, DOI 10.1152/physrev.1986.66.4.1121; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; Meller E, 2003, BRAIN RES, V979, P57, DOI 10.1016/S0006-8993(03)02866-X; MINER JN, 1991, TRENDS BIOCHEM SCI, V16, P423, DOI 10.1016/0968-0004(91)90168-U; MORATALLA R, 1992, J NEUROSCI, V12, P2609; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Oitzl MS, 2001, P NATL ACAD SCI USA, V98, P12790, DOI 10.1073/pnas.231313998; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; Piazza PV, 1997, BRAIN RES REV, V25, P359, DOI 10.1016/S0165-0173(97)00025-8; Qiu I, 2001, BIOCHEM BIOPH RES CO, V287, P1017, DOI 10.1006/bbrc.2001.5691; Richter-Levin G, 2000, MOL NEUROBIOL, V22, P11, DOI 10.1385/MN:22:1-3:011; Sananbenesi F, 2003, J NEUROSCI, V23, P11436; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; STORM SM, 1990, ONCOGENE, V5, P345; STRAWHECKER JM, 1989, ONCOGENE, V4, P1317; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; Valjent E, 2004, EUR J NEUROSCI, V19, P1826, DOI 10.1111/j.1460-9568.2004.03278.x; Wei Q, 2004, P NATL ACAD SCI USA, V101, P11851, DOI 10.1073/pnas.0402208101; Widen C, 2000, J BIOL CHEM, V275, P39296, DOI 10.1074/jbc.M006943200; Yuryev A, 1998, Cell Res, V8, P81	50	175	181	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					664	672		10.1038/nn1441	http://dx.doi.org/10.1038/nn1441			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15834420				2022-12-17	WOS:000228895100028
J	Tan, J; Town, T; Crawford, F; Mori, T; DelleDonne, A; Crescentini, R; Obregon, D; Flavell, RA; Mullan, MJ				Tan, J; Town, T; Crawford, F; Mori, T; DelleDonne, A; Crescentini, R; Obregon, D; Flavell, RA; Mullan, MJ			Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice	NATURE NEUROSCIENCE			English	Article							PRECURSOR PROTEIN; MICROGLIAL ACTIVATION; ENDOTHELIAL-CELLS; BETA-SECRETASE; SMOOTH-MUSCLE; MOUSE MODEL; DISEASE; PATHOLOGY; ATHEROSCLEROSIS; INFLAMMATION	We have shown that interaction of CD40 with CD40L enables microglial activation in response to amyloid-beta peptide (Abeta), which is associated with Alzheimer's disease (AD)-like neuronal tau hyperphosphorylation in vivo. Here we report that transgenic mice overproducing Abeta, but deficient in CD40L, showed decreased astrocytosis and microgliosis associated with diminished Abeta levels and beta-amyloid plaque load. Furthermore, in the PSAPP transgenic mouse model of AD, a depleting antibody against CD40L caused marked attenuation of Abeta/beta-amyloid pathology, which was associated with decreased amyloidogenic processing of amyloid precursor protein (APP) and increased circulating levels of Abeta. Conversely, in neuroblastoma cells overexpressing wild-type human APP, the CD40-CD40L interaction resulted in amyloidogenic APP processing. These findings suggest several possible mechanisms underlying mitigation of AD pathology in response to CD40L depletion, and validate the CD40-CD40L interaction as a target for therapeutic intervention in AD.	Univ S Florida, Roskamp Inst, Dept Psychiat, Tampa, FL 33613 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	State University System of Florida; University of South Florida; Howard Hughes Medical Institute; Yale University	Mullan, MJ (corresponding author), Univ S Florida, Roskamp Inst, Dept Psychiat, 3515 E Fletcher Ave, Tampa, FL 33613 USA.		Tan, Jun/I-5339-2012	Mullan, Michael/0000-0002-1473-7527				BALL MJ, 1985, LANCET, V1, P14; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; Calingasan NY, 2002, NEUROBIOL AGING, V23, P31, DOI 10.1016/S0197-4580(01)00246-9; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; DiCarlo G, 2001, NEUROBIOL AGING, V22, P1007, DOI 10.1016/S0197-4580(01)00292-5; Giulian D, 1999, AM J HUM GENET, V65, P13, DOI 10.1086/302477; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Jantzen PT, 2002, J NEUROSCI, V22, P2246, DOI 10.1523/JNEUROSCI.22-06-02246.2002; Johnson D, 1997, EDN, V42, P94; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; McGeer EG, 1998, EXP GERONTOL, V33, P371, DOI 10.1016/S0531-5565(98)00013-8; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Nguyen VT, 1998, EUR J IMMUNOL, V28, P2537, DOI 10.1002/(SICI)1521-4141(199808)28:08<2537::AID-IMMU2537>3.0.CO;2-1; Piguet PF, 2001, AM J PATHOL, V159, P733, DOI 10.1016/S0002-9440(10)61744-0; Qiao XX, 2001, EUR J NEUROSCI, V14, P474, DOI 10.1046/j.0953-816x.2001.01666.x; Rogers J, 1996, NEUROBIOL AGING, V17, P681, DOI 10.1016/0197-4580(96)00115-7; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SCHMIDT ML, 1990, AM J PATHOL, V136, P1069; Schonbeck U, 2000, P NATL ACAD SCI USA, V97, P7458, DOI 10.1073/pnas.97.13.7458; Schonbeck U, 1997, J BIOL CHEM, V272, P19569, DOI 10.1074/jbc.272.31.19569; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Tan J, 2002, EMBO J, V21, P643, DOI 10.1093/emboj/21.4.643; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Togo T, 2000, BRAIN RES, V885, P117, DOI 10.1016/S0006-8993(00)02984-X; Wilcock DM, 2001, DNA CELL BIOL, V20, P731, DOI 10.1089/10445490152717596; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	35	175	182	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1288	1293		10.1038/nn968	http://dx.doi.org/10.1038/nn968			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12402041				2022-12-17	WOS:000179447500011
J	Wong, PC; Cai, HB; Borchelt, DR; Price, DL				Wong, PC; Cai, HB; Borchelt, DR; Price, DL			Genetically engineered mouse models of neurodegenerative diseases	NATURE NEUROSCIENCE			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; AMYLOID PRECURSOR PROTEIN; SPINAL MUSCULAR-ATROPHY; FAMILIAL ALZHEIMERS-DISEASE; MOTOR-NEURON DEGENERATION; BETA-SECRETASE; TRANSGENIC MICE; SUPEROXIDE-DISMUTASE; KNOCKOUT MICE; ANIMAL-MODEL	Recent research has significantly advanced our understanding of the molecular mechanisms of neurodegenerative diseases, including Alzheimer's disease (AD) and motor neuron disease. Here we emphasize the use of genetically engineered mouse models that are instrumental for understanding why AD is a neuronal disease, and for validating attractive therapeutic targets. In motor neuron diseases, Cu/Zn superoxide dismutase and survival motor neuron mouse models are useful in testing disease mechanisms and therapeutic strategies for amyotrophic lateral sclerosis (ALS) and spinal motor atrophy, respectively, but the mechanisms that account for selective motor neuron loss remain uncertain. We anticipate that, in the future, therapies based on understanding disease mechanisms will be identified and tested in mouse model systems.	Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Neuropathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wong, PC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, 558 Ross Res Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.		Cai, Huaibin/H-3359-2013	Cai, Huaibin/0000-0002-8596-6108	NIA NIH HHS [AG10480, AG07914, AG05146, AG14248, AG10491] Funding Source: Medline; NINDS NIH HHS [NS38065, NS38377, NS40014, NS37771, NS37145, NS20471, NS10580, NS07435] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS020471, R01NS037145, R01NS037771, P50NS038377, R01NS038065, P50NS020471, R01NS040014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010480, P01AG014248, R35AG007914, P01AG010491] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albert MS, 2000, NEUROLOGY, V55, P166, DOI 10.1212/WNL.55.2.166; ANDERSEN PM, 2000, AMYOTROPHIC LATERAL, P223; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Beach TG, 2000, J NEUROPATH EXP NEUR, V59, P308, DOI 10.1093/jnen/59.4.308; Beaulieu JM, 2000, J NEUROSCI, V20, P5321, DOI 10.1523/JNEUROSCI.20-14-05321.2000; Bodendorf U, 2001, J BIOL CHEM, V276, P12019, DOI 10.1074/jbc.M008861200; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; Eisler WP.WolfeM, 2001, SCIENCE, V293, P1449; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Eyer J, 1998, NATURE, V391, P584, DOI 10.1038/35378; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Goedert M, 1998, CURR OPIN NEUROBIOL, V8, P619, DOI 10.1016/S0959-4388(98)80090-1; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hadland BK, 2001, P NATL ACAD SCI USA, V98, P7487, DOI 10.1073/pnas.131202798; Hardy J, 1998, SCIENCE, V282, P1075, DOI 10.1126/science.282.5391.1075; Heber S, 2000, J NEUROSCI, V20, P7951; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Ince P, 2000, AMYOTROPHIC LATERAL, P83; Jablonka S, 2000, HUM MOL GENET, V9, P341, DOI 10.1093/hmg/9.3.341; JACKSON M, 2000, AMYOTROPHIC LATERAL, P263; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Kong JM, 2000, NEUROSCI LETT, V281, P72, DOI 10.1016/S0304-3940(00)00808-9; Kopan R, 2002, NEURON, V33, P321, DOI 10.1016/S0896-6273(02)00585-8; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Lee VMY, 1999, NEURON, V24, P507, DOI 10.1016/S0896-6273(00)81106-X; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lin X, 1999, NEURON, V24, P499, DOI 10.1016/S0896-6273(00)81104-6; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Pagliardini S, 2000, HUM MOL GENET, V9, P47, DOI 10.1093/hmg/9.1.47; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; Petit A, 2001, NAT CELL BIOL, V3, P507, DOI 10.1038/35074581; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Price DL, 1998, SCIENCE, V282, P1079, DOI 10.1126/science.282.5391.1079; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Serpell LC, 2000, BIOCHEMISTRY-US, V39, P13269, DOI 10.1021/bi000637v; SHAW PJ, 2000, AMYOTROPHIC LATERAL, P113; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Wong PC, 2001, SCIENCE, V293, P1434; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zoghbi HY, 1999, CURR OPIN NEUROBIOL, V9, P566, DOI 10.1016/S0959-4388(99)00013-6	98	175	183	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					633	639		10.1038/nn0702-633	http://dx.doi.org/10.1038/nn0702-633			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12085093				2022-12-17	WOS:000176414300012
J	Murthy, VN; Stevens, CF				Murthy, VN; Stevens, CF			Reversal of synaptic vesicle docking at central synapses	NATURE NEUROSCIENCE			English	Article							SINGLE PRESYNAPTIC BOUTONS; TRANSMITTER RELEASE; EXOCYTOSIS; COMPONENTS; TURNOVER; FUSION; RIBBON; POOLS; CYCLE	We used quantitative fluorescence imaging of vesicles labeled with membrane-soluble dyes to determine rates of undocking and spontaneous exocytosis of vesicles docked to the active zone of hippocampal synapses in culture. Individual vesicles undock about once per two minutes and spontaneously exocytose about once per eight minutes. Thus, not only does undocking occur, but it is over threefold faster than spontaneous fusion.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Stevens, CF (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Murthy, Venkatesh/0000-0003-2443-4252				BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; Calakos N, 1996, PHYSIOL REV, V76, P1; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Martin TFJ, 1997, TRENDS CELL BIOL, V7, P271, DOI 10.1016/S0962-8924(97)01060-X; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schikorski T, 1997, J NEUROSCI, V17, P5858; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642	23	175	178	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					503	507		10.1038/9149	http://dx.doi.org/10.1038/9149			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448213				2022-12-17	WOS:000084735900008
J	Adams, KL; Gallo, V				Adams, Katrina L.; Gallo, Vittorio			The diversity and disparity of the glial scar	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; CHONDROITIN SULFATE PROTEOGLYCANS; OLIGODENDROCYTE PRECURSOR CELLS; NEURAL STEM-CELLS; REACTIVE ASTROCYTES; NG2 PROTEOGLYCAN; CNS INJURY; NG2-POSITIVE CELLS; MACROPHAGE SUBSETS	Injury or disease to the CNS results in multifaceted cellular and molecular responses. One such response, the glial scar, is a structural formation of reactive glia around an area of severe tissue damage. While traditionally viewed as a barrier to axon regeneration, beneficial functions of the glial scar have also been recently identified. In this Perspective, we discuss the divergent roles of the glial scar during CNS regeneration and explore the possibility that these disparities are due to functional heterogeneity within the cells of the glial scar-specifically, astrocytes, NG2 glia and microglia.	[Adams, Katrina L.; Gallo, Vittorio] Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA	Children's National Health System	Adams, KL (corresponding author), Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA.	katrina.adams@childrensnational.org; vgallo@cnmcresearch.org	Adams, Katrina/GLV-6737-2022	Adams, Katrina/0000-0001-5290-4245	NINDS [R01NS090383, F32NS098647]; NICHD (District of Columbia Intellectual and Developmental Disabilities Research Center) [U54HD090257]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS090383, F32NS098647] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD (District of Columbia Intellectual and Developmental Disabilities Research Center); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to kindly thank J. Triplett, E. Goldstein and T. Forbes for critically reading the manuscript. This work was supported by R01NS090383 from NINDS (V.G.), U54HD090257 from NICHD (District of Columbia Intellectual and Developmental Disabilities Research Center) (V.G.) and F32NS098647 from NINDS (K.L.A.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albert M, 2007, BRAIN PATHOL, V17, P129, DOI 10.1111/j.1750-3639.2006.00043.x; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Anderson MA, 2014, NEUROSCI LETT, V565, P23, DOI 10.1016/j.neulet.2013.12.030; Assinck P, 2017, J NEUROSCI, V37, P8635, DOI 10.1523/JNEUROSCI.2409-16.2017; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Ben Haim L, 2017, NAT REV NEUROSCI, V18, P31, DOI [10.1038/nm.2016.159, 10.1038/nrn.2016.159]; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bergles DE, 2010, BRAIN RES REV, V63, P130, DOI 10.1016/j.brainresrev.2009.12.003; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Chai H, 2017, NEURON, V95, P531, DOI 10.1016/j.neuron.2017.06.029; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; De Biase LM, 2017, NEURON, V95, P341, DOI 10.1016/j.neuron.2017.06.020; de Castro R, 2005, EXP NEUROL, V192, P299, DOI 10.1016/j.expneurol.2004.11.027; Dimou L, 2015, GLIA, V63, P1429, DOI 10.1002/glia.22859; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; DOU CL, 1994, J NEUROSCI, V14, P7616; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Dyck SM, 2015, EXP NEUROL, V269, P169, DOI 10.1016/j.expneurol.2015.04.006; Faiz M, 2015, CELL STEM CELL, V17, P624, DOI 10.1016/j.stem.2015.08.002; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Filous AR, 2014, J NEUROSCI, V34, P16369, DOI 10.1523/JNEUROSCI.1309-14.2014; Gee JM, 2014, NEURON, V83, P1058, DOI 10.1016/j.neuron.2014.07.024; Gotz M, 2015, GLIA, V63, P1452, DOI 10.1002/glia.22850; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Hackett AR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00199; Hackett AR, 2016, NEUROBIOL DIS, V89, P10, DOI 10.1016/j.nbd.2016.01.017; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Hammond TR, 2015, CELL REP, V13, P2090, DOI 10.1016/j.celrep.2015.11.002; Hammond TR, 2014, NEURON, V81, P588, DOI 10.1016/j.neuron.2013.11.015; Hara M, 2017, NAT MED, V23, P818, DOI 10.1038/nm.4354; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Kawabori M, 2015, METAB BRAIN DIS, V30, P381, DOI 10.1007/s11011-014-9531-6; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim S, 2007, J NEUROCHEM, V103, P2640, DOI 10.1111/j.1471-4159.2007.04995.x; Komitova M, 2011, GLIA, V59, P800, DOI 10.1002/glia.21152; Kucharova K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-158; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974; Larson VA, 2016, BRAIN RES, V1638, P138, DOI 10.1016/j.brainres.2015.09.010; Lau LW, 2012, ANN NEUROL, V72, P419, DOI 10.1002/ana.23599; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lin CCJ, 2017, NAT NEUROSCI, V20, P396, DOI 10.1038/nn.4493; Martin-Lopez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074039; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Molofsky AV, 2014, NATURE, V509, P189, DOI 10.1038/nature13161; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Nimmerjahn A, 2012, COLD SPRING HARB PRO, DOI 10/1101/pdb.prot068155; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parras CM, 2007, J NEUROSCI, V27, P4233, DOI 10.1523/JNEUROSCI.0126-07.2007; Pendleton JC, 2013, EXP NEUROL, V247, P113, DOI 10.1016/j.expneurol.2013.04.003; Perea G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4262; Petrosyan HA, 2013, J NEUROSCI, V33, P4032, DOI 10.1523/JNEUROSCI.4702-12.2013; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Ren YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep41122; Rodriguez JP, 2014, J NEUROSCI, V34, P10285, DOI 10.1523/JNEUROSCI.4915-13.2014; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Sabelstrom H, 2013, SCIENCE, V342, P637, DOI 10.1126/science.1242576; Shimada IS, 2012, J NEUROSCI, V32, P7926, DOI 10.1523/JNEUROSCI.4303-11.2012; Silver J, 2016, EXP NEUROL, V286, P147, DOI 10.1016/j.expneurol.2016.06.018; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Soleman S, 2012, BRAIN, V135, P1210, DOI 10.1093/brain/aws027; Tan AM, 2006, J NEUROSCI, V26, P4729, DOI 10.1523/JNEUROSCI.3900-05.2006; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Vigano F, 2013, NAT NEUROSCI, V16, P1370, DOI 10.1038/nn.3503; Wang YP, 2011, J NEUROSCI, V31, P6053, DOI 10.1523/JNEUROSCI.5524-09.2011; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; White RE, 2010, J COMP NEUROL, V518, P1370, DOI 10.1002/cne.22282; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zukor KA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-1	81	174	177	7	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2018	21	1					9	15		10.1038/s41593-017-0033-9	http://dx.doi.org/10.1038/s41593-017-0033-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT4WL	29269757	Green Accepted			2022-12-17	WOS:000423155800006
J	Otsu, Y; Couchman, K; Lyons, DG; Collot, M; Agarwal, A; Mallet, JM; Pfrieger, FW; Bergles, DE; Charpak, S				Otsu, Yo; Couchman, Kiri; Lyons, Declan G.; Collot, Mayeul; Agarwal, Amit; Mallet, Jean-Maurice; Pfrieger, Frank W.; Bergles, Dwight E.; Charpak, Serge			Calcium dynamics in astrocyte processes during neurovascular coupling	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; OLFACTORY-BULB; BLOOD-FLOW; NEURONAL-ACTIVITY; IN-VIVO; ADULT; SIGNALS; BRAIN; STIMULATION; INHIBITION	Enhanced neuronal activity in the brain triggers a local increase in blood flow, termed functional hyperemia, via several mechanisms, including calcium (Ca2+) signaling in astrocytes. However, recent in vivo studies have questioned the role of astrocytes in functional hyperemia because of the slow and sparse dynamics of their somatic Ca2+ signals and the absence of glutamate metabotropic receptor 5 in adults. Here, we reexamined their role in neurovascular coupling by selectively expressing a genetically encoded Ca2+ sensor in astrocytes of the olfactory bulb. We show that in anesthetized mice, the physiological activation of olfactory sensory neuron (OSN) terminals reliably triggers Ca2+ increases in astrocyte processes but not in somata. These Ca2+ increases systematically precede the onset of functional hyperemia by 1-2 s, reestablishing astrocytes as potential regulators of neurovascular coupling.	[Otsu, Yo; Couchman, Kiri; Lyons, Declan G.; Charpak, Serge] INSERM, U1128, Paris, France; [Otsu, Yo; Couchman, Kiri; Lyons, Declan G.; Charpak, Serge] Univ Paris 05, Lab Neurophysiol & New Microscopies, Paris, France; [Collot, Mayeul; Mallet, Jean-Maurice] CNRS, UMR 7203, Paris, France; [Collot, Mayeul; Mallet, Jean-Maurice] Univ Paris 06, Lab Biomol, Paris, France; [Agarwal, Amit; Bergles, Dwight E.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Pfrieger, Frank W.] Univ Strasbourg, Inst Cellular & Integrat Neurosci INCI, CNRS UPR 3212, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Johns Hopkins University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Charpak, S (corresponding author), INSERM, U1128, Paris, France.	serge.charpak@parisdescartes.fr	Bergles, Dwight/U-8343-2019; Mallet, Jean-Maurice/H-2113-2011; Charpak, Serge/M-9412-2017; Agarwal, Amit/B-7735-2008; Lyons, Declan/GWR-1942-2022; Pfrieger, Frank/AAX-3208-2020; Otsu, Yo/P-6353-2017	Bergles, Dwight/0000-0002-7133-7378; Mallet, Jean-Maurice/0000-0001-8570-9542; Agarwal, Amit/0000-0001-7948-4498; Lyons, Declan/0000-0003-1775-4653; Pfrieger, Frank/0000-0001-7085-1431; Otsu, Yo/0000-0003-2828-5063; Collot, Mayeul/0000-0002-8673-1730	INSERM; Agence Nationale de la Recherche (Project Angioneurins) [R11036KK]; Leducq Foundation; Human Frontier Science Program Organization [RGP008912009-C]; Fondation pour la Recherche Medicale (equipe FRM); US National Institutes of Health [MH084020]; Agence Nationale de la Recherche; ERC Advanced Grant "Imaging-in-the-magnet"; Ecole des Neurosciences de Paris (Paris School of Neuroscience); Fondation pour la Recherche Medicale [FDT20130928252]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH084020, P50MH100024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050274] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche (Project Angioneurins)(French National Research Agency (ANR)); Leducq Foundation(Leducq Foundation); Human Frontier Science Program Organization(Human Frontier Science Program); Fondation pour la Recherche Medicale (equipe FRM)(Fondation pour la Recherche Medicale); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche(French National Research Agency (ANR)); ERC Advanced Grant "Imaging-in-the-magnet"; Ecole des Neurosciences de Paris (Paris School of Neuroscience); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank C. Pouzat for his critical comments. Support was provided by INSERM, the Agence Nationale de la Recherche (Project Angioneurins R11036KK), the Leducq Foundation, the Human Frontier Science Program Organization (RGP008912009-C), the Fondation pour la Recherche Medicale (equipe FRM) and the US National Institutes of Health (MH084020 to D.E.B.). K.C. was supported by the Agence Nationale de la Recherche and the ERC Advanced Grant "Imaging-in-the-magnet." D.G.L. was supported by a doctoral fellowship from Ecole des Neurosciences de Paris (Paris School of Neuroscience) and a bursary from the Fondation pour la Recherche Medicale (FDT20130928252). The team of S.C. is part of the Ecole des Neurosciences de Paris Ile-de-France network. We thank W. Frostle (Ciba-Geigy) for the kind gift of CGP55845A (3-[1-(S)(3,4-dichlorophenyl)ethyl]amino-2(S)hydroxypropyl-P-benzyl-phosphonic acid).	Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bonder DE, 2014, J NEUROSCI, V34, P13139, DOI 10.1523/JNEUROSCI.2591-14.2014; Bonfanti L, 2007, PROG NEUROBIOL, V83, P24, DOI 10.1016/j.pneurobio.2006.11.002; Calcinaghi N, 2011, J CEREBR BLOOD F MET, V31, P1967, DOI 10.1038/jcbfm.2011.96; Chaigneau E, 2007, J NEUROSCI, V27, P6452, DOI 10.1523/JNEUROSCI.3141-06.2007; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Dong HW, 2007, J NEUROSCI, V27, P5654, DOI 10.1523/JNEUROSCI.5495-06.2007; Dunn KM, 2014, AM J PHYSIOL-HEART C, V306, pH1, DOI 10.1152/ajpheart.00364.2013; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Gurden H, 2006, NEURON, V52, P335, DOI 10.1016/j.neuron.2006.07.022; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Haustein MD, 2014, NEURON, V82, P413, DOI 10.1016/j.neuron.2014.02.041; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Jego P, 2014, J CEREBR BLOOD F MET, V34, P1599, DOI 10.1038/jcbfm.2014.144; Jian KH, 2010, BRAIN RES, V1354, P47, DOI 10.1016/j.brainres.2010.07.104; Kosaka T, 2011, NEUROSCI RES, V69, P93, DOI 10.1016/j.neures.2010.10.002; Kunzelmann P, 1999, GLIA, V25, P111, DOI 10.1002/(SICI)1098-1136(19990115)25:2<111::AID-GLIA2>3.0.CO;2-I; Lecoq J, 2009, J NEUROSCI, V29, P3067, DOI 10.1523/JNEUROSCI.6187-08.2009; Lind BL, 2013, P NATL ACAD SCI USA, V110, pE4678, DOI 10.1073/pnas.1310065110; Masamoto K, 2012, J CEREBR BLOOD F MET, V32, P1233, DOI 10.1038/jcbfm.2012.50; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nissant A, 2011, EUR J NEUROSCI, V33, P1069, DOI 10.1111/j.1460-9568.2011.07605.x; Nizar K, 2013, J NEUROSCI, V33, P8411, DOI 10.1523/JNEUROSCI.3285-12.2013; Oheim M, 2014, BBA-MOL CELL RES, V1843, P2284, DOI 10.1016/j.bbamcr.2014.03.010; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Paukert M, 2014, NEURON, V82, P1263, DOI 10.1016/j.neuron.2014.04.038; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Petzold GC, 2008, NEURON, V58, P897, DOI 10.1016/j.neuron.2008.04.029; Reeves AMB, 2011, J NEUROSCI, V31, P9353, DOI 10.1523/JNEUROSCI.0127-11.2011; Roux L, 2011, P NATL ACAD SCI USA, V108, P18442, DOI 10.1073/pnas.1107386108; Rusakov DA, 2014, TRENDS NEUROSCI, V37, P228, DOI 10.1016/j.tins.2014.02.008; Schulz K, 2012, NAT METHODS, V9, P597, DOI [10.1038/NMETH.2013, 10.1038/nmeth.2013]; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Shepherd GM, 1998, SYNAPTIC ORG BRAIN, DOI [10.1093/acprof:oso/9780195159561.001.1, DOI 10.1093/ACPROF:OSO/9780195159561.001.1]; Shigetomi E, 2013, J GEN PHYSIOL, V141, P633, DOI 10.1085/jgp.201210949; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Slezak M, 2007, GLIA, V55, P1565, DOI 10.1002/glia.20570; Sun W, 2013, SCIENCE, V339, P197, DOI 10.1126/science.1226740; Takata N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066525; VANDENPOL AN, 1995, J COMP NEUROL, V359, P253, DOI 10.1002/cne.903590206; Volterra A, 2014, NAT REV NEUROSCI, V15, P327, DOI 10.1038/nrn3725; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Winpenny E, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-12; Winship IR, 2007, J NEUROSCI, V27, P6268, DOI 10.1523/JNEUROSCI.4801-06.2007; Yang YJ, 2011, GLIA, V59, P200, DOI 10.1002/glia.21089	48	174	177	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2015	18	2					210	218		10.1038/nn.3906	http://dx.doi.org/10.1038/nn.3906			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CA0UM	25531572	Green Accepted			2022-12-17	WOS:000348631800011
J	Jadhav, SP; Wolfe, J; Feldman, DE				Jadhav, Shantanu P.; Wolfe, Jason; Feldman, Daniel E.			Sparse temporal coding of elementary tactile features during active whisker sensation	NATURE NEUROSCIENCE			English	Article							RAT BARREL CORTEX; PRIMARY SOMATOSENSORY CORTEX; CORTICAL MAP PLASTICITY; TEXTURE-DISCRIMINATION; SENSORY DEPRIVATION; SENSORIMOTOR SYSTEM; VIBRISSAL SYSTEM; BEHAVIOR; PERFORMANCE; SYNCHRONY	How the brain encodes relevant sensory stimuli in the context of active, natural sensation is not known. During active tactile sensation by rodents, whisker movement across surfaces generates complex whisker micro-motion, including discrete, transient slip-stick events, which carry information about surface properties. We simultaneously measured whisker motion and neural activity in somatosensory cortex (S1) in rats whisking across surfaces. Slip-stick motion events were prominently encoded by one or two low-probability, precisely timed spikes in S1 neurons, resulting in a probabilistically sparse ensemble code. Slips could be efficiently decoded from transient, correlated spiking (similar to 20-ms time scale) in small (similar to 100 neuron) populations. Slip responses contributed substantially to increased firing rate and transient firing synchrony on surfaces, and firing synchrony was an important cue for surface texture. Slips are thus a fundamental encoded tactile feature in natural whisker input streams and are represented by sparse, temporally precise, synchronous spiking in S1.	[Jadhav, Shantanu P.; Feldman, Daniel E.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Jadhav, Shantanu P.] Univ Calif San Diego, Computat Neurobiol Grad Program, La Jolla, CA 92093 USA; [Jadhav, Shantanu P.; Feldman, Daniel E.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Wolfe, Jason] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	University of California System; University of California Berkeley; University of California System; University of California San Diego; University of California System; University of California Berkeley; University of California System; University of California San Diego	Feldman, DE (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.	dfeldman@berkeley.edu	Jadhav, Shantanu/H-6654-2013	Jadhav, Shantanu/0000-0001-5821-0551				Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Brecht M, 2007, CURR OPIN NEUROBIOL, V17, P408, DOI 10.1016/j.conb.2007.07.008; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Bruno RM, 2003, J NEUROSCI, V23, P9565; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; GUICROBLES E, 1989, BEHAV BRAIN RES, V31, P285, DOI 10.1016/0166-4328(89)90011-9; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Itoh H, 2003, J NEUROPHYSIOL, V89, P1774, DOI 10.1152/jn.00630.2002; JOHNSON KO, 1992, ANNU REV NEUROSCI, V15, P227, DOI 10.1146/annurev.neuro.15.1.227; Joris PX, 2008, NEUROSCIENCE, V154, P65, DOI 10.1016/j.neuroscience.2008.03.002; Kass RE, 2003, NETWORK-COMP NEURAL, V14, P5, DOI 10.1088/0954-898X/14/1/301; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Krupa DJ, 2004, SCIENCE, V304, P1989, DOI 10.1126/science.1093318; Lee SH, 2004, J NEUROPHYSIOL, V91, P223, DOI 10.1152/jn.00541.2003; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; Moore CI, 2004, J NEUROPHYSIOL, V91, P2390, DOI 10.1152/jn.00925.2003; Mountcastle V.B., 2005, SENSORY HAND; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Prigg T, 2002, PHYSIOL BEHAV, V77, P671, DOI 10.1016/S0031-9384(02)00917-4; Puccini GD, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000137; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Stuttgen MC, 2008, NAT NEUROSCI, V11, P1091, DOI 10.1038/nn.2162; Temereanca S, 2003, J NEUROPHYSIOL, V89, P2137, DOI 10.1152/jn.00582.2002; Venkatachalam S, 1999, J NEUROSCI METH, V90, P37, DOI 10.1016/S0165-0270(99)00065-5; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Waters J, 2006, J NEUROSCI, V26, P8267, DOI 10.1523/JNEUROSCI.2152-06.2006; Wolfe J, 2008, PLOS BIOL, V6, P1661, DOI 10.1371/journal.pbio.0060215	50	174	173	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2009	12	6					792	2328		10.1038/nn.2328	http://dx.doi.org/10.1038/nn.2328			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	450DJ	19430473				2022-12-17	WOS:000266380900024
J	Luna, R; Hernandez, A; Brody, CD; Romo, R				Luna, R; Hernandez, A; Brody, CD; Romo, R			Neural codes for perceptual discrimination in primary somatosensory cortex	NATURE NEUROSCIENCE			English	Article							PARAMETRIC WORKING-MEMORY; CORTICAL-NEURONS; DECISION-MAKING; PSYCHOPHYSICAL MEASUREMENTS; FLUTTER-VIBRATION; AREA MT; SENSE; FREQUENCY; PERIODICITY; PERFORMANCE	We sought to determine the neural code(s) for frequency discrimination of vibrotactile stimuli. We tested five possible candidate codes by analyzing the responses of single neurons recorded in primary somatosensory cortex of trained monkeys while they discriminated between two consecutive vibrotactile stimuli. Differences in the frequency of two stimuli could be discriminated using information from (i) time intervals between spikes, (ii) average spiking rate during each stimulus, (iii) absolute number of spikes elicited by each stimulus, (iv) average rate of bursts of spikes or ( v) absolute number of spike bursts elicited by each stimulus. However, only a spike count code, in which spikes are integrated over a time window that has most of its mass in the first 250 ms of each stimulus period, covaried with behavior on a trial-by-trial basis, was consistent with psychophysical biases induced by manipulation of stimulus duration, and produced neurometric discrimination thresholds similar to behavioral psychophysical thresholds.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Universidad Nacional Autonoma de Mexico; Cold Spring Harbor Laboratory	Romo, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	rromo@ifc.unam.mx		Luna, Rogelio/0000-0003-0711-7562; romo, ranulfo/0000-0003-3529-3635	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067991] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; BAIR W, 1994, J NEUROSCI, V14, P2870; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Carandini M, 2000, CURR BIOL, V10, pR605, DOI 10.1016/S0960-9822(00)00637-0; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; Gescheider GA, 1999, SOMATOSENS MOT RES, V16, P229; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Kepecs A, 2002, J NEUROSCI, V22, P9053; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; POGGIO GF, 1964, J NEUROPHYSIOL, V27, P517, DOI 10.1152/jn.1964.27.4.517; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1071, DOI 10.1152/jn.1992.67.5.1071; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; [No title captured]	35	174	175	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1210	1219		10.1038/nn1513	http://dx.doi.org/10.1038/nn1513			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16056223				2022-12-17	WOS:000231483800021
J	Tanzi, RE				Tanzi, RE			The synaptic A beta hypothesis of Alzheimer disease	NATURE NEUROSCIENCE			English	Editorial Material							LONG-TERM POTENTIATION; AMYLOID-PROTEIN; IN-VIVO; OLIGOMERS	A beta peptide is linked to Alzheimer pathology, but its toxic mechanism remains unclear. New work shows that A leads to internalization of NMDA receptors, reducing their availability at synapses. The authors also suggest a molecular mechanism for this endocytosis.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Genet & Aging Res Unit, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Tanzi, RE (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Genet & Aging Res Unit, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454				Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Dougherty JJ, 2003, J NEUROSCI, V23, P6740; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; Lee HG, 2004, AM J PATHOL, V165, P1461, DOI 10.1016/S0002-9440(10)63404-9; Moir RD, 2005, J BIOL CHEM, V280, P17458, DOI 10.1074/jbc.M414176200; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Tanzi E., 1893, RIV SPER FRENIAT MED, V19, P419; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	15	174	182	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					977	979		10.1038/nn0805-977	http://dx.doi.org/10.1038/nn0805-977			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16047022				2022-12-17	WOS:000230760200003
J	De Paola, V; Arber, S; Caroni, P				De Paola, V; Arber, S; Caroni, P			AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks	NATURE NEUROSCIENCE			English	Article							LONG-LASTING POTENTIATION; TERM SYNAPTIC PLASTICITY; DENDRITIC SPINES; MOSSY FIBERS; TRANSGENIC MICE; LATE-PHASE; SYNAPSES; SYNAPTOGENESIS; PROTEINS; CULTURES	The formation and disassembly of synapses in mature neuropil could provide a substrate to encode experience in the brain. Although there is evidence for postsynaptic spine dynamics in mature systems, contributions to circuit rearrangements by presynaptic terminals have remained unclear. We used hippocampal slice cultures from mice expressing spectral variants of green fluorescent protein (GFP) that are targeted to the membrane and/or synaptic vesicles in neuronal subsets to image identified presynaptic terminals. In mature tissues with no net change in synapse numbers, subpopulations of presynaptic terminals appeared and disappeared within 1-3 days. The three terminal types established by mossy fibers had distinct properties. High-frequency stimulation increased the fraction of dynamic terminals for 1-2 days, a process mediated by activation of AMPA receptors, protein kinase A (PKA) and protein synthesis. Thus, synaptic activity can make stable presynaptic terminals become dynamic, providing a candidate mechanism to convert experience into changes in network connectivity.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Basel, Friedrich Miescher Inst, CH-4056 Basel, Switzerland; Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Friedrich Miescher Institute for Biomedical Research; University of Basel; University of Basel	Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.		de paola, vincenzo/B-4900-2016	de paola, vincenzo/0000-0001-9987-8291; Arber, Silvia/0000-0002-6261-250X				Acsady L, 1998, J NEUROSCI, V18, P3386; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; AMARAL DG, 1979, ANAT EMBRYOL, V155, P241, DOI 10.1007/BF00317638; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Bastmeyer M, 1996, J NEUROSCI, V16, P1450; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; DAILEY ME, 1994, J NEUROSCI, V14, P1060, DOI 10.1523/JNEUROSCI.14-03-01060.1994; Dailey ME, 1996, J NEUROSCI, V16, P2983; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Hatada Y, 2000, J NEUROSCI, V20, part. no.; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Horch HW, 1999, NEURON, V23, P353; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Mizuhashi S, 2001, J NEUROSCI, V21, P6181, DOI 10.1523/JNEUROSCI.21-16-06181.2001; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Smart FM, 2000, HIPPOCAMPUS, V10, P542, DOI 10.1002/1098-1063(2000)10:5<542::AID-HIPO4>3.3.CO;2-Z; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toth K, 2000, J PHYSIOL-LONDON, V525, P41, DOI 10.1111/j.1469-7793.2000.00041.x; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Wiederkehr A, 1997, EXP CELL RES, V236, P103, DOI 10.1006/excr.1997.3709; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Ziv NE, 2001, CURR OPIN NEUROBIOL, V11, P536, DOI 10.1016/S0959-4388(00)00246-4	48	174	176	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					491	500		10.1038/nn1046	http://dx.doi.org/10.1038/nn1046			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12692557				2022-12-17	WOS:000182553200016
J	Nadarajah, B; Alifragis, P; Wong, ROL; Parnavelas, JG				Nadarajah, B; Alifragis, P; Wong, ROL; Parnavelas, JG			Ventricle-directed migration in the developing cerebral cortex	NATURE NEUROSCIENCE			English	Article							TANGENTIAL CELL DISPERSION; CENTRAL-NERVOUS-SYSTEM; LOCAL CIRCUIT NEURONS; GANGLIONIC EMINENCE; BASAL FOREBRAIN; DLX GENES; NEOCORTEX; ZONE; SPECIFICATION; DEPENDENCE	It is believed that postmitotic neurons migrate away from their sites of origin in the germinal zones to populate distant targets. Contrary to this notion, we found, using time-lapse imaging of brain slices, populations of neurons positioned at various levels of the developing neocortex that migrate towards the cortical ventricular zone. After a pause in this proliferative zone, they migrate radially in the direction of the pial surface to take up positions in the cortical plate. Immunohistochemical analysis together with tracer labeling in brain slices showed that cells showing ventricle-directed migration in the developing cortex are GABAergic interneurons originating in the ganglionic eminence in the ventral telencephalon. We speculate that combinations of chemoattractant and chemorepellent molecules are involved in this ventricle-directed migration and that interneurons may seek the cortical ventricular zone to receive layer information.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of London; University College London; Washington University (WUSTL)	Parnavelas, JG (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	j.parnavelas@ucl.ac.uk		Alifragis, Pavlos/0000-0003-0844-2316				Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BERRY M, 1965, J ANAT, V99, P691; CAVANAGH ME, 1988, J COMP NEUROL, V268, P1, DOI 10.1002/cne.902680102; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Denaxa M, 2001, DEVELOPMENT, V128, P4635; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; GRAY GE, 1990, EXPERIENTIA, V46, P929, DOI 10.1007/BF01939386; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; KOMURO H, 1995, J NEUROSCI, V15, P1110; Lavdas AA, 1999, J NEUROSCI, V19, P7881; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; Mione MC, 1997, J NEUROSCI, V17, P2018; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Neyt C, 1997, J NEUROSCI, V17, P9194; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; ORourke NA, 1997, DEVELOPMENT, V124, P997; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1978, POSTGRAD MED J, V54, P25; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Tamamaki N, 1997, J NEUROSCI, V17, P8313; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; Wichterle H, 2001, DEVELOPMENT, V128, P3759	32	174	180	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					218	224		10.1038/nn813	http://dx.doi.org/10.1038/nn813			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850632				2022-12-17	WOS:000174146000011
J	Hannan, AJ; Blakemore, C; Katsnelson, A; Vitalis, T; Huber, KM; Bear, M; Roder, J; Kim, D; Shin, HS; Kind, PC				Hannan, AJ; Blakemore, C; Katsnelson, A; Vitalis, T; Huber, KM; Bear, M; Roder, J; Kim, D; Shin, HS; Kind, PC			PLC-beta 1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; MOUSE SOMATOSENSORY CORTEX; CAT VISUAL-CORTEX; CRITICAL PERIOD; MONOAMINE-OXIDASE; BARREL CORTEX; POSTNATAL-DEVELOPMENT; PATTERN-FORMATION; RAT	During development of the cerebral cortex, the invasion of thalamic axons and subsequent differentiation of cortical neurons are tightly coordinated. Here we provide evidence that glutamate neurotransmission triggers a critical signaling mechanism involving the activation of phospholipase C-beta1 (PLC-beta1) by metabotropic glutamate receptors (mGluRs). Homozygous null mutation of either PLC-beta1 or mGluR5 dramatically disrupts the cytoarchitectural differentiation of 'barrels' in the mouse somatosensory cortex, despite segregation in the pattern of thalamic innervation. Furthermore, group 1 mGluR-stimulated phosphoinositide hydrolysis is dramatically reduced in PLC-beta1(-/-) mice during barrel development. Our data indicate that PLC-beta1 activation via mGluR5 is critical for the coordinated development of the neocortex, and that presynaptic and postsynaptic components of cortical differentiation can be genetically dissociated.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Univ Edinburgh, Dept Biomed Sci, Edinburgh EH8 9XD, Midlothian, Scotland; Brown Univ, Dept Neurosci, Providence, RI 02912 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Pohang Univ Sci & Technol, Dept Life Sci, Natl CRI Ctr Calcium & Learning, Pohang 790784, South Korea	University of Oxford; University of Edinburgh; Brown University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Pohang University of Science & Technology (POSTECH)	Kind, PC (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.		Roder, John/G-6468-2013; De Granzial, Nadine-Tania Vitalis/K-8485-2017; Huber, Kimberly/X-5534-2019; Kim, Daesoo/C-1625-2011	De Granzial, Nadine-Tania Vitalis/0000-0002-5531-3771; Kim, Daesoo/0000-0001-9915-1463; Kind, Peter/0000-0002-4256-9639; Hannan, Anthony/0000-0001-7532-8922; Blakemore, Colin/0000-0003-2659-7899				Abdel-Majid RM, 1998, NAT GENET, V19, P289, DOI 10.1038/980; AGMON A, 1995, J NEUROSCI, V15, P549; AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; Bevilacqua JA, 1995, J NEUROSCI, V15, P7916; Blue ME, 1997, J COMP NEUROL, V386, P16; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; Cases O, 1998, J NEUROSCI, V18, P6914; CHIAIA NL, 1992, DEV BRAIN RES, V66, P244, DOI 10.1016/0165-3806(92)90086-C; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; DIXON JF, 1994, P NATL ACAD SCI USA, V91, P8358, DOI 10.1073/pnas.91.18.8358; DUDEK SM, 1989, SCIENCE, V246, P673, DOI 10.1126/science.2573152; FABBRI M, 1994, J BIOL CHEM, V269, P26848; Fitzjohn SM, 1999, NEUROPHARMACOLOGY, V38, P1577, DOI 10.1016/S0028-3908(99)00123-9; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; Glazewski S, 2000, NAT NEUROSCI, V3, P911, DOI 10.1038/78820; GREENOUGH WT, 1988, DEV BRAIN RES, V43, P148, DOI 10.1016/0165-3806(88)90160-5; Hannan AJ, 1998, NEUROPHARMACOLOGY, V37, P593, DOI 10.1016/S0028-3908(98)00056-2; HENDERSON TA, 1992, DEV BRAIN RES, V66, P146, DOI 10.1016/0165-3806(92)90152-M; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Jia ZP, 1998, LEARN MEMORY, V5, P331; KATO N, 1993, P NATL ACAD SCI USA, V90, P3650, DOI 10.1073/pnas.90.8.3650; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KILLACKEY HP, 1979, J COMP NEUROL, V183, P285, DOI 10.1002/cne.901830206; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; KIND P, 1994, CEREB CORTEX, V4, P361, DOI 10.1093/cercor/4.4.361; Kind PC, 1997, J NEUROSCI, V17, P1471; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; Lu YM, 1997, J NEUROSCI, V17, P5196; Munoz A, 1999, J COMP NEUROL, V409, P549; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; OCONNOR JJ, 1995, J NEUROSCI, V15, P2013, DOI 10.1523/JNEUROSCI.15-03-02013.1995; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; REID SNM, 1995, J COMP NEUROL, V355, P470, DOI 10.1002/cne.903550311; Sabatini DD, 1996, BIOCELL, V20, P287; SCHLAGGAR BL, 1991, SCIENCE, V252, P1556, DOI 10.1126/science.2047863; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; Vitalis T, 1998, J COMP NEUROL, V393, P169, DOI 10.1002/(SICI)1096-9861(19980406)393:2<169::AID-CNE3>3.0.CO;2-0; Walikonis RS, 2000, J NEUROSCI, V20, P4069; WELKER E, 1986, J NEUROSCI, V6, P3355; Welker E, 1996, SCIENCE, V271, P1864, DOI 10.1126/science.271.5257.1864; Westermann P, 1996, BIOCHEM J, V320, P651, DOI 10.1042/bj3200651; WOOLSEY TA, 1975, P NATL ACAD SCI USA, V72, P2165, DOI 10.1073/pnas.72.6.2165; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; ZHENG F, 1992, NEURON, V9, P163, DOI 10.1016/0896-6273(92)90231-2	50	174	181	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					282	288		10.1038/85132	http://dx.doi.org/10.1038/85132			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224545				2022-12-17	WOS:000167178300016
J	Keysers, C; Gazzola, V; Wagenmakers, EJ				Keysers, Christian; Gazzola, Valeria; Wagenmakers, Eric-Jan			Using Bayes factor hypothesis testing in neuroscience to establish evidence of absence	NATURE NEUROSCIENCE			English	Review							INFERENCE; FALLACY	Most neuroscientists would agree that for brain research to progress, we have to know which experimental manipulations have no effect as much as we must identify those that do have an effect. The dominant statistical approaches used in neuroscience rely onPvalues and can establish the latter but not the former. This makes non-significant findings difficult to interpret: do they support the null hypothesis or are they simply not informative? Here we show how Bayesian hypothesis testing can be used in neuroscience studies to establish both whether there is evidence of absence and whether there is absence of evidence. Through simple tutorial-style examples of Bayesiant-tests and ANOVA using the open-source project JASP, this article aims to empower neuroscientists to use this approach to provide compelling and rigorous evidence for the absence of an effect. Keysers et al. show whyPvalues do not differentiate inconclusive null findings from those that provide important evidence for the absence of an effect. They provide a tutorial on how to use Bayesian hypothesis testing to overcome this issue.	[Keysers, Christian; Gazzola, Valeria] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Keysers, Christian; Gazzola, Valeria; Wagenmakers, Eric-Jan] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam	Keysers, C (corresponding author), Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands.; Keysers, C (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	c.keysers@nin.knaw.nl	Keysers, Christian/H-6251-2013	Keysers, Christian/0000-0002-2845-5467				ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Bayarri MJ, 2012, ANN STAT, V40, P1550, DOI 10.1214/12-AOS1013; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Carrillo M, 2019, CURR BIOL, V29, P1301, DOI 10.1016/j.cub.2019.03.024; Consonni G, 2018, BAYESIAN ANAL, V13, P627, DOI 10.1214/18-BA1103; Cremers HR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184923; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; EDWARDS W, 1963, PSYCHOL REV, V70, P193, DOI 10.1037/h0044139; EFRON B, 1986, AM STAT, V40, P11, DOI 10.2307/2683111; Etz A, 2017, STAT SCI, V32, P313, DOI 10.1214/16-STS599; Gallistel CR, 2009, PSYCHOL REV, V116, P439, DOI 10.1037/a0015251; Gelman A, 2006, AM STAT, V60, P328, DOI 10.1198/000313006X152649; Gronau QF, 2020, AM STAT, V74, P137, DOI 10.1080/00031305.2018.1562983; Jeffreys, 1961, THEORY PROBABILITY; Jeffreys H., 1961, THEORY PROBABILITY, V3; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Lee M.D., 2013, BAYESIAN COGNITIVE M; Lee MD, 2018, PSYCHON B REV, V25, P114, DOI 10.3758/s13423-017-1238-3; Love J, 2019, J STAT SOFTW, V88, P1, DOI 10.18637/jss.v088.i02; Marsman M, 2019, STAT NEERL, V73, P351, DOI 10.1111/stan.12173; Morey RD, 2016, PSYCHON B REV, V23, P103, DOI 10.3758/s13423-015-0947-8; Morey RD, 2011, PSYCHOL METHODS, V16, P406, DOI 10.1037/a0024377; Myung IJ, 1997, PSYCHON B REV, V4, P79, DOI 10.3758/BF03210778; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Rouder JN, 2016, PSYCHON B REV, V23, P1779, DOI 10.3758/s13423-016-1026-5; Rouder JN, 2014, PSYCHON B REV, V21, P301, DOI 10.3758/s13423-014-0595-4; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; ROZEBOOM WW, 1960, PSYCHOL BULL, V57, P416, DOI 10.1037/h0042040; Schonbrodt FD, 2018, PSYCHON B REV, V25, P128, DOI 10.3758/s13423-017-1230-y; Stefan AM, 2019, BEHAV RES METHODS, V51, P1042, DOI 10.3758/s13428-018-01189-8; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Szucs D, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000797; van Doorn J, 2020, J APPL STAT, V47, P2984, DOI 10.1080/02664763.2019.1709053; Wagenmakers E. J., 2017, PSYCHOL SCI SCRUTINY, P123, DOI DOI 10.1002/9781119095910.CH8; Wagenmakers EJ, 2018, PSYCHON B REV, V25, P58, DOI [10.3758/s13423-017-1323-7, 10.3758/s13423-017-1343-3]; Wagenmakers EJ, 2016, CURR DIR PSYCHOL SCI, V25, P169, DOI 10.1177/0963721416643289; Wrinch D, 1923, PHILOS MAG, V45, P368, DOI 10.1080/14786442308634125	38	173	173	7	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2020	23	7					788	+		10.1038/s41593-020-0660-4	http://dx.doi.org/10.1038/s41593-020-0660-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	MD6MH	32601411	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000544085200003
J	Sankowski, R; Bottcher, C; Masuda, T; Geirsdottir, L; Sagar; Sindram, E; Seredenina, T; Muhs, A; Scheiwe, C; Shah, MJ; Heiland, DH; Schnell, O; Grun, D; Priller, J; Prinz, M				Sankowski, Roman; Bottcher, Chotima; Masuda, Takahiro; Geirsdottir, Laufey; Sagar; Sindram, Elena; Seredenina, Tamara; Muhs, Andreas; Scheiwe, Christian; Shah, Mukesch Johannes; Heiland, Dieter Henrik; Schnell, Oliver; Grun, Dominic; Priller, Josef; Prinz, Marco			Mapping microglia states in the human brain through the integration of high-dimensional techniques	NATURE NEUROSCIENCE			English	Article							GENE-EXPRESSION; MYELOID CELLS; SINGLE; HETEROGENEITY; MACROPHAGES; DIVERSITY; FATE; AGE; MYELINOGENESIS; MAINTENANCE	Microglia are tissue-resident macrophages of the CNS that orchestrate local immune responses and contribute to several neurological and psychiatric diseases. Little is known about human microglia and how they orchestrate their highly plastic, context-specific adaptive responses during pathology. Here we combined two high-dimensional technologies, single-cell RNA-sequencing and time-of-flight mass cytometry, to identify microglia states in the human brain during homeostasis and disease. This approach enabled us to identify and characterize a previously unappreciated spectrum of transcriptional states in human microglia. These transcriptional states are determined by their spatial distribution, and they further change with aging and brain tumor pathology. This description of multiple microglia phenotypes in the human CNS may open promising new avenues for subset-specific therapeutic interventions.	[Sankowski, Roman; Masuda, Takahiro; Geirsdottir, Laufey; Sindram, Elena; Prinz, Marco] Univ Freiburg, Inst Neuropathol, Fac Med, Freiburg, Germany; [Sankowski, Roman] Univ Freiburg, Fac Med, Berta Ottenstein Programme Clinician Scientists, Freiburg, Germany; [Bottcher, Chotima; Priller, Josef] Charite Univ Med Berlin, Dept Neuropsychiat, Berlin, Germany; [Bottcher, Chotima; Priller, Josef] Charite Univ Med Berlin, Lab Mol Psychiat, Berlin, Germany; [Sagar; Grun, Dominic] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Seredenina, Tamara; Muhs, Andreas] AC Immune, Lausanne, Switzerland; [Scheiwe, Christian; Shah, Mukesch Johannes; Heiland, Dieter Henrik; Schnell, Oliver] Univ Freiburg, Dept Neurosurg, Fac Med, Freiburg, Germany; [Grun, Dominic; Prinz, Marco] Univ Freiburg, Signalling Res Ctr BIOSS, Freiburg, Germany; [Grun, Dominic; Prinz, Marco] Univ Freiburg, Signalling Res Ctr CIBSS, Freiburg, Germany; [Priller, Josef] DZNE, Berlin, Germany; [Priller, Josef] BIH, Berlin, Germany; [Priller, Josef] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Priller, Josef] UK DRI, Edinburgh, Midlothian, Scotland; [Prinz, Marco] Univ Freiburg, Fac Med, Ctr Basics NeuroModulat NeuroModulBasics, Freiburg, Germany	University of Freiburg; University of Freiburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; University of Freiburg; University of Freiburg; University of Freiburg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Berlin Institute of Health; University of Edinburgh; University of Freiburg	Prinz, M (corresponding author), Univ Freiburg, Inst Neuropathol, Fac Med, Freiburg, Germany.; Priller, J (corresponding author), Charite Univ Med Berlin, Dept Neuropsychiat, Berlin, Germany.; Priller, J (corresponding author), Charite Univ Med Berlin, Lab Mol Psychiat, Berlin, Germany.; Grun, D (corresponding author), Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.; Grun, D; Prinz, M (corresponding author), Univ Freiburg, Signalling Res Ctr BIOSS, Freiburg, Germany.; Grun, D; Prinz, M (corresponding author), Univ Freiburg, Signalling Res Ctr CIBSS, Freiburg, Germany.; Priller, J (corresponding author), DZNE, Berlin, Germany.; Priller, J (corresponding author), BIH, Berlin, Germany.; Priller, J (corresponding author), Univ Edinburgh, Edinburgh, Midlothian, Scotland.; Priller, J (corresponding author), UK DRI, Edinburgh, Midlothian, Scotland.; Prinz, M (corresponding author), Univ Freiburg, Fac Med, Ctr Basics NeuroModulat NeuroModulBasics, Freiburg, Germany.	gruen@ie-freiburg.mpg.de; josef.priller@charite.de; marco.prinz@uniklinik-freiburg.de	Priller, Josef/ABW-3835-2022; Heiland, Dieter Henrik/ABE-8856-2020; Masuda, Takahiro/AAY-6719-2021; scheiwe, christian/GWZ-7062-2022	Heiland, Dieter Henrik/0000-0002-9258-3033; Masuda, Takahiro/0000-0003-3687-452X; scheiwe, christian/0000-0003-1695-8689; Shah, Mukesch Johannes/0000-0002-7224-9185; Priller, Josef/0000-0001-7596-0979; , Dr. Sagar/0000-0002-8657-4704; Bottcher, Chotima/0000-0002-6226-586X; Sankowski, Roman/0000-0001-9215-8021	Berta-Ottenstein Programme for Clinician Scientists; Sobek Foundation; Ernst-Jung Foundation; German Research Foundation [SFB 992, SFB1160, SFB/TRR167 "NeuroMac"]; Ministry of Science, Research and Arts, Baden-Wuerttemberg (Sonderlinie "Neuroinflammation"); BMBF; German Research Foundation (DFG) under Germany's Excellence Strategy (CIBSS) [EXC-2189, 390939984]; Berlin Institute of Health [CRG2aSP6]; UK DRI (Momentum Award); Max Planck Society; German Research Foundation (DFG) [SPP1937 GR4980/1-1, GR4980/3-1, GRK2344 MeInBio]; DFG under Germany's Excellence Strategy (CIBSS) [EXC-2189, 390939984]; ERC [818846]; Behrens-Weise-Foundation; MRC [MC_PC_16031] Funding Source: UKRI	Berta-Ottenstein Programme for Clinician Scientists; Sobek Foundation; Ernst-Jung Foundation; German Research Foundation(German Research Foundation (DFG)); Ministry of Science, Research and Arts, Baden-Wuerttemberg (Sonderlinie "Neuroinflammation"); BMBF(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG) under Germany's Excellence Strategy (CIBSS)(German Research Foundation (DFG)); Berlin Institute of Health; UK DRI (Momentum Award); Max Planck Society(Max Planck SocietyFoundation CELLEX); German Research Foundation (DFG)(German Research Foundation (DFG)); DFG under Germany's Excellence Strategy (CIBSS)(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); Behrens-Weise-Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank J. Bodinek-Wersing, T. El Gaz, E. Barleon and A. Fromming for excellent technical support. R.S. is supported by the Berta-Ottenstein Programme for Clinician Scientists. M.P. is supported by the Sobek Foundation, the Ernst-Jung Foundation, the German Research Foundation (SFB 992, SFB1160, Reinhart-Koselleck-Grant) and the Ministry of Science, Research and Arts, Baden-Wuerttemberg (Sonderlinie "Neuroinflammation") and by the BMBF-funded competence network of multiple sclerosis (KKNMS). This study was supported by the German Research Foundation (DFG) under Germany's Excellence Strategy (CIBSS, EXC-2189, project ID 390939984). The authors would also like to acknowledge the assistance of the BCRT Flow Cytometry Lab (Charite-Universitatsmedizin Berlin, Germany). C.B., M.P. and J.P. are supported by the German Research Foundation (SFB/TRR167 "NeuroMac"). J.P. received additional funding from the Berlin Institute of Health (CRG2aSP6) and the UK DRI (Momentum Award). D.G. was supported by the Max Planck Society, the German Research Foundation (DFG) (SPP1937 GR4980/1-1, GR4980/3-1 and GRK2344 MeInBio), by the DFG under Germany's Excellence Strategy (CIBSS, EXC-2189, project ID 390939984), by the ERC (818846, ImmuNiche, ERC-2018-COG) and by the Behrens-Weise-Foundation.	Abadi M., 2016, TENSORFLOW LARGE SCA, DOI DOI 10.1038/S41598-021-85274-7; Ajami B, 2018, NAT NEUROSCI, V21, P541, DOI 10.1038/s41593-018-0100-x; Allaire J, 2017, KERAS R INTERFACE KE; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Bottcher C, 2019, NAT NEUROSCI, V22, P78, DOI 10.1038/s41593-018-0290-2; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Jordao MJC, 2019, SCIENCE, V363, P365, DOI 10.1126/science.aat7554; Darmanis S, 2017, CELL REP, V21, P1399, DOI 10.1016/j.celrep.2017.10.030; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Filbin MG, 2018, SCIENCE, V360, P331, DOI 10.1126/science.aao4750; Galatro TF, 2017, NAT NEUROSCI, V20, P1162, DOI 10.1038/nn.4597; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Grun D, 2016, CELL STEM CELL, V19, P266, DOI 10.1016/j.stem.2016.05.010; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Hagemeyer N, 2017, ACTA NEUROPATHOL, V134, P441, DOI 10.1007/s00401-017-1747-1; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Herman JS, 2018, NAT METHODS, V15, P379, DOI 10.1038/nmeth.4662; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Jakel S, 2019, NATURE, V566, P543, DOI 10.1038/s41586-019-0903-2; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma F, 2019, AUTOMATED IDENTIFICA, DOI [10.1101/532093v1, DOI 10.1101/532093V1]; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Masuda T, 2019, NATURE, V566, P388, DOI 10.1038/s41586-019-0924-x; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Prinz M, 2017, NAT IMMUNOL, V18, P385, DOI 10.1038/ni.3703; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; R Core Team, 2019, R LANG ENV STAT COMP; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Safaiyan S, 2016, NAT NEUROSCI, V19, P995, DOI 10.1038/nn.4325; Schirmer L, 2019, NATURE, V573, P75, DOI 10.1038/s41586-019-1404-z; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; Van Hove H, 2019, NAT NEUROSCI, V22, P1021, DOI 10.1038/s41593-019-0393-4; Velmeshev D, 2019, SCIENCE, V364, P685, DOI 10.1126/science.aav8130; Venteicher AS, 2017, SCIENCE, V355, DOI 10.1126/science.aai8478; Wlodarczyk A, 2017, EMBO J, V36, P3292, DOI 10.15252/embj.201696056; Wu YE, 2017, NEURON, V96, P313, DOI 10.1016/j.neuron.2017.09.026; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhong SJ, 2018, NATURE, V555, P524, DOI 10.1038/nature25980	61	173	173	2	28	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2019	22	12					2098	+		10.1038/s41593-019-0532-y	http://dx.doi.org/10.1038/s41593-019-0532-y			26	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JR5CX	31740814				2022-12-17	WOS:000499644100018
J	Rudolph, MD; Graham, AM; Feczko, E; Miranda-Dominguez, O; Rasmussen, JM; Nardos, R; Entringer, S; Wadhwa, PD; Buss, C; Fair, DA				Rudolph, Marc D.; Graham, Alice M.; Feczko, Eric; Miranda-Dominguez, Oscar; Rasmussen, Jerod M.; Nardos, Rahel; Entringer, Sonja; Wadhwa, Pathik D.; Buss, Claudia; Fair, Damien A.			Maternal IL-6 during pregnancy can be estimated from newborn brain connectivity and predicts future working memory in offspring	NATURE NEUROSCIENCE			English	Article							IMMUNE ACTIVATION; EXECUTIVE FUNCTION; INFANTS; NETWORK; CONNECTOME; BIRTH; CLASSIFICATION; SCHIZOPHRENIA; SEGREGATION; REGRESSION	Several lines of evidence support the link between maternal inflammation during pregnancy and increased likelihood of neurodevelopmental and psychiatric disorders in offspring. This longitudinal study seeks to advance understanding regarding implications of systemic maternal inflammation during pregnancy, indexed by plasma interleukin-6 (IL-6) concentrations, for large-scale brain system development and emerging executive function skills in offspring. We assessed maternal IL-6 during pregnancy, functional magnetic resonance imaging acquired in neonates, and working memory (an important component of executive function) at 2 years of age. Functional connectivity within and between multiple neonatal brain networks can be modeled to estimate maternal IL-6 concentrations during pregnancy. Brain regions heavily weighted in these models overlap substantially with those supporting working memory in a large meta-analysis. Maternal IL-6 also directly accounts for a portion of the variance of working memory at 2 years of age. Findings highlight the association of maternal inflammation during pregnancy with the developing functional architecture of the brain and emerging executive function.	[Rudolph, Marc D.; Graham, Alice M.; Feczko, Eric; Miranda-Dominguez, Oscar; Fair, Damien A.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Feczko, Eric] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Rasmussen, Jerod M.; Entringer, Sonja; Wadhwa, Pathik D.; Buss, Claudia] Univ Calif Irvine, Dev Hlth & Dis Res Program, Irvine, CA 92697 USA; [Nardos, Rahel] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Entringer, Sonja; Buss, Claudia] Charite, Berlin, Germany; [Entringer, Sonja; Buss, Claudia] Free Univ Berlin, Berlin, Germany; [Entringer, Sonja; Buss, Claudia] Humboldt Univ, Berlin, Germany; [Entringer, Sonja; Buss, Claudia] BIH, Berlin, Germany; [Fair, Damien A.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Fair, Damien A.] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California Irvine; Oregon Health & Science University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Oregon Health & Science University; Oregon Health & Science University	Fair, DA (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.; Buss, C (corresponding author), Univ Calif Irvine, Dev Hlth & Dis Res Program, Irvine, CA 92697 USA.; Buss, C (corresponding author), Charite, Berlin, Germany.; Buss, C (corresponding author), Free Univ Berlin, Berlin, Germany.; Buss, C (corresponding author), Humboldt Univ, Berlin, Germany.; Buss, C (corresponding author), BIH, Berlin, Germany.; Fair, DA (corresponding author), Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA.; Fair, DA (corresponding author), Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA.	claudia.buss@charite.de; faird@ohsu.edu	Buss, Claudia/ABC-3687-2020; Miranda-Dominguez, Oscar/A-7412-2019; Nardos, Rahel/ABD-3471-2021; Entringer, Sonja/ABB-9405-2020	Miranda-Dominguez, Oscar/0000-0002-3622-0166; Buss, Claudia/0000-0002-8738-3133; Rudolph, Marc/0000-0001-7046-1169; Nardos, Rahel/0000-0002-0534-3825; Entringer, Sonja/0000-0002-9926-7076; Fair, Damien/0000-0001-8602-393X	National Institute of Mental Health [R01 MH091351, R01 MH105538]; National Institutes of Health [R01 MH096773, K99/R00 MH091238]; Oregon Clinical and Translational Research Institute; NIMH [K99 MH111805]; Gates Foundation; Destafano Innovation Fund; OHSU Fellowship for Diversity and Inclusion in Research Program; National Library of Medicine Postdoctoral Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH111805, R01MH115357, F32MH105283, R00MH091238, R01MH096773, R01MH091351, K99MH091238, R01MH105538] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007088] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Clinical and Translational Research Institute; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Gates Foundation(Bill & Melinda Gates Foundation); Destafano Innovation Fund; OHSU Fellowship for Diversity and Inclusion in Research Program; National Library of Medicine Postdoctoral Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We greatly acknowledge the assistance of E.R. Earl at OHSU for pipeline preparation and assistance. This work was funded by the National Institute of Mental Health (grants R01 MH091351 to C.B. and P.D.W. and R01 MH105538 to C.B., D.A.F and P.D.W.) and was supported by the National Institutes of Health (grants R01 MH096773 and K99/R00 MH091238 to D.A.F.), Oregon Clinical and Translational Research Institute (D. A. F), NIMH K99 MH111805 (A.G.), the Gates Foundation (D. A. F, R.N., A.G., C.B.), the Destafano Innovation Fund (D. A. F.), an OHSU Fellowship for Diversity and Inclusion in Research Program (O.M.-D.) and a National Library of Medicine Postdoctoral Fellowship (E.F.).	Abdi Herve, 2013, Methods Mol Biol, V930, P549, DOI 10.1007/978-1-62703-059-5_23; Beck DM, 2011, J COGN DEV, V12, P169, DOI 10.1080/15248372.2011.563485; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; BREIMAN L, 1992, INT STAT REV, V60, P291, DOI 10.2307/1403680; Buka SL, 2001, ARCH GEN PSYCHIAT, V58, P1032, DOI 10.1001/archpsyc.58.11.1032; Burgess GC, 2016, BRAIN CONNECT, V6, P669, DOI 10.1089/brain.2016.0435; Buss C, 2017, J AM ACAD CHILD PSY, V56, P373, DOI 10.1016/j.jaac.2017.03.001; Buss C, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003406; Buss Claudia, 2012, Cerebrum, V2012, P4; Combrisson E, 2015, J NEUROSCI METH, V250, P126, DOI 10.1016/j.jneumeth.2015.01.010; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Di Martino A, 2014, NEURON, V83, P1335, DOI 10.1016/j.neuron.2014.08.050; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fonov V., 2009, NEUROIMAGE, V47, pS102, DOI [10.1016/s1053-8119(09)70884-5, DOI 10.1016/S1053-8119(09)70884-5, 10.1016/S1053-8119(09)70884-5]; Gao W, 2017, NEUROSCIENTIST, V23, P169, DOI 10.1177/1073858416635986; Gao W, 2015, BRAIN STRUCT FUNCT, V220, P1173, DOI 10.1007/s00429-014-0710-3; Gao W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025278; Gartstein MA, 2003, INFANT BEHAV DEV, V26, P64, DOI 10.1016/S0163-6383(02)00169-8; Goodman S, 2008, SEMIN HEMATOL, V45, P135, DOI 10.1053/j.seminhematol.2008.04.003; Graham AM, 2018, BIOL PSYCHIAT, V83, P109, DOI 10.1016/j.biopsych.2017.05.027; Graham AM, 2016, DEV COGN NEUROS-NETH, V18, P12, DOI 10.1016/j.dcn.2015.09.006; Graham AM, 2015, J CHILD PSYCHOL PSYC, V56, P321, DOI 10.1111/jcpp.12400; Grayson DS, 2017, NEUROIMAGE, V160, P15, DOI 10.1016/j.neuroimage.2017.01.079; Hagmann P, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00043; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Hava G, 2006, DEV PSYCHOBIOL, V48, P162, DOI 10.1002/dev.20116; Hughes C, 2007, DEV PSYCHOL, V43, P1447, DOI 10.1037/0012-1649.43.6.1447; Khambhati A. N., 2017, MODELLING INTERPRETI, DOI [10.1101/124016(2017), DOI 10.1101/124016(2017)]; Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; Kohavi R., 1995, INT JOINT C ART INT, V14, P1137, DOI DOI 10.1067/MOD.2000.109031; Kohli S, 2007, J ONCOL PRACT, V3, P54, DOI 10.1200/JOP.0722001; Li G, 2015, J NEUROSCI, V35, P9150, DOI 10.1523/JNEUROSCI.4107-14.2015; Menon V., 2015, BRAIN MAPPING ENCY R, P597, DOI [10.1016/B978-0-12-397025-1.00052-X, DOI 10.1016/B978-0-12-397025-1.00052-X]; Menon Vinod, 2010, Brain Struct Funct, V214, P655, DOI 10.1007/s00429-010-0262-0; Miranda-Dominguez O, 2014, J NEUROSCI, V34, P5552, DOI 10.1523/JNEUROSCI.4229-13.2014; Monk C, 2012, DEV PSYCHOPATHOL, V24, P1361, DOI 10.1017/S0954579412000764; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Posner MI, 2012, NEUROIMAGE, V61, P450, DOI 10.1016/j.neuroimage.2011.12.040; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Pruett JR, 2015, DEV COGN NEUROS-NETH, V12, P123, DOI 10.1016/j.dcn.2015.01.003; Qin SZ, 2012, P NATL ACAD SCI USA, V109, P7941, DOI 10.1073/pnas.1120408109; Rudolph MD, 2017, DEV COGN NEUROS-NETH, V24, P93, DOI 10.1016/j.dcn.2017.01.010; Schwarz E, 2016, AM J MED GENET B, V171, P121, DOI 10.1002/ajmg.b.32353; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Short SJ, 2013, NEUROIMAGE, V64, P156, DOI 10.1016/j.neuroimage.2012.09.021; Smith S, 2001, NEUROIMAGE, V13, pS249; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Smyser CD, 2016, NEUROIMAGE, V136, P1, DOI 10.1016/j.neuroimage.2016.05.029; Smyser CD, 2016, CEREB CORTEX, V26, P322, DOI 10.1093/cercor/bhu251; Smyser CD, 2011, NEUROIMAGE, V56, P1437, DOI 10.1016/j.neuroimage.2011.02.073; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Sporns O, 2014, BRAIN, V137, P2117, DOI 10.1093/brain/awu148; Stafford JM, 2014, P NATL ACAD SCI USA, V111, P18745, DOI 10.1073/pnas.1404346111; Talairach J., 1988, COPLANAR STEREOTAXIC; Thomason ME, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004978; Wei HG, 2012, BBA-MOL BASIS DIS, V1822, P831, DOI 10.1016/j.bbadis.2012.01.011; Wu WL, 2017, BRAIN BEHAV IMMUN, V62, P11, DOI 10.1016/j.bbi.2016.11.007; Yarkoni T, 2011, FRONT NEUROINFORM, DOI [DOI 10.3389/CONF.FNINF.2011.08.00058, 10.3389/conf.fninf.2011.08.00058]	63	173	175	6	46	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2018	21	5					765	+		10.1038/s41593-018-0128-y	http://dx.doi.org/10.1038/s41593-018-0128-y			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GE4EB	29632361	Green Accepted, Green Submitted			2022-12-17	WOS:000431166100016
J	Shigetomi, E; Kracun, S; Sofroniew, MV; Khakh, BS				Shigetomi, Eiji; Kracun, Sebastian; Sofroniew, Michael V.; Khakh, Baljit S.			A genetically targeted optical sensor to monitor calcium signals in astrocyte processes	NATURE NEUROSCIENCE			English	Article							IN-SITU; HIPPOCAMPAL ASTROCYTES; NEURAL ACTIVITY; CA2+ INDICATOR; GLUTAMATE; GLIA; ACTIVATION; OSCILLATIONS; NEURONS; MICE	Calcium signaling is studied as a potential form of astrocyte excitability that may control astrocyte involvement in synaptic and cerebrovascular regulation. Fundamental questions remain unanswered about astrocyte calcium signaling, as current methods can not resolve calcium in small volume compartments, such as near the cell membrane and in distal cell processes. We modified the genetically encoded calcium sensor GCaMP2 with a membrane-tethering domain, Lck, increasing the level of Lck-GCaMP2 near the plasma membrane tenfold as compared with conventional GCaMP2. Using Lck-GCaMP2 in rat hippocampal astrocyte-neuron cocultures, we measured near-membrane calcium signals that were evoked pharmacologically or by single action potential-mediated neurotransmitter release. Moreover, we identified highly localized and frequent spontaneous calcium signals in astrocyte somata and processes that conventional GCaMP2 failed to detect. Lck-GCaMP2 acts as a genetically targeted calcium sensor for monitoring calcium signals in previously inaccessible parts of astrocytes, including fine processes.	[Shigetomi, Eiji; Kracun, Sebastian; Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Sofroniew, Michael V.; Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Khakh, BS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	bkhakh@mednet.ucla.edu	SHIGETOMI, EIJI/I-2372-2012; Sofroniew, Michael/ABE-8857-2020	Shigetomi, Eiji/0000-0002-5267-6155	National Institutes of Health [NS060677, NS057624]; Whitehall Foundation; S&R Foundation Ryuji Ueno Award; Stein-Oppenheimer Foundation Endowment Award; Uehara Memorial Foundation Fellowship of Japan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060677, R21NS071292, R01NS057624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; S&R Foundation Ryuji Ueno Award; Stein-Oppenheimer Foundation Endowment Award; Uehara Memorial Foundation Fellowship of Japan(Uehara Memorial Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Looger for a preprint of a manuscript on GCaMP3, A. Sagasti for the GCaMP2 plasmid, D.E. Bergles for insightful discussions and for the Lck domain plasmid, and M. Simon for MrgA1-EGFP. Our work was supported by the National Institutes of Health (NS060677 and NS057624), the Whitehall Foundation, a S&R Foundation Ryuji Ueno Award for Ion Channels or Barrier Function Research and a Stein-Oppenheimer Foundation Endowment Award (B.S.K.). E.S. was partly supported by the Uehara Memorial Foundation Fellowship of Japan.	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Atkin SD, 2009, J NEUROSCI METH, V181, P212, DOI 10.1016/j.jneumeth.2009.05.006; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bekar LK, 2008, CEREB CORTEX, V18, P2789, DOI 10.1093/cercor/bhn040; Benediktsson AM, 2005, J NEUROSCI METH, V141, P41, DOI 10.1016/j.jneumeth.2004.05.013; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Fiacco TA, 2009, ANNU REV PHARMACOL, V49, P151, DOI 10.1146/annurev.pharmtox.011008.145602; GOBEL W, 2001, NAT METHODS, V4, P13; GOLDMAN JE, 1990, BRAIN RES, V528, P189, DOI 10.1016/0006-8993(90)91657-3; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Jaiswal JK, 2007, NAT CHEM BIOL, V3, P92, DOI 10.1038/nchembio855; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lee SY, 2007, J PHYSIOL-LONDON, V581, P887, DOI 10.1113/jphysiol.2007.134676; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Porter JT, 1996, J NEUROSCI, V16, P5073; Reyes RC, 2009, NEUROCHEM INT, V55, P2, DOI 10.1016/j.neuint.2008.12.018; Richler E, 2008, NAT METHODS, V5, P87, DOI 10.1038/NMETH1144; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Shigetomi Eiji, 2009, J Vis Exp, DOI 10.3791/1142; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tritsch NX, 2007, NEURON, V54, P497, DOI 10.1016/j.neuron.2007.05.008; Wang P, 2006, J COASTAL RES, P816; Zlatkine P, 1997, J CELL SCI, V110, P673	50	173	178	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					759	U143		10.1038/nn.2557	http://dx.doi.org/10.1038/nn.2557			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20495558	Green Accepted			2022-12-17	WOS:000278003300022
J	Kandler, K; Clause, A; Noh, J				Kandler, Karl; Clause, Amanda; Noh, Jihyun			Tonotopic reorganization of developing auditory brainstem circuits	NATURE NEUROSCIENCE			English	Review							LATERAL SUPERIOR OLIVE; EXPERIENCE-DEPENDENT REFINEMENT; VENTRAL COCHLEAR NUCLEUS; INHIBITORY SYNAPSES; POSTNATAL-DEVELOPMENT; SOUND LOCALIZATION; DENDRITIC ARBORS; GLYCINERGIC/GABAERGIC SYNAPSES; SYNAPTIC PLASTICITY; CONGENITAL DEAFNESS	A fundamental organizing principle of auditory brain circuits is tonotopy, the orderly representation of the sound frequency to which neurons are most sensitive. Tonotopy arises from the coding of frequency along the cochlea and the topographic organization of auditory pathways. The mechanisms that underlie the establishment of tonotopy are poorly understood. In auditory brainstem pathways, topographic precision is present at very early stages in development, which may suggest that synaptic reorganization contributes little to the construction of precise tonotopic maps. Accumulating evidence from several brainstem nuclei, however, is now changing this view by demonstrating that developing auditory brainstem circuits undergo a marked degree of refinement on both a subcellular and circuit level.	[Kandler, Karl; Clause, Amanda; Noh, Jihyun] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Inst Eye & Ear, Pittsburgh, PA 15260 USA; [Kandler, Karl; Clause, Amanda; Noh, Jihyun] Univ Pittsburgh, Sch Med, Dept Neurobiol, Inst Eye & Ear, Pittsburgh, PA USA; [Kandler, Karl; Clause, Amanda] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kandler, K (corresponding author), Univ Pittsburgh, Sch Med, Dept Otolaryngol, Inst Eye & Ear, Pittsburgh, PA 15260 USA.	kkarl@pitt.edu		Clause, Amanda/0000-0002-2078-7280; Kandler, Karl/0000-0002-6053-6400	National Institute on Deafness and Other Communication Disorders; Alfred R. Sloan Foundation; Pennsylvania Lions Hearing Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004199] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Alfred R. Sloan Foundation(Alfred P. Sloan Foundation); Pennsylvania Lions Hearing Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. Goldring for editorial support and B. Cornell for insightful discussions. Our work was supported by grants from the National Institute on Deafness and Other Communication Disorders, the Alfred R. Sloan Foundation and the Pennsylvania Lions Hearing Research Foundation.	Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BANKS MI, 1992, J NEUROSCI, V12, P2819; Blaesse P, 2005, CELL TISSUE RES, V320, P33, DOI 10.1007/s00441-004-1054-8; Cao XJ, 2008, J COMP NEUROL, V510, P297, DOI 10.1002/cne.21788; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Chang EH, 2003, J NEUROPHYSIOL, V90, P1479, DOI 10.1152/jn.00386.2003; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Cramer KS, 2005, HEARING RES, V206, P42, DOI 10.1016/j.heares.2004.11.024; Cramer KS, 2004, DEV BIOL, V269, P26, DOI 10.1016/j.ydbio.2004.01.002; Dahmen JC, 2007, CURR OPIN NEUROBIOL, V17, P456, DOI 10.1016/j.conb.2007.07.004; Eggermont JJ, 2008, EAR HEARING, V29, P819, DOI 10.1097/AUD.0b013e3181853030; Ehrlich I, 1999, J PHYSIOL-LONDON, V520, P121, DOI 10.1111/j.1469-7793.1999.00121.x; Farinas I, 2001, J NEUROSCI, V21, P6170, DOI 10.1523/JNEUROSCI.21-16-06170.2001; FRIAUF E, 1990, NEUROSCI LETT, V120, P58, DOI 10.1016/0304-3940(90)90167-8; Friauf E, 1997, J COMP NEUROL, V385, P117, DOI 10.1002/(SICI)1096-9861(19970818)385:1<117::AID-CNE7>3.0.CO;2-5; FRIAUF E, 1992, EUR J NEUROSCI, V4, P798, DOI 10.1111/j.1460-9568.1992.tb00190.x; Fujino K, 2003, P NATL ACAD SCI USA, V100, P265, DOI 10.1073/pnas.0135345100; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Gillespie DC, 2005, NAT NEUROSCI, V8, P332, DOI 10.1038/nn1397; Grothe B, 2003, NAT REV NEUROSCI, V4, P540, DOI 10.1038/nrn1136; Gurung B, 2004, J COMP NEUROL, V479, P309, DOI 10.1002/cne.20328; Hashimoto K, 2005, NEUROSCI RES, V53, P221, DOI 10.1016/j.neures.2005.07.007; Hoffpauir BK, 2006, J NEUROSCI, V26, P5511, DOI 10.1523/JNEUROSCI.5525-05.2006; Huffman KJ, 2007, DEV NEUROBIOL, V67, P1655, DOI 10.1002/dneu.20535; JACKSON H, 1982, J NEUROSCI, V2, P1736; JHAVERI S, 1982, NEUROSCIENCE, V7, P837, DOI 10.1016/0306-4522(82)90046-X; Jones TA, 2007, J NEUROPHYSIOL, V98, P1898, DOI 10.1152/jn.00472.2007; Kakazu Y, 1999, J NEUROSCI, V19, P2843; KANDLER K, 1995, J NEUROSCI, V15, P6890; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Keuroghlian AS, 2007, PROG NEUROBIOL, V82, P109, DOI 10.1016/j.pneurobio.2007.03.005; KIL J, 1995, J COMP NEUROL, V353, P317, DOI 10.1002/cne.903530302; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; KITZES LM, 1995, J COMP NEUROL, V353, P341, DOI 10.1002/cne.903530303; Kotak VC, 1998, J NEUROSCI, V18, P4646; Kotak VC, 2000, J NEUROSCI, V20, P5820, DOI 10.1523/JNEUROSCI.20-15-05820.2000; Kotak VC, 2003, BIOL CYBERN, V89, P363, DOI 10.1007/s00422-003-0441-7; KOTAK VC, 1995, J NEUROPHYSIOL, V74, P1611, DOI 10.1152/jn.1995.74.4.1611; Koundakjian EJ, 2007, J NEUROSCI, V27, P14078, DOI 10.1523/JNEUROSCI.3765-07.2007; Kullmann DM, 2000, CELL MOL LIFE SCI, V57, P1551, DOI 10.1007/PL00000640; Kullmann PHM, 2008, NEUROSCIENCE, V154, P338, DOI 10.1016/j.neuroscience.2008.02.026; Kullmann PHM, 2002, EUR J NEUROSCI, V15, P1093, DOI 10.1046/j.1460-9568.2002.01946.x; Kullmann PHM, 2001, DEV BRAIN RES, V131, P143, DOI 10.1016/S0165-3806(01)00271-1; Leake PA, 2002, J COMP NEUROL, V448, P6, DOI 10.1002/cne.10176; Leake PA, 2006, J COMP NEUROL, V497, P13, DOI 10.1002/cne.20968; Leao RN, 2006, J PHYSIOL-LONDON, V571, P563, DOI 10.1113/jphysiol.2005.098780; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; LIPPE W, 1985, J COMP NEUROL, V237, P273, DOI 10.1002/cne.902370211; LIPPE WR, 1994, J NEUROSCI, V14, P1486, DOI 10.1523/JNEUROSCI.14-03-01486.1994; LIPPE WR, 1992, J NEUROSCI, V12, P962; Lu T, 2007, J NEUROSCI, V27, P808, DOI 10.1523/JNEUROSCI.4871-06.2007; Lu Y, 2007, J NEUROPHYSIOL, V97, P635, DOI 10.1152/jn.00915.2006; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; Magnusson AK, 2008, NEURON, V59, P125, DOI 10.1016/j.neuron.2008.05.011; Maier JK, 2008, BRAIN RES, V1220, P47, DOI 10.1016/j.brainres.2008.01.083; Meier J, 2003, CELL TISSUE RES, V311, P271, DOI 10.1007/s00441-002-0694-9; Miko IJ, 2007, J COMP NEUROL, V505, P669, DOI 10.1002/cne.21530; Molea D, 2003, J COMP NEUROL, V466, P577, DOI 10.1002/cne.10896; Nabekura J, 2004, NAT NEUROSCI, V7, P17, DOI 10.1038/nn1170; Nishimaki T, 2007, EUR J NEUROSCI, V26, P323, DOI 10.1111/j.1460-9568.2007.05656.x; Rietzel HJ, 1998, J COMP NEUROL, V390, P20; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; RUSSELL FA, 1995, J COMP NEUROL, V352, P607, DOI 10.1002/cne.903520409; Russo NM, 2008, CLIN NEUROPHYSIOL, V119, P1720, DOI 10.1016/j.clinph.2008.01.108; Russo NM, 2005, BEHAV BRAIN RES, V156, P95, DOI 10.1016/j.bbr.2004.05.012; SANES DH, 1989, J COMP NEUROL, V279, P436, DOI 10.1002/cne.902790308; SANES DH, 1993, EUR J NEUROSCI, V5, P570, DOI 10.1111/j.1460-9568.1993.tb00522.x; SANES DH, 1992, J COMP NEUROL, V321, P637, DOI 10.1002/cne.903210410; SANES DH, 1991, J NEUROBIOL, V22, P837, DOI 10.1002/neu.480220805; SANES DH, 1988, J NEUROSCI, V8, P682; SANES DH, 1993, J NEUROSCI, V13, P2627, DOI 10.1523/JNEUROSCI.13-06-02627.1993; SANES DH, 1983, SCIENCE, V221, P1183, DOI 10.1126/science.6612332; SANES DH, 1992, DEV BRAIN RES, V67, P47, DOI 10.1016/0165-3806(92)90024-Q; Seal RP, 2006, CURR OPIN PHARMACOL, V6, P114, DOI 10.1016/j.coph.2005.12.001; Seidl AH, 2005, J NEUROPHYSIOL, V94, P1028, DOI 10.1152/jn.01143.2004; Snyder RL, 1997, J COMP NEUROL, V384, P293, DOI 10.1002/(SICI)1096-9861(19970728)384:2<293::AID-CNE9>3.0.CO;2-X; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Tollin DJ, 2003, NEUROSCIENTIST, V9, P127, DOI 10.1177/1073858403252228; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Tzounopoulos T, 2004, NAT NEUROSCI, V7, P719, DOI 10.1038/nn1272; Walmsley B, 2006, J PHYSIOL-LONDON, V572, P313, DOI 10.1113/jphysiol.2006.104851; Walsh Edward J., 1992, P161; WALSH EJ, 1988, HEARING RES, V36, P233, DOI 10.1016/0378-5955(88)90065-2; Werthat F, 2008, DEV NEUROBIOL, V68, P1454, DOI 10.1002/dneu.20660; Wible B, 2004, BIOL PSYCHOL, V67, P299, DOI 10.1016/j.biopsycho.2004.02.002; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Youssoufian M, 2005, J NEUROPHYSIOL, V94, P3168, DOI 10.1152/jn.00342.2005	91	173	176	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2009	12	6					711	717		10.1038/nn.2332	http://dx.doi.org/10.1038/nn.2332			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	450DJ	19471270	Green Accepted			2022-12-17	WOS:000266380900012
J	Kim, G; Kandler, K				Kim, G; Kandler, K			Elimination and strengthening of glycinergic/GABAergic connections during tonotopic map formation	NATURE NEUROSCIENCE			English	Article							SUPERIOR OLIVARY NUCLEUS; CENTRAL AUDITORY-SYSTEM; VISUAL-CORTEX; DEVELOPMENTAL-CHANGES; DEPENDENT REFINEMENT; SYNAPSE ELIMINATION; DOMINANCE COLUMNS; SPINAL NEURONS; PLASTICITY; GLYCINE	Synapse elimination and strengthening are central mechanisms for the developmental organization of excitatory neuronal networks. Little is known, however, about whether these processes are also involved in establishing precise inhibitory circuits. We examined the development of functional connectivity before hearing onset in rats in the tonotopically organized, glycinergic pathway from the medial nucleus of the trapezoid body (MNTB) to the lateral superior olive (LSO), which is part of the mammalian sound localization system. We found that LSO neurons became functionally disconnected from similar to75% of their initial inputs, resulting in a two-fold sharpening of functional topography. This was accompanied by a 12-fold increase in the synaptic conductance generated by maintained individual inputs. Functional elimination of MNTB-LSO synapses was restricted to the period when these glycinergic/GABAergic synapses are excitatory. These results provide new insights into the mechanisms by which precisely organized inhibitory circuits are established during development.	Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kandler, K (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, 3500 Terrace St, Pittsburgh, PA 15261 USA.	kkarl@pitt.edu		Kim, Gunsoo/0000-0001-9318-8329; Kandler, Karl/0000-0002-6053-6400	NIDCD NIH HHS [R01 DC004199, DC04199] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004199] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; BLATCHLEY BJ, 1987, DEV BRAIN RES, V32, P75, DOI 10.1016/0165-3806(87)90140-4; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; BOUDREAU JC, 1968, J NEUROPHYSIOL, V31, P442, DOI 10.1152/jn.1968.31.3.442; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Ehrlich I, 1999, J PHYSIOL-LONDON, V520, P121, DOI 10.1111/j.1469-7793.1999.00121.x; FRIAUF E, 1992, EUR J NEUROSCI, V4, P798, DOI 10.1111/j.1460-9568.1992.tb00190.x; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRANTYN R, 1995, PERSPECT DEV NEUROBI, V2, P387; Gubellini P, 2001, EUR J NEUROSCI, V14, P1937, DOI 10.1046/j.0953-816x.2001.01823.x; HELFERT RH, 1986, J COMP NEUROL, V244, P533, DOI 10.1002/cne.902440409; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; IRVINE DRF, 1992, SPRINGER HDB AUDITOR, V2, P153; JACKSON H, 1982, J NEUROSCI, V2, P1736; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; KANDLER K, 1995, EUR J NEUROSCI, V7, P1773, DOI 10.1111/j.1460-9568.1995.tb00697.x; KANDLER K, 1995, J NEUROSCI, V15, P6890; KANDLER K, 1998, IMAGING NEURONS, P271; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kaufman L, 2009, FINDING GROUPS DATA; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; Kotak VC, 1998, J NEUROSCI, V18, P4646; Kotak VC, 1996, J NEUROSCI, V16, P1836; Kotak VC, 2000, J NEUROSCI, V20, P5820, DOI 10.1523/JNEUROSCI.20-15-05820.2000; Kullmann PHM, 2002, EUR J NEUROSCI, V15, P1093, DOI 10.1046/j.1460-9568.2002.01946.x; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lohmann C, 1998, J NEUROBIOL, V34, P97, DOI 10.1002/(SICI)1097-4695(19980205)34:2<97::AID-NEU1>3.0.CO;2-6; PURVES D, 1985, PRINCIPLES NEURAL DE; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Rietzel HJ, 1998, J COMP NEUROL, V390, P20; Rozas C, 2001, J NEUROSCI, V21, P6791, DOI 10.1523/JNEUROSCI.21-17-06791.2001; SANES DH, 1993, EUR J NEUROSCI, V5, P570, DOI 10.1111/j.1460-9568.1993.tb00522.x; SANES DH, 1991, J NEUROBIOL, V22, P837, DOI 10.1002/neu.480220805; SANES DH, 1993, J NEUROSCI, V13, P2627, DOI 10.1523/JNEUROSCI.13-06-02627.1993; Sanes DH, 2000, HEARING RES, V147, P46, DOI 10.1016/S0378-5955(00)00119-2; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705	50	173	180	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					282	290		10.1038/nn1015	http://dx.doi.org/10.1038/nn1015			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12577063				2022-12-17	WOS:000181178300017
J	Ingram, SL; Prasad, BM; Amara, SG				Ingram, SL; Prasad, BM; Amara, SG			Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; SUBSTANTIA-NIGRA NEURONS; CHLORIDE CHANNEL; GLUTAMATE TRANSPORTER; D-AMPHETAMINE; RAT; RELEASE; RECEPTORS; COCAINE; BRAIN	Uptake by Na+/Cl- -dependent neurotransmitter transporters is the principal mechanism by which extracellular biogenic amine concentrations are regulated. In addition to uptake, the cloned transporter proteins also elicit ion channel-like currents, but the physiological consequences of these currents are unknown. Here, whole-cell patch clamp and perforated-patch recordings show that substrates of the dopamine transporter (DAT), such as dopamine (DA) and amphetamine, increase the firing activity of rat DA neurons in culture. We found that these substrates elicit inward currents that are Na+-dependent and blocked by cocaine. These currents are primarily comprised of anions and result in an excitatory response in DA neurons at lower DA concentrations than are required for D2 autoreceptor activation. Thus, in addition to clearing extracellular DA, our results suggest that the currents associated with DAT modulate excitability and may regulate release of neurotransmitter from midbrain DA neurons.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Amara, SG (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Amara, Susan/0000-0001-8914-1106	NIDA NIH HHS [DAO07595] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007595, R37DA007595] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ali DW, 1998, J PHYSIOL-LONDON, V509, P211, DOI 10.1111/j.1469-7793.1998.211bo.x; Backus KH, 1998, J PHYSIOL-LONDON, V507, P783, DOI 10.1111/j.1469-7793.1998.783bs.x; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; BRUNS D, 1993, NEURON, V10, P559, DOI 10.1016/0896-6273(93)90159-O; BUNNEY BS, 1978, N-S ARCH PHARMACOL, V304, P255, DOI 10.1007/BF00507966; Cao YW, 1997, J NEUROSCI, V17, P2257; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Cragg SJ, 1997, J NEUROPHYSIOL, V77, P863, DOI 10.1152/jn.1997.77.2.863; DeFelice LJ, 1996, BIOPHYS J, V70, P579, DOI 10.1016/S0006-3495(96)79604-2; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Eliasof S, 1996, P NATL ACAD SCI USA, V93, P4153, DOI 10.1073/pnas.93.9.4153; ESHLEMAN AJ, 1994, MOL PHARMACOL, V45, P312; Falkenburger BH, 2001, SCIENCE, V293, P2465, DOI 10.1126/science.1060645; FATIMASHAD K, 1993, P ROY SOC B-BIOL SCI, V253, P69, DOI 10.1098/rspb.1993.0083; FRANCIOLINI F, 1987, J GEN PHYSIOL, V90, P453, DOI 10.1085/jgp.90.4.453; GALLI A, 1995, J EXP BIOL, V198, P2197; Galli A, 1998, P NATL ACAD SCI USA, V95, P13260, DOI 10.1073/pnas.95.22.13260; GEFFEN LB, 1976, NATURE, V260, P258, DOI 10.1038/260258a0; GU H, 1994, J BIOL CHEM, V269, P7124; Hoffman AF, 1998, J PHARMACOL EXP THER, V287, P487; Jaffe EH, 1998, J NEUROSCI, V18, P3548; Jayanthi LD, 2002, BRIT J PHARMACOL, V135, P1927, DOI 10.1038/sj.bjp.0704658; KIM KM, 1995, NEUROSCIENCE, V69, P1145, DOI 10.1016/0306-4522(95)00326-E; KRUEGER BK, 1990, J NEUROCHEM, V55, P260, DOI 10.1111/j.1471-4159.1990.tb08847.x; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; LACEY MG, 1990, BRIT J PHARMACOL, V99, P731, DOI 10.1111/j.1476-5381.1990.tb12998.x; LESTER HA, 1994, ANNU REV PHARMACOL, V34, P219; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; MERCURI NB, 1989, BRIT J PHARMACOL, V98, P127, DOI 10.1111/j.1476-5381.1989.tb16872.x; NICHOLSON LFB, 1992, NEUROSCIENCE, V50, P355, DOI 10.1016/0306-4522(92)90429-6; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Paladini CA, 2001, NAT NEUROSCI, V4, P275, DOI 10.1038/85124; Paladini CA, 1999, BRAIN RES, V832, P145, DOI 10.1016/S0006-8993(99)01484-5; Prasad BM, 2001, J NEUROSCI, V21, P7561, DOI 10.1523/JNEUROSCI.21-19-07561.2001; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shi WX, 2000, J NEUROSCI, V20, P3504, DOI 10.1523/JNEUROSCI.20-09-03504.2000; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sonders MS, 1997, J NEUROSCI, V17, P960; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; SULZER D, 1993, J NEUROCHEM, V60, P527, DOI 10.1111/j.1471-4159.1993.tb03181.x; TRENT F, 1991, EUR J PHARMACOL, V204, P265, DOI 10.1016/0014-2999(91)90851-G; Volkow ND, 1999, J PHARMACOL EXP THER, V291, P409; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469	48	173	175	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					971	978		10.1038/nn920	http://dx.doi.org/10.1038/nn920			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12352983				2022-12-17	WOS:000178242200016
J	Hu, HY				Hu, HY			Cell-surface heparan sulfate is involved in the repulsive guidance activities of Slit2 protein	NATURE NEUROSCIENCE			English	Article							GROWTH-ASSOCIATED MOLECULE; LONG-RANGE GUIDANCE; AXON GUIDANCE; NEURONAL MIGRATION; FIBROBLAST-GROWTH; ROBO RECEPTORS; HB-GAM; PROTEOGLYCAN GLYPICAN-1; MAMMALIAN HOMOLOGS; VERTEBRATE SLIT	Slit proteins are a family of secreted guidance proteins that can repel neuronal migration and axon growth via interaction with their cellular roundabout receptors (Robos). Here it was shown that Slit2-Robo-1 interactions were enhanced by cell-surface heparan sulfate. Removal of heparan sulfate decreased the affinity of Slit for Robe by about threefold. In addition, removal of cell-surface heparan sulfate by heparinase III abolished the chemorepulsive response to Slit2 normally shown by both the migrating neurons and growing axons. These results indicate essential roles for cell-surface heparan sulfate in the repulsive activities of Slit2.	Metrohlth Med Ctr, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA	MetroHealth System	Hu, HY (corresponding author), Metrohlth Med Ctr, Rammelkamp Ctr Educ & Res, 2500 Metrohlth Dr, Cleveland, OH 44109 USA.	hhu@metrohealth.org			NINDS NIH HHS [NS38877] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038877] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Battye R, 1999, DEVELOPMENT, V126, P2475; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Binari RC, 1997, DEVELOPMENT, V124, P2623; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Chen JH, 2001, J NEUROSCI, V21, P1548, DOI 10.1523/JNEUROSCI.21-05-01548.2001; Erskine L, 2000, J NEUROSCI, V20, P4975; Hacker U, 1997, DEVELOPMENT, V124, P3565; Haerry TE, 1997, DEVELOPMENT, V124, P3055; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; Itoh A, 1998, MOL BRAIN RES, V62, P175, DOI 10.1016/S0169-328X(98)00224-1; KARTHIKEYAN L, 1994, J CELL SCI, V107, P3213; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kinnunen A, 1998, EUR J NEUROSCI, V10, P635, DOI 10.1046/j.1460-9568.1998.00082.x; Kinnunen A, 1999, EUR J NEUROSCI, V11, P491, DOI 10.1046/j.1460-9568.1999.00457.x; Kinnunen T, 1996, J BIOL CHEM, V271, P2243, DOI 10.1074/jbc.271.4.2243; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Liang Y, 1999, J BIOL CHEM, V274, P17885, DOI 10.1074/jbc.274.25.17885; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lin XH, 1999, DEVELOPMENT, V126, P3715; Litwack ED, 1998, DEV DYNAM, V211, P72, DOI 10.1002/(SICI)1097-0177(199801)211:1<72::AID-AJA7>3.3.CO;2-8; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Nakayama M, 1998, GENOMICS, V51, P27, DOI 10.1006/geno.1998.5341; Niclou SP, 2000, J NEUROSCI, V20, P4962; NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Ringstedt T, 2000, J NEUROSCI, V20, P4983; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Saunders S, 1997, DEV BIOL, V190, P78, DOI 10.1006/dbio.1997.8690; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	50	173	181	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					695	701		10.1038/89482	http://dx.doi.org/10.1038/89482			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	448HK	11426225				2022-12-17	WOS:000169621300014
J	Kohda, K; Wang, Y; Yuzaki, M				Kohda, K; Wang, Y; Yuzaki, M			Mutation of a glutamate receptor motif reveals its role in gating and delta 2 receptor channel properties	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; RAT HIPPOCAMPAL-NEURONS; METHYL-D-ASPARTATE; PURKINJE-CELLS; AMPA RECEPTORS; ACTIVATION KINETICS; CA2+ PERMEABILITY; NMDA RECEPTORS; BINDING-SITES; SUBUNIT	Despite its importance in the cerebellum, the functions of the orphan glutamate receptor delta 2 are unknown. We examined a mutant delta 2 receptor channel in lurcher mice that was constitutively active in the absence of ligand. Because this mutation was within a highly conserved motif (YTANLAAF), we tested its effect on several glutamate receptors. Mutant delta 2 receptors showed distinct channel properties, including double rectification of the current-voltage relationship, sensitivity to a polyamine antagonist and moderate Ca2+ permeability, whereas other constitutively active mutant glutamate channels resembled wildtype channels in these respects. Moreover, the kinetics of ligand-activated currents were strikingly altered. We conclude that the delta 2 receptor has a functional ion channel pore similar to that of glutamate receptors. The motif may have a role in the channel gating of glutamate receptors.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Yuzaki, M (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michi.yuzaki@stjude.org	Yuzaki, Michisuke/K-5328-2013; Kohda, Kazuhisa/L-4731-2013	Yuzaki, Michisuke/0000-0002-5750-3544; 	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036925] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765] Funding Source: Medline; NINDS NIH HHS [NS36925] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; Clements JD, 1998, J NEUROSCI, V18, P119; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; HIRANO T, 1995, NEUROREPORT, V6, P524, DOI 10.1097/00001756-199502000-00029; HIRANO T, 1994, NEUROSCI LETT, V182, P172, DOI 10.1016/0304-3940(94)90790-0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.neuro.12.1.85; Jeromin A, 1996, J NEUROPHYSIOL, V76, P3578, DOI 10.1152/jn.1996.76.5.3578; JOHANSEN TH, 1995, MOL PHARMACOL, V48, P946; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; Koike M, 1997, NEUROSCI RES, V29, P27, DOI 10.1016/S0168-0102(97)00067-9; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; LESTER RAJ, 1992, J NEUROSCI, V12, P635; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; OZAWA S, 1984, Neuroscience Research, V1, P275, DOI 10.1016/0168-0102(84)90034-8; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PARTIN KM, 1995, NEURON, V14, P833, DOI 10.1016/0896-6273(95)90227-9; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Wang YZ, 1997, NATURE, V389, P502, DOI 10.1038/39062; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Yamada KA, 1996, BRIT J PHARMACOL, V117, P1663, DOI 10.1111/j.1476-5381.1996.tb15337.x; Yuzaki M, 1996, SCIENCE, V273, P1112, DOI 10.1126/science.273.5278.1112; Yuzaki M, 1996, J NEUROSCI, V16, P4651; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	43	173	176	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					315	322		10.1038/73877	http://dx.doi.org/10.1038/73877			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725919				2022-12-17	WOS:000087945400010
J	Ximerakis, M; Lipnick, SL; Innes, BT; Simmons, SK; Adiconis, X; Dionne, D; Mayweather, BA; Nguyen, L; Niziolek, Z; Ozek, C; Butty, VL; Isserlin, R; Buchanan, SM; Levine, SS; Regev, A; Bader, GD; Levin, JZ; Rubin, LL				Ximerakis, Methodios; Lipnick, Scott L.; Innes, Brendan T.; Simmons, Sean K.; Adiconis, Xian; Dionne, Danielle; Mayweather, Brittany A.; Nguyen, Lan; Niziolek, Zachary; Ozek, Ceren; Butty, Vincent L.; Isserlin, Ruth; Buchanan, Sean M.; Levine, Stuart S.; Regev, Aviv; Bader, Gary D.; Levin, Joshua Z.; Rubin, Lee L.			Single-cell transcriptomic profiling of the aging mouse brain	NATURE NEUROSCIENCE			English	Article							GENOME-WIDE EXPRESSION; NEURAL STEM-CELLS; GENE-EXPRESSION; RNA-SEQ; MOLECULAR CENSUS; REVEALS; IDENTIFICATION; MICROGLIA; HALLMARKS; YOUNG	The mammalian brain is complex, with multiple cell types performing a variety of diverse functions, but exactly how each cell type is affected in aging remains largely unknown. Here we performed a single-cell transcriptomic analysis of young and old mouse brains. We provide comprehensive datasets of aging-related genes, pathways and ligand-receptor interactions in nearly all brain cell types. Our analysis identified gene signatures that vary in a coordinated manner across cell types and gene sets that are regulated in a cell-type specific manner, even at times in opposite directions. These data reveal that aging, rather than inducing a universal program, drives a distinct transcriptional course in each cell population, and they highlight key molecular processes, including ribosome biogenesis, underlying brain aging. Overall, these large-scale datasets (accessible online at https://portals.broadinstitute.org/single_cell/study/aging-mouse-brain) provide a resource for the neuroscience community that will facilitate additional discoveries directed towards understanding and modifying the aging process.	[Ximerakis, Methodios; Lipnick, Scott L.; Mayweather, Brittany A.; Ozek, Ceren; Buchanan, Sean M.; Rubin, Lee L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Ximerakis, Methodios; Lipnick, Scott L.; Mayweather, Brittany A.; Ozek, Ceren; Buchanan, Sean M.; Rubin, Lee L.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ximerakis, Methodios; Lipnick, Scott L.; Simmons, Sean K.; Adiconis, Xian; Dionne, Danielle; Nguyen, Lan; Regev, Aviv; Levin, Joshua Z.; Rubin, Lee L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Lipnick, Scott L.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Innes, Brendan T.; Isserlin, Ruth; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Niziolek, Zachary] Harvard Univ, Bauer Core, Fac Arts & Sci, Div Sci, Cambridge, MA 02138 USA; [Butty, Vincent L.; Levine, Stuart S.] MIT, BioMicro Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Toronto; Harvard University; Massachusetts Institute of Technology (MIT)	Ximerakis, M; Rubin, LL (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Ximerakis, M; Rubin, LL (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Ximerakis, M; Rubin, LL (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	methodios_ximerakis@harvard.edu; lee_rubin@harvard.edu	Ximerakis, Methodios/AAE-7642-2020	Ximerakis, Methodios/0000-0002-2815-7558; Dionne, Danielle/0000-0002-8338-4323; Innes, Brendan/0000-0003-2496-3154; Butty, Vincent/0000-0003-1173-2429; Rubin, Lee/0000-0002-8658-841X; Levine, Stuart/0000-0001-7363-562X	Ono Pharmaceutical Co., Ltd; Stanley Center for Psychiatric Research; Klarman Cell Observatory	Ono Pharmaceutical Co., Ltd(Ono Pharmaceutical Co Ltd); Stanley Center for Psychiatric Research; Klarman Cell Observatory	We acknowledge T. Okino and his team at Ono Pharmaceuticals for fruitful discussions and useful suggestions during the progress of this work. We are grateful to F. Rapino, N. Rodriguez-Muela, K. Pfaff, A. Freeman and J. LaLonde for their helpful advice in different aspects of our work and/or for reviewing the manuscript. We also thank the stuff members of the Harvard Bauer Core Facility, the Harvard Center for Biological Imaging and the Harvard Stem Cell and Regenerative Biology Histology Core for their technical advice and assistance. The work was supported by Ono Pharmaceutical Co., Ltd (L.L.R.), the Stanley Center for Psychiatric Research and the Klarman Cell Observatory (J.Z.L). The funders had no role in the study design, experiments performed, data collection, data analysis and interpretation, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Angelidis I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08831-9; [Anonymous], 2018, NATURE, V562, P367, DOI DOI 10.1038/S41586-018-0590-4; Artegiani B, 2017, CELL REP, V21, P3271, DOI 10.1016/j.celrep.2017.11.050; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boisvert MM, 2018, CELL REP, V22, P269, DOI 10.1016/j.celrep.2017.12.039; Buchwalter A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00322-z; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Campbell JN, 2017, NAT NEUROSCI, V20, P484, DOI 10.1038/nn.4495; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; Davie K, 2018, CELL, V174, P982, DOI 10.1016/j.cell.2018.05.057; de Magalhaes JP, 2012, FASEB J, V26, P4821, DOI 10.1096/fj.12-210872; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Derr A, 2016, GENOME RES, V26, P1397, DOI 10.1101/gr.207902.116; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dulken B, 2019, NATURE, V571, P205, DOI 10.1038/s41586-019-1362-5; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Enge M, 2017, CELL, V171, P321, DOI 10.1016/j.cell.2017.09.004; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Frenk S, 2018, BIOGERONTOLOGY, V19, P547, DOI 10.1007/s10522-018-9750-z; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Gonskikh Y, 2017, MECH AGEING DEV, V168, P30, DOI 10.1016/j.mad.2017.04.003; Gupta I, 2018, NAT BIOTECHNOL, V36, P1197, DOI 10.1038/nbt.4259; Habib N, 2017, NAT METHODS, V14, P955, DOI [10.1038/NMETH.4407, 10.1038/nmeth.4407]; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Hochgerner H, 2018, NAT NEUROSCI, V21, P290, DOI 10.1038/s41593-017-0056-2; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Hrvatin S, 2018, NAT NEUROSCI, V21, P120, DOI 10.1038/s41593-017-0029-5; Kalamakis G, 2019, CELL, V176, P1407, DOI 10.1016/j.cell.2019.01.040; Kantzer CG, 2017, GLIA, V65, P990, DOI 10.1002/glia.23140; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kirouac DC, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.71; Kowalczyk MS, 2015, GENOME RES, V25, P1860, DOI 10.1101/gr.192237.115; Kucera Mike, 2016, F1000Res, V5, P1717; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Leeman DS, 2018, SCIENCE, V359, P1277, DOI 10.1126/science.aag3048; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MZ, 2012, TRENDS NEUROSCI, V35, P619, DOI 10.1016/j.tins.2012.06.003; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llorens-Bobadilla E, 2015, CELL STEM CELL, V17, P329, DOI 10.1016/j.stem.2015.07.002; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; Martinez-Jimenez CP, 2017, SCIENCE, V355, P1433, DOI 10.1126/science.aah4115; Mathews PM, 2016, AGEING RES REV, V32, P38, DOI 10.1016/j.arr.2016.06.003; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; Mattson MP, 2018, CELL METAB, V27, P1176, DOI 10.1016/j.cmet.2018.05.011; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Olah M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02926-5; Peters MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9570; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Rodriques SG, 2019, SCIENCE, V363, P1463, DOI 10.1126/science.aaw1219; Romanov RA, 2017, NAT NEUROSCI, V20, P176, DOI 10.1038/nn.4462; Rosenberg AB, 2018, SCIENCE, V360, P176, DOI 10.1126/science.aam8999; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Saxena A, 2012, BIOTECHNIQUES, V52, P381, DOI 10.2144/0000113878; Shah PT, 2018, CELL, V173, P1045, DOI 10.1016/j.cell.2018.03.063; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; Soreq L, 2017, CELL REP, V18, P557, DOI 10.1016/j.celrep.2016.12.011; Soumillon M., 2014, CHARACTERIZATION DIR, DOI [10.1101/003236v1, DOI 10.1101/003236V1]; Spitzer SO, 2019, NEURON, V101, P459, DOI 10.1016/j.neuron.2018.12.020; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Steffen KK, 2016, CELL METAB, V23, P1004, DOI 10.1016/j.cmet.2016.05.013; Straub AC, 2012, NATURE, V491, P473, DOI 10.1038/nature11626; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Tepe B, 2018, CELL REP, V25, P2689, DOI 10.1016/j.celrep.2018.11.034; Ubink R, 2000, J COMP NEUROL, V423, P13, DOI 10.1002/1096-9861(20000717)423:1<13::AID-CNE2>3.0.CO;2-P; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Walter J, 2011, NEUROBIOL AGING, V32, P1906, DOI 10.1016/j.neurobiolaging.2009.11.011; Warren LA, 2007, AGING CELL, V6, P775, DOI 10.1111/j.1474-9726.2007.00337.x; Wu YE, 2017, NEURON, V96, P313, DOI 10.1016/j.neuron.2017.09.026; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411; Xu C, 2015, BIOINFORMATICS, V31, P1974, DOI 10.1093/bioinformatics/btv088; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhang XM, 2017, J CELL BIOL, V216, P2151, DOI 10.1083/jcb.201702099; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zywitza V, 2018, CELL REP, V25, P2457, DOI 10.1016/j.celrep.2018.11.003	102	172	177	10	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2019	22	10					1696	+		10.1038/s41593-019-0491-3	http://dx.doi.org/10.1038/s41593-019-0491-3			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JI3VE	31551601	Green Submitted, Green Published			2022-12-17	WOS:000493396200020
J	Paz, JT; Huguenard, JR				Paz, Jeanne T.; Huguenard, John R.			Microcircuits and their interactions in epilepsy: is the focus out of focus?	NATURE NEUROSCIENCE			English	Review							TEMPORAL-LOBE EPILEPSY; ACTIVITY-DEPENDENT DISINHIBITION; THALAMOCORTICAL FEEDFORWARD INHIBITION; HIPPOCAMPAL PYRAMIDAL CELLS; THALAMIC RETICULAR NUCLEUS; LATERAL GENICULATE-NUCLEUS; EXCITATORY SYNAPTIC INPUT; FAST-SPIKING INTERNEURONS; CAT VISUAL-CORTEX; ABSENCE SEIZURES	Epileptic seizures represent dysfunctional neural networks dominated by excessive and/or hypersynchronous activity. Recent progress in the field has outlined two concepts regarding mechanisms of seizure generation, or ictogenesis. First, all seizures, even those associated with what have historically been thought of as 'primary generalized' epilepsies, appear to originate in local microcircuits and then propagate from that initial ictogenic zone. Second, seizures propagate through cerebral networks and engage microcircuits in distal nodes, a process that can be weakened or even interrupted by suppressing activity in such nodes. We describe various microcircuit motifs, with a special emphasis on one that has been broadly implicated in several epilepsies: feed-forward inhibition. Furthermore, we discuss how, in the dynamic network in which seizures propagate, focusing on circuit 'choke points' remote from the initiation site might be as important as that of the initial dysfunction, the seizure 'focus'.	[Paz, Jeanne T.] Gladstone Inst, San Francisco, CA USA; [Paz, Jeanne T.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Huguenard, John R.] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Stanford University	Huguenard, JR (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA.	jeanne.paz@gladsone.ucsf.edu; john.huguenard@stanford.edu	Huguenard, John/I-5016-2012; Huguenard, John/K-6429-2019	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191	US National Institutes of Health; Citizens United Against Epilepsy; National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034774, R01NS090911] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Citizens United Against Epilepsy; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank C. Makinson for critical comments. This work is supported by the US National Institutes of Health and the National Institute of Neurological Disorders and Stroke, and Citizens United Against Epilepsy.	Andolina IM, 2013, J NEUROPHYSIOL, V109, P889, DOI 10.1152/jn.00194.2012; Ang CW, 2006, J NEUROSCI, V26, P11850, DOI 10.1523/JNEUROSCI.2354-06.2006; Avoli M, 2012, EPILEPSIA, V53, P779, DOI 10.1111/j.1528-1167.2012.03421.x; Bacci A, 2003, J NEUROSCI, V23, P859; Bagnall MW, 2011, NEURON, V71, P180, DOI 10.1016/j.neuron.2011.05.032; BEKENSTEIN JW, 1993, SCIENCE, V259, P97, DOI 10.1126/science.8093417; Beyer B, 2008, HUM MOL GENET, V17, P1738, DOI 10.1093/hmg/ddn064; Brill J, 2010, CEREB CORTEX, V20, P2926, DOI 10.1093/cercor/bhq040; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Cammarota M, 2013, J PHYSIOL-LONDON, V591, P807, DOI 10.1113/jphysiol.2012.238154; Caputi A, 2013, CURR OPIN NEUROBIOL, V23, P179, DOI 10.1016/j.conb.2013.01.021; CHEUNG H, 1992, EPILEPSY RES, V13, P107; Clasadonte J., 2012, JASPERS BASIC MECH E; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Danober L, 1998, PROG NEUROBIOL, V55, P27, DOI 10.1016/S0301-0082(97)00091-9; Deleuze C, 2006, J NEUROSCI, V26, P8633, DOI 10.1523/JNEUROSCI.2333-06.2006; DICHTER M, 1969, J NEUROPHYSIOL, V32, P649, DOI 10.1152/jn.1969.32.5.649; Dinocourt C, 2003, J COMP NEUROL, V459, P407, DOI 10.1002/cne.10622; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; DU F, 1995, J NEUROSCI, V15, P6301; Dutton SB, 2013, NEUROBIOL DIS, V49, P211, DOI 10.1016/j.nbd.2012.08.012; Ewell LA, 2010, J NEUROSCI, V30, P12597, DOI 10.1523/JNEUROSCI.1854-10.2010; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Golshani P, 2001, P NATL ACAD SCI USA, V98, P4172, DOI 10.1073/pnas.061013698; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grasse DW, 2013, EXP NEUROL, V248, P72, DOI 10.1016/j.expneurol.2013.05.004; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007; HUGUENARD JR, 1994, J NEUROPHYSIOL, V71, P2576, DOI 10.1152/jn.1994.71.6.2576; Huntsman MM, 1999, SCIENCE, V283, P541, DOI 10.1126/science.283.5401.541; Inoue T, 2006, J NEUROPHYSIOL, V96, P1746, DOI 10.1152/jn.00301.2006; JACOBSON S, 1974, BRAIN RES, V74, P149, DOI 10.1016/0006-8993(74)90118-8; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Jones E. G., 2007, THALAMUS, V2; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Krook-Magnuson E, 2014, ENEURO, V1, DOI 10.1523/ENEURO.0005-14.2014; Krook-Magnuson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2376; Lacey CJ, 2012, J NEUROSCI, V32, P11067, DOI 10.1523/JNEUROSCI.5604-11.2012; LADAROLA MJ, 1982, SCIENCE, V218, P1237; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; Leao RN, 2012, NAT NEUROSCI, V15, P1524, DOI 10.1038/nn.3235; Lee SH, 2014, NEURON, V82, P1129, DOI 10.1016/j.neuron.2014.03.034; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; Maheshwari A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00156; MCCARREN M, 1985, J NEUROPHYSIOL, V53, P557, DOI 10.1152/jn.1985.53.2.557; Molnar G, 2008, PLOS BIOL, V6, P1842, DOI 10.1371/journal.pbio.0060222; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Paz JT, 2011, NAT NEUROSCI, V14, P1167, DOI 10.1038/nn.2896; Paz JT, 2007, J NEUROSCI, V27, P929, DOI 10.1523/JNEUROSCI.4677-06.2007; Peng ZC, 2013, J NEUROSCI, V33, P14392, DOI 10.1523/JNEUROSCI.2045-13.2013; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Polack PO, 2007, J NEUROSCI, V27, P6590, DOI 10.1523/JNEUROSCI.0753-07.2007; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Pothmann L, 2014, J NEUROSCI, V34, P9720, DOI 10.1523/JNEUROSCI.2395-13.2014; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; PRINCE DA, 1967, ARCH NEUROL-CHICAGO, V16, P194, DOI 10.1001/archneur.1967.00470200082007; Rossignol E, 2013, ANN NEUROL, V74, P209, DOI 10.1002/ana.23913; Sah N, 2013, EUR J NEUROSCI, V38, P2542, DOI 10.1111/ejn.12262; Sasaki S, 2006, J NEUROSCI, V26, P3056, DOI 10.1523/JNEUROSCI.5422-05.2006; Schevon CA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2056; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Skardoutsou A, 2003, SEIZURE-EUR J EPILEP, V12, P599, DOI 10.1016/S1059-1311(03)00102-X; Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106; Sohal VS, 2006, J NEUROSCI, V26, P4247, DOI 10.1523/JNEUROSCI.3812-05.2006; Sohal VS, 2003, J NEUROSCI, V23, P8978; Sohal VS, 2003, J NEUROSCI, V23, P3649; SOMOGYI P, 1983, NEUROSCIENCE, V10, P261, DOI 10.1016/0306-4522(83)90133-1; Sun Qian-Quan, 2005, Thalamus & Related Systems, V3, P261, DOI 10.1017/S1472928807000283; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Swadlow HA, 2002, NAT NEUROSCI, V5, P403, DOI 10.1038/nn847; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Tai C, 2014, P NATL ACAD SCI USA, V111, pE3139, DOI 10.1073/pnas.1411131111; Tamas G, 1997, J NEUROSCI, V17, P6352; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P524, DOI 10.1152/jn.1989.61.3.524; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P501, DOI 10.1152/jn.1989.61.3.501; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; Vercueil L, 1998, EPILEPSY RES, V31, P39, DOI 10.1016/S0920-1211(98)00011-4; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vigeland LE, 2013, J NEUROSCI, V33, P1887, DOI 10.1523/JNEUROSCI.4046-12.2013; Walker J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031415; Wang Y, 2014, EXP NEUROL, V251, P101, DOI 10.1016/j.expneurol.2013.11.014; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; WILLOW M, 1985, MOL PHARMACOL, V27, P549; WILSON DH, 1975, NEUROLOGY, V25, P1149, DOI 10.1212/WNL.25.12.1149; Woodruff AR, 2011, J NEUROSCI, V31, P17872, DOI 10.1523/JNEUROSCI.3894-11.2011; Wuarin JP, 2001, J NEUROPHYSIOL, V85, P1067, DOI 10.1152/jn.2001.85.3.1067; Xiang ZX, 2002, J NEUROPHYSIOL, V88, P740, DOI 10.1152/jn.2002.88.2.740; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; YAARI Y, 1986, ANN NEUROL, V20, P171, DOI 10.1002/ana.410200202; Yamakawa K, 2011, EPILEPSIA, V52, P70, DOI 10.1111/j.1528-1167.2011.03006.x; Zhang SLJ, 1997, J NEUROPHYSIOL, V78, P2280, DOI 10.1152/jn.1997.78.5.2280; Zhang W, 2012, J NEUROSCI, V32, P1183, DOI 10.1523/JNEUROSCI.5342-11.2012; Zhu YH, 2004, J NEUROSCI, V24, P5101, DOI 10.1523/JNEUROSCI.0544-04.2004	108	172	178	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2015	18	3					351	359		10.1038/nn.3950	http://dx.doi.org/10.1038/nn.3950			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC2SO	25710837	Green Accepted			2022-12-17	WOS:000350195100012
J	Anaclet, C; Ferrari, L; Arrigoni, E; Bass, CE; Saper, CB; Lu, J; Fuller, PM				Anaclet, Christelle; Ferrari, Loris; Arrigoni, Elda; Bass, Caroline E.; Saper, Clifford B.; Lu, Jun; Fuller, Patrick M.			The GABAergic parafacial zone is a medullary slow wave sleep-promoting center	NATURE NEUROSCIENCE			English	Article							VENTROLATERAL PREOPTIC NUCLEUS; TRACTUS-SOLITARIUS; RAT; NEURONS; WAKEFULNESS; SYSTEMS; EEG; INNERVATION; HOMEOSTASIS; MODULATION	Work in animals and humans has suggested the existence of a slow wave sleep (SWS)-promoting/electroencephalogram (EEG)-synchronizing center in the mammalian lower brainstem. Although sleep-active GABAergic neurons in the medullary parafacial zone (PZ) are needed for normal SWS, it remains unclear whether these neurons can initiate and maintain SWS or EEG slow-wave activity (SWA) in behaving mice. We used genetically targeted activation and optogenetically based mapping to examine the downstream circuitry engaged by SWS-promoting PZ neurons, and we found that this circuit uniquely and potently initiated SWS and EEG SWA, regardless of the time of day. PZ neurons monosynaptically innervated and released synaptic GABA onto parabrachial neurons, which in turn projected to and released synaptic glutamate onto cortically projecting neurons of the magnocellular basal forebrain; thus, there is a circuit substrate through which GABAergic PZ neurons can potently trigger SWS and modulate the cortical EEG.	[Anaclet, Christelle; Ferrari, Loris; Arrigoni, Elda; Saper, Clifford B.; Lu, Jun; Fuller, Patrick M.] Harvard Univ, Sch Med, Dept Neurol, Div Sleep Med, Boston, MA 02115 USA; [Anaclet, Christelle; Ferrari, Loris; Arrigoni, Elda; Saper, Clifford B.; Lu, Jun; Fuller, Patrick M.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Bass, Caroline E.] SUNY Buffalo, Dept Pharmacol & Toxicol, Sch Med & Biomed Sci, Buffalo, NY 14260 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lu, J (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Div Sleep Med, Boston, MA 02115 USA.	jlu@bidmc.harvard.edu; pfuller@bidmc.harvard.edu	Saper, Clifford/L-3815-2019	Bass, Caroline/0000-0002-5856-6387; Anaclet, Christelle/0000-0002-0526-8132	US National Institutes of Health [NS073613, NS061863, NS062727, NS061841, NS085477, DA024763, MH103399, HL095491]; G. Harold and Leila Y. Mathers Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH103399, K99MH103399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062727, R01NS073613, R01NS085477, R01NS061841, R01NS061863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA024763] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to Q.H. Ha, M. Ha and S. Keating for superb technical assistance and M. Debruyne for helpful comments. We are also indebted to B. Lowell and L. Vong (Beth Israel Deaconess Medical Center) for supplying us with the breeder pairs for developing our Vgat-IRES-cre and Vglut2-IRES-cre mouse lines. This work was supported by US National Institutes of Health grants NS073613, NS061863, NS062727, NS061841, NS085477, DA024763, MH103399 and HL095491 and by the G. Harold and Leila Y. Mathers Foundation.	AFFANNI J, 1962, SCIENCE, V137, P126, DOI 10.1126/science.137.3524.126; Anaclet C, 2012, J NEUROSCI, V32, P17970, DOI 10.1523/JNEUROSCI.0620-12.2012; BATINI C, 1958, SCIENCE, V128, P30, DOI 10.1126/science.128.3314.30-a; BONVALLET M, 1961, SCIENCE, V133, P1133, DOI 10.1126/science.133.3459.1133; Borbely A. A., 2005, PRINCIPLES PRACTICE, P405; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Chou TC, 2002, J NEUROSCI, V22, P977, DOI 10.1523/JNEUROSCI.22-03-00977.2002; Dang-Vu TT, 2008, P NATL ACAD SCI USA, V105, P15160, DOI 10.1073/pnas.0801819105; FRANKEN P, 1991, NEUROSCI LETT, V130, P141, DOI 10.1016/0304-3940(91)90382-4; Franken P, 1999, SLEEP, V22, P155; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Fuller PM, 2007, J PHYSIOL-LONDON, V584, P735, DOI 10.1113/jphysiol.2007.140160; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; Jones BE, 2004, PROG BRAIN RES, V145, P157, DOI 10.1016/S0079-6123(03)45011-5; Kaur S, 2013, J NEUROSCI, V33, P7627, DOI 10.1523/JNEUROSCI.0173-13.2013; LAGUZZI R, 1984, BRAIN RES, V304, P321, DOI 10.1016/0006-8993(84)90336-6; Lu J, 2000, J NEUROSCI, V20, P3830, DOI 10.1523/JNEUROSCI.20-10-03830.2000; Lu J, 2008, J COMP NEUROL, V508, P648, DOI 10.1002/cne.21685; Magnes J., 1961, ARCH ITAL BIOL, V99, P33; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; NOSJEAN A, 1987, NEUROSCIENCE, V23, P469, DOI 10.1016/0306-4522(87)90070-4; Peyron C, 1998, J NEUROSCI, V18, P9996; Puizillout J.J., 1986, NEUROPHYSIOL CLIN, V16, P95; REINOSOBARBERO F, 1995, ANESTHESIOLOGY, V82, P144, DOI 10.1097/00000542-199501000-00019; SAPER CB, 1984, J COMP NEUROL, V222, P313, DOI 10.1002/cne.902220302; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Schachter SC, 1998, EPILEPSIA, V39, P677, DOI 10.1111/j.1528-1157.1998.tb01151.x; Sherin JE, 1998, J NEUROSCI, V18, P4705; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; TOBLER I, 1986, ELECTROEN CLIN NEURO, V64, P74, DOI 10.1016/0013-4694(86)90044-1; Tobler I., 2005, PRINCIPLES PRACTICE, V4th ed, P77; Vetrivelan R, 2012, SLEEP, V35, P1511, DOI 10.5665/sleep.2200; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Vyazovskiy VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050677	36	172	179	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2014	17	9					1217	1224		10.1038/nn.3789	http://dx.doi.org/10.1038/nn.3789			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO2DJ	25129078	Green Accepted, Green Submitted			2022-12-17	WOS:000341125400015
J	Huynh, JL; Garg, P; Thin, TH; Yoo, S; Dutta, R; Trapp, BD; Haroutunian, V; Zhu, J; Donovan, MJ; Sharp, AJ; Casaccia, P				Huynh, Jimmy L.; Garg, Paras; Thin, Tin Htwe; Yoo, Seungyeul; Dutta, Ranjan; Trapp, Bruce D.; Haroutunian, Vahram; Zhu, Jun; Donovan, Michael J.; Sharp, Andrew J.; Casaccia, Patrizia			Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains	NATURE NEUROSCIENCE			English	Article							APPEARING WHITE-MATTER; MONOZYGOTIC TWINS DISCORDANT; CPG ISLAND SHORES; DNA METHYLATION; CATHEPSIN-X; BCL-W; GENETIC RISK; STEM-CELLS; GENOME; DISEASE	Using the Illumina 450K array and a stringent statistical analysis with age and gender correction, we report genome-wide differences in DNA methylation between pathology-free regions derived from human multiple sclerosis-affected and control brains. Differences were subtle, but widespread and reproducible in an independent validation cohort. The transcriptional consequences of differential DNA methylation were further defined by genome-wide RNA-sequencing analysis and validated in two independent cohorts. Genes regulating oligodendrocyte survival, such as BCL2L2 and NDRG1, were hypermethylated and expressed at lower levels in multiple sclerosis-affected brains than in controls, while genes related to proteolytic processing (for example, LGMN, CTSZ) were hypomethylated and expressed at higher levels. These results were not due to differences in cellular composition between multiple sclerosis and controls. Thus, epigencimic changes in genes affecting oligodendrocyte susceptibility to damage are detected in pathology-free areas of multiple sclerosis-affected brains.	[Huynh, Jimmy L.; Casaccia, Patrizia] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Huynh, Jimmy L.; Garg, Paras; Yoo, Seungyeul; Zhu, Jun; Sharp, Andrew J.; Casaccia, Patrizia] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA; [Thin, Tin Htwe; Donovan, Michael J.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY USA; [Dutta, Ranjan; Trapp, Bruce D.] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA; [Haroutunian, Vahram] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Casaccia, Patrizia] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cleveland Clinic Foundation; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Casaccia, P (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.	patrizia.casaccia@mssm.edu	Yoo, Seungyeul/GOJ-7783-2022	Yoo, Seungyeul/0000-0001-5616-2293	Icahn School of Medicine seed funds; US National Institutes of Health (NIH) NINDS [R01NS052738-06, R37NSO42925-10]; NIH NIMH [R01MH090948-01]; NIH NINDS [R01NS38667]; NIH NIA [PO lAG02219]; VA-MIRECC; NIH Fellowship [F31NS077504-01]; scholarship from the Foundation of the Consortium of Multiple Sclerosis Centers' MS Workforce of the Future; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD073731] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090948, P50MH066392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052738, F31NS077504, R01NS042925, P01NS038667, R37NS042925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG002219, P50AG005138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033660] Funding Source: NIH RePORTER	Icahn School of Medicine seed funds; US National Institutes of Health (NIH) NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); VA-MIRECC; NIH Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); scholarship from the Foundation of the Consortium of Multiple Sclerosis Centers' MS Workforce of the Future; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to all the members of the Casaccia and Sharp laboratory for technical help, to C. Watson for assistance with the CETS analysis, to F. Zhang and W Zhang for advice and assistance with the RNA-seq alignment, to F. Lublin and G. John for critical reading of the manuscript and to P.L. De Jager (Brigham and Women's Hospital), S. Baranzini (University of California at San Francisco) and N. Schaeren-Wiemers (University Hospital, Basel) for discussions. The Work has been funded by Icahn School of Medicine seed funds and grants from the US National Institutes of Health (NIH) NINDS (R01NS052738-06 and R37NSO42925-10) to P.C., from NIH NIDA (R01DA033660) and NIH NHGRI (R01HG006696) to A.J.S., from NIH NIMH (R01MH090948-01) to J.Z., from NIH NINDS (R01NS38667) to B.D.T. and from NIH NIA (PO lAG02219), NIH NIMH (P50MH066392) and VA-MIRECC to V.H. J.L.H. is the recipient of NIH Fellowship F31NS077504-01 and a scholarship from the Foundation of the Consortium of Multiple Sclerosis Centers' MS Workforce of the Future. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. We thank R. Reynolds and the UK Multiple Sclerosis Tissue Bank at Imperial College London (funded by the UK MS Society, grant no.910/09) for the provision of multiple sclerosis tissue samples, as well as the Human Brain and Spinal Fluid Resource Center, Veterans Affairs West Los Angeles Healthcare Center, which is sponsored by NINDS, NIMH, National Multiple Sclerosis Society and Department of Veterans Affairs.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ascherio A, 2012, NAT REV NEUROL, V8, P602, DOI 10.1038/nrneurol.2012.198; Bakulski KM, 2012, J ALZHEIMERS DIS, V29, P571, DOI 10.3233/JAD-2012-111223; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Beck H, 2001, EUR J IMMUNOL, V31, P3726, DOI 10.1002/1521-4141(200112)31:12<3726::AID-IMMU3726>3.0.CO;2-O; Bock C, 2012, NAT REV GENET, V13, P705, DOI 10.1038/nrg3273; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Chapman HA, 1998, CURR OPIN IMMUNOL, V10, P93, DOI 10.1016/S0952-7915(98)80038-1; Cosker KE, 2013, J NEUROSCI, V33, P5195, DOI 10.1523/JNEUROSCI.3862-12.2013; Dempster EL, 2011, HUM MOL GENET, V20, P4786, DOI 10.1093/hmg/ddr416; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Graumann U, 2003, BRAIN PATHOL, V13, P554, DOI 10.1111/j.1750-3639.2003.tb00485.x; Guintivano J, 2013, EPIGENETICS-US, V8, P290, DOI 10.4161/epi.23924; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Hedstrom AK, 2011, MULT SCLER J, V17, P788, DOI 10.1177/1352458511399610; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Hu XL, 2004, EUR J NEUROSCI, V20, P1177, DOI 10.1111/j.1460-9568.2004.03554.x; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jevnikar Z, 2008, J CELL SCI, V121, P2652, DOI 10.1242/jcs.023721; Kos J, 2009, CELL ADHES MIGR, V3, P164, DOI 10.4161/cam.3.2.7403; Lim AL, 2012, J MED GENET, V49, P689, DOI 10.1136/jmedgenet-2012-100858; Lindberg RLP, 2004, J NEUROIMMUNOL, V152, P154, DOI 10.1016/j.jneuroim.2004.03.011; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Mastronardi FG, 2006, J NEUROSCI, V26, P11387, DOI 10.1523/JNEUROSCI.3349-06.2006; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Murphy B, 2007, AM J PATHOL, V171, P1258, DOI 10.2353/ajpath.2007.070269; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Obermajer N, 2008, CONNECT TISSUE RES, V49, P193, DOI 10.1080/03008200802143158; Obermajer N, 2009, INT J BIOCHEM CELL B, V41, P1685, DOI 10.1016/j.biocel.2009.02.019; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Pedre X, 2011, J NEUROSCI, V31, P3435, DOI 10.1523/JNEUROSCI.4507-10.2011; PRINCIPATO GB, 1984, BIOCHEM INT, V9, P351; Ramagopalan SV, 2010, LANCET NEUROL, V9, P727, DOI 10.1016/S1474-4422(10)70094-6; Ratovitski T, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.185348; Ross AJ, 2001, DEV BIOL, V239, P295, DOI 10.1006/dbio.2001.0445; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Santamaria I, 1998, J BIOL CHEM, V273, P16816, DOI 10.1074/jbc.273.27.16816; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sharp AJ, 2011, GENOME RES, V21, P1592, DOI 10.1101/gr.112680.110; Sheffield NC, 2013, GENOME RES, V23, P777, DOI 10.1101/gr.152140.112; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; SWANK RL, 1990, LANCET, V336, P37, DOI 10.1016/0140-6736(90)91533-G; von Geldern G, 2012, NAT REV NEUROL, V8, P678, DOI 10.1038/nrneurol.2012.194; Wendt W, 2007, EXP NEUROL, V204, P525, DOI 10.1016/j.expneurol.2007.01.007; Yao MZ, 2005, J NEUROSCI, V25, P1149, DOI 10.1523/JNEUROSCI.4736-04.2005	50	172	176	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					121	130		10.1038/nn.3588	http://dx.doi.org/10.1038/nn.3588			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24270187	Green Accepted			2022-12-17	WOS:000329080000022
J	Freeman, J; Ziemba, CM; Heeger, DJ; Simoncelli, EP; Movshon, A				Freeman, Jeremy; Ziemba, Corey M.; Heeger, David J.; Simoncelli, Eero P.; Movshon, Anthony			A functional and perceptual signature of the second visual area in primates	NATURE NEUROSCIENCE			English	Article							HUMAN OCCIPITAL CORTEX; NATURAL SCENES; BORDER OWNERSHIP; V2; MOTION; CELLS; REPRESENTATION; SELECTIVITY; STATISTICS; MODELS	There is no generally accepted account of the function of the second visual cortical area (V2), partly because no simple response properties robustly distinguish V2 neurons from those in primary visual cortex (V1). We constructed synthetic stimuli replicating the higher-order statistical dependencies found in natural texture images and used them to stimulate macaque V1 and V2 neurons. Most V2 cells responded more vigorously to these textures than to control stimuli lacking naturalistic structure; V1 cells did not. Functional magnetic resonance imaging (fMRI) measurements in humans revealed differences between V1 and V2 that paralleled the neuronal measurements. The ability of human observers to detect naturalistic structure in different types of texture was well predicted by the strength of neuronal and fMRI responses in V2 but not in V1. Together, these results reveal a particular functional role for V2 in the representation of natural image structure.	[Freeman, Jeremy; Ziemba, Corey M.; Heeger, David J.; Simoncelli, Eero P.; Movshon, Anthony] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Heeger, David J.; Simoncelli, Eero P.; Movshon, Anthony] NYU, Dept Psychol, New York, NY 10003 USA; [Simoncelli, Eero P.] NYU, Howard Hughes Med Inst, New York, NY USA; [Simoncelli, Eero P.] NYU, Courant Inst Math Sci, New York, NY USA	New York University; New York University; Howard Hughes Medical Institute; New York University; New York University	Freeman, J (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	freemanj11@janelia.hhmi.org	Ziemba, Corey/AAE-1531-2022	Ziemba, Corey/0000-0002-6808-2087; Simoncelli, Eero/0000-0002-1206-527X	US National Institutes of Health [EY04440]; Howard Hughes Medical Institute; New York University Center for Brain Imaging; US National Science Foundation Graduate Research Fellowships; NATIONAL EYE INSTITUTE [R01EY022428, R37EY004440, R01EY004440] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); New York University Center for Brain Imaging; US National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to G. Boynton for discussions, to M. Landy for comments on the manuscript, to M. Brotzmang for help programming the Mechanical Turk experiments and to members of the Movshon laboratory for help with physiological experiments. This work was supported by US National Institutes of Health grant EY04440, the Howard Hughes Medical Institute, the New York University Center for Brain Imaging and US National Science Foundation Graduate Research Fellowships to J.F. and C.M.Z.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Adelson EH, 2001, PROC SPIE, V4299, P1, DOI 10.1117/12.429489; Angelucci A, 2002, J NEUROSCI, V22, P8633; Anzai A, 2007, NAT NEUROSCI, V10, P1313, DOI 10.1038/nn1975; Balas B, 2008, PATTERN RECOGN, V41, P972, DOI 10.1016/j.patcog.2007.08.007; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Craft E, 2007, J NEUROPHYSIOL, V97, P4310, DOI 10.1152/jn.00203.2007; Dawid A. P., 1979, APPL STAT, V28, P20, DOI [DOI 10.2307/2346806, 10.2307/2346806]; El-Shamayleh Y, 2011, J NEUROSCI, V31, P8543, DOI 10.1523/JNEUROSCI.5974-10.2011; Fang F, 2009, J NEUROSCI, V29, P460, DOI 10.1523/JNEUROSCI.4628-08.2009; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; Felsen G, 2005, NAT NEUROSCI, V8, P1643, DOI 10.1038/nn1608; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; Gardner JL, 2008, J NEUROSCI, V28, P3988, DOI 10.1523/JNEUROSCI.5476-07.2008; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Glickfeld LL, 2013, NAT NEUROSCI, V16, P219, DOI 10.1038/nn.3300; Gromping U, 2007, AM STAT, V61, P139, DOI 10.1198/000313007X188252; Heeger D.J., 1995, P 22 ANN C COMP GRAP, P229, DOI DOI 10.1145/218380.218446; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Heeger DJ, 1996, P NATL ACAD SCI USA, V93, P623, DOI 10.1073/pnas.93.2.623; Hegde J, 2000, J NEUROSCI, V20, part. no.; Hegde J, 2007, CEREB CORTEX, V17, P1100, DOI 10.1093/cercor/bhl020; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Mahon LE, 2001, VISUAL NEUROSCI, V18, P973, DOI 10.1017/S0952523801186141; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; McDermott JH, 2011, NEURON, V71, P926, DOI 10.1016/j.neuron.2011.06.032; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; PETERHANS E, 1989, J NEUROSCI, V9, P1749; Portilla J, 2000, INT J COMPUT VISION, V40, P49, DOI 10.1023/A:1026553619983; Qiu FTT, 2007, NAT NEUROSCI, V10, P1492, DOI 10.1038/nn1989; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Rust NC, 2005, NAT NEUROSCI, V8, P1647, DOI 10.1038/nn1606; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; SCHILLER PH, 1977, BRAIN RES, V126, P366, DOI 10.1016/0006-8993(77)90734-X; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Simoncelli E.P., 1997, 31 AS C SIGN SYST CO, V1, P673, DOI DOI 10.1109/ACSSC.1997.680530; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Thomas OM, 2002, NAT NEUROSCI, V5, P472, DOI 10.1038/nn837; Thomson MGA, 2000, PERCEPTION, V29, P1057, DOI 10.1068/p2867; Vintch Brett, 2012, Adv Neural Inf Process Syst, V25, P3113; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Willmore BDB, 2010, J NEUROSCI, V30, P2102, DOI 10.1523/JNEUROSCI.4099-09.2010; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	54	172	172	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					974	+		10.1038/nn.3402	http://dx.doi.org/10.1038/nn.3402			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23685719	Green Accepted			2022-12-17	WOS:000321180900033
J	Klockener, T; Hess, S; Belgardt, BF; Paeger, L; Verhagen, LAW; Husch, A; Sohn, JW; Hampel, B; Dhillon, H; Zigman, JM; Lowell, BB; Williams, KW; Elmquist, JK; Horvath, TL; Kloppenburg, P; Bruning, JC				Kloeckener, Tim; Hess, Simon; Belgardt, Bengt F.; Paeger, Lars; Verhagen, Linda A. W.; Husch, Andreas; Sohn, Jong-Woo; Hampel, Brigitte; Dhillon, Harveen; Zigman, Jeffrey M.; Lowell, Bradford B.; Williams, Kevin W.; Elmquist, Joel K.; Horvath, Tamas L.; Kloppenburg, Peter; Bruening, Jens C.			High-fat feeding promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neurons	NATURE NEUROSCIENCE			English	Article							VENTROMEDIAL HYPOTHALAMIC NUCLEUS; STEROIDOGENIC FACTOR-I; PROOPIOMELANOCORTIN NEURONS; BODY-WEIGHT; EXPRESSING NEURONS; ARCUATE NUCLEUS; POMC NEURONS; FOOD-INTAKE; GLUCOSE; LEPTIN	Steroidogenic factor 1 (SF-1)-expressing neurons of the ventromedial hypothalamus (VMH) control energy homeostasis, but the role of insulin action in these cells remains undefined. We show that insulin activates phosphatidylinositol-3-OH kinase (PI3K) signaling in SF-1 neurons and reduces firing frequency in these cells through activation of K-ATP channels. These effects were abrogated in mice with insulin receptor deficiency restricted to SF-1 neurons (SF-1(Delta IR) mice). Whereas body weight and glucose homeostasis remained the same in SF-1(Delta IR) mice as in controls under a normal chow diet, they were protected from diet-induced leptin resistance, weight gain, adiposity and impaired glucose tolerance. High-fat feeding activated PI3K signaling in SF-1 neurons of control mice, and this response was attenuated in the VMH of SF-1(Delta IR) mice. Mimicking diet-induced overactivation of PI3K signaling by disruption of the phosphatidylinositol-3,4,5-trisphosphate phosphatase PTEN led to increased body weight and hyperphagia under a normal chow diet. Collectively, our experiments reveal that high-fat diet-induced, insulin-dependent PI3K activation in VMH neurons contributes to obesity development.	[Kloeckener, Tim; Belgardt, Bengt F.; Verhagen, Linda A. W.; Hampel, Brigitte; Bruening, Jens C.] Univ Cologne, Inst Genet, Dept Mouse Genet & Metab, D-5000 Cologne, Germany; [Kloeckener, Tim; Belgardt, Bengt F.; Verhagen, Linda A. W.; Hampel, Brigitte; Bruening, Jens C.] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, Cologne, Germany; [Kloeckener, Tim; Hess, Simon; Belgardt, Bengt F.; Paeger, Lars; Verhagen, Linda A. W.; Husch, Andreas; Hampel, Brigitte; Kloppenburg, Peter; Bruening, Jens C.] Univ Cologne, CMMC, Cologne, Germany; [Kloeckener, Tim; Hess, Simon; Belgardt, Bengt F.; Paeger, Lars; Verhagen, Linda A. W.; Husch, Andreas; Hampel, Brigitte; Kloppenburg, Peter; Bruening, Jens C.] Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Kloeckener, Tim; Belgardt, Bengt F.; Verhagen, Linda A. W.; Hampel, Brigitte; Bruening, Jens C.] Max Planck Inst Neurol Res, Cologne, Germany; [Hess, Simon; Paeger, Lars; Husch, Andreas; Kloppenburg, Peter] Univ Cologne, Inst Zool, Bioctr, D-5000 Cologne, Germany; [Sohn, Jong-Woo; Zigman, Jeffrey M.; Williams, Kevin W.; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Ctr Hypothalam Res, Dallas, TX 75390 USA; [Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Dhillon, Harveen; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Ctr Life Sci, Boston, MA 02215 USA; [Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA	University of Cologne; University of Cologne; University of Cologne; University of Cologne; Max Planck Society; University of Cologne; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Beth Israel Deaconess Medical Center; Yale University	Bruning, JC (corresponding author), Univ Cologne, Inst Genet, Dept Mouse Genet & Metab, Weyertal 121, D-5000 Cologne, Germany.	jens.bruening@uni-koeln.de	Williams, Kevin W/AAA-4243-2020; Sohn, Jong Woo/D-6700-2014; Williams, Kevin W/ABD-5818-2021	Williams, Kevin W/0000-0002-8434-8658; Williams, Kevin W/0000-0002-8434-8658; Zigman, Jeffrey/0000-0003-3477-1295; Paeger, Lars/0000-0001-8716-3483; Belgardt, Bengt-Frederik/0000-0003-4537-9002	Federal Ministry of Education and Research [KL 762/2-2, FP7-HEALTH-2009-241592, FP7-KBBE-2010-4-266408, FKZ 01GI0845]; Deutsche Forschungsgemeinschaft [Br. 1492/7-1]; US National Institute of Health [R01DK53301, RL1DK081185, K01DK087780, R01 DK071051, P30 DK046200, P30 DK057521, OD006850, DK080000, PL1 DK081182, UL1RR024923, K08 DK068069-01A2]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [PL1DK081182, P30DK057521, RL1DK081185, K01DK087780, R01DK071051, P30DK046200, R01DK080000, R01DK053301, K08DK068069] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006850] Funding Source: NIH RePORTER	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Schmall and T. Rayle for secretarial assistance and S. Irlenbusch and H. Wratil for technical assistance. We thank M. Low (Oregon Health & Science University) for providing POMC<SUP>GFP</SUP> mice. Recombinant mouse leptin was obtained from A. F. Parlow, the National Hormone and Peptide Program (NHPP), National Institute of Diabetes and Digestive and Kidney Diseases. This work was supported by grants from the Deutsche Forschungsgemeinschaft (KL 762/2-2 to P. K.); Cologne Center for Molecular Medicine (CMMC); under FP7-HEALTH-2009-241592 (European Union) EurOCHIP; under FP7-KBBE-2010-4-266408 (European Union) Full4Health and through the Kompetenznetz Adipositas (Competence Network for Adipositas) funded by the Federal Ministry of Education and Research (FKZ 01GI0845) to J.C.B.; and also through funds from the Deutsche Forschungsgemeinschaft (Br. 1492/7-1 to J.C.B.). This work was supported by US National Institute of Health grants R01DK53301 and RL1DK081185 (to J.K.E.); K01DK087780 (to K. W. W.); R01 DK071051, P30 DK046200 and P30 DK057521 (to B. B. L.); OD006850 and DK080000 (to T. L. H.); and PL1 DK081182, UL1RR024923 and K08 DK068069-01A2 (to J.M.Z.).	AKAIKE N, 1994, JPN J PHYSIOL, V44, P433, DOI 10.2170/jjphysiol.44.433; Asnicar MA, 2001, ENDOCRINOLOGY, V142, P4394, DOI 10.1210/en.142.10.4394; Belgardt BF, 2008, CELL METAB, V7, P291, DOI 10.1016/j.cmet.2008.01.006; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Bingham NC, 2008, ENDOCRINOLOGY, V149, P2138, DOI 10.1210/en.2007-1200; Brown LM, 2006, PHYSIOL BEHAV, V89, P687, DOI 10.1016/j.physbeh.2006.08.008; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Choudhury AI, 2005, J CLIN INVEST, V115, P940; CLARK JT, 1987, REGUL PEPTIDES, V17, P31, DOI 10.1016/0167-0115(87)90030-9; Cotero VE, 2009, AM J PHYSIOL-ENDOC M, V296, pE1101, DOI 10.1152/ajpendo.90932.2008; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Davidowa H, 2001, NEUROREPORT, V12, P3201, DOI 10.1097/00001756-200110290-00012; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Gelling RW, 2006, CELL METAB, V3, P67, DOI 10.1016/j.cmet.2005.11.013; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Hallschmid M, 2004, DIABETES, V53, P3024, DOI 10.2337/diabetes.53.11.3024; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; Janoschek R, 2006, P NATL ACAD SCI USA, V103, P10707, DOI 10.1073/pnas.0600425103; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Kloppenburg P, 2007, J NEUROPHYSIOL, V98, P2910, DOI 10.1152/jn.00660.2007; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Li G, 2003, DIABETES, V52, P1951, DOI 10.2337/diabetes.52.8.1951; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; MAYER J, 1956, NATURE, V178, P1399, DOI 10.1038/1781399a0; McMinn JE, 2000, AM J PHYSIOL-REG I, V279, pR695, DOI 10.1152/ajpregu.2000.279.2.R695; Mullier A, 2010, J COMP NEUROL, V518, P943, DOI 10.1002/cne.22273; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Plum L, 2007, CELL METAB, V6, P431, DOI 10.1016/j.cmet.2007.10.012; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Plum L, 2009, NAT MED, V15, P1195, DOI 10.1038/nm.2026; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; SHINODA K, 1995, DEV DYNAM, V204, P22, DOI 10.1002/aja.1002040104; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Xu Y, 2010, CELL METAB, V12, P88, DOI 10.1016/j.cmet.2010.05.002; Ye JH, 2006, J NEUROSCI METH, V158, P251, DOI 10.1016/j.jneumeth.2006.06.006	50	172	175	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					911	U139		10.1038/nn.2847	http://dx.doi.org/10.1038/nn.2847			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21642975	Green Accepted			2022-12-17	WOS:000292081700020
J	Wu, XS; McNeil, BD; Xu, JH; Fan, JM; Xue, L; Melicoff, E; Adachi, R; Bai, L; Wu, LG				Wu, Xin-Sheng; McNeil, Benjamin D.; Xu, Jianhua; Fan, Junmei; Xue, Lei; Melicoff, Ernestina; Adachi, Roberto; Bai, Li; Wu, Ling-Gang			Ca2+ and calmodulin initiate all forms of endocytosis during depolarization at a nerve terminal	NATURE NEUROSCIENCE			English	Article							ADRENAL CHROMAFFIN CELLS; RETINAL BIPOLAR CELLS; CLATHRIN-MEDIATED ENDOCYTOSIS; FROG NEUROMUSCULAR-JUNCTION; SYNAPTIC VESICLE EXOCYTOSIS; READILY RELEASABLE POOL; FAST CNS SYNAPSE; HIPPOCAMPAL SYNAPSES; RAPID ENDOCYTOSIS; PHYSIOLOGICAL TEMPERATURES	Although endocytosis maintains synaptic transmission, how endocytosis is initiated is unclear. We found that calcium influx initiated all forms of endocytosis at a single nerve terminal in rodents, including clathrin-dependent slow endocytosis, bulk endocytosis, rapid endocytosis and endocytosis overshoot (excess endocytosis), with each being evoked with a correspondingly higher calcium threshold. As calcium influx increased, endocytosis gradually switched from very slow endocytosis to slow endocytosis to bulk endocytosis to rapid endocytosis and to endocytosis overshoot. The calcium-induced endocytosis rate increase was a result of the speeding up of membrane invagination and fission. Pharmacological experiments suggested that the calcium sensor mediating these forms of endocytosis is calmodulin. In addition to its role in recycling vesicles, calcium/calmodulin-initiated endocytosis facilitated vesicle mobilization to the readily releasable pool, probably by clearing fused vesicle membrane at release sites. Our findings provide a unifying mechanism for the initiation of various forms of endocytosis that are critical in maintaining exocytosis.	[Wu, Xin-Sheng; McNeil, Benjamin D.; Xu, Jianhua; Fan, Junmei; Xue, Lei; Bai, Li; Wu, Ling-Gang] Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20824 USA; [Melicoff, Ernestina; Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Texas System; UTMD Anderson Cancer Center	Wu, LG (corresponding author), Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20824 USA.	wul@ninds.nih.gov	fan, junmei/D-6147-2011	McNeil, Benjamin/0000-0001-7545-3598; Adachi, Roberto/0000-0002-0146-0768; Melicoff, Ernestina/0000-0001-5696-7112; Xu, Jianhua/0000-0003-0084-8856	National Institute of Neurological Disorders; US National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003009, ZIANS003105] Funding Source: NIH RePORTER	National Institute of Neurological Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke Intramural Research Program of the US National Institutes of Health.	Artalejo CR, 1996, NEURON, V16, P195, DOI 10.1016/S0896-6273(00)80036-7; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; Balaji J, 2008, J NEUROSCI, V28, P6742, DOI 10.1523/JNEUROSCI.1082-08.2008; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; Clayton EL, 2007, J PHYSIOL-LONDON, V585, P687, DOI 10.1113/jphysiol.2007.137539; Cousin MA, 1998, NEUROSCI LETT, V253, P1, DOI 10.1016/S0304-3940(98)00610-7; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; HENKEL AW, 1995, NEUROPHARMACOLOGY, V34, P1397, DOI 10.1016/0028-3908(95)00126-Q; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; Kopp-Scheinpflug C, 2008, NEUROSCIENCE, V154, P160, DOI 10.1016/j.neuroscience.2008.01.088; Kushmerick C, 2006, J NEUROSCI, V26, P1366, DOI 10.1523/JNEUROSCI.3889-05.2006; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Nicholson-Tomishima K, 2004, P NATL ACAD SCI USA, V101, P16648, DOI 10.1073/pnas.0406968101; Nucifora PGP, 1998, J PHYSIOL-LONDON, V508, P483, DOI 10.1111/j.1469-7793.1998.483bq.x; Poskanzer KE, 2006, NEURON, V50, P49, DOI 10.1016/j.neuron.2006.02.021; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Renden R, 2007, J NEUROPHYSIOL, V98, P3349, DOI 10.1152/jn.00898.2007; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Satzler K, 2002, J NEUROSCI, V22, P10567; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007; Wu W, 2005, J NEUROSCI, V25, P11676, DOI 10.1523/JNEUROSCI.2972-05.2005; Wu W, 2007, P NATL ACAD SCI USA, V104, P10234, DOI 10.1073/pnas.0611512104; Wu XS, 2007, J NEUROSCI, V27, P3046, DOI 10.1523/JNEUROSCI.4415-06.2007; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631	50	172	175	4	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1003	U70		10.1038/nn.2355	http://dx.doi.org/10.1038/nn.2355			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19633667	Green Accepted			2022-12-17	WOS:000268396300014
J	Naka, H; Nakamura, S; Shimazaki, T; Okano, H				Naka, Hayato; Nakamura, Shiho; Shimazaki, Takuya; Okano, Hideyuki			Requirement for COUP-TFI and II in the temporal specification of neural stem cells in CNS development	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROMOTER-TRANSCRIPTION FACTORS; DEVELOPING SPINAL-CORD; ASTROCYTE DIFFERENTIATION; DROSOPHILA NEUROBLASTS; GANGLIONIC EMINENCE; NUCLEAR RECEPTORS; PROGENITOR CELLS; FETAL-BRAIN; FATE	In the developing CNS, subtypes of neurons and glial cells are generated according to a schedule that is defined by cell-intrinsic mechanisms that function at the progenitor-cell level. However, no critical molecular switch for the temporal specification of CNS progenitor cells has been identified. We found that chicken ovalbumin upstream promoter-transcription factor I and II (Coup-tfI and Coup-tfII, also known as Nr2f1 and Nr2f2) are required for the temporal specification of neural stem/progenitor cells (NSPCs), including their acquisition of gliogenic competence, as demonstrated by their responsiveness to gliogenic cytokines. COUP-TFI and II are transiently co-expressed in the ventricular zone of the early embryonic CNS. The double knockdown of Coup-tfI/II in embryonic stem cell (ESC)-derived NSPCs and the developing mouse forebrain caused sustained neurogenesis and the prolonged generation of early-born neurons. These findings reveal a part of the timer mechanisms for generating diverse types of neurons and glial cells during CNS development.	[Naka, Hayato; Nakamura, Shiho; Shimazaki, Takuya; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; [Naka, Hayato; Nakamura, Shiho; Shimazaki, Takuya; Okano, Hideyuki] Japan Sci & Technol Agcy, Core Res Evolut Sci Technol, Solut Oriented Res Sci & Technol, Saitama 3320012, Japan	Keio University; Japan Science & Technology Agency (JST)	Okano, H (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	shimazak@sc.itc.keio.ac.jp; hidokano@sc.itc.keio.ac.jp	Okano, Hideyuki/I-7584-2019; Shimazaki, Takuya/L-1159-2013	Shimazaki, Takuya/0000-0002-3936-2098	Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan; 21st Century Center Of Excellence program of MEXT to Keio University; Japan Society for the Promotion of Science Fellows	Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 21st Century Center Of Excellence program of MEXT to Keio University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to H. Miyoshi (Riken BioResource Center) for the lentivirus constructs, R. F. Hevner (University of Washington) for the antibody to Tbr1, S. Mitani (Tokyo Women's Medical University) for the antibody to GFP (mFX73) and K. Shimamura (Kumamoto University) for the Vp16 and Drosophila engrailed constructs. We also thank the members of the Okano laboratory for discussion, technical advice and/or critical reading of the manuscript. This study was supported by Core Research for Evolutional Science Technology/Solution-Oriented Research for Science and Technology-Japan Science and Technology Agency (H. O.), grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan (T. S. and H. O.), a grant-in-aid from the 21st Century Center Of Excellence program of MEXT to Keio University, a Keio University grant-in-aid for encouragement of young medical scientists (H. N.), and a grant-in-aid for Japan Society for the Promotion of Science Fellows (H. N.).	Armentano M, 2007, NAT NEUROSCI, V10, P1277, DOI 10.1038/nn1958; Armentano M, 2006, DEVELOPMENT, V133, P4151, DOI 10.1242/dev.02600; Bailey P, 1998, NUCLEIC ACIDS RES, V26, P5501, DOI 10.1093/nar/26.23.5501; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011; Gauthier AS, 2007, NEURON, V54, P245, DOI 10.1016/j.neuron.2007.03.027; Ge WH, 2002, J NEUROSCI RES, V69, P848, DOI 10.1002/jnr.10364; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jacob J, 2007, NAT NEUROSCI, V10, P1433, DOI 10.1038/nn1985; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jiang X, 2004, J BIOL CHEM, V279, P38480, DOI 10.1074/jbc.M403948200; Kanai MI, 2005, DEV CELL, V8, P203, DOI 10.1016/j.devcel.2004.12.014; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Olsson M, 1998, NEUROSCIENCE, V84, P867, DOI 10.1016/S0306-4522(97)00532-0; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; QIU YH, 1994, P NATL ACAD SCI USA, V91, P4451, DOI 10.1073/pnas.91.10.4451; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Stenman J, 2003, J NEUROSCI, V23, P167; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Tripodi M, 2004, DEVELOPMENT, V131, P6119, DOI 10.1242/dev.01530; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Udolph G, 2001, DEVELOPMENT, V128, P1457; Wang HF, 2001, NEUROSCIENCE, V103, P999, DOI 10.1016/S0306-4522(00)00590-X	49	172	176	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2008	11	9					1014	1023		10.1038/nn.2168	http://dx.doi.org/10.1038/nn.2168			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	341NA	19160499				2022-12-17	WOS:000258720000011
J	Lee, D				Lee, Daeyeol			Game theory and neural basis of social decision making	NATURE NEUROSCIENCE			English	Review							DOPAMINE NEURONS ENCODE; ANTERIOR CINGULATE; PREFRONTAL CORTEX; EXPECTED REWARD; SIGNALS; REPRESENTATION; COOPERATION; EVOLUTION; ULTIMATUM; RESPONSES	Decision making in a social group has two distinguishing features. First, humans and other animals routinely alter their behavior in response to changes in their physical and social environment. As a result, the outcomes of decisions that depend on the behavior of multiple decision makers are difficult to predict and require highly adaptive decision-making strategies. Second, decision makers may have preferences regarding consequences to other individuals and therefore choose their actions to improve or reduce the well-being of others. Many neurobiological studies have exploited game theory to probe the neural basis of decision making and suggested that these features of social decision making might be reflected in the functions of brain areas involved in reward evaluation and reinforcement learning. Molecular genetic studies have also begun to identify genetic mechanisms for personal traits related to reinforcement learning and complex social decision making, further illuminating the biological basis of social behavior.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University	Lee, D (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St,SHM B404, New Haven, CT 06510 USA.	daeyeol.lee@yale.edu	Lee, Daeyeol/A-6794-2008	Lee, Daeyeol/0000-0003-3474-019X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RL1DA024855] Funding Source: NIH RePORTER; NIDA NIH HHS [DA024855, RL1 DA024855-01, RL1 DA024855] Funding Source: Medline; NIMH NIH HHS [R01 MH073246, MH073246] Funding Source: Medline; NINDS NIH HHS [R01 NS044270-05, R01 NS044270] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Bhatt M, 2005, GAME ECON BEHAV, V52, P424, DOI 10.1016/j.geb.2005.03.007; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Burnham TC, 2007, P ROY SOC B-BIOL SCI, V274, P2327, DOI 10.1098/rspb.2007.0546; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Coricelli G, 2007, TRENDS COGN SCI, V11, P258, DOI 10.1016/j.tics.2007.04.003; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety J, 2004, NEUROIMAGE, V23, P744, DOI 10.1016/j.neuroimage.2004.05.025; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Erev I, 1998, AM ECON REV, V88, P848; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Feltovich N, 2000, ECONOMETRICA, V68, P605, DOI 10.1111/1468-0262.00125; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Fudenberg D., 1998, THEORY LEARNING GAME; Fukui H, 2006, NEUROIMAGE, V32, P913, DOI 10.1016/j.neuroimage.2006.03.039; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P2363, DOI 10.1098/rspb.2003.2509; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Izquierdo A, 2007, P NATL ACAD SCI USA, V104, P14128, DOI 10.1073/pnas.0706583104; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kawato M, 2007, CURR OPIN NEUROBIOL, V17, P205, DOI 10.1016/j.conb.2007.03.004; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Lee D, 2005, COGNITIVE BRAIN RES, V25, P416, DOI 10.1016/j.cogbrainres.2005.07.003; Lee D, 2004, COGNITIVE BRAIN RES, V22, P45, DOI 10.1016/j.cogbrainres.2004.07.007; Lee D, 2007, J NEUROSCI, V27, P8170, DOI 10.1523/JNEUROSCI.1561-07.2007; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Lohrenz T, 2007, P NATL ACAD SCI USA, V104, P9493, DOI 10.1073/pnas.0608842104; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; Mookherjee D, 1997, GAME ECON BEHAV, V19, P97, DOI 10.1006/game.1997.0540; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Penke L, 2007, EUR J PERSONALITY, V21, P549, DOI 10.1002/per.629; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROREPORT, V15, P2539, DOI 10.1097/00001756-200411150-00022; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; SALLY D, 1995, RATION SOC, V7, P58, DOI 10.1177/1043463195007001004; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Sandholm TW, 1996, BIOSYSTEMS, V37, P147, DOI 10.1016/0303-2647(95)01551-5; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Schotter A, 1996, J ECON BEHAV ORGAN, V31, P37, DOI 10.1016/S0167-2681(96)00863-3; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Sohn JW, 2007, J NEUROSCI, V27, P13655, DOI 10.1523/JNEUROSCI.2982-07.2007; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Tankersley D, 2007, NAT NEUROSCI, V10, P150, DOI 10.1038/nn1833; Tomlin D, 2006, SCIENCE, V312, P1047, DOI 10.1126/science.1125596; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Tsujimoto S, 2004, CEREB CORTEX, V14, P47, DOI 10.1093/cercor/bhg090; Wallace B, 2007, P NATL ACAD SCI USA, V104, P15631, DOI 10.1073/pnas.0706642104; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Yacubian J, 2007, P NATL ACAD SCI USA, V104, P8125, DOI 10.1073/pnas.0702029104	99	172	175	11	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					404	409		10.1038/nn2065	http://dx.doi.org/10.1038/nn2065			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18368047	Green Accepted			2022-12-17	WOS:000254359300009
J	Holloway, CC; Clayton, DE				Holloway, CC; Clayton, DE			Estrogen synthesis in the male brain triggers development of the avian song control pathway in vitro	NATURE NEUROSCIENCE			English	Article							ZEBRA FINCH BRAIN; SEXUAL-DIFFERENTIATION; CEREBRAL-CORTEX; ORGANOTYPIC CULTURE; AXONAL CONNECTIONS; AROMATASE-ACTIVITY; MESSENGER-RNA; ADULT MALE; SYSTEM; BEHAVIOR	Sexual differentiation of the brain is determined in part by steroids such as estrogen, which are generally assumed to arise from the gonads. Here we show that estrogens are produced autonomously in cultured juvenile male zebra finch brain slices, and this brain-derived estrogen is both necessary and sufficient to trigger formation in vitro of a key male-specific synaptic connection in the telencephalic song control circuit. Male-like development was stimulated in female slices cultured with male slices or exposed to estrogen, and estrogen antagonists inhibited song circuit development in slices of either sex. These results reveal a new mode of sex-specific neural development, induced not by differential exposure to gonadal steroids, but rather by differential synthesis of steroids in the brain.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Illinois, Beckman Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Clayton, DE (corresponding author), Univ Illinois, Dept Cell & Struct Biol, B107 CLS Labs,601 S Goodwin Ave, Urbana, IL 61801 USA.		Clayton, David/B-2190-2008	Clayton, David/0000-0002-6395-3488	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025742] Funding Source: NIH RePORTER; NIMH NIH HHS [MH52086] Funding Source: Medline; NINDS NIH HHS [NS25742] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AdkinsRegan E, 1996, BEHAVIOUR, V133, P847, DOI 10.1163/156853996X00279; ADKINSREGAN E, 1990, GEN COMP ENDOCR, V78, P93, DOI 10.1016/0016-6480(90)90051-M; Arnold AP, 1997, J NEUROBIOL, V33, P572, DOI 10.1002/(SICI)1097-4695(19971105)33:5<572::AID-NEU6>3.3.CO;2-6; BALTHAZART J, 1994, BEHAVIOUR, V131, P225, DOI 10.1163/156853994X00451; Bottjer SW, 1997, BIOESSAYS, V19, P1109, DOI 10.1002/bies.950191210; Brenowitz EA, 1997, J NEUROBIOL, V33, P495, DOI 10.1002/(SICI)1097-4695(19971105)33:5<495::AID-NEU1>3.3.CO;2-D; Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171; Dailey ME, 1996, J NEUROSCI, V16, P2983; DISTLER PG, 1992, DEV BRAIN RES, V67, P181, DOI 10.1016/0165-3806(92)90218-L; Dittrich F, 1999, P NATL ACAD SCI USA, V96, P8241, DOI 10.1073/pnas.96.14.8241; Foster EF, 1998, J COMP NEUROL, V397, P118; GAHR M, 1988, P NATL ACAD SCI USA, V85, P7380, DOI 10.1073/pnas.85.19.7380; Gahr M, 1999, J NEUROSCI, V19, P2628; GOLDMAN SA, 1992, J NEUROSCI, V12, P2532; GURNEY ME, 1980, SCIENCE, V208, P1380, DOI 10.1126/science.208.4450.1380; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; HUTCHISON JB, 1984, J ENDOCRINOL, V103, P363, DOI 10.1677/joe.0.1030363; Jacobs EC, 1999, DEV NEUROSCI-BASEL, V21, P453, DOI 10.1159/000017413; KONISHI M, 1985, NATURE, V315, P145, DOI 10.1038/315145a0; MacGregor JI, 1998, PHARMACOL REV, V50, P151; MACLUSKY NJ, 1994, MOL CELL NEUROSCI, V5, P691, DOI 10.1006/mcne.1994.1083; MATHEWS GA, 1991, J NEUROBIOL, V22, P957, DOI 10.1002/neu.480220907; MATHEWS GA, 1990, GEN COMP ENDOCR, V80, P48, DOI 10.1016/0016-6480(90)90147-E; Molnar Z, 1999, EXP NEUROL, V156, P363, DOI 10.1006/exnr.1999.7032; MOONEY R, 1994, J NEUROSCI, V14, P6532; Mooney R, 1999, CURR OPIN NEUROBIOL, V9, P121, DOI 10.1016/S0959-4388(99)80015-4; NIBLOCK MM, 1995, DEV BRAIN RES, V85, P288, DOI 10.1016/0165-3806(95)00002-U; NORDEEN EJ, 1987, J COMP NEUROL, V259, P393, DOI 10.1002/cne.902590307; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; SCHLINGER BA, 1992, ENDOCRINOLOGY, V130, P289, DOI 10.1210/en.130.1.289; SCHLINGER BA, 1992, P NATL ACAD SCI USA, V89, P7650, DOI 10.1073/pnas.89.16.7650; SCHLINGER BA, 1991, P NATL ACAD SCI USA, V88, P4191, DOI 10.1073/pnas.88.10.4191; Schlinger BA, 1997, J NEUROBIOL, V33, P619, DOI 10.1002/(SICI)1097-4695(19971105)33:5<619::AID-NEU9>3.0.CO;2-7; SCHLINGER BA, 1994, J NEUROSCI, V14, P7541; SIMPSON HB, 1991, J NEUROBIOL, V22, P755, DOI 10.1002/neu.480220710; SIMPSON HB, 1991, J NEUROBIOL, V22, P777, DOI 10.1002/neu.480220711; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Toran-Allerand CD, 1999, FRONT NEUROENDOCRIN, V20, P97, DOI 10.1006/frne.1999.0177; TORANALLERAND CD, 1991, PSYCHONEUROENDOCRINO, V16, P7, DOI 10.1016/0306-4530(91)90068-5; Vanson A, 1996, GEN COMP ENDOCR, V102, P342, DOI 10.1006/gcen.1996.0077; VOCKEL A, 1990, BRAIN RES, V511, P291, DOI 10.1016/0006-8993(90)90174-A; WADE J, 1994, BRAIN RES, V639, P347, DOI 10.1016/0006-8993(94)91752-3; Wade J, 1996, P NATL ACAD SCI USA, V93, P5264, DOI 10.1073/pnas.93.11.5264; WADE J, 1994, GEN COMP ENDOCR, V94, P53, DOI 10.1006/gcen.1994.1059; WADE J, 1995, J NEUROBIOL, V27, P240, DOI 10.1002/neu.480270210; WRAY S, 1993, MICROSC RES TECHNIQ, V25, P46, DOI 10.1002/jemt.1070250108	46	172	178	0	78	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					170	175		10.1038/84001	http://dx.doi.org/10.1038/84001			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175878				2022-12-17	WOS:000167178100016
J	Whitney, D; Cavanagh, P				Whitney, D; Cavanagh, P			Motion distorts visual space: shifting the perceived position of remote stationary objects	NATURE NEUROSCIENCE			English	Article							INDUCED MOVEMENT; MACAQUE MONKEY; FUNCTIONAL-PROPERTIES; ATTENTION SHIFT; AREA MT; EXTRAPOLATION; DISPLACEMENT; DIRECTION; STIMULI; NEURONS	To perceive the relative positions of objects in the visual field, the visual system must assign locations to each stimulus. This assignment is determined by the object's retinal position, the direction of gaze, eye movements, and the motion of the object itself. Here we show that perceived location is also influenced by motion signals that originate in distant regions of the visual field. When a pair of stationary lines are flashed, straddling but not overlapping a rotating radial grating, the lines appear displaced in a direction consistent with that of the grating's motion, even when the lines are a substantial distance from the grating. The results indicate that motion's influence on position is not restricted to the moving object itself, and that even the positions of stationary objects are coded by mechanisms that receive input from motion-sensitive neurons.	Harvard Univ, Vis Sci Lab, Cambridge, MA 02138 USA	Harvard University	Whitney, D (corresponding author), Harvard Univ, Vis Sci Lab, 33 Kirkland St, Cambridge, MA 02138 USA.							ANSTIS SM, 1976, VISION RES, V16, P1391, DOI 10.1016/0042-6989(76)90157-7; BALDO MVC, 1995, NATURE, V378, P565, DOI 10.1038/378565a0; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Cai RH, 1997, NATURE, V386, P601, DOI 10.1038/386601a0; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; CROPPER SJ, 1994, VISION RES, V34, P49, DOI 10.1016/0042-6989(94)90256-9; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; Deubel H, 1996, VISION RES, V36, P985, DOI 10.1016/0042-6989(95)00203-0; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; DICHGANS J, 1972, SCIENCE, V178, P1217, DOI 10.1126/science.178.4066.1217; Duncker K, 1929, PSYCHOL FORSCH, V12, P180, DOI 10.1007/BF02409210; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; EDELMAN GM, 1978, MINDFUL BRAIN CORTIC, P55; FELLEMAN DJ, 1984, J NEUROPHYSIOL, V52, P488, DOI 10.1152/jn.1984.52.3.488; FREYD JJ, 1987, J EXP PSYCHOL, V19, P369; FROHLICH FW, 1929, EMPFINDUNGSZEIT; GOGEL WC, 1972, PERCEPT PSYCHOPHYS, V11, P309, DOI 10.3758/BF03210385; HUGHES PC, 1972, PERCEPT PSYCHOPHYS, V11, P135, DOI 10.3758/BF03210359; KELLY DH, 1979, J OPT SOC AM, V69, P1340, DOI 10.1364/JOSA.69.001340; KERTESZ AE, 1969, VISION RES, V9, P995, DOI 10.1016/0042-6989(69)90105-9; KHURANA B, 1995, NATURE, V378, P566, DOI 10.1038/378566a0; LEVI DM, 1990, VISION RES, V30, P557, DOI 10.1016/0042-6989(90)90068-V; MATIN L, 1976, PERCEPT PSYCHOPHYS, V20, P138, DOI 10.3758/BF03199445; MATIN L, 1972, HDB SENSORY PHYSIOLO, V7, P331; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MERKER BH, 1981, VISION RES, V21, P543, DOI 10.1016/0042-6989(81)90099-7; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1328, DOI 10.1152/jn.1986.55.6.1328; NAKAYAMA K, 1984, VISION RES, V24, P293, DOI 10.1016/0042-6989(84)90054-3; NAKAYAMA K, 1985, VISION RES, V25, P625, DOI 10.1016/0042-6989(85)90171-3; NAWROT M, 1990, VISION RES, V30, P1439, DOI 10.1016/0042-6989(90)90025-G; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Nishida S, 1999, NATURE, V397, P610, DOI 10.1038/17600; Purushothaman G, 1998, NATURE, V396, P424, DOI 10.1038/24766; RAMACHANDRAN VS, 1987, NATURE, V328, P645, DOI 10.1038/328645a0; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; REINHARDTRUTLAND AH, 1988, PSYCHOL BULL, V103, P57, DOI 10.1037/0033-2909.103.1.57; Rock I., 1990, LEGACY SOLOMON ASCH, P243; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Schlag J, 2000, NATURE, V403, P38, DOI 10.1038/47402; Snowden RJ, 1998, CURR BIOL, V8, P1343, DOI 10.1016/S0960-9822(07)00567-2; SNOWDEN RJ, 1989, VISION RES, V29, P1777, DOI 10.1016/0042-6989(89)90160-0; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; VERSTRATEN F, IN PRESS VISION RES; Whitney D, 2000, VISION RES, V40, P137, DOI 10.1016/S0042-6989(99)00166-2; Whitney D, 1998, NAT NEUROSCI, V1, P656, DOI 10.1038/3659; WITKIN HA, 1948, J EXP PSYCHOL, V38, P762, DOI 10.1037/h0053671; ZEKI S, 1990, CODING EFFICIENCY, P321	49	172	173	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					954	959		10.1038/78878	http://dx.doi.org/10.1038/78878			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966628				2022-12-17	WOS:000167177400024
J	Yan, W; Suga, N				Yan, W; Suga, N			Corticofugal modulation of the midbrain frequency map in the bat auditory system	NATURE NEUROSCIENCE			English	Article							INTRACOCHLEAR ELECTRICAL-STIMULATION; NEONATALLY DEAFENED CAT; BIG BROWN BAT; INFERIOR COLLICULUS; INTRACORTICAL MICROSTIMULATION; EPTESICUS-FUSCUS; ADULT MAMMALS; CORTEX; REPRESENTATION; PLASTICITY	The auditory system, like the visual and somatosensory systems, contains topographic maps in its central neural pathways. These maps can be modified by sensory deprivation, injury and experience in both young and adult animals. Such plasticity has been explained by changes in the divergent and convergent projections of the ascending sensory system. Another possibility, however, is that plasticity may be mediated by descending corticofugal connections. We have investigated the role of descending connections from the cortex to the inferior colliculus of the big brown bat. Electrical stimulation of the auditory cortex causes a downward shift in the preferred frequencies of collicular neurons toward that of the stimulated cortical neurons. This results in a change in the frequency map within the colliculus. Moreover, similar changes can be induced by repeated bursts of sound at moderate intensities. Thus, one role of the mammalian corticofugal system may be to modify subcortical sensory maps in response to sensory experience.	Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Suga, N (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	suga@biodec.wustl.edu			NIDCD NIH HHS [DC 00175] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000175] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AMATO G, 1969, Archivio Italiano di Scienze Mediche Tropicali e di Parassitologia, V53, P291; ANDERSEN P, 1973, BRAIN BEHAV EVOLUT, V6, P170, DOI 10.1159/000123705; ANDERSEN RA, 1980, J COMP NEUROL, V191, P479, DOI 10.1002/cne.901910310; CASSEDAY JH, 1992, J COMP NEUROL, V319, P34, DOI 10.1002/cne.903190106; CLARK SA, 1988, NATURE, V332, P444, DOI 10.1038/332444a0; DEAR SP, 1993, NATURE, V364, P620, DOI 10.1038/364620a0; EVANS EF, 1975, AUDIOLOGY, V14, P419; He JF, 1997, J NEUROPHYSIOL, V77, P896, DOI 10.1152/jn.1997.77.2.896; HERBERT H, 1991, J COMP NEUROL, V304, P103, DOI 10.1002/cne.903040108; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; HUFFMAN RF, 1990, BRAIN RES REV, V15, P295, DOI 10.1016/0165-0173(90)90005-9; Irvine DRF, 1996, CLIN EXP PHARMACOL P, V23, P939, DOI 10.1111/j.1440-1681.1996.tb01146.x; JEN PHS, 1989, J COMP PHYSIOL A, V165, P1, DOI 10.1007/BF00613794; JENKINS WM, 1990, NEUROPSYCHOLOGIA, V28, P573, DOI 10.1016/0028-3932(90)90035-M; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; KATSUKI Y., 1962, JOUR ACOUSTICAL SOC AMER, V34, P1396, DOI 10.1121/1.1918357; KELLY JP, 1981, BRAIN RES, V212, P1, DOI 10.1016/0006-8993(81)90027-5; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; MASSOPUST LC, 1962, EXP NEUROL, V6, P465, DOI 10.1016/0014-4886(62)90072-9; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; PETTET MW, 1992, P NATL ACAD SCI USA, V89, P8366, DOI 10.1073/pnas.89.17.8366; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, CEREB CORTEX, V2, P181, DOI 10.1093/cercor/2.3.181; RYUGO DK, 1976, EXP NEUROL, V51, P377, DOI 10.1016/0014-4886(76)90262-4; Saldana E, 1996, J COMP NEUROL, V371, P15, DOI 10.1002/(SICI)1096-9861(19960715)371:1<15::AID-CNE2>3.0.CO;2-O; SNYDER RL, 1991, HEARING RES, V56, P246, DOI 10.1016/0378-5955(91)90175-9; SNYDER RL, 1990, HEARING RES, V50, P7, DOI 10.1016/0378-5955(90)90030-S; SPENGLER F, 1994, NEUROREPORT, V5, P949, DOI 10.1097/00001756-199404000-00024; SUGA N, 1964, J PHYSIOL-LONDON, V172, P449, DOI 10.1113/jphysiol.1964.sp007432; SUGA N, 1977, J EXP BIOL, V69, P207; SUN X, 1989, BRAIN RES, V495, P1, DOI 10.1016/0006-8993(89)91212-2; Sun XD, 1996, NEUROSCI LETT, V212, P131, DOI 10.1016/0304-3940(96)12788-9; SYKA J, 1984, NEUROSCI LETT, V51, P235, DOI 10.1016/0304-3940(84)90557-3; VILLA AEP, 1991, EXP BRAIN RES, V86, P506, DOI 10.1007/BF00230524; WATANABE T, 1966, EXP BRAIN RES, V2, P302; WEINBERGER NM, 1993, P NATL ACAD SCI USA, V90, P2394, DOI 10.1073/pnas.90.6.2394; Yan J, 1996, SCIENCE, V273, P1100, DOI 10.1126/science.273.5278.1100; Zhang YF, 1997, NATURE, V387, P900, DOI 10.1038/43180	39	172	178	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					54	58		10.1038/255	http://dx.doi.org/10.1038/255			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195109				2022-12-17	WOS:000076361000018
J	Browning, M; Behrens, TE; Jocham, G; O'Reilly, JX; Bishop, SJ				Browning, Michael; Behrens, Timothy E.; Jocham, Gerhard; O'Reilly, Jill X.; Bishop, Sonia J.			Anxious individuals have difficulty learning the causal statistics of aversive environments	NATURE NEUROSCIENCE			English	Article							ADAPTIVE GAIN; UNCERTAINTY; ANXIETY; INTOLERANCE; SURPRISE	Statistical regularities in the causal structure of the environment enable us to predict the probable outcomes of our actions. Environments differ in the extent to which action-outcome contingencies are stable or volatile. Difficulty in being able to use this information to optimally update outcome predictions might contribute to the decision-making difficulties seen in anxiety. We tested this using an aversive learning task manipulating environmental volatility. Human participants low in trait anxiety matched updating of their outcome predictions to the volatility of the current environment, as predicted by a Bayesian model. Individuals with high trait anxiety showed less ability to adjust updating of outcome expectancies between stable and volatile environments. This was linked to reduced sensitivity of the pupil dilatory response to volatility, potentially indicative of altered norepinephrinergic responsivity to changes in this aspect of environmental information.	[Browning, Michael; Behrens, Timothy E.; Jocham, Gerhard; O'Reilly, Jill X.; Bishop, Sonia J.] John Radcliffe Hosp, Funct MRI Brain Ctr, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Jocham, Gerhard] Univ Magdeburg, Ctr Behav Brain Sci, D-39106 Magdeburg, Germany; [Bishop, Sonia J.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Bishop, Sonia J.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of Oxford; Otto von Guericke University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bishop, SJ (corresponding author), John Radcliffe Hosp, Funct MRI Brain Ctr, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.	sbishop@berkeley.edu	browning, michael/M-7338-2017	browning, michael/0000-0001-9108-3144; Behrens, Timothy/0000-0003-0048-1177; O'Reilly, Jill/0000-0002-6998-455X	European Research Council grant [GA 260932]; US National Institutes of Health grant [R01MH091848]; Medical Research Council [MR/L019639/1, G0802459] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091848] Funding Source: NIH RePORTER; MRC [G0802459, MR/L019639/1] Funding Source: UKRI	European Research Council grant(European Research Council (ERC)); US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank S. Hicks and C. Kennard for use of the eye-tracking system. This research was supported by European Research Council grant GA 260932 and US National Institutes of Health grant R01MH091848.	Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bestmann S, 2008, CURR BIOL, V18, P775, DOI 10.1016/j.cub.2008.04.051; Birrell J, 2011, CLIN PSYCHOL REV, V31, P1198, DOI 10.1016/j.cpr.2011.07.009; BUTLER G, 1983, ADV BEHAV RES THER, V5, P51, DOI 10.1016/0146-6402(83)90015-2; Carleton RN, 2007, J ANXIETY DISORD, V21, P105, DOI 10.1016/j.janxdis.2006.03.014; Casey BJ, 2013, NAT REV NEUROSCI, V14, P810, DOI 10.1038/nrn3621; Charney DS, 2002, NEUROPSYCHOPHARMACOL, P901; Eldar E, 2013, NAT NEUROSCI, V16, P1146, DOI 10.1038/nn.3428; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Gorman Jack M, 2002, Psychopharmacol Bull, V36 Suppl 2, P49; Hartley CA, 2012, BIOL PSYCHIAT, V72, P113, DOI 10.1016/j.biopsych.2011.12.027; Indovina I, 2011, NEURON, V69, P563, DOI 10.1016/j.neuron.2010.12.034; MacKay David JC, 2003, INFORM THEORY INFERE; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, pE3660, DOI 10.1073/pnas.1305373110; Paulus MP, 2012, TRENDS COGN SCI, V16, P476, DOI 10.1016/j.tics.2012.07.009; Payzan-LeNestour E, 2013, NEURON, V79, P191, DOI 10.1016/j.neuron.2013.04.037; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; Spielberger CD, 1989, STATE TRAIT ANXIETY; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	24	171	172	5	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2015	18	4					590	+		10.1038/nn.3961	http://dx.doi.org/10.1038/nn.3961			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CE4DL	25730669	Green Accepted, Green Submitted			2022-12-17	WOS:000351780900023
J	Domingos, AI; Vaynshteyn, J; Voss, HU; Ren, XY; Gradinaru, V; Zang, F; Deisseroth, K; de Araujo, IE; Friedman, J				Domingos, Ana I.; Vaynshteyn, Jake; Voss, Henning U.; Ren, Xueying; Gradinaru, Viviana; Zang, Feng; Deisseroth, Karl; de Araujo, Ivan E.; Friedman, Jeffrey			Leptin regulates the reward value of nutrient	NATURE NEUROSCIENCE			English	Article							SWEET TASTE; ORBITOFRONTAL CORTEX; WANTING FOOD; WEIGHT-LOSS; DOPAMINE; NEURONS; BRAIN; SUCROSE; RESTRICTION; CIRCUITRY	We developed an assay for quantifying the reward value of nutrient and used it to analyze the effects of metabolic state and leptin. In this assay, mice chose between two sippers, one of which dispensed water and was coupled to optogenetic activation of dopaminergic (DA) neurons and the other of which dispensed natural or artificial sweeteners. This assay measured the reward value of sweeteners relative to lick-induced optogenetic activation of DA neurons. Mice preferred optogenetic stimulation of DA neurons to sucralose, but not to sucrose. However, the mice preferred sucralose plus optogenetic stimulation versus sucrose. We found that food restriction increased the value of sucrose relative to sucralose plus optogenetic stimulation, and that leptin decreased it. Our data suggest that leptin suppresses the ability of sucrose to drive taste-independent DA neuronal activation and provide new insights into the mechanism of leptin's effects on food intake.	[Domingos, Ana I.; Vaynshteyn, Jake; Friedman, Jeffrey] Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA; [Voss, Henning U.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Ren, Xueying; de Araujo, Ivan E.] Yale Univ, Sch Med, JB Pierce Lab, New Haven, CT USA; [Ren, Xueying] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Gradinaru, Viviana; Zang, Feng; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Friedman, Jeffrey] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Cornell University; Yale University; The John B Pierce Laboratory, Inc; Yale University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Rockefeller University	Friedman, J (corresponding author), Rockefeller Univ, Mol Genet Lab, 1230 York Ave, New York, NY 10021 USA.	friedj@mail.rockefeller.edu	Ren, Xueying/ABF-8967-2021; Ren, Xueying/AAA-9464-2020	Ren, Xueying/0000-0002-6503-0425; Domingos, Ana/0000-0002-7938-4814; De Araujo, Ivan/0000-0003-3081-3339	Klarman Family Foundation for Eating Disorders (KFFfED); Fundacao para a Ciencia e Tecnologia (Portugal); US National Institutes of Health [DC009997, MH075957]; Gatsby Foundation; Defense Advanced Research Projects Agency; Nancy M. and Samuel C. Fleming Research Scholar Award in Intercampus Collaborations; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH075957, R01MH075957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009997] Funding Source: NIH RePORTER	Klarman Family Foundation for Eating Disorders (KFFfED); Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Foundation; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Nancy M. and Samuel C. Fleming Research Scholar Award in Intercampus Collaborations; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank F. Pestilli for helping with the bootstrap analysis. We thank the Klarman Family Foundation for Eating Disorders (KFFfED) for supporting this work. A.I.D. was supported by Fundacao para a Ciencia e Tecnologia (Portugal) and KFFfED. J.V. was supported by KFFfED. X.R. and I.E.d.A. were supported by US National Institutes of Health grant DC009997 to I.E.d.A. F.Z., V.G. and K.D. were supported by the US National Institutes of Health (grant MH075957), the Gatsby Foundation and Defense Advanced Research Projects Agency. H.U.V. was partially supported by the Nancy M. and Samuel C. Fleming Research Scholar Award in Intercampus Collaborations.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; BARTOSHUK LM, 1979, SCIENCE, V205, P934, DOI 10.1126/science.472717; Bellisle F, 2007, EUR J CLIN NUTR, V61, P691, DOI 10.1038/sj.ejcn.1602649; Berridge KC, 2000, NEUROSCI BIOBEHAV R, V24, P173, DOI 10.1016/S0149-7634(99)00072-X; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; BUKOWIECKI LJ, 1983, AM J PHYSIOL, V244, pR500, DOI 10.1152/ajpregu.1983.244.4.R500; Cameron JD, 2008, PHYSIOL BEHAV, V94, P474, DOI 10.1016/j.physbeh.2008.02.014; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Epstein LH, 2003, PHYSIOL BEHAV, V78, P221, DOI 10.1016/S0031-9384(02)00978-2; Eric Walters D., 1991, SWEETENERS DISCOVERY; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Figlewicz DP, 2006, PHYSIOL BEHAV, V89, P611, DOI 10.1016/j.physbeh.2006.07.023; Figlewicz DP, 2001, PHYSIOL BEHAV, V73, P229, DOI 10.1016/S0031-9384(01)00486-3; Finlayson G, 2007, NEUROSCI BIOBEHAV R, V31, P987, DOI 10.1016/j.neubiorev.2007.03.004; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Fulton S, 2004, BEHAV BRAIN RES, V155, P319, DOI 10.1016/j.bbr.2004.05.021; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Glencoe C, 2002, GLENCOE CHEM MATTER; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Haley S, 2005, SWEETENER CONSUMPTIO, P1; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Lewis SR, 2006, PHYSIOL BEHAV, V87, P595, DOI 10.1016/j.physbeh.2005.12.002; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lydall ES, 2010, PSYCHOPHARMACOLOGY, V209, P153, DOI 10.1007/s00213-010-1779-x; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Ren XY, 2010, J NEUROSCI, V30, P8012, DOI 10.1523/JNEUROSCI.5749-09.2010; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; ROZIN P, 1980, INT J OBESITY, V4, P356; Sclafani A, 2001, APPETITE, V36, P79, DOI 10.1006/appe.2000.0370; Servant G, 2010, P NATL ACAD SCI USA, V107, P4746, DOI 10.1073/pnas.0911670107; Shigemura N, 2003, ARCH HISTOL CYTOL, V66, P253, DOI 10.1679/aohc.66.253; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Umabiki M, 2010, TOHOKU J EXP MED, V220, P267, DOI 10.1620/tjem.220.267; Ventura E.E., 2010, OBESITY SILVER SPRIN, V19, P687; WEIJNEN JAWM, 1989, PHYSIOL BEHAV, V46, P923, DOI 10.1016/0031-9384(89)90192-3; Wise RA, 2008, NEUROTOX RES, V14, P169, DOI 10.1007/BF03033808; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	45	171	176	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1562	U92		10.1038/nn.2977	http://dx.doi.org/10.1038/nn.2977			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22081158	Green Accepted			2022-12-17	WOS:000297546300016
J	Liu, T; Xu, ZZ; Park, CK; Berta, T; Ji, RR				Liu, Tong; Xu, Zhen-Zhong; Park, Chul-Kyu; Berta, Temugin; Ji, Ru-Rong			Toll-like receptor 7 mediates pruritus	NATURE NEUROSCIENCE			English	Article							ITCH SENSATION; INFLAMMATION; ACTIVATION; PAIN	Toll-like receptors are typically expressed in immune cells to regulate innate immunity. We found that functional Toll-like receptor 7 (TLR7) was expressed in C-fiber primary sensory neurons and was important for inducing itch (pruritus), but was not necessary for eliciting mechanical, thermal, inflammatory and neuropathic pain in mice. Our results indicate that TLR7 mediates itching and is a potential therapeutic target for anti-itch treatment in skin disease conditions.	[Liu, Tong; Xu, Zhen-Zhong; Park, Chul-Kyu; Berta, Temugin; Ji, Ru-Rong] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Sensory Plast Lab, Boston, MA 02115 USA; [Liu, Tong; Xu, Zhen-Zhong; Park, Chul-Kyu; Berta, Temugin; Ji, Ru-Rong] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ji, RR (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Sensory Plast Lab, 75 Francis St, Boston, MA 02115 USA.	rrji@zeus.bwh.harvard.edu	Liu, Tong/C-7810-2012; Ji, Ru-Rong/L-7070-2017; Liu, Tong/E-3648-2010; Berta, Temugin/A-6908-2016; Berta, Temugin/AAK-6365-2020	Ji, Ru-Rong/0000-0002-9355-3688; Berta, Temugin/0000-0002-4486-8288; Berta, Temugin/0000-0002-4486-8288; Xu, Zhen-Zhong/0000-0001-6578-211X	US National Institutes of Health [R01-DE17794, R01-NS54362, R01-NS67686]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS054362, R01NS067686, R01NS054932] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by US National Institutes of Health grants R01-DE17794, R01-NS54362 and R01-NS67686 to R.-R.J.	Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Madan V, 2010, LANCET, V375, P673, DOI 10.1016/S0140-6736(09)61196-X; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shim WS, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-29; Shimada SG, 2008, PAIN, V139, P681, DOI 10.1016/j.pain.2008.08.002; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999	15	171	177	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1460	1462		10.1038/nn.2683	http://dx.doi.org/10.1038/nn.2683			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21037581	Green Accepted			2022-12-17	WOS:000284525800009
J	Ohira, K; Furuta, T; Hioki, H; Nakamura, KC; Kuramoto, E; Tanaka, Y; Funatsu, N; Shimizu, K; Oishi, T; Hayashi, M; Miyakawa, T; Kaneko, T; Nakamura, S				Ohira, Koji; Furuta, Takahiro; Hioki, Hiroyuki; Nakamura, Kouichi C.; Kuramoto, Eriko; Tanaka, Yasuyo; Funatsu, Nobuo; Shimizu, Keiko; Oishi, Takao; Hayashi, Motoharu; Miyakawa, Tsuyoshi; Kaneko, Takeshi; Nakamura, Shun			Ischemia-induced neurogenesis of neocortical layer 1 progenitor cells	NATURE NEUROSCIENCE			English	Article							SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; CORTICAL NEUROGENESIS; GABAERGIC NEURONS; CEREBRAL-CORTEX; EXPRESSION; PROLIFERATION; MIGRATION; RATS; SOMATOSTATIN	Adult mammalian neurogenesis occurs in the hippocampus and the olfactory bulb, whereas neocortical adult neurogenesis remains controversial. Several occurrences of neocortical adult neurogenesis in injured neocortex were recently reported, suggesting that neural stem cells (NSCs) or neuronal progenitor cells (NPCs) that can be activated by injury are maintained in the adult brain. However, it is not clear whether or where neocortical NSCs/NPCs exist in the brain. We found NPCs in the neocortical layer 1 of adult rats and observed that their proliferation was highly activated by global forebrain ischemia. Using retrovirus-mediated labeling of layer 1 proliferating cells with membrane-targeted green fluorescent protein, we found that the newly generated neurons were GABAergic and that the neurons were functionally integrated into the neuronal circuitry. Our results suggest that layer 1 NPCs are a source of adult neurogenesis under ischemic conditions.	[Ohira, Koji; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Aichi, Japan; [Ohira, Koji; Furuta, Takahiro; Hioki, Hiroyuki; Nakamura, Kouichi C.; Kuramoto, Eriko; Tanaka, Yasuyo; Kaneko, Takeshi] Kyoto Univ, Grad Sch Med, Dept Morphol Brain Sci, Kyoto, Japan; [Funatsu, Nobuo; Nakamura, Shun] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Biochem & Cellular Biol, Tokyo, Japan; [Ohira, Koji; Nakamura, Kouichi C.; Miyakawa, Tsuyoshi; Kaneko, Takeshi; Nakamura, Shun] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan; [Shimizu, Keiko; Oishi, Takao; Hayashi, Motoharu] Kyoto Univ, Primate Res Inst, Dept Cellular & Mol Biol, Aichi, Japan; [Miyakawa, Tsuyoshi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Aichi, Japan; [Nakamura, Shun] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Tokyo, Japan	Fujita Health University; Kyoto University; National Center for Neurology & Psychiatry - Japan; Japan Science & Technology Agency (JST); Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Tokyo University of Agriculture & Technology	Ohira, K (corresponding author), Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Aichi, Japan.	ohira@fujita-hu.ac.jp; kaneko@mbs.med.kyoto-u.ac.jp	Hioki, Hiroyuki/J-9412-2017; Nakamura, Shun/GVN-8593-2022; Miyakawa, Tsuyoshi/A-7741-2008; Nakamura, Kouichi/B-3425-2008; Nakamura, Kouichi C./S-7099-2019	Hioki, Hiroyuki/0000-0002-0152-7854; Miyakawa, Tsuyoshi/0000-0003-0137-8200; Nakamura, Kouichi/0000-0001-7053-0507; Ohira, Koji/0000-0003-0170-8652; Oishi, Takao/0000-0003-1067-3746				Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Adams RD, 1977, PRINCIPLES NEUROLOGY; ALTMAN J, 1963, ANAT REC, V145, P573, DOI 10.1002/ar.1091450409; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Ehninger D, 2003, CEREB CORTEX, V13, P845, DOI 10.1093/cercor/13.8.845; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GASS P, 1995, J CEREBR BLOOD F MET, V15, P989, DOI 10.1038/jcbfm.1995.125; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Hioki H, 2007, GENE THER, V14, P872, DOI 10.1038/sj.gt.3302924; Jiang W, 2001, STROKE, V32, P1201, DOI 10.1161/01.STR.32.5.1201; Jimenez D, 2003, DEV NEUROSCI-BASEL, V25, P105, DOI 10.1159/000072260; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kameda H, 2008, NEUROSCI RES, V61, P79, DOI 10.1016/j.neures.2008.01.014; KAPLAN MS, 1981, J COMP NEUROL, V195, P323, DOI 10.1002/cne.901950211; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Koketsu D, 2003, J NEUROSCI, V23, P937; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Kress GJ, 2009, NEUROSCIENCE, V158, P211, DOI 10.1016/j.neuroscience.2008.03.021; KUBOTA Y, 1994, BRAIN RES, V649, P159, DOI 10.1016/0006-8993(94)91060-X; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Leker RR, 2007, STROKE, V38, P153, DOI 10.1161/01.STR.0000252156.65953.a9; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nag S, 1996, J NEUROPATH EXP NEUR, V55, P880, DOI 10.1097/00005072-199608000-00003; Nery S, 2003, CEREB CORTEX, V13, P895, DOI 10.1093/cercor/13.9.895; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Ohira K, 2005, J NEUROSCI, V25, P1343, DOI 10.1523/JNEUROSCI.4436-04.2005; REN JQ, 1992, EXP BRAIN RES, V92, P1; Richichi C, 2004, J NEUROSCI, V24, P3051, DOI 10.1523/JNEUROSCI.4056-03.2004; Sairanen TR, 2001, J NEUROL SCI, V186, P87, DOI 10.1016/S0022-510X(01)00508-1; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Staiger JF, 2000, NEUROSCIENCE, V99, P7, DOI 10.1016/S0306-4522(00)00166-4; Stewart RR, 2002, J NEUROBIOL, V50, P305, DOI 10.1002/neu.10038; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; Tallent MK, 1999, J NEUROPHYSIOL, V81, P1626, DOI 10.1152/jn.1999.81.4.1626; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Tonchev AB, 2005, J NEUROSCI RES, V81, P776, DOI 10.1002/jnr.20604; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Xu XM, 2006, J COMP NEUROL, V499, P144, DOI 10.1002/cne.21101; Yang ZG, 2007, ANN NEUROL, V61, P199, DOI 10.1002/ana.21068; Zecevic N, 2001, J NEUROSCI, V21, P5607, DOI 10.1523/JNEUROSCI.21-15-05607.2001	50	171	180	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					173	U51		10.1038/nn.2473	http://dx.doi.org/10.1038/nn.2473			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20037576				2022-12-17	WOS:000273985800012
J	Bateup, HS; Svenningsson, P; Kuroiwa, M; Gong, S; Nishi, A; Heintz, N; Greengard, P				Bateup, Helen S.; Svenningsson, Per; Kuroiwa, Mahomi; Gong, Shiaoching; Nishi, Akinori; Heintz, Nathaniel; Greengard, Paul			Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs	NATURE NEUROSCIENCE			English	Article							DOPAMINE-RECEPTORS; ADENOSINE A(2A); STRIATOPALLIDAL NEURONS; CYCLIC-AMP; ACTIVATION; D-1; D1; BRAIN; MICE	DARPP-32 is a dual-function protein kinase/phosphatase inhibitor that is involved in striatal signaling. The phosphorylation of DARPP-32 at threonine 34 is essential for mediating the effects of both psychostimulant and antipsychotic drugs; however, these drugs are known to have opposing behavioral and clinical effects. We hypothesized that these drugs exert differential effects on striatonigral and striatopallidal neurons, which comprise distinct output pathways of the basal ganglia. To directly test this idea, we developed bacterial artificial chromosome transgenic mice that allowed the analysis of DARPP-32 phosphorylation selectively in striatonigral and striatopallidal neurons. Using this new methodology, we found that cocaine, a psychostimulant, and haloperidol, a sedation-producing antipsychotic, exert differential effects on DARPP-32 phosphorylation in the two neuronal populations that can explain their opposing behavioral effects. Furthermore, we found that a variety of drugs that target the striatum have cell type-specific effects that previous methods were not able to discern.	[Bateup, Helen S.; Svenningsson, Per; Nishi, Akinori; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Svenningsson, Per] Karolinska Inst, Dept Physiol & Pharmacol, Ctr Mol Med, S-17177 Stockholm, Sweden; [Kuroiwa, Mahomi; Nishi, Akinori] Kurume Univ, Sch Med, Dept Pharmacol, Fukuoka 8300011, Japan; [Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, Mol Biol Lab, New York, NY 10065 USA; [Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, GENSAT Project, New York, NY 10065 USA	Rockefeller University; Karolinska Institutet; Kurume University; Rockefeller University; Rockefeller University	Greengard, P (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10065 USA.	greengard@rockefeller.edu	Svenningsson, Per JL/K-5210-2014	Greengard, Paul/0000-0002-4437-0893	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NIDA NIH HHS [P01 DA010044, P01 DA010044-020002, P01 DA010044-04, DA10044, P01 DA010044-040002, P01 DA010044-05, P01 DA010044-030002, P01 DA010044-050002] Funding Source: Medline; NIMH NIH HHS [P50 MH074866-03, P50 MH074866, P50 MH074866-02, P50 MH074866-04, P50 MH074866-01, MH074866] Funding Source: Medline; PHS HHS [90AZ2791] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ade KK, 2008, J NEUROSCI, V28, P1185, DOI 10.1523/JNEUROSCI.3908-07.2008; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; CAMERON DL, 1993, NATURE, V366, P344, DOI 10.1038/366344a0; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538; FINK JS, 1992, MOL BRAIN RES, V14, P186, DOI 10.1016/0169-328X(92)90173-9; Fredholm BB, 1999, PHARMACOL REV, V51, P83; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hakansson K, 2006, J NEUROCHEM, V96, P482, DOI 10.1111/j.1471-4159.2005.03558.x; HEMMINGS HC, 1986, J NEUROSCI, V6, P1469; Jin LQ, 2001, J NEUROCHEM, V78, P981, DOI 10.1046/j.1471-4159.2001.00470.x; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; LeMoine C, 1997, J NEUROSCI, V17, P8038; Lindskog M, 2002, NATURE, V418, P774, DOI 10.1038/nature00817; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Nishi A, 2005, P NATL ACAD SCI USA, V102, P1199, DOI 10.1073/pnas.0409138102; Nishi A, 1997, J NEUROSCI, V17, P8147; Pothos EN, 1998, J NEUROSCI, V18, P5575; Pozzi L, 2003, J NEUROCHEM, V86, P451, DOI 10.1046/j.1471-4159.2003.01851.x; Schmitz Y, 2002, J NEUROSCI, V22, P8002; Stoof JC, 1981, NATURE, V294, P366, DOI 10.1038/294366a0; Svenningsson P, 1999, PROG NEUROBIOL, V59, P355, DOI 10.1016/S0301-0082(99)00011-8; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Svenningsson P, 1998, NEUROSCIENCE, V84, P223, DOI 10.1016/S0306-4522(97)00510-1; Svenningsson P, 1998, J COMP NEUROL, V399, P229, DOI 10.1002/(SICI)1096-9861(19980921)399:2<229::AID-CNE6>3.0.CO;2-2; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Zachariou V, 2006, NEUROPSYCHOPHARMACOL, V31, P555, DOI 10.1038/sj.npp.1300832; Zhang Y, 2006, J NEUROSCI, V26, P2645, DOI 10.1523/JNEUROSCI.3923-05.2006	38	171	177	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					932	939		10.1038/nn.2153	http://dx.doi.org/10.1038/nn.2153			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18622401	Green Accepted			2022-12-17	WOS:000257969100019
J	Bautista, DM; Sigal, YM; Milstein, AD; Garrison, JL; Zorn, JA; Tsuruda, PR; Nicoll, RA; Julius, D				Bautista, Diana M.; Sigal, Yaron M.; Milstein, Aaron D.; Garrison, Jennifer L.; Zorn, Julie A.; Tsuruda, Pamela R.; Nicoll, Roger A.; Julius, David			Pungent agents from Szechuan peppers excite sensory neurons by inhibiting two-pore potassium channels	NATURE NEUROSCIENCE			English	Article							K+ CHANNEL; TRPA1; TRESK; EXPRESSION; RECEPTORS; TASK-3; ANESTHETICS; NOCICEPTION; MODULATION; ACTIVATION	In traditional folk medicine, Xanthoxylum plants are referred to as 'toothache trees' because their anesthetic or counter-irritant properties render them useful in the treatment of pain. Psychophysical studies have identified hydroxy-alpha-sanshool as the compound most responsible for the unique tingling and buzzing sensations produced by Szechuan peppercorns or other Xanthoxylum preparations. Although it is generally agreed that sanshool elicits its effects by activating somatosensory neurons, the underlying cellular and molecular mechanisms remain a matter of debate. Here we show that hydroxy-alpha-sanshool excites two types of sensory neurons, including small-diameter unmyelinated cells that respond to capsaicin (but not mustard oil) as well as large-diameter myelinated neurons that express the neurotrophin receptor TrkC. We found that hydroxy-alpha-sanshool excites neurons through a unique mechanism involving inhibition of pH-and anesthetic-sensitive two-pore potassium channels (KCNK3, KCNK9 and KCNK18), providing a framework for understanding the unique and complex psychophysical sensations associated with the Szechuan pepper experience.	[Bautista, Diana M.; Sigal, Yaron M.; Tsuruda, Pamela R.; Nicoll, Roger A.; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Bautista, Diana M.; Sigal, Yaron M.; Tsuruda, Pamela R.; Nicoll, Roger A.; Julius, David] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, 600 16th St, San Francisco, CA 94143 USA.	julius@cmp.ucsf.edu		Milstein, Aaron/0000-0002-7186-5779	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038256] Funding Source: NIH RePORTER; NIMH NIH HHS [R37 MH038256-25, R37 MH038256] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; ALMERS W, 1985, FEBS LETT, V192, P13, DOI 10.1016/0014-5793(85)80033-8; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Brickley SG, 2007, J NEUROSCI, V27, P9329, DOI 10.1523/JNEUROSCI.1427-07.2007; Bryant BP, 1999, BRAIN RES, V842, P452, DOI 10.1016/S0006-8993(99)01878-8; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Feliciangeli S, 2007, CELL, V130, P563, DOI 10.1016/j.cell.2007.06.012; Fields H. L., 1987, PAIN; FOSTER S, 2000, E CENTRAL MED PLANTS; Funfschilling U, 2004, J COMP NEUROL, V480, P392, DOI 10.1002/cne.20359; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Han J, 2002, J PHYSIOL-LONDON, V542, P431, DOI 10.1113/jphysiol.2002.017590; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Julius David, 2005, Harvey Lect, V101, P89; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Kang DW, 2004, J PHYSIOL-LONDON, V554, P64, DOI 10.1113/jphysiol.2003.054387; Kato AS, 2007, J NEUROSCI, V27, P4969, DOI 10.1523/JNEUROSCI.5561-06.2007; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Koo JY, 2007, EUR J NEUROSCI, V26, P1139, DOI 10.1111/j.1460-9568.2007.05743.x; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Liu CH, 2004, ANESTH ANALG, V99, P1715, DOI 10.1213/01.ANE.0000136849.07384.44; McGee H., 2004, FOOD COOKING SCI LOR; MCMAHON SB, 2006, WALL MELZACKS TXB PA, P49; Meyer RA, 2006, WALL MELZACKS TXB PA, V5, P3; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; SNYDER SH, 1977, SCI AM, V236, P44, DOI 10.1038/scientificamerican0377-44; Sugai E, 2005, BIOSCI BIOTECH BIOCH, V69, P1958, DOI 10.1271/bbb.69.1958; Sugai E, 2005, BIOSCI BIOTECH BIOCH, V69, P1951, DOI 10.1271/bbb.69.1951; Talley EM, 2002, J BIOL CHEM, V277, P17733, DOI 10.1074/jbc.M200502200; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016	42	171	185	6	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					772	779		10.1038/nn.2143	http://dx.doi.org/10.1038/nn.2143			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18568022	Green Accepted			2022-12-17	WOS:000257089400014
J	Sowell, ER; Kan, E; Yoshii, J; Thompson, PM; Bansal, R; Xu, DR; Toga, AW; Peterson, BS				Sowell, Elizabeth R.; Kan, Eric; Yoshii, June; Thompson, Paul M.; Bansal, Ravi; Xu, Dongrong; Toga, Arthur W.; Peterson, Bradley S.			Thinning of sensorimotor cortices in children with Tourette syndrome	NATURE NEUROSCIENCE			English	Article							BASAL GANGLIA; BRAIN; VOLUMES; MRI	The basal ganglia portions of cortico-striato-thalamo-cortical (CSTC) circuits have consistently been implicated in the pathogenesis of Tourette syndrome, whereas motor and sensorimotor cortices in these circuits have been relatively overlooked. Using magnetic resonance imaging, we detected cortical thinning in frontal and parietal lobes in groups of Tourette syndrome children relative to controls. This thinning was most prominent in ventral portions of the sensory and motor homunculi that control the facial, orolingual and laryngeal musculature that is commonly involved in tic symptoms. Correlations of cortical thickness in sensorimotor regions with tic symptoms suggest that these brain regions are important in the pathogenesis of Tourette syndrome.	[Bansal, Ravi; Xu, Dongrong; Peterson, Bradley S.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Bansal, Ravi; Xu, Dongrong; Peterson, Bradley S.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Sowell, Elizabeth R.; Kan, Eric; Yoshii, June; Thompson, Paul M.; Toga, Arthur W.] Univ Calif Los Angeles, Dept Neurol, Lab Neuro Imaging, Los Angeles, CA 90095 USA	Columbia University; New York State Psychiatry Institute; University of California System; University of California Los Angeles	Peterson, BS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Psychiat, 1051 Riversisde Dr,Unit 74, New York, NY 10032 USA.	petersob@child.cpmc.columbia.edu	Thompson, Paul M/C-4194-2018	Thompson, Paul M/0000-0002-4720-8867	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642, U54RR021813, R21RR019771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB001561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH074677, R01MH068318, K01MH001733, R01MH059139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016570] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM005639] Funding Source: NIH RePORTER; NCRR NIH HHS [U54 RR021813, RR019771, P41 RR013642-11, P41 RR013642, U54 RR021813-01, R21 RR019771] Funding Source: Medline; NIA NIH HHS [P50 AG016570-100004, P50 AG016570-10, AG016570, P50 AG016570] Funding Source: Medline; NIBIB NIH HHS [R21 EB001561, R21 EB001561-03, EB01651] Funding Source: Medline; NIMH NIH HHS [R01 MH068318-05, MH59139, K01 MH01733, R01 MH059139, K02 MH074677, K02 MH074677-04, K01 MH001733-04, MH068318, R01 MH059139-04, R01 MH068318, R01 MH068318-04] Funding Source: Medline; NINDS NIH HHS [NS3753] Funding Source: Medline; NLM NIH HHS [LM05639, R01 LM005639] Funding Source: Medline; PHS HHS [MHK02-74677] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Albin RL, 2006, TRENDS NEUROSCI, V29, P175, DOI 10.1016/j.tins.2006.01.001; Fredericksen KA, 2002, NEUROLOGY, V58, P85, DOI 10.1212/WNL.58.1.85; HYDE TM, 1995, NEUROLOGY, V45, P1176, DOI 10.1212/WNL.45.6.1176; Kalanithi PSA, 2005, P NATL ACAD SCI USA, V102, P13307, DOI 10.1073/pnas.0502624102; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Peterson BS, 2003, ARCH GEN PSYCHIAT, V60, P415, DOI 10.1001/archpsyc.60.4.415; Peterson BS, 2001, ARCH GEN PSYCHIAT, V58, P427, DOI 10.1001/archpsyc.58.5.427; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; SINGER HS, 1993, NEUROLOGY, V43, P950, DOI 10.1212/WNL.43.5.950; Singh PJ, 2003, INT J FATIGUE, V25, P1, DOI 10.1016/S0142-1123(02)00067-1; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; SPESSOT AL, 2006, MANUAL DEV PSYCHOPAT, P436; Thompson PM, 2004, NEUROIMAGE, V23, pS2, DOI 10.1016/j.neuroimage.2004.07.071; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Ziemann U, 1997, AM J PSYCHIAT, V154, P1277	15	171	173	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					637	639		10.1038/nn.2121	http://dx.doi.org/10.1038/nn.2121			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18488025	Green Accepted			2022-12-17	WOS:000256133700009
J	Wienisch, M; Klingauf, J				Wienisch, Martin; Klingauf, Jurgen			Vesicular proteins exocytosed and subsequently retrieved by compensatory endocytosis are nonidentical	NATURE NEUROSCIENCE			English	Article							FROG NEUROMUSCULAR-JUNCTION; SYNAPTIC VESICLE ENDOCYTOSIS; CULTURED HIPPOCAMPAL-NEURONS; NERVE-TERMINALS; TRANSMITTER RELEASE; MEMBRANE-PROTEINS; CLATHRIN; SYNAPSES; KINETICS; DYNAMIN	Upon exocytosis, synaptic vesicle proteins are released into the plasma membrane and have to be retrieved by compensatory endocytosis. When green fluorescent protein-labeled versions of the vesicle proteins synaptobrevin-2 and synaptotagmin-1 are overexpressed in rat hippocampal neurons, up to 30% are found on axonal membranes under resting conditions. To test whether and to what extent these plasma membrane-stranded proteins participate in exo-endocytic cycling, a new proteolytic approach was used to visualize the fate of newly exocytosed proteins separately from that of the plasma membrane-stranded ones. We found that both pools were mixed and that endocytosed vesicles were largely composed of previously stranded molecules. The degree of nonidentity of vesicular proteins exo-and endocytosed depended on stimulus duration. By using an antibody to the external domain of synaptotagmin-1, we estimated that under physiological conditions a few percent of vesicular proteins were located near the active zone, from where they were preferentially recycled upon stimulation.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society	Klingauf, J (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, Fassberg 11, D-37077 Gottingen, Germany.	J.Klingauf@mpi-bpc.mpg.de						Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Estes PS, 1996, J NEUROSCI, V16, P5443; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Koenig JH, 1998, P NATL ACAD SCI USA, V95, P12677, DOI 10.1073/pnas.95.21.12677; Kugler S, 2001, MOL CELL NEUROSCI, V17, P78, DOI 10.1006/mcne.2000.0929; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Loerke D, 2005, TRAFFIC, V6, P918, DOI 10.1111/j.1600-0854.2005.00329.x; Martin TFJ, 2000, NAT CELL BIOL, V2, pE9, DOI 10.1038/71392; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Mueller VJ, 2004, J NEUROSCI, V24, P2004, DOI 10.1523/JNEUROSCI.4080-03.2004; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Pennuto M, 2003, MOL BIOL CELL, V14, P4909, DOI 10.1091/mbc.E03-06-0380; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Schikorski T, 1997, J NEUROSCI, V17, P5858; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Taubenblatt P, 1999, J CELL SCI, V112, P3559; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Vanden Berghe P, 2006, J PHYSIOL-LONDON, V572, P707, DOI 10.1113/jphysiol.2005.100842; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1	49	171	175	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1019	1027		10.1038/nn1739	http://dx.doi.org/10.1038/nn1739			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16845386	Green Published			2022-12-17	WOS:000240080300014
J	Toyofuku, T; Yoshida, J; Sugimoto, T; Zhang, H; Kumanogoh, A; Hori, M; Kikutani, H				Toyofuku, T; Yoshida, J; Sugimoto, T; Zhang, H; Kumanogoh, A; Hori, M; Kikutani, H			FARP2 triggers signals for Sema3A-mediated axonal repulsion	NATURE NEUROSCIENCE			English	Article							GROWTH-CONE COLLAPSE; NUCLEOTIDE EXCHANGE FACTOR; GTPASE-ACTIVATING PROTEIN; RECEPTOR PLEXIN-B1; CELL-ADHESION; FERM DOMAIN; RHO-GTPASES; FAMILY; BETA-1-INTEGRIN; MORPHOGENESIS	Sema3A, a prototypical semaphorin, acts as a chemorepellent or a chemoattractant for axons by activating a receptor complex comprising neuropilin-1 as the ligand-binding subunit and plexin-A1 as the signal-transducing subunit. How the signals downstream of plexin-A1 are triggered upon Sema3A stimulation, however, is unknown. Here we show that, in the presence of neuropilin-1, the FERM domain - containing guanine nucleotide exchange factor (GEF) FARP2 associates directly with plexin-A1. Sema3A binding to neuropilin-1 induces the dissociation of FARP2 from plexin-A1, resulting in activation of FARP2' s Rac GEF activity, Rnd1 recruitment to plexin-A1, and downregulation of R-Ras. Simultaneously, the FERM domain of FARP2 sequesters phosphatidylinositol phosphate kinase type I isoform PIPKI gamma 661 from talin, thereby inhibiting its kinase activity. These activities are required for Sema3A-mediated repulsion of outgrowing axons and suppression of neuronal adhesion. We therefore conclude that FARP2 is a key molecule involved in the response of neuronal growth cones to class-3 semaphorins.	Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Saitama 3326612, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Toyofuku, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	toyofuku@medone.med.osaka-u.ac.jp; kikutani@ragtime.biken.osaka-u.ac.jp	Kumanogoh, Atsushi/C-7354-2009; Kikutani, Hitoshi/C-9525-2009					Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Gallo G, 1998, CURR BIOL, V8, pR80, DOI 10.1016/S0960-9822(98)70051-X; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Grabham PW, 1997, J NEUROSCI, V17, P5455; Grabham PW, 2000, J CELL SCI, V113, P3003; Jin Z, 1997, J NEUROSCI, V17, P6256; Keely PJ, 1999, J CELL BIOL, V145, P1077, DOI 10.1083/jcb.145.5.1077; Koyano Y, 1997, BIOCHEM BIOPH RES CO, V241, P369, DOI 10.1006/bbrc.1997.7826; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kubo T, 2002, J NEUROSCI, V22, P8504; Kuhn TB, 1999, J NEUROSCI, V19, P1965; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Lin MZ, 2000, CELL, V101, P239, DOI 10.1016/S0092-8674(00)80833-8; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.3.CO;2-L; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Turner LJ, 2004, J BIOL CHEM, V279, P33199, DOI 10.1074/jbc.M402943200; Van Triest M, 2001, METHOD ENZYMOL, V333, P343; Vastrik I, 1999, CURR BIOL, V9, P991, DOI 10.1016/S0960-9822(99)80447-3; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X; ZHENG Y, 1995, METHOD ENZYMOL, V256, P77	43	171	184	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1712	1719		10.1038/nn1596	http://dx.doi.org/10.1038/nn1596			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286926				2022-12-17	WOS:000233576200020
J	Adolphs, R; Tranel, D; Buchanan, TW				Adolphs, R; Tranel, D; Buchanan, TW			Amygdala damage impairs emotional memory for gist but not details of complex stimuli	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; BASOLATERAL AMYGDALA; DECLARATIVE MEMORY; ENHANCED MEMORY; CONSOLIDATION; HIPPOCAMPUS; PERCEPTION; AROUSAL; EVENTS; STRESS	Neurobiological studies demonstrate the amygdala's role in emotional memory, and psychological studies suggest a particular pattern: enhanced memory for the gist but not the details of complex stimuli. We hypothesized that these two findings are related. Whereas normal ( n = 52) and brain- damaged ( n = 22) controls showed the expected enhancement of gist memory when the encoding context was emotional, persons with unilateral damage to the medial temporal lobe including the amygdala ( n = 16) did not show this pattern. Furthermore, amygdala volume showed a significant positive correlation with gist memory but not with overall memory. A further study in four subjects with selective medial temporal damage sparing the amygdala, and one with selective damage confined to the amygdala, confirmed the specificity of this effect to the amygdala. The data support a model whereby the amygdala focuses processing resources on gist, possibly accounting for features of traumatic memories and eyewitness testimony in real life.	CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; Univ Iowa, Coll Med, Dept Neurol, Div Cognit Neurosci, Iowa City, IA 52242 USA	California Institute of Technology; University of Iowa	Adolphs, R (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	radolphs@hss.caltech.edu		Tranel, Daniel/0000-0002-1338-1389; Buchanan, Tony/0000-0002-9166-8457	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067681] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH67681] Funding Source: Medline; PHS HHS [P01 19632] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; Adolphs R, 2001, BEHAV NEUROSCI, V115, P983, DOI 10.1037//0735-7044.115.5.983; Adolphs R., 2000, AMYGDALA FUNCTIONAL, P587; Akirav I, 1999, J NEUROSCI, V19, P10530; ALLEN JS, IN PRESS J CLIN NEUR; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Brierley B, 2004, J NEUROL NEUROSUR PS, V75, P593, DOI 10.1136/jnnp.2002.006403; BURKE A, 1992, MEM COGNITION, V20, P277, DOI 10.3758/BF03199665; Cahill L, 1995, CONSCIOUS COGN, V4, P410, DOI 10.1006/ccog.1995.1048; Cahill L, 2003, NEUROBIOL LEARN MEM, V79, P81, DOI 10.1016/S1074-7427(02)00019-9; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 2001, NEUROBIOL LEARN MEM, V75, P1, DOI 10.1006/nlme.2000.3999; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Canli T, 2000, J NEUROSCI, V20; CHRISTIANSON SA, 1991, COGNITION EMOTION, V5, P81, DOI 10.1080/02699939108411027; Dolan RS, 2000, NEUROIMAGE, V11, P203, DOI 10.1006/nimg.2000.0538; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; Frank RJ, 1997, NEUROIMAGE, V5, P13, DOI 10.1006/nimg.1996.0250; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Hamann SB, 1997, NEUROPSYCHOLOGY, V11, P104; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Ikegaya Y, 1996, EUR J NEUROSCI, V8, P1833, DOI 10.1111/j.1460-9568.1996.tb01327.x; Kensinger EA, 2004, P NATL ACAD SCI USA, V101, P3310, DOI 10.1073/pnas.0306408101; LaBar KS, 1998, PSYCHOL SCI, V9, P490, DOI 10.1111/1467-9280.00090; Lang P.J., 1988, INT AFFECTIVE PICTUR; Loftus Elizabeth F, 1996, EYEWITNESS TESTIMONY; MAASS A, 1989, LAW HUMAN BEHAV, V13, P397, DOI 10.1007/BF01056411; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Mori E, 1999, AM J PSYCHIAT, V156, P216; Packard MG, 1999, PSYCHOBIOLOGY, V27, P377; Parker A, 1998, J COGNITIVE NEUROSCI, V10, P691, DOI 10.1162/089892998563103; Phelps EA, 1997, BRAIN COGNITION, V35, P85, DOI 10.1006/brcg.1997.0929; Phelps EA, 1998, NEUROCASE, V4, P527, DOI 10.1080/13554799808410645; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; REISBERG D, 1992, EMORY S COG, V4, P162, DOI 10.1017/CBO9780511664069.009; Richardson MP, 2004, NAT NEUROSCI, V7, P278, DOI 10.1038/nn1190; Smith APR, 2004, J COGNITIVE NEUROSCI, V16, P760, DOI 10.1162/089892904970816; Wessel I, 1998, COGNITION EMOTION, V12, P93, DOI 10.1080/026999398379790	39	171	180	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					512	518		10.1038/nn1413	http://dx.doi.org/10.1038/nn1413			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	911XP	15735643				2022-12-17	WOS:000228040400023
J	Kiecker, C; Lumsden, A				Kiecker, C; Lumsden, A			Hedgehog signaling from the ZLI regulates diencephalic regional identity	NATURE NEUROSCIENCE			English	Article							PROGENITOR-CELL IDENTITY; VENTRAL NEURAL-TUBE; SONIC-HEDGEHOG; DEVELOPING BRAIN; EXPRESSION PATTERNS; PROSOMERIC MODEL; NEURONAL FATE; ZONA LIMITANS; LONG-RANGE; FOREBRAIN	The zona limitans intrathalamica (ZLI), a narrow compartment in the vertebrate forebrain that bisects the diencephalon transversely, expresses the secreted factor sonic hedgehog (Shh). Because genetic disruption of Shh in mouse causes severe early developmental defects, this strategy has not been useful in identifying a ZLI-specific role for this gene. To modulate Shh signaling in a spatiotemporally restricted manner, we carried out gain- and loss-of-function experiments in chick embryos using in ovo electroporation and found that Shh signaling is required for region-specific gene expression in thalamus and prethalamus, the major diencephalic brain areas flanking the ZLI. We further show that differential competence of thalamic and prethalamic primordia in responding to Shh signaling is regulated by the transcription factor Irx3. We show that, through the release of Shh, the ZLI functions as a local signaling center that regulates the acquisition of identity for these important diencephalic regions.	Univ London Kings Coll, MRC, Ctr Dev Neurobiol, London SE1 1UL, England	University of London; King's College London	Lumsden, A (corresponding author), Univ London Kings Coll, MRC, Ctr Dev Neurobiol, 4th Floor,New Hunts House,Guys Hosp Campus, London SE1 1UL, England.	andrew.lumsden@kcl.ac.uk	Kiecker, Clemens/C-7170-2009; Lumsden, Andrew/C-5146-2009					Agarwala S, 2001, SCIENCE, V291, P2147, DOI 10.1126/science.1058624; Braun MM, 2003, DEVELOPMENT, V130, P5579, DOI 10.1242/dev.00685; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Caspary T, 2002, CURR BIOL, V12, P1628, DOI 10.1016/S0960-9822(02)01147-8; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Echevarria D, 2003, BRAIN RES REV, V43, P179, DOI 10.1016/j.brainresrev.2003.08.002; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; FIGDOR MC, 1993, NATURE, V363, P630, DOI 10.1038/363630a0; Garcia-Lopez R, 2004, DEV BIOL, V268, P514, DOI 10.1016/j.ydbio.2003.12.038; Gomez-Skarmeta JL, 2002, CURR OPIN GENET DEV, V12, P403, DOI 10.1016/S0959-437X(02)00317-9; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Hargrave M, 2000, DEV BIOL, V219, P142, DOI 10.1006/dbio.1999.9581; Hashimoto-Torii K, 2003, MECH DEVELOP, V120, P1097, DOI 10.1016/j.mod.2003.09.001; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Ishibashi M, 2002, DEVELOPMENT, V129, P4807; Jessell TM, 2000, CURR OPIN NEUROBIOL, V10, P599, DOI 10.1016/S0959-4388(00)00136-7; Kawakami T, 2002, DEVELOPMENT, V129, P5753, DOI 10.1242/dev.00178; Kitamura K, 1997, MECH DEVELOP, V67, P83, DOI 10.1016/S0925-4773(97)00110-X; Kobayashi D, 2002, DEVELOPMENT, V129, P83; Larsen CW, 2001, J NEUROSCI, V21, P4699, DOI 10.1523/JNEUROSCI.21-13-04699.2001; Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Matsumoto K, 2004, NAT NEUROSCI, V7, P605, DOI 10.1038/nn1249; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Nakamura H, 2000, DEV GROWTH DIFFER, V42, P199; Niss K, 1998, MECH DEVELOP, V76, P151, DOI 10.1016/S0925-4773(98)00103-8; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Pasini A, 2002, BIOESSAYS, V24, P427, DOI 10.1002/bies.10085; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; RUBENSTEIN JLR, 1994, SCIENCE, V266, P578, DOI 10.1126/science.7939711; RUIZ IAA, 2002, NAT REV NEUROSCI, V3, P24, DOI DOI 10.1038/NRN704; Shimamura K, 1995, DEVELOPMENT, V121, P3923; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Zeltser LM, 2001, NAT NEUROSCI, V4, P683, DOI 10.1038/89455	50	171	171	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1242	1249		10.1038/nn1338	http://dx.doi.org/10.1038/nn1338			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494730				2022-12-17	WOS:000224749400017
J	Nabekura, J; Katsurabayashi, S; Kakazu, Y; Shibata, S; Matsubara, A; Jinno, S; Mizoguchi, Y; Sasaki, A; Ishibashi, H				Nabekura, J; Katsurabayashi, S; Kakazu, Y; Shibata, S; Matsubara, A; Jinno, S; Mizoguchi, Y; Sasaki, A; Ishibashi, H			Developmental switch from GABA to glycine release in single central synaptic terminals	NATURE NEUROSCIENCE			English	Article							LATERAL SUPERIOR OLIVE; AUDITORY BRAIN-STEM; GAMMA-AMINOBUTYRIC-ACID; POSTSYNAPTIC CURRENTS; NEURONS; RECEPTORS; INHIBITION; MOTONEURONS; GLUTAMATE; SYSTEM	Early in postnatal development, inhibitory inputs to rat lateral superior olive (LSO) neurons change from releasing predominantly GABA to releasing predominantly glycine into the synapse. Here we show that spontaneous miniature inhibitory postsynaptic currents (mIPSCs) also change from GABAergic to glycinergic over the first two postnatal weeks. Many 'mixed' mIPSCs, resulting from co-release of glycine and GABA from the same vesicles, are seen during this transition. Immunohistochemistry showed that a large number of terminals contained both GABA and glycine at postnatal day 8 (P8). By P14, both the content of GABA in these mixed terminals and the contribution of GABA to the mixed mIPSCs had decreased. The content of glycine in terminals increased over the same period. Our results indicate that switching from GABAergic to glycinergic inputs to the LSO may occur at the level of a single presynaptic terminal. This demonstrates a new form of developmental plasticity at the level of a single central synapse.	Kyushu Univ, Grad Sch Med Sci, Dept Cellular & Syst Physiol, Fukuoka 8128582, Japan; Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; Hirosaki Univ, Sch Med, Dept Otorhinolaryngol, Hirosaki, Aomori 0368562, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Anat & Neurobiol, Fukuoka 8128582, Japan	Kyushu University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Hirosaki University; Kyushu University	Nabekura, J (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Cellular & Syst Physiol, Fukuoka 8128582, Japan.							Akaike N, 2003, TRENDS PHARMACOL SCI, V24, P44, DOI 10.1016/S0165-6147(02)00010-X; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Chang EH, 2003, J NEUROPHYSIOL, V90, P1479, DOI 10.1152/jn.00386.2003; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Dumoulin A, 2001, J NEUROSCI, V21, P6045, DOI 10.1523/JNEUROSCI.21-16-06045.2001; Friauf E, 1997, J COMP NEUROL, V385, P117, DOI 10.1002/(SICI)1096-9861(19970818)385:1<117::AID-CNE7>3.0.CO;2-5; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Gao XB, 2001, J NEUROPHYSIOL, V85, P425, DOI 10.1152/jn.2001.85.1.425; Gasnier B, 2000, BIOCHIMIE, V82, P327, DOI 10.1016/S0300-9084(00)00221-2; HABECKER BA, 1995, DEV BIOL, V167, P307, DOI 10.1006/dbio.1995.1025; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Kakazu Y, 2000, J NEUROPHYSIOL, V84, P281, DOI 10.1152/jn.2000.84.1.281; Kakazu Y, 1999, J NEUROSCI, V19, P2843; KANDLER K, 1995, J NEUROSCI, V15, P6890; KAUFMAN DL, 1986, SCIENCE, V232, P1138, DOI 10.1126/science.3518061; Keller AF, 2001, J NEUROSCI, V21, P7871, DOI 10.1523/JNEUROSCI.21-20-07871.2001; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; Korada S, 1999, J COMP NEUROL, V409, P664, DOI 10.1002/(SICI)1096-9861(19990712)409:4<664::AID-CNE10>3.0.CO;2-S; Kotak VC, 1998, J NEUROSCI, V18, P4646; Kotak VC, 2001, J NEUROPHYSIOL, V86, P536, DOI 10.1152/jn.2001.86.1.536; Kullmann PHM, 2002, EUR J NEUROSCI, V15, P1093, DOI 10.1046/j.1460-9568.2002.01946.x; Lauder JM, 1998, PERSPECT DEV NEUROBI, V5, P247; Levi S, 1999, J NEUROSCI, V19, P7434, DOI 10.1523/JNEUROSCI.19-17-07434.1999; Matsubara A, 1996, J NEUROSCI, V16, P4457; Nabekura J, 1996, J NEUROPHYSIOL, V76, P2447, DOI 10.1152/jn.1996.76.4.2447; O'Brien JA, 1999, J NEUROPHYSIOL, V82, P1638, DOI 10.1152/jn.1999.82.3.1638; Ornung G, 1996, J COMP NEUROL, V365, P413; OTIS TS, 1994, P NATL ACAD SCI USA, V91, P7698, DOI 10.1073/pnas.91.16.7698; OTTERSEN OP, 1992, NEUROSCIENCE, V46, P519, DOI 10.1016/0306-4522(92)90141-N; Rietzel HJ, 1998, J COMP NEUROL, V390, P20; Russier M, 2002, J PHYSIOL-LONDON, V541, P123, DOI 10.1113/jphysiol.2001.016063; SANES DH, 1991, J NEUROBIOL, V22, P837, DOI 10.1002/neu.480220805; Sanes DH, 2000, HEARING RES, V147, P46, DOI 10.1016/S0378-5955(00)00119-2; SCHOTZINGER RJ, 1988, NATURE, V335, P637, DOI 10.1038/335637a0; Smith AJ, 2000, J PHYSIOL-LONDON, V529, P681, DOI 10.1111/j.1469-7793.2000.00681.x; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; Yang HW, 1997, BRAIN RES, V749, P301, DOI 10.1016/S0006-8993(96)01326-1	40	171	177	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					17	23		10.1038/nn1170	http://dx.doi.org/10.1038/nn1170			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699415				2022-12-17	WOS:000187636000008
J	Bushara, KO; Hanakawa, T; Immisch, I; Toma, K; Kansaku, K; Hallett, M				Bushara, KO; Hanakawa, T; Immisch, I; Toma, K; Kansaku, K; Hallett, M			Neural correlates of cross-modal binding	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; ATTENTION; CORTEX	Little is known about how the brain binds together signals from multiple sensory modalities to produce unified percepts of objects and events in the external world. Using event-related functional magnetic resonance imaging (fMRI) in humans, we measured transient brain responses to auditory/visual binding, as evidenced by a sound-induced change in visual motion perception. Identical auditory and visual stimuli were presented in all trials, but in some trials they were perceived to be bound together and in others they were perceived as unbound unimodal events. Cross-modal binding was associated with higher activity in multimodal areas, but lower activity in predominantly unimodal areas. This activation pattern suggests that a reciprocal and 'competitive' interaction between multimodal and unimodal areas underlies the perceptual interpretation of simultaneous signals from multiple sensory modalities.	Minneapolis Vet Affairs Med Ctr, Serv Neurol, Minneapolis, MN 55417 USA; NINDS, Human Motor Control Sect, NIH, Bethesda, MD 20892 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Bushara, KO (corresponding author), Minneapolis Vet Affairs Med Ctr, Serv Neurol, Room 4B135,1 Vet Dr, Minneapolis, MN 55417 USA.	busha001@umn.edu	Hanakawa, Takashi/A-6536-2011		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002669, ZIANS002669] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALHO K, 1994, PSYCHOPHYSIOLOGY, V31, P469, DOI 10.1111/j.1469-8986.1994.tb01050.x; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Driver J, 1996, NATURE, V381, P66, DOI 10.1038/381066a0; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MORRELL LK, 1968, J EXP PSYCHOL, V77, P14, DOI 10.1037/h0021289; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Spence C, 2001, PERCEPT PSYCHOPHYS, V63, P330, DOI 10.3758/BF03194473; Stein BE, 1998, EXP BRAIN RES, V123, P124, DOI 10.1007/s002210050553; VANGELDEREN P, 1995, P NATL ACAD SCI USA, V92, P6906, DOI 10.1073/pnas.92.15.6906; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79	16	171	173	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					190	195		10.1038/nn993	http://dx.doi.org/10.1038/nn993			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12496761				2022-12-17	WOS:000180669100020
J	Lloyd, DM; Shore, DI; Spence, C; Calvert, GA				Lloyd, DM; Shore, DI; Spence, C; Calvert, GA			Multisensory representation of limb position in human premotor cortex	NATURE NEUROSCIENCE			English	Article							VIBROTACTILE REACTION-TIMES; HAND; TOUCH; ARM		McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada; John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	McMaster University; University of Oxford; University of Oxford; University of Oxford	Shore, DI (corresponding author), McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada.		Shore, David I/F-5109-2010	Calvert, Gemma/0000-0002-5487-8076; Lloyd, Donna/0000-0003-3589-7383				Beltramello A, 1998, ITAL J NEUROL SCI, V19, P277, DOI 10.1007/BF00713853; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; BRADSHAW JL, 1988, CAN J PSYCHOL, V42, P44, DOI 10.1037/h0084178; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Groh JM, 1996, J NEUROPHYSIOL, V75, P412, DOI 10.1152/jn.1996.75.1.412; Ladavas E, 2000, EXP BRAIN RES, V131, P458, DOI 10.1007/s002219900264; Obayashi S, 2000, NEUROREPORT, V11, P3499, DOI 10.1097/00001756-200011090-00020; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; PIERSONSAVAGE JM, 1988, BRAIN, V111, P1531, DOI 10.1093/brain/111.6.1531; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; Spence C, 2001, PSYCHOL SCI, V12, P90, DOI 10.1111/1467-9280.00316; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	14	171	173	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					17	18		10.1038/nn991	http://dx.doi.org/10.1038/nn991			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12483217				2022-12-17	WOS:000180089300009
J	Tarr, MJ; Williams, P; Hayward, WG; Gauthier, I				Tarr, MJ; Williams, P; Hayward, WG; Gauthier, I			Three-dimensional object recognition is viewpoint dependent	NATURE NEUROSCIENCE			English	Article							3-DIMENSIONAL OBJECTS; TEMPORAL CORTEX; INVARIANCE; VIEW		Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA; Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA; Univ Wollongong, Dept Psychol, Wollongong, NSW 2552, Australia; Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Brown University; University of Massachusetts System; University of Massachusetts Boston; University of Wollongong; Yale University	Tarr, MJ (corresponding author), Brown Univ, Dept Cognit & Linguist Sci, Box 1978, Providence, RI 02912 USA.	Michael_Tarr@brown.edu	Hayward, William G/C-2369-2009; Hayward, William Gordon/D-4911-2009	Hayward, William/0000-0002-7248-0301; Gauthier, Isabel/0000-0002-6249-4769				BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; BIEDERMAN I, 1993, J EXP PSYCHOL HUMAN, V19, P1162, DOI 10.1037/0096-1523.19.6.1162; BULTHOFF HH, 1992, P NATL ACAD SCI USA, V89, P60, DOI 10.1073/pnas.89.1.60; Hayward WG, 1997, J EXP PSYCHOL HUMAN, V23, P1511, DOI 10.1037/0096-1523.23.5.1511; HUMPHREY GK, 1992, CAN J PSYCHOL, V46, P170, DOI 10.1037/h0084320; JOLICOEUR P, 1985, MEM COGNITION, V13, P289, DOI 10.3758/BF03202498; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Marr D., 1982, VISION COMPUTATIONAL; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Tarr MJ, 1997, PSYCHOL SCI, V8, P282, DOI 10.1111/j.1467-9280.1997.tb00439.x; TARR MJ, 1995, PSYCHON B REV, V2, P55, DOI 10.3758/BF03214412	13	171	175	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					275	277		10.1038/1089	http://dx.doi.org/10.1038/1089			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	127QD	10195159				2022-12-17	WOS:000076361300009
J	Shine, JM; Breakspear, M; Bell, PT; Martens, KE; Shine, R; Koyejo, O; Sporns, O; Poldrack, RA				Shine, James M.; Breakspear, Michael; Bell, Peter T.; Martens, Kayla Ehgoetz; Shine, Richard; Koyejo, Oluwasanmi; Sporns, Olaf; Poldrack, Russell A.			Human cognition involves the dynamic integration of neural activity and neuromodulatory systems	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL CONNECTIVITY; BRAIN DYNAMICS; CONNECTOME; NETWORKS; ARCHITECTURES; MODELS; CORE	The human brain integrates diverse cognitive processes into a coherent whole, shifting fluidly as a function of changing environmental demands. Despite recent progress, the neurobiological mechanisms responsible for this dynamic system-level integration remain poorly understood. Here we investigated the spatial, dynamic, and molecular signatures of system-wide neural activity across a range of cognitive tasks. We found that neuronal activity converged onto a low-dimensional manifold that facilitates the execution of diverse task states. Flow within this attractor space was associated with dissociable cognitive functions, unique patterns of network-level topology, and individual differences in fluid intelligence. The axes of the low-dimensional neurocognitive architecture aligned with regional differences in the density of neuromodulatory receptors, which in turn relate to distinct signatures of network controllability estimated from the structural connectome. These results advance our understanding of functional brain organization by emphasizing the interface between neural activity, neuromodulatory systems, and cognitive function.	[Shine, James M.; Martens, Kayla Ehgoetz; Shine, Richard] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia; [Breakspear, Michael] QIMR Berghofer, Brisbane, Qld, Australia; [Breakspear, Michael] Metro North Mental Hlth Serv, Brisbane, Qld, Australia; [Breakspear, Michael] Univ Newcastle, Hunter Med Res Inst, Callaghan, NSW, Australia; [Bell, Peter T.] 5Univ Queensland, Brisbane, Qld, Australia; [Shine, Richard] Macquarie Univ, Sydney, NSW, Australia; [Koyejo, Oluwasanmi] Univ Illinois, Champaign, IL USA; [Sporns, Olaf] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Poldrack, Russell A.] Stanford Univ, Dept Psychol, Stanford, CA USA	University of Sydney; QIMR Berghofer Medical Research Institute; Hunter Medical Research Institute; University of Newcastle; Macquarie University; University of Illinois System; University of Illinois Urbana-Champaign; Indiana University System; Indiana University Bloomington; Stanford University	Shine, JM (corresponding author), Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia.	mac.shine@sydney.edu.au	Sporns, Olaf/A-1667-2010; Breakspear, Michael/ABF-6302-2020	Sporns, Olaf/0000-0001-7265-4036; Breakspear, Michael/0000-0003-4943-3969; Poldrack, Russell/0000-0001-6755-0259; Shine, James/0000-0003-1762-5499	NHMRC CJ Martin Fellowship [GNT1072403]; University of Sydney SOAR Fellowship	NHMRC CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney SOAR Fellowship	We would like to thank T. Verstynen for the diffusion data, and D. Bassett for the controllability code. The funding for the study was provided by an NHMRC CJ Martin Fellowship (GNT1072403) and a University of Sydney SOAR Fellowship (J.M.S.).	Al-Aidroos N, 2012, P NATL ACAD SCI USA, V109, P14675, DOI 10.1073/pnas.1202095109; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Avery MC, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00108; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bell PT, 2016, NEUROSCI BIOBEHAV R, V71, P313, DOI 10.1016/j.neubiorev.2016.08.036; Boly M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125337; Breakspear M, 2017, NAT NEUROSCI, V20, P340, DOI 10.1038/nn.4497; Brezina V, 2010, PHILOS T R SOC B, V365, P2363, DOI 10.1098/rstb.2010.0105; BROOMHEAD DS, 1986, PHYSICA D, V20, P217, DOI 10.1016/0167-2789(86)90031-X; Cocchi L, 2017, PROG NEUROBIOL, V158, P132, DOI 10.1016/j.pneurobio.2017.07.002; Cohen J, 2002, CURR OPIN NEUROBIOL, V12, P223, DOI 10.1016/S0959-4388(02)00314-8; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; Cunningham JP, 2014, NAT NEUROSCI, V17, P1500, DOI 10.1038/nn.3776; DeSalvo MN, 2014, BRAIN BEHAV, V4, P877, DOI 10.1002/brb3.286; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Fulcher BD, 2016, P NATL ACAD SCI USA, V113, P1435, DOI 10.1073/pnas.1513302113; Ghosh A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000196; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Gollo LL, 2015, PHILOS T R SOC B, V370, P54, DOI 10.1098/rstb.2014.0165; Gordon EM, 2016, CEREB CORTEX, V26, P288, DOI 10.1093/cercor/bhu239; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Gu S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9414; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Honey CJ, 2012, NEURON, V76, P423, DOI 10.1016/j.neuron.2012.08.011; Huys R, 2014, PSYCHOL REV, V121, P302, DOI 10.1037/a0037014; Kato S, 2015, CELL, V163, P656, DOI 10.1016/j.cell.2015.09.034; Kennel MB, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026209; Krienen FM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0526; Le Van Quyen M, 2003, BIOL RES, V36, P67, DOI 10.4067/S0716-97602003000100006; Lemon WC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8924; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Moran RJ, 2013, J NEUROSCI, V33, P8227, DOI 10.1523/JNEUROSCI.4255-12.2013; Nichols ALA, 2017, SCIENCE, V356, DOI 10.1126/science.aam6851; Ott E, 2008, CHAOS, V18, DOI 10.1063/1.2930766; Pillai AS, 2017, NEURON, V94, P1010, DOI 10.1016/j.neuron.2017.05.013; Poldrack RA, 2016, ANNU REV PSYCHOL, V67, P587, DOI 10.1146/annurev-psych-122414-033729; Poldrack RA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002707; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2013, NEURON, V79, P798, DOI 10.1016/j.neuron.2013.07.035; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shine JM, 2018, NEUROIMAGE, V180, P396, DOI 10.1016/j.neuroimage.2017.08.010; Shine JM, 2018, ELIFE, V7, DOI 10.7554/eLife.31130; Shine JM, 2016, NEURON, V92, P544, DOI 10.1016/j.neuron.2016.09.018; Shine JM, 2015, NEUROIMAGE, V122, P399, DOI 10.1016/j.neuroimage.2015.07.064; Stitt I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08050-6; Thompson WH, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006196; Tononi G, 1999, P NATL ACAD SCI USA, V96, P3257, DOI 10.1073/pnas.96.6.3257; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; Tu CY, 2018, NEUROIMAGE, V176, P83, DOI 10.1016/j.neuroimage.2018.04.010; van den Heuvel MP, 2016, TRENDS COGN SCI, V20, P345, DOI 10.1016/j.tics.2016.03.001; van den Heuvel MP, 2013, J NEUROSCI, V33, P14489, DOI 10.1523/JNEUROSCI.2128-13.2013; Puig MV, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00058; Vidaurre D, 2017, P NATL ACAD SCI USA, V114, P12827, DOI 10.1073/pnas.1705120114; Woodman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064339; Yeh FC, 2018, NEUROIMAGE, V178, P57, DOI 10.1016/j.neuroimage.2018.05.027	60	170	171	11	58	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2019	22	2					289	+		10.1038/s41593-018-0312-0	http://dx.doi.org/10.1038/s41593-018-0312-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HI9BQ	30664771				2022-12-17	WOS:000456750100015
J	Herisson, F; Frodermann, V; Courties, G; Rohde, D; Sun, Y; Vandoorne, K; Wojtkiewicz, GR; Masson, GS; Vinegoni, C; Kim, J; Kim, DE; Weissleder, R; Swirski, FK; Moskowitz, MA; Nahrendorf, M				Herisson, Fanny; Frodermann, Vanessa; Courties, Gabriel; Rohde, David; Sun, Yuan; Vandoorne, Katrien; Wojtkiewicz, Gregory R.; Masson, Gustavo Santos; Vinegoni, Claudio; Kim, Jiwon; Kim, Dong-Eog; Weissleder, Ralph; Swirski, Filip K.; Moskowitz, Michael A.; Nahrendorf, Matthias			Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration	NATURE NEUROSCIENCE			English	Article							COMPUTED-TOMOGRAPHY; MAST-CELLS; STROKE; PATHOLOGY; SYSTEM; MOUSE; INFLAMMATION; NEUTROPHILS; VESSELS; HUMANS	Innate immune cells recruited to inflammatory sites have short life spans and originate from the marrow, which is distributed throughout the long and flat bones. While bone marrow production and release of leukocyte increases after stroke, it is currently unknown whether its activity rises homogeneously throughout the entire hematopoietic system. To address this question, we employed spectrally resolved in vivo cell labeling in the murine skull and tibia. We show that in murine models of stroke and aseptic meningitis, skull bone marrow-derived neutrophils are more likely to migrate to the adjacent brain tissue than cells that reside in the tibia. Confocal microscopy of the skull-dura interface revealed myeloid cell migration through microscopic vascular channels crossing the inner skull cortex. These observations point to a direct local interaction between the brain and the skull bone marrow through the meninges.	[Herisson, Fanny; Frodermann, Vanessa; Courties, Gabriel; Rohde, David; Sun, Yuan; Vandoorne, Katrien; Wojtkiewicz, Gregory R.; Masson, Gustavo Santos; Vinegoni, Claudio; Weissleder, Ralph; Swirski, Filip K.; Nahrendorf, Matthias] Massachusetts Gen Hosp, Dept Imaging, Ctr Syst Biol, Boston, MA 02114 USA; [Herisson, Fanny; Frodermann, Vanessa; Courties, Gabriel; Rohde, David; Sun, Yuan; Vandoorne, Katrien; Wojtkiewicz, Gregory R.; Masson, Gustavo Santos; Vinegoni, Claudio; Weissleder, Ralph; Swirski, Filip K.; Moskowitz, Michael A.; Nahrendorf, Matthias] Harvard Med Sch, Boston, MA 02115 USA; [Kim, Jiwon; Kim, Dong-Eog] Dongguk Univ, Dept Neurol, Mol Imaging & Neurovasc Res Lab, Coll Med, Goyang, South Korea; [Weissleder, Ralph] Harvard Med Sch, Dept Syst Biol, Boston, MA USA; [Moskowitz, Michael A.] Massachusetts Gen Hosp, Dept Radiol, Stroke & Neurovasc Regulat Lab, Boston, MA USA; [Moskowitz, Michael A.] Massachusetts Gen Hosp, Dept Neurol, Stroke & Neurovasc Regulat Lab, Boston, MA 02114 USA; [Nahrendorf, Matthias] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Dongguk University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Dept Imaging, Ctr Syst Biol, Boston, MA 02114 USA.; Nahrendorf, M (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.	mnahrendorf@mgh.harvard.edu	Vinegoni, Claudio/A-9490-2012; vinegoni, claudio/AGU-2461-2022; Swirski, Filip/AAF-1340-2019; Wojtkiewicz, Gregory/L-3660-2018	Vinegoni, Claudio/0000-0002-9818-3639; Frodermann, Vanessa/0000-0001-5566-6692; Wojtkiewicz, Gregory/0000-0002-3148-8411; Swirski, Filip/0000-0002-3163-9152; Courties, Gabriel/0000-0002-0003-7407; Vandoorne, Katrien/0000-0002-8132-8280	National Institutes of Health [NS084863, HL139598]; American Heart Association [16SDG30190009]; Cure Alzheimer's Fund; Global Research Lab (GRL) program of the National Research Foundation, Korean government [NRF-2015K1A1A2028228]; Netherlands Organisation for Scientific Research (NWO) [835.15.014]; Deutsche Forschungsgemeinschaft [RO5071/1-1]; MGH Research Scholar program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL139598, R01HL128264, R01HL131495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Cure Alzheimer's Fund; Global Research Lab (GRL) program of the National Research Foundation, Korean government; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MGH Research Scholar program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank M. Ericsson (HMS Electron Microscopy Facility) for skull sample preparation, sectioning, and assistance with EM imaging. We acknowledge D. Capen (Center for Systems Biology and Program in Membrane Biology/Division of Nephrology, MGH) for help with interpretation of electron microscopy data. The authors thank the MGH mouse imaging program and the Center for Skeletal Research Core (NIH P30 AR066261) for assistance with imaging. This work was funded in part by grants from the National Institutes of Health (NS084863 and HL139598), the American Heart Association (16SDG30190009), the Cure Alzheimer's Fund, the Global Research Lab (GRL) program (NRF-2015K1A1A2028228) of the National Research Foundation by the Korean government, and by fellowships from the Netherlands Organisation for Scientific Research (NWO, Rubicon Grant: 835.15.014), the Deutsche Forschungsgemeinschaft (RO5071/1-1), and the MGH Research Scholar program.	Abtin A, 2014, NAT IMMUNOL, V15, P45, DOI 10.1038/ni.2769; Adeeb N, 2012, CHILD NERV SYST, V28, P827, DOI 10.1007/s00381-012-1744-6; Arac A, 2014, AM J PATHOL, V184, P2493, DOI 10.1016/j.ajpath.2014.06.003; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Coles JA, 2017, PROG NEUROBIOL, V156, P107, DOI 10.1016/j.pneurobio.2017.05.002; Courties G, 2015, CIRC RES, V116, P407, DOI 10.1161/CIRCRESAHA.116.305207; Courties G, 2014, JAMA NEUROL, V71, P233, DOI 10.1001/jamaneurol.2013.5026; Faraco G, 2017, J MOL MED, V95, P1143, DOI 10.1007/s00109-017-1573-x; GAMACHE DA, 1986, J NEUROSURG, V65, P679, DOI 10.3171/jns.1986.65.5.0679; Gelderblom M, 2015, AGEING RES REV, V24, P77, DOI 10.1016/j.arr.2015.07.004; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Hershkovitz I, 1999, AM J PHYS ANTHROPOL, V108, P345, DOI 10.1002/(SICI)1096-8644(199903)108:3<345::AID-AJPA9>3.3.CO;2-J; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Itkin T, 2016, NATURE, V532, P323, DOI 10.1038/nature17624; Jickling GC, 2015, J CEREBR BLOOD F MET, V35, P888, DOI 10.1038/jcbfm.2015.45; Kamel H, 2012, ARCH NEUROL-CHICAGO, V69, P576, DOI 10.1001/archneurol.2011.3590; Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b; Kim JY, 2015, THERANOSTICS, V5, P1098, DOI 10.7150/thno.11679; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Lelios I, 2014, METHODS MOL BIOL, V1193, P15, DOI 10.1007/978-1-4939-1212-4_2; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; McKittrick CM, 2015, J CEREBR BLOOD F MET, V35, P638, DOI 10.1038/jcbfm.2014.239; Michaud JP, 2013, CELL REP, V5, P646, DOI 10.1016/j.celrep.2013.10.010; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Park L, 2017, CIRC RES, V121, P258, DOI 10.1161/CIRCRESAHA.117.311054; Perez-de-Puig I, 2015, ACTA NEUROPATHOL, V129, P239, DOI 10.1007/s00401-014-1381-0; Prokop S, 2015, J EXP MED, V212, P1811, DOI 10.1084/jem.20150479; de Lazaro GR, 2016, AM J PHYS ANTHROPOL, V159, P313, DOI 10.1002/ajpa.22878; Sellner J, 2006, NEUROBIOL DIS, V21, P647, DOI 10.1016/j.nbd.2005.09.007; Shi YJ, 2016, TRANSL STROKE RES, V7, P89, DOI 10.1007/s12975-016-0447-9; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Zenaro E, 2015, NAT MED, V21, P880, DOI 10.1038/nm.3913; Zenker W, 1996, ANAT EMBRYOL, V193, P1	37	170	171	5	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2018	21	9					1209	+		10.1038/s41593-018-0213-2	http://dx.doi.org/10.1038/s41593-018-0213-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HL5SD	30150661	Green Accepted			2022-12-17	WOS:000458789500003
J	Krashes, MJ; Lowell, BB; Garfield, AS				Krashes, Michael J.; Lowell, Bradford B.; Garfield, Alastair S.			Melanocortin-4 receptor-regulated energy homeostasis	NATURE NEUROSCIENCE			English	Review							AGOUTI-RELATED PROTEIN; CENTRAL-NERVOUS-SYSTEM; MITOGEN-ACTIVATED PROTEIN; BROWN ADIPOSE-TISSUE; EARLY-ONSET OBESITY; PARAVENTRICULAR NUCLEUS; FOOD-INTAKE; INVERSE AGONIST; MESSENGER-RNA; AGRP NEURONS	The melanocortin system provides a conceptual blueprint for the central control of energetic state. Defined by four principal molecular components-two antagonistically acting ligands and two cognate receptors-this phylogenetically conserved system serves as a prototype for hierarchical energy balance regulation. Over the last decade the application of conditional genetic techniques has facilitated the neuroanatomical dissection of the melanocortinergic network and identified the specific neural substrates and circuits that underscore the regulation of feeding behavior, energy expenditure, glucose homeostasis and autonomic outflow. In this regard, the melanocortin-4 receptor is a critical coordinator of mammalian energy homeostasis and body weight. Drawing on recent advances in neuroscience and genetic technologies, we consider the structure and function of the melanocortin-4 receptor circuitry and its role in energy homeostasis.	[Krashes, Michael J.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Krashes, Michael J.] NIDA, NIH, Baltimore, MD USA; [Lowell, Bradford B.; Garfield, Alastair S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Dept Med,Med Sch, Boston, MA 02215 USA; [Garfield, Alastair S.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Edinburgh	Krashes, MJ (corresponding author), NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA.; Krashes, MJ (corresponding author), NIDA, NIH, Baltimore, MD USA.	michael.krashes@nih.gov; agarfiel@staffmail.ed.ac.uk	Krashes, Michael/P-7677-2019	Garfield, Alastair/0000-0002-9628-6140	University of Edinburgh; US National Institutes of Health [R01 DK096010, R01 DK089044, R01 DK071051, R01 DK075632, R37 DK053477, P30 DK046200, P30 DK057521, DK075087, DK075090]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, R01DK089044, R01DK075090, ZIADK075090, ZIADK075087, P30DK046200, R01DK096010, R37DK053477, R01DK071051, R01DK075632] Funding Source: NIH RePORTER	University of Edinburgh; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a University of Edinburgh Chancellor's Fellowship (A.S.G.) and US National Institutes of Health grants to B.B.L. (R01 DK096010, R01 DK089044, R01 DK071051, R01 DK075632, R37 DK053477, BNORC Transgenic Core P30 DK046200, BADERC Transgenic Core P30 DK057521) and to M.J.K. (Intramural Research Program, NIDDK; DK075087, DK075090).	Albarado DC, 2004, ENDOCRINOLOGY, V145, P243, DOI 10.1210/en.2003-0452; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Arble DM, 2015, ENDOCRINOLOGY, V156, P1685, DOI 10.1210/en.2014-1937; Asai M, 2013, SCIENCE, V341, P275, DOI 10.1126/science.1233000; Aston-Jones G, 2013, BRAIN RES, V1511, P1, DOI 10.1016/j.brainres.2013.01.026; Atasoy D, 2014, NAT NEUROSCI, V17, P1830, DOI 10.1038/nn.3854; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Bagnol D, 1999, J NEUROSCI, V19; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Becskei C, 2007, BRAIN RES, V1162, P76, DOI 10.1016/j.brainres.2007.06.016; Berglund ED, 2014, NAT NEUROSCI, V17, P911, DOI 10.1038/nn.3737; Berridge KC, 2004, PHYSIOL BEHAV, V81, P179, DOI 10.1016/j.physbeh.2004.02.004; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Bewick GA, 2005, FASEB J, V19, P1680, DOI 10.1096/fj.04-3434fje; Breit A, 2006, J BIOL CHEM, V281, P37447, DOI 10.1074/jbc.M605982200; Breit A, 2011, MOL CELL ENDOCRINOL, V331, P232, DOI 10.1016/j.mce.2010.07.007; Buch TRH, 2009, J BIOL CHEM, V284, P26411, DOI 10.1074/jbc.M109.039339; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Carter ME, 2015, J NEUROSCI, V35, P4582, DOI 10.1523/JNEUROSCI.3729-14.2015; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Chai BX, 2006, PEPTIDES, V27, P2846, DOI 10.1016/j.peptides.2006.05.005; Challis BG, 2004, P NATL ACAD SCI USA, V101, P4695, DOI 10.1073/pnas.0306931101; Chen AS, 2000, TRANSGENIC RES, V9, P145, DOI 10.1023/A:1008983615045; Chen KY, 2015, J CLIN ENDOCR METAB, V100, P1639, DOI 10.1210/jc.2014-4024; Chen M, 2012, ENDOCRINOLOGY, V153, P4256, DOI 10.1210/en.2012-1113; Chen M, 2009, CELL METAB, V9, P548, DOI 10.1016/j.cmet.2009.05.004; Coll AP, 2013, EUR J PHARMACOL, V719, P202, DOI 10.1016/j.ejphar.2013.04.051; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Corander MP, 2011, ENDOCRINOLOGY, V152, P1819, DOI 10.1210/en.2010-1450; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cui H, 2013, GENES BRAIN BEHAV, V12, P658, DOI 10.1111/gbb.12057; Cui HX, 2012, PHYSIOL BEHAV, V106, P201, DOI 10.1016/j.physbeh.2012.01.025; Daniels D, 2003, BRAIN RES, V986, P1, DOI 10.1016/S0006-8993(03)03162-7; Dietrich MO, 2015, CELL, V160, P1222, DOI 10.1016/j.cell.2015.02.024; Dodd GT, 2015, CELL, V160, P88, DOI 10.1016/j.cell.2014.12.022; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Fan W, 2004, NAT NEUROSCI, V7, P335, DOI 10.1038/nn1214; Fani L, 2014, INT J OBESITY, V38, P163, DOI 10.1038/ijo.2013.80; Farooqi IS, 2006, DIABETES, V55, P2549, DOI 10.2337/db06-0214; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Flak JN, 2014, NAT NEUROSCI, V17, P1744, DOI 10.1038/nn.3861; GANTZ I, 1993, J BIOL CHEM, V268, P15174; Garfield AS, 2015, NAT NEUROSCI, V18, P863, DOI 10.1038/nn.4011; Garfield AS, 2014, CELL METAB, V20, P1030, DOI 10.1016/j.cmet.2014.11.006; Garfield AS, 2009, TRENDS ENDOCRIN MET, V20, P203, DOI 10.1016/j.tem.2009.02.002; Gautron L, 2015, CELL, V161, P133, DOI 10.1016/j.cell.2015.02.023; Ghamari-Langroudi M, 2015, NATURE, V520, P94, DOI 10.1038/nature14051; Girardet C, 2014, BBA-MOL BASIS DIS, V1842, P482, DOI 10.1016/j.bbadis.2013.05.004; Greenfield JR, 2011, J NEUROENDOCRINOL, V23, P186, DOI 10.1111/j.1365-2826.2010.02088.x; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Haskell-Luevano C, 2001, REGUL PEPTIDES, V99, P1, DOI 10.1016/S0167-0115(01)00234-8; Hatoum IJ, 2012, J CLIN ENDOCR METAB, V97, pE1023, DOI 10.1210/jc.2011-3432; Hentges ST, 2009, J NEUROSCI, V29, P13684, DOI 10.1523/JNEUROSCI.3770-09.2009; Holder JL, 2004, AM J PHYSIOL-ENDOC M, V287, pE105, DOI 10.1152/ajpendo.00446.2003; Hull C.L., 1943, PRINCIPLES BEHAV INT, DOI DOI 10.2307/1416955; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jarvie BC, 2012, J COMP NEUROL, V520, P3863, DOI 10.1002/cne.23127; Keys Ancel, 1946, JOUR AMER DIETETIC ASSOC, V22, P582; Kievit P, 2013, DIABETES, V62, P490, DOI 10.2337/db12-0598; Kim MS, 2000, DIABETES, V49, P177, DOI 10.2337/diabetes.49.2.177; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Krude H, 2003, J CLIN ENDOCR METAB, V88, P4633, DOI 10.1210/jc.2003-030502; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; Kumar KG, 2009, PEPTIDES, V30, P1892, DOI 10.1016/j.peptides.2009.07.012; Kuo JJ, 2004, HYPERTENSION, V43, P370, DOI 10.1161/01.HYP.0000111836.54204.93; Kuo JJ, 2003, HYPERTENSION, V41, P768, DOI 10.1161/01.HYP.0000048194.97428.1A; Lee ECY, 2015, PHARM PAT ANAL, V4, P95, DOI [10.4155/PPA.15.1, 10.4155/ppa.15.1]; Li P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080295; Li P, 2013, EXP PHYSIOL, V98, P435, DOI 10.1113/expphysiol.2012.067256; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Mandelblat-Cerf Y, 2015, ELIFE, V4, DOI 10.7554/eLife.07122; Marsh DJ, 1999, NAT GENET, V21, P119, DOI 10.1038/5070; Michaud JL, 2001, HUM MOL GENET, V10, P1465, DOI 10.1093/hmg/10.14.1465; Millington GWM, 2001, NEUROSCIENCE, V108, P437, DOI 10.1016/S0306-4522(01)00428-6; Mirshahi UL, 2011, J CLIN ENDOCR METAB, V96, pE2088, DOI 10.1210/jc.2011-1549; Molosh AI, 2013, NEUROPSYCHOPHARMACOL, V38, P1352, DOI 10.1038/npp.2013.33; Monge-Roffarello B, 2014, AM J PHYSIOL-REG I, V307, pR158, DOI 10.1152/ajpregu.00059.2014; Morgan DA, 2015, DIABETES, V64, P1976, DOI 10.2337/db14-1257; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; NAGAI K, 1987, J CLIN BIOCHEM NUTR, V3, P103, DOI 10.3164/jcbn.3.103; Newman EA, 2006, J SURG RES, V132, P201, DOI 10.1016/j.jss.2006.02.003; Ni XP, 2006, J HYPERTENS, V24, P2239, DOI 10.1097/01.hjh.0000249702.49854.fa; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Panaro BL, 2014, CELL METAB, V20, P1018, DOI 10.1016/j.cmet.2014.10.004; Perez-Tilve D, 2010, NAT NEUROSCI, V13, P877, DOI 10.1038/nn.2569; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Richard D, 2011, FRONT BIOSCI-LANDMRK, V16, P1233, DOI 10.2741/3786; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; Sebag JA, 2013, SCIENCE, V341, P278, DOI 10.1126/science.1232995; Semjonous NM, 2009, INT J OBESITY, V33, P775, DOI 10.1038/ijo.2009.96; Shah BP, 2014, P NATL ACAD SCI USA, V111, P13193, DOI 10.1073/pnas.1407843111; Shen Y, 2013, J NEUROSCI, V33, P464, DOI 10.1523/JNEUROSCI.3282-12.2013; SIMS JS, 1986, BEHAV BRAIN RES, V22, P265, DOI 10.1016/0166-4328(86)90071-9; Skibicka KP, 2009, ENDOCRINOLOGY, V150, P5351, DOI 10.1210/en.2009-0804; Sohn JW, 2013, CELL, V152, P612, DOI 10.1016/j.cell.2012.12.022; Song CK, 2008, AM J PHYSIOL-REG I, V295, pR417, DOI 10.1152/ajpregu.00174.2008; Song CK, 2005, AM J PHYSIOL-REG I, V289, pR1467, DOI 10.1152/ajpregu.00348.2005; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Sutton GM, 2006, ENDOCRINOLOGY, V147, P2183, DOI 10.1210/en.2005-1209; Tallam LS, 2006, HYPERTENSION, V48, P58, DOI 10.1161/01.HYP.0000227966.36744.d9; Tallam LS, 2005, HYPERTENSION, V46, P326, DOI 10.1161/01.HYP.0000175474.99326.bf; Thiele TE, 1998, AM J PHYSIOL-REG I, V274, pR248, DOI 10.1152/ajpregu.1998.274.1.R248; Tolle V, 2008, DIABETES, V57, P86, DOI 10.2337/db07-0733; Tolson KP, 2014, ENDOCRINOLOGY, V155, P2436, DOI 10.1210/en.2013-2125; Turer AT, 2012, CIRC RES, V111, P1565, DOI [10.1161/CIRCRESAHA.111.262493, 10.1161/circresaha.111.262493]; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Vardy E, 2015, NEURON, V86, P936, DOI 10.1016/j.neuron.2015.03.065; Vaughan C, 2006, PEPTIDES, V27, P2829, DOI 10.1016/j.peptides.2006.07.008; Vaughan CH, 2011, BRAIN RES, V1411, P17, DOI 10.1016/j.brainres.2011.07.003; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Vongs A, 2004, REGUL PEPTIDES, V120, P113, DOI 10.1016/j.regpep.2004.02.018; Voss-Andreae A, 2007, ENDOCRINOLOGY, V148, P1550, DOI 10.1210/en.2006-1389; Wang DQ, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00040; Weide K, 2003, PHYSIOL GENOMICS, V13, P47, DOI 10.1152/physiolgenomics.00129.2002; Wittmann G, 2013, J COMP NEUROL, V521, P3287, DOI 10.1002/cne.23350; Xu YZ, 2013, CELL METAB, V18, P860, DOI 10.1016/j.cmet.2013.11.003; Yang YK, 1999, MOL ENDOCRINOL, V13, P148, DOI 10.1210/me.13.1.148; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Zhan C, 2013, J NEUROSCI, V33, P3624, DOI 10.1523/JNEUROSCI.2742-12.2013; Zhang YB, 2005, FASEB J, V19, P1482, DOI 10.1096/fj.05-3851com	140	170	177	0	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2016	19	2					206	219		10.1038/nn.4202	http://dx.doi.org/10.1038/nn.4202			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DC4EG	26814590	Green Accepted			2022-12-17	WOS:000369172600008
J	Park, HD; Correia, S; Ducorps, A; Tallon-Baudry, C				Park, Hyeong-Dong; Correia, Stephanie; Ducorps, Antoine; Tallon-Baudry, Catherine			Spontaneous fluctuations in neural responses to heartbeats predict visual detection	NATURE NEUROSCIENCE			English	Article							BRAIN ACTIVITY; DEFAULT-MODE; PREFRONTAL CORTEX; PARIETAL CORTEX; OSCILLATIONS; POTENTIALS; TASK; REPRESENTATION; PERFORMANCE; TOPOGRAPHY	Spontaneous fluctuations of ongoing neural activity substantially affect sensory and cognitive performance. Because bodily signals are constantly relayed up to the neocortex, neural responses to bodily signals are likely to shape ongoing activity. Here, using magnetoencephalography, we show that in humans, neural events locked to heartbeats before stimulus onset predict the detection of a faint visual grating in the posterior right inferior parietal lobule and the ventral anterior cingulate cortex, two regions that have multiple functional correlates and that belong to the same resting-state network. Neither fluctuations in measured bodily parameters nor overall cortical excitability could account for this finding. Neural events locked to heartbeats therefore shape visual conscious experience, potentially by contributing to the neural maps of the organism that might underlie subjectivity. Beyond conscious vision, our results show that neural events locked to a basic physiological input such as heartbeats underlie behaviorally relevant differential activation in multifunctional cortical areas.	[Park, Hyeong-Dong; Correia, Stephanie; Tallon-Baudry, Catherine] Ecole Normale Super, Cognit Neurosci Lab, INSERM, F-75231 Paris, France; [Ducorps, Antoine] Univ Paris 06, CNRS, INSERM, Cenir, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Tallon-Baudry, C (corresponding author), Ecole Normale Super, Cognit Neurosci Lab, INSERM, 24 Rue Lhomond, F-75231 Paris, France.	catherine.tallon-baudry@ens.fr	Tallon-Baudry, Catherine/J-8637-2015	Tallon-Baudry, Catherine/0000-0001-8480-5831; Park, Hyeong-Dong/0000-0001-9508-7353	Agence Nationale de la Recherche [ANR-BLAN-12-BSH2-0002-01, ANR-10-LABX-0087 IEC, ANR-10-IDEX-0001-02 PSL]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche grants ANR-BLAN-12-BSH2-0002-01 to C. T. B., ANR-10-LABX-0087 IEC and ANR-10-IDEX-0001-02 PSL<SUP>star</SUP>. We thank E. Koechlin for useful suggestions on the manuscript and C. Gitton for excellent technical support during data acquisition.	Amour J.A., 2004, BASIC CLIN NEUROCARD; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Boyle J, 2009, IEEE T INF TECHNOL B, V13, P890, DOI 10.1109/TITB.2009.2031239; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Christoff K, 2011, TRENDS COGN SCI, V15, P104, DOI 10.1016/j.tics.2011.01.001; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Crick F., 1990, Seminars in the Neurosciences, V2, P263; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; Damasio A, 2013, NAT REV NEUROSCI, V14, P143, DOI 10.1038/nrn3403; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dirlich G, 1998, EVOKED POTENTIAL, V108, P299, DOI 10.1016/S0168-5597(98)00003-3; Fan J, 2012, J NEUROSCI, V32, P11176, DOI 10.1523/JNEUROSCI.1172-12.2012; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fukushima H, 2011, INT J PSYCHOPHYSIOL, V79, P259, DOI 10.1016/j.ijpsycho.2010.10.015; Gray MA, 2007, P NATL ACAD SCI USA, V104, P6818, DOI 10.1073/pnas.0609509104; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; He BJ, 2013, J NEUROSCI, V33, P4672, DOI 10.1523/JNEUROSCI.2922-12.2013; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kern M, 2013, NEUROIMAGE, V81, P178, DOI 10.1016/j.neuroimage.2013.05.042; Lacey B.C., 1974, CARDIOVASCULAR PSYCH, P538; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Linkenkaer-Hansen K, 2004, J NEUROSCI, V24, P10186, DOI 10.1523/JNEUROSCI.2584-04.2004; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Macmillan NA., 2005, DETECTION THEORY USE; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P23, DOI 10.1016/0013-4694(93)90064-3; Marguet SL, 2011, J NEUROSCI, V31, P6414, DOI 10.1523/JNEUROSCI.5773-10.2011; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; MONTOYA P, 1993, ELECTROEN CLIN NEURO, V88, P163, DOI 10.1016/0168-5597(93)90001-6; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Palva JM, 2013, P NATL ACAD SCI USA, V110, P3585, DOI 10.1073/pnas.1216855110; Park H.D., PHIL T R B IN PRESS; Patterson JC, 2002, NEUROIMAGE, V17, P1797, DOI 10.1006/nimg.2002.1306; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Qin PM, 2011, NEUROIMAGE, V57, P1221, DOI 10.1016/j.neuroimage.2011.05.028; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Sadaghiani S, 2009, J NEUROSCI, V29, P13410, DOI 10.1523/JNEUROSCI.2592-09.2009; Schandry R, 1996, BIOL PSYCHOL, V42, P75, DOI 10.1016/0301-0511(95)05147-3; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vinnik E, 2012, J NEUROPHYSIOL, V108, P2717, DOI 10.1152/jn.00196.2012; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Vogt B.A., 2009, CINGULATE NEUROBIOLO, P220; Wong SW, 2007, NEUROIMAGE, V35, P698, DOI 10.1016/j.neuroimage.2006.12.027; Ziegler G, 2009, EUR J NEUROSCI, V30, P2205, DOI 10.1111/j.1460-9568.2009.07008.x	57	170	171	4	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2014	17	4					612	U178		10.1038/nn.3671	http://dx.doi.org/10.1038/nn.3671			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AD6XR	24609466				2022-12-17	WOS:000333405300022
J	Salmaso, N; Jablonska, B; Scafidi, J; Vaccarino, FM; Gallo, V				Salmaso, Natalina; Jablonska, Beata; Scafidi, Joseph; Vaccarino, Flora M.; Gallo, Vittorio			Neurobiology of premature brain injury	NATURE NEUROSCIENCE			English	Article							WHITE-MATTER INJURY; LOW-BIRTH-WEIGHT; PERINATAL HYPOXIA; ENVIRONMENTAL ENRICHMENT; PRETERM; INTERNEURONS; INFANT; GROWTH; BORN; VULNERABILITY	Every year in the United States, an estimated 500,000 babies are born preterm (before 37 completed weeks of gestation), and this number is rising, along with the recognition of brain injuries due to preterm delivery. A common underlying pathogenesis appears to be perinatal hypoxia induced by immature lung development, which causes injury to vulnerable neurons and glia. Abnormal growth and maturation of susceptible cell types, particularly neurons and oligodendrocytes, in preterm babies with very low birth weight is associated with decreased cerebral and cerebellar volumes and increases in cerebral ventricular size. Here we reconcile these observations with recent studies using models of perinatal hypoxia that show perturbations in the maturation and function of interneurons, oligodendrocytes and astroglia. Together, these findings suggest that the global mechanism by which perinatal hypoxia alters development is through a delay in maturation of affected cell types, including astroglia, oligodendroglia and neurons.	[Salmaso, Natalina; Vaccarino, Flora M.] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Salmaso, Natalina; Vaccarino, Flora M.] Yale Univ, Program Neurodev & Regenerat, New Haven, CT 06520 USA; [Jablonska, Beata; Scafidi, Joseph; Gallo, Vittorio] Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA; [Vaccarino, Flora M.] Yale Univ, Kavli Inst Neurosci, New Haven, CT USA; [Vaccarino, Flora M.] Yale Univ, Dept Neurobiol, New Haven, CT USA	Yale University; Yale University; Children's National Health System; Yale University; Yale University	Gallo, V (corresponding author), Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA.	flora.vaccarino@yale.edu; vgallo@cnmcresearch.org		Salmaso, Natalina/0000-0002-9661-5194; Scafidi, Joseph/0000-0003-2379-1370; Vaccarino, Flora/0000-0003-2167-981X	US National Institutes of Health NINDS [P01 NS062686, R01 NS060750, R01NS045702]; NICHD [P30HD040677]; NIA [R21 AG034495]; Brain and Behavior Research Foundation; state of Connecticut; Women's Health Research at Yale; Cerebral Palsy International Research Foundation; Canadian Institute of Health Research fellowship; NINDS [K08NS073793]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045702, K08NS073793] Funding Source: NIH RePORTER	US National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Brain and Behavior Research Foundation; state of Connecticut; Women's Health Research at Yale; Cerebral Palsy International Research Foundation; Canadian Institute of Health Research fellowship(Canadian Institutes of Health Research (CIHR)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	a This research has been supported by the US National Institutes of Health NINDS (P01 NS062686 and R01 NS060750 to F. M. V. and R01NS045702 to V. G.), NICHD (P30HD040677 to V. G.) and NIA (R21 AG034495 to FMV), and by grants from the Brain and Behavior Research Foundation (F. M. V.), the state of Connecticut (F. M. V.), Women's Health Research at Yale (F. M. V.) and the Cerebral Palsy International Research Foundation (V. G.). N.S. is recipient of a Canadian Institute of Health Research fellowship. J.S. is the recipient of K08NS073793 (NINDS). We are particularly grateful to L. Ment for support and discussion. We thank J. Ritter for help with figures.	Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; [Anonymous], 2010, J NEUROSCI, V30, P5590; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Back SA, 1998, J NEUROSCI, V18, P6241; Back SA, 2012, NEUROTHERAPEUTICS, V9, P359, DOI 10.1007/s13311-012-0108-y; Ball G, 2012, CEREB CORTEX, V22, P1016, DOI 10.1093/cercor/bhr176; Baroncelli L, 2010, CELL DEATH DIFFER, V17, P1092, DOI 10.1038/cdd.2009.193; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Beauchamp MH, 2008, BRAIN, V131, P2986, DOI 10.1093/brain/awn227; Bi B, 2011, J NEUROSCI, V31, P9205, DOI 10.1523/JNEUROSCI.0518-11.2011; Brown NC, 2009, J PEDIATR-US, V155, P32, DOI 10.1016/j.jpeds.2009.01.038; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; Carroll J, 2012, PEDIATR RES, V71, P459, DOI 10.1038/pr.2011.53; Cengiz P, 2011, DEV NEUROSCI-BASEL, V33, P270, DOI 10.1159/000328430; Dean JM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004669; Eikenes L, 2011, NEUROIMAGE, V54, P1774, DOI 10.1016/j.neuroimage.2010.10.037; Fagel DM, 2009, J NEUROSCI, V29, P1202, DOI 10.1523/JNEUROSCI.4516-08.2009; Fan LW, 2005, BEHAV BRAIN RES, V165, P80, DOI 10.1016/j.bbr.2005.06.033; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Ganat Y, 2002, NEUROSCIENCE, V112, P977, DOI 10.1016/S0306-4522(02)00060-X; Goldman SA, 2012, SCIENCE, V338, P491, DOI 10.1126/science.1218071; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Ishibashi N, 2012, CIRCULATION, V125, P859, DOI 10.1161/CIRCULATIONAHA.111.048215; Jablonska B, 2012, J NEUROSCI, V32, P14775, DOI 10.1523/JNEUROSCI.2060-12.2012; Jensen FE, 2009, CLIN PERINATOL, V36, P881, DOI 10.1016/j.clp.2009.08.001; Jeon I, 2012, STEM CELLS, V30, P2054, DOI 10.1002/stem.1135; Johnson S, 2010, J AM ACAD CHILD PSY, V49, P453, DOI 10.1016/j.jaac.2010.02.002; Komitova M, 2013, J NEUROSCI, V33, P13375, DOI 10.1523/JNEUROSCI.5286-12.2013; Ment LR, 2003, JAMA-J AM MED ASSOC, V289, P705, DOI 10.1001/jama.289.6.705; Myers EH, 2010, NEUROIMAGE, V51, P1445, DOI 10.1016/j.neuroimage.2010.03.049; Ness JK, 2001, DEV NEUROSCI-BASEL, V23, P203, DOI 10.1159/000046144; Nguyen L, 2006, MENT RETARD DEV D R, V12, P85, DOI 10.1002/mrdd.20103; Nobuta H, 2012, ANN NEUROL, V72, P750, DOI 10.1002/ana.23670; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Patz S, 2004, CEREB CORTEX, V14, P342, DOI 10.1093/cercor/bhg132; Preston M, 2013, ANN NEUROL, V73, P266, DOI 10.1002/ana.23788; Raymond M, 2011, J NEUROSCI, V31, P17864, DOI 10.1523/JNEUROSCI.3179-11.2011; Reid MV, 2012, J NEUROPATH EXP NEUR, V71, P640, DOI 10.1097/NEN.0b013e31825cfa81; Salmaso N, 2012, J NEUROSCI, V32, P8930, DOI 10.1523/JNEUROSCI.1398-12.2012; Scafidi J, 2009, INT J DEV NEUROSCI, V27, P863, DOI 10.1016/j.ijdevneu.2009.05.009; Schwaller B, 2004, MOL CELL NEUROSCI, V25, P650, DOI 10.1016/j.mcn.2003.12.006; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stevens HE, 2012, BIOL PSYCHIAT, V71, P1090, DOI 10.1016/j.biopsych.2012.03.013; Luu TM, 2011, PEDIATRICS, V128, P313, DOI 10.1542/peds.2010-2655; Vaccarino FM, 1999, CURR TOP DEV BIOL, V46, P179, DOI 10.1016/S0070-2153(08)60329-4; Vannucci RC, 2005, DEV NEUROSCI-BASEL, V27, P81, DOI 10.1159/000085978; Volpe JJ, 2003, PEDIATRICS, V112, P176, DOI 10.1542/peds.112.1.176	49	170	183	4	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2014	17	3					341	346		10.1038/nn.3604	http://dx.doi.org/10.1038/nn.3604			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB8CA	24569830	Green Accepted			2022-12-17	WOS:000332016500006
J	Lapray, D; Lasztoczi, B; Lagler, M; Viney, TJ; Katona, L; Valenti, O; Hartwich, K; Borhegyi, Z; Somogyi, P; Klausberger, T				Lapray, Damien; Lasztoczi, Balint; Lagler, Michael; Viney, Tim James; Katona, Linda; Valenti, Ornella; Hartwich, Katja; Borhegyi, Zsolt; Somogyi, Peter; Klausberger, Thomas			Behavior-dependent specialization of identified hippocampal interneurons	NATURE NEUROSCIENCE			English	Article							EXPRESSING GABAERGIC NEURONS; OSCILLATIONS IN-VITRO; NETWORK OSCILLATIONS; PYRAMIDAL CELLS; PLACE CELLS; POSITIVE INTERNEURONS; GAMMA OSCILLATIONS; PHASE PRECESSION; RAT HIPPOCAMPUS; BARREL CORTEX	A large variety of GABAergic interneurons control information processing in the hippocampal circuits governing the formation of neuronal representations. Whether distinct hippocampal interneuron types contribute differentially to information processing during behavior is not known. We employed a new technique for recording and labeling interneurons and pyramidal cells in drug-free, freely moving rats. Recorded parvalbumin-expressing basket interneurons innervated somata and proximal pyramidal cell dendrites, whereas nitric oxide synthase- and neuropeptide Y-expressing ivy cells provided synaptic and extrasynaptic dendritic modulation. Basket and ivy cells showed distinct spike-timing dynamics, firing at different rates and times during theta and ripple oscillations. Basket, but not ivy, cells changed their firing rates during movement, sleep and quiet wakefulness, suggesting that basket cells coordinate cell assemblies in a behavioral state-contingent manner, whereas persistently firing ivy cells might control network excitability and homeostasis. Different interneuron types provide GABA to specific subcellular domains at defined times and rates, thereby differentially controlling network activity during behavior.	[Lapray, Damien; Lasztoczi, Balint; Viney, Tim James; Katona, Linda; Hartwich, Katja; Somogyi, Peter; Klausberger, Thomas] Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford, England; [Lapray, Damien; Lasztoczi, Balint; Lagler, Michael; Valenti, Ornella; Borhegyi, Zsolt; Somogyi, Peter; Klausberger, Thomas] Med Univ Vienna, Ctr Brain Res, Dept Cognit Neurobiol, Vienna, Austria	University of Oxford; Medical University of Vienna	Lapray, D (corresponding author), Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford, England.	damien.lapray@pharm.ox.ac.uk; peter.somogyi@pharm.ox.ac.uk; thomas.klausberger@meduniwien.ac.at	Katona, Linda/ABB-7768-2021; Borhegyi, Zsolt/G-2152-2010	Katona, Linda/0000-0002-9942-4502; Borhegyi, Zsolt/0000-0001-5556-8742; Valenti, Ornella/0000-0003-3647-6046; Viney, Tim/0000-0001-6444-1188	European Research Council [242689]; Vienna Science and Technology Fund [SCIC03]; Austrian Science Fund [W1205]; Medical Research Council [MC_U138197110, MC_U138197107] Funding Source: researchfish; MRC [MC_U138197107, MC_U138197110] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Vienna Science and Technology Fund; Austrian Science Fund(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank A. Koroknai for the reconstruction of the dendritic tree of cell D26p, I. Lukacs for the reconstruction of cell TV08k, J. Somogyi for confocal microscopic data acquisition and illustrations, K. Detzner for electron microscopy and immunohistochemistry, R. Hauer and E. Borok for histological processing, T. Sakatani for contributions to microdrive development, B. Micklem for help with the preparation of illustrations, J. O'Neill for help with place cell analysis, Y. Dalezios and G. Dorffner for advice on statistics, and R. Guillery, D. Dupret, M. Capogna, J. Csicsvari and L. Marton for comments on an earlier version of the manuscript. This work was supported in part by grant 242689 of the European Research Council, grant SCIC03 of the Vienna Science and Technology Fund and grant W1205 of the Austrian Science Fund.	Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Buzsaki G., 2006, RHYTHMS BRAIN; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cossart R, 2006, HIPPOCAMPUS, V16, P408, DOI 10.1002/hipo.20169; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Ego-Stengel V, 2007, HIPPOCAMPUS, V17, P161, DOI 10.1002/hipo.20253; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Fuentealba P, 2008, NEURON, V57, P917, DOI 10.1016/j.neuron.2008.01.034; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Gloveli T, 2005, J PHYSIOL-LONDON, V562, P131, DOI 10.1113/jphysiol.2004.073007; Gulyas AI, 2010, J NEUROSCI, V30, P15134, DOI 10.1523/JNEUROSCI.4104-10.2010; Hacker SO, 2005, CONTEMP TOP LAB ANIM, V44, P7; Haiss F, 2010, J NEUROSCI METH, V187, P67, DOI 10.1016/j.jneumeth.2009.12.015; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; Hartwich K, 2009, J NEUROSCI, V29, P9563, DOI 10.1523/JNEUROSCI.1397-09.2009; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hu H, 2010, SCIENCE, V327, P52, DOI 10.1126/science.1177876; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Lasztoczi B, 2011, J NEUROSCI, V31, P18073, DOI 10.1523/JNEUROSCI.3573-11.2011; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Markwardt SJ, 2011, NAT NEUROSCI, V14, P1407, DOI 10.1038/nn.2935; Maurer AP, 2006, J NEUROSCI, V26, P13485, DOI 10.1523/JNEUROSCI.2882-06.2006; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Szabadics J, 2009, J NEUROSCI, V29, P4239, DOI 10.1523/JNEUROSCI.5390-08.2009; Tricoire L, 2010, J NEUROSCI, V30, P2165, DOI 10.1523/JNEUROSCI.5123-09.2010; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Vizi ES, 2000, PHARMACOL REV, V52, P63; YLINEN A, 1995, J NEUROSCI, V15, P30	50	170	171	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1265	U130		10.1038/nn.3176	http://dx.doi.org/10.1038/nn.3176			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22864613	Green Accepted			2022-12-17	WOS:000308072600017
J	Amemori, KI; Graybiel, AM				Amemori, Ken-ichi; Graybiel, Ann M.			Localized microstimulation of primate pregenual cingulate cortex induces negative decision-making	NATURE NEUROSCIENCE			English	Article							REWARD SIGNALS; AVOIDANCE GOALS; NEURONS; DEPRESSION; CONFLICT; ANXIETY; NEUROBIOLOGY; INFORMATION; PREDICTOR; HUMANS	The pregenual anterior cingulate cortex (pACC) has been implicated in human anxiety disorders and depression, but the circuit-level mechanisms underlying these disorders are unclear. In healthy individuals, the pACC is involved in cost-benefit evaluation. We developed a macaque version of an approach-avoidance decision task used to evaluate anxiety and depression in humans and, with multi-electrode recording and cortical microstimulation, we probed pACC function as monkeys performed this task. We found that the macaque pACC has an opponent process-like organization of neurons representing motivationally positive and negative subjective value. Spatial distribution of these two neuronal populations overlapped in the pACC, except in one subzone, where neurons with negative coding were more numerous. Notably, microstimulation in this subzone, but not elsewhere in the pACC, increased negative decision-making, and this negative biasing was blocked by anti-anxiety drug treatment. This cortical zone could be critical for regulating negative emotional valence and anxiety in decision-making.	[Graybiel, Ann M.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Graybiel, AM (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	graybiel@mit.edu	Amemori, Ken-ichi/L-4206-2013	Amemori, Ken-ichi/0000-0001-8500-6820; Graybiel, Ann/0000-0002-4326-7720	US National Institutes of Health [R01 NS025529]; Office of Naval Research [N000140710903]; National Parkinson Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025529] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); National Parkinson Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Amemori and M. Cantor for their help with animal training and surgical procedures, P. Tierney, H. Shimazu, T. Desrochers, J. Feingold and Y. Ninokura and H. Hall for their technical advice, and D. Pizzagalli, R. Desimone, K. Goosens, J. Goldberg, D. Pfaff and Y. Kubota for reading the manuscript in draft form. This work was supported by a US National Institutes of Health Javits Merit grant (R01 NS025529), the Office of Naval Research (N000140710903), the Lynn Diamond Fellowship of the National Parkinson Foundation and Mr. Ira J. Jaffe.	Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; Dickson JM, 2004, COGNITIVE THER RES, V28, P415, DOI 10.1023/B:COTR.0000031809.20488.ee; Dickson JM, 2006, PERS INDIV DIFFER, V41, P1527, DOI 10.1016/j.paid.2006.06.005; EBLEN F, 1995, J NEUROSCI, V15, P5999; Elliot AJ, 2002, J PERS SOC PSYCHOL, V82, P804, DOI 10.1037/0022-3514.82.5.804; Elliot AJ, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P1; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; Fujiyama F, 2011, EUR J NEUROSCI, V33, P668, DOI 10.1111/j.1460-9568.2010.07564.x; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Goldstein RZ, 2009, P NATL ACAD SCI USA, V106, P9453, DOI 10.1073/pnas.0900491106; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hayden BY, 2010, J NEUROSCI, V30, P3339, DOI 10.1523/JNEUROSCI.4874-09.2010; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kennerley SW, 2009, EUR J NEUROSCI, V29, P2061, DOI 10.1111/j.1460-9568.2009.06743.x; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Lee D, 2007, J NEUROSCI, V27, P8170, DOI 10.1523/JNEUROSCI.1561-07.2007; Levy I, 2010, J NEUROPHYSIOL, V103, P1036, DOI 10.1152/jn.00853.2009; Lewin K., 1935, DYNAMIC THEORY PERS; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1997, NEUROREPORT, V8, P1057, DOI 10.1097/00001756-199703030-00048; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Miller N.E., 1971, SELECTED PAPERS CONF; Ottenbreit ND, 2004, BEHAV RES THER, V42, P293, DOI 10.1016/S0005-7967(03)00140-2; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Pizzagalli DA, 2011, NEUROPSYCHOPHARMACOL, V36, P183, DOI 10.1038/npp.2010.166; RAJAKUMAR N, 1993, J COMP NEUROL, V331, P286, DOI 10.1002/cne.903310210; Rowlett JK, 2006, PSYCHOPHARMACOLOGY, V184, P201, DOI 10.1007/s00213-005-0228-8; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; SMITH WK, 1945, J NEUROPHYSIOL, V8, P241, DOI 10.1152/jn.1945.8.4.241; Talmi D, 2009, J NEUROSCI, V29, P14617, DOI 10.1523/JNEUROSCI.2026-09.2009; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TREIT D, 1985, NEUROSCI BIOBEHAV R, V9, P203, DOI 10.1016/0149-7634(85)90046-6; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; VOGEL JR, 1971, PSYCHOPHARMACOLOGIA, V21, P1, DOI 10.1007/BF00403989; Vogt BA, 2005, J COMP NEUROL, V485, P218, DOI 10.1002/cne.20512; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; von Neumann John, 1947, THEORY GAMES EC BEHA	50	170	171	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					776	785		10.1038/nn.3088	http://dx.doi.org/10.1038/nn.3088			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22484571	Green Accepted, Green Submitted			2022-12-17	WOS:000303270200023
J	Helmstaedter, M; Briggman, KL; Denk, W				Helmstaedter, Moritz; Briggman, Kevin L.; Denk, Winfried			High-accuracy neurite reconstruction for high-throughput neuroanatomy	NATURE NEUROSCIENCE			English	Article							ELECTRON-MICROSCOPY; VALIDATION	Neuroanatomic analysis depends on the reconstruction of complete cell shapes. High-throughput reconstruction of neural circuits, or connectomics, using volume electron microscopy requires dense staining of all cells, which leads even experts to make annotation errors. Currently, reconstruction speed rather than acquisition speed limits the determination of neural wiring diagrams. We developed a method for fast and reliable reconstruction of densely labeled data sets. Our approach, based on manually skeletonizing each neurite redundantly (multiple times) with a visualization-annotation software tool called KNOSSOS, is similar to 50-fold faster than volume labeling. Errors are detected and eliminated by a redundant-skeleton consensus procedure (RESCOP), which uses a statistical model of how true neurite connectivity is transformed into annotation decisions. RESCOP also estimates the reliability of consensus skeletons. Focused reannotation of difficult locations promises a rather steep increase of reliability as a function of the average skeleton redundancy and thus the nearly error-free analysis of large neuroanatomical datasets.	[Helmstaedter, Moritz; Briggman, Kevin L.; Denk, Winfried] Max Planck Inst Med Res, Heidelberg, Germany	Max Planck Society	Helmstaedter, M (corresponding author), Max Planck Inst Med Res, Heidelberg, Germany.	moritz.helmstaedter@mpimf-heidelberg.mpg.de	denk, winfried/I-6627-2012		Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank B. Andres, F. Hamprecht, U. Kothe, V. Jain, S. Seung and S. Turaga for many fruitful discussions and comments on the manuscript, J. Bollmann and A. Schaefer for helpful comments on the manuscript, C. Roome for information technology support, J. Kornfeld and F. Svara for programming KNOSSOS, and J. Hanne, H. Jakobi and H. Wissler for help with annotator training. We thank N. Abazova, E. Abs, A. Antunes, P. Bastians, J. Bauer, M. Beez, M. Beining, S. Bender, S. Best, L. Brosi, M. Bucher, E. Buckler, J. Buhmann, C. Burkhardt, F. Drawitsch, L. Ehm, S. Ehm, C. Fianke, R. Foltin, S. Freiss, M. Funk, A. Gebhardt, M. Gruen, K. Haase, J. Hammerich, J. Hanne, B. Hauber, M. Hensen, L. Hofmann, P. Hofmann, M. Hulser, F. Isensee, H. Jakobi, M. Jonczyk, A. Joschko, A. Juenger, S. Kaspar, K. Kessler, A. Khan, M. Kiapes, A. Klein, C. Klein, S. Laiouar, T. Lang, L. Lebelt, H. Lesch, C. Lieven, D. Luft, E. Moeller, A. Muellner, M. Mueller, D. Ollech, A. Oppold, T. Otolski, S. Oumohand, S. Pfarr, M. Pohrath, A. Poos, S. Putzke, J. Reinhardt, A. Rommerskirchen, M. Roth, J. Sambel, K. Schramm, C. Sellmann, J. Sieber, I. Sonntag, M. Stahlberg, T. Stratmann, J. Trendel, F. Trogisch, M. Uhrig, A. Vogel, J. Volz, C. Weber, P. Weber, K. Weiss, L. Weisshaar, E. Wiegand, T. Wiegand, M. Wiese, R. Wiggers, C. Willburger and A. Zegarra for neurite skeletonizations. This work was funded by the Max Planck Society.	Andres B, 2008, LECT NOTES COMPUT SC, V5096, P142, DOI 10.1007/978-3-540-69321-5_15; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; BRIGGMAN KL, 2011, NATURE IN PRESS; CAJAL SRY, 1999, TEXTURA SISTEMA NERV; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Crook S, 2007, NEUROINFORMATICS, V5, P96, DOI 10.1007/s12021-007-0003-6; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Golgi, 1873, GAZ MED ITAL LOMBARD, V33, P244, DOI DOI 10.1056/NEJMOA1602253; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hayworth K., 2006, MICROSCOPY MICROA S2, V12, P86, DOI [10.1017/s1431927606066268, DOI 10.1017/S1431927606066268]; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; Jeong WK, 2010, IEEE COMPUT GRAPH, V30, P58, DOI 10.1109/MCG.2010.56; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Kording K, 2007, SCIENCE, V318, P606, DOI 10.1126/science.1142998; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Martin D, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P416, DOI 10.1109/ICCV.2001.937655; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; STEVENS JK, 1980, SCIENCE, V207, P317, DOI 10.1126/science.7350663; STRETTON AO, 1968, SCIENCE, V162, P132, DOI 10.1126/science.162.3849.132; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Turaga SC, 2010, NEURAL COMPUT, V22, P511, DOI 10.1162/neco.2009.10-08-881; Wang S, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON NANOSCALE ARCHITECTURE, P1; WANG W, 2009, IEEE INT S BIOM IM N, P342; Warfield SK, 2008, PHILOS T R SOC A, V366, P2361, DOI 10.1098/rsta.2008.0040; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033	32	170	173	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1081	U189		10.1038/nn.2868	http://dx.doi.org/10.1038/nn.2868			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21743472				2022-12-17	WOS:000293123700024
J	Ganguly, K; Dimitrov, DF; Wallis, JD; Carmena, JM				Ganguly, Karunesh; Dimitrov, Dragan F.; Wallis, Jonathan D.; Carmena, Jose M.			Reversible large-scale modification of cortical networks during neuroprosthetic control	NATURE NEUROSCIENCE			English	Article							BRAIN-COMPUTER INTERFACE; MOTOR CORTEX; REACHING MOVEMENTS; ARM MOVEMENTS; PERFORMANCE; ADAPTATION; STABILITY; PATTERNS; NEURONS; SIGNALS	Brain-machine interfaces (BMIs) provide a framework for studying cortical dynamics and the neural correlates of learning. Neuroprosthetic control has been associated with tuning changes in specific neurons directly projecting to the BMI (hereafter referred to as direct neurons). However, little is known about the larger network dynamics. By monitoring ensembles of neurons that were either causally linked to BMI control or indirectly involved, we found that proficient neuroprosthetic control is associated with large-scale modifications to the cortical network in macaque monkeys. Specifically, there were changes in the preferred direction of both direct and indirect neurons. Notably, with learning, there was a relative decrease in the net modulation of indirect neural activity in comparison with direct activity. These widespread differential changes in the direct and indirect population activity were markedly stable from one day to the next and readily coexisted with the long-standing cortical network for upper limb control. Thus, the process of learning BMI control is associated with differential modification of neural populations based on their specific relation to movement control.	[Ganguly, Karunesh; Wallis, Jonathan D.; Carmena, Jose M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Ganguly, Karunesh] San Francisco VA Med Ctr, Dept Neurol & Rehabil, San Francisco, CA USA; [Ganguly, Karunesh; Carmena, Jose M.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Ganguly, Karunesh] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Dimitrov, Dragan F.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Wallis, Jonathan D.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Carmena, Jose M.] Univ Calif Berkeley, Program Cognit Sci, Berkeley, CA 94720 USA; [Carmena, Jose M.] Univ Calif San Francisco, Joint Grad Grp Bioengn, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Carmena, JM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	carmena@eecs.berkeley.edu		Wallis, Joni/0000-0001-7262-7417	Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development; American Heart Association/American Stroke Association; National Institute of Neurological Disorders and Stroke [NS21135]; Alfred P. Sloan Foundation; Christopher and Dana Reeve Foundation; National Science Foundation [0954243]; Defense Advanced Research Projects Agency [N66001-10-C-2008]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040813, R56NS021135, R37NS021135, R01NS021135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019028] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development(US Department of Veterans Affairs); American Heart Association/American Stroke Association(American Heart Association); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Christopher and Dana Reeve Foundation; National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development, and the American Heart Association/American Stroke Association (to K. G.), the National Institute of Neurological Disorders and Stroke grant number NS21135 (to J.D.W.), the Alfred P. Sloan Foundation, the Christopher and Dana Reeve Foundation, the National Science Foundation CAREER Award #0954243 and the Defense Advanced Research Projects Agency contract N66001-10-C-2008 (to J.M.C.).	Ajemian R, 2008, NEURON, V58, P414, DOI 10.1016/j.neuron.2008.02.033; Arce F, 2010, J NEUROSCI, V30, P9189, DOI 10.1523/JNEUROSCI.1603-10.2010; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; CAMINITI R, 1990, J NEUROSCI, V10, P2039; Carmena JM, 2005, J NEUROSCI, V25, P10712, DOI 10.1523/JNEUROSCI.2772-05.2005; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Chestek CA, 2007, J NEUROSCI, V27, P10742, DOI 10.1523/JNEUROSCI.0959-07.2007; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; Davidson AG, 2007, SCIENCE, V318, P1934, DOI 10.1126/science.1149774; Fetz EE, 2007, J PHYSIOL-LONDON, V579, P571, DOI 10.1113/jphysiol.2006.127142; FETZ EE, 1973, J NEUROPHYSIOL, V36, P179, DOI 10.1152/jn.1973.36.2.179; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; Galan F, 2008, CLIN NEUROPHYSIOL, V119, P2159, DOI 10.1016/j.clinph.2008.06.001; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; Ganguly K, 2010, J MOTOR BEHAV, V42, P355, DOI 10.1080/00222895.2010.526457; Ganguly K, 2009, J NEUROSCI, V29, P12948, DOI 10.1523/JNEUROSCI.2471-09.2009; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Green AM, 2011, TRENDS NEUROSCI, V34, P61, DOI 10.1016/j.tins.2010.11.003; Greenberg PA, 2004, J NEUROPHYSIOL, V92, P1042, DOI 10.1152/jn.00062.2004; Grossman SE, 2008, J NEUROSCI, V28, P2864, DOI 10.1523/JNEUROSCI.4063-07.2008; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; Jarosiewicz B, 2008, P NATL ACAD SCI USA, V105, P19486, DOI 10.1073/pnas.0808113105; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; Legenstein R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000180; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Nicolelis MAL, 2009, NAT REV NEUROSCI, V10, P530, DOI 10.1038/nrn2653; Padoa-Schioppa C, 2002, NEURON, V36, P751, DOI 10.1016/S0896-6273(02)01028-0; Paz R, 2004, PLOS BIOL, V2, P264, DOI 10.1371/journal.pbio.0020045; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; Rokni U, 2007, NEURON, V54, P653, DOI 10.1016/j.neuron.2007.04.030; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101	45	170	171	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					662	U164		10.1038/nn.2797	http://dx.doi.org/10.1038/nn.2797			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21499255	Green Accepted			2022-12-17	WOS:000289886600024
J	Tosoni, A; Galati, G; Romani, GL; Corbetta, M				Tosoni, Annalisa; Galati, Gaspare; Romani, Gian Luca; Corbetta, Maurizio			Sensory-motor mechanisms in human parietal cortex underlie arbitrary visual decisions	NATURE NEUROSCIENCE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; PERCEPTUAL DECISION; SINGLE NEURONS; GENERAL MECHANISM; FRONTAL-CORTEX; FUNCTIONAL MRI; CORTICAL AREA; ORGANIZATION; ACTIVATION; LOCATION	The neural mechanism underlying simple perceptual decision-making in monkeys has been recently conceptualized as an integrative process in which sensory evidence supporting different response options accumulates gradually over time. For example, intraparietal neurons accumulate motion information in favor of a specific oculomotor choice over time. It is unclear, however, whether this mechanism generalizes to more complex decisions that are based on arbitrary stimulus-response associations. In a task requiring arbitrary association of visual stimuli (faces or places) with different actions (eye or hand-pointing movements), we found that activity of effector-specific regions in human posterior parietal cortex reflected the 'strength' of the sensory evidence in favor of the preferred response. These regions did not respond to sensory stimuli per se but integrated sensory evidence toward the decision outcome. We conclude that even arbitrary decisions can be mediated by sensory-motor mechanisms that are completely triggered by contextual stimulus-response associations.	[Tosoni, Annalisa; Romani, Gian Luca; Corbetta, Maurizio] G Annunzio Fdn, Dept Clin Sci & Bioimaging, I-66013 Chieti, Italy; [Tosoni, Annalisa; Galati, Gaspare; Romani, Gian Luca; Corbetta, Maurizio] G Annunzio Fdn, Inst Adv Biomed Technol, I-66013 Chieti, Italy; [Galati, Gaspare] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Galati, Gaspare] Santa Lucia Fdn, Neuroimaging Lab, I-00179 Rome, Italy; [Corbetta, Maurizio] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Corbetta, Maurizio] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Corbetta, Maurizio] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Sapienza University Rome; IRCCS Santa Lucia; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Tosoni, A (corresponding author), G Annunzio Fdn, Dept Clin Sci & Bioimaging, Via Vestini 31, I-66013 Chieti, Italy.	tosonia@npg.wustl.edu	Corbetta, Maurizio/AAZ-5219-2020; Tosoni, Annalisa/J-7410-2016; Galati, Gaspare/F-3277-2011	Tosoni, Annalisa/0000-0001-9004-2623; Galati, Gaspare/0000-0002-0640-4247; CORBETTA, MAURIZIO/0000-0001-8295-3304	EU [FP6-MEXC-CT-2004-006783]; US National Institute of Mental Health [R01MH71920-06, NS48013]; Italian Ministry of University and Research [PRIN 2005119851_004]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048013] Funding Source: NIH RePORTER	EU(European Commission); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to E. Lombardi for her assistance in data collection. We also thank C. Lewis and C. Sestieri for technical support on data analysis, and A. Snyder, M. McAvoy and E. Akbudak for software and hardware development. This work was supported by the EU FP6-MEXC-CT-2004-006783 project (Investigations in Brain Sciences Education Network), US National Institute of Mental Health grant R01MH71920-06 and US National Institutes of Health grant NS48013 to M. C., by Italian Ministry of University and Research grant PRIN 2005119851_004 to G. G., and by the 3rd Ph.D. Internationalization Program of the Italian Ministry of University and Research.	Astafiev SV, 2003, J NEUROSCI, V23, P4689; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Calton JL, 2002, NAT NEUROSCI, V5, P580, DOI 10.1038/nn862; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; COLES MGH, 1985, J EXP PSYCHOL HUMAN, V11, P529, DOI 10.1037/0096-1523.11.5.529; Connolly JD, 2003, EXP BRAIN RES, V153, P140, DOI 10.1007/s00221-003-1587-1; Corbetta M, 2005, NEUROPSYCHOLOGIA, V43, P2041, DOI 10.1016/j.neuropsychologia.2005.03.020; Cui H, 2007, NEURON, V56, P552, DOI 10.1016/j.neuron.2007.09.031; Dickinson AR, 2003, J NEUROPHYSIOL, V90, P2460, DOI 10.1152/jn.00788.2002; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Finney D.J., 1971, PROBIT ANAL; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Galletti C, 1999, EUR J NEUROSCI, V11, P575, DOI 10.1046/j.1460-9568.1999.00467.x; Heekeren HR, 2006, P NATL ACAD SCI USA, V103, P10023, DOI 10.1073/pnas.0603949103; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Jack AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000452; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; MCKEE SP, 1985, PERCEPT PSYCHOPHYS, V37, P286, DOI 10.3758/BF03211350; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Ollinger JM, 2001, NEUROIMAGE, V13, P210, DOI 10.1006/nimg.2000.0710; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rorie AE, 2005, TRENDS COGN SCI, V9, P41, DOI 10.1016/j.tics.2004.12.007; Schluppeck D, 2005, J NEUROPHYSIOL, V94, P1372, DOI 10.1152/jn.01290.2004; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadlen MN, 2008, BETTER CONSCIOUS DEC, P71, DOI 10.7551/mitpress/9780262195805.003.0004; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Stoet G, 2004, NEURON, V42, P1003, DOI 10.1016/j.neuron.2004.06.003; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322	43	170	170	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2008	11	12					1446	1453		10.1038/nn.2221	http://dx.doi.org/10.1038/nn.2221			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	375JF	18997791	Green Accepted, Green Published			2022-12-17	WOS:000261109300018
J	Lee, Y; Samaco, RC; Gatchel, JR; Thaller, C; Orr, HT; Zoghbi, HY				Lee, Yoontae; Samaco, Rodney C.; Gatchel, Jennifer R.; Thaller, Christina; Orr, Harry T.; Zoghbi, Huda Y.			miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis	NATURE NEUROSCIENCE			English	Article							SPINOCEREBELLAR ATAXIA TYPE-1; TRANSGENIC MICE; TRINUCLEOTIDE REPEAT; NEURODEGENERATION; EXPANSION; MICRORNAS; MODEL	Spinocerebellar ataxia type 1 is caused by expansion of a translated CAG repeat in ataxin1 (ATXN1). The level of the polyglutamine-expanded protein is one of the factors that contributes to disease severity. Here we found that miR-19, miR-101 and miR-130 co-regulate ataxin1 levels and that their inhibition enhanced the cytotoxicity of polyglutamine-expanded ATXN1 in human cells. We provide a new candidate mechanism for modulating the pathogenesis of neurodegenerative diseases sensitive to protein dosage.	[Lee, Yoontae; Samaco, Rodney C.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gatchel, Jennifer R.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Thaller, Christina; Zoghbi, Huda Y.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Lee, Yoontae; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Orr, Harry T.] Univ Minnesota, Dept Biochem Biophys & Mol Biol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.tmc.edu		Orr, Harry/0000-0001-6118-741X; Gatchel, Jennifer/0000-0002-3892-9742; Zoghbi, Huda/0000-0002-0700-3349; Samaco, Rodney/0000-0001-5636-5314	US National Institutes of Health [NS27699, HD24064, NS22920]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022920, R37NS022920, R01NS027699, R37NS027699] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Ao, Y. Liu and A. Liang of the Baylor College of Medicine In Situ Hybridization core for technical assistance and V. N. Kim and members of the Zoghbi laboratory for helpful discussions and comments on the manuscript. This research was supported by US National Institutes of Health grants NS27699 and HD24064 to H. Y. Z. and NS22920 to H. T. O. H. Y. Z. is an investigator with the Howard Hughes Medical Institute.	BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Cemal CK, 2002, HUM MOL GENET, V11, P1075, DOI 10.1093/hmg/11.9.1075; Clark HB, 1997, J NEUROSCI, V17, P7385; Huynh DP, 2000, NAT GENET, V26, P44, DOI 10.1038/79162; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Rich T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001014; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; ZOGHBI HY, 1995, SEMIN CELL BIOL, V6, P29, DOI 10.1016/1043-4682(95)90012-8	15	170	182	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2008	11	10					1137	1139		10.1038/nn.2183	http://dx.doi.org/10.1038/nn.2183			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	352WQ	18758459	Green Accepted			2022-12-17	WOS:000259528500007
J	Reynolds, SM; Berridge, KC				Reynolds, Sheila M.; Berridge, Kent C.			Emotional environments retune the valence of appetitive versus fearful functions in nucleus accumbens	NATURE NEUROSCIENCE			English	Article							DEFENSIVE BEHAVIOR; INCENTIVE SALIENCE; FEEDING-BEHAVIOR; SHELL; GABA; ADDICTION; GRADIENTS; SYSTEMS; REWARD	The nucleus accumbens mediates both appetitive motivation for rewards and fearful motivation toward threats, which are generated in part by glutamate-related circuits organized in a keyboard fashion. At rostral sites of the medial shell, localized glutamate disruptions typically generate intense appetitive behaviors in rats, but the disruption incrementally generates fearful behaviors as microinjection sites move more caudally. We found that exposure to stressful environments caused caudal fear-generating zones to expand rostrally, filling similar to 90% of the shell. Conversely, a preferred home environment caused fear-generating zones to shrink and appetitive-generating zones to expand caudally, filling similar to 90% of the shell. Thus, the emotional environments retuned the generation of motivation in corticolimbic circuits.	[Reynolds, Sheila M.; Berridge, Kent C.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Berridge, KC (corresponding author), Univ Michigan, Dept Psychol, 525 E Univ Ave, Ann Arbor, MI 48109 USA.	sheilar@umich.edu; berridge@umich.edu	Berridge, Kent C/C-1525-2009	Berridge, Kent C/0000-0002-6031-2626	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA014679, R01DA015188] Funding Source: NIH RePORTER; NIDA NIH HHS [DA015188, R01 DA015188-06A1, DA14679, R01 DA015188-05, F31 DA014679, R01 DA015188] Funding Source: Medline; NIMH NIH HHS [R01 MH063649-07, R01 MH063649-06A1, R01 MH063649, MH63649] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; MALDONADOIRIZARRY CS, 1995, J NEUROSCI, V15, P6779; Owings D.H., 1998, ANIMAL VOCAL COMMUNI; Reynolds SM, 2003, EUR J NEUROSCI, V17, P2187, DOI 10.1046/j.1460-9568.2003.02642.x; Reynolds SM, 2002, J NEUROSCI, V22, P7308; Reynolds SM, 2001, J NEUROSCI, V21, P3261, DOI 10.1523/JNEUROSCI.21-09-03261.2001; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Stratford TR, 1997, J NEUROSCI, V17, P4434; VALENSTEIN ES, 1969, SCIENCE, V163, P1084, DOI 10.1126/science.163.3871.1084; WILKIE DM, 1979, J EXP ANAL BEHAV, V31, P299, DOI 10.1901/jeab.1979.31-299	14	170	172	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					423	425		10.1038/nn2061	http://dx.doi.org/10.1038/nn2061			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344996	Green Accepted			2022-12-17	WOS:000254359300013
J	Anzai, A; Peng, XM; Van Essen, DC				Anzai, Akiyuki; Peng, Xinmiao; Van Essen, David C.			Neurons inmonkey visual area V2 encode combinations of orientations	NATURE NEUROSCIENCE			English	Article							OF-FIT TESTS; RECEPTIVE-FIELDS; STRIATE-CORTEX; FUNCTIONAL ARCHITECTURE; SIMPLE CELLS; MONKEY; STEREOPSIS; RESPONSES; CAT	Contours and textures are important attributes of object surfaces, and are often described by combinations of local orientations in visual images. To elucidate the neural mechanisms underlying contour and texture processing, we examined receptive field (RF) structures of neurons in visual area V2 of the macaque monkey for encoding combinations of orientations. By measuring orientation tuning at several locations within the classical RF, we found that a majority (70%) of V2 neurons have similar orientation tuning throughout the RF. However, many others have RFs containing subregions tuned to different orientations, most commonly about 90 degrees apart. By measuring interactions between two positions within the RF, we found that approximately one-third of neurons show inhibitory interactions that make them selective for combinations of orientations. These results indicate that V2 neurons could play an important role in analyzing contours and textures and could provide useful cues for surface segmentation.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Anzai, A (corresponding author), Univ Rochester, Ctr Visual Sci, Meliora Hall 248, Rochester, NY 14627 USA.	aanzai@cvs.rochester.edu	Van Essen, David/ABA-8888-2020		NATIONAL EYE INSTITUTE [R01EY002091] Funding Source: NIH RePORTER; NEI NIH HHS [EY 02091] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Berry D.A., 1996, STAT BAYESIAN PERSPE; BROWN BM, 1994, J R STAT SOC B, V56, P275; Carandini M, 1997, J NEUROSCI, V17, P8621; DEANGELIS GC, 1995, PERCEPTION, V24, P3, DOI 10.1068/p240003; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DEVALOIS RL, 1985, J OPT SOC AM A, V2, P1115, DOI 10.1364/JOSAA.2.001115; DOBBINS A, 1987, NATURE, V329, P438, DOI 10.1038/329438a0; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Fisher NI, 2001, BIOMETRIKA, V88, P499, DOI 10.1093/biomet/88.2.499; FSHER NI, 1993, STAT ANAL CIRCULAR D; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Hegde J, 2000, J NEUROSCI, V20, part. no.; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1987, J NEUROSCI, V7, P3378; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; HUBEL DH, 1970, NATURE, V225, P41, DOI 10.1038/225041a0; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; KUYPERS HGJ, 1965, EXP NEUROL, V11, P245, DOI 10.1016/0014-4886(65)90016-6; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; Mahon LE, 2001, VISUAL NEUROSCI, V18, P973, DOI 10.1017/S0952523801186141; NAKAYAMA K, 1995, INVITATION COGNITIVE, V2, P1; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; POLAT U, 1994, VISION RES, V34, P73, DOI 10.1016/0042-6989(94)90258-5; PRESS WH, 1988, MODELING DATA NUMERI, P517; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rubin N, 2001, PERCEPTION, V30, P339, DOI 10.1068/p3173; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; SILVERMAN BW, 1981, J ROY STAT SOC B MET, V43, P97; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; VANESSEN DC, 1986, J COMP NEUROL, V244, P541; Walker GA, 2002, J NEUROSCI, V22, P5659; WATSON GS, 1961, BIOMETRIKA, V48, P109, DOI 10.2307/2333135	37	170	171	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1313	1321		10.1038/nn1975	http://dx.doi.org/10.1038/nn1975			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17873872				2022-12-17	WOS:000249720800019
J	Szapiro, G; Barbour, B				Szapiro, German; Barbour, Boris			Multiple climbing fibers signal to molecular layer interneurons exclusively via glutamate spillover	NATURE NEUROSCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; AMPA RECEPTORS; SYNAPTIC-TRANSMISSION; PRESYNAPTIC INHIBITION; NMDA RECEPTORS; GABA RELEASE; ACTIVATION; SYNAPSES; TRANSPORTERS; RAT	Spillover of glutamate under physiological conditions has only been established as an adjunct to conventional synaptic transmission. Here we describe a pure spillover connection between the climbing fiber and molecular layer interneurons in the rat cerebellar cortex. We show that, instead of acting via conventional synapses, multiple climbing fibers activate AMPA- and NMDA-type glutamate receptors on interneurons exclusively via spillover. Spillover from the climbing fiber represents a form of glutamatergic volume transmission that could be triggered in a regionalized manner by experimentally observed synchronous climbing fiber activity. Climbing fibers are known to direct parallel fiber synaptic plasticity in interneurons, so one function of this spillover is likely to involve controlling synaptic plasticity.	Ecole Normale Super, CNRS, Neurobiol Lab, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite	Barbour, B (corresponding author), Ecole Normale Super, CNRS, Neurobiol Lab, 46 Rue Ulm, F-75005 Paris, France.	barbour@ens.fr		Barbour, Boris/0000-0002-1911-0539				Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Atluri PP, 1998, J NEUROSCI, V18, P8214; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Beierlein M, 2006, J NEUROSCI, V26, P9935, DOI 10.1523/JNEUROSCI.0958-06.2006; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Cox, 1966, STAT ANAL SERIES EVE; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; DODGE FA, 1969, J PHYSIOL-LONDON, V200, P267, DOI 10.1113/jphysiol.1969.sp008692; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; Ekerot CF, 2001, EUR J NEUROSCI, V13, P1303, DOI 10.1046/j.0953-816x.2001.01499.x; Foster KA, 2004, NEURON, V43, P119, DOI 10.1016/j.neuron.2004.06.022; Glitsch M, 1999, J NEUROSCI, V19, P511; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Kollo M, 2006, J NEUROSCI, V26, P2684, DOI 10.1523/JNEUROSCI.5257-05.2006; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Lang EJ, 1999, J NEUROSCI, V19, P2728; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; Marcaggi P, 2005, NEUROPHARMACOLOGY, V49, P843, DOI 10.1016/j.neuropharm.2005.07.011; Marcaggi P, 2005, NAT NEUROSCI, V8, P776, DOI 10.1038/nn1458; Marcaggi P, 2003, J PHYSIOL-LONDON, V552, P89, DOI 10.1113/jphysiol.2003.044263; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Owe SG, 2006, J PHYSIOL-LONDON, V577, P591, DOI 10.1113/jphysiol.2006.116830; Palay S.L., 1974, CEREBELLAR CORTEX; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Satake S, 2006, J NEUROSCI, V26, P2278, DOI 10.1523/JNEUROSCI.4894-05.2006; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; Satake S, 2004, EUR J NEUROSCI, V19, P2464, DOI 10.1111/j.0953-816X.2004.03347.x; SATO Y, 1992, J NEUROPHYSIOL, V68, P2051, DOI 10.1152/jn.1992.68.6.2051; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Smith SL, 2005, P NATL ACAD SCI USA, V102, P14901, DOI 10.1073/pnas.0505028102; Sugihara I, 1999, J COMP NEUROL, V414, P131; Takayasu Y, 2006, J NEUROSCI, V26, P6563, DOI 10.1523/JNEUROSCI.5342-05.2006; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Xu-Friedman MA, 1999, BIOPHYS J, V76, P2029, DOI 10.1016/S0006-3495(99)77360-1; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000	47	170	171	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					735	742		10.1038/nn1907	http://dx.doi.org/10.1038/nn1907			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17515900	Green Submitted			2022-12-17	WOS:000246799800016
J	Paton, JFR; Abdala, APL; Koizumi, H; Smith, JC; St John, WM				Paton, JFR; Abdala, APL; Koizumi, H; Smith, JC; St John, WM			Respiratory rhythm generation during gasping depends on persistent sodium current	NATURE NEUROSCIENCE			English	Article							PRE-BOTZINGER COMPLEX; PATTERNS; MODELS; EUPNEA	In severe hypoxia, homeostatic mechanisms maintain function of the brainstem respiratory network. We hypothesized that hypoxia involves a transition from neuronal mechanisms of normal breathing (eupnea) to a rudimentary pattern of inspiratory movements (gasping). We provide evidence for hypoxia-driven transformation within the central respiratory oscillator, in which gasping relies on persistent sodium current, whereas eupnea does not depend on this cellular mechanism.	Univ Bristol, Sch Med Sci, Bristol Heart Inst, Dept Physiol, Bristol BS8 1TH, Avon, England; NINDS, Cellular & Syst Neurobiol Sect, NIH, Bethesda, MD 20892 USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Physiol, Lebanon, NH 03756 USA	University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Dartmouth College	Paton, JFR (corresponding author), Univ Bristol, Sch Med Sci, Bristol Heart Inst, Dept Physiol, Bristol BS8 1TH, Avon, England.	Julian.F.R.Paton@Bristol.ac.uk	Paton, Julian/AAM-2121-2020; Sheikh, Ana Paula Abdala/G-9104-2014; Abdala, Ana Paula/G-9104-2014	Sheikh, Ana Paula Abdala/0000-0001-6566-9205; Paton, Julian/0000-0001-7410-2913; Abdala, Ana Paula/0000-0001-6051-2591	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Butera RJ, 1999, J NEUROPHYSIOL, V82, P398, DOI 10.1152/jn.1999.82.1.398; Del Negro CA, 2005, J NEUROSCI, V25, P446, DOI 10.1523/JNEUROSCI.2237-04.2005; Del Negro CA, 2002, NEURON, V34, P821, DOI 10.1016/S0896-6273(02)00712-2; Del Negro CA, 2001, J NEUROPHYSIOL, V86, P59, DOI 10.1152/jn.2001.86.1.59; Hammarstrom AKM, 2000, J PHYSIOL-LONDON, V529, P107, DOI 10.1111/j.1469-7793.2000.00107.x; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; Pena F, 2004, NEURON, V43, P105, DOI 10.1016/j.neuron.2004.06.023; Ramirez JM, 2005, RESP PHYSIOL NEUROBI, V147, P145, DOI 10.1016/j.resp.2005.05.003; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; Rybak IA, 2003, EUR J NEUROSCI, V18, P239, DOI 10.1046/j.1460-9568.2003.02739.x; Smith JC, 2000, RESP PHYSIOL, V122, P131, DOI 10.1016/S0034-5687(00)00155-9; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; St-John WM, 2000, RESP PHYSIOL, V123, P201, DOI 10.1016/S0034-5687(00)00177-8; St-John WM, 2003, RESP PHYSIOL NEUROBI, V139, P97, DOI 10.1016/S1569-9048(03)00193-9; St-John WM, 1998, PROG NEUROBIOL, V56, P97, DOI 10.1016/S0301-0082(98)00031-8	15	170	170	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					311	313		10.1038/nn1650	http://dx.doi.org/10.1038/nn1650			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16474390				2022-12-17	WOS:000235645600009
J	Eiraku, M; Tohgo, A; Ono, K; Kaneko, M; Fujishima, K; Hirano, T; Kengaku, M				Eiraku, M; Tohgo, A; Ono, K; Kaneko, M; Fujishima, K; Hirano, T; Kengaku, M			DNER acts as a neuron-specific Notch ligand during Bergmann glial development	NATURE NEUROSCIENCE			English	Article							MULTIPLE FUNCTIONAL ROLES; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; OLIGODENDROCYTE DIFFERENTIATION; BRAIN-DEVELOPMENT; PROGENITOR CELLS; RECEPTOR; ACTIVATION; EXPRESSION; MIGRATION	Differentiation of CNS glia is regulated by Notch signaling through neuron-glia interaction. Here, we identified Delta/Notch-like EGF-related receptor (DNER), a neuron-specific transmembrane protein, as a previously unknown ligand of Notch during cellular morphogenesis of Bergmann glia in the mouse cerebellum. DNER binds to Notch1 at cell-cell contacts and activates Notch signaling in vitro. In the developing cerebellum, DNER is highly expressed in Purkinje cell dendrites, which are tightly associated with radial fibers of Bergmann glia expressing Notch. DNER specifically binds to Bergmann glia in culture and induces process extension by activating gamma-secretase- and Deltex-dependent Notch signaling. Inhibition of Deltex-dependent, but not RBP-J-dependent, Notch signaling in Bergmann glia suppresses formation and maturation of radial fibers in organotypic slice cultures. Additionally, deficiency of DNER retards the formation of radial fibers and results in abnormal arrangement of Bergmann glia. Thus, DNER mediates neuron-glia interaction and promotes morphological differentiation of Bergmann glia through Deltex-dependent Notch signaling.	RIKEN Brain Sci Inst, Lab Neural Cell Polar, Wako, Saitama 3510198, Japan; Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; Japan Sci & Technol Corp, CREST, Saitama 3320012, Japan; Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808575, Japan; Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Okazaki, Aichi 4448585, Japan	RIKEN; Kyoto University; Japan Science & Technology Agency (JST); Tohoku University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Kengaku, M (corresponding author), RIKEN Brain Sci Inst, Lab Neural Cell Polar, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kengaku@brain.riken.jp		Eiraku, Mototsugu/0000-0002-9433-9085				ALTMAN J, 1997, DEV CEERBELLAR SYSTE; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; DE SB, 1999, NATURE, V398, P518; Eiraku M, 2002, J BIOL CHEM, V277, P25400, DOI 10.1074/jbc.M110793200; FISHER M, 1984, P NATL ACAD SCI-BIOL, V81, P4414, DOI 10.1073/pnas.81.14.4414; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Genoud S, 2002, J CELL BIOL, V158, P709, DOI 10.1083/jcb.200202002; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Hojo M, 2000, DEVELOPMENT, V127, P2515; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Irvin DK, 2001, J COMP NEUROL, V436, P167, DOI 10.1002/cne.1059.abs; Irvin DK, 2004, J NEUROSCI RES, V75, P330, DOI 10.1002/jnr.10843; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kawaji K, 2004, MOL CELL NEUROSCI, V25, P228, DOI 10.1016/j.mcn.2003.10.006; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; LORDKIPANIDZE T, 2005, GLIA; Malatesta P, 2000, DEVELOPMENT, V127, P5253; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Parks AL, 2000, DEVELOPMENT, V127, P1373; Patten BA, 2003, J NEUROSCI, V23, P6132, DOI 10.1523/JNEUROSCI.23-14-06132.2003; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Sakamoto K, 2002, DEV BIOL, V241, P313, DOI 10.1006/dbio.2001.0517; Shawber C, 1996, DEVELOPMENT, V122, P3765; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Tanaka M, 2003, NEUROSCI LETT, V353, P87, DOI 10.1016/j.neulet.2003.08.080; Tanaka M, 2003, J NEUROSCI, V23, P2804, DOI 10.1523/jneurosci.23-07-02804.2003; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Yamada K, 2000, J COMP NEUROL, V418, P106; Yamamoto N, 2001, J BIOL CHEM, V276, P45031, DOI 10.1074/jbc.M105245200; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	50	170	175	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					873	880		10.1038/nn1492	http://dx.doi.org/10.1038/nn1492			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15965470				2022-12-17	WOS:000230137100014
J	Hendricks, JC; Williams, JA; Panckeri, K; Kirk, D; Tello, M; Yin, JCP; Sehgal, A				Hendricks, JC; Williams, JA; Panckeri, K; Kirk, D; Tello, M; Yin, JCP; Sehgal, A			A non-circadian role for cAMP signaling and CREB activity in Drosophila rest homeostasis	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; GENE-EXPRESSION; SLEEP; ANTIDEPRESSANT; INDUCTION; INCREASES; ACTIVATOR; WAKING; CLOCK; STATE	In the fruit fly, Drosophila melanogaster, rest shares features with mammalian sleep, including prolonged immobility, decreased sensory responsiveness and a homeostatic rebound after deprivation. To understand the molecular regulation of sleep-like rest, we investigated the involvement of a candidate gene, cAMP response-element binding protein (CREB). The duration of rest was inversely related to cAMP signaling and CREB activity. Acutely blocking CREB activity in transgenic flies did not affect the clock, but increased rest rebound. CREB mutants also had a prolonged and increased homeostatic rebound. In wild types, in vivo CREB activity increased after rest deprivation and remained elevated for a 72-hour recovery period. These data indicate that cAMP signaling has a non-circadian role in waking and rest homeostasis in Drosophila.	Univ Penn, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Pennsylvania	Hendricks, JC (corresponding author), Univ Penn, Ctr Sleep & Resp Neurobiol, 991 Maloney Bldg,3600 Spruce St, Philadelphia, PA 19104 USA.				NCI NIH HHS [SCOR-HL-60287] Funding Source: Medline; NHLBI NIH HHS [R01-HL-59649] Funding Source: Medline; NIMH NIH HHS [R01 MH067774] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA015753] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Capece ML, 1997, AM J PHYSIOL-REG I, V273, pR1430, DOI 10.1152/ajpregu.1997.273.4.R1430; Cirelli C, 1996, SCIENCE, V274, P1211, DOI 10.1126/science.274.5290.1211; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DUDAI Y, 1983, NEUROSCI LETT, V42, P207, DOI 10.1016/0304-3940(83)90408-1; Duman RS, 1998, J ECT, V14, P181; Eresh S, 1997, EMBO J, V16, P2014, DOI 10.1093/emboj/16.8.2014; Everson CA, 2000, AM J PHYSIOL-REG I, V278, pR905, DOI 10.1152/ajpregu.2000.278.4.R905; Freeland K, 2000, BIOCHEM J, V345, P233, DOI 10.1042/0264-6021:3450233; HABENER JF, 1995, VITAM HORM, V91, P1; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2000, PROG NEUROBIOL, V61, P339, DOI 10.1016/S0301-0082(99)00048-9; Jewett ME, 1999, SLEEP, V22, P171, DOI 10.1093/sleep/22.2.171; Kilduff TS, 2000, NEURON, V26, P295, DOI 10.1016/S0896-6273(00)81163-0; Lelkes Z, 1998, PHARMACOL BIOCHEM BE, V60, P835, DOI 10.1016/S0091-3057(98)00038-0; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; Naylor E, 2000, J NEUROSCI, V20, P8138; Nibuya M, 1996, J NEUROSCI, V16, P2365; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Park SK, 2000, J BIOL CHEM, V275, P20588, DOI 10.1074/jbc.M002460200; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; YIN JCP, 1995, MOL CELL BIOL, V15, P5123; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zamboni G, 1999, ARCH ITAL BIOL, V137, P249	32	170	173	1	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1108	1115		10.1038/nn743	http://dx.doi.org/10.1038/nn743			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11687816				2022-12-17	WOS:000171970900014
J	Klim, JR; Williams, LA; Limone, F; San Juan, IG; Davis-Dusenbery, BN; Mordes, DA; Burberry, A; Steinbaugh, MJ; Gamage, KK; Kirchner, R; Moccia, R; Casse, SH; Chen, KC; Wainger, BJ; Woolf, CJ; Eggan, K				Klim, Joseph R.; Williams, Luis A.; Limone, Francesco; San Juan, Irune Guerra; Davis-Dusenbery, Brandi N.; Mordes, Daniel A.; Burberry, Aaron; Steinbaugh, Michael J.; Gamage, Kanchana K.; Kirchner, Rory; Moccia, Rob; Casse, Seth H.; Chen, Kuchuan; Wainger, Brian J.; Woolf, Clifford J.; Eggan, Kevin			ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; RNA; EXPRESSION; MUTATIONS; STATHMIN; SCG10; DEGENERATION; GENERATION; GENES; MODEL	The findings that amyotrophic lateral sclerosis (ALS) patients almost universally display pathological mislocalization of the RNA-binding protein TDP-43 and that mutations in its gene cause familial ALS have nominated altered RNA metabolism as a disease mechanism. However, the RNAs regulated by TDP-43 in motor neurons and their connection to neuropathy remain to be identified. Here we report transcripts whose abundances in human motor neurons are sensitive to TDP-43 depletion. Notably, expression of STMN2, which encodes a microtubule regulator, declined after TDP-43 knockdown and TDP-43 mislocalization as well as in patient-specific motor neurons and postmortem patient spinal cord. STMN2 loss upon reduced TDP-43 function was due to altered splicing, which is functionally important, as we show STMN2 is necessary for normal axonal outgrowth and regeneration. Notably, post-translational stabilization of STMN2 rescued neurite outgrowth and axon regeneration deficits induced by TDP-43 depletion. We propose that restoring STMN2 expression warrants examination as a therapeutic strategy for ALS.	[Klim, Joseph R.; Williams, Luis A.; Limone, Francesco; San Juan, Irune Guerra; Davis-Dusenbery, Brandi N.; Mordes, Daniel A.; Burberry, Aaron; Gamage, Kanchana K.; Moccia, Rob; Casse, Seth H.; Eggan, Kevin] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Klim, Joseph R.; Williams, Luis A.; Limone, Francesco; San Juan, Irune Guerra; Davis-Dusenbery, Brandi N.; Mordes, Daniel A.; Burberry, Aaron; Gamage, Kanchana K.; Moccia, Rob; Casse, Seth H.; Eggan, Kevin] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Klim, Joseph R.; Williams, Luis A.; Limone, Francesco; San Juan, Irune Guerra; Davis-Dusenbery, Brandi N.; Mordes, Daniel A.; Burberry, Aaron; Gamage, Kanchana K.; Moccia, Rob; Casse, Seth H.; Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Klim, Joseph R.; Williams, Luis A.; Limone, Francesco; San Juan, Irune Guerra; Davis-Dusenbery, Brandi N.; Mordes, Daniel A.; Burberry, Aaron; Gamage, Kanchana K.; Moccia, Rob; Casse, Seth H.; Eggan, Kevin] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Limone, Francesco] Royal Netherlands Acad Arts & Sci, Hubrecht Inst Dev Biol & Stem Cell Res, Utrecht, Netherlands; [San Juan, Irune Guerra] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, Amsterdam, Netherlands; [Mordes, Daniel A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Steinbaugh, Michael J.; Kirchner, Rory] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Gamage, Kanchana K.] Amgen Inc, Amgen Res, Cambridge, MA USA; [Casse, Seth H.] Harvard Med Sch, Boston, MA USA; [Casse, Seth H.] Harvard Med Sch, Med Scientist Training Program, Boston, MA USA; [Chen, Kuchuan; Wainger, Brian J.; Woolf, Clifford J.] Harvard Med Sch, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA USA; [Chen, Kuchuan; Wainger, Brian J.; Woolf, Clifford J.] Harvard Med Sch, Dept Neurobiol, Boston, MA USA; [Wainger, Brian J.] Massachusetts Gen Hosp, Massachusetts Gen Inst Neurodegenerat Dis, Boston, MA 02114 USA; [Williams, Luis A.] Q State Biosci, Cambridge, MA USA; [Davis-Dusenbery, Brandi N.] Seven Bridges Genom, Cambridge, MA USA; [Moccia, Rob] Pfizer Inc, Cambridge, MA USA	Harvard University; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Vrije Universiteit Amsterdam; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Amgen; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Pfizer	Eggan, K (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Eggan, K (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.; Eggan, K (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Eggan, K (corresponding author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.	eggan@mcb.harvard.edu	Woolf, Clifford/A-9784-2010; Steinbaugh, Michael/E-9175-2012	Guerra San Juan, Irune/0000-0001-6233-6659; Klim, Joseph/0000-0001-8119-2144; Kirchner, Rory/0000-0003-4814-5885; Steinbaugh, Michael/0000-0002-2403-2221	HHMI; Project ALS; HSCI; Target ALS; NINDS [NIH5R01NS089742]; Milton Safenowitz postdoctoral fellowship from the ALS Association; US National Institutes of Health [1K99AG057808-01A1]; MGH training grant [5T32CA009216]; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG057808] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); Project ALS; HSCI; Target ALS; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Milton Safenowitz postdoctoral fellowship from the ALS Association; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by HHMI, Project ALS, HSCI, Target ALS and the NINDS grant NIH5R01NS089742 to K.E. J.R.K. is the Project ALS Tom Kirchhoff Family Postdoctoral Fellow. B.N.D.-D. was supported by the Milton Safenowitz postdoctoral fellowship from the ALS Association. A. Burberry was supported by the US National Institutes of Health (1K99AG057808-01A1). D.A.M. was funded by the MGH training grant (5T32CA009216) and is grateful for the assistance of the Massachusetts ADRC neuropathology core in preparing tissue samples. B.J.W. is a New York Stem Cell Foundation - Robertson Investigator. We thank D. Cleveland for the generous gift of TDP-43 (FL9) antibody.	Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Amoroso MW, 2013, J NEUROSCI, V33, P574, DOI 10.1523/JNEUROSCI.0906-12.2013; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Ariyannur PS, 2010, BRAIN RES, V1335, P1, DOI 10.1016/j.brainres.2010.04.008; Bellouze S, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0111-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bieche I, 2003, GENOMICS, V81, P400, DOI 10.1016/S0888-7543(03)00031-4; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Chauvin S, 2015, PROG NEUROBIOL, V126, P1, DOI 10.1016/j.pneurobio.2014.09.002; Colombrita C, 2015, BBA-GENE REGUL MECH, V1849, P1398, DOI 10.1016/j.bbagrm.2015.10.015; D'Erchia AM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10488-7; Davis-Dusenbery BN, 2014, DEVELOPMENT, V141, P491, DOI 10.1242/dev.097410; de Boer AS, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009351; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Fratta P, 2018, EMBO J, V37, DOI 10.15252/embj.201798684; Grenningloh G, 2004, J NEUROBIOL, V58, P60, DOI 10.1002/neu.10279; Han SSW, 2011, NEURON, V70, P626, DOI 10.1016/j.neuron.2011.05.003; Highley JR, 2014, NEUROPATH APPL NEURO, V40, P670, DOI 10.1111/nan.12148; Humphrey J, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0274-1; Kaplan A, 2014, NEURON, V81, P333, DOI 10.1016/j.neuron.2013.12.009; Kasashima K, 2002, NUCLEIC ACIDS RES, V30, P4519, DOI 10.1093/nar/gkf567; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Ling JP, 2015, SCIENCE, V349, P650, DOI 10.1126/science.aab0983; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin KR, 2012, HUM MOL GENET, V21, P3025, DOI 10.1093/hmg/dds134; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Miller RG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub3; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nicolas A, 2018, NEURON, V97, P1268, DOI 10.1016/j.neuron.2018.02.027; Park YY, 2013, HEPATOLOGY, V58, P182, DOI 10.1002/hep.26310; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Rabin SJ, 2010, HUM MOL GENET, V19, P313, DOI 10.1093/hmg/ddp498; Ravits J, 2013, AMYOTROPH LAT SCL FR, V14, P5, DOI 10.3109/21678421.2013.778548; Serio A, 2013, P NATL ACAD SCI USA, V110, P4697, DOI 10.1073/pnas.1300398110; Shiga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043120; Shin JE, 2014, EXP NEUROL, V252, P1, DOI 10.1016/j.expneurol.2013.11.007; Shin JE, 2012, P NATL ACAD SCI USA, V109, pE3696, DOI 10.1073/pnas.1216204109; Smith BN, 2014, NEURON, V84, P324, DOI 10.1016/j.neuron.2014.09.027; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Steinbaugh M. J, 2017, F1000RES, V6, P1976, DOI 10.12688/f1000research.12093.1; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; van Eersel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022850; White MA, 2018, NAT NEUROSCI, V21, P552, DOI 10.1038/s41593-018-0113-5; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Wu MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076000; Yang CX, 2014, P NATL ACAD SCI USA, V111, pE1121, DOI 10.1073/pnas.1322641111; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540	61	169	170	8	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2019	22	2					167	+		10.1038/s41593-018-0300-4	http://dx.doi.org/10.1038/s41593-018-0300-4			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HI9BQ	30643292	Green Accepted			2022-12-17	WOS:000456750100004
J	Ajami, B; Samusik, N; Wieghofer, P; Ho, PP; Crotti, A; Bjornson, Z; Prinz, M; Fantl, WJ; Nolan, GP; Steinman, L				Ajami, Bahareh; Samusik, Nikolay; Wieghofer, Peter; Ho, Peggy P.; Crotti, Andrea; Bjornson, Zach; Prinz, Marco; Fantl, Wendy J.; Nolan, Garry P.; Steinman, Lawrence			Single-cell mass cytometry reveals distinct populations of brain myeloid cells in mouse neuroinflammation and neurodegeneration models	NATURE NEUROSCIENCE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; PERTUSSIS TOXIN; IMMUNE CELLS; SPINAL-CORD; MICROGLIA; MONOCYTES; DISEASE; CNS	Neuroinflammation and neurodegeneration may represent two poles of brain pathology. Brain myeloid cells, particularly microglia, play key roles in these conditions. We employed single-cell mass cytometry (CyTOF) to compare myeloid cell populations in the experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis, the R6/2 model of Huntington's disease (HD) and the mutant superoxide dismutase 1 (mSOD1) model of amyotrophic lateral sclerosis (ALS). We identified three myeloid cell populations exclusive to the CNS and present in each disease model. Blood-derived monocytes comprised five populations and migrated to the brain in EAE, but not in HD and ALS models. Single-cell analysis resolved differences in signaling and cytokine production within similar myeloid populations in EAE compared to HD and ALS models. Moreover, these analyses highlighted alpha 5 integrin on myeloid cells as a potential therapeutic target for neuroinflammation. Together, these findings illustrate how neuropathology may differ between inflammatory and degenerative brain disease.	[Ajami, Bahareh; Ho, Peggy P.; Steinman, Lawrence] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Samusik, Nikolay; Bjornson, Zach; Fantl, Wendy J.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Wieghofer, Peter; Prinz, Marco] Univ Freiburg, Fac Med, Inst Neuropathol, Freiburg, Germany; [Wieghofer, Peter] Univ Leipzig, Inst Anat, Leipzig, Germany; [Crotti, Andrea] Univ Calif San Diego, Dept Cell & Mol Med, San Diego, CA 92103 USA; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	Stanford University; Stanford University; University of Freiburg; Leipzig University; University of California System; University of California San Diego; University of Freiburg	Ajami, B; Steinman, L (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA.	b.ajami@stanford.edu; steinman@stanford.edu	Ajami, Bahareh/AAA-7262-2019; Wieghofer, Peter/AAV-9572-2020; Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043; /0000-0002-6848-318X; Ajami, Bahareh/0000-0003-0320-4677; Steinman, Lawrence/0000-0002-2437-2250	Department of Defense (CDMRP) [U19 AI057229, 1U19AI100627]; Northrop-Grumman Corporation [R01CA184968, 1R33CA183654-01, R33CA183692, 1R01GM10983601, 1R21CA183660, 1R01NS08953304, OPP1113682, 5UH2AR067676, 1R01CA19665701, R01HL120724]; Canadian Institute for Health Research [201102MFE-246400-166230]; Rachford & Carlotta A. Harris Endowed Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276] Funding Source: NIH RePORTER	Department of Defense (CDMRP)(United States Department of Defense); Northrop-Grumman Corporation; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Rachford & Carlotta A. Harris Endowed Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Butovsky (Harvard University) for the generous gift of 4D4 and FCRLS antibody. We thank A. Trejo and A. Jager for mass cytometry quality control and maintenance, and S. Douglas and V. Giangarra for technical assistance. This work was supported by grants to G. PN.: U19 AI057229, 1U19AI100627, Department of Defense (CDMRP), Northrop-Grumman Corporation, R01CA184968, 1R33CA183654-01, R33CA183692, 1R01GM10983601, 1R21CA183660, 1R01NS08953304, OPP1113682, 5UH2AR067676, 1R01CA19665701, R01HL120724. G.P.N. is supported by the Rachford & Carlotta A. Harris Endowed Chair. B.A was supported by a three-year postdoctoral fellowship from the Canadian Institute for Health Research (201102MFE-246400-166230).	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Bannerman PG, 2005, BRAIN, V128, P1877, DOI 10.1093/brain/awh550; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Boroujerdi A, 2013, EXP NEUROL, V250, P43, DOI 10.1016/j.expneurol.2013.09.009; Brendecke SM, 2015, SEMIN IMMUNOPATHOL, V37, P591, DOI 10.1007/s00281-015-0520-6; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Chen X, 2006, EUR J IMMUNOL, V36, P671, DOI 10.1002/eji.200535353; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; Estes ML, 2014, BRAIN PATHOL, V24, P623, DOI 10.1111/bpa.12198; Fienberg HG, 2012, CYTOM PART A, V81A, P467, DOI 10.1002/cyto.a.22067; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Ginhoux F, 2011, M S-MED SCI, V27, P719, DOI 10.1051/medsci/2011278013; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Graeber MB, 2014, BRAIN PATHOL, V24, P620, DOI 10.1111/bpa.12192; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hofstetter HH, 2002, J IMMUNOL, V169, P117, DOI 10.4049/jimmunol.169.1.117; Hou WQ, 2003, J IMMUNOL, V170, P1728, DOI 10.4049/jimmunol.170.4.1728; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Kim H, 2007, BRAIN RES, V1162, P113, DOI 10.1016/j.brainres.2007.05.072; LEVARLET B, 1992, J LEUKOCYTE BIOL, V51, P415, DOI 10.1002/jlb.51.4.415; LINTHICUM DS, 1982, CELL IMMUNOL, V73, P299, DOI 10.1016/0008-8749(82)90457-9; Liu F, 2005, J IMMUNOL, V174, P5936, DOI 10.4049/jimmunol.174.10.5936; Lu JQ, 2013, J NEUROPATH EXP NEUR, V72, P1135, DOI 10.1097/NEN.0000000000000011; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Obrietan K, 2004, J NEUROSCI, V24, P791, DOI 10.1523/JNEUROSCI.3493-03.2004; Pino PA, 2011, JOVE-J VIS EXP, DOI 10.3791/2348; Prinz M, 2017, NAT NEUROSCI, V20, P136, DOI 10.1038/nn.4475; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Reiman R, 2002, EUR J IMMUNOL, V32, P1157, DOI 10.1002/1521-4141(200204)32:4<1157::AID-IMMU1157>3.3.CO;2-D; Rogers J, 1996, NEUROBIOL AGING, V17, P681, DOI 10.1016/0197-4580(96)00115-7; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Samusik N, 2016, NAT METHODS, V13, P493, DOI [10.1038/NMETH.3863, 10.1038/nmeth.3863]; Silvestroni A, 2009, NEUROREPORT, V20, P1098, DOI 10.1097/WNR.0b013e32832e34ee; SOBEL RA, 1989, AM J PATHOL, V135, P161; Solomon JN, 2006, GLIA, V53, P744, DOI 10.1002/glia.20331; Spitzer MH, 2015, SCIENCE, V349, DOI 10.1126/science.1259425; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Steinman L, 2014, ANNU REV IMMUNOL, V32, P257, DOI 10.1146/annurev-immunol-032713-120227; Steinman L, 2012, J CELL BIOL, V199, P413, DOI 10.1083/jcb.201207175; Sudduth TL, 2013, NEUROBIOL AGING, V34, P1051, DOI 10.1016/j.neurobiolaging.2012.09.012; Weber MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016009; Wlodarczyk A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-57; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhao WH, 2013, J NEUROIMMUNE PHARM, V8, P888, DOI 10.1007/s11481-013-9489-x; Zhou ZG, 2009, J NEUROCHEM, V110, P1617, DOI 10.1111/j.1471-4159.2009.06263.x; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	62	169	171	4	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2018	21	4					541	+		10.1038/s41593-018-0100-x	http://dx.doi.org/10.1038/s41593-018-0100-x			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB1FG	29507414	Green Accepted			2022-12-17	WOS:000428796000013
J	Chen, SX; Kim, AN; Peters, AJ; Komiyama, T				Chen, Simon X.; Kim, An Na; Peters, Andrew J.; Komiyama, Takaki			Subtype-specific plasticity of inhibitory circuits in motor cortex during motor learning	NATURE NEUROSCIENCE			English	Article							CRITICAL-PERIOD PLASTICITY; DENDRITIC SPINES; STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; VISUAL-CORTEX; INTRACORTICAL MICROSTIMULATION; GABAERGIC NEURONS; TRANSGENIC MICE; ADULT NEOCORTEX; BEHAVING MICE	Motor skill learning induces long-lasting reorganization of dendritic spines, principal sites of excitatory synapses, in the motor cortex. However, mechanisms that regulate these excitatory synaptic changes remain poorly understood. Here, using in vivo two-photon imaging in awake mice, we found that learning-induced spine reorganization of layer (L) 2/3 excitatory neurons occurs in the distal branches of their apical dendrites in L1 but not in the perisomatic dendrites. This compartment-specific spine reorganization coincided with subtype-specific plasticity of local inhibitory circuits. Somatostatin-expressing inhibitory neurons (SOM-INs), which mainly inhibit distal dendrites of excitatory neurons, showed a decrease in axonal boutons immediately after the training began, whereas parvalbumin-expressing inhibitory neurons (PV-INs), which mainly inhibit perisomatic regions of excitatory neurons, exhibited a gradual increase in axonal boutons during training. Optogenetic enhancement and suppression of SOM-IN activity during training destabilized and hyperstabilized spines, respectively, and both manipulations impaired the learning of stereotyped movements. Our results identify SOM inhibition of distal dendrites as a key regulator of learning-related changes in excitatory synapses and the acquisition of motor skills.	[Chen, Simon X.; Kim, An Na; Peters, Andrew J.; Komiyama, Takaki] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA; [Chen, Simon X.; Kim, An Na; Peters, Andrew J.; Komiyama, Takaki] Univ Calif San Diego, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Chen, Simon X.; Kim, An Na; Peters, Andrew J.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Komiyama, Takaki] Univ Calif San Diego, PRESTO, Japan Sci & Technol Agcy, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Komiyama, T (corresponding author), Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA.	tkomiyama@ucsd.edu		Chen, Simon/0000-0002-7595-7443; Komiyama, Takaki/0000-0001-9609-4600; Peters, Andrew/0000-0001-9351-1456	Japan Science and Technology Agency (PRESTO); Pew Charitable Trusts; Alfred P. Sloan Foundation; David & Lucile Packard Foundation; Human Frontier Science Program; McKnight Foundation; US National Institutes of Health [R01 NS091010A]; University of California San Diego Center for Brain Activity Mapping; New York Stem Cell Foundation (NYSCF); Neuroplasticity of Aging Training Grant [AG000216]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061847, R01NS091010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC012641, R01DC014690] Funding Source: NIH RePORTER	Japan Science and Technology Agency (PRESTO)(Japan Science & Technology Agency (JST)); Pew Charitable Trusts; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); David & Lucile Packard Foundation(The David & Lucile Packard Foundation); Human Frontier Science Program(Human Frontier Science Program); McKnight Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego Center for Brain Activity Mapping; New York Stem Cell Foundation (NYSCF); Neuroplasticity of Aging Training Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank C. Levelt (Netherlands Institute for Neuroscience) for the Gephyrin-GFP construct and B. Bloodgood, R. Malinow and members of the Komiyama laboratory for comments and discussions. This work was supported by grants from Japan Science and Technology Agency (PRESTO), Pew Charitable Trusts, Alfred P. Sloan Foundation, David & Lucile Packard Foundation, Human Frontier Science Program, McKnight Foundation, US National Institutes of Health (R01 NS091010A), University of California San Diego Center for Brain Activity Mapping and New York Stem Cell Foundation (NYSCF) to T.K. S.X.C. is a Human Frontier Science Program postdoctoral fellow. A.J.P. is supported by the Neuroplasticity of Aging Training Grant (AG000216). T.K. is a NYSCF-Robertson Investigator.	Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Chen JL, 2011, NAT NEUROSCI, V14, P587, DOI 10.1038/nn.2799; Cichon J, 2015, NATURE, V520, P180, DOI 10.1038/nature14251; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Gidon A, 2012, NEURON, V75, P330, DOI 10.1016/j.neuron.2012.05.015; Hasan MT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3258; Hayama T, 2013, NAT NEUROSCI, V16, P1409, DOI 10.1038/nn.3496; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hill TC, 2013, J NEUROSCI, V33, P678, DOI 10.1523/JNEUROSCI.1404-12.2013; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; Levelt CN, 2012, ANNU REV NEUROSCI, V35, P309, DOI 10.1146/annurev-neuro-061010-113813; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Munoz-Cuevas FJ, 2013, NAT NEUROSCI, V16, P1367, DOI 10.1038/nn.3498; Nudo RJ, 1996, J NEUROSCI, V16, P785; Peters AJ, 2014, NATURE, V510, P263, DOI 10.1038/nature13235; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Picard N, 2013, NAT NEUROSCI, V16, P1340, DOI 10.1038/nn.3477; Pronichev I V, 1998, Neurosci Behav Physiol, V28, P80, DOI 10.1007/BF02461916; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rokni U, 2007, NEURON, V54, P653, DOI 10.1016/j.neuron.2007.04.030; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Sheffield MEJ, 2015, NATURE, V517, P200, DOI 10.1038/nature13871; Steele PM, 1999, J NEUROPHYSIOL, V81, P1559, DOI 10.1152/jn.1999.81.4.1559; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Xue MS, 2014, NATURE, V511, P596, DOI 10.1038/nature13321; Yang G, 2014, SCIENCE, V344, P1173, DOI 10.1126/science.1249098; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577	47	169	171	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2015	18	8					1109	+		10.1038/nn.4049	http://dx.doi.org/10.1038/nn.4049			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CN7HO	26098758	Green Accepted, Green Submitted			2022-12-17	WOS:000358605400011
J	Merkle, FT; Fuentealba, LC; Sanders, TA; Magno, L; Kessaris, N; Alvarez-Buylla, A				Merkle, Florian T.; Fuentealba, Luis C.; Sanders, Timothy A.; Magno, Lorenza; Kessaris, Nicoletta; Alvarez-Buylla, Arturo			Adult neural stem cells in distinct microdomains generate previously unknown interneuron types	NATURE NEUROSCIENCE			English	Article							OLFACTORY-BULB; CONTINUOUS NEUROGENESIS; ORGANIZATION; EXPRESSION; ZONE; TELENCEPHALON; ASTROCYTES; FOREBRAIN; ORIGINS; NEURONS	Throughout life, neural stem cells (NSCs) in different domains of the ventricular-subventricular zone (V-SVZ) of the adult rodent brain generate several subtypes of interneurons that regulate the function of the olfactory bulb. The full extent of diversity among adult NSCs and their progeny is not known. Here, we report the generation of at least four previously unknown olfactory bulb interneuron subtypes that are produced in finely patterned progenitor domains in the anterior ventral V-SVZ of both the neonatal and adult mouse brain. Progenitors of these interneurons are responsive to sonic hedgehog and are organized into microdomains that correlate with the expression domains of the Nkx6.2 and Zic family of transcription factors. This work reveals an unexpected degree of complexity in the specification and patterning of NSCs in the postnatal mouse brain.	[Merkle, Florian T.; Fuentealba, Luis C.; Sanders, Timothy A.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Merkle, Florian T.; Fuentealba, Luis C.; Sanders, Timothy A.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Merkle, Florian T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Merkle, Florian T.] Harvard Univ, Dept Cellular & Dev Biol, Cambridge, MA 02138 USA; [Merkle, Florian T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Magno, Lorenza; Kessaris, Nicoletta] UCL, Wolfson Inst Biomed Res, London, England; [Magno, Lorenza; Kessaris, Nicoletta] UCL, Dept Cell & Dev Biol, London, England	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard University; Harvard University; University of London; University College London; University of London; University College London	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu	Kessaris, Nicoletta/AAD-6774-2019; Magno, Lorenza/H-1107-2014	Kessaris, Nicoletta/0000-0003-1191-6009; Magno, Lorenza/0000-0002-2350-9796; Merkle, Florian/0000-0002-8513-2998; Alvarez-Buylla, Arturo/0000-0003-4426-8925	US National Science Foundation; Jane Coffin Childs Memorial Fund; US National Institutes of Health (NIH); Harvard Stem Cell Institute; Howard Hughes Medical Institute; Helen Hay Whitney Foundation; NIH [HD 32116, NS 28478]; John G. Bowes Research Fund; European Research Council [207807]; UK Medical Research Council [86419]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028478, R37NS028478, R29NS028478] Funding Source: NIH RePORTER; Medical Research Council [G0501173] Funding Source: researchfish; MRC [G0501173] Funding Source: UKRI	US National Science Foundation(National Science Foundation (NSF)); Jane Coffin Childs Memorial Fund; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John G. Bowes Research Fund; European Research Council(European Research Council (ERC)European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank T. Nguyen, Z. Mirzadeh and R. Ihrie for comments and discussions that improved this study, and D. Rowitch (University of California, San Francisco) and R. Segal (Harvard Medical School) for generously sharing antibodies. R. Romero provided outstanding technical assistance with histology M. Grist, U. Dennehy and M. Humphreys generated the Nkx6.2::CreER<SUP>T2</SUP> transgenic mice, and Gli1 ::CreER<SUP>T2</SUP> mice were generously provided by A. Joyner (Sloan-Kettering Institute). F.T.M. was supported by the US National Science Foundation, the Jane Coffin Childs Memorial Fund, the US National Institutes of Health (NIH) and the Harvard Stem Cell Institute. L.C.F. was supported by the Howard Hughes Medical Institute and the Helen Hay Whitney Foundation. This study was supported by grants from the NIH (HD 32116 and NS 28478), the John G. Bowes Research Fund, the European Research Council (207807) and the UK Medical Research Council (86419).	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Alonso M, 2008, J NEUROSCI, V28, P11089, DOI 10.1523/JNEUROSCI.3713-08.2008; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Alvarez-Buylla A, 2008, COLD SH Q B, V73, P357, DOI 10.1101/sqb.2008.73.019; Moreno-Bravo JA, 2010, DEV DYNAM, V239, P2094, DOI 10.1002/dvdy.22327; ARUGA J, 1994, J NEUROCHEM, V63, P1880; Blanes T., 1898, REV TRIM MICROG, V3, P99; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Ihrie RA, 2011, NEURON, V71, P250, DOI 10.1016/j.neuron.2011.05.018; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Inan M, 2012, CEREB CORTEX, V22, P820, DOI 10.1093/cercor/bhr148; Inoue T, 2007, J NEUROSCI, V27, P5461, DOI 10.1523/JNEUROSCI.4046-06.2007; Kelsch W, 2007, PLOS BIOL, V5, P2501, DOI 10.1371/journal.pbio.0050300; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; KOSAKA K, 1995, NEUROSCI RES, V23, P73, DOI 10.1016/0168-0102(95)00930-R; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Laariva-Sahd J, 2008, J COMP NEUROL, V510, P309, DOI 10.1002/cne.21790; LOPEZMASCARAQUE L, 1990, J COMP NEUROL, V301, P243, DOI 10.1002/cne.903010208; Magno L, 2009, BRAIN RES, V1304, P164, DOI 10.1016/j.brainres.2009.09.050; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Marin O, 2000, J NEUROSCI, V20, P6063; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; PRICE JL, 1970, J CELL SCI, V7, P631; PRICE M, 1993, J NEUROBIOL, V24, P1385, DOI 10.1002/neu.480241010; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Sakamoto M, 2011, P NATL ACAD SCI USA, V108, P8479, DOI 10.1073/pnas.1018782108; SCHNEIDER SP, 1978, BRAIN RES BULL, V3, P73, DOI 10.1016/0361-9230(78)90063-1; Seri B, 2006, CEREB CORTEX, V16, pI103, DOI 10.1093/cercor/bhk027; Shepherd G.M., 2004, NEUROBIOLOGY; SHEPHERD GM, 1972, PHYSIOL REV, V52, P864, DOI 10.1152/physrev.1972.52.4.864; Shepherd GM, 2007, BRAIN RES REV, V55, P373, DOI 10.1016/j.brainresrev.2007.03.005; Sussel L, 1999, DEVELOPMENT, V126, P3359; Taniguchi H, 2013, SCIENCE, V339, P70, DOI 10.1126/science.1227622; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; VANGEHUCHTEN A, 1891, CELLULE, V7, P205; Ventura RE, 2007, J NEUROSCI, V27, P4297, DOI 10.1523/JNEUROSCI.0399-07.2007; Waclaw RR, 2006, NEURON, V49, P503, DOI 10.1016/j.neuron.2006.01.018; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007	47	169	172	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2014	17	2					207	214		10.1038/nn.3610	http://dx.doi.org/10.1038/nn.3610			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AA2FH	24362763	Green Accepted, Green Submitted			2022-12-17	WOS:000330910000014
J	Wu, LJ; Wu, GX; Sharif, MRA; Baker, A; Jia, YH; Fahey, FH; Luo, HBR; Feener, EP; Clapham, DE				Wu, Long-Jun; Wu, Gongxiong; Sharif, M. Reza Akhavan; Baker, Amanda; Jia, Yonghui; Fahey, Frederic H.; Luo, Hongbo R.; Feener, Edward P.; Clapham, David E.			The voltage-gated proton channel Hv1 enhances brain damage from ischemic stroke	NATURE NEUROSCIENCE			English	Article							NADPH OXIDASE; MICROGLIAL ACTIVATION; CEREBRAL-ISCHEMIA; INTRACELLULAR PH; ACID EXTRUSION; MECHANISMS; CELLS; MICE; CURRENTS; SLICES	Phagocytic cell NADPH oxidase (NOX) generates reactive oxygen species (ROS) as part of innate immunity. Unfortunately, ischemia can also induce this pathway and inflict damage on native cells. The voltage-gated proton channel Hv1 enables NOX function by compensating cellular loss of electrons with protons. Accordingly, we investigated whether NOX-mediated brain damage in stroke can be inhibited by suppression of Hv1. We found that mouse and human brain microglia, but not neurons or astrocytes, expressed large Hv1-mediated currents. Hv1 was required for NOX-dependent ROS generation in brain microglia in situ and in vivo. Mice lacking Hv1 were protected from NOX-mediated neuronal death and brain damage 24 h after stroke. These results indicate that Hv1-dependent ROS production is responsible for a substantial fraction of brain damage at early time points after ischemic stroke and provide a rationale for Hv1 as a therapeutic target for the treatment of ischemic stroke.	[Wu, Long-Jun; Clapham, David E.] Childrens Hosp Boston, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA; [Wu, Long-Jun; Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Wu, Gongxiong; Feener, Edward P.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA USA; [Sharif, M. Reza Akhavan] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA; [Baker, Amanda; Fahey, Frederic H.] Childrens Hosp Boston, Dept Radiol, Boston, MA USA; [Jia, Yonghui; Luo, Hongbo R.] Childrens Hosp Boston, Dept Lab Med, Boston, MA USA; [Jia, Yonghui; Luo, Hongbo R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Childrens Hosp Boston, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Baker, Amanda L/H-2966-2014; Clapham, David/R-5974-2019; Clapham, David/S-1123-2019; Wu, Long-Jun/E-2684-2012; Wu, Long-Jun/AAK-7113-2020	Baker, Amanda L/0000-0002-3328-7146; Clapham, David/0000-0002-4459-9428; Wu, Long-Jun/0000-0001-8019-3380	US National Institutes of Health [R01 MH090293, R01 EY019029]; Harvard Medical School; American Heart Association [11SDG7340011]; NATIONAL EYE INSTITUTE [R01EY019029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS072040] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School; American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Silberstein, W. Yang and M. Kurtev for technical assistance, S. Doctrow (Boston University) for kindly providing us with EUK-207, Y. Kirichok (University of California, San Francisco) for Hv1 antibody, and D. Chaudhuri for critical reading of the manuscript. This work was supported by the US National Institutes of Health (R01 MH090293 to D.E.C. and R01 EY019029 to E.P.F.). L.-J.W. is supported by a Lefler postdoctoral fellowship from Harvard Medical School and a Scientist Development Grant from the American Heart Association (11SDG7340011).	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Cheng YM, 2008, NEUROSCIENCE, V151, P1084, DOI 10.1016/j.neuroscience.2007.12.007; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De Simoni A, 2008, EUR J NEUROSCI, V28, P1146, DOI 10.1111/j.1460-9568.2008.06417.x; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeCoursey TE, 2008, J PHYSIOL-LONDON, V586, P5305, DOI 10.1113/jphysiol.2008.161703; Dringen R, 2005, ANTIOXID REDOX SIGN, V7, P1223, DOI 10.1089/ars.2005.7.1223; Gambhir SS, 2001, J NUCL MED, V42, p1S; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Iovannisci D, 2010, J GEN PHYSIOL, V136, P35, DOI 10.1085/jgp.200910379; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; Lai AY, 2006, CAN J PHYSIOL PHARM, V84, P49, DOI 10.1139/y05-143; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100; Lyons SA, 2000, J CEREBR BLOOD F MET, V20, P1537, DOI 10.1097/00004647-200011000-00003; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Musset B, 2008, P NATL ACAD SCI USA, V105, P11020, DOI 10.1073/pnas.0800886105; Nathan C, 2010, CELL, V140, DOI 10.1016/j.cell.2010.03.008; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ransohoff RM, 2007, NAT NEUROSCI, V10, P1507, DOI 10.1038/nn1207-1507; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schilling M, 2003, EXP NEUROL, V183, P25, DOI 10.1016/S0014-4886(03)00082-7; Schilling T, 2007, BRAIN RES, V1186, P21, DOI 10.1016/j.brainres.2007.10.027; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI 10.1089/ARS.2009.2578; Steinhubl SR, 2008, AM J CARDIOL, V101, p14D, DOI 10.1016/j.amjcard.2008.02.003; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; VISENTIN S, 1995, J NEUROSCI RES, V42, P439, DOI 10.1002/jnr.490420402; Walder CE, 1997, STROKE, V28, P2252, DOI 10.1161/01.STR.28.11.2252; WHITTINGHAM TS, 1984, J NEUROSCI, V4, P793; Wu LJ, 2007, GLIA, V55, P810, DOI 10.1002/glia.20500; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005	43	169	174	1	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					565	573		10.1038/nn.3059	http://dx.doi.org/10.1038/nn.3059			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22388960	Green Submitted, Green Accepted			2022-12-17	WOS:000302114500016
J	Brown, MR; Kronengold, J; Gazula, VR; Chen, Y; Strumbos, JG; Sigworth, FJ; Navaratnam, D; Kaczmarek, LK				Brown, Maile R.; Kronengold, Jack; Gazula, Valeswara-Rao; Chen, Yi; Strumbos, John G.; Sigworth, Fred J.; Navaratnam, Dhasakumar; Kaczmarek, Leonard K.			Fragile X mental retardation protein controls gating of the sodium-activated potassium channel Slack	NATURE NEUROSCIENCE			English	Article							AUDITORY NEURONS; TRANSLATION; GENE; RNA	In humans, the absence of Fragile X mental retardation protein (FMRP), an RNA-binding protein, results in Fragile X syndrome, the most common inherited form of intellectual disability. Using biochemical and electrophysiological studies, we found that FMRP binds to the C terminus of the Slack sodium-activated potassium channel to activate the channel in mice. Our findings suggest that Slack activity provides a link between patterns of neuronal firing and changes in protein translation.	[Brown, Maile R.; Kronengold, Jack; Gazula, Valeswara-Rao; Strumbos, John G.; Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Chen, Yi; Sigworth, Fred J.; Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Navaratnam, Dhasakumar] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Navaratnam, Dhasakumar] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University	Kaczmarek, LK (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	leonard.kaczmarek@yale.edu			US National Institutes of Health [NS61479, DC008449, DC01919]; FRAXA Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018492, F32NS061479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001919, F32DC008449] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FRAXA Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by US National Institutes of Health grants NS61479 (M.R.B.), DC008449 (J.K.), DC01919 and the FRAXA Research Foundation (L.K.K.).	Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; DRYER SE, 1994, TRENDS NEUROSCI, V17, P155, DOI 10.1016/0166-2236(94)90093-0; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Ramos A, 2006, STRUCTURE, V14, P21, DOI 10.1016/j.str.2005.09.018; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Sjekloca L, 2009, BIOCHEM J, V419, P347, DOI 10.1042/BJ20082197; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Wang LY, 1998, J PHYSIOL-LONDON, V509, P183, DOI 10.1111/j.1469-7793.1998.183bo.x; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zukin RS, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.014.2009	13	169	179	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					819	821		10.1038/nn.2563	http://dx.doi.org/10.1038/nn.2563			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20512134	Green Accepted			2022-12-17	WOS:000279173900012
J	Orger, MB; Kampff, AR; Severi, KE; Bollmann, JH; Engert, F				Orger, Michael B.; Kampff, Adam R.; Severi, Kristen E.; Bollmann, Johann H.; Engert, Florian			Control of visually guided behavior by distinct populations of spinal projection neurons	NATURE NEUROSCIENCE			English	Article							IDENTIFIED RETICULOSPINAL NEURONS; LARVAL ZEBRAFISH; MAUTHNER CELL; PREY CAPTURE; DECISION-MAKING; LASER-ABLATION; MOTOR CONTROL; HINDBRAIN; INTERNEURONS; ORGANIZATION	A basic question in the field of motor control is how different actions are represented by activity in spinal projection neurons. We used a new behavioral assay to identify visual stimuli that specifically drive basic motor patterns in zebrafish. These stimuli evoked consistent patterns of neural activity in the neurons projecting to the spinal cord, which we could map throughout the entire population using in vivo two-photon calcium imaging. We found that stimuli that drive distinct behaviors activated distinct subsets of projection neurons, consisting, in some cases, of just a few cells. This stands in contrast to the distributed activation seen for more complex behaviors. Furthermore, targeted cell by cell ablations of the neurons associated with evoked turns abolished the corresponding behavioral response. This description of the functional organization of the zebrafish motor system provides a framework for identifying the complete circuit underlying a vertebrate behavior.	[Orger, Michael B.; Kampff, Adam R.; Bollmann, Johann H.; Engert, Florian] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Severi, Kristen E.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Harvard University; Northeastern University	Orger, MB (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	morger@mcb.harvard.edu	Severi, Kristen/AAB-8943-2019	Severi, Kristen/0000-0002-4568-1538; Kampff, Adam/0000-0003-3079-019X; Orger, Michael/0000-0002-9763-8902	NATIONAL EYE INSTITUTE [R01EY014429] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014429, R01 EY014429-01A2, R01 EY014429-05] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bhatt DH, 2007, NEURON, V53, P91, DOI 10.1016/j.neuron.2006.11.011; Bizzi E, 2002, NEUROSCIENTIST, V8, P437, DOI 10.1177/107385802236969; Borla MA, 2002, BRAIN BEHAV EVOLUT, V60, P207, DOI 10.1159/000066699; Bosch TJ, 2001, J COMP NEUROL, V439, P306, DOI 10.1002/cne.1352; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Budick SA, 2000, J EXP BIOL, V203, P2565; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; Chong M, 2007, DEV NEUROBIOL, V67, P933, DOI 10.1002/dneu.20398; Chung SH, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-30; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; Deliagina TG, 2002, BRAIN RES REV, V40, P166, DOI 10.1016/S0165-0173(02)00199-6; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Gahtan E, 2004, J NEUROBIOL, V59, P147, DOI 10.1002/neu.20000; Gahtan E, 2003, J COMP NEUROL, V459, P186, DOI 10.1002/cne.10621; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; Gahtan E, 2001, J NEUROSCI METH, V108, P97, DOI 10.1016/S0165-0270(01)00382-X; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; Kimura Y, 2006, J NEUROSCI, V26, P5684, DOI 10.1523/JNEUROSCI.4993-05.2006; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; LEE RKK, 1991, J COMP NEUROL, V304, P34; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Lister JA, 1999, DEVELOPMENT, V126, P3757; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; MENDELSON B, 1986, J COMP NEUROL, V251, P172, DOI 10.1002/cne.902510204; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; NISSANOV J, 1990, BRAIN RES, V517, P88, DOI 10.1016/0006-8993(90)91012-6; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Orger MB, 2000, NAT NEUROSCI, V3, P1128, DOI 10.1038/80649; Orlovsky G.N., 1999, NEURONAL CONTROL LOC; PEARSON KG, 1993, ANNU REV NEUROSCI, V16, P265, DOI 10.1146/annurev.ne.16.030193.001405; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Sato T, 2007, J NEUROSCI, V27, P5271, DOI 10.1523/JNEUROSCI.0883-07.2007; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; WIERSMA CAG, 1964, COMP BIOCHEM PHYSIOL, V12, P509, DOI 10.1016/0010-406X(64)90153-7; WU J, 1994, SCIENCE, V263, P820, DOI 10.1126/science.8303300; Zelenin PV, 2007, J NEUROSCI, V27, P1024, DOI 10.1523/JNEUROSCI.4925-06.2007; Zelenin PV, 2005, EUR J NEUROSCI, V22, P2271, DOI 10.1111/j.1460-9568.2005.04395.x; Zottoli SJ, 1999, J COMP PHYSIOL A, V184, P207, DOI 10.1007/s003590050319	45	169	173	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					327	333		10.1038/nn2048	http://dx.doi.org/10.1038/nn2048			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18264094	Green Accepted, Green Published			2022-12-17	WOS:000253548300016
J	Lin, MT; Lujan, R; Watanabe, M; Adelman, JP; Maylie, J				Lin, Mike T.; Lujan, Rafael; Watanabe, Masahiko; Adelman, John P.; Maylie, James			SK2 channel plasticity contributes to LTP at Schaffer collateral-CA1 synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CA2+-ACTIVATED POTASSIUM CHANNEL; SYNAPTIC PLASTICITY; SMALL-CONDUCTANCE; AMPA RECEPTORS; DENDRITIC SPINES; CALCIUM-CHANNELS; PROTEIN-KINASE; LATE-PHASE; I-H	Long-term potentiation (LTP) of synaptic strength at Schaffer collateral synapses has largely been attributed to changes in the number and biophysical properties of AMPA receptors (AMPARs). Small-conductance Ca2(+)-activated K+ channels (SK2 channels) are functionally coupled with NMDA receptors (NMDARs) in CA1 spines such that their activity modulates the shape of excitatory postsynaptic potentials (EPSPs) and increases the threshold for induction of LTP. Here we show that LTP induction in mouse hippocampus abolishes SK2 channel activity in the potentiated synapses. This effect is due to SK2 channel internalization from the postsynaptic density (PSD) into the spine. Blocking PKA or cell dialysis with a peptide representing the C-terminal domain of SK2 that contains three known PKA phosphorylation sites blocks the internalization of SK2 channels after LTP induction. Thus the increase in AMPARs and the decrease in SK2 channels combine to produce the increased EPSP underlying LTP.	[Lin, Mike T.; Adelman, John P.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Lujan, Rafael] Univ Castilla La Mancha, Dept Ciencias Med, Albacete 02006, Spain; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Maylie, James] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA	Oregon Health & Science University; Universidad de Castilla-La Mancha; Hokkaido University; Oregon Health & Science University	Adelman, JP (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	adelman@ohsu.edu; mayliej@ohsu.edu	Lujan, Rafael/G-2555-2015; WATANABE, Masahiko/A-4055-2012; Watanabe, Masahiko/S-3614-2019	WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138; Lujan Miras, Rafael/0000-0003-2001-9545	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076752, R01MH081860, F32MH080480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038880] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH081860, F32 MH080480, R01 MH076752, R01 MH081860-01A1, R01 MH076752-03] Funding Source: Medline; NINDS NIH HHS [R01 NS038880-08, R01 NS038880] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown GP, 2000, J NEUROSCI, V20, P7880; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P19, DOI 10.1113/jphysiol.1983.sp014477; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Otmakhova NA, 2004, J NEUROPHYSIOL, V92, P2027, DOI 10.1152/jn.00427.2004; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pereda AE, 1998, P NATL ACAD SCI USA, V95, P13272, DOI 10.1073/pnas.95.22.13272; Ren YJ, 2006, J BIOL CHEM, V281, P11769, DOI 10.1074/jbc.M513125200; Roth-Alpermann C, 2006, P NATL ACAD SCI USA, V103, P11039, DOI 10.1073/pnas.0600894103; Sailer CA, 2004, MOL CELL NEUROSCI, V26, P458, DOI 10.1016/j.mcn.2004.03.002; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stackman RW, 2002, J NEUROSCI, V22, P10163; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Xu J, 2005, J NEUROSCI, V25, P1750, DOI 10.1523/JNEUROSCI.4217-04.2005; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112	48	169	172	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					170	177		10.1038/nn2041	http://dx.doi.org/10.1038/nn2041			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18204442	Green Accepted			2022-12-17	WOS:000252712100011
J	Sieburth, D; Madison, JM; Kaplan, JM				Sieburth, Derek; Madison, Jon M.; Kaplan, Joshua M.			PKC-1 regulates secretion of neuropeptides	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; READILY RELEASABLE POOL; CAENORHABDITIS-ELEGANS; SYNAPTIC-TRANSMISSION; TRANSMITTER RELEASE; PHORBOL ESTERS; DEPENDENT PHOSPHORYLATION; NEUROTRANSMITTER RELEASE; FLUORESCENT PROTEIN; CYTOSOLIC PROTEIN	The secretion of neurotransmitters and neuropeptides is mediated by distinct organelles-synaptic vesicles (SVs) and dense-core vesicles (DCVs), respectively. Relatively little is known about the factors that differentially regulate SV and DCV secretion. Here we show that protein kinase C-1 (PKC-1), which is most similar to the vertebrate PKC eta and epsilon isoforms, regulates exocytosis of DCVs in Caenorhabditis elegans motor neurons. Mutants lacking PCK-1 activity had delayed paralysis induced by the acetylcholinesterase inhibitor aldicarb, whereas mutants with increased PKC-1 activity had more rapid aldicarb-induced paralysis. Imaging and electrophysiological assays indicated that SV release occurred normally in pkc-1 mutants. By contrast, genetic analysis of aldicarb responses and imaging of fluorescently tagged neuropeptides indicated that mutants lacking PKC-1 had reduced neuropeptide secretion. Similar neuropeptide secretion defects were found in mutants lacking unc-31 ( encoding the protein CAPS) or unc-13 (encoding Munc13). These results suggest that PKC-1 selectively regulates DCV release from neurons.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Simches 7,185 Cambridge St, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu			NINDS NIH HHS [1F32NS10310] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010310] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Barclay JW, 2003, J BIOL CHEM, V278, P10538, DOI 10.1074/jbc.M211114200; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; BRENNER S, 1974, GENETICS, V77, P71; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; Craig TJ, 2003, J NEUROCHEM, V86, P1450, DOI 10.1046/j.1471-4159.2003.01955.x; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Fares H, 2002, TRAFFIC, V3, P11, DOI 10.1034/j.1600-0854.2002.30103.x; Fares H, 2001, GENETICS, V159, P133; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Genoud S, 1999, J NEUROCHEM, V72, P1699, DOI 10.1046/j.1471-4159.1999.721699.x; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Gonelle-Gispert C, 2002, BIOCHEM J, V368, P223, DOI 10.1042/BJ20020896; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Jacob TC, 2003, J NEUROSCI, V23, P2122; Kang LJ, 2006, CELL METAB, V3, P463, DOI 10.1016/j.cmet.2006.04.012; KUPFERMANN I, 1991, PHYSIOL REV, V71, P683, DOI 10.1152/physrev.1991.71.3.683; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; LAND M, 1994, J BIOL CHEM, V269, P9234; LAND M, 1994, J BIOL CHEM, V269, P14820; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Lonart G, 2000, J BIOL CHEM, V275, P27703; Madison JM, 2005, CURR BIOL, V15, P2236, DOI 10.1016/j.cub.2005.10.049; Martin TFJ, 2003, BBA-MOL CELL RES, V1641, P157, DOI 10.1016/S0167-4889(03)00093-4; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Minami N, 1998, J PHYSIOL-LONDON, V512, P219, DOI 10.1111/j.1469-7793.1998.219bf.x; Misonou H, 1998, CELL MOL NEUROBIOL, V18, P379, DOI 10.1023/A:1022593330685; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagy G, 2002, J NEUROSCI, V22, P9278; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; NGUYEN M, 1995, GENETICS, V140, P527; NISHIZAKI T, 1992, J BIOL CHEM, V267, P23972; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Okochi Y, 2005, EMBO J, V24, P2127, DOI 10.1038/sj.emboj.7600697; Perrais D, 2004, J PHYSIOL-LONDON, V560, P413, DOI 10.1113/jphysiol.2004.064410; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Rao S, 2001, J NEUROBIOL, V49, P159, DOI 10.1002/neu.1072; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 2002, CURR OPIN NEUROBIOL, V12, P499, DOI 10.1016/S0959-4388(02)00360-4; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Searl TJ, 2003, J PHYSIOL-LONDON, V553, P445, DOI 10.1113/jphysiol.2003.051300; SHAPIRA R, 1987, NATURE, V325, P58, DOI 10.1038/325058a0; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Silinsky EM, 2003, BRIT J PHARMACOL, V138, P1191, DOI 10.1038/sj.bjp.0705213; Smith C, 1999, J NEUROSCI, V19, P589; Speidel D, 2005, NEURON, V46, P75, DOI 10.1016/j.neuron.2005.02.019; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Stevens DR, 2005, CURR BIOL, V15, P2243, DOI 10.1016/j.cub.2005.10.055; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Waters J, 2000, J NEUROSCI, V20, P7863; Yang Y, 2002, P NATL ACAD SCI USA, V99, P17060, DOI 10.1073/pnas.242624699; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x	65	169	187	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					49	57		10.1038/nn1810	http://dx.doi.org/10.1038/nn1810			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17128266				2022-12-17	WOS:000243096100015
J	Ramanan, N; Shen, Y; Sarsfield, S; Lemberger, T; Schutz, G; Linden, DJ; Ginty, DD				Ramanan, N; Shen, Y; Sarsfield, S; Lemberger, T; Schutz, G; Linden, DJ; Ginty, DD			SRF mediates activity-induced gene expression and synaptic plasticity but not neuronal viability	NATURE NEUROSCIENCE			English	Article							SERUM RESPONSE FACTOR; NMDA RECEPTOR ACTIVATION; ELEMENT-BINDING PROTEIN; IMMEDIATE-EARLY GENES; C-FOS; TRANSCRIPTION FACTORS; HIPPOCAMPAL-NEURONS; SIGNALING PATHWAYS; CRE RECOMBINASE; NERVOUS-SYSTEM	Synaptic activity-dependent gene expression is critical for certain forms of neuronal plasticity and survival in the mammalian nervous system, yet the mechanisms by which coordinated regulation of activity-induced genes supports neuronal function is unclear. Here, we show that deletion of serum response factor (SRF) in specific neuronal populations in adult mice results in profound deficits in activity-dependent immediate early gene expression, but components of upstream signaling pathways and cyclic AMP - response element binding protein ( CREB)- dependent transactivation remain intact. Moreover, SRF-deficient CA1 pyramidal neurons show attenuation of long-term synaptic potentiation, a model for neuronal information storage. Furthermore, in contrast to the massive neurodegeneration seen in adult mice lacking CREB family members, SRF-deficient adult neurons show normal morphologies and basal excitatory synaptic transmission. These findings indicate that the transcriptional events underlying neuronal survival and plasticity are dissociable and that SRF plays a prominent role in use-dependent modification of synaptic strength in the adult brain.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Helmholtz Association; German Cancer Research Center (DKFZ)	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St,Preclin Teaching Bldg Room 1015, Baltimore, MD 21205 USA.	dginty@jhmi.edu	Sarsfield, Sarah/Y-5113-2019; RAMANAN, NARENDRAKUMAR/L-7487-2018; Lemberger, Thomas/A-7301-2008	Lemberger, Thomas/0000-0002-2499-4025				Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Balschun D, 2003, J NEUROSCI, V23, P6304; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Bottai D, 2002, J NEUROSCI, V22, P167, DOI 10.1523/JNEUROSCI.22-01-00167.2002; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; Chang SH, 2004, J NEUROSCI, V24, P2277, DOI 10.1523/JNEUROSCI.4868-03.2004; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deogracias R, 2004, MOL CELL NEUROSCI, V26, P470, DOI 10.1016/j.mcn.2004.03.007; Fujino T, 2003, MOL CELL NEUROSCI, V24, P538, DOI 10.1016/S1044-7431(03)00230-6; Gass P, 1998, LEARN MEMORY, V5, P274; GREENBERG ME, 1987, MOL CELL BIOL, V7, P1217, DOI 10.1128/MCB.7.3.1217; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; MISRA RP, 1991, MOL CELL BIOL, V11, P4545, DOI 10.1128/MCB.11.9.4545; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; ROBERTSON LM, 1995, NEURON, V14, P241, DOI 10.1016/0896-6273(95)90282-1; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sato M, 2001, J NEUROSCI, V21, P3797, DOI 10.1523/JNEUROSCI.21-11-03797.2001; Schratt G, 2004, EMBO J, V23, P1834, DOI 10.1038/sj.emboj.7600188; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Spencer JA, 1996, J BIOL CHEM, V271, P16535, DOI 10.1074/jbc.271.28.16535; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; Treisman R, 1990, Semin Cancer Biol, V1, P47; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; WALLACE CS, 1995, MOL BRAIN RES, V32, P211, DOI 10.1016/0169-328X(95)00076-5; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	46	169	169	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					759	767		10.1038/nn1462	http://dx.doi.org/10.1038/nn1462			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880109				2022-12-17	WOS:000229345300016
J	Yi, DJ; Woodman, GF; Widders, D; Marois, R; Chun, MM				Yi, DJ; Woodman, GF; Widders, D; Marois, R; Chun, MM			Neural fate of ignored stimuli: dissociable effects of perceptual and working memory load	NATURE NEUROSCIENCE			English	Article							VISUAL-SEARCH; SELECTIVE ATTENTION; MECHANISMS; SYSTEM; CORTEX	Observers commonly experience functional blindness to unattended visual events, and this problem has fuelled an intense debate concerning the fate of unattended visual information in neural processing. Here we used functional magnetic resonance imaging ( fMRI) to demonstrate that the type of task that a human subject engages in determines the way in which ignored visual background stimuli are processed in parahippocampal cortex. Increasing the perceptual difficulty of a foveal target task attenuated processing of task-irrelevant background scenes, whereas increasing the number of objects held in working memory did not have this effect. These dissociable effects of perceptual and working memory load clarify how task-irrelevant, unattended stimuli are processed in category-selective areas in human ventral visual cortex.	Yale Univ, Dept Psychol, New Haven, CT 06520 USA; Vanderbilt Univ, Dept Psychol, Ctr Integrat & Cognit Neurosci, Nashville, TN 37203 USA; Vanderbilt Univ, Vanderbilt Vis Res Ctr, Nashville, TN 37203 USA	Yale University; Vanderbilt University; Vanderbilt University	Chun, MM (corresponding author), Yale Univ, Dept Psychol, POB 208205,2 Hillhouse Ave, New Haven, CT 06520 USA.	marvin.chun@yale.edu		Chun, Marvin/0000-0003-1070-7993	NATIONAL EYE INSTITUTE [F32EY015043, R01EY014193] Funding Source: NIH RePORTER; NEI NIH HHS [EY014193, F32EY015043] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Chun MM, 2002, CURR OPIN NEUROBIOL, V12, P184, DOI 10.1016/S0959-4388(02)00309-4; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Dobbins IG, 2004, NATURE, V428, P316, DOI 10.1038/nature02400; EGER E, IN PRESS J NEUROPHYS; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Gehring WJ, 2002, COGNITIVE BRAIN RES, V13, P267, DOI 10.1016/S0926-6410(01)00132-X; Goldstein B., 2001, BLACKWELL HDB PERCEP, P272; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Ishai A, 2004, P NATL ACAD SCI USA, V101, P9827, DOI 10.1073/pnas.0403559101; Jiang Y, 2000, SCIENCE, V287, P643, DOI 10.1126/science.287.5453.643; Jiang YH, 2001, J EXP PSYCHOL HUMAN, V27, P895, DOI 10.1037//0096-1523.27.4.895; Jolicoeur P, 1999, J EXP PSYCHOL HUMAN, V25, P1097, DOI 10.1037/0096-1523.25.4.1097; KAHNEMAN D, 1983, J EXP PSYCHOL HUMAN, V9, P497, DOI 10.1037/0096-1523.9.4.497; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; LAVIE N, IN PRESS J EXP PSYCH; Luck S. J., 2002, STEVENS HDB EXPT PSY, V1, P235; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Marois R, 2004, NEURON, V41, P465, DOI 10.1016/S0896-6273(04)00012-1; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; Oh SH, 2004, PSYCHON B REV, V11, P275, DOI 10.3758/BF03196570; PASHLER HE, 1998, PSYCHOL ATTENTION; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Ranganath C, 2004, COGNITIVE BRAIN RES, V20, P37, DOI 10.1016/j.cogbrainres.2003.11.017; Rees G, 1999, SCIENCE, V286, P2504, DOI 10.1126/science.286.5449.2504; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; TREISMAN AM, 1960, Q J EXP PSYCHOL, V12, P242, DOI 10.1080/17470216008416732; TREISMAN AM, 1969, PSYCHOL REV, V76, P282, DOI 10.1037/h0027242; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Woodman GF, 2004, PSYCHON B REV, V11, P269, DOI 10.3758/BF03196569; Woodman GF, 2001, PSYCHOL SCI, V12, P219, DOI 10.1111/1467-9280.00339	42	169	172	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					992	996		10.1038/nn1294	http://dx.doi.org/10.1038/nn1294			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15286791				2022-12-17	WOS:000223546700019
J	Mato, S; Chevaleyre, V; Robbe, D; Pazos, A; Castillo, PE; Manzoni, OJ				Mato, S; Chevaleyre, V; Robbe, D; Pazos, A; Castillo, PE; Manzoni, OJ			A single in-vivo exposure to Delta 9THC blocks endocannabinoid-mediated synaptic plasticity	NATURE NEUROSCIENCE			English	Article							DOPAMINE NEURONS; RAT-BRAIN; GABAERGIC SYNAPSES; NUCLEUS-ACCUMBENS; DELTA(9)-TETRAHYDROCANNABINOL; POTENTIATION; DEPRESSION	Endogenous cannabinoids (eCB) mediate synaptic plasticity in brain regions involved in learning and reward. Here we show that in mice, a single in-vivo exposure to Delta9-tetrahydrocannabinol (THC) abolishes the retrograde signaling that underlies eCB-mediated synaptic plasticity in both nucleus accumbens (NAc) and hippocampus in vitro. This effect is reversible within 3 days and is associated with a transient modification in the functional properties of cannabinoid receptors.	Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Inst Magendie Neurosci, Equipe INSERM Avenir, F-33077 Bordeaux, France; Univ Cantabria, Dept Physiol & Pharmacol, Santander 39011, Cantabria, Spain	Yeshiva University; Albert Einstein College of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universidad de Cantabria	Castillo, PE (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	pcastill@aecom.yu.edu; manzoni@bordeaux.inserm.fr	Manzoni, Olivier/M-7899-2016; Mato, Susana/AAU-3129-2020; robbe, david/O-5439-2016	Manzoni, Olivier/0000-0002-5579-6208; Mato, Susana/0000-0002-2005-9793; robbe, david/0000-0002-9450-0553; Castillo, Pablo/0000-0002-9834-1801; Chevaleyre, Vivien/0000-0002-3679-4856; Pazos, Angel/0000-0001-8047-8802				Breivogel CS, 1999, J NEUROCHEM, V73, P2447, DOI 10.1046/j.1471-4159.1999.0732447.x; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Gerdeman GL, 2003, BRIT J PHARMACOL, V140, P781, DOI 10.1038/sj.bjp.0705466; Hoffman AF, 2003, J NEUROSCI, V23, P4815; Hutcheson DM, 1998, BRIT J PHARMACOL, V125, P1567, DOI 10.1038/sj.bjp.0702228; Maldonado R, 2002, PHARMACOL THERAPEUT, V95, P153, DOI 10.1016/S0163-7258(02)00254-1; Mato S, 2003, EUR J NEUROSCI, V17, P1747, DOI 10.1046/j.1460-9568.2003.02599.x; Melis M, 2002, J NEUROSCI, V22, P2074, DOI 10.1523/JNEUROSCI.22-06-02074.2002; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Romero J, 1997, MOL BRAIN RES, V46, P100, DOI 10.1016/S0169-328X(96)00277-X; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sim LJ, 1996, J NEUROSCI, V16, P8057; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	15	169	175	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					585	586		10.1038/nn1251	http://dx.doi.org/10.1038/nn1251			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15146190				2022-12-17	WOS:000221640300010
J	Trinh, K; Storm, DR				Trinh, K; Storm, DR			Vomeronasal organ detects odorants in absence of signaling through main olfactory epithelium	NATURE NEUROSCIENCE			English	Article							ADENYLYL-CYCLASE; PHEROMONE RECEPTOR; MICE DEFICIENT; NEURONS; TRANSDUCTION; EXPRESSION; SYSTEM; PROTEIN; ANOSMIA; CHANNEL	It is commonly assumed that odorants are detected by the main olfactory epithelium (MOE) and pheromones are sensed through the vomeronasal organ (VNO). The complete loss of MOE-mediated olfaction in type-3 adenylyl cyclase knockout mice (AC3(-/-)) allowed us to examine chemosensory functions of the VNO in the absence of signaling through the MOE. Here we report that AC3(-/-) mice are able to detect certain volatile odorants via the VNO. These same odorants elicited electro-olfactogram transients in the VNO and MOE of wild-type mice, but only VNO responses in AC3(-/-) mice. This indicates that some odorants are detected through an AC3-independent pathway in the VNO.	Univ Washington, Program Mol & Cellular Biol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Program Mol & Cellular Biol, Box 357750,1959 NE Pacific St, Seattle, WA 98195 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004156] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL07312-22] Funding Source: Medline; NIDCD NIH HHS [DC04156] Funding Source: Medline; NIGMS NIH HHS [T32 GMO7270] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amoore J E, 1970, MOL BASIS ODOR, P28; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BAKER H, 1993, BRAIN RES, V614, P109, DOI 10.1016/0006-8993(93)91023-L; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Berghard A, 1996, P NATL ACAD SCI USA, V93, P2365, DOI 10.1073/pnas.93.6.2365; Berghard A, 1996, J NEUROSCI, V16, P909; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; Briand L, 2000, FEBS LETT, V476, P179, DOI 10.1016/S0014-5793(00)01719-1; BROWN RE, 1987, PHYSIOL BEHAV, V40, P65, DOI 10.1016/0031-9384(87)90186-7; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Dudley CA, 2001, BRAIN RES, V915, P32, DOI 10.1016/S0006-8993(01)02820-7; Dulac C, 1998, CHEM SENSES, V23, P467, DOI 10.1093/chemse/23.4.467; Dulac C, 2000, CURR OPIN NEUROBIOL, V10, P511, DOI 10.1016/S0959-4388(00)00121-5; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Fewell GD, 2002, BRAIN RES, V941, P91, DOI 10.1016/S0006-8993(02)02613-6; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Gore AC, 2000, J NEUROENDOCRINOL, V12, P1200, DOI 10.1046/j.1365-2826.2000.00578.x; GREGG B, 1981, PHYSIOL BEHAV, V26, P1133, DOI 10.1016/0031-9384(81)90221-3; Hagino-Yamagishi K, 2001, J BIOCHEM-TOKYO, V129, P509, DOI 10.1093/oxfordjournals.jbchem.a002884; HALPERN M, 1984, TRENDS NEUROSCI, V7, P472, DOI 10.1016/S0166-2236(84)80258-1; HARDING JW, 1978, BRAIN RES, V140, P271, DOI 10.1016/0006-8993(78)90460-2; Horowitz LF, 1999, P NATL ACAD SCI USA, V96, P3194, DOI 10.1073/pnas.96.6.3194; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Kolunie JM, 1995, HORM BEHAV, V29, P492, DOI 10.1006/hbeh.1995.1285; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; LOWE G, 1993, J PHYSIOL-LONDON, V462, P175, DOI 10.1113/jphysiol.1993.sp019550; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; NOVOTNY M, 1986, SCIENCE, V231, P722, DOI 10.1126/science.3945805; Petrulis A, 1999, PHYSIOL BEHAV, V66, P73, DOI 10.1016/S0031-9384(98)00259-5; Puche AC, 1999, J NEUROSCI, V19, P1359; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; SIPOS ML, 1995, PHYSIOL BEHAV, V58, P529, DOI 10.1016/0031-9384(95)00089-2; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wei J, 1998, NEURON, V21, P495, DOI 10.1016/S0896-6273(00)80561-9; Wei Y, 1996, Chin Med Sci J, V11, P1; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; YAMAZAKI F, 1989, PHYSL ECOL JPN SPEC, V1, P529; Zufall F, 2001, TRENDS NEUROSCI, V24, P191, DOI 10.1016/S0166-2236(00)01765-3	48	169	173	0	18	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					519	525		10.1038/nn1039	http://dx.doi.org/10.1038/nn1039			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12665798				2022-12-17	WOS:000182553200019
J	Foulkes, L; Blakemore, SJ				Foulkes, Lucy; Blakemore, Sarah-Jayne			Studying individual differences in human adolescent brain development	NATURE NEUROSCIENCE			English	Article							SOCIAL EXCLUSION; SOCIOECONOMIC-STATUS; PEER INFLUENCES; RISK-TAKING; BULLYING VICTIMIZATION; ANTISOCIAL-BEHAVIOR; NEURAL SENSITIVITY; CIGARETTE-SMOKING; FAMILY ASSISTANCE; PARENTING STYLE	Adolescence is a period of social, psychological and biological development. During adolescence, relationships with others become more complex, peer relationships are paramount and social cognition develops substantially. These psychosocial changes are paralleled by structural and functional changes in the brain. Existing research in adolescent neurocognitive development has focused largely on averages, but this obscures meaningful individual variation in development. In this Perspective, we propose that the field should now move toward studying individual differences. We start by discussing individual variation in structural and functional brain development. To illustrate the importance of considering individual differences in development, we consider three sources of variation that contribute to neurocognitive processing: socioeconomic status, culture and peer environment. To assess individual differences in neurodevelopmental trajectories, large-scale longitudinal datasets are required. Future developmental neuroimaging studies should attempt to characterize individual differences to move toward a more nuanced understanding of neurocognitive changes during adolescence.	[Foulkes, Lucy; Blakemore, Sarah-Jayne] UCL Inst Cognit Neurosci, London, England; [Foulkes, Lucy] Univ York, Dept Educ, York, N Yorkshire, England	University of London; University College London; University of York - UK	Blakemore, SJ (corresponding author), UCL Inst Cognit Neurosci, London, England.	s.blakemore@ucl.ac.uk			Wellcome Trust [104908/Z/14/Z]; Jacobs Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Jacobs Foundation	We thank C. Tamnes and K. Mills for comments on an earlier draft of the manuscript. The authors are funded by the Wellcome Trust (grant to S.I.B.: 104908/Z/14/Z) and the Klaus J. Jacobs Prize from the Jacobs Foundation.	Abrams D, 2011, BRIT J DEV PSYCHOL, V29, P110, DOI 10.1348/026151010X494089; Arseneault L, 2010, PSYCHOL MED, V40, P717, DOI 10.1017/S0033291709991383; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2014, ANNU REV PSYCHOL, V65, P187, DOI 10.1146/annurev-psych-010213-115202; Bonell C., 2015, HEALTH TECHNOL ASSES, V19, pvii; Bonell C, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19530; Byrd AL, 2014, BIOL PSYCHIAT, V75, P9, DOI 10.1016/j.biopsych.2013.05.004; Caouette JD, 2014, DEV COGN NEUROS-NETH, V8, P65, DOI 10.1016/j.dcn.2013.10.003; Cascio CN., 2017, CULT BRAIN, V5, P50, DOI [10.1007/s40167-016-0046-3, DOI 10.1007/S40167-016-0046-3]; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; Choudhury S, 2010, SOC COGN AFFECT NEUR, V5, P159, DOI 10.1093/scan/nsp030; Copeland WE, 2013, JAMA PSYCHIAT, V70, P419, DOI 10.1001/jamapsychiatry.2013.504; Craig W, 2009, INT J PUBLIC HEALTH, V54, P216, DOI 10.1007/s00038-009-5413-9; Crone EA, 2016, J CHILD PSYCHOL PSYC, V57, P353, DOI 10.1111/jcpp.12502; Crone EA, 2015, WIRES COGN SCI, V6, P53, DOI 10.1002/wcs.1327; D'Amico EJ, 2006, J ADOLESCENT HEALTH, V39, P481, DOI 10.1016/j.jadohealth.2006.02.010; DARLING N, 1993, PSYCHOL BULL, V113, P487, DOI 10.1037/0033-2909.113.3.487; Dubois J, 2016, TRENDS COGN SCI, V20, P425, DOI 10.1016/j.tics.2016.03.014; Duell N., 2017, J YOUTH ADOLESC; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Falk EB, 2014, J ADOLESCENT HEALTH, V54, pS22, DOI 10.1016/j.jadohealth.2013.12.035; Farah MJ, 2017, NEURON, V96, P56, DOI 10.1016/j.neuron.2017.08.034; Fuligni AJ, 1999, CHILD DEV, V70, P1030, DOI 10.1111/1467-8624.00075; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gilmore JH, 2012, CEREB CORTEX, V22, P2478, DOI 10.1093/cercor/bhr327; Goddings AL, 2014, NEUROIMAGE, V88, P242, DOI 10.1016/j.neuroimage.2013.09.073; Gorrese A, 2013, PERS INDIV DIFFER, V55, P559, DOI 10.1016/j.paid.2013.04.025; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Harper JM, 2016, J RES ADOLESCENCE, V26, P101, DOI 10.1111/jora.12174; Harrell AW, 2009, J CHILD FAM STUD, V18, P378, DOI 10.1007/s10826-008-9241-y; HEADEN SW, 1991, AM J PUBLIC HEALTH, V81, P854, DOI 10.2105/AJPH.81.7.854; Herting M.M, 2017, DEV COGN NEUROSCI; Herting MM, 2017, FRONT NEUROENDOCRIN, V44, P122, DOI 10.1016/j.yfrne.2016.12.003; Kaufmann T, 2017, NAT NEUROSCI, V20, P513, DOI 10.1038/nn.4511; Kerr M, 2012, DEV PSYCHOL, V48, P1540, DOI 10.1037/a0027720; Kievit R.A, 2017, DEV COGN NEUROSCI; Kim-Spoon J, 2017, DEV COGN NEUROS-NETH, V26, P69, DOI 10.1016/j.dcn.2017.04.009; King K. M., 2017, DEV COGN NEUROSCI; Knafo A, 2013, DEV PSYCHOPATHOL, V25, P1, DOI 10.1017/S0954579412000855; Knoll LJ, 2017, J ADOLESCENCE, V60, P53, DOI 10.1016/j.adolescence.2017.07.002; Knoll LJ, 2015, PSYCHOL SCI, V26, P583, DOI 10.1177/0956797615569578; Lamblin M, 2017, NEUROSCI BIOBEHAV R, V80, P57, DOI 10.1016/j.neubiorev.2017.05.010; LANDRINE H, 1994, J BEHAV MED, V17, P331, DOI 10.1007/BF01857956; Lansford JE, 2003, J RES ADOLESCENCE, V13, P161, DOI 10.1111/1532-7795.1302002; LARSON R, 1991, CHILD DEV, V62, P284, DOI 10.1111/j.1467-8624.1991.tb01531.x; Loke AY, 2013, INT J ENV RES PUB HE, V10, P3868, DOI 10.3390/ijerph10093868; Kanacri BPL, 2017, CHILD DEV, V88, P1100, DOI 10.1111/cdev.12863; Madhyastha T., 2017, DEV COGN NEUROSCI; Masten CL, 2009, SOC COGN AFFECT NEUR, V4, P143, DOI 10.1093/scan/nsp007; McCrory E, 2010, J CHILD PSYCHOL PSYC, V51, P1079, DOI 10.1111/j.1469-7610.2010.02271.x; Miller JG, 2012, CHILD DEV PERSPECT, V6, P35, DOI 10.1111/j.1750-8606.2011.00188.x; Mills KL, 2016, NEUROIMAGE, V141, P273, DOI 10.1016/j.neuroimage.2016.07.044; Mills KL, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150117; Mills KL, 2014, DEV NEUROSCI-BASEL, V36, P147, DOI 10.1159/000362328; Mills KL, 2014, DEV COGN NEUROS-NETH, V9, P172, DOI 10.1016/j.dcn.2014.04.004; Motta-Mena NV, 2017, DEVELOPMENTAL SCI, V20, DOI 10.1111/desc.12451; Muscatell KA, 2012, NEUROIMAGE, V60, P1771, DOI 10.1016/j.neuroimage.2012.01.080; Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983; Noble KG, 2012, DEVELOPMENTAL SCI, V15, P516, DOI 10.1111/j.1467-7687.2012.01147.x; OBRIEN SF, 1988, CHILD DEV, V59, P1360, DOI 10.2307/1130498; Oldehinkel AJ, 2007, J ABNORM CHILD PSYCH, V35, P417, DOI 10.1007/s10802-007-9100-0; Ordaz SJ, 2013, J NEUROSCI, V33, P18109, DOI 10.1523/JNEUROSCI.1741-13.2013; Peake SJ, 2013, NEUROIMAGE, V82, P23, DOI 10.1016/j.neuroimage.2013.05.061; ROHNER RP, 1984, J CROSS CULT PSYCHOL, V15, P111, DOI 10.1177/0022002184015002002; Rosenberg MD, 2016, NAT NEUROSCI, V19, P165, DOI 10.1038/nn.4179; Rudolph KD, 2016, SOC COGN AFFECT NEUR, V11, P829, DOI 10.1093/scan/nsw021; Schriber RA, 2016, DEV COGN NEUROS-NETH, V19, P1, DOI 10.1016/j.dcn.2015.12.009; Sebastian C, 2010, BRAIN COGNITION, V72, P134, DOI 10.1016/j.bandc.2009.06.008; Sebastian CL, 2011, NEUROIMAGE, V57, P686, DOI 10.1016/j.neuroimage.2010.09.063; Shanahan MJ, 2005, J GERONTOL B-PSYCHOL, V60, P65, DOI 10.1093/geronb/60.Special_Issue_1.65; Sherman L., 2017, DEV COGN NEUROSCI; Simmonds DJ, 2017, NEUROIMAGE, V157, P695, DOI 10.1016/j.neuroimage.2017.01.016; Singham T, 2017, JAMA PSYCHIAT, V74, P1112, DOI 10.1001/jamapsychiatry.2017.2678; Somerville LH, 2016, NEURON, V92, P1164, DOI 10.1016/j.neuron.2016.10.059; Steinberg L., 2017, DEV SCI; Steinberg L, 2007, DEV PSYCHOL, V43, P1531, DOI 10.1037/0012-1649.43.6.1531; Symeonidou I, 2016, J EXP CHILD PSYCHOL, V149, P81, DOI 10.1016/j.jecp.2015.11.007; Takizawa R, 2014, AM J PSYCHIAT, V171, P777, DOI 10.1176/appi.ajp.2014.13101401; Tamnes C. K., 2017, LONGITUDINAL DEV HIP; Tamnes CK, 2017, J NEUROSCI, V37, P3402, DOI 10.1523/JNEUROSCI.3302-16.2017; Telzer EH, 2017, DEV PSYCHOPATHOL, P1; Telzer EH, 2015, SOC COGN AFFECT NEUR, V10, P389, DOI 10.1093/scan/nsu064; Telzer EH, 2013, J COGNITIVE NEUROSCI, V25, P374, DOI 10.1162/jocn_a_00331; Telzer EH, 2010, SOC NEUROSCI-UK, V5, P508, DOI 10.1080/17470911003687913; Telzer EH, 2009, DEV PSYCHOL, V45, P1177, DOI 10.1037/a0014728; Tippett N, 2014, AM J PUBLIC HEALTH, V104, pE48, DOI 10.2105/AJPH.2014.301960; Tompkins V, 2017, J EXP CHILD PSYCHOL, V158, P1, DOI 10.1016/j.jecp.2017.01.001; Unger J B, 2001, Nicotine Tob Res, V3, P167; Unger JB, 2002, PREV MED, V34, P476, DOI 10.1006/pmed.2001.0996; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; van Harmelen AL, 2017, PSYCHOL MED, V47, P2312, DOI 10.1017/S0033291717000836; Vijayakumar N, 2017, NEUROIMAGE, V153, P359, DOI 10.1016/j.neuroimage.2017.02.050; Vijayakumar N, 2016, HUM BRAIN MAPP, V37, P2027, DOI 10.1002/hbm.23154; Volkow ND, 2017, DEV COGN NEUROSCI; Welborn BL, 2016, SOC COGN AFFECT NEUR, V11, P100, DOI 10.1093/scan/nsv095; Wierenga L. M., 2017, CEREB CORTEX; Wierenga L, 2014, NEUROIMAGE, V96, P67, DOI 10.1016/j.neuroimage.2014.03.072; Will GJ, 2016, J ABNORM CHILD PSYCH, V44, P43, DOI 10.1007/s10802-015-9983-0; Williams DR, 2016, HEALTH PSYCHOL, V35, P407, DOI 10.1037/hea0000242; Wolf LK, 2015, J ADOLESCENCE, V43, P5, DOI 10.1016/j.adolescence.2015.05.003	100	168	170	12	132	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2018	21	3					315	323		10.1038/s41593-018-0078-4	http://dx.doi.org/10.1038/s41593-018-0078-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FZ7JH	29403031	Green Submitted, Green Accepted			2022-12-17	WOS:000427776400006
J	Bettencourt, KC; Xu, YD				Bettencourt, Katherine C.; Xu, Yaoda			Decoding the content of visual short-term memory under distraction in occipital and parietal areas	NATURE NEUROSCIENCE			English	Article							SURFACE-BASED ANALYSIS; WORKING-MEMORY; NEURAL MECHANISMS; OBJECT INDIVIDUATION; MENTAL-IMAGERY; CORTEX; REPRESENTATIONS; ATTENTION; SEGMENTATION; INFORMATION	Recent studies have provided conflicting accounts regarding where in the human brain visual short-term memory (VSTM) content is stored, with strong univariate fMRI responses being reported in superior intraparietal sulcus (IPS), but robust multivariate decoding being reported in occipital cortex. Given the continuous influx of information in everyday vision, VSTM storage under distraction is often required. We found that neither distractor presence nor predictability during the memory delay affected behavioral performance. Similarly, superior IPS exhibited consistent decoding of VSTM content across all distractor manipulations and had multivariate responses that closely tracked behavioral VSTM performance. However, occipital decoding of VSTM content was substantially modulated by distractor presence and predictability. Furthermore, we found no effect of target-distractor similarity on VSTM behavioral performance, further challenging the role of sensory regions in VSTM storage. Overall, consistent with previous univariate findings, our results indicate that superior IPS, but not occipital cortex, has a central role in VSTM storage.	[Bettencourt, Katherine C.; Xu, Yaoda] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	Xu, YD (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	yaodaxu@fas.harvard.edu			US National Institutes of Health (NIH) [1R01EY022355]; NIH [F32-EY022874]; NATIONAL EYE INSTITUTE [F32EY022874, R01EY022355] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank J. Swisher for his retinotopy code and members of the Harvard Vision Lab for their valuable comments on this study. This research was supported by US National Institutes of Health (NIH) grant 1R01EY022355 to Y.X. and NIH grant F32-EY022874 to K.C.B.	Albers AM, 2013, CURR BIOL, V23, P1427, DOI 10.1016/j.cub.2013.05.065; Beck DM, 2006, CEREB CORTEX, V16, P712, DOI 10.1093/cercor/bhj017; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bressler DW, 2010, NEUROIMAGE, V53, P526, DOI 10.1016/j.neuroimage.2010.06.063; Christophel TB, 2012, J NEUROSCI, V32, P12983, DOI 10.1523/JNEUROSCI.0184-12.2012; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Emrich SM, 2013, J NEUROSCI, V33, P6516, DOI 10.1523/JNEUROSCI.5732-12.2013; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Ester EF, 2015, NEURON, V87, P893, DOI 10.1016/j.neuron.2015.07.013; Ester EF, 2009, J NEUROSCI, V29, P15258, DOI 10.1523/JNEUROSCI.4388-09.2009; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Hou YY, 2012, NEUROPSYCHOLOGIA, V50, P2916, DOI 10.1016/j.neuropsychologia.2012.08.022; Jacob SN, 2014, NEURON, V83, P226, DOI 10.1016/j.neuron.2014.05.009; Jeong SK, 2013, J COGNITIVE NEUROSCI, V25, P117, DOI 10.1162/jocn_a_00298; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Keogh R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029221; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Kriegeskorte N, 2013, TRENDS COGN SCI, V17, P401, DOI 10.1016/j.tics.2013.06.007; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Lee SH, 2013, NAT NEUROSCI, V16, P997, DOI 10.1038/nn.3452; Linden DEJ, 2012, J NEUROPHYSIOL, V107, P628, DOI 10.1152/jn.00105.2011; Liu TS, 2011, J NEUROSCI, V31, P4484, DOI 10.1523/JNEUROSCI.5745-10.2011; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mendoza-Halliday D, 2014, NAT NEUROSCI, V17, P1255, DOI 10.1038/nn.3785; Nelissen N, 2013, J NEUROSCI, V33, P16443, DOI 10.1523/JNEUROSCI.2625-13.2013; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; Qi XL, 2015, J NEUROPHYSIOL, V113, P44, DOI 10.1152/jn.00413.2014; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Riggall AC, 2012, J NEUROSCI, V32, P12990, DOI 10.1523/JNEUROSCI.1892-12.2012; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Slotnick SD, 2005, CEREB CORTEX, V15, P1570, DOI 10.1093/cercor/bhi035; Sneve MH, 2012, NEUROIMAGE, V63, P166, DOI 10.1016/j.neuroimage.2012.06.053; Sprague TC, 2014, CURR BIOL, V24, P2174, DOI 10.1016/j.cub.2014.07.066; Straw Andrew D, 2008, Front Neuroinform, V2, P4, DOI 10.3389/neuro.11.004.2008; Suzuki M, 2013, NAT NEUROSCI, V16, P98, DOI 10.1038/nn.3282; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Tseng P, 2010, NEUROPSYCHOLOGIA, V48, P1063, DOI 10.1016/j.neuropsychologia.2009.12.005; Vogel EK, 2006, J EXP PSYCHOL HUMAN, V32, P1436, DOI 10.1037/0096-1523.32.6.1436; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Xu Y., 2015, MECH SENSORY WORKING, VXXV, P33; Xu YD, 2010, J NEUROSCI, V30, P14020, DOI 10.1523/JNEUROSCI.3011-10.2010; Xu YD, 2009, TRENDS COGN SCI, V13, P167, DOI 10.1016/j.tics.2009.01.008; Xu YD, 2009, J COGNITIVE NEUROSCI, V21, P511, DOI 10.1162/jocn.2008.21024; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921	59	168	171	3	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2016	19	1					150	+		10.1038/nn.4174	http://dx.doi.org/10.1038/nn.4174			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ7BH	26595654	Green Accepted			2022-12-17	WOS:000367254400025
J	Palmer, LM; Shai, AS; Reeve, JE; Anderson, HL; Paulsen, O; Larkum, ME				Palmer, Lucy M.; Shai, Adam S.; Reeve, James E.; Anderson, Harry L.; Paulsen, Ole; Larkum, Matthew E.			NMDA spikes enhance action potential generation during sensory input	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; IN-VIVO; CORTICAL-NEURONS; BASAL DENDRITES; SYNAPTIC INTEGRATION; APICAL DENDRITES; CEREBRAL-CORTEX; TUFT DENDRITES; QX-314; CELLS	Recent evidence in vitro suggests that the tuft dendrites of pyramidal neurons are capable of evoking local NMDA receptor-dependent electrogenesis, so-called NMDA spikes. However, it has so far proved difficult to demonstrate their existence in vivo. Moreover, it is not clear whether NMDA spikes are relevant to the output of pyramidal neurons. We found that local NMDA spikes occurred in tuft dendrites of layer 2/3 pyramidal neurons both spontaneously and following sensory input, and had a large influence on the number of output action potentials. Using two-photon activation of an intracellular caged NMDA receptor antagonist (tc-MK801), we found that isolated NMDA spikes typically occurred in multiple branches simultaneously and that sensory stimulation substantially increased their probability. Our results demonstrate that NMDA receptors have a vital role in coupling the tuft region of the layer 2/3 pyramidal neuron to the cell body, enhancing the effectiveness of layer 1 input.	[Palmer, Lucy M.] Univ Melbourne, Florey Inst, Melbourne, Vic, Australia; [Palmer, Lucy M.; Larkum, Matthew E.] Univ Bern, Inst Physiol, Bern, Switzerland; [Palmer, Lucy M.; Larkum, Matthew E.] Humboldt Univ, D-10099 Berlin, Germany; [Shai, Adam S.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; [Reeve, James E.; Anderson, Harry L.] Univ Oxford, Dept Chem, Oxford OX1 3QZ, England; [Paulsen, Ole] Univ Cambridge, Dept Physiol Dev & Neurosci, Physiol Lab, Cambridge, England	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Bern; Humboldt University of Berlin; California Institute of Technology; University of Oxford; University of Cambridge	Palmer, LM (corresponding author), Univ Melbourne, Florey Inst, Melbourne, Vic, Australia.	lucymareepalmer@gmail.com	Anderson, Harry Laurence/E-7843-2011; Reeve, James/GYI-8415-2022; Paulsen, Ole/ABB-4843-2020	Anderson, Harry Laurence/0000-0002-1801-8132; Paulsen, Ole/0000-0002-2258-5455; Larkum, Matthew/0000-0001-9799-2656; Palmer, Lucy/0000-0003-3676-657X	SystemsX.ch (NeuroChoice); Swiss National Science Foundation [31003A_130694]; Whitaker International Program; DFG [EXC 257 NeuroCure]; BBSRC [BB/H002383/2] Funding Source: UKRI; MRC [G0400571] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H002383/2] Funding Source: researchfish; Medical Research Council [G0400571] Funding Source: researchfish	SystemsX.ch (NeuroChoice); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Whitaker International Program; DFG(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank F. Haiss and B. Weber for designing the custom-made two-photon microscope, and D. Langer and F. Helmchen for the imaging software Helioscan. We also thank S. Murphy and R. Min for their comments on the manuscript. We further acknowledge the GENIE Program and the Janelia Farm Research Campus for the use of GCaMP6. This work was supported by SystemsX.ch (NeuroChoice), Swiss National Science Foundation (31003A_130694), the Whitaker International Program and the DFG (EXC 257 NeuroCure).	ANDRADE R, 1991, EUR J PHARMACOL, V199, P259, DOI 10.1016/0014-2999(91)90467-5; Antic SD, 2010, J NEUROSCI RES, V88, P2991, DOI 10.1002/jnr.22444; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; CAULLER LJ, 1994, J NEUROSCI, V14, P751; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen XW, 2013, CELL REP, V4, P31, DOI 10.1016/j.celrep.2013.05.042; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; CONNORS BW, 1982, J PHARMACOL EXP THER, V220, P476; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Gordon U, 2006, J NEUROSCI, V26, P12717, DOI 10.1523/JNEUROSCI.3502-06.2006; Hay E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002107; Hill DN, 2013, P NATL ACAD SCI USA, V110, P13618, DOI 10.1073/pnas.1312599110; Hines M.L., 1998, METHODS NEURONAL MOD, P129; HUBEL DH, 1982, ANNU REV NEUROSCI, V5, P363, DOI 10.1146/annurev.ne.05.030182.002051; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Larkum ME, 2008, CURR OPIN NEUROBIOL, V18, P321, DOI 10.1016/j.conb.2008.08.013; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 2007, J NEUROSCI, V27, P8999, DOI 10.1523/JNEUROSCI.1717-07.2007; Larkum ME, 2002, J NEUROSCI, V22, P6991; Lavzin M, 2012, NATURE, V490, P397, DOI 10.1038/nature11451; Ledergerber D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033146; Ledergerber D, 2010, J NEUROSCI, V30, P13031, DOI 10.1523/JNEUROSCI.2254-10.2010; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; Major G, 2013, ANNU REV NEUROSCI, V36, P1, DOI 10.1146/annurev-neuro-062111-150343; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; PERKINS KL, 1995, J NEUROPHYSIOL, V73, P911, DOI 10.1152/jn.1995.73.2.911; Plotkin JL, 2011, NAT NEUROSCI, V14, P881, DOI 10.1038/nn.2848; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Reeve James E, 2012, Commun Integr Biol, V5, P240, DOI 10.4161/cib.19400; Rhodes P, 2006, J NEUROSCI, V26, P6704, DOI 10.1523/JNEUROSCI.3791-05.2006; Rodriguez-Moreno A, 2011, J NEUROSCI, V31, P8564, DOI 10.1523/JNEUROSCI.0274-11.2011; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; Self MW, 2013, CURR BIOL, V23, P2121, DOI 10.1016/j.cub.2013.09.013; Self MW, 2012, P NATL ACAD SCI USA, V109, P11031, DOI 10.1073/pnas.1119527109; Smith SL, 2013, NATURE, V503, P115, DOI 10.1038/nature12600; Stuart G, 1998, J NEUROSCI, V18, P3501; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Talbot MJ, 1996, J NEUROPHYSIOL, V76, P2120, DOI 10.1152/jn.1996.76.3.2120; TAYLOR RE, 1959, AM J PHYSIOL, V196, P1071, DOI 10.1152/ajplegacy.1959.196.5.1071; Waters J, 2003, J NEUROSCI, V23, P8558; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; ZADOR AM, 1995, J NEUROSCI, V15, P1669, DOI 10.1523/JNEUROSCI.15-03-01669.1995	53	168	170	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2014	17	3					383	390		10.1038/nn.3646	http://dx.doi.org/10.1038/nn.3646			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB8CA	24487231				2022-12-17	WOS:000332016500011
J	Chowdhury, R; Guitart-Masip, M; Lambert, C; Dayan, P; Huys, Q; Duzel, E; Dolan, RJ				Chowdhury, Rumana; Guitart-Masip, Marc; Lambert, Christian; Dayan, Peter; Huys, Quentin; Duezel, Emrah; Dolan, Raymond J.			Dopamine restores reward prediction errors in old age	NATURE NEUROSCIENCE			English	Article							REINFORCEMENT LEARNING SIGNALS; PARKINSONS-DISEASE; DECISION-MAKING; HUMAN STRIATUM; DIFFUSION MRI; NEUROMODULATION; BRAIN	Senescence affects the ability to utilize information about the likelihood of rewards for optimal decision-making. Using functional magnetic resonance imaging in humans, we found that healthy older adults had an abnormal signature of expected value, resulting in an incomplete reward prediction error (RPE) signal in the nucleus accumbens, a brain region that receives rich input projections from substantia nigra/ventral tegmental area (SN/VTA) dopaminergic neurons. Structural connectivity between SN/VTA and striatum, measured by diffusion tensor imaging, was tightly coupled to inter-individual differences in the expression of this expected reward value signal. The dopamine precursor levodopa (L-DOPA) increased the task-based learning rate and task performance in some older adults to the level of young adults. This drug effect was linked to restoration of a canonical neural RPE. Our results identify a neurochemical signature underlying abnormal reward processing in older adults and indicate that this can be modulated by L-DOPA.	[Chowdhury, Rumana; Duezel, Emrah] UCL, Inst Cognit Neurosci, London, England; [Chowdhury, Rumana; Guitart-Masip, Marc; Lambert, Christian; Huys, Quentin; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Guitart-Masip, Marc] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Lambert, Christian] St Georges Univ London, Stroke & Dementia Res Ctr, London, England; [Dayan, Peter; Huys, Quentin] UCL, Gatsby Computat Neurosci Unit, London, England; [Huys, Quentin] Swiss Fed Inst Technol, Dept Biol Engn, Translat Neuroimaging Unit, Zurich, Switzerland; [Huys, Quentin] Univ Zurich, Zurich, Switzerland; [Huys, Quentin] Zurich Univ Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland; [Duezel, Emrah] Univ Magdeburg, Inst Cognit Neurol & Dementia Res, D-39106 Magdeburg, Germany; [Duezel, Emrah] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany	University of London; University College London; University of London; University College London; Karolinska Institutet; St Georges University London; University of London; University College London; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Otto von Guericke University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Chowdhury, R (corresponding author), UCL, Inst Cognit Neurosci, London, England.	rumana.neuro@gmail.com	Duzel, Emrah/A-1794-2010	Huys, Quentin/0000-0002-8999-574X; Lambert, Christian/0000-0001-8281-4611; Guitart Masip, Marc/0000-0002-2294-6492; Dayan, Peter/0000-0003-3476-1839; Dolan, Ray/0000-0001-9356-761X; Duzel, Emrah/0000-0002-0139-5388	Wellcome Trust [078865/Z/05/Z, 091593/Z/10/Z, WT088286MA]; Academy of Medical Sciences (AMS) [AMS-SGCL8-Lambert] Funding Source: researchfish; National Institute for Health Research [CL-2012-16-501] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank J. Medhora and L. Sasse for their assistance with data collection, and H. Barron and M. Klein-Flugge for their assistance with time course analyses. R.C. is supported by a Wellcome Trust Research Training Fellowship (WT088286MA). R.J.D. is supported by the Wellcome Trust (grant number 078865/Z/05/Z). The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust (091593/Z/10/Z).	Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Brett M., 2002, NEUROIMAGE, V16, P1140, DOI DOI 10.1016/S1053-8119(02)90013-3; Choi WY, 2005, J NEUROSCI, V25, P6729, DOI 10.1523/JNEUROSCI.1498-05.2005; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Cox KM, 2008, COGN AFFECT BEHAV NE, V8, P304, DOI 10.3758/CABN.8.3.304; Coxon JP, 2012, J NEUROSCI, V32, P8401, DOI 10.1523/JNEUROSCI.6360-11.2012; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; de Wit S, 2012, PSYCHOPHARMACOLOGY, V219, P621, DOI 10.1007/s00213-011-2563-2; Dickinson A, 2000, BEHAV NEUROSCI, V114, P468, DOI 10.1037/0735-7044.114.3.468; Dickinson A., 2002, STEVENS HDB EXPT PSY; Draganski B, 2011, NEUROIMAGE, V55, P1423, DOI 10.1016/j.neuroimage.2011.01.052; Duzel E, 2010, NEUROSCI BIOBEHAV R, V34, P660, DOI 10.1016/j.neubiorev.2009.08.006; Eppinger B, 2008, NEUROPSYCHOLOGIA, V46, P521, DOI 10.1016/j.neuropsychologia.2007.09.001; Eppinger B, 2011, ANN NY ACAD SCI, V1235, P1, DOI 10.1111/j.1749-6632.2011.06230.x; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Forstmann BU, 2012, NEUROIMAGE, V60, P370, DOI 10.1016/j.neuroimage.2011.12.044; Forstmann BU, 2011, J NEUROSCI, V31, P17242, DOI 10.1523/JNEUROSCI.0309-11.2011; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Guitart-Masip M, 2012, NEUROIMAGE, V62, P154, DOI 10.1016/j.neuroimage.2012.04.024; Guitart-Masip M, 2012, P NATL ACAD SCI USA, V109, P7511, DOI 10.1073/pnas.1202229109; Haber SN, 2000, J NEUROSCI, V20, P2369; Huys QJM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002028; Jocham G, 2011, J NEUROSCI, V31, P1606, DOI 10.1523/JNEUROSCI.3904-10.2011; Klein-Flugge MC, 2011, NEURON, V72, P654, DOI 10.1016/j.neuron.2011.08.024; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; Li JA, 2011, J NEUROSCI, V31, P5504, DOI 10.1523/JNEUROSCI.6316-10.2011; Li SC, 2002, NEUROSCI BIOBEHAV R, V26, P795, DOI 10.1016/S0149-7634(02)00066-0; Lutti A, 2010, MAGN RESON MED, V64, P229, DOI 10.1002/mrm.22421; Mell T, 2005, NEUROPSYCHOLOGIA, V43, P554, DOI 10.1016/j.neuropsychologia.2004.07.010; Nagy Z, 2007, MAGN RESON MED, V58, P763, DOI 10.1002/mrm.21379; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Rutledge RB, 2009, J NEUROSCI, V29, P15104, DOI 10.1523/JNEUROSCI.3524-09.2009; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; Samanez-Larkin GR, 2011, SOC COGN AFFECT NEUR, V6, P207, DOI 10.1093/scan/nsq043; Samanez-Larkin GR, 2010, J NEUROSCI, V30, P1426, DOI 10.1523/JNEUROSCI.4902-09.2010; Schonberg T, 2007, J NEUROSCI, V27, P12860, DOI 10.1523/JNEUROSCI.2496-07.2007; Schott BH, 2007, BRAIN, V130, P2412, DOI 10.1093/brain/awm147; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schwarzkopf DS, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00200; Shohamy D, 2010, TRENDS COGN SCI, V14, P464, DOI 10.1016/j.tics.2010.08.002; Simon DA, 2011, J NEUROSCI, V31, P5526, DOI 10.1523/JNEUROSCI.4647-10.2011; Vaillancourt DE, 2012, NEUROBIOL AGING, V33, P35, DOI 10.1016/j.neurobiolaging.2010.02.006; Worthy DA, 2011, PSYCHOL SCI, V22, P1375, DOI 10.1177/0956797611420301; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042	54	168	172	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					648	+		10.1038/nn.3364	http://dx.doi.org/10.1038/nn.3364			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23525044	Green Accepted, Green Published			2022-12-17	WOS:000318029300022
J	Russo, SJ; Bolanos, CA; Theobald, DE; DeCarolis, NA; Renthal, W; Kumar, A; Winstanley, CA; Renthal, NE; Wiley, MD; Self, DW; Russell, DS; Neve, RL; Eisch, AJ; Nestler, EJ				Russo, Scott J.; Bolanos, Carlos A.; Theobald, David E.; DeCarolis, Nathan A.; Renthal, William; Kumar, Arvind; Winstanley, Catharine A.; Renthal, Nora E.; Wiley, Matthew D.; Self, David W.; Russell, David S.; Neve, Rachael L.; Eisch, Amelia J.; Nestler, Eric J.			IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; PHOSPHOLIPASE-C-GAMMA; NEUROTROPHIC FACTOR; CHRONIC MORPHINE; DRUG-ADDICTION; NUCLEUS-ACCUMBENS; COCAINE; WITHDRAWAL; REWARD; RATS	Chronic morphine administration ( via subcutaneous pellet) decreases the size of dopamine neurons in the ventral tegmental area (VTA), a key reward region in the brain, yet the molecular basis and functional consequences of this effect are unknown. In this study, we used viral-mediated gene transfer in rat to show that chronic morphine-induced downregulation of the insulin receptor substrate 2 (IRS2)-thymoma viral proto-oncogene (Akt) signaling pathway in the VTA mediates the decrease in dopamine cell size seen after morphine exposure and that this downregulation diminishes morphine reward, as measured by conditioned place preference. We further show that the reduction in size of VTA dopamine neurons persists up to 2 weeks after morphine withdrawal, which parallels the tolerance to morphine's rewarding effects caused by previous chronic morphine exposure. These findings directly implicate the IRS2-Akt signaling pathway as a critical regulator of dopamine cell morphology and opiate reward.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; Florida State Univ, Neurosci Program, Tallahassee, FL 32306 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat, Belmont, MA 02178 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Yale University; Harvard University; McLean Hospital	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Russo, Scott/R-7107-2019; Winstanley, Catharine/K-5003-2015; Kumar, Arvind/B-6094-2009	Russo, Scott/0000-0002-6470-1805; Winstanley, Catharine/0000-0001-7032-4471; Eisch, Amelia/0000-0001-6476-5385; Kumar, Arvind/0000-0003-2879-3826; Renthal, William/0000-0003-0206-2101	NIDA NIH HHS [F32 DA019727, K08 DA000302-05] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA019727, K08DA000302] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ahmed SH, 2000, NEUROPSYCHOPHARMACOL, V22, P413, DOI 10.1016/S0893-133X(99)00133-5; Aston-Jones G, 2004, NEUROPHARMACOLOGY, V47, P167, DOI 10.1016/j.neuropharm.2004.06.020; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BECHARA A, 1992, BEHAV NEUROSCI, V106, P364, DOI 10.1037/0735-7044.106.2.364; Bechara A, 1998, PHARMACOL BIOCHEM BE, V59, P1, DOI 10.1016/S0091-3057(97)00047-6; BERHOW MT, 1995, NEUROSCIENCE, V68, P969, DOI 10.1016/0306-4522(95)00207-Y; Bolanos CA, 2003, J NEUROSCI, V23, P7569; Bolanos CA, 2004, NEUROMOL MED, V5, P69, DOI 10.1385/NMM:5:1:069; Georges F, 2006, J NEUROSCI, V26, P5720, DOI 10.1523/JNEUROSCI.5032-05.2006; Glass MJ, 2004, SYNAPSE, V53, P191, DOI 10.1002/syn.20049; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P1485, DOI 10.1038/sj.npp.1300192; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P865, DOI 10.1038/sj.npp.1300122; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P292, DOI 10.1038/sj.npp.1300037; Horger BA, 1999, J NEUROSCI, V19, P4110; Izzo E, 2002, NAT NEUROSCI, V5, P1263, DOI 10.1038/nn977; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kenny PJ, 2006, J NEUROSCI, V26, P5894, DOI 10.1523/JNEUROSCI.0740-06.2006; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Muller DL, 2004, J PHARMACOL EXP THER, V310, P774, DOI 10.1124/jpet.104.066548; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; Olson VG, 2005, J NEUROSCI, V25, P5553, DOI 10.1523/JNEUROSCI.0345-05.2005; Paladini CA, 2004, J NEUROSCI, V24, P5209, DOI 10.1523/JNEUROSCI.1079-04.2004; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pierce RC, 2001, REV NEUROSCIENCE, V12, P95; RASMUSSEN K, 1990, J NEUROSCI, V10, P2308; Robinson TE, 2002, SYNAPSE, V46, P271, DOI 10.1002/syn.10146; ROSNOW RL, 1989, AM PSYCHOL, V44, P1276, DOI 10.1037/0003-066X.44.10.1276; Russo SJ, 2003, NEUROSCIENCE, V120, P523, DOI 10.1016/S0306-4522(03)00317-8; SELF DW, 1995, SYNAPSE, V21, P312, DOI 10.1002/syn.890210405; SHIPPENBERG TS, 1988, PSYCHOPHARMACOLOGY, V96, P110, DOI 10.1007/BF02431542; SklairTavron L, 1996, P NATL ACAD SCI USA, V93, P11202, DOI 10.1073/pnas.93.20.11202; Spiga S, 2003, EUR J NEUROSCI, V17, P605, DOI 10.1046/j.1460-9568.2003.02435.x; Walker JR, 2003, PHARMACOL BIOCHEM BE, V75, P349, DOI 10.1016/S0091-3057(03)00094-7; WISE RA, 1989, NEUROSCI BIOBEHAV R, V13, P129, DOI 10.1016/S0149-7634(89)80021-1; Wolf DH, 1999, J NEUROCHEM, V73, P1520, DOI 10.1046/j.1471-4159.1999.0731520.x; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Ziolkowska B, 2006, BRAIN RES, V1069, P1, DOI 10.1016/j.brainres.2005.11.042	40	168	172	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					93	99		10.1038/nn1812	http://dx.doi.org/10.1038/nn1812			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17143271				2022-12-17	WOS:000243096100020
J	Wang, HB; Ferguson, GD; Pineda, VV; Cundiff, PE; Storm, DR				Wang, HB; Ferguson, GD; Pineda, VV; Cundiff, PE; Storm, DR			Overexpression of type-1 adenylyl cyclase in mouse forebrain enhances recognition memory and LTP	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-A; HIPPOCAMPAL CA1 REGION; SYNAPTIC PLASTICITY; MUTANT MICE; LATE-PHASE; MUSHROOM BODIES; PERFORANT PATH; CROSS-TALK; DROSOPHILA	Cyclic AMP is a positive regulator of synaptic plasticity and is required for several forms of hippocampus-dependent memory including recognition memory. The type I adenylyl cyclase, Adcy1 (also known as AC1), is crucial in memory formation because it couples Ca2+ to cyclic AMP increases in the hippocampus. Because Adcy1 is neurospecific, it is a potential pharmacological target for increasing cAMP specifically in the brain and for improving memory. We have generated transgenic mice that overexpress Adcy1 in the forebrain using the Camk2a (also known as alpha-CaMKII) promoter. These mice showed elevated long-term potentiation (LTP), increased memory for object recognition and slower rates of extinction for contextual memory. The increase in recognition memory and lower rates of contextual memory extinction may be due to enhanced extracellular signal-related kinase (ERK)/mitogen-activated protein kinase (MAPK) signaling, which is elevated in mice that overexpress Adcy1.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Box 357280,1959 NE Pacific St, Seattle, WA 98195 USA.	dstorm@u.washington.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498, F31NS042475] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 20498, 1F31NS042475-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; Bramham CR, 1997, NEUROREPORT, V8, P719, DOI 10.1097/00001756-199702100-00028; CASTELLUCCI VF, 1982, J NEUROSCI, V2, P1673; CHEN CN, 1986, P NATL ACAD SCI USA, V83, P9313, DOI 10.1073/pnas.83.24.9313; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Cooke SF, 2003, CELL MOL LIFE SCI, V60, P1, DOI 10.1007/s000180300000; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; FYKSE EM, 1995, J NEUROSCI, V15, P2385, DOI 10.1523/JNEUROSCI.15-03-02385.1995; Gerlai R, 2002, HIPPOCAMPUS, V12, P657, DOI 10.1002/hipo.10101; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Koh MT, 2003, NEUROREPORT, V14, P405, DOI 10.1097/01.wnr.0000058519.74643.df; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lisman JE, 2001, CURR BIOL, V11, pR788, DOI 10.1016/S0960-9822(01)00472-9; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Matynia A, 2002, ANNU REV GENET, V36, P687, DOI 10.1146/annurev.genet.36.062802.091007; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MYHRER T, 1988, BEHAV NEUROSCI, V102, P356, DOI 10.1037/0735-7044.102.3.356; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Pineda VV, 2004, NEURON, V41, P153, DOI 10.1016/S0896-6273(03)00813-4; Reed JM, 1997, BEHAV NEUROSCI, V111, P667, DOI 10.1037/0735-7044.111.4.667; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; Szapiro G, 2003, HIPPOCAMPUS, V13, P53, DOI 10.1002/hipo.10043; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Tully T, 2003, NAT REV DRUG DISCOV, V2, P267, DOI 10.1038/nrd1061; Vianna MR, 2003, NEUROBIOL LEARN MEM, V79, P199, DOI 10.1016/S1074-7427(03)00003-0; Villacres EC, 1998, J NEUROSCI, V18, P3186; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Weeber EJ, 2002, NEURON, V33, P845, DOI 10.1016/S0896-6273(02)00634-7; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; Yamamoto M, 2000, BBA-MOL BASIS DIS, V1535, P60, DOI 10.1016/S0925-4439(00)00083-1; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	50	168	173	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					635	642		10.1038/nn1248	http://dx.doi.org/10.1038/nn1248			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15133516				2022-12-17	WOS:000221640300018
J	Carter, AG; Regehr, WG				Carter, AG; Regehr, WG			Quantal events shape cerebellar interneuron firing	NATURE NEUROSCIENCE			English	Article							NEOSTRIATAL CHOLINERGIC INTERNEURONS; SYNAPTIC CURRENTS; PYRAMIDAL CELLS; PURKINJE-CELLS; STELLATE CELLS; NEOCORTICAL NEURONS; MEMBRANE-PROPERTIES; CORTICAL-NEURONS; INHIBITORY CELLS; INVITRO	Many small synaptic inputs or one large input are needed to influence principal cell firing, whereas individual quanta exert little influence. However, the role of a quantum may be greater for small interneurons with high input resistances. Using dynamic clamp recordings, we found that individual quanta strongly influence rat cerebellar stellate cell firing. When the frequency of synaptic inputs was low, the timing of recent spikes regulated the influence of excitatory quanta. In contrast, when input frequency was high, spike timing was less important than interactions with other inputs. Inhibitory quanta rapidly terminated firing, whereas small numbers of coincident excitatory quanta reliably and rapidly triggered firing. Our results suggest that stellate cells achieve temporal precision through coincidence detection and disynaptic inhibition, despite their high resistances and long membrane time constants. Thus, we propose that small interneurons can process synaptic inputs in a fundamentally different way from principal cells.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02215 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02215 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NINDS NIH HHS [N01-NS32405-01] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABELES M, 1982, ISRAEL J MED SCI, V18, P83; Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; [Anonymous], [No title captured]; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Auger C, 1997, NEURON, V19, P139, DOI 10.1016/S0896-6273(00)80354-2; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; Bennett BD, 1998, J NEUROSCI, V18, P8539; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; CALLAWAY JC, 1995, J NEUROSCI, V15, P2777; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; CLELAND BG, 1971, NATURE-NEW BIOL, V231, P191, DOI 10.1038/newbio231191a0; Eccles J. C, 1957, PHYSL NERVE CELLS; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; FETZ EE, 1983, J PHYSIOL-LONDON, V341, P387, DOI 10.1113/jphysiol.1983.sp014812; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GULYAS AI, 1993, EUR J NEUROSCI, V5, P1729, DOI 10.1111/j.1460-9568.1993.tb00240.x; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Jaeger D, 1999, J NEUROSCI, V19, P6090, DOI 10.1523/JNEUROSCI.19-14-06090.1999; Kondo S, 1998, J PHYSIOL-LONDON, V509, P221, DOI 10.1111/j.1469-7793.1998.221bo.x; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mann-Metzer P, 2002, J NEUROPHYSIOL, V87, P149, DOI 10.1152/jn.00310.2001; Mark MD, 2000, EUR J BIOCHEM, V267, P5830, DOI 10.1046/j.1432-1327.2000.01670.x; MASON A, 1991, J NEUROSCI, V11, P72; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; MIDTGAARD J, 1992, J PHYSIOL-LONDON, V457, P329, DOI 10.1113/jphysiol.1992.sp019381; MIDTGAARD J, 1992, J PHYSIOL-LONDON, V457, P355, DOI 10.1113/jphysiol.1992.sp019382; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; Nusser Z, 2001, BIOPHYS J, V80, P1251, DOI 10.1016/S0006-3495(01)76101-2; Oertel D, 1991, Curr Opin Neurobiol, V1, P221, DOI 10.1016/0959-4388(91)90082-I; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; Palay SL, 1974, CEREBELLAR CORTEX CY, P348; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; REYES AD, 1993, J NEUROPHYSIOL, V69, P1661, DOI 10.1152/jn.1993.69.5.1661; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; SAYER RJ, 1989, J NEUROSCI, V9, P840; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Sui JL, 1999, ADV SEC MESS PHOSPH, V33, P179; ZHANG S, 1994, J NEUROPHYSIOL, V72, P705, DOI 10.1152/jn.1994.72.2.705; [No title captured]	50	168	169	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1309	1318		10.1038/nn970	http://dx.doi.org/10.1038/nn970			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12411959				2022-12-17	WOS:000179447500014
J	Coffey, PJ; Girman, S; Wang, SM; Hetherington, L; Keegan, DJ; Adamson, P; Greenwood, J; Lund, RD				Coffey, PJ; Girman, S; Wang, SM; Hetherington, L; Keegan, DJ; Adamson, P; Greenwood, J; Lund, RD			Long-term preservation of cortically dependent visual function in RCS rats by transplantation	NATURE NEUROSCIENCE			English	Article							PUPILLARY LIGHT REFLEX; DISCRIMINATION	Cell transplantation is one way of limiting the progress of retinal degeneration in animal models of blinding diseases such as retinitis pigmentosa (RP) and age-related macular degeneration (AMD). Here we transplanted a human retinal pigment epithelia] (RPE) cell line into the subretinal space of one such model, the Royal College of Surgeons (RCS) rat, and showed, using head tracking to moving stripes and pattern discrimination in conjunction with single-unit cortical physiology, that cortically mediated vision can be preserved with this treatment.	Univ Utah, Moran Eye Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA; Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England; Univ Coll, Inst Ophthalmol, London EC1V 9EL, England	Utah System of Higher Education; University of Utah; University of Sheffield; University of London; University College London	Lund, RD (corresponding author), Univ Utah, Moran Eye Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA.			Coffey, Peter/0000-0002-5427-2939; Greenwood, John/0000-0003-4496-2984				BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; COWEY A, 1979, EXP BRAIN RES, V35, P443; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; DELCERRO M, 1991, NEUROREPORT, V2, P529, DOI 10.1097/00001756-199109000-00008; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; KANUGA N, IN PRESS INVEST OPHT; LAVAIL MM, 1974, VISION RES, V14, P693, DOI 10.1016/0042-6989(74)90066-2; LI LX, 1988, EXP EYE RES, V47, P911, DOI 10.1016/0014-4835(88)90073-5; Lund RD, 2001, P NATL ACAD SCI USA, V98, P9942, DOI 10.1073/pnas.171266298; Sauve Y, 2001, NEUROSCIENCE, V103, P51, DOI 10.1016/S0306-4522(00)00557-1; TREJO LJ, 1982, VISION RES, V22, P1163, DOI 10.1016/0042-6989(82)90081-5; Whiteley SJO, 1996, EXP NEUROL, V140, P100, DOI 10.1006/exnr.1996.0120	13	168	179	1	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					53	56		10.1038/nn782	http://dx.doi.org/10.1038/nn782			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753416				2022-12-17	WOS:000173031800015
J	Fletcher, PC; Anderson, JM; Shanks, DR; Honey, R; Carpenter, TA; Donovan, T; Papadakis, N; Bullmore, ET				Fletcher, PC; Anderson, JM; Shanks, DR; Honey, R; Carpenter, TA; Donovan, T; Papadakis, N; Bullmore, ET			Responses of human frontal cortex to surprising events are predicted by formal associative learning theory	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; BRAIN ACTIVITY; CONFLICT; FMRI; INHIBITION; ACTIVATION; SELECTION; MEMORIES	Learning depends on surprise and is not engendered by predictable occurrences. In this functional magnetic resonance imaging (fMRI) study of causal associative learning, we show that dorsolateral prefrontal cortex (DLPFC) is associated specifically with the adjustment of inferential learning on the basis of unpredictability. At the outset, when all associations were unpredictable, DLPFC activation was maximal. This response attenuated with learning but, subsequently, activation here was evoked by surprise violations of the learned association. Furthermore, the magnitude of DLPFC response to a surprise event was sensitive to the relationship that had been learned and was predictive of subsequent behavioral change. In short, the physiological response properties of right DLPFC satisfied specific predictions made by associative learning theory.	Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Brain Mapping Unit, Cambridge CB2 2QQ, England; UCL, Dept Psychol, London WC1E 6BT, England; Univ Western Australia, Ctr Clin Res Neuropsychiat, Perth, WA 6009, Australia; Univ Cambridge, Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England; Univ Sheffield, Sheffield S3 7RH, S Yorkshire, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; University of Western Australia; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Sheffield	Fletcher, PC (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Brain Mapping Unit, Box 189,Hills Rd, Cambridge CB2 2QQ, England.	pcf22@cam.ac.uk	Shanks, David/A-1510-2015; Bullmore, Ed/C-1706-2012; Donovan, Tim/AAF-3563-2019; Fletcher, Paul/F-5380-2011	Shanks, David/0000-0002-4600-6323; Bullmore, Ed/0000-0002-8955-8283; Fletcher, Paul/0000-0001-8257-1517; Donovan, Tim/0000-0003-4112-861X				Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 1998, HUM BRAIN MAPP, V6, P373, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<373::AID-HBM8>3.3.CO;2-G; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Dickinson A, 2001, Q J EXP PSYCHOL-B, V54, P3, DOI 10.1080/02724990042000010; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; Fletcher PC, 2000, NEUROIMAGE, V12, P404, DOI 10.1006/nimg.2000.0633; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Fuster J., 2015, PREFRONTAL CORTEX; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Liddle PF, 2001, HUM BRAIN MAPP, V12, P100, DOI 10.1002/1097-0193(200102)12:2<100::AID-HBM1007>3.0.CO;2-6; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Matute H, 1996, J EXP PSYCHOL LEARN, V22, P182, DOI 10.1037/0278-7393.22.1.182; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nelson H. E, 1982, NATL ADULT READING T; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Shanks D.R, 1995, PSYCHOL ASS LEARNING; Sussman G., 1975, COMPUTATIONAL MODEL; Talairach J., 1988, COPLANAR STEREOTAXIC; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; WASSERMAN EA, 1993, J EXP PSYCHOL LEARN, V19, P174, DOI 10.1037/0278-7393.19.1.174; Zeki S, 1998, BRAIN, V121, P1669, DOI 10.1093/brain/121.9.1669; [No title captured]	34	168	170	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					1043	1048		10.1038/nn733	http://dx.doi.org/10.1038/nn733			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	478CR	11559855				2022-12-17	WOS:000171325800020
J	Anderson, J; Lampl, I; Reichova, I; Carandini, M; Ferster, D				Anderson, J; Lampl, I; Reichova, I; Carandini, M; Ferster, D			Stimulus dependence of two-state fluctuations of membrane potential in cat visual cortex	NATURE NEUROSCIENCE			English	Article							NEURONS IN-VIVO; LESS-THAN-1 HZ OSCILLATION; SPINY NEURONS; CORTICAL-NEURONS; INTRACELLULAR ANALYSIS; NEOCORTICAL NEURONS; NUCLEUS BASALIS; FIRING PATTERNS; COMPLEX CELLS; VARIABILITY	Membrane potentials of cortical neurons fluctuate between a hyperpolarized ('down') state and a depolarized ('up') state which may be separated by up to 30 mV, reflecting rapid but infrequent transitions between two patterns of synaptic input. Here we show that such fluctuations may contribute to representation of visual stimuli by cortical cells. In complex cells of anesthetized cats, where such fluctuations are most prominent, prolonged visual stimulation increased the probability of the up state. This probability increase was related to stimulus strength: its dependence on stimulus orientation and contrast matched each cell's averaged membrane potential. Thus targe fluctuations in membrane potential are not simply noise on which visual responses are superimposed, but may provide a substrate for encoding sensory information.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Univ Zurich, ETH, Inst Neuroinformat, CH-8057 Zurich, Switzerland	Northwestern University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Ferster, D (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 N Campus Dr, Evanston, IL 60208 USA.	ferster@nwu.edu	Carandini, Matteo/ABD-8296-2021; Carandini, Matteo/C-1922-2008	Carandini, Matteo/0000-0003-4880-7682; Carandini, Matteo/0000-0003-4880-7682; Anderson, Jeffrey/0000-0002-9669-3846; Lampl, Ilan/0000-0002-9380-0730	NEI NIH HHS [R01EY04726, P32EY07128] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004726] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Azouz R, 1999, J NEUROSCI, V19, P2209; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BLANTON MG, 1989, J NEUROSCI METH, P30; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P659, DOI 10.1113/jphysiol.1991.sp018730; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; GUSTAFSSON B, 1984, J PHYSIOL-LONDON, V347, P431, DOI 10.1113/jphysiol.1984.sp015074; JAGADEESH B, 1992, SCIENCE, V257, P552, DOI 10.1126/science.1636094; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; METHERATE R, 1993, J NEUROSCI, V13, P5312, DOI 10.1523/JNEUROSCI.13-12-05312.1993; METHERATE R, 1992, J NEUROSCI, V12, P4701; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Plenz D, 1998, J NEUROSCI, V18, P266; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SOMERS DC, 1995, J NEUROSCI, V15, P5448; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; WILSON CJ, 1981, BRAIN RES, V220, P67, DOI 10.1016/0006-8993(81)90211-0; WILSON CJ, 1993, PROG BRAIN RES, V99, P277; Wilson CJ, 1996, J NEUROSCI, V16, P2397	32	168	173	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					617	621		10.1038/75797	http://dx.doi.org/10.1038/75797			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816319				2022-12-17	WOS:000087249500019
J	Feinstein, JS; Buzza, C; Hurlemann, R; Follmer, RL; Dahdaleh, NS; Coryell, WH; Welsh, MJ; Tranel, D; Wemmie, JA				Feinstein, Justin S.; Buzza, Colin; Hurlemann, Rene; Follmer, Robin L.; Dahdaleh, Nader S.; Coryell, William H.; Welsh, Michael J.; Tranel, Daniel; Wemmie, John A.			Fear and panic in humans with bilateral amygdala damage	NATURE NEUROSCIENCE			English	Article							DOUBLE DISSOCIATION; CARBON-DIOXIDE; DISORDER; RECOGNITION; EMOTION; FMRI	Decades of research have highlighted the amygdala's influential role in fear. We found that inhalation of 35% CO2 evoked not only fear, but also panic attacks, in three rare patients with bilateral amygdala damage. These results indicate that the amygdala is not required for fear and panic, and make an important distinction between fear triggered by external threats from the environment versus fear triggered internally by CO2.	[Feinstein, Justin S.; Tranel, Daniel] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Feinstein, Justin S.; Tranel, Daniel] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Buzza, Colin; Hurlemann, Rene; Follmer, Robin L.; Coryell, William H.; Wemmie, John A.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Hurlemann, Rene] Univ Bonn, Dept Psychiat, Bonn, Germany; [Dahdaleh, Nader S.; Welsh, Michael J.; Wemmie, John A.] Univ Iowa, Dept Neurosurg, Iowa City, IA USA; [Welsh, Michael J.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Welsh, Michael J.; Wemmie, John A.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Welsh, Michael J.; Tranel, Daniel; Wemmie, John A.] Univ Iowa, Interdisciplinary Grad Program Neurosci, Iowa City, IA USA; [Welsh, Michael J.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Wemmie, John A.] Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Bonn; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Tranel, D (corresponding author), Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA.	daniel.tranel@uiowa.edu; john-wemmie@uiowa.edu	Hurlemann, Rene/G-4164-2012; Hurlemann, Rene/AAL-5515-2020	Hurlemann, Rene/0000-0003-2628-565X; Hurlemann, Rene/0000-0003-2628-565X; Wemmie, John/0000-0001-7531-9065; Tranel, Daniel/0000-0002-1338-1389; Welsh, Michael/0000-0002-1646-6206; coryell, william/0000-0003-3989-7276	Doris Duke Clinical Research Fellowship; National Institute of Neurological Disorders and Stroke [P50 NS19632]; Department of Veterans Affairs; National Institutes of Mental Health [5RO1MH085724]; McKnight Neuroscience of Brain Disorders Award; Ministry of Innovation, Science, Research and Technology of the German State of North Rhine-Westphalia (MIWFT); University of Bonn; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS019632, P01NS019632] Funding Source: NIH RePORTER	Doris Duke Clinical Research Fellowship(Doris Duke Charitable Foundation (DDCF)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); McKnight Neuroscience of Brain Disorders Award; Ministry of Innovation, Science, Research and Technology of the German State of North Rhine-Westphalia (MIWFT); University of Bonn; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Wunsch for technical support and M. Coryell and J. Potash for critically reading this manuscript. C.B. was supported by a Doris Duke Clinical Research Fellowship. D.T. was supported by the National Institute of Neurological Disorders and Stroke (P50 NS19632). J.A.W. was supported by the Department of Veterans Affairs (Merit Award), the National Institutes of Mental Health (5RO1MH085724) and a McKnight Neuroscience of Brain Disorders Award. R.H. was supported by a Starting Independent Researcher Grant (NEMO-Neuromodulation of Emotion) jointly provided by the Ministry of Innovation, Science, Research and Technology of the German State of North Rhine-Westphalia (MIWFT) and the University of Bonn. M.J.W. receives funding from the Howard Hughes Medical Institute.	Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; Adolphs R., 2000, AMYGDALA FUNCTIONAL, P587; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Becker B, 2012, BIOL PSYCHIAT, V72, P70, DOI 10.1016/j.biopsych.2011.11.024; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Colasanti A, 2008, NEUROPSYCHOPHARMACOL, V33, P3103, DOI 10.1038/npp.2008.31; Damasio A, 2003, ANN NY ACAD SCI, V1001, P253, DOI 10.1196/annals.1279.014; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Del-Ben CM, 2009, NEURAL PLAST, V2009, DOI 10.1155/2009/108135; Feinstein JS, 2011, CURR BIOL, V21, P34, DOI 10.1016/j.cub.2010.11.042; Funayama ES, 2001, J COGNITIVE NEUROSCI, V13, P721, DOI 10.1162/08989290152541395; Khalsa SS, 2009, NAT NEUROSCI, V12, P1494, DOI 10.1038/nn.2411; Massana G, 2003, NEUROIMAGE, V19, P80, DOI 10.1016/S1053-8119(03)00036-3; Ottaviani C, 2012, PSYCHIAT RES-NEUROIM, V203, P159, DOI 10.1016/j.pscychresns.2011.12.010; Pillay SS, 2006, J AFFECT DISORDERS, V94, P173, DOI 10.1016/j.jad.2006.04.007; Preter M, 2008, PROG NEURO-PSYCHOPH, V32, P603, DOI 10.1016/j.pnpbp.2007.07.029; Rassovsky Y, 2003, J ANXIETY DISORD, V17, P1, DOI 10.1016/S0887-6185(02)00181-0; Wemmie John A, 2011, Dialogues Clin Neurosci, V13, P475; Wiest G, 2006, ARCH NEUROL-CHICAGO, V63, P1798, DOI 10.1001/archneur.63.12.1798; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	20	167	171	1	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					270	272		10.1038/nn.3323	http://dx.doi.org/10.1038/nn.3323			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	097LE	23377128	Green Accepted, Green Submitted			2022-12-17	WOS:000315474800008
J	Tsai, JW; Lian, WN; Kemal, S; Kriegstein, AR; Vallee, RB				Tsai, Jin-Wu; Lian, Wei-Nan; Kemal, Shahrnaz; Kriegstein, Arnold R.; Vallee, Richard B.			Kinesin 3 and cytoplasmic dynein mediate interkinetic nuclear migration in neural stem cells	NATURE NEUROSCIENCE			English	Article							NEURONAL MIGRATION; ENVELOPE BREAKDOWN; AXONAL-TRANSPORT; BINDING PROTEIN; MYOSIN-II; MOTOR; CENTROSOME; DYNACTIN; LIS1; SUPERFAMILY	Radial glial progenitor cells exhibit bidirectional cell cycle-dependent nuclear oscillations. The purpose and underlying mechanism of this unusual 'interkinetic nuclear migration' are poorly understood. We investigated the basis for this behavior by live imaging of nuclei, centrosomes and microtubules in embryonic rat brain slices, coupled with the use of RNA interference (RNAi) and the myosin inhibitor blebbistatin. We found that nuclei migrated independent of centrosomes and unidirectionally away from or toward the ventricular surface along microtubules, which were uniformly oriented from the ventricular surface to the pial surface of the brain. RNAi directed against cytoplasmic dynein specifically inhibited nuclear movement toward the apical surface. An RNAi screen of kinesin genes identified Kif1a, a member of the kinesin-3 family, as the motor for basally directed nuclear movement. These observations provide direct evidence that kinesins are involved in nuclear migration and neurogenesis and suggest that a cell cycle-dependent switch between distinct microtubule motors drives interkinetic nuclear migration.	[Tsai, Jin-Wu; Lian, Wei-Nan; Kemal, Shahrnaz; Vallee, Richard B.] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	Columbia University; University of California System; University of California San Francisco	Vallee, RB (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10027 USA.	rv2025@columbia.edu		Tsai, Jin-Wu/0000-0003-0135-759X	US National Institutes of Health [HD40182]; New York State Spinal Cord Injury Research Board; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040182] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Spinal Cord Injury Research Board; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank K.H. Bremner for assistance in surgical procedures, X. Wang for help in molecular cloning, G. Kreitzer for reagents and X. Wang, G. Kreitzer, W. Gruber, J. Canman and S. Cappello for helpful comments and suggestions. This work was supported by US National Institutes of Health grant HD40182 to R.B.V. and a New York State Spinal Cord Injury Research Board fellowship to J.- W.T.	Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hammond JW, 2009, PLOS BIOL, V7, P650, DOI 10.1371/journal.pbio.1000072; Hebbar S, 2008, J CELL BIOL, V182, P1063, DOI 10.1083/jcb.200803071; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; MESSIER PE, 1973, J EMBRYOL EXP MORPH, V30, P661; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Splinter D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000350; Stepanova T, 2003, J NEUROSCI, V23, P2655; TAKAHASHI T, 1993, J NEUROSCI, V13, P820; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; WATTERSON RL, 1956, ANAT REC, V124, P379; WEBSTER W, 1978, AM J ANAT, V152, P209, DOI 10.1002/aja.1001520204; Whited JL, 2004, DEVELOPMENT, V131, P4677, DOI 10.1242/dev.01366; Wozniak MJ, 2004, TRAFFIC, V5, P400, DOI 10.1111/j.1600-0854.2004.00191.x; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018	50	167	168	3	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1463	U43		10.1038/nn.2665	http://dx.doi.org/10.1038/nn.2665			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21037580	Green Submitted, Green Accepted			2022-12-17	WOS:000284525800010
J	Delgado, MR; Gillis, MM; Phelps, EA				Delgado, Mauricio R.; Gillis, M. Meredith; Phelps, Elizabeth A.			Regulating the expectation of reward via cognitive strategies	NATURE NEUROSCIENCE			English	Article							EMOTION REGULATION; NEGATIVE EMOTION; NEURAL BASES; ANTICIPATION; STRIATUM; FMRI	Previous emotion regulation research has been successful in altering aversive emotional reactions. It is unclear, however, whether such strategies can also efficiently regulate expectations of reward arising from conditioned stimuli, which can at times be maladaptive ( for example, drug cravings). Using a monetary reward-conditioning procedure with cognitive strategies, we observed attenuation in both the physiological ( skin conductance) and neural correlates ( striatum) of reward expectation as participants engaged in emotion regulation.	[Gillis, M. Meredith; Phelps, Elizabeth A.] NYU, Dept Psychol, New York, NY 10003 USA; [Delgado, Mauricio R.] Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA	New York University; Rutgers State University Newark; Rutgers State University New Brunswick	Phelps, EA (corresponding author), NYU, Dept Psychol, 6 Washington Pl,Room 863, New York, NY 10003 USA.	liz.phelps@nyu.edu	sarinopoulos, isidoros/B-5453-2010		NIDA NIH HHS [R03 DA022998, T32 DA022981-01A2, T32 DA022981, DA022998] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA022998, T32DA022981] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Delgado MR, 2006, SOC COGN AFFECT NEUR, V1, P250, DOI 10.1093/scan/nsl025; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Potenza Marc N, 2003, J Gambl Stud, V19, P7, DOI 10.1023/A:1021219012324; ROBBINS TW, 1992, SEMIN NEUROSCI, V4, P119; Sinha R, 2005, PSYCHOPHARMACOLOGY, V183, P171, DOI 10.1007/s00213-005-0147-8	15	167	169	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					880	881		10.1038/nn.2141	http://dx.doi.org/10.1038/nn.2141			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	330UU	18587392	Green Accepted			2022-12-17	WOS:000257969100011
J	Kim, YJ; Grabowecky, M; Paller, KA; Muthu, K; Suzuki, S				Kim, Yee Joon; Grabowecky, Marcia; Paller, Ken A.; Muthu, Krishnakumar; Suzuki, Satoru			Attention induces synchronization-based response gain in steady-state visual evoked potentials	NATURE NEUROSCIENCE			English	Article							ELECTROPHYSIOLOGICAL EVIDENCE; FREQUENCY SELECTIVITY; CORTICAL-NEURONS; MODULATION; CORTEX; DISCRIMINATION; SENSITIVITY; COMPETITION; MECHANISMS; DYNAMICS	When attention is voluntarily directed to a spatial location, visual sensitivity increases at that location. What causes this improved sensitivity? Studies of single neuron spike rates in monkeys have provided mixed results in regard to whether attending to a stimulus increases its effective contrast ( contrast gain) or multiplicatively boosts stimulus-driven neural responses ( response or activity gain). We monitored frequency-tagged steady-state visual evoked potentials (SSVEPs) in humans and found that voluntary sustained attention multiplicatively increased stimulus-driven population electrophysiological activity. Analyses of intertrial phase coherence showed that this attentional response gain was at least partially due to the increased synchronization of SSVEPs to stimulus flicker. These results suggest that attention operates in a complementary manner at different levels; attention seems to increase single-neuron spike rates in a variety of ways, including contrast, response and activity gains, while also inducing a multiplicative boost on neural population activity via enhanced response synchronization.	Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Suzuki, S (corresponding author), Northwestern Univ, Dept Psychol, 2029 Sheridan Rd, Evanston, IL 60208 USA.	satoru@northwestern.edu	Paller, Ken/M-2676-2019	Paller, Ken/0000-0003-4415-4143	NATIONAL EYE INSTITUTE [R01EY014110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034639, R29NS034639] Funding Source: NIH RePORTER; NEI NIH HHS [EY14110] Funding Source: Medline; NINDS NIH HHS [NS34639] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Buia C, 2006, J COMPUT NEUROSCI, V20, P247, DOI 10.1007/s10827-006-6358-0; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; CAMPBELL FW, 1970, J PHYSIOL-LONDON, V207, P635, DOI 10.1113/jphysiol.1970.sp009085; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Di Russo F, 2001, VISION RES, V41, P2435, DOI 10.1016/S0042-6989(01)00134-1; Ding J, 2006, CEREB CORTEX, V16, P1016, DOI 10.1093/cercor/bhj044; EDWARDS DP, 1995, VISION RES, V35, P1501, DOI 10.1016/0042-6989(94)00253-I; Fell J, 2003, BRAIN RES REV, V42, P265, DOI 10.1016/S0165-0173(03)00178-4; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Hou C, 2003, J NEUROSCI, V23, P8630; Huang LQ, 2005, VISION RES, V45, P1201, DOI 10.1016/j.visres.2004.10.024; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Ling S, 2006, VISION RES, V46, P1210, DOI 10.1016/j.visres.2005.05.008; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Morrone MC, 2002, CURR BIOL, V12, P1134, DOI 10.1016/S0960-9822(02)00921-1; Muller MM, 1998, COGNITIVE BRAIN RES, V6, P249, DOI 10.1016/S0926-6410(97)00036-0; Muller MM, 2003, NATURE, V424, P309, DOI 10.1038/nature01812; Niebur E, 1994, J Comput Neurosci, V1, P141, DOI 10.1007/BF00962722; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; Regan D., 1989, HUMAN BRAIN ELECTROP; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; SCHILLER PH, 1990, VISUAL NEUROSCI, V5, P321, DOI 10.1017/S0952523800000420; SPERLING G, 1978, SCIENCE, V202, P315, DOI 10.1126/science.694536; Srinivasan R, 1999, J NEUROSCI, V19, P5435; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Suzuki S, 2001, VISION RES, V41, P3883, DOI 10.1016/S0042-6989(01)00249-8; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TREISMAN A, 1990, J EXP PSYCHOL HUMAN, V16, P459, DOI 10.1037/0096-1523.16.3.459; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005	50	167	169	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					117	125		10.1038/nn1821	http://dx.doi.org/10.1038/nn1821			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17173045				2022-12-17	WOS:000243096100023
J	Hofer, SB; Mrsic-Flogel, TD; Bonhoeffer, T; Hubener, M				Hofer, SB; Mrsic-Flogel, TD; Bonhoeffer, T; Hubener, M			Prior experience enhances plasticity in adult visual cortex	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; MONOCULAR DEPRIVATION; CRITICAL-PERIOD; DEPENDENT PLASTICITY; AUDITORY-SYSTEM; MOUSE; RECOVERY; CATS; ADAPTATION; RESPONSES	The brain has a remarkable capacity to adapt to alterations in its sensory environment, which is normally much more pronounced in juvenile animals. Here we show that in adult mice, the ability to adapt to changes can be improved profoundly if the mouse has already experienced a similar change in its sensory environment earlier in life. Using the standard model for sensory plasticity in mouse visual cortex-ocular dominance (OD) plasticity-we found that a transient shift in OD, induced by monocular deprivation (MD) earlier in life, renders the adult visual cortex highly susceptible to subsequent MD many weeks later. Irrespective of whether the first MD was experienced during the critical period (around postnatal day 28) or in adulthood, OD shifts induced by a second MD were faster, more persistent and specific to repeated deprivation of the same eye. The capacity for plasticity in the mammalian cortex can therefore be conditioned by past experience.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Hubener, M (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany.	mark@neuro.mpg.de	Bonhoeffer, Tobias/B-9481-2009	Bonhoeffer, Tobias/0000-0001-7897-6634; Hofer, Sonja/0000-0003-4921-8521; Mrsic-Flogel, Tom/0000-0002-8947-408X				Antonini A, 1999, J NEUROSCI, V19, P4388; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; DeBello WM, 2001, J NEUROSCI, V21, P3161, DOI 10.1523/JNEUROSCI.21-09-03161.2001; DRAGER UC, 1978, J NEUROPHYSIOL, V41, P28, DOI 10.1152/jn.1978.41.1.28; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gordon JA, 1996, J NEUROSCI, V16, P3274; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hubener M, 2003, CURR OPIN NEUROBIOL, V13, P413, DOI 10.1016/S0959-4388(03)00102-8; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kind PC, 2002, NATURE, V416, P430, DOI 10.1038/416430a; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Liao DS, 2004, J NEUROPHYSIOL, V92, P2113, DOI 10.1152/jn.00266.2004; Linkenhoker BA, 2005, NAT NEUROSCI, V8, P93, DOI 10.1038/nn1367; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; MCGONIGLE BO, 1978, NATURE, V272, P364, DOI 10.1038/272364a0; MITCHELL DE, 1977, J COMP NEUROL, V176, P53, DOI 10.1002/cne.901760104; MUIR DW, 1973, SCIENCE, V180, P420, DOI 10.1126/science.180.4084.420; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Schuett S, 2002, J NEUROSCI, V22, P6549; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yang YP, 2005, NAT NEUROSCI, V8, P791, DOI 10.1038/nn1464	32	167	171	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					127	132		10.1038/nn1610	http://dx.doi.org/10.1038/nn1610			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16327785				2022-12-17	WOS:000234288000026
J	Hochgerner, H; Zeisel, A; Lobnnerberg, P; Linnarsson, S				Hochgerner, Hannah; Zeisel, Amit; Lobnnerberg, Peter; Linnarsson, Sten			Conserved properties of dentate gyrus neurogenesis across postnatal development revealed by single-cell RNA sequencing	NATURE NEUROSCIENCE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; NEURAL STEM-CELLS; PROMOTES LUNG TUMORIGENESIS; NEURONAL DEVELOPMENT; MICE; ASTROCYTES; ZONE; PROGENITORS; PRIMATES; BEHAVIOR	The dentate gyrus of the hippocampus is a brain region in which neurogenesis persists into adulthood; however, the relationship between developmental and adult dentate gyrus neurogenesis has not been examined in detail. Here we used single-cell RNA sequencing to reveal the molecular dynamics and diversity of dentate gyrus cell types in perinatal, juvenile, and adult mice. We found distinct quiescent and proliferating progenitor cell types, linked by transient intermediate states to neuroblast stages and fully mature granule cells. We observed shifts in the molecular identity of quiescent and proliferating radial glia and granule cells during the postnatal period that were then maintained through adult stages. In contrast, intermediate progenitor cells, neuroblasts, and immature granule cells were nearly indistinguishable at all ages. These findings demonstrate the fundamental similarity of postnatal and adult neurogenesis in the hippocampus and pinpoint the early postnatal transformation of radial glia from embryonic progenitors to adult quiescent stem cells.	[Hochgerner, Hannah; Zeisel, Amit; Lobnnerberg, Peter; Linnarsson, Sten] Karolinska Inst, Div Mol Neurobiol, Dept Med Biochem & Biophys, Stockholm, Sweden; [Hochgerner, Hannah; Zeisel, Amit; Lobnnerberg, Peter; Linnarsson, Sten] Sci Life Lab, Solna, Sweden	Karolinska Institutet	Linnarsson, S (corresponding author), Karolinska Inst, Div Mol Neurobiol, Dept Med Biochem & Biophys, Stockholm, Sweden.; Linnarsson, S (corresponding author), Sci Life Lab, Solna, Sweden.	sten.linnarsson@ki.se	Linnarsson, Sten/HCH-3909-2022	Hochgerner, Hannah/0000-0002-7739-666X	Knut and Alice Wallenberg foundation [2015.0041]; Human Frontiers Science Program	Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Human Frontiers Science Program(Human Frontier Science Program)	The authors thank P. Ernfors for critical discussion of the data and manuscript and A. Johnsson for lab management. The study was supported by the Knut and Alice Wallenberg foundation (2015.0041 to S.L.) and the Human Frontiers Science Program to A.Z. DNA sequencing was performed at the National Genomics Infrastructure, and single-cell RNA sequencing at the Eukaryotic Single-cell Genomics Facility, both at Science for Life Laboratory, Stockholm, Sweden.	ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Enikolopov G, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018804; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gilley JA, 2011, HIPPOCAMPUS, V21, P33, DOI 10.1002/hipo.20719; Gotz M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018853; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Habib N, 2016, DIV SEQ SINGLE NUCL; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Kang J, 2017, ONCOGENE, V36, P1585, DOI 10.1038/onc.2016.328; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kim W, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.125; Knobloch M, 2014, STEM CELL REP, V3, P735, DOI 10.1016/j.stemcr.2014.08.013; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kuckenberg P, 2012, REPROD BIOMED ONLINE, V25, P12, DOI 10.1016/j.rbmo.2012.02.015; Lawson K. A., 2016, KAUFMANS ATLAS MOUSE, P51; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malatesta P, 2013, DEVELOPMENT, V140, P483, DOI 10.1242/dev.085852; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; Mateus-Pinheiro A, 2017, MOL PSYCHIATR, V22, P1725, DOI 10.1038/mp.2016.169; Miller JA, 2013, DEVELOPMENT, V140, P4633, DOI 10.1242/dev.097212; Nicola Z, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00053; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Overstreet-Wadiche LS, 2006, HIPPOCAMPUS, V16, P208, DOI 10.1002/hipo.20152; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Piatti VC, 2006, NEUROSCIENTIST, V12, P463, DOI 10.1177/1073858406293538; Pinto L, 2009, NAT NEUROSCI, V12, P1229, DOI 10.1038/nn.2399; Ponti G, 2013, P NATL ACAD SCI USA, V110, pE1045, DOI 10.1073/pnas.1219563110; Schemmer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071113; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van Dongen S, 2012, METHODS MOL BIOL, V804, P281, DOI 10.1007/978-1-61779-361-5_15; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Walker TL, 2016, STEM CELL REP, V6, P552, DOI 10.1016/j.stemcr.2016.03.002; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	50	166	167	9	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2018	21	2					290	+		10.1038/s41593-017-0056-2	http://dx.doi.org/10.1038/s41593-017-0056-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV0TB	29335606	Green Submitted			2022-12-17	WOS:000424269900020
J	Sances, S; Bruijn, LI; Chandran, S; Eggan, K; Ho, R; Klim, JR; Livesey, MR; Lowry, E; Macklis, JD; Rushton, D; Sadegh, C; Sareen, D; Wichterle, H; Zhang, SC; Svendsen, CN				Sances, Samuel; Bruijn, Lucie I.; Chandran, Siddharthan; Eggan, Kevin; Ho, Ritchie; Klim, Joseph R.; Livesey, Matt R.; Lowry, Emily; Macklis, Jeffrey D.; Rushton, David; Sadegh, Cameron; Sareen, Dhruv; Wichterle, Hynek; Zhang, Su-Chun; Svendsen, Clive N.			Modeling ALS with motor neurons derived from human induced pluripotent stem cells	NATURE NEUROSCIENCE			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; DIRECTED DIFFERENTIATION; PROJECTION NEURONS; SPINAL-CORD; MOUSE MODEL; IN-VITRO; CORTICAL HYPEREXCITABILITY; HEXANUCLEOTIDE REPEAT; NEURAL DEVELOPMENT; INDUCTIVE SIGNALS	Directing the differentiation of induced pluripotent stem cells into motor neurons has allowed investigators to develop new models of amyotrophic lateral sclerosis (ALS). However, techniques vary between laboratories and the cells do not appear to mature into fully functional adult motor neurons. Here we discuss common developmental principles of both lower and upper motor neuron development that have led to specific derivation techniques. We then suggest how these motor neurons may be matured further either through direct expression or administration of specific factors or coculture approaches with other tissues. Ultimately, through a greater understanding of motor neuron biology, it will be possible to establish more reliable models of ALS. These in turn will have a greater chance of validating new drugs that may be effective for the disease.	[Sances, Samuel; Ho, Ritchie; Rushton, David; Sareen, Dhruv; Svendsen, Clive N.] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA; [Bruijn, Lucie I.] ALS Assoc Headquarters, Washington, DC USA; [Chandran, Siddharthan; Livesey, Matt R.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Eggan, Kevin; Macklis, Jeffrey D.; Sadegh, Cameron] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Klim, Joseph R.; Macklis, Jeffrey D.; Sadegh, Cameron] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Livesey, Matt R.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Lowry, Emily; Wichterle, Hynek] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Macklis, Jeffrey D.; Sadegh, Cameron] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Zhang, Su-Chun] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA	Cedars Sinai Medical Center; University of Edinburgh; Harvard University; Harvard University; University of Edinburgh; Columbia University; Harvard University; University of Wisconsin System; University of Wisconsin Madison	Svendsen, CN (corresponding author), Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA.	clive.svendsen@cshs.org	Eggan, Kevin/P-7119-2018	Livesey, Matthew/0000-0002-3441-7977; Lowry, Emily R./0000-0002-8412-3168; Klim, Joseph/0000-0001-8119-2144; SADEGH, CAMERON/0000-0003-2231-9015; Chandran, Siddharthan/0000-0001-6827-1593; Ho, Ritchie/0000-0003-1496-4436	ALS Association [15-IIP-194]; US National Institutes of Health [R01NS075672, R01NS045523, R01NS049553, R37NS041590]; Spastic Paraplegia Foundation; Project ALS; Track ALS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049553, R01NS075672, R01NS041590, R37NS041590, R01NS045523] Funding Source: NIH RePORTER	ALS Association; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spastic Paraplegia Foundation; Project ALS; Track ALS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank S. Svendsen for assistance in editing this manuscript. All authors were funded by various grants from the ALS Association. The corticospinal motor neuron, UMN and cortical projection neuron work of J.D.M. and C.S. was supported by US National Institutes of Health grants R01NS075672, R01NS045523, R01NS049553 and R37NS041590, and by grants from the ALS Association and Spastic Paraplegia Foundation. Work of H.W. and E.L. was also funded in part by Project ALS and Track ALS. Work of J.K. was funded in part by Project ALS. Contributions from S.C.Z. were funded by ALS Association grant 15-IIP-194.	Acampora D, 1999, CEREB CORTEX, V9, P533, DOI 10.1093/cercor/9.6.533; Adams KL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7778; Amin ND, 2015, SCIENCE, V350, P1525, DOI 10.1126/science.aad2509; Amoroso MW, 2013, J NEUROSCI, V33, P574, DOI 10.1523/JNEUROSCI.0906-12.2013; Andoniadou CL, 2013, CELL MOL LIFE SCI, V70, P3739, DOI 10.1007/s00018-013-1269-5; Aota S, 2003, DEV BIOL, V257, P1, DOI 10.1016/S0012-1606(03)00058-7; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Bae JS, 2013, J CLIN NEUROL, V9, P65, DOI 10.3988/jcn.2013.9.2.65; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Bryson JB, 2014, SCIENCE, V344, P94, DOI 10.1126/science.1248523; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Cambray N, 2002, DEVELOPMENT, V129, P4855; CAMU W, 1992, J NEUROSCI METH, V44, P59, DOI 10.1016/0165-0270(92)90114-S; Cederquist GY, 2013, J NEUROSCI, V33, P6321, DOI 10.1523/JNEUROSCI.5140-12.2013; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Chen B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-78; Chen H, 2014, CELL STEM CELL, V14, P796, DOI 10.1016/j.stem.2014.02.004; Chou SJ, 2013, MOL CELL NEUROSCI, V56, P1, DOI 10.1016/j.mcn.2013.02.006; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Crawford TQ, 2007, DEV DYNAM, V236, P886, DOI 10.1002/dvdy.21083; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Davis-Dusenbery BN, 2014, DEVELOPMENT, V141, P491, DOI 10.1242/dev.097410; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Delestree N, 2014, J PHYSIOL-LONDON, V592, P1687, DOI 10.1113/jphysiol.2013.265843; Devlin AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6999; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Diaz-Alonso J, 2012, J NEUROSCI, V32, P16651, DOI 10.1523/JNEUROSCI.0681-12.2012; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Du ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7626; Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Ensini M, 1998, DEVELOPMENT, V125, P969; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; Frey D, 2000, J NEUROSCI, V20, P2534; Gaspard N, 2009, NAT PROTOC, V4, P1454, DOI 10.1038/nprot.2009.157; Gaspard N, 2010, CURR OPIN NEUROBIOL, V20, P37, DOI 10.1016/j.conb.2009.12.001; Georgala PA, 2011, DEV NEUROBIOL, V71, P690, DOI 10.1002/dneu.20895; Gogliotti RG, 2012, J NEUROSCI, V32, P3818, DOI 10.1523/JNEUROSCI.5775-11.2012; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gouti M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001937; GREENWALD I, 1992, CELL, V68, P271, DOI 10.1016/0092-8674(92)90470-W; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Hansen DV, 2011, NEURON, V70, P645, DOI 10.1016/j.neuron.2011.05.006; Hashimoto-Torii K, 2008, NEURON, V60, P273, DOI 10.1016/j.neuron.2008.09.026; Hayworth CR, 2009, NEUROSCIENCE, V164, P975, DOI 10.1016/j.neuroscience.2009.08.031; Hjelm BE, 2013, HUM MOL GENET, V22, P3534, DOI 10.1093/hmg/ddt208; Hosoyama T, 2014, STEM CELL TRANSL MED, V3, P564, DOI 10.5966/sctm.2013-0143; Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Janesick A, 2014, DEVELOPMENT, V141, P2260, DOI 10.1242/dev.103705; Jessell TM, 2000, CURR OPIN NEUROBIOL, V10, P599, DOI 10.1016/S0959-4388(00)00136-7; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johansson PA, 2013, DEVELOPMENT, V140, P1055, DOI 10.1242/dev.090860; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Kicheva A, 2014, SCIENCE, V345, P1577, DOI 10.1126/science.1254927; Kirkby LA, 2013, NEURON, V80, P1129, DOI 10.1016/j.neuron.2013.10.030; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Krencik R, 2011, NAT PROTOC, V6, P1710, DOI 10.1038/nprot.2011.405; Kuo JJ, 2004, J NEUROPHYSIOL, V91, P571, DOI 10.1152/jn.00665.2003; Lamas NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110324; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Leroy F, 2014, ELIFE, V3, DOI 10.7554/eLife.04046; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lippmann ES, 2015, STEM CELL REP, V4, P632, DOI 10.1016/j.stemcr.2015.02.018; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; MacDonald JL, 2009, PROG NEUROBIOL, V88, P170, DOI 10.1016/j.pneurobio.2009.04.002; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; Maury Y, 2015, NAT BIOTECHNOL, V33, P89, DOI 10.1038/nbt.3049; McKenna WL, 2011, J NEUROSCI, V31, P549, DOI 10.1523/JNEUROSCI.4131-10.2011; Mertens J, 2015, CELL STEM CELL, V17, P705, DOI 10.1016/j.stem.2015.09.001; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Mizutani K, 2005, DEVELOPMENT, V132, P1295, DOI 10.1242/dev.01693; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Nasu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053024; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Ozdinler PH, 2011, J NEUROSCI, V31, P4166, DOI 10.1523/JNEUROSCI.4184-10.2011; Olivera-Martinez I, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001415; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Patani R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1216; Patterson M, 2012, CELL RES, V22, P178, DOI 10.1038/cr.2011.133; Philippidou P, 2013, NEURON, V80, P12, DOI 10.1016/j.neuron.2013.09.020; Pieri M, 2003, NEUROSCI LETT, V351, P153, DOI 10.1016/j.neulet.2003.07.010; Qu QH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4449; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Reinhardt P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059252; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Roy A, 2014, CEREB CORTEX, V24, P1361, DOI 10.1093/cercor/bhs421; Sadegh C, 2014, J COMP NEUROL, V522, P2691, DOI 10.1002/cne.23576; Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425; Sareen D, 2014, J COMP NEUROL, V522, P2707, DOI 10.1002/cne.23578; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Schafer MKH, 1995, J MOL NEUROSCI, V6, P225, DOI 10.1007/BF02736782; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Sohur US, 2014, CEREB CORTEX, V24, P293, DOI 10.1093/cercor/bhs342; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Stein JL, 2014, NEURON, V83, P69, DOI 10.1016/j.neuron.2014.05.035; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; Stifani N, 2014, FRONT CELL NEUROSCI, V8, P1, DOI 10.3389/fncel.2014.00293; Storey KG, 1998, DEVELOPMENT, V125, P473; Svendsen CN, 2013, HUM MOL GENET, V22, pR32, DOI 10.1093/hmg/ddt379; Swarup V, 2011, PROG NEURO-PSYCHOPH, V35, P363, DOI 10.1016/j.pnpbp.2010.08.006; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takazawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040154; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X; Thomsen GM, 2014, J NEUROSCI, V34, P15587, DOI 10.1523/JNEUROSCI.2037-14.2014; Tiberi L, 2012, CURR OPIN CELL BIOL, V24, P269, DOI 10.1016/j.ceb.2012.01.010; Tirard M, 2012, P NATL ACAD SCI USA, V109, P21122, DOI 10.1073/pnas.1215366110; Toma JS, 2015, J NEUROSCI, V35, P1291, DOI 10.1523/JNEUROSCI.2126-14.2015; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Turner DA, 2014, DEVELOPMENT, V141, P4243, DOI 10.1242/dev.112979; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; van Zundert B, 2008, J NEUROSCI, V28, P10864, DOI 10.1523/JNEUROSCI.1340-08.2008; Vucic S, 2008, BRAIN, V131, P1540, DOI 10.1093/brain/awn071; Vucic S, 2006, BRAIN, V129, P2436, DOI 10.1093/brain/awl172; Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wilson JM, 2005, J NEUROSCI, V25, P5710, DOI 10.1523/JNEUROSCI.0274-05.2005; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Ziemann U, 1997, NEUROLOGY, V49, P1292, DOI 10.1212/WNL.49.5.1292	147	166	170	2	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2016	19	4					542	553		10.1038/nn.4273	http://dx.doi.org/10.1038/nn.4273			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH6OI	27021939	Green Accepted			2022-12-17	WOS:000372909800008
J	Zweifel, LS; Fadok, JP; Argilli, E; Garelick, MG; Jones, GL; Dickerson, TMK; Allen, JM; Mizumori, SJY; Bonci, A; Palmiter, RD				Zweifel, Larry S.; Fadok, Jonathan P.; Argilli, Emmanuela; Garelick, Michael G.; Jones, Graham L.; Dickerson, Tavis M. K.; Allen, James M.; Mizumori, Sheri J. Y.; Bonci, Antonello; Palmiter, Richard D.			Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; ACOUSTIC STARTLE RESPONSE; PREPULSE INHIBITION; NMDA-RECEPTORS; DISCHARGE RATE; FEAR; POTENTIATION; STIMULI; MICE; AMPHETAMINE	Generalized anxiety is thought to result, in part, from impairments in contingency awareness during conditioning to cues that predict aversive or fearful outcomes. Dopamine neurons of the ventral midbrain exhibit heterogeneous responses to aversive stimuli that are thought to provide a critical modulatory signal to facilitate orientation to environmental changes and assignment of motivational value to unexpected events. Here we describe a mouse model in which activation of dopamine neurons in response to an aversive stimulus is attenuated by conditional genetic inactivation of functional NMDA receptors on dopamine neurons. We discovered that altering the magnitude of excitatory responses by dopamine neurons in response to an aversive stimulus was associated with impaired conditioning to a cue that predicts an aversive outcome. Impaired conditioning by these mice was associated with the development of a persistent, generalized anxiety-like phenotype. These data are consistent with a role for dopamine in facilitating contingency awareness that is critical for the prevention of generalized anxiety.	[Zweifel, Larry S.; Jones, Graham L.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Zweifel, Larry S.; Jones, Graham L.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Zweifel, Larry S.; Fadok, Jonathan P.; Dickerson, Tavis M. K.; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Zweifel, Larry S.; Fadok, Jonathan P.; Dickerson, Tavis M. K.; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Fadok, Jonathan P.; Garelick, Michael G.] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; [Argilli, Emmanuela; Bonci, Antonello] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA; [Argilli, Emmanuela; Bonci, Antonello] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Allen, James M.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Mizumori, Sheri J. Y.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zweifel, LS (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	larryz@uw.edu; palmiter@uw.edu	Zweifel, Larry/O-3284-2017; Fadok, Jonathan/AAX-2999-2020	Zweifel, Larry/0000-0003-3465-5331; Fadok, Jonathan/0000-0002-0608-5151	US National Institutes of Health [2T32 GM007270, 4 R25 GM 058501-05, 1 R01 MH58755]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R25GM058501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058755] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. D. Guler and members of the Palmiter laboratory for thoughtful discussion of this manuscript. We thank G. Froelich, V. Wall and M.J. Kim for technical support. This work was supported in part by US National Institutes of Health grants 2T32 GM007270 (to J.P.F.), 4 R25 GM 058501-05 (to T. M. K. D.) and 1 R01 MH58755 (to S.J.Y.M.).	Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; CHIODO LA, 1979, BRAIN RES, V176, P385, DOI 10.1016/0006-8993(79)90994-6; CHIODO LA, 1980, BRAIN RES, V189, P544, DOI 10.1016/0006-8993(80)90366-2; DAVIS M, 1993, BEHAV BRAIN RES, V58, P175, DOI 10.1016/0166-4328(93)90102-V; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; Flood DG, 2010, PSYCHOPHARMACOLOGY, V211, P325, DOI 10.1007/s00213-010-1901-0; Grillon C, 2002, BIOL PSYCHIAT, V51, P851, DOI 10.1016/S0006-3223(01)01370-1; Grillon C, 2002, BIOL PSYCHIAT, V52, P958, DOI 10.1016/S0006-3223(02)01665-7; Grillon C, 2006, PSYCHOPHARMACOLOGY, V186, P434, DOI 10.1007/s00213-005-0124-2; Hunter AJ, 2000, HUM MOL GENET, V9, P893, DOI 10.1093/hmg/9.6.893; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Jovanovic T, 2010, PSYCHONEUROENDOCRINO, V35, P846, DOI 10.1016/j.psyneuen.2009.11.009; Koch M, 1997, BEHAV BRAIN RES, V89, P35, DOI 10.1016/S0166-4328(97)02296-1; Komendantov AO, 2004, J NEUROPHYSIOL, V91, P346, DOI 10.1152/jn.00062.2003; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lovibond PF, 2002, J EXP PSYCHOL-ANIM B, V28, P3, DOI 10.1037//0097-7403.28.1.3; Luo AH, 2008, EUR J NEUROSCI, V27, P408, DOI 10.1111/j.1460-9568.2007.05985.x; MANTZ J, 1989, BRAIN RES, V476, P377, DOI 10.1016/0006-8993(89)91263-8; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; OVERTON P, 1992, SYNAPSE, V10, P131, DOI 10.1002/syn.890100208; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Ralph RJ, 1999, J NEUROSCI, V19, P4627; Richardson R, 2000, BEHAV BRAIN RES, V110, P109, DOI 10.1016/S0166-4328(99)00189-8; Robinson S, 2004, P NATL ACAD SCI USA, V101, P13329, DOI 10.1073/pnas.0405084101; Sanchez MM, 2005, BIOL PSYCHIAT, V57, P373, DOI 10.1016/j.biopsych.2004.11.032; SCHULTZ W, 1987, J NEUROPHYSIOL, V57, P201, DOI 10.1152/jn.1987.57.1.201; Swerdlow NR, 2000, J NEUROSCI, V20, P4325; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zweifel LS, 2008, NEURON, V59, P486, DOI 10.1016/j.neuron.2008.05.028; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	37	166	168	3	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					620	U112		10.1038/nn.2808	http://dx.doi.org/10.1038/nn.2808			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21499253	Green Accepted			2022-12-17	WOS:000289886600018
J	Bandyopadhyay, S; Shamma, SA; Kanold, PO				Bandyopadhyay, Sharba; Shamma, Shihab A.; Kanold, Patrick O.			Dichotomy of functional organization in the mouse auditory cortex	NATURE NEUROSCIENCE			English	Article							TONOTOPIC ORGANIZATION; VISUAL-CORTEX; MODULAR ORGANIZATION; RESPONSE PROPERTIES; CORTICAL-NEURONS; MACAQUE MONKEY; IN-VIVO; CAT; REPRESENTATION; FREQUENCY	The sensory areas of the cerebral cortex possess multiple topographic representations of sensory dimensions. The gradient of frequency selectivity (tonotopy) is the dominant organizational feature in the primary auditory cortex, whereas other feature-based organizations are less well established. We probed the topographic organization of the mouse auditory cortex at the single-cell level using in vivo two-photon Ca2+ imaging. Tonotopy was present on a large scale but was fractured on a fine scale. Intensity tuning, which is important in level-invariant representation, was observed in individual cells, but was not topographically organized. The presence or near absence of putative subthreshold responses revealed a dichotomy in topographic organization. Inclusion of subthreshold responses revealed a topographic clustering of neurons with similar response properties, whereas such clustering was absent in supra-threshold responses. This dichotomy indicates that groups of nearby neurons with locally shared inputs can perform independent parallel computations in the auditory cortex.	[Bandyopadhyay, Sharba; Kanold, Patrick O.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Bandyopadhyay, Sharba; Shamma, Shihab A.; Kanold, Patrick O.] Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; [Shamma, Shihab A.] Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Kanold, PO (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	pkanold@umd.edu	Shamma, Shihab A/F-9852-2012	Kanold, Patrick/0000-0002-7529-5435	National Institute on Deafness and Other Communications Disorders [R21DC009454, R01DC009607, RO1DC005779]; Air Force Office of Scientific Research Defense University Research Instrumentation Program; ISR Seed; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009607, R01DC005779, R21DC009454] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communications Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Air Force Office of Scientific Research Defense University Research Instrumentation Program; ISR Seed; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank D. Winkowski for many helpful comments and help with imaging and J. Zemskova and A. Sheikh for histological help. This work was supported by the National Institute on Deafness and Other Communications Disorders (R21DC009454 and R01DC009607 to P.O.K., and RO1DC005779 to S. A. S.), Air Force Office of Scientific Research Defense University Research Instrumentation Program (S. A. S. and P.O.K.) and an ISR Seed Grant (S. A. S. and P.O.K.).	Bandyopadhyay S, 2004, J NEUROSCI, V24, P531, DOI 10.1523/JNEUROSCI.4234-03.2004; Barbour DL, 2003, SCIENCE, V299, P1073, DOI 10.1126/science.1080425; Bizley JK, 2005, CEREB CORTEX, V15, P1637, DOI 10.1093/cercor/bhi042; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Ehret G, 1997, J COMP PHYSIOL A, V181, P547, DOI 10.1007/s003590050139; EVANS EF, 1965, J PHYSIOL-LONDON, V179, P238, DOI 10.1113/jphysiol.1965.sp007659; Galindo-Leon EE, 2009, NEURON, V62, P705, DOI 10.1016/j.neuron.2009.05.001; GOLDSTEIN MH, 1975, BRAIN RES, V100, P188, DOI 10.1016/0006-8993(75)90258-9; GOLDSTEIN MH, 1970, J NEUROPHYSIOL, V33, P188, DOI 10.1152/jn.1970.33.1.188; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Kalatsky VA, 2005, P NATL ACAD SCI USA, V102, P13325, DOI 10.1073/pnas.0505592102; KEIFER J, 1992, J NEUROSCI, V12, P3187, DOI 10.1523/JNEUROSCI.12-08-03187.1992; Koulakov AA, 2009, J NEUROSCI, V29, P3685, DOI 10.1523/JNEUROSCI.4500-08.2009; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3503, DOI 10.1152/jn.1996.76.5.3503; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; MERZENICH MM, 1973, BRAIN RES, V63, P343, DOI 10.1016/0006-8993(73)90101-7; Moreaux L, 2008, FRONT NEUROSCI-SWITZ, V2, P176, DOI 10.3389/neuro.01.032.2008; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nelken I, 2004, J NEUROPHYSIOL, V92, P2574, DOI 10.1152/jn.00276.2004; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Recanzone GH, 1999, J COMP NEUROL, V415, P460, DOI 10.1002/(SICI)1096-9861(19991227)415:4<460::AID-CNE4>3.0.CO;2-F; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; Sadagopan S, 2008, J NEUROSCI, V28, P3415, DOI 10.1523/JNEUROSCI.2743-07.2008; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Shoham S, 2006, J COMP PHYSIOL A, V192, P777, DOI 10.1007/s00359-006-0117-6; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stiebler I, 1997, J COMP PHYSIOL A, V181, P559, DOI 10.1007/s003590050140; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Stronks HC, 2010, HEARING RES, V260, P20, DOI 10.1016/j.heares.2009.10.015; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; Tsytsarev Vassiliy, 2009, Front Neuroeng, V2, P2, DOI 10.3389/neuro.16.002.2009; Wallace MN, 2008, EXP BRAIN RES, V184, P179, DOI 10.1007/s00221-007-1092-z; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Wang XQ, 2001, J NEUROPHYSIOL, V86, P2616, DOI 10.1152/jn.2001.86.5.2616; YASUDA R, 2004, SCI STKE, P15; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; YOUNG ED, 1979, J ACOUST SOC AM, V66, P1381, DOI 10.1121/1.383532; Zhao CP, 2009, J NEUROSCI, V29, P15479, DOI 10.1523/JNEUROSCI.4471-09.2009	50	166	168	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					361	U23		10.1038/nn.2490	http://dx.doi.org/10.1038/nn.2490			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20118924	Green Accepted			2022-12-17	WOS:000274860100019
J	Tsao, DY; Schweers, N; Moeller, S; Freiwald, WA				Tsao, Doris Y.; Schweers, Nicole; Moeller, Sebastian; Freiwald, Winrich A.			Patches of face-selective cortex in the macaque frontal lobe	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; FUNCTIONAL MRI; PERCEPTION; MONKEY; RESPONSES; AREA	In primates, specialized occipital-temporal face areas support the visual analysis of faces, but it is unclear whether similarly specialized areas exist in the frontal lobe. Using functional magnetic resonance imaging in alert macaques, we identified three discrete regions of highly face-selective cortex in ventral prefrontal cortex, one of which was strongly lateralized to the right hemisphere. These prefrontal face patches may constitute dedicated modules for retrieving and responding to facial information.	[Tsao, Doris Y.] Univ Bremen, Inst Brain Res, D-28334 Bremen, Germany; Univ Bremen, Ctr Adv Imaging, D-28334 Bremen, Germany	University of Bremen; University of Bremen	Tsao, DY (corresponding author), Univ Bremen, Inst Brain Res, POB 330440, D-28334 Bremen, Germany.	doris@nmr.mgh.harvard.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Denys K, 2004, J COGNITIVE NEUROSCI, V16, P1505, DOI 10.1162/0898929042568505; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hoffman KL, 2007, CURR BIOL, V17, P766, DOI 10.1016/j.cub.2007.03.040; Ishai A, 2005, BRAIN RES BULL, V67, P87, DOI 10.1016/j.brainresbull.2005.05.027; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Nakahara K, 2002, SCIENCE, V295, P1532, DOI 10.1126/science.1067653; O Scalaidhe SP, 1999, CEREB CORTEX, V9, P459, DOI 10.1093/cercor/9.5.459; Petrides M, 2005, NATURE, V435, P1235, DOI 10.1038/nature03628; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; Rolls ET, 2006, EXP BRAIN RES, V170, P74, DOI 10.1007/s00221-005-0191-y; ROLLS ET, 1999, BRAIN EMOTION; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111	15	166	166	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					877	879		10.1038/nn.2158	http://dx.doi.org/10.1038/nn.2158			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18622399	Green Accepted			2022-12-17	WOS:000257969100010
J	Kucenas, S; Takada, N; Park, HC; Woodruff, E; Broadie, K; Appel, B				Kucenas, Sarah; Takada, Norio; Park, Hae-Chul; Woodruff, Elvin; Broadie, Kendal; Appel, Bruce			CNS-derived glia ensheath peripheral nerves and mediate motor root development	NATURE NEUROSCIENCE			English	Article							TRANSCRIPTION FACTOR SOX10; NEURAL CREST CELLS; TUBE VENT CELLS; NERVOUS-SYSTEM; FINE-STRUCTURE; DROSOPHILA-MELANOGASTER; SONIC-HEDGEHOG; SCHWANN-CELLS; FLOOR PLATE; ZEBRAFISH	Motor function requires that motor axons extend from the spinal cord at regular intervals and that they are myelinated by Schwann cells. Little attention has been given to another cellular structure, the perineurium, which ensheaths the motor nerve, forming a flexible, protective barrier. Consequently, the origin of perineurial cells and their roles in motor nerve formation are poorly understood. Using time-lapse imaging in zebrafish, we show that perineurial cells are born in the CNS, arising as ventral spinal-cord glia before migrating into the periphery. In embryos lacking perineurial glia, motor neurons inappropriately migrated outside of the spinal cord and had aberrant axonal projections, indicating that perineurial glia carry out barrier and guidance functions at motor axon exit points. Additionally, reciprocal signaling between perineurial glia and Schwann cells was necessary for motor nerve ensheathment by both cell types. These insights reveal a new class of CNS-born glia that critically contributes to motor nerve development.	[Kucenas, Sarah; Takada, Norio; Woodruff, Elvin; Broadie, Kendal; Appel, Bruce] Vanderbilt Univ, Dept Biol Sci, Vanderbilt Kennedy Ctr Res Human Dev, Vanderbilt Program Dev Biol, Nashville, TN 37235 USA; [Kucenas, Sarah; Takada, Norio; Woodruff, Elvin; Broadie, Kendal; Appel, Bruce] Vanderbilt Univ, Vanderbilt Ctr Mol Neurosci, Nashville, TN 37235 USA; [Park, Hae-Chul] Korea Univ, Sch Med, Ansan 425707, Gyeonggido, South Korea	Vanderbilt University; Vanderbilt University; Korea University; Korea University Medicine (KU Medicine)	Appel, B (corresponding author), Vanderbilt Univ, Dept Biol Sci, Vanderbilt Kennedy Ctr Res Human Dev, Vanderbilt Program Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.	b.appel@vanderbilt.edu	Appel, Bruce/X-6418-2019	Appel, Bruce/0000-0003-4500-0672; Kucenas, Sarah/0000-0002-1950-751X	NCRR NIH HHS [P40 RR012546] Funding Source: Medline; NIGMS NIH HHS [R01 GM054544] Funding Source: Medline; NIMH NIH HHS [T32 MH065215, MH65215-03] Funding Source: Medline; NINDS NIH HHS [R01 NS046668-04, R01 NS046668] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046668] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKERT K, 1976, CELL TISSUE RES, V165, P281; ALLT G, 1969, J ANAT, V105, P283; Berger P, 2006, GLIA, V54, P243, DOI 10.1002/glia.20386; Boot MJ, 2003, ANAT EMBRYOL, V206, P327, DOI 10.1007/s00429-002-0302-5; Bourne GH, 1968, STRUCTURE FUNCTION N; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; BUNGE MB, 1989, SCIENCE, V243, P229, DOI 10.1126/science.2492115; BURKEL WE, 1967, ANAT RECORD, V158, P177, DOI 10.1002/ar.1091580207; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dickinson DP, 2004, J ANAT, V205, P79, DOI 10.1111/j.0021-8782.2004.00319.x; DuPlessis DG, 1996, J ANAT, V189, P631; Dutton KA, 2001, DEVELOPMENT, V128, P4113; ERLANDSON RA, 1991, ULTRASTRUCT PATHOL, V15, P335, DOI 10.3109/01913129109016243; Freeman MR, 2006, TRENDS NEUROSCI, V29, P82, DOI 10.1016/j.tins.2005.12.002; GAMBLE HJ, 1964, J ANAT, V98, P655; GUYTON AC, 1972, STRUCTURE FUNCTION N; HALLER FR, 1971, AM J ANAT, V131, P1, DOI 10.1002/aja.1001310102; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Jones DS, 1937, ANAT REC, V70, P45, DOI 10.1002/ar.1090700106; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; KLAMBT C, 1991, GLIA, V4, P205, DOI 10.1002/glia.440040212; KRISTENSSON K, 1971, ACTA NEUROPATHOL, V17, P127, DOI 10.1007/BF00687488; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Macarenco RS, 2007, ARCH PATHOL LAB MED, V131, P625; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; NORDLANDER RH, 1981, J COMP NEUROL, V199, P535, DOI 10.1002/cne.901990407; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; OLSSON Y, 1990, CRIT REV NEUROBIOL, V5, P265; Ono F, 2004, J NEUROSCI, V24, P5475, DOI 10.1523/JNEUROSCI.0851-04.2004; Paratore C, 2001, DEVELOPMENT, V128, P3949; Parker RJ, 2006, SEMIN CELL DEV BIOL, V17, P66, DOI 10.1016/j.semcdb.2005.11.012; Parmantier E, 1999, NEURON, V23, P713, DOI 10.1016/S0896-6273(01)80030-1; Raven CP, 1937, J COMP NEUROL, V67, P221, DOI 10.1002/cne.900670205; Schafer M, 2007, DEV BIOL, V301, P117, DOI 10.1016/j.ydbio.2006.09.018; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Sepp KJ, 2000, GLIA, V30, P122, DOI 10.1002/(SICI)1098-1136(200004)30:2<122::AID-GLIA2>3.0.CO;2-B; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Ungos JM, 2003, DEVELOPMENT, V130, P5351, DOI 10.1242/dev.00722; Vermeren M, 2003, NEURON, V37, P403, DOI 10.1016/S0896-6273(02)01188-1; WESTON JA, 1963, DEV BIOL, V6, P279, DOI 10.1016/0012-1606(63)90016-2; Yaneza M, 2002, DEV DYNAM, V223, P163, DOI 10.1002/dvdy.1241; Zuchner S, 2006, NAT CLIN PRACT NEURO, V2, P45, DOI 10.1038/ncpneuro0071; ZUHORSTE GM, 2006, CURR OPIN NEUROL, V19, P464	50	166	169	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					143	151		10.1038/nn2025	http://dx.doi.org/10.1038/nn2025			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18176560	Green Accepted			2022-12-17	WOS:000252712100008
J	He, HY; Ray, B; Dennis, K; Quinlan, EM				He, Hai-Yan; Ray, Baisali; Dennis, Katie; Quinlan, Elizabeth M.			Experience-dependent recovery of vision following chronic deprivation amblyopia	NATURE NEUROSCIENCE			English	Review							OCULAR DOMINANCE PLASTICITY; ADULT VISUAL-CORTEX; MONOCULAR DEPRIVATION; SELECTIVITY; RATS	The shift in ocular dominance induced by brief monocular deprivation is greatest during a postnatal critical period and is thought to decline irreversibly thereafter. However, here we demonstrate that complete visual deprivation through dark exposure restores rapid ocular dominance plasticity in adult rats. In addition, the loss of visual acuity resulting from chronic monocular deprivation is reversed if dark exposure precedes removal of the occlusion in adulthood, suggesting a potential use for dark exposure in the treatment of adult amblyopia.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Quinlan, EM (corresponding author), Univ Maryland, Dept Biol, 1210 Biol Psychol Bldg 144, College Pk, MD 20742 USA.	equinlan@umd.edu		He, Haiyan/0000-0002-6692-6012	NATIONAL EYE INSTITUTE [R03EY013818] Funding Source: NIH RePORTER; NEI NIH HHS [EY13818] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Iny K, 2006, J NEUROSCI, V26, P7368, DOI 10.1523/JNEUROSCI.0124-06.2006; Liao DS, 2004, J NEUROPHYSIOL, V92, P2113, DOI 10.1152/jn.00266.2004; MERABET LB, 1909, J NEUROPHYSIOL, V97, P1633; Mitchell Donald E, 2002, Clin Exp Optom, V85, P5; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Polat U, 2004, P NATL ACAD SCI USA, V101, P6692, DOI 10.1073/pnas.0401200101; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Yashiro K, 2005, J NEUROSCI, V25, P11684, DOI 10.1523/JNEUROSCI.4362-05.2005	16	166	172	3	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1134	1136		10.1038/nn1965	http://dx.doi.org/10.1038/nn1965			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17694050				2022-12-17	WOS:000249144000014
J	Thierry, G; Martin, CD; Downing, P; Pegna, AJ				Thierry, Guillaume; Martin, Clara D.; Downing, Paul; Pegna, Alan J.			Controlling for interstimulus perceptual variance abolishes N170 face selectivity	NATURE NEUROSCIENCE			English	Article							HUMAN EXTRASTRIATE CORTEX; EVENT-RELATED POTENTIALS; OBJECT; RECOGNITION; EXPERTISE; DYNAMICS; SPECIFICITY; ATTENTION; COMPONENT; STIMULI	Establishing when and how the human brain differentiates between object categories is key to understanding visual cognition. Event-related potential (ERP) investigations have led to the consensus that faces selectively elicit a negative wave peaking 170 ms after presentation, the 'N170'. In such experiments, however, faces are nearly always presented from a full front view, whereas other stimuli are more perceptually variable, leading to uncontrolled interstimulus perceptual variance (ISPV). Here, we compared ERPs elicited by faces, cars and butterflies while-for the first time-controlling ISPV (low or high). Surprisingly, the N170 was sensitive, not to object category, but to ISPV. In addition, we found category effects independent of ISPV 70 ms earlier than has been generally reported. These results demonstrate early ERP category effects in the visual domain, call into question the face selectivity of the N170 and establish ISPV as a critical factor to control in experiments relying on multitrial averaging.	Univ Wales, Sch Psychol, Bangor LL57 2AS, Gwynedd, Wales; Univ Lyon, CNRS, Inst Sci Cognit, Lab Langage Cerveau & Cognit, F-69675 Bron, France; Univ Hosp Geneva, Neurol Clin, Neuropsychol Unit, Lab Expt Neuropsychol, CH-1211 Geneva, Switzerland	Bangor University; Centre National de la Recherche Scientifique (CNRS); University of Geneva	Thierry, G (corresponding author), Univ Wales, Sch Psychol, Brigantia Bldg,Penrallt Rd, Bangor LL57 2AS, Gwynedd, Wales.	g.thierry@bangor.ac.uk	Thierry, Guillaume/C-2688-2008; Martin, Clara/B-4563-2012; Pegna, A J/D-1297-2017	Thierry, Guillaume/0000-0003-1325-2656; Martin, Clara/0000-0003-2701-5045; Pegna, A J/0000-0001-9920-9290; Downing, Paul/0000-0002-5046-2858				ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; BENNETT TL, 1992, NEUROPSYCHOLOGY EPIL, P73; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Boehm SG, 2006, NEUROIMAGE, V30, P1021, DOI 10.1016/j.neuroimage.2005.10.028; Carmel D, 2002, COGNITION, V83, P1, DOI 10.1016/S0010-0277(01)00162-7; Cauquil AS, 2000, NEUROREPORT, V11, P2167, DOI 10.1097/00001756-200007140-00021; Cornelissen P, 2003, J COGNITIVE NEUROSCI, V15, P731, DOI 10.1162/jocn.2003.15.5.731; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Eimer M, 1999, NEUROREPORT, V10, P255, DOI 10.1097/00001756-199902050-00010; Gauthier I, 2003, NAT NEUROSCI, V6, P428, DOI 10.1038/nn1029; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Herrmann MJ, 2005, BRAIN TOPOGR, V18, P77, DOI 10.1007/s10548-005-0277-7; Herrmann MJ, 2005, J NEURAL TRANSM, V112, P1073, DOI 10.1007/s00702-004-0250-8; HILLYARD SA, 1989, HDB PHYSL 1, P519; Itier RJ, 2006, NEUROIMAGE, V29, P667, DOI 10.1016/j.neuroimage.2005.07.041; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jeffreys DA, 1996, VIS COGN, V3, P1, DOI 10.1080/713756729; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Lehmann D., 1987, HDB ELECTROENCEPHALO, P309; Linkenkaer-Hansen K, 1998, NEUROSCI LETT, V253, P147, DOI 10.1016/S0304-3940(98)00586-2; Liu J, 2000, NEUROREPORT, V11, P337, DOI 10.1097/00001756-200002070-00023; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Lueschow A, 2004, PSYCHOPHYSIOLOGY, V41, P350, DOI 10.1111/j.1469-8986.2004.00159.x; Michel CM, 2001, BRAIN RES REV, V36, P108, DOI 10.1016/S0165-0173(01)00086-8; Michel CM, 1999, NEWS PHYSIOL SCI, V14, P206; PASCUALMARQUI RD, 1995, IEEE T BIO-MED ENG, V42, P658, DOI 10.1109/10.391164; Pegna AJ, 1997, HUM BRAIN MAPP, V5, P410, DOI 10.1002/(SICI)1097-0193(1997)5:6<410::AID-HBM2>3.0.CO;2-6; Pegna AJ, 2004, HUM BRAIN MAPP, V22, P300, DOI 10.1002/hbm.20039; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rossion B, 2002, COGNITION, V85, P189, DOI 10.1016/S0010-0277(02)00101-4; Rossion B, 2002, PSYCHOL SCI, V13, P250, DOI 10.1111/1467-9280.00446; Schendan HE, 1998, PSYCHOPHYSIOLOGY, V35, P240, DOI 10.1017/S004857729897010X; Schweinberger SR, 2002, COGNITIVE BRAIN RES, V14, P398, DOI 10.1016/S0926-6410(02)00142-8; Schweinberger SR, 2003, CORTEX, V39, P9, DOI 10.1016/S0010-9452(08)70071-6; Seeck M, 2001, EPILEPSY BEHAV, V2, P545, DOI 10.1006/ebeh.2001.0266; Seeck M, 1997, NEUROREPORT, V8, P2749, DOI 10.1097/00001756-199708180-00021; Tarkiainen A, 2002, BRAIN, V125, P1125, DOI 10.1093/brain/awf112; *U LJUBJ FAC COMP, CVL FAC DAT; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Xu YD, 2005, NEUROPSYCHOLOGIA, V43, P588, DOI 10.1016/j.neuropsychologia.2004.07.016	43	166	168	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					505	511		10.1038/nn1864	http://dx.doi.org/10.1038/nn1864			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	150PL	17334361				2022-12-17	WOS:000245228600022
J	Anggono, V; Smillie, KJ; Graham, ME; Valova, VA; Cousin, MA; Robinson, PJ				Anggono, Victor; Smillie, Karen J.; Graham, Mark E.; Valova, Valentina A.; Cousin, Michael A.; Robinson, Phillip J.			Syndapin I is the phosphorylation-regulated dynamin I partner in synaptic vesicle endocytosis	NATURE NEUROSCIENCE			English	Article							ACTIN-BINDING PROTEIN; PROLINE-RICH DOMAIN; NERVE-TERMINALS; MEDIATED ENDOCYTOSIS; GTPASE DYNAMIN; SH3 DOMAIN; CYTOSKELETON; AMPHIPHYSIN-1; ENDOPHILIN; CELLS	Dynamin I is dephosphorylated at Ser-774 and Ser-778 during synaptic vesicle endocytosis (SVE) in nerve terminals. Phosphorylation was proposed to regulate the assembly of an endocytic protein complex with amphiphysin or endophilin. Instead, we found it recruits syndapin I for SVE and does not control amphiphysin or endophilin binding in rat synaptosomes. After depolarization, syndapin showed a calcineurin-mediated interaction with dynamin. A peptide mimicking the phosphorylation sites disrupted the dynamin-syndapin complex, not the dynamin-endophilin complex, arrested SVE and produced glutamate release fatigue after repetitive stimulation. Pseudophosphorylation of Ser-774 or Ser-778 inhibited syndapin binding without affecting amphiphysin recruitment. Site mutagenesis to alanine arrested SVE in cultured neurons. The effects of the sites were additive for syndapin I binding and SVE. Thus syndapin I is a central component of the endocytic protein complex for SVE via stimulus-dependent recruitment to dynamin I and has a key role in synaptic transmission.	Childrens Med Res Inst, Cell Signalling Unit, Wentworthville, NSW 2145, Australia; Univ Edinburgh, Membrane Biol Grp, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland	Children's Medical Research Institute - Australia; University of Edinburgh	Robinson, PJ (corresponding author), Childrens Med Res Inst, Cell Signalling Unit, Locked Bag 23, Wentworthville, NSW 2145, Australia.	phrobins@mail.usyd.edu.au	Robinson, Phillip J/G-4008-2011; Anggono, Victor/J-2750-2013; Graham, Mark E/A-6480-2014	Robinson, Phillip J/0000-0002-7878-0313; Anggono, Victor/0000-0002-4062-4884; Graham, Mark E/0000-0002-7290-1217; Smillie, Karen/0000-0003-4369-0470; Cousin, Michael/0000-0002-1762-160X	Wellcome Trust [GR070569, 070569] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Cousin MA, 2000, J NEUROCHEM, V75, P1645, DOI 10.1046/j.1471-4159.2000.0751645.x; Cousin MA, 2003, J BIOL CHEM, V278, P29065, DOI 10.1074/jbc.M302386200; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Floyd SR, 2001, J BIOL CHEM, V276, P8104, DOI 10.1074/jbc.M008932200; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; Larsen MR, 2004, MOL CELL PROTEOMICS, V3, P456, DOI 10.1074/mcp.M300105-MCP200; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Solomaha E, 2005, J BIOL CHEM, V280, P23147, DOI 10.1074/jbc.M501745200; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tibbs GR, 1996, J NEUROCHEM, V67, P389; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Xue J, 2004, BIOCHEM J, V381, P753, DOI 10.1042/BJ20040455	40	166	175	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					752	760		10.1038/nn1695	http://dx.doi.org/10.1038/nn1695			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16648848	Green Accepted			2022-12-17	WOS:000237895200015
J	Tropea, D; Kreiman, G; Lyckman, A; Mukherjee, S; Yu, HB; Horng, S; Sur, M				Tropea, D; Kreiman, G; Lyckman, A; Mukherjee, S; Yu, HB; Horng, S; Sur, M			Gene expression changes and molecular pathways mediating activity-dependent plasticity in visual cortex	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR-I; OCULAR DOMINANCE PLASTICITY; BINDING PROTEIN-5 IGFBP-5; CORTICAL PLASTICITY; CRITICAL PERIOD; MONOCULAR DEPRIVATION; STRIATE CORTEX; NEUROTROPHIC FACTOR; BRAIN-DEVELOPMENT; CEREBRAL-CORTEX	Two key models for examining activity-dependent development of primary visual cortex (V1) involve either reduction of activity in both eyes via dark-rearing (DR) or imbalance of activity between the two eyes via monocular deprivation (MD). Combining DNA microarray analysis with computational approaches, RT-PCR, immunohistochemistry and physiological imaging, we find that DR leads to (i) upregulation of genes subserving synaptic transmission and electrical activity, consistent with a coordinated response of cortical neurons to reduction of visual drive, and (ii) downregulation of parvalbumin expression, implicating parvalbumin-expressing interneurons as underlying the delay in cortical maturation after DR. MD partially activates homeostatic mechanisms but differentially upregulates molecular pathways related to growth factors and neuronal degeneration, consistent with reorganization of connections after MD. Expression of a binding protein of insulin-like growth factor-1 (IGF1) is highly upregulated after MD, and exogenous application of IGF1 prevents the physiological effects of MD on ocular dominance plasticity examined in vivo.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; Duke Univ, Inst Genome Sci & Policy, CIEMAS, Durham, NC 27708 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Duke University	Sur, M (corresponding author), MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msur@mit.edu	Tropea, Daniela/AAX-8147-2020	Kreiman, Gabriel/0000-0003-3505-8475; Tropea, Daniela/0000-0001-9730-6636; Mukherjee, Sayan/0000-0002-6715-3920				Abdelhaleem M, 2004, BBA-REV CANCER, V1704, P37, DOI 10.1016/j.bbcan.2004.05.001; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BEAR MF, 1990, J NEUROSCI, V10, P909; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; Bondy CA, 2002, INT REV NEUROBIOL, V51, P189, DOI 10.1016/S0074-7742(02)51006-0; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Gordon JA, 1996, J NEUROSCI, V16, P3274; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Iwadate H, 2003, LIFE SCI, V73, P3149, DOI 10.1016/j.lfs.2003.06.010; Justicia C, 2000, GLIA, V30, P253, DOI 10.1002/(SICI)1098-1136(200005)30:3<253::AID-GLIA5>3.0.CO;2-O; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Lodovichi C, 2000, J NEUROSCI, V20, P2155; MAFFEI L, 1992, J NEUROSCI, V12, P4651; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mataga N, 2002, P NATL ACAD SCI USA, V99, P7717, DOI 10.1073/pnas.102088899; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Morales B, 2002, J NEUROSCI, V22, P8084; Murray KD, 2003, NEUROSCIENCE, V122, P407, DOI 10.1016/j.neuroscience.2003.07.015; NEVE RL, 1989, P NATL ACAD SCI USA, V86, P4781, DOI 10.1073/pnas.86.12.4781; Obata S, 1999, CEREB CORTEX, V9, P238, DOI 10.1093/cercor/9.3.238; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Ossipow V, 2004, MOL CELL NEUROSCI, V27, P70, DOI 10.1016/j.mcn.2004.05.003; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Prasad SS, 2002, NEUROSCIENCE, V111, P35, DOI 10.1016/S0306-4522(01)00570-X; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Tonner E, 2000, ADV EXP MED BIOL, V480, P45; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Tropea D, 2003, J NEUROSCI, V23, P7034, DOI 10.1523/JNEUROSCI.23-18-07034.2003; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Wallace W, 2004, J NEUROSCI, V24, P6928, DOI 10.1523/JNEUROSCI.1110-04.2004; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Xu WF, 2005, J INTERF CYTOK RES, V25, P113, DOI 10.1089/jir.2005.25.113; Xue J, 2001, MOL BRAIN RES, V93, P95, DOI 10.1016/S0169-328X(01)00168-1; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x	50	166	168	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					660	668		10.1038/nn1689	http://dx.doi.org/10.1038/nn1689			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16633343				2022-12-17	WOS:000237417200017
J	Chen, X; Garelick, MG; Wang, HB; Li, V; Athos, J; Storm, DR				Chen, X; Garelick, MG; Wang, HB; Li, V; Athos, J; Storm, DR			PI3 kinase signaling is required for retrieval and extinction of contextual memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; MEDIATED GENE-EXPRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN-SYNTHESIS; BEHAVIORAL SENSITIZATION; MOLECULAR MECHANISMS; INHIBITORY AVOIDANCE; GLUTAMATE RECEPTORS; DORSAL HIPPOCAMPUS; RAT HIPPOCAMPUS	Memory retrieval is a dynamic aspect of memory formation that can be studied separately from other stages of memory processing. Although several signal transduction pathways including ERK/MAP kinase have been implicated in memory retrieval, the underlying signaling events are poorly defined. Here we report that re-exposure of mice to context after contextual training stimulates the activity of phosphatidylinositol 3 kinase (PI3K) in the hippocampus. Inhibition of PI3K activity in the hippocampus in vivo blocked contextual memory retrieval and extinction. Inhibitors of PI3K signaling also blocked increases in ERK/MAP kinase activity associated with memory retrieval. This suggests that PI3K activation in the hippocampus is critical for memory retrieval and is required for activation of ERK/MAP kinase during retrieval.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	dstorm@u.washington.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498, R01NS037056] Funding Source: NIH RePORTER; NINDS NIH HHS [NS20498, NS37056] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Athos J., 2001, CURRENT PROTOCOLS NE; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Barros DM, 2004, NEUROSCIENCE, V126, P651, DOI 10.1016/j.neuroscience.2004.03.010; Berman DE, 2000, J NEUROSCI, V20, P7017, DOI 10.1523/JNEUROSCI.20-18-07017.2000; Bevilaqua LRM, 2003, EUR J NEUROSCI, V17, P897, DOI 10.1046/j.1460-9568.2003.02524.x; BLANCHAR.RJ, 1969, J COMP PHYSIOL PSYCH, V68, P129, DOI 10.1037/h0027676; Blum S, 1999, J NEUROSCI, V19, P3535; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; Chan D, 1998, NETW COMPUT, V9, P18; Chang SH, 2004, J NEUROSCI, V24, P2277, DOI 10.1523/JNEUROSCI.4868-03.2004; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Holt W, 1999, J NEUROSCI, V19, P9054, DOI 10.1523/JNEUROSCI.19-20-09054.1999; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Izquierdo LA, 2001, EUR J NEUROSCI, V13, P1464, DOI 10.1046/j.0953-816x.2001.01530.x; Izzo E, 2002, NAT NEUROSCI, V5, P1263, DOI 10.1038/nn977; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Mizuno M, 2003, MOL PSYCHIATR, V8, P217, DOI 10.1038/sj.mp.4001215; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Opazo P, 2003, J NEUROSCI, V23, P3679; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Sanna PP, 2002, J NEUROSCI, V22, P3359; Slotnick B.M., 1975, STEREOTAXIC ATLAS AL; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Strekalova T, 2003, GENES BRAIN BEHAV, V2, P3, DOI 10.1034/j.1601-183X.2003.00001.x; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Szapiro G, 2000, NEUROSCIENCE, V99, P1, DOI 10.1016/S0306-4522(00)00236-0; Szapiro G, 2003, HIPPOCAMPUS, V13, P53, DOI 10.1002/hipo.10043; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; VLAHOS CJ, 1995, J IMMUNOL, V154, P2413; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2	50	166	166	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					925	931		10.1038/nn1482	http://dx.doi.org/10.1038/nn1482			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15937483				2022-12-17	WOS:000230137100020
J	Heerssen, HM; Pazyra, MF; Segal, RA				Heerssen, HM; Pazyra, MF; Segal, RA			Dynein motors transport activated Trks to promote survival of target-dependent neurons	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; RETROGRADE AXONAL-TRANSPORT; RAT SYMPATHETIC NEURONS; INDUCED DIFFERENTIATION; NEUROTROPHIN RECEPTORS; COMPARTMENTED CULTURES; LOCAL-CONTROL; NGF; COMPLEX; DYNACTIN	Mutations that alter dynein function are associated with neurodegenerative diseases, but it is not known why defects in dynein-dependent transport impair neuronal survival. Here we show that dynein function in axons is selectively required for the survival of neurons that depend on target-derived neurotrophins. Stimulation of axon terminals with neurotrophins causes internalization of neurotrophin receptors (Trks). Using real-time imaging of fluorescently tagged Trks, we show that dynein is required for rapid transport of internalized, activated receptors from axon terminals to remote cell bodies. When dynein-based transport is inhibited, neurotrophin stimulation of axon terminals does not support survival. These studies indicate that defects in dynein-based transport reduce trafficking of activated Trks and thereby obstruct the prosurvival effect of target-derived trophic factors, leading to degeneration of target-dependent neurons.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Segal, RA (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 44 Binney St, Boston, MA 02115 USA.	rosalind_segal@dfci.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS049381] Funding Source: NIH RePORTER; NINDS NIH HHS [NS49381, NS65148] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beattie EC, 1996, COLD SPRING HARB SYM, V61, P389; Bhattacharyya A, 2002, J NEUROBIOL, V51, P302, DOI 10.1002/neu.10062; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; CAMPENOT RB, 1994, J NEUROBIOL, V25, P599, DOI 10.1002/neu.480250603; CLAUDE P, 1982, J NEUROSCI, V2, P431; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAVIES PJA, 1984, DIABETES CARE, V7, P35; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Ferhat L, 1998, J NEUROSCI, V18, P7822; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HENDRY IA, 1974, BRAIN RES, V82, P117, DOI 10.1016/0006-8993(74)90897-X; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; KORSCHING S, 1983, NEUROSCI LETT, V39, P1, DOI 10.1016/0304-3940(83)90155-6; KRANENBURG O, 1999, J BIOL CHEM, V274, P24575; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; Liu X, 2000, DEV DYNAM, V218, P94, DOI 10.1002/(SICI)1097-0177(200005)218:1<94::AID-DVDY8>3.0.CO;2-Z; MacInnis BL, 2002, SCIENCE, V295, P1536, DOI 10.1126/science.1064913; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Muresan V, 2000, J NEUROCYTOL, V29, P799, DOI 10.1023/A:1010943424272; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; Parkinson NJ, 2001, NAT GENET, V29, P61, DOI 10.1038/ng710; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Senger DL, 1997, J CELL BIOL, V138, P411, DOI 10.1083/jcb.138.2.411; STOCKEL K, 1975, BRAIN RES, V99, P1, DOI 10.1016/0006-8993(75)90604-6; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; Ure DR, 1997, J NEUROSCI, V17, P1282; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Waterman H, 1998, J BIOL CHEM, V273, P13819, DOI 10.1074/jbc.273.22.13819; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yano H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0003.2001; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	50	166	170	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					596	604		10.1038/nn1242	http://dx.doi.org/10.1038/nn1242			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15122257				2022-12-17	WOS:000221640300013
J	Rico, B; Xu, BJ; Reichardt, LF				Rico, B; Xu, BJ; Reichardt, LF			TrkB receptor signaling is required for establishment of GABAergic synapses in the cerebellum	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR; TARGETED DISRUPTION; INHIBITORY SYNAPSES; GRANULE NEURONS; NERVOUS-SYSTEM; IN-VIVO; BRAIN; BDNF; RAT; EXPRESSION	Neurotrophins are essential to the normal development and maintenance of the nervous system. Neurotrophin signaling is mediated by Trk family tyrosine kinases such as TrkA, TrkB and TrkC, as well as by the pan-neurotrophin receptor p75NTR. Here we have deleted the trkB gene in cerebellar precursors by Wnt1-driven Cre-mediated recombination to study the function of the TrkB in the cerebellum. Despite the absence of TrkB, the mature cerebellum of mutant mice appears similar to that of wild type, with all types of cell present in normal numbers and positions. Granule and Purkinje cell dendrites appear normal and the former have typical numbers of excitatory synapses. By contrast, inhibitory interneurons are strongly affected: although present in normal numbers, they express reduced amounts of GABAergic markers and develop reduced numbers of GABAergic boutons and synaptic specializations. Thus, TrkB is essential to the development of GABAergic neurons and regulates synapse formation in addition to its role in the development of axon terminals.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Reichardt, LF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Rico, Beatriz/0000-0002-0581-851X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016033, P01 NS016033-23] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; ALTMAN J, 1976, J COMP NEUROL, V165, P65, DOI 10.1002/cne.901650106; ALTMAN J, 1976, J COMP NEUROL, V165, P49, DOI 10.1002/cne.901650105; Balkowiec A, 1998, J PHYSIOL-LONDON, V510, P527, DOI 10.1111/j.1469-7793.1998.527bk.x; Bao SW, 1999, LEARN MEMORY, V6, P276; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; Chai Y, 2000, DEVELOPMENT, V127, P1671; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Fukuda T, 1998, J COMP NEUROL, V399, P424, DOI 10.1002/(SICI)1096-9861(19980928)399:3<424::AID-CNE10>3.0.CO;2-8; GAO WQ, 1995, J NEUROSCI, V15, P2656; GREIF KF, 1991, NEUROCHEM RES, V16, P235, DOI 10.1007/BF00966086; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 1999, DEVELOPMENT, V126, P2191; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Ito M, 1984, CEREBELLUM NEURAL CO; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Lindholm D, 1997, PERSPECT DEV NEUROBI, V5, P83; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Martinez A, 1998, J NEUROSCI, V18, P7336; Marty S, 2000, J NEUROSCI, V20, P8087; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; MIZUNO K, 1994, DEV BIOL, V165, P243, DOI 10.1006/dbio.1994.1250; Morara S, 1996, NEUROREPORT, V7, P2993, DOI 10.1097/00001756-199611250-00039; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Palay S.L., 1974, CEREBELLAR CORTEX CY; Rabacchi SA, 1999, J NEUROBIOL, V40, P254, DOI 10.1002/(SICI)1097-4695(199908)40:2<254::AID-NEU11>3.0.CO;2-4; ROCAMORA N, 1993, MOL BRAIN RES, V17, P1, DOI 10.1016/0169-328X(93)90065-W; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; SEGAL RA, 1992, NEURON, V9, P1041, DOI 10.1016/0896-6273(92)90064-K; Seil FJ, 2000, J NEUROSCI, V20, P5367, DOI 10.1523/JNEUROSCI.20-14-05367.2000; Shimada A, 1998, J NEUROSCI, V18, P8559; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; TOJO H, 1995, NEUROSCI LETT, V192, P169, DOI 10.1016/0304-3940(95)11637-C; VALVERDE F, 1993, NEUROSCI PROTOCOLS, V1, P1; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; WIDMER HR, 1994, DEV BRAIN RES, V80, P279, DOI 10.1016/0165-3806(94)90114-7; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yan Q, 1997, J COMP NEUROL, V378, P135	46	166	168	1	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					225	233		10.1038/nn808	http://dx.doi.org/10.1038/nn808			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11836532	Green Accepted			2022-12-17	WOS:000174146000012
J	Constantinidis, C; Franowicz, MN; Goldman-Rakic, PS				Constantinidis, C; Franowicz, MN; Goldman-Rakic, PS			The sensory nature of mnemonic representation in the primate prefrontal cortex	NATURE NEUROSCIENCE			English	Article							SPATIAL WORKING-MEMORY; NEURONAL-ACTIVITY; DELAYED-ALTERNATION; NEURAL ACTIVITY; FRONTAL-CORTEX; SINGLE NEURONS; UNIT-ACTIVITY; MONKEY; SYSTEM; AREA	A long-standing issue concerning the function of the primate dorsolateral prefrontal cortex is whether the activity of prefrontal neurons reflects the perceived sensory attributes of a remembered stimulus, or the decision to execute a motor response. To distinguish between these possibilities, we recorded neuronal activity from monkeys trained to make a saccade toward the brighter of two memoranda, under conditions of varied luminance. Our results indicated that during the delay period when sensory information was no longer available, neuronal discharge was modulated by the luminance of the stimulus appearing in the receptive field, and was directly correlated with psychophysical performance in the task. The findings suggest that although prefrontal cortex codes for a diversity of representations, including the decision for an impending response, a population of neurons maintains the dimensional attributes of remembered stimuli throughout the delay period, which allows for flexibility in the outcome of a mnemonic process.	Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA	Yale University	Goldman-Rakic, PS (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, 333 Cedar St, New Haven, CT 06510 USA.	patricia.goldman-rakic@yale.edu	Constantinidis, Christos/ABB-5760-2021	Constantinidis, Christos/0000-0001-7441-022X	NIMH NIH HHS [MH11812, MH38546] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH011812, R01MH038546, R37MH038546] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adcock RA, 2000, P NATL ACAD SCI USA, V97, P3567, DOI 10.1073/pnas.060588897; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; BOUSSAOUD D, 1993, EXP BRAIN RES, V95, P15, DOI 10.1007/BF00229650; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; BUTTERS N, 1969, SCIENCE, V165, P1271, DOI 10.1126/science.165.3899.1271; Constantinidis C, 1996, J NEUROPHYSIOL, V76, P1352, DOI 10.1152/jn.1996.76.2.1352; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814, DOI 10.1152/jn.1990.63.4.814; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; FUNAHASHI S, 1991, J NEUROPHYSIOL, V65, P1464, DOI 10.1152/jn.1991.65.6.1464; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Goldman-Rakic PS, 1987, HDB PHYSL 1, V5, P373, DOI DOI 10.1002/CPHY.CP010509; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; KUBOTA K, 1971, J NEUROPHYSIOL, V34, P337, DOI 10.1152/jn.1971.34.3.337; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Levy R, 1999, J NEUROSCI, V19, P5149; Miller EK, 1996, J NEUROSCI, V16, P5154; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; NIKI H, 1976, BRAIN RES, V105, P79, DOI 10.1016/0006-8993(76)90924-0; Owen AM, 1998, P NATL ACAD SCI USA, V95, P7721, DOI 10.1073/pnas.95.13.7721; QUINTANA J, 1992, NEUROREPORT, V3, P721, DOI 10.1097/00001756-199208000-00018; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Sawaguchi T, 1999, J NEUROPHYSIOL, V82, P2070, DOI 10.1152/jn.1999.82.5.2070; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046, DOI 10.1152/jn.1997.77.2.1046; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30	48	166	169	0	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					311	316		10.1038/85179	http://dx.doi.org/10.1038/85179			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224549				2022-12-17	WOS:000167178300020
J	Schoppa, NE; Westbrook, GL				Schoppa, NE; Westbrook, GL			Regulation of synaptic timing in the olfactory bulb by an A-type potassium current	NATURE NEUROSCIENCE			English	Article							CA1 PYRAMIDAL NEURONS; NMDA RECEPTORS; DENDRODENDRITIC INHIBITION; HIPPOCAMPAL-NEURONS; ODOR STIMULATION; SODIUM-CHANNELS; GANGLION-CELLS; GRANULE CELLS; K+ CHANNELS; RAT	Although rapid synaptic transmission confers signal fidelity, the activity of some neuronal circuits depends on prolonged excitation or inhibition. Here we demonstrate that GABAergic granule cells in the rat olfactory bulb produce prolonged inhibition of mitral cells through a precise kinetic matching between transmitter-gated and voltage-gated channels in their dendritic membrane. A transient A-type potassium current (I-A) specifically attenuated dendrodendritic inputs mediated by fast-acting AMPA receptors such that the excitation and subsequent inhibitory output of granule cells followed the prolonged kinetics of their NMDA receptors. Altering the weights of the AMPA and NMDA receptor-mediated inputs by modulating I-A provides a mechanism to regulate the timing of inhibition according to the demands on the bulb network.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Schoppa, NE (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.				NIDCD NIH HHS [5F32 DC00270] Funding Source: Medline; NINDS NIH HHS [NS26494] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026494, R29NS026494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC000270] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANGELIDES KJ, 1988, J CELL BIOL, V106, P1911, DOI 10.1083/jcb.106.6.1911; Azouz R, 1996, J PHYSIOL-LONDON, V492, P211, DOI 10.1113/jphysiol.1996.sp021302; BARDONI R, 1993, J NEUROPHYSIOL, V69, P2222, DOI 10.1152/jn.1993.69.6.2222; BUZSAKI G, 1997, CAN J PHYSL PHARM, V75, P505; CASSELL JF, 1986, J PHYSIOL-LONDON, V374, P273, DOI 10.1113/jphysiol.1986.sp016079; CHEN QX, 1991, J NEUROSCI, V11, P337; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198, DOI 10.1113/jphysiol.1957.sp005887; COVARRUBIAS M, 1994, NEURON, V13, P1403, DOI 10.1016/0896-6273(94)90425-1; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DICKENSON AH, 1990, BRAIN RES, V506, P31, DOI 10.1016/0006-8993(90)91195-M; GAGE PW, 1992, TRENDS NEUROSCI, V15, P46, DOI 10.1016/0166-2236(92)90025-4; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; HAMILTON KA, 1989, J NEUROPHYSIOL, V62, P609, DOI 10.1152/jn.1989.62.3.609; HARRISON TA, 1986, J NEUROPHYSIOL, V56, P1571, DOI 10.1152/jn.1986.56.6.1571; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; HUGUENARD JR, 1991, J NEUROPHYSIOL, V66, P1304, DOI 10.1152/jn.1991.66.4.1304; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JAHR CE, 1982, J PHYSIOL-LONDON, V326, P213, DOI 10.1113/jphysiol.1982.sp014187; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LUNDH H, 1978, BRAIN RES, V153, P307, DOI 10.1016/0006-8993(78)90409-2; Magee JC, 1998, J NEUROSCI, V18, P7613; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MOLGO J, 1977, J PHARMACOL EXP THER, V203, P653; MORI K, 1978, J PHYSIOL-LONDON, V279, P569, DOI 10.1113/jphysiol.1978.sp012362; MULLER D, 1986, J PHYSIOL-LONDON, V379, P479, DOI 10.1113/jphysiol.1986.sp016265; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; NOWYCKY MC, 1981, J NEUROPHYSIOL, V46, P639, DOI 10.1152/jn.1981.46.3.639; Petersen KR, 1999, PFLUG ARCH EUR J PHY, V437, P381, DOI 10.1007/s004240050792; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; SALT TE, 1986, NATURE, V322, P263, DOI 10.1038/322263a0; Schoppa NE, 1998, J NEUROSCI, V18, P6790; SEGAL M, 1984, J NEUROSCI, V4, P604; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; SPENCER AN, 1989, NATURE, V340, P636, DOI 10.1038/340636a0; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; TANK DW, 1994, SCIENCE, V265, P1819, DOI 10.1126/science.265.5180.1819; WOLLNER DA, 1986, P NATL ACAD SCI USA, V83, P8424, DOI 10.1073/pnas.83.21.8424; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	47	166	171	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1106	1113		10.1038/16033	http://dx.doi.org/10.1038/16033			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570488				2022-12-17	WOS:000085810100015
J	Stemmler, M; Koch, C				Stemmler, M; Koch, C			How voltage-dependent conductances can adapt to maximize the information encoded by neuronal firing rate	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; PYRAMIDAL NEURONS; CULTURED NEURONS; RESPONSES; DENDRITES; CONTRAST; SLICES	Information from the senses must be compressed into the limited range of responses that spiking neurons can generate. For optimal compression, the neuron's response should match the statistics of stimuli encountered in nature. Given a maximum firing rate, a nerve cell should learn to use each available firing rate equally often. Given a set mean firing rate, it should self-organize to respond with high firing rates only to comparatively rare events. Here we derive an unsupervised learning rule that continuously adapts membrane conductances of a Hodgkin-Huxley model neuron to optimize the representation of sensory information in the firing rate. Maximizing information transfer between the stimulus and the cell's firing rate can be interpreted as a non-Hebbian developmental mechanism.	Innovat Kolleg Theoret Biol, D-10115 Berlin, Germany; CALTECH, Computat & Neurol Syst Program, Pasadena, CA 91125 USA	California Institute of Technology	Stemmler, M (corresponding author), Innovat Kolleg Theoret Biol, Invalidenstr 43, D-10115 Berlin, Germany.			Koch, Christof/0000-0001-6482-8067				Ahmed B, 1997, CEREB CORTEX, V7, P559, DOI 10.1093/cercor/7.6.559; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI 10.3109/0954898X.2011.638888; Baddeley R, 1997, P ROY SOC B-BIOL SCI, V264, P1775, DOI 10.1098/rspb.1997.0246; BADDELEY RJ, 1991, P ROY SOC B-BIOL SCI, V246, P219, DOI 10.1098/rspb.1991.0147; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BELL AJ, 1992, NEURAL INFORMATION P, V4, P59; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; CONNOR JA, 1977, BIOPHYS J, V18, P81, DOI 10.1016/S0006-3495(77)85598-7; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Gabbiani F, 1996, NEURAL COMPUT, V8, P44, DOI 10.1162/neco.1996.8.1.44; GRANIT R, 1963, J PHYSIOL-LONDON, V168, P911, DOI 10.1113/jphysiol.1963.sp007230; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HELLER J, 1995, J COMPUT NEUROSCI, V2, P175, DOI 10.1007/BF00961433; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; JAGADEESH B, 1992, SCIENCE, V257, P552, DOI 10.1126/science.1636094; Koch C., 1998, BIOPHYSICS COMPUTATI; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; LINSKER R, 1992, NEURAL COMPUT, V4, P691, DOI 10.1162/neco.1992.4.5.691; MASON A, 1990, J NEUROSCI, V10, P1415; MOYER JR, 1996, J NEUROSCI, V16, P5546; PINSKER MS, 1964, INFORMATION INFORMAT; Purves D, 1994, NEURAL ACTIVITY GROW; Reif F., 1965, FUNDAMENTALS STAT TH; Rieke F., 1997, SPIKES EXPLORING NEU; RUDERMAN DL, 1995, NETWORK, V5, P517; Schreurs BG, 1998, J NEUROSCI, V18, P5498, DOI 10.1523/JNEUROSCI.18-14-05498.1998; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; STEIN RB, 1967, BIOPHYS J, V7, P797, DOI 10.1016/S0006-3495(67)86623-2; TOVEE MJ, 1993, J NEUROPHYSIOL, V70, P640, DOI 10.1152/jn.1993.70.2.640; Tsypkin Y, 1971, ADAPTATION LEARNING; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157	37	166	167	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					521	527		10.1038/9173	http://dx.doi.org/10.1038/9173			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448216				2022-12-17	WOS:000084735900011
J	Wan, Q; Man, HY; Liu, F; Braunton, J; Niznik, HB; Pang, SF; Brown, GM; Wang, YT				Wan, Q; Man, HY; Liu, F; Braunton, J; Niznik, HB; Pang, SF; Brown, GM; Wang, YT			Differential modulation of GABA(A) receptor function by Mel(1a) and Mel(1b) receptors	NATURE NEUROSCIENCE			English	Article							MELATONIN RECEPTORS; CLONING		Univ Toronto, Hosp Sick Children, Res Inst, Brain & Behav Program, McMaster Bldg,Room 5018F,555 Univ Ave, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Pediat & Lab Med & Pathobiol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Clarke Inst Psychiat, Toronto, ON M5T 1R8, Canada; Univ Hong Kong, Dept Physiol, Hong Kong, Peoples R China	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Hong Kong	Wang, YT (corresponding author), Univ Toronto, Hosp Sick Children, Res Inst, Brain & Behav Program, McMaster Bldg,Room 5018F,555 Univ Ave, Toronto, ON M5G 1X8, Canada.	y.t.wang@utoronto.ca	Wang, Yu Tian/A-4729-2008; Wang, Yu Tian/J-8255-2015					Arendt J., 1995, MELATONIN MAMMALIAN; Conway S, 1997, FEBS LETT, V407, P121, DOI 10.1016/S0014-5793(97)00315-3; Costa E, 1998, ANNU REV PHARMACOL, V38, P321, DOI 10.1146/annurev.pharmtox.38.1.321; Dubocovich ML, 1998, FASEB J, V12, P1211, DOI 10.1096/fasebj.12.12.1211; Liu C, 1997, NEURON, V19, P91, DOI 10.1016/S0896-6273(00)80350-5; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.ne.17.030194.003033; Oaknin-Bendahan Sol, 1992, Journal of Basic and Clinical Physiology and Pharmacology, V3, P253; RALPH MR, 1989, J NEUROSCI, V9, P2858; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; Reppert SM, 1997, J BIOL RHYTHM, V12, P528, DOI 10.1177/074873049701200606; Reppert SM, 1997, CELL, V89, P487, DOI 10.1016/S0092-8674(00)80229-9; Wagner S, 1997, NATURE, V387, P598, DOI 10.1038/42468; Weaver DR, 1996, NEUROREPORT, V8, P109, DOI 10.1097/00001756-199612200-00022; Wilsbacher LD, 1998, CURR OPIN GENET DEV, V8, P595, DOI 10.1016/S0959-437X(98)80017-8	15	166	170	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					401	403		10.1038/8062	http://dx.doi.org/10.1038/8062			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321240				2022-12-17	WOS:000084609400006
J	Sun, J; Perona, P				Sun, J; Perona, P			Where is the sun?	NATURE NEUROSCIENCE			English	Article							SHAPE; PERCEPTION; REFLECTANCE		CALTECH 136 93, Pasadena, CA 91125 USA; Univ Padua, I-35131 Padua, Italy	California Institute of Technology; University of Padua	Perona, P (corresponding author), CALTECH 136 93, Pasadena, CA 91125 USA.							BRAUN J, 1993, SPATIAL VISION, V7, P311, DOI 10.1163/156856893X00469; BRAUN J, 1990, PERCEPTION, V19, pA112; Brewster D., 1847, EDINBURGH PHILOS T, V15, P657, DOI [DOI 10.1017/S0080456800030234, 10.1017/S0080456800030234]; BULTHOFF HH, 1988, J OPT SOC AM A, V5, P1749, DOI 10.1364/JOSAA.5.001749; Durost WN, 1934, GENET PSYCHOL MONOG, V16, P225; ENNS JT, 1990, SCIENCE, V247, P721, DOI 10.1126/science.2300824; KLEFFNER DA, 1992, PERCEPT PSYCHOPHYS, V52, P18, DOI 10.3758/BF03206757; Metzger W, 1936, GESETZE SEHENS; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; RAMACHANDRAN VS, 1988, NATURE, V331, P163, DOI 10.1038/331163a0; Rittenhouse D., 1786, T AM PHILOS SOC, V2, P37, DOI DOI 10.2307/1005164; Sun J, 1996, NATURE, V379, P165, DOI 10.1038/379165a0; Sun JY, 1996, VISION RES, V36, P2515, DOI 10.1016/0042-6989(95)00336-3; Todd JT, 1996, INVEST OPHTH VIS SCI, V37, P4282; VANFIEANDT K, 1938, PSYCHOL I MONOG	15	166	166	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					183	184		10.1038/630	http://dx.doi.org/10.1038/630			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195141				2022-12-17	WOS:000076361200007
J	Veit, J; Hakim, R; Jadi, MP; Sejnowski, TJ; Adesnik, H				Veit, Julia; Hakim, Richard; Jadi, Monika P.; Sejnowski, Terrence J.; Adesnik, Hillel			Cortical gamma band synchronization through somatostatin interneurons	NATURE NEUROSCIENCE			English	Article							MOUSE VISUAL-CORTEX; IN-VIVO; INHIBITORY STABILIZATION; NEURONAL SYNCHRONIZATION; SURROUND SUPPRESSION; STIMULUS SELECTIVITY; LONG-RANGE; OSCILLATIONS; MODULATION; RESPONSES	Gamma band rhythms may synchronize distributed cell assemblies to facilitate information transfer within and across brain areas, yet their underlying mechanisms remain hotly debated. Most circuit models postulate that soma-targeting parvalbumin-positive GABAergic neurons are the essential inhibitory neuron subtype necessary for gamma rhythms. Using cell-type-specific optogenetic manipulations in behaving animals, we show that dendrite-targeting somatostatin (SOM) interneurons are critical for a visually induced, context-dependent gamma rhythm in visual cortex. A computational model independently predicts that context-dependent gamma rhythms depend critically on SOM interneurons. Further in vivo experiments show that SOM neurons are required for long-distance coherence across the visual cortex. Taken together, these data establish an alternative mechanism for synchronizing distributed networks in visual cortex. By operating through dendritic and not just somatic inhibition, SOM-mediated oscillations may expand the computational power of gamma rhythms for optimizing the synthesis and storage of visual perceptions.	[Veit, Julia; Hakim, Richard; Adesnik, Hillel] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Veit, Julia; Hakim, Richard; Adesnik, Hillel] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Jadi, Monika P.; Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Jadi, Monika P.; Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	Adesnik, H (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Adesnik, H (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	hadesnik@berkeley.edu	Sejnowski, Terrence/AAV-5558-2021; Veit, Julia/AAB-6873-2020; Core, Vector/CAF-4832-2022	Veit, Julia/0000-0002-6418-1846; Hakim, Richard/0000-0002-6991-1801	NEI [R01EY023756-01]; New York Stem Cell Foundation; Swiss National Foundation [P300PA_164719, P2FRP3_155172]; NEI grant [5K99EY025026-02]; Howard Hughes Medical Institute (HHMI); HHMI; NATIONAL EYE INSTITUTE [R01EY023756, K99EY025026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP2NS087725] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); New York Stem Cell Foundation; Swiss National Foundation(Swiss National Science Foundation (SNSF)); NEI grant; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); HHMI(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank D. Taylor for technical assistance, K. Chesnov and D. Abdelhalim for help with histology, and J. Isaacson, M. Feller, D. Feldman, Y. Dan and B. Atallah for comments on the manuscript. This work was supported by NEI grant R01EY023756-01. H.A. is a New York Stem Cell Foundation Robertson Investigator. This work was supported by The New York Stem Cell Foundation. J.V. was supported by grants from the Swiss National Foundation (P300PA_164719 and P2FRP3_155172). M.P.J. was supported by NEI grant 5K99EY025026-02 and Howard Hughes Medical Institute (HHMI). T.J.S. was supported by HHMI.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Biederlack J, 2006, NEURON, V52, P1073, DOI 10.1016/j.neuron.2006.11.012; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gieselmann MA, 2008, EUR J NEUROSCI, V28, P447, DOI 10.1111/j.1460-9568.2008.06358.x; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hamm JP, 2016, CELL REP, V16, P597, DOI 10.1016/j.celrep.2016.06.037; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Hilscher MM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001392; Jadi M.P., 2014, P IEEE I ELECT ELECT, V102, DOI 10.1109/JPROC.2014.2312671.; Jadi MP, 2016, BIOL PSYCHIAT, V79, P716, DOI 10.1016/j.biopsych.2015.07.005; Jadi MP, 2014, P NATL ACAD SCI USA, V111, P6780, DOI 10.1073/pnas.1405300111; JAGADEESH B, 1992, SCIENCE, V257, P552, DOI 10.1126/science.1636094; Jia XX, 2013, J NEUROSCI, V33, P17, DOI 10.1523/JNEUROSCI.1687-12.2013; Jia XX, 2011, J NEUROSCI, V31, P9390, DOI 10.1523/JNEUROSCI.0645-11.2011; Koepsell K, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.004.2009; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lepousez G, 2010, J NEUROSCI, V30, P870, DOI 10.1523/JNEUROSCI.4958-09.2010; Lin LC, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00110; Litwin-Kumar A, 2016, J NEUROPHYSIOL, V115, P1399, DOI 10.1152/jn.00732.2015; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Mitra P., 2008, OBSERVED BRAIN DYNAM; Munoz W, 2014, CELL REP, V9, P2304, DOI 10.1016/j.celrep.2014.11.042; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Neuenschwander S, 1996, NATURE, V379, P728, DOI 10.1038/379728a0; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Perrenoud Q, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002383; Perry G, 2013, NEUROIMAGE, V68, P83, DOI 10.1016/j.neuroimage.2012.11.043; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pluta S, 2015, NAT NEUROSCI, V18, P1631, DOI 10.1038/nn.4123; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Saleem AB, 2017, NEURON, V93, P315, DOI 10.1016/j.neuron.2016.12.028; Shadlen M.N., 1999, NEURON, V24.1, P111, DOI DOI 10.1016/S0896-627380822-3; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Smith SL, 2013, NATURE, V503, P115, DOI 10.1038/nature12600; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Storchi R, 2017, NEURON, V93, P299, DOI 10.1016/j.neuron.2016.12.027; Thiele A, 2003, NATURE, V421, P366, DOI 10.1038/nature01285; Traub R.D., 2010, CORTICAL OSCILLATION; Tsodyks MV, 1997, J NEUROSCI, V17, P4382; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Vinck M, 2015, NEURON, V86, P740, DOI 10.1016/j.neuron.2015.03.028; Vinck M, 2010, NEUROIMAGE, V51, P112, DOI 10.1016/j.neuroimage.2010.01.073; Wang XJ, 1996, J NEUROSCI, V16, P6402; Whittington MA, 2011, DEV NEUROBIOL, V71, P92, DOI 10.1002/dneu.20814; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Zhang SY, 2014, SCIENCE, V345, P660, DOI 10.1126/science.1254126	64	165	170	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2017	20	7					951	+		10.1038/nn.4562	http://dx.doi.org/10.1038/nn.4562			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY6TB	28481348	Green Accepted			2022-12-17	WOS:000404115100010
J	Fenselau, H; Campbell, JN; Verstegen, AMJ; Madara, JC; Xu, J; Shah, BP; Resch, JM; Yang, ZF; Mandelblat-Cerf, Y; Livneh, Y; Lowell, BB				Fenselau, Henning; Campbell, John N.; Verstegen, Anne M. J.; Madara, Joseph C.; Xu, Jie; Shah, Bhavik P.; Resch, Jon M.; Yang, Zongfang; Mandelblat-Cerf, Yael; Livneh, Yoav; Lowell, Bradford B.			A rapidly acting glutamatergic ARC -> PVH satiety circuit postsynaptically regulated by alpha-MSH	NATURE NEUROSCIENCE			English	Article							HYPOTHALAMIC PROOPIOMELANOCORTIN NEURONS; POMC NEURONS; FOOD-INTAKE; PARAVENTRICULAR NUCLEUS; FRAMESHIFT MUTATION; ENERGY-EXPENDITURE; OBESITY; MELANOCORTIN; OXYTOCIN; AGRP	Arcuate nucleus (ARC) neurons sense the fed or fasted state and regulate hunger. Agouti-related protein (AgRP) neurons in the ARC (ARC(AgRP) neurons) are stimulated by fasting and, once activated, they rapidly (within minutes) drive hunger. Pro-opiomelanocortin (ARC(POMc)) neurons are viewed as the counterpoint to ARC(AgRP) neurons. They are regulated in an opposite fashion and decrease hunger. However, unlike ARC(AgRP) neurons, ARC(POMC) neurons are extremely slow in affecting hunger (many hours). Thus, a temporally analogous, rapid ARC satiety pathway does not exist or is presently unidentified. Here we show that glutamate-releasing ARC neurons expressing oxytocin receptor, unlike ARC(POMC) neurons, rapidly cause satiety when chemo- or optogenetically manipulated. These glutamatergic ARC projections synaptically converge with GABAergic ARC(AgRP) projections on melanocortin-4 receptor (MC4R)-expressing satiety neurons in the paraventricular hypothalamus (PVHMc4R neurons). Transmission across the ARC(GIutamatergic)-> PvH(MC4R) synapse is potentiated by the ARCPcmc neuron-derived MC4R agonist, ot-melanocyte stimulating hormone (alpha-MSH). This excitatory ARC -> PVH satiety circuit, and its modulation by alpha-MSH, provides insight into regulation of hunger and satiety.	[Fenselau, Henning; Campbell, John N.; Verstegen, Anne M. J.; Madara, Joseph C.; Xu, Jie; Shah, Bhavik P.; Resch, Jon M.; Yang, Zongfang; Mandelblat-Cerf, Yael; Livneh, Yoav; Lowell, Bradford B.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA; [Lowell, Bradford B.] Harvard Med Sch, Program Neurosci, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Lowell, BB (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA.; Lowell, BB (corresponding author), Harvard Med Sch, Program Neurosci, Boston, MA 02115 USA.	blowell@bidmc.harvard.edu	Core, Vector/CAF-4832-2022; Livneh, Yoav/AAA-4007-2021	Livneh, Yoav/0000-0002-0434-4201; xu, jie/0000-0001-7761-4666; Resch, Jon/0000-0002-5409-7771	NIH [R01 DK075632, R01 DK096010, R01 DK089044, R01 DKI11401, P30 DK046200, P30 DK057521, F32 DK103387]; AHA Postdoctoral Fellowship [14POST20100011]; Charles A. King postdoctoral fellowship; EMBO postdoctoral fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111401, F32DK103387, R01DK089044, P30DK057521, R37DK053477, R01DK075632, R01DK096010, P30DK046200] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Postdoctoral Fellowship(American Heart Association); Charles A. King postdoctoral fellowship; EMBO postdoctoral fellowship(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of B.B.L.'s laboratory for discussions. This research was funded by the following NIH grants to B.B.L.: R01 DK075632, R01 DK096010, R01 DK089044, R01 DKI11401, P30 DK046200, P30 DK057521; to J.M.R.: F32 DK103387; to J.N.C.: AHA Postdoctoral Fellowship 14POST20100011. Y.M.-C. was supported by a Charles A. King postdoctoral fellowship. Y.L. was supported by an EMBO postdoctoral fellowship.	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Atasoy D, 2014, NAT NEUROSCI, V17, P1830, DOI 10.1038/nn.3854; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Bagnol D, 1999, J NEUROSCI, V19; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Blakely RD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005595; Blevins JE, 2015, PHYSIOL BEHAV, V152, P438, DOI 10.1016/j.physbeh.2015.05.023; Blevins JE, 2015, AM J PHYSIOL-REG I, V308, pR431, DOI 10.1152/ajpregu.00441.2014; Branco T, 2016, CELL, V165, P1749, DOI 10.1016/j.cell.2016.05.019; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Cravo RM, 2011, NEUROSCIENCE, V173, P37, DOI 10.1016/j.neuroscience.2010.11.022; Garfield AS, 2015, NAT NEUROSCI, V18, P863, DOI 10.1038/nn.4011; Gautron L, 2015, CELL, V161, P133, DOI 10.1016/j.cell.2015.02.023; Giraudo SQ, 1998, BRAIN RES, V809, P302, DOI 10.1016/S0006-8993(98)00837-3; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jarvie BC, 2012, J COMP NEUROL, V520, P3863, DOI 10.1002/cne.23127; Koch M, 2015, NATURE, V519, P45, DOI 10.1038/nature14260; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Langlet F, 2014, J NEUROENDOCRINOL, V26, P753, DOI 10.1111/jne.12191; Lawson EA, 2015, OBESITY, V23, P950, DOI 10.1002/oby.21069; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Maejima Y, 2014, FEBS LETT, V588, P4404, DOI 10.1016/j.febslet.2014.10.010; Morton GJ, 2014, NAT REV NEUROSCI, V15, P367, DOI 10.1038/nrn3745; Myers MG, 2012, NATURE, V491, P357, DOI 10.1038/nature11705; Nakajima M, 2014, CELL, V159, P295, DOI 10.1016/j.cell.2014.09.020; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]; Rodriguez EM, 2010, PEPTIDES, V31, P757, DOI 10.1016/j.peptides.2010.01.003; Shah BP, 2014, P NATL ACAD SCI USA, V111, P13193, DOI 10.1073/pnas.1407843111; Shen Y, 2013, J NEUROSCI, V33, P464, DOI 10.1523/JNEUROSCI.3282-12.2013; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wittmann G, 2013, J COMP NEUROL, V521, P3287, DOI 10.1002/cne.23350; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Zhan C, 2013, J NEUROSCI, V33, P3624, DOI 10.1523/JNEUROSCI.2742-12.2013	47	165	168	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2017	20	1					42	51		10.1038/nn.4442	http://dx.doi.org/10.1038/nn.4442			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EG5LO	27869800	Green Accepted, Green Submitted			2022-12-17	WOS:000391085500011
J	Buzsaki, G; Schomburg, EW				Buzsaki, Gyoergy; Schomburg, Erik W.			What does gamma coherence tell us about inter-regional neural communication?	NATURE NEUROSCIENCE			English	Article							LOCAL-FIELD POTENTIALS; HIPPOCAMPAL THETA-RHYTHM; VISUAL-CORTEX; HIGH-FREQUENCY; LARGE-SCALE; OSCILLATIONS; CA1; SYNCHRONY; POWER; MECHANISMS	Neural oscillations have been measured and interpreted in multitudinous ways, with a variety of hypothesized functions in physiology, information processing and cognition. Much attention has been paid in recent years to gamma-band (30-100 Hz) oscillations and synchrony, with an increasing interest in 'high gamma' (> 100 Hz) signals as mesoscopic measures of inter-regional communication. The biophysical origins of the measured variables are often difficult to precisely identify, however, making their interpretation fraught with pitfalls. Here we discuss how measurements of inter-regional gamma coherence can be prone to misinterpretation and suggest strategies for deciphering the roles that synchronized oscillations across brain networks may play in neural function.	[Buzsaki, Gyoergy; Schomburg, Erik W.] NYU, Sch Med, Neurosci Inst, New York, NY 10012 USA; [Buzsaki, Gyoergy] NYU, Ctr Neural Sci, Sch Med, New York, NY 10003 USA	New York University; New York University	Buzsaki, G (corresponding author), NYU, Sch Med, Neurosci Inst, New York, NY 10012 USA.	gyorgy.buzsaki@nyumc.org		Buzsaki, Gyorgy/0000-0002-3100-4800	US National Institutes of Health [MH54671, MH102840]; Mather's Foundation; Human Frontier Science Program; US National Science Foundation (Temporal Dynamics of Learning Center) [SBE 0542013]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102840, R01MH054671] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mather's Foundation; Human Frontier Science Program(Human Frontier Science Program); US National Science Foundation (Temporal Dynamics of Learning Center); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Fernandez-Ruiz, K. Mizuseki, A. Berenyi and members of the Buzsaki laboratory for discussions and feedback. This work was supported by US National Institutes of Health grants (MH54671, MH102840), the Mather's Foundation, The Human Frontier Science Program and the US National Science Foundation (Temporal Dynamics of Learning Center Grant SBE 0542013).	Akam T, 2014, NAT REV NEUROSCI, V15, P111, DOI 10.1038/nrn3668; Aru J, 2015, CURR OPIN NEUROBIOL, V31, P51, DOI 10.1016/j.conb.2014.08.002; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Barbieri F, 2014, J NEUROSCI, V34, P14589, DOI 10.1523/JNEUROSCI.5365-13.2014; Bastos AM, 2015, CURR OPIN NEUROBIOL, V31, P173, DOI 10.1016/j.conb.2014.11.001; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Berenyi A, 2014, J NEUROPHYSIOL, V111, P1132, DOI 10.1152/jn.00785.2013; Bieri KW, 2014, NEURON, V82, P670, DOI 10.1016/j.neuron.2014.03.013; Bishop GH, 1933, AM J PHYSIOL, V103, P213, DOI 10.1152/ajplegacy.1932.103.1.213; Borgers C, 2008, P NATL ACAD SCI USA, V105, P18023, DOI 10.1073/pnas.0809511105; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Brunet NM, 2014, P NATL ACAD SCI USA, V111, P3626, DOI 10.1073/pnas.1309714111; Buffalo EA, 2011, P NATL ACAD SCI USA, V108, P11262, DOI 10.1073/pnas.1011284108; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Cabral HO, 2014, NEURON, V81, P402, DOI 10.1016/j.neuron.2013.11.010; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fernandez-Ruiz A, 2012, J NEUROSCI, V32, P5165, DOI 10.1523/JNEUROSCI.4499-11.2012; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Gaona CM, 2011, J NEUROSCI, V31, P2091, DOI 10.1523/JNEUROSCI.4722-10.2011; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Histed MH, 2014, P NATL ACAD SCI USA, V111, pE178, DOI 10.1073/pnas.1318750111; Jia XX, 2013, NEURON, V77, P762, DOI 10.1016/j.neuron.2012.12.036; Kandel A, 1997, J NEUROSCI, V17, P6783; Killian NJ, 2012, NATURE, V491, P761, DOI 10.1038/nature11587; Kovach CK, 2011, NEUROIMAGE, V54, P213, DOI 10.1016/j.neuroimage.2010.08.002; Lachaux JP, 2012, PROG NEUROBIOL, V98, P279, DOI 10.1016/j.pneurobio.2012.06.008; Lasztoczi B, 2014, NEURON, V81, P1126, DOI 10.1016/j.neuron.2014.01.021; Ledberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027575; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Muresan RC, 2008, J NEUROPHYSIOL, V99, P1333, DOI 10.1152/jn.00772.2007; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Roberts MJ, 2013, NEURON, V78, P523, DOI 10.1016/j.neuron.2013.03.003; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schomburg EW, 2014, NEURON, V84, P470, DOI 10.1016/j.neuron.2014.08.051; Schomburg EW, 2012, J NEUROSCI, V32, P11798, DOI 10.1523/JNEUROSCI.0656-12.2012; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Smith MA, 2013, J NEUROPHYSIOL, V109, P940, DOI 10.1152/jn.00846.2012; Srinath R, 2014, J NEUROPHYSIOL, V112, P741, DOI 10.1152/jn.00851.2013; Stujenske JM, 2014, NEURON, V83, P919, DOI 10.1016/j.neuron.2014.07.026; Sullivan D, 2011, J NEUROSCI, V31, P8605, DOI 10.1523/JNEUROSCI.0294-11.2011; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Vaidya SP, 2013, NAT NEUROSCI, V16, P1812, DOI 10.1038/nn.3562; van Kerkoerle T, 2014, P NATL ACAD SCI USA, V111, P14332, DOI 10.1073/pnas.1402773111; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vicente R, 2008, P NATL ACAD SCI USA, V105, P17157, DOI 10.1073/pnas.0809353105; Whithain EM, 2007, CLIN NEUROPHYSIOL, V118, P1877, DOI 10.1016/j.clinph.2007.04.027; Yamamoto J, 2014, CELL, V157, P845, DOI 10.1016/j.cell.2014.04.009; YLINEN A, 1995, J NEUROSCI, V15, P30; Zanos TP, 2011, J NEUROPHYSIOL, V105, P474, DOI 10.1152/jn.00642.2010; Zemankovics R, 2013, J NEUROSCI, V33, P12337, DOI 10.1523/JNEUROSCI.3680-12.2013	70	165	165	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2015	18	4					484	489		10.1038/nn.3952	http://dx.doi.org/10.1038/nn.3952			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CE4DL	25706474	Green Accepted			2022-12-17	WOS:000351780900005
J	Kramer, RH; Mourot, A; Adesnik, H				Kramer, Richard H.; Mourot, Alexandre; Adesnik, Hillel			Optogenetic pharmacology for control of native neuronal signaling proteins	NATURE NEUROSCIENCE			English	Review							OPTICAL CONTROL; ION CHANNELS; PHOTOCHEMICAL CONTROL; GLUTAMATE-RECEPTOR; VISUAL RESPONSES; DENDRITIC SPINES; CAGED GLUTAMATE; REMOTE-CONTROL; LIGHT; 2-PHOTON	The optical neuroscience revolution is transforming how we study neural circuits. By providing a precise way to manipulate endogenous neuronal signaling proteins, it also has the potential to transform our understanding of molecular neuroscience. Recent advances in chemical biology have produced light-sensitive compounds that photoregulate a wide variety of proteins underlying signaling between and within neurons. Chemical tools for optopharmacology include caged agonists and antagonists and reversibly photoswitchable ligands. These reagents act on voltage-gated ion channels and neurotransmitter receptors, enabling control of neuronal signaling with a high degree of spatial and temporal precision. By covalently attaching photoswitch molecules to genetically tagged proteins, the newly emerging methodology of optogenetic pharmacology allows biochemically precise control in targeted subsets of neurons. Now that the tools for manipulating endogenous neuronal signaling proteins are available, they can be implemented in vivo to enhance our understanding of the molecular bases of brain function and dysfunctions.	[Kramer, Richard H.; Adesnik, Hillel] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Mourot, Alexandre] Univ Paris 06, CNRS, UMR 7102, Paris, France	University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Kramer, RH (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	rhkramer@berkeley.edu	Mourot, Alexandre/H-4636-2013	Mourot, Alexandre/0000-0002-8839-7481	National Eye Institute; US National Institutes of Health; NATIONAL EYE INSTITUTE [P30EY003176] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants to R.H.K. from the National Eye Institute and the US National Institutes of Health.	Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Banghart MR, 2012, NEURON, V73, P249, DOI 10.1016/j.neuron.2011.11.016; Banghart MR, 2009, ANGEW CHEM INT EDIT, V48, P9097, DOI 10.1002/anie.200904504; Baranauskas G, 2003, NAT NEUROSCI, V6, P258, DOI 10.1038/nn1019; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Canepari M, 2001, J NEUROSCI METH, V112, P29, DOI 10.1016/S0165-0270(01)00451-4; Caporale N, 2011, MOL THER, V19, P1212, DOI 10.1038/mt.2011.103; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Donaldson ZR, 2013, CURR OPIN NEUROBIOL, V23, P399, DOI 10.1016/j.conb.2013.01.011; Donato L, 2012, ANGEW CHEM INT EDIT, V51, P1840, DOI 10.1002/anie.201106559; Ellis-Davies GCR, 2011, ACS CHEM NEUROSCI, V2, P185, DOI 10.1021/cn100111a; Fehrentz T, 2011, ANGEW CHEM INT EDIT, V50, P12156, DOI 10.1002/anie.201103236; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fino E, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.002.2009; Fortin DL, 2008, NAT METHODS, V5, P331, DOI [10.1038/NMETH.1187, 10.1038/nmeth.1187]; Fortin DL, 2011, J NEUROPHYSIOL, V106, P488, DOI 10.1152/jn.00251.2011; Howe JR, 1996, J NEUROPHYSIOL, V76, P510, DOI 10.1152/jn.1996.76.1.510; Kokel D, 2013, NAT CHEM BIOL, V9, P257, DOI [10.1038/NCHEMBIO.1183, 10.1038/nchembio.1183]; LESTER HA, 1980, J GEN PHYSIOL, V75, P207, DOI 10.1085/jgp.75.2.207; Levitz J., 2013, NAT NEUROSCI; Lutz C, 2008, NAT METHODS, V5, P821, DOI [10.1038/nmeth.1241, 10.1038/NMETH.1241]; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Mourot A, 2012, NAT METHODS, V9, P396, DOI [10.1038/NMETH.1897, 10.1038/nmeth.1897]; Mourot A, 2011, ACS CHEM NEUROSCI, V2, P536, DOI 10.1021/cn200037p; Muller K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt002; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; Palma-Cerda F, 2012, NEUROPHARMACOLOGY, V63, P624, DOI 10.1016/j.neuropharm.2012.05.010; Polosukhina A, 2012, NEURON, V75, P271, DOI 10.1016/j.neuron.2012.05.022; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Sandoz G, 2012, NEURON, V74, P1005, DOI 10.1016/j.neuron.2012.04.026; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Stein M, 2012, ANGEW CHEM INT EDIT, V51, P10500, DOI 10.1002/anie.201205475; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Tochitsky I, 2012, NAT CHEM, V4, P105, DOI [10.1038/nchem.1234, 10.1038/NCHEM.1234]; Verde EMR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.002.2008; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Volgraf M, 2007, J AM CHEM SOC, V129, P260, DOI 10.1021/ja067269o; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Yue L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2094; Zhou XX, 2012, SCIENCE, V338, P810, DOI 10.1126/science.1226854	50	165	177	5	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					816	823		10.1038/nn.3424	http://dx.doi.org/10.1038/nn.3424			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799474	Green Accepted			2022-12-17	WOS:000321180900011
J	Graf, ABA; Kohn, A; Jazayeri, M; Movshon, JA				Graf, Arnulf B. A.; Kohn, Adam; Jazayeri, Mehrdad; Movshon, J. Anthony			Decoding the activity of neuronal populations in macaque primary visual cortex	NATURE NEUROSCIENCE			English	Article							NEURAL POPULATIONS; CODING EFFICIENCY; SINGLE NEURONS; CODES; DISCRIMINATION; INFORMATION; ORIENTATION; CELLS; VARIABILITY; COMPUTATION	Visual function depends on the accuracy of signals carried by visual cortical neurons. Combining information across neurons should improve this accuracy because single neuron activity is variable. We examined the reliability of information inferred from populations of simultaneously recorded neurons in macaque primary visual cortex. We considered a decoding framework that computes the likelihood of visual stimuli from a pattern of population activity by linearly combining neuronal responses and tested this framework for orientation estimation and discrimination. We derived a simple parametric decoder assuming neuronal independence and a more sophisticated empirical decoder that learned the structure of the measured neuronal response distributions, including their correlated variability. The empirical decoder used the structure of these response distributions to perform better than its parametric variant, indicating that their structure contains critical information for sensory decoding. These results show how neuronal responses can best be used to inform perceptual decision-making.	[Graf, Arnulf B. A.; Kohn, Adam; Jazayeri, Mehrdad; Movshon, J. Anthony] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Graf, ABA (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	graf@vis.caltech.edu			US National Institutes of Health [EY2017, EY4440]; Swartz Foundation;  [EY7158]; NATIONAL EYE INSTITUTE [R37EY004440, R01EY002017, R01EY004440] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swartz Foundation; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to M. Smith and R. Kelly for their help with recording and to E. Simoncelli and M. Yanike for helpful comments on the manuscript. This research was supported by US National Institutes of Health research grants EY2017 and EY4440, training grant EY7158 and the Swartz Foundation.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; [Anonymous], 2002, LEARNING KERNELS; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Averbeck BB, 2006, J NEUROPHYSIOL, V95, P3633, DOI 10.1152/jn.00919.2005; Bair W, 2002, J NEUROSCI, V22, P3189, DOI 10.1523/JNEUROSCI.22-08-03189.2002; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Benucci A, 2009, NAT NEUROSCI, V12, P1317, DOI 10.1038/nn.2398; BEVERLEY KI, 1975, J PHYSIOL-LONDON, V249, P387, DOI 10.1113/jphysiol.1975.sp011021; BRADLEY A, 1987, J NEUROPHYSIOL, V57, P755, DOI 10.1152/jn.1987.57.3.755; Braitenberg VB, 1998, CORTEX STAT GEOMETRY; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; Carandini M, 1997, J NEUROSCI, V17, P8621; Dayan P., 2001, THEORETICAL NEUROSCI; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FOLDIAK P, 1993, COMPUTATION AND NEURAL SYSTEMS, P55; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Jaynes E, 2003, PROBABILITY THEORY L; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Jazayeri M, 2007, NATURE, V446, P912, DOI 10.1038/nature05739; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Montani F, 2007, J NEUROSCI, V27, P2338, DOI 10.1523/JNEUROSCI.3417-06.2007; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Oram MW, 1998, TRENDS NEUROSCI, V21, P259, DOI 10.1016/S0166-2236(97)01216-2; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 1996, J NEUROSCI, V16, pU5; Shamir M, 2006, NEURAL COMPUT, V18, P1951, DOI 10.1162/neco.2006.18.8.1951; Simoncelli E. P., 2009, COGNITIVE NEUROSCIEN; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Vapnik V., 2000, NATURE STAT LEARNING; VOGELS R, 1990, J NEUROSCI, V10, P3543; Wu S, 2001, NEURAL COMPUT, V13, P775, DOI 10.1162/089976601300014349; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	50	165	167	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					239	U332		10.1038/nn.2733	http://dx.doi.org/10.1038/nn.2733			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21217762	Green Accepted			2022-12-17	WOS:000286595400022
J	Seuntjens, E; Nityanandam, A; Miquelajauregui, A; Debruyn, J; Stryjewska, A; Goebbels, S; Nave, KA; Huylebroeck, D; Tarabykin, V				Seuntjens, Eve; Nityanandam, Anjana; Miquelajauregui, Amaya; Debruyn, Joke; Stryjewska, Agata; Goebbels, Sandra; Nave, Klaus-Armin; Huylebroeck, Danny; Tarabykin, Victor			Sip1 regulates sequential fate decisions by feedback signaling from postmitotic neurons to progenitors	NATURE NEUROSCIENCE			English	Article							SMAD-INTERACTING PROTEIN-1; CORTICAL-NEURONS; TEMPORAL IDENTITY; CELL PRODUCTION; DIFFERENTIATION; SPECIFICATION; GLIA; GENE; PROLIFERATION; NEUROGENESIS	The fate of cortical progenitors, which progressively generate neurons and glial cells during development, is determined by temporally and spatially regulated signaling mechanisms. We found that the transcription factor Sip1 (Zfhx1b), which is produced at high levels in postmitotic neocortical neurons, regulates progenitor fate non-cell autonomously. Conditional deletion of Sip1 in young neurons induced premature production of upper-layer neurons at the expense of deep layers, precocious and increased generation of glial precursors, and enhanced postnatal astrocytogenesis. The premature upper-layer generation coincided with overexpression of the neurotrophin-3 (Ntf3) gene and upregulation of fibroblast growth factor 9 (Fgf9) gene expression preceded precocious gliogenesis. Exogenous application of Fgf9 to mouse cortical slices induced excessive generation of glial precursors in the germinal zone. Our data suggest that Sip1 restrains the production of signaling factors in postmitotic neurons that feed back to progenitors to regulate the timing of cell fate switch and the number of neurons and glial cells throughout corticogenesis.	[Seuntjens, Eve; Debruyn, Joke; Stryjewska, Agata; Huylebroeck, Danny] KULeuven, Ctr Human Genet, Lab Mol Biol Celgen, Leuven, Belgium; [Seuntjens, Eve; Debruyn, Joke; Stryjewska, Agata; Huylebroeck, Danny] VIB, Dept Mol & Dev Genet, Louvain, Belgium; [Nityanandam, Anjana; Miquelajauregui, Amaya; Goebbels, Sandra; Nave, Klaus-Armin; Tarabykin, Victor] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Tarabykin, Victor] Charite, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany	KU Leuven; Flanders Institute for Biotechnology (VIB); Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Huylebroeck, D (corresponding author), KULeuven, Ctr Human Genet, Lab Mol Biol Celgen, Leuven, Belgium.	danny.huylebroeck@med.kuleuven.be; tarabykin@em.mpg.de	Seuntjens, Eve/AAM-2478-2021; Tarabykin, Victor/F-9467-2014; Miquelajauregui, Amaya/L-5578-2014; Nave, Klaus-Armin/C-8883-2011	Tarabykin, Viktor/0000-0001-8931-7263; Huylebroeck, Danny/0000-0003-4862-1079; Seuntjens, Eve/0000-0002-0126-461X	Research Foundation Flanders [G.0288.07]; inter-universitary attraction pole network [IUAP-PAI6/20]; EC-FP6 Project Endotrack [LSHG-CT-2006-19050]; Max-Planck Society; Deutsche Forschungsgemeinschaft; Marie Curie Host Fellow For Early Stage Researchers Training (NEUREST) [MEST-CT-2004-504193]	Research Foundation Flanders(FWO); inter-universitary attraction pole network; EC-FP6 Project Endotrack; Max-Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Marie Curie Host Fellow For Early Stage Researchers Training (NEUREST)(European Commission)	We thank the Flanders Institute for Biotechnology Microarray Facility, J. Allemeersch and P. Van Hummelen for their skillful analysis of our samples. We thank R. Hevner, D. Ornitz, L. Lei, J. Alberta and C. Stiles for reagents; P. Vanderhaeghen for advice and G. Fishell for numerous discussions. The D. H. laboratory thanks H. Van den Berghe for continuous support. E. S. was a postdoctoral fellow with the Research Foundation Flanders and the Franqui Foundation. This study was supported by the Research Foundation Flanders (G.0288.07), the inter-universitary attraction pole network (IUAP-PAI6/20) and the EC-FP6 Project Endotrack (LSHG-CT-2006-19050). The V. T. laboratory was supported by Max-Planck Society, Heisenberg Program and Exc 257 of Deutsche Forschungsgemeinschaft, and Fritz Thyssen Foundation. A. N. was a Marie Curie Host Fellow For Early Stage Researchers Training (NEUREST MEST-CT-2004-504193).	Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Bayer S.A., 1991, NEOCORTICAL DEV; Belliveau MJ, 1999, DEVELOPMENT, V126, P555; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BULLOUGH WS, 1964, EXP CELL RES, V33, P176, DOI 10.1016/S0014-4827(64)81025-9; Cinaroglu A, 2005, J NEUROSCI RES, V79, P329, DOI 10.1002/jnr.20363; Desai AR, 2000, DEVELOPMENT, V127, P2863; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fukumitsu H, 2006, J NEUROSCI, V26, P13218, DOI 10.1523/JNEUROSCI.4251-06.2006; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Gorski JA, 2002, J NEUROSCI, V22, P6309; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Higashi Y, 2002, GENESIS, V32, P82, DOI 10.1002/gene.10048; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Lander AD, 2009, PLOS BIOL, V7, P84, DOI 10.1371/journal.pbio.1000015; Lee SJ, 1999, CURR OPIN GENET DEV, V9, P604, DOI 10.1016/S0959-437X(99)00004-0; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; Miquelajauregui A, 2007, P NATL ACAD SCI USA, V104, P12919, DOI 10.1073/pnas.0609863104; Moal FDL, 2007, HUM MUTAT, V28, P313, DOI 10.1002/humu.20452; Morrow T, 2001, DEVELOPMENT, V128, P3585; Neophytou C, 1997, DEVELOPMENT, V124, P2345; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Polleux F, 2002, SCI STKE, V136, P19; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Smith KM, 2006, NAT NEUROSCI, V9, P787, DOI 10.1038/nn1705; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027/MACHINEREADABLECITATION/RIS]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Van de Putte T, 2003, AM J HUM GENET, V72, P465, DOI 10.1086/346092; Van Grunsven LA, 2006, DEV DYNAM, V235, P1491, DOI 10.1002/dvdy.20727; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Verstappen G, 2008, HUM MOL GENET, V17, P1175, DOI 10.1093/hmg/ddn007; Waid DK, 1998, DEVELOPMENT, V125, P1059; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Zhang XM, 2001, DEVELOPMENT, V128, P943; Zhao SL, 2001, DEVELOPMENT, V128, P5051	50	165	169	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1373	1380		10.1038/nn.2409	http://dx.doi.org/10.1038/nn.2409			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19838179				2022-12-17	WOS:000271194100009
J	Melcher, D				Melcher, David			Predictive remapping of visual features precedes saccadic eye movements	NATURE NEUROSCIENCE			English	Article							PARIETAL CORTEX; ORIENTATION; TIME; REPRESENTATION; INTEGRATION; ADAPTATION; PERCEPTION; NEURONS; MOTION; FIELD	The frequent occurrence of saccadic eye movements raises the question of how information is combined across separate glances into a stable, continuous percept. Here I show that visual form processing is altered at both the current fixation position and the location of the saccadic target before the saccade. When human observers prepared to follow a displacement of the stimulus with the eyes, visual form adaptation was transferred from current fixation to the future gaze position. This transfer of adaptation also influenced the perception of test stimuli shown at an intermediate position between fixation and saccadic target. Additionally, I found a presaccadic transfer of adaptation when observers prepared to move their eyes toward a stationary adapting stimulus in peripheral vision. The remapping of visual processing, demonstrated here with form adaptation, may help to explain our impression of a smooth transition, with no temporal delay, of visual perception across glances.	Univ Trent, Ctr Mind Brain Studies, Dept Cognit Sci, I-38068 Rovereto, Italy; Oxford Brookes Univ, Dept Psychol, Oxford OX3 0BP, England	University of Trento; Oxford Brookes University	Melcher, D (corresponding author), Univ Trent, Ctr Mind Brain Studies, Dept Cognit Sci, Corso Bettini 31, I-38068 Rovereto, Italy.	david.melcher@form.unitn.it	Melcher, David/D-1775-2010	Melcher, David/0000-0003-0926-585X				BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Carpenter RHS, 1988, MOVEMENTS EYES; d'Avossa G, 2007, NAT NEUROSCI, V10, P249, DOI 10.1038/nn1824; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; GALLETTI C, 1993, EXP BRAIN RES, V96, P221; Georgeson M, 2004, CURR BIOL, V14, pR751, DOI 10.1016/j.cub.2004.09.011; GEORGESON MA, 1976, PERCEPTION, V5, P99, DOI 10.1068/p050099; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; Khayat PS, 2004, P NATL ACAD SCI USA, V101, P12712, DOI 10.1073/pnas.0301935101; Kusunoki M, 2003, J NEUROPHYSIOL, V89, P1519, DOI 10.1152/jn.00519.2002; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; MCCONKIE GW, 1979, PERCEPT PSYCHOPHYS, V25, P221, DOI 10.3758/BF03202990; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; Melcher D, 2003, NAT NEUROSCI, V6, P877, DOI 10.1038/nn1098; Melcher D, 2001, NATURE, V412, P401, DOI 10.1038/35086646; Merriam ER, 2005, NEUROSCIENTIST, V11, P484, DOI 10.1177/1073858405276871; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; PARKER DM, 1972, Q J EXP PSYCHOL, V24, P1, DOI 10.1080/14640747208400260; ROBINSON DA, 1964, J PHYSIOL-LONDON, V174, P245, DOI 10.1113/jphysiol.1964.sp007485; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373	25	165	166	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					903	907		10.1038/nn1917	http://dx.doi.org/10.1038/nn1917			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17589507				2022-12-17	WOS:000247560200021
J	Winocur, G; Moscovitch, M; Sekeres, M				Winocur, Gordon; Moscovitch, Morris; Sekeres, Melanie			Memory consolidation or transformation: context manipulation and hippocampal representations of memory	NATURE NEUROSCIENCE			English	Article							RETROGRADE-AMNESIA; DORSAL HIPPOCAMPAL; SPATIAL MEMORY; LESIONS; FEAR; NEUROANATOMY; ANTEROGRADE; MONKEYS; COMPLEX; DAMAGE	The traditional view is that the hippocampus is necessary for retaining memories until they are consolidated in their original form in the neocortex. An alternative view is that the original memory, which is hippocampus- and context- dependent, becomes transformed with time to one that is more schematic and independent of the hippocampus. By manipulating context in two protocols that are widely used to investigate hippocampal- neocortical interactions in memory, we find evidence for the transformation view.	Rotman Res Inst, Baycrest Ctr, Toronto, ON M6A 2E1, Canada; Trent Univ, Dept Psychol, Peterborough, ON K9J 7B8, Canada; Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada; Baycrest Ctr Geriatr Care, Dept Psychol, Toronto, ON M6A 2E1, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Baycrest; Trent University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto	Winocur, G (corresponding author), Rotman Res Inst, Baycrest Ctr, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	gwinocur@rotman-baycrest.on.ca		Sekeres, Melanie/0000-0002-7952-3175				ALVAREZ P, 1995, J NEUROSCI, V15, P3796; Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Bunsey M, 1995, HIPPOCAMPUS, V5, P546, DOI 10.1002/hipo.450050606; Clark RE, 2002, J NEUROSCI, V22, P4663, DOI 10.1523/JNEUROSCI.22-11-04663.2002; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; GISQUETVERRIER P, 1986, ANIM LEARN BEHAV, V14, P349, DOI 10.3758/BF03200078; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; Rosenbaum RS, 2001, BEHAV BRAIN RES, V127, P183, DOI 10.1016/S0166-4328(01)00363-1; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4	15	165	165	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					555	557		10.1038/nn1880	http://dx.doi.org/10.1038/nn1880			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17396121				2022-12-17	WOS:000245948000011
J	Glickfeld, LL; Scanziani, M				Glickfeld, Lindsey L.; Scanziani, Massimo			Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells	NATURE NEUROSCIENCE			English	Article							DUAL INTRACELLULAR-RECORDINGS; HIPPOCAMPAL PYRAMIDAL CELLS; RAT HIPPOCAMPUS; GABAERGIC INTERNEURONS; NETWORK OSCILLATIONS; FEEDFORWARD INHIBITION; DENDRITIC INHIBITION; GAMMA OSCILLATIONS; GABA RELEASE; IN-VITRO	Cannabinoids are powerful modulators of inhibition, yet the precise spike timing of cannabinoid receptor (CB1R)-expressing inhibitory neurons in relation to other neurons in the circuit is poorly understood. Here we found that the spike timing of CB1R-expressing basket cells, a major target for cannabinoids in the rat hippocampus, was distinct from the other main group of basket cells, the CB1R-negative. Despite receiving the same afferent inputs, the synaptic and biophysical properties of the two cell types were tuned to detect different features of activity. CB1R-negative basket cells responded reliably and immediately to subtle and repetitive excitation. In contrast, CB1R-positive basket cells responded later and did not follow repetitive activity, but were better suited to integrate the consecutive excitation of independent afferents. This temporal separation in the activity of the two basket cell types generated distinct epochs of somatic inhibition that were differentially affected by endocannabinoids.	Univ Calif San Diego, Div Biol, Grad Program Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Scanziani, M (corresponding author), Univ Calif San Diego, Div Biol, Grad Program Neurosci, La Jolla, CA 92093 USA.	massimo@ucsd.edu			NIDA NIH HHS [T32 DA007315, 5T32DA007315] Funding Source: Medline; NIMH NIH HHS [MH70058, MH71401, R01 MH071401, R01 MH070058] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070058, R01MH071401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007315] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Ameri A, 1999, PROG NEUROBIOL, V58, P315, DOI 10.1016/S0301-0082(98)00087-2; ANDERSEN P, 1962, NATURE, V196, P645, DOI 10.1038/196645a0; ANDERSEN P, 1963, NATURE, V198, P540, DOI 10.1038/198540a0; ANDERSEN P, 1973, EXP BRAIN RES, V17, P152; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Deuchars J, 1996, NEUROSCIENCE, V74, P1009, DOI 10.1016/0306-4522(96)00251-5; DINGLEDINE R, 1980, BRAIN RES, V185, P277, DOI 10.1016/0006-8993(80)91068-9; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Fukuda T, 1996, NEUROSCI RES, V26, P181, DOI 10.1016/S0168-0102(96)01102-9; Galarreta M, 2004, J NEUROSCI, V24, P9770, DOI 10.1523/JNEUROSCI.3027-04.2004; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Katona I, 1999, J NEUROSCI, V19, P4544; KATSUMARU H, 1988, EXP BRAIN RES, V72, P347; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Losonczy A, 2004, P NATL ACAD SCI USA, V101, P1362, DOI 10.1073/pnas.0304752101; Losonczy A, 2002, J PHYSIOL-LONDON, V542, P193, DOI 10.1113/jphysiol.2002.020024; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Matyas F, 2004, EUR J NEUROSCI, V19, P1243, DOI 10.1111/j.1460-9568.2004.03225.x; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Morales M, 2002, HIPPOCAMPUS, V12, P756, DOI 10.1002/hipo.10025; Nicoll RA, 2004, SCI AM, V291, P68, DOI 10.1038/scientificamerican1204-68; PITLER TA, 1994, NEURON, V13, P1447; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; SIK A, 1995, J NEUROSCI, V15, P6651; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; Wierenga CJ, 2003, NEUROSCIENCE, V118, P1129, DOI 10.1016/S0306-4522(03)00060-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	42	165	166	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					807	815		10.1038/nn1688	http://dx.doi.org/10.1038/nn1688			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16648849	Green Accepted			2022-12-17	WOS:000237895200021
J	Saghatelyan, A; de Chevigny, A; Schachner, M; Lledo, PM				Saghatelyan, A; de Chevigny, A; Schachner, M; Lledo, PM			Tenascin-R mediates activity-dependent recruitment of neuroblasts in the adult mouse forebrain	NATURE NEUROSCIENCE			English	Article							EXTRACELLULAR-MATRIX; OLFACTORY-BULB; CELL-ADHESION; MICE DEFICIENT; NEURONS; MIGRATION; INDUCTION; BRAIN; GLYCOPROTEINS; LOCALIZATION	Neuroblasts arising in the adult forebrain that travel to the olfactory bulb use two modes of migration: tangentially, along the rostral migratory stream, and radially, in the core of the olfactory bulb where they start to ascend to the outer layers. Although the mechanisms of tangential migration have been extensively studied, the factors controlling radial migration remain unexplored. Here we report that the extracellular matrix glycoprotein tenascin-R, expressed in the adult mouse olfactory bulb, initiates both the detachment of neuroblasts from chains and their radial migration. Expression of tenascin-R is activity dependent, as it is markedly reduced by odor deprivation. Furthermore, grafting of tenascin-R-transfected cells into non-neurogenic regions reroutes migrating neuroblasts toward these regions. The identification of an extracellular microenvironment capable of directing migrating neuroblasts provides insights into the mechanisms regulating radial migration in the adult olfactory bulb and offers promising therapeutic venues for brain repair.	Inst Pasteur, CNRS, URA 2182, Lab Percept & Memory, F-75015 Paris, France; Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Hamburg; University Medical Center Hamburg-Eppendorf	Lledo, PM (corresponding author), Inst Pasteur, CNRS, URA 2182, Lab Percept & Memory, 25 Rue Dr Roux, F-75015 Paris, France.	pmlledo@pasteur.fr	de Chevigny, Antoine/M-7477-2016	de Chevigny, Antoine/0000-0002-7413-0591; Saghatelyan, Armen/0000-0003-4962-0465				Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Boudreau N, 1998, CURR OPIN CELL BIOL, V10, P640, DOI 10.1016/S0955-0674(98)80040-9; Bruckner G, 2000, J COMP NEUROL, V428, P616, DOI 10.1002/1096-9861(20001225)428:4<616::AID-CNE3>3.0.CO;2-K; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chazal G, 2000, J NEUROSCI, V20, P1446; Cummings DM, 1997, J NEUROSCI, V17, P7433; Cummings DM, 1997, EXP NEUROL, V148, P360, DOI 10.1006/exnr.1997.6660; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; FRAZIER LL, 1988, J COMP NEUROL, V269, P355, DOI 10.1002/cne.902690304; FUSS B, 1993, J CELL BIOL, V120, P1237, DOI 10.1083/jcb.120.5.1237; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; HENEGAR JR, 1991, BRAIN RES, V568, P230, DOI 10.1016/0006-8993(91)91402-M; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.0.CO;2-G; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kennedy Timothy E., 1995, Current Opinion in Neurobiology, V5, P83, DOI 10.1016/0959-4388(95)80091-3; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MEISAMI E, 1976, BRAIN RES, V107, P437, DOI 10.1016/0006-8993(76)90243-2; Milev P, 1998, J BIOL CHEM, V273, P6998, DOI 10.1074/jbc.273.12.6998; MORGANTI MC, 1990, EXP NEUROL, V109, P98, DOI 10.1016/S0014-4886(05)80012-3; Murase S, 2002, J NEUROSCI, V22, P3568; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nikonenko A, 2003, J COMP NEUROL, V456, P338, DOI 10.1002/cne.10537; Pesheva P, 2000, PROG NEUROBIOL, V61, P465, DOI 10.1016/S0301-0082(99)00061-1; PESHEVA P, 1993, NEURON, V10, P69, DOI 10.1016/0896-6273(93)90243-K; Probstmeier R, 1999, EUR J NEUROSCI, V11, P2474, DOI 10.1046/j.1460-9568.1999.00670.x; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Saghatelyan AK, 2003, MOL CELL NEUROSCI, V24, P271, DOI 10.1016/S1044-7431(03)00163-5; Saghatelyan AK, 2001, MOL CELL NEUROSCI, V17, P226, DOI 10.1006/mcne.2000.0922; Srinivasan J, 1998, P NATL ACAD SCI USA, V95, P15753, DOI 10.1073/pnas.95.26.15753; Svendsen CN, 1996, PERSPECT DEV NEUROBI, V3, P133; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Thomas LB, 1996, GLIA, V17, P1; Weber P, 1999, J NEUROSCI, V19, P4245, DOI 10.1523/jneurosci.19-11-04245.1999; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Xiao ZC, 1997, J BIOL CHEM, V272, P32092, DOI 10.1074/jbc.272.51.32092; Xiao ZC, 1999, J BIOL CHEM, V274, P26511, DOI 10.1074/jbc.274.37.26511; Xiao ZC, 1998, J NEUROSCI RES, V52, P390, DOI 10.1002/(SICI)1097-4547(19980515)52:4<390::AID-JNR3>3.0.CO;2-4	41	165	181	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					347	356		10.1038/nn1211	http://dx.doi.org/10.1038/nn1211			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034584				2022-12-17	WOS:000220482500013
J	Haist, F; Gore, JB; Mao, H				Haist, F; Gore, JB; Mao, H			Consolidation of human memory over decades revealed by functional magnetic resonance imaging	NATURE NEUROSCIENCE			English	Article							GRADED RETROGRADE-AMNESIA; MEDIAL TEMPORAL-LOBE; HIPPOCAMPAL-FORMATION; CONTEXTUAL FEAR; BRAIN; REGISTRATION; RECOGNITION; ACTIVATION; IMPAIRMENT; VALIDATION	Medial temporal lobe (MTL) lesions typically produce retrograde amnesia characterized by the disproportionate loss of recently acquired memories. Temporally graded memory loss is interpreted traditionally as evidence for a consolidation process guided by the MTL. Here, using functional magnetic resonance imaging (fMRI), we show temporally graded changes in MTL activity in healthy older adults taking a famous faces remote memory test. Evidence for temporally graded change in the hippocampal formation was mixed, suggesting it may participate only in consolidation processes lasting a few years. Entorhinal cortex was associated with temporally graded changes extending up to 20 years. These findings support the basic tenets of consolidation theory and suggest that the entorhinal cortex, rather than the hippocampal formation, participates in memory consolidation over decades.	Childrens Hosp, Res Ctr, Lab Res Neursci Autism, La Jolla, CA 92037 USA; Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92037 USA; Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA	Children's Hospital Los Angeles; University System of Georgia; Georgia State University; University of California System; University of California San Diego; Emory University	Haist, F (corresponding author), Childrens Hosp, Res Ctr, Lab Res Neursci Autism, 8110 La Jolla Shores Dr,Suite 201, La Jolla, CA 92037 USA.		Haist, Frank/C-3177-2013	Haist, Frank/0000-0002-7254-6083				ALBERT MS, 1981, ARCH NEUROL-CHICAGO, V38, P495, DOI 10.1001/archneur.1981.00510080057008; ALBERT MS, 1979, ARCH NEUROL-CHICAGO, V36, P211, DOI 10.1001/archneur.1979.00500400065010; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cohen N.J., 1993, MEMORY AMNESIA HIPPO, DOI DOI 10.1136/JNNP.58.1.128-A; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Eichenbaum H, 1999, CURR BIOL, V9, pR482, DOI 10.1016/S0960-9822(99)80301-7; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Ivanco TL, 2000, HIPPOCAMPUS, V10, P143, DOI 10.1002/(SICI)1098-1063(2000)10:2<143::AID-HIPO3>3.0.CO;2-G; KAPUR N, 1995, CORTEX, V31, P99, DOI 10.1016/S0010-9452(13)80108-6; Kapur N, 1999, PSYCHOL BULL, V125, P800, DOI 10.1037/0033-2909.125.6.800; Kapur N, 1999, HIPPOCAMPUS, V9, P247, DOI 10.1002/(SICI)1098-1063(1999)9:3<247::AID-HIPO5>3.0.CO;2-W; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Knowlton BJ, 1998, CURR OPIN NEUROBIOL, V8, P293, DOI 10.1016/S0959-4388(98)80154-2; KRITCHEVSKY M, 1989, NEUROLOGY, V39, P213, DOI 10.1212/WNL.39.2.213; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Lynch G, 1998, NEUROBIOL LEARN MEM, V70, P82, DOI 10.1006/nlme.1998.3840; Maguire EA, 2001, NEUROREPORT, V12, P441, DOI 10.1097/00001756-200103050-00004; Markowitsch HJ, 2000, PRINCIPLES BEHAV COG, P257; MARSLENWILSON WD, 1975, NEUROPSYCHOLOGIA, V13, P353, DOI 10.1016/0028-3932(75)90013-5; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; MILNER PM, 1989, NEUROPSYCHOLOGIA, V27, P23, DOI 10.1016/0028-3932(89)90087-0; Moscovitch M, 1998, CURR OPIN NEUROBIOL, V8, P297, DOI 10.1016/S0959-4388(98)80155-4; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.0.CO;2-D; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Parkin AJ, 1997, CURR BIOL, V7, pR768, DOI 10.1016/S0960-9822(06)00400-3; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1989, J NEUROSCI, V9, P828; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SQUIRE LR, 1992, PSYCHOL REV, V99, P582; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Talairach J., 1988, COPLANAR STEREOTAXIC; Thornton JA, 1997, J NEUROSCI, V17, P8536; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; YONEDA Y, 1994, EUR NEUROL, V34, P243, DOI 10.1159/000117051; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	50	165	168	0	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1139	1145		10.1038/nn739	http://dx.doi.org/10.1038/nn739			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	489AY	11600889				2022-12-17	WOS:000171970900018
J	Treue, S; Hol, K; Rauber, HJ				Treue, S; Hol, K; Rauber, HJ			Seeing multiple directions of motion - physiology and psychophysics	NATURE NEUROSCIENCE			English	Article							VECTORIAL TRANSPARENT MOTION; VISUAL AREA MT; GLOBAL DIRECTION; MACAQUE MONKEY; CORTICAL AREA; MST NEURONS; PERCEPTION; MODEL; RESPONSES; STIMULI	Dot patterns sliding transparently across one another are normally perceived as independently moving surfaces. Recordings from direction-selective neurons in area MT of the macaque suggested that this perceptual segregation did not depend on the presence of two peaks in the population activity. Rather, the visual system seemed to use overall shape of the population response to determine the number and directions of motion components. This approach explained a number of perceptual phenomena, including susceptibility of the motion system to direction metamers, motion patterns combining three or five directions incorrectly perceived by subjects as comprising only two directions. Our findings offer insights into the coding of multi-valued sensory signals and provide constraints for biologically based computational models.	Univ Tubingen, Dept Neurol, Cognit Neurosci Lab, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Treue, S (corresponding author), Univ Tubingen, Dept Neurol, Cognit Neurosci Lab, Morgenstelle 15, D-72076 Tubingen, Germany.	treue@uni-tuebingen.de						ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Braddick O, 1997, PERCEPTION, V26, P995, DOI 10.1068/p260995; BRADLEY DC, 1995, NATURE, V373, P609, DOI 10.1038/373609a0; Britten KH, 1998, J NEUROPHYSIOL, V80, P762, DOI 10.1152/jn.1998.80.2.762; Croner LJ, 1997, VISION RES, V37, P1415, DOI 10.1016/S0042-6989(96)00299-4; Croner LJ, 1999, J NEUROSCI, V19, P3935; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Grunewald A, 1996, NATURE, V384, P358, DOI 10.1038/384358a0; JASINSCHI R, 1992, J OPT SOC AM A, V9, P1865, DOI 10.1364/JOSAA.9.001865; MARSHAK W, 1979, SCIENCE, V205, P1399, DOI 10.1126/science.472756; MATHER G, 1980, Q J EXP PSYCHOL, V32, P325, DOI 10.1080/14640748008401168; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; MILLIGAN JB, 1992, INVEST OPHTHALMOL S; PASTERNAK T, 1990, J NEUROSCI, V10, P3079; QIAN N, 1994, J NEUROSCI, V14, P7357; QIAN N, 1994, J NEUROSCI, V14, P7381; Rauber HJ, 1999, VISION RES, V39, P3187, DOI 10.1016/S0042-6989(99)00025-5; Recanzone GH, 1997, J NEUROPHYSIOL, V78, P2904, DOI 10.1152/jn.1997.78.6.2904; SAITO H, 1989, EXP BRAIN RES, V75, P1; SALZMAN CD, 1994, SCIENCE, V264, P231, DOI 10.1126/science.8146653; SCHOPPMANN A, 1976, NEUROSCI LETT, V2, P177, DOI 10.1016/0304-3940(76)90011-2; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; SNOWDEN RJ, 1992, EXP BRAIN RES, V88, P389, DOI 10.1007/BF02259114; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; van der Smagt MJ, 1999, NAT NEUROSCI, V2, P595, DOI 10.1038/10150; vanWezel RJA, 1996, VISION RES, V36, P2805, DOI 10.1016/0042-6989(95)00324-X; VERSTRATEN FAJ, 1994, VISION RES, V34, P349, DOI 10.1016/0042-6989(94)90093-0; Wang RY, 1997, J COMPUT NEUROSCI, V4, P287, DOI 10.1023/A:1008868232355; WATAMANIUK SNJ, 1993, J OPT SOC AM A, V10, P16, DOI 10.1364/JOSAA.10.000016; WATAMANIUK SNJ, 1992, VISION RES, V32, P931, DOI 10.1016/0042-6989(92)90036-I; WILLIAMS D, 1991, VISION RES, V31, P275, DOI 10.1016/0042-6989(91)90118-O; WILLIAMS DW, 1984, VISION RES, V24, P55, DOI 10.1016/0042-6989(84)90144-5; WILSON HR, 1994, VISUAL NEUROSCI, V11, P1205, DOI 10.1017/S0952523800007008; ZEKI S, 1983, PROC R SOC SER B-BIO, V217, P449, DOI 10.1098/rspb.1983.0020; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818; ZEMEL RS, ADV NEURAL INFORMATI, V11; Zohary E, 1996, VISION RES, V36, P2321, DOI 10.1016/0042-6989(95)00287-1	39	165	166	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					270	276		10.1038/72985	http://dx.doi.org/10.1038/72985			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700260	Green Published			2022-12-17	WOS:000085810500017
J	Azzi, A; Dallmann, R; Casserly, A; Rehrauer, H; Patrignani, A; Maier, B; Kramer, A; Brown, SA				Azzi, Abdelhalim; Dallmann, Robert; Casserly, Alison; Rehrauer, Hubert; Patrignani, Andrea; Maier, Bert; Kramer, Achim; Brown, Steven A.			Circadian behavior is light-reprogrammed by plastic DNA methylation	NATURE NEUROSCIENCE			English	Article							MEMORY FORMATION; HUMAN-CELLS; CLOCK; DEMETHYLATION; EXPRESSION; STABILITY; PROMOTER; GENES; ROLES; SLEEP	The timing of daily circadian behavior can be highly variable among different individuals, and twin studies have suggested that about half of this variability is environmentally controlled. Similar plasticity can be seen in mice exposed to an altered lighting environment, for example, 22-h instead of 24-h, which stably alters the genetically determined period of circadian behavior for months. The mechanisms mediating these environmental influences are unknown. We found that transient exposure of mice to such lighting stably altered global transcription in the suprachiasmatic nucleus (SCN) of the hypothalamus (the master clock tissue regulating circadian behavior in mammals). In parallel, genome-wide methylation profiling revealed global alterations in promoter DNA methylation in the SCN that correlated with these changes. Behavioral, transcriptional and DNA methylation changes were reversible after prolonged re-entrainment to 24-h d. Notably, infusion of a methyltransferase inhibitor to the SCN suppressed period changes. We conclude that the SCN utilizes DNA methylation as a mechanism to drive circadian clock plasticity.	[Azzi, Abdelhalim; Dallmann, Robert; Casserly, Alison; Brown, Steven A.] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Rehrauer, Hubert; Patrignani, Andrea] Univ Zurich, Funct Genom Ctr, Zurich, Switzerland; [Maier, Bert; Kramer, Achim] Charite, Inst Med Immunol, Lab Chronobiol, D-13353 Berlin, Germany	University of Zurich; University of Zurich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Brown, SA (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland.	steven.brown@pharma.uzh.ch	Azzi, Abdelhalim/AAM-9320-2021; Maier, Bert/B-2501-2009; Dallmann, Bob/AAA-4929-2022	Azzi, Abdelhalim/0000-0003-2429-2100; Casserly, Alison/0000-0003-1698-2144; Partigiani, Andrea/0000-0001-8019-3911; Kramer, Achim/0000-0001-9671-6078; Maier, Bert/0000-0002-5254-008X; Dallmann, Robert/0000-0002-7490-0218	Velux Foundation; Swiss National Science Foundation; Zurich Clinical Research Program 'Sleep and Health'	Velux Foundation(Velux Fonden); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Zurich Clinical Research Program 'Sleep and Health'	This work was supported by the Velux Foundation, the Swiss National Science Foundation and the Zurich Clinical Research Program 'Sleep and Health'. A. A. and S. A. B. are members of the Zurich Neurozentrum graduate program, and S. A. B. is also a member of the Molecular Life Sciences program. R. D. is a Feodor Lynen Fellow of the Humboldt Foundation.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barclay NL, 2010, CHRONOBIOL INT, V27, P278, DOI 10.3109/07420521003663801; Belden WJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002166; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brown S, 2005, AM POETRY REV, V34, P3; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Champion C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012388; Chang AM, 2011, J PHYSIOL-LONDON, V589, P1095, DOI 10.1113/jphysiol.2010.201194; Ciarleglio CM, 2011, NAT NEUROSCI, V14, P25, DOI 10.1038/nn.2699; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Franchini DM, 2012, ANNU REV GENET, V46, P419, DOI 10.1146/annurev-genet-110711-155451; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Halbritter F, 2012, NAT METHODS, V9, P7, DOI 10.1038/nmeth.1809; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hur YM, 2007, J SLEEP RES, V16, P17, DOI 10.1111/j.1365-2869.2007.00562.x; Kaas GA, 2013, NEURON, V79, P1086, DOI 10.1016/j.neuron.2013.08.032; Koskenvuo M, 2007, J SLEEP RES, V16, P156, DOI 10.1111/j.1365-2869.2007.00580.x; Kowalska E, 2012, MOL CELL BIOL, V32, P4585, DOI 10.1128/MCB.00334-12; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; LeGates TA, 2012, NATURE, V491, P594, DOI 10.1038/nature11673; Lemaire M, 2009, CANCER CHEMOTH PHARM, V63, P411, DOI 10.1007/s00280-008-0750-6; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Maekawa F, 2012, EPIGENETICS-US, V7, P1046, DOI 10.4161/epi.21539; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Masri S, 2013, NAT REV NEUROSCI, V14, P69, DOI 10.1038/nrn3393; Milagro FI, 2012, CHRONOBIOL INT, V29, P1180, DOI 10.3109/07420528.2012.719967; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Molyneux PC, 2008, BRAIN RES, V1228, P127, DOI 10.1016/j.brainres.2008.05.091; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Oakes CC, 2006, EPIGENETICS-US, V1, P146, DOI 10.4161/epi.1.3.3392; Pagani L, 2011, P NATL ACAD SCI USA, V108, P7218, DOI 10.1073/pnas.1008882108; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Rai K, 2010, CELL, V142, P930, DOI 10.1016/j.cell.2010.08.030; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Rudenko A, 2013, NEURON, V79, P1109, DOI 10.1016/j.neuron.2013.08.003; Shi FQ, 2013, ENVIRON MOL MUTAGEN, V54, P406, DOI 10.1002/em.21790; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Stevenson TJ, 2013, P NATL ACAD SCI USA, V110, P16651, DOI 10.1073/pnas.1310643110; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Zhang L, 2013, EUR REV MED PHARMACO, V17, P1874; Zhu Y, 2011, CHRONOBIOL INT, V28, P852, DOI 10.3109/07420528.2011.618896; Zovkic IB, 2013, LEARN MEMORY, V20, P61, DOI 10.1101/lm.026575.112	49	164	168	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2014	17	3					377	382		10.1038/nn.3651	http://dx.doi.org/10.1038/nn.3651			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB8CA	24531307				2022-12-17	WOS:000332016500010
J	Soria-Gomez, E; Bellocchio, L; Reguero, L; Lepousez, G; Martin, C; Bendahmane, M; Ruehle, S; Remmers, F; Desprez, T; Matias, I; Wiesner, T; Cannich, A; Nissant, A; Wadleigh, A; Pape, HC; Chiarlone, AP; Quarta, C; Verrier, D; Vincent, P; Massa, F; Lutz, B; Guzman, M; Gurden, H; Ferreira, G; Lledo, PM; Grandes, P; Marsicano, G				Soria-Gomez, Edgar; Bellocchio, Luigi; Reguero, Leire; Lepousez, Gabriel; Martin, Claire; Bendahmane, Mounir; Ruehle, Sabine; Remmers, Floor; Desprez, Tifany; Matias, Isabelle; Wiesner, Theresa; Cannich, Astrid; Nissant, Antoine; Wadleigh, Aya; Pape, Hans-Christian; Chiarlone, Anna Paola; Quarta, Carmelo; Verrier, Daniele; Vincent, Peggy; Massa, Federico; Lutz, Beat; Guzman, Manuel; Gurden, Hirac; Ferreira, Guillaume; Lledo, Pierre-Marie; Grandes, Pedro; Marsicano, Giovanni			The endocannabinoid system controls food intake via olfactory processes	NATURE NEUROSCIENCE			English	Article							CANNABINOID RECEPTOR; CB1 RECEPTOR; HIPPOCAMPUS; MODULATION; NEURONS; BULB; SENSITIVITY; PERFORMANCE; PROJECTIONS; ACTIVATION	Hunger arouses sensory perception, eventually leading to an increase in food intake, but the underlying mechanisms remain poorly understood. We found that cannabinoid type-1 (CB1) receptors promote food intake in fasted mice by increasing odor detection. CB1 receptors were abundantly expressed on axon terminals of centrifugal cortical glutamatergic neurons that project to inhibitory granule cells of the main olfactory bulb (MOB). Local pharmacological and genetic manipulations revealed that endocannabinoids and exogenous cannabinoids increased odor detection and food intake in fasted mice by decreasing excitatory drive from olfactory cortex areas to the MOB. Consistently, cannabinoid agonists dampened in vivo optogenetically stimulated excitatory transmission in the same circuit. Our data indicate that cortical feedback projections to the MOB crucially regulate food intake via CB1 receptor signaling, linking the feeling of hunger to stronger odor processing. Thus, CB1 receptor-dependent control of cortical feedback projections in olfactory circuits couples internal states to perception and behavior.	[Soria-Gomez, Edgar; Desprez, Tifany; Matias, Isabelle; Wiesner, Theresa; Cannich, Astrid; Wadleigh, Aya; Verrier, Daniele; Vincent, Peggy; Marsicano, Giovanni] INSERM, NeuroCtr Magendie Endocannabinoids & Neuroadap, U862, Bordeaux, France; [Soria-Gomez, Edgar; Desprez, Tifany; Matias, Isabelle; Wiesner, Theresa; Cannich, Astrid; Wadleigh, Aya; Verrier, Daniele; Vincent, Peggy; Massa, Federico; Marsicano, Giovanni] Univ Bordeaux, NeuroCtr Magendie, U862, Bordeaux, France; [Bellocchio, Luigi; Chiarlone, Anna Paola; Guzman, Manuel] Univ Complutense, Sch Biol, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; [Bellocchio, Luigi; Chiarlone, Anna Paola; Guzman, Manuel] CIBERNED, Madrid, Spain; [Reguero, Leire; Grandes, Pedro] Univ Basque Country UPV EHU, Fac Med & Dent, Dept Neurosci, Leioa, Spain; [Lepousez, Gabriel; Nissant, Antoine; Lledo, Pierre-Marie] Inst Pasteur, Lab Percept & Memory, Paris, France; [Lepousez, Gabriel; Nissant, Antoine; Lledo, Pierre-Marie] CNRS, UMR 3571, Paris, France; [Martin, Claire; Bendahmane, Mounir] Univ Paris Diderot & Sud, IMNC, CNRS, UMR 8165, Orsay, France; [Ruehle, Sabine; Remmers, Floor; Lutz, Beat] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, D-55122 Mainz, Germany; [Pape, Hans-Christian] Univ Munster, Inst Physiol 1, Munster, Germany; [Quarta, Carmelo] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy; [Ferreira, Guillaume] INRA, UMR 1286, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Complutense University of Madrid; CIBERNED; University of Basque Country; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Johannes Gutenberg University of Mainz; University of Munster; University of Bologna; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Marsicano, G (corresponding author), INSERM, NeuroCtr Magendie Endocannabinoids & Neuroadap, U862, Bordeaux, France.	giovanni.marsicano@inserm.fr	Marsicano, Giovanni/I-9603-2016; Grandes, Pedro/H-7494-2015; Soria-Gomez, Edgar/AAH-3567-2019; Martin, Claire/T-1360-2019; Lutz, Beat/AAG-4538-2022; Lutz, Beat/AFK-6229-2022; Remmers, Floortje/G-9645-2012; Quarta, Carmelo/AAC-1629-2020; Grandes, Pedro/AAA-1627-2019; Massa, Federico/C-5697-2011; Zucca, Aya/G-2458-2015; Reguero, Leire/H-6865-2015	Grandes, Pedro/0000-0003-3947-4230; Soria-Gomez, Edgar/0000-0002-1361-5915; Martin, Claire/0000-0001-5340-8323; Remmers, Floortje/0000-0002-8436-0606; Massa, Federico/0000-0002-9427-3418; Zucca, Aya/0000-0001-8613-8315; Reguero, Leire/0000-0002-0267-5568; Quarta, Carmelo/0000-0002-1352-4239; Guzman, Manuel/0000-0001-7475-118X; Wiesner, Theresa/0000-0001-5620-2945; Ferreira, Guillaume/0000-0001-5984-8143; Marsicano, Giovanni/0000-0003-3804-1951	INSERM; EU-Fp7 (REPROBESITY) [HEALTH-F2-2008-223713]; European Research Council (ENDOFOOD) [ERC-2010-StG-260515]; Fondation pour la Recherche Medicale [FRM-DRM-20101220445]; Region Aquitaine; LABEX BRAIN [ANR-10-LABX-43]; Fyssen Foundation; EMBO Post-doc Fellowship; RTA, I.S. Carlos III [RD12/0028/0004]; Basque Country Government [BCG IT764-13]; University of the Basque Country [UFI11/41]; MINECO [BFU2012-33334, SAF2012-35759]; Postdoctoral Specialization Contract from the University of the Basque Country UPV/EHU; Deutsche Forschungsgemeinschaft [SFB-TRR 58]; CONACyT; "AG2R-La-Mondiale"	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); EU-Fp7 (REPROBESITY); European Research Council (ENDOFOOD)(European Research Council (ERC)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Region Aquitaine(Region Nouvelle-Aquitaine); LABEX BRAIN; Fyssen Foundation; EMBO Post-doc Fellowship; RTA, I.S. Carlos III; Basque Country Government(Basque Government); University of the Basque Country; MINECO(Spanish Government); Postdoctoral Specialization Contract from the University of the Basque Country UPV/EHU; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); "AG2R-La-Mondiale"	We thank D. Gonzales, N. Aubailly and all of the personnel of the Animal Facility of the NeuroCentre Magendie for mouse care and genotyping, A. Desprez for help with the odor task set-up, D. Herrera and S. Rahayel (NutriBrain School 2012) for help with some experiments, all of the members of the Marsicano laboratory for useful discussions, A. Bacci, D. Cota, V. Deroche and M. Valley for critically reading the manuscript, and K. Deisseroth (Stanford University) and B. L. Roth (University of North Carolina) for providing the plasmids coding for ChR2 and DREADD, respectively. This work was supported by INSERM (G. M.), EU-Fp7 (REPROBESITY, HEALTH-F2-2008-223713, G. M.), European Research Council (ENDOFOOD, ERC-2010-StG-260515, G. M.), Fondation pour la Recherche Medicale (FRM-DRM-20101220445, G. M.), Region Aquitaine (G. M.), LABEX BRAIN (ANR-10-LABX-43), Fyssen Foundation (E. S.-G.), EMBO Post-doc Fellowship (L. B.), RTA, I.S. Carlos III (RD12/0028/0004, P. G.), Basque Country Government BCG IT764-13 (P. G.), University of the Basque Country UFI11/41 (P. G.), MINECO BFU2012-33334 (P. G.), Postdoctoral Specialization Contract from the University of the Basque Country UPV/EHU (L. R.), MINECO SAF2012-35759 (M. G.), Deutsche Forschungsgemeinschaft (SFB-TRR 58, B. L. and H.-C. P.), CONACyT (E. S.-G.). The Lledo laboratory is part of the Ecole des Neurosciences de Paris Ile-de-France network, a member of the Bio-Psy Labex and is supported partially by "AG2R-La-Mondiale".	Albrecht J, 2009, RHINOLOGY, V47, P160; Aschenbrenner K, 2008, J PSYCHIATR RES, V43, P129, DOI 10.1016/j.jpsychires.2008.03.003; Bechara A, 2005, TRENDS COGN SCI, V9, P159, DOI 10.1016/j.tics.2005.02.002; Bellocchio L, 2013, P NATL ACAD SCI USA, V110, P4786, DOI 10.1073/pnas.1218573110; Bellocchio L, 2010, NAT NEUROSCI, V13, P281, DOI 10.1038/nn.2494; Boyd AM, 2012, NEURON, V76, P1161, DOI 10.1016/j.neuron.2012.10.020; Brisbois TD, 2006, J PALLIATIVE CARE, V22, P111, DOI 10.1177/082585970602200208; Cameron JD, 2012, APPETITE, V58, P978, DOI 10.1016/j.appet.2012.02.050; DAVIS BJ, 1981, J COMP NEUROL, V203, P475, DOI 10.1002/cne.902030310; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; DiPatrizio NV, 2012, TRENDS NEUROSCI, V35, P403, DOI 10.1016/j.tins.2012.04.006; Fadool DA, 2004, NEURON, V41, P389, DOI 10.1016/S0896-6273(03)00844-4; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; GOETZL FR, 1947, GASTROENTEROLOGY, V9, P444; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; Julliard AK, 2007, BEHAV BRAIN RES, V183, P123, DOI 10.1016/j.bbr.2007.05.033; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kato HK, 2012, NEURON, V76, P962, DOI 10.1016/j.neuron.2012.09.037; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lourenco J, 2011, J NEUROSCI, V31, P3243, DOI 10.1523/JNEUROSCI.3512-10.2011; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; Marinelli S, 2009, NAT NEUROSCI, V12, P1488, DOI 10.1038/nn.2430; Markopoulos F, 2012, NEURON, V76, P1175, DOI 10.1016/j.neuron.2012.10.028; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2009, CURR TOP BEHAV NEURO, V1, P201, DOI 10.1007/978-3-540-88955-7_8; Marsicano Giovanni, 2008, P161, DOI 10.1007/978-0-387-74349-3_10; McNamara AM, 2008, LEARN MEMORY, V15, P117, DOI 10.1101/lm.785608; Meissner K, 2011, BIOL PSYCHOL, V86, P289, DOI 10.1016/j.biopsycho.2011.01.001; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Monory Krisztina, 2007, PLoS Biol, V5, pe269, DOI 10.1371/journal.pbio.0050269; Mor M, 2004, J MED CHEM, V47, P4998, DOI 10.1021/jm031140x; Neville KR, 2003, J NEUROPHYSIOL, V90, P3921, DOI 10.1152/jn.00475.2003; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Palouzier-Paulignan B, 2012, CHEM SENSES, V37, P769, DOI 10.1093/chemse/bjs059; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Rinberg D, 2006, SEMIN CELL DEV BIOL, V17, P454, DOI 10.1016/j.semcdb.2006.04.009; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Ruehle S, 2013, J NEUROSCI, V33, P10264, DOI 10.1523/JNEUROSCI.4171-12.2013; Sanchez-Andrade G, 2005, J REPROD DEVELOP, V51, P547, DOI 10.1262/jrd.17031; Shepherd GM, 1998, SYNAPTIC ORG BRAIN, DOI [10.1093/acprof:oso/9780195159561.001.1, DOI 10.1093/ACPROF:OSO/9780195159561.001.1]; Steindel F, 2013, J NEUROCHEM, V124, P795, DOI 10.1111/jnc.12137; TART CT, 1970, NATURE, V226, P701, DOI 10.1038/226701a0; Tong J, 2011, J NEUROSCI, V31, P5841, DOI 10.1523/JNEUROSCI.5680-10.2011; Wang ZJ, 2012, J NEUROSCI, V32, P8475, DOI 10.1523/JNEUROSCI.5333-11.2012; Witt Rochelle M, 2009, J Vis Exp, DOI 10.3791/949; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhou W, 2010, CURR BIOL, V20, P1356, DOI 10.1016/j.cub.2010.05.059	54	164	165	1	50	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2014	17	3					407	415		10.1038/nn.3647	http://dx.doi.org/10.1038/nn.3647			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB8CA	24509429	Green Published			2022-12-17	WOS:000332016500014
J	Piomelli, D; Sasso, O				Piomelli, Daniele; Sasso, Oscar			Peripheral gating of pain signals by endogenous lipid mediators	NATURE NEUROSCIENCE			English	Review							ACID AMIDE HYDROLASE; CANNABINOID CB2 RECEPTORS; DORSAL-ROOT GANGLIA; PPAR-ALPHA; 2-ARACHIDONOYL GLYCEROL; MECHANICAL HYPERALGESIA; INFLAMMATORY RESPONSE; N-ACYLETHANOLAMINES; INHIBITION REVEALS; THERAPEUTIC TARGET	Primary sensory afferents and their neighboring host-defense cells are a rich source of lipid-derived mediators that contribute to the sensation of pain caused by tissue damage and inflammation. But an increasing number of lipid molecules have been shown to act in an opposite way, to suppress the inflammatory process, restore homeostasis in damaged tissues and attenuate pain sensitivity by regulating neural pathways that transmit nociceptive signals from the periphery of the body to the CNS. Here we review the molecular and cellular mechanisms that contribute to the modulatory actions of lipid mediators in peripheral nociceptive signaling.	[Piomelli, Daniele] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Piomelli, Daniele; Sasso, Oscar] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Piomelli, Daniele] Ist Italiano Tecnol, Dept Drug Discovery & Dev, Genoa, Italy	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Istituto Italiano di Tecnologia - IIT	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA.	piomelli@uci.edu			American Asthma Foundation; National Institute on Drug Abuse; US National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012413, R41DA033683, DP1DA031387] Funding Source: NIH RePORTER	American Asthma Foundation; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank B.D. Hammock, A.G. Hohmann and C.N. Serhan for thoughtful discussions. Work in D.P.'s laboratory is funded in part by grants from the American Asthma Foundation and the National Institute on Drug Abuse, one of the US National Institutes of Health.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Akopian AN, 2009, TRENDS PHARMACOL SCI, V30, P79, DOI 10.1016/j.tips.2008.10.008; Amaya F, 2006, PAIN, V124, P175, DOI 10.1016/j.pain.2006.04.001; Anand U, 2008, PAIN, V138, P667, DOI 10.1016/j.pain.2008.06.007; Armirotti A, 2012, ACS MED CHEM LETT, V3, P422, DOI 10.1021/ml300056y; Bannenberg G, 2010, BBA-MOL CELL BIOL L, V1801, P1260, DOI 10.1016/j.bbalip.2010.08.002; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beltramo M, 2006, EUR J NEUROSCI, V23, P1530, DOI 10.1111/j.1460-9568.2006.04684.x; Bortolini M, 2013, EXPERT OPIN DRUG SAF, V12, P65, DOI 10.1517/14740338.2013.741585; Buckley NE, 2008, BRIT J PHARMACOL, V153, P309, DOI 10.1038/sj.bjp.0707527; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Castillo PE, 2012, NEURON, V76, P70, DOI 10.1016/j.neuron.2012.09.020; Clapper JR, 2010, NAT NEUROSCI, V13, P1265, DOI 10.1038/nn.2632; D'Agostino G, 2009, EUR J PHARMACOL, V613, P54, DOI 10.1016/j.ejphar.2009.04.022; Desroches J, 2008, BRIT J PHARMACOL, V155, P913, DOI 10.1038/bjp.2008.322; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Dubrac S, 2011, DERM-ENDOCRINOL, V3, P23, DOI 10.4161/derm.3.1.14615; Dziadulewicz EK, 2007, J MED CHEM, V50, P3851, DOI 10.1021/jm070317a; Elmes SJR, 2004, EUR J NEUROSCI, V20, P2311, DOI 10.1111/j.1460-9568.2004.03690.x; FERREIRA SH, 1972, NATURE-NEW BIOL, V240, P200, DOI 10.1038/newbio240200a0; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; GAMMON CM, 1989, J NEUROCHEM, V53, P95, DOI 10.1111/j.1471-4159.1989.tb07299.x; Gangadharan V, 2013, PAIN, V154, P2801, DOI 10.1016/j.pain.2013.08.019; Gatta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031111; Gervois P, 2012, EXPERT OPIN THER TAR, V16, P1113, DOI 10.1517/14728222.2012.715633; Gregg LC, 2012, J NEUROSCI, V32, P9457, DOI 10.1523/JNEUROSCI.0013-12.2012; Gregus AM, 2012, P NATL ACAD SCI USA, V109, P6721, DOI 10.1073/pnas.1110460109; Guindon J, 2008, BRIT J PHARMACOL, V153, P319, DOI 10.1038/sj.bjp.0707531; Guindon J, 2011, BRIT J PHARMACOL, V163, P1464, DOI 10.1111/j.1476-5381.2010.01192.x; Guindon J, 2009, CNS NEUROL DISORD-DR, V8, P403, DOI 10.2174/187152709789824660; Hermanson DJ, 2013, NAT NEUROSCI, V16, P1291, DOI 10.1038/nn.3480; Hohmann AG, 2004, J PHARMACOL EXP THER, V308, P446, DOI 10.1124/jpet.103.060079; Hohmann AG, 1999, NEUROSCIENCE, V90, P923, DOI 10.1016/S0306-4522(98)00524-7; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Inceoglu B, 2012, P NATL ACAD SCI USA, V109, P11390, DOI 10.1073/pnas.1208708109; Jhaveri MD, 2007, MOL NEUROBIOL, V36, P26, DOI 10.1007/s12035-007-8007-7; Jhaveri MD, 2006, J NEUROSCI, V26, P13318, DOI 10.1523/JNEUROSCI.3326-06.2006; Ji RR, 2011, TRENDS NEUROSCI, V34, P599, DOI 10.1016/j.tins.2011.08.005; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Khasabova IA, 2004, J NEUROSCI, V24, P1744, DOI 10.1523/JNEUROSCI.4298-03.2004; Khasabova IA, 2008, J NEUROSCI, V28, P11141, DOI 10.1523/JNEUROSCI.2847-08.2008; Khasabova IA, 2013, NEUROBIOL DIS, V58, P19, DOI 10.1016/j.nbd.2013.04.018; Khasabova IA, 2012, J NEUROSCI, V32, P12735, DOI 10.1523/JNEUROSCI.0130-12.2012; Khasabova IA, 2011, PHARMACOL RES, V64, P60, DOI 10.1016/j.phrs.2011.03.007; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kostadinova R, 2005, CURR MED CHEM, V12, P2995, DOI 10.2174/092986705774462905; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lever IJ, 2009, J NEUROSCI, V29, P3766, DOI 10.1523/JNEUROSCI.4071-08.2009; Liu J, 2003, J BIOL CHEM, V278, P45034, DOI 10.1074/jbc.M306062200; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035168; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; LoVerme J, 2005, LIFE SCI, V77, P1685, DOI 10.1016/j.lfs.2005.05.012; LoVerme J, 2006, J PHARMACOL EXP THER, V319, P1051, DOI 10.1124/jpet.106.111385; LoVerme J, 2006, J BIOL CHEM, V281, P22815, DOI 10.1074/jbc.M604751200; Malan TP, 2001, PAIN, V93, P239, DOI 10.1016/S0304-3959(01)00321-9; McDowell TS, 2013, NEUROSCI LETT, V551, P34, DOI 10.1016/j.neulet.2013.06.066; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Michalski CW, 2007, GASTROENTEROLOGY, V132, P1968, DOI 10.1053/j.gastro.2007.02.035; Mitrirattanakul S, 2006, PAIN, V126, P102, DOI 10.1016/j.pain.2006.06.016; Morgenweck J, 2010, NEUROPHARMACOLOGY, V58, P337, DOI 10.1016/j.neuropharm.2009.10.008; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Naidu PS, 2009, J PHARMACOL EXP THER, V329, P48, DOI 10.1124/jpet.108.143487; Pacher P, 2011, PROG LIPID RES, V50, P193, DOI 10.1016/j.plipres.2011.01.001; Palazzo E, 2012, CNS NEUROL DISORD-DR, V11, P148, DOI 10.2174/187152712800269731; Pamplona FA, 2012, P NATL ACAD SCI USA, V109, P21134, DOI 10.1073/pnas.1202906109; Park KA, 2005, TRENDS PHARMACOL SCI, V26, P571, DOI 10.1016/j.tips.2005.09.010; Patwardhan AM, 2009, P NATL ACAD SCI USA, V106, P18820, DOI 10.1073/pnas.0905415106; Petrosino S, 2010, BIOCHIMIE, V92, P724, DOI 10.1016/j.biochi.2010.01.006; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Piomelli D, 2014, NEUROPHARMACOLOGY, V76, P228, DOI 10.1016/j.neuropharm.2013.07.026; Price TJ, 2003, NEUROSCIENCE, V120, P155, DOI 10.1016/S0306-4522(03)00333-6; Richardson D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2401; Richardson JD, 1998, PAIN, V75, P111, DOI 10.1016/S0304-3959(97)00213-3; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Ruiz-Medina J, 2012, PSYCHOPHARMACOLOGY, V222, P477, DOI 10.1007/s00213-012-2662-8; Sachs D, 2004, P NATL ACAD SCI USA, V101, P3680, DOI 10.1073/pnas.0308382101; Sagar DR, 2005, EUR J NEUROSCI, V22, P371, DOI 10.1111/j.1460-9568.2005.04206.x; Sasso O, 2013, PAIN, V154, P350, DOI 10.1016/j.pain.2012.10.018; Sasso O, 2012, PHARMACOL RES, V65, P553, DOI 10.1016/j.phrs.2012.02.012; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Stander S, 2005, J DERMATOL SCI, V38, P177, DOI 10.1016/j.jdermsci.2005.01.007; Stein C, 2011, PHARMACOL REV, V63, P860, DOI 10.1124/pr.110.003145; Sugawara K, 2013, J ALLERGY CLIN IMMUN, V132, P182, DOI 10.1016/j.jaci.2013.01.002; Svizenska IH, 2013, J HISTOCHEM CYTOCHEM, V61, P529, DOI 10.1369/0022155413491269; Taylor BK, 2002, INFLAMMATION, V26, P121, DOI 10.1023/A:1015500531113; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tsuboi K, 2013, CNS NEUROL DISORD-DR, V12, P7, DOI 10.2174/1871527311312010005; Ueda N, 2013, FEBS J, V280, P1874, DOI 10.1111/febs.12152; Varga K, 1998, FASEB J, V12, P1035, DOI 10.1096/fasebj.12.11.1035; Veress G, 2013, BRAIN STRUCT FUNCT, V218, P733, DOI 10.1007/s00429-012-0425-2; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yao B, 2009, CURR TOP BEHAV NEURO, V1, P37, DOI 10.1007/978-3-540-88955-7_2; Yu ZY, 2007, LIPIDS, V42, P491, DOI 10.1007/s11745-007-3054-4; Zhao PW, 2013, LIFE SCI, V92, P453, DOI 10.1016/j.lfs.2012.06.039; Zhu C, 2011, MOL PHARMACOL, V79, P786, DOI 10.1124/mol.110.070201	100	164	167	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2014	17	2					164	174		10.1038/nn.3612	http://dx.doi.org/10.1038/nn.3612			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AA2FH	24473264	Green Submitted, Green Accepted			2022-12-17	WOS:000330910000008
J	Labouebe, G; Liu, S; Dias, C; Zou, HY; Wong, JCY; Karunakaran, S; Clee, SM; Phillips, AG; Boutrel, B; Borgland, SL				Labouebe, Gwenael; Liu, Shuai; Dias, Carine; Zou, Haiyan; Wong, Jovi C. Y.; Karunakaran, Subashini; Clee, Susanne M.; Phillips, Anthony G.; Boutrel, Benjamin; Borgland, Stephanie L.			Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; SYNAPTIC PLASTICITY; INTRAVENTRICULAR INSULIN; NUCLEUS-ACCUMBENS; SUCROSE INTAKE; FOOD-INTAKE; LEPTIN; BRAIN; RATS; TRANSMISSION	The prevalence of obesity has markedly increased over the past few decades. Exploration of how hunger and satiety signals influence the reward system can help us understand non-homeostatic feeding. Insulin may act in the ventral tegmental area (VIA), a critical site for reward-seeking behavior, to suppress feeding. However, the neural mechanisms underlying insulin effects in the VIA remain unknown. We demonstrate that insulin, a circulating catabolic peptide that inhibits feeding, can induce long-term depression (LTD) of mouse excitatory synapses onto VIA dopamine neurons. This effect requires endocannabinoid-mediated presynaptic inhibition of glutamate release. Furthermore, after a sweetened high-fat meal, which elevates endogenous insulin, insulin-induced LTD is occluded. Finally, insulin in the VIA reduces food anticipatory behavior in mice and conditioned place preference for food in rats. Taken together, these results suggest that insulin in the VIA suppresses excitatory synaptic transmission and reduces anticipatory activity and preference for food-related cues.	[Labouebe, Gwenael; Liu, Shuai; Zou, Haiyan; Wong, Jovi C. Y.; Borgland, Stephanie L.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Labouebe, Gwenael; Boutrel, Benjamin] Univ Lausanne Hosp, Ctr Psychiat Neurosci, Dept Psychiat, Lausanne, Switzerland; [Liu, Shuai; Borgland, Stephanie L.] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Dias, Carine; Phillips, Anthony G.] Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada; [Karunakaran, Subashini; Clee, Susanne M.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Fudan University; University of British Columbia; University of British Columbia	Borgland, SL (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada.	borgland@mail.ubc.ca	Borgland, Stephanie/M-2936-2016; Borgland, Stephanie/GPC-5260-2022; Clee, Susanne/F-7312-2010; Clee, Susanne/AAC-4278-2020	Borgland, Stephanie/0000-0001-7546-5687; Borgland, Stephanie/0000-0001-7546-5687; Clee, Susanne/0000-0001-7946-688X; Wong, Jovi/0000-0001-7980-9352; Boutrel, Benjamin/0000-0003-4988-759X	Canadian Institute of Health Research [102617]; Swiss National Science Foundation [31003A-133056]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors would like to thank K. Lee for performing the insulin measurements and K. Haas, B. MacVicar and Y.T. Wang for suggestions on the manuscript. This research was supported by a Canadian Institute of Health Research operating grant (102617) and a Canadian Institute of Health Research new investigator award to S.L.B. G.L. was supported by a Swiss National Science Foundation postdoctoral fellowship. Behavioral experiments done in B.B.'s laboratory were supported by the Swiss National Science Foundation (31003A-133056).	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Ahn S, 1999, J NEUROSCI, V19; Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007; BALTENSPERGER K, 1992, P NATL ACAD SCI USA, V89, P7885, DOI 10.1073/pnas.89.17.7885; Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; Bisogno T, 1999, BIOCHEM BIOPH RES CO, V256, P377, DOI 10.1006/bbrc.1999.0254; Blum ID, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036117; Bonci A, 1999, J NEUROSCI, V19, P3723; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Borgland SL, 2009, J NEUROSCI, V29, P11215, DOI 10.1523/JNEUROSCI.6096-08.2009; Bruijnzeel AW, 2011, BEHAV BRAIN RES, V219, P254, DOI 10.1016/j.bbr.2011.01.020; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Figlewicz DP, 2008, AM J PHYSIOL-REG I, V295, pR388, DOI 10.1152/ajpregu.90334.2008; Figlewicz DP, 2006, PHYSIOL BEHAV, V89, P611, DOI 10.1016/j.physbeh.2006.07.023; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Figlewicz DP, 2004, BEHAV NEUROSCI, V118, P479, DOI 10.1037/0735-7044.118.3.479; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Gerozissis K, 2008, EUR J PHARMACOL, V585, P38, DOI 10.1016/j.ejphar.2008.01.050; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Henny P, 2012, NAT NEUROSCI, V15, P613, DOI 10.1038/nn.3048; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Massa F, 2010, J NEUROSCI, V30, P6273, DOI 10.1523/JNEUROSCI.2648-09.2010; Mebel DM, 2012, EUR J NEUROSCI, V36, P2336, DOI 10.1111/j.1460-9568.2012.08168.x; Melis M, 2004, J NEUROSCI, V24, P53, DOI 10.1523/JNEUROSCI.4503-03.2004; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Overton PG, 1999, NEUROREPORT, V10, P221, DOI 10.1097/00001756-199902050-00004; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Pan B, 2008, J NEUROSCI, V28, P1385, DOI 10.1523/JNEUROSCI.4033-07.2008; Ronesi J, 2004, J NEUROSCI, V24, P1673, DOI 10.1523/JNEUROSCI.5214-03.2004; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Schaffer L, 2008, BIOCHEM BIOPH RES CO, V376, P380, DOI 10.1016/j.bbrc.2008.08.151; Sipols AJ, 2002, PEPTIDES, V23, P2181, DOI 10.1016/S0196-9781(02)00246-2; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Thompson JL, 2011, BEHAV BRAIN RES, V217, P446, DOI 10.1016/j.bbr.2010.09.028; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Vigneri R, 2010, ACTA DIABETOL, V47, P271, DOI 10.1007/s00592-010-0215-3; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Woods SC, 2003, CURR PHARM DESIGN, V9, P795, DOI 10.2174/1381612033455323; Yin HH, 2006, J NEUROSCI, V26, P11811, DOI 10.1523/JNEUROSCI.3196-06.2006	50	164	167	4	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					300	308		10.1038/nn.3321	http://dx.doi.org/10.1038/nn.3321			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23354329	Green Submitted, Green Accepted			2022-12-17	WOS:000315474800012
J	Calderon, DP; Fremont, R; Kraenzlin, F; Khodakhah, K				Calderon, D. Paola; Fremont, Rachel; Kraenzlin, Franca; Khodakhah, Kamran			The neural substrates of rapid-onset Dystonia-Parkinsonism	NATURE NEUROSCIENCE			English	Article							BASAL GANGLIA; DENTATE STIMULATION; NEURONAL ACTIVITY; NA+/K+-ATPASE; MOTOR SYSTEM; OUABAIN; RAT; CEREBELLUM; MICE; NA,K-ATPASE	Although dystonias are a common group of movement disorders, the mechanisms by which brain dysfunction results in dystonia are not understood. Rapid-onset Dystonia-Parkinsonism (RDP) is a hereditary dystonia caused by mutations in the ATP1A3 gene. Affected individuals can be free of symptoms for years, but rapidly develop persistent dystonia and Parkinsonism-like symptoms after a stressful experience. Using a mouse model, we found that an adverse interaction between the cerebellum and basal ganglia can account for the symptoms of these individuals. The primary instigator of dystonia was the cerebellum, whose aberrant activity altered basal ganglia function, which in turn caused dystonia. This adverse interaction between the cerebellum and basal ganglia was mediated through a di-synaptic thalamic pathway that, when severed, alleviated dystonia. Our results provide a unifying hypothesis for the involvement of cerebellum and basal ganglia in the generation of dystonia and suggest therapeutic strategies for the treatment of RDP.	[Calderon, D. Paola; Fremont, Rachel; Kraenzlin, Franca; Khodakhah, Kamran] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Khodakhah, K (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	k.khodakhah@einstein.yu.edu	Calderon, Diany/D-4683-2011	Fremont, Rachel/0000-0001-5285-7899	US National Institutes of Health [NS063227, NS054251, NS058949]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050808, R01NS063227, R21NS054251, R01NS058949] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the members of the Khodakhah laboratory for invaluable discussions and comments on the manuscript, and for evaluating and scoring motor dysfunction. We also thank D. Purpura, R. Sillitoe and S. Reeber for help and advice. This work was supported by US National Institutes of Health grants NS063227 and NS054251 to K. K. Additional support was provided by an administrative supplement to US National Institutes of Health grant NS058949 (A. Brashear).	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; ALLEN JC, 1970, ARCH BIOCHEM BIOPHYS, V141, P322, DOI 10.1016/0003-9861(70)90138-4; ANDREW J, 1983, BRAIN, V106, P981, DOI 10.1093/brain/106.4.981; Bagrov AY, 2008, NAT CLIN PRACT NEPHR, V4, P378, DOI 10.1038/ncpneph0848; Bauer N, 2005, HYPERTENSION, V45, P1024, DOI 10.1161/01.HYP.0000165024.47728.f7; Brashear A, 2007, BRAIN, V130, P828, DOI 10.1093/brain/awl340; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; BROWN LL, 1989, J NEUROSCI, V9, P4033; Campbell DB, 1999, EXP NEUROL, V160, P268, DOI 10.1006/exnr.1999.7171; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; DeAndrade MP, 2011, BEHAV BRAIN RES, V216, P659, DOI 10.1016/j.bbr.2010.09.009; DONALDSON J, 1972, CAN J BIOCHEM CELL B, V50, P888, DOI 10.1139/o72-124; Fahn S, 1987, RECENT DEV PARKINSON; FRAIOLI B, 1975, APPL NEUROPHYSIOL, V38, P81; HEIMBURGER RF, 1967, CONFIN NEUROL, V29, P101; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Ichinohe N, 2000, BRAIN RES, V880, P191, DOI 10.1016/S0006-8993(00)02744-X; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jinnah HA, 2006, NEUROLOGY, V67, P1740, DOI 10.1212/01.wnl.0000246112.19504.61; Jinnah HA, 2005, MOVEMENT DISORD, V20, P283, DOI 10.1002/mds.20364; Kim JH, 2007, NAT NEUROSCI, V10, P196, DOI 10.1038/nn1839; Le Ber I, 2006, NEUROLOGY, V67, P1769, DOI 10.1212/01.wnl.0000244484.60489.50; LeDoux M S, 1998, Adv Neurol, V78, P63; LEDOUX MS, 1993, EXP NEUROL, V120, P302, DOI 10.1006/exnr.1993.1064; Lepoutre AC, 2006, J NEUROL NEUROSUR PS, V77, P1229, DOI 10.1136/jnnp.2005.083998; LI CL, 1969, EXP NEUROL, V24, P298, DOI 10.1016/0014-4886(69)90023-5; LORDEN JF, 1992, EXP NEUROL, V118, P95, DOI 10.1016/0014-4886(92)90026-M; Manto MU, 2005, CEREBELLUM, V4, P2, DOI 10.1080/14734220510007914; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Muller U, 2009, BRAIN, V132, P2005, DOI 10.1093/brain/awp172; NIEOULLON A, 1978, BRAIN RES, V148, P143, DOI 10.1016/0006-8993(78)90384-0; Pizoli CE, 2002, J NEUROSCI, V22, P7825; RATCHESON RA, 1969, EXP NEUROL, V25, P268, DOI 10.1016/0014-4886(69)90050-8; Richter A, 1998, MOVEMENT DISORD, V13, P718, DOI 10.1002/mds.870130419; Rousseaux M, 1996, REV NEUROL, V152, P732; Ruktanonchai DJ, 1998, PHYSIOL BEHAV, V63, P403, DOI 10.1016/S0031-9384(97)00457-5; RUMBACH L, 1995, MOVEMENT DISORD, V10, P522, DOI 10.1002/mds.870100424; Sotnikova TD, 2005, PLOS BIOL, V3, P1488, DOI 10.1371/journal.pbio.0030271; Stacy MA, 2006, HDB DYSTONIA; Tanabe LM, 2009, NAT REV NEUROL, V5, P598, DOI 10.1038/nrneurol.2009.160; URAYAMA O, 1988, BIOCHEM BIOPH RES CO, V156, P796, DOI 10.1016/S0006-291X(88)80914-8; Weidemann H, 2004, J NEUROENDOCRINOL, V16, P458, DOI 10.1111/j.1365-2826.2004.01181.x; Yoon JH, 2007, ARCH NEUROL-CHICAGO, V64, P1652, DOI 10.1001/archneur.64.11.1652; Zadro I, 2008, MOVEMENT DISORD, V23, P919, DOI 10.1002/mds.21981; ZERVAS NT, 1967, CONFIN NEUROL, V29, P93; Zhang YR, 2010, CLIN EXP PHARMACOL P, V37, P613, DOI 10.1111/j.1440-1681.2010.05364.x; Zhang YR, 2010, J COMP PHYSIOL B, V180, P117, DOI 10.1007/s00360-009-0391-z	49	164	165	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					357	365		10.1038/nn.2753	http://dx.doi.org/10.1038/nn.2753			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21297628	Green Accepted			2022-12-17	WOS:000287650100017
J	Fredj, NB; Burrone, J				Fredj, Naila Ben; Burrone, Juan			A resting pool of vesicles is responsible for spontaneous vesicle fusion at the synapse	NATURE NEUROSCIENCE			English	Article							SPONTANEOUS NEUROTRANSMITTER RELEASE; PRESYNAPTIC TERMINALS; TRANSMITTER RELEASE; SYNAPTOTAGMIN-I; PROTEINS; SYNAPTOPHLUORIN; TRANSMISSION; MOBILIZATION; POPULATIONS; EXOCYTOSIS	Synapses relay information through the release of neurotransmitters stored in presynaptic vesicles. The identity, kinetics and location of the vesicle pools that are mobilized by neuronal activity have been studied using a variety of techniques. We created a genetically encoded probe, biosyn, which consists of a biotinylated VAMP2 expressed at presynaptic terminals. We exploited the high-affinity interaction between streptavidin and biotin to label biosyn with fluorescent streptavidin during vesicle fusion. This approach allowed us to tag vesicles sequentially to visualize and establish the identity of presynaptic pools. Using this technique, we were able to distinguish between two different pools of vesicles in rat hippocampal neurons: one that was released in response to presynaptic activity and another, distinct vesicle pool that spontaneously fused with the plasma membrane. We found that the spontaneous vesicles belonged to a 'resting pool' that is normally not mobilized by neuronal activity and whose function was previously unknown.	[Fredj, Naila Ben; Burrone, Juan] Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England	University of London; King's College London	Burrone, J (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England.	juan.burrone@kcl.ac.uk	Burrone, Juan/C-5654-2009	Burrone, Juan/0000-0003-1233-668X	Medical Research Council; Wellcome Trust; MRC [G9900989, G0600197] Funding Source: UKRI; Medical Research Council [G0600197, G9900989] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank O. Burrone for kindly donating the modified BirA expression construct and for helpful advice and discussion on experimental protocols. We would also like to thank I. Thompson and the members of the Thompson and Burrone laboratories for helpful discussions and suggestions. We would finally like to thank V. N. Murthy for his input in the initial stages of this project and L. Lagnado, Q. Ch'ng, M. Grubb and L. Andreae for critical reading of the manuscript. This work was supported by a Medical Research Council project grant and a Wellcome Trust project grant to J.B.	Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Atasoy D, 2008, J NEUROSCI, V28, P10151, DOI 10.1523/JNEUROSCI.2432-08.2008; Burrone J, 2006, NAT PROTOC, V1, P2970, DOI 10.1038/nprot.2006.449; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Deitcher DL, 1998, J NEUROSCI, V18, P2028; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Fernandez-Alfonso T, 2008, BRAIN CELL BIOL, V36, P87, DOI 10.1007/s11068-008-9030-y; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Groemer TW, 2007, NAT NEUROSCI, V10, P145, DOI 10.1038/nn1831; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980; Katz B., 1969, RELEASE NEURAL TRANS; Li ZY, 2005, P NATL ACAD SCI USA, V102, P6131, DOI 10.1073/pnas.0501145102; Mathew SS, 2008, J NEUROSCI, V28, P725, DOI 10.1523/JNEUROSCI.3625-07.2008; Maximov A, 2007, J CELL BIOL, V176, P113, DOI 10.1083/jcb.200607021; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004; Poskanzer KE, 2004, NEUROPHARMACOLOGY, V47, P714, DOI 10.1016/j.neuropharm.2004.07.026; Prange O, 1999, J NEUROSCI, V19, P6427; Predonzani A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-41; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Sabatini BL, 1999, ANNU REV PHYSIOL, V61, P521, DOI 10.1146/annurev.physiol.61.1.521; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schikorski T, 1997, J NEUROSCI, V17, P5858; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Zenisek D, 2008, P NATL ACAD SCI USA, V105, P4922, DOI 10.1073/pnas.0709067105	36	164	165	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2009	12	6					751	U102		10.1038/nn.2317	http://dx.doi.org/10.1038/nn.2317			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	450DJ	19430474	Green Accepted			2022-12-17	WOS:000266380900019
J	Armentano, M; Chou, SJ; Tomassy, GS; Leingaertner, A; O'Leary, DDM; Studer, M				Armentano, Maria; Chou, Shen-Ju; Tomassy, Giulio Srubek; Leingaertner, Axel; O'Leary, Dennis D. M.; Studer, Michele			COUP-TFI regulates the balance of cortical patterning between frontal/motor and sensory areas	NATURE NEUROSCIENCE			English	Article							THALAMOCORTICAL AXONS; CEREBRAL-CORTEX; DIFFERENTIAL EXPRESSION; DEVELOPING NEOCORTEX; EMX2; PAX6; REGIONALIZATION; SPECIFICATION; FOREBRAIN; NEURONS	We used cortex-specific deletion of the transcription factor gene COUP-TFI (also known as Nr2f1) in mice to demonstrate previously unknown fundamental roles for it in patterning mammalian neocortex into areas. The highest COUP-TFI expression is observed in the cortical progenitors and progeny in parietal and occipital cortex that form sensory areas, and the lowest expression was observed in frontal cortex that includes motor areas. Cortical deletion of COUP-TFI resulted in massive expansion of frontal areas, including motor, to occupy most of neocortex, paralleled by marked compression of sensory areas to caudal occipital cortex. These area patterning changes are preceded and paralleled by corresponding changes in molecular markers of area identity and altered axonal projections to maintain patterned area-specific input and output connections. We conclude that COUP-TFI is required for balancing patterning of neocortex into frontal/motor and sensory areas by acting in its expression domain to repress frontal/motor area identities and to specify sensory area identities.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; TIGEM, Dev Disorders Program, I-80131 Naples, Italy	Salk Institute; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	doleary@salk.edu; studer@tigem.it	Studer, Michele/P-4580-2016	Studer, Michele/0000-0001-7105-2957	NINDS NIH HHS [R01 NS50646, R37 NS31558] Funding Source: Medline; Telethon [TGM06A04, TGM06S01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050646, R37NS031558] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Armentano M, 2006, DEVELOPMENT, V133, P4151, DOI 10.1242/dev.02600; Bishop KM, 2002, J NEUROSCI, V22, P7627; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Braisted JE, 1999, DEV BIOL, V208, P430, DOI 10.1006/dbio.1999.9216; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; FUJIMIYA M, 1986, J COMP NEUROL, V246, P191, DOI 10.1002/cne.902460205; Fukuchi-Shimogori T, 2003, NAT NEUROSCI, V6, P825, DOI 10.1038/nn1093; Gorski JA, 2002, J NEUROSCI, V22, P6309; Grove EA, 2003, ANNU REV NEUROSCI, V26, P355, DOI 10.1146/annurev.neuro.26.041002.131137; Hamasaki T, 2004, NEURON, V43, P359, DOI 10.1016/j.neuron.2004.07.016; Leingartner A, 2003, CEREB CORTEX, V13, P648, DOI 10.1093/cercor/13.6.648; Liu Q, 2000, J NEUROSCI, V20, P7682; Mackenzie D J, 1999, J Craniomaxillofac Trauma, V5, P9; Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Manuel M, 2007, DEVELOPMENT, V134, P545, DOI 10.1242/dev.02764; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Molnar Z, 1998, J NEUROSCI, V18, P5723; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Muzio L, 2002, CEREB CORTEX, V12, P129, DOI 10.1093/cercor/12.2.129; Nakagawa Y, 2003, DEV NEUROSCI-BASEL, V25, P234, DOI 10.1159/000072271; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rash BG, 2006, CURR OPIN NEUROBIOL, V16, P25, DOI 10.1016/j.conb.2006.01.004; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Stoykova A, 2000, J NEUROSCI, V20, P8042; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Takeuchi A, 2007, CEREB CORTEX, V17, P1531, DOI 10.1093/cercor/bhl064; Tripodi M, 2004, DEVELOPMENT, V131, P6119, DOI 10.1242/dev.01530; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	33	164	166	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1277	1286		10.1038/nn1958	http://dx.doi.org/10.1038/nn1958			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828260				2022-12-17	WOS:000249720800014
J	Kiyonaka, S; Wakamori, M; Miki, T; Uriu, Y; Nonaka, M; Bito, H; Beedle, AM; Mori, E; Hara, Y; De Waard, M; Kanagawa, M; Itakura, M; Takahashi, M; Campbell, KP; Mori, Y				Kiyonaka, Shigeki; Wakamori, Minoru; Miki, Takafumi; Uriu, Yoshitsugu; Nonaka, Mio; Bito, Haruhiko; Beedle, Aaron M.; Mori, Emiko; Hara, Yuji; De Waard, Michel; Kanagawa, Motoi; Itakura, Makoto; Takahashi, Masami; Campbell, Kevin P.; Mori, Yasuo			RIM1 confers sustained activity and neurotransmitter vesicle anchring to presynaptic Ca+2 channels	NATURE NEUROSCIENCE			English	Article							VOLTAGE-DEPENDENT INACTIVATION; NEURONAL CALCIUM-CHANNELS; I-II-LOOP; CA2+ CHANNELS; BETA-SUBUNIT; N-TYPE; SYNAPTIC-TRANSMISSION; RAB3 EFFECTOR; PROTEIN; RELEASE	The molecular organization of presynaptic active zones is important for the neurotransmitter release that is triggered by depolarization-induced Ca2+ influx. Here, we demonstrate a previously unknown interaction between two components of the presynaptic active zone, RIM1 and voltage-dependent Ca2+ channels (VDCCs), that controls neurotransmitter release in mammalian neurons. RIM1 associated with VDCC beta-subunits via its C terminus to markedly suppress voltage-dependent inactivation among different neuronal VDCCs. Consistently, in pheochromocytoma neuroendocrine PC12 cells, acetylcholine release was significantly potentiated by the full-length and C-terminal RIM1 constructs, but membrane docking of vesicles was enhanced only by the full-length RIM1. The beta construct beta-AID dominant negative, which disrupts the RIM1-beta association, accelerated the inactivation of native VDCC currents, suppressed vesicle docking and acetylcholine release in PC12 cells, and inhibited glutamate release in cultured cerebellar neurons. Thus, RIM1 association with b in the presynaptic active zone supports release via two distinct mechanisms: sustaining Ca2+ influx through inhibition of channel inactivation, and anchoring neurotransmitter-containing vesicles in the vicinity of VDCCs.	Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan; Univ Tokyo, Grad Sch Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan; Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; INSERM, U607, Lab Canaux Calc Fonct & Pathol, F-38054 Grenoble 09, France; Kitasato Univ, Sch Med, Dept Biochem, Sagamihara, Kanagawa 2288555, Japan	Kyoto University; University of Tokyo; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; Institut National de la Sante et de la Recherche Medicale (Inserm); Kitasato University	Mori, Y (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Katsura Campus,Nishikyo Ku, Kyoto 6158510, Japan.	mori@sbchem.kyoto-u.ac.jp	Beedle, Aaron M/K-1902-2015; De Waard, Michel/G-7406-2014; Beedle, Aaron/AAI-7014-2020; Bito, Haruhiko/A-8635-2008; Kiyonaka, Shigeki/AAM-7303-2021; Wakamori, Minoru/AAE-2661-2019	Beedle, Aaron M/0000-0002-1019-3235; De Waard, Michel/0000-0002-2782-9615; Kanagawa, Motoi/0000-0003-0984-6398; Bito, Haruhiko/0000-0001-6315-9594; Campbell, Kevin/0000-0003-2066-5889; Wakamori, Minoru/0000-0001-8574-3310				Atwood HL, 2006, SCIENCE, V312, P1008, DOI 10.1126/science.1128445; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Burgess DL, 1999, MOL CELL NEUROSCI, V13, P293, DOI 10.1006/mcne.1999.0748; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Geib S, 2002, J BIOL CHEM, V277, P10003, DOI 10.1074/jbc.M106231200; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Kang MG, 2006, P NATL ACAD SCI USA, V103, P5561, DOI 10.1073/pnas.0601289103; Khanna R, 2006, NEUROSCIENCE, V140, P1201, DOI 10.1016/j.neuroscience.2006.04.053; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Liu HY, 1996, J NEUROSCI, V16, P7557; Maximov A, 2002, J NEUROSCI, V22, P6939; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Nishiki T, 1997, BIOCHEM BIOPH RES CO, V239, P57, DOI 10.1006/bbrc.1997.7427; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Nonaka M, 2006, J NEUROSCI, V26, P763, DOI 10.1523/JNEUROSCI.2489-05.2006; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schoch S, 2006, EMBO J, V25, P5852, DOI 10.1038/sj.emboj.7601425; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Spafford JD, 2003, CURR OPIN NEUROBIOL, V13, P308, DOI 10.1016/S0959-4388(03)00061-8; Stanley EF, 2003, EUR J NEUROSCI, V17, P1303, DOI 10.1046/j.1460-9568.2003.02536.x; Stotz SC, 2000, J BIOL CHEM, V275, P24575, DOI 10.1074/jbc.M000399200; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; Vendel AC, 2006, J NEUROSCI, V26, P2635, DOI 10.1523/JNEUROSCI.0067-06.2006; WANG L, 2000, CHEM J INTERNET, V2, P44; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2003, GENOMICS, V81, P126, DOI 10.1016/S0888-7543(02)00024-1; Weimer RM, 2006, J NEUROSCI, V26, P8040, DOI 10.1523/JNEUROSCI.2350-06.2006; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	50	164	170	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					691	701		10.1038/nn1904	http://dx.doi.org/10.1038/nn1904			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17496890	Green Accepted, Green Submitted			2022-12-17	WOS:000246799800011
J	McKay, LC; Janczewski, WA; Feldman, JL				McKay, LC; Janczewski, WA; Feldman, JL			Sleep-disordered breathing after targeted ablation of preBotzinger complex neurons	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MULTIPLE SYSTEM ATROPHY; DISEASE	Ablation of preBotzinger complex (preBotC) neurons, critical for respiratory rhythm generation, resulted in a progressive, increasingly severe disruption of respiratory pattern, initially during sleep and then also during wakefulness in adult rats. Sleep-disordered breathing is highly prevalent in elderly humans and in some patients with neurodegenerative disease. We propose that sleep-disordered breathing results from loss of preBotC neurons and could underlie death during sleep in these populations.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Feldman, JL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	feldman@ucla.edu	feldman, jack/AAO-7505-2021	feldman, jack/0000-0003-3692-9412; McKay, Leanne/0000-0003-4012-1985	NHLBI NIH HHS [R01 HL070029, HL70029, R01 HL070029-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070029] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALEXIANU ME, 1994, ANN NEUROL, V36, P846, DOI 10.1002/ana.410360608; Alheid GF, 2002, J NEUROCYTOL, V31, P693, DOI 10.1023/A:1025799830302; Benarroch EE, 2003, BRAIN, V126, P2183, DOI 10.1093/brain/awg220; Berry RB, 1997, SLEEP, V20, P654, DOI 10.1093/sleep/20.8.654; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Ferguson KA, 1996, CHEST, V110, P664, DOI 10.1378/chest.110.3.664; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; KRIEGER J, 1983, SLEEP, V6, P108, DOI 10.1093/sleep/6.2.108; Leung RST, 2001, AM J RESP CRIT CARE, V164, P2147, DOI 10.1164/ajrccm.164.12.2107045; Maria B, 2003, RESP MED, V97, P1151, DOI 10.1016/S0954-6111(03)00188-4; MENDELSON WB, 1988, PHYSIOL BEHAV, V43, P229, DOI 10.1016/0031-9384(88)90243-0; MUNSCHAUER FE, 1990, NEUROLOGY, V40, P677, DOI 10.1212/WNL.40.4.677; Siegel JM, 2004, J CLIN PSYCHIAT, V65, P4; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005	15	164	168	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1142	1144		10.1038/nn1517	http://dx.doi.org/10.1038/nn1517			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116455	Green Accepted			2022-12-17	WOS:000231483800011
J	Baunez, C; Dias, C; Cador, M; Amalric, M				Baunez, C; Dias, C; Cador, M; Amalric, M			The subthalamic nucleus exerts opposite control on cocaine and 'natural' rewards	NATURE NEUROSCIENCE			English	Article							HIGH-FREQUENCY STIMULATION; PREFRONTAL CORTEX; BASAL GANGLIA; REACTION-TIME; ORBITOFRONTAL CORTEX; BILATERAL LESIONS; NEURONAL-ACTIVITY; SEEKING BEHAVIOR; VENTRAL STRIATUM; DOPAMINE	A challenge in treating drug addicts is preventing their pathological motivation for the drug without impairing their general affective state toward natural reinforcers. Here we have shown that discrete lesions of the subthalamic nucleus greatly decreased the motivation of rats for cocaine while increasing it for food reward. The subthalamic nucleus, a key structure controlling basal ganglia outputs, is therefore able to oppositely modulate the effect of 'natural' rewards and drugs of abuse on behavior. Modulating the activity of the subthalamic nucleus might prove to be a new target for the treatment of cocaine addiction.	Univ Aix Marseille 1, CNRS, UMR 6155, Lab Neurobiol Cognit, F-13402 Marseille, France; Univ Bordeaux 2, CNRS, UMR 5541, Lab Neuropsychobiol Desadaptat, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Baunez, C (corresponding author), Univ Aix Marseille 1, CNRS, UMR 6155, Lab Neurobiol Cognit, F-13402 Marseille, France.	cbaunez@up.univ-mrs.fr	BAUNEZ, Christelle/B-2255-2008; Baunez, Christelle/J-6664-2019; Baunez, Christelle/L-9989-2019; LE MOINE, Catherine/E-2671-2014	Baunez, Christelle/0000-0002-4368-652X; Amalric, Marianne/0000-0002-9915-6763				Absher JR, 2000, NEUROPSY NEUROPSY BE, V13, P220; Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; BAUNEZ C, 1995, J NEUROSCI, V15, P6531; Baunez C, 2002, J NEUROSCI, V22, P562, DOI 10.1523/JNEUROSCI.22-02-00562.2002; Baunez C, 1997, EUR J NEUROSCI, V9, P2086, DOI 10.1111/j.1460-9568.1997.tb01376.x; Baunez C, 1999, PSYCHOPHARMACOLOGY, V141, P57, DOI 10.1007/s002130050806; BENAZZOUZ A, 1993, EUR J NEUROSCI, V5, P382, DOI 10.1111/j.1460-9568.1993.tb00505.x; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Carelli RM, 2002, PHYSIOL BEHAV, V76, P379, DOI 10.1016/S0031-9384(02)00760-6; Carelli RM, 2000, J NEUROSCI, V20, P4255; Chudasama Y, 2003, J NEUROSCI, V23, P5477; Darbaky Y, 2003, EUR J NEUROSCI, V18, P951, DOI 10.1046/j.1460-9568.2003.02803.x; DEPOORTERE RY, 1993, PHARMACOL BIOCHEM BE, V45, P539, DOI 10.1016/0091-3057(93)90503-L; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; GROENEWEGEN HJ, 1990, J COMP NEUROL, V294, P607, DOI 10.1002/cne.902940408; Hassani OK, 2001, J NEUROPHYSIOL, V85, P2477, DOI 10.1152/jn.2001.85.6.2477; Henderson JM, 1999, EUR J NEUROSCI, V11, P2749, DOI 10.1046/j.1460-9568.1999.00692.x; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Hollerman JR, 1998, J NEUROPHYSIOL, V80, P947, DOI 10.1152/jn.1998.80.2.947; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; Ito R, 2002, J NEUROSCI, V22, P6247; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Krack P, 2001, BASAL GANGLIA AND THALAMUS IN HEALTH AND MOVEMENT DISORDERS, P333; LIMOUSIN P, 1995, LANCET, V345, P91, DOI 10.1016/S0140-6736(95)90062-4; Lorrain DS, 2000, BEHAV BRAIN RES, V107, P9, DOI 10.1016/S0166-4328(99)00109-6; Mallet L, 2002, LANCET, V360, P1302, DOI 10.1016/S0140-6736(02)11339-0; Maurice N, 1998, J NEUROSCI, V18, P9539; Maurice N, 1998, SYNAPSE, V29, P363, DOI 10.1002/(SICI)1098-2396(199808)29:4<363::AID-SYN8>3.0.CO;2-3; Moro E, 1999, NEUROLOGY, V53, P85, DOI 10.1212/WNL.53.1.85; Phillips JM, 1999, EUR J NEUROSCI, V11, P1003, DOI 10.1046/j.1460-9568.1999.00509.x; Piazza PV, 2000, J NEUROSCI, V20, P4226; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; PONTIERI FE, 1995, EUR J PHARMACOL, V284, P205, DOI 10.1016/0014-2999(95)00441-M; Porrino LJ, 2004, J NEUROSCI, V24, P3554, DOI 10.1523/JNEUROSCI.5578-03.2004; ROBLEDO P, 1993, BEHAV BRAIN RES, V55, P159, DOI 10.1016/0166-4328(93)90112-4; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Trepanier LL, 2000, BRAIN COGNITION, V42, P324, DOI 10.1006/brcg.1999.1108; TRILLET M, 1995, REV NEUROL, V151, P416; Turner MS, 2001, J NEUROSCI, V21, P2820, DOI 10.1523/JNEUROSCI.21-08-02820.2001; Uslaner JM, 2003, EUR J NEUROSCI, V17, P2180, DOI 10.1046/j.1460-9568.2003.02638.x; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Volkow ND, 2002, NEUROBIOL LEARN MEM, V78, P610, DOI 10.1006/nlme.2002.4099; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; WHITTIER JR, 1947, ARCH NEURO PSYCHIATR, V58, P672, DOI 10.1001/archneurpsyc.1947.02300350022002	50	164	167	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					484	489		10.1038/nn1429	http://dx.doi.org/10.1038/nn1429			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15793577				2022-12-17	WOS:000228040400019
J	Kapfer, C; Seidl, AH; Schweizer, H; Grothe, B				Kapfer, C; Seidl, AH; Schweizer, H; Grothe, B			Experience-dependent refinement of inhibitory inputs to auditory coincidence-detector neurons	NATURE NEUROSCIENCE			English	Article							MEDIAL SUPERIOR OLIVE; SYNAPSE ELIMINATION; PYRAMIDAL CELLS; BRAIN-STEM; HIPPOCAMPAL-NEURONS; CRITICAL PERIOD; TRAPEZOID BODY; GUINEA-PIG; RECEPTORS; NUCLEUS	The spatial arrangement of inputs on to single neurons is assumed to be crucial in accurate signal processing. In mammals, the most precise temporal processing occurs in the context of sound localization. Medial superior olivary neurons can encode microsecond differences in the arrival time of low-frequency sounds at the two ears. Here we show that in mammals with well developed low-frequency hearing, a spatial refinement of ionotropic inhibitory inputs occurs on medial superior olivary neurons during development. This refinement is experience dependent and does not develop in mammals that do not use interaural time differences for sound localization.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; Univ Munich, Inst Zool, D-80333 Munich, Germany	Max Planck Society; University of Munich	Grothe, B (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18A, D-82152 Martinsried, Germany.	bgrothe@neuro.mpg.de	Grothe, Benedikt/A-7877-2010	Grothe, Benedikt/0000-0001-7317-0615				Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; Alvarez FJ, 1997, J COMP NEUROL, V379, P150; ASCHENBERGER H, 2000, J NEUROSCI, V20, P9162; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; CANT NB, 1992, HEARING RES, V58, P26, DOI 10.1016/0378-5955(92)90005-8; CHAPMAN B, 1986, NATURE, V324, P154, DOI 10.1038/324154a0; CLARK GM, 1969, BRAIN RES, V14, P293, DOI 10.1016/0006-8993(69)90111-5; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; ERULKAR SD, 1972, PHYSIOL REV, V52, P237, DOI 10.1152/physrev.1972.52.1.237; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; GROTHE B, 1994, J NEUROSCI, V14, P1701, DOI 10.1523/JNEUROSCI.14-03-01701.1994; Grothe B, 2000, PROG NEUROBIOL, V61, P581, DOI 10.1016/S0301-0082(99)00068-4; Grothe B, 1998, J NEUROSCI, V18, P6608; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; HEFFNER RS, 1988, BEHAV NEUROSCI, V102, P422, DOI 10.1037/0735-7044.102.3.422; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; INBODY SB, 1981, BRAIN RES, V210, P361, DOI 10.1016/0006-8993(81)90910-0; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; Kakizawa S, 2000, J NEUROSCI, V20, P4954; KANDLER K, 1995, J NEUROSCI, V15, P6890; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; Komatsu Y, 1996, J NEUROSCI, V16, P6342; Kotak VC, 2000, J NEUROSCI, V20, P5820, DOI 10.1523/JNEUROSCI.20-15-05820.2000; LANGFORD TL, 1984, HEARING RES, V15, P39, DOI 10.1016/0378-5955(84)90223-5; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lin B, 2000, EUR J NEUROSCI, V12, P4155, DOI 10.1111/j.1460-9568.2000.01311.x; Nyiri G, 2001, EUR J NEUROSCI, V13, P428, DOI 10.1046/j.1460-9568.2001.01407.x; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; PERKINS RE, 1973, J COMP NEUROL, V148, P387, DOI 10.1002/cne.901480306; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rietzel HJ, 1998, J COMP NEUROL, V390, P20; RUSSELL FA, 1995, J COMP NEUROL, V352, P607, DOI 10.1002/cne.903520409; SANES DH, 1993, EUR J NEUROSCI, V5, P570, DOI 10.1111/j.1460-9568.1993.tb00522.x; SANES DH, 1992, J COMP NEUROL, V321, P637, DOI 10.1002/cne.903210410; SANES DH, 1988, J NEUROSCI, V8, P682; SANES DH, 1993, J NEUROSCI, V13, P2627, DOI 10.1523/JNEUROSCI.13-06-02627.1993; Simon JZ, 1999, NEUROCOMPUTING, V26-7, P263, DOI 10.1016/S0925-2312(99)00020-X; Smith PH, 1998, J NEUROPHYSIOL, V79, P3127, DOI 10.1152/jn.1998.79.6.3127; SMITH PH, 1993, J COMP NEUROL, V331, P245, DOI 10.1002/cne.903310208; SPITZER MW, 1995, J NEUROPHYSIOL, V73, P1668, DOI 10.1152/jn.1995.73.4.1668; Suneja SK, 1998, EXP NEUROL, V154, P473, DOI 10.1006/exnr.1998.6946; VATER M, 1995, J COMP NEUROL, V358, P155, DOI 10.1002/cne.903580202; WITHINGTONWRAY DJ, 1990, EUR J NEUROSCI, V2, P693, DOI 10.1111/j.1460-9568.1990.tb00459.x; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465	48	164	168	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					247	253		10.1038/nn810	http://dx.doi.org/10.1038/nn810			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850629				2022-12-17	WOS:000174146000015
J	Dobbin, MM; Madabhushi, R; Pan, L; Chen, Y; Kim, D; Gao, J; Ahanonu, B; Pao, PC; Qiu, Y; Zhao, YM; Tsai, LH				Dobbin, Matthew M.; Madabhushi, Ram; Pan, Ling; Chen, Yue; Kim, Dohoon; Gao, Jun; Ahanonu, Biafra; Pao, Ping-Chieh; Qiu, Yi; Zhao, Yingming; Tsai, Li-Huei			SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons	NATURE NEUROSCIENCE			English	Article							DNA-DAMAGE; CROSS-LINKING; STRAND BREAKS; I-TASSER; CHROMATIN; ACTIVATION; ACETYLATION; PROTEINS; REPAIR; P53	Defects in DNA repair have been linked to cognitive decline with age and neurodegenerative disease, yet the mechanisms that protect neurons from genotoxic stress remain largely obscure. We sought to characterize the roles of the NAD+-dependent deacetylase SIRT1 in the neuronal response to DNA double-strand breaks (DSBs). We found that SIRT1 was rapidly recruited to DSBs in postmitotic neurons, where it showed a synergistic relationship with ataxia telangiectasia mutated (ATM). SIRT1 recruitment to breaks was ATM dependent; however, SIRT1 also stimulated ATM autophosphorylation and activity and stabilized ATM at DSB sites. After DSB induction, SIRT1 also bound the neuroprotective class I histone deacetylase HDAC1. We found that SIRT1 deacetylated HDAC1 and stimulated its enzymatic activity, which was necessary for DSB repair through the nonhomologous end-joining pathway. HDAC1 mutations that mimic a constitutively acetylated state rendered neurons more susceptible to DNA damage, whereas pharmacological SIRT1 activators that promoted HDAC1 deacetylation also reduced DNA damage in two mouse models of neurodegeneration. We propose that SIRT1 is an apical transducer of the DSB response and that SIRT1 activation offers an important therapeutic avenue in neurodegeneration.	[Dobbin, Matthew M.; Madabhushi, Ram; Pan, Ling; Gao, Jun; Ahanonu, Biafra; Pao, Ping-Chieh; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Dobbin, Matthew M.; Madabhushi, Ram; Pan, Ling; Gao, Jun; Ahanonu, Biafra; Pao, Ping-Chieh; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Dobbin, Matthew M.; Madabhushi, Ram; Pan, Ling; Gao, Jun; Ahanonu, Biafra; Pao, Ping-Chieh; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Chen, Yue; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Chen, Yue; Zhao, Yingming] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China; [Kim, Dohoon] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Qiu, Yi] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Chicago; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Massachusetts Institute of Technology (MIT); Whitehead Institute; State University System of Florida; University of Florida	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Ahanonu, Biafra/AAY-8776-2020; Pan, Ling/K-9333-2013; Pao, Ping-Chieh/AAG-9742-2019	Ahanonu, Biafra/0000-0002-2021-5848; Pan, Ling/0000-0001-9947-9071; Pao, Ping-Chieh/0000-0001-6788-7185; , Yi/0000-0002-3282-6072	US National Institutes of Health (NIH) [AG27916]; Howard Hughes Medical Institute; Neurodegeneration Consortium; Glenn award for research in biological mechanisms of aging; NIH [R01 HL095674, U54 RR020389, T32 GM007484, T32 MH081728]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R36MH081728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027916, R01AG046174] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Neurodegeneration Consortium; Glenn award for research in biological mechanisms of aging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. W. Alt (Harvard Medical School) and E.N. Olson (University of Texas Southwestern Medical Center) for providing the Sirt1<SUP>loxP/loxP</SUP> and Hdac1<SUP>loxP/loxP</SUP> mice, respectively; R. Huganir (Johns Hopkins University) for providing the lentiviral Cre constructs; V. Suri, J. Ellis and G. Vlasuk (Sirtris) for providing compound # 10 and, together with J. Graff, for critical comments on the manuscript; M. Kastan (St. Jude's Medical Research Hospital) for gifting the I-PpoI-ER construct; and V. Gorbunova (University of Rochester) for providing the NHEJ constructs. This work was supported by funding from US National Institutes of Health (NIH) PO1 grant AG27916, the Howard Hughes Medical Institute, the Neurodegeneration Consortium and the Glenn award for research in biological mechanisms of aging to L.-H. T., NIH grant R01 HL095674 to Y.Q. and NIH grant U54 RR020389 to Y.Z.M.M.D. was supported by NIH training grants T32 GM007484 and T32 MH081728.	Adamec E, 1999, BRAIN RES, V849, P67, DOI 10.1016/S0006-8993(99)02004-1; Ball AR, 2011, CURR OPIN CELL BIOL, V23, P277, DOI 10.1016/j.ceb.2011.03.012; Berkovich E, 2008, NAT PROTOC, V3, P915, DOI 10.1038/nprot.2008.54; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Dai H, 2010, J BIOL CHEM, V285, P32695, DOI 10.1074/jbc.M110.133892; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; Dundr M, 2003, CURR PROTOC CELL BIO; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gan L, 2008, NEURON, V58, P10, DOI 10.1016/j.neuron.2008.03.015; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Haumaitre C, 2008, MOL CELL BIOL, V28, P6373, DOI 10.1128/MCB.00413-08; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kruhlak Michael J., 2009, V523, P125, DOI 10.1007/978-1-59745-190-1_9; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luo Y, 2009, J BIOL CHEM, V284, P34901, DOI 10.1074/jbc.M109.038356; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Peng LR, 2012, MOL CELL BIOL, V32, P2823, DOI 10.1128/MCB.00496-12; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Takamiya K, 2008, J NEUROSCI, V28, P5752, DOI 10.1523/JNEUROSCI.0654-08.2008; Vonesch C, 2008, IEEE T IMAGE PROCESS, V17, P539, DOI 10.1109/TIP.2008.917103; Yang T, 2012, J BIOL CHEM, V287, P40279, DOI 10.1074/jbc.M112.349704; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Yuan ZM, 1999, J BIOL CHEM, V274, P1883, DOI 10.1074/jbc.274.4.1883; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao YX, 2003, ANAL CHEM, V75, P3751, DOI 10.1021/ac034184m	50	163	170	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1008	U54		10.1038/nn.3460	http://dx.doi.org/10.1038/nn.3460			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23852118	Green Accepted, Green Submitted			2022-12-17	WOS:000322323000010
J	Chen, DY; Bambah-Mukku, D; Pollonini, G; Alberini, CM				Chen, Dillon Y.; Bambah-Mukku, Dhananjay; Pollonini, Gabriella; Alberini, Cristina M.			Glucocorticoid receptors recruit the CaMKII alpha-BDNF-CREB pathways to mediate memory consolidation	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; IMMEDIATE-EARLY GENE; STRESS; ACTIVATION; TRKB; PHOSPHORYLATION; HIPPOCAMPUS; PLASTICITY; BRAIN; TRANSCRIPTION	Emotionally important events are well remembered. Although memories of emotional experiences are known to be mediated and modulated by stress hormones such as glucocorticoids, little is known about the underlying molecular mechanisms. We found that the hippocampal glucocorticoid receptors that are critically engaged during the formation of long-term inhibitory avoidance memory in rats were coupled to the activation of CaMKII alpha, TrkB, ERK, Akt, PLC gamma and CREB, as well as a to a substantial induction of Arc and synaptic GluA1. Most of these changes, which are initiated by a nongenomic effect of glucocorticoid receptors, were also downstream of the activation of brain-derived neurotrophic factor (BDNF). Hippocampal administration of BDNF, but not of other neurotrophins, selectively rescued both the amnesia and the molecular impairments produced by glucocorticoid receptor inhibition. Thus, glucocorticoid receptors mediate long-term memory formation by recruiting the CaMKII alpha-BDNF-CREB-dependent neural plasticity pathways.	[Bambah-Mukku, Dhananjay; Pollonini, Gabriella; Alberini, Cristina M.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Chen, Dillon Y.; Bambah-Mukku, Dhananjay] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Chen, Dillon Y.; Bambah-Mukku, Dhananjay] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA	New York University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Alberini, CM (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	ca60@nyu.edu		Bambah-Mukku, Dhananjay/0000-0001-5822-6326	US National Institutes of Health [RO1-MH065635, F31-MH816213]; National Alliance for Research on Schizophrenia and Depression (NARSAD); Philoctetes Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065635, R37MH065635] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Philoctetes Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Stern, S. Sheng, S. Taubenfeld and S. Katz for technical assistance, A. Suzuki and X. Ye for comments on the manuscript, and R. Testi for valuable discussions. This work was supported by grants from the US National Institutes of Health (RO1-MH065635), National Alliance for Research on Schizophrenia and Depression (NARSAD) and the Philoctetes Foundation to C. M. A. and US National Institutes of Health grant F31-MH816213 to D.Y.C.	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Allaman I, 2004, J NEUROCHEM, V88, P900, DOI 10.1046/j.1471-4159.2003.02235.x; Alonso M, 2002, HIPPOCAMPUS, V12, P551, DOI 10.1002/hipo.10035; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Bekinschtein P, 2008, NEUROSCIENTIST, V14, P147, DOI 10.1177/1073858407305850; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; BLACK JW, 1964, LANCET, V1, P1081; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; BROGDEN RN, 1993, DRUGS, V45, P384, DOI 10.2165/00003495-199345030-00007; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Chameau P, 2007, J NEUROPHYSIOL, V97, P5, DOI 10.1152/jn.00821.2006; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; De Kloet ER, 2004, ANN NY ACAD SCI, V1018, P1, DOI 10.1196/annals.1296.001; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; DUNCAN GE, 1991, BRAIN RES, V561, P84, DOI 10.1016/0006-8993(91)90752-H; FANSELOW MS, 1993, J EXP PSYCHOL ANIM B, V19, P121, DOI 10.1037/0097-7403.19.2.121; Garcia-Osta A, 2006, J NEUROSCI, V26, P7919, DOI 10.1523/JNEUROSCI.1674-06.2006; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Jeanneteau F, 2008, P NATL ACAD SCI USA, V105, P4862, DOI 10.1073/pnas.0709102105; Ji JZ, 2003, EUR J NEUROSCI, V17, P1947, DOI 10.1046/j.1460-9568.2003.02620.x; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Liu WH, 2010, J BIOL CHEM, V285, P6101, DOI 10.1074/jbc.M109.050229; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; McGaugh JL, 2003, MEMORY EMOTION MAKIN; MCGUINNESS TL, 1989, J NEUROSCI, V9, P4138; McReynolds JR, 2010, NEUROBIOL LEARN MEM, V93, P312, DOI 10.1016/j.nlm.2009.11.005; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Molteni R, 2010, J PSYCHOPHARMACOL, V24, P595, DOI 10.1177/0269881108099815; Morimoto M, 1996, NEUROSCI RES, V26, P235, DOI 10.1016/S0168-0102(96)01105-4; Numakawa T, 2009, P NATL ACAD SCI USA, V106, P647, DOI 10.1073/pnas.0800888106; Ou LC, 2010, NEUROBIOL LEARN MEM, V93, P372, DOI 10.1016/j.nlm.2009.12.003; Pevzner A, 2012, NEUROBIOL LEARN MEM, V97, P313, DOI 10.1016/j.nlm.2012.02.004; Revest JM, 2010, MOL PSYCHIATR, V15, P1140, DOI 10.1038/mp.2010.40; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; Roozendaal B, 1997, EUR J NEUROSCI, V9, P76, DOI 10.1111/j.1460-9568.1997.tb01355.x; Sandi C, 2011, TRENDS NEUROSCI, V34, P165, DOI 10.1016/j.tins.2011.01.006; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Sindreu CB, 2007, NEURON, V53, P79, DOI 10.1016/j.neuron.2006.11.024; Takahashi T, 2002, J NEUROCHEM, V83, P1441, DOI 10.1046/j.1471-4159.2002.01251.x; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003	50	163	169	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1707	+		10.1038/nn.3266	http://dx.doi.org/10.1038/nn.3266			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23160045	Green Accepted			2022-12-17	WOS:000311706700017
J	Katzel, D; Zemelman, BV; Buetfering, C; Wolfel, M; Miesenbock, G				Kaetzel, Dennis; Zemelman, Boris V.; Buetfering, Christina; Woelfel, Markus; Miesenboeck, Gero			The columnar and laminar organization of inhibitory connections to neocortical excitatory cells	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; SOMATOSENSORY CORTEX; PYRAMIDAL CELLS; BARREL CORTEX; GABAERGIC INTERNEURONS; DISYNAPTIC INHIBITION; CORTICAL-NEURONS; MARTINOTTI CELLS; RAT NEOCORTEX; PHOTOSTIMULATION	The cytoarchitectonic similarities of different neocortical regions have given rise to the idea of 'canonical' connectivity between excitatory neurons of different layers within a column. It is unclear whether similarly general organizational principles also exist for inhibitory neocortical circuits. Here we delineate and compare local inhibitory-to-excitatory wiring patterns in all principal layers of primary motor (M1), somatosensory (S1) and visual (V1) cortex, using genetically targeted photostimulation in a mouse knock-in line that conditionally expresses channelrhodopsin-2 in GABAergic neurons. Inhibitory inputs to excitatory neurons derived largely from the same cortical layer within a three-column diameter. However, subsets of pyramidal cells in layers 2/3 and 5B received extensive translaminar inhibition. These neurons were prominent in V1, where they might correspond to complex cells, less numerous in barrel cortex and absent in M1. Although inhibitory connection patterns were stereotypical, the abundance of individual motifs varied between regions and cells, potentially reflecting functional specializations.	[Kaetzel, Dennis; Buetfering, Christina; Miesenboeck, Gero] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Zemelman, Boris V.; Woelfel, Markus; Miesenboeck, Gero] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	University of Oxford; Yale University	Miesenbock, G (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	gero.miesenboeck@dpag.ox.ac.uk	Buetfering, Christina/CAG-0104-2022; Buetfering, Christina/I-2879-2014	Miesenboeck, Gero/0000-0003-2940-3228; Zemelman, Boris/0000-0003-2463-4887; Katzel, Dennis/0000-0002-7334-9823	UK Medical Research Council; US National Institutes of Health; Dana Foundation; US Office of Naval Research; Boehringer Ingelheim Fonds; Christopher Welch Scholarship Fund; MRC [G0700888, G0701225] Funding Source: UKRI; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017297] Funding Source: NIH RePORTER; Medical Research Council [G0700888, G0701225] Funding Source: researchfish; Wellcome Trust [090309/Z/09/Z] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; US Office of Naval Research(Office of Naval Research); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Christopher Welch Scholarship Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank P. Chambon (Universite de Strasbourg), F. Costantini (Columbia University), S. Dymecki (Harvard Medical School), G. Nagel (Universitat Wurzburg) and P. Soriano (Mount Sinai School of Medicine) for plasmids and T. Ellender, M. Kohl, K. Lamsa, W. Nissen, T. Nottoli, R. Roorda, Y. Tan and L. Upton for assistance and/or discussions. This work was supported by the UK Medical Research Council (G. M.), the US National Institutes of Health (G.M.), the Dana Foundation (G.M.), the US Office of Naval Research (G.M.), the Boehringer Ingelheim Fonds (D.K.) and the Christopher Welch Scholarship Fund (D.K.).	Barbour DL, 2008, J NEUROSCI, V28, P11174, DOI 10.1523/JNEUROSCI.2093-08.2008; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Blatow M, 2005, J PHYSIOL-LONDON, V562, P99, DOI 10.1113/jphysiol.2004.078584; Brill J, 2009, J NEUROSCI, V29, P7413, DOI 10.1523/JNEUROSCI.6098-08.2009; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Chance FS, 2000, NETWORK-COMP NEURAL, V11, P119, DOI 10.1088/0954-898X/11/2/301; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Douglas RJ, 2007, NEURON, V56, P226, DOI 10.1016/j.neuron.2007.10.017; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1983, PROG BRAIN RES, V58, P209, DOI 10.1016/S0079-6123(08)60022-9; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hegemann P, 2001, J PHYCOL, V37, P668, DOI 10.1046/j.1529-8817.2001.01095.x; Helmstaedter M, 2009, CEREB CORTEX, V19, P926, DOI 10.1093/cercor/bhn141; Hirsch JA, 2003, CEREB CORTEX, V13, P63, DOI 10.1093/cercor/13.1.63; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Miesenbock G, 2005, ANNU REV NEUROSCI, V28, P533, DOI 10.1146/annurev.neuro.28.051804.101610; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Mountcastle V.B., 1978, MINDFUL BRAIN CORTIC, P7; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Otsuka T, 2009, J NEUROSCI, V29, P10533, DOI 10.1523/JNEUROSCI.2219-09.2009; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 1996, J PHYSIOL-LONDON, V496, P81, DOI 10.1113/jphysiol.1996.sp021667; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	49	163	164	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					100	U135		10.1038/nn.2687	http://dx.doi.org/10.1038/nn.2687			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21076426	Green Accepted			2022-12-17	WOS:000285684900020
J	Fritz, JB; David, SV; Radtke-Schuller, S; Yin, PB; Shamma, SA				Fritz, Jonathan B.; David, Stephen V.; Radtke-Schuller, Susanne; Yin, Pingbo; Shamma, Shihab A.			Adaptive, behaviorally gated, persistent encoding of task-relevant auditory information in ferret frontal cortex	NATURE NEUROSCIENCE			English	Article							PRIMATE PREFRONTAL CORTEX; RECEPTIVE-FIELDS; SELECTIVE REPRESENTATION; TOP-DOWN; ATTENTION; MEMORY; PLASTICITY; PREMOTOR; NEURONS; ORGANIZATION	Top-down signals from frontal cortex are thought to be important in cognitive control of sensory processing. To explore this interaction, we compared activity in ferret frontal cortex and primary auditory cortex (A1) during auditory and visual tasks requiring discrimination between classes of reference and target stimuli. Frontal cortex responses were behaviorally gated, selectively encoded the timing and invariant behavioral meaning of target stimuli, could be rapid in onset, and sometimes persisted for hours following behavior. These results are consistent with earlier findings in A1 that attention triggered rapid, selective, persistent, task-related changes in spectrotemporal receptive fields. Simultaneously recorded local field potentials revealed behaviorally gated changes in inter-areal coherence that were selectively modulated between frontal cortex and focal regions of A1 that were responsive to target sounds. These results suggest that A1 and frontal cortex dynamically establish a functional connection during auditory behavior that shapes the flow of sensory information and maintains a persistent trace of recent task-relevant stimulus features.	[Fritz, Jonathan B.; David, Stephen V.; Yin, Pingbo; Shamma, Shihab A.] Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; [Radtke-Schuller, Susanne] Univ Munich, Bioctr, Div Neurobiol, Munich, Germany	University System of Maryland; University of Maryland College Park; University of Munich	Fritz, JB (corresponding author), Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA.	ripple@umd.edu	Shamma, Shihab A/F-9852-2012; Fritz, Jonathan/AAK-4863-2020	Fritz, Jonathan/0000-0002-0625-172X; David, Stephen/0000-0003-4135-3104	US National Institutes of Health [R03DC005938, R01DC005779, F32DC008453]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007657, R03DC005938, F32DC008453, R01DC005779] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank A. Duque, J. Bizley, V. Bajo, F. Nodal and A. King for discussion and for generously sharing their unpublished neuroanatomical data on the ferret frontal cortex and its connectivity with auditory cortex, N. Mesgarani for assistance with customized MATLAB software development, M. Elhilali for discussion and for analysis of memory effects in A1, S. Gotts for discussion of LFP coherence, C. Carr for cheerfully sharing laboratory resources for neuroanatomical studies and A. Israelson, A. Rubin, K. Donaldson and D. Levitt for assistance in training the ferrets in this study. This research was funded by grants from the US National Institutes of Health (R03DC005938 to J. B. F., R01DC005779 to S. A. S. and J. B. F. and F32DC008453 to S. V. D.).	Anton-Erxleben K, 2009, CEREB CORTEX, V19, P2466, DOI 10.1093/cercor/bhp002; Baddeley Alan, 1986, WORKING MEMORY; Bizley JK, 2005, CEREB CORTEX, V15, P1637, DOI 10.1093/cercor/bhi042; Bodner M, 1996, NEUROREPORT, V7, P1905, DOI 10.1097/00001756-199608120-00006; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; DIPELLEGRINO G, 1993, SOMATOSENS MOT RES, V10, P245; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duque A, 2010, CEREB CORTEX, V20, P1020, DOI 10.1093/cercor/bhp164; Ehlis AC, 2009, NEUROSCIENCE, V159, P1032, DOI 10.1016/j.neuroscience.2009.01.015; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Everling S, 2006, EUR J NEUROSCI, V23, P2197, DOI 10.1111/j.1460-9568.2006.04736.x; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Frey S, 2008, PROG BRAIN RES, V169, P117, DOI 10.1016/S0079-6123(07)00007-6; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Fritz JB, 2005, J NEUROSCI, V25, P7623, DOI 10.1523/JNEUROSCI.1318-05.2005; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Fritz JB, 2007, J NEUROPHYSIOL, V98, P2337, DOI 10.1152/jn.00552.2007; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Funahashi S, 2006, NEUROSCIENCE, V139, P251, DOI 10.1016/j.neuroscience.2005.07.003; Fusi S, 2007, NEURON, V54, P319, DOI 10.1016/j.neuron.2007.03.017; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Golmayo L, 2003, NEUROSCIENCE, V119, P597, DOI 10.1016/S0306-4522(03)00031-9; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Jung MW, 2008, REV NEUROSCIENCE, V19, P29; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; Lemus L, 2009, P NATL ACAD SCI USA, V106, P14640, DOI 10.1073/pnas.0907505106; Messinger A, 2009, J NEUROSCI, V29, P5640, DOI 10.1523/JNEUROSCI.3857-08.2009; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitra P., 2008, OBSERVED BRAIN DYNAM; Morishima Y, 2009, NAT NEUROSCI, V12, P85, DOI 10.1038/nn.2237; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Murthy A, 2001, J NEUROPHYSIOL, V86, P2634, DOI 10.1152/jn.2001.86.5.2634; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rasmusson DD, 2007, NEUROSCIENCE, V149, P232, DOI 10.1016/j.neuroscience.2007.06.057; Roelfsema PR, 2010, TRENDS COGN SCI, V14, P64, DOI 10.1016/j.tics.2009.11.005; Romanski Lizabeth M., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P421, DOI 10.3758/CABN.4.4.421; Russ BE, 2007, HEARING RES, V229, P204, DOI 10.1016/j.heares.2006.10.010; Salinas E, 2009, J NEUROSCI, V29, P4369, DOI 10.1523/JNEUROSCI.0164-09.2009; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Woodman GF, 2007, CEREB CORTEX, V17, pI118, DOI 10.1093/cercor/bhm065	50	163	163	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					1011	U143		10.1038/nn.2598	http://dx.doi.org/10.1038/nn.2598			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20622871	Green Accepted			2022-12-17	WOS:000280400600021
J	Badre, D; Hoffman, J; Cooney, JW; D'Esposito, M				Badre, David; Hoffman, Joshua; Cooney, Jeffrey W.; D'Esposito, Mark			Hierarchical cognitive control deficits following damage to the human frontal lobe	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; PREMOTOR CORTEX; WORKING-MEMORY; ORGANIZATION; ARCHITECTURE; BEHAVIOR; MODEL; INFORMATION; SELECTION	Cognitive control permits us to make decisions about abstract actions, such as whether to e-mail versus call a friend, and to select the concrete motor programs required to produce those actions, based on our goals and knowledge. The frontal lobes are necessary for cognitive control at all levels of abstraction. Recent neuroimaging data have motivated the hypothesis that the frontal lobes are organized hierarchically, such that control is supported in progressively caudal regions as decisions are made at more concrete levels of action. We found that frontal damage impaired action decisions at a level of abstraction that was dependent on lesion location (rostral lesions affected more abstract tasks, whereas caudal lesions affected more concrete tasks), in addition to impairing tasks requiring more, but not less, abstract action control. Moreover, two adjacent regions were distinguished on the basis of the level of control, consistent with previous functional magnetic resonance imaging results. These results provide direct evidence for a rostro-caudal hierarchical organization of the frontal lobes.	[Badre, David] Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA; [Badre, David] Brown Univ, Dept Psychol, Providence, RI 02912 USA; [Hoffman, Joshua; Cooney, Jeffrey W.; D'Esposito, Mark] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [D'Esposito, Mark] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	Brown University; Brown University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Badre, D (corresponding author), Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA.	david_badre@brown.edu		Cooney, Jeffrey/0000-0002-9903-5400	US National Institutes of Health [MH63901, NS40813]; Veterans Administration Research Service; National Research Service Award [F32 NS053337]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS053337, P01NS040813] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Research Service(US Department of Veterans Affairs); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to R.T. Knight and D. Scabini for their help with patient recruitment and lesion characterization. We also would like to thank W. Heindel and A. Kayser for their input on revisions of this manuscript. This work was supported by the US National Institutes of Health (grants MH63901 and NS40813), the Veterans Administration Research Service and a National Research Service Award (F32 NS053337).	Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; BARBAS H, 1987, J COMP NEUROL, V256, P211, DOI 10.1002/cne.902560203; Botvinick MM, 2008, TRENDS COGN SCI, V12, P201, DOI 10.1016/j.tics.2008.02.009; Botvinick MM, 2007, PHILOS T R SOC B, V362, P1615, DOI 10.1098/rstb.2007.2056; Buckner RL, 2003, J NEUROSCI, V23, P3999; Bunge Silvia A., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P564; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Christoff K, 2003, BEHAV NEUROSCI, V117, P1161, DOI 10.1037/0735-7044.117.6.1161; Christoff K, 2007, PERSPECTIVES RULE GU; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Courtney S. M., 2007, WORKING MEMORY BEHAV, P369, DOI DOI 10.1093/ACPROF:OSO/9780198570394.003.0021; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Dreher JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003227; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Fuster J., 2015, PREFRONTAL CORTEX; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; HALSBAND U, 1985, BEHAV BRAIN RES, V18, P269, DOI 10.1016/0166-4328(85)90035-X; Hampshire A, 2007, J NEUROSCI, V27, P6219, DOI 10.1523/JNEUROSCI.0851-07.2007; Hampshire A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002520; Hazy TE, 2007, PHILOS T R SOC B, V362, P1601, DOI 10.1098/rstb.2007.2055; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Jeffreys H., 1961, THEORY PROBABILITY, V3; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; O'Reilly RC, 2002, CEREB CORTEX, V12, P246, DOI 10.1093/cercor/12.3.246; Passingham R.E., 2002, PRINCIPLES FRONTAL L, P221; Passingham RE., 1993, FRONTAL LOBES VOLUNT; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P873, DOI 10.1073/pnas.90.3.873; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Rowe JB, 2007, J NEUROSCI, V27, P13303, DOI 10.1523/JNEUROSCI.2349-07.2007; Rushworth MFS, 2005, J NEUROSCI, V25, P11628, DOI 10.1523/JNEUROSCI.2765-05.2005; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Stuss D., 1987, FRONTAL LOBES REVISI, P141; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081	50	163	163	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2009	12	4					515	522		10.1038/nn.2277	http://dx.doi.org/10.1038/nn.2277			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	424JN	19252496	Green Accepted			2022-12-17	WOS:000264563100027
J	Singh, KK; Park, KJ; Hong, EJ; Kramer, BM; Greenberg, ME; Kaplan, DR; Miller, FD				Singh, Karun K.; Park, Katya J.; Hong, Elizabeth J.; Kramer, Bianca M.; Greenberg, Michael E.; Kaplan, David R.; Miller, Freda D.			Developmental axon pruning mediated by BDNF-p75NTR-dependent axon degeneration	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; P75 NEUROTROPHIN RECEPTOR; SYMPATHETIC NEURONS; WALLERIAN DEGENERATION; TARGET INNERVATION; IN-VIVO; RAT EYE; TRKA; BDNF; SURVIVAL	The mechanisms that regulate the pruning of mammalian axons are just now being elucidated. Here, we describe a mechanism by which, during developmental sympathetic axon competition, winning axons secrete brain-derived neurotrophic factor (BDNF) in an activity-dependent fashion, which binds to the p75 neurotrophin receptor (p75NTR) on losing axons to cause their degeneration and, ultimately, axon pruning. Specifically, we found that pruning of rat and mouse sympathetic axons that project to the eye requires both activity-dependent BDNF and p75NTR. p75NTR and BDNF are also essential for activity-dependent axon pruning in culture, where they mediate pruning by directly causing axon degeneration. p75NTR, which is enriched in losing axons, causes axonal degeneration by suppressing TrkA-mediated signaling that is essential for axonal maintenance. These data provide a mechanism that explains how active axons can eliminate less-active, competing axons during developmental pruning by directly promoting p75NTR-mediated axonal degeneration.	[Singh, Karun K.; Park, Katya J.; Kramer, Bianca M.; Miller, Freda D.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Singh, Karun K.; Park, Katya J.; Kramer, Bianca M.; Kaplan, David R.; Miller, Freda D.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Park, Katya J.; Kaplan, David R.] Hosp Sick Children, Cell Biol Grp, Toronto, ON M5G 1X8, Canada; [Hong, Elizabeth J.; Greenberg, Michael E.] Childrens Hosp, Boston, MA 02115 USA; [Hong, Elizabeth J.; Greenberg, Michael E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kaplan, David R.; Miller, Freda D.] Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; [Miller, Freda D.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Toronto; University of Toronto	Miller, FD (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	fredam@sickkids.ca	Kramer, Bianca/M-3356-2014	Kramer, Bianca/0000-0002-5965-6560	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Atwal JK, 2003, J NEUROSCI, V23, P7602; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; CAMPENOT RB, 1991, J NEUROSCI, V11, P1126; CAMPENOT RB, 1981, SCIENCE, V214, P579, DOI 10.1126/science.7292000; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Cao LX, 2007, CURR BIOL, V17, P911, DOI 10.1016/j.cub.2007.04.040; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; COGGESHALL RE, 1984, J NEUROSCI METH, V12, P125, DOI 10.1016/0165-0270(84)90011-6; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; Dhanoa NK, 2006, EXP NEUROL, V198, P416, DOI 10.1016/j.expneurol.2005.12.022; Friedman WJ, 1998, NEUROSCIENCE, V84, P101, DOI 10.1016/S0306-4522(97)00526-5; Gan WB, 1998, SCIENCE, V282, P1508, DOI 10.1126/science.282.5393.1508; Hibbert AP, 2006, MOL CELL NEUROSCI, V32, P387, DOI 10.1016/j.mcn.2006.06.001; HILL CE, 1989, INT J DEV NEUROSCI, V7, P539, DOI 10.1016/0736-5748(89)90013-0; Kaplan DR, 2003, NAT NEUROSCI, V6, P435, DOI 10.1038/nn0503-435; Kohn J, 1999, J NEUROSCI, V19, P5393; Korhonen JM, 1999, J BIOL CHEM, V274, P37307, DOI 10.1074/jbc.274.52.37307; LAWRENCE JM, 1979, BRAIN RES, V168, P13, DOI 10.1016/0006-8993(79)90124-0; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MA Y, 1992, J CELL BIOL, V117, P135, DOI 10.1083/jcb.117.1.135; MacInnis BL, 2005, MOL CELL NEUROSCI, V28, P430, DOI 10.1016/j.mcn.2004.10.003; MacPhee IJ, 1997, J BIOL CHEM, V272, P23547, DOI 10.1074/jbc.272.38.23547; Majdan M, 1999, INT J DEV NEUROSCI, V17, P153, DOI 10.1016/S0736-5748(99)00016-7; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Michael GJ, 1997, J NEUROSCI, V17, P8476; Miller FD, 2001, CELL MOL LIFE SCI, V58, P1045, DOI 10.1007/PL00000919; MILLER FD, 1994, DEV BIOL, V161, P206, DOI 10.1006/dbio.1994.1021; MYTILINEOU C, 1976, BRAIN RES, V109, P382, DOI 10.1016/0006-8993(76)90538-2; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; Plachta N, 2007, NAT NEUROSCI, V10, P712, DOI 10.1038/nn1897; PURVES D, 1988, NATURE, V336, P123, DOI 10.1038/336123a0; Singh KK, 2005, NEURON, V45, P837, DOI 10.1016/j.neuron.2005.01.049; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; VIDOVIC M, 1987, DEV BRAIN RES, V32, P133, DOI 10.1016/0165-3806(87)90146-5; VIDOVIC M, 1988, J AUTONOM NERV SYST, V22, P57, DOI 10.1016/0165-1838(88)90154-3; Yeo TT, 1997, J NEUROSCI, V17, P7594; Yiu G, 2003, CURR OPIN NEUROBIOL, V13, P545, DOI 10.1016/j.conb.2003.09.006; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	45	163	166	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					649	658		10.1038/nn.2114	http://dx.doi.org/10.1038/nn.2114			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18382462				2022-12-17	WOS:000256133700011
J	Wang, XL; Zhang, MS; Cohen, IS; Goldberg, ME				Wang, Xiaolan; Zhang, Mingsha; Cohen, Ian S.; Goldberg, Michael E.			The proprioceptive representation of eye position in monkey primary somatosensory cortex	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; SUPERIOR COLLICULUS; COROLLARY DISCHARGE; MUSCLE PROPRIOCEPTION; VISUAL SPACE; AREA 3A; NEURONS; INFORMATION; MOVEMENTS; LOCALIZATION	The cerebral cortex must have access to an eye position signal, as humans can report passive changes in eye position in total darkness, and visual responses in many cortical areas are modulated by eye position. The source of this signal is unknown. Here we demonstrate a representation of eye position in monkey primary somatosensory cortex, in the representation of the trigeminal nerve, near cells with a tactile representation of the contralateral brow. The neurons have eye position signals that increase monotonically with increasing orbital eccentricity from near the center of gaze, with directionally selectivity tuned in a Gaussian manner. All directions of eye position are represented in a single hemisphere. The signal is proprioceptive, because it can be obliterated by anesthetizing the contralateral orbit. It is not related to foveal or peripheral visual stimulation, and it represents the position of the eye in the head and not the angle of gaze in space.	Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, Mahoney Ctr Brain & Behav, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University	Zhang, MS (corresponding author), Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, Mahoney Ctr Brain & Behav, 1051 Riverside Dr,Unit 87, New York, NY 10032 USA.	mz2132@columbia.edu			NEI NIH HHS [R24 EY015634, R01 EY014978, R21 EY017938, 1 R01 EY014978-01, R01 EY017039, 1 R24 EY015634-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY017039, R21EY017938, R24EY015634, R01EY014978] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSEN RA, 1983, J NEUROSCI, V3, P532; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bisley JW, 2004, J NEUROSCI, V24, P1833, DOI 10.1523/JNEUROSCI.5007-03.2004; Buttner-Ennever JA, 2002, CURR OPIN NEUROL, V15, P35, DOI 10.1097/00019052-200202000-00007; Campos M, 2006, J NEUROPHYSIOL, V95, P505, DOI 10.1152/jn.00639.2005; Dengis CA, 1998, EXP BRAIN RES, V119, P475, DOI 10.1007/s002210050363; Donaldson IML, 2000, PHILOS T R SOC B, V355, P1685, DOI 10.1098/rstb.2000.0732; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; DUHAMEL JR, 1992, BRAIN, V115, P1387, DOI 10.1093/brain/115.5.1387; Eberhorn AC, 2005, ANN NY ACAD SCI, V1039, P1, DOI 10.1196/annals.1325.001; GAUTHIER GM, 1990, SCIENCE, V249, P58, DOI 10.1126/science.2367852; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; Hays A., 1982, WESCON C P, V2, P1; HENN V, 1984, BRAIN, V107, P619, DOI 10.1093/brain/107.2.619; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Klier EM, 2003, J NEUROPHYSIOL, V89, P2839, DOI 10.1152/jn.00763.2002; Krubitzer L, 2004, J COMP NEUROL, V471, P97, DOI 10.1002/cne.20025; LAL R, 1990, J NEUROPHYSIOL, V63, P502, DOI 10.1152/jn.1990.63.3.502; LEWIS RF, 1994, J NEUROPHYSIOL, V72, P1028, DOI 10.1152/jn.1994.72.2.1028; Lewis RF, 1998, J NEUROPHYSIOL, V80, P1605, DOI 10.1152/jn.1998.80.3.1605; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; PHILLIPS CG, 1971, J PHYSIOL-LONDON, V217, P419, DOI 10.1113/jphysiol.1971.sp009579; PORTER JD, 1983, J COMP NEUROL, V218, P208, DOI 10.1002/cne.902180208; Pouget A, 1999, Prog Brain Res, V121, P81; RICHMOND BJ, 1980, J NEUROPHYSIOL, V43, P1156, DOI 10.1152/jn.1980.43.4.1156; ROBINSON DA, 1970, J NEUROPHYSIOL, V33, P393, DOI 10.1152/jn.1970.33.3.393; Rose D, 1999, PERCEPTION, V28, P675, DOI 10.1068/p2881; SAKATA H, 1980, J NEUROPHYSIOL, V43, P1654, DOI 10.1152/jn.1980.43.6.1654; SALINAS E, 1995, J NEUROSCI, V15, P6461; SKAVENSKI AA, 1972, VISION RES, V12, P221, DOI 10.1016/0042-6989(72)90113-7; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; STEINBACH MJ, 1986, ACTA PSYCHOL, V63, P297, DOI 10.1016/0001-6918(86)90049-1; STEINBACH MJ, 1987, VISION RES, V27, P1737, DOI 10.1016/0042-6989(87)90103-9; Taylor A, 2006, J PHYSIOL-LONDON, V571, P711, DOI 10.1113/jphysiol.2005.101634; VANOPSTAL AJ, 1995, J NEUROPHYSIOL, V74, P1593, DOI 10.1152/jn.1995.74.4.1593; Widener GL, 1997, J NEUROPHYSIOL, V77, P2446, DOI 10.1152/jn.1997.77.5.2446; WISE SP, 1981, J NEUROPHYSIOL, V45, P482, DOI 10.1152/jn.1981.45.3.482; WURTZ RH, 1969, J NEUROPHYSIOL, V32, P727, DOI 10.1152/jn.1969.32.5.727; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	41	163	164	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					640	646		10.1038/nn1878	http://dx.doi.org/10.1038/nn1878			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17396123				2022-12-17	WOS:000245948000021
J	Priebe, NJ; Mechler, F; Carandini, M; Ferster, D				Priebe, NJ; Mechler, F; Carandini, M; Ferster, D			The contribution of spike threshold to the dichotomy of cortical simple and complex cells	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; MONKEY STRIATE CORTEX; RECEPTIVE-FIELDS; ORIENTATION SELECTIVITY; FUNCTIONAL ARCHITECTURE; FREQUENCY-SELECTIVITY; SYNAPTIC INTEGRATION; CONTRAST INVARIANCE; IN-VIVO; AREA 17	The existence of two classes of cells, simple and complex, discovered by Hubel and Wiesel in 1962, is one of the fundamental features of cat primary visual cortex. A quantitative measure used to distinguish simple and complex cells is the ratio between modulated and unmodulated components of spike responses to drifting gratings, an index that forms a bimodal distribution. We have found that the modulation ratio, when derived from the subthreshold membrane potential instead of from spike rate, is unimodally distributed, but highly skewed. The distribution of the modulation ratio as derived from spike rate can, in turn, be predicted quantitatively by the nonlinear properties of spike threshold applied to the skewed distribution of the subthreshold modulation ratio. Threshold also increases the spatial segregation of ON and OFF regions of the receptive field, a defining attribute of simple cells. The distinction between simple and complex cells is therefore enhanced by threshold, much like the selectivity for stimulus features such as orientation and direction. In this case, however, a continuous distribution in the spatial organization of synaptic inputs is transformed into two distinct classes of cells.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Cornell Univ, Coll Med, Dept Neurol & Neurosci, New York, NY 10021 USA; Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	Northwestern University; Cornell University; The Smith-Kettlewell Eye Research Institute	Ferster, D (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2205 Tech Dr, Evanston, IL 60208 USA.	ferster@northwestern.edu	Carandini, Matteo/ABD-8296-2021; Carandini, Matteo/C-1922-2008	Carandini, Matteo/0000-0003-4880-7682; Carandini, Matteo/0000-0003-4880-7682	NEI NIH HHS [R01 EY009314-10, R01 EY009314] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009314] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Carandini M, 1996, J NEUROPHYSIOL, V76, P3425, DOI 10.1152/jn.1996.76.5.3425; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Conway BR, 2003, J NEUROPHYSIOL, V89, P2726, DOI 10.1152/jn.00550.2002; DEAN AF, 1983, J PHYSIOL-LONDON, V344, P305, DOI 10.1113/jphysiol.1983.sp014941; DEVALOIS RL, 1980, ANNU REV PSYCHOL, V31, P309, DOI 10.1146/annurev.ps.31.020180.001521; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; FOSTER KH, 1985, J PHYSIOL-LONDON, V365, P331, DOI 10.1113/jphysiol.1985.sp015776; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GLEZER VD, 1982, BIOL CYBERN, V43, P35, DOI 10.1007/BF00337286; GLEZER VD, 1980, BIOL CYBERN, V37, P195, DOI 10.1007/BF00337038; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; HEGGELUND P, 1986, J PHYSIOL-LONDON, V373, P277, DOI 10.1113/jphysiol.1986.sp016047; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2002, J PHYSIOL-LONDON, V540, P335, DOI 10.1113/jphysiol.2001.012777; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kagan I, 2002, J NEUROPHYSIOL, V88, P2557, DOI 10.1152/jn.00858.2001; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Martinez LM, 2001, NEURON, V32, P515, DOI 10.1016/S0896-6273(01)00489-5; MATA ML, IN PRESS J NEUROPHYS; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; REID RC, 1991, J NEUROPHYSIOL, V66, P505, DOI 10.1152/jn.1991.66.2.505; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Sokal R. R., 1995, BIOMETRY PRINCIPLES; SPITZER H, 1988, PROG NEUROBIOL, V31, P285, DOI 10.1016/0301-0082(88)90016-0; Tao L, 2004, P NATL ACAD SCI USA, V101, P366, DOI 10.1073/pnas.2036460100; Volgushev M, 1996, J PHYSIOL-LONDON, V496, P597, DOI 10.1113/jphysiol.1996.sp021711	46	163	164	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1113	1122		10.1038/nn1310	http://dx.doi.org/10.1038/nn1310			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15338009	Green Accepted			2022-12-17	WOS:000224156900021
J	Tarr, MJ; Warren, WH				Tarr, MJ; Warren, WH			Virtual reality in behavioral neuroscience and beyond	NATURE NEUROSCIENCE			English	Review							FLOW; TECHNOLOGY	Virtual reality (VR) has finally come of age for serious applications in the behavioral neurosciences. After capturing the public imagination a decade ago, enthusiasm for VR flagged due to hardware limitations, an absent commercial market and manufacturers who dropped the mass-market products that normally drive technological development. Recently, however, improvements in computer speed, quality of head-mounted displays and wide-area tracking systems have made VR attractive for both research and real-world applications in neuroscience, cognitive science and psychology. New and exciting applications for VR have emerged in research, training, rehabilitation, teleoperation, virtual archeology and tele-immersion.	Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA; Brown Univ, Brain Sci Program, Providence, RI 02912 USA	Brown University; Brown University	Tarr, MJ (corresponding author), Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA.		Warren, William H./AAX-7781-2021		NATIONAL EYE INSTITUTE [R01EY010923] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY010923] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aginsky V, 1997, J ENVIRON PSYCHOL, V17, P317, DOI 10.1006/jevp.1997.0070; [Anonymous], 2002, BBC NEWS ONLINE; Cruz-Neira C., 1994, COMMUN ACM, V35, P65; FOLEY JD, 1987, SCI AM, V257, P126, DOI 10.1038/scientificamerican1087-126; GIBSON JJ, 1979, ECOLOGICAL APPROACH, V3; HAFNER K, 1998, NY TIMES        1119; Kearns MJ, 2002, PERCEPTION, V31, P349, DOI 10.1068/p3311; Lanier J, 2001, SCI AM, V284, P66, DOI 10.1038/scientificamerican0401-66; Loomis JM, 1999, BEHAV RES METH INS C, V31, P557, DOI 10.3758/BF03200735; North MM, 1997, PRESENCE-TELEOP VIRT, V6, P127, DOI 10.1162/pres.1997.6.1.127; North MM, 1996, PRESENCE-TELEOP VIRT, V5, P346, DOI 10.1162/pres.1996.5.3.346; NORTH MN, 1998, VIRTUAL ENV CLIN PSY, P112; RIVA G, 1998, VIRTUAL ENV CLIN PSY, P191; Riva G., 1998, VIRTUAL ENV CLIN PSY; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Spiro JE, 2001, NAT NEUROSCI, V4, P120, DOI 10.1038/83930; van Veen HAHC, 1998, FUTURE GENER COMP SY, V14, P231, DOI 10.1016/S0167-739X(98)00027-2; Vote E, 2002, IEEE COMPUT GRAPH, V22, P38, DOI 10.1109/MCG.2002.1028725; Wanke L A, 1998, Pharm Pract Manag Q, V18, P13; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; ZHANG S, IN PRESS IEEE T VISU	22	163	166	2	55	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1089	1092		10.1038/nn948	http://dx.doi.org/10.1038/nn948			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403993				2022-12-17	WOS:000179041300021
J	Everling, S; Tinsley, CJ; Gaffan, D; Duncan, J				Everling, S; Tinsley, CJ; Gaffan, D; Duncan, J			Filtering of neural signals by focused attention in the monkey prefrontal cortex	NATURE NEUROSCIENCE			English	Article							SELECTIVE VISUAL-ATTENTION; GO/NO-GO DISCRIMINATION; FRONTAL EYE FIELD; TARGET SELECTION; PARIETAL CORTEX; UNIT-ACTIVITY; HUMAN BRAIN; NEURONS; MACAQUE; MECHANISMS	Prefrontal cortex is thought to be important in attention and awareness. Here we recorded the activity of prefrontal neurons in monkeys carrying out a focused attention task. Having directed attention to one location, monkeys monitored a stream of visual objects, awaiting a predefined target. Although neurons rarely discriminated between one non-target and another, they commonly discriminated between targets and non-targets. From the onset of the visual response, this target/non-target discrimination was effectively eliminated when the same objects appeared at an unattended location in the opposite visual hemifield. The results show that, in prefrontal cortex, filtering of ignored locations is strong, early and spatially global. Such filtering may be important in blindness to unattended signals-a conspicuous aspect of human selective attention.	MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Duncan, J (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 2EF, England.		Everling, Stefan/K-5208-2013; Everling, Stefan/AAR-8687-2020	Everling, Stefan/0000-0001-9714-9757; Duncan, John/0000-0002-9695-2764; Tinsley, Chris/0000-0002-9369-443X				BAYNES K, 1986, BRAIN, V109, P99, DOI 10.1093/brain/109.1.99; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Broadbent Donald Eric, 2013, PERCEPTION COMMUNICA; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dell'Acqua R, 2001, PERCEPT PSYCHOPHYS, V63, P777, DOI 10.3758/BF03194437; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 1999, J EXP PSYCHOL GEN, V128, P450, DOI 10.1037/0096-3445.128.4.450; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hasegawa RP, 2000, J NEUROPHYSIOL, V84, P1692, DOI 10.1152/jn.2000.84.3.1692; Jiang Y, 2000, SCIENCE, V287, P643, DOI 10.1126/science.287.5453.643; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; Reynolds JH, 1999, J NEUROSCI, V19, P1736; ROCK I, 1992, COGNITIVE PSYCHOL, V24, P502, DOI 10.1016/0010-0285(92)90017-V; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; SAKAGAMI M, 1994, EXP BRAIN RES, V97, P423; SATO T, 1988, J NEUROPHYSIOL, V60, P344, DOI 10.1152/jn.1988.60.1.344; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; Shulman GL, 2001, P NATL ACAD SCI USA, V98, P313, DOI 10.1073/pnas.021381198; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; VANVOORHIS S, 1977, PERCEPT PSYCHOPHYS, V22, P54, DOI 10.3758/BF03206080; WATANABE M, 1986, BRAIN RES, V382, P1, DOI 10.1016/0006-8993(86)90104-6; WATANABE M, 1986, BRAIN RES, V382, P15, DOI 10.1016/0006-8993(86)90105-8	37	163	166	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					671	676		10.1038/nn874	http://dx.doi.org/10.1038/nn874			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12068302				2022-12-17	WOS:000176414300017
J	Calton, JL; Dickinson, AR; Snyder, LH				Calton, JL; Dickinson, AR; Snyder, LH			Non-spatial, motor-specific activation in posterior parietal cortex	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; MACAQUE MONKEY; PREMOTOR CORTEX; PARIETOOCCIPITAL CORTEX; NEURONAL-ACTIVITY; REFERENCE FRAMES; CEREBRAL-CORTEX; VISUAL PATHWAYS; RESPONSES; REPRESENTATION	A localized cluster of neurons in macaque posterior parietal cortex, termed the parietal reach region (PRR), is activated when a reach is planned to a visible or remembered target. To explore the role of PRR in sensorimotor transformations, we tested whether cells would be activated when a reach is planned to an as-yet unspecified goal. Over one-third of PRR cells increased their firing after an instruction to prepare a reach, but not after an instruction to prepare a saccade, when the target of the movement remained unknown. A partially overlapping population (two-thirds of cells) was activated when the monkey was informed of the target location but not the type of movement to be made. Thus a subset of PRR neurons separately code spatial and effector-specific information, consistent with a role in specifying potential motor responses to particular targets.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Snyder, LH (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.		Snyder, Lawrence H/A-4593-2017		NIMH NIH HHS [F32 MH012145, F32 MH012145-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH012145] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ASSAD JA, 1995, NATURE, V373, P518, DOI 10.1038/373518a0; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Basso MA, 1998, J NEUROSCI, V18, P7519; Battaglia-Mayer A, 2000, J NEUROPHYSIOL, V83, P2374, DOI 10.1152/jn.2000.83.4.2374; Ben Hamed S, 2001, EXP BRAIN RES, V140, P127, DOI 10.1007/s002210100785; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Boussaoud D, 1999, EXP BRAIN RES, V128, P170, DOI 10.1007/s002210050832; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Cisek P, 2002, J NEUROPHYSIOL, V87, P1149, DOI 10.1152/jn.00443.2001; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; COLBY CL, 1991, NEUROPSYCHOLOGIA, V29, P517, DOI 10.1016/0028-3932(91)90008-V; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Colby CL, 1998, NEURON, V20, P15, DOI 10.1016/S0896-6273(00)80429-8; COLBY CL, 1988, J COMP NEUROL, V269, P392, DOI 10.1002/cne.902690307; Dorris MC, 1998, J NEUROSCI, V18, P7015; Eskandar EN, 1999, NAT NEUROSCI, V2, P88, DOI 10.1038/4594; Fattori P, 2001, EUR J NEUROSCI, V13, P2309, DOI 10.1046/j.0953-816x.2001.01618.x; Ferraina S, 1997, J NEUROPHYSIOL, V77, P1034, DOI 10.1152/jn.1997.77.2.1034; Ferraina S, 2001, J NEUROPHYSIOL, V85, P462, DOI 10.1152/jn.2001.85.1.462; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hoshi E, 2000, NATURE, V408, P466, DOI 10.1038/35044075; HYVARINEN J, 1974, BRAIN, V97, P673, DOI 10.1093/brain/97.1.673; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; KALASKA JF, 1995, CEREB CORTEX, V5, P410, DOI 10.1093/cercor/5.5.410; KURATA K, 1991, NEUROSCI RES, V12, P263, DOI 10.1016/0168-0102(91)90116-G; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Kusunoki M, 2000, VISION RES, V40, P1459, DOI 10.1016/S0042-6989(99)00212-6; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Linden JF, 1999, J NEUROPHYSIOL, V82, P343, DOI 10.1152/jn.1999.82.1.343; Mazzoni P, 1996, J NEUROPHYSIOL, V76, P1439, DOI 10.1152/jn.1996.76.3.1439; Mazzoni P, 1996, J NEUROPHYSIOL, V75, P1233, DOI 10.1152/jn.1996.75.3.1233; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Murata A, 1996, J NEUROPHYSIOL, V75, P2180, DOI 10.1152/jn.1996.75.5.2180; Obayashi S, 2001, NEUROIMAGE, V14, P853, DOI 10.1006/nimg.2001.0878; Paxinos G., 2000, RHESUS MONKEY BRAIN; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; ROBINSON DL, 1978, J NEUROPHYSIOL, V41, P910, DOI 10.1152/jn.1978.41.4.910; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Tanne J, 1995, NEUROREPORT, V7, P267, DOI 10.1097/00001756-199512000-00064; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; WISE SP, 1989, SOMATOSENS MOT RES, V6, P455, DOI 10.3109/08990228909144687	48	163	164	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					580	588		10.1038/nn862	http://dx.doi.org/10.1038/nn862			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12021766				2022-12-17	WOS:000175874600019
J	Belin, P; Zatorre, RJ				Belin, P; Zatorre, RJ			'What', 'where' and 'how' in auditory cortex	NATURE NEUROSCIENCE			English	Letter							MOTOR CORTEX		McGill Univ, Montreal Neurol Inst, Neuropsychol Cognit Neurosci Unit, Montreal, PQ, Canada	McGill University	Belin, P (corresponding author), McGill Univ, Montreal Neurol Inst, Neuropsychol Cognit Neurosci Unit, Montreal, PQ, Canada.		Belin, Pascal/C-6247-2009	Belin, Pascal/0000-0002-7578-6365; Fritz, Jonathan/0000-0002-0625-172X				Cisek P, 1999, NEUROSCI LETT, V272, P1, DOI 10.1016/S0304-3940(99)00338-9; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; FETZ EE, 1992, BEHAV BRAIN SCI, V15, P679; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; KUHN THOMAS S., 1970, STRUCTURE SCI REVOLU, P150; SCOTT SH, J PHYSIOL P IN PRESS	6	163	165	1	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					965	966		10.1038/79890	http://dx.doi.org/10.1038/79890			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017161				2022-12-17	WOS:000167177500007
J	Wikenheiser, AM; Redish, AD				Wikenheiser, Andrew M.; Redish, A. David			Hippocampal theta sequences reflect current goals	NATURE NEUROSCIENCE			English	Article							PHASE PRECESSION; PLACE CELLS; SPATIAL ALTERNATION; GAMMA OSCILLATIONS; DYNAMICS; MEMORY; EXPERIENCE; NAVIGATION; NEURONS; CODE	Hippocampal information processing is discretized by oscillations, and the ensemble activity of place cells is organized into temporal sequences bounded by theta cycles. Theta sequences represent time-compressed trajectories through space. Their forward-directed nature makes them an intuitive candidate mechanism for planning future trajectories, but their connection to goal-directed behavior remains unclear. As rats performed a value-guided decision-making task, the extent to which theta sequences projected ahead of the animal's current location varied on a moment-by-moment basis depending on the rat's goals. Look-ahead extended farther on journeys to distant goals than on journeys to more proximal goals and was predictive of the animal's destination. On arrival at goals, however, look-ahead was similar regardless of where the animal began its journey from. Together, these results provide evidence that hippocampal theta sequences contain information related to goals or intentions, pointing toward a potential spatial basis for planning.	[Wikenheiser, Andrew M.] Univ Minnesota, Grad Program Neurosci, Minneapolis, MN USA; [Redish, A. David] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Redish, AD (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	redish@umn.edu		Wikenheiser, Andrew/0000-0002-7190-4993	US National Institutes of Health [T32-DA-07234, R01-MH-080318, R56-MH-080318]; University of Minnesota Doctoral Dissertation Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH080318, R01MH080318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007234] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Doctoral Dissertation Fellowship(University of Minnesota System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank members of the Redish laboratory for discussion about this work. A.M.W. was supported by US National Institutes of Health grant T32-DA-07234 and a University of Minnesota Doctoral Dissertation Fellowship. A.D.R. was supported by US National Institutes of Health grant R01-MH-080318. This work was also supported by US National Institutes of Health grant R56-MH-080318.	Barron HC, 2013, NAT NEUROSCI, V16, P1492, DOI 10.1038/nn.3515; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bieri KW, 2014, NEURON, V82, P670, DOI 10.1016/j.neuron.2014.03.013; Bornstein AM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003387; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Cabral HO, 2014, NEURON, V81, P402, DOI 10.1016/j.neuron.2013.11.010; Cohen N.J., 1993, MEMORY AMNESIA HIPPO, DOI DOI 10.1136/JNNP.58.1.128-A; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Erdem UM, 2014, J PHYSIOL-PARIS, V108, P28, DOI 10.1016/j.jphysparis.2013.07.002; Foster DJ, 2007, HIPPOCAMPUS, V17, P1093, DOI 10.1002/hipo.20345; Gupta AS, 2012, NAT NEUROSCI, V15, P1032, DOI 10.1038/nn.3138; Gupta K, 2013, NEUROSCIENCE, V247, P395, DOI 10.1016/j.neuroscience.2013.04.056; Howard LR, 2014, CURR BIOL, V24, P1331, DOI 10.1016/j.cub.2014.05.001; Hyman JM, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/neuro.07.002.2010; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Jones MW, 2005, HIPPOCAMPUS, V15, P867, DOI 10.1002/hipo.20119; Lisman J, 2009, PHILOS T R SOC B, V364, P1193, DOI 10.1098/rstb.2008.0316; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Malhotra S, 2012, REV NEUROSCIENCE, V23, P39, DOI 10.1515/revneuro-2011-0064; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; Maurer AP, 2012, HIPPOCAMPUS, V22, P737, DOI 10.1002/hipo.20936; Mehta M.R., 1996, SOC NEUR ABSTR, V758; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; MEL BW, 1992, NEURAL COMPUT, V4, P502, DOI 10.1162/neco.1992.4.4.502; O'Keefe J., 1993, HIPPOCAMPUS, V3, P317, DOI DOI 10.1002/HIP0.450030307); O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Robbe D, 2009, J NEUROSCI, V29, P12597, DOI 10.1523/JNEUROSCI.2407-09.2009; Schacter DL, 2009, PHILOS T R SOC B, V364, P1245, DOI 10.1098/rstb.2008.0308; Schmidt B, 2013, NATURE, V497, P42, DOI 10.1038/nature12095; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Singer AC, 2013, NEURON, V77, P1163, DOI 10.1016/j.neuron.2013.01.027; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Spiers HJ, 2015, CURR OPIN BEHAV SCI, V1, P47, DOI 10.1016/j.cobeha.2014.08.005; Takahashi M, 2014, J NEUROPHYSIOL, V111, P1601, DOI 10.1152/jn.00395.2013; Takahashi M, 2009, J NEUROPHYSIOL, V102, P556, DOI 10.1152/jn.91159.2008; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; van der Meer MAA, 2011, J NEUROSCI, V31, P2843, DOI 10.1523/JNEUROSCI.4869-10.2011; Viard A, 2011, J NEUROSCI, V31, P4613, DOI 10.1523/JNEUROSCI.4640-10.2011; Wikenheiser AM, 2015, CURR OPIN NEUROBIOL, V32, P8, DOI 10.1016/j.conb.2014.10.002; Wikenheiser AM, 2013, P NATL ACAD SCI USA, V110, P8308, DOI 10.1073/pnas.1220738110	50	162	165	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2015	18	2					289	294		10.1038/nn.3909	http://dx.doi.org/10.1038/nn.3909			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CA0UM	25559082	Green Accepted			2022-12-17	WOS:000348631800019
J	Carandini, M; Churchland, AK				Carandini, Matteo; Churchland, Anne K.			Probing perceptual decisions in rodents	NATURE NEUROSCIENCE			English	Review							POSTERIOR PARIETAL CORTEX; PREFRONTAL CORTEX; MOTOR CORTEX; FUNCTIONAL SPECIALIZATION; OBJECT LOCALIZATION; SUPERIOR COLLICULUS; SINGLE NEURON; RATS; DISCRIMINATION; REPRESENTATION	The study of perceptual decision-making offers insight into how the brain uses complex, sometimes ambiguous information to guide actions. Understanding the underlying processes and their neural bases requires that one pair recordings and manipulations of neural activity with rigorous psychophysics. Though this research has been traditionally performed in primates, it seems increasingly promising to pursue it at least partly in mice and rats. However, rigorous psychophysical methods are not yet as developed for these rodents as they are for primates. Here we give a brief overview of the sensory capabilities of rodents and of their cortical areas devoted to sensation and decision. We then review methods of psychophysics, focusing on the technical issues that arise in their implementation in rodents. These methods represent a rich set of challenges and opportunities.	[Carandini, Matteo] UCL, UCL Inst Ophthalmol, London, England; [Churchland, Anne K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of London; University College London; Cold Spring Harbor Laboratory	Churchland, AK (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	churchland@cshl.edu	Carandini, Matteo/ABD-8296-2021	Carandini, Matteo/0000-0003-4880-7682	European Research Council; Wellcome Trust; GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience; US National Eye Institute [EY022979, EY019072]; US National Science Foundation; McKnight Foundation; John Merck Fund; Chapman Foundation; Marie Robertson Memorial Fund of Cold Spring Harbor Laboratory; NATIONAL EYE INSTITUTE [R01EY022979, R00EY019072, K99EY019072] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience(GlaxoSmithKline); US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Science Foundation(National Science Foundation (NSF)); McKnight Foundation; John Merck Fund; Chapman Foundation; Marie Robertson Memorial Fund of Cold Spring Harbor Laboratory; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank A. Kepecs, A. Zador and L. Busse for comments. M.C.'s research is supported by the European Research Council, by the Wellcome Trust, and by the GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience. A.K.C.'s research is supported by the US National Eye Institute (grants EY022979 and EY019072), the US National Science Foundation, the McKnight Foundation, the John Merck Fund, the Chapman Foundation and the Marie Robertson Memorial Fund of Cold Spring Harbor Laboratory.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/S0896-6273(04)00753-6; Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bennur S, 2011, J NEUROSCI, V31, P913, DOI 10.1523/JNEUROSCI.4417-10.2011; Bourne M C, 1938, Br J Ophthalmol, V22, P613, DOI 10.1136/bjo.22.10.613; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Busse L, 2011, J NEUROSCI, V31, P11351, DOI 10.1523/JNEUROSCI.6689-10.2011; Chambers RA, 1996, NEUROPSYCHOPHARMACOL, V15, P587, DOI 10.1016/S0893-133X(96)00132-7; Chen GF, 2013, P NATL ACAD SCI USA, V110, P378, DOI 10.1073/pnas.1215834110; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Daan S, 2011, J BIOL RHYTHM, V26, P118, DOI 10.1177/0748730410397645; Dawkins R., 2017, ANCESTORS TALE PILGR; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Everitt BJ, 2007, ANN NY ACAD SCI, V1121, P576, DOI 10.1196/annals.1401.022; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Felsen G, 2012, J NEUROPHYSIOL, V108, P135, DOI 10.1152/jn.01181.2011; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Green DM., 1966, SIGNAL DETECTION THE; Grinband J, 2006, NEURON, V49, P757, DOI 10.1016/j.neuron.2006.01.032; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Histed MH, 2012, J NEUROPHYSIOL, V107, P758, DOI 10.1152/jn.00609.2011; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Huberman AD, 2011, TRENDS NEUROSCI, V34, P464, DOI 10.1016/j.tins.2011.07.002; Hut RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017527; Jaramillo S, 2011, NAT NEUROSCI, V14, P246, DOI 10.1038/nn.2688; Kato HK, 2012, NEURON, V76, P962, DOI 10.1016/j.neuron.2012.09.037; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kerr JND, 2012, CURR OPIN NEUROBIOL, V22, P45, DOI 10.1016/j.conb.2011.12.002; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kim B, 2008, J NEUROSCI, V28, P2991, DOI 10.1523/JNEUROSCI.5424-07.2008; KOLB B, 1987, BEHAV BRAIN RES, V23, P127, DOI 10.1016/0166-4328(87)90050-7; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Krubitzer L, 2007, NEURON, V56, P201, DOI 10.1016/j.neuron.2007.10.002; Kvitsiani D., NATURE IN PRESS; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lepora NF, 2012, J R SOC INTERFACE, V9, P1517, DOI 10.1098/rsif.2011.0750; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Macmillan NA., 2005, DETECTION THEORY USE; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; Meier P, 2011, J VISION, V11, DOI 10.1167/11.9.1; Merten K, 2012, P NATL ACAD SCI USA, V109, P6289, DOI 10.1073/pnas.1121084109; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nakamura K, 1999, J NEUROPHYSIOL, V82, P2503, DOI 10.1152/jn.1999.82.5.2503; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; Navalpakkam V, 2010, P NATL ACAD SCI USA, V107, P5232, DOI 10.1073/pnas.0911972107; Newton JR, 2004, NAT NEUROSCI, V7, P968, DOI 10.1038/nn1306; Ng L, 2010, METHODS, V50, P55, DOI 10.1016/j.ymeth.2009.10.001; Nitz DA, 2012, NAT NEUROSCI, V15, P1365, DOI 10.1038/nn.3213; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Peron S, 2011, NAT METHODS, V8, P30, DOI [10.1038/nmeth.f.325, 10.1038/NMETH.F.325]; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Platt ML, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001092; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; PREUSS TM, 1995, J COGNITIVE NEUROSCI, V7, P1, DOI 10.1162/jocn.1995.7.1.1; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; REEP RL, 1994, EXP BRAIN RES, V100, P67; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Roitman JD, 2002, J NEUROSCI, V22, P9475; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Sanders JI, 2012, J NEUROPHYSIOL, V108, P3416, DOI 10.1152/jn.00669.2012; Save E, 2009, NEUROBIOL LEARN MEM, V91, P172, DOI 10.1016/j.nlm.2008.08.005; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Schwarz C, 2010, SOMATOSENS MOT RES, V27, P131, DOI 10.3109/08990220.2010.513111; Sheppard JP, 2013, J VISION, V13, DOI 10.1167/13.6.4; SINNAMON HM, 1984, PHYSIOL BEHAV, V33, P185, DOI 10.1016/0031-9384(84)90098-2; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; Sparks DL, 1999, CURR OPIN NEUROBIOL, V9, P698, DOI 10.1016/S0959-4388(99)00039-2; Stuttgen MC, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00125; Sul JH, 2011, NAT NEUROSCI, V14, P1202, DOI 10.1038/nn.2881; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Tafazoli S, 2012, J NEUROSCI, V32, P21, DOI 10.1523/JNEUROSCI.3932-11.2012; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Umeda T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015500; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Whitlock JR, 2012, NEURON, V73, P789, DOI 10.1016/j.neuron.2011.12.028; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Zeng HK, 2012, PROG BRAIN RES, V196, P193, DOI 10.1016/B978-0-444-59426-6.00010-0; Znamenskiy P, 2013, NATURE, V497, P482, DOI 10.1038/nature12077; Zoccolan D, 2009, P NATL ACAD SCI USA, V106, P8748, DOI 10.1073/pnas.0811583106	98	162	162	0	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					824	831		10.1038/nn.3410	http://dx.doi.org/10.1038/nn.3410			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799475	Green Accepted			2022-12-17	WOS:000321180900012
J	Jablonska, B; Aguirre, A; Raymond, M; Szabo, G; Kitabatake, Y; Sailor, KA; Ming, GL; Song, HJ; Gallo, V				Jablonska, Beata; Aguirre, Adan; Raymond, Matthew; Szabo, Gabor; Kitabatake, Yasuji; Sailor, Kurt A.; Ming, Guo-Li; Song, Hongjun; Gallo, Vittorio			Chordin-induced lineage plasticity of adult SVZ neuroblasts after demyelination	NATURE NEUROSCIENCE			English	Article							BONE MORPHOGENETIC PROTEIN; NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; OLIG GENE-FUNCTION; SUBVENTRICULAR ZONE; PROGENITOR CELLS; MULTIPLE-SCLEROSIS; SPINAL-CORD; BRAIN; MOUSE	The mechanisms that regulate the developmental potential of adult neural progenitor populations under physiological and pathological conditions remain poorly defined. Glutamic acid decarboxylase 65 (GAD65)- and Doublecortin (Dcx)-expressing cells constitute major progenitor populations in the adult mouse subventricular zone (SVZ). Under normal physiological conditions, SVZ-derived GAD65-positive and Dcx-positive cells expressed the transcription factor Pax6 and migrated along the rostral migratory stream to the olfactory bulb to generate interneurons. After lysolecithin-induced demyelination of corpus callosum, however, these cells altered their molecular and cellular properties and migratory path. Demyelination upregulated chordin in the SVZ, which redirected GAD65-positive and Dcx-positive progenitors from neuronal to glial fates, generating new oligodendrocytes in the corpus callosum. Our findings suggest that the lineage plasticity of SVZ progenitor cells could be a potential therapeutic strategy for diseased or injured brain.	[Jablonska, Beata; Aguirre, Adan; Raymond, Matthew; Gallo, Vittorio] Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA; [Raymond, Matthew] George Washington Univ, Inst Biomed Sci, Washington, DC USA; [Szabo, Gabor] Hungarian Acad Sci, Inst Expt Med, Dept Gene Technol & Dev Neurobiol, Budapest, Hungary; [Kitabatake, Yasuji; Sailor, Kurt A.; Ming, Guo-Li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Children's National Health System; George Washington University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Johns Hopkins University	Gallo, V (corresponding author), Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA.	vgallo@cnmcresearch.org	Ming, Guo-li/J-7880-2013; Sailor, Kurt/GSO-2237-2022; Szabo, Gabor/A-5087-2008; Sailor, Kurt Andrew/AFN-4046-2022	Sailor, Kurt/0000-0002-9574-6838; Szabo, Gabor/0000-0001-5438-5151; Sailor, Kurt Andrew/0000-0002-9574-6838; Kitabatake, Yasuji/0000-0002-2907-9512; Ming, Guo-li/0000-0002-2517-6075	US National Institutes of Health [R01NS045702, R01NS056427, K99NS057944, R01NS047344, R01AG024984, R01NS048271]; Hungarian National Office for Research and Technology [GVOP-3.1.1.-2004-05-0230-/3.0]; US National Institutes of Health Intellectual and Developmental Disabilities Research Center [P30HD40677]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH084018, R21MH087874, R33MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047344, R56NS047344, R01NS048271, R01NS045702, K99NS057944, R01NS047344, R01NS056427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian National Office for Research and Technology(National Office for Research and Technology); US National Institutes of Health Intellectual and Developmental Disabilities Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. Gage (Salk Institute) and J. Goldman (Columbia University) for the gift of pNIT-GFP and dS-Red retrovirus and D. Rowitch (University of California San Francisco) for the gift of antibodies to Olig2. We thank T. Hawley for assistance with FACS sorting. We are particularly grateful to J. Corbin for discussion. This work was supported by US National Institutes of Health grants R01NS045702 and R01NS056427 to V. G., K99NS057944 to A. A., R01NS047344 and R01AG024984 to H. S. and R01NS048271 to G. M. and by the Hungarian National Office for Research and Technology GVOP-3.1.1.-2004-05-0230-/3.0 to G. S. and US National Institutes of Health Intellectual and Developmental Disabilities Research Center P30HD40677 to V. G.	Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Ara J, 2008, J NEUROSCI RES, V86, P125, DOI 10.1002/jnr.21462; Bani-Yaghoub M, 2008, BIOCHEM CELL BIOL, V86, P361, DOI [10.1139/O08-116, 10.1139/o08-116]; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Canoll P, 2008, ACTA NEUROPATHOL, V116, P465, DOI 10.1007/s00401-008-0432-9; Chang A, 2008, BRAIN, V131, P2366, DOI 10.1093/brain/awn157; Chen HL, 2007, STEM CELLS, V25, P63, DOI 10.1634/stemcells.2006-0339; Chou J, 2006, J NEUROL SCI, V240, P21, DOI 10.1016/j.jns.2005.08.015; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Coskun V, 2002, J NEUROSCI RES, V69, P795, DOI 10.1002/jnr.10336; DEININGER M, 1995, ACTA NEUROPATHOL, V90, P76; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fuller ML, 2007, ANN NEUROL, V62, P288, DOI 10.1002/ana.21179; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hampton DW, 2007, EUR J NEUROSCI, V26, P3024, DOI 10.1111/j.1460-9568.2007.05940.x; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Israelsson C, 2006, J NEUROSCI RES, V84, P47, DOI 10.1002/jnr.20856; Jablonska B, 2007, J CELL BIOL, V179, P1231, DOI 10.1083/jcb.200702031; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; Kim Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008122; Kondo Toru, 2009, Brain and Nerve (Tokyo), V61, P741; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Mekki-Dauriac S, 2002, DEVELOPMENT, V129, P5117; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Nait-Oumesmar B, 2008, J NEUROL SCI, V265, P26, DOI 10.1016/j.jns.2007.09.032; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Palmer TD, 1999, J NEUROSCI, V19, P8487; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Samanta J, 2007, J NEUROSCI, V27, P7397, DOI 10.1523/JNEUROSCI.1434-07.2007; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; See J, 2007, MOL CELL NEUROSCI, V35, P171, DOI 10.1016/j.mcn.2007.02.012; See JM, 2009, J NEUROPATH EXP NEUR, V68, P595, DOI 10.1097/NEN.0b013e3181a66ad9; Shen H, 2008, NEUROSCI LETT, V442, P15, DOI 10.1016/j.neulet.2008.06.052; Shen Q, 2002, DEVELOPMENT, V129, P4843; Staugaitis SM, 2009, NEURON GLIA BIOL, V5, P35, DOI 10.1017/S1740925X09990342; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007; Wang Y, 2001, STROKE, V32, P2170, DOI 10.1161/hs0901.095650; Zhao C, 2005, J NEUROL SCI, V233, P87, DOI 10.1016/j.jns.2005.03.008	50	162	167	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					541	U43		10.1038/nn.2536	http://dx.doi.org/10.1038/nn.2536			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20418875	Green Accepted			2022-12-17	WOS:000277065700011
J	Andreu-Agullo, C; Morante-Redolat, JM; Delgado, AC; Farinas, I				Andreu-Agullo, Celia; Manuel Morante-Redolat, Jose; Delgado, Ana C.; Farinas, Isabel			Vascular niche factor PEDF modulates Notch-dependent stemness in the adult subependymal zone	NATURE NEUROSCIENCE			English	Article							EPITHELIUM-DERIVED FACTOR; NF-KAPPA-B; AMYLOID PRECURSOR PROTEIN; NEURAL DEVELOPMENT; MAMMALIAN NOTCH; GENE-EXPRESSION; CELLS; RECEPTOR; SIGNAL; BRAIN	We sought to address the fundamental question of how stem cell microenvironments can regulate self-renewal. We found that Notch was active in astroglia-like neural stem cells (NSCs), but not in transit-amplifying progenitors of the murine subependymal zone, and that the level of Notch transcriptional activity correlated with self-renewal and multipotency. Moreover, dividing NSCs appeared to balance renewal with commitment via controlled segregation of Notch activity, leading to biased expression of known (Hes1) and previously unknown (Egfr) Notch target genes in daughter cells. Pigment epithelium-derived factor (PEDF) enhanced Notch-dependent transcription in cells with low Notch signaling, thereby subverting the output of an asymmetrical division to the production of two highly self-renewing cells. Mechanistically, PEDF induced a non-canonical activation of the NF-kappa B pathway, leading to the dismissal of the transcriptional co-repressor N-CoR from specific Notch-responsive promoters. Our data provide a basis for stemness regulation in vascular niches and indicate that Notch and PEDF cooperate to regulate self-renewal.	[Andreu-Agullo, Celia; Manuel Morante-Redolat, Jose; Delgado, Ana C.; Farinas, Isabel] Univ Valencia, Dept Biol Celular, E-46100 Burjassot, Spain; [Andreu-Agullo, Celia; Manuel Morante-Redolat, Jose; Delgado, Ana C.; Farinas, Isabel] Univ Valencia, CIBER Enfermedades Neurodegenerat, E-46100 Burjassot, Spain	University of Valencia; University of Valencia	Farinas, I (corresponding author), Univ Valencia, Dept Biol Celular, E-46100 Burjassot, Spain.	isabel.farinas@uv.es	Fariñas, Isabel/L-7118-2014; Morante-Redolat, Jose Manuel/L-9397-2014	Morante-Redolat, Jose Manuel/0000-0003-0610-1665	Ministerio de Ciencia e Innovacion; Ministerio de Sanidad; Generalitat Valenciana; Fundacion 'la Caixa'; Formacion del Profesorado Universitario predoctoral fellowship; CIBERNED	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Sanidad(Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Fundacion 'la Caixa'(La Caixa Foundation); Formacion del Profesorado Universitario predoctoral fellowship; CIBERNED(Instituto de Salud Carlos III)	We are grateful to A. Bigas, J.L. de la Pompa, N. Gaiano, W. C. Greene, O. Hermanson, S. Hitoshi, A. Israel, K. Jepsen, M. Karin, R. Kopan, G. Leclercq, M. G. Rosenfeld, S. Sun, D. van der Kooy, Y. Zhan and V. Meni for kindly providing constructs and reagents. We also thank E. Porlan and H. Mira for technical advice, M. P. Rubio for excellent technical assistance, and E. Porlan and S. R. Ferron for critical reading of the manuscript and valuable discussions. We gratefully acknowledge the help of M. A. Marques-Torrejon with the infusion experiments and of A. Martinez and D. Gil with cytometry. We are also grateful to E. Lai for comments on the manuscript. This work was supported by grants from Ministerio de Ciencia e Innovacion (SAF Program), Ministerio de Sanidad (Red Tercel, Centro de Investigacion Biomeica en Red sobre Enfermedades Neurodegenerativas, CIBERNED), Generalitat Valenciana (Programa Prometeo) and Fundacion 'la Caixa'. C. A.-A. was a recipient of a Formacion del Profesorado Universitario predoctoral fellowship. J. M. M.-R. and A. C. D. were funded by CIBERNED.	Alexson TO, 2006, DEV NEUROSCI-BASEL, V28, P34, DOI 10.1159/000090751; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Ang HL, 2007, BIOESSAYS, V29, P1039, DOI 10.1002/bies.20647; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Campos LS, 2006, J BIOL CHEM, V281, P5300, DOI 10.1074/jbc.M511886200; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012; Ciccolini F, 2005, DEV BIOL, V284, P112, DOI 10.1016/j.ydbio.2005.05.007; Denis-Donini S, 2005, DEV BRAIN RES, V154, P81, DOI 10.1016/j.devbrainres.2004.10.010; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Espinosa L, 2002, J CELL SCI, V115, P1295; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Givogri MI, 2006, DEV NEUROSCI-BASEL, V28, P81, DOI 10.1159/000090755; Harhaj EW, 1999, MOL CELL BIOL, V19, P7088; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yabe T, 2005, GLIA, V50, P223, DOI 10.1002/glia.20171; Yabe T, 2001, J BIOL CHEM, V276, P43313, DOI 10.1074/jbc.M107831200; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	49	162	168	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1514	U57		10.1038/nn.2437	http://dx.doi.org/10.1038/nn.2437			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19898467				2022-12-17	WOS:000272065600011
J	Bolduc, FV; Bell, K; Cox, H; Broadie, KS; Tully, T				Bolduc, Francois V.; Bell, Kimberly; Cox, Hilary; Broadie, Kendal S.; Tully, Tim			Excess protein synthesis in Drosophila Fragile X mutants impairs long-term memory	NATURE NEUROSCIENCE			English	Article							MENTAL-RETARDATION PROTEIN; MUSHROOM BODIES; MOUSE MODEL; PATHWAY; TRANSLATION; SYNAPSES; RECEPTOR	We used Drosophila olfactory memory as a model to study the molecular basis of cognitive defects in Fragile X syndrome in vivo. We observed that fragile X protein was acutely required and interacted with argonaute1 and staufen in the formation of long-term memory. Occlusion of long-term memory formation in Fragile X mutants could be rescued by protein synthesis inhibitors, suggesting that excess baseline protein synthesis could negatively affect cognition.	[Bolduc, Francois V.; Tully, Tim] Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Broadie, Kendal S.] Vanderbilt Univ, Nashville, TN 37235 USA; [Bolduc, Francois V.; Bell, Kimberly; Cox, Hilary; Tully, Tim] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Tully, Tim] Dart Neurosci LLC, San Diego, CA 92121 USA	Cold Spring Harbor Laboratory; Vanderbilt University; Cold Spring Harbor Laboratory	Tully, T (corresponding author), Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	Tim_Tully@dartneuroscience.com		Bell, Kimberly/0000-0003-2204-8569	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066910] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH066910-04] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Chuang SC, 2005, J NEUROSCI, V25, P8048, DOI 10.1523/JNEUROSCI.1777-05.2005; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Michel CI, 2004, J NEUROSCI, V24, P5798, DOI 10.1523/JNEUROSCI.1102-04.2004; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Weiler IJ, 2004, P NATL ACAD SCI USA, V101, P17504, DOI 10.1073/pnas.0407533101	15	162	163	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2008	11	10					1143	1145		10.1038/nn.2175	http://dx.doi.org/10.1038/nn.2175			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	352WQ	18776892	Green Accepted			2022-12-17	WOS:000259528500009
J	Robles, E; Gomez, TM				Robles, Estuardo; Gomez, Timothy M.			Focal adhesion kinase signaling at sites of integrin-mediated adhesion controls axon pathfinding	NATURE NEUROSCIENCE			English	Article							SCANNING ELECTRON-MICROSCOPE; CENTRAL-NERVOUS-SYSTEM; GROWTH CONE FILOPODIA; SRC FAMILY KINASES; TYROSINE PHOSPHORYLATION; SPINAL-CORD; XENOPUS-LAEVIS; CELL-MIGRATION; BASAL LAMINA; GUIDANCE	Extracellular matrix (ECM) components regulate neurite outgrowth in tissue culture and in vivo. Live imaging of phosphotyrosine (PY) signals revealed that Xenopus laevis growth cones extending on permissive ECM substrata assemble adhesive point contacts containing enriched levels of tyrosine-phosphorylated proteins. Whereas focal adhesion kinase (FAK) signaling is dispensable for the assembly of focal adhesions in non-neuronal cells, FAK activity is required for the formation of growth cone point contacts. FAK-dependent point contacts promote rapid neurite outgrowth by stabilizing lamellipodial protrusions on permissive ECM substrata. Moreover, local FAK activity is required for ECM-dependent growth cone turning in vitro, suggesting that FAK may control axon pathfinding in vivo. Consistent with this possibility, proper growth and guidance of Rohon-Beard sensory neurons and spinal commissural interneurons requires FAK activity. These findings identify FAK as a key regulator of axon growth and guidance downstream of growth cone-ECM interactions.	Univ Wisconsin, Dept Anat, Bardeen Labs SMI 257, Madison, WI 53706 USA; Univ Wisconsin, Neurosci Training Program, Bardeen Labs SMI 257, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gomez, TM (corresponding author), Univ Wisconsin, Dept Anat, Bardeen Labs SMI 257, 1300 Univ Ave, Madison, WI 53706 USA.	tmgomez@wisc.edu		Gomez, Timothy/0000-0002-1515-8228; Robles, Estuardo/0000-0002-1202-2050	NINDS NIH HHS [NS41564, R01 NS041564-06, R01 NS041564] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041564, R56NS041564] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON H, 1988, DEVELOPMENT, V104, P601; BERNHARDT RR, 1994, J COMP NEUROL, V350, P122, DOI 10.1002/cne.903500109; Bonner J, 2001, J NEUROSCI, V21, P9782, DOI 10.1523/JNEUROSCI.21-24-09782.2001; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; CALALB MB, 1995, MOL CELL BIOL, V15, P954; CLARKE JDW, 1991, DEVELOPMENT, V112, P499; EASTER SS, 1984, J NEUROSCI, V4, P2173; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gomez TM, 1996, J NEUROBIOL, V29, P18, DOI 10.1002/(SICI)1097-4695(199601)29:1<18::AID-NEU2>3.0.CO;2-A; Gomez TM, 2003, METHOD CELL BIOL, V71, P129, DOI 10.1016/S0091-679X(03)01008-2; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; GUAN JL, 1991, CELL REGUL, V2, P951, DOI 10.1091/mbc.2.11.951; HENS MD, 1995, DEV BIOL, V170, P274, DOI 10.1006/dbio.1995.1214; HIROSE G, 1979, DEV BIOL, V71, P191, DOI 10.1016/0012-1606(79)90163-5; Hoang B, 1998, J NEUROSCI, V18, P7847; IDE C, 1983, BRAIN RES, V288, P61, DOI 10.1016/0006-8993(83)90081-1; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; JACOBSON M, 1981, J NEUROSCI, V1, P918; KLEITMAN N, 1989, CELL MOTIL CYTOSKEL, V13, P288, DOI 10.1002/cm.970130407; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; KROTOSKI D, 1990, J EXP ZOOL, V253, P139, DOI 10.1002/jez.1402530204; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Liu Y, 2005, J NEUROSCI, V25, P10556, DOI 10.1523/JNEUROSCI.2710-05.2005; Matise MP, 1999, DEVELOPMENT, V126, P3649; Menegon A, 1999, EUR J NEUROSCI, V11, P3777, DOI 10.1046/j.1460-9568.1999.00798.x; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moon MS, 2005, DEV BIOL, V288, P474, DOI 10.1016/j.ydbio.2005.09.049; Paulus JD, 2006, DEV DYNAM, V235, P213, DOI 10.1002/dvdy.20604; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; ROBERTS A, 1982, J EMBRYOL EXP MORPH, V69, P237; Robles E, 2005, J NEUROSCI, V25, P7669, DOI 10.1523/JNEUROSCI.2680-05.2005; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Ruest PJ, 2000, CELL GROWTH DIFFER, V11, P41; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; SCHERER SS, 1984, J NEUROCYTOL, V13, P519, DOI 10.1007/BF01148079; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Somasekhar T, 1997, DEV BRAIN RES, V99, P208, DOI 10.1016/S0165-3806(97)00011-4; SOMASEKHAR T, 1995, DEV BRAIN RES, V88, P53, DOI 10.1016/0165-3806(95)00080-W; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.3.CO;2-L; Suter DM, 2001, J CELL BIOL, V155, P427, DOI 10.1083/jcb.200107063; TAYLOR JSH, 1983, J EMBRYOL EXP MORPH, V75, P49; Volberg T, 2001, J CELL SCI, V114, P2279; WU DY, 1993, J CELL BIOL, V123, P653, DOI 10.1083/jcb.123.3.653; YAGINUMA H, 1991, J COMP NEUROL, V304, P78, DOI 10.1002/cne.903040107; Zacharias U, 2002, MOL CELL NEUROSCI, V21, P626, DOI 10.1006/mcne.2002.1203	49	162	164	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1274	1283		10.1038/nn1762	http://dx.doi.org/10.1038/nn1762			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16964253				2022-12-17	WOS:000241493900021
J	Hoogenraad, CC; Milstein, AD; Ethell, IM; Henkemeyer, M; Sheng, M				Hoogenraad, CC; Milstein, AD; Ethell, IM; Henkemeyer, M; Sheng, M			GRIP1 controls dendrite morphogenesis by regulating EphB receptor trafficking	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; DOMAIN PROTEIN GRIP1; HIPPOCAMPAL-NEURONS; AMPA RECEPTORS; ENDOPLASMIC-RETICULUM; SYNAPTIC PLASTICITY; AXONAL-TRANSPORT; KINESIN; EPHRINS; MICROTUBULES	The function of the multi-PDZ domain scaffold protein GRIP1 (glutamate receptor interacting protein 1) in neurons is unclear. To explore the function of GRIP1 in hippocampal neurons, we used RNA interference (RNAi) to knock down the expression of GRIP1. Knockdown of GRIP1 by small interfering RNA (siRNA) in cultured hippocampal neurons caused a loss of dendrites, associated with mislocalization of the GRIP-interacting proteins GluR2 (AMPA receptor subunit), EphB2 (receptor tyrosine kinase) and KIF5 (also known as kinesin 1; microtubule motor). The loss of dendrites by GRIP1-siRNA was rescued by overexpression of the extracellular domain of EphB2, and was phenocopied by overexpression of the intracellular domain of EphB2 and extracellular application of ephrinB-Fc fusion proteins. Neurons from EphB1-EphB2-EphB3 triple knockout mice showed abnormal dendrite morphogenesis. Disruption of the KIF5-GRIP1 interaction inhibited EphB2 trafficking and strongly impaired dendritic growth. These results indicate an important role for GRIP1 in dendrite morphogenesis by serving as an adaptor protein for kinesin-dependent transport of EphB receptors to dendrites.	MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Ctr Basic Res Nerve Growth & Regener, Dallas, TX 75390 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; University of California System; University of California Riverside; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sheng, M (corresponding author), MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA.	msheng@mit.edu	Hoogenraad, Casper/B-8866-2011	Hoogenraad, Casper/0000-0002-2666-0758; Ethell, Iryna/0000-0002-1324-6611; Milstein, Aaron/0000-0002-7186-5779; Henkemeyer, Mark/0000-0002-7525-1061; Sheng, Morgan/0000-0002-8703-5366	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332, R01MH067121] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH067121-03, MH66332, R01 MH066332] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Birgbauer E, 2001, DEVELOPMENT, V128, P3041; Bladt F, 2002, P NATL ACAD SCI USA, V99, P6816, DOI 10.1073/pnas.092130099; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Burette A, 1999, J COMP NEUROL, V411, P601; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cowan CA, 2002, TRENDS CELL BIOL, V12, P339, DOI 10.1016/S0962-8924(02)02317-6; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DeSouza S, 2002, J NEUROSCI, V22, P3493; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; DOTTI CG, 1988, J NEUROSCI, V8, P1454; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hering H, 2003, J NEUROSCI, V23, P11759; Horton AC, 2003, J NEUROSCI, V23, P6188; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KRIJNSELOCKER J, 1995, MOL BIOL CELL, V6, P1315, DOI 10.1091/mbc.6.10.1315; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Lin SX, 2002, MOL BIOL CELL, V13, P96, DOI 10.1091/mbc.01-05-0224; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Yu WQ, 2000, J NEUROSCI, V20, P5782, DOI 10.1523/JNEUROSCI.20-15-05782.2000; Zhou XF, 2001, J NEUROSCI RES, V66, P1054, DOI 10.1002/jnr.10029.abs	50	162	169	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					906	915		10.1038/nn1487	http://dx.doi.org/10.1038/nn1487			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15965473				2022-12-17	WOS:000230137100018
J	Gillespie, DC; Kim, G; Kandler, K				Gillespie, DC; Kim, G; Kandler, K			Inhibitory synapses in the developing auditory system are glutamatergic	NATURE NEUROSCIENCE			English	Article							LATERAL SUPERIOR OLIVE; GAMMA-AMINOBUTYRIC-ACID; GABAERGIC SYNAPSES; CALCIUM RESPONSES; SYNAPTIC ACTIVITY; BRAIN-STEM; GUINEA-PIG; GLYCINE; RECEPTORS; NEURONS	Activity-dependent synapse refinement is crucial for the formation of precise excitatory and inhibitory neuronal circuits. Whereas the mechanisms that guide refinement of excitatory circuits are becoming increasingly clear, the mechanisms guiding inhibitory circuits have remained obscure. In the lateral superior olive (LSO), a nucleus in the mammalian sound localization system that receives inhibitory input from the medial nucleus of the trapezoid body (MNTB), specific elimination and strengthening of synapses that are both GABAergic and glycinergic (GABA/glycinergic synapses) is essential for the formation of a precise tonotopic map. We provide evidence that immature GABA/glycinergic synapses in the rat LSO also release the excitatory neurotransmitter glutamate, which activates postsynaptic NMDA receptors (NMDARs). Immunohistochemical studies demonstrate synaptic colocalization of the vesicular glutamate transporter 3 with the vesicular GABA transporter, indicating that GABA, glycine and glutamate are released from single MNTB terminals. Glutamatergic transmission at MNTB-LSO synapses is most prominent during the period of synapse elimination. Synapse-specific activation of NMDARs by glutamate release at GABAergic and glycinergic synapses could be important in activity-dependent refinement of inhibitory circuits.	Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Ctr Neurol Basis Cognit, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kandler, K (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, W1412 Biomed Sci Tower,3500 Terrace St, Pittsburgh, PA 15261 USA.	kkarl@pitt.edu		Kim, Gunsoo/0000-0001-9318-8329; Kandler, Karl/0000-0002-6053-6400; Gillespie, Deda/0000-0002-3736-9886	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004199] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC004199] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aamodt SM, 2000, J NEUROPHYSIOL, V83, P1580, DOI 10.1152/jn.2000.83.3.1580; Ahmadi S, 2003, SCIENCE, V300, P2094, DOI 10.1126/science.1083970; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; BLEDSOE SC, 1990, BRAIN RES, V517, P189, DOI 10.1016/0006-8993(90)91025-C; BOUDREAU JC, 1968, J NEUROPHYSIOL, V31, P442, DOI 10.1152/jn.1968.31.3.442; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Dickson KS, 2003, CURR BIOL, V13, pR920, DOI 10.1016/j.cub.2003.11.015; DOCHERTY M, 1987, NATURE, V330, P64, DOI 10.1038/330064a0; Ehrlich I, 1999, J PHYSIOL-LONDON, V520, P121, DOI 10.1111/j.1469-7793.1999.00121.x; Ene FA, 2003, J NEUROPHYSIOL, V90, P2581, DOI 10.1152/jn.00238.2003; Fon EA, 2001, MUSCLE NERVE, V24, P581, DOI 10.1002/mus.1044; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Furuta A, 1997, J NEUROSCI, V17, P8363; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Givens R S, 1998, Methods Enzymol, V291, P1; GLENDENNING KK, 1991, J COMP NEUROL, V310, P377, DOI 10.1002/cne.903100308; Gutierrez R, 2003, J NEUROSCI, V23, P5594; Harkany T, 2004, J NEUROSCI, V24, P4978, DOI 10.1523/JNEUROSCI.4884-03.2004; HELFERT RH, 1989, BRAIN RES, V501, P269, DOI 10.1016/0006-8993(89)90644-6; HELFERT RH, 1992, J COMP NEUROL, V323, P305, DOI 10.1002/cne.903230302; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Kandler K, 2004, CURR OPIN NEUROBIOL, V14, P96, DOI 10.1016/j.conb.2004.01.017; KANDLER K, 1995, J NEUROSCI, V15, P6890; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Korada S, 1999, J COMP NEUROL, V409, P664, DOI 10.1002/(SICI)1096-9861(19990712)409:4<664::AID-CNE10>3.0.CO;2-S; Kotak VC, 1998, J NEUROSCI, V18, P4646; Kullmann PHM, 2002, EUR J NEUROSCI, V15, P1093, DOI 10.1046/j.1460-9568.2002.01946.x; Kullmann PHM, 2001, DEV BRAIN RES, V131, P143, DOI 10.1016/S0165-3806(01)00271-1; Lehmann E D, 1999, Diabetes Technol Ther, V1, P41, DOI 10.1089/152091599317567; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; McLean HA, 1996, J PHYSIOL-LONDON, V496, P471, DOI 10.1113/jphysiol.1996.sp021699; MICHEVA KD, 1995, P NATL ACAD SCI USA, V92, P11834, DOI 10.1073/pnas.92.25.11834; MOORE MJ, 1983, J NEUROSCI, V3, P237; Morishita W, 1996, J NEUROPHYSIOL, V76, P59, DOI 10.1152/jn.1996.76.1.59; Nabekura J, 2004, NAT NEUROSCI, V7, P17, DOI 10.1038/nn1170; OMALLEY DM, 1989, P NATL ACAD SCI USA, V86, P3414, DOI 10.1073/pnas.86.9.3414; OTIS TS, 1994, P NATL ACAD SCI USA, V91, P7698, DOI 10.1073/pnas.91.16.7698; Sanes DH, 2000, HEARING RES, V147, P46, DOI 10.1016/S0378-5955(00)00119-2; Schwartz I.R., 1992, MAMMALIAN AUDITORY P, P117; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Walker MC, 2001, NEURON, V29, P703, DOI 10.1016/S0896-6273(01)00245-8; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5	49	162	175	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					332	338		10.1038/nn1397	http://dx.doi.org/10.1038/nn1397			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15746915				2022-12-17	WOS:000227354600018
J	Hewitt, SA; Wamsteeker, JI; Kurz, EU; Bains, JS				Hewitt, Sarah A.; Wamsteeker, Jaclyn I.; Kurz, Ebba U.; Bains, Jaideep S.			Altered chloride homeostasis removes synaptic inhibitory constraint of the stress axis	NATURE NEUROSCIENCE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; K-CL COTRANSPORTER; LAMINA-I NEURONS; NEUROPATHIC PAIN; GABAERGIC TRANSMISSION; INTRACELLULAR CHLORIDE; PARVOCELLULAR NEURONS; PYRAMIDAL NEURONS; GABA(A) RECEPTOR; DOWN-REGULATION	In mammals, stress elicits a stereotyped endocrine response that requires an increase in the activity of hypothalamic parvocellular neuroendocrine neurons. The output of these cells is normally constrained by powerful GABA-mediated synaptic inhibition. We found that acute restraint stress in rats released the system from inhibitory synaptic drive in vivo by down-regulating the transmembrane anion transporter KCC2. This manifested as a depolarizing shift in the reversal potential of GABA(A)-mediated synaptic currents that rendered GABA inputs largely ineffective. Notably, repetitive activation of GABA synapses after stress resulted in a more rapid collapse of the anion gradient and was sufficient to increase the activity of neuroendocrine cells. Our data indicate that hypothalamic neurons integrate psychological cues to mount the endocrine response to stress by regulating anion gradients.	[Hewitt, Sarah A.; Wamsteeker, Jaclyn I.; Bains, Jaideep S.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Hewitt, Sarah A.; Wamsteeker, Jaclyn I.] Univ Calgary, Dept Neurosci, Calgary, AB, Canada; [Kurz, Ebba U.] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB, Canada; [Kurz, Ebba U.] Univ Calgary, So Alberta Canc Res Inst, Calgary, AB, Canada; [Bains, Jaideep S.] Univ Calgary, Dept Phys & Biophys, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Bains, JS (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	jsbains@ucalgary.ca		Bains, Jaideep/0000-0002-3634-6463	Alberta Heritage Foundation; Hotchkiss Brain Institute; Faculty of Graduate Studies; University of Calgary; Government of Alberta; Canadian Institutes for Health Research	Alberta Heritage Foundation(Alberta Heritage Foundation for Medical Research); Hotchkiss Brain Institute; Faculty of Graduate Studies; University of Calgary; Government of Alberta; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	We thank members of the Bains laboratory, Q. J. Pittman and W. H. Mehaffey for comments and thoughtful discussion regarding the manuscript. We also thank C. Sank for assistance with microinjections and corticosterone assays. S. A. H. was supported by a studentship from the Alberta Heritage Foundation for Medical Research. J. I. W. is supported by a T. Chen Fong Scholarship from the Hotchkiss Brain Institute and scholarships from the Faculty of Graduate Studies, University of Calgary and the Government of Alberta. J. S. B. is an Alberta Heritage Foundation for Medical Research Senior Scholar. This work is funded by an Operating Grant from the Canadian Institutes for Health Research.	Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Boudaba C, 1996, J NEUROSCI, V16, P7151; Cole RAL, 2002, J NEUROSCI, V22, P959, DOI 10.1523/JNEUROSCI.22-03-00959.2002; Cordero-Erausquin M, 2005, J NEUROSCI, V25, P9613, DOI 10.1523/JNEUROSCI.1488-05.2005; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Cullinan WE, 2000, BRAIN RES, V887, P118, DOI 10.1016/S0006-8993(00)03000-6; Daftary SS, 2000, NEUROSCIENCE, V96, P743, DOI 10.1016/S0306-4522(00)00003-8; DECAVEL C, 1990, J COMP NEUROL, V302, P1019, DOI 10.1002/cne.903020423; DeFazio RA, 2000, J NEUROSCI, V20, P8069; DeFazio RA, 2001, NEUROREPORT, V12, P2537, DOI 10.1097/00001756-200108080-00049; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Grob M, 2005, J PHYSIOL-LONDON, V569, P885, DOI 10.1113/jphysiol.2005.095794; Hewitt SA, 2006, J NEUROPHYSIOL, V95, P2193, DOI 10.1152/jn.01135.2005; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Khazipov R, 2004, EUR J NEUROSCI, V19, P590, DOI 10.1111/j.0953-816X.2003.03152.x; Laviolette SR, 2004, NAT NEUROSCI, V7, P160, DOI 10.1038/nn1182; Luther JA, 2002, J NEUROENDOCRINOL, V14, P929, DOI 10.1046/j.1365-2826.2002.00867.x; Mercado A, 2004, NEUROCHEM RES, V29, P17, DOI 10.1023/B:NERE.0000010432.44566.21; Mount DB, 1998, J EXP BIOL, V201, P2091; Pacak K, 1995, ANN NY ACAD SCI, V771, P115, DOI 10.1111/j.1749-6632.1995.tb44675.x; Pathak HR, 2007, J NEUROSCI, V27, P14012, DOI 10.1523/JNEUROSCI.4390-07.2007; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Prescott SA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-32; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; ROLAND BL, 1993, J COMP NEUROL, V332, P123, DOI 10.1002/cne.903320109; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P501, DOI 10.1152/jn.1989.61.3.501; Vale C, 2003, J NEUROSCI, V23, P7516; Verkuyl JM, 2005, EUR J NEUROSCI, V21, P113, DOI 10.1111/j.1460-9568.2004.03846.x; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007; Williams JR, 1999, J BIOL CHEM, V274, P12656, DOI 10.1074/jbc.274.18.12656; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471	40	161	164	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2009	12	4					438	443		10.1038/nn.2274	http://dx.doi.org/10.1038/nn.2274			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	424JN	19252497				2022-12-17	WOS:000264563100018
J	Lupi, D; Oster, H; Thompson, S; Foster, RG				Lupi, Daniela; Oster, Henrik; Thompson, Stewart; Foster, Russell G.			The acute light-induction of sleep is mediated by OPN4-based photoreception	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; CIRCADIAN RESPONSES; NON-CONE; NON-ROD; MELANOPSIN; COMPONENTS; BEHAVIOR; NUCLEUS; GENES; ROLES	Sleep is regulated by both homeostatic and circadian mechanisms. The latter, termed 'process c', helps synchronize sleep-wake patterns to the appropriate time of the day. However, in the absence of a circadian clock, overall sleep-wake rhythmicity is preserved and remains synchronized to the external light-dark cycle, indicating that there is an additional, clock-independent photic input to sleep. We found that the direct photic regulation of sleep in mice is predominantly mediated by melanopsin (OPN4)-based photoreception of photosensitive retinal ganglion cells (pRGCs). Moreover, OPN4-dependent sleep regulation was correlated with the activation of sleep-promoting neurons in the ventrolateral preoptic area and the superior colliculus. Collectively, our findings describe a previously unknown pathway in sleep regulation and identify the pRGC/OPN4 signaling system as a potentially new pharmacological target for the selective manipulation of sleep and arousal states.	[Lupi, Daniela; Oster, Henrik; Thompson, Stewart; Foster, Russell G.] John Radcliffe Hosp, Nuffield Lab Ophthalmol, Circadian & Visual Neurosci Grp, Oxford OX3 9DU, England	University of Oxford	Foster, RG (corresponding author), John Radcliffe Hosp, Nuffield Lab Ophthalmol, Circadian & Visual Neurosci Grp, Levels 5&6 W Wing,Headley Way, Oxford OX3 9DU, England.	russell.foster@eye.ox.ac.uk	Oster, Henrik/O-4426-2019; Oster, Henrik/D-2335-2013	Oster, Henrik/0000-0002-1414-7068; Oster, Henrik/0000-0002-1414-7068; FOSTER, RUSSELL/0000-0001-6055-2067	Wellcome Trust Program; European Commission; Max Planck Society; Deutsche Forschungsgemeinschaft	Wellcome Trust Program(Wellcome Trust); European Commission(European CommissionEuropean Commission Joint Research Centre); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank S. Hattar (Johns Hopkins University) for generously donating the Opn4<SUP>-/-</SUP> mice, N. Naujokat for technical assistance and S. N. Peirson for helpful comments on this manuscript. This work was supported by a Wellcome Trust Program grant and a European Commission grant (EuClock) to R. G. F. H. O. was supported by an Otto Hahn fellowship of the Max Planck Society and an Emmy Noether fellowship of the Deutsche Forschungsgemeinschaft.	Abraham D, 2007, MOL IMMUNOL, V44, P732, DOI 10.1016/j.molimm.2006.04.019; Albrecht U, 2002, METHODS, V28, P465, DOI 10.1016/S1046-2023(02)00266-9; Bae K, 2000, J NEUROSCI, V20, P1746; Benca RM, 1998, SLEEP, V21, P451, DOI 10.1093/sleep/21.5.451; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Borbely A A, 1982, Hum Neurobiol, V1, P195; BORBELY AA, 1976, BRAIN RES, V114, P305, DOI 10.1016/0006-8993(76)90673-9; BORBELY AA, 1978, PROG NEUROBIOL, V10, P1, DOI 10.1016/0301-0082(78)90018-7; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Conte I, 2005, DEV DYNAM, V234, P718, DOI 10.1002/dvdy.20463; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; David-Gray ZK, 1998, NAT NEUROSCI, V1, P655, DOI 10.1038/3656; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; FOSTER RG, 2003, NOVART FDN SYMP, V253, P52; FOSTER RG, 2003, NOVART FDN SYMP, V253, P102; FOSTER RG, 2003, NOVART FDN SYMP, V253, P23; Foster Russell G., 2003, Novartis Foundation Symposium, V253, P3; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Fuller PM, 2006, J BIOL RHYTHM, V21, P482, DOI 10.1177/0748730406294627; Gaus SE, 2002, NEUROSCIENCE, V115, P285, DOI 10.1016/S0306-4522(02)00308-1; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hankins MW, 2002, CURR BIOL, V12, P191, DOI 10.1016/S0960-9822(02)00659-0; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; HOLT CE, 1993, J NEUROBIOL, V24, P1400, DOI 10.1002/neu.480241011; Jud C, 2005, BIOL PROCED ONLINE, V7, P101, DOI 10.1251/bpo109; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lockley SW, 2006, SLEEP, V29, P161; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Miller AM, 1998, P NATL ACAD SCI USA, V95, P8957, DOI 10.1073/pnas.95.15.8957; Mrosovsky N, 2005, J COMP PHYSIOL A, V191, P1011, DOI 10.1007/s00359-005-0017-1; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Paxinos G, 2004, J CHEM NEUROANAT, V27, P217, DOI 10.1016/j.jchemneu.2004.03.005; Peirson S, 2006, NEURON, V49, P331, DOI 10.1016/j.neuron.2006.01.006; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Peirson SN, 2007, CURR BIOL, V17, P1363, DOI 10.1016/j.cub.2007.07.045; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; PROVENCIO I, 1994, VISION RES, V34, P1799, DOI 10.1016/0042-6989(94)90304-2; Rieux C, 2002, J BIOL RHYTHM, V17, P121, DOI 10.1177/074873002129002410; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	50	161	172	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2008	11	9					1068	1073		10.1038/nn.2179	http://dx.doi.org/10.1038/nn.2179			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	341NA	19160505	Green Published			2022-12-17	WOS:000258720000017
J	Labouebe, G; Lomazzi, M; Cruz, HG; Creton, C; Lujan, R; Li, M; Yanagawa, Y; Obata, K; Watanabe, M; Wickman, K; Boyer, SB; Slesinger, PA; Luscher, C				Labouebe, Gwenael; Lomazzi, Marta; Cruz, Hans G.; Creton, Cyril; Lujan, Rafael; Li, Meng; Yanagawa, Yuchio; Obata, Kunihiko; Watanabe, Masahiko; Wickman, Kevin; Boyer, Stephanie B.; Slesinger, Paul A.; Luescher, Christian			RGS2 modulates coupling between GABA(B) receptors and GIRK channels in dopamine neurons of the ventral tegmental area	NATURE NEUROSCIENCE			English	Article							GAMMA-HYDROXYBUTYRIC ACID; K+-CHANNEL; INWARD RECTIFIER; PROTEIN; EXPRESSION; REGULATORS; SUBUNITS; AGONISTS; CLONING; INHIBITION	Agonists of GABA(B) receptors exert a bi-directional effect on the activity of dopamine (DA) neurons of the ventral tegmental area, which can be explained by the fact that coupling between GABA(B) receptors and G protein-gated inwardly rectifying potassium (GIRK) channels is significantly weaker in DA neurons than in GABA neurons. Thus, low concentrations of agonists preferentially inhibit GABA neurons and thereby disinhibit DA neurons. This disinhibition might confer reinforcing properties on addictive GABA(B) receptor agonists such as gamma-hydroxybutyrate (GHB) and its derivatives. Here we show that, in DA neurons of mice, the low coupling efficiency reflects the selective expression of heteromeric GIRK2/3 channels and is dynamically modulated by a member of the regulator of G protein signaling (RGS) protein family. Moreover, repetitive exposure to GHB increases the GABA(B) receptor-GIRK channel coupling efficiency through downregulation of RGS2. Finally, oral self-administration of GHB at a concentration that is normally rewarding becomes aversive after chronic exposure. On the basis of these results, we propose a mechanism that might underlie tolerance to GHB.	Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva 4, Switzerland; Univ Castilla La Mancha, Fac Med CRIB, Dept Med Sci, Albacete 02006, Spain; Imperial Coll London, London W12 0NN, England; Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma, Japan; RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; Hokkaido Univ, Sch Med, Dept Anat, Kita Ku, Sapporo, Hokkaido 0608638, Japan; Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, CH-1211 Geneva, Switzerland	University of Geneva; Universidad de Castilla-La Mancha; Imperial College London; Gunma University; RIKEN; Hokkaido University; University of Minnesota System; University of Minnesota Twin Cities; Salk Institute; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, Michel-Servet 1, CH-1211 Geneva 4, Switzerland.	Christian.Luscher@medecine.unige.ch	Lujan, Rafael/G-2555-2015; WATANABE, Masahiko/A-4055-2012; Lüscher, Christian/A-2496-2011; Li, Meng/I-6941-2013; Watanabe, Masahiko/S-3614-2019	WATANABE, Masahiko/0000-0001-5037-7138; Lüscher, Christian/0000-0001-7917-4596; Watanabe, Masahiko/0000-0001-5037-7138; Lujan Miras, Rafael/0000-0003-2001-9545; Wickman, Kevin/0000-0002-5179-9540	MRC [MC_U120085817] Funding Source: UKRI; Medical Research Council [MC_U120085817] Funding Source: Medline; NIDA NIH HHS [P50 DA011806, DA011806] Funding Source: Medline; NIMH NIH HHS [MH61933, R01 MH061933] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA011806] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Andriamampandry C, 2003, FASEB J, V17, P1691, DOI 10.1096/fj.02-0846fje; AXELROD D, 1983, J MICROSC-OXFORD, V129, P19, DOI 10.1111/j.1365-2818.1983.tb04158.x; Bettahi H, 2002, J BIOL CHEM, V277, P48282, DOI 10.1074/jbc.M209599200; Brebner K, 2002, ALCOHOL ALCOHOLISM, V37, P478, DOI 10.1093/alcalc/37.5.478; Chuang HH, 1998, P NATL ACAD SCI USA, V95, P11727, DOI 10.1073/pnas.95.20.11727; COLOMBO G, 1995, EUR J PHARMACOL, V285, P103, DOI 10.1016/0014-2999(95)00493-5; Cousins MS, 2002, DRUG ALCOHOL DEPEN, V65, P209, DOI 10.1016/S0376-8716(01)00163-6; Crunelli V, 2006, CURR OPIN PHARMACOL, V6, P44, DOI 10.1016/j.coph.2005.10.001; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Doupnik CA, 2004, METHOD ENZYMOL, V389, P131; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Gold SJ, 2003, EUR J NEUROSCI, V17, P971, DOI 10.1046/j.1460-9568.2003.02529.x; Gold SJ, 1997, J NEUROSCI, V17, P8024; Inanobe A, 1999, J NEUROSCI, V19, P1006; Jaen C, 2006, J BIOL CHEM, V281, P34549, DOI 10.1074/jbc.M603177200; Jelacic TM, 2000, J BIOL CHEM, V275, P36211, DOI 10.1074/jbc.M007087200; Karschin C, 1996, J NEUROSCI, V16, P3559; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 2003, EUR J NEUROSCI, V18, P2722, DOI 10.1111/j.1460-9568.2003.03013.x; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; Liao YJ, 1996, J NEUROSCI, V16, P7137; Luscher C, 2006, PLOS MED, V3, P2005, DOI 10.1371/journal.pmed.0030437; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Martellotta MC, 1997, PSYCHOPHARMACOLOGY, V132, P1, DOI 10.1007/s002130050312; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Pfaff T, 1999, EUR J NEUROSCI, V11, P2874, DOI 10.1046/j.1460-9568.1999.00704.x; Popov SG, 2000, J BIOL CHEM, V275, P18962, DOI 10.1074/jbc.M001128200; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Schoots O, 1999, CELL SIGNAL, V11, P871, DOI 10.1016/S0898-6568(99)00059-5; Shea L, 1997, BIOCHEM PHARMACOL, V53, P519, DOI 10.1016/S0006-2952(96)00768-X; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; Snead OC, 2005, NEW ENGL J MED, V352, P2721, DOI 10.1056/NEJMra044047; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Taymans JM, 2003, J NEUROCHEM, V84, P1118, DOI 10.1046/j.1471-4159.2003.01610.x; Torrecilla M, 2002, J NEUROSCI, V22, P4328, DOI 10.1523/JNEUROSCI.22-11-04328.2002; Traynor JR, 2005, MOL INTERV, V5, P30, DOI 10.1124/mi.5.1.7; Wallen A, 2003, ANN NY ACAD SCI, V991, P48; Wickman K, 2000, J NEUROSCI, V20, P5608, DOI 10.1523/JNEUROSCI.20-15-05608.2000; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x	49	161	166	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1559	1568		10.1038/nn2006	http://dx.doi.org/10.1038/nn2006			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17965710				2022-12-17	WOS:000251172900013
J	Ahissar, M; Lubin, Y; Putter-Katz, H; Banai, K				Ahissar, Merav; Lubin, Yedida; Putter-Katz, Hanna; Banai, Karen			Dyslexia and the failure to form a perceptual anchor	NATURE NEUROSCIENCE			English	Article							AUDITORY FREQUENCY DISCRIMINATION; DEVELOPMENTAL DYSLEXIA; PROCESSING DEFICITS; MISMATCH; CHILDREN; MEMORY; BRAIN; PITCH; INTELLIGENCE; REPETITION	In a large subgroup of dyslexic individuals (D-LDs), reading difficulties are part of a broader learning and language disability. Recent studies indicate that D-LDs perform poorly in many psychoacoustic tasks compared with individuals with normal reading ability. We found that D-LDs perform as well as normal readers in speech perception in noise and in a difficult tone comparison task. However, their performance did not improve when these same tasks were performed with a smaller stimulus set. In contrast to normal readers, they did not benefit from stimulus-specific repetitions, suggesting that they have difficulties forming perceptual anchors. These findings are inconsistent with previously suggested static models of dyslexia. Instead, we propose that D-LDs' core deficit is a general difficulty in dynamically constructing stimulus-specific predictions, deriving from deficient stimulus-specific adaptation mechanisms. This hypothesis provides a direct link between D-LDs' high-level difficulties and mechanisms at the level of specific neuronal circuits.	Hebrew Univ Jerusalem, Dept Psychol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Cognit Sci, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel; Northwestern Univ, Dept Commun Sci, Evanston, IL 60208 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Northwestern University	Ahissar, M (corresponding author), Hebrew Univ Jerusalem, Dept Psychol, IL-91904 Jerusalem, Israel.	msmerava@mscc.huji.ac.il	Banai, Karen/J-1448-2019	Banai, Karen/0000-0002-2990-0470; Ahissar, Merav/0000-0001-7694-8111				Ahissar M, 2000, P NATL ACAD SCI USA, V97, P6832, DOI 10.1073/pnas.97.12.6832; Amitay S, 2002, JARO-J ASSOC RES OTO, V3, P302, DOI 10.1007/s101620010093; Baldeweg T, 1999, ANN NEUROL, V45, P495, DOI 10.1002/1531-8249(199904)45:4<495::AID-ANA11>3.0.CO;2-M; Baldeweg T, 2006, TRENDS COGN SCI, V10, P93, DOI 10.1016/j.tics.2006.01.010; Banai K, 2005, J NEUROSCI, V25, P9850, DOI 10.1523/JNEUROSCI.2373-05.2005; Banai K, 2004, AUDIOL NEURO-OTOL, V9, P328, DOI 10.1159/000081282; Banai K, 2006, CEREB CORTEX, V16, P1718, DOI 10.1093/cercor/bhj107; Ben-Yehudah G, 2004, NEUROREPORT, V15, P627, DOI 10.1097/00001756-200403220-00011; Ben-Yehudah G, 2004, VISION RES, V44, P1047, DOI 10.1016/j.visres.2003.12.001; Ben-Yehudah G, 2001, BRAIN, V124, P1381, DOI 10.1093/brain/124.7.1381; Brosnan M, 2002, NEUROPSYCHOLOGIA, V40, P2144, DOI 10.1016/S0028-3932(02)00046-5; Clement S, 1999, J ACOUST SOC AM, V106, P2805, DOI 10.1121/1.428106; Deary LJ, 2004, AM J PSYCHOL, V117, P1, DOI 10.2307/1423593; Demonet JF, 2004, LANCET, V363, P1451, DOI 10.1016/S0140-6736(04)16106-0; Dreschler WA, 2001, AUDIOLOGY, V40, P148; France SJ, 2002, PERCEPT PSYCHOPHYS, V64, P169, DOI 10.3758/BF03195783; Goswami U, 2003, TRENDS COGN SCI, V7, P534, DOI 10.1016/j.tics.2003.10.003; Goswami U, 2002, P NATL ACAD SCI USA, V99, P10911, DOI 10.1073/pnas.122368599; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; Halliday LF, 2005, J SPEECH LANG HEAR R, V48, P1187, DOI 10.1044/1092-4388(2005/083); Hari R, 2001, TRENDS COGN SCI, V5, P525, DOI 10.1016/S1364-6613(00)01801-5; HARRIS JD, 1948, AM J PSYCHOL, V61, P309, DOI 10.2307/1417151; Hartley DEH, 2002, J ACOUST SOC AM, V112, P2962, DOI 10.1121/1.1512701; Heath SM, 1999, J CHILD PSYCHOL PSYC, V40, P637, DOI 10.1111/1469-7610.00480; Helland T, 2000, CHILD NEUROPSYCHOL, V6, P37, DOI 10.1076/0929-7049(200003)6:1;1-B;FT037; Hulslander J, 2004, J EXP CHILD PSYCHOL, V88, P274, DOI 10.1016/j.jecp.2004.03.006; KONIG E, 1957, J ACOUST SOC AM, V29, P606; Kujala T, 2006, CLIN NEUROPHYSIOL, V117, P885, DOI 10.1016/j.clinph.2006.01.002; LYON GR, 1995, ANN DYSLEXIA, V45, P3, DOI 10.1007/BF02648210; Maurer U, 2003, NEUROREPORT, V14, P2245, DOI 10.1097/00001756-200312020-00022; McAnally KI, 1996, P ROY SOC B-BIOL SCI, V263, P961, DOI 10.1098/rspb.1996.0142; McArthur GM, 2004, J SPEECH LANG HEAR R, V47, P527, DOI 10.1044/1092-4388(2004/041); Mengler ED, 2005, DYSLEXIA, V11, P155, DOI 10.1002/dys.302; MORI S, 1992, J ACOUST SOC AM, V91, P246, DOI 10.1121/1.402768; Naatanen R., 1992, ATTENTION BRAIN FUNC; Putter-Katz H, 2005, PLASTICITY AND SIGNAL REPRESENTATION IN THE AUDITORY SYSTEM, P251, DOI 10.1007/0-387-23181-1_23; Ramus F, 2004, TRENDS NEUROSCI, V27, P720, DOI 10.1016/j.tins.2004.10.004; RAZ N, 1987, PERS INDIV DIFFER, V8, P201, DOI 10.1016/0191-8869(87)90175-9; Renvall H, 2003, ANN NEUROL, V53, P551, DOI 10.1002/ana.10504; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Shovman MM, 2006, VISION RES, V46, P3514, DOI 10.1016/j.visres.2006.05.011; Sperling AJ, 2005, NAT NEUROSCI, V8, P862, DOI 10.1038/nn1474; Sperling AJ, 2004, ANN DYSLEXIA, V54, P281, DOI 10.1007/s11881-004-0014-z; SWANSON HL, 1993, J EXP CHILD PSYCHOL, V56, P87, DOI 10.1006/jecp.1993.1027; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Wechsler D, 1997, WECHSLER ADULT INTEL; Wright BA, 2004, P NATL ACAD SCI USA, V101, P9942, DOI 10.1073/pnas.0401825101	50	161	167	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1558	1564		10.1038/nn1800	http://dx.doi.org/10.1038/nn1800			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	110TP	17115044				2022-12-17	WOS:000242404000021
J	Dackis, C; O'Brien, C				Dackis, C; O'Brien, C			Neurobiology of addiction: treatment and public policy ramifications	NATURE NEUROSCIENCE			English	Editorial Material							OPIOID RECEPTOR GENE; DOPAMINE-D-2 RECEPTORS; COCAINE DEPENDENCE; ALCOHOL DEPENDENCE; BETA-ENDORPHIN; EXTRACELLULAR DOPAMINE; NUCLEUS-ACCUMBENS; SEEKING BEHAVIOR; CENTRAL SWEDEN; D2 RECEPTORS	In the United States, efforts to treat addiction are hampered by prejudice and a public view that treats it as a disorder of self-control, not a disease. We highlight select advances in addiction research that, if disseminated to the public, could reverse these misconceptions and facilitate changes in policy to improve treatment access and care delivery for this highly prevalent disease.	Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Treatment Res Ctr, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Dackis, C (corresponding author), Univ Penn, Dept Psychiat, 3900 Chestnut St, Philadelphia, PA 19104 USA.	dackis@mail.med.upenn.edu						ALTSHULER HL, 1980, PHARMACOL BIOCHEM BE, V13, P233, DOI 10.1016/S0091-3057(80)80035-9; Bart G, 2005, NEUROPSYCHOPHARMACOL, V30, P417, DOI 10.1038/sj.npp.1300598; Bart G, 2004, MOL PSYCHIATR, V9, P547, DOI 10.1038/sj.mp.4001504; BELENKA S, 2005, EC BENEFITS DRUG TRE; Brody AL, 2004, PSYCHIAT RES-NEUROIM, V130, P269, DOI 10.1016/j.pscychresns.2003.12.006; Czoty PW, 2004, PSYCHOPHARMACOLOGY, V174, P381, DOI 10.1007/s00213-003-1752-z; Dackis C, 2003, ANN NY ACAD SCI, V1003, P328, DOI 10.1196/annals.1300.021; Dackis C. A., 2005, DRUG DISCOV TODAY, V2, P79; Dackis CA, 2001, J SUBST ABUSE TREAT, V21, P111, DOI 10.1016/S0740-5472(01)00192-1; DACKIS CA, 2002, DIS NERV SYST, P431; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; GENAZZANI AR, 1982, J CLIN ENDOCR METAB, V55, P583, DOI 10.1210/jcem-55-3-583; Georges F, 2003, NEUROPSYCHOPHARMACOL, V28, P1140, DOI 10.1038/sj.npp.1300161; Gerrits MAFM, 2002, BRAIN RES, V924, P141, DOI 10.1016/S0006-8993(01)03105-5; Gianoulakis C, 1996, ARCH GEN PSYCHIAT, V53, P250; Grusser SM, 2004, PSYCHOPHARMACOLOGY, V175, P296, DOI 10.1007/s00213-004-1828-4; Haney Margaret, 2004, Expert Rev Vaccines, V3, P11, DOI 10.1586/14760584.3.1.11; Heinz A, 2005, ARCH GEN PSYCHIAT, V62, P57, DOI 10.1001/archpsyc.62.1.57; Heinz A, 2004, AM J PSYCHIAT, V161, P1783, DOI 10.1176/appi.ajp.161.10.1783; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; KALIVAS PW, 1990, SYNAPSE, V5, P48, DOI 10.1002/syn.890050104; Kish SJ, 2001, NEUROPSYCHOPHARMACOL, V24, P561, DOI 10.1016/S0893-133X(00)00209-8; Martinez D, 2004, NEUROPSYCHOPHARMACOL, V29, P1190, DOI 10.1038/sj.npp.1300420; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; MPCLELLAN AT, 2000, JAMA-J AM MED ASSOC, V284, P1689; Myrick H, 2004, NEUROPSYCHOPHARMACOL, V29, P393, DOI 10.1038/sj.npp.1300295; O'Brien CP, 2005, AM J PSYCHIAT, V162, P1423, DOI 10.1176/appi.ajp.162.8.1423; O'Malley SS, 2002, PSYCHOPHARMACOLOGY, V160, P19, DOI 10.1007/s002130100919; OMALLEY SS, 1992, ARCH GEN PSYCHIAT, V49, P881; Oslin DW, 2003, NEUROPSYCHOPHARMACOL, V28, P1546, DOI 10.1038/sj.npp.1300219; Rammes G, 2001, NEUROPHARMACOLOGY, V40, P749, DOI 10.1016/S0028-3908(01)00008-9; Reid MS, 1996, NEUROREPORT, V7, P1325, DOI 10.1097/00001756-199605170-00022; Roberts AJ, 2000, J PHARMACOL EXP THER, V293, P1002; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; ROSSETTI ZL, 1992, ANN NY ACAD SCI, V654, P513, DOI 10.1111/j.1749-6632.1992.tb26016.x; Rouge-Pont F, 2002, J NEUROSCI, V22, P3293, DOI 10.1523/JNEUROSCI.22-08-03293.2002; Schultz W, 2001, NEUROSCIENTIST, V7, P293, DOI 10.1177/107385840100700406; Sell LA, 2000, DRUG ALCOHOL DEPEN, V60, P207, DOI 10.1016/S0376-8716(99)00158-1; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Thanos PK, 2001, J NEUROCHEM, V78, P1094, DOI 10.1046/j.1471-4159.2001.00492.x; Tupala E, 2004, PROG NEURO-PSYCHOPH, V28, P1221, DOI 10.1016/j.pnpbp.2004.06.022; VESCOVI PP, 1992, ALCOHOL ALCOHOLISM, V27, P471; Volkow ND, 2004, NEUROPHARMACOLOGY, V47, P3, DOI 10.1016/j.neuropharm.2004.07.019; Volkow ND, 2001, AM J PSYCHIAT, V158, P2015, DOI 10.1176/appi.ajp.158.12.2015; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; Weisner C, 2001, JAMA-J AM MED ASSOC, V286, P1715, DOI 10.1001/jama.286.14.1715; Xi ZX, 2002, J PHARMACOL EXP THER, V303, P608, DOI 10.1124/jpet.102.039735	50	161	164	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1431	1436		10.1038/nn1105-1431	http://dx.doi.org/10.1038/nn1105-1431			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16251982				2022-12-17	WOS:000232966600010
J	Singer, JH; Lassova, L; Vardi, N; Diamond, JS				Singer, JH; Lassova, L; Vardi, N; Diamond, JS			Coordinated multivesicular release at a mammalian ribbon synapse	NATURE NEUROSCIENCE			English	Article							ROD BIPOLAR CELLS; AII AMACRINE CELLS; RABBIT RETINA; QUANTAL ANALYSIS; RAT RETINA; ASYNCHRONOUS RELEASE; EXCITATORY SYNAPSES; SIGNAL INTERNEURONS; TIME-COURSE; VESICLES	Traditional models of synaptic transmission hold that release sites within an active zone operate independently. Although the release of multiple vesicles (multivesicular release; MVR) from single active zones occurs at some central synapses, MVR is not thought to require coordination among release sites. Ribbon synapses seem to be optimized to release many vesicles over an extended period, but the dynamics of MVR at ribbon synapses is unknown. We examined MVR at a ribbon synapse in a retinal slice preparation using paired recordings from presynaptic rod bipolar and postsynaptic AII amacrine cells. When evoked release was highly desynchronized, discrete postsynaptic events were larger than quantal miniature excitatory postsynaptic currents (mEPSCs) but had the same time course. The amplitude of these multiquantal mEPSCs, which seem to arise from the essentially simultaneous release of multiple vesicles, was reduced by lowering release probability. The release synchrony reflected in these multivesicular events suggests that release within an active zone is coordinated during MVR.	NINDS, Synapt Physiol Unit, NIH, Bethesda, MD 20892 USA; Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Pennsylvania	Singer, JH (corresponding author), NINDS, Synapt Physiol Unit, NIH, MSC-4066,Bldg 26,Room 2C-09, Bethesda, MD 20892 USA.	singerj@ninds.nih.gov	Diamond, Jeffrey/C-1835-2015	Diamond, Jeffrey/0000-0002-1770-2629	NATIONAL EYE INSTITUTE [R01EY000828, R01EY011105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K22NS043365] Funding Source: NIH RePORTER; NEI NIH HHS [EY11105, EY00828] Funding Source: Medline; NINDS NIH HHS [K22 NS043365] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALVAREZ DT, 1993, NATURE, V363, P554, DOI DOI 10.1038/363554A0; ALVAREZ DT, 1990, J GEN PHYSIOL, V95, P397, DOI DOI 10.1085/JGP.95.3.397; Auger C, 1998, J NEUROSCI, V18, P4532; Barlow H B, 1971, Vision Res, VSuppl 3, P87; CHUN MH, 1993, J COMP NEUROL, V332, P421, DOI 10.1002/cne.903320404; Cui JJ, 2003, J PHYSIOL-LONDON, V553, P895, DOI 10.1113/jphysiol.2003.052092; DELCASTILLO J, 1954, J PHYSL, V124, P157; Diamond JS, 1997, J NEUROSCI, V17, P4672; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; Hansen NJ, 1999, J BIOL CHEM, V274, P22871, DOI 10.1074/jbc.274.32.22871; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; Katz B., 1969, RELEASE NEURAL TRANS; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Koulen P, 1998, EUR J NEUROSCI, V10, P1446, DOI 10.1046/j.1460-9568.1998.00156.x; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Li W, 2002, J COMP NEUROL, V448, P230, DOI 10.1002/cne.10189; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Muresan V, 1999, J NEUROSCI, V19, P1027; NELSON R, 1982, J NEUROPHYSIOL, V47, P928, DOI 10.1152/jn.1982.47.5.928; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Parsons TD, 2003, NEURON, V37, P379, DOI 10.1016/S0896-6273(03)00062-X; PROPST JW, 1987, J NEUROSCI, V7, P3654; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; SAKITT B, 1972, J PHYSIOL-LONDON, V223, P131, DOI 10.1113/jphysiol.1972.sp009838; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Singer JH, 2003, J NEUROSCI, V23, P10923; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; STERLING P, 1988, J NEUROSCI, V8, P623; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; STRETTOI E, 1990, J COMP NEUROL, V295, P449, DOI 10.1002/cne.902950309; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; VANDERKLOOT W, 1988, J PHYSIOL-LONDON, V402, P595, DOI 10.1113/jphysiol.1988.sp017224; VANEY DI, 1991, J COMP NEUROL, V310, P154, DOI 10.1002/cne.903100203; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; YOUNG HM, 1991, J COMP NEUROL, V310, P139, DOI 10.1002/cne.903100202; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	47	161	161	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					826	833		10.1038/nn1280	http://dx.doi.org/10.1038/nn1280			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15235608				2022-12-17	WOS:000222930800012
J	Watanabe, T; Nanez, JE; Koyama, S; Mukai, I; Liederman, J; Sasaki, Y				Watanabe, T; Nanez, JE; Koyama, S; Mukai, I; Liederman, J; Sasaki, Y			Greater plasticity in lower-level than higher-level visual motion processing in a passive perceptual learning task	NATURE NEUROSCIENCE			English	Article							DISCRIMINATION TASK; CEREBRAL-CORTEX; V1 NEURONS; ORIENTATION; DIRECTION; SPECIFICITY; ATTENTION; IMPROVEMENT; INTEGRATION; DISPLAYS	Simple exposure is sufficient to sensitize the human visual system to a particular direction of motion, but the underlying mechanisms of this process are unclear. Here, in a passive perceptual learning task, we found that exposure to task-irrelevant motion improved sensitivity to the local motion directions within the stimulus, which are processed at low levels of the visual system. In contrast, task-irrelevant motion had no effect on sensitivity to the global motion direction, which is processed at higher levels. The improvement persisted for at least several months. These results indicate that when attentional influence is limited, lower-level motion processing is more receptive to long-term modification than higher-level motion processing in the visual cortex.	Boston Univ, Dept Psychol, Boston, MA 02215 USA; Arizona State Univ W, Dept Social & Behav Sci, Phoenix, AZ 85069 USA; Massachusetts Gen Hosp, NMR Ctr, Charlestown, MA 02129 USA	Boston University; Arizona State University; Arizona State University-Downtown Phoenix; Harvard University; Massachusetts General Hospital	Watanabe, T (corresponding author), Boston Univ, Dept Psychol, 64 Cummington St, Boston, MA 02215 USA.		KOYAMA, SHINICHI/H-2754-2019	KOYAMA, SHINICHI/0000-0001-6280-5750; Sasaki, Yuka/0000-0002-0061-0250				AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; BEARD BL, 1995, VISION RES, V35, P1679, DOI 10.1016/0042-6989(94)00267-P; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; Fahle M, 2002, PERCEPTUAL LEARNING; Fine I, 2002, J VISION, V2, P190, DOI 10.1167/2.2.5; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; FURMANSKI CS, IN PRESS J VISION S; Gilbert C D, 1993, Curr Opin Neurobiol, V3, P100, DOI 10.1016/0959-4388(93)90042-W; Gilbert CD, 1996, CURR OPIN NEUROBIOL, V6, P269, DOI 10.1016/S0959-4388(96)80083-3; Gold J, 1999, NATURE, V402, P176, DOI 10.1038/46027; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Grossberg S, 1999, SPATIAL VISION, V12, P163, DOI 10.1163/156856899X00102; Grzywacz N. M., 1989, Proceedings. Workshop on Visual Motion (IEEE Cat. No.89CH2716-9), P148, DOI 10.1109/WVM.1989.47104; GRZYWACZ NM, 1991, COMPUTATIONAL MODELS, P231; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Herzog MH, 1997, VISION RES, V37, P2133, DOI 10.1016/S0042-6989(97)00043-6; Ito M, 1998, NEURON, V20, P1191, DOI 10.1016/S0896-6273(00)80499-7; Jones MJ, 1997, CURR BIOL, V7, P991, DOI 10.1016/S0960-9822(06)00419-2; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KOYAMA S, IN PRESS J VISION S; Liu ZL, 1999, P NATL ACAD SCI USA, V96, P14085, DOI 10.1073/pnas.96.24.14085; Matthews N, 2001, VISION RES, V41, P463, DOI 10.1016/S0042-6989(00)00269-8; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; RAMACHANDRAN V, 1994, NATURE, V368, P592; RAMACHANDRAN VS, 1973, PERCEPTION, V2, P371, DOI 10.1068/p020371; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rubin N, 1997, CURR BIOL, V7, P461, DOI 10.1016/S0960-9822(06)00217-X; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schoups AA, 1996, P NATL ACAD SCI USA, V93, P7358, DOI 10.1073/pnas.93.14.7358; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Sigman M, 2000, NAT NEUROSCI, V3, P264, DOI 10.1038/72979; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; VAINA LM, 1995, COGNITIVE BRAIN RES, V2, P155, DOI 10.1016/0926-6410(95)90004-7; WATAMANIUK SNJ, 1989, VISION RES, V29, P47, DOI 10.1016/0042-6989(89)90173-9; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; WATANABE T, 1995, VISION RES, V35, P2853, DOI 10.1016/0042-6989(95)00064-7; WATANABE T, IN PRERSS J VISION S; WILLIAMS D, 1986, NATURE, V324, P253, DOI 10.1038/324253a0; WILLIAMS DW, 1984, VISION RES, V24, P55, DOI 10.1016/0042-6989(84)90144-5; Zohary E, 1996, VISION RES, V36, P2321, DOI 10.1016/0042-6989(95)00287-1	50	161	165	2	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					1003	1009		10.1038/nn915	http://dx.doi.org/10.1038/nn915			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	597VV	12219093				2022-12-17	WOS:000178242200020
J	Shen, K; Teruel, MN; Connor, JH; Shenolikar, S; Meyer, T				Shen, K; Teruel, MN; Connor, JH; Shenolikar, S; Meyer, T			Molecular memory by reversible translocation of calcium/calmodulin-dependent protein kinase II	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; CA-2+ CALMODULIN; MUTANT MICE; AUTOPHOSPHORYLATION; BINDING; STIMULATION; MECHANISM; SUBUNIT; NEURONS	Synaptic plasticity is thought to be a key process for learning, memory and other cognitive functions of the nervous system. The initial events of plasticity require the conversion of brief electrical signals into alterations of the biochemical properties of synapses that last for much longer than the initial stimuli. Here we show that a regulator of synaptic plasticity, calcium/calmodulin-dependent protein kinase II alpha (CaMKII), sequentially translocates to postsynaptic sites, undergoes autophosphorylation and gets trapped for several minutes until its dissociation is induced by secondary autophosphorylation and phosphatase 1 action. Once dissociated, CaMKII shows facilitated translocation for several minutes. This suggests that trapping of CaMKII by its targets and priming of CaMKII translocation may function as biochemical memory mechanisms that change the signaling capacity of synapses.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University; Stanford University; Duke University	Meyer, T (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	tobias1@stanford.edu		Meyer, Tobias/0000-0003-4339-3804; Teruel, Mary/0000-0002-2854-3598; Connor, John/0000-0002-8867-7256	NIGMS NIH HHS [R01-GM48113] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048113] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Cho YH, 1998, SCIENCE, V279, P867, DOI 10.1126/science.279.5352.867; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; ERONDU NE, 1985, J NEUROSCI, V5, P3270; FONG YL, 1989, J BIOL CHEM, V264, P16759; Gardoni F, 1999, FEBS LETT, V456, P394, DOI 10.1016/S0014-5793(99)00985-0; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Ouyang Y, 1997, J NEUROSCI, V17, P5416; PATTON BL, 1990, J BIOL CHEM, V265, P11204; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; SHIELDS SM, 1985, J NEUROSCI, V5, P3414; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Strack S, 1997, J NEUROCHEM, V68, P2119; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Teruel MN, 1999, J NEUROSCI METH, V93, P37, DOI 10.1016/S0165-0270(99)00112-0; WALDMANN R, 1990, BIOCHEMISTRY-US, V29, P1679, DOI 10.1021/bi00459a002	31	161	170	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					881	886		10.1038/78783	http://dx.doi.org/10.1038/78783			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966618				2022-12-17	WOS:000167177400014
J	Hernandez, JCC; Bracko, O; Kersbergen, CJ; Muse, V; Haft-Javaherian, M; Berg, M; Park, L; Vinarcsik, LK; Ivasyk, I; Rivera, DA; Kang, YM; Cortes-Canteli, M; Peyrounette, M; Doyeux, V; Smith, A; Zhou, J; Otte, G; Beverly, JD; Davenport, E; Davit, Y; Lin, CP; Strickland, S; Iadecola, C; Lorthois, S; Nishimura, N; Schaffer, CB				Hernandez, Jean C. Cruz; Bracko, Oliver; Kersbergen, Calvin J.; Muse, Victorine; Haft-Javaherian, Mohammad; Berg, Maxime; Park, Laibaik; Vinarcsik, Lindsay K.; Ivasyk, Iryna; Rivera, Daniel A.; Kang, Yiming; Cortes-Canteli, Marta; Peyrounette, Myriam; Doyeux, Vincent; Smith, Amy; Zhou, Joan; Otte, Gabriel; Beverly, Jeffrey D.; Davenport, Elizabeth; Davit, Yohan; Lin, Charles P.; Strickland, Sidney; Iadecola, Costantino; Lorthois, Sylvie; Nishimura, Nozomi; Schaffer, Chris B.			Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer's disease mouse models	NATURE NEUROSCIENCE			English	Article							TRANSGENIC MICE; COGNITIVE DECLINE; IN-VIVO; PATHOLOGY; DYSFUNCTION; LEUKOCYTES; PATTERNS; PEPTIDE	Cerebral blood flow (CBF) reductions in Alzheimer's disease patients and related mouse models have been recognized for decades, but the underlying mechanisms and resulting consequences for Alzheimer's disease pathogenesis remain poorly understood. In APP/PS1 and 5xFAD mice we found that an increased number of cortical capillaries had stalled blood flow as compared to in wild-type animals, largely due to neutrophils that had adhered in capillary segments and blocked blood flow. Administration of antibodies against the neutrophil marker Ly6G reduced the number of stalled capillaries, leading to both an immediate increase in CBF and rapidly improved performance in spatial and working memory tasks. This study identified a previously uncharacterized cellular mechanism that explains the majority of the CBF reduction seen in two mouse models of Alzheimer's disease and demonstrated that improving CBF rapidly enhanced short-term memory function. Restoring cerebral perfusion by preventing neutrophil adhesion may provide a strategy for improving cognition in Alzheimer's disease patients.	[Hernandez, Jean C. Cruz; Bracko, Oliver; Kersbergen, Calvin J.; Muse, Victorine; Haft-Javaherian, Mohammad; Vinarcsik, Lindsay K.; Ivasyk, Iryna; Rivera, Daniel A.; Kang, Yiming; Zhou, Joan; Otte, Gabriel; Beverly, Jeffrey D.; Davenport, Elizabeth; Lorthois, Sylvie; Nishimura, Nozomi; Schaffer, Chris B.] Cornell Univ, Nancy E & Peter C Meinig Sch Biomed Engn, Ithaca, NY 14853 USA; [Berg, Maxime; Peyrounette, Myriam; Doyeux, Vincent; Smith, Amy; Davit, Yohan; Lorthois, Sylvie] Univ Toulouse, CNRS, Inst Mecan Fluides Toulouse, INPT,UPS, Toulouse, France; [Park, Laibaik; Iadecola, Costantino] Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY USA; [Cortes-Canteli, Marta; Strickland, Sidney] Rockefeller Univ, Patricia & John Rosenwald Lab Neurobiol & Genet, 1230 York Ave, New York, NY 10021 USA; [Cortes-Canteli, Marta] Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain; [Lin, Charles P.] Harvard Med Sch, Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02115 USA; [Lin, Charles P.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02115 USA	Cornell University; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Cornell University; Rockefeller University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Nishimura, N; Schaffer, CB (corresponding author), Cornell Univ, Nancy E & Peter C Meinig Sch Biomed Engn, Ithaca, NY 14853 USA.	nn62@cornell.edu; cs385@cornell.edu	Iadecola, c/ABB-8377-2020; Bracko, Oliver/AAU-2753-2020; Schaffer, Chris B./A-7409-2008; Cortes-Canteli, Marta/L-5449-2014; Javaherian, Mohammad Haft/P-1379-2014	Bracko, Oliver/0000-0002-9414-6590; Schaffer, Chris B./0000-0002-7800-9596; Cortes-Canteli, Marta/0000-0001-8802-4338; Javaherian, Mohammad Haft/0000-0002-8551-5008; PARK, LAIBAIK/0000-0001-7601-663X; Strickland, Sidney/0000-0002-3072-9244; Kang, Yiming/0000-0002-8852-7696; Vinarcsik, Lou/0000-0002-1183-2588; Muse, Victorine P./0000-0003-1583-6970; Kersbergen, Calvin/0000-0001-6173-2094; Berg, Maxime/0000-0003-1403-1978	National Institutes of Health [AG049952, NS37853, NS097805, AG031620]; Alzheimer's Drug Discovery Foundation; Alzheimer's Art Quilt Initiative; BrightFocus Foundation; European Research Council [615102]; DFG German Research Foundation; National Science Foundation Graduate Research Fellowship; L'Oreal Fellowship for Women in Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037853, R01NS097805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG049952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Drug Discovery Foundation; Alzheimer's Art Quilt Initiative; BrightFocus Foundation(BrightFocus Foundation); European Research Council(European Research Council (ERC)European Commission); DFG German Research Foundation(German Research Foundation (DFG)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); L'Oreal Fellowship for Women in Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health grants Nos. AG049952 (C.B.S.), NS37853 (C.I.), NS097805 (L.P.) and AG031620 (N.N.), the Alzheimer's Drug Discovery Foundation (C.B.S.), the Alzheimer's Art Quilt Initiative (C.B.S.), the BrightFocus Foundation (C.B.S.), European Research Council grant No. 615102 (S.L.), the DFG German Research Foundation (O.B.), a National Science Foundation Graduate Research Fellowship (J.C.H.), the L'Oreal Fellowship for Women in Science (N.N.) and used computing resources at CALMIP (S.L.). We thank F. Lauwers for the human vascular data, P. Tsai, P. Blinder and D. Kleinfeld for the mouse vascular data and M. Gulinello for guidance on behavior experiments. Finally, we thank J.R. Fetcho, J.H. Goldberg and M.I. Kotlikoff for commenting on the manuscript.	Bennett RE, 2018, P NATL ACAD SCI USA, V115, pE1289, DOI 10.1073/pnas.1710329115; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Chen Y, 2011, NEUROLOGY, V77, P1977, DOI 10.1212/WNL.0b013e31823a0ef7; Chibber R, 2007, CURR DIABETES REV, V3, P3, DOI 10.2174/157339907779802139; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Dai WY, 2009, RADIOLOGY, V250, P856, DOI 10.1148/radiol.2503080751; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; Dijkstra E. W., 1959, NUMER MATH, V1, P269, DOI [10.1007/BF01386390, DOI 10.1007/BF01386390]; ENGLER RL, 1983, AM J PATHOL, V111, P98; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Goldsmith Harry S, 2017, Surg Neurol Int, V8, P133, DOI 10.4103/sni.sni_116_17; Haft-Javaherian M., 2018, DEEP CONVOLUTIONAL N; Hasenberg A, 2015, NAT METHODS, V12, P445, DOI [10.1038/NMETH.3322, 10.1038/nmeth.3322]; Hattori Y, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002757; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Iadecola C, 2016, CELL MOL NEUROBIOL, V36, P151, DOI 10.1007/s10571-015-0319-y; Ilesanmi OO, 2010, HEMATOL REP, V2, P10, DOI 10.4081/hr.2010.e2; Ishikawa M, 2016, ACTA NEUROCHIR, V158, P1057, DOI 10.1007/s00701-016-2792-6; Iturria-Medina Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11934; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kloner RA, 2011, J CARDIOVASC PHARM T, V16, P244, DOI 10.1177/1074248411405990; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; Lauwers F, 2008, NEUROIMAGE, V39, P936, DOI 10.1016/j.neuroimage.2007.09.024; Lavkan AH, 1998, CRIT CARE MED, V26, P1677, DOI 10.1097/00003246-199810000-00021; Li HM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-28; Lorthois S, 2011, NEUROIMAGE, V54, P2840, DOI 10.1016/j.neuroimage.2010.10.040; Marshall RS, 2001, BRAIN, V124, P1208, DOI 10.1093/brain/124.6.1208; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Niwa K, 2002, NEUROBIOL DIS, V9, P61, DOI 10.1006/nbdi.2001.0460; Niwa K, 2001, AM J PHYSIOL-HEART C, V281, pH2417, DOI 10.1152/ajpheart.2001.281.6.H2417; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Park L, 2008, P NATL ACAD SCI USA, V105, P1347, DOI 10.1073/pnas.0711568105; Park L, 2013, P NATL ACAD SCI USA, V110, P3089, DOI 10.1073/pnas.1300021110; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Roher AE, 2012, VASC HEALTH RISK MAN, V8, P599, DOI 10.2147/VHRM.S34874; Royea J, 2017, J NEUROSCI, V37, P5562, DOI 10.1523/JNEUROSCI.0329-17.2017; Santisakultarm TP, 2014, J THROMB HAEMOST, V12, P2120, DOI 10.1111/jth.12738; Santos Claudia Y, 2017, Alzheimers Dement (Amst), V7, P69, DOI 10.1016/j.dadm.2017.01.005; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; VILLRINGER A, 1991, MICROVASC RES, V42, P305, DOI 10.1016/0026-2862(91)90064-I; Wang J, 2017, NAT REV NEUROL, V13, P612, DOI 10.1038/nrneurol.2017.111; Wang JX, 2012, BLOOD, V120, P1489, DOI 10.1182/blood-2012-01-404046; Wang L, 2016, INT C PATT RECOG, P283, DOI 10.1109/ICPR.2016.7899647; Wiesmann M, 2017, THERANOSTICS, V7, P1277, DOI 10.7150/thno.18509; Wolters FJ, 2017, CIRCULATION, V136, P719, DOI 10.1161/CIRCULATIONAHA.117.027448; Zenaro E, 2015, NAT MED, V21, P880, DOI 10.1038/nm.3913; Zuliani G, 2008, J NEUROL SCI, V272, P164, DOI 10.1016/j.jns.2008.05.020	50	160	163	11	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2019	22	3					413	+		10.1038/s41593-018-0329-4	http://dx.doi.org/10.1038/s41593-018-0329-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HM4DL	30742116	Green Accepted, Green Submitted			2022-12-17	WOS:000459423800012
J	Orr, AG; Hsiao, EC; Wang, MM; Ho, K; Kim, DH; Wang, X; Guo, WK; Kang, J; Yu, GQ; Adame, A; Devidze, N; Dubal, DB; Masliah, E; Conklin, BR; Mucke, L				Orr, Anna G.; Hsiao, Edward C.; Wang, Max M.; Ho, Kaitlyn; Kim, Daniel H.; Wang, Xin; Guo, Weikun; Kang, Jing; Yu, Gui-Qiu; Adame, Anthony; Devidze, Nino; Dubal, Dena B.; Masliah, Eliezer; Conklin, Bruce R.; Mucke, Lennart			Astrocytic adenosine receptor A(2A) and G(s)-coupled signaling regulate memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; GLUTAMATE UPTAKE; TRANSGENIC MICE; MOUSE; ALZHEIMERS; EXPRESSION; CONSOLIDATION; NUCLEUS; LEVEL; GENE	Astrocytes express a variety of G protein-coupled receptors and might influence cognitive functions, such as learning and memory. However, the roles of astrocytic G(s)-coupled receptors in cognitive function are not known. We found that humans with Alzheimer's disease (AD) had increased levels of the Gs-coupled adenosine receptor A(2A) in astrocytes. Conditional genetic removal of these receptors enhanced long-term memory in young and aging mice and increased the levels of Arc (also known as Arg3.1), an immediate-early gene that is required for long-term memory. Chemogenetic activation of astrocytic G(s)-coupled signaling reduced long-term memory in mice without affecting learning. Like humans with AD, aging mice expressing human amyloid precursor protein (hAPP) showed increased levels of astrocytic A(2A) receptors. Conditional genetic removal of these receptors enhanced memory in aging hAPP mice. Together, these findings establish a regulatory role for astrocytic Gs-coupled receptors in memory and suggest that AD-linked increases in astrocytic A(2A) receptor levels contribute to memory loss.	[Orr, Anna G.; Wang, Max M.; Ho, Kaitlyn; Kim, Daniel H.; Wang, Xin; Guo, Weikun; Kang, Jing; Yu, Gui-Qiu; Devidze, Nino; Dubal, Dena B.; Mucke, Lennart] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Orr, Anna G.; Dubal, Dena B.; Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Hsiao, Edward C.; Conklin, Bruce R.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Hsiao, Edward C.] Univ Calif San Francisco, Dept Med, Div Endocrinol & Metab, San Francisco, CA 94143 USA; [Hsiao, Edward C.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Adame, Anthony; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Adame, Anthony; Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92103 USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco	Orr, AG (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	anna.orr@gladstone.ucsf.edu; lmucke@gladstone.ucsf.edu	Conklin, Bruce/E-4738-2019; Dubal, Dena/AAL-2091-2021	Orr, Anna/0000-0002-4036-4277; Conklin, Bruce/0000-0003-1463-6061	US National Institutes of Health [AG039220, AR056299, AG034531, HL60664, HL100406, AG022074, N5065780]; MetLife Foundation Award; National Center for Research Resources [RR18938]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060664, U01HL100406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR056299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131, K08AG034531, F32AG039220, P01AG022074] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MetLife Foundation Award; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P.E. Sanchez for advice on behavioral experiments, R. Ponnusamy for comments on the manuscript, J.-F. Chen (Boston University School of Medicine) for providing loxP-Adora2a transgenic mice, N. Deglon (Lausanne University Hospital) for providing the lentiviral vector and packaging plasmids, B. Khakh (University of California, Los Angeles) for providing the plasmid encoding the membrane-targeting region of lck, S.-W MM and L. Gan (Gladstone Institute of Neurological Disease) for providing brain tissue from Tau-P3OIS mice, L. Leung and Y. Huang (Gladstone Institute of Neurological Disease) for providing brain tissue from ApoE3-KI and ApoE4-KI mice, A. Lundquist, G. Shlager, C. Wang and E. Whiting for technical support, R. Craft, T. Hamto, I. Lo and B. Masatsugu of the Gladstone Behavioral Core for advice and technical support, and M. Dela Cruz and A. Cheung for administrative assistance. This study was supported by US National Institutes of Health grants AG039220 to AGO., AR056299 to E.C.H., AG034531 to D.B.D. HL60664 and HL100406 to B.R.C.; and AG022074 and N5065780 to L.M., and a MetLife Foundation Award to L.M. The Gladkorie lhstitutes received support from a National Center for Research Resources Grant RR18938.	Albasanz JL, 2008, BRAIN PATHOL, V18, P211, DOI 10.1111/j.1750-3639.2007.00112.x; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Altevogt BM, 2004, J NEUROSCI, V24, P4313, DOI 10.1523/JNEUROSCI.3303-03.2004; Bai XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066873; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Bastia E, 2005, NEUROPSYCHOPHARMACOL, V30, P891, DOI 10.1038/sj.npp.1300630; Bogenpohl JW, 2012, J COMP NEUROL, V520, P570, DOI 10.1002/cne.22751; Borota D, 2014, NAT NEUROSCI, V17, P201, DOI 10.1038/nn.3623; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chang WC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001317; Chen JF, 2007, PROG NEUROBIOL, V83, P310, DOI 10.1016/j.pneurobio.2007.09.002; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Fox IJ, 2004, DEV BRAIN RES, V153, P121, DOI 10.1016/j.devbrainres.2004.07.011; Fredholm BB, 2001, PHARMACOL REV, V53, P527; GOLDMAN JE, 1990, BRAIN RES, V528, P189, DOI 10.1016/0006-8993(90)91657-3; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Han HJ, 2012, J NEUROSCI, V32, P10574, DOI 10.1523/JNEUROSCI.0893-12.2012; Han J, 2012, CELL, V148, P1039, DOI 10.1016/j.cell.2012.01.037; Hardt O, 2013, TRENDS COGN SCI, V17, P111, DOI 10.1016/j.tics.2013.01.001; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Ji B, 2008, J NEUROSCI, V28, P12255, DOI 10.1523/JNEUROSCI.2312-08.2008; Karasinska JM, 2013, NEUROBIOL DIS, V54, P445, DOI 10.1016/j.nbd.2013.01.018; Laurent C, 2016, MOL PSYCHIATR, V21, P97, DOI 10.1038/mp.2014.151; Lazarus M, 2011, J NEUROSCI, V31, P10067, DOI 10.1523/JNEUROSCI.6730-10.2011; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Matos M, 2013, J NEUROSCI, V33, P18492, DOI 10.1523/JNEUROSCI.1828-13.2013; Matos M, 2012, GLIA, V60, P702, DOI 10.1002/glia.22290; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Murray PD, 2009, GLIA, V57, P828, DOI 10.1002/glia.20809; OCALLAGHAN JP, 1991, NEUROBIOL AGING, V12, P171, DOI 10.1016/0197-4580(91)90057-Q; Orr AG, 2009, NAT NEUROSCI, V12, P872, DOI 10.1038/nn.2341; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Pickel VM, 2006, SYNAPSE, V60, P496, DOI 10.1002/syn.20326; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Rebola N, 2008, NEURON, V57, P121, DOI 10.1016/j.neuron.2007.11.023; Saura J, 2005, J NEUROCHEM, V95, P919, DOI 10.1111/j.1471-4159.2005.03395.x; Stenzel D, 2011, DEVELOPMENT, V138, P4451, DOI 10.1242/dev.071381; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Vianna MRM, 2000, LEARN MEMORY, V7, P333, DOI 10.1101/lm.34600; Wimmer ME, 2012, NEUROBIOL AGING, V33, P2220, DOI 10.1016/j.neurobiolaging.2011.07.007; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	50	160	170	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2015	18	3					423	434		10.1038/nn.3930	http://dx.doi.org/10.1038/nn.3930			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC2SO	25622143	Green Accepted			2022-12-17	WOS:000350195100023
J	Suzuki, M; Gottlieb, J				Suzuki, Mototaka; Gottlieb, Jacqueline			Distinct neural mechanisms of distractor suppression in the frontal and parietal lobe	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; VISUOSPATIAL WORKING-MEMORY; CORTICAL NETWORK MODEL; PREFRONTAL CORTEX; EYE FIELD; ACCUMULATOR MODEL; VISUAL-ATTENTION; DECISION-MAKING; MONKEY; NEURONS	The posterior parietal cortex and the prefrontal cortex are associated with eye movements and visual attention, but their specific contributions are poorly understood. We compared the dorsolateral prefrontal cortex (dlPFC) and the lateral intraparietal area (LIP) in monkeys using a memory saccade task in which a salient distractor flashed at a variable timing and location during the memory delay. We found that the two areas had similar responses to target selection, but made distinct contributions to distractor suppression. Distractor responses were more strongly suppressed and more closely correlated with performance in the dlPFC relative to LIP. Moreover, reversible inactivation of the dlPFC produced much larger increases in distractibility than inactivation of LIP. These findings suggest that LIP and dlPFC mediate different aspects of selective attention. Although both areas can contribute to the perceptual selection of salient information, the dlPFC has a decisive influence on whether and how attended stimulus is linked with actions.	[Suzuki, Mototaka; Gottlieb, Jacqueline] Dept Neurosci, New York, NY USA; [Gottlieb, Jacqueline] Columbia Univ, Kavli Inst Brain Res, New York, NY USA	Columbia University	Gottlieb, J (corresponding author), Dept Neurosci, New York, NY USA.	jg2141@columbia.edu	Suzuki, Mototaka/A-1457-2008	Suzuki, Mototaka/0000-0002-2151-4882	Swiss National Science Foundation Fellowship [PBELB-120948]; Human Frontier Science Program Cross-Disciplinary Fellowship [LT00934/2008-C]; NATIONAL EYE INSTITUTE [P30EY019007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH091590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030095] Funding Source: NIH RePORTER	Swiss National Science Foundation Fellowship(Swiss National Science Foundation (SNSF)); Human Frontier Science Program Cross-Disciplinary Fellowship(Human Frontier Science Program); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Golberg, D. Salzman and V. Ferrera for their comments on an earlier version of the manuscript. This work was supported by a Swiss National Science Foundation Fellowship (PBELB-120948) and a Human Frontier Science Program Cross-Disciplinary Fellowship to M. S. (LT00934/2008-C).	Anderson JC, 2011, J NEUROSCI, V31, P10872, DOI 10.1523/JNEUROSCI.0622-11.2011; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Balan PF, 2009, J NEUROSCI, V29, P8166, DOI 10.1523/JNEUROSCI.0243-09.2009; BARASH S, 1991, J NEUROPHYSIOL, V66, P1095, DOI 10.1152/jn.1991.66.3.1095; Bays PM, 2010, J NEUROSCI, V30, P5968, DOI 10.1523/JNEUROSCI.0997-10.2010; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Bisley JW, 2006, J NEUROPHYSIOL, V95, P1696, DOI 10.1152/jn.00848.2005; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Boehnke SE, 2011, EUR J NEUROSCI, V34, P766, DOI 10.1111/j.1460-9568.2011.07805.x; Brown GG, 2010, CURR TOP BEHAV NEURO, V4, P181, DOI 10.1007/7854_2010_54; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Chafee MV, 2000, J NEUROPHYSIOL, V83, P1550, DOI 10.1152/jn.2000.83.3.1550; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Doyle AE, 2006, J CLIN PSYCHIAT, V67, P21; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Furman M, 2008, NEURON, V60, P1153, DOI 10.1016/j.neuron.2008.12.003; Ganguli S, 2008, NEURON, V58, P15, DOI 10.1016/j.neuron.2008.01.038; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Hasegawa RP, 2004, NEURON, V43, P415, DOI 10.1016/j.neuron.2004.07.013; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Katsuki F, 2012, NAT NEUROSCI, V15, P1160, DOI 10.1038/nn.3164; Katsuki F, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00017; Kisvarday ZF, 2002, J NEUROCYTOL, V31, P255, DOI 10.1023/A:1024122009448; Klingberg T, 2006, NEUROPSYCHOLOGIA, V44, P2171, DOI 10.1016/j.neuropsychologia.2005.11.019; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Mayo JP, 2008, J NEUROPHYSIOL, V100, P1923, DOI 10.1152/jn.90549.2008; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Oristaglio J, 2006, J NEUROSCI, V26, P8310, DOI 10.1523/JNEUROSCI.1779-06.2006; Pearce J.M., 2010, 2 THEORIES ATTENTION; Powell KD, 2000, J NEUROPHYSIOL, V84, P301, DOI 10.1152/jn.2000.84.1.301; Premereur E, 2012, J NEUROPHYSIOL, V108, P1392, DOI 10.1152/jn.00323.2012; Premereur E, 2011, J NEUROSCI, V31, P12307, DOI 10.1523/JNEUROSCI.2241-11.2011; Purcell BA, 2012, J NEUROSCI, V32, P3433, DOI 10.1523/JNEUROSCI.4622-11.2012; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Sawaguchi T, 2001, J NEUROPHYSIOL, V86, P2041, DOI 10.1152/jn.2001.86.4.2041; Schall JD, 2011, EUR J NEUROSCI, V33, P1991, DOI 10.1111/j.1460-9568.2011.07715.x; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Wang X.J., 2009, ENCY NEUROSCIENCE, P667; Wang XJ, 2004, P NATL ACAD SCI USA, V101, P1368, DOI 10.1073/pnas.0305337101; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006; Wardak C, 2004, NEURON, V42, P501, DOI 10.1016/S0896-6273(04)00185-0; Wardak C, 2002, J NEUROSCI, V22, P9877	52	160	160	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					98	U139		10.1038/nn.3282	http://dx.doi.org/10.1038/nn.3282			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23242309	Green Accepted			2022-12-17	WOS:000312633900018
J	Barkat, TR; Polley, DB; Hensch, TK				Barkat, Tania Rinaldi; Polley, Daniel B.; Hensch, Takao K.			A critical period for auditory thalamocortical connectivity	NATURE NEUROSCIENCE			English	Article							IN-VIVO; CORTEX; PLASTICITY; EXPERIENCE; REPRESENTATION; ORGANIZATION; INPUTS; MOUSE; SELECTIVITY; PERCEPTION	Neural circuits are shaped by experience during periods of heightened brain plasticity in early postnatal life. Exposure to acoustic features produces age-dependent changes through largely unresolved cellular mechanisms and sites of origin. We isolated the refinement of auditory thalamocortical connectivity by in vivo recordings and day-by-day voltage-sensitive dye imaging in an acute brain slice preparation. Passive tone-rearing modified response strength and topography in mouse primary auditory cortex (A1) during a brief, 3-d window, but did not alter tonotopic maps in the thalamus. Gene-targeted deletion of a forebrain-specific cell-adhesion molecule (Icam5) accelerated plasticity in this critical period. Consistent with its normal role of slowing spinogenesis, loss of Icam5 induced precocious stubby spine maturation on pyramidal cell dendrites in neocortical layer 4 (L4), identifying a primary locus of change for the tonotopic plasticity. The evolving postnatal connectivity between thalamus and cortex in the days following hearing onset may therefore determine a critical period for auditory processing.	[Barkat, Tania Rinaldi; Hensch, Takao K.] Harvard Univ, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Polley, Daniel B.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Eaton Peabody Lab,Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Hensch, TK (corresponding author), Harvard Univ, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	hensch@mcb.harvard.edu	Hensch, Takao/L-4182-2019	Rinaldi Barkat, Tania/0000-0001-8650-0986; Polley, Daniel/0000-0002-5120-2409	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency; Human Frontiers Science Program; National Institute on Deafness and Other Communication Disorders [009836]; Harvard Society of Fellows; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009836] Funding Source: NIH RePORTER	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Human Frontiers Science Program(Human Frontier Science Program); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Harvard Society of Fellows; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Icam5<SUP>-/-</SUP> mice and antibody were kindly provided by M. Mishina (University of Tokyo) and Y. Yoshihara (RIKEN BSI), respectively. We thank M. Nakamura, A. Takesian, N. Gogolla, E.-J. Yang, K. Quast, M. Marcotrigiano, M. Kelly, R. Pavlyuk, B. Jones O'Brien and V. Khatri for technical assistance and comments. This work was supported by Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (T. K. H.), the Human Frontiers Science Program (T. K. H.), the National Institute on Deafness and Other Communication Disorders (grant 009836, D. B. P.) and the Harvard Society of Fellows (T.R.B.).	ALFORD BR, 1963, ANN OTO RHINOL LARYN, V72, P237, DOI 10.1177/000348946307200119; ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.ne.17.030194.001153; Bajo VM, 2010, NAT NEUROSCI, V13, P253, DOI 10.1038/nn.2466; Cruikshank SJ, 2002, J NEUROPHYSIOL, V87, P361, DOI 10.1152/jn.00549.2001; de Villers-Sidani E, 2008, NAT NEUROSCI, V11, P957, DOI 10.1038/nn.2144; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Geissler DB, 2004, EUR J NEUROSCI, V19, P1027, DOI 10.1111/j.1460-9568.2004.03205.x; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Hackett TA, 2011, J NEUROSCI, V31, P2983, DOI 10.1523/JNEUROSCI.5333-10.2011; Han YK, 2007, NAT NEUROSCI, V10, P1191, DOI 10.1038/nn1941; Harris JA, 2006, HEARING RES, V216, P127, DOI 10.1016/j.heares.2006.03.016; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Insanally MN, 2009, J NEUROSCI, V29, P5456, DOI 10.1523/JNEUROSCI.5311-08.2009; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Kanold PO, 2010, ANNU REV NEUROSCI, V33, P23, DOI 10.1146/annurev-neuro-060909-153244; Kaur S, 2005, NEUROSCIENCE, V134, P1033, DOI 10.1016/j.neuroscience.2005.04.052; Keuroghlian AS, 2007, PROG NEUROBIOL, V82, P109, DOI 10.1016/j.pneurobio.2007.03.005; Kim H, 2009, J NEUROSCI, V29, P5163, DOI 10.1523/JNEUROSCI.0365-09.2009; King AJ, 2009, NAT NEUROSCI, V12, P698, DOI 10.1038/nn.2308; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; MASINO SA, 1993, P NATL ACAD SCI USA, V90, P9998, DOI 10.1073/pnas.90.21.9998; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Matsuno H, 2006, J NEUROSCI, V26, P1776, DOI 10.1523/JNEUROSCI.2651-05.2006; MOGDANS J, 1994, J NEUROPHYSIOL, V72, P2875, DOI 10.1152/jn.1994.72.6.2875; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; Nakamura K, 2001, EUR J NEUROSCI, V13, P179, DOI 10.1046/j.0953-816X.2000.01366.x; Oviedo HV, 2010, NAT NEUROSCI, V13, P1413, DOI 10.1038/nn.2659; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Popescu MV, 2010, NEURON, V65, P718, DOI 10.1016/j.neuron.2010.02.019; Razak KA, 2008, P NATL ACAD SCI USA, V105, P4465, DOI 10.1073/pnas.0709504105; Richardson RJ, 2009, J NEUROSCI, V29, P6406, DOI 10.1523/JNEUROSCI.0258-09.2009; Sanes DH, 2009, CURR OPIN NEUROBIOL, V19, P188, DOI 10.1016/j.conb.2009.05.014; SANES DH, 1983, SCIENCE, V221, P1183, DOI 10.1126/science.6612332; Seidl AH, 2005, J NEUROPHYSIOL, V94, P1028, DOI 10.1152/jn.01143.2004; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SMITH ZDJ, 1983, J COMP NEUROL, V220, P199, DOI 10.1002/cne.902200207; Stiebler I, 1997, J COMP PHYSIOL A, V181, P559, DOI 10.1007/s003590050140; Sun YJ, 2010, NATURE, V465, P927, DOI 10.1038/nature09079; Werker JF, 2005, DEV PSYCHOBIOL, V46, P233, DOI 10.1002/dev.20060; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; Winer JA, 2005, TRENDS NEUROSCI, V28, P255, DOI 10.1016/j.tins.2005.03.009; Winer JA, 1999, HEARING RES, V130, P42, DOI 10.1016/S0378-5955(98)00217-2; Yan W, 1998, NAT NEUROSCI, V1, P54, DOI 10.1038/255; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398; Zhao CP, 2009, J NEUROSCI, V29, P15479, DOI 10.1523/JNEUROSCI.4471-09.2009; Zhou X, 2008, NEUROSCIENCE, V154, P390, DOI 10.1016/j.neuroscience.2008.01.026	50	160	163	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1189	U252		10.1038/nn.2882	http://dx.doi.org/10.1038/nn.2882			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21804538	Green Accepted			2022-12-17	WOS:000294284900020
J	Meaney, MJ; Ferguson-Smith, AC				Meaney, Michael J.; Ferguson-Smith, Anne C.			Epigenetic regulation of the neural transcriptome: the meaning of the marks	NATURE NEUROSCIENCE			English	Article							DNA METHYLATION; HUMAN BRAIN; HISTONE H3; CHROMATIN-STRUCTURE; MECP2; CPG; HETEROCHROMATIN; PROMOTER; DISEASE; COMPLEX	The field of epigenetics provides neurobiologists with candidate mechanisms for experience-dependent changes in gene transcription. The ability to realize the potential of epigenetics in defining the causal pathways lying between environmental signals, transcriptional regulation and neural function will depend on moving beyond correlational studies focusing on individual epigenetic marks. Here we attempt to provide a conceptual framework for integrative research on nucleotide sequence, chromatin modifications, RNA signaling and their interactions in understanding experience-dependent phenotypic plasticity. Studies in genomic imprinting may serve as an existing model for such approaches.	[Meaney, Michael J.] McGill Univ, Douglas Hosp Mental Hlth Univ Inst, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada; [Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Meaney, Michael J.; Ferguson-Smith, Anne C.] Singapore Inst Clin Sci, Singapore, Singapore	McGill University; University of Cambridge; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Meaney, MJ (corresponding author), McGill Univ, Douglas Hosp Mental Hlth Univ Inst, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada.	michael.meaney@mcgill.ca	Meaney, Michael/N-5931-2019; Ferguson-Smith, Anne C/G-7534-2011	Ferguson-Smith, Anne/0000-0002-7608-5894	MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784B] Funding Source: researchfish; Medical Research Council [G0800784] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akbarian S, 2009, BIOL PSYCHIAT, V65, P198, DOI 10.1016/j.biopsych.2008.08.015; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Angrisano T, 2006, NUCLEIC ACIDS RES, V34, P364, DOI 10.1093/nar/gkj400; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen M, 2009, CELL METAB, V9, P548, DOI 10.1016/j.cmet.2009.05.004; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Davies W, 2008, ADV EXP MED BIOL, V626, P62; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Fujita H, 2003, MOL CELL BIOL, V23, P2645, DOI 10.1128/MCB.23.8.2645-2657.2003; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Hall SE, 2010, CURR BIOL, V20, P149, DOI 10.1016/j.cub.2009.11.035; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Li F, 2008, CELL, V135, P272, DOI 10.1016/j.cell.2008.08.036; Luo SW, 2009, EMBO J, V28, P2568, DOI 10.1038/emboj.2009.178; McEwen KR, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-2; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Plagge A, 2006, CYTOGENET GENOME RES, V113, P178, DOI 10.1159/000090830; Renthal W, 2008, TRENDS MOL MED, V14, P341, DOI 10.1016/j.molmed.2008.06.004; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Sanz LA, 2008, EMBO J, V27, P2523, DOI 10.1038/emboj.2008.142; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Weiss A, 1997, GENES CELLS, V2, P481, DOI 10.1046/j.1365-2443.1997.1390337.x; Yamazawa K, 2010, AM J MED GENET C, V154C, P329, DOI 10.1002/ajmg.c.30270; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005; Zhang TY, 2010, J NEUROSCI, V30, P13130, DOI 10.1523/JNEUROSCI.1039-10.2010; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	58	160	165	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1313	1318		10.1038/nn1110-1313	http://dx.doi.org/10.1038/nn1110-1313			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20975754				2022-12-17	WOS:000283658200007
J	Rasch, B; Pommer, J; Diekelmann, S; Born, J				Rasch, Bjoern; Pommer, Julian; Diekelmann, Susanne; Born, Jan			Pharmacological REM sleep suppression paradoxically improves rather than impairs skill memory	NATURE NEUROSCIENCE			English	Article							CONSOLIDATION; ANTIDEPRESSANTS	Rapid eye movement (REM) sleep has been considered important for consolidation of memories, particularly of skills. Contrary to expectations, we found that REM sleep suppression by administration of selective serotonin or norepinephrine re-uptake inhibitors after training did not impair consolidation of skills or word-pairs in healthy men but rather enhanced gains in finger tapping accuracy together with sleep spindles. Our results indicate that REM sleep as a unitary phenomenon is not required for skill-memory consolidation.	[Rasch, Bjoern; Pommer, Julian; Diekelmann, Susanne; Born, Jan] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; [Rasch, Bjoern] Univ Basel, Dept Mol Psychol, CH-4055 Basel, Switzerland	University of Lubeck; University of Basel	Rasch, B (corresponding author), Med Univ Lubeck, Dept Neuroendocrinol, Haus 23A,Ratzeburger Allee 160, D-23538 Lubeck, Germany.	rasch@kfg.uni-luebeck.de; born@kfg.uni-luebeck.de	Born, Jan/K-2596-2016; Rasch, Björn/A-3119-2015	Born, Jan/0000-0002-1847-6248; Rasch, Björn/0000-0001-7607-3415	Deutsche Forschungsgemeinschaft [SFB 654]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank E. Wiege, I. von Lutzau, H. Ruf and A. Otterbein for technical assistance and L. Marshall for helpful discussions. This work was supported by a grant from the Deutsche Forschungsgemeinschaft SFB 654 'Plasticity and Sleep'.	AMADOBOCCARA I, 1995, NEUROSCI BIOBEHAV R, V19, P479, DOI 10.1016/0149-7634(94)00068-C; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Mayers AG, 2005, HUM PSYCHOPHARM CLIN, V20, P533, DOI 10.1002/hup.726; McCarley RW, 2007, SLEEP MED, V8, P302, DOI 10.1016/j.sleep.2007.03.005; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; Peigneux P, 2001, NEUROREPORT, V12, pA111, DOI 10.1097/00001756-200112210-00001; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; SMITH C, 1985, NEUROSCI BIOBEHAV R, V9, P157, DOI 10.1016/0149-7634(85)90042-9; Smith CT, 2004, PSYCHOL BELG, V44, P81; Tamaki M, 2008, SLEEP, V31, P204, DOI 10.1093/sleep/31.2.204; Vertes RP, 2004, NEURON, V44, P135, DOI 10.1016/j.neuron.2004.08.034; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031	15	160	160	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2009	12	4					396	397		10.1038/nn.2206	http://dx.doi.org/10.1038/nn.2206			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	424JN	18836440				2022-12-17	WOS:000264563100013
J	Ulanovsky, N; Moss, CF				Ulanovsky, Nachum; Moss, Cynthia F.			Hippocampal cellular and network activity in freely moving echolocating bats	NATURE NEUROSCIENCE			English	Article							THETA-RHYTHM; EPTESICUS-FUSCUS; PHASE PRECESSION; PYRAMIDAL CELLS; OSCILLATIONS; PLACE; SLEEP; DYNAMICS; MEMORY; RAT	The hippocampus is crucial for episodic and spatial memory. In freely moving rodents, hippocampal pyramidal neurons show spatially selective firing when the animal passes through a neuron's 'place- field', and theta-band oscillation is continuously present during locomotion. Here we report the first hippocampal recordings from echolocating bats, mammals phylogenetically distant from rodents, which showed place cells very similar to those of rodents. High- frequency 'ripple' oscillations were also rodent- like. Theta oscillation, however, differed from rodents in two important ways: ( i) theta occurred when bats explored the environment without locomoting, using distal sensing through echolocation, and ( ii) theta was not continuous, but occurred in short intermittent bouts. The intermittence of theta suggests that models of hippocampal function that rely on continuous theta may not apply to bats. Our data support the hypothesis that theta oscillation in the mammalian hippocampus is involved in sequence learning and hence, theta power should increase with sensory- input rate-which explains why theta power correlates with running speed in rodents and with echolocation call rate in bats.	Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Ulanovsky, N (corresponding author), Univ Maryland, Dept Psychol, College Pk, MD 20742 USA.	nulanovsky@psyc.umd.edu	Moss, Cynthia/J-5208-2017	Moss, Cynthia/0000-0001-6916-0000; Ulanovsky, Nachum/0000-0001-8598-4667	NIMH NIH HHS [R01 MH56366] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056366] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amaral D, 2007, HIPPOCAMPUS BOOK, P37; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Bodizs R, 2001, HIPPOCAMPUS, V11, P747, DOI 10.1002/hipo.1090; Bragin A, 1999, HIPPOCAMPUS, V9, P137; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cantero JL, 2003, J NEUROSCI, V23, P10897; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; ELLINS SR, 1974, BRAIN BEHAV EVOLUT, V9, P248, DOI 10.1159/000123669; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Georges-Francois P, 1999, CEREB CORTEX, V9, P197, DOI 10.1093/cercor/9.3.197; Griffin D. R., 1970, P233; Griffin D.R., 1958, LISTENING DARK; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; JUNG MW, 1994, J NEUROSCI, V14, P7347; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lengyel M, 2005, BIOL CYBERN, V92, P393, DOI 10.1007/s00422-005-0567-x; Ludvig N, 2004, BRAIN RES, V1014, P97, DOI 10.1016/j.brainres.2004.03.071; MACRIDES F, 1982, J NEUROSCI, V2, P1705; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; MCCRACKEN GF, 1993, ANIM BEHAV, V45, P811, DOI 10.1006/anbe.1993.1094; MULLER HC, 1979, J MAMMAL, V60, P198; MULLER RU, 1987, J NEUROSCI, V7, P1935; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OKEEFE J, 1978, HIPPOCAMPU COGNITIVE; ONO T, 1993, J NEUROPHYSIOL, V70, P1516, DOI 10.1152/jn.1993.70.4.1516; RINGO JL, 1994, J NEUROPHYSIOL, V71, P1285, DOI 10.1152/jn.1994.71.3.1285; ROBINSON TE, 1980, BRAIN RES REV, V2, P69, DOI 10.1016/0165-0173(80)90004-1; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Siegel JJ, 2000, HIPPOCAMPUS, V10, P627, DOI 10.1002/1098-1063(2000)10:6<627::AID-HIPO1000>3.0.CO;2-W; SIMMONS JA, 1990, J COMP PHYSIOL A, V166, P449; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; STEWART M, 1991, BRAIN RES, V538, P59, DOI 10.1016/0006-8993(91)90376-7; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; Suzuki WA, 2000, CURR OPIN NEUROBIOL, V10, P768, DOI 10.1016/S0959-4388(00)00148-3; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; WILLIAMS TC, 1970, ANIM BEHAV, V18, P302, DOI 10.1016/S0003-3472(70)80042-2; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WINSON J, 1972, BEHAV BIOL, V7, P479, DOI 10.1016/S0091-6773(72)80210-4	50	160	162	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					224	233		10.1038/nn1829	http://dx.doi.org/10.1038/nn1829			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17220886				2022-12-17	WOS:000244175200017
J	Series, P; Latham, PE; Pouget, A				Series, P; Latham, PE; Pouget, A			Tuning curve sharpening for orientation selectivity: coding efficiency and the impact of correlations	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; POPULATION CODE; INTEGRATION; MODEL; V1; INFORMATION; VARIABILITY; COMPUTATION; MECHANISMS; INVARIANT	Several studies have shown that the information conveyed by bell-shaped tuning curves increases as their width decreases, leading to the notion that sharpening of tuning curves improves population codes. This notion, however, is based on assumptions that the noise distribution is independent among neurons and independent of the tuning curve width. Here we reexamine these assumptions in networks of spiking neurons by using orientation selectivity as an example. We compare two principal classes of model: one in which the tuning curves are sharpened through cortical lateral interactions, and one in which they are not. We report that sharpening through lateral interactions does not improve population codes but, on the contrary, leads to a severe loss of information. In addition, the sharpening models generate complicated codes that rely extensively on pairwise correlations. Our study generates several experimental predictions that can be used to distinguish between these two classes of model.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Gatsby Computat Neurosci Unit, London WC1N 3AR, England	University of Rochester; University of London; University College London	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	alex@bcs.rochester.edu		Pouget, Alexandre/0000-0003-3054-6365; Series, Peggy/0000-0002-8580-7975	NIMH NIH HHS [R01 MH62447] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062447] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Averbeck BB, 2003, J NEUROSCI, V23, P7630; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; Cover T.M., 2006, ELEMENTS INFORMATION, DOI [10.1002/047174882X, DOI 10.1002/047174882X]; David E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.5555/104279.104293; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Duda R. O., 1973, PATTERN CLASSIFICATI; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Fitzpatrick DC, 1997, NATURE, V388, P871, DOI 10.1038/42246; Gershon ED, 1998, J NEUROPHYSIOL, V79, P1135, DOI 10.1152/jn.1998.79.3.1135; Green DM., 1966, SIGNAL DETECTION THE; Hess R, 1999, TRENDS COGN SCI, V3, P480, DOI 10.1016/S1364-6613(99)01410-2; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; Latham PE, 2003, J PHYSIOL-PARIS, V97, P683, DOI 10.1016/j.jphysparis.2004.01.022; Lee D, 1998, J NEUROSCI, V18, P1161; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Li ZP, 1998, NEURAL COMPUT, V10, P903, DOI 10.1162/089976698300017557; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nirenberg S, 2003, P NATL ACAD SCI USA, V100, P7348, DOI 10.1073/pnas.1131895100; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Panzeri S, 2003, CEREB CORTEX, V13, P45, DOI 10.1093/cercor/13.1.45; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; Rolls ET, 2003, J NEUROPHYSIOL, V89, P2810, DOI 10.1152/jn.01070.2002; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SCLAR G, 1982, EXP BRAIN RES, V46, P457; Series P, 2003, J PHYSIOL-PARIS, V97, P453, DOI 10.1016/j.jphysparis.2004.01.023; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shamir M, 2004, NEURAL COMPUT, V16, P1105, DOI 10.1162/089976604773717559; Shapley R, 2003, NEURON, V38, P689, DOI 10.1016/S0896-6273(03)00332-5; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SOFTKY WR, 1993, J NEUROSCI, V13, P334; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Spiridon M, 2001, NETWORK-COMP NEURAL, V12, P409, DOI 10.1088/0954-898X/12/4/301; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Teich AF, 2003, J NEUROPHYSIOL, V89, P2086, DOI 10.1152/jn.00970.2002; Troyer TW, 1998, J NEUROSCI, V18, P5908; Wu S, 2001, NEURAL COMPUT, V13, P775, DOI 10.1162/089976601300014349; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Yoon H, 1999, ADV NEUR IN, V11, P167; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0; Zucker SW, 1989, NEURAL COMPUT, V1, P68, DOI 10.1162/neco.1989.1.1.68	48	160	161	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1129	1135		10.1038/nn1321	http://dx.doi.org/10.1038/nn1321			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452579				2022-12-17	WOS:000224156900023
J	Hutcheson, DM; Everitt, BJ; Robbins, TW; Dickinson, A				Hutcheson, DM; Everitt, BJ; Robbins, TW; Dickinson, A			The role of withdrawal in heroin addiction: enhances reward or promotes avoidance?	NATURE NEUROSCIENCE			English	Article							OPPONENT-PROCESS THEORY; MOTIVATION; DEPENDENCE; RATS; COCAINE; REINFORCEMENT; DYNAMICS	The compulsive nature of heroin abuse has been attributed to the fact that drug self-administration enables an addict to escape from and avoid the severe withdrawal symptoms resulting from opiate dependence. However, studies of incentive learning under natural motivational states suggest an alternative hypothesis, that withdrawal from heroin functions as a motivational state that enhances the incentive value of the drug, thereby enabling it to function as a much more effective reward for self-administration. In support of this hypothesis, we show here that previous experience with heroin in withdrawal is necessary for subsequent heroin-seeking behavior to be enhanced when dependent rats once again experience withdrawal.	Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Hutcheson, DM (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.		Robbins, Trevor W/A-7551-2008	Robbins, Trevor/0000-0003-0642-5977; Everitt, Barry/0000-0003-4431-6536	MRC [G9537855] Funding Source: UKRI; Medical Research Council [G9537855] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmed SH, 2000, NEUROPSYCHOPHARMACOL, V22, P413, DOI 10.1016/S0893-133X(99)00133-5; Arroyo M, 1998, PSYCHOPHARMACOLOGY, V140, P331, DOI 10.1007/s002130050774; BALLEINE B, 1992, J EXP PSYCHOL ANIM B, V18, P236, DOI 10.1037/0097-7403.18.3.236; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Balleine BW, 2000, J NEUROSCI, V20, P8954; BOZARTH MA, 1984, SCIENCE, V224, P516, DOI 10.1126/science.6324347; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; GOLDBERG SR, 1971, J PHARMACOL EXP THER, V179, P268; HAND TH, 1988, BRAIN RES, V474, P364, DOI 10.1016/0006-8993(88)90452-0; KHANTZIAN EJ, 1985, AM J PSYCHIAT, V142, P1259; KOOB GF, 1989, NEUROSCI BIOBEHAV R, V13, P135, DOI 10.1016/S0149-7634(89)80022-3; Koob GF, 1996, NEURON, V16, P893, DOI 10.1016/S0896-6273(00)80109-9; MALDONADO R, 1995, BRIT J PHARMACOL, V114, P1031, DOI 10.1111/j.1476-5381.1995.tb13309.x; Mucha R F, 1986, NIDA Res Monogr, V75, P567; Nader K, 1997, ANNU REV PSYCHOL, V48, P85, DOI 10.1146/annurev.psych.48.1.85; Olmstead MC, 2000, PSYCHOPHARMACOLOGY, V152, P123, DOI 10.1007/s002130000498; Olmstead MC, 2001, BEHAV NEUROSCI, V115, P394, DOI 10.1037/0735-7044.115.2.394; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; SOLOMON RL, 1980, AM PSYCHOL, V35, P691, DOI 10.1037/0003-066X.35.8.691; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; WIKLER A, 1973, ARCH GEN PSYCHIAT, V28, P611; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469	23	160	168	1	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					943	947		10.1038/nn0901-943	http://dx.doi.org/10.1038/nn0901-943			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	467JL	11528427				2022-12-17	WOS:000170698600022
J	Griffiths, TD; Uppenkamp, S; Johnsrude, I; Josephs, O; Patterson, RD				Griffiths, TD; Uppenkamp, S; Johnsrude, I; Josephs, O; Patterson, RD			Encoding of the temporal regularity of sound in the human brainstem	NATURE NEUROSCIENCE			English	Article							LOW-FREQUENCY TONES; STRENGTH; NOISE	We measured the neural activity associated with the temporal structure of sound in the human auditory pathway from cochlear nucleus to cortex. The temporal structure includes regularities at the millisecond level and pitch sequences at the hundreds-of-milliseconds level. Functional magnetic resonance imaging (fMRI) of the whole brain with cardiac triggering allowed simultaneous observation of activity in the brainstem, thalamus and cerebrum. This work shows that the process of recoding temporal patterns into a more stable form begins as early as the cochlear nucleus and continues up to auditory cortex.	Univ Cambridge, Dept Physiol, Ctr Neural Basis Hearing, Cambridge CB2 3EG, England; Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Newcastle Univ, Sch Med, Dept Physiol Sci, Auditory Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England	University of Cambridge; University of London; University College London; Newcastle University - UK	Griffiths, TD (corresponding author), Univ Cambridge, Dept Physiol, Ctr Neural Basis Hearing, Downing St, Cambridge CB2 3EG, England.	t.d.griffiths@ncl.ac.uk	Johnsrude, Ingrid S/G-4694-2011	Johnsrude, Ingrid S/0000-0002-7810-1333; Griffiths, Timothy/0000-0001-8066-4381				Chawla D, 1999, NEURAL COMPUT, V11, P1389, DOI 10.1162/089976699300016287; Duvernoy HM, 1999, HUMAN BRAIN; Griffiths TD, 1999, NEUROREPORT, V10, P3825, DOI 10.1097/00001756-199912160-00019; Griffiths TD, 1998, NAT NEUROSCI, V1, P422, DOI 10.1038/1637; Guimaraes AR, 1998, HUM BRAIN MAPP, V6, P33, DOI 10.1002/(SICI)1097-0193(1998)6:1<33::AID-HBM3>3.0.CO;2-M; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; LANGNER G, 1992, HEARING RES, V60, P115, DOI 10.1016/0378-5955(92)90015-F; LANGNER G, 1988, J NEUROPHYSIOL, V60, P1799, DOI 10.1152/jn.1988.60.6.1799; MOORE WE, 1994, SPORT PSYCHOL, V8, P1; Nobili R, 1998, TRENDS NEUROSCI, V21, P159, DOI 10.1016/S0166-2236(97)01192-2; Patterson RD, 1996, J ACOUST SOC AM, V100, P3286, DOI 10.1121/1.417212; Patterson RD, 2000, J ACOUST SOC AM, V107, P1578, DOI 10.1121/1.428442; PATTERSON RD, 1995, J ACOUST SOC AM, V98, P1890, DOI 10.1121/1.414456; PATTERSON RD, 1994, P 3 ICSLP YOK JAP, P1395; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769, DOI 10.1152/jn.1967.30.4.769; ROUILLER E, 1979, HEARING RES, V1, P213, DOI 10.1016/0378-5955(79)90015-7; Wiegrebe L, 2001, J NEUROPHYSIOL, V85, P1206, DOI 10.1152/jn.2001.85.3.1206; Yost WA, 1996, J ACOUST SOC AM, V99, P1066, DOI 10.1121/1.414593; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994	21	160	162	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					633	637		10.1038/88459	http://dx.doi.org/10.1038/88459			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369945				2022-12-17	WOS:000169061800017
J	Jontes, JD; Buchanan, J; Smith, SJ				Jontes, JD; Buchanan, J; Smith, SJ			Growth cone and dendrite dynamics in zebrafish embryos: early events in synaptogenesis imaged in vivo	NATURE NEUROSCIENCE			English	Article							RETICULOSPINAL NEURONS; SPINAL-CORD; IN-VIVO; IDENTIFIED MOTONEURONES; CORTICORUBRAL AXONS; TIME-LAPSE; ARBORS; ULTRASTRUCTURE; INTERNEURONS; PROTRUSIONS	We used time-lapse fluorescence microscopy to observe the growth of Mauthner cell axone and their postsynaptic targets, the primary motor neurons, in spinal cords of developing zebrafish embryos. Upon reaching successive motor neurons, the Mauthner growth cone paused briefly before continuing along its path. Varicosities formed at regular intervals and were preferentially associated with the target regions of the primary motor neurons. In addition, the postsynaptic motor neurons showed highly dynamic filopodia, which transiently interacted with both the growth cone and the axon. Both Mauthner cell and motor neurons were highly active, each showing motility sufficient to initiate synaptogenesis.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Smith, SJ (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.							CELIO MR, 1979, J NEUROCYTOL, V8, P19, DOI 10.1007/BF01206455; Dailey ME, 1996, J NEUROSCI, V16, P2983; DIAMOND J, 1971, FISH PHYSIOL, V5, P265; Dynes JL, 1998, NEURON, V20, P1081, DOI 10.1016/S0896-6273(00)80490-0; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; FETCHO JR, 1988, J NEUROSCI, V8, P4192; Fiala JC, 1998, J NEUROSCI, V18, P8900; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; KAETHNER RJ, 1992, J NEUROSCI, V12, P3257, DOI 10.1523/JNEUROSCI.12-08-03257.1992; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; LIU DW, 1988, J PHYSIOL-LONDON, V403, P73, DOI 10.1113/jphysiol.1988.sp017239; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MENDELSON B, 1986, J COMP NEUROL, V251, P160, DOI 10.1002/cne.902510203; MENDELSON B, 1986, J COMP NEUROL, V251, P172, DOI 10.1002/cne.902510204; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; MYERS PZ, 1985, J COMP NEUROL, V236, P555, DOI 10.1002/cne.902360411; MYERS PZ, 1986, J NEUROSCI, V6, P2278; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; OROURKE NA, 1994, NEURON, V12, P921, DOI 10.1016/0896-6273(94)90343-3; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; SAITO Y, 1992, NEUROSCI LETT, V147, P81, DOI 10.1016/0304-3940(92)90779-7; Saito Y, 1997, J NEUROSCI, V17, P8792; Shoji W, 1998, DEVELOPMENT, V125, P1275; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; Westerfield M, 1995, ZEBRAFISH BOOK; Witte S, 1996, J NEUROBIOL, V31, P219, DOI 10.1002/(SICI)1097-4695(199610)31:2<219::AID-NEU7>3.0.CO;2-E; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; YASARGIL GM, 1968, NATURE, V220, P241, DOI 10.1038/220241a0; YASARGIL GM, 1990, J NEUROCYTOL, V19, P111, DOI 10.1007/BF01188443; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	34	160	162	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					231	237		10.1038/72936	http://dx.doi.org/10.1038/72936			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700254				2022-12-17	WOS:000085810500011
J	Alder, J; Lee, KJ; Jessell, TM; Hatten, ME				Alder, J; Lee, KJ; Jessell, TM; Hatten, ME			Generation of cerebellar granule neurons in vivo by transplantation of BMP-treated neural progenitor cells	NATURE NEUROSCIENCE			English	Article							CREST CELLS; COMMISSURAL INTERNEURONS; PATTERN-FORMATION; PURKINJE-CELLS; MOUSE EMBRYOS; CHICK-EMBRYO; SPINAL-CORD; PLATE CELLS; EXPRESSION; HINDBRAIN	Cerebellar granule neurons, the most abundant class of CNS neurons, have a critical role in cerebellar function. Granule neurons are generated at the dorsal border of the mesencephalon and metencephalon, the rhombic lip. In the mouse embryo, rhombic lip cells express a number of granule neuron markers, notably the bHLH transcription factor Math1. Dorsal midline cells adjacent to the rhombic lip express Bmp6, Bmp7 and Gdf7, three genes encoding peptide growth factors of the bone morphogenetic protein (BMP) family. These BMPs induced the expression of granule neuron markers in cultured neural tissue. Moreover, BMP-treated neural cells formed mature granule neurons after transplantation into the early postnatal cerebellum, suggesting that BMPs initiate the program of granule cell specification.	Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10021 USA; Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA	Rockefeller University; Columbia University; Howard Hughes Medical Institute	Hatten, ME (corresponding author), Rockefeller Univ, Dev Neurobiol Lab, 1230 York Ave, New York, NY 10021 USA.	hatten@rockvax.rockefeller.edu		Lee, Kevin/0000-0001-9823-0952; Alder, Janet/0000-0002-5694-4946	NINDS NIH HHS [NS0532-05] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; Altman J., 1996, DEV CEREBELLAR SYSTE; Arkell R, 1997, DEVELOPMENT, V124, P1; Arnold DB, 1997, P NATL ACAD SCI USA, V94, P8842, DOI 10.1073/pnas.94.16.8842; ARUGA J, 1994, J NEUROCHEM, V63, P1880; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; BenArie N, 1996, HUM MOL GENET, V5, P1207, DOI 10.1093/hmg/5.9.1207; CHAN WY, 1988, DEVELOPMENT, V102, P427; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; DAVIS CA, 1991, DEVELOPMENT, V111, P287; Eccles JC, 1967, CEREBELLUM NEURONAL; Fiez JA, 1996, NEURON, V16, P13, DOI 10.1016/S0896-6273(00)80018-5; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GAO WQ, 1994, DEVELOPMENT, V120, P1059; GAO WQ, 1993, SCIENCE, V260, P367, DOI 10.1126/science.8469990; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; HALLONET MER, 1993, EUR J NEUROSCI, V5, P1145, DOI 10.1111/j.1460-9568.1993.tb00969.x; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Helms AW, 1998, DEVELOPMENT, V125, P919; Ito M, 1984, CEREBELLUM NEURAL CO; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; KUHAR SG, 1993, DEVELOPMENT, V117, P97; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; MARTINEZ S, 1989, EUR J NEUROSCI, V1, P549, DOI 10.1111/j.1460-9568.1989.tb00362.x; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; Muhr J, 1997, NEURON, V19, P487, DOI 10.1016/S0896-6273(00)80366-9; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; PARR BA, 1993, DEVELOPMENT, V119, P247; Peringa A, 1995, CURR OPIN NEUROL, V8, P437, DOI 10.1097/00019052-199512000-00006; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; RYDER EF, 1994, NEURON, V12, P1011, DOI 10.1016/0896-6273(94)90310-7; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SMEYNE RJ, 1995, MOL CELL NEUROSCI, V6, P230, DOI 10.1006/mcne.1995.1019; TAN SS, 1985, CELL TISSUE RES, V240, P403; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O	50	160	162	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					535	540		10.1038/9189	http://dx.doi.org/10.1038/9189			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448218				2022-12-17	WOS:000084735900013
J	Cook, PB; McReynolds, JS				Cook, PB; McReynolds, JS			Lateral inhibition in the inner retina is important for spatial tuning of ganglion cells	NATURE NEUROSCIENCE			English	Article							TIGER SALAMANDER RETINA; MUDPUPPY RETINA; HORIZONTAL CELLS; PLEXIFORM LAYER; AMACRINE CELLS; SYNAPTIC INPUTS; RECEPTIVE-FIELD; RABBIT RETINA; GABA RECEPTOR; BIPOLAR CELL	The center-surround receptive-field organization in retinal ganglion cells is widely believed to result mainly from lateral inhibition at the first synaptic lever (in the outer retina). Inhibition at the second synaptic level (in the inner retina) is thought to mediate more complex response properties. Here we show that much of the sustained surround antagonism in certain on-center ganglion cells results from lateral inhibition in the inner retina, via GABAergic amacrine cells, and that the lateral conduction of this signal requires voltage-gated sodium currents. Blocking lateral inhibition in the inner retina eliminates the preference of small-center ganglion cells for small stimuli but has little effect on ganglion cells with large receptive-field centers. These results illustrate how lateral inhibition at successive synaptic stages can selectively control the size of neural receptive-field centers.	Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Cook, PB (corresponding author), Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA.	pcook@umich.edu			NEI NIH HHS [EY07003, EY01653] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY001653] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARKIN MS, 1988, J NEUROPHYSIOL, V60, P1122, DOI 10.1152/jn.1988.60.3.1122; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; BELGUM JH, 1983, J PHYSIOL-LONDON, V340, P599, DOI 10.1113/jphysiol.1983.sp014782; BELGUM JH, 1982, J PHYSIOL-LONDON, V326, P91, DOI 10.1113/jphysiol.1982.sp014179; BELGUM JH, 1987, J PHYSIOL-LONDON, V388, P233, DOI 10.1113/jphysiol.1987.sp016612; Bloomfield SA, 1996, J NEUROPHYSIOL, V75, P1878, DOI 10.1152/jn.1996.75.5.1878; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; CONNORS BW, 1982, J PHARMACOL EXP THER, V220, P476; Cook PB, 1998, J NEUROSCI, V18, P2301; Cook PB, 1998, J NEUROPHYSIOL, V79, P197, DOI 10.1152/jn.1998.79.1.197; DAW NW, 1990, TRENDS NEUROSCI, V13, P110, DOI 10.1016/0166-2236(90)90187-F; DJAMGOZ MBA, 1984, NEUROSCI LETT, V49, P233, DOI 10.1016/0304-3940(84)90295-7; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; ENROTHCUGELL C, 1980, J PHYSIOL-LONDON, V302, P49; GILBERTSON TA, 1991, J NEUROPHYSIOL, V66, P2002, DOI 10.1152/jn.1991.66.6.2002; GOLARD A, 1992, J NEUROPHYSIOL, V68, P351, DOI 10.1152/jn.1992.68.2.351; Hare WA, 1996, J NEUROPHYSIOL, V76, P2005, DOI 10.1152/jn.1996.76.3.2005; Jacobs AL, 1998, J NEUROPHYSIOL, V80, P447, DOI 10.1152/jn.1998.80.1.447; KARWOSKI CJ, 1976, VISION RES, V16, P1483, DOI 10.1016/0042-6989(76)90169-3; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; LUKASIEWICZ PD, 1994, J NEUROSCI, V14, P1213, DOI 10.1523/JNEUROSCI.14-03-01213.1994; LUKASIEWICZ PD, 1994, J NEUROSCI, V14, P1202, DOI 10.1523/JNEUROSCI.14-03-01202.1994; MANGEL SC, 1991, J PHYSIOL-LONDON, V442, P211, DOI 10.1113/jphysiol.1991.sp018790; MCREYNOLDS JS, 1989, NEUROBIOLOGY INNER R, P209; MILLER RF, 1976, BRAIN RES, V104, P157, DOI 10.1016/0006-8993(76)90657-0; NAKA K, 1972, J PHYSIOL-LONDON, V223, P449, DOI 10.1113/jphysiol.1972.sp009857; SCHWARTZ EA, 1973, J PHYSIOL-LONDON, V230, P1; THIBOS LN, 1978, J PHYSIOL-LONDON, V278, P79, DOI 10.1113/jphysiol.1978.sp012294; THIBOS LN, 1978, J PHYSIOL-LONDON, V278, P101, DOI 10.1113/jphysiol.1978.sp012295; TORIS CB, 1995, J COMP NEUROL, V352, P535, DOI 10.1002/cne.903520405; Verweij J, 1996, VISION RES, V36, P3943, DOI 10.1016/S0042-6989(96)00142-3; WERBLIN F, 1988, VISUAL NEUROSCI, V1, P317, DOI 10.1017/S0952523800001978; WERBLIN FS, 1974, J GEN PHYSIOL, V63, P88, DOI 10.1085/jgp.63.1.88; WERBLIN FS, 1974, J GEN PHYSIOL, V63, P62, DOI 10.1085/jgp.63.1.62; WERBLIN FS, 1972, SCIENCE, V175, P1008, DOI 10.1126/science.175.4025.1008; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P331; YANG CY, 1991, J COMP NEUROL, V312, P19, DOI 10.1002/cne.903120103	38	160	161	1	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					714	719		10.1038/3714	http://dx.doi.org/10.1038/3714			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196588				2022-12-17	WOS:000077323400016
J	Kuchibhotla, KV; Gill, JV; Lindsay, GW; Papadoyannis, ES; Field, RE; Sten, TAH; Miller, KD; Froemke, RC				Kuchibhotla, Kishore V.; Gill, Jonathan V.; Lindsay, Grace W.; Papadoyannis, Eleni S.; Field, Rachel E.; Sten, Tom A. Hindmarsh; Miller, Kenneth D.; Froemke, Robert C.			Parallel processing by cortical inhibition enables context-dependent behavior	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; RECEPTIVE-FIELD PLASTICITY; PRIMARY AUDITORY-CORTEX; DISINHIBITORY MICROCIRCUIT; CHOLINERGIC NEURONS; NUCLEUS BASALIS; TASK; EXCITATION; MODULATION; RESPONSES	Physical features of sensory stimuli are fixed, but sensory perception is context dependent. The precise mechanisms that govern contextual modulation remain unknown. Here, we trained mice to switch between two contexts: passively listening to pure tones and performing a recognition task for the same stimuli. Two-photon imaging showed that many excitatory neurons in auditory cortex were suppressed during behavior, while some cells became more active. Whole-cell recordings showed that excitatory inputs were affected only modestly by context, but inhibition was more sensitive, with PV*, SONI+, and VIP* interneurons balancing inhibition and disinhibition within the network. Cholinergic modulation was involved in context switching, with cholinergic axons increasing activity during behavior and directly depolarizing inhibitory cells. Network modeling captured these findings, but only when modulation coincidently drove all three interneuron subtypes, ruling out either inhibition or disinhibition alone as sole mechanism for active engagement. Parallel processing of cholinergic modulation by cortical interneurons therefore enables context-dependent behavior.	[Kuchibhotla, Kishore V.; Gill, Jonathan V.; Papadoyannis, Eleni S.; Field, Rachel E.; Sten, Tom A. Hindmarsh; Froemke, Robert C.] NYU, Dept Otolaryngol, Sch Med, Skirball Inst,Neurosci Inst, 550 1St Ave, New York, NY 10016 USA; [Kuchibhotla, Kishore V.; Gill, Jonathan V.; Papadoyannis, Eleni S.; Field, Rachel E.; Sten, Tom A. Hindmarsh; Froemke, Robert C.] NYU, Dept Neurosci, Sch Med, Skirball Inst,Neurosci Inst, New York, NY 10016 USA; [Kuchibhotla, Kishore V.; Gill, Jonathan V.; Papadoyannis, Eleni S.; Field, Rachel E.; Sten, Tom A. Hindmarsh; Froemke, Robert C.] NYU, Dept Physiol, Sch Med, Skirball Inst,Neurosci Inst, New York, NY 10016 USA; [Kuchibhotla, Kishore V.; Gill, Jonathan V.; Papadoyannis, Eleni S.; Field, Rachel E.; Sten, Tom A. Hindmarsh; Froemke, Robert C.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Lindsay, Grace W.; Miller, Kenneth D.] Columbia Univ, Swartz Program Theoret Neurosci, Ctr Theoret Neurosci, Dept Neurosci,Kavli Inst Brain Sci, New York, NY USA	New York University; New York University; New York University; New York University; Columbia University	Froemke, RC (corresponding author), NYU, Dept Otolaryngol, Sch Med, Skirball Inst,Neurosci Inst, 550 1St Ave, New York, NY 10016 USA.; Froemke, RC (corresponding author), NYU, Dept Neurosci, Sch Med, Skirball Inst,Neurosci Inst, New York, NY 10016 USA.; Froemke, RC (corresponding author), NYU, Dept Physiol, Sch Med, Skirball Inst,Neurosci Inst, New York, NY 10016 USA.; Froemke, RC (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	robert.froemke@med.nyu.edu		Froemke, Robert/0000-0002-1230-6811; Hindmarsh Sten, Tom/0000-0002-0829-3659; Lindsay, Grace/0000-0001-9904-7471	NIDCD [DC009635, DC012557, DC05014]; Sloan Research Fellowship; Klingenstein Fellowship; NIDA [T32 DA007254]; Charles H. Revson Senior Fellowship in Biomedical Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS064929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC009635, K99DC015014, R00DC015014, R00DC009635, R01DC012557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007254] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Sloan Research Fellowship(Alfred P. Sloan Foundation); Klingenstein Fellowship(Klingenstein Philanthropies); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Charles H. Revson Senior Fellowship in Biomedical Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank I. Carcea, G. Fishell, B. Kripkee, M. Long, M. Picardo, D. Rinberg, R. Tsien, and D. Vallentin for comments on earlier versions of this manuscript; K. Katlowitz, X. Lin, H. Lu, J. Merel, and L. Paniniski for assistance with statistics and analysis; and G. Kosche, E. Morina, A. Resulaj, and C. Wilson for technical assistance. Artwork in Figures 1, 4, 5 and 6 was made by S.E. Ross. We thank the GENIE Program and the Janelia Farm Research Campus, Howard Hughes Medical Institute for provision of GCaMP6s and Scanlmage. Artwork in Figures I, 4, and 6 was made by S.E. Ross. This work was funded by grants from the NIDCD (DC009635 and DC012557), a Sloan Research Fellowship, and a Klingenstein Fellowship (R.C.F.) and by a grant from the NIDA (T32 DA007254), the Charles H. Revson Senior Fellowship in Biomedical Sciences, and a grant from the NIDCD (DC05014) (K.V.K.).	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Atiani S, 2014, NEURON, V82, P486, DOI 10.1016/j.neuron.2014.02.029; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Chubykin AA, 2013, NEURON, V77, P723, DOI 10.1016/j.neuron.2012.12.039; David SV, 2012, P NATL ACAD SCI USA, V109, P2144, DOI 10.1073/pnas.1117717109; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; FERSTER D, 1986, J NEUROSCI, V6, P1284; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Froemke RC, 2015, ANNU REV NEUROSCI, V38, P195, DOI 10.1146/annurev-neuro-071714-034002; Froemke RC, 2013, NAT NEUROSCI, V16, P79, DOI 10.1038/nn.3274; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Gennari SP, 2007, NEUROIMAGE, V35, P1278, DOI 10.1016/j.neuroimage.2007.01.015; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Hangya B, 2015, CELL, V162, P1155, DOI 10.1016/j.cell.2015.07.057; HASSELMO ME, 1993, TRENDS NEUROSCI, V16, P218, DOI 10.1016/0166-2236(93)90159-J; HUBEL DH, 1959, SCIENCE, V129, P1279, DOI 10.1126/science.129.3358.1279; Jaramillo S, 2014, J NEUROSCI, V34, P5291, DOI 10.1523/JNEUROSCI.4888-13.2014; Kato HK, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.024; Kawai H, 2007, NAT NEUROSCI, V10, P1168, DOI 10.1038/nn1956; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kruglikov I, 2008, NEURON, V58, P911, DOI 10.1016/j.neuron.2008.04.024; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Leonard MK, 2014, TRENDS COGN SCI, V18, P472, DOI 10.1016/j.tics.2014.05.001; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Lin SC, 2008, NEURON, V59, P138, DOI 10.1016/j.neuron.2008.04.031; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; Marlin BJ, 2015, NATURE, V520, P499, DOI 10.1038/nature14402; Mayse JD, 2015, NAT NEUROSCI, V18, P1501, DOI 10.1038/nn.4110; McGinley MJ, 2015, NEURON, V87, P179, DOI 10.1016/j.neuron.2015.05.038; METHERATE R, 1990, SYNAPSE, V6, P133, DOI 10.1002/syn.890060204; MILLER JM, 1972, SCIENCE, V177, P449, DOI 10.1126/science.177.4047.449; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Pinto L, 2013, NAT NEUROSCI, V16, P1857, DOI 10.1038/nn.3552; Rodgers CC, 2014, NEURON, V82, P1157, DOI 10.1016/j.neuron.2014.04.031; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Schneider DM, 2014, NATURE, V513, P189, DOI 10.1038/nature13724; TABOSSI P, 1988, J EXP PSYCHOL LEARN, V14, P153, DOI 10.1037/0278-7393.14.1.153; Tan AYY, 2009, NEUROSCIENCE, V163, P1302, DOI 10.1016/j.neuroscience.2009.07.032; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; VOLKOV IO, 1991, NEUROSCIENCE, V43, P307, DOI 10.1016/0306-4522(91)90295-Y; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Williamson RS, 2015, CURR BIOL, V25, P1885, DOI 10.1016/j.cub.2015.05.045; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; Xue MS, 2014, NATURE, V511, P596, DOI 10.1038/nature13321; Zhou M, 2014, NAT NEUROSCI, V17, P841, DOI 10.1038/nn.3701	50	159	161	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2017	20	1					62	71		10.1038/nn.4436	http://dx.doi.org/10.1038/nn.4436			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EG5LO	27798631	Green Accepted			2022-12-17	WOS:000391085500013
J	Chattarji, S; Tomar, A; Suvrathan, A; Ghosh, S; Rahman, MM				Chattarji, Sumantra; Tomar, Anupratap; Suvrathan, Aparna; Ghosh, Supriya; Rahman, Mohammed Mostafizur			Neighborhood matters: divergent patterns of stress-induced plasticity across the brain	NATURE NEUROSCIENCE			English	Review							LONG-TERM POTENTIATION; MEDIAL PREFRONTAL CORTEX; TISSUE-PLASMINOGEN ACTIVATOR; HIPPOCAMPAL CA3C NEURONS; ANXIETY-LIKE BEHAVIOR; DENDRITIC SPINE LOSS; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; BASOLATERAL AMYGDALA; APICAL DENDRITES	The fact that exposure to severe stress leads to the development of psychiatric disorders serves as the basic rationale for animal models of stress disorders. Clinical and neuroimaging studies have shown that three brain areas involved in learning and memory-the hippocampus, amygdala and prefrontal cortex-undergo distinct structural and functional changes in individuals with stress disorders. These findings from patient studies pose several challenges for animal models of stress disorders. For instance, why does stress impair cognitive function, yet enhance fear and anxiety? Can the same stressful experience elicit contrasting patterns of plasticity in the hippocampus, amygdala and prefrontal cortex? How does even a brief exposure to traumatic stress lead to long-lasting behavioral abnormalities? Thus, animal models of stress disorders must not only capture the unique spatio-temporal features of structural and functional alterations in these brain areas, but must also provide insights into the underlying neuronal plasticity mechanisms. This Review will address some of these key questions by describing findings from animal models on how stress-induced plasticity varies across different brain regions and thereby gives rise to the debilitating emotional and cognitive symptoms of stress-related psychiatric disorders.	[Chattarji, Sumantra; Rahman, Mohammed Mostafizur] Natl Ctr Biol Sci, Ctr Brain Dev & Repair, Inst Stem Cell Biol & Regenerat Med, Bangalore, Karnataka, India; [Tomar, Anupratap] RIKEN Brain Sci Inst, Lab Circuit & Behav Physiol, Wako, Saitama, Japan; [Suvrathan, Aparna] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Ghosh, Supriya] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); RIKEN; Stanford University; University of Chicago	Chattarji, S (corresponding author), Natl Ctr Biol Sci, Ctr Brain Dev & Repair, Inst Stem Cell Biol & Regenerat Med, Bangalore, Karnataka, India.	shona@ncbs.res.in	Ghosh, Supriya/ABG-2932-2021; Mohammed Mostafizur, Rahman/CAJ-3009-2022	Mohammed Mostafizur, Rahman/0000-0002-9355-4867; Ghosh, Supriya/0000-0002-1956-1807	Department of Biotechnology (DBT); Defense Research and Development Organization (DRDO), Government of India; Wadhwani Foundation; National Centre for Biological Sciences (NCBS), India	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Defense Research and Development Organization (DRDO), Government of India(Defence Research & Development Organisation (DRDO)); Wadhwani Foundation; National Centre for Biological Sciences (NCBS), India	This work was supported by the Department of Biotechnology (DBT) and Defense Research and Development Organization (DRDO), Government of India, the Wadhwani Foundation, and the National Centre for Biological Sciences (NCBS), India.	Abe K, 2001, JPN J PHARMACOL, V86, P18, DOI 10.1254/jjp.86.18; Adamec RE, 1999, PHYSIOL BEHAV, V65, P723; Akirav I, 2002, J NEUROSCI, V22, P9912; Akirav I, 1999, J NEUROSCI, V19, P10530; Allsop SA, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00241; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, V5th, DOI 10.1176/appi.books.9780890425596; Anisman H, 2005, NEUROSCI BIOBEHAV R, V29, P525, DOI 10.1016/j.neubiorev.2005.03.007; Armony JL, 2005, AM J PSYCHIAT, V162, P1961, DOI 10.1176/appi.ajp.162.10.1961; Arnsten AFT, 2015, NAT NEUROSCI, V18, P1376, DOI 10.1038/nn.4087; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bennur S, 2007, NEUROSCIENCE, V144, P8, DOI 10.1016/j.neuroscience.2006.08.075; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Britton JC, 2005, BIOL PSYCHIAT, V57, P832, DOI 10.1016/j.biopsych.2004.12.025; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Chen YC, 2008, J NEUROSCI, V28, P2903, DOI 10.1523/JNEUROSCI.0225-08.2008; Chen YC, 2010, P NATL ACAD SCI USA, V107, P13123, DOI 10.1073/pnas.1003825107; Cohen H, 2008, BIOL PSYCHIAT, V64, P708, DOI 10.1016/j.biopsych.2008.05.025; Conrad CD, 1999, BEHAV NEUROSCI, V113, P902, DOI 10.1037/0735-7044.113.5.902; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Cordero MI, 2003, HORM BEHAV, V44, P338, DOI 10.1016/S0018-506X(03)00160-0; Davis M, 1999, ANN NY ACAD SCI, V877, P281, DOI 10.1111/j.1749-6632.1999.tb09273.x; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.ne.15.030192.002033; de Asis JM, 2001, AM J PSYCHIAT, V158, P1321, DOI 10.1176/appi.ajp.158.8.1321; de Kloet CS, 2006, J PSYCHIATR RES, V40, P550, DOI 10.1016/j.jpsychires.2005.08.002; DIAMOND DM, 1992, HIPPOCAMPUS, V2, P421, DOI 10.1002/hipo.450020409; DIAMOND DM, 1994, ANN NY ACAD SCI, V746, P411; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; File S.E., 2000, AMYGDALA FUNCTIONAL, P195; Francis DD, 2002, J NEUROSCI, V22, P7840; Ghosh S, 2013, J NEUROSCI, V33, P7234, DOI 10.1523/JNEUROSCI.0638-13.2013; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Goldwater DS, 2009, NEUROSCIENCE, V164, P798, DOI 10.1016/j.neuroscience.2009.08.053; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Herman JP, 2002, PHARMACOL BIOCHEM BE, V71, P457, DOI 10.1016/S0091-3057(01)00681-5; Holderbach R, 2007, BIOL PSYCHIAT, V62, P92, DOI 10.1016/j.biopsych.2006.07.007; Hong WZ, 2014, CELL, V158, P1348, DOI 10.1016/j.cell.2014.07.049; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; Karst H, 2010, P NATL ACAD SCI USA, V107, P14449, DOI 10.1073/pnas.0914381107; Kim EJ, 2015, CURR BIOL, V25, P1362, DOI 10.1016/j.cub.2015.03.048; Kim JJ, 2007, P NATL ACAD SCI USA, V104, P18297, DOI 10.1073/pnas.0708644104; Kim JJ, 2001, J NEUROSCI, V21, P5222, DOI 10.1523/JNEUROSCI.21-14-05222.2001; Kim JJ, 2005, J NEUROSCI, V25, P1532, DOI 10.1523/JNEUROSCI.4623-04.2005; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kole MHP, 2004, NEUROSCIENCE, V125, P337, DOI 10.1016/j.neuroscience.2004.02.014; Koob GF, 2009, BRAIN RES, V1293, P61, DOI 10.1016/j.brainres.2009.03.038; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; KRUGERS HJ, 1993, NEUROSCI LETT, V154, P73, DOI 10.1016/0304-3940(93)90174-J; Kumar S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5537; Lakshminarasimhan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030481; LEDOUX JE, 1994, SCI AM, V270, P50, DOI 10.1038/scientificamerican0694-50; LIANG KC, 1994, BEHAV NEUROSCI, V108, P241, DOI 10.1037/0735-7044.108.2.241; Liang ZF, 2014, NEUROIMAGE, V103, P485, DOI 10.1016/j.neuroimage.2014.08.050; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; MANDELL AJ, 1963, SCIENCE, V139, P1212, DOI 10.1126/science.139.3560.1212; Manzanares PAR, 2005, J NEUROSCI, V25, P8725, DOI 10.1523/JNEUROSCI.2260-05.2005; Maroun M, 2003, J NEUROSCI, V23, P4406; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MCDONALD A J, 1992, P67; MCDONALD AJ, 1982, J COMP NEUROL, V212, P293, DOI 10.1002/cne.902120307; MCDONALD AJ, 1992, BRAIN RES BULL, V28, P179, DOI 10.1016/0361-9230(92)90177-Y; McEwen BS, 2015, NAT NEUROSCI, V18, P1353, DOI 10.1038/nn.4086; McEwen BS, 2013, NEURON, V79, P16, DOI 10.1016/j.neuron.2013.06.028; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Namburi P, 2015, NATURE, V520, P675, DOI 10.1038/nature14366; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; NIBUYA M, 1995, J NEUROSCI, V15, P7539; OKEEFE J, 1979, BEHAV BRAIN SCI, V2, P487, DOI 10.1017/S0140525X00063949; PACKARD MG, 1994, P NATL ACAD SCI USA, V91, P8477, DOI 10.1073/pnas.91.18.8477; Padival M, 2013, NEUROPSYCHOPHARMACOL, V38, P1748, DOI 10.1038/npp.2013.74; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Pawlak R, 2003, NAT NEUROSCI, V6, P168, DOI 10.1038/nn998; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Pikkarainen M, 1999, J COMP NEUROL, V403, P229; PITKANEN A, 1994, J NEUROSCI, V14, P2200; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Rao RP, 2012, BIOL PSYCHIAT, V72, P466, DOI 10.1016/j.biopsych.2012.04.008; Rau V, 2005, NEUROSCI BIOBEHAV R, V29, P1207, DOI 10.1016/j.neubiorev.2005.04.010; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; RESNICK HS, 1995, AM J PSYCHIAT, V152, P1675; Richter-Levin G, 2010, CEREB CORTEX, V20, P2433, DOI 10.1093/cercor/bhp311; Roberson-Nay R, 2006, BIOL PSYCHIAT, V60, P966, DOI 10.1016/j.biopsych.2006.02.018; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Root CM, 2014, NATURE, V515, P269, DOI 10.1038/nature13897; Roozendaal B, 1996, NEUROBIOL LEARN MEM, V65, P1, DOI 10.1006/nlme.1996.0001; Roozendaal B, 2004, J NEUROSCI, V24, P1385, DOI 10.1523/JNEUROSCI.4664-03.2004; Roozendaal B, 2003, P NATL ACAD SCI USA, V100, P1328, DOI 10.1073/pnas.0337480100; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; RUBIN RT, 1966, SCIENCE, V153, P767, DOI 10.1126/science.153.3737.767; Sandi Carmen, 2007, Neural Plasticity, V2007, DOI 10.1055/2007/78970; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Schelling G, 2004, BIOL PSYCHIAT, V55, P627, DOI 10.1016/j.biopsych.2003.09.014; Schelling G, 2006, ANN NY ACAD SCI, V1071, P46, DOI 10.1196/annals.1364.005; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; SHORS TJ, 1992, SCIENCE, V257, P537, DOI 10.1126/science.1636089; Shors TJ, 1998, LEARN MEMORY, V5, P220; Siuciak JA, 1997, PHARMACOL BIOCHEM BE, V56, P131, DOI 10.1016/S0091-3057(96)00169-4; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Starkman MN, 1999, BIOL PSYCHIAT, V46, P1595, DOI 10.1016/S0006-3223(99)00203-6; STARKMAN MN, 1992, BIOL PSYCHIAT, V32, P756, DOI 10.1016/0006-3223(92)90079-F; Stewart MG, 2005, NEUROSCIENCE, V131, P43, DOI 10.1016/j.neuroscience.2004.10.031; Suvrathan A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0151; Tomar A, 2015, HIPPOCAMPUS, V25, P38, DOI 10.1002/hipo.22348; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; VONBARDELEBEN U, 1989, J NEUROENDOCRINOL, V1, P485, DOI 10.1111/j.1365-2826.1989.tb00150.x; Vouimba RM, 2004, EUR J NEUROSCI, V19, P1887, DOI 10.1111/j.1460-9568.2004.03294.x; Vouimba RM, 2006, STRESS, V9, P29, DOI 10.1080/10253890600610973; Vyas A, 2004, BEHAV NEUROSCI, V118, P1450, DOI 10.1037/0735-7044.118.6.1450; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vyas A, 2003, BRAIN RES, V965, P290, DOI 10.1016/S0006-8993(02)04162-8; Vyas A, 2002, J NEUROSCI, V22, P6810; Wang MN, 2012, J PSYCHOPHARMACOL, V26, P56, DOI 10.1177/0269881111409606; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; Wilson IA, 2005, J NEUROSCI, V25, P6877, DOI 10.1523/JNEUROSCI.1744-05.2005; Woodward SH, 2006, BIOL PSYCHIAT, V59, P582, DOI 10.1016/j.biopsych.2005.07.033; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; Xu L, 1998, P NATL ACAD SCI USA, V95, P3204, DOI 10.1073/pnas.95.6.3204; Yehuda R, 1998, BIOL PSYCHIAT, V44, P1305, DOI 10.1016/S0006-3223(98)00276-5; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106; Zhong P, 2008, J PHYSIOL-LONDON, V586, P4465, DOI 10.1113/jphysiol.2008.155143; Zohar J, 2011, EUR NEUROPSYCHOPHARM, V21, P796, DOI 10.1016/j.euroneuro.2011.06.001	146	159	162	1	44	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2015	18	10					1364	1375		10.1038/nn.4115	http://dx.doi.org/10.1038/nn.4115			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CS2OK	26404711				2022-12-17	WOS:000361910600005
J	Marchette, SA; Vass, LK; Ryan, J; Epstein, RA				Marchette, Steven A.; Vass, Lindsay K.; Ryan, Jack; Epstein, Russell A.			Anchoring the neural compass: coding of local spatial reference frames in human medial parietal lobe	NATURE NEUROSCIENCE			English	Article							HEAD-DIRECTION CELLS; RETROSPLENIAL CORTEX; ENTORHINAL CORTEX; PATH-INTEGRATION; HUMAN-MEMORY; PLACE CELLS; NAVIGATION; BRAIN; ENVIRONMENTS; MAP	The neural systems that code for location and facing direction during spatial navigation have been investigated extensively; however, the mechanisms by which these quantities are referenced to external features of the world are not well understood. To address this issue, we examined behavioral priming and functional magnetic resonance imaging activity patterns while human subjects recalled spatial views from a recently learned virtual environment. Behavioral results indicated that imagined location and facing direction were represented during this task, and multivoxel pattern analyses indicated that the retrosplenial complex (RSC) was the anatomical locus of these spatial codes. Critically, in both cases, location and direction were defined on the basis of fixed elements of the local environment and generalized across geometrically similar local environments. These results suggest that RSC anchors internal spatial representations to local topographical features, thus allowing us to stay oriented while we navigate and retrieve from memory the experience of being in a particular place.	[Marchette, Steven A.; Vass, Lindsay K.; Ryan, Jack; Epstein, Russell A.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	University of Pennsylvania	Marchette, SA (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	stmar@sas.upenn.edu			US National Institutes of Health [EY022350]; National Science Foundation [SBE-0541957, SBE-1041707]; NATIONAL EYE INSTITUTE [R01EY022350] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the US National Institutes of Health (EY022350) and the National Science Foundation (SBE-0541957 and SBE-1041707). We thank A. Stigliani for assistance with data collection and three anonymous referees for useful comments on an earlier version of the manuscript.	Aguirre GK, 1999, BRAIN, V122, P1613, DOI 10.1093/brain/122.9.1613; Baumann O, 2010, J NEUROSCI, V30, P12897, DOI 10.1523/JNEUROSCI.3077-10.2010; Burgess N, 2004, COGNITION, V94, P149, DOI 10.1016/j.cognition.2004.01.001; Burgess N, 2008, ANN NY ACAD SCI, V1124, P77, DOI 10.1196/annals.1440.002; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Cho JW, 2001, BEHAV NEUROSCI, V115, P3, DOI 10.1037//0735-7044.115.1.3; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Dudchenko PA, 2005, BEHAV NEUROSCI, V119, P1511, DOI 10.1037/0735-7044.119.6.1511; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Epstein RA, 2007, J NEUROPHYSIOL, V97, P3670, DOI 10.1152/jn.00003.2007; Epstein RA, 2007, J NEUROSCI, V27, P6141, DOI 10.1523/JNEUROSCI.0799-07.2007; Gallistel CR, 1990, ORG LEARNING; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hassabis D, 2007, J NEUROSCI, V27, P14365, DOI 10.1523/JNEUROSCI.4549-07.2007; Hassabis D, 2009, CURR BIOL, V19, P546, DOI 10.1016/j.cub.2009.02.033; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Jacobs J, 2013, NAT NEUROSCI, V16, P1188, DOI 10.1038/nn.3466; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Knight R, 2011, J NEUROSCI, V31, P15681, DOI 10.1523/JNEUROSCI.2257-11.2011; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Lambrey S, 2012, CEREB CORTEX, V22, P166, DOI 10.1093/cercor/bhr101; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Maguire EA, 2001, SCAND J PSYCHOL, V42, P225, DOI 10.1111/1467-9450.00233; Marchette SA, 2011, MEM COGNITION, V39, P1401, DOI 10.3758/s13421-011-0108-x; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; McNaughton Bruce L., 1995, P585; Mou WM, 2002, J EXP PSYCHOL LEARN, V28, P162, DOI 10.1037//0278-7393.28.1.162; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Ranganath C, 2012, NAT REV NEUROSCI, V13, P713, DOI 10.1038/nrn3338; Rosenbaum RS, 2004, HIPPOCAMPUS, V14, P826, DOI 10.1002/hipo.10218; Sato N, 2006, P NATL ACAD SCI USA, V103, P17001, DOI 10.1073/pnas.0604277103; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Sharp PE, 2006, BEHAV BRAIN RES, V174, P206, DOI 10.1016/j.bbr.2006.05.034; Shelton AL, 2001, COGNITIVE PSYCHOL, V43, P274, DOI 10.1006/cogp.2001.0758; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Spiers HJ, 2015, CEREB CORTEX, V25, P10, DOI 10.1093/cercor/bht198; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1995, J NEUROPHYSIOL, V74, P1953, DOI 10.1152/jn.1995.74.5.1953; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Valerio S, 2012, NAT NEUROSCI, V15, P1445, DOI 10.1038/nn.3215; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Vass LK, 2013, J NEUROSCI, V33, P6133, DOI 10.1523/JNEUROSCI.3873-12.2013; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005; Yoder RM, 2011, TRENDS NEUROSCI, V34, P561, DOI 10.1016/j.tins.2011.08.004; Yoder RM, 2011, J NEUROPHYSIOL, V105, P2989, DOI 10.1152/jn.01041.2010; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044886	50	159	161	3	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2014	17	11					1598	1606		10.1038/nn.3834	http://dx.doi.org/10.1038/nn.3834			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AS0LT	25282616	Green Accepted			2022-12-17	WOS:000343969300026
J	Takahashi, H; Katayama, K; Sohya, K; Miyamoto, H; Prasad, T; Matsumoto, Y; Ota, M; Yasuda, H; Tsumoto, T; Aruga, J; Craig, AM				Takahashi, Hideto; Katayama, Kei-ichi; Sohya, Kazuhiro; Miyamoto, Hiroyuki; Prasad, Tuhina; Matsumoto, Yoshifumi; Ota, Maya; Yasuda, Hiroki; Tsumoto, Tadaharu; Aruga, Jun; Craig, Ann Marie			Selective control of inhibitory synapse development by Slitrk3-PTP delta trans-synaptic interaction	NATURE NEUROSCIENCE			English	Article							PTP-DELTA; TYROSINE PHOSPHATASES; PROTEIN FAMILY; NEUREXINS; ADHESION; AUTISM; GABA; LAR; DIFFERENTIATION; NEUROLIGIN-2	Balanced development of excitatory and inhibitory synapses is required for normal brain function, and an imbalance in this development may underlie the pathogenesis of many neuropsychiatric disorders. Compared with the many identified trans-synaptic adhesion complexes that organize excitatory synapses, little is known about the organizers that are specific for inhibitory synapses. We found that Slit and NTRK-like family member 3 (Slitrk3) acts as a postsynaptic adhesion molecule that selectively regulates inhibitory synapse development via trans-interaction with axonal tyrosine phosphatase receptor PTP delta. When expressed in fibroblasts, Slitrk3 triggered only inhibitory presynaptic differentiation in contacting axons of co-cultured rat hippocampal neurons. Recombinant Slitrk3 preferentially localized to inhibitory postsynaptic sites. Slitrk3-deficient mice exhibited decreases in inhibitory, but not excitatory, synapse number and function in hippocampal CA1 neurons and exhibited increased seizure susceptibility and spontaneous epileptiform activity. Slitrk3 required trans-interaction with axonal PTP delta to induce inhibitory presynaptic differentiation. These results identify Slitrk3-PTP delta as an inhibitory-specific trans-synaptic organizing complex that is required for normal functional GABAergic synapse development.	[Katayama, Kei-ichi; Matsumoto, Yoshifumi; Ota, Maya; Aruga, Jun] RIKEN Brain Sci Inst BSI, Lab Behav & Dev Disorders, Wako, Saitama, Japan; [Takahashi, Hideto; Prasad, Tuhina; Craig, Ann Marie] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Takahashi, Hideto; Prasad, Tuhina; Craig, Ann Marie] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Sohya, Kazuhiro; Tsumoto, Tadaharu] RIKEN BSI, Lab Cort Circuit Plast, Wako, Saitama, Japan; [Sohya, Kazuhiro; Miyamoto, Hiroyuki] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan; [Miyamoto, Hiroyuki] RIKEN BSI, Lab Neurobiol Synapse, Wako, Saitama, Japan; [Yasuda, Hiroki] Gunma Univ, Grad Sch Med, Educat & Res Support Ctr, Maebashi, Gunma 371, Japan	RIKEN; University of British Columbia; University of British Columbia; RIKEN; Japan Science & Technology Agency (JST); RIKEN; Gunma University	Aruga, J (corresponding author), RIKEN Brain Sci Inst BSI, Lab Behav & Dev Disorders, Wako, Saitama, Japan.	jaruga@brain.riken.jp; acraig@mail.ubc.ca	Takahashi, Hideto/T-2650-2018; Craig, Ann Marie/M-2054-2014; Aruga, Jun/H-5837-2011; Katayama, Kei-ichi/J-4699-2013	Takahashi, Hideto/0000-0002-6473-5060; Aruga, Jun/0000-0001-7936-1375; Katayama, Kei-ichi/0000-0003-0527-4644; Yasuda, Hiroki/0000-0001-5911-609X	NeuroDevNet Canadian Network of Centre of Excellence; US National Institutes of Health [MH070860]; Canadian Institutes of Health Research [MOP-84241]; Canada Research Chair; Japan Society for the Promotion of Science; National Alliance for Research on Schizophrenia and Depression; RIKEN BSI; Ministry of Education, Culture, Sports, Science (Japan) [21240031]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070860] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23500461, 21200016] Funding Source: KAKEN	NeuroDevNet Canadian Network of Centre of Excellence; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Alliance for Research on Schizophrenia and Depression(NARSAD); RIKEN BSI; Ministry of Education, Culture, Sports, Science (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank X. Zhou (Brain Research Centre, University of British Columbia) for excellent preparation of neuron cultures, N. Takashima (Lab for Behavioral and Developmental Disorders, RIKEN BSI) for technical assistance with seizure experiments and C. Nishioka (Research Resource Center, RIKEN BSI) for help generating Slitrk3 knockout mice. This work was supported by a NeuroDevNet Canadian Network of Centre of Excellence Opportunities Initiative Award, US National Institutes of Health grant MH070860, Canadian Institutes of Health Research grant MOP-84241 and Canada Research Chair awards to A. M. C., a Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad and a National Alliance for Research on Schizophrenia and Depression (Brain and Behavior Research Fund) Young Investigator grant to H. T., and RIKEN BSI funds and a Ministry of Education, Culture, Sports, Science (Japan) Grant-in-Aid for Scientific Research (A) (21240031) to J.A.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Akerman CJ, 2007, TRENDS NEUROSCI, V30, P382, DOI 10.1016/j.tins.2007.06.002; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Beaubien F, 2009, DEV DYNAM, V238, P3285, DOI 10.1002/dvdy.22160; BENSON DL, 1994, J NEUROCYTOL, V23, P279, DOI 10.1007/BF01188497; Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Cline H, 2005, CURR BIOL, V15, pR203, DOI 10.1016/j.cub.2005.03.010; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Katayama K, 2010, MOL PSYCHIATR, V15, P177, DOI 10.1038/mp.2008.97; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Kwon SK, 2010, J BIOL CHEM, V285, P13966, DOI 10.1074/jbc.M109.061127; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Mohler H, 2006, J RECEPT SIG TRANSD, V26, P731, DOI 10.1080/10799890600920035; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Piton A, 2011, MOL PSYCHIATR, V16, P867, DOI 10.1038/mp.2010.54; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schormair B, 2008, NAT GENET, V40, P946, DOI 10.1038/ng.190; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Singer HS, 2003, BRAIN DEV-JPN, V25, pS70, DOI 10.1016/S0387-7604(03)90012-X; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Suzuki T, 2009, HUM MOL GENET, V18, P1099, DOI 10.1093/hmg/ddp006; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Talebizadeh Z, 2008, AUTISM RES, V1, P240, DOI 10.1002/aur.33; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; Valnegri P, 2011, HUM MOL GENET, V20, P4797, DOI 10.1093/hmg/ddr418; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Yoshida T, 2011, J NEUROSCI, V31, P13485, DOI 10.1523/JNEUROSCI.2136-11.2011; Zuchner S, 2006, MOL PSYCHIATR, V11, P888, DOI 10.1038/sj.mp.4001865	50	159	159	0	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					389	U214		10.1038/nn.3040	http://dx.doi.org/10.1038/nn.3040			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22286174	Green Accepted			2022-12-17	WOS:000300793100012
J	Alto, LT; Havton, LA; Conner, JM; Hollis, ER; Blesch, A; Tuszynski, MH				Alto, Laura Taylor; Havton, Leif A.; Conner, James M.; Hollis, Edmund R., II; Blesch, Armin; Tuszynski, Mark H.			Chemotropic guidance facilitates axonal regeneration and synapse formation after spinal cord injury	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; RETINAL GANGLION-CELLS; ADULT-RAT; FUNCTIONAL RECOVERY; SUPERIOR COLLICULUS; NEUROTROPHIC FACTOR; CHONDROITINASE ABC; PRIMARY AFFERENTS; SENSORY NEURONS; GENE DELIVERY	A principal objective of spinal cord injury (SCI) research is the restoration of axonal connectivity to denervated targets. We tested the hypothesis that chemotropic mechanisms would guide regenerating spinal cord axons to appropriate brainstem targets. We subjected rats to cervical level 1 (C1) lesions and combinatorial treatments to elicit axonal bridging into and beyond lesion sites. Lentiviral vectors expressing neurotrophin-3 (NT-3) were then injected into an appropriate brainstem target, the nucleus gracilis, and an inappropriate target, the reticular formation. NT-3 expression in the correct target led to reinnervation of the nucleus gracilis in a dose-related fashion, whereas NT-3 expression in the reticular formation led to mistargeting of regenerating axons. Axons regenerating into the nucleus gracilis formed axodendritic synapses containing rounded vesicles, reflective of pre-injury synaptic architecture. Thus, we report for the first time, to the best of our knowledge, the reinnervation of brainstem targets after SCI and an essential role for chemotropic axon guidance in target selection.	[Alto, Laura Taylor; Conner, James M.; Hollis, Edmund R., II; Blesch, Armin; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Havton, Leif A.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Tuszynski, Mark H.] Vet Adm Med Ctr, Los Angeles, CA 91343 USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Tuszynski, MH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	ablesch@ucsd.edu; mtuszynski@ucsd.edu		Hollis, Edmund/0000-0002-4535-4668; Blesch, Armin/0000-0003-1133-1174	US National Institutes of Health [NS09881, NS54883]; Veterans Administration; International Spinal Research Trust, Wings for Life; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Bernard and Anne Spitzer Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS009881, R01NS054883, R01NS049881] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); International Spinal Research Trust, Wings for Life; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Bernard and Anne Spitzer Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Ma and B. Sjorstrand for technical assistance and J. Silver for helpful suggestions. This work was supported by the US National Institutes of Health (NS09881 and NS54883), the Veterans Administration, the International Spinal Research Trust, Wings for Life, the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and the Bernard and Anne Spitzer Charitable Trust.	Arevalo JC, 2005, CURR OPIN CELL BIOL, V17, P112, DOI 10.1016/j.ceb.2005.01.004; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; DEBIASI S, 1994, J COMP NEUROL, V347, P275, DOI 10.1002/cne.903470209; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Genc B, 2004, PLOS BIOL, V2, P2112, DOI 10.1371/journal.pbio.0020403; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; Havton LA, 2005, J NEUROSCI METH, V149, P101, DOI 10.1016/j.jneumeth.2005.03.014; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Hwang SJ, 2001, NEUROSCI LETT, V312, P137, DOI 10.1016/S0304-3940(01)02204-2; KEIRSTEAD SA, 1989, SCIENCE, V246, P255, DOI 10.1126/science.2799387; Kohama I, 2001, J NEUROSCI, V21, P944, DOI 10.1523/JNEUROSCI.21-03-00944.2001; LAMOTTE CC, 1991, J COMP NEUROL, V311, P546, DOI 10.1002/cne.903110409; LETOURNEAU PC, 1978, DEV BIOL, V66, P183, DOI 10.1016/0012-1606(78)90283-X; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; Ma L, 2002, NEURON, V36, P623, DOI 10.1016/S0896-6273(02)01021-8; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; MCQUARRIE IG, 1977, BRAIN RES, V132, P443, DOI 10.1016/0006-8993(77)90193-7; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; NIEUWENHUYS R, 1994, ANAT EMBRYOL, V190, P307; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Peters A, 1996, J NEUROCYTOL, V25, P687, DOI 10.1007/BF02284835; Postigo A, 2002, GENE DEV, V16, P633, DOI 10.1101/gad.217902; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ramer MS, 1999, EUR J NEUROSCI, V11, P837, DOI 10.1046/j.1460-9568.1999.00491.x; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; RUSTIONI A, 1974, J COMP NEUROL, V155, P441, DOI 10.1002/cne.901550406; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHREYER DJ, 1993, J NEUROBIOL, V24, P959, DOI 10.1002/neu.480240709; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Tan AM, 2007, EXP NEUROL, V206, P257, DOI 10.1016/j.expneurol.2007.05.013; Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006; Tessarollo L, 2004, J NEUROSCI, V24, P2575, DOI 10.1523/JNEUROSCI.5514-03.2004; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; TUSZYNSKI MH, 1995, P NATL ACAD SCI USA, V92, P4621, DOI 10.1073/pnas.92.10.4621; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; ZHANG L, 1994, J NEUROSCI, V14, P5187; Zhou XF, 2000, EUR J NEUROSCI, V12, P100, DOI 10.1046/j.1460-9568.2000.00884.x	50	159	164	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1106	U8		10.1038/nn.2365	http://dx.doi.org/10.1038/nn.2365			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19648914	Green Submitted, Green Accepted			2022-12-17	WOS:000269317300011
J	Joksimovic, M; Yun, BA; Kittappa, R; Anderegg, AM; WChang, W; Taketo, MM; McKay, RDG; Awatramani, RB				Joksimovic, Milan; Yun, Beth A.; Kittappa, Raja; Anderegg, Angela M.; WChang, Wendy; Taketo, Makoto M.; McKay, Ronald D. G.; Awatramani, Rajeshwar B.			Wnt antagonism of Shh facilitates midbrain floor plate neurogenesis	NATURE NEUROSCIENCE			English	Article							BETA-CATENIN GENE; SONIC-HEDGEHOG; DOPAMINERGIC-NEURONS; EXPRESSION; CELLS; FATE; PROGENITORS; BRAIN; IDENTIFICATION; FOREBRAIN	The floor plate, an essential ventral midline organizing center that produces the morphogen Shh, has distinct properties along the neuraxis. The neurogenic potential of the floor plate and its underlying mechanisms remain unknown. Using Shh as a driver for lineage analysis, we found that the mouse midbrain, but not the hindbrain, floor plate is neurogenic, giving rise to dopamine (DA) neurons. Distinct spatiotemporal Shh and Wnt expression may distinguish the neurogenetic potential of these structures. We discovered an inhibitory role for Shh: removal of Shh resulted in neurogenesis from the hindbrain midline and, conversely, high doses of Shh inhibited proliferation and DA neuron production in midbrain cultures. We found that Wnt/beta-catenin signaling is necessary and sufficient for antagonizing Shh, DA progenitor marker induction and promotion of dopaminergic neurogenesis. These findings demonstrate how the dynamic interplay of canonical Wnt/beta-catenin signaling and Shh may orchestrate floor plate neurogenesis or a lack thereof.	[Joksimovic, Milan; Yun, Beth A.; Anderegg, Angela M.; Awatramani, Rajeshwar B.] Northwestern Univ, Feinberg Med Sch, Dept Neurol, Chicago, IL 60611 USA; [Joksimovic, Milan; Yun, Beth A.; Anderegg, Angela M.; Awatramani, Rajeshwar B.] Northwestern Univ, Feinberg Med Sch, Ctr Genet Med, Chicago, IL 60611 USA; [Kittappa, Raja; WChang, Wendy; McKay, Ronald D. G.] NINDS, Mol Biol Lab, Porter Neurosci Res Ctr, Bethesda, MD 20892 USA; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Kyoto University	Awatramani, RB (corresponding author), Northwestern Univ, Feinberg Med Sch, Dept Neurol, 7-113 Lurie Bldg,303 Super St, Chicago, IL 60611 USA.	r-awatramani@northwestern.edu		Joksimovic, Milan/0000-0002-3936-4632	Dana Foundation; American Parkinson's Disease Association; Parkinson's Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002981, Z01NS002981] Funding Source: NIH RePORTER	Dana Foundation; American Parkinson's Disease Association; Parkinson's Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Tabin for Shh::cre mice and Shh cDNA; M. German for antibody to Lmx1a; T. Muller and C. Birchmeier for antibody to Lmx1b; D. Anderson for antibody to Ngn2; T. Edlund for antibodies to Gbx2; and A. Klar for the Spon1l cDNA. We thank A. Chenn for supplying Ctnnb1 mouse strains. We thank J. Kessler for suggestions. R. B. A was supported by the Dana Foundation and the American Parkinson's Disease Association. M. J. was supported by the Parkinson's Disease Foundation.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Alvarez-Medina R, 2008, DEVELOPMENT, V135, P237, DOI 10.1242/dev.012054; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Andersson E, 2006, DEVELOPMENT, V133, P507, DOI 10.1242/dev.02224; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Bayly RD, 2007, DEVELOPMENT, V134, P2115, DOI 10.1242/dev.02850; Blaess S, 2006, DEVELOPMENT, V133, P1799, DOI 10.1242/dev.02339; Bonilla S, 2008, GLIA, V56, P809, DOI 10.1002/glia.20654; Brault V, 2001, DEVELOPMENT, V128, P1253; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Epstein DJ, 1999, DEVELOPMENT, V126, P281; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Geng X, 2008, DEV CELL, V15, P236, DOI 10.1016/j.devcel.2008.07.003; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Manning L, 2006, DEV CELL, V11, P873, DOI 10.1016/j.devcel.2006.09.021; Mckay R, 2008, NEURON, V58, P659, DOI 10.1016/j.neuron.2008.05.016; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Ono Y, 2007, DEVELOPMENT, V134, P3213, DOI 10.1242/dev.02879; Patten I, 2003, DEVELOPMENT, V130, P4809, DOI 10.1242/dev.00694; Placzek M, 2005, NAT REV NEUROSCI, V6, P230, DOI 10.1038/nrn1628; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Scherz PJ, 2007, DEV BIOL, V308, P343, DOI 10.1016/j.ydbio.2007.05.030; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Wrobel CN, 2007, DEV BIOL, V309, P285, DOI 10.1016/j.ydbio.2007.07.013; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	37	159	164	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2009	12	2					125	131		10.1038/nn.2243	http://dx.doi.org/10.1038/nn.2243			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	404VV	19122665				2022-12-17	WOS:000263182000012
J	Lee, TS; Yang, CF; Romero, RD; Mumford, D				Lee, TS; Yang, CF; Romero, RD; Mumford, D			Neural activity in early visual cortex reflects behavioral experience and higher-order perceptual saliency	NATURE NEUROSCIENCE			English	Article							INTERACTIVE ACTIVATION; CONTEXTUAL MODULATION; MACAQUE MONKEY; AREAS V1; ATTENTION; TEXTURE; SHAPE; MECHANISMS; RESPONSES; VISION	We report here that shape-from-shading stimuli evoked a long-latency contextual pop-out response in V1 and V2 neurons of macaque monkeys, particularly after the monkeys had used the stimuli in a behavioral task. The magnitudes of the pop-out responses were correlated to the monkeys' behavioral performance, suggesting that these signals are neural correlates of perceptual pop-out saliency. The signals changed with the animal's behavioral adaptation to stimulus contingencies, indicating that perceptual saliency is also a function of experience and behavioral relevance. The evidence that higher-order stimulus attributes and task experience can influence early visual processing supports the notion that perceptual computation is an interactive and plastic process involving multiple cortical areas.	Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA; Brown Univ, Div Appl Math, Providence, RI 02912 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Brown University	Lee, TS (corresponding author), Carnegie Mellon Univ, Ctr Neural Basis Cognit, 4400 5th Ave, Pittsburgh, PA 15213 USA.	tai@cnbc.cmu.edu		Yang, Cindy/0000-0001-6144-4658	NCRR NIH HHS [2P41RR06009-11] Funding Source: Medline; NEI NIH HHS [EY08298] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ahissar M, 2001, PSYCHOL SCI, V12, P56, DOI 10.1111/1467-9280.00310; Bakin JS, 2000, J NEUROSCI, V20, P8188; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; BRAUN J, 1993, SPATIAL VISION, V7, P311, DOI 10.1163/156856893X00469; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; DECO G, IN PRESS NEUROCOMPUT; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; GROSSBERG S, 1987, COGNITIVE SCI, V11, P23, DOI 10.1111/j.1551-6708.1987.tb00862.x; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; JULESZ B, 1975, SCI AM, V232, P34, DOI 10.1038/scientificamerican0475-34; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; LAMME VAF, 1995, J NEUROSCI, V10, P649; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Li ZP, 1999, NETWORK-COMP NEURAL, V10, P187, DOI 10.1088/0954-898X/10/2/305; Logothetis N, 1998, CURR OPIN NEUROBIOL, V8, P536; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; Nothdurft HC, 1999, VISUAL NEUROSCI, V16, P15, DOI 10.1017/S0952523899156189; Pollen DA, 1999, CEREB CORTEX, V9, P4, DOI 10.1093/cercor/9.1.4; RAMACHANDRAN VS, 1988, NATURE, V331, P163, DOI 10.1038/331163a0; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Rossi AF, 2001, J NEUROSCI, V21, P1698, DOI 10.1523/JNEUROSCI.21-05-01698.2001; STEMMLER M, 1995, SCIENCE, V269, P1877, DOI 10.1126/science.7569930; Sun J, 1996, NATURE, V379, P165, DOI 10.1038/379165a0; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WURTZ RH, 1969, J NEUROPHYSIOL, V32, P975, DOI 10.1152/jn.1969.32.6.975; Zipser K, 1996, J NEUROSCI, V16, P7376	37	159	161	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					589	597		10.1038/nn860	http://dx.doi.org/10.1038/nn860			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12021764				2022-12-17	WOS:000175874600020
J	Pardal, R; Lopez-Barneo, J				Pardal, R; Lopez-Barneo, J			Low glucose-sensing cells in the carotid body	NATURE NEUROSCIENCE			English	Article							CHEMORECEPTOR CELLS; GLOMUS CELLS; K+ CURRENT; HYPOGLYCEMIA; HYPOXIA; PLAY		Univ Sevilla, Dept Fisiol, Lab Invest Biomed, E-41013 Seville, Spain; Univ Sevilla, Hosp Univ Virgen Rocio, E-41013 Seville, Spain	University of Sevilla; University of Sevilla; Virgen del Rocio University Hospital	Lopez-Barneo, J (corresponding author), Univ Sevilla, Dept Fisiol, Lab Invest Biomed, E-41013 Seville, Spain.		IBIS, FISIOPATOLOGIA/O-9510-2015; Pardal, Ricardo/C-4370-2015; IBIS, NEUROBIOLOGIA/O-9922-2015	Pardal, Ricardo/0000-0003-1085-0714; 				ALVAREZBUYLLA R, 1994, BRAIN RES, V654, P167, DOI 10.1016/0006-8993(94)91585-7; ALVAREZBUYLLA R, 1988, RESP PHYSIOL, V72, P347, DOI 10.1016/0034-5687(88)90093-X; AUER RN, 1986, STROKE, V17, P699, DOI 10.1161/01.STR.17.4.699; CANE P, 1986, DIABETES, V35, P268, DOI 10.2337/diabetes.35.3.268; DONOVAN CM, 1994, P NATL ACAD SCI USA, V91, P2863, DOI 10.1073/pnas.91.7.2863; GERICH JE, 1988, DIABETES METAB REV, V4, P93, DOI 10.1002/dmr.5610040202; HAVENER AL, 1997, DIABETES, V46, P1521; LOPEZBARNEO J, 1988, SCIENCE, V241, P580, DOI 10.1126/science.2456613; MARTIN RL, 1994, TRENDS NEUROSCI, V17, P251, DOI 10.1016/0166-2236(94)90008-6; Perez-Garcia MT, 2000, J NEUROSCI, V20, P5689, DOI 10.1523/JNEUROSCI.20-15-05689.2000; ZINKER BA, 1994, AM J PHYSIOL, V266, pE921, DOI 10.1152/ajpendo.1994.266.6.E921	15	159	166	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					197	198		10.1038/nn812	http://dx.doi.org/10.1038/nn812			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850631				2022-12-17	WOS:000174146000007
J	Zheng, F; Gingrich, MB; Traynelis, SF; Conn, PJ				Zheng, F; Gingrich, MB; Traynelis, SF; Conn, PJ			Tyrosine kinase potentiates NMDA receptor currents by reducing tonic zinc inhibition	NATURE NEUROSCIENCE			English	Article							METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; ACTIVATED CHANNELS; GLUTAMATE-RECEPTOR; CORTICAL-NEURONS; PROTEIN; MODULATION; SENSITIVITY; RESPONSES	Activation of the tyrosine kinase Src potentiates NMDA receptor currents, which is thought to be necessary for induction of hippocampal long-term potentiation. Although the carboxy(C)-terminal domain of the NR2A subunit contains potential tyrosine phosphorylation sites, the mechanism by which Src modulates synaptic plasticity and NMDA receptor currents is not fully understood. Here we present evidence from NR1 mutants and splice variants that Src potentiates NMDA-receptor currents by reducing the tonic inhibition of receptors composed of NR1 and NR2A subunits by extracellular zinc. Using site-directed mutagenesis, we have identified three C-terminal tyrosine residues of NR2A that are required for Src's modulation of the zinc sensitivity of NMDA receptors. Our data link two modulatory sites of NMDA receptors that were previously thought to be independent.	Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Zheng, F (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.		Zheng, Fang/J-1400-2016; Conn, Peter/D-7848-2012	Zheng, Fang/0000-0002-6626-1938; 				BERS DM, 1994, METHOD CELL BIOL, V40, P3; BOGDEN JD, 1977, CLIN CHEM, V23, P485; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; CHRISTINE CW, 1990, J NEUROSCI, V10, P108; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; EDMONDS B, 1992, P ROY SOC B-BIOL SCI, V250, P279, DOI 10.1098/rspb.1992.0160; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; LEGENDRE P, 1990, J PHYSIOL-LONDON, V429, P429, DOI 10.1113/jphysiol.1990.sp018266; Li CY, 1996, J NEUROPHYSIOL, V76, P3048, DOI 10.1152/jn.1996.76.5.3048; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Miyakawa T, 1997, SCIENCE, V278, P698, DOI 10.1126/science.278.5338.698; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; Paoletti P, 1997, J NEUROSCI, V17, P5711; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; SMART TG, 1994, PROG NEUROBIOL, V42, P393, DOI 10.1016/0301-0082(94)90082-5; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; SULLIVAN JM, 1994, NEURON, V13, P929, DOI 10.1016/0896-6273(94)90258-5; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; TRAYNELIS SF, IN PRESS J NEUROSCI; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Williams K, 1996, NEUROSCI LETT, V215, P9, DOI 10.1016/S0304-3940(96)12924-4; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	37	159	161	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					185	191		10.1038/634	http://dx.doi.org/10.1038/634			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195142				2022-12-17	WOS:000076361200008
J	Dworkin, JD; Linn, KA; Teich, EG; Zurn, P; Shinohara, RT; Bassett, DS				Dworkin, Jordan D.; Linn, Kristin A.; Teich, Erin G.; Zurn, Perry; Shinohara, Russell T.; Bassett, Danielle S.			The extent and drivers of gender imbalance in neuroscience reference lists	NATURE NEUROSCIENCE			English	Article							CITATION PATTERNS; BIAS; SCIENCE; NAME; GAP	Similarly to many scientific disciplines, neuroscience has increasingly attempted to confront pervasive gender imbalances. Although publishing and conference participation are often highlighted, recent research has called attention to the prevalence of gender imbalance in citations. Because of the downstream effects of citations on visibility and career advancement, understanding the role of gender in citation practices is vital for addressing scientific inequity. Here, we investigate whether gendered patterns are present in neuroscience citations. Using data from five top neuroscience journals, we find that reference lists tend to include more papers with men as first and last author than would be expected if gender were unrelated to referencing. Importantly, we show that this imbalance is driven largely by the citation practices of men and is increasing over time as the field diversifies. We assess and discuss possible mechanisms and consider how researchers might approach these issues in their own work. Using data from top neuroscience journals, this study finds that women-led work tends to be undercited relative to expectations. This imbalance is driven largely by the citation practices of men and is increasing over time as the field diversifies.	[Dworkin, Jordan D.; Linn, Kristin A.; Shinohara, Russell T.] Univ Penn, Penn Stat Imaging & Visualizat Ctr, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Teich, Erin G.; Bassett, Danielle S.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Zurn, Perry] Amer Univ, Dept Philosophy & Relig, Washington, DC 20016 USA; [Bassett, Danielle S.] Univ Penn, Dept Phys & Astron, Coll Arts & Sci, Philadelphia, PA 19104 USA; [Bassett, Danielle S.] Univ Penn, Sch Engn & Appl Sci, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Bassett, Danielle S.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bassett, Danielle S.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bassett, Danielle S.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; American University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; The Santa Fe Institute	Bassett, DS (corresponding author), Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA.; Bassett, DS (corresponding author), Univ Penn, Dept Phys & Astron, Coll Arts & Sci, Philadelphia, PA 19104 USA.; Bassett, DS (corresponding author), Univ Penn, Sch Engn & Appl Sci, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA.; Bassett, DS (corresponding author), Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Bassett, DS (corresponding author), Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA.; Bassett, DS (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	dsb@seas.upenn.edu	; Dworkin, Jordan/T-7192-2017	Teich, Erin/0000-0001-7553-7054; Dworkin, Jordan/0000-0002-5720-1298	National Institute of Neurological Disorders and Stroke [R01 NS085211, R01 NS060910]; John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation; NSF CAREER award [PHY-1554488]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank D. Lydon-Staley and D. Zhou for constructive comments on an earlier version of this manuscript. R.T.S. would like to acknowledge support from the National Institute of Neurological Disorders and Stroke (R01 NS085211 and R01 NS060910). D.S.B. acknowledges support from the John D. and Catherine T. MacArthur Foundation, the Alfred P. Sloan Foundation and an NSF CAREER award (PHY-1554488). The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the funding agencies.	Ahmed Sara., 2012, BEING INCLUDED RACIS, DOI DOI 10.1215/9780822395324; Aksnes DW, 2019, SAGE OPEN, V9, DOI 10.1177/2158244019829575; AlShebli BK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07634-8; Anderson E, 2010, IMPERATIVE OF INTEGRATION, P1; [Anonymous], 2018, NAT NEUROSCI, V21, P1, DOI 10.1038/s41593-017-0052-6; Bergstrom CT, 2008, J NEUROSCI, V28, P11433, DOI 10.1523/JNEUROSCI.0003-08.2008; Bertrand M, 2004, AM ECON REV, V94, P991, DOI 10.1257/0002828042002561; Blevins C, 2015, DIGIT HUMANITIES Q, V9; Boring A, 2017, J PUBLIC ECON, V145, P27, DOI 10.1016/j.jpubeco.2016.11.006; Brownstein Michael, 2019, STANFORD ENCY PHILOS; Caplar N, 2017, NAT ASTRON, V1, DOI 10.1038/s41550-017-0141; Chakravartty P, 2018, J COMMUN, V68, P254, DOI 10.1093/joc/jqy003; Clarke JA, 2018, NORTHWEST U LAW REV, V113, P505; Colgan J, 2017, PS-POLIT SCI POLIT, V50, P456, DOI 10.1017/S1049096516002997; Conaway W, 2015, ONLINE LEARN, V19, P162; De Paola B, 2015, ECONOMICA, V82, P162, DOI 10.1111/ecca.12107; Dion ML, 2018, POLIT ANAL, V26, P312, DOI 10.1017/pan.2018.12; Fang D, 2000, JAMA-J AM MED ASSOC, V284, P1085, DOI 10.1001/jama.284.9.1085; Fausto-Sterling A., 2000, SEXING BODY GENDER P; Feder E., 2014, MAKING SENSE INTERSE; Ferber MA, 2011, FEM ECON, V17, P151, DOI 10.1080/13545701.2010.541857; Gutierrez M, 2012, PRESUMED INCOMPETENT; Henry P.J., 2010, SAGE HDB PREJUDICE S, P426, DOI DOI 10.4135/9781446200919.N26; HOLM S, 1979, SCAND J STAT, V6, P65; Holman L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216128; Holman L, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004956; Huang JM, 2020, P NATL ACAD SCI USA, V117, P4609, DOI 10.1073/pnas.1914221117; Jadidi M, 2018, ADV COMPLEX SYST, V21, DOI 10.1142/S0219525917500114; Jagsi R, 2009, ANN INTERN MED, V151, P804, DOI 10.7326/0003-4819-151-11-200912010-00009; Joels M, 2014, NEURON, V82, P1196, DOI 10.1016/j.neuron.2014.05.021; King MM., 2017, SOCIUS SOCIOLOGICAL, V3, P1, DOI DOI 10.1177/2378023117738903; Lamont J., 2017, STANFORD ENCY PHILOS; MacNell L, 2015, INNOV HIGH EDUC, V40, P291, DOI 10.1007/s10755-014-9313-4; Maliniak D, 2013, INT ORGAN, V67, P889, DOI 10.1017/S0020818313000209; Mengel F, 2019, J EUR ECON ASSOC, V17, P535, DOI 10.1093/jeea/jvx057; Mitchell SM, 2013, INT STUD PERSPECT, V14, P485, DOI 10.1111/insp.12026; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Nielsen MW, 2016, SCI PUBL POLICY, V43, P386, DOI 10.1093/scipol/scv052; Olsaretti S, 2018, OXFORD HDB DISTRIBUT, V1, DOI [10.1093/oxfordhb/9780199645121.013.38, DOI 10.1093/OXFORDHB/9780199645121.013.38]; PALUDI MA, 1985, SEX ROLES, V12, P353, DOI 10.1007/BF00287601; Penders B, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006036; Petersen AM, 2014, P NATL ACAD SCI USA, V111, P15316, DOI 10.1073/pnas.1323111111; Posselt Julie., 2016, INSIDE GRADUATE ADMI; ROSSITER MW, 1993, SOC STUD SCI, V23, P325, DOI 10.1177/030631293023002004; Sarsons H, 2017, AM ECON REV, V107, P141, DOI 10.1257/aer.p20171126; Schrouff J, 2019, EUR J NEUROSCI, V50, P3094, DOI 10.1111/ejn.14397; Stryker S, 2008, SEAL STUDIES; Sumner JL, 2018, PS-POLIT SCI POLIT, V51, P396, DOI 10.1017/S1049096517002074; Thiem Y., 2018, PUBLICATION ETHICS; Toth Csaba, 2014, AMIA Annu Symp Proc, V2014, P1105; Uhly KM, 2017, STUD HIGH EDUC, V42, P760, DOI 10.1080/03075079.2015.1072151; van der Lee R, 2015, P NATL ACAD SCI USA, V112, P12349, DOI 10.1073/pnas.1510159112; Walker M. U, 2010, AQUINAS LECT 2010, V2010; Way SF, 2019, P NATL ACAD SCI USA, V116, P10729, DOI 10.1073/pnas.1817431116; West JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066212; Wilhelm I, 2018, PHILOS STUD, V175, P1441, DOI 10.1007/s11098-017-0919-0; Wood SN., 2017, GEN ADDITIVE MODELS, V2nd ed, DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Yang Y, 2019, P NATL ACAD SCI USA, V116, P2033, DOI 10.1073/pnas.1721438116; Young IM, 2011, JUSTICE AND THE POLITICS OF DIFFERENCE, P1; Zippel K., 2017, WOMEN GLOBAL SCI ADV, DOI [10.1515/9781503601505, DOI 10.1515/9781503601505]	61	158	158	9	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2020	23	8					918	+		10.1038/s41593-020-0658-y	http://dx.doi.org/10.1038/s41593-020-0658-y		JUN 2020	14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	MQ7WY	32561883	Green Submitted			2022-12-17	WOS:000541321700001
J	Makino, H; Komiyama, T				Makino, Hiroshi; Komiyama, Takaki			Learning enhances the relative impact of top-down processing in the visual cortex	NATURE NEUROSCIENCE			English	Article							CEREBRAL-CORTEX; LAYER 6; RETROSPLENIAL CORTEX; CELLULAR RESOLUTION; GABAERGIC NEURONS; INTERNEURONS; CONNECTIONS; CELLS; DISCRIMINATION; REPRESENTATION	Theories have proposed that, in sensory cortices, learning can enhance top-down modulation by higher brain areas while reducing bottom-up sensory drives. To address circuit mechanisms underlying this process, we examined the activity of layer 2/3 (L2/3) excitatory neurons in the mouse primary visual cortex (V1) as well as L4 excitatory neurons, the main bottom-up source, and long-range top-down projections from the retrosplenial cortex (RSC) during associative learning over days using chronic two-photon calcium imaging. During learning, L4 responses gradually weakened, whereas RSC inputs became stronger. Furthermore, L2/3 acquired a ramp-up response temporal profile, potentially encoding the timing of the associated event, which coincided with a similar change in RSC inputs. Learning also reduced the activity of somatostatin-expressing inhibitory neurons (SOM-INs) in V1 that could potentially gate top-down inputs. Finally, RSC inactivation or SOM-IN activation was sufficient to partially reverse the learning-induced changes in L2/3. Together, these results reveal a learning-dependent dynamic shift in the balance between bottom-up and top-down information streams and uncover a role of SOM-INs in controlling this process.	[Makino, Hiroshi; Komiyama, Takaki] Univ Calif San Diego, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA; [Makino, Hiroshi; Komiyama, Takaki] Univ Calif San Diego, Dept Neurosci, La Jolla, CA USA; [Komiyama, Takaki] Univ Calif San Diego, PRESTO, JST, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Komiyama, T (corresponding author), Univ Calif San Diego, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA.	tkomiyama@ucsd.edu	Makino, Hiroshi/Q-3779-2016	Makino, Hiroshi/0000-0003-1591-8001; Komiyama, Takaki/0000-0001-9609-4600	US National Institutes of Health [1R01NS091010-01, 1R01DC014690-01]; Japan Science and Technology Agency (PRESTO); Pew Charitable Trusts; Alfred P. Sloan Foundation; David & Lucile Packard Foundation; Human Frontier Science Program; McKnight Foundation; New York Stem Cell Foundation (NYSCF); Uehara Memorial Foundation Research Fellowship; JSPS postdoctoral fellowship for Research Abroad; NATIONAL EYE INSTITUTE [R01EY025349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014690, R21DC012641] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Science and Technology Agency (PRESTO)(Japan Science & Technology Agency (JST)); Pew Charitable Trusts; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); David & Lucile Packard Foundation(The David & Lucile Packard Foundation); Human Frontier Science Program(Human Frontier Science Program); McKnight Foundation; New York Stem Cell Foundation (NYSCF); Uehara Memorial Foundation Research Fellowship(Uehara Memorial Foundation); JSPS postdoctoral fellowship for Research Abroad; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank A. Kim and L. Xiao for technical assistance, L.L. Looger, J. Akerboom, D.S. Kim and the GENIE Project at Janelia Farm for making GCaMP available, S. Olsen, B. Liu, S. Ruediger-Lee and M. Scanziani for help with visual stimulation and circular treadmill, S. Shabel and R. Malinow for help with slice experiments, and M. Basso, R. Malinow, J. Serences and members of the Komiyama laboratory for comments and discussions. This work was supported by grants from the US National Institutes of Health (1R01NS091010-01, 1R01DC014690-01), Japan Science and Technology Agency (PRESTO), Pew Charitable Trusts, Alfred P. Sloan Foundation, David & Lucile Packard Foundation, Human Frontier Science Program, McKnight Foundation, and the New York Stem Cell Foundation (NYSCF) to T.K. H.M. was supported by the Uehara Memorial Foundation Research Fellowship and the JSPS postdoctoral fellowship for Research Abroad. T.K. is a NYSCF-Robertson Investigator.	Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bortone DS, 2014, NEURON, V82, P474, DOI 10.1016/j.neuron.2014.02.021; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown SP, 2009, CURR OPIN NEUROBIOL, V19, P415, DOI 10.1016/j.conb.2009.07.011; Callaway EM, 2004, NEURAL NETWORKS, V17, P625, DOI 10.1016/j.neunet.2004.04.004; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; CAULLER LJ, 1994, J NEUROSCI, V14, P751; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cottam JCH, 2013, J NEUROSCI, V33, P19567, DOI 10.1523/JNEUROSCI.2624-13.2013; Deco G, 2004, VISION RES, V44, P621, DOI 10.1016/j.visres.2003.09.037; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Gdalyahu A, 2012, NEURON, V75, P121, DOI 10.1016/j.neuron.2012.04.035; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gilbert CD, 2013, NAT REV NEUROSCI, V14, P350, DOI 10.1038/nrn3476; Glickfeld LL, 2013, J NEUROSCI, V33, P19416, DOI 10.1523/JNEUROSCI.3560-13.2013; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Hinton GE, 2007, TRENDS COGN SCI, V11, P428, DOI 10.1016/j.tics.2007.09.004; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Krupa DJ, 2004, SCIENCE, V304, P1989, DOI 10.1126/science.1093318; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; Lukoyanov NV, 2006, BEHAV BRAIN RES, V173, P229, DOI 10.1016/j.bbr.2006.06.026; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MIGNARD M, 1991, SCIENCE, V251, P1249, DOI 10.1126/science.1848727; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Palmer L, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00026; Paxinos G, 2013, PAXINOS FRANKLINS MO; Peters AJ, 2014, NATURE, V510, P263, DOI 10.1038/nature13235; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Velez-Fort M, 2014, NEURON, V83, P1431, DOI 10.1016/j.neuron.2014.08.001; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang SY, 2014, SCIENCE, V345, P660, DOI 10.1126/science.1254126; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	57	158	158	3	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2015	18	8					1116	+		10.1038/nn.4061	http://dx.doi.org/10.1038/nn.4061			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CN7HO	26167904	Green Accepted, Green Submitted			2022-12-17	WOS:000358605400012
J	Dudok, B; Barna, L; Ledri, M; Szabo, SI; Szabadits, E; Pinter, B; Woodhams, SG; Henstridge, CM; Balla, GY; Nyilas, R; Varga, C; Lee, SH; Matolcsi, M; Cervenak, J; Kacskovics, I; Watanabe, M; Sagheddu, C; Melis, M; Pistis, M; Soltesz, I; Katona, I				Dudok, Barna; Barna, Laszlo; Ledri, Marco; Szabo, Szilard I.; Szabadits, Eszter; Pinter, Balazs; Woodhams, Stephen G.; Henstridge, Christopher M.; Balla, Gyula Y.; Nyilas, Rita; Varga, Csaba; Lee, Sang-Hun; Matolcsi, Mate; Cervenak, Judit; Kacskovics, Imre; Watanabe, Masahiko; Sagheddu, Claudia; Melis, Miriam; Pistis, Marco; Soltesz, Ivan; Katona, Istvan			Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling	NATURE NEUROSCIENCE			English	Article							GABA RELEASE; ENDOCANNABINOID SYSTEM; INHIBITORY SYNAPSES; CA2+ CHANNELS; RECEPTOR; MARIJUANA; MODULATION; TOLERANCE; TERMINALS; TRAFFICKING	A major challenge in neuroscience is to determine the nanoscale position and quantity of signaling molecules in a cell type- and subcellular compartment-specific manner. We developed a new approach to this problem by combining cell-specific physiological and anatomical characterization with super-resolution imaging and studied the molecular and structural parameters shaping the physiological properties of synaptic endocannabinoid signaling in the mouse hippocampus. We found that axon terminals of perisomatically projecting GABAergic interneurons possessed increased CB1 receptor number, active-zone complexity and receptor/effector ratio compared with dendritically projecting interneurons, consistent with higher efficiency of cannabinoid signaling at somatic versus dendritic synapses. Furthermore, chronic Delta(9)-tetrahydrocannabinol administration, which reduces cannabinoid efficacy on GABA release, evoked marked CB1 downregulation in a dose-dependent manner. Full receptor recovery required several weeks after the cessation of Delta(9)-tetrahydrocannabinol treatment. These findings indicate that cell type-specific nanoscale analysis of endogenous protein distribution is possible in brain circuits and identify previously unknown molecular properties controlling endocannabinoid signaling and cannabis-induced cognitive dysfunction.	[Dudok, Barna; Barna, Laszlo; Ledri, Marco; Szabo, Szilard I.; Szabadits, Eszter; Pinter, Balazs; Woodhams, Stephen G.; Henstridge, Christopher M.; Balla, Gyula Y.; Katona, Istvan] Hungarian Acad Sci, Inst Expt Med, Momentum Lab Mol Neurobiol, Budapest, Hungary; [Dudok, Barna; Balla, Gyula Y.] Semmelweis Univ, Sch PhD Studies, H-1085 Budapest, Hungary; [Varga, Csaba; Lee, Sang-Hun; Soltesz, Ivan] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Matolcsi, Mate] Hungarian Acad Sci, Alfred Renyi Inst Math, Budapest, Hungary; [Cervenak, Judit; Kacskovics, Imre] ImmunoGenes Kft, Budakeszi, Hungary; [Kacskovics, Imre] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan; [Sagheddu, Claudia; Melis, Miriam; Pistis, Marco] Cittadella Univ Monserrato, Univ Cagliari, Dept Biomed Sci, Monserrato, Italy; [Pistis, Marco] CNR, Inst Neurosci, Cagliari, Italy	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Semmelweis University; University of California System; University of California Irvine; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Alfred Renyi Institute of Mathematics; Eotvos Lorand University; Hokkaido University; University of Cagliari; Consiglio Nazionale delle Ricerche (CNR)	Katona, I (corresponding author), Hungarian Acad Sci, Inst Expt Med, Momentum Lab Mol Neurobiol, Budapest, Hungary.	katona@koki.hu	Dudok, Barna/G-1515-2011; Melis, Miriam/AAF-3235-2020; SAGHEDDU, CLAUDIA/AIC-9000-2022; WATANABE, Masahiko/A-4055-2012; Henstridge, Christopher/J-3848-2019; Watanabe, Masahiko/S-3614-2019; lee, sang hun/Q-4650-2019; Kacskovics, Imre/J-8449-2013; Pistis, Marco/A-3773-2013; Katona, Istvan/D-9729-2011	Dudok, Barna/0000-0001-5078-0090; Melis, Miriam/0000-0001-9631-8651; SAGHEDDU, CLAUDIA/0000-0002-5315-2898; WATANABE, Masahiko/0000-0001-5037-7138; Henstridge, Christopher/0000-0002-0393-180X; Watanabe, Masahiko/0000-0001-5037-7138; lee, sang hun/0000-0002-9005-5966; Kacskovics, Imre/0000-0002-0402-3862; Pistis, Marco/0000-0002-4622-3205; Woodhams, Stephen/0000-0002-0249-2905; Nyilas, Rita/0000-0002-9634-9535; Ledri, Marco/0000-0001-8317-7976; Barna, Laszlo/0000-0002-3856-5774; Soltesz, Ivan/0000-0003-1493-3744; Katona, Istvan/0000-0003-2808-3330; Varga, Csaba/0000-0002-9188-1282	European Research Council [243153]; Momentum Program of the Hungarian Academy of Sciences [LP2013-54/2013]; Hungarian Academy of Sciences Equipment Grant [IF-22/2012]; Wellcome Trust International Senior Research Fellowship [090946/Z/09/Z]; US National Institutes of Health [NS74432]; Italian Ministry of University [200928EEX4]; Fondazione Banco di Sardegna; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074432] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Momentum Program of the Hungarian Academy of Sciences; Hungarian Academy of Sciences Equipment Grant; Wellcome Trust International Senior Research Fellowship(Wellcome Trust); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to E. Tischler and G. Goda for their excellent technical assistance, I. Mihaly for bouton distribution analysis, and C. Cserep and C. Fekete for their help with immunostaining and antibody labeling protocols. The authors are indebted to A. Zimmer (University of Bonn) for providing the CB<INF>1</INF> knockout mouse line and to A. Timar for his help with software analysis. We also thank N. Hajos, N. Holderith, N. Lenkey and Z. Nusser for their comments on the manuscript. The help of the Nikon Microscopy Center at the Institute of Experimental Medicine, Nikon Europe B.V., Nikon Austria GmbH and Auro-Science Consulting is greatly acknowledged for kindly providing microscopy support. This study was primarily supported by the European Research Council Grant 243153 and by the Momentum Program (LP2013-54/2013) of the Hungarian Academy of Sciences to I. Katona. The project was also funded by the Hungarian Academy of Sciences Equipment Grant (IF-22/2012) for super-resolution microscopy. I. Katona is a recipient of the Wellcome Trust International Senior Research Fellowship (090946/Z/09/Z). Additional support was provided by the US National Institutes of Health (NS74432) to I.S., and by the Italian Ministry of University (Grant PRIN 2009: 200928EEX4) and "Fondazione Banco di Sardegna" to M.P.	Baranyi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076839; Bass CE, 2000, DRUG ALCOHOL DEPEN, V60, P113, DOI 10.1016/S0376-8716(99)00150-7; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bolla KI, 2002, NEUROLOGY, V59, P1337, DOI 10.1212/01.WNL.0000031422.66442.49; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Chen K, 2003, NEURON, V39, P599, DOI 10.1016/S0896-6273(03)00499-9; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Choquet D, 2013, NEURON, V80, P691, DOI 10.1016/j.neuron.2013.10.013; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; DeLong GT, 2010, DRUG ALCOHOL DEPEN, V112, P126, DOI 10.1016/j.drugalcdep.2010.05.019; Deschout H, 2014, NAT METHODS, V11, P253, DOI 10.1038/nmeth.2843; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Fukudome Y, 2004, EUR J NEUROSCI, V19, P2682, DOI 10.1111/j.0953-816X.2004.03384.x; Hangya B, 2014, CURR OPIN NEUROBIOL, V26, P117, DOI 10.1016/j.conb.2014.01.007; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; HEISHMAN SJ, 1990, PHARMACOL BIOCHEM BE, V37, P561, DOI 10.1016/0091-3057(90)90028-G; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Hirvonen J, 2012, MOL PSYCHIATR, V17, P642, DOI 10.1038/mp.2011.82; Hoffman AF, 2007, LEARN MEMORY, V14, P63, DOI 10.1101/lm.439007; Holderith N, 2012, NAT NEUROSCI, V15, P988, DOI 10.1038/nn.3137; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huestis MA, 2001, ARCH GEN PSYCHIAT, V58, P322, DOI 10.1001/archpsyc.58.4.322; Jung KM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2045; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katona I, 1999, J NEUROSCI, V19, P4544; Katona I, 2012, ANNU REV NEUROSCI, V35, P529, DOI 10.1146/annurev-neuro-062111-150420; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lee SH, 2010, J NEUROSCI, V30, P7993, DOI 10.1523/JNEUROSCI.6238-09.2010; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Lovinger David M., 2008, V184, P435; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Maccarrone M, 2010, NEUROPSYCHOPHARMACOL, V35, P1500, DOI 10.1038/npp.2010.19; MacGillavry HD, 2013, NEURON, V78, P615, DOI 10.1016/j.neuron.2013.03.009; Maglione M, 2013, NAT NEUROSCI, V16, P790, DOI 10.1038/nn.3403; McKinney DL, 2008, J PHARMACOL EXP THER, V324, P664, DOI 10.1124/jpet.107.130328; Mikasova L, 2008, P NATL ACAD SCI USA, V105, P18596, DOI 10.1073/pnas.0805959105; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Nair D, 2013, J NEUROSCI, V33, P13204, DOI 10.1523/JNEUROSCI.2381-12.2013; Nyilas R, 2008, J NEUROSCI, V28, P1058, DOI 10.1523/JNEUROSCI.5102-07.2008; O'Rourke NA, 2012, NAT REV NEUROSCI, V13, P365, DOI 10.1038/nrn3170; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Pertwee RG, 2012, PHILOS T R SOC B, V367, P3353, DOI 10.1098/rstb.2011.0381; Puighermanal E, 2013, NEUROPSYCHOPHARMACOL, V38, P1334, DOI 10.1038/npp.2013.31; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Specht CG, 2013, NEURON, V79, P308, DOI 10.1016/j.neuron.2013.05.013; Stott CG, 2013, EUR J CLIN PHARMACOL, V69, P1135, DOI 10.1007/s00228-012-1441-0; Tappe-Theodor A, 2007, J NEUROSCI, V27, P4165, DOI 10.1523/JNEUROSCI.5648-06.2007; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Varga C, 2012, P NATL ACAD SCI USA, V109, pE2726, DOI 10.1073/pnas.1210929109; Varvel SA, 2005, J PHARMACOL EXP THER, V314, P329, DOI 10.1124/jpet.104.080739; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Vida I, 1998, J PHYSIOL-LONDON, V506, P755, DOI 10.1111/j.1469-7793.1998.755bv.x; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Zhang LH, 2010, J NEUROSCI, V30, P5724, DOI 10.1523/JNEUROSCI.0795-10.2010; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	64	158	160	1	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2015	18	1					75	+		10.1038/nn.3892	http://dx.doi.org/10.1038/nn.3892			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX5WH	25485758	Green Accepted			2022-12-17	WOS:000346995000014
J	Li, SX; Huang, S; Bren, N; Noridomi, K; Dellisanti, CD; Sine, SM; Chen, L				Li, Shu-Xing; Huang, Sun; Bren, Nina; Noridomi, Kaori; Dellisanti, Cosma D.; Sine, Steven M.; Chen, Lin			Ligand-binding domain of an alpha(7)-nicotinic receptor chimera and its complex with agonist	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; X-RAY-STRUCTURE; CURARIFORM ANTAGONISTS; CRYSTAL-STRUCTURE; PROTEIN REVEALS; ALPHA-7 SUBUNIT; LOOP; MUTAGENESIS; PERMEATION	The alpha(7) acetylcholine receptor (AChR) mediates pre- and postsynaptic neurotransmission in the central nervous system and is a potential therapeutic target in neurodegenerative, neuropsychiatric and inflammatory disorders. We determined the crystal structure of the extracellular domain of a receptor chimera constructed from the human alpha(7) AChR and Lymnaea stagnalis acetylcholine binding protein (AChBP), which shares 64% sequence identity and 71% similarity with native alpha(7). We also determined the structure with bound epibatidine, a potent AChR agonist. Comparison of the structures revealed molecular rearrangements and interactions that mediate agonist recognition and early steps in signal transduction in alpha(7) AChRs. The structures further revealed a ring of negative charge within the central vestibule, poised to contribute to cation selectivity. Structure-guided mutational studies disclosed distinctive contributions to agonist recognition and signal transduction in alpha(7) AChRs. The structures provide a realistic template for structure-aided drug design and for defining structure-function relationships of alpha(7) AChRs.	[Li, Shu-Xing; Noridomi, Kaori; Dellisanti, Cosma D.; Chen, Lin] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Li, Shu-Xing; Noridomi, Kaori; Dellisanti, Cosma D.; Chen, Lin] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Huang, Sun; Bren, Nina; Sine, Steven M.] Mayo Clin, Dept Physiol & Biomed Engn, Coll Med, Rochester, MN USA; [Sine, Steven M.] Mayo Clin, Dept Neurol, Coll Med, Rochester, MN USA; [Chen, Lin] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; Mayo Clinic; Mayo Clinic; University of Southern California	Chen, L (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	sine@mayo.edu; linchen@usc.edu	Li, Shu-Xing/C-5370-2011; chen, Lin/A-3392-2008	chen, Lin/0000-0003-4798-6199; Noridomi, Kaori/0000-0002-4303-7511	US National Institutes of Health [NS031744, HL076334, GM064642]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031744, R37NS031744] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Advanced Light Source Berkeley Center for Structural Biology staff members C. Ralston, P. Zwart, C. Bertoldo, A. Rozales and K. Royal for help with data collection, N. Chelyapov and University of Southern California NanoBiophysics Core Facility for help with multi-angle light scattering analyses and P. Taylor for providing cDNA encoding AChBP. This work is supported by US National Institutes of Health grants NS031744 to S. M. S. and HL076334 and GM064642 to L.C.	Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; D'Andrea MR, 2006, CURR PHARM DESIGN, V12, P677, DOI 10.2174/138161206775474224; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; Gao F, 2003, J BIOL CHEM, V278, P23020, DOI 10.1074/jbc.M301151200; Gao F, 2006, MOL PHARMACOL, V70, P1230, DOI 10.1124/mol.106.027185; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Grosman C, 2000, J GEN PHYSIOL, V115, P637, DOI 10.1085/jgp.115.5.637; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; JONES DH, 1992, BIOTECHNIQUES, V12, P528; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Martin LF, 2004, PSYCHOPHARMACOLOGY, V174, P54, DOI 10.1007/s00213-003-1750-1; Metrangolo P, 2005, ACCOUNTS CHEM RES, V38, P386, DOI 10.1021/ar0400995; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Mukhtasimova N, 2007, J NEUROSCI, V27, P4110, DOI 10.1523/JNEUROSCI.0025-07.2007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SEGUELA P, 1993, J NEUROSCI, V13, P596; SINE SM, 1994, J BIOL CHEM, V269, P8808; Sine SM, 2002, J NEUROBIOL, V53, P431, DOI 10.1002/neu.10139; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200; Zouridakis M, 2009, BBA-PROTEINS PROTEOM, V1794, P355, DOI 10.1016/j.bbapap.2008.11.002	38	158	165	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1253	U173		10.1038/nn.2908	http://dx.doi.org/10.1038/nn.2908			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21909087	Green Accepted			2022-12-17	WOS:000295254200013
J	Bromberg-Martin, ES; Hikosaka, O				Bromberg-Martin, Ethan S.; Hikosaka, Okihide			Lateral habenula neurons signal errors in the prediction of reward information	NATURE NEUROSCIENCE			English	Article							MIDBRAIN DOPAMINE NEURONS; OBSERVING RESPONSES; STIMULATION; UNCERTAINTY; ACQUISITION; ENCODE; DECISIONS; CORTEX	Humans and animals have the ability to predict future events, which they cultivate by continuously searching their environment for sources of predictive information. However, little is known about the neural systems that motivate this behavior. We hypothesized that information-seeking is assigned value by the same circuits that support reward-seeking, such that neural signals encoding reward prediction errors (RPEs) include analogous information prediction errors (IPEs). To test this, we recorded from neurons in the lateral habenula, a nucleus that encodes RPEs, while monkeys chose between cues that provided different chances to view information about upcoming rewards. We found that a subpopulation of lateral habenula neurons transmitted signals resembling IPEs, responding when reward information was unexpectedly cued, delivered or denied. These signals evaluated information sources reliably, even when the monkey's decisions did not. These neurons could provide a common instructive signal for reward-seeking and information-seeking behavior.	[Bromberg-Martin, Ethan S.; Hikosaka, Okihide] NEI, Sensorimotor Res Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Bromberg-Martin, ES (corresponding author), NEI, Sensorimotor Res Lab, US Natl Inst Hlth, Bldg 10, Bethesda, MD 20892 USA.	bromberge@mail.nih.gov			National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000415] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank M. Matsumoto, S. Hong, I. Monosov, M. Yasuda, S. Yamamoto, Y. Tachibana, H. Kim and D. Lee for valuable discussions. This work was supported by the intramural research program at the National Eye Institute.	Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Beierholm U.R., 2010, PLOS COMPUT BIOL, V6, P9; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Bromberg-Martin ES, 2010, NEURON, V67, P499, DOI 10.1016/j.neuron.2010.06.031; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; Butko NJ, 2010, IEEE T AUTON MENT DE, V2, P91, DOI 10.1109/TAMD.2010.2051029; Caplin A, 2001, Q J ECON, V116, P55, DOI 10.1162/003355301556347; CHEW SH, 1994, J RISK UNCERTAINTY, V8, P267, DOI 10.1007/BF01064045; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; DALY HB, 1992, LEARNING AND MEMORY : THE BEHAVIORAL AND BIOLOGICAL SUBSTRATES, P81; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Eliaz K, 2007, AM ECON REV, V97, P166, DOI 10.1257/aer.97.2.166; Fantino E., 1977, HDB OPERANT BEHAV; Friedman A, 2011, NEUROPHARMACOLOGY, V60, P381, DOI 10.1016/j.neuropharm.2010.10.006; Hayden BY, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00166; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; Hong S, 2008, NEURON, V60, P720, DOI 10.1016/j.neuron.2008.09.035; Houk JC, 1995, MODELS INFORM PROCES, P249; Ikemoto S, 2010, NEUROSCI BIOBEHAV R, V35, P129, DOI 10.1016/j.neubiorev.2010.02.001; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Joshua M, 2009, CURR OPIN NEUROBIOL, V19, P615, DOI 10.1016/j.conb.2009.10.001; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; KREPS DM, 1978, ECONOMETRICA, V46, P185, DOI 10.2307/1913656; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; Luhmann CC, 2008, J NEUROSCI, V28, P14459, DOI 10.1523/JNEUROSCI.5058-08.2008; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Nakamura K, 2008, J NEUROSCI, V28, P5331, DOI 10.1523/JNEUROSCI.0021-08.2008; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Oyama K, 2010, J NEUROSCI, V30, P11447, DOI 10.1523/JNEUROSCI.1719-10.2010; Ranade SP, 2009, J NEUROPHYSIOL, V102, P3026, DOI 10.1152/jn.00507.2009; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Salas R, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00036; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Shumake J, 2010, J NEUROSCI, V30, P5876, DOI 10.1523/JNEUROSCI.3604-09.2010; SUTHERLAND RJ, 1981, J COMP PHYSIOL PSYCH, V95, P781, DOI 10.1037/h0077833; WARD EF, 1971, PSYCHON SCI, V24, P139, DOI 10.3758/BF03331790; WYCKOFF LB, 1952, PSYCHOL REV, V59, P431, DOI 10.1037/h0053932	50	158	158	0	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1209	U149		10.1038/nn.2902	http://dx.doi.org/10.1038/nn.2902			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21857659	Green Accepted			2022-12-17	WOS:000294284900023
J	Chadick, JZ; Gazzaley, A				Chadick, James Z.; Gazzaley, Adam			Differential coupling of visual cortex with default or frontal-parietal network based on goals	NATURE NEUROSCIENCE			English	Article							WORKING-MEMORY PERFORMANCE; TOP-DOWN MODULATION; FUNCTIONAL INTERACTIONS; COGNITIVE TASK; HUMAN BRAIN; SUPPRESSION; ATTENTION	The relationship between top-down enhancement and suppression of sensory cortical activity and large-scale neural networks remains unclear. Functional connectivity analysis of human functional magnetic resonance imaging data revealed that visual cortical areas that selectively process relevant information are functionally connected with the frontal-parietal network, whereas those that process irrelevant information are simultaneously coupled with the default network. This indicates that sensory cortical regions are differentially and dynamically coupled with distinct networks on the basis of task goals.	[Chadick, James Z.; Gazzaley, Adam] Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Neurol Physiol & Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Gazzaley, A (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Neurol Physiol & Psychiat, San Francisco, CA 94143 USA.	adam.gazzaley@ucsf.edu			US National Institutes of Health [5R01AG030395]; Larry L. Hillblom Center for the Biology of Aging; NATIONAL INSTITUTE ON AGING [R01AG030395] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Center for the Biology of Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank A. Rutman, M. Ruben, J.A. Anguera, E. Morsella and T. Zanto for their assistance. This work was supported by the grants from the US National Institutes of Health, including 5R01AG030395 (A.G.), and Larry L. Hillblom Center for the Biology of Aging Graduate Fellowship (J.Z.C.).	Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Gazzaley A, 2007, CEREB CORTEX, V17, pI125, DOI 10.1093/cercor/bhm113; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rissman J, 2009, NEUROPSYCHOLOGIA, V47, P1637, DOI 10.1016/j.neuropsychologia.2009.01.036; Rutman AM, 2010, J COGNITIVE NEUROSCI, V22, P1224, DOI 10.1162/jocn.2009.21257; Zanto TP, 2009, J NEUROSCI, V29, P3059, DOI 10.1523/JNEUROSCI.4621-08.2009	15	158	161	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					830	832		10.1038/nn.2823	http://dx.doi.org/10.1038/nn.2823			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21623362	Green Accepted			2022-12-17	WOS:000292081700009
J	Salazar, H; Llorente, I; Jara-Oseguera, A; Garcia-Villegas, R; Munari, M; Gordon, SE; Islas, LD; Rosenbaum, T				Salazar, Hector; Llorente, Itzel; Jara-Oseguera, Andres; Garcia-Villegas, Refugio; Munari, Mika; Gordon, Sharona E.; Islas, Leon D.; Rosenbaum, Tamara			A single N-terminal cysteine in TRPV1 determines activation by pungent compounds from onion and garlic	NATURE NEUROSCIENCE			English	Article							ION-CHANNEL; COVALENT MODIFICATION; CAPSAICIN RECEPTOR; VANILLOID RECEPTOR; ANKYRIN REPEATS; S-NITROSYLATION; TRPA1; CHEMISTRY; ALLIUM; PAIN	Some members of the transient receptor potential (TRP) family of cation channels mediate sensory responses to irritant substances. Although it is well known that TRPA1 channels are activated by pungent compounds found in garlic, onion, mustard and cinnamon extracts, activation of TRPV1 by these extracts remains controversial. Here we establish that TRPV1 is activated by pungent extracts from onion and garlic, as well as by allicin, the active compound in these preparations, and participates together with TRPA1 in the pain-related behavior induced by this compound. We found that in TRPV1 these agents act by covalent modification of cysteine residues. In contrast to TRPA1 channels, modification of a single cysteine located in the N-terminal region of TRPV1 was necessary and sufficient for all the effects we observed. Our findings point to a conserved mechanism of activation in TRP channels, which provides new insights into the molecular basis of noxious stimuli detection.	[Salazar, Hector; Llorente, Itzel; Jara-Oseguera, Andres; Rosenbaum, Tamara] Univ Nacl Autonoma Mexico, Dept Biofis, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Jara-Oseguera, Andres; Islas, Leon D.] Univ Nacl Autonoma Mexico, Dept Fisiol, Fac Med, Mexico City 04510, DF, Mexico; [Garcia-Villegas, Refugio] Estudios Avanzados Inst Politecn Nacl, Ctr Invest, Dept Fisiol Biofis & Neurosci, Mexico City 07360, DF, Mexico; [Munari, Mika; Gordon, Sharona E.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; CIO - Centro de Investigaciones en Optica A.C.; University of Washington; University of Washington Seattle	Rosenbaum, T (corresponding author), Univ Nacl Autonoma Mexico, Dept Biofis, Inst Fisiol Celular, Circuito Exterior S-N,Ciudad Univ, Mexico City 04510, DF, Mexico.	trosenba@ifc.unam.mx	Islas, Leon D/AAW-9845-2020	Islas, Leon D/0000-0002-7461-5214; Garcia-Villegas, Refugio/0000-0001-8468-6676; Jara Oseguera, Andres/0000-0001-5921-9320; Rosenbaum, Tamara/0000-0002-4791-3195	NATIONAL EYE INSTITUTE [R01EY017564] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY017564, R01 EY017564-04] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; BLOCK E, 1985, SCI AM, V252, P114, DOI 10.1038/scientificamerican0385-114; Block E, 1996, ADV EXP MED BIOL, V401, P155; CALVEY EM, 1994, J CHROMATOGR SCI, V32, P93, DOI 10.1093/chromsci/32.3.93; Calvey EM, 1998, PHYTOCHEMISTRY, V49, P359, DOI 10.1016/S0031-9422(98)00191-5; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Cortright DN, 2007, BBA-MOL BASIS DIS, V1772, P978, DOI 10.1016/j.bbadis.2007.03.003; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; JARA A, 2007, BIOPHYS J, V92, P3901; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Jones MG, 2004, J EXP BOT, V55, P1903, DOI 10.1093/jxb/erh138; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Matalon S, 2003, AM J PHYSIOL-LUNG C, V285, pL1184, DOI 10.1152/ajplung.00281.2003; Michels KB, 2002, ANN EPIDEMIOL, V12, P21, DOI 10.1016/S1047-2797(01)00238-1; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Susankova K, 2006, MOL PHARMACOL, V70, P383, DOI 10.1124/mol.106.023069; Szallasi A, 1999, PHARMACOL REV, V51, P159; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vyklicky L, 2002, NEUROSCIENCE, V111, P435, DOI 10.1016/S0306-4522(02)00051-9; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821	35	158	164	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					255	261		10.1038/nn2056	http://dx.doi.org/10.1038/nn2056			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18297068	Green Accepted			2022-12-17	WOS:000253548300007
J	Darcy, KJ; Staras, K; Collinson, LM; Goda, Y				Darcy, KJ; Staras, K; Collinson, LM; Goda, Y			Constitutive sharing of recycling synaptic vesicles between presynaptic boutons	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL-NEURONS; RELEASE; PLASTICITY; TRANSPORT; VISUALIZATION; TRANSMITTER; ENDOCYTOSIS; GLUTAMATE; MEMBRANE; TURNOVER	The synaptic vesicle cycle is vital for sustained neurotransmitter release. It has been assumed that functional synaptic vesicles are replenished autonomously at individual presynaptic terminals. Here we tested this assumption by using FM dyes in combination with fluorescence recovery after photobleaching and correlative light and electron microscopy in cultured rat hippocampal neurons. After photobleaching, synapses acquired recently recycled FM dye-labeled vesicles originating from nonphotobleached synapses by a process requiring dynamic actin turnover. The imported vesicles entered the functional pool at their host synapses, as revealed by the exocytic release of the dye upon stimulation. FM1-43 photoconversion and ultrastructural analysis confirmed the incorporation of imported vesicles into the presynaptic terminal, where they mixed with the native vesicle pools. Our results demonstrate that synaptic vesicle recycling is not confined to individual presynaptic terminals as is widely believed; rather, a substantial proportion of recycling vesicles are shared constitutively between boutons.	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, MRC, Cell Biol Unit, London WC1E 6BT, England; UCL, MRC, Mol Cell Biol Lab, Electron Microscopy Facil, London WC1E 6BT, England; UCL, Cell Biol Unit, London WC1E 6BT, England; Dept Pharmacol, Cell Biol Unit, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Goda, Y (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	y.goda@ucl.ac.uk	Goda, Yukiko/AAR-5641-2020; Goda, Yukiko/A-6576-2016	Goda, Yukiko/0000-0003-0352-9498; Goda, Yukiko/0000-0003-0352-9498; Staras, Kevin/0000-0003-4141-339X; Collinson, Lucy/0000-0003-0260-613X	MRC [MC_U122669937] Funding Source: UKRI; Medical Research Council [MC_U122669937] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmari SE, 2002, NEURON, V34, P333, DOI 10.1016/S0896-6273(02)00685-2; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; Bridgman PC, 2004, J NEUROBIOL, V58, P164, DOI 10.1002/neu.10320; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Henkel AW, 1996, J NEUROSCI, V16, P3960; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hiruma H, 2003, J NEUROSCI, V23, P8967; Hopf FW, 2002, J NEUROSCI, V22, P775, DOI 10.1523/JNEUROSCI.22-03-00775.2002; Jordan R, 2005, BIOPHYS J, V89, P2091, DOI 10.1529/biophysj.105.061663; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Kraszewski K, 1996, J NEUROSCI, V16, P5905; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Matteoli M, 2004, TRENDS CELL BIOL, V14, P133, DOI 10.1016/j.tcb.2004.01.007; Micheva KD, 2005, J NEUROSCI, V25, P7481, DOI 10.1523/JNEUROSCI.1801-05.2005; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Pennuto M, 2002, MOL BIOL CELL, V13, P2706, DOI 10.1091/mbc.E02-01-0036; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Shtrahman M, 2005, BIOPHYS J, V89, P3615, DOI 10.1529/biophysj.105.059295; STINCHCOMBE JC, 1995, J CELL BIOL, V131, P1387, DOI 10.1083/jcb.131.6.1387; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	42	158	161	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					315	321		10.1038/nn1640	http://dx.doi.org/10.1038/nn1640			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16462738				2022-12-17	WOS:000235645600010
J	Racz, B; Blanpied, TA; Ehlers, MD; Weinberg, RJ				Racz, B; Blanpied, TA; Ehlers, MD; Weinberg, RJ			Lateral organization of endocytic machinery in dendritic spines	NATURE NEUROSCIENCE			English	Article							SYNAPSES; AMPA; PLASTICITY; RECEPTORS; MEMBRANE	Postsynaptic membrane trafficking plays an important role in synaptic plasticity, but the organization of trafficking machinery within dendritic spines is poorly understood. We use immunocytochemical analysis of rat hippocampal neurons to show that proteins mediating endocytosis are systematically arrayed within dendritic spines, tangential to the synapse. Thus, previously unrecognized lateral domains of the spine organize endocytic protein machinery at sites removed from the postsynaptic density.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Neuroproteom Lab, Durham, NC 27710 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Duke University	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Rácz, Bence/J-4220-2019; Weinberg, Richard/AAC-1898-2020	Rácz, Bence/0000-0002-1933-5332; Blanpied, Thomas/0000-0003-4957-557X; Weinberg, Richard/0000-0001-9689-7278				Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; He Y, 2000, J COMP NEUROL, V418, P255; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Petralia RS, 2003, EUR J NEUROSCI, V18, P3207, DOI 10.1111/j.1460-9568.2003.03074.x; Segal M, 2002, PROG BRAIN RES, V138, P53, DOI 10.1016/S0079-6123(02)38070-1; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211	15	158	167	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					917	918		10.1038/nn1303	http://dx.doi.org/10.1038/nn1303			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15322548				2022-12-17	WOS:000223546700007
J	Otten, LJ; Henson, RNA; Rugg, MD				Otten, LJ; Henson, RNA; Rugg, MD			State-related and item-related neural correlates of successful memory encoding	NATURE NEUROSCIENCE			English	Article							RECOGNITION MEMORY; BRAIN ACTIVITY; ACQUISITION; PERFORMANCE; EXPERIENCE; RETRIEVAL; PREDICTS; TASK	Neuroimaging studies show that the efficacy of long-term memory encoding of a stimulus is indexed by transient neural activity elicited by that stimulus. Here, we show that successful memory encoding is also indexed by neural activity that is tonically maintained throughout a study task. Using functional magnetic resonance imaging (fMRI), transient and sustained neural activity were dissociated with a mixed event-related and blocked design. In a series of short task blocks, human subjects made semantic or phonological decisions about visually presented words. After statistically removing item-related activity, we found that the mean level of activity across a task block was correlated with the number of words subsequently remembered from that block. These correlations were found in inferior medial parietal and left prefrontal cortex for the semantic task, and in superior medial parietal cortex for the phonological task. Our findings suggest that state-related activity in these brain regions is involved in memory encoding.	Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Psychol, London WC1H 0AP, England; Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	University of London; University College London; University of London; University College London; University of London; University College London	Otten, LJ (corresponding author), Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	l.otten@ucl.ac.uk	Henson, Richard/H-8822-2019; Otten, Leun/C-6036-2008	Henson, Richard/0000-0002-0712-2639; 				Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Bernstein LJ, 2002, NEUROPSYCHOLOGIA, V40, P86, DOI 10.1016/S0028-3932(01)00070-7; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Buckner RL, 2001, J COGNITIVE NEUROSCI, V13, P406, DOI 10.1162/08989290151137430; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; Davachi L, 2001, J COGNITIVE NEUROSCI, V13, P1059, DOI 10.1162/089892901753294356; Donaldson DI, 2001, NEUROIMAGE, V13, P129, DOI 10.1006/nimg.2000.0664; Fernandez G, 1999, HIPPOCAMPUS, V9, P35, DOI 10.1002/(SICI)1098-1063(1999)9:1<35::AID-HIPO4>3.0.CO;2-Z; Fernandez G, 2001, BRAIN RES BULL, V55, P1, DOI 10.1016/S0361-9230(01)00494-4; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1997, TRENDS COGN SCI, V1, P21, DOI 10.1016/S1364-6613(97)01001-2; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Henson R, 2001, NEUROIMAGE, V13, pS149; Henson RNA, 1999, J NEUROSCI, V19, P3962; Holmes AP., 1998, NEUROIMAGE, V7, pS754, DOI DOI 10.1016/S1053-8119(18)31587-8; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Kuera H., 1967, COMPUTATIONAL ANAL P; Otten LJ, 2001, CEREB CORTEX, V11, P1150, DOI 10.1093/cercor/11.12.1150; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Otten LJ, 2001, CURR BIOL, V11, P1528, DOI 10.1016/S0960-9822(01)00454-7; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Pashler H, 2001, ANNU REV PSYCHOL, V52, P629, DOI 10.1146/annurev.psych.52.1.629; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Rosen BR, 1998, P NATL ACAD SCI USA, V95, P773, DOI 10.1073/pnas.95.3.773; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; RUGG MD, IN PRESS HDB MEMORY; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188	32	158	161	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1339	1344		10.1038/nn967	http://dx.doi.org/10.1038/nn967			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12402040				2022-12-17	WOS:000179447500018
J	King, M; Su, W; Chang, A; Zuckerman, A; Pasternak, GW				King, M; Su, W; Chang, A; Zuckerman, A; Pasternak, GW			Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs	NATURE NEUROSCIENCE			English	Article							TUMOR-NECROSIS-FACTOR; ANTISENSE OLIGODEOXYNUCLEOTIDES; MORPHINE ANALGESIA; D-PENICILLAMINE(2,5) ENKEPHALIN; ORPHANIN FQ/NOCICEPTIN; ENDOTHELIAL-CELLS; RECEPTOR MECHANISMS; BLOOD; BARRIER; EXPRESSION	Many peptides and transmitters found within the brain also have peripheral sites of action. We now demonstrate that the brain releases functionally active neurotransmitters/neuromodulators directly from the brain into the blood through a saturable P-glycoprotein (Pgp) transport system. Downregulating Pgp1 expression with antisense reduced the brain-to-blood transport of morphine, beta -endorphin and other opioids. Lowering Pgp expression significantly enhanced systemic morphine analgesia and prevented tolerance, but diminished the analgesic activity of centrally administered morphine, implying that supraspinal analgesia resulted from a combination of central and peripheral mechanisms activated by morphine transported from the brain to the blood. Similarly, mice with a disruption of the Mdr1a gene were more sensitive to systemic morphine and less sensitive to morphine given centrally. This ability of the Pgp transport system to pump functionally active compounds from the brain to periphery defines a potentially important mechanism for the central nervous system to modulate peripheral systems.	Mem Sloan Kettering Canc Ctr, Cotzias Lab Neurooncol, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Pasternak, GW (corresponding author), Mem Sloan Kettering Canc Ctr, Cotzias Lab Neurooncol, 1275 York Ave, New York, NY 10021 USA.				NCI NIH HHS [CA08748] Funding Source: Medline; NIDA NIH HHS [DA02615, DA07242, T32DA07274, DA00220] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007274, R01DA002615, R37DA007242, R01DA007242, R56DA002615] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aquilante CL, 1999, LIFE SCI, V66, pL47; BANKS WA, 1987, LIFE SCI, V41, P1319, DOI 10.1016/0024-3205(87)90606-0; Banks WA, 1996, LIFE SCI, V59, P1923, DOI 10.1016/S0024-3205(96)00380-3; BANKS WA, 1993, J NEUROSCI RES, V35, P690, DOI 10.1002/jnr.490350611; Beaulieu E, 1997, BIOCHEM J, V326, P539, DOI 10.1042/bj3260539; BODNAR RJ, 1989, CANCER RES, V49, P6280; Chen CP, 1999, PHARM RES-DORDR, V16, P296, DOI 10.1023/A:1018892811980; Chen CP, 1998, J PHARMACOL EXP THER, V287, P545; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Egleton RD, 1999, J PHARM SCI-US, V88, P392, DOI 10.1021/js980410+; Gao ZQ, 1998, ANTICANCER RES, V18, P3073; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Gottesman MM, 1995, ANNU REV GENET, V29, P607, DOI 10.1146/annurev.ge.29.120195.003135; HEGMANN EJ, 1992, CANCER RES, V52, P6969; Jonker JW, 1999, BRIT J PHARMACOL, V127, P43, DOI 10.1038/sj.bjp.0702497; King MA, 1997, NEUROSCI LETT, V223, P113, DOI 10.1016/S0304-3940(97)13414-0; Kolesnikov Y, 1999, J PHARMACOL EXP THER, V290, P247; Kolesnikov YA, 1999, EUR J PHARMACOL, V374, pR1, DOI 10.1016/S0014-2999(99)00318-0; Kolesnikov YA, 1996, J PHARMACOL EXP THER, V279, P502; Kolesnikov YA, 1997, P NATL ACAD SCI USA, V94, P8220, DOI 10.1073/pnas.94.15.8220; Letrent SP, 1999, DRUG METAB DISPOS, V27, P827; LING GSF, 1983, EUR J PHARMACOL, V86, P487; LING GSF, 1985, J PHARMACOL EXP THER, V232, P149; Mathis JP, 1997, BIOCHEM BIOPH RES CO, V230, P462, DOI 10.1006/bbrc.1996.5867; Motomura S, 1998, BLOOD, V91, P3163, DOI 10.1182/blood.V91.9.3163.3163_3163_3171; PAN YX, 1994, REGUL PEPTIDES, V54, P217, DOI 10.1016/0167-0115(94)90468-5; Pan YX, 1996, FEBS LETT, V395, P207; PAN YX, 1995, MOL PHARMACOL, V47, P1180; Pardridge WM, 1997, J NEUROCHEM, V68, P1278; Regina A, 1998, J NEUROCHEM, V71, P705; ROERIG SC, 1984, BRAIN RES, V308, P360, DOI 10.1016/0006-8993(84)91078-3; Rohde DS, 1997, NEUROSCIENCE, V80, P599, DOI 10.1016/S0306-4522(97)00096-1; Romero LI, 1996, AM J PHYSIOL-REG I, V270, pR518, DOI 10.1152/ajpregu.1996.270.3.R518; RONINSON IB, 1991, MOL CELLULAR BIOL MU, P189; Rossi GC, 1996, NEUROSCI LETT, V216, P1; ROSSI GC, 1993, BRAIN RES, V624, P171, DOI 10.1016/0006-8993(93)90075-X; Rossi GC, 1997, J PHARMACOL EXP THER, V282, P858; ROSSI GC, 1994, BRAIN RES, V665, P85, DOI 10.1016/0006-8993(94)91155-X; SCHINKEL AH, 1995, EUR J CANCER, V31A, P1295, DOI 10.1016/0959-8049(95)00130-B; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; SCHINKEL AH, 1996, J CLIN INVEST, V97, P25617; STANDIFER KM, 1994, NEURON, V12, P805, DOI 10.1016/0896-6273(94)90333-6; Standifer KM, 1996, MOL PHARMACOL, V50, P293; STANDIFER KM, 1995, J NEUROCHEM, V65, P1981; TALLARIDA RJ, 1987, MANUAL PHARM CALCULA; TATSUTA T, 1992, J BIOL CHEM, V267, P20383; Thompson SJ, 2000, ANESTHESIOLOGY, V92, P1392, DOI 10.1097/00000542-200005000-00030; Wang LW, 1998, J PHYSIOL-LONDON, V511, P33, DOI 10.1111/j.1469-7793.1998.033bi.x; Xie RJ, 1999, BRIT J PHARMACOL, V128, P563, DOI 10.1038/sj.bjp.0702804	50	158	165	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					268	274		10.1038/85115	http://dx.doi.org/10.1038/85115			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224543				2022-12-17	WOS:000167178300014
J	Vanderhaeghen, P; Lu, Q; Prakash, N; Frisen, J; Walsh, CA; Frostig, RD; Flanagan, JG				Vanderhaeghen, P; Lu, Q; Prakash, N; Frisen, J; Walsh, CA; Frostig, RD; Flanagan, JG			A mapping label required for normal scale of body representation in the cortex	NATURE NEUROSCIENCE			English	Article							RECEPTOR TYROSINE KINASES; RETINAL AXON GUIDANCE; SOMATOSENSORY CORTEX; CEREBRAL-CORTEX; VISUAL-CORTEX; SYNAPTIC PLASTICITY; CORTICAL CIRCUITS; CRITICAL PERIOD; BARREL CORTEX; IN-VITRO	The neocortical primary somatosensory area (S1) consists of a map of the body surface. The cortical area devoted to different regions, such as parts of the face or hands, reflects their functional importance. Here we investigated the role of genetically determined positional labels in neocortical mapping. Ephrin-A5 was expressed in a medial > lateral gradient across S1, whereas its receptor EphA4 was in a matching gradient across the thalamic ventrobasal (VB) complex, which provides S1 input. Ephrin-A5 had topographically specific effects on VB axon guidance in vitro. Ephrin-A5 gene disruption caused graded, topographically specific distortion in the S1 body map, with medial regions contracted and lateral regions expanded, changing relative areas up to 50% in developing and adult mice. These results provide evidence for within-area thalamocortical mapping labels and show that a genetic difference can cause a lasting change in relative scale of different regions within a topographic map.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA; Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Beth Israel Deaconess Med Ctr, Dept Neurol, Div Neurogenet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California Irvine; University of California System; University of California Irvine; Karolinska Institutet; Harvard University; Beth Israel Deaconess Medical Center	Flanagan, JG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.		Flanagan, John/AAM-2995-2020	Vanderhaeghen, Pierre/0000-0001-7899-5720; Prakash, Neal/0000-0003-0288-6573				AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Castellani V, 1998, J NEUROSCI, V18, P4663; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CHIAIA NL, 1992, J NEUROSCI, V12, P62; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Donoghue MJ, 1999, J NEUROSCI, V19, P5967, DOI 10.1523/JNEUROSCI.19-14-05967.1999; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gao PP, 1998, P NATL ACAD SCI USA, V95, P5329, DOI 10.1073/pnas.95.9.5329; Gao WQ, 1998, MOL CELL NEUROSCI, V11, P247, DOI 10.1006/mcne.1998.0696; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Howe MJA, 1998, BEHAV BRAIN SCI, V21, P399, DOI 10.1017/S0140525X9800123X; Hubel DH, 1998, NEURON, V20, P401, DOI 10.1016/S0896-6273(00)80984-8; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; Kaas Jon H., 1995, P51; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KILLACKEY HP, 1995, TRENDS NEUROSCI, V18, P402, DOI 10.1016/0166-2236(95)93937-S; KILLACKEY HP, 1994, J NEUROSCI, V14, P1496, DOI 10.1523/JNEUROSCI.14-03-01496.1994; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; MCCASLAND JS, 1992, P NATL ACAD SCI USA, V89, P1832, DOI 10.1073/pnas.89.5.1832; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; MOLNAR Z, 1991, NATURE, V351, P475, DOI 10.1038/351475a0; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; Paxinos G, 1995, RAT NERVOUS SYSTEM; Penfield W, 1950, CEREBRAL CORTEX MAN, DOI DOI 10.1001/JAMA.1950.02920160086033; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RENEHAN WE, 1994, J NEUROSCI, V14, P721; RIDDLE DR, 1995, J NEUROSCI, V15, P4184; ROE AW, 1990, SCIENCE, V250, P818, DOI 10.1126/science.2237432; SCHLAGGAR BL, 1993, DEV BRAIN RES, V75, P19, DOI 10.1016/0165-3806(93)90061-E; SCHLAGGAR BL, 1991, SCIENCE, V252, P1556, DOI 10.1126/science.2047863; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; WALTER J, 1987, DEVELOPMENT, V101, P909; WELKER E, 1986, EXP BRAIN RES, V63, P650, DOI 10.1007/BF00237487; WHITE LE, 1994, NATURE, V368, P197, DOI 10.1038/368197a0; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Woolsey CN, 1958, BIOL BIOCH BASES BEH, P63	50	158	160	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					358	365		10.1038/73929	http://dx.doi.org/10.1038/73929			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725925				2022-12-17	WOS:000087945400016
J	Kirov, SA; Harris, KM				Kirov, SA; Harris, KM			Dendrites are more spiny on mature hippocampal neurons when synapses are inactivated	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; METHYL-D-ASPARTATE; PYRAMIDAL CELLS; SLICE CULTURES; NERVOUS-SYSTEM; AREA CA1; DENSITY; ACTIN; PLASTICITY; STABILITY	Dendrites of CA1 pyramidal neurons in mature rat hippocampal slices were exposed to different levels of synaptic activation. In some slices, synaptic transmission was blocked with glutamate receptor antagonists, sodium and calcium channel blockers and/or a nominally calcium-free medium with high magnesium. In other slices, synapses were activated with low-frequency control stimulation or repeated tetanic stimulation. In slices with blocked synaptic transmission, dendrites were spinier than in either of the activated states. Thus, mature neurons can increase their numbers of spines, possibly compensating for lost synaptic activity.	Childrens Hosp, Dept Neurol, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Harris, KM (corresponding author), Childrens Hosp, Dept Neurol, Div Neurosci, Enders 260,300 Longwood Ave, Boston, MA 02115 USA.	harrisk@hub.tch.harvard.edu		Harris, Kristen/0000-0002-1943-4744	NIMH NIH HHS [MH/DA57351] Funding Source: Medline; NINDS NIH HHS [NS21184, NS33574] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS021184, R01NS021184, R23NS021184, R01NS033574] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andersen P, 1998, BRAIN RES REV, V26, P353, DOI 10.1016/S0165-0173(97)00042-8; ANNIS CM, 1994, J NEUROBIOL, V25, P1483, DOI 10.1002/neu.480251202; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; Bravin M, 1999, P NATL ACAD SCI USA, V96, P1704, DOI 10.1073/pnas.96.4.1704; CHANG FLF, 1982, BRAIN RES, V232, P283, DOI 10.1016/0006-8993(82)90274-8; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Collin C, 1997, J NEUROPHYSIOL, V77, P1614, DOI 10.1152/jn.1997.77.3.1614; Dailey ME, 1996, J NEUROSCI, V16, P2983; DALVA MB, 1994, J NEUROSCI, V14, P3588; Drakew A, 1996, NEUROSCIENCE, V70, P31, DOI 10.1016/0306-4522(95)00379-W; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; FIFKOVA E, 1985, BRAIN RES REV, V9, P187, DOI 10.1016/0165-0173(85)90012-8; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; GOULD E, 1990, J NEUROSCI, V10, P1286; GRAY EG, 1959, J ANAT, V93, P420; GREENOUGH WT, 1988, TRENDS NEUROSCI, V11, P142, DOI 10.1016/0166-2236(88)90139-7; HAAS HL, 1984, J PHYSIOL-LONDON, V354, P185, DOI 10.1113/jphysiol.1984.sp015371; Halpain S, 1998, J NEUROSCI, V18, P9835; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HORNER CH, 1993, PROG NEUROBIOL, V41, P281, DOI 10.1016/0301-0082(93)90002-A; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; JENSEN FE, 1989, J NEUROSCI METH, V29, P217, DOI 10.1016/0165-0270(89)90146-5; Jiang MH, 1998, J NEUROSCI, V18, P8356; Kirov SA, 1999, J NEUROSCI, V19, P2876; Kossel AH, 1997, J NEUROSCI, V17, P9634; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; MULLER M, 1993, P NATL ACAD SCI USA, V90, P257, DOI 10.1073/pnas.90.1.257; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; PAPA M, 1995, J NEUROSCI, V15, P1; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; Paul L A, 1986, Adv Neurol, V44, P775; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; ROCHA M, 1995, P NATL ACAD SCI USA, V92, P8026, DOI 10.1073/pnas.92.17.8026; RUSAKOV DA, 1995, J NEUROSCI METH, V60, P11, DOI 10.1016/0165-0270(94)00215-3; SEGAL M, 1995, NEUROSCI LETT, V193, P73, DOI 10.1016/0304-3940(95)11665-J; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Sorra KE, 1998, J NEUROSCI, V18, P658; TAYLOR CP, 1982, SCIENCE, V218, P810, DOI 10.1126/science.7134978; TROMMALD M, 1995, J COMP NEUROL, V353, P260, DOI 10.1002/cne.903530208; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035, DOI 10.1523/JNEUROSCI.10-12-04035.1990	50	158	160	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					878	883		10.1038/13178	http://dx.doi.org/10.1038/13178			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FE	10491607				2022-12-17	WOS:000083883200012
J	Busche, MA; Wegmann, S; Dujardin, S; Commins, C; Schiantarelli, J; Klickstein, N; Kamath, T; Carlson, G; Nelken, I; Hyman, BT				Busche, Marc Aurel; Wegmann, Susanne; Dujardin, Simon; Commins, Caitlin; Schiantarelli, Julia; Klickstein, Naomi; Kamath, Tarunv; Carlson, Georgea; Nelken, Israel; Hyman, Bradley T.			Tau impairs neural circuits, dominating amyloid-beta effects, in Alzheimer models in vivo	NATURE NEUROSCIENCE			English	Article							TRANSGENIC MICE; NEUROFIBRILLARY TANGLES; MOUSE MODEL; ENTORHINAL CORTEX; A-BETA; DISEASE; PLAQUES; MEMORY; DYSFUNCTION; REDUCTION	The coexistence of amyloid-beta (A beta) plaques and tau neurofibrillary tangles in the neocortex is linked to neural system failure and cognitive decline in Alzheimer's disease. However, the underlying neuronal mechanisms are unknown. By employing in vivo two-photon Ca2+ imaging of layer 2/3 cortical neurons in mice expressing human A beta and tau, we reveal a dramatic tau-dependent suppression of activity and silencing of many neurons, which dominates over A beta-dependent neuronal hyperactivity. We show that neurofibrillary tangles are neither sufficient nor required for the silencing, which instead is dependent on soluble tau. Surprisingly, although rapidly effective in tau mice, suppression of tau gene expression was much less effective in rescuing neuronal impairments in mice containing both A beta and tau. Together, our results reveal how A beta and tau synergize to impair the functional integrity of neural circuits in vivo and suggest a possible cellular explanation contributing to disappointing results from anti-A beta therapeutic trials.	[Busche, Marc Aurel; Wegmann, Susanne; Dujardin, Simon; Commins, Caitlin; Schiantarelli, Julia; Klickstein, Naomi; Kamath, Tarunv; Hyman, Bradley T.] Harvard Med Sch, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; [Busche, Marc Aurel] UCL, UK Dementia Res Inst, London, England; [Wegmann, Susanne] German Ctr Neurodegenerat Dis DZNE, Berlin, Germany; [Carlson, Georgea] McLaughlin Res Inst Biomed Sci, Great Falls, MT USA; [Nelken, Israel] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Neurobiol, Jerusalem, Israel; [Nelken, Israel] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel	Harvard University; Massachusetts General Hospital; University of London; University College London; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); McLaughlin Research Institute for Biomedical Sciences, Inc.; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Busche, MA; Hyman, BT (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA.; Busche, MA (corresponding author), UCL, UK Dementia Res Inst, London, England.	m.busche@ucl.ac.uk; bhyman@mgh.harvard.edu	Nelken, Israel/B-7753-2011; Dujardin, Simon/ABA-1796-2020	Nelken, Israel/0000-0002-6645-107X; Busche, Marc Aurel/0000-0002-4416-7553; Kamath, Tarun/0000-0002-6148-6433; Dujardin, Simon/0000-0002-5614-341X; Schiantarelli, Julia/0000-0001-5705-1309	EMBO Long-Term Fellowship [ALTF 590-2016]; Alzheimer Forschung Initiative; UK Dementia Research Institute; ERC [340063]; Massachusetts Alzheimer's Disease Research Center [P50AG005134]; JPB foundation; National Institutes of Health [1R01AG0586741]; Tau Consortium; MRC [UKDRI-1010] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [P50AG005134, RF1AG058674] Funding Source: NIH RePORTER	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Alzheimer Forschung Initiative; UK Dementia Research Institute; ERC(European Research Council (ERC)European Commission); Massachusetts Alzheimer's Disease Research Center; JPB foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tau Consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A.B. Robbins, D.L. Corjuc, A.D. Roe, and E. Hudry for their excellent technical support, and all members of the Hyman laboratory for providing comments and advice throughout the project. We thank Matthias Staufenbiel for helpful discussions and experimental suggestions. We acknowledge the Genetically-Encoded Neuronal Indicator and Effector (GENIE) project and the Janelia Research Campus of the Howard Hughes Medical Institute and specifically V. Jayaraman, R.A. Kerr, D.S. Kim, L.L. Looger, and K. Svoboda from the GENIE Project, Janelia Research Campus, Howard Hughes Medical Institute for making AAV.Syn.GCaMP6f publicly available. We thank Dr P. Davies for kindly providing the PHF1 and Alz50 antibodies. We thank the following funding agencies for their support: M.A.B. was supported by an EMBO Long-Term Fellowship (grant no. ALTF 590-2016), the Alzheimer Forschung Initiative, and the UK Dementia Research Institute. I.N. was supported by an advanced ERC grant (project RATLAND; grant no. 340063). B.T.H. received support from the Massachusetts Alzheimer's Disease Research Center (grant no. P50AG005134), the JPB foundation, the National Institutes of Health (grant no. 1R01AG0586741), and the Tau Consortium.	Alexander GE, 2002, AM J PSYCHIAT, V159, P738, DOI 10.1176/appi.ajp.159.5.738; Angulo SL, 2017, NEUROBIOL DIS, V108, P261, DOI 10.1016/j.nbd.2017.08.015; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Bennett RE, 2017, AM J PATHOL, V187, P1601, DOI 10.1016/j.ajpath.2017.03.011; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bradley KM, 2002, BRAIN, V125, P1772, DOI 10.1093/brain/awf185; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Busche MA, 2015, NAT NEUROSCI, V18, P1725, DOI 10.1038/nn.4163; Castillo-Carranza DL, 2014, J NEUROSCI, V34, P4260, DOI 10.1523/JNEUROSCI.3192-13.2014; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; Devos SL, 2013, J NEUROSCI, V33, P12887, DOI 10.1523/JNEUROSCI.2107-13.2013; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Froudarakis E, 2014, NAT NEUROSCI, V17, P851, DOI 10.1038/nn.3707; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Grienberger C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1783; Hatch RJ, 2017, ACTA NEUROPATHOL, V133, P717, DOI 10.1007/s00401-017-1674-1; He ZH, 2018, NAT MED, V24, P29, DOI 10.1038/nm.4443; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hurtado DE, 2010, AM J PATHOL, V177, P1977, DOI 10.2353/ajpath.2010.100346; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jackson RJ, 2016, EUR J NEUROSCI, V44, P3056, DOI 10.1111/ejn.13442; Jacobs HIL, 2018, NAT NEUROSCI, V21, P424, DOI 10.1038/s41593-018-0070-z; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jelic V, 1997, J NEUROL NEUROSUR PS, V63, P59, DOI 10.1136/jnnp.63.1.59; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Keskin AD, 2017, P NATL ACAD SCI USA, V114, P8631, DOI 10.1073/pnas.1708106114; Khan UA, 2014, NAT NEUROSCI, V17, P304, DOI 10.1038/nn.3606; Kuchibhotla KV, 2014, P NATL ACAD SCI USA, V111, P510, DOI 10.1073/pnas.1318807111; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Menkes-Caspi N, 2015, NEURON, V85, P959, DOI 10.1016/j.neuron.2015.01.025; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Pontecorvo MJ, 2017, BRAIN, V140, P748, DOI 10.1093/brain/aww334; Quiroz YT, 2018, JAMA NEUROL, V75, P548, DOI 10.1001/jamaneurol.2017.4907; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rudinskiy N, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-63; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Scholl M, 2016, NEURON, V89, P971, DOI 10.1016/j.neuron.2016.01.028; Silverman DHS, 2001, JAMA-J AM MED ASSOC, V286, P2120, DOI 10.1001/jama.286.17.2120; Sydow A, 2011, J NEUROSCI, V31, P2511, DOI 10.1523/JNEUROSCI.5245-10.2011; Van der Jeugd A, 2012, ACTA NEUROPATHOL, V123, P787, DOI 10.1007/s00401-012-0987-3; Wang L, 2016, JAMA NEUROL, V73, P1070, DOI 10.1001/jamaneurol.2016.2078; Zott B, 2018, ANNU REV NEUROSCI, V41, P277, DOI 10.1146/annurev-neuro-080317-061725	53	157	159	3	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2019	22	1					57	+		10.1038/s41593-018-0289-8	http://dx.doi.org/10.1038/s41593-018-0289-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE5CJ	30559471	Green Accepted			2022-12-17	WOS:000453388700009
J	Jaffe, AE; Straub, RE; Shin, JH; Tao, R; Gao, Y; Collado-Torres, L; Kam-Thong, T; Xi, HLS; Quan, J; Chen, Q; Colantuoni, C; Ulrich, WS; Maher, BJ; Deep-Soboslay, A; Cross, AJ; Brandon, NJ; Leek, JT; Hyde, TM; Kleinman, JE; Weinberger, DR				Jaffe, Andrew E.; Straub, Richard E.; Shin, Joo Heon; Tao, Ran; Gao, Yuan; Collado-Torres, Leonardo; Kam-Thong, Tony; Xi, Hualin S.; Quan, Jie; Chen, Qiang; Colantuoni, Carlo; Ulrich, William S.; Maher, Brady J.; Deep-Soboslay, Amy; Cross, Alan J.; Brandon, Nicholas J.; Leek, Jeffrey T.; Hyde, Thomas M.; Kleinman, Joel E.; Weinberger, Daniel R.		BrainSeq Consortium	Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; RNA-SEQ; EXPRESSION ANALYSIS; DNA METHYLATION; R PACKAGE; DISEASE; RISK; ASSOCIATION; INSIGHTS; LOCI	Genome-wide association studies have identified 108 schizophrenia risk loci, but biological mechanisms for individual loci are largely unknown. Using developmental, genetic and illness-based RNA sequencing expression analysis in human brain, we characterized the human brain transcriptome around these loci and found enrichment for developmentally regulated genes with novel examples of shifting isoform usage across pre- and postnatal life. We found widespread expression quantitative trait loci (eQTLs), including many with transcript specificity and previously unannotated sequence that were independently replicated. We leveraged this general eQTL database to show that 48.1% of risk variants for schizophrenia associate with nearby expression. We lastly found 237 genes significantly differentially expressed between patients and controls, which replicated in an independent dataset, implicated synaptic processes, and were strongly regulated in early development. These findings together offer genetics-and diagnosis-related targets for better modeling of schizophrenia risk. This resource is publicly available at http://eqtl.brainseq.org/phase1.	[Jaffe, Andrew E.; Straub, Richard E.; Shin, Joo Heon; Tao, Ran; Gao, Yuan; Collado-Torres, Leonardo; Chen, Qiang; Colantuoni, Carlo; Ulrich, William S.; Maher, Brady J.; Deep-Soboslay, Amy; Hyde, Thomas M.; Kleinman, Joel E.; Weinberger, Daniel R.] Johns Hopkins Med Campus, Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Jaffe, Andrew E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA; [Jaffe, Andrew E.; Collado-Torres, Leonardo; Leek, Jeffrey T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Jaffe, Andrew E.; Collado-Torres, Leonardo; Leek, Jeffrey T.] Johns Hopkins Univ, Ctr Computat Biol, Baltimore, MD 21218 USA; [Jaffe, Andrew E.; Weinberger, Daniel R.] Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Jaffe, Andrew E.; Maher, Brady J.; Hyde, Thomas M.; Kleinman, Joel E.; Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Kam-Thong, Tony] F Hoffmann La Roche Ltd, Roche Pharma Res & Early Dev, Roche Innovat Ctr Basel, Pharmaceut Sci, Basel, Switzerland; [Xi, Hualin S.; Quan, Jie] Pfizer Inc, Computat Sci, Cambridge, MA USA; [Colantuoni, Carlo; Hyde, Thomas M.; Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Colantuoni, Carlo; Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Cross, Alan J.; Brandon, Nicholas J.] AstraZeneca, IMED Biotech Unit, Neurosci, Boston, MA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Roche Holding; Pfizer; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; AstraZeneca	Jaffe, AE; Weinberger, DR (corresponding author), Johns Hopkins Med Campus, Lieber Inst Brain Dev, Baltimore, MD 21205 USA.; Jaffe, AE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA.; Jaffe, AE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA.; Jaffe, AE (corresponding author), Johns Hopkins Univ, Ctr Computat Biol, Baltimore, MD 21218 USA.; Jaffe, AE; Weinberger, DR (corresponding author), Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.; Jaffe, AE; Weinberger, DR (corresponding author), Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.; Weinberger, DR (corresponding author), Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Weinberger, DR (corresponding author), Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	andrew.jaffe@libd.org; drweinberger@libd.org	chen, qiang/HGU-5418-2022; chen, qiang/GWZ-7308-2022; Maher, Brady/GPC-8697-2022; Jaffe, Andrew/GPF-5693-2022; Cross, Alan J/L-5456-2016	Jaffe, Andrew/0000-0001-6886-1454; Cross, Alan J/0000-0002-2992-2258; Colantuoni, Carlo/0000-0001-6818-6380; Collado-Torres, Leonardo/0000-0003-2140-308X; Brandon, Nicholas/0000-0002-3917-0096	Lieber Institute for Brain Development; Maltz Research Laboratories; NIH [R21MH109956]; Consejo Nacional de Ciencia y Tecnologia Mexico [351535]; Common Fund of the Office of the Director of the National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS; NCI/SAIC-Frederick, Inc. (SAIC-F) subcontracts [10X5170, 10X5171, X105172]; Laboratory, Data Analysis, and Coordinating Center (LDACC) [HHSN268201000029C]; SAIC-F subcontract [105T1035]; SAIC-F [HHSN261200800001E]; Takeda Pharmaceuticals Company Limited; F. Hoffman-La Roche Ltd; NIH grants [R01MH085542, R01MH093725, P50MH066392, P50MH080405, R01MH097276, R01-MH-075916, P50M096891, P50MH08405351, R37MH057881, R37MH05788151, HHSN271201300031C, AG02219, AG05138, MH06692];  [DA006227];  [DA033684];  [N01MH000028];  [MH090941];  [MH101814];  [MH090951];  [MH090937];  [MH101820];  [MH101825];  [MH090936];  [MH101819];  [MH090948];  [MH101782];  [MH101810];  [MH101822]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH109956, R01MH075916, R01MH101814, R37MH057881, R01MH101782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005138] Funding Source: NIH RePORTER	Lieber Institute for Brain Development; Maltz Research Laboratories; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tecnologia Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Common Fund of the Office of the Director of the National Institutes of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI/SAIC-Frederick, Inc. (SAIC-F) subcontracts; Laboratory, Data Analysis, and Coordinating Center (LDACC); SAIC-F subcontract; SAIC-F; Takeda Pharmaceuticals Company Limited; F. Hoffman-La Roche Ltd; NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Zielke, R. D. Vigorito and R. M. Johnson of the National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland for providing fetal, child and adolescent brain specimens. This work was supported by the funding from Lieber Institute for Brain Development and the Maltz Research Laboratories and partially supported by NIH R21MH109956 (A.E.J.) and Consejo Nacional de Ciencia y Tecnologia Mexico 351535 (L.C.-T.). The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health. Additional funds were provided by the NCI, NHGRI, NHLBI, NIDA, NIMH and NINDS. Donors were enrolled at Biospecimen Source Sites funded by NCI/SAIC-Frederick, Inc. (SAIC-F) subcontracts to the National Disease Research Interchange (10X5170), Roswell Park Cancer Institute (10X5171) and Science Care, Inc. (X105172). The Laboratory, Data Analysis, and Coordinating Center (LDACC) was funded through a contract (HHSN268201000029C) to The Broad Institute, Inc. Biorepository operations were funded through an SAIC-F subcontract to the Van Andel Institute (105T1035). Additional data repository and project management were provided by SAIC-F (HHSN261200800001E). The Brain Bank was supported by supplements to University of Miami grants DA006227 and DA033684 and to contract N01MH000028. Statistical methods development grants were made to the University of Geneva (MH090941 and MH101814), the University of Chicago (MH090951, MH090937, MH101820, MH101825), the University of North Carolina - Chapel Hill (MH090936 and MH101819), Harvard University (MH090948), Stanford University (MH101782), Washington University St Louis (MH101810) and the University of Pennsylvania (MH101822). The data used for the analyses described in this manuscript were obtained from dbGaP accession number phs000424.v6.p1 on October 6, 2015. Data were generated as part of the CommonMind Consortium supported by funding from Takeda Pharmaceuticals Company Limited, F. Hoffman-La Roche Ltd and NIH grants R01MH085542, R01MH093725, P50MH066392, P50MH080405, R01MH097276, R01-MH-075916, P50M096891, P50MH08405351, R37MH057881, R37MH05788151, HHSN271201300031C, AG02219, AG05138 and MH06692. Brain tissue for the study was obtained from the following brain bank collections: the Mount Sinai NIH Brain and Tissue Repository, the University of Pennsylvania Alzheimer's Disease Core Center, the University of Pittsburgh NeuroBioBank and Brain and Tissue Repositories and the NIMH Human Brain Collection Core. CMC leadership: Pamela Sklar and Joseph Buxbaum (Icahn School of Medicine at Mount Sinai), Bernie Devlin and David Lewis (University of Pittsburgh), Raquel Gur and Chang-Gyu Hahn (University of Pennsylvania), Keisuke Hirai and Hiroyoshi Toyoshiba (Takeda Pharmaceuticals Company Limited), Enrico Domenici and Laurent Essioux (F. Hoffman-La Roche Ltd), Lara Mangravite and Mette Peters (Sage Bionetworks), and Thomas Lehner and Barbara Lipska (NIMH).	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Birnbaum R, 2017, NAT REV NEUROSCI, V18, P727, DOI 10.1038/nrn.2017.125; Birnbaum R, 2014, AM J PSYCHIAT, V171, P758, DOI 10.1176/appi.ajp.2014.13111452; Brainspan, 2011, ATL DEV HUM BRAIN; BUCHANAN RW, 1994, J NERV MENT DIS, V182, P193, DOI 10.1097/00005053-199404000-00001; BUJA A, 1992, MULTIVAR BEHAV RES, V27, P509, DOI 10.1207/s15327906mbr2704_2; Collado-Torres L, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw852; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Delaneau O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-540; Frazee AC, 2015, NAT BIOTECHNOL, V33, P243, DOI 10.1038/nbt.3172; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hyde TM, 2011, J NEUROSCI, V31, P11088, DOI 10.1523/JNEUROSCI.1234-11.2011; Jaffe AE, 2017, P NATL ACAD SCI USA, V114, P7130, DOI 10.1073/pnas.1617384114; Jaffe AE, 2016, NAT NEUROSCI, V19, P40, DOI 10.1038/nn.4181; Jaffe AE, 2015, NAT NEUROSCI, V18, P154, DOI 10.1038/nn.3898; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Kao WT, 2010, P NATL ACAD SCI USA, V107, P15619, DOI 10.1073/pnas.1005410107; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li YI, 2016, SCIENCE, V352, P600, DOI 10.1126/science.aad9417; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nellore A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1118-6; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pohl A, 2014, BIOINFORMATICS, V30, P1618, DOI 10.1093/bioinformatics/btu056; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramu A., 2016, REGTOOLS V 0 1 0; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Scharpf RB, 2011, J STAT SOFTW, V40, P1; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027/MACHINEREADABLECITATION/RIS]; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Stouffer S.A., 1949, THE AM SOLDIER, V1; Tan W, 2007, J BIOL CHEM, V282, P24343, DOI 10.1074/jbc.M702953200; Tao R, 2014, JAMA PSYCHIAT, V71, P1112, DOI 10.1001/jamapsychiatry.2014.1079; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tyner C, 2017, NUCLEIC ACIDS RES, V45, pD626, DOI 10.1093/nar/gkw1134; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Weinberger DR, 2011, SCHIZOPHRENIA, P393; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	49	157	160	3	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2018	21	8					1117	+		10.1038/s41593-018-0197-y	http://dx.doi.org/10.1038/s41593-018-0197-y			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO3BK	30050107	Green Accepted, Green Submitted			2022-12-17	WOS:000439859000014
J	Wang, J; Narain, D; Hosseini, EA; Jazayeri, M				Wang, Jing; Narain, Devika; Hosseini, Eghbal A.; Jazayeri, Mehrdad			Flexible timing by temporal scaling of cortical responses	NATURE NEUROSCIENCE			English	Article							SUPPLEMENTARY EYE FIELD; SCALAR EXPECTANCY-THEORY; PREFRONTAL CORTEX; NEURONAL-ACTIVITY; ELECTRICAL-STIMULATION; INTERNAL CLOCK; NEURAL-NETWORK; BASAL GANGLIA; TIME; INTERVAL	Musicians can perform at different tempos, speakers can control the cadence of their speech, and children can flexibly vary their temporal expectations of events. To understand the neural basis of such flexibility, we recorded from the medial frontal cortex of nonhuman primates trained to produce different time intervals with different effectors. Neural responses were heterogeneous, nonlinear, and complex, and they exhibited a remarkable form of temporal invariance: firing rate profiles were temporally scaled to match the produced intervals. Recording from downstream neurons in the caudate and from thalamic neurons projecting to the medial frontal cortex indicated that this phenomenon originates within cortical networks. Recurrent neural network models trained to perform the task revealed that temporal scaling emerges from nonlinearities in the network and that the degree of scaling is controlled by the strength of external input. These findings demonstrate a simple and general mechanism for conferring temporal flexibility upon sensorimotor and cognitive functions.	[Wang, Jing; Narain, Devika; Jazayeri, Mehrdad] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Wang, Jing; Narain, Devika; Hosseini, Eghbal A.; Jazayeri, Mehrdad] MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Narain, Devika] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Narain, Devika] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Erasmus University Rotterdam; Erasmus MC	Jazayeri, M (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Jazayeri, M (corresponding author), MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mjaz@mit.edu	Hosseini, Eghbal/ABG-3273-2020	Hosseini, Eghbal/0000-0002-0088-9765; Narain, Devika/0000-0001-7249-1273; Wang, Jing/0000-0002-4761-6748; Jazayeri, Mehrdad/0000-0002-9764-6961	Netherlands Scientific Organization (NWO) [2015/446-14-008]; NIH [NINDS-NS078127]; Sloan Foundation; Klingenstein Foundation; Simons Foundation; Center for Sensorimotor Neural Engineering; McGovern Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078127] Funding Source: NIH RePORTER	Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Foundation(Alfred P. Sloan Foundation); Klingenstein Foundation(Klingenstein Philanthropies); Simons Foundation; Center for Sensorimotor Neural Engineering(National Science Foundation (NSF)); McGovern Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M.S. Fee, J.J. DiCarlo, and R. Desimone for comments on the manuscript, and we thank D. Sussillo for advice on modeling. D.N. was supported by the Rubicon Grant (2015/446-14-008) from the Netherlands Scientific Organization (NWO). M.J. is supported by the NIH (NINDS-NS078127), the Sloan Foundation, the Klingenstein Foundation, the Simons Foundation, the Center for Sensorimotor Neural Engineering, and the McGovern Institute.	Bartolo R, 2014, J NEUROSCI, V34, P3910, DOI 10.1523/JNEUROSCI.2679-13.2014; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Buhusi CV, 2002, BEHAV NEUROSCI, V116, P291, DOI 10.1037//0735-7044.116.2.291; Buonomano DV, 2010, TRENDS COGN SCI, V14, P520, DOI 10.1016/j.tics.2010.09.002; Chaudhuri R, 2015, NEURON, V88, P419, DOI 10.1016/j.neuron.2015.09.008; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; Emmons EB, 2017, J NEUROSCI, V37, P8718, DOI 10.1523/JNEUROSCI.1376-17.2017; FRIED I, 1991, J NEUROSCI, V11, P3656; Fujii N, 2002, J NEUROPHYSIOL, V87, P2158, DOI 10.1152/jn.00867.2001; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Gouvea TS, 2015, ELIFE, V4, DOI 10.7554/eLife.11386; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hanks TD, 2014, ELIFE, V3, DOI 10.7554/eLife.02260; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Jazayeri M, 2015, CURR BIOL, V25, P2599, DOI 10.1016/j.cub.2015.08.038; Jin DZZ, 2009, P NATL ACAD SCI USA, V106, P19156, DOI 10.1073/pnas.0909881106; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; KILLEEN PR, 1988, PSYCHOL REV, V95, P274, DOI 10.1037/0033-295X.95.2.274; Komura Y, 2001, NATURE, V412, P546, DOI 10.1038/35087595; Kunimatsu J, 2012, EUR J NEUROSCI, V36, P3258, DOI 10.1111/j.1460-9568.2012.08242.x; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Li N, 2016, NATURE, V532, P459, DOI 10.1038/nature17643; Lu XF, 2002, NEURON, V34, P317, DOI 10.1016/S0896-6273(02)00657-8; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Matell MS, 2003, BEHAV NEUROSCI, V117, P760, DOI 10.1037/0735-7044.117.4.760; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Mello GBM, 2015, CURR BIOL, V25, P1113, DOI 10.1016/j.cub.2015.02.036; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Merchant H, 2011, P NATL ACAD SCI USA, V108, P19784, DOI 10.1073/pnas.1112933108; Namboodiri VMK, 2014, P NATL ACAD SCI USA, V111, pE2239, DOI 10.1073/pnas.1404555111; PARTHASARATHY HB, 1992, J NEUROSCI, V12, P4468; Rakitin BC, 1998, J EXP PSYCHOL-ANIM B, V24, P15, DOI 10.1037/0097-7403.24.1.15; SCHULTZ W, 1988, EXP BRAIN RES, V71, P431; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Soares S, 2016, SCIENCE, V354, P1273, DOI 10.1126/science.aah5234; Stuphorn V, 2006, NAT NEUROSCI, V9, P925, DOI 10.1038/nn1714; Sussillo D, 2015, NAT NEUROSCI, V18, P1025, DOI 10.1038/nn.4042; Sussillo D, 2013, NEURAL COMPUT, V25, P626, DOI 10.1162/NECO_a_00409; Tanaka M, 2006, NAT NEUROSCI, V9, P20, DOI 10.1038/nn1617; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Xu M, 2014, P NATL ACAD SCI USA, V111, P480, DOI 10.1073/pnas.1321314111	48	157	158	5	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2018	21	1					102	+		10.1038/s41593-017-0028-6	http://dx.doi.org/10.1038/s41593-017-0028-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FT4WL	29203897	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-17	WOS:000423155800018
J	van Veen, V; Krug, MK; Schooler, JW; Carter, CS				van Veen, Vincent; Krug, Marie K.; Schooler, Jonathan W.; Carter, Cameron S.			Neural activity predicts attitude change in cognitive dissonance	NATURE NEUROSCIENCE			English	Article							HUMAN ORBITOFRONTAL CORTEX; BRAIN ACTIVITY; NEGATIVE AFFECT; RESPONSE CONFLICT; FORCED COMPLIANCE; CINGULATE CORTEX; CHOICE; MODEL; PAIN; MECHANISMS	When our actions conflict with our prior attitudes, we often change our attitudes to be more consistent with our actions. This phenomenon, known as cognitive dissonance, is considered to be one of the most influential theories in psychology. However, the neural basis of this phenomenon is unknown. Using a Solomon four-group design, we scanned participants with functional MRI while they argued that the uncomfortable scanner environment was nevertheless a pleasant experience. We found that cognitive dissonance engaged the dorsal anterior cingulate cortex and anterior insula; furthermore, we found that the activation of these regions tightly predicted participants' subsequent attitude change. These effects were not observed in a control group. Our findings elucidate the neural representation of cognitive dissonance, and support the role of the anterior cingulate cortex in detecting cognitive conflict and the neural prediction of attitude change.	[van Veen, Vincent] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [van Veen, Vincent; Krug, Marie K.; Carter, Cameron S.] Univ Calif Davis, Imaging Res Ctr, Sacramento, CA 95817 USA; [Schooler, Jonathan W.] Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA	University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Santa Barbara	van Veen, V (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	vanveen@berkeley.edu; cameron.carter@ucdmc.ucdavis.edu	Schooler, Jonathan/ABE-6434-2020; Schooler, Jonathan/AAZ-3977-2020		US National Institute of Mental Health; Burroughs-Wellcome Foundation	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Burroughs-Wellcome Foundation(Burroughs Wellcome Fund)	We are grateful to M. Greenberg, G. Hein and K. Ochsner for discussions, and to S. Ravizza, D. Tamir, S. Ursu and A. Watrous for help with data collection. This research was supported by grants from the US National Institute of Mental Health and the Burroughs-Wellcome Foundation to C. S. C.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Batson CD, 2003, PERS SOC PSYCHOL B, V29, P1190, DOI 10.1177/0146167203254600; BEM DJ, 1967, PSYCHOL REV, V74, P183, DOI 10.1037/h0024835; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; BRAVER MCW, 1988, PSYCHOL BULL, V104, P150, DOI 10.1037/0033-2909.104.1.150; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; COOPER J, 1984, ADV EXP SOC PSYCHOL, V17, P229, DOI 10.1016/S0065-2601(08)60121-5; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; CROYLE RT, 1983, J PERS SOC PSYCHOL, V45, P782, DOI 10.1037/0022-3514.45.4.782; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; ELLIOT AJ, 1994, J PERS SOC PSYCHOL, V67, P382, DOI 10.1037/0022-3514.67.3.382; FESTINGER L, 1959, J ABNORM SOC PSYCH, V58, P203, DOI 10.1037/h0041593; Festinger L, 1957, THEORY COGNITIVE DIS; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Hajcak G, 2004, BRAIN COGNITION, V56, P189, DOI 10.1016/j.bandc.2003.11.001; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Harmon-Jones E., 1999, COGNITIVE DISSONANCE; Harmon-Jones E, 2008, EUR J SOC PSYCHOL, V38, P35, DOI 10.1002/ejsp.399; Harmon-Jones E, 2008, SOC PERSONAL PSYCHOL, V2, P1518, DOI 10.1111/j.1751-9004.2008.00110.x; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; HOYT MF, 1972, J PERS SOC PSYCHOL, V23, P205, DOI 10.1037/h0033034; Immordino-Yang MH, 2009, P NATL ACAD SCI USA, V106, P8021, DOI 10.1073/pnas.0810363106; Jones AD, 2002, COGN AFFECT BEHAV NE, V2, P300, DOI 10.3758/CABN.2.4.300; Jones E. E., 1985, HDB SOCIAL PSYCHOL, P47; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Langleben DD, 2002, NEUROIMAGE, V15, P727, DOI 10.1006/nimg.2001.1003; Lieberman MD, 2001, PSYCHOL SCI, V12, P135, DOI 10.1111/1467-9280.00323; LINDER DE, 1967, J PERS SOC PSYCHOL, V6, P245, DOI 10.1037/h0021220; LOSCH ME, 1990, J EXP SOC PSYCHOL, V26, P289, DOI 10.1016/0022-1031(90)90040-S; Luu P, 2000, J EXP PSYCHOL GEN, V129, P43, DOI 10.1037//0096-3445.129.1.43; Nunez JM, 2005, NEUROIMAGE, V25, P267, DOI 10.1016/j.neuroimage.2004.10.041; Sharot T, 2009, J NEUROSCI, V29, P3760, DOI 10.1523/JNEUROSCI.4972-08.2009; Shultz TR, 1996, PSYCHOL REV, V103, P219, DOI 10.1037/0033-295X.103.2.219; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; SOLOMON RL, 1949, PSYCHOL BULL, V46, P137, DOI 10.1037/h0062958; Takahashi H, 2009, SCIENCE, V323, P937, DOI 10.1126/science.1165604; Ursu S, 2005, COGNITIVE BRAIN RES, V23, P51, DOI 10.1016/j.cogbrainres.2005.01.004; Ursu S, 2008, BRAIN RES, V1227, P110, DOI 10.1016/j.brainres.2008.06.033; Van Overwalle F, 2002, PERS SOC PSYCHOL REV, V6, P204, DOI 10.1207/S15327957PSPR0603_6; van Veen V, 2005, NEUROIMAGE, V27, P497, DOI 10.1016/j.neuroimage.2005.04.042; van Veen V, 2006, CURR DIR PSYCHOL SCI, V15, P237, DOI 10.1111/j.1467-8721.2006.00443.x; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Westen D, 2006, J COGNITIVE NEUROSCI, V18, P1947, DOI 10.1162/jocn.2006.18.11.1947	50	157	157	2	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1469	1474		10.1038/nn.2413	http://dx.doi.org/10.1038/nn.2413			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	511UE	19759538				2022-12-17	WOS:000271194100022
J	Jeyifous, O; LWaites, C; Specht, CG; Fujisawa, S; Schubert, M; Lin, EI; Marshall, J; Aoki, C; de Silva, T; Montgomery, JM; Garner, CC; Green, WN				Jeyifous, Okunola; LWaites, Clarissa; Specht, Christian G.; Fujisawa, Sho; Schubert, Manja; Lin, Eric I.; Marshall, John; Aoki, Chiye; de Silva, Tharani; Montgomery, Johanna M.; Garner, Craig C.; Green, William N.			SAP97 and CASK mediate sorting of NMDA receptors through a previously unknown secretory pathway	NATURE NEUROSCIENCE			English	Article							SYNAPTIC VESICLE EXOCYTOSIS; HIPPOCAMPAL-NEURONS; AMPA RECEPTORS; ENDOPLASMIC-RETICULUM; EXCITATORY SYNAPSES; SURFACE EXPRESSION; GOLGI TRANSPORT; TRAFFICKING; COMPLEX; DENDRITES	Synaptic plasticity is dependent on the differential sorting, delivery and retention of neurotransmitter receptors, but the mechanisms underlying these processes are poorly understood. We found that differential sorting of glutamate receptor subtypes began in the endoplasmic reticulum of rat hippocampal neurons. As AMPA receptors (AMPARs) were trafficked to the plasma membrane via the conventional somatic Golgi network, NMDA receptors (NMDARs) were diverted from the somatic endoplasmic reticulum into a specialized endoplasmic reticulum subcompartment that bypasses somatic Golgi, merging instead with dendritic Golgi outposts. This endoplasmic reticulum subcompartment was composed of highly mobile vesicles containing the NMDAR subunits NR1 and NR2B, the microtubule-dependent motor protein KIF17, and the postsynaptic adaptor proteins CASK and SAP97. Our data demonstrate that the retention and trafficking of NMDARs in this endoplasmic reticulum subcompartment requires both CASK and SAP97. These findings indicate that NMDARs are sorted away from AMPARs via a non-conventional secretory pathway that utilizes dendritic Golgi outposts.	[Jeyifous, Okunola; LWaites, Clarissa; Specht, Christian G.; Garner, Craig C.] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Fujisawa, Sho; Aoki, Chiye] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Schubert, Manja; de Silva, Tharani; Montgomery, Johanna M.] Univ Auckland, Dept Physiol, Auckland, New Zealand; [Lin, Eric I.; Green, William N.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Marshall, John] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Stanford University; New York University; University of Auckland; University of Chicago; Brown University	Garner, CC (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA.	cgarner@stanford.edu; wgreen@midway.uchicago.edu	Schubert, Manja/AAJ-9575-2021; Aoki, Chiye/T-9405-2019	Schubert, Manja/0000-0003-3592-2470; Aoki, Chiye/0000-0003-4010-9425; Specht, Christian G/0000-0001-6038-7735; Jeyifous, Okunola/0000-0002-4176-4694; Garner, Craig/0000-0003-1970-5417	Nancy Pritzker Family and US National Institutes of Health [DA016758]; Deutsche Forschungsgemeinschaft; US National Institutes of Health [NS043782, DA13602, DA019695]; Albert & Ellen Grass Faculty; NATIONAL EYE INSTITUTE [P30EY013079, R01EY013145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043782, R56NS043782, R01NS041091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA019695, R01DA013602, R01DA016758] Funding Source: NIH RePORTER	Nancy Pritzker Family and US National Institutes of Health; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert & Ellen Grass Faculty; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank S. Leal-Ortiz for assistance with the generation of lentivirus and shRNA, L. A. Needleman and J. Marks. Also, thanks to B. Margolis for the CASK constructs, J. Lippincott-Schwartz for the Galtase-GFP construct and V. Bindokas for help and advice with imaging protocols. This work was supported by the Nancy Pritzker Family and US National Institutes of Health grant DA016758 to C. C. G., a Deutsche Forschungsgemeinschaft postdoctoral fellowship to C. G. S., The Marsden Fund (Royal Society of New Zealand) to J. M. M., US National Institutes of Health grants NS043782, DA13602 and DA019695 to W. N. G., and the Albert & Ellen Grass Faculty Award to W. N. G. and J. M.	BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Bannai H, 2004, J CELL SCI, V117, P163, DOI 10.1242/jcs.00854; Bassand P, 1999, EUR J NEUROSCI, V11, P2031, DOI 10.1046/j.1460-9568.1999.00611.x; Bresler T, 2004, J NEUROSCI, V24, P1507, DOI 10.1523/JNEUROSCI.3819-03.2004; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; CLAUDIO T, 1992, METHOD ENZYMOL, V207, P391; Cognet L., 2006, SCI STKE, V2006, ppe13, DOI DOI 10.1126/STKE.3272006PE13; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Dotti CG, 2003, NAT CELL BIOL, V5, P591, DOI 10.1038/ncb0703-591b; Dresbach T, 2006, J BIOL CHEM, V281, P6038, DOI 10.1074/jbc.M508784200; Dumas TC, 2005, PROG NEUROBIOL, V76, P189, DOI 10.1016/j.pneurobio.2005.08.002; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Fujisawa S, 2003, NEUROSCIENCE, V121, P51, DOI 10.1016/S0306-4522(03)00341-5; Gardoni F, 2003, J BIOL CHEM, V278, P44745, DOI 10.1074/jbc.M303576200; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; Guillaud L, 2003, J NEUROSCI, V23, P131; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Horton AC, 2003, J NEUROSCI, V23, P6188; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Leal-Ortiz S, 2008, J CELL BIOL, V181, P831, DOI 10.1083/jcb.200711167; Lee S, 2002, MOL CELL BIOL, V22, P1778, DOI 10.1128/MCB.22.6.1778-1791.2002; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mauceri D, 2007, J NEUROCHEM, V100, P1032, DOI 10.1111/j.1471-4159.2006.04267.x; Mironov SL, 2006, J CELL SCI, V119, P4926, DOI 10.1242/jcs.03254; Montgomery JM, 2004, CELL MOL LIFE SCI, V61, P911, DOI 10.1007/s00018-003-3364-5; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Perestenko PV, 2003, J BIOL CHEM, V278, P43525, DOI 10.1074/jbc.M306206200; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; PHEND KD, 1995, J HISTOCHEM CYTOCHEM, V43, P283, DOI 10.1177/43.3.7532656; Pierce JP, 2001, CURR BIOL, V11, P351, DOI 10.1016/S0960-9822(01)00077-X; Rao A, 1998, J NEUROSCI, V18, P1217; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Tang BL, 2001, J NEUROCHEM, V79, P923, DOI 10.1046/j.1471-4159.2001.00674.x; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Wu HJ, 1998, J CELL SCI, V111, P2365; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007	50	157	159	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1011	U81		10.1038/nn.2362	http://dx.doi.org/10.1038/nn.2362			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19620977	Green Accepted			2022-12-17	WOS:000268396300015
J	Kindt, KS; Viswanath, V; Macpherson, L; Quast, K; Hu, HZ; Patapoutian, A; Schafer, WR				Kindt, Katie S.; Viswanath, Veena; Macpherson, Lindsey; Quast, Kathleen; Hu, Hongzhen; Patapoutian, Ardem; Schafer, William R.			Caenorhabditis elegans TRPA-1 functions in mechanosensation	NATURE NEUROSCIENCE			English	Article							ION-CHANNEL TRPA1; SENSORY NEURONS; CANDIDATE; ACTIVATION; PROTEIN	Members of the transient receptor potential ( TRP) ion channel family mediate diverse sensory transduction processes in both vertebrates and invertebrates. In particular, members of the TRPA subfamily have distinct thermosensory roles in Drosophila, and mammalian TRPA1 is postulated to have a function in noxious cold sensation and mechanosensation. Here we show that mutations in trpa-1, the C. elegans ortholog of mouse Trpa1, confer specific defects in mechanosensory behaviors related to nosetouch responses and foraging. trpa-1 is expressed and functions in sensory neurons required for these mechanosensory behaviors, and contributes to neural responses of these cells to touch, particularly after repeated mechanical stimulation. Furthermore, mechanical pressure can activate C. elegans TRPA- 1 heterologously expressed in mammalian cells. Collectively, these data demonstrate that trpa-1 encodes an ion channel that can be activated in response to mechanical pressure and is required for mechanosensory neuron function, suggesting a possible role in mechanosensory transduction or modulation.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Novartis; MRC Laboratory Molecular Biology; University of California System; University of California San Diego; Scripps Research Institute	Patapoutian, A (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John Hopkins Rd, San Diego, CA 92121 USA.	apatapou@gnf.org; wschafer@mrc-lmb.cam.ac.uk	Kindt, Katie/AAS-3275-2020	Hu, Hongzhen/0000-0002-8967-7522; Kindt, Katie/0000-0002-1065-8215; Macpherson, Lindsey/0000-0002-1089-3733; Schafer, William/0000-0002-6676-8034	MRC [MC_U105185857] Funding Source: UKRI; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018341, R01DA016445] Funding Source: NIH RePORTER; Medical Research Council [MC_U105185857] Funding Source: Medline; NIDA NIH HHS [R01DA018341, R01DA016445] Funding Source: Medline; NIDCR NIH HHS [R01DE016927] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bianchi L, 2004, NAT NEUROSCI, V7, P1337, DOI 10.1038/nn1347; Chakfe Y, 2006, AM J PHYSIOL-REG I, V290, pR1183, DOI 10.1152/ajpregu.00716.2005; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chalfie M, 1997, BIOL BULL, V192, P125, DOI 10.2307/1542584; Chanda SK, 2003, P NATL ACAD SCI USA, V100, P12153, DOI 10.1073/pnas.1934839100; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Cho HW, 2002, J NEUROSCI, V22, P1238, DOI 10.1523/JNEUROSCI.22-04-01238.2002; Colbert HA, 1997, J NEUROSCI, V17, P8259; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Goodman Miriam B, 2006, WormBook, P1; Hamill OP, 1997, ANNU REV PHYSIOL, V59, P621, DOI 10.1146/annurev.physiol.59.1.621; Harbinder S, 1997, P NATL ACAD SCI USA, V94, P13128, DOI 10.1073/pnas.94.24.13128; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Hilliard MA, 2005, EMBO J, V24, P1489, DOI 10.1038/sj.emboj.7600639; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Kanzaki M, 1999, SCIENCE, V285, P1493; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; McBride D W Jr, 1999, Methods Enzymol, V294, P482; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; SACHS F, 1990, J PHYSIOL-LONDON, V431, P103; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	50	157	169	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					568	577		10.1038/nn1886	http://dx.doi.org/10.1038/nn1886			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17450139				2022-12-17	WOS:000245948000013
J	Jaramillo, F; Wiesenfeld, K				Jaramillo, F; Wiesenfeld, K			Mechanoelectrical transduction assisted by Brownian motion: a role for noise in the auditory system	NATURE NEUROSCIENCE			English	Article							SACCULAR HAIR-CELLS; STOCHASTIC RESONANCE; INFORMATION-TRANSFER; BUNDLES; MECHANORECEPTORS; ENHANCEMENT; ADAPTATION; RESPONSES; CHANNELS; CRAYFISH	The organs of the vestibular, auditory and lateral line systems rely on a common strategy for the stimulation of their primary receptors, the hair cells: stimuli induce shear between hair cell epithelia and accessory structures to which hair bundles, the hair cells' mechanosensitive organelles, are attached. The inner hair cells of the cochlea, whose hair bundles are not attached to the overlying tectorial membrane, are a notable exception. Because their hair bundles are not restrained, they undergo significant Brownian motion, a characteristic traditionally thought to blunt the sensitivity of hearing. Contrary to this view, the work reported here indicates that Brownian motion of the hair bundle serves to enhance the sensitivity of mechanoelectrical transduction.	Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA; Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	Emory University; University System of Georgia; Georgia Institute of Technology	Jaramillo, F (corresponding author), Emory Univ, Sch Med, Dept Physiol, 1648 Pierce Dr, Atlanta, GA 30322 USA.	fjaram@physio.emory.edu						ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; ATKINS PW, 1978, PHYSICAL CHEM; BEZRUKOV SM, 1995, NATURE, V378, P362, DOI 10.1038/378362a0; Collins JJ, 1996, J NEUROPHYSIOL, V76, P642, DOI 10.1152/jn.1996.76.1.642; COREY DP, 1983, J NEUROSCI, V3, P962; DALLOS P, 1985, J NEUROSCI, V5, P1591; DALLOS P, 1972, SCIENCE, V177, P356, DOI 10.1126/science.177.4046.356; DENK W, 1989, P NATL ACAD SCI USA, V86, P5371, DOI 10.1073/pnas.86.14.5371; DENK W, 1992, HEARING RES, V60, P89, DOI 10.1016/0378-5955(92)90062-R; DEVRIES HL, 1948, PHYSICA, V14, P48, DOI 10.1016/0031-8914(48)90060-3; DOUGLASS JK, 1993, NATURE, V365, P337, DOI 10.1038/365337a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRIS GG, 1968, J ACOUST SOC AM, V44, P176, DOI 10.1121/1.1911052; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1986, HEARING RES, V23, P93, DOI 10.1016/0378-5955(86)90178-4; HOWARD J, 1988, ANNU REV BIOPHYS BIO, V17, P99; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Levin JE, 1996, NATURE, V380, P165, DOI 10.1038/380165a0; LINDEMAN HH, 1972, ACTA OTOLARYNGOL, V72, P229; MCNAMARA B, 1989, PHYS REV A, V39, P4854, DOI 10.1103/PhysRevA.39.4854; Narins PM, 1997, AUDIT NEUROSCI, V3, P389; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Ruggero M A, 1992, Curr Opin Neurobiol, V2, P449, DOI 10.1016/0959-4388(92)90179-O; RUSSELL IJ, 1992, P ROY SOC B-BIOL SCI, V250, P217, DOI 10.1098/rspb.1992.0152; RUSSELL IJ, 1986, NATURE, V321, P517, DOI 10.1038/321517a0; SVRCEKSEILER WA, IN PRESS J THEOR BIO; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0	27	157	158	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					384	388		10.1038/1597	http://dx.doi.org/10.1038/1597			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196528				2022-12-17	WOS:000076361400016
J	Kaufmann, T; van der Meer, D; Doan, NT; Schwarz, E; Lund, MJ; Agartz, I; Alnaes, D; Barch, DM; Baur-Streubel, R; Bertolino, A; Bettella, F; Beyer, MK; Boen, E; Borgwardt, S; Brandt, CL; Buitelaar, J; Celius, EG; Cervenka, S; Conzelmann, A; Cordova-Palomera, A; Dale, AM; de Quervain, DJF; Carlo, P; Djurovic, S; Dorum, ES; Eisenacher, S; Elvsashagen, T; Espeseth, T; Fatouros-Bergman, H; Flyckt, L; Franke, B; Frei, O; Haatveit, B; Haberg, AK; Harbo, HF; Hartman, CA; Heslenfeld, D; Hoekstra, PJ; Hogestol, EA; Jernigan, TL; Jonassen, R; Jonsson, EG; Kirsch, P; Ktoszewska, I; Kolskar, KK; Landro, NI; Hellard, S; Lesch, KP; Lovestone, S; Lundervold, A; Lundervold, AJ; Maglanoc, LA; Malt, UF; Mecocci, P; Melle, I; Meyer-Lindenberg, A; Moberget, T; Norbom, LB; Nordvik, JE; Nyberg, L; Oosterlaan, J; Papalino, M; Papassotiropoulos, A; Pauli, P; Pergola, G; Persson, K; Richard, G; Rokicki, J; Sanders, AM; Selbaek, G; Shadrin, AA; Smeland, OB; Soininen, H; Sowa, P; Steen, VM; Tsolaki, M; Ulrichsen, KM; Vellas, B; Wang, L; Westman, E; Ziegler, GC; Zink, M; Andreassen, OA; Westlye, LT; Farde, L; Flyckts, L; Engberg, G; Erhardt, S; Fatouros-Bergmann, H; Schwieler, L; Piehl, F; Collste, K; Victorsson, P; Malmqvist, A; Hedberg, M; Orhan, F				Kaufmann, Tobias; van der Meer, Dennis; Nhat Trung Doan; Schwarz, Emanuel; Lund, Martina J.; Agartz, Ingrid; Alnaes, Dag; Barch, Deanna M.; Baur-Streubel, Ramona; Bertolino, Alessandro; Bettella, Francesco; Beyer, Mona K.; Boen, Erlend; Borgwardt, Stefan; Brandt, Christine L.; Buitelaar, Jan; Celius, Elisabeth G.; Cervenka, Simon; Conzelmann, Annette; Cordova-Palomera, Aldo; Dale, Anders M.; de Quervain, Dominique J. F.; Carlo, PasqualeDi; Djurovic, Srdjan; Dorum, Erlend S.; Eisenacher, Sarah; Elvsashagen, Torbjorn; Espeseth, Thomas; Fatouros-Bergman, Helena; Flyckt, Lena; Franke, Barbara; Frei, Oleksandr; Haatveit, Beathe; Haberg, Asta K.; Harbo, Hanne F.; Hartman, Catharina A.; Heslenfeld, Dirk; Hoekstra, Pieter J.; Hogestol, Einar A.; Jernigan, Terry L.; Jonassen, Rune; Jonsson, Erik G.; Kirsch, Peter; Ktoszewska, Iwona; Kolskar, Knut K.; Landro, Nils Inge; Hellard, StephanieLe; Lesch, Klaus-Peter; Lovestone, Simon; Lundervold, Arvid; Lundervold, Astri J.; Maglanoc, Luigi A.; Malt, Ulrik F.; Mecocci, Patrizia; Melle, Ingrid; Meyer-Lindenberg, Andreas; Moberget, Torgeir; Norbom, Linn B.; Nordvik, Jan Egil; Nyberg, Lars; Oosterlaan, Jaap; Papalino, Marco; Papassotiropoulos, Andreas; Pauli, Paul; Pergola, Giulio; Persson, Karin; Richard, Genevieve; Rokicki, Jaroslav; Sanders, Anne-Marthe; Selbaek, Geir; Shadrin, Alexey A.; Smeland, Olav B.; Soininen, Hilkka; Sowa, Piotr; Steen, Vidar M.; Tsolaki, Magda; Ulrichsen, Kristine M.; Vellas, Bruno; Wang, Lei; Westman, Eric; Ziegler, Georg C.; Zink, Mathias; Andreassen, Ole A.; Westlye, Lars T.; Farde, Lars; Flyckts, Lena; Engberg, Goran; Erhardt, Sophie; Fatouros-Bergmann, Helena; Schwieler, Lilly; Piehl, Fredrik; Collste, Karin; Victorsson, Pauliina; Malmqvist, Anna; Hedberg, Mikael; Orhan, Funda		Karolinska Schizophrenia Project K	Common brain disorders are associated with heritable patterns of apparent aging of the brain	NATURE NEUROSCIENCE			English	Article							MULTIPLE-SCLEROSIS; AGE; SCHIZOPHRENIA; ALZHEIMERS; LOCI; MRI	Common risk factors for psychiatric and other brain disorders are likely to converge on biological pathways influencing the development and maintenance of brain structure and function across life. Using structural MRI data from 45,615 individuals aged 3-96 years, we demonstrate distinct patterns of apparent brain aging in several brain disorders and reveal genetic pleiotropy between apparent brain aging in healthy individuals and common brain disorders.	[Kaufmann, Tobias; van der Meer, Dennis; Nhat Trung Doan; Lund, Martina J.; Agartz, Ingrid; Alnaes, Dag; Bettella, Francesco; Brandt, Christine L.; Cordova-Palomera, Aldo; Dorum, Erlend S.; Elvsashagen, Torbjorn; Frei, Oleksandr; Haatveit, Beathe; Jonsson, Erik G.; Kolskar, Knut K.; Maglanoc, Luigi A.; Melle, Ingrid; Moberget, Torgeir; Norbom, Linn B.; Richard, Genevieve; Rokicki, Jaroslav; Sanders, Anne-Marthe; Shadrin, Alexey A.; Smeland, Olav B.; Ulrichsen, Kristine M.; Andreassen, Ole A.; Westlye, Lars T.] Univ Oslo, Oslo Univ Hosp, NORMENT, Div Mental Hlth & Addict, Oslo, Norway; [Kaufmann, Tobias; van der Meer, Dennis; Nhat Trung Doan; Lund, Martina J.; Agartz, Ingrid; Alnaes, Dag; Bettella, Francesco; Beyer, Mona K.; Brandt, Christine L.; Celius, Elisabeth G.; Cordova-Palomera, Aldo; Dorum, Erlend S.; Elvsashagen, Torbjorn; Frei, Oleksandr; Haatveit, Beathe; Harbo, Hanne F.; Hogestol, Einar A.; Jonsson, Erik G.; Kolskar, Knut K.; Maglanoc, Luigi A.; Malt, Ulrik F.; Melle, Ingrid; Moberget, Torgeir; Norbom, Linn B.; Richard, Genevieve; Rokicki, Jaroslav; Sanders, Anne-Marthe; Selbaek, Geir; Shadrin, Alexey A.; Smeland, Olav B.; Ulrichsen, Kristine M.; Andreassen, Ole A.; Westlye, Lars T.] Univ Oslo, Inst Clin Med, Oslo, Norway; [van der Meer, Dennis; Celius, Elisabeth G.] Maastricht Univ, Sch Mental Hlth & Neurosci, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Schwarz, Emanuel; Eisenacher, Sarah; Meyer-Lindenberg, Andreas; Zink, Mathias] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, Mannheim, Germany; [Agartz, Ingrid; Boen, Erlend; Landro, Nils Inge] Diakonhjemmet Hosp, Dept Psychiat, Oslo, Norway; [Agartz, Ingrid; Cervenka, Simon; Fatouros-Bergman, Helena; Flyckt, Lena; Jonsson, Erik G.; Farde, Lars; Flyckts, Lena; Fatouros-Bergmann, Helena; Collste, Karin; Victorsson, Pauliina] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden; [Agartz, Ingrid; Cervenka, Simon; Fatouros-Bergman, Helena; Flyckt, Lena; Jonsson, Erik G.; Farde, Lars; Flyckts, Lena; Fatouros-Bergmann, Helena; Collste, Karin; Victorsson, Pauliina] Stockholm Cty Council, Stockholm Hlth Care Serv, Stockholm, Sweden; [Barch, Deanna M.] Washington Univ, Dept Psychol & Brain Sci, St Louis, MO 63110 USA; [Barch, Deanna M.] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [Barch, Deanna M.] Washington Univ, Dept Radiol, St Louis, MO 63110 USA; [Baur-Streubel, Ramona; Pauli, Paul] Univ Wurzburg, Dept Psychol 1, Wurzburg, Germany; [Bertolino, Alessandro] Bari Univ Hosp, Inst Psychiat, Bari, Italy; [Bertolino, Alessandro; Carlo, PasqualeDi; Papalino, Marco; Pergola, Giulio] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Beyer, Mona K.; Sowa, Piotr] Oslo Univ Hosp, Sect Neuroradiol, Div Radiol & Nucl Med, Oslo, Norway; [Boen, Erlend] Oslo Univ Hosp, Div Mental Hlth & Addict, Psychosomat & CL Psychiat, Oslo, Norway; [Borgwardt, Stefan] Univ Basel, Dept Psychiat UPK, Basel, Switzerland; [Borgwardt, Stefan; Westman, Eric] Univ Lubeck, Dept Psychiat Psychosomat & Psychotherapy, Lubeck, Germany; [Borgwardt, Stefan] Kings Coll London, Inst Psychiat, London, England; [Buitelaar, Jan] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Nijmegen, Netherlands; [Buitelaar, Jan] Karakter Child & Adolescent Psychiat Univ Ctr, Nijmegen, Netherlands; [Elvsashagen, Torbjorn; Harbo, Hanne F.; Hogestol, Einar A.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Conzelmann, Annette] Univ Tubingen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Tubingen, Germany; [Dale, Anders M.] Univ Calif San Diego, Ctr Multimodal Imaging & Genet, La Jolla, CA 92093 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [de Quervain, Dominique J. F.; Papassotiropoulos, Andreas] Univ Basel, Div Cognit Neurosci, Basel, Switzerland; [de Quervain, Dominique J. F.] Univ Basel, Transfac Res Platform Mol & Cognit Neurosci, Basel, Switzerland; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Djurovic, Srdjan; Hellard, StephanieLe; Steen, Vidar M.] Univ Bergen, Dept Clin Sci, NORMENT, Bergen, Norway; [Dorum, Erlend S.; Espeseth, Thomas; Haatveit, Beathe; Kolskar, Knut K.; Landro, Nils Inge; Maglanoc, Luigi A.; Norbom, Linn B.; Richard, Genevieve; Rokicki, Jaroslav; Sanders, Anne-Marthe; Ulrichsen, Kristine M.; Westlye, Lars T.] Univ Oslo, Dept Psychol, Oslo, Norway; [Dorum, Erlend S.; Kolskar, Knut K.; Richard, Genevieve; Sanders, Anne-Marthe; Ulrichsen, Kristine M.] Sunnaas Rehabil Hosp HT, Nesodden, Norway; [Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, Nijmegen, Netherlands; [Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Psychiat, Nijmegen, Netherlands; [Haberg, Asta K.] Univ Sci & Technol, Dept Neuromed & Movement Sci Norwegian, Trondheim, Norway; [Haberg, Asta K.] St Olavs Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Hartman, Catharina A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Heslenfeld, Dirk; Oosterlaan, Jaap] Vrije Univ Amsterdam, Clin Neuropsychol Sect, Amsterdam, Netherlands; [Heslenfeld, Dirk] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [Hoekstra, Pieter J.] Univ Groningen, Univ Med Ctr Groningen, Dept Child & Adolescent Psychiat, Groningen, Netherlands; [Jernigan, Terry L.] Univ Calif San Diego, Ctr Human Dev, San Diego, CA 92103 USA; [Jernigan, Terry L.] Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA; [Jernigan, Terry L.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Jernigan, Terry L.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Jonassen, Rune] Oslo Metropolitan Univ, Fac Hlth Sci, Oslo, Norway; [Kirsch, Peter] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Clin Psychol, Mannheim, Germany; [Kirsch, Peter] Bernstein Ctr Computat Neurosci Heidelberg Mannhe, Mannheim, Germany; [Ktoszewska, Iwona] Med Univ Lodz, Dept Old Age Psychiat & Psychot Disorders, Lodz, Poland; [Lesch, Klaus-Peter; Ziegler, Georg C.] Univ Wurzburg, Ctr Mental Hlth, Div Mol Psychiat, Wurzburg, Germany; [Lesch, Klaus-Peter] Sechenov First Moscow State Med Univ, Inst Mol Med, Lab Psychiat Neurobiol, Moscow, Russia; [Lesch, Klaus-Peter] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Dept Neurosci, Maastricht, Netherlands; [Lovestone, Simon] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Lundervold, Arvid] Univ Bergen, Dept Biomed, Bergen, Norway; [Lundervold, Arvid] Haukeland Hosp, Mohn Med Imaging & Visualizat Ctr, Dept Radiol, Bergen, Norway; [Lundervold, Astri J.] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Malt, Ulrik F.] Oslo Univ Hosp, Dept Res & Educ, Oslo, Norway; [Mecocci, Patrizia] Univ Perugia, Inst Gerontol & Geriatr, Perugia, Italy; [Nordvik, Jan Egil] CatoSenteret Rehabil Ctr Son, Oslo, Norway; [Nyberg, Lars] Umea Univ, Umea Ctr Funct Brain Imaging, Dept Radiat Sci, Umea, Sweden; [Nyberg, Lars] Umea Univ, Umea Ctr Funct Brain Imaging, Dept Integrat Med Biol, Umea, Sweden; [Oosterlaan, Jaap] Amsterdam UMC Univ Amsterdam, Emma Childrens Hosp, Amsterdam, Netherlands; [Oosterlaan, Jaap] Vrije Univ Amsterdam, Dept Pediat, Emma Neurosci Grp, Amsterdam Reprod & Dev, Amsterdam, Netherlands; [Papassotiropoulos, Andreas] Univ Basel, Div Mol Neurosci, Basel, Switzerland; [Papassotiropoulos, Andreas] Univ Basel, Dept Biozentrum, Life Sci Training Facil, Basel, Switzerland; [Persson, Karin; Selbaek, Geir] Oslo Univ Hosp, Dept Geriatr Med, Oslo, Norway; [Persson, Karin; Selbaek, Geir] Vestfold Hosp Trust, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway; [Soininen, Hilkka] Univ Eastern Finland, Inst Clin Med, Dept Neurol, Kuopio, Finland; [Soininen, Hilkka] Neurol Kuopio Univ Hosp, Neuroctr, Kuopio, Finland; [Steen, Vidar M.] Haukeland Hosp, Dept Med Genet, Dr E Martens Res Grp Biol Psychiat, Bergen, Norway; [Tsolaki, Magda] Aristotle Univ Thessaloniki, Dept Neurol 1, Thessaloniki, Greece; [Vellas, Bruno] UPS, CHU Toulouse, UMR Inserm 1027, Toulouse, France; [Wang, Lei] Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Westman, Eric] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Zink, Mathias] Dist Hosp Ansbach, Ansbach, Germany; [Engberg, Goran; Erhardt, Sophie; Schwieler, Lilly; Malmqvist, Anna; Hedberg, Mikael; Orhan, Funda] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Piehl, Fredrik] Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden	University of Oslo; University of Oslo; Maastricht University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Diakonhjemmet Hospital; Karolinska Institutet; Stockholm County Council; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Wurzburg; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Oslo; University of Oslo; University of Basel; University of Lubeck; University of London; King's College London; Radboud University Nijmegen; Radboud University Nijmegen; University of Oslo; Eberhard Karls University of Tubingen; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Basel; University of Basel; University of Oslo; University of Bergen; University of Oslo; Radboud University Nijmegen; Radboud University Nijmegen; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Groningen; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Groningen; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Oslo Metropolitan University (OsloMet); Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Medical University Lodz; University of Wurzburg; Sechenov First Moscow State Medical University; Maastricht University; University of Oxford; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; University of Perugia; Umea University; Umea University; Emma Children's Hospital; University of Amsterdam; Vrije Universiteit Amsterdam; University of Basel; University of Basel; University of Oslo; University of Eastern Finland; University of Bergen; Haukeland University Hospital; Aristotle University of Thessaloniki; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Northwestern University; Feinberg School of Medicine; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Kaufmann, T; Westlye, LT (corresponding author), Univ Oslo, Oslo Univ Hosp, NORMENT, Div Mental Hlth & Addict, Oslo, Norway.; Kaufmann, T; Westlye, LT (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.; Westlye, LT (corresponding author), Univ Oslo, Dept Psychol, Oslo, Norway.	bias.kaufmann@medisin.uio.no; l.t.westlye@psykologi.uio.no	van der Meer, Dennis/H-6663-2019; Andreassen, Ole A./AAY-7531-2020; Franke, Barbara/D-4836-2009; Westman, Eric/H-5771-2011; Pergola, Giulio/B-9754-2013; Kaufmann, Tobias/M-8972-2017; Erhardt, Sophie/F-5596-2011; Borgwardt, Stefan/Q-6168-2018; Ziegler, Georg C/N-8985-2015; Buitelaar, J.K./AAY-7522-2020; Smeland, Olav/ADE-5677-2022; Smeland, Olav Bjerkehagen/AAM-5284-2020; Conzelmann, Annette/AAJ-6879-2021; Mecocci, Patrizia/W-2116-2019; Rokicki, Jaroslav/AAR-7509-2021	van der Meer, Dennis/0000-0002-0466-386X; Franke, Barbara/0000-0003-4375-6572; Westman, Eric/0000-0002-3115-2977; Pergola, Giulio/0000-0002-9193-1841; Kaufmann, Tobias/0000-0002-4003-1018; Erhardt, Sophie/0000-0001-7359-5250; Borgwardt, Stefan/0000-0002-5792-3987; Ziegler, Georg C/0000-0001-9411-3169; Smeland, Olav Bjerkehagen/0000-0002-3761-5215; Mecocci, Patrizia/0000-0003-0729-5246; Rokicki, Jaroslav/0000-0003-3258-1674; Jonsson, Erik/0000-0001-8368-6332; Tsolaki, Magda/0000-0002-2072-8010; Papassotiropoulos, Andreas/0000-0002-2210-9651; Westlye, Lars T./0000-0001-8644-956X; de Quervain, Dominique/0000-0001-7131-2464; Jonassen, Rune/0000-0002-5611-4635; Selbaek, Geir/0000-0001-6511-8219; Norbom, Linn/0000-0001-7489-2724; Frei, Oleksandr/0000-0002-6427-2625	Research Council of Norway [276082, 213837, 223273 NORMENT, 204966, 229129, 249795, 273345, 283798 SYNSCHIZ]; South-Eastern Norway Regional Health Authority [2013-123, 2014-097, 2015-073, 2016083]; Stiftelsen Kristian Gerhard Jebsen [SKGJ-MED-008]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (ERC Starting Grant) [802998 BRAINMINT]; NVIDIA Corporation GPU Grant; European Commission 7th Framework Programme [602450]	Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority; Stiftelsen Kristian Gerhard Jebsen; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (ERC Starting Grant); NVIDIA Corporation GPU Grant; European Commission 7th Framework Programme(European Commission)	The author list between I.A. and M.Z. is in alphabetic order. The authors were funded by the Research Council of Norway (276082 LifespanHealth (T.K.), 213837 (O.A.A), 223273 NORMENT (O.A.A.), 204966 (L.T.W.), 229129 (O.A.A.), 249795 (L.T.W.), 273345 (L.T.W.) and 283798 SYNSCHIZ (O.A.A.)), the South-Eastern Norway Regional Health Authority (2013-123 (O.A.A.), 2014-097 (L.T.W.), 2015-073 (L.T.W.) and 2016083 (L.T.W.)), Stiftelsen Kristian Gerhard Jebsen (SKGJ-MED-008), the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (ERC Starting Grant, Grant agreement No. 802998 BRAINMINT (L.T.W.)), NVIDIA Corporation GPU Grant (T.K.), and the European Commission 7th Framework Programme (602450, IMAGEMEND (A.M.-L.)). The data used in this study were gathered from various sources. A detailed overview of the included cohorts and acknowledgement of their respective funding sources and cohort-specific details is provided in Supplementary Table 1. Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni. loni.usc.edu), the AddNeuroMed consortium and the Pediatric Imaging, Neurocognition and Genetics (PING) study database (www.chd.ucsd.edu/research/ping-study.html, now shared through the NIMH Data Archive (NDA)). The investigators within the ADNI and PING studies contributed to the design and implementation of ADNI and PING or provided data but did not participate in the analysis or writing of this report. This publication is solely the responsibility of the authors and does not necessarily represent the views of the National Institutes of Health or PING investigators. Complete listings of participating sites and study investigators can be found at http://adni.loni.usc.edu/wpcontent/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf and http://pingstudy.ucsd.edu/investigators.html. The AddNeuroMed consortium was led by S.L., B.V., P.M., M.T., I.K. and H.S.	Andreassen OA, 2015, MOL PSYCHIATR, V20, P207, DOI 10.1038/mp.2013.195; Andreassen OA, 2013, AM J HUM GENET, V92, P197, DOI 10.1016/j.ajhg.2013.01.001; Aubert-Broche B, 2014, NEUROLOGY, V83, P2140, DOI 10.1212/WNL.0000000000001045; Bansal V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05510-z; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Cole JH, 2018, MOL PSYCHIATR, V23, P1385, DOI 10.1038/mp.2017.62; Cole JH, 2017, TRENDS NEUROSCI, V40, P681, DOI 10.1016/j.tins.2017.10.001; Cole JH, 2017, NEUROIMAGE, V163, P115, DOI 10.1016/j.neuroimage.2017.07.059; Demontis D, 2019, NAT GENET, V51, P63, DOI 10.1038/s41588-018-0269-7; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Ecker C, 2015, LANCET NEUROL, V14, P1121, DOI 10.1016/S1474-4422(15)00050-2; Ellison-Wright I, 2010, SCHIZOPHR RES, V117, P1, DOI 10.1016/j.schres.2009.12.022; Faraone SV, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.20; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Franke K, 2010, NEUROIMAGE, V50, P883, DOI 10.1016/j.neuroimage.2010.01.005; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8; Ho Daniel E., 2011, J STAT SOFTW, V42, P1, DOI [10.18637/jss.v042.i08, DOI 10.18637/JSS.V042.I08]; Insel TR, 2015, SCIENCE, V348, P499, DOI 10.1126/science.aab2358; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; JERNIGAN TL, 1991, BIOL PSYCHIAT, V29, P68, DOI 10.1016/0006-3223(91)90211-4; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Le TT, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00317; Marin O, 2016, NAT MED, V22, P1229, DOI 10.1038/nm.4225; Masters CL, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.56; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Parikshak NN, 2015, NAT REV GENET, V16, P441, DOI 10.1038/nrg3934; Patsopoulos N., 2017, BIORXIV, DOI [10.1101/143933v1, DOI 10.1101/143933V1]; Pedersen G, 2012, COMPR PSYCHIAT, V53, P292, DOI 10.1016/j.comppsych.2011.04.007; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2019, R LANG ENV STAT COMP; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ritchie SJ, 2018, CEREB CORTEX, V28, P2959, DOI 10.1093/cercor/bhy109; Rosen AFG, 2018, NEUROIMAGE, V169, P407, DOI 10.1016/j.neuroimage.2017.12.059; Smith SM, 2018, NEURON, V97, P263, DOI 10.1016/j.neuron.2017.12.018; Stahl Eli A, 2019, Nat Genet, V51, P793, DOI 10.1038/s41588-019-0397-8; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wolfers T, 2018, JAMA PSYCHIAT, V75, P1146, DOI 10.1001/jamapsychiatry.2018.2467; Wray Naomi R, 2018, Nat Genet, V50, P668, DOI 10.1038/s41588-018-0090-3	48	156	156	15	66	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2019	22	10					1617	+		10.1038/s41593-019-0471-7	http://dx.doi.org/10.1038/s41593-019-0471-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JI3VE	31551603	Green Accepted, Green Submitted			2022-12-17	WOS:000493396200012
J	Melamed, Z; Lopez-Erauskin, J; Baughn, MW; Zhang, O; Drenner, K; YingSun; Freyermuth, F; McMahons, MA; Beccari, MS; Artates, JW; Ohkubo, T; Rodriguez, M; Lin, NW; Wu, DM; Bennetts, CF; Rigos, F; Da Cruz, S; Ravits, J; Lagier-Tourenne, C; Cleveland, DW				Melamed, Ze'ev; Lopez-Erauskin, Jone; Baughn, Michael W.; Zhang, Ouyang; Drenner, Kevin; YingSun; Freyermuth, Fernande; McMahons, Moira A.; Beccari, Melinda S.; Artates, Jon W.; Ohkubo, Takuya; Rodriguez, Maria; Lin, Nianwei; Wu, Dongmei; Bennetts, C. Frank; Rigos, Frank; Da Cruz, Sandrine; Ravits, John; Lagier-Tourenne, Clotilde; Cleveland, Don W.			Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration	NATURE NEUROSCIENCE			English	Article							MICROTUBULE-DESTABILIZING PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; HEXANUCLEOTIDE REPEAT; UP-REGULATION; MOUSE MODEL; RNA; TDP-43; ALS; SCG10; DEGENERATION	Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are associated with loss of nuclear transactive response DNA-binding protein 43 (TDP-43). Here we identify that TDP-43 regulates expression of the neuronal growth-associated factor stathmin-2. Lowered TDP-43 levels, which reduce its binding to sites within the first intron of stathmin-2 pre-messenger RNA, uncover a cryptic polyadenylation site whose utilization produces a truncated, non-functional mRNA. Reduced stathmin-2 expression is found in neurons trans-differentiated from patient fibroblasts expressing an ALS-causing TDP-43 mutation, in motor cortex and spinal motor neurons from patients with sporadic ALS and familial ALS with GGGGCC repeat expansion in the C9orf72 gene, and in induced pluripotent stem cell (iPSC)-derived motor neurons depleted of TDP-43. Remarkably, while reduction in TDP-43 is shown to inhibit axonal regeneration of iPSC-derived motor neurons, rescue of stathmin-2 expression restores axonal regenerative capacity. Thus, premature polyadenylation-mediated reduction in stathmin-2 is a hallmark of ALS-FTD that functionally links reduced nuclear TDP-43 function to enhanced neuronal vulnerability.	[Melamed, Ze'ev; Lopez-Erauskin, Jone; Baughn, Michael W.; Drenner, Kevin; YingSun; Artates, Jon W.; Da Cruz, Sandrine; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Melamed, Ze'ev; Lopez-Erauskin, Jone; Baughn, Michael W.; Zhang, Ouyang; Drenner, Kevin; YingSun; Beccari, Melinda S.; Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Freyermuth, Fernande; Lagier-Tourenne, Clotilde] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Freyermuth, Fernande; Lagier-Tourenne, Clotilde] Broad Inst Harvard Univ & MIT, Cambridge, MA 02142 USA; [McMahons, Moira A.; Bennetts, C. Frank; Rigos, Frank] Ionis Pharmaceut, Carlsbad, CA USA; [Ohkubo, Takuya; Rodriguez, Maria; Ravits, John; Cleveland, Don W.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Lin, Nianwei; Wu, Dongmei] iXCells Biotechnol, San Diego, CA USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Ionis Pharmaceuticals, Inc.; University of California System; University of California San Diego	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.; Cleveland, DW (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Lagier-Tourenne, C (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA.; Lagier-Tourenne, C (corresponding author), Broad Inst Harvard Univ & MIT, Cambridge, MA 02142 USA.; Cleveland, DW (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	clagier-tourenne@mgh.harvard.edu; dcleveland@ucsd.edu	lagier-Tourenne, Clotilde/ABE-6303-2020; Lin, Nianwei/AAD-9805-2019; Cleveland, Don/AAN-9783-2021	lagier-Tourenne, Clotilde/0000-0002-3058-8322; Baughn, Michael/0000-0001-8525-8024; McMahon, Moira/0000-0001-9810-8623; Cleveland, Don/0000-0002-1934-3682; Beccari, Melinda/0000-0003-1019-6388	NINDS/NIH [R01-NS27036, R01-NS087227, R01-NS088578]; Target ALS [S20A00]; Muscular Dystrophy Association (MDA); EMBO long-term fellowship; Human Frontiers Science Program (HFSP) long-term fellowship; Milton Safenowitz postdoctoral fellowship; National Institute of General Medical Sciences of the National Institutes of Health [T32-GM008666]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027036, R01NS088578, R01NS087227] Funding Source: NIH RePORTER	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Target ALS; Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program (HFSP) long-term fellowship(Human Frontier Science Program); Milton Safenowitz postdoctoral fellowship; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The plasmids for expression of Brn2 and shPTB were kind gifts from X. D. Fu, UCSD. We thank the viral vector core facility at Sanford Burnham Prebys (SBP) Medical Discovery Institute for the kind contribution of the SIN18 vector. We thank B. Ren for providing the Illumina sequencing platform. We thank A. Goginashvili for valued input on the manuscript. We thank J. Nuovo at Phylogeny Inc. (Columbus, OH) for performing the chromogenic in situ hybridization experiment. This work was supported by grants from NINDS/NIH R01-NS27036 to D.W.C, Target ALS (S20A00) and NINDS/NIH (R01-NS087227) to C.L.-T. and R01-NS088578 to J.R. C.L.-T. was recipient of a Career Development grant from the Muscular Dystrophy Association (MDA). Z.M was recipient of EMBO long-term fellowship and is currently supported by the Human Frontiers Science Program (HFSP) long-term fellowship. J.L.-E. was recipient of a Milton Safenowitz postdoctoral fellowship. M.W.B. and M.S.B. were supported by the National Institute of General Medical Sciences of the National Institutes of Health Award T32-GM008666. M.A.M, C.F.B., and F.R. are employees and D.W.C. is a consultant for Ionis Pharmaceuticals.	Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Bellouze S, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0111-6; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Brunden KR, 2017, NEUROBIOL DIS, V105, P328, DOI 10.1016/j.nbd.2016.12.021; Chauvin S, 2015, PROG NEUROBIOL, V126, P1, DOI 10.1016/j.pneurobio.2014.09.002; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duncan JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068324; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Fratta P, 2018, EMBO J, V37, DOI 10.15252/embj.201798684; Graf ER, 2011, J NEUROSCI, V31, P15026, DOI 10.1523/JNEUROSCI.2024-11.2011; Humphrey J, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0274-1; Jeong YH, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-016-0144-x; Kapitein LC, 2015, NEURON, V87, P492, DOI 10.1016/j.neuron.2015.05.046; Krach F, 2018, ACTA NEUROPATHOL, V136, P405, DOI 10.1007/s00401-018-1870-7; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Ling JP, 2015, SCIENCE, V349, P650, DOI 10.1126/science.aab0983; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Mason MRJ, 2002, MOL CELL NEUROSCI, V20, P595, DOI 10.1006/mcne.2002.1140; Masuda A, 2015, GENE DEV, V29, P1045, DOI 10.1101/gad.255737.114; Minteer Shelley D., 2006, V321, P157; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Morii H, 2006, J NEUROBIOL, V66, P1101, DOI 10.1002/neu.20295; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Prudencio M, 2015, NAT NEUROSCI, V18, P1175, DOI 10.1038/nn.4065; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Riederer BM, 1997, P NATL ACAD SCI USA, V94, P741, DOI 10.1073/pnas.94.2.741; Rot G, 2017, CELL REP, V19, P1056, DOI 10.1016/j.celrep.2017.04.028; Saberi S, 2015, NEUROL CLIN, V33, P855, DOI 10.1016/j.ncl.2015.07.012; Selvaraj BT, 2012, J CELL BIOL, V199, P437, DOI 10.1083/jcb.201203109; Shin JE, 2014, EXP NEUROL, V252, P1, DOI 10.1016/j.expneurol.2013.11.007; Shin JE, 2012, P NATL ACAD SCI USA, V109, pE3696, DOI 10.1073/pnas.1216204109; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; Strey CW, 2004, AM J PATHOL, V165, P1701, DOI 10.1016/S0002-9440(10)63426-8; Sun MK, 2017, ACTA NEUROPATHOL, V133, P923, DOI 10.1007/s00401-017-1701-2; Sun SY, 2015, P NATL ACAD SCI USA, V112, pE6993, DOI 10.1073/pnas.1520639112; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Tian B, 2017, NAT REV MOL CELL BIO, V18, P18, DOI 10.1038/nrm.2016.116; Tian B, 2012, WIRES RNA, V3, P385, DOI 10.1002/wrna.116; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Wen HL, 2010, HUM MOL GENET, V19, P1766, DOI 10.1093/hmg/ddq058; White MA, 2018, NAT NEUROSCI, V21, P552, DOI 10.1038/s41593-018-0113-5; Xue YC, 2016, NAT NEUROSCI, V19, P807, DOI 10.1038/nn.4297; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yusuf M, 2013, NEUROGENETICS, V14, P63, DOI 10.1007/s10048-012-0350-9	58	156	158	7	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2019	22	2					180	+		10.1038/s41593-018-0293-z	http://dx.doi.org/10.1038/s41593-018-0293-z			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HI9BQ	30643298	Green Accepted, Green Submitted			2022-12-17	WOS:000456750100005
J	Faraco, G; Brea, D; Garcia-Bonilla, L; Wang, G; Racchumi, G; Chang, H; Buendia, I; Santisteban, MM; Segarral, SG; Koizumi, K; Sugiyama, Y; Murphy, M; Voss, H; Anrather, J; Ladecola, C				Faraco, Giuseppe; Brea, David; Garcia-Bonilla, Lidia; Wang, Gang; Racchumi, Gianfranco; Chang, Haejoo; Buendia, Izaskun; Santisteban, Monica M.; Segarral, Steven G.; Koizumi, Kenzo; Sugiyama, Yukio; Murphy, Michelle; Voss, Henning; Anrather, Joseph; Ladecola, Costantino			Dietary salt promotes neurovascular and cognitive dysfunction through a gut-initiated TH17 response	NATURE NEUROSCIENCE			English	Article							PATHOGENIC T(H)17 CELLS; CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; HYPERTENSION; DISEASE; SODIUM; HEALTH; MICE; PHOSPHORYLATION	A diet rich in salt is linked to an increased risk of cerebrovascular diseases and dementia, but it remains unclear how dietary salt harms the brain. We report that, in mice, excess dietary salt suppresses resting cerebral blood flow and endothelial function, leading to cognitive impairment. The effect depends on expansion of TH17 cells in the small intestine, resulting in a marked increase in plasma interleukin-17 (IL-17). Circulating IL-17, in turn, promotes endothelial dysfunction and cognitive impairment by the Rho kinase-dependent inhibitory phosphorylation of endothelial nitric oxide synthase and reduced nitric oxide production in cerebral endothelial cells. The findings reveal a new gut-brain axis linking dietary habits to cognitive impairment through a gut-initiated adaptive immune response compromising brain function via circulating IL-17. Thus, the TH17 cell-IL-17 pathway is a putative target to counter the deleterious brain effects induced by dietary salt and other diseases associated with TH17 polarization.	[Faraco, Giuseppe; Brea, David; Garcia-Bonilla, Lidia; Wang, Gang; Racchumi, Gianfranco; Chang, Haejoo; Buendia, Izaskun; Santisteban, Monica M.; Segarral, Steven G.; Koizumi, Kenzo; Sugiyama, Yukio; Murphy, Michelle; Anrather, Joseph; Ladecola, Costantino] Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA; [Voss, Henning] Weill Cornell Med, Dept Radiol, New York, NY USA	Cornell University; Cornell University	Ladecola, C (corresponding author), Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA.	coi2001@med.cornell.edu	Buendia, Izaskun/AAB-2338-2020; Voss, Henning/C-2194-2009; Santisteban, Monica M./AAF-6093-2021; Faraco, Giuseppe/AAP-6784-2020; Brea López, David/M-1128-2015; Iadecola, c/ABB-8377-2020	Voss, Henning/0000-0003-2811-2074; Santisteban, Monica M./0000-0002-2836-9075; Faraco, Giuseppe/0000-0001-8675-4580; Brea López, David/0000-0003-2365-7374; Sugiyama, Yukio/0000-0002-5712-9599; Buendia, Izaskun/0000-0002-1021-7444	Feil Family Foundation; National Institutes of Health [R37-NS089323, IR01-NS095441]; American Heart Association; Fondation Leducq (Sphingonet); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS089323, R01NS095441] Funding Source: NIH RePORTER	Feil Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fondation Leducq (Sphingonet); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully acknowledge support from the Feil Family Foundation. This work was supported by National Institutes of Health grants R37-NS089323 (C.I.) and IR01-NS095441 (C.I.), by a Scientist Development Grant from the American Heart Association (G.F.) and by a network grant from the Fondation Leducq (Sphingonet) (C.L., J.A., G.F.).	Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Binger KJ, 2015, J CLIN INVEST, V125, P4223, DOI 10.1172/JCI80919; Boegehold MA, 2013, J VASC RES, V50, P458, DOI 10.1159/000355270; Chen BR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000787; Cochet H, 2013, EUR RADIOL, V23, P332, DOI 10.1007/s00330-012-2598-8; Cohen SJ, 2013, CURR BIOL, V23, P1685, DOI 10.1016/j.cub.2013.07.002; Cosic A, 2016, J PHYSIOL-LONDON, V594, P4917, DOI 10.1113/JP272297; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Faraco G, 2016, J CLIN INVEST, V126, P4674, DOI 10.1172/JCI86950; Faraco G, 2013, HYPERTENSION, V62, P759, DOI 10.1161/HYPERTENSIONAHA.113.01761; Farquhar WB, 2015, J AM COLL CARDIOL, V65, P1042, DOI 10.1016/j.jacc.2014.12.039; Ferro Jose M, 2014, Handb Clin Neurol, V120, P595, DOI 10.1016/B978-0-7020-4087-0.00040-1; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Guterbaum TJ, 2013, J VASC RES, V50, P410, DOI 10.1159/000354225; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Hernandez AL, 2015, J CLIN INVEST, V125, P4212, DOI 10.1172/JCI81151; Heye AK, 2016, J CEREBR BLOOD F MET, V36, P264, DOI 10.1038/jcbfm.2015.64; Nguyen H, 2013, CARDIOVASC RES, V97, P696, DOI 10.1093/cvr/cvs422; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Jackman KA, 2014, STROKE, V45, P1460, DOI 10.1161/STROKEAHA.114.004816; Katusic ZS, 2014, EUR HEART J, V35, P888, DOI 10.1093/eurheartj/eht544; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Kotchen TA, 2013, NEW ENGL J MED, V368, P1229, DOI 10.1056/NEJMra1212606; Liou TH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05110; Love S, 2016, BRAIN PATHOL, V26, P607, DOI 10.1111/bpa.12401; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Marshall O, 2014, JAMA NEUROL, V71, P1275, DOI 10.1001/jamaneurol.2014.1668; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Nicholls MG, 2011, CURR HYPERTENS REP, V13, P325, DOI 10.1007/s11906-011-0216-9; Oh YS, 2016, HYPERTENSION, V68, P281, DOI 10.1161/HYPERTENSIONAHA.116.07415; Park L, 2011, P NATL ACAD SCI USA, V108, P5063, DOI 10.1073/pnas.1015413108; Poggesi A, 2016, J CEREBR BLOOD F MET, V36, P72, DOI 10.1038/jcbfm.2015.116; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; ROSENBLUM WI, 1992, AM J PHYSIOL, V262, pH961, DOI 10.1152/ajpheart.1992.262.4.H961; Schlote J, 2013, KIDNEY BLOOD PRESS R, V37, P379, DOI 10.1159/000355716; Smith L, 2003, HYPERTENSION, V41, P787, DOI 10.1161/01.HYP.0000051643.05700.56; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Sugimoto M, 2007, BIOCHEM BIOPH RES CO, V361, P462, DOI 10.1016/j.bbrc.2007.07.030; Tablazon ILD, 2013, AM J CLIN DERMATOL, V14, P1, DOI 10.1007/s40257-012-0005-5; Toda N, 2009, PHARMACOL REV, V61, P62, DOI 10.1124/pr.108.000547; Wang G, 2013, AM J PHYSIOL-REG I, V304, pR1096, DOI 10.1152/ajpregu.00367.2012; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; ZEMEL MB, 1988, AM J CARDIOL, V61, pH7, DOI 10.1016/0002-9149(88)91098-3; 2010, STRATEGIES REDUCE SO, P1	50	156	161	8	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2018	21	2					240	+		10.1038/s41593-017-0059-z	http://dx.doi.org/10.1038/s41593-017-0059-z			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV0TB	29335605	Green Accepted			2022-12-17	WOS:000424269900015
J	Herrera, CG; Cadavieco, MC; Jego, S; Ponomarenko, A; Korotkova, T; Adamantidis, A				Herrera, Carolina Gutierrez; Cadavieco, Marta Carus; Jego, Sonia; Ponomarenko, Alexey; Korotkova, Tatiana; Adamantidis, Antoine			Hypothalamic feedforward inhibition of thalamocortical network controls arousal and consciousness	NATURE NEUROSCIENCE			English	Article							LESS-THAN-1 HZ OSCILLATION; RETICULAR NUCLEUS; GABAERGIC NEURONS; THALAMIC NEURONS; SLEEP; HYPOCRETIN; DYNAMICS; SYSTEM; LEPTIN; OREXIN	During non-rapid eye movement (NREM) sleep, synchronous synaptic activity in the thalamocortical network generates predominantly low-frequency oscillations (< 4 Hz) that are modulated by inhibitory inputs from the thalamic reticular nucleus (TRN). Whether TRN cells integrate sleep-wake signals from subcortical circuits remains unclear. We found that GABA neurons from the lateral hypothalamus (LHGABA) exert a strong inhibitory control over TRN GABA neurons (TRNGABA). We found that optogenetic activation of this circuit recapitulated state-dependent changes of TRN neuron activity in behaving mice and induced rapid arousal during NREM, but not REM, sleep. During deep anesthesia, activation of this circuit induced sustained cortical arousal. In contrast, optogenetic silencing of LHGABA-TRNGABA transmission increased the duration of NREM sleep and amplitude of delta (1-4 Hz) oscillations. Collectively, these results demonstrate that TRN cells integrate subcortical arousal inputs selectively during NREM sleep and may participate in sleep intensity.	[Herrera, Carolina Gutierrez; Adamantidis, Antoine] Univ Bern, Inselspital Univ Hosp, Dept Neurol, Bern, Switzerland; [Herrera, Carolina Gutierrez; Jego, Sonia; Adamantidis, Antoine] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Herrera, Carolina Gutierrez; Adamantidis, Antoine] Univ Bern, Dept Preclin Res DKF, Bern, Switzerland; [Cadavieco, Marta Carus; Ponomarenko, Alexey; Korotkova, Tatiana] Leibniz Inst Mol Pharmacol FMP, NeuroCure Cluster Excellence, Berlin, Germany	University of Bern; University Hospital of Bern; McGill University; University of Bern; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Adamantidis, A (corresponding author), Univ Bern, Inselspital Univ Hosp, Dept Neurol, Bern, Switzerland.; Adamantidis, A (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.; Adamantidis, A (corresponding author), Univ Bern, Dept Preclin Res DKF, Bern, Switzerland.	antoine.adamantidis@dkf.unibe.ch	Ponomarenko, Alexey/F-7783-2017; Core, Vector/CAF-4832-2022; Schindler, Kaspar/L-7115-2013	Ponomarenko, Alexey/0000-0002-5185-0107; Schindler, Kaspar/0000-0002-2387-7767; Carus Cadavieco, Marta/0000-0003-4050-9138; Gutierrez Herrera, Carolina/0000-0002-7916-3341; Adamantidis, Antoine/0000-0003-2531-5175	Strauss Clinical Fellowship; Human Frontier Science Program [RGY0076/2012]; Douglas Foundation; McGill University; Canadian Fund for Innovation (CFI); Canadian Research Chair (CRC Tier 2); Canadian Institute for Health Research (CIHR); Natural Science and Engineering Council of Canada (NSERC); Inselspital; Swiss National Fund; University of Bern; Deutsche Forschungsgemeinschaft (DFG) [Exc 257 NeuroCure, SPP1665]	Strauss Clinical Fellowship; Human Frontier Science Program(Human Frontier Science Program); Douglas Foundation; McGill University; Canadian Fund for Innovation (CFI)(Canada Foundation for Innovation); Canadian Research Chair (CRC Tier 2); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Inselspital; Swiss National Fund(Swiss National Science Foundation (SNSF)); University of Bern; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank the Tidis laboratory members for their technical help and comments on a previous version of the manuscript. We thank the laboratory of H.-R. Widmer for the use of the fluorescence microscope, and the animal facility personnel at the Douglas Research Center. Optogenetic plasmids were kindly provided by K. Deisseroth (Stanford University). LT-HSV-GFP was kindly provided by M. Mameli (Institut du Fer a Moulin). C.G.H. was supported by a Strauss Clinical Fellowship. A. A. and T.K. were supported by the Human Frontier Science Program (RGY0076/2012). A. A. was supported by the Douglas Foundation, McGill University, Canadian Fund for Innovation (CFI), Canadian Research Chair (CRC Tier 2), Canadian Institute for Health Research (CIHR) and the Natural Science and Engineering Council of Canada (NSERC), Inselspital, Swiss National Fund and University of Bern. T.K. and A.P. were supported by the Deutsche Forschungsgemeinschaft (DFG; Exc 257 NeuroCure, T.K. and A. P.; SPP1665, A.P.).	Adamantidis A, 2008, EUR J NEUROSCI, V27, P1793, DOI 10.1111/j.1460-9568.2008.06129.x; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Andrada J, 2012, ANESTH ANALG, V114, P661, DOI 10.1213/ANE.0b013e3182405228; BARONE FC, 1994, BRAIN RES BULL, V33, P575, DOI 10.1016/0361-9230(94)90083-3; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Bonnavion P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7266; BORBELY AA, 1989, J BIOL RHYTHM, V4, P149; Brill J, 2007, PEPTIDES, V28, P250, DOI 10.1016/j.peptides.2006.08.043; Browne SH, 2001, J NEUROPHYSIOL, V86, P2312, DOI 10.1152/jn.2001.86.5.2312; Carter ME, 2012, P NATL ACAD SCI USA, V109, pE2635, DOI 10.1073/pnas.1202526109; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Carter ME, 2009, J NEUROSCI, V29, P10939, DOI 10.1523/JNEUROSCI.1205-09.2009; CONTRERAS D, 1993, J PHYSIOL-LONDON, V470, P273, DOI 10.1113/jphysiol.1993.sp019858; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; Cox CL, 1997, J NEUROSCI, V17, P70, DOI 10.1523/JNEUROSCI.17-01-00070.1997; Cox CL, 1997, P NATL ACAD SCI USA, V94, P8854, DOI 10.1073/pnas.94.16.8854; DESTEXHE A, 1994, NEUROREPORT, V5, P2217, DOI 10.1097/00001756-199411000-00003; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Fuentealba P, 2005, PROG NEUROBIOL, V75, P125, DOI 10.1016/j.pneurobio.2005.01.002; Giber K, 2015, NAT NEUROSCI, V18, P562, DOI 10.1038/nn.3951; Golshani P, 2001, P NATL ACAD SCI USA, V98, P4172, DOI 10.1073/pnas.061013698; Halassa MM, 2014, CELL, V158, P808, DOI 10.1016/j.cell.2014.06.025; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hassani OK, 2010, EUR J NEUROSCI, V32, P448, DOI 10.1111/j.1460-9568.2010.07295.x; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007; Huntsman MM, 2006, J PHYSIOL-LONDON, V572, P459, DOI 10.1113/jphysiol.2006.106617; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Kempadoo KA, 2013, J NEUROSCI, V33, P7618, DOI 10.1523/JNEUROSCI.2588-12.2013; Kim A, 2012, P NATL ACAD SCI USA, V109, P20673, DOI 10.1073/pnas.1217897109; Kim U, 1997, SCIENCE, V278, P130, DOI 10.1126/science.278.5335.130; Knyihar-Csillik E, 2005, ANN ANAT, V187, P245, DOI 10.1016/j.aanat.2004.11.004; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Le Masson G, 2002, NATURE, V417, P854, DOI 10.1038/nature00825; Lee SH, 2012, NEURON, V76, P209, DOI 10.1016/j.neuron.2012.09.012; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Lorincz ML, 2015, J NEUROSCI, V35, P5442, DOI 10.1523/JNEUROSCI.3603-14.2015; MacDonald KD, 1998, J NEUROPHYSIOL, V79, P474, DOI 10.1152/jn.1998.79.1.474; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Nieh EH, 2015, CELL, V160, P528, DOI 10.1016/j.cell.2015.01.003; Peyron C, 1998, J NEUROSCI, V18, P9996; Pita-Almenar JD, 2014, J NEUROSCI, V34, P14463, DOI 10.1523/JNEUROSCI.2321-14.2014; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Schone C, 2014, CELL REP, V7, P697, DOI 10.1016/j.celrep.2014.03.055; Schofield CM, 2007, J NEUROSCI, V27, P7954, DOI 10.1523/JNEUROSCI.0377-07.2007; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Steriade M, 2003, FRONT BIOSCI-LANDMRK, V8, pD878, DOI 10.2741/1043; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Sun YG, 2013, J NEUROSCI, V33, P2048, DOI 10.1523/JNEUROSCI.3177-12.2013; Timofeev I, 2011, CURR TOP MED CHEM, V11, P2457, DOI 10.2174/156802611797470376; Tortorella S, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00216; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106; Zhang Z, 2015, NAT NEUROSCI, V18, P553, DOI 10.1038/nn.3957	60	156	161	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2016	19	2					290	+		10.1038/nn.4209	http://dx.doi.org/10.1038/nn.4209			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DC4EG	26691833	Green Accepted			2022-12-17	WOS:000369172600017
J	Mosher, KI; Andres, RH; Fukuhara, T; Bieri, G; Hasegawa-Moriyama, M; He, YB; Guzman, R; Wyss-Coray, T				Mosher, Kira I.; Andres, Robert H.; Fukuhara, Takeshi; Bieri, Gregor; Hasegawa-Moriyama, Maiko; He, Yingbo; Guzman, Raphael; Wyss-Coray, Tony			Neural progenitor cells regulate microglia functions and activity	NATURE NEUROSCIENCE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; ENDOTHELIAL GROWTH-FACTOR; RECOVERY; BRAIN	We found mouse neural progenitor cells (NPCs) to have a secretory protein profile distinct from other brain cells and to modulate microglial activation, proliferation and phagocytosis. NPC-derived vascular endothelial growth factor was necessary and sufficient to exert at least some of these effects in mice. Thus, neural precursor cells may not only be shaped by microglia, but also regulate microglia functions and activity.	[Mosher, Kira I.; Fukuhara, Takeshi; Bieri, Gregor; Hasegawa-Moriyama, Maiko; He, Yingbo; Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Mosher, Kira I.; Bieri, Gregor] Stanford Univ, Sch Med, Neurosci IDP Program, Stanford, CA 94305 USA; [Andres, Robert H.; Guzman, Raphael] Stanford Univ, Med Ctr, Dept Neurosurg, Stanford, CA 94305 USA; [Wyss-Coray, Tony] Vet Adm Palo Alto Hlth Care Syst, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University	Wyss-Coray, T (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	raphaelg@stanford.edu; twc@stanford.edu	Wyss-Coray, Tony/AAF-3380-2019; Fukuhara, Takeshi/GLN-6928-2022	Wyss-Coray, Tony/0000-0001-5893-0831; Guzman, Raphael/0000-0001-9620-0581; Mosher, Kira/0000-0002-3041-3186	National Institute of Neurological Disorders and Stroke [NS069375-01A1]; Department of Veterans Affairs; US National Institutes of Health Institute on Aging [R01 AG027505]; California Initiative for Regenerative Medicine; National Science Foundation; Ruth L. Kirschstein NRSA [1 F31 AG040877-01A1]; Swiss National Science Foundation [PBBEB-117034, PASMP3-123221/1]; Evelyn L. Neizer Fund; American Heart Association [AHA 083527N]; Bechtel Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG040877, R01AG027505] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Veterans Affairs(US Department of Veterans Affairs); US National Institutes of Health Institute on Aging; California Initiative for Regenerative Medicine; National Science Foundation(National Science Foundation (NSF)); Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Evelyn L. Neizer Fund; American Heart Association(American Heart Association); Bechtel Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors wish to thank S. Villeda and R. Wabl for assistance with the neural progenitor cell cultures and M. Lochrie and the Stanford Neuroscience Gene Vector and Virus Core for generating the shRNA lentiviruses (supported by National Institute of Neurological Disorders and Stroke P30 core grant, NS069375-01A1). This work was supported by grants from the Department of Veterans Affairs (T.W.-C.) and US National Institutes of Health Institute on Aging (R01 AG027505, T.W.-C.), a California Initiative for Regenerative Medicine Award (T.W.-C.), a National Science Foundation predoctoral fellowship (K.I.M.), a Ruth L. Kirschstein NRSA predoctoral fellowship (1 F31 AG040877-01A1, K.I.M.), the Swiss National Science Foundation (PBBEB-117034 and PASMP3-123221/1, R.H.A.), the Evelyn L. Neizer Fund (R.H.A.), the American Heart Association (AHA 083527N, R.G.), and the Bechtel Foundation (R.G.).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Forstreuter F, 2002, J NEUROIMMUNOL, V132, P93, DOI 10.1016/S0165-5728(02)00315-6; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Klassen HJ, 2003, CYTOKINE, V22, P101, DOI 10.1016/S1043-4666(03)00120-0; Lu ZJ, 2011, NAT CELL BIOL, V13, P1076, DOI 10.1038/ncb2299; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moriyama M, 2011, J NEUROSCI, V31, P3981, DOI 10.1523/JNEUROSCI.3617-10.2011; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pluchino S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005959; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Skalnikova H, 2011, PROTEOMICS, V11, P691, DOI 10.1002/pmic.201000402; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103; ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4	14	156	165	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1485	1487		10.1038/nn.3233	http://dx.doi.org/10.1038/nn.3233			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23086334	Green Accepted, Green Published			2022-12-17	WOS:000310424900007
J	Kauer, TM; Figueiredo, JL; Hingtgen, S; Shah, K				Kauer, Timo M.; Figueiredo, Jose-Luiz; Hingtgen, Shawn; Shah, Khalid			Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas	NATURE NEUROSCIENCE			English	Article							GLIOBLASTOMA-MULTIFORME CELLS; RADIOTHERAPY PLUS CONCOMITANT; IN-VIVO; S-TRAIL; ADJUVANT TEMOZOLOMIDE; MALIGNANT GLIOMA; BRAIN-TUMORS; APOPTOSIS; DELIVERY; CANCER	Therapeutically engineered stem cells have shown promise for glioblastoma multiforme (GBM) therapy; however, key preclinical studies are urgently needed for their clinical translation. In this study, we investigated a new approach to GBM treatment using therapeutic stem cells encapsulated in biodegradable, synthetic extracellular matrix (sECM) in mouse models of human GBM resection. Using multimodal imaging, we first showed quantitative surgical debulking of human GBM tumors in mice, which resulted in increased survival. Next, sECM encapsulation of engineered stem cells increased their retention in the tumor resection cavity, permitted tumor-selective migration and release of diagnostic and therapeutic proteins in vivo. Simulating the clinical scenario of GBM treatment, the release of tumor-selective S-TRAIL (secretable tumor necrosis factor apoptosis inducing ligand) from sECM-encapsulated stem cells in the resection cavity eradicated residual tumor cells by inducing caspase-mediated apoptosis, delayed tumor regrowth and significantly increased survival of mice. This study demonstrates the efficacy of encapsulated therapeutic stem cells in mouse models of GBM resection and may have implications for developing effective therapies for GBM.	[Kauer, Timo M.; Figueiredo, Jose-Luiz; Hingtgen, Shawn; Shah, Khalid] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurotherapy & Imaging Lab, Boston, MA 02114 USA; [Kauer, Timo M.; Figueiredo, Jose-Luiz; Hingtgen, Shawn; Shah, Khalid] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Shah, Khalid] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Shah, Khalid] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Shah, K (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurotherapy & Imaging Lab, Boston, MA 02114 USA.	kshah@helix.mgh.harvard.edu			Alliance for Cancer Cell and Gene Therapy; American Cancer Society; James McDonald Foundation; NATIONAL CANCER INSTITUTE [R01CA138922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071197] Funding Source: NIH RePORTER	Alliance for Cancer Cell and Gene Therapy; American Cancer Society(American Cancer Society); James McDonald Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Prestwich (University of Utah) and T. Zarembinski (Biotime Inc.) for providing us with sECMs, H. Wakimoto (Massachusetts General Hospital) for providing the primary GBM lines and D. Bhere for critical reading of the manuscript. This work was supported by the Alliance for Cancer Cell and Gene Therapy (K.S.), American Cancer Society (K.S.) and James McDonald Foundation (K.S.).	Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Affronti ML, 2009, CANCER, V115, P3501, DOI 10.1002/cncr.24398; Akbar U, 2009, J NEURO-ONCOL, V94, P203, DOI 10.1007/s11060-009-9857-9; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Asthagiri AR, 2007, NEUROL CLIN, V25, P975, DOI 10.1016/j.ncl.2007.07.006; Bagci-Onder T, 2011, CANCER RES, V71, P154, DOI 10.1158/0008-5472.CAN-10-1601; Balyasnikova IV, 2011, CANCER LETT, V310, P148, DOI 10.1016/j.canlet.2011.06.029; Chen JA, 2010, TUMOR BIOL, V31, P613, DOI 10.1007/s13277-010-0077-x; Choi SA, 2012, EUR J CANCER, V48, P129, DOI 10.1016/j.ejca.2011.04.033; Corsten MF, 2008, LANCET ONCOL, V9, P376, DOI 10.1016/S1470-2045(08)70099-8; de Oliveira MS, 2009, J NEURO-ONCOL, V93, P191, DOI 10.1007/s11060-008-9775-2; Ehtesham M, 2002, CANCER RES, V62, P7170; Erpolat OP, 2009, TUMORI J, V95, P191; Germano IM, 2006, J NEUROSURG, V105, P88, DOI 10.3171/jns.2006.105.1.88; Grigoriadis N, 2011, EXP NEUROL, V230, P78, DOI 10.1016/j.expneurol.2011.02.021; Hall B, 2007, INT J HEMATOL, V86, P8, DOI 10.1532/IJH97.06230; Hingtgen S, 2008, MOL CANCER THER, V7, P3575, DOI 10.1158/1535-7163.MCT-08-0640; Hingtgen SD, 2010, STEM CELLS, V28, P832, DOI 10.1002/stem.313; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Kahana S, 2011, CELL SIGNAL, V23, P1348, DOI 10.1016/j.cellsig.2011.03.017; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim SM, 2010, STEM CELLS, V28, P2217, DOI 10.1002/stem.543; Kock N, 2007, NEOPLASIA, V9, P435, DOI 10.1593/neo.07223; Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016; Mattis VB, 2011, LANCET NEUROL, V10, P383, DOI 10.1016/S1474-4422(11)70022-9; Menon LG, 2009, STEM CELLS, V27, P2320, DOI 10.1002/stem.136; Minniti G, 2008, J NEURO-ONCOL, V88, P97, DOI 10.1007/s11060-008-9538-0; Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005; Muldoon LL, 2007, J CLIN ONCOL, V25, P2295, DOI 10.1200/JCO.2006.09.9861; Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685; Pan LJ, 2009, J NEUROSCI RES, V87, P3207, DOI 10.1002/jnr.22142; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Panner A, 2005, MOL CELL BIOL, V25, P8809, DOI 10.1128/MCB.25.20.8809-8823.2005; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Potter W, 2008, FRONT BIOSCI-LANDMRK, V13, P806, DOI 10.2741/2721; Ren B, 2009, CANCER RES, V69, P3856, DOI 10.1158/0008-5472.CAN-08-2940; Rieger J, 1998, FEBS LETT, V427, P124, DOI 10.1016/S0014-5793(98)00409-8; Sarin H, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-77; Sasportas LS, 2009, P NATL ACAD SCI USA, V106, P4822, DOI 10.1073/pnas.0806647106; Shah K, 2008, J NEUROSCI, V28, P4406, DOI 10.1523/JNEUROSCI.0296-08.2008; Shah K, 2012, ADV DRUG DELIVER REV, V64, P739, DOI 10.1016/j.addr.2011.06.010; Siegelin MD, 2009, NEUROSCI LETT, V454, P223, DOI 10.1016/j.neulet.2009.03.031; Snyder EY, 2011, EXP NEUROL, V230, P75, DOI 10.1016/j.expneurol.2011.03.012; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Terrovitis J, 2008, J AM COLL CARDIOL, V52, P1652, DOI 10.1016/j.jacc.2008.06.051; Tian XB, 2011, J BIOL CHEM, V286, P29408, DOI 10.1074/jbc.M110.197665; van Eekelen M, 2010, ONCOGENE, V29, P3185, DOI 10.1038/onc.2010.75; Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xu XY, 2009, PROSTAG OTH LIPID M, V89, P140, DOI 10.1016/j.prostaglandins.2009.07.006	50	156	162	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					197	204		10.1038/nn.3019	http://dx.doi.org/10.1038/nn.3019			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22197831	Green Accepted			2022-12-17	WOS:000299603500010
J	Chatzigeorgiou, M; Yoo, S; Watson, JD; Lee, WH; Spencer, WC; Kindt, KS; Hwang, SW; Miller, DM; Treinin, M; Driscoll, M; Schafer, WR				Chatzigeorgiou, Marios; Yoo, Sungjae; Watson, Joseph D.; Lee, Wei-Hsiang; Spencer, W. Clay; Kindt, Katie S.; Hwang, Sun Wook; Miller, David M., III; Treinin, Millet; Driscoll, Monica; Schafer, William R.			Specific roles for DEG/ENaC and TRP channels in touch and thermosensation in C. elegans nociceptors	NATURE NEUROSCIENCE			English	Article							CAPSAICIN RECEPTOR; GENE-EXPRESSION; MOTOR-NEURONS; ION-CHANNEL; ASH NEURONS; PAIN; MECHANOSENSATION; IDENTIFICATION; ADAPTATION; BEHAVIOR	Polymodal nociceptors detect noxious stimuli, including harsh touch, toxic chemicals and extremes of heat and cold. The molecular mechanisms by which nociceptors are able to sense multiple qualitatively distinct stimuli are not well understood. We found that the C. elegans PVD neurons are mulitidendritic nociceptors that respond to harsh touch and cold temperatures. The harsh touch modality specifically required the DEG/ENaC proteins MEC-10 and DEGT-1, which represent putative components of a harsh touch mechanotransduction complex. In contrast, responses to cold required the TRPA-1 channel and were MEC-10 and DEGT-1 independent. Heterologous expression of C. elegans TRPA-1 conferred cold responsiveness to other C. elegans neurons and to mammalian cells, indicating that TRPA-1 is a cold sensor. Our results suggest that C. elegans nociceptors respond to thermal and mechanical stimuli using distinct sets of molecules and identify DEG/ENaC channels as potential receptors for mechanical pain.	[Chatzigeorgiou, Marios; Schafer, William R.] MRC Lab Mol Biol, Div Cell Biol, Cambridge, England; [Yoo, Sungjae; Hwang, Sun Wook] Korea Univ, Grad Sch Med, Seoul, South Korea; [Watson, Joseph D.; Spencer, W. Clay; Miller, David M., III] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN USA; [Lee, Wei-Hsiang; Driscoll, Monica] Rutgers State Univ, Dept Mol Biol & Biochem, Nelson Biol Labs, Piscataway, NJ 08855 USA; [Kindt, Katie S.; Schafer, William R.] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; [Treinin, Millet] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Med Neurobiol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel	MRC Laboratory Molecular Biology; Korea University; Korea University Medicine (KU Medicine); Vanderbilt University; Rutgers State University New Brunswick; University of California System; University of California San Diego; Hebrew University of Jerusalem	Schafer, WR (corresponding author), MRC Lab Mol Biol, Div Cell Biol, Cambridge, England.	wschafer@mrc-lmb.cam.ac.uk	Kindt, Katie/AAS-3275-2020; Spencer, William/E-8529-2010	Schafer, William/0000-0002-6676-8034; Hwang, Sun Wook/0000-0001-8460-7480	Medical Research Council; National Institute on Drug Abuse; National Institute of Neurological Disorders and Stroke; Ministry of Education, Science and Technology of Korea [M103KV010015-06K2201-01510]; National Research Foundation of Korea [KRF-2008-331-E00457, 2009-0076543]; US-Israel Binational Science Foundation [2005036]; MRC [MC_U105185857] Funding Source: UKRI; Medical Research Council [MC_U105185857] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034435, R01NS026115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016445] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the Caenorhabditis Genetics Center, the National Bioresource Project and the Mitani laboratory for worm strains, N. Barry for help with microscopy, I. Rabinowitz for writing software to analyze averaged ratio traces, D. Cattermole and P. Heard in the LMB technical workshop for designing and building thermal controllers, the Vanderbilt Functional Genomics Shared Resource for help with microarray experiments and R. Branicky for comments on the manuscript. This research was supported by the Medical Research Council and grants from the National Institute on Drug Abuse (W.R.S.) and the National Institute of Neurological Disorders and Stroke (M.D. and D.M.M.), from the Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Education, Science and Technology of Korea (code M103KV010015-06K2201-01510) and National Research Foundation of Korea (codes KRF-2008-331-E00457 and 2009-0076543) to S.W.H., and from the US-Israel Binational Science Foundation (grant 2005036 to M.T. and D.M.M.).	Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bianchi L, 2004, NAT NEUROSCI, V7, P1337, DOI 10.1038/nn1347; Bounoutas A, 2007, PFLUG ARCH EUR J PHY, V454, P691, DOI 10.1007/s00424-006-0187-x; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Colbert HA, 1997, J NEUROSCI, V17, P8259; CROLL NA, 1975, J ZOOL, V176, P159, DOI 10.1111/j.1469-7998.1975.tb03191.x; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Fox RM, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-42; GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Goodman Miriam B, 2006, WormBook, P1; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Hall DH., 2008, C ELEGANS ATLAS; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Kahn-Kirby AH, 2006, ANNU REV PHYSIOL, V68, P719, DOI 10.1146/annurev.physiol.68.040204.100715; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kerr Rex A, 2006, WormBook, P1; Kindt KS, 2007, NAT NEUROSCI, V10, P568, DOI 10.1038/nn1886; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; SMITH CJ, DEV BIOL IN PRESS; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Srivastava N, 2009, J NEUROPHYSIOL, V102, P1172, DOI 10.1152/jn.90952.2008; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; Von Stetina SE, 2007, GENE DEV, V21, P332, DOI 10.1101/gad.1502107; Watson JD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-84; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Yassin L, 2002, BIOCHEMISTRY-US, V41, P12329, DOI 10.1021/bi020193y; Zhang SF, 2004, CURR BIOL, V14, P1888, DOI 10.1016/j.cub.2004.10.030; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	48	156	162	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					861	U106		10.1038/nn.2581	http://dx.doi.org/10.1038/nn.2581			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20512132	Green Accepted			2022-12-17	WOS:000279173900019
J	Kim, JY; Shen, S; Dietz, K; He, Y; Howell, O; Reynolds, R; Casaccia, P				Kim, Jin Young; Shen, Siming; Dietz, Karen; He, Ye; Howell, Owain; Reynolds, Richard; Casaccia, Patrizia			HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage	NATURE NEUROSCIENCE			English	Article							MULTIPLE-SCLEROSIS; HISTONE DEACETYLASES; NEURONAL DAMAGE; CELL-DEATH; TRANSPORT; INHIBITORS; PROTEIN; DEMYELINATION; DISEASE; INJURY	Histone deacetylase 1 (HDAC1) is a nuclear enzyme involved in transcriptional repression. We detected cytosolic HDAC1 in damaged axons in brains of humans with multiple sclerosis and of mice with cuprizone-induced demyelination, in ex vivo models of demyelination and in cultured neurons exposed to glutamate and tumor necrosis factor-alpha. Nuclear export of HDAC1 was mediated by the interaction with the nuclear receptor CRM-1 and led to impaired mitochondrial transport. The formation of complexes between exported HDAC1 and members of the kinesin family of motor proteins hindered the interaction with cargo molecules, thereby inhibiting mitochondrial movement and inducing localized beading. This effect was prevented by inhibiting HDAC1 nuclear export with leptomycin B, treating neurons with pharmacological inhibitors of HDAC activity or silencing HDAC1 but not other HDAC isoforms. Together these data identify nuclear export of HDAC1 as a critical event for impaired mitochondrial transport in damaged neurons.	[Kim, Jin Young; Shen, Siming; Casaccia, Patrizia] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Grad Sch Biomed Sci, Grad Program Neurosci, Piscataway, NJ 08854 USA; [Kim, Jin Young; Dietz, Karen; He, Ye; Casaccia, Patrizia] Mt Sinai Sch Med, Dept Neurosci & Genet & Genom, New York, NY USA; [Howell, Owain; Reynolds, Richard] Univ London Imperial Coll Sci Technol & Med, Fac Med, Charing Cross Hosp Campus, Dept Cellular & Mol Neurosci,Div Neurosci & Menta, London, England	Rutgers State University New Brunswick; Rutgers State University Medical Center; Icahn School of Medicine at Mount Sinai; Imperial College London	Casaccia, P (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Grad Sch Biomed Sci, Grad Program Neurosci, Piscataway, NJ 08854 USA.	patrizia.casaccia@mssm.edu	He, Ye/G-7500-2011	KIM, Jin Young/0000-0003-4438-1872; Howell, Owain/0000-0003-2157-9157; He, Ye/0000-0002-3936-4958	New Jersey Multiple Sclerosis Research Foundation; NMSS [RG-3957]; New Jersey Commission [07-3203-BIR-E-0]; Christopher and Dana Reeve Foundation [CB1-0704-2];  [NIH-RO1 NS-42925]; MRC [G0700356] Funding Source: UKRI; Medical Research Council [G0700356] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042925] Funding Source: NIH RePORTER	New Jersey Multiple Sclerosis Research Foundation; NMSS(National Multiple Sclerosis Society); New Jersey Commission; Christopher and Dana Reeve Foundation; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the University of California Los Angeles Brain Bank and the UK MS Tissue Bank at Imperial College of London for providing the multiple sclerosis tissue samples, C. Seiser (University of Vienna) for providing the antibodies to the N-terminal domain of HDAC1, R. Bansal (University of Connecticut Health Science Center at Farmington) for anti-O4 hybridoma supernatant, X. Pedre and J. Li for rodent handling, S. Schreiber (Broad Institute, Massachusetts Institute of Technology) for tubacin, E. Nestler and H. Covington (Mount Sinai School of Medicine) for MS-275, S. Lagger for sharing unpublished results and critical comments on the manuscript, P. Lobel for discussions regarding MALDI-TOF data, J. Zheng and K. Teng for helpful discussion and R. Rosa for the support of the New Jersey Multiple Sclerosis Research Foundation. The study was supported by NIH-RO1 NS-42925 (P.C.) and NMSS RG-3957. J.Y.K.'s salary was supported in part also by grant no. 07-3203-BIR-E-0 from the New Jersey Commission on Traumatic Brain injury and CB1-0704-2 from the Christopher and Dana Reeve Foundation to P. C.	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6; Birgbauer E, 2004, J NEUROSCI RES, V78, P157, DOI 10.1002/jnr.20248; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Bruck W, 2005, J NEUROL, V252, pV3, DOI 10.1007/s00415-005-5002-7; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chen ZX, 2002, CANCER LETT, V188, P127, DOI 10.1016/S0304-3835(02)00322-1; Dasmahapatra G, 2006, MOL PHARMACOL, V69, P288, DOI 10.1124/mol.105.016154; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Fisher E, 2007, ANN NEUROL, V62, P219, DOI 10.1002/ana.21113; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Gu HD, 2005, P NATL ACAD SCI USA, V102, P7571, DOI 10.1073/pnas.0502658102; Hoshino M, 2003, J NEUROCHEM, V87, P257, DOI 10.1046/j.1471-4159.2003.01991.x; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kiaei M, 2005, NEURODEGENER DIS, V2, P246, DOI 10.1159/000090364; King AE, 2007, EUR J NEUROSCI, V26, P2151, DOI 10.1111/j.1460-9568.2007.05845.x; Kurnellas MP, 2007, BIOCHEM SOC T, V35, P923, DOI 10.1042/BST0350923; Li JD, 2008, J NEUROSCI, V28, P6118, DOI 10.1523/JNEUROSCI.0184-08.2008; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; Ouardouz M, 2009, ANN NEUROL, V65, P160, DOI 10.1002/ana.21539; PANT HC, 1988, BIOCHEM J, V256, P665, DOI 10.1042/bj2560665; Perez-Olle R, 2005, J NEUROCHEM, V93, P861, DOI 10.1111/j.1471-4159.2005.03095.x; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Schumacher PA, 1999, NEUROSCIENCE, V91, P733, DOI 10.1016/S0306-4522(98)00552-1; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Uo T, 2009, J NEUROSCI, V29, P2824, DOI 10.1523/JNEUROSCI.6186-08.2009; Viatour P, 2003, J BIOL CHEM, V278, P46541, DOI 10.1074/jbc.M306381200; WATSON DF, 1991, BRAIN RES, V539, P103, DOI 10.1016/0006-8993(91)90691-N; Wegner C, 2006, NEUROLOGY, V67, P960, DOI 10.1212/01.wnl.0000237551.26858.39; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yabe JT, 1999, J CELL SCI, V112, P3799; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang YG, 2001, J VIROL, V75, P9571, DOI 10.1128/JVI.75.20.9571-9578.2001	49	156	161	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					180	U63		10.1038/nn.2471	http://dx.doi.org/10.1038/nn.2471			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20037577	Green Accepted			2022-12-17	WOS:000273985800013
J	Chen, Y; Martinez-Conde, S; Macknik, SL; Bereshpolova, Y; Swadlow, HA; Alonso, JM				Chen, Yao; Martinez-Conde, Susana; Macknik, Stephen L.; Bereshpolova, Yulia; Swadlow, Harvey A.; Alonso, Jose-Manuel			Task difficulty modulates the activity of specific neuronal populations in primary visual cortex	NATURE NEUROSCIENCE			English	Article							AREA V4; SELECTIVE ATTENTION; SPATIAL ATTENTION; MACAQUE MONKEYS; CONTRAST SENSITIVITY; NEURAL MECHANISMS; EYE-MOVEMENTS; RESPONSES; LOAD; PERFORMANCE	Spatial attention enhances our ability to detect stimuli at restricted regions of the visual field. This enhancement is thought to depend on the difficulty of the task being performed, but the underlying neuronal mechanisms for this dependency remain largely unknown. We found that task difficulty modulates neuronal firing rate at the earliest stages of cortical visual processing (area V1) in monkey (Macaca mulatta). These modulations were spatially specific: increasing task difficulty enhanced V1 neuronal firing rate at the focus of attention and suppressed it in regions surrounding the focus. Moreover, we found that response enhancement and suppression are mediated by distinct populations of neurons that differ in direction selectivity, spike width, interspike-interval distribution and contrast sensitivity. Our results provide strong support for center-surround models of spatial attention and suggest that task difficulty modulates the activity of specific populations of neurons in the primary visual cortex.	[Chen, Yao; Alonso, Jose-Manuel] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA; [Martinez-Conde, Susana; Macknik, Stephen L.] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Bereshpolova, Yulia; Swadlow, Harvey A.] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA	State University of New York (SUNY) System; SUNY Optometry; Barrow Neurological Institute; University of Connecticut	Alonso, JM (corresponding author), SUNY Coll Optometry, Dept Biol Sci, 33W 42nd St, New York, NY 10036 USA.	jalonso@sunyopt.edu	Macknik, Stephen L./H-7704-2019	Macknik, Stephen L./0000-0002-3143-9230	NEI NIH HHS [R03 EY014345-03, R03 EY014345, EY14345] Funding Source: Medline; NIMH NIH HHS [R01 MH064024, MH-64024] Funding Source: Medline; NINDS NIH HHS [R21 NS059753-01A1, R21 NS059753] Funding Source: Medline; NATIONAL EYE INSTITUTE [R03EY014345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059753] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ardid S, 2007, J NEUROSCI, V27, P8486, DOI 10.1523/JNEUROSCI.1145-07.2007; Bahrami B, 2007, CURR BIOL, V17, P509, DOI 10.1016/j.cub.2007.01.070; Bichot NP, 2001, J NEUROSCI, V21, P713, DOI 10.1523/JNEUROSCI.21-02-00713.2001; Boudreau CE, 2006, J NEUROPHYSIOL, V96, P2377, DOI 10.1152/jn.01072.2005; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; Carrasco M, 2006, PROG BRAIN RES, V154, P33; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hasegawa RP, 2004, J NEUROPHYSIOL, V92, P1524, DOI 10.1152/jn.01110.2003; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Kelley TA, 2008, CEREB CORTEX, V18, P114, DOI 10.1093/cercor/bhm036; LABERGE D, 1991, J EXP PSYCHOL HUMAN, V17, P65, DOI 10.1037/0096-1523.17.1.65; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lavie N, 1997, PSYCHOL SCI, V8, P395, DOI 10.1111/j.1467-9280.1997.tb00432.x; Liu TS, 2005, NEURON, V45, P469, DOI 10.1016/j.neuron.2004.12.039; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; Martinez-Conde S, 2006, PROG BRAIN RES, V154, P151; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; MAUNSELL JHR, 2004, VISUAL NEUROSCIENCES, P1538; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Movshon JA, 1996, J NEUROSCI, V16, P7733; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Pestilli F, 2005, VISION RES, V45, P1867, DOI 10.1016/j.visres.2005.01.019; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Ringach DL, 2002, J NEUROSCI, V22, P5639; Roelfsema PR, 2004, NAT NEUROSCI, V7, P982, DOI 10.1038/nn1304; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; SPITZER H, 1991, EXP BRAIN RES, V83, P340; Super H, 2005, PROG BRAIN RES, V147, P263, DOI 10.1016/S0079-6123(04)47020-4; Swadlow HA, 2005, J NEUROPHYSIOL, V93, P2959, DOI 10.1152/jn.01141.2004; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Yantis S., 1996, CONVERGING OPERATION, P45, DOI DOI 10.1037/10187-002; Yoshor D, 2007, J NEUROSCI, V27, P13205, DOI 10.1523/JNEUROSCI.2944-07.2007	50	156	156	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					974	982		10.1038/nn.2147	http://dx.doi.org/10.1038/nn.2147			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18604204	Green Accepted			2022-12-17	WOS:000257969100024
J	Qiu, FTT; Sugihara, T; von der Heydt, R				Qiu, Fangtu T.; Sugihara, Tadashi; von der Heydt, Ruediger			Figure-ground mechanisms provide structure for selective attention	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; CORTICAL AREAS V1; NEURAL MECHANISMS; V4; V2; SEGMENTATION; MONKEY; ORGANIZATION; OBJECTS	Attention depends on figure- ground organization: figures draw attention, whereas shapes of the ground tend to be ignored. Recent research has revealed mechanisms for figure- ground organization in the visual cortex, but how these mechanisms relate to the attention process remains unclear. Here we show that the influences of figure- ground organization and volitional ( top- down) attention converge in single neurons of area V2 in Macaca mulatta. Although we found assignment of border ownership for attended and for ignored figures, attentional modulation was stronger when the attended figure was located on the neuron's preferred side of border ownership. When the border between two overlapping figures was placed in the receptive field, responses depended on the side of attention, and enhancement was generally found on the neuron's preferred side of border ownership. This correlation suggests that the neural network that creates figure- ground organization also provides the interface for the top- down selection process.	Johns Hopkins Univ, Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Qiu, FTT (corresponding author), Johns Hopkins Univ, Krieger Mind Brain Inst, 3400 N Charles St, Baltimore, MD 21218 USA.	von.der.heydt@jhu.edu		von der Heydt, Rudiger/0000-0002-8741-813X	NATIONAL EYE INSTITUTE [R01EY016281, R01EY002966] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY002966, R01 EY016281, EY16281, R01 EY002966-29A1, EY02966] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bender DB, 2001, J NEUROPHYSIOL, V85, P219, DOI 10.1152/jn.2001.85.1.219; Conner CE, 1997, J NEUROSCI, V17, P3201; Craft E, 2007, J NEUROPHYSIOL, V97, P4310, DOI 10.1152/jn.00203.2007; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Driver J, 1996, COGNITIVE PSYCHOL, V31, P248, DOI 10.1006/cogp.1996.0018; Driver J, 2001, COGNITION, V80, P61, DOI 10.1016/S0010-0277(00)00151-7; Friedman HS, 2003, J PHYSIOL-LONDON, V548, P593, DOI 10.1113/jphysiol.2002.033555; Girard P, 2001, J NEUROPHYSIOL, V85, P1328, DOI 10.1152/jn.2001.85.3.1328; Goldberg ME, 2006, PROG BRAIN RES, V155, P157, DOI 10.1016/S0079-6123(06)55010-1; GROSSBERG S, 1980, PSYCHOL REV, V87, P1, DOI 10.1037/0033-295X.87.1.1; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Koffka Kurt, 1999, PRINCIPLES GESTALT P; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MACK A, 1992, COGNITIVE PSYCHOL, V24, P475, DOI 10.1016/0010-0285(92)90016-U; Marcus DS, 2002, J NEUROPHYSIOL, V88, P2648, DOI 10.1152/jn.00916.2001; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MOTTER BC, 1994, J NEUROSCI, V14, P2190; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; Qiu FTT, 2007, NAT NEUROSCI, V10, P283, DOI 10.1038/nn1853; Qiu FTT, 2005, NEURON, V47, P155, DOI 10.1016/j.neuron.2005.05.028; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Rubin E., 1921, VISUELL WAHRGENOMMEN; SCHILLER PH, 1993, VISUAL NEUROSCI, V10, P717, DOI 10.1017/S0952523800005423; SCHUETZE H, 2003, J VIS, V3, P114; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000; Zipser K, 1996, J NEUROSCI, V16, P7376	29	156	159	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1492	1499		10.1038/nn1989	http://dx.doi.org/10.1038/nn1989			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	225HT	17922006	Green Accepted			2022-12-17	WOS:000250508400028
J	Martin, M; T Chen, B; Hopf, FW; Bowers, MS; Bonci, A				Martin, Miquel; T Chen, Billy; Hopf, F. Woodward; Bowers, M. Scott; Bonci, Antonello			Cocaine self-administration selectively abolishes LTD in the core of the nucleus accumbens	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; BEHAVIORAL SENSITIZATION; SEEKING BEHAVIOR; MOTIVATION; EXPRESSION; ADDICTION; CIRCUITRY; STRIATUM; AMYGDALA; DRUGS	The core and shell of the nucleus accumbens have critical, differential roles in drug-dependent behaviors. Here we show that operant cocaine self-administration inhibits long-term depression ( LTD) in both structures after 1 d of abstinence. However, after 21 d of abstinence, LTD was abolished exclusively in the nucleus accumbens core of cocaine self-administering rats, suggesting that voluntary cocaine self-administration induced long- lasting neuroadaptations in the core that could underlie drug-seeking behavior and relapse.	Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94608 USA; Univ Calif San Francisco, Wheeler Ctr Neurobiol Drug Addict, San Francisco, CA 94608 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bonci, A (corresponding author), Ernest Gallo Clin & Res Ctr, 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.	bonci@itsa.ucsf.edu		Bowers, M Scott/0000-0003-0047-6765	NIDA NIH HHS [1R01DA15096-01] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015096] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		[Anonymous], 2000, DIAGNOSTIC STAT MANU, V4th; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Gerdeman GL, 2003, TRENDS NEUROSCI, V26, P184, DOI 10.1016/S0166-2236(03)00065-1; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kalivas PW, 2003, PSYCHOPHARMACOLOGY, V168, P44, DOI 10.1007/s00213-003-1393-2; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; Rebec GV, 1997, BRAIN RES, V776, P61, DOI 10.1016/S0006-8993(97)01004-4; Shaham Y, 2005, NAT NEUROSCI, V8, P1437, DOI 10.1038/nn1105-1437; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Udo T, 2004, PSYCHOPHARMACOLOGY, V174, P237, DOI 10.1007/s00213-003-1734-1; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077	15	156	159	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					868	869		10.1038/nn1713	http://dx.doi.org/10.1038/nn1713			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16732275				2022-12-17	WOS:000238590800008
J	Wadiche, JI; Jahr, CE				Wadiche, JI; Jahr, CE			Patterned expression of Purkinje cell glutamate transporters controls synaptic plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; CLIMBING FIBER INNERVATION; GATED CHLORIDE CHANNEL; KAINATE RECEPTORS; MICE LACKING; RAT-BRAIN; CURRENTS; EAAT4; CEREBELLUM; ACTIVATION	Glutamate transporters are responsible for clearing synaptically released glutamate from the extracellular space. If expressed at high enough densities, transporters can prevent activation of extrasynaptic receptors by rapidly lowering glutamate concentrations to insignificant levels. We find that synaptic activation of metabotropic glutamate receptors expressed by Purkinje cells is prevented in regions of rat cerebellum where the density of the glutamate transporter EAAT4 is high. The consequences of metabotropic receptor stimulation, including activation of a depolarizing conductance, cannabinoid-mediated presynaptic inhibition and long-term depression, are also limited in Purkinje cells expressing high levels of EAAT4. We conclude that neuronal uptake sites must be overwhelmed by glutamate to activate perisynaptic metabotropic glutamate receptors. Regional differences in glutamate transporter expression affect the degree of metabotropic glutamate receptor activation and therefore regulate synaptic plasticity.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Jahr, CE (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	jahr@ohsu.edu		Wadiche, Jacques/0000-0001-8180-2061	NINDS NIH HHS [NS40056] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040056, R56NS040056] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Auger C, 2000, NEURON, V28, P547, DOI 10.1016/S0896-6273(00)00132-X; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Bergles DE, 2002, J NEUROSCI, V22, P10153; Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; CASADO M, 1993, J BIOL CHEM, V268, P27313; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dehnes Y, 1998, J NEUROSCI, V18, P3606; Delaney AJ, 2002, NEURON, V36, P475, DOI 10.1016/S0896-6273(02)01008-5; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Dzubay JA, 1999, J NEUROSCI, V19, P5265; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Galante M, 2004, J NEUROSCI, V24, P4865, DOI 10.1523/JNEUROSCI.0403-04.2004; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Harrison J, 2003, J NEUROSCI, V23, P377, DOI 10.1523/JNEUROSCI.23-02-00377.2003; Huang YHH, 2004, J NEUROSCI, V24, P103, DOI 10.1523/JNEUROSCI.4473-03.2004; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Jinno S, 2003, J COMP NEUROL, V458, P412, DOI 10.1002/cne.10585; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Nagao S, 1997, NEUROSCIENCE, V78, P929; Nishiyama H, 2004, J NEUROSCI, V24, P3926, DOI 10.1523/JNEUROSCI.5610-03.2004; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Ozol K, 1999, J COMP NEUROL, V412, P95; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; Takayasu Y, 2004, EUR J NEUROSCI, V19, P1285, DOI 10.1111/j.1460-9568.2004.03224.x; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Welsh JP, 2002, ADV NEUROL, V89, P331	46	156	158	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1329	1334		10.1038/nn1539	http://dx.doi.org/10.1038/nn1539			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16136036				2022-12-17	WOS:000232145900016
J	Severson, CA; Wang, WG; Pieribone, VA; Dohle, CI; Richerson, GB				Severson, CA; Wang, WG; Pieribone, VA; Dohle, CI; Richerson, GB			Midbrain serotonergic neurons are central pH chemoreceptors	NATURE NEUROSCIENCE			English	Article							FREELY MOVING CATS; PANIC DISORDER; RAPHE NEURONS; HYPOTHESIS	Serotonergic neurons in the medulla are central respiratory chemoreceptors. Here we show that serotonergic neurons in the midbrain of rats are also highly chemosensitive to small changes in CO2/pH and are closely associated with large penetrating arteries. We propose that midbrain raphe neurons are sensors of blood CO2 that maintain pH homeostasis by inducing arousal, anxiety and changes in cerebrovascular tone in response to respiratory acidosis.	Yale Univ, Dept Neurol, New Haven, CT 06510 USA; Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; John BL Pierce Lab, New Haven, CT 06510 USA; Ruhr Univ Bochum, Dept Neurophysiol, D-44801 Bochum, Germany; Vet Affairs Med Ctr, West Haven, CT 06516 USA	Yale University; Yale University; Yale University; The John B Pierce Laboratory, Inc; Ruhr University Bochum; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Richerson, GB (corresponding author), Yale Univ, Dept Neurol, 333 Cedar St, New Haven, CT 06510 USA.			Pieribone, Vincent/0000-0002-5836-5454; Richerson, George/0000-0001-5696-1554				Azmitia EC, 1999, NEUROPSYCHOPHARMACOL, V21, pS33; Berry RB, 1997, SLEEP, V20, P654, DOI 10.1093/sleep/20.8.654; Bradley SR, 2002, NAT NEUROSCI, V5, P401, DOI 10.1038/nn848; Eldridge F.L., 1991, EXERCISE PULMONARY P, V52, P309; GORMAN JM, 1989, AM J PSYCHIAT, V146, P148; Grove G, 1997, J NEUROPSYCH CLIN N, V9, P198; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Jacobs BL, 1997, CURR OPIN NEUROBIOL, V7, P820, DOI 10.1016/S0959-4388(97)80141-9; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; KLEIN DF, 1993, ARCH GEN PSYCHIAT, V50, P306; SCHEIBEL ME, 1975, EXP NEUROL, V47, P316, DOI 10.1016/0014-4886(75)90260-5; Veasey SC, 1997, NEUROSCIENCE, V79, P161, DOI 10.1016/S0306-4522(96)00673-2; VEASEY SC, 1995, J NEUROSCI, V15, P5346; Wang WG, 2001, J NEUROPHYSIOL, V85, P2224, DOI 10.1152/jn.2001.85.5.2224; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658	15	156	160	1	9	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1139	1140		10.1038/nn1130	http://dx.doi.org/10.1038/nn1130			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14517544				2022-12-17	WOS:000186229200010
J	Ditterich, J; Mazurek, ME; Shadlen, MN				Ditterich, J; Mazurek, ME; Shadlen, MN			Microstimulation of visual cortex affects the speed of perceptual decisions	NATURE NEUROSCIENCE			English	Article							TRANSPARENT MOTION PERCEPTION; SACCADIC EYE-MOVEMENTS; AREA MT; MACAQUE MT; DIRECTION; PSYCHOPHYSICS; SIGNALS; PROBABILITY; RESPONSES; NEURONS	Direction-selective neurons in the middle temporal visual area (MT) are crucially involved in motion perception, although it is not known exactly how the activity of these neurons is interpreted by the rest of the brain. Here we report that in a two-alternative task, the activity of MT neurons is interpreted as evidence for one direction and against the other. We measured the speed and accuracy of decisions as rhesus monkeys performed a direction- discrimination task. On half of the trials, we stimulated direction- selective neurons in area MT, thereby causing the monkeys to choose the neurons' preferred direction more often. Microstimulation quickened decisions in favor of the preferred direction and slowed decisions in favor of the opposite direction. Even on trials in which microstimulation did not induce a preferred direction choice, it still affected response times. Our findings suggest that during the formation of a decision, sensory evidence for competing propositions is compared and accumulates to a decision-making threshold.	Univ Washington, Natl Primate Res Ctr, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Shadlen, MN (corresponding author), Univ Washington, Natl Primate Res Ctr, Howard Hughes Med Inst, 1959 NE Pacific St, Seattle, WA 98195 USA.	shadlen@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00166] Funding Source: Medline; NEI NIH HHS [EY11378] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Albright T D, 1993, Rev Oculomot Res, V5, P177; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; CELEBRINI S, 1995, J NEUROPHYSIOL, V73, P437, DOI 10.1152/jn.1995.73.2.437; Churchland MM, 2001, J NEUROSCI, V21, P9387, DOI 10.1523/JNEUROSCI.21-23-09387.2001; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Escobar, 1999, STAT METHODS RELIABI; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; GOOD IJ, 1979, BIOMETRIKA, V66, P393, DOI 10.1093/biomet/66.2.393; Green DM., 1966, SIGNAL DETECTION THE; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; LAMING DRJ, 1969, J MATH PSYCHOL, V6, P81, DOI 10.1016/0022-2496(69)90030-3; LEVINSON E, 1975, J PHYSIOL-LONDON, V250, P347, DOI 10.1113/jphysiol.1975.sp011058; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; PANTLE A, 1974, VISION RES, V14, P1229, DOI 10.1016/0042-6989(74)90221-1; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Press W.H, 1992, NUMERICAL RECIPES C, P666; QIAN N, 1994, J NEUROSCI, V14, P7367; QIAN N, 1994, J NEUROSCI, V14, P7357; Rudolph K, 1999, CEREB CORTEX, V9, P90, DOI 10.1093/cercor/9.1.90; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; Van Essen DC, 2002, CURR OPIN NEUROBIOL, V12, P574, DOI 10.1016/S0959-4388(02)00361-6; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Van Wezel RJA, 2002, J NEUROPHYSIOL, V88, P3469, DOI 10.1152/jn.00276.2002; Wald A., 1947, SEQUENTIAL ANAL	30	156	192	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					891	898		10.1038/nn1094	http://dx.doi.org/10.1038/nn1094			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	705UP	12858179				2022-12-17	WOS:000184413700020
J	Dragoi, V; Sharma, J; Miller, EK; Sur, M				Dragoi, V; Sharma, J; Miller, EK; Sur, M			Dynamics of neuronal sensitivity in visual cortex and local feature discrimination	NATURE NEUROSCIENCE			English	Article							ORIENTATION SELECTIVITY; SYNAPTIC DEPRESSION; RECEPTIVE-FIELDS; NATURAL SCENES; ADAPTATION; STATISTICS; V1; CONTRAST; INHIBITION; PLASTICITY	A striking aspect of natural scenes is that image features such as line orientation are strongly correlated at neighboring spatial locations but not at distant locations. Thus, during the viewing of a scene, eye movements are often accompanied by a change in the orientation structure of the image. How does this behavior influence the discrimination of local features and their encoding by visual cortical neurons? Here we examined the perceived changes in orientation induced by brief exposure to oriented image patterns in monkeys and humans, and then used reverse correlation to investigate dynamic changes in neuronal sensitivity in the primary visual cortex (V1) of behaving monkeys. Whereas brief adaptation to an oriented grating impaired identification of nearby orientations by broadening orientation selectivity and changing the preferred orientation of individual V1 neurons, it actually enhanced the identification of orthogonal orientations by sharpening neuronal selectivity. Hence, successive exposure to image patches of dissimilar spatial structure enhances both the ability to discriminate local features and the encoding of these features by V1 neurons.	MIT, Dept Brain & Cognit Sci, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Dragoi, V (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Ctr Learning & Memory, 45 Carleton St, Cambridge, MA 02139 USA.	vdragoi@ai.mit.edu	Miller, Earl K./AAE-8187-2019	Miller, Earl K./0000-0002-0582-6958				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Andrews TJ, 1999, VISION RES, V39, P2947, DOI 10.1016/S0042-6989(99)00019-X; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V200, pP11; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; Carandini M, 1998, NEUROPHARMACOLOGY, V37, P501, DOI 10.1016/S0028-3908(98)00069-0; CHANDRAN PKG, 1985, ADV CAPD, V1, P18; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Clifford CWG, 2001, VISION RES, V41, P151, DOI 10.1016/S0042-6989(00)00248-0; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Dragoi V, 2000, J NEUROPHYSIOL, V83, P1019, DOI 10.1152/jn.2000.83.2.1019; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2001, NEURON, V32, P1181, DOI 10.1016/S0896-6273(01)00540-2; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; FERSTER D, 1986, J NEUROSCI, V6, P1284; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gallant JL, 1998, NEUROREPORT, V9, P2153, DOI 10.1097/00001756-199806220-00045; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Green DM., 1966, SIGNAL DETECTION THE; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NELSON SB, 1991, J NEUROSCI, V11, P344; Rainer G, 1999, J NEUROSCI, V19, P5493; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Reinagel P, 1999, NETWORK-COMP NEURAL, V10, P341, DOI 10.1088/0954-898X/10/4/304; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SIMONCELLI EP, 1999, ADV NEURAL INFORMATI, V11; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P229, DOI 10.1111/j.1475-1313.1992.tb00296.x; Troyer TW, 1998, J NEUROSCI, V18, P5908; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; Varela JA, 1999, J NEUROSCI, V19, P4293; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; WORGOTTER F, 1991, EXP BRAIN RES, V83, P665; Yarbus A.L., 1967, EYE MOVEMENT VISION	47	156	159	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					883	891		10.1038/nn900	http://dx.doi.org/10.1038/nn900			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12161755				2022-12-17	WOS:000177656300019
J	Ji, N; Freeman, J; Smith, SL				Ji, Na; Freeman, Jeremy; Smith, Spencer L.			Technologies for imaging neural activity in large volumes	NATURE NEUROSCIENCE			English	Review							MOUSE VISUAL-CORTEX; IN-VIVO; HIGH-SPEED; CELLULAR-RESOLUTION; FLUORESCENCE MICROSCOPY; MULTIPHOTON MICROSCOPY; NONLINEAR MICROSCOPY; FUNCTIONAL SPECIALIZATION; SCANNING MICROSCOPY; 2-PHOTON MICROSCOPE	Neural circuitry has evolved to form distributed networks that act dynamically across large volumes. Conventional microscopy collects data from individual planes and cannot sample circuitry across large volumes at the temporal resolution relevant to neural circuit function and behaviors. Here we review emerging technologies for rapid volume imaging of neural circuitry. We focus on two critical challenges: the inertia of optical systems, which limits image speed, and aberrations, which restrict the image volume. Optical sampling time must be long enough to ensure high-fidelity measurements, but optimized sampling strategies and point-spread function engineering can facilitate rapid volume imaging of neural activity within this constraint. We also discuss new computational strategies for processing and analyzing volume imaging data of increasing size and complexity. Together, optical and computational advances are providing a broader view of neural circuit dynamics and helping elucidate how brain regions work in concert to support behavior.	[Ji, Na; Freeman, Jeremy] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Smith, Spencer L.] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Smith, Spencer L.] Univ N Carolina, Sch Med, Neurosci Ctr, Chapel Hill, NC 27599 USA; [Smith, Spencer L.] Univ N Carolina, Sch Med, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Ji, N; Freeman, J (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.; Smith, SL (corresponding author), Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.; Smith, SL (corresponding author), Univ N Carolina, Sch Med, Neurosci Ctr, Chapel Hill, NC 27599 USA.; Smith, SL (corresponding author), Univ N Carolina, Sch Med, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA.	jin@janelia.hhmi.org; freemanj11@janelia.hhmi.org; slab@email.unc.edu			Howard Hughes Medical Institute; Human Frontier Science Program [CDA00063/2012, RGP0027/2016]; National Science Foundation [1450824]; Whitehall Foundation; Klingenstein Foundation; McKnight Foundation; Simons Foundation [SCGB 325407SS]; National Institutes of Health [R01NS091335, R01EY024294]; NATIONAL EYE INSTITUTE [R01EY024294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091335] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Human Frontier Science Program(Human Frontier Science Program); National Science Foundation(National Science Foundation (NSF)); Whitehall Foundation; Klingenstein Foundation(Klingenstein Philanthropies); McKnight Foundation; Simons Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Kuhl and A. Chen for help with illustrations, C. Xu for providing the high-resolution version of Figure 5c and N. Sofroniew for providing comments. N.J. and J.F. are supported by Howard Hughes Medical Institute. S.L.S. is supported by grants from the Human Frontier Science Program (CDA00063/2012 and RGP0027/2016), the National Science Foundation (1450824), the Whitehall Foundation, the Klingenstein Foundation, the McKnight Foundation, the Simons Foundation (SCGB 325407SS) and the National Institutes of Health (R01NS091335 and R01EY024294).	Ahrens MB, 2008, NETWORK-COMP NEURAL, V19, P35, DOI 10.1080/09548980701813936; Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Akemann W, 2015, OPT EXPRESS, V23, P28191, DOI 10.1364/OE.23.028191; Amat F, 2014, NAT METHODS, V11, P951, DOI [10.1038/NMETH.3036, 10.1038/nmeth.3036]; Amir W, 2007, OPT LETT, V32, P1731, DOI 10.1364/OL.32.001731; Andermann ML, 2013, NEURON, V80, P900, DOI 10.1016/j.neuron.2013.07.052; Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; Bewersdorf J, 1998, OPT LETT, V23, P655, DOI 10.1364/OL.23.000655; Blum M, 2011, PROC SPIE, V8167, DOI 10.1117/12.897608; Bocarsly ME, 2015, BIOMED OPT EXPRESS, V6, P4546, DOI 10.1364/BOE.6.004546; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; Botcherby EJ, 2008, OPT COMMUN, V281, P880, DOI 10.1016/j.optcom.2007.10.007; Botcherby EJ, 2006, OPT COMMUN, V268, P253, DOI 10.1016/j.optcom.2006.07.026; Botcherby EJ, 2007, OPT LETT, V32, P2007, DOI 10.1364/OL.32.002007; Botcherby EJ, 2012, P NATL ACAD SCI USA, V109, P2919, DOI 10.1073/pnas.1111662109; Buist AH, 1998, J MICROSC-OXFORD, V192, P217, DOI 10.1046/j.1365-2818.1998.00431.x; Bullen A, 1997, BIOPHYS J, V73, P477, DOI 10.1016/S0006-3495(97)78086-X; Callamaras N, 1999, CELL CALCIUM, V26, P271, DOI 10.1054/ceca.1999.0085; Chen JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14679; Chen JL, 2013, J PHYSIOL-LONDON, V591, P4689, DOI 10.1113/jphysiol.2013.259804; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Cheng A, 2011, NAT METHODS, V8, P139, DOI 10.1038/NMETH.1552; Chia TH, 2009, J NEUROPHYSIOL, V102, P1310, DOI 10.1152/jn.91208.2008; Clack NG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002591; Colon J, 2015, OPT LETT, V40, P3300, DOI 10.1364/OL.40.003300; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; Cotton RJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00151; Dal Maschio M, 2011, OPT LETT, V36, P3503, DOI 10.1364/OL.36.003503; Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Engelbrecht CJ, 2009, OPT EXPRESS, V17, P6421, DOI 10.1364/OE.17.006421; Fan GY, 1999, BIOPHYS J, V76, P2412, DOI 10.1016/S0006-3495(99)77396-0; Freeman J, 2015, ELIFE, V4, DOI 10.7554/eLife.05241; Freeman J, 2014, NAT METHODS, V11, P941, DOI [10.1038/NMETH.3041, 10.1038/nmeth.3041]; Froudarakis E, 2014, NAT NEUROSCI, V17, P851, DOI 10.1038/nn.3707; Glickfeld LL, 2013, NAT NEUROSCI, V16, P219, DOI 10.1038/nn.3300; Gobel W, 2007, NAT METHODS, V4, P73, DOI 10.1038/NMETH989; Gong YY, 2015, SCIENCE, V350, P1361, DOI 10.1126/science.aab0810; Grewe BF, 2011, BIOMED OPT EXPRESS, V2, P2035, DOI 10.1364/BOE.2.002035; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Grosenick L, 2015, NEURON, V86, P106, DOI 10.1016/j.neuron.2015.03.034; Hammond AT, 2000, TRAFFIC, V1, P935, DOI 10.1034/j.1600-0854.2000.011203.x; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2016, NAT NEUROSCI, V19, P1165, DOI 10.1038/nn.4365; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Heys JG, 2014, NEURON, V84, P1079, DOI 10.1016/j.neuron.2014.10.048; Hill DN, 2013, P NATL ACAD SCI USA, V110, P13618, DOI 10.1073/pnas.1312599110; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Horton N., 2013, OPTICS LIFE SCI; Horton NG, 2013, NAT PHOTONICS, V7, P205, DOI [10.1038/nphoton.2012.336, 10.1038/NPHOTON.2012.336]; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Iyer V, 2006, J NEUROPHYSIOL, V95, P535, DOI 10.1152/jn.00865.2005; Iyer V, 2003, J BIOMED OPT, V8, P460, DOI 10.1117/1.1580827; Ji N, 2014, NEURON, V83, P1242, DOI 10.1016/j.neuron.2014.08.009; Ji N, 2010, NAT METHODS, V7, P141, DOI 10.1038/NMETH.1411; Jia N, 2012, P NATL ACAD SCI USA, V109, P22, DOI 10.1073/pnas.1109202108; Judkewitz B, 2013, NAT PHOTONICS, V7, P300, DOI [10.1038/nphoton.2013.31, 10.1038/NPHOTON.2013.31]; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Kaplan A, 2001, OPT LETT, V26, P1078, DOI 10.1364/OL.26.001078; Katona G, 2012, NAT METHODS, V9, P201, DOI [10.1038/nmeth.1851, 10.1038/NMETH.1851]; Katona G, 2011, P NATL ACAD SCI USA, V108, P2148, DOI 10.1073/pnas.1009270108; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kim KH, 2007, OPT EXPRESS, V15, P11658, DOI 10.1364/OE.15.011658; Kirkby PA, 2010, OPT EXPRESS, V18, P13720, DOI 10.1364/OE.18.013720; Kobat D, 2009, OPT EXPRESS, V17, P13354, DOI 10.1364/OE.17.013354; Kong LJ, 2015, NAT METHODS, V12, P759, DOI [10.1038/NMETH.3476, 10.1038/nmeth.3476]; Konstantinou G, 2016, OPT EXPRESS, V24, P6283, DOI 10.1364/OE.24.006283; Latimer KW, 2015, SCIENCE, V349, P184, DOI 10.1126/science.aaa4056; Lechleiter JD, 2002, BIOPHYS J, V83, P2292, DOI 10.1016/S0006-3495(02)73989-1; Levene MJ, 2004, J NEUROPHYSIOL, V91, P1908, DOI 10.1152/jn.01007.2003; Lillis KP, 2008, J NEUROSCI METH, V172, P178, DOI 10.1016/j.jneumeth.2008.04.024; Lorincz A, 2007, P NATL ACAD SCI USA, V104, P1033, DOI 10.1073/pnas.0605412104; Low RJ, 2014, P NATL ACAD SCI USA, V111, P18739, DOI 10.1073/pnas.1421753111; Lu R., 2016, VIDEO RATE VOLUMETRI; Marblestone AH, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00137; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; Maruyama R, 2014, NEURAL NETWORKS, V55, P11, DOI 10.1016/j.neunet.2014.03.007; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; McMullen JD, 2011, J MICROSC-OXFORD, V241, P119, DOI 10.1111/j.1365-2818.2010.03419.x; Meltzer S J, 1897, Science, V5, P217, DOI 10.1126/science.5.110.217; Mermillod-Blondin A, 2008, OPT LETT, V33, P2146, DOI 10.1364/OL.33.002146; Moghimi MJ, 2013, J MICROELECTROMECH S, V22, P938, DOI 10.1109/JMEMS.2013.2251320; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Negrean A, 2014, BIOMED OPT EXPRESS, V5, P1588, DOI 10.1364/BOE.5.001588; Nguyen QT, 2001, CELL CALCIUM, V30, P383, DOI 10.1054/ceca.2001.0246; Nicolelis MAL, 2002, CURR OPIN NEUROBIOL, V12, P602, DOI 10.1016/S0959-4388(02)00374-4; Nikolenko V, 2007, NAT METHODS, V4, P943, DOI 10.1038/NMETH1105; Otsu Y, 2008, J NEUROSCI METH, V173, P259, DOI 10.1016/j.jneumeth.2008.06.015; Peron SP, 2015, NEURON, V86, P783, DOI 10.1016/j.neuron.2015.03.027; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Podgorski K., 2016, J NEUROPHYSIOL; Reddy GD, 2008, NAT NEUROSCI, V11, P713, DOI 10.1038/nn.2116; Reddy GD, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2141504; Roorda RD, 2004, J NEUROPHYSIOL, V92, P609, DOI 10.1152/jn.00087.2004; Rothschild Ryan Mark, 2010, Front Neuroeng, V3, P112, DOI 10.3389/fneng.2010.00112; Rupprecht P, 2016, BIOMED OPT EXPRESS, V7, P1656, DOI 10.1364/BOE.7.001656; Sadovsky AJ, 2011, J NEUROPHYSIOL, V106, P1591, DOI 10.1152/jn.00334.2011; Seelig JD, 2015, NATURE, V521, P186, DOI 10.1038/nature14446; Sheetz KE, 2008, OPT EXPRESS, V16, P17574, DOI 10.1364/OE.16.017574; Sheffield MEJ, 2015, NATURE, V517, P200, DOI 10.1038/nature13871; SHEPPARD CJR, 1991, APPL OPTICS, V30, P3563, DOI 10.1364/AO.30.003563; Smith CW, 2011, OPT LETT, V36, P663, DOI 10.1364/OL.36.000663; Smith SL, 2004, J NEUROSCI METH, V133, P109, DOI 10.1016/j.jneumeth.2003.10.001; Sofroniew N.J., 2016, LARGE FIELD OF VIEW; Sofroniew NJ, 2015, ELIFE, V4, DOI 10.7554/eLife.12559; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Stirman J.N., 2016, NAT BIOTECH; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Sun WZ, 2016, NAT NEUROSCI, V19, P308, DOI 10.1038/nn.4196; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tao XD, 2011, OPT LETT, V36, P1062, DOI 10.1364/OL.36.001062; Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022; Theriault G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00139; Theriault G, 2013, OPT EXPRESS, V21, P10095, DOI 10.1364/OE.21.010095; Tischbirek C, 2015, P NATL ACAD SCI USA, V112, P11377, DOI 10.1073/pnas.1514209112; Tsai PS, 2015, OPT EXPRESS, V23, P13833, DOI 10.1364/OE.23.013833; Valmianski I, 2010, J NEUROPHYSIOL, V104, P1803, DOI 10.1152/jn.00484.2010; Varga Z, 2011, P NATL ACAD SCI USA, V108, P15420, DOI 10.1073/pnas.1112355108; Voigt FF, 2015, PROC SPIE, V9329, DOI 10.1117/12.2076388; Wang C, 2014, NAT METHODS, V11, P1037, DOI [10.1038/NMETH.3068, 10.1038/nmeth.3068]; Wang K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8276; Wang K, 2014, NAT METHODS, V11, P625, DOI [10.1038/NMETH.2925, 10.1038/nmeth.2925]; Wang K, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2013.2276860; Wang QX, 2012, J NEUROSCI, V32, P4386, DOI 10.1523/JNEUROSCI.6063-11.2012; Wang QX, 2011, J NEUROSCI, V31, P1905, DOI 10.1523/JNEUROSCI.3488-10.2011; Watson BO, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.006.2009; WELFORD WT, 1960, J OPT SOC AM, V50, P749, DOI 10.1364/JOSA.50.000749; Wilt BA, 2013, BIOPHYS J, V104, P51, DOI 10.1016/j.bpj.2012.07.058; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang WJ, 2016, NEURON, V89, P269, DOI 10.1016/j.neuron.2015.12.012; Yatsenko D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004083; Zheng GA, 2013, OPT EXPRESS, V21, P15131, DOI 10.1364/OE.21.015131; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	145	155	158	7	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2016	19	9					1154	1164		10.1038/nn.4358	http://dx.doi.org/10.1038/nn.4358			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU5SA	27571194	Green Accepted, Green Submitted			2022-12-17	WOS:000382270400011
J	Day, JJ; Childs, D; Guzman-Karlsson, MC; Kibe, M; Moulden, J; Song, E; Tahir, A; Sweatt, JD				Day, Jeremy J.; Childs, Daniel; Guzman-Karlsson, Mikael C.; Kibe, Mercy; Moulden, Jerome; Song, Esther; Tahir, Absar; Sweatt, J. David			DNA methylation regulates associative reward learning	NATURE NEUROSCIENCE			English	Article							NUCLEUS-ACCUMBENS CORE; VENTRAL TEGMENTAL AREA; EPIGENETIC MECHANISMS; GENE-TRANSCRIPTION; EXPRESSION; DOPAMINE; BEHAVIOR; NEURONS; ADDICTION; AMYGDALA	Reward-related memories are essential for adaptive behavior and evolutionary fitness, but they are also a core component of maladaptive brain diseases such as addiction. Reward learning requires dopamine neurons located in the ventral tegmental area (VTA), which encode relationships between predictive cues and future rewards. Recent evidence suggests that epigenetic mechanisms, including DNA methylation, are essential regulators of neuronal plasticity and experience-driven behavioral change. However, the role of epigenetic mechanisms in reward learning is poorly understood. Here we show that the formation of reward-related associative memories in rats upregulates key plasticity genes in the VTA, which are correlated with memory strength and associated with gene-specific changes in DNA methylation. Moreover, DNA methylation in the VTA is required for the formation of stimulus-reward associations. These results provide the first evidence that that activity-dependent methylation and demethylation of DNA is an essential substrate for the behavioral and neuronal plasticity driven by reward-related experiences.	[Day, Jeremy J.; Childs, Daniel; Guzman-Karlsson, Mikael C.; Kibe, Mercy; Moulden, Jerome; Song, Esther; Tahir, Absar; Sweatt, J. David] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Day, Jeremy J.; Childs, Daniel; Guzman-Karlsson, Mikael C.; Kibe, Mercy; Moulden, Jerome; Song, Esther; Tahir, Absar; Sweatt, J. David] Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sweatt, JD (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA.	dsweatt@uab.edu	Day, Jeremy/AAW-2464-2020	Day, Jeremy/0000-0002-7361-3399; Childs, Daniel/0000-0001-7643-2836; Sweatt, J. David/0000-0003-3567-485X	US National Institute on Drug Abuse [DA029419]; US National Institutes of Mental Health [MH091122, MH057014]; Evelyn F. McKnight Brain Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091122, R01MH057014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA029419] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Evelyn F. McKnight Brain Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank all members of the Sweatt laboratory, particularly G. Kaas and I. Zovkic, for comments and suggestions during the completion of these studies. We would also like to thank the Intellectual and Developmental Disabilities Research Core at the University of Alabama at Birmingham for assistance with cell culture experiments. This work is supported by the US National Institute on Drug Abuse (DA029419 to J.J.D.), the US National Institutes of Mental Health (MH091122 and MH057014 to J.D.S.) and the Evelyn F. McKnight Brain Research Foundation.	Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Deng JV, 2010, NAT NEUROSCI, V13, P1128, DOI 10.1038/nn.2614; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Im HI, 2010, NAT NEUROSCI, V13, P1120, DOI 10.1038/nn.2615; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lamprecht R, 1996, LEARN MEMORY, V3, P31, DOI 10.1101/lm.3.1.31; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Maddox SA, 2011, LEARN MEMORY, V18, P579, DOI 10.1101/lm.2243411; Margolis EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042365; Margolis EB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015222; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Parkinson JA, 2000, BEHAV NEUROSCI, V114, P42, DOI 10.1037/0735-7044.114.1.42; Paxinos G, 2005, RAT BRAIN STEREOTAXI, DOI 10.1016/c2009-0-63235-9; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Saunders BT, 2013, NEUROSCI BIOBEHAV R, V37, P1955, DOI 10.1016/j.neubiorev.2013.02.008; Saunders BT, 2013, NEUROPSYCHOPHARMACOL, V38, P249, DOI 10.1038/npp.2012.161; Schirrmacher E, 2006, BIOCONJUGATE CHEM, V17, P261, DOI 10.1021/bc050300b; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yun IA, 2004, J NEUROSCI, V24, P2923, DOI 10.1523/JNEUROSCI.5282-03.2004	53	155	159	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1445	+		10.1038/nn.3504	http://dx.doi.org/10.1038/nn.3504			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23974711	Green Accepted			2022-12-17	WOS:000324795300017
J	Ashton, RS; Conway, A; Pangarkar, C; Bergen, J; Lim, KI; Shah, P; Bissell, M; Schaffer, DV				Ashton, Randolph S.; Conway, Anthony; Pangarkar, Chinmay; Bergen, Jamie; Lim, Kwang-Il; Shah, Priya; Bissell, Mina; Schaffer, David V.			Astrocytes regulate adult hippocampal neurogenesis through ephrin-B signaling	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; PROGENITOR CELLS; IN-VIVO; SUBVENTRICULAR ZONE; ANALYSIS REVEALS; NERVOUS-SYSTEM; SELF-RENEWAL; DIFFERENTIATION; PROLIFERATION; BRAIN	Neurogenesis in the adult hippocampus involves activation of quiescent neural stem cells (NSCs) to yield transiently amplifying NSCs, progenitors, and, ultimately, neurons that affect learning and memory. This process is tightly controlled by microenvironmental cues, although a few endogenous factors are known to regulate neuronal differentiation. Astrocytes have been implicated, but their role in juxtacrine (that is, cell-cell contact dependent) signaling in NSC niches has not been investigated. We found that ephrin-B2 presented from rodent hippocampal astrocytes regulated neurogenesis in vivo. Furthermore, clonal analysis in NSC fate-mapping studies revealed a previously unknown role for ephrin-B2 in instructing neuronal differentiation. In addition, ephrin-B2 signaling, transduced by EphB4 receptors on NSCs, activated beta-catenin in vitro and in vivo independently of Wnt signaling and upregulated proneural transcription factors. Ephrin-B2(+) astrocytes therefore promote neuronal differentiation of adult NSCs through juxtacrine signaling, findings that advance our understanding of adult neurogenesis and may have future regenerative medicine implications.	[Ashton, Randolph S.; Conway, Anthony; Bergen, Jamie; Lim, Kwang-Il; Shah, Priya; Schaffer, David V.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Pangarkar, Chinmay; Bissell, Mina] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Schaffer, DV (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.	schaffer@berkeley.edu		Shah, Priya/0000-0001-7518-2839	US National Institutes of Health grant [EB007295]; Lawrence Berkeley National Lab Laboratory Directed Research and Development grant [3668DS]; California Institute of Regenerative Medicine training grant [T1-00007]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB007295] Funding Source: NIH RePORTER	US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lawrence Berkeley National Lab Laboratory Directed Research and Development grant; California Institute of Regenerative Medicine training grant; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank R. Fletcher for his guidance in mouse breeding and genotyping. This research was supported by US National Institutes of Health grant EB007295, Lawrence Berkeley National Lab Laboratory Directed Research and Development grant 3668DS and California Institute of Regenerative Medicine training grant T1-00007.	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Aoki M, 2004, J BIOL CHEM, V279, P32643, DOI 10.1074/jbc.M313247200; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Barrios A, 2003, CURR BIOL, V13, P1571, DOI 10.1016/j.cub.2003.08.030; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Davis S., 1994, DEVELOPMENT, V266, P816; del Valle K, 2011, INT J DEV NEUROSCI, V29, P9, DOI 10.1016/j.ijdevneu.2010.10.005; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Elmi M, 2010, MOL CELL NEUROSCI, V45, P121, DOI 10.1016/j.mcn.2010.06.003; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Hara Y, 2010, STEM CELLS, V28, P974, DOI 10.1002/stem.427; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; Martinez A, 2005, BRAIN RES REV, V49, P211, DOI 10.1016/j.brainresrev.2005.02.001; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Nomura T, 2010, CELL STEM CELL, V7, P730, DOI 10.1016/j.stem.2010.11.009; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Picco V, 2007, DEVELOPMENT, V134, P1491, DOI 10.1242/dev.003939; Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Tattersfield AS, 2004, NEUROSCIENCE, V127, P319, DOI 10.1016/j.neuroscience.2004.04.061; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Xu NJ, 2011, NAT NEUROSCI, V14, P1421, DOI 10.1038/nn.2931	48	155	160	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1399	1406		10.1038/nn.3212	http://dx.doi.org/10.1038/nn.3212			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22983209	Green Accepted, Green Submitted			2022-12-17	WOS:000309335300020
J	Holmes, A; Fitzgerald, PJ; MacPherson, KP; DeBrouse, L; Colacicco, G; Flynn, SM; Masneuf, S; Pleil, KE; Li, C; Marcinkiewcz, CA; Kash, TL; Gunduz-Cinar, O; Camp, M				Holmes, Andrew; Fitzgerald, Paul J.; MacPherson, Kathryn P.; DeBrouse, Lauren; Colacicco, Giovanni; Flynn, Shaun M.; Masneuf, Sophie; Pleil, Kristen E.; Li, Chia; Marcinkiewcz, Catherine A.; Kash, Thomas L.; Gunduz-Cinar, Ozge; Camp, Marguerite			Chronic alcohol remodels prefrontal neurons and disrupts NMDAR-mediated fear extinction encoding	NATURE NEUROSCIENCE			English	Article							EXPRESSION; ETHANOL; CONSOLIDATION; DYSFUNCTION; WITHDRAWAL; RESISTANCE; AMYGDALA; CORTEX; MEMORY	Alcoholism is frequently co-morbid with post-traumatic stress disorder, but it is unclear how alcohol affects the neural circuits mediating recovery from trauma. We found that chronic intermittent ethanol (CIE) impaired fear extinction and remodeled the dendritic arbor of medial prefrontal cortical (mPFC) neurons in mice. CIE impaired extinction encoding by infralimbic mPFC neurons in vivo and functionally downregulated burst-mediating NMDA GluN1 receptors. These findings suggest that alcohol may increase risk for trauma-related anxiety disorders by disrupting mPFC-mediated extinction of fear.	[Holmes, Andrew; Fitzgerald, Paul J.; MacPherson, Kathryn P.; DeBrouse, Lauren; Colacicco, Giovanni; Flynn, Shaun M.; Masneuf, Sophie; Gunduz-Cinar, Ozge; Camp, Marguerite] NIAAA, Lab Behav & Genom Neurosci, US Natl Inst Hlth, Bethesda, MD 90034 USA; [Flynn, Shaun M.; Gunduz-Cinar, Ozge] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Pleil, Kristen E.; Li, Chia; Marcinkiewcz, Catherine A.; Kash, Thomas L.] Univ N Carolina, Dept Pharmacol, Bowles Ctr Alcohol Studies, Chapel Hill, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Uniformed Services University of the Health Sciences - USA; University of North Carolina; University of North Carolina Chapel Hill	Holmes, A (corresponding author), NIAAA, Lab Behav & Genom Neurosci, US Natl Inst Hlth, Bethesda, MD 90034 USA.	andrew.holmes@nih.gov	Gunduz Cinar, Ozge/B-2970-2009; Kash, Thomas/G-9625-2013; Marcinkiewcz, Catherine/X-2339-2019; Gunduz Cinar, Ozge/E-5756-2010	Marcinkiewcz, Catherine/0000-0001-7161-7815; Gunduz Cinar, Ozge/0000-0002-3826-8905	US Department of Defense in the Center for Neuroscience and Regenerative Medicine; US National Institutes of Health grants [AA019454, AA017668, AA020911, AA021043]; US Department of Defense grant [PT090344]; US National Alliance for Research on Schizophrenia and Depression; Bowles Center for Alcohol Studies; US National Institute on Alcohol Abuse and Alcoholism Intramural Research Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000411, U01AA020911, K99AA017668, R00AA017668, F32AA021043, R01AA019454] Funding Source: NIH RePORTER	US Department of Defense in the Center for Neuroscience and Regenerative Medicine(United States Department of Defense); US National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense grant; US National Alliance for Research on Schizophrenia and Depression(NARSAD); Bowles Center for Alcohol Studies; US National Institute on Alcohol Abuse and Alcoholism Intramural Research Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Y. Shaham and C. Wellman for valuable comments, and B. Hurd, A. Plitt, D. Fisher and R. Daut for assistance with the CIE procedure. This work was supported by the US Department of Defense in the Center for Neuroscience and Regenerative Medicine (A.H., S.M.F. and O.G.-C.), US National Institutes of Health grants AA019454, AA017668 and AA020911 to T.L.K., C.L. and C,A,M., and AA021043 to K.E.P., US Department of Defense grant PT090344 (T.L.K. and K.E.P.), US National Alliance for Research on Schizophrenia and Depression (T.L.K.), Bowles Center for Alcohol Studies (T.L.K.), and the US National Institute on Alcohol Abuse and Alcoholism Intramural Research Program (A.H., P.J.F., K.P.M., L.D., S.M., G.C., O.G.-C. and M.C.).	BAUM M, 1969, J COMP PHYSIOL PSYCH, V69, P238, DOI 10.1037/h0028188; Bertotto ME, 2006, NEUROSCIENCE, V142, P979, DOI 10.1016/j.neuroscience.2006.07.013; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Goldstein RZ, 2004, NEUROPSYCHOLOGIA, V42, P1447, DOI 10.1016/j.neuropsychologia.2004.04.002; Herry C, 2006, EUR J NEUROSCI, V24, P261, DOI 10.1111/j.1460-9568.2006.04893.x; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Izquierdo A, 2006, J NEUROSCI, V26, P5733, DOI 10.1523/JNEUROSCI.0474-06.2006; Lattal KM, 2007, BEHAV NEUROSCI, V121, P1280, DOI 10.1037/0735-7044.121.6.1280; Martin KP, 2011, CEREB CORTEX, V21, P2366, DOI 10.1093/cercor/bhr021; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Pfefferbaum A, 1998, ARCH GEN PSYCHIAT, V55, P905, DOI 10.1001/archpsyc.55.10.905; Ripley TL, 2003, EUR J NEUROSCI, V18, P441, DOI 10.1046/j.1460-9568.2003.02759.x; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Whittle N, 2010, J NEUROSCI, V30, P13586, DOI 10.1523/JNEUROSCI.0849-10.2010; WHO, 2006, WORLD HLTH REPORT 20	17	155	156	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1359	1361		10.1038/nn.3204	http://dx.doi.org/10.1038/nn.3204			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22941108	Green Accepted, Green Submitted			2022-12-17	WOS:000309335300012
J	Kuhl, BA; Shah, AT; DuBrow, S; Wagner, AD				Kuhl, Brice A.; Shah, Arpeet T.; DuBrow, Sarah; Wagner, Anthony D.			Resistance to forgetting associated with hippocampus-mediated reactivation during new learning	NATURE NEUROSCIENCE			English	Article							SLOW-WAVE SLEEP; MEMORY CONSOLIDATION; PATTERN SEPARATION; TEMPORAL-LOBE; TRANSITIVE INFERENCE; DECLARATIVE MEMORY; VENTRAL STRIATUM; BRAIN ACTIVITY; DENTATE GYRUS; ACTIVATION	One of the reasons why we forget past experiences is because we acquire new memories in the interim. Although the hippocampus is thought to be important for acquiring and retaining memories, there is little evidence linking neural operations during new learning to the forgetting (or remembering) of earlier events. We found that, during the encoding of new memories, responses in the human hippocampus are predictive of the retention of memories for previously experienced, overlapping events. This brain-behavior relationship is evident in neural responses to individual events and in differences across individuals. We found that the hippocampus accomplishes this function by reactivating older memories as new memories are formed; in this case, reactivating neural responses that represented monetary rewards associated with older memories. These data reveal a fundamental mechanism by which the hippocampus tempers the forgetting of older memories as newer memories are acquired.	[Kuhl, Brice A.; Shah, Arpeet T.; DuBrow, Sarah; Wagner, Anthony D.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Wagner, Anthony D.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Kuhl, BA (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	brice.kuhl@yale.edu; awagner@stanford.edu			National Institute of Mental Health [5R01-MH080309]; Alfred P. Sloan Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080309] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Knutson, J. Cooper, G. Samanez-Larkin and S. McClure for helpful advice and discussions. This work was supported by the National Institute of Mental Health (5R01-MH080309) and the Alfred P. Sloan Foundation.	Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Anderson MC, 2003, J MEM LANG, V49, P415, DOI 10.1016/j.jml.2003.08.006; Anderson MC, 1999, J EXP PSYCHOL LEARN, V25, P608, DOI 10.1037/0278-7393.25.3.608; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; BARNES JM, 1959, J EXP PSYCHOL, V58, P97, DOI 10.1037/h0047507; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Heckers S, 2004, HIPPOCAMPUS, V14, P153, DOI 10.1002/hipo.10189; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Hupbach A, 2008, LEARN MEMORY, V15, P574, DOI 10.1101/lm.1022308; Hupbach A, 2007, LEARN MEMORY, V14, P47, DOI 10.1101/lm.365707; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Kirwan CB, 2007, LEARN MEMORY, V14, P625, DOI 10.1101/lm.663507; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2007, ANN NY ACAD SCI, V1104, P54, DOI 10.1196/annals.1390.020; Kumaran D, 2009, NEURON, V63, P889, DOI 10.1016/j.neuron.2009.07.030; Lansink CS, 2008, J NEUROSCI, V28, P6372, DOI 10.1523/JNEUROSCI.1054-08.2008; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; O'Reilly RC, 2000, HIPPOCAMPUS, V10, P389, DOI 10.1002/1098-1063(2000)10:4<389::AID-HIPO5>3.0.CO;2-P; Okado Y, 2005, LEARN MEMORY, V12, P3, DOI 10.1101/lm.87605; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Peigneux P, 2006, PLOS BIOL, V4, P647, DOI 10.1371/journal.pbio.0040100; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Pennartz CMA, 2004, J NEUROSCI, V24, P6446, DOI 10.1523/JNEUROSCI.0575-04.2004; Pilzecker, 1900, Z PSYCHOL, V1, P1; Rasch B, 2007, CURR OPIN NEUROBIOL, V17, P698, DOI 10.1016/j.conb.2007.11.007; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Shohamy D, 2008, NEURON, V60, P378, DOI 10.1016/j.neuron.2008.09.023; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Zalesak M, 2009, PSYCHIAT RES-NEUROIM, V172, P24, DOI 10.1016/j.pscychresns.2008.09.008	47	155	160	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2010	13	4					501	U128		10.1038/nn.2498	http://dx.doi.org/10.1038/nn.2498			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	575NI	20190745	Green Accepted			2022-12-17	WOS:000276073500021
J	Thoby-Brisson, M; Karlen, M; Wu, N; Charnay, P; Champagnat, J; Fortin, G				Thoby-Brisson, Muriel; Karlen, Mattias; Wu, Ning; Charnay, Patrick; Champagnat, Jean; Fortin, Gilles			Genetic identification of an embryonic parafacial oscillator coupling to the preBotzinger complex	NATURE NEUROSCIENCE			English	Article							CONGENITAL CENTRAL HYPOVENTILATION; RESPIRATORY RHYTHM GENERATION; PRE-BOTZINGER COMPLEX; FATAL CENTRAL APNEA; NEONATAL-RAT; DEVELOPING HINDBRAIN; NERVOUS-SYSTEM; MOUSE EMBRYO; IN-VITRO; NEURONS	The hindbrain transcription factors Phox2b and Egr2 (also known as Krox20) are linked to the development of the autonomic nervous system and rhombomere-related regulation of breathing, respectively. Mutations in these proteins can lead to abnormal breathing behavior as a result of an alteration in an unidentified neuronal system. We characterized a bilateral embryonic parafacial (e-pF) population of rhythmically bursting neurons at embryonic day (E) 14.5 in mice. These cells expressed Phox2b, were derived from Egr2-expressing precursors and their development was dependent on the integrity of the Egr2 gene. Silencing or eliminating the e-pF oscillator, but not the putative inspiratory oscillator (preBotzinger complex, preBotC), led to an abnormally slow rhythm, demonstrating that the e-pF controls the respiratory rhythm. The e-pF oscillator, the only one active at E14.5, entrained and then coupled with the preBotC, which emerged independently at E15.5. These data establish the dual organization of the respiratory rhythm generator at the time of its inception, when it begins to drive fetal breathing.	[Thoby-Brisson, Muriel; Wu, Ning; Champagnat, Jean; Fortin, Gilles] CNRS, Inst Neurobiol Alfred Fessard, UPR2216, Gif Sur Yvette, France; [Karlen, Mattias] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Charnay, Patrick] Ecole Normale Super, INSERM, U784, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Fortin, G (corresponding author), CNRS, Inst Neurobiol Alfred Fessard, UPR2216, Gif Sur Yvette, France.	gilles.fortin@inaf.cnrs-gif.fr	Thoby-Brisson, Muriel/E-1167-2014	Thoby-Brisson, Muriel/0000-0003-3214-1724; Charnay, Patrick/0000-0002-3847-6042; Fortin, Gilles/0000-0002-2123-8603	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; ANR [ANR-07-Neuro-007-01]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); ANR(French National Research Agency (ANR))	We thank J. F. Brunet and C. Goridis for comments on the manuscript and the Phox2b antibody, and K. Kullander for VGlut2 mutant mice. This work benefited from the facilities and expertise of the Imagif Cell Biology Unit of the Gif campus. This work was supported by the Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale (M. T.-B.) and ANR grant ANR-07-Neuro-007-01 (G. F.).	Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; Borday C, 2006, J NEUROBIOL, V66, P1285, DOI 10.1002/neu.20271; Brunet Jean-Francois, 2008, P25, DOI 10.1007/978-0-387-70765-5_3; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Coutinho AP, 2004, J NEUROSCI, V24, P9383, DOI 10.1523/JNEUROSCI.2408-04.2004; Dauger S, 2003, DEVELOPMENT, V130, P6635, DOI 10.1242/dev.00866; del Toro ED, 2001, J NEUROSCI, V21, P5637, DOI 10.1523/JNEUROSCI.21-15-05637.2001; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Frere SGA, 2004, MOL NEUROBIOL, V30, P279, DOI 10.1385/MN:30:3:279; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; GREER JJ, 1991, J PHYSIOL-LONDON, V437, P727, DOI 10.1113/jphysiol.1991.sp018622; Guyenet PG, 2008, J APPL PHYSIOL, V105, P404, DOI 10.1152/japplphysiol.90452.2008; Jacquin TD, 1996, NEURON, V17, P747, DOI 10.1016/S0896-6273(00)80206-8; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; Kobayashi K, 2001, J APPL PHYSIOL, V91, P316, DOI 10.1152/jappl.2001.91.1.316; Koizumi H, 2008, J NEUROSCI, V28, P2353, DOI 10.1523/JNEUROSCI.3553-07.2008; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; Mellen NM, 2003, NEURON, V37, P821, DOI 10.1016/S0896-6273(03)00092-8; Milsom WK, 2008, ADV EXP MED BIOL, V605, P293; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Onimaru H, 2005, NEUROSCIENCE, V131, P969, DOI 10.1016/j.neuroscience.2004.11.041; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; Onimaru H, 2008, J NEUROSCI, V28, P12845, DOI 10.1523/JNEUROSCI.3625-08.2008; Pagliardini S, 2003, J NEUROSCI, V23, P9575; Pagliardini S, 2008, J NEUROSCI, V28, P11030, DOI 10.1523/JNEUROSCI.1648-08.2008; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Ren J, 2006, J NEUROSCI, V26, P3721, DOI 10.1523/JNEUROSCI.0026-06.2006; Rubin JE, 2009, P NATL ACAD SCI USA, V106, P2939, DOI 10.1073/pnas.0808776106; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; Shirasawa S, 2000, NAT GENET, V24, P287, DOI 10.1038/73516; SMITH JC, 1989, J COMP NEUROL, V281, P69, DOI 10.1002/cne.902810107; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Spengler CM, 2001, RESP PHYSIOL, V129, P247, DOI 10.1016/S0034-5687(01)00294-8; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stornetta RL, 2006, J NEUROSCI, V26, P10305, DOI 10.1523/JNEUROSCI.2917-06.2006; SUZUE T, 1984, J PHYSIOL-LONDON, V354, P173, DOI 10.1113/jphysiol.1984.sp015370; Thoby-Brisson M, 2005, J NEUROSCI, V25, P4307, DOI 10.1523/JNEUROSCI.0551-05.2005; Vasilakos K, 2005, J NEUROBIOL, V62, P369, DOI 10.1002/neu.20102; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Voiculescu O, 2001, DEVELOPMENT, V128, P4967; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Weese-Mayer DE, 2005, RESP PHYSIOL NEUROBI, V149, P73, DOI 10.1016/j.resp.2005.06.010; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0	49	155	156	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1028	U100		10.1038/nn.2354	http://dx.doi.org/10.1038/nn.2354			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19578380				2022-12-17	WOS:000268396300017
J	Kim, N; Burden, SJ				Kim, Natalie; Burden, Steven J.			MuSK controls where motor axons grow and form synapses	NATURE NEUROSCIENCE			English	Article							NEUROMUSCULAR-JUNCTION FORMATION; ACETYLCHOLINE-RECEPTOR CLUSTERS; NERVE MUSCLE JUNCTIONS; TYROSINE KINASE MUSK; SKELETAL-MUSCLE; IN-VIVO; CHOLINE-ACETYLTRANSFERASE; STRIATED-MUSCLE; MESSENGER-RNA; MUTANT MICE	Motor axons approach muscles that are regionally prespecialized, as acetylcholine receptors are clustered in the central region of muscle before and independently of innervation. This muscle prepattern requires MuSK, a receptor tyrosine kinase that is essential for synapse formation. It is not known how muscle prepatterning is established, and whether motor axons recognize this prepattern. Here we show that expression of Musk is prepatterned in muscle and that early Musk expression in developing myotubes is sufficient to establish muscle prepatterning. We further show that ectopic Musk expression promotes ectopic synapse formation, indicating that muscle prepatterning normally has an instructive role in directing where synapses will form. In addition, ectopic Musk expression stimulates synapse formation in the absence of Agrin and rescues the lethality of Agrn mutant mice, demonstrating that the postsynaptic cell, and MuSK in particular, has a potent role in regulating the formation of synapses.	[Kim, Natalie; Burden, Steven J.] NYU, Helen L & Martin S Kimmel Ctr, Mol Neurobiol Program, Sch Med,Biol & Med Skirball Inst Biomol Med, New York, NY 10016 USA	New York University	Burden, SJ (corresponding author), NYU, Helen L & Martin S Kimmel Ctr, Mol Neurobiol Program, Sch Med,Biol & Med Skirball Inst Biomol Med, 540 First Ave, New York, NY 10016 USA.	burden@saturn.med.nyu.edu	Tuluc, Petronel/C-2527-2011	Burden, Steven/0000-0002-3550-6891	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036193, R01NS027963, R01NS036193] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 36193, R01 NS027963-10, R01 NS027963] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; BENNETT MR, 1974, J PHYSIOL-LONDON, V241, P515, DOI 10.1113/jphysiol.1974.sp010670; BENNETT MR, 1975, COLD SPRING HARB SYM, V40, P409, DOI 10.1101/SQB.1976.040.01.039; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Campagna JA, 1995, NEURON, V15, P1365, DOI 10.1016/0896-6273(95)90014-4; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Dimitropoulou A, 2005, MOL CELL NEUROSCI, V28, P292, DOI 10.1016/j.mcn.2004.09.013; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; FONTAINE B, 1988, EMBO J, V7, P603, DOI 10.1002/j.1460-2075.1988.tb02853.x; Fu AKY, 2001, MOL BRAIN RES, V96, P21, DOI 10.1016/S0169-328X(01)00253-4; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Glass DJ, 1996, COLD SPRING HARB SYM, V61, P435; Glass DJ, 1997, CURR OPIN NEUROBIOL, V7, P379, DOI 10.1016/S0959-4388(97)80066-9; Herbst R, 2002, DEVELOPMENT, V129, P5449, DOI 10.1242/dev.00112; Hesser BA, 1999, FEBS LETT, V442, P133, DOI 10.1016/S0014-5793(98)01641-X; Jaworski A, 2006, J NEUROSCI, V26, P655, DOI 10.1523/JNEUROSCI.4506-05.2006; Jones G, 1999, J NEUROSCI, V19, P3376; Kandel E.R., 2000, PRINCIPLES NEURAL SC; Lacazette E, 2003, J CELL BIOL, V161, P727, DOI 10.1083/jcb.200210156; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin YR, 2005, CRYST GROWTH DES, V5, P579, DOI 10.1021/cg049747h; MINTY AJ, 1982, CELL, V30, P185, DOI 10.1016/0092-8674(82)90024-1; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Moore C, 2001, P NATL ACAD SCI USA, V98, P14655, DOI 10.1073/pnas.251291598; Nguyen QT, 1996, CURR OPIN NEUROBIOL, V6, P104, DOI 10.1016/S0959-4388(96)80015-8; Panzer JA, 2006, J NEUROSCI, V26, P934, DOI 10.1523/JNEUROSCI.3656-05.2006; Sander A, 2001, J CELL BIOL, V155, P1287, DOI 10.1083/jcb.200105034; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; SLATER CR, 1982, DEV BIOL, V94, P11, DOI 10.1016/0012-1606(82)90063-X; SLATER CR, 1982, DEV BIOL, V94, P23, DOI 10.1016/0012-1606(82)90064-1; Strochlic L, 2005, BIOESSAYS, V27, P1129, DOI 10.1002/bies.20305; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; Watty A, 2000, P NATL ACAD SCI USA, V97, P4585, DOI 10.1073/pnas.080061997; WILLIAMS PE, 1971, J CELL SCI, V9, P751; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; ZHANG M, 1995, DEV DYNAM, V204, P168, DOI 10.1002/aja.1002040207	44	155	160	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					19	27		10.1038/nn2026	http://dx.doi.org/10.1038/nn2026			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18084289	Green Accepted			2022-12-17	WOS:000252117900008
J	Silvanto, J; Cowey, A; Lavie, N; Walsh, V				Silvanto, J; Cowey, A; Lavie, N; Walsh, V			Striate cortex (V1) activity gates awareness of motion	NATURE NEUROSCIENCE			English	Article								A key question in understanding visual awareness is whether any single cortical area is indispensable. In a transcranial magnetic stimulation experiment, we show that observers' awareness of activity in extrastriate area V5 depends on the amount of activity in striate cortex (V1). From the timing and pattern of effects, we infer that back-projections from extrastriate cortex influence information content in V1, but it is V1 that determines whether that information reaches awareness.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Psychol, London WC1H 0AP, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; University College London; University of London; University College London; University of Oxford	Silvanto, J (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	juha.silvanto@ucl.ac.uk	Lavie, Nilli/A-3560-2010	Silvanto, Juha/0000-0001-6044-5296				Angelucci A, 2002, J NEUROSCI, V22, P8633; Cowey A, 2000, NEUROREPORT, V11, P3269, DOI 10.1097/00001756-200009280-00044; COWEY A, 1991, TRENDS NEUROSCI, V14, P140, DOI 10.1016/0166-2236(91)90085-9; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Lamme VAF, 2000, VISION RES, V40, P1507, DOI 10.1016/S0042-6989(99)00243-6; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; Pollen DA, 1999, CEREB CORTEX, V9, P4, DOI 10.1093/cercor/9.1.4; Pollen DA, 2003, CEREB CORTEX, V13, P807, DOI 10.1093/cercor/13.8.807; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; SILVANTO J, IN PRESS CEREB CORTE; Stewart LM, 2001, NEUROPSYCHOLOGIA, V39, P415, DOI 10.1016/S0028-3932(00)00130-5; TYRRELL RA, 1988, BEHAV RES METH INSTR, V20, P137, DOI 10.3758/BF03203817; Weiskrantz L., 1986, BLINDSIGHT CASE STUD	14	155	158	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					143	144		10.1038/nn1379	http://dx.doi.org/10.1038/nn1379			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15643428				2022-12-17	WOS:000226638200010
J	Patton, BL; Cunningham, JM; Thyboll, J; Kortesmaa, J; Westerblad, H; Edstrom, L; Tryggvason, K; Sanes, JR				Patton, BL; Cunningham, JM; Thyboll, J; Kortesmaa, J; Westerblad, H; Edstrom, L; Tryggvason, K; Sanes, JR			Properly formed but improperly localized synaptic specializations in the absence of laminin alpha 4	NATURE NEUROSCIENCE			English	Article							NEUROMUSCULAR-JUNCTION; ACTIVE ZONES; S-LAMININ; MUSCLE; DIFFERENTIATION; EXPRESSION; ISOFORMS; CHAINS; ROLES; CLEFT	Precise apposition of pre- to postsynaptic specializations is required for optimal function of chemical synapses, but little is known about how it is achieved. At the skeletal neuromuscular junction, active zones (transmitter release sites) in the nerve terminal lie directly opposite junctional folds in the postsynaptic membrane. Few active zones or junctional folds form in mice lacking the laminin beta2 chain, which is normally concentrated in the synaptic cleft. beta2 and the broadly expressed gamma1 chain form heterotrimers with alpha chains, three of which, alpha2, alpha4 and alpha5, are present in the synaptic cleft. Thus, alpha2 beta2 gamma1, alpha4 beta2 gamma1 and alpha5 beta2 gamma1 heterotrimers are all lost in beta2 mutants. In mice lacking laminin alpha4, active zones and junctional folds form in normal numbers, but are not precisely apposed to each other. Thus, formation and localization of synaptic specializations are regulated separately, and alpha4 beta2 gamma1 (called laminin-9) is critical in the latter process.	Washington Univ, Med Ctr, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA; Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Clin Neurosci, S-17177 Stockholm, Sweden	Washington University (WUSTL); Oregon Health & Science University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Patton, BL (corresponding author), Washington Univ, Med Ctr, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.			Westerblad, Hakan/0000-0002-8180-3029				BLOCH RJ, 1988, AM J PHYSIOL, V254, pC345, DOI 10.1152/ajpcell.1988.254.3.C345; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Cho SI, 1998, J NEUROBIOL, V37, P339, DOI 10.1002/(SICI)1097-4695(19981115)37:3<339::AID-NEU1>3.3.CO;2-0; COHEN MW, 1991, J NEUROSCI, V11, P1032; Cohen MW, 2000, J NEUROSCI, V20, P4912; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; GILBERT JJ, 1973, J NEUROPATH EXP NEUR, V32, P345, DOI 10.1097/00005072-197307000-00001; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; JOHSNSSON C, 2000, AM J PHYSIOL-REG I, V278, pR598; LAW PK, 1983, EXP NEUROL, V80, P361, DOI 10.1016/0014-4886(83)90289-3; Marques MJ, 2000, J NEUROSCI, V20, P3663, DOI 10.1523/JNEUROSCI.20-10-03663.2000; MARTIN PT, 1995, SCIENCE, V269, P413, DOI 10.1126/science.7618109; MATTHEWSBELLINGER JA, 1983, J NEUROSCI, V3, P644; MERISH L, 1996, AM LIT HIST, V8, P1; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Patton BL, 1999, NEUROMUSCULAR DISORD, V9, P423, DOI 10.1016/S0960-8966(99)00033-4; Patton BL, 1998, NATURE, V393, P698, DOI 10.1038/31502; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; PORTER BE, 1995, NEURON, V14, P549, DOI 10.1016/0896-6273(95)90311-9; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; Reese T, 2000, NMR BIOMED, V13, P361, DOI 10.1002/1099-1492(200010)13:6<361::AID-NBM654>3.0.CO;2-C; Ringelmann B, 1999, EXP CELL RES, V246, P165, DOI 10.1006/excr.1998.4244; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SANES JR, 1978, J CELL BIOL, V78, P176, DOI 10.1083/jcb.78.1.176; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Son YJ, 1999, EUR J NEUROSCI, V11, P3457, DOI 10.1046/j.1460-9568.1999.00766.x; Son YJ, 2000, J BIOL CHEM, V275, P451, DOI 10.1074/jbc.275.1.451; Sunderland WJ, 2000, J NEUROSCI, V20, P1009, DOI 10.1523/JNEUROSCI.20-03-01009.2000; Uteshev VV, 2000, BIOPHYS J, V79, P2825, DOI 10.1016/S0006-3495(00)76521-0; Wood SJ, 1997, J PHYSIOL-LONDON, V500, P165, DOI 10.1113/jphysiol.1997.sp022007; Xie XP, 1997, P NATL ACAD SCI USA, V94, P6983, DOI 10.1073/pnas.94.13.6983	35	155	158	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					597	604		10.1038/88414	http://dx.doi.org/10.1038/88414			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369940				2022-12-17	WOS:000169061800012
J	Staley, KJ; Longacher, M; Bains, JS; Yee, A				Staley, KJ; Longacher, M; Bains, JS; Yee, A			Presynaptic modulation of CA3 network activity	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PYRAMIDAL CELLS; SYNCHRONIZED AFTERDISCHARGES; SYNAPTIC TRANSMISSION; EPILEPTIFORM ACTIVITY; HIPPOCAMPAL SYNAPSES; GRANULE CELLS; IN-VITRO; RAT; INHIBITION	The simultaneous discharge of hippocampal CA3 pyramidal cells is a widely studied in vitro model of physiological and pathological network synchronization. This network is rapidly activated because of extensive positive feedback mediated by recurrent axon collaterals. Here we show that population-burst duration is limited by depletion of the releasable glutamate pool at these recurrent synapses. Postsynaptic inhibitory conductances further limit burst duration but are not necessary for burst termination. The interval between bursts in vitro depends on the rate of replenishment of releasable glutamate vesicles and the probability of release of those vesicles at recurrent synapses. Therefore presynaptic factors controlling glutamate release at recurrent synapses regulate the probability and duration of synchronous discharges of the CA3 network.	Univ Colorado, Hlth Sci Ctr, Dept Neurol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Staley, KJ (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Neurol, Box B182,4200 E 9th Ave, Denver, CO 80262 USA.	Kevin.Staley@UCHSC.edu		Bains, Jaideep/0000-0002-3634-6463				Anderson Caroline M., 1997, Epilepsia, V38, P16; Barbarosie M, 1997, J NEUROSCI, V17, P9308; BUSH PC, 1994, J NEUROPHYSIOL, V71, P2183, DOI 10.1152/jn.1994.71.6.2183; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Capogna M, 1996, J NEUROPHYSIOL, V75, P2017, DOI 10.1152/jn.1996.75.5.2017; CHAMBERLIN NL, 1990, J NEUROPHYSIOL, V64, P1000, DOI 10.1152/jn.1990.64.3.1000; Chambon A., 1989, J STRAT SYST THER, V8, P3, DOI [https://doi.org/10.1521/jsst.1989.8.bonus.3, DOI 10.1521/JSST.1989.8.BONUS.3]; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DUNWIDDIE TV, 1980, EPILEPSIA, V21, P541, DOI 10.1111/j.1528-1157.1980.tb04305.x; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; JEFFERYS JGR, 1993, EPILEPSIES, P241; Kim U, 1997, SCIENCE, V278, P130, DOI 10.1126/science.278.5335.130; KORN SJ, 1987, J NEUROPHYSIOL, V57, P325, DOI 10.1152/jn.1987.57.1.325; LI XM, 1994, POTENTIAL ANAL, V3, P339, DOI 10.1007/BF01049807; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; MACVICAR BA, 1982, BRAIN RES, V242, P341; MADISON DV, 1996, NEURON S, V10, P55; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; Mayr O., 1970, ORIGINS FEEDBACK CON; MILES R, 1984, NEUROSCIENCE, V12, P1179, DOI 10.1016/0306-4522(84)90012-5; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; MUELLER AL, 1983, EPILEPSIA, V24, P57, DOI 10.1111/j.1528-1157.1983.tb04866.x; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Otis T, 1996, J NEUROSCI, V16, P7496; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; RAFIQ A, 1993, J NEUROPHYSIOL, V70, P1962, DOI 10.1152/jn.1993.70.5.1962; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; RUTECKI PA, 1990, J NEUROPHYSIOL, V64, P1077, DOI 10.1152/jn.1990.64.4.1077; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; SCHARFMAN HE, 1994, J NEUROSCI, V14, P6041; Schikorski T, 1997, J NEUROSCI, V17, P5858; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; STASHEFF SF, 1989, SCIENCE, V245, P648, DOI 10.1126/science.2569762; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; SWARTZWELDER HS, 1987, BRAIN RES, V410, P362; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Taylor RT, 1995, BIOREMED SER, V3, P15; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; TRAUB RD, 1993, J PHYSIOL-LONDON, V461, P525, DOI 10.1113/jphysiol.1993.sp019527; Traub RD, 1996, EPILEPSIA, V37, P879, DOI 10.1111/j.1528-1157.1996.tb00042.x; TRAUB RD, 1984, NEUROSCIENCE, V12, P1191, DOI 10.1016/0306-4522(84)90013-7; TRAUB RD, 1991, NEURONAL NETWORKS HI, pCH6; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; WHITTINGTON MA, 1994, J PHYSIOL-LONDON, V481, P593, DOI 10.1113/jphysiol.1994.sp020466; WONG RKS, 1981, J NEUROPHYSIOL, V45, P86, DOI 10.1152/jn.1981.45.1.86; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110	49	155	157	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					201	209		10.1038/651	http://dx.doi.org/10.1038/651			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195144				2022-12-17	WOS:000076361200010
J	Wang, YX; Romani, S; Lustig, B; Leonardo, A; Pastalkova, E				Wang, Yingxue; Romani, Sandro; Lustig, Brian; Leonardo, Anthony; Pastalkova, Eva			Theta sequences are essential for internally generated hippocampal firing fields	NATURE NEUROSCIENCE			English	Article							PHASE PRECESSION; PYRAMIDAL CELLS; PLACE CELLS; SPATIAL PERIODICITY; PATH-INTEGRATION; UNIT-ACTIVITY; MEMORY; DYNAMICS; SPACE; REPRESENTATION	Sensory cue inputs and memory-related internal brain activities govern the firing of hippocampal neurons, but which specific firing patterns are induced by either of the two processes remains unclear. We found that sensory cues guided the firing of neurons in rats on a timescale of seconds and supported the formation of spatial firing fields. Independently of the sensory inputs, the memory-related network activity coordinated the firing of neurons not only on a second-long timescale, but also on a millisecond-long timescale, and was dependent on medial septum inputs. We propose a network mechanism that might coordinate this internally generated firing. Overall, we suggest that two independent mechanisms support the formation of spatial firing fields in hippocampus, but only the internally organized system supports short-timescale sequential firing and episodic memory.	[Romani, Sandro] Columbia Univ, Ctr Theoret Neurosci, New York, NY USA; [Lustig, Brian] Univ Chicago, Neurosci Grad Program, Chicago, IL 60637 USA	Columbia University; University of Chicago	Pastalkova, E (corresponding author), Janelia Res Campus, Ashburn, VA USA.	pastak@janelia.hhmi.org		Romani, Sandro/0000-0002-4727-4207	Howard Hughes Medical Institute; Human Frontier Science Program Long-Term Fellowship	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program)	We thank W Denk and G. Buzsaki for critical discussions and advice. We thank L. Abbott, M. Tsodyks and S. Druckmann for advice. We thank R. Egnor, A. Karpova, V. Jayaraman, A. Lee, J. Magee, N. Spruston, K. Svoboda, D. Hunt, A. Landragin and V. Bowman for their comments on early versions of the manuscript. We thank R. Wright for editorial help and mentorship. This work was supported by the Howard Hughes Medical Institute (E.P. And S.R.) and a Human Frontier Science Program Long-Term Fellowship (S.R.).	Ainge JA, 2007, HIPPOCAMPUS, V17, P988, DOI 10.1002/hipo.20301; Arikan R, 2002, J NEUROSCI METH, V118, P51, DOI 10.1016/S0165-0270(02)00143-7; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Berenyi A, 2014, J NEUROPHYSIOL, V111, P1132, DOI 10.1152/jn.00785.2013; Brandon MP, 2014, NEURON, V82, P789, DOI 10.1016/j.neuron.2014.04.013; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Carr H., 1917, J ANIMAL BEHAV, V7, P365; CHROBAK JJ, 1989, BEHAV NEURAL BIOL, V52, P357, DOI 10.1016/S0163-1047(89)90472-X; Cressant A, 1997, J NEUROSCI, V17, P2531; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Dudchenko PA, 2000, J NEUROSCI, V20, P2964; Fenton AA, 2010, J NEUROSCI, V30, P4613, DOI 10.1523/JNEUROSCI.5576-09.2010; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Gill PR, 2011, HIPPOCAMPUS, V21, P1240, DOI 10.1002/hipo.20832; Gupta AS, 2012, NAT NEUROSCI, V15, P1032, DOI 10.1038/nn.3138; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hirase H, 1999, EUR J NEUROSCI, V11, P4373, DOI 10.1046/j.1460-9568.1999.00853.x; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Jaramillo J, 2014, J NEUROSCI, V34, P7715, DOI 10.1523/JNEUROSCI.5136-13.2014; Knierim JJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0369; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Leibold C, 2006, NEURAL COMPUT, V18, P904, DOI 10.1162/089976606775774714; MacDonald CJ, 2013, J NEUROSCI, V33, P14607, DOI 10.1523/JNEUROSCI.1537-13.2013; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McNaughton BL, 1996, J EXP BIOL, V199, P173; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Mittelstaedt H, 1998, NEUROSCI BIOBEHAV R, V22, P473, DOI 10.1016/S0149-7634(97)00032-8; MIZUMORI SJY, 1989, J NEUROSCI, V9, P3915; MIZUMORI SJY, 1989, BRAIN RES, V500, P99, DOI 10.1016/0006-8993(89)90303-X; Modi MN, 2014, ELIFE, V3, DOI 10.7554/eLife.01982; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MULLER RU, 1989, J NEUROSCI, V9, P4101; Navratilova Z, 2012, HIPPOCAMPUS, V22, P772, DOI 10.1002/hipo.20939; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; PETSCHE H, 1960, ELECTROEN CLIN NEURO, V12, P589, DOI 10.1016/0013-4694(60)90101-2; Rivard B, 2004, J GEN PHYSIOL, V124, P9, DOI 10.1085/jgp.200409015; Robbe D, 2009, J NEUROSCI, V29, P12597, DOI 10.1523/JNEUROSCI.2407-09.2009; Romani S, 2015, HIPPOCAMPUS, V25, P94, DOI 10.1002/hipo.22355; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Thurley K, 2008, NEURAL COMPUT, V20, P1285, DOI 10.1162/neco.2008.07-06-292; Tolman EC, 1925, PSYCHOL REV, V32, P285, DOI 10.1037/h0072784; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Ulanoysky N, 2011, HIPPOCAMPUS, V21, P150, DOI 10.1002/hipo.20731; Vandecasteele M, 2012, JOVE-J VIS EXP, DOI 10.3791/3568; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Walden A., 1993, SPECTRAL ANALYSIS FO; Whishaw IQ, 1998, J NEUROSCI, V18, P3050; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	59	154	157	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2015	18	2					282	288		10.1038/nn.3904	http://dx.doi.org/10.1038/nn.3904			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CA0UM	25531571				2022-12-17	WOS:000348631800018
J	Malik, AN; Vierbuchen, T; Hemberg, M; Rubin, AA; Ling, E; Couch, CH; Stroud, H; Spiegel, I; Farh, KKH; Harmin, DA; Greenberg, ME				Malik, Athar N.; Vierbuchen, Thomas; Hemberg, Martin; Rubin, Alex A.; Ling, Emi; Couch, Cameron H.; Stroud, Hume; Spiegel, Ivo; Farh, Kyle Kai-How; Harmin, David A.; Greenberg, Michael E.			Genome-wide identification and characterization of functional neuronal activity-dependent enhancers	NATURE NEUROSCIENCE			English	Article							SYNAPSE DEVELOPMENT; GENE; TRANSCRIPTION; RECEPTORS; STIMULATION; MECHANISMS; EXPRESSION; NARP	Experience-dependent gene transcription is required for nervous system development and function. However, the DNA regulatory elements that control this program of gene expression are not well defined. Here we characterize the enhancers that function across the genome to mediate activity-dependent transcription in mouse cortical neurons. We find that the subset of enhancers enriched for monomethylation of histone H3 Lys4 (H3K4me1) and binding of the transcriptional coactivator CREBBP (also called CBP) that shows increased acetylation of histone H3 Lys27 (H3K27ac) after membrane depolarization of cortical neurons functions to regulate activity-dependent transcription. A subset of these enhancers appears to require binding of FOS, which was previously thought to bind primarily to promoters. These findings suggest that FOS functions at enhancers to control activity-dependent gene programs that are critical for nervous system function and provide a resource of functional cis-regulatory elements that may give insight into the genetic variants that contribute to brain development and disease.	[Malik, Athar N.; Vierbuchen, Thomas; Rubin, Alex A.; Ling, Emi; Couch, Cameron H.; Stroud, Hume; Spiegel, Ivo; Farh, Kyle Kai-How; Harmin, David A.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Malik, Athar N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Malik, Athar N.] Harvard Univ, Sch Med, Div Hlth Sci & Technol, Cambridge, MA USA; [Malik, Athar N.] MIT, Cambridge, MA 02139 USA; [Hemberg, Martin] Harvard Univ, Childrens Hosp Boston, Dept Ophthalmol, Boston, MA 02115 USA; [Ling, Emi] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Farh, Kyle Kai-How] MIT & Harvard, Broad Inst, Cambridge, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	michael_greenberg@hms.harvard.edu	Stroud, Hume/ABF-1325-2021; Spiegel, Ivo/O-4025-2014	Spiegel, Ivo/0000-0003-0979-1358; Vierbuchen, Thomas/0000-0002-5690-5680; Malik, Athar N./0000-0002-1545-4107; Ling, Emi/0000-0001-5287-0284	US National Institutes of Health (NIH) [5R37NS028829-25]; National Institute of General Medical Sciences [T32GM007753]; National Cancer Institute Institutional Training grant [T32CA009361]; National Science Foundation Graduate Research Fellowship [DGE0946799, DGE1144152]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028829] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute Institutional Training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all the members of M.E.G.'s lab for their scientific support and helpful discussions. This work was funded by the US National Institutes of Health (NIH project 5R37NS028829-25 to M.E.G.), the National Institute of General Medical Sciences award number T32GM007753 (A.N.M.) and National Cancer Institute Institutional Training grant T32CA009361 (T.V.). T.V. and H.S. are both Howard Hughes Medical Institute Fellows of the Damon Runyon Cancer Research Foundation. E.L. is supported by the National Science Foundation Graduate Research Fellowship under grant numbers DGE0946799 and DGE1144152. The content of this study is solely the responsibility of the authors and does not necessarily represent the official views of the funding sources mentioned.	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Gu Y, 2013, NEURON, V79, P335, DOI 10.1016/j.neuron.2013.05.016; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; HSU YC, 1995, GENOMICS, V28, P220, DOI 10.1006/geno.1995.1134; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; Leslie JH, 2011, PROG NEUROBIOL, V94, P223, DOI 10.1016/j.pneurobio.2011.05.002; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Lyons MR, 2011, PROG NEUROBIOL, V94, P259, DOI 10.1016/j.pneurobio.2011.05.003; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Sugo N, 2010, EUR J NEUROSCI, V31, P1521, DOI 10.1111/j.1460-9568.2010.07218.x; Telese F, 2013, NEURON, V77, P606, DOI 10.1016/j.neuron.2013.01.034; Visel A, 2013, CELL, V152, P895, DOI 10.1016/j.cell.2012.12.041; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730	38	154	158	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2014	17	10					1330	1339		10.1038/nn.3808	http://dx.doi.org/10.1038/nn.3808			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AP8KD	25195102	Green Accepted			2022-12-17	WOS:000342327000013
J	Lin, AC; Bygrave, AM; de Calignon, A; Lee, T; Miesenbock, G				Lin, Andrew C.; Bygrave, Alexei M.; de Calignon, Alix; Lee, Tzumin; Miesenboeck, Gero			Sparse, decorrelated odor coding in the mushroom body enhances learned odor discrimination	NATURE NEUROSCIENCE			English	Article							SYNAPTIC-TRANSMISSION; TARGETED EXPRESSION; ANTENNAL LOBE; DROSOPHILA; NEURONS; REPRESENTATIONS; INHIBITION; FEEDBACK; MEMORIES; NORMALIZATION	Sparse coding may be a general strategy of neural systems for augmenting memory capacity. In Drosophila melanogaster, sparse odor coding by the Kenyon cells of the mushroom body is thought to generate a large number of precisely addressable locations for the storage of odor-specific memories. However, it remains untested how sparse coding relates to behavioral performance. Here we demonstrate that sparseness is controlled by a negative feedback circuit between Kenyon cells and the GABAergic anterior paired lateral (APL) neuron. Systematic activation and blockade of each leg of this feedback circuit showed that Kenyon cells activated APL and APL inhibited Kenyon cells. Disrupting the Kenyon cell-APL feedback loop decreased the sparseness of Kenyon cell odor responses, increased inter-odor correlations and prevented flies from learning to discriminate similar, but not dissimilar, odors. These results suggest that feedback inhibition suppresses Kenyon cell activity to maintain sparse, decorrelated odor coding and thus the odor specificity of memories.	[Lin, Andrew C.; Bygrave, Alexei M.; de Calignon, Alix; Miesenboeck, Gero] Univ Oxford, Ctr Neural Circuits & Behav, Oxford, England; [Lee, Tzumin] Howard Hughes Med Inst, Ashburn, VA USA	University of Oxford; Howard Hughes Medical Institute	Miesenbock, G (corresponding author), Univ Oxford, Ctr Neural Circuits & Behav, Oxford, England.	gero.miesenboeck@cncb.ox.ac.uk		Miesenboeck, Gero/0000-0003-2940-3228; Lin, Andrew/0000-0001-6310-9765; Bygrave, Alexei/0000-0003-2291-923X	Wellcome Trust [090309/Z/09/Z]; Gatsby Charitable Foundation; UK Medical Research Council [G0700888]; US National Institutes of Health [R01DA030601]; Oxford Martin School; Howard Hughes Medical Institute; Sir Henry Wellcome Postdoctoral Fellowship [089021/Z/09/Z]; Wellcome Trust OXION studentship; MRC [G0700888, G0701225] Funding Source: UKRI; Medical Research Council [G0701225, G0700888] Funding Source: researchfish; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030601] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oxford Martin School; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sir Henry Wellcome Postdoctoral Fellowship; Wellcome Trust OXION studentship(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Parnas and S. DasGupta for discussions; Y. Tan, R. Roorda, C. Talbot and J. Beevers for technical assistance; L. Looger (Janelia Farm Research Campus) for a plasmid encoding GCaMP3; and S. Goodwin (University of Oxford), C.-H. Lee (US National Institutes of Health), L. Luo (Stanford University), K. Scott (University of California, Berkeley), S. Waddell (University of Oxford), the Bloomington Stock Center, the Kyoto Drosophila Genetic Resource Center and the Vienna Drosophila RNAi Center for fly strains. This work was supported by grants from the Wellcome Trust (090309/Z/09/Z; G.M.), the Gatsby Charitable Foundation (G.M.), the UK Medical Research Council (G0700888; G.M.), the US National Institutes of Health (R01DA030601; G.M.), the Oxford Martin School (G.M.), the Howard Hughes Medical Institute (T.L.), a Sir Henry Wellcome Postdoctoral Fellowship (089021/Z/09/Z; A.C.L.) and a Wellcome Trust OXION studentship (A.M.B.).	Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Assisi C, 2007, NAT NEUROSCI, V10, P1176, DOI 10.1038/nn1947; Awasaki T, 2011, NAT NEUROSCI, V14, P821, DOI 10.1038/nn.2833; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Boyd AM, 2012, NEURON, V76, P1161, DOI 10.1016/j.neuron.2012.10.020; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Campbell RAA, 2013, J NEUROSCI, V33, P10568, DOI 10.1523/JNEUROSCI.0682-12.2013; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Franks KM, 2011, NEURON, V72, P49, DOI 10.1016/j.neuron.2011.08.020; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Gupta N, 2012, J NEUROSCI, V32, P8138, DOI 10.1523/JNEUROSCI.1066-12.2012; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Honegger KS, 2011, J NEUROSCI, V31, P11772, DOI 10.1523/JNEUROSCI.1099-11.2011; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Hu AQ, 2010, P NATL ACAD SCI USA, V107, P10262, DOI 10.1073/pnas.0914912107; Ito I, 2008, NAT NEUROSCI, V11, P1177, DOI 10.1038/nn.2192; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jortner RA, 2007, J NEUROSCI, V27, P1659, DOI 10.1523/JNEUROSCI.4171-06.2007; Kakihara K, 2008, MECH DEVELOP, V125, P325, DOI 10.1016/j.mod.2007.10.012; Kanerva P., 1988, SPARSE DISTRIBUTED M; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Lei ZC, 2013, BIOCHEM BIOPH RES CO, V436, P35, DOI 10.1016/j.bbrc.2013.05.036; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Liu X, 2007, NEURON, V56, P1090, DOI 10.1016/j.neuron.2007.10.036; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; Luo SX, 2010, P NATL ACAD SCI USA, V107, P10713, DOI 10.1073/pnas.1005635107; Markopoulos F, 2012, NEURON, V76, P1175, DOI 10.1016/j.neuron.2012.10.028; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mishra D, 2010, J NEUROGENET, V24, P168, DOI 10.3109/01677063.2010.498066; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Papadopoulou M, 2011, SCIENCE, V332, P721, DOI 10.1126/science.1201835; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; Pitman JL, 2011, CURR BIOL, V21, P855, DOI 10.1016/j.cub.2011.03.069; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Ren QZ, 2012, J NEUROSCI, V32, P11524, DOI 10.1523/JNEUROSCI.0827-12.2012; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; Thum AS, 2007, J NEUROSCI, V27, P11132, DOI 10.1523/JNEUROSCI.2712-07.2007; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; TREVES A, 1991, NETWORK-COMP NEURAL, V2, P371, DOI 10.1088/0954-898X/2/4/004; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wu CL, 2011, CURR BIOL, V21, P848, DOI 10.1016/j.cub.2011.02.041; Wu YY, 2012, LEARN MEMORY, V19, P478, DOI 10.1101/lm.025726.112	67	154	157	3	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2014	17	4					559	U116		10.1038/nn.3660	http://dx.doi.org/10.1038/nn.3660			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AD6XR	24561998	Green Accepted			2022-12-17	WOS:000333405300016
J	Vogel-Ciernia, A; Matheos, DP; Barrett, RM; Kramar, EA; Azzawi, S; Chen, YC; Magnan, CN; Zeller, M; Sylvain, A; Haettig, J; Jia, YS; Tran, A; Dang, R; Post, RJ; Chabrier, M; Babayan, AH; Wu, JI; Crabtree, GR; Baldi, P; Baram, TZ; Lynch, G; Wood, MA				Vogel-Ciernia, Annie; Matheos, Dina P.; Barrett, Ruth M.; Kramar, Enikoe A.; Azzawi, Soraya; Chen, Yuncai; Magnan, Christophe N.; Zeller, Michael; Sylvain, Angelina; Haettig, Jakob; Jia, Yousheng; Tran, Anthony; Dang, Richard; Post, Rebecca J.; Chabrier, Meredith; Babayan, Alex H.; Wu, Jiang I.; Crabtree, Gerald R.; Baldi, Pierre; Baram, Tallie Z.; Lynch, Gary; Wood, Marcelo A.			The neuron-specific chromatin regulatory subunit BAF53b is necessary for synaptic plasticity and memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; REMODELING COMPLEX; DENDRITIC SPINE; MUTATIONS; EXPRESSION; BINDING; QUANTIFICATION; SYNAPSES; RECEPTOR; ARID1B	Recent exome sequencing studies have implicated polymorphic Brg1-Associated Factor (BAF) complexes (mammalian SWI/SNF chromatin remodeling complexes) in several human intellectual disabilities and cognitive disorders. However, it is currently unknown how mutations in BAF complexes result in impaired cognitive function. Postmitotic neurons express a neuron-specific assembly, nBAF, characterized by the neuron-specific subunit BAF53b. Mice harboring selective genetic manipulations of BAF53b have severe defects in long-term memory and long-lasting forms of hippocampal synaptic plasticity. We rescued memory impairments in BAF53b mutant mice by reintroducing BAF53b in the adult hippocampus, which suggests a role for BAF53b beyond neuronal development. The defects in BAF53b mutant mice appeared to derive from alterations in gene expression that produce abnormal postsynaptic components, such as spine structure and function, and ultimately lead to deficits in synaptic plasticity. Our results provide new insight into the role of dominant mutations in subunits of BAF complexes in human intellectual and cognitive disorders.	[Vogel-Ciernia, Annie; Matheos, Dina P.; Azzawi, Soraya; Sylvain, Angelina; Haettig, Jakob; Tran, Anthony; Dang, Richard; Post, Rebecca J.; Chabrier, Meredith; Wood, Marcelo A.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA; [Vogel-Ciernia, Annie; Matheos, Dina P.; Azzawi, Soraya; Sylvain, Angelina; Haettig, Jakob; Tran, Anthony; Dang, Richard; Post, Rebecca J.; Wood, Marcelo A.] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92717 USA; [Barrett, Ruth M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Kramar, Enikoe A.; Chen, Yuncai; Jia, Yousheng; Babayan, Alex H.; Baram, Tallie Z.; Lynch, Gary] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Chen, Yuncai; Baram, Tallie Z.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Magnan, Christophe N.; Zeller, Michael; Baldi, Pierre] Univ Calif Irvine, Dept Comp Sci, Irvine, CA USA; [Magnan, Christophe N.; Zeller, Michael; Baldi, Pierre] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA USA; [Wu, Jiang I.; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Wu, Jiang I.; Crabtree, Gerald R.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Lynch, Gary] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Oregon Health & Science University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Howard Hughes Medical Institute; Stanford University; Stanford University; University of California System; University of California Irvine	Wood, MA (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA.	mwood@uci.edu	magnan, christophe/AAJ-7622-2021; Post, Rebecca/AAQ-5236-2020; Baram, Tallie Z/J-6447-2014	magnan, christophe/0000-0002-7044-2571; Post, Rebecca/0000-0001-5652-5816; 	US National Institutes of Health [MH081004, DA025922, T32-AG00096-29, P01 NS045260, NS 28912, MH73136, LM010235]; ONR [N00014-10-1-0072]; National Science Foundation [IIS-0513376]; National Library of Medicine [T15 LM07443]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073136, F31MH098565, R01MH081004, R01MH101491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS046789, P01NS045260, R01NS028912, R01NS046789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036984, R01DA025922] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007443, R01LM010235] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ONR(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We wish to acknowledge the University of California at Irvine Institute for Genomics and Bioinformatics and Genomics High-Throughput Facility, and J. Hayes for additional computing support. We would like to thank J. Guzowski and T. Miyashita for their technical expertise and the use of the BX61 microscope and XC10 camera. This work was supported by grants from the US National Institutes of Health (MH081004 and DA025922 to M.A.W., and training grant T32-AG00096-29 to A.V.C.). G.L., E.K. and Y.J. were supported by grants from the US National Institutes of Health (P01 NS045260) and ONR (#N00014-10-1-0072). T.Z.B. was supported by US National Institutes of Health grants NS 28912 and MH73136. The work of M.Z., C.M. and P.B. was supported by grants from the National Science Foundation (IIS-0513376), the US National Institutes of Health (LM010235) and the National Library of Medicine (T15 LM07443) to P.B.	Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babayan AH, 2012, J NEUROSCI, V32, P12854, DOI 10.1523/JNEUROSCI.2024-12.2012; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Barrett RM, 2011, NEUROPSYCHOPHARMACOL, V36, P1545, DOI 10.1038/npp.2011.61; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Chen Y, 2013, MOL PSYCHIATR, V18, P485, DOI 10.1038/mp.2012.17; Colgin LL, 2005, NEUROSCI LETT, V385, P46, DOI 10.1016/j.neulet.2005.05.005; Day JJ, 2011, NEUROBIOL LEARN MEM, V96, P2, DOI 10.1016/j.nlm.2010.12.008; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fedulov V, 2007, J NEUROSCI, V27, P8031, DOI 10.1523/JNEUROSCI.2003-07.2007; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Geisler S, 2002, HISTOCHEM CELL BIOL, V117, P69, DOI 10.1007/s00418-001-0357-z; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Halgren C, 2012, CLIN GENET, V82, P248, DOI 10.1111/j.1399-0004.2011.01755.x; Hansen KF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015497; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kayala MA, 2012, NUCLEIC ACIDS RES, V40, pW553, DOI 10.1093/nar/gks420; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Lauterborn JC, 2007, J NEUROSCI, V27, P10685, DOI 10.1523/JNEUROSCI.2624-07.2007; Lawlor PA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-11; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Levenga J, 2012, PROG BRAIN RES, V197, P153, DOI 10.1016/B978-0-444-54299-1.00008-X; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nelson ED, 2011, NEUROBIOL LEARN MEM, V96, P53, DOI 10.1016/j.nlm.2011.02.015; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Olave I, 2002, GENE DEV, V16, P2509, DOI 10.1101/gad.992102; Park J, 2002, MOL CELL BIOL, V22, P1307, DOI 10.1128/MCB.22.5.1307-1316.2002; Pfaffl MW, 2002, DOMEST ANIM ENDOCRIN, V22, P91, DOI 10.1016/S0739-7240(01)00128-X; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Van Houdt JKJ, 2012, NAT GENET, V44, P445, DOI 10.1038/ng.1105; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zahir FR, 2011, PEDIATR RES, V69, p92R, DOI 10.1203/PDR.0b013e318213565e; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	59	154	154	0	33	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					552	+		10.1038/nn.3359	http://dx.doi.org/10.1038/nn.3359			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT		Green Submitted, Green Accepted			2022-12-17	WOS:000318029300011
J	Di Leone, RJ; Taylor, JR; Picciotto, MR				Di Leone, Ralph J.; Taylor, Jane R.; Picciotto, Marina R.			The drive to eat: comparisons and distinctions between mechanisms of food reward and drug addiction	NATURE NEUROSCIENCE			English	Review							MU-OPIOID RECEPTOR; MELANIN-CONCENTRATING HORMONE; NEUROPEPTIDE-Y; COCAINE SEEKING; DOPAMINE; LEPTIN; BEHAVIOR; ENERGY; STRESS; BRAIN	The growing rates of obesity have prompted comparisons between the uncontrolled intake of food and drugs; however, an evaluation of the equivalence of food- and drug-related behaviors requires a thorough understanding of the underlying neural circuits driving each behavior. Although it has been attractive to borrow neurobiological concepts from addiction to explore compulsive food seeking, a more integrated model is needed to understand how food and drugs differ in their ability to drive behavior. In this Review, we will examine the commonalities and differences in the systems-level and behavioral responses to food and to drugs of abuse, with the goal of identifying areas of research that would address gaps in our understanding and ultimately identify new treatments for obesity or drug addiction.	[Di Leone, Ralph J.; Taylor, Jane R.; Picciotto, Marina R.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA	Yale University	Picciotto, MR (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	marina.picciotto@yale.edu	Picciotto, Marina R./F-8747-2012	Picciotto, Marina R./0000-0002-4404-1280; DiLeone, Ralph/0000-0002-4770-2590	US National Institutes of Health [DK076964, DA011017, DA015222, DA15425, DA014241]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015425, R01DA011717, R01DA014241, R01DA015222] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by US National Institutes of Health grants DK076964 (R.J.D.), DA011017 (J.R.T.), DA015222 (J.R.T.) DA15425 (M.R.P.) and DA014241 (M.R.P.).	Abizaid A, 2011, NEUROSCIENCE, V192, P500, DOI 10.1016/j.neuroscience.2011.06.001; Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Ahmed SH, 1997, PSYCHOPHARMACOLOGY, V132, P289, DOI 10.1007/s002130050347; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Avena NM, 2003, NEUROSCIENCE, V122, P17, DOI 10.1016/S0306-4522(03)00502-5; Baldo BA, 2002, BEHAV BRAIN RES, V137, P165, DOI 10.1016/S0166-4328(02)00293-0; Baldo BA, 2007, PSYCHOPHARMACOLOGY, V191, P439, DOI 10.1007/s00213-007-0741-z; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Benoit SC, 2000, J NEUROSCI, V20, P3442, DOI 10.1523/JNEUROSCI.20-09-03442.2000; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; BLANCHARD DC, 1995, PSYCHONEUROENDOCRINO, V20, P117, DOI 10.1016/0306-4530(94)E0045-B; Boules M, 2007, BRAIN RES, V1127, P90, DOI 10.1016/j.brainres.2006.10.025; Brabant C, 2010, BEHAV NEUROSCI, V124, P828, DOI 10.1037/a0021221; Cannon CM, 2003, J NEUROSCI, V23, P10827; Chung SJ, 2009, P NATL ACAD SCI USA, V106, P6772, DOI 10.1073/pnas.0811331106; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Dar R, 2004, PSYCHOPHARMACOLOGY, V173, P18, DOI 10.1007/s00213-004-1781-2; Davidson TL, 2009, HIPPOCAMPUS, V19, P235, DOI 10.1002/hipo.20499; DiLeone RJ, 2003, LIFE SCI, V73, P759, DOI 10.1016/S0024-3205(03)00408-9; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Edwards CMB, 1999, J ENDOCRINOL, V160, pR7, DOI 10.1677/joe.0.160R007; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Forlano PM, 2007, J COMP NEUROL, V505, P235, DOI 10.1002/cne.21447; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gearhardt AN, 2009, J ADDICT MED, V3, P1, DOI 10.1097/ADM.0b013e318193c993; Goeders NE, 2002, J PHARMACOL EXP THER, V301, P785, DOI 10.1124/jpet.301.3.785; Grakalic I, 2010, NEUROSCIENCE, V165, P313, DOI 10.1016/j.neuroscience.2009.10.051; Gray MA, 2007, NEURON, V54, P183, DOI 10.1016/j.neuron.2007.03.024; Guegan T, 2013, EUR NEUROPSYCHOPHARM, V23, P240, DOI 10.1016/j.euroneuro.2012.04.009; Guegan T, 2013, EUR NEUROPSYCHOPHARM, V23, P146, DOI 10.1016/j.euroneuro.2012.04.004; Havel PJ, 2001, EXP BIOL MED, V226, P963, DOI 10.1177/153537020122601102; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Horvath TL, 2004, NAT REV NEUROSCI, V5, P662, DOI 10.1038/nrn1479; Hsu R, 2005, EUR J NEUROSCI, V21, P2233, DOI 10.1111/j.1460-9568.2005.04038.x; Hunter RG, 2003, CNS NEUROL DISORD-DR, V2, P201, DOI 10.2174/1568007033482896; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Jerlhag E, 2010, PSYCHOPHARMACOLOGY, V211, P415, DOI 10.1007/s00213-010-1907-7; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kearns David N, 2011, Curr Drug Abuse Rev, V4, P261; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Kenny PJ, 2011, NAT REV NEUROSCI, V12, P638, DOI 10.1038/nrn3105; Koob George F., 1995, P759; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; KYRKOULI SE, 1990, PEPTIDES, V11, P995, DOI 10.1016/0196-9781(90)90023-X; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Lof E, 2010, PSYCHOPHARMACOLOGY, V212, P321, DOI 10.1007/s00213-010-1957-x; Lu L, 2004, NEUROPHARMACOLOGY, V47, P214, DOI 10.1016/j.neuropharm.2004.06.027; Maric T, 2009, PEPTIDES, V30, P721, DOI 10.1016/j.peptides.2008.11.006; Mena JD, 2011, J NEUROSCI, V31, P3249, DOI 10.1523/JNEUROSCI.2050-10.2011; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Nair SG, 2006, PHYSIOL BEHAV, V88, P559, DOI 10.1016/j.physbeh.2006.05.014; Narasimhaiah R, 2009, PSYCHOPHARMACOLOGY, V204, P95, DOI 10.1007/s00213-008-1438-7; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Pickens CL, 2012, PSYCHOPHARMACOLOGY, V221, P341, DOI 10.1007/s00213-011-2585-9; Pierce RC, 2010, NEUROSCI BIOBEHAV R, V35, P212, DOI 10.1016/j.neubiorev.2010.01.007; Piguet O, 2011, J MOL NEUROSCI, V45, P589, DOI 10.1007/s12031-011-9547-x; Ren XY, 2010, J NEUROSCI, V30, P8012, DOI 10.1523/JNEUROSCI.5749-09.2010; Richelson E, 2003, LIFE SCI, V73, P679, DOI 10.1016/S0024-3205(03)00388-6; SALAMONE JD, 1993, PHARMACOL BIOCHEM BE, V44, P605, DOI 10.1016/0091-3057(93)90174-R; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Schwartz GJ, 2000, NUTRITION, V16, P866, DOI 10.1016/S0899-9007(00)00464-0; Seymour B, 2006, J NEUROSCI, V26, P1061, DOI 10.1523/JNEUROSCI.4418-05.2006; Shalev U, 2001, J NEUROSCI, V21; Shiraishi T, 2000, PHYSIOL BEHAV, V71, P251, DOI 10.1016/S0031-9384(00)00341-3; Singh A, 2009, P NATL ACAD SCI USA, V106, P13100, DOI 10.1073/pnas.0903723106; Smagin GN, 1999, AM J PHYSIOL-REG I, V276, pR1461, DOI 10.1152/ajpregu.1999.276.5.R1461; Small DM, 2008, NEURON, V57, P786, DOI 10.1016/j.neuron.2008.01.021; Smith RJ, 2010, NEUROPHARMACOLOGY, V58, P179, DOI 10.1016/j.neuropharm.2009.06.042; Sorensen LB, 2003, INT J OBESITY, V27, P1152, DOI 10.1038/sj.ijo.0802391; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; Stark R, 2005, BIOL PSYCHOL, V70, P19, DOI 10.1016/j.biopsycho.2004.11.014; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; Torregrossa MM, 2008, BIOL PSYCHIAT, V63, P253, DOI 10.1016/j.biopsych.2007.11.014; Troop NA, 1997, BRIT J MED PSYCHOL, V70, P373, DOI 10.1111/j.2044-8341.1997.tb01913.x; van den Pol AN, 2003, NEURON, V40, P1059, DOI 10.1016/S0896-6273(03)00809-2; Vucetic Z, 2011, NEUROPSYCHOPHARMACOL, V36, P1199, DOI 10.1038/npp.2011.4; Wheeler RA, 2011, BIOL PSYCHIAT, V69, P1067, DOI 10.1016/j.biopsych.2011.02.014; WISE RA, 1978, CAN J PSYCHOL, V32, P77, DOI 10.1037/h0081678; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854; Wise RA, 2011, NAT REV NEUROSCI, V12, P479, DOI 10.1038/nrn3043; WRIGHT C, 1990, AM J MED, V88, P647, DOI 10.1016/0002-9343(90)90534-K; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Yamamoto T, 2007, CHEM SENSES, V32, P105, DOI 10.1093/chemse/bjj045; Zapata A, 2010, J NEUROSCI, V30, P15457, DOI 10.1523/JNEUROSCI.4072-10.2010; Zhang M, 1998, J PHARMACOL EXP THER, V285, P908; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212	92	154	157	1	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1330	1335		10.1038/nn.3202	http://dx.doi.org/10.1038/nn.3202			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	23007187	Green Accepted			2022-12-17	WOS:000309335300007
J	Saper, CB; Romanovsky, AA; Scammell, TE				Saper, Clifford B.; Romanovsky, Andrej A.; Scammell, Thomas E.			Neural circuitry engaged by prostaglandins during the sickness syndrome	NATURE NEUROSCIENCE			English	Review							LIPOPOLYSACCHARIDE-INDUCED FEVER; EYE-MOVEMENT SLEEP; SLOW-WAVE SLEEP; VENTROLATERAL PREOPTIC NEURONS; LATERAL HYPOTHALAMIC AREA; BRAIN ENDOTHELIAL-CELLS; RAT-BRAIN; BACTERIAL LIPOPOLYSACCHARIDE; MESSENGER-RNA; THERMOREGULATORY RESPONSE	During illnesses caused by infectious disease or other sources of inflammation, a suite of brain-mediated responses called the sickness syndrome occurs, which includes fever, anorexia, sleepiness, hyperalgesia and elevated corticosteroid secretion. Much of the sickness syndrome is mediated by prostaglandins acting on the brain and can be prevented by nonsteroidal anti-inflammatory drugs, such as aspirin or ibuprofen, that block prostaglandin synthesis. By examining which prostaglandins are produced at which sites and how they interact with the nervous system, researchers have identified specific neural circuits that underlie the sickness syndrome.	[Saper, Clifford B.; Scammell, Thomas E.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; [Saper, Clifford B.; Scammell, Thomas E.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Sleep Med, Boston, MA USA; [Romanovsky, Andrej A.] St Josephs Hosp, Informat Syst Lab, Phoenix, AZ USA; [Romanovsky, Andrej A.] Med Ctr, Phoenix, AZ USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; St. Joseph's Hospital and Medical Center	Saper, CB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA.	csaper@bidmc.harvard.edu	Saper, Clifford/L-3815-2019	Romanovsky, Andrej/0000-0003-3772-8575	US Public Health Service [NS055367, HL095491, NS072337, NS41233]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055367, R01NS072337, R01NS041233] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge support from US Public Health Service grants NS055367 (T.E.S.), HL095491 (C.B.S., T.E.S.), NS072337 (C.B.S.) and NS41233 (A.A.R.).	Abe M, 2001, BRAIN RES, V916, P41, DOI 10.1016/S0006-8993(01)02861-X; Almeida MC, 2006, EUR J NEUROSCI, V23, P3359, DOI 10.1111/j.1460-9568.2006.04854.x; Banks WA, 2010, NEUROBIOL DIS, V37, P26, DOI 10.1016/j.nbd.2009.07.031; Bjorness TE, 2009, CURR NEUROPHARMACOL, V7, P238, DOI 10.2174/157015909789152182; Bode JG, 2012, CELL SIGNAL, V24, P1185, DOI 10.1016/j.cellsig.2012.01.018; Breder CD, 1996, BRAIN RES, V713, P64, DOI 10.1016/0006-8993(95)01474-8; Chamberlin NL, 2003, NEUROSCIENCE, V119, P913, DOI 10.1016/S0306-4522(03)00246-X; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; DUNN AJ, 1992, LIFE SCI, V51, P219, DOI 10.1016/0024-3205(92)90078-4; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; Elmquist JK, 1996, J COMP NEUROL, V371, P85, DOI 10.1002/(SICI)1096-9861(19960715)371:1<85::AID-CNE5>3.0.CO;2-H; Engblom D, 2003, NAT NEUROSCI, V6, P1137, DOI 10.1038/nn1137; ERICSSON A, 1994, J NEUROSCI, V14, P897; Gadek-Michalska A, 2005, J PHYSIOL PHARMACOL, V56, P287; Garcia-Bueno B, 2009, J NEUROSCI, V29, P12970, DOI 10.1523/JNEUROSCI.2373-09.2009; Hansen MK, 2000, AUTON NEUROSCI-BASIC, V85, P83, DOI 10.1016/S1566-0702(00)00224-1; Hori T, 2000, ANN NY ACAD SCI, V917, P106; Huang QH, 1999, AM J PHYSIOL-REG I, V276, pR864, DOI 10.1152/ajpregu.1999.276.3.R864; Huang ZL, 2003, J NEUROSCI, V23, P5975, DOI 10.1523/JNEUROSCI.23-14-05975.2003; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; Inoue W, 2002, NEUROSCI RES, V44, P51, DOI 10.1016/S0168-0102(02)00083-4; Ivanov AI, 2004, FRONT BIOSCI-LANDMRK, V9, P1977, DOI 10.2741/1383; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Kluger MJ, 1998, ANN NY ACAD SCI, V856, P224, DOI 10.1111/j.1749-6632.1998.tb08329.x; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; KOZAK W, 1995, AM J PHYSIOL-REG I, V269, pR969, DOI 10.1152/ajpregu.1995.269.5.R969; KOZAK W, 1994, AM J PHYSIOL, V266, pR125, DOI 10.1152/ajpregu.1994.266.1.R125; Krueger JM, 2011, PROG BRAIN RES, V193, P39, DOI 10.1016/B978-0-444-53839-0.00003-X; KRUEGER JM, 1986, AM J PHYSIOL, V251, pR591, DOI 10.1152/ajpregu.1986.251.3.R591; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Lazarus M, 2011, J NEUROSCI, V31, P10067, DOI 10.1523/JNEUROSCI.6730-10.2011; Luheshi GN, 2000, AUTON NEUROSCI-BASIC, V85, P127, DOI 10.1016/S1566-0702(00)00231-9; Maness LM, 1998, AM J PHYSIOL-ENDOC M, V275, pE207, DOI 10.1152/ajpendo.1998.275.2.E207; MATSUMURA H, 1994, P NATL ACAD SCI USA, V91, P11998, DOI 10.1073/pnas.91.25.11998; Matsumura K, 1998, J NEUROSCI, V18, P6279; Matsuoka Y, 2003, P NATL ACAD SCI USA, V100, P4132, DOI 10.1073/pnas.0633341100; Mizoguchi A, 2001, P NATL ACAD SCI USA, V98, P11674, DOI 10.1073/pnas.201398898; Morrison SF, 2011, J APPL PHYSIOL, V110, P1137, DOI 10.1152/japplphysiol.01227.2010; Morrow JD, 2005, BRAIN BEHAV IMMUN, V19, P40, DOI 10.1016/j.bbi.2004.04.001; Mullington J, 2000, AM J PHYSIOL-REG I, V278, pR947, DOI 10.1152/ajpregu.2000.278.4.R947; Nadjar A, 2010, NEUROBIOL DIS, V39, P393, DOI 10.1016/j.nbd.2010.05.005; Nakamura K, 2000, J COMP NEUROL, V421, P543, DOI 10.1002/(SICI)1096-9861(20000612)421:4<543::AID-CNE6>3.0.CO;2-3; Nakamura K, 2002, J NEUROSCI, V22, P4600, DOI 10.1523/JNEUROSCI.22-11-04600.2002; Nakamura K, 2011, AM J PHYSIOL-REG I, V301, pR1207, DOI 10.1152/ajpregu.00109.2011; Ohinata K, 2008, FEBS LETT, V582, P679, DOI 10.1016/j.febslet.2008.01.050; Ohinata K, 2006, PROSTAG OTH LIPID M, V81, P31, DOI 10.1016/j.prostaglandins.2006.06.008; Oishi Y, 2008, P NATL ACAD SCI USA, V105, P19992, DOI 10.1073/pnas.0810926105; Oka T, 2000, J COMP NEUROL, V428, P20, DOI 10.1002/1096-9861(20001204)428:1<20::AID-CNE3>3.0.CO;2-X; Oka T, 2003, J PHYSIOL-LONDON, V551, P945, DOI 10.1113/jphysiol.2003.048140; ONOE H, 1992, J NEUROSCI, V12, P2715; Parsadaniantz SM, 2000, J NEUROENDOCRINOL, V12, P766, DOI 10.1046/j.1365-2826.2000.00517.x; Pecchi E, 2006, PHYSIOL GENOMICS, V25, P485, DOI 10.1152/physiolgenomics.00306.2005; Rizvi TA, 1996, J NEUROSCI, V16, P333; Romanovsky AA, 1997, AM J PHYSIOL-REG I, V273, pR407, DOI 10.1152/ajpregu.1997.273.1.R407; Romanovsky AA, 1996, AM J PHYSIOL-REG I, V271, pR244, DOI 10.1152/ajpregu.1996.271.1.R244; Romanovsky AA, 1997, AM J PHYSIOL-REG I, V273, pR777, DOI 10.1152/ajpregu.1997.273.2.R777; Romanovsky AA, 2004, FRONT BIOSCI-LANDMRK, V9, P494, DOI 10.2741/1247; Romanovsky AA, 2000, AUTON NEUROSCI-BASIC, V85, P133, DOI 10.1016/S1566-0702(00)00232-0; Romanovsky AA, 1998, AM J PHYSIOL-REG I, V275, pR323, DOI 10.1152/ajpregu.1998.275.1.R323; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; Rorato R, 2009, EXP PHYSIOL, V94, P371, DOI 10.1113/expphysiol.2008.045435; Roth J, 2002, PFLUG ARCH EUR J PHY, V443, P411, DOI 10.1007/s004240100718; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Satoh S, 1996, P NATL ACAD SCI USA, V93, P5980, DOI 10.1073/pnas.93.12.5980; Scammell TE, 1998, AM J PHYSIOL-REG I, V274, pR783, DOI 10.1152/ajpregu.1998.274.3.R783; Scammell TE, 2001, NEUROSCIENCE, V107, P653, DOI 10.1016/S0306-4522(01)00383-9; Scammell TE, 1996, J NEUROSCI, V16, P6246; Schiltz JC, 2002, J NEUROSCI, V22, P5606; Schiltz JC, 2007, J COMP NEUROL, V502, P455, DOI 10.1002/cne.21329; Schmelzer KR, 2006, P NATL ACAD SCI USA, V103, P13646, DOI 10.1073/pnas.0605908103; Serrats J, 2010, NEURON, V65, P94, DOI 10.1016/j.neuron.2009.11.032; Steiner AA, 2005, AM J PHYSIOL-REG I, V289, pR1253, DOI 10.1152/ajpregu.00371.2005; Steiner AA, 2006, PLOS BIOL, V4, P1517, DOI 10.1371/journal.pbio.0040284; Swiergiel AH, 2002, J PHARMACOL EXP THER, V302, P1031, DOI 10.1124/jpet.102.036640; SZEKELY M, 1979, ACTA PHYSIOL HUNG, V53, P265; SZELENYI Z, 1994, BRAIN RES, V638, P69, DOI 10.1016/0006-8993(94)90634-3; Tanaka M, 2009, AM J PHYSIOL-REG I, V296, pR1248, DOI 10.1152/ajpregu.91010.2008; Terao A, 1998, NEUROREPORT, V9, P3791, DOI 10.1097/00001756-199812010-00005; Ueno A, 2001, BIOCHEM PHARMACOL, V62, P157, DOI 10.1016/S0006-2952(01)00654-2; UENO R, 1982, P NATL ACAD SCI-BIOL, V79, P6093, DOI 10.1073/pnas.79.19.6093; URADE Y, 1993, P NATL ACAD SCI USA, V90, P9070, DOI 10.1073/pnas.90.19.9070; Urade Y, 2011, SLEEP MED REV, V15, P411, DOI 10.1016/j.smrv.2011.08.003; Uschakov A, 2007, NEUROSCIENCE, V150, P104, DOI 10.1016/j.neuroscience.2007.05.055; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233; Vasilache AM, 2007, NEUROSCI LETT, V423, P179, DOI 10.1016/j.neulet.2007.06.048; Wang LX, 2006, AM J PHYSIOL-GASTR L, V291, pG611, DOI 10.1152/ajpgi.00533.2005; Wang LX, 2002, NEUROSCI LETT, V325, P47; WATKINS LR, 1994, BRAIN RES, V654, P15, DOI 10.1016/0006-8993(94)91566-0; Wieczorek M, 2005, PHYSIOL BEHAV, V85, P500, DOI 10.1016/j.physbeh.2005.05.012; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Wu Q, 2011, EUR J PHARMACOL, V660, P21, DOI 10.1016/j.ejphar.2010.10.110; Yamagata K, 2001, J NEUROSCI, V21, P2669, DOI 10.1523/JNEUROSCI.21-08-02669.2001; Yates DT, 2011, J ANIM SCI, V89, P4286, DOI 10.2527/jas.2011-3969; Yoshida H, 2003, AM J PHYSIOL-REG I, V285, pR99, DOI 10.1152/ajpregu.00609.2002; Yoshida K, 2009, J NEUROSCI, V29, P11954, DOI 10.1523/JNEUROSCI.2643-09.2009; Zhang YH, 2003, J COMP NEUROL, V463, P3, DOI 10.1002/cne.10743	100	154	161	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1088	1095		10.1038/nn.3159	http://dx.doi.org/10.1038/nn.3159			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22837039	Green Accepted			2022-12-17	WOS:000306844500010
J	Billig, GM; Pal, B; Fidzinski, P; Jentsch, TJ				Billig, Gwendolyn M.; Pal, Balazs; Fidzinski, Pawel; Jentsch, Thomas J.			Ca2+-activated Cl- currents are dispensable for olfaction	NATURE NEUROSCIENCE			English	Article							ACTIVATED CHLORIDE CHANNEL; NUCLEOTIDE-GATED CHANNEL; SENSORY NEURONS; MICE DEFICIENT; TMEM16A; ACCUMULATION; CONDUCTANCE; PROTEIN; DISCRIMINATION; AMPLIFICATION	Canonical olfactory signal transduction involves the activation of cyclic AMP-activated cation channels that depolarize the cilia of receptor neurons and raise intracellular calcium. Calcium then activates Cl- currents that may be up to tenfold larger than cation currents and are believed to powerfully amplify the response. We identified Anoctamin2 (Ano2, also known as TMEM16B) as the ciliary Ca2+-activated Cl- channel of olfactory receptor neurons. Ano2 is expressed in the main olfactory epithelium (MOE) and in the vomeronasal organ (VNO), which also expresses the related Ano1 channel. Disruption of Ano2 in mice virtually abolished Ca2+-activated Cl- currents in the MOE and VNO. Ano2 disruption reduced fluid-phase electro-olfactogram responses by only similar to 40%, did not change air-phase electro-olfactograms and did not reduce performance in olfactory behavioral tasks. In contrast with the current view, cyclic nucleotide-gated cation channels do not need a boost by Cl- channels to achieve near-physiological levels of olfaction.	[Billig, Gwendolyn M.; Pal, Balazs; Fidzinski, Pawel; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, Leibniz Inst Mol Pharmakol FMP, Berlin, Germany; [Billig, Gwendolyn M.] Free Univ Berlin, Grad Program, D-1000 Berlin, Germany; [Jentsch, Thomas J.] Charite, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jentsch, TJ (corresponding author), Max Delbruck Ctr Mol Med MDC, Leibniz Inst Mol Pharmakol FMP, Berlin, Germany.	jentsch@fmp-berlin.de	Fidzinski, Pawel/AAM-8884-2020; Billig, Gwendolyn M/A-1297-2012	Fidzinski, Pawel/0000-0001-6373-4763; Jentsch, Thomas/0000-0002-3509-2553	Prix Louis-Jeantet de Medecine	Prix Louis-Jeantet de Medecine	We thank P. Mombaerts (Max Planck Institute for Biophysics) for providing Cnga2<SUP>-</SUP>, P2-IRES-tauLacZ and M72-IRES-tauLacZ mice, V. Hagen (FMP) for caged 8-Br-cAMP, I. Zarour and U. Heinemann (Charite) for help with ion-selective microelectrodes, S. Jabs and L. Leisle for help with flash photolysis, P. Mombaerts and B. Schroeder (MDC) for helpful discussions and N. Kronke and F. Binder for technical assistance. This work was supported, in part, by the Prix Louis-Jeantet de Medecine to T.J.J.	Boccaccio A, 2007, J NEUROPHYSIOL, V98, P153, DOI 10.1152/jn.00270.2007; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Bonigk W, 1999, J NEUROSCI, V19, P5332; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CHIU D, 1988, CHEM SENSES, V13, P677; Cygnar K. D., 2010, J VIS EXP; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Gribkoff VK, 1996, MOL PHARMACOL, V50, P206; Hengl T, 2010, P NATL ACAD SCI USA, V107, P6052, DOI 10.1073/pnas.0909032107; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; KELLER A, 1975, J NEUROCHEM, V24, P1101, DOI 10.1111/j.1471-4159.1975.tb03883.x; Kelliher KR, 2003, P NATL ACAD SCI USA, V100, P4299, DOI 10.1073/pnas.0736071100; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; Kleene SJ, 1996, J NEUROPHYSIOL, V75, P1386, DOI 10.1152/jn.1996.75.4.1386; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; Lin WH, 2004, J NEUROSCI, V24, P3703, DOI 10.1523/JNEUROSCI.0188-04.2004; Lindemann B, 2001, BIOPHYS J, V80, P1712, DOI 10.1016/S0006-3495(01)76142-5; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Nickell WT, 2007, J PHYSIOL-LONDON, V583, P1005, DOI 10.1113/jphysiol.2007.129601; Nickell WT, 2006, J NEUROPHYSIOL, V95, P2003, DOI 10.1152/jn.00962.2005; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Pifferi S, 2009, J PHYSIOL-LONDON, V587, P4265, DOI 10.1113/jphysiol.2009.176131; Pinato G, 2008, CHEM SENSES, V33, P397, DOI 10.1093/chemse/bjn007; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Reuter D, 1998, J NEUROSCI, V18, P6623; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Sagheddu C, 2010, J PHYSIOL-LONDON, V588, P4189, DOI 10.1113/jphysiol.2010.194407; Schneppenheim R, 2007, J THROMB HAEMOST, V5, P722, DOI 10.1111/j.1538-7836.2007.02460.x; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shimazaki R, 2006, CHEM SENSES, V31, P425, DOI 10.1093/chemse/bjj047; Slotnick B, 2005, CURR PROTOC NEUROSCI; Smith DW, 2008, PHYSIOL BEHAV, V93, P44, DOI 10.1016/j.physbeh.2007.07.011; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Vogalis F, 2005, J PHYSIOL-LONDON, V562, P785, DOI 10.1113/jphysiol.2004.079228; Windmuller O, 2005, BRAIN, V128, P2042, DOI 10.1093/brain/awh545; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zou DJ, 2007, J NEUROSCI, V27, P6675, DOI 10.1523/JNEUROSCI.0699-07.2007	50	154	157	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					763	U370		10.1038/nn.2821	http://dx.doi.org/10.1038/nn.2821			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21516098	Green Accepted			2022-12-17	WOS:000290958000020
J	Gras, C; Amilhon, B; Lepicard, EM; Poirel, O; Vinatier, J; Herbin, M; Dumas, S; Tzavara, ET; Wade, MR; Nomikos, GG; Hanoun, N; Saurini, F; Kemel, ML; Gasnier, B; Giros, B; El Mestikawy, S				Gras, Christelle; Amilhon, Benedicte; Lepicard, Eve M.; Poirel, Odile; Vinatier, Jacqueline; Herbin, Marc; Dumas, Sylvie; Tzavara, Eleni T.; Wade, Mark R.; Nomikos, George G.; Hanoun, Naima; Saurini, Francoise; Kemel, Marie-Louise; Gasnier, Bruno; Giros, Bruno; El Mestikawy, Salah			The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone	NATURE NEUROSCIENCE			English	Article							CHOLINERGIC CELL ABLATION; SYNAPTIC VESICLES; MOLECULAR-CLONING; BASAL GANGLIA; DOPAMINE; RELEASE; NEURONS; MOUSE; IDENTIFICATION; LOCALIZATION	Three subtypes of vesicular transporters accumulate glutamate into synaptic vesicles to promote its vesicular release. One of the subtypes, VGLUT3, is expressed in neurons, including cholinergic striatal interneurons, that are known to release other classical transmitters. Here we showed that disruption of the Slc17a8 gene (also known as Vglut3) caused an unexpected hypocholinergic striatal phenotype. Vglut3(-/-) mice were more responsive to cocaine and less prone to haloperidol-induced catalepsy than wild-type littermates, and acetylcholine release was decreased in striatum slices lacking VGLUT3. These phenotypes were associated with a colocalization of VGLUT3 and the vesicular acetylcholine transporter (VAChT) in striatal synaptic vesicles and the loss of a synergistic effect of glutamate on vesicular acetylcholine uptake. We propose that this vesicular synergy between two transmitters is the result of the unbalanced bioenergetics of VAChT, which requires anion co-entry for continuing vesicular filling. Our study reveals a previously unknown effect of glutamate on cholinergic synapses with potential functional and pharmacological implications.	[Gras, Christelle; Amilhon, Benedicte; Lepicard, Eve M.; Poirel, Odile; Vinatier, Jacqueline; Tzavara, Eleni T.; Giros, Bruno; El Mestikawy, Salah] Univ Paris 06, INSERM, U513, F-75005 Paris, France; [Gras, Christelle; Amilhon, Benedicte; Lepicard, Eve M.; Poirel, Odile; Vinatier, Jacqueline; Tzavara, Eleni T.; Giros, Bruno; El Mestikawy, Salah] Univ Paris 06, F-75005 Paris, France; [Herbin, Marc] MNHN, CNRS, UMR 7179, USM 301, F-75005 Paris, France; [Dumas, Sylvie] Helios Biosci, Fac Med, F-94010 Creteil, France; [Wade, Mark R.; Nomikos, George G.] Amgen Cambridge Res Ctr, Cambridge, MA 02139 USA; [Wade, Mark R.; Nomikos, George G.] Univ Paris 06, Fac Med, INSERM, UMR 677, Paris 13, France; [Kemel, Marie-Louise] Coll France, INSERM, U 667, F-75231 Paris, France; [Gasnier, Bruno] Univ Paris 07, CNRS, Inst Biol Physico Chim, UPR 1929, F-75005 Paris, France; [Giros, Bruno; El Mestikawy, Salah] McGill Univ, Dept Psychiat, Douglas Hosp, Res Ctr, Quebec City, PQ, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; McGill University	El Mestikawy, S (corresponding author), Univ Paris 06, INSERM, U513, 9 Quai St Bernard, F-75005 Paris, France.	salah.elmestikawy@snv.jussieu.fr	Kemel, Marie-Louise/M-4967-2018; GIROS, Bruno/ABD-5790-2021; Amilhon, Bénédicte/AAZ-3182-2021; Gasnier, Bruno/AAD-9124-2022; hanoun, naima NH/M-6408-2014	GIROS, Bruno/0000-0001-5876-9822; Gasnier, Bruno/0000-0003-4458-6296; el mestikawy, salah/0000-0002-6253-0002				Bankston LA, 1996, J BIOL CHEM, V271, P17132, DOI 10.1074/jbc.271.29.17132; BESSON MJ, 1969, P NATL ACAD SCI USA, V62, P741, DOI 10.1073/pnas.62.3.741; Blanchet F, 1998, NEUROSCIENCE, V85, P1025, DOI 10.1016/S0306-4522(97)00610-6; Bonsi P, 2007, AMINO ACIDS, V32, P189, DOI 10.1007/s00726-006-0320-3; Calabresi P, 2000, TRENDS NEUROSCI, V23, P120, DOI 10.1016/S0166-2236(99)01501-5; Calabresi P, 2006, LANCET NEUROL, V5, P974, DOI 10.1016/S1474-4422(06)70600-7; Consolo S, 1996, EUR J NEUROSCI, V8, P2702, DOI 10.1111/j.1460-9568.1996.tb01565.x; Contant C, 1996, NEUROSCIENCE, V71, P937, DOI 10.1016/0306-4522(95)00507-2; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Duplus E, 2008, J NEUROCHEM, V104, P1321, DOI 10.1111/j.1471-4159.2007.05074.x; Ferguson SM, 2003, J NEUROSCI, V23, P9697; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Franklin K. B., 1997, MOUSE BRAIN STEREOTA; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Fujiyama F, 2004, EUR J NEUROSCI, V20, P3322, DOI 10.1111/j.1460-9568.2004.03807.x; Gasnier B, 2000, BIOCHIMIE, V82, P327, DOI 10.1016/S0300-9084(00)00221-2; Gras C, 2002, J NEUROSCI, V22, P5442; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; HAMON M, 1988, J PHARMACOL EXP THER, V246, P745; Herbin M, 2004, J COMP PHYSIOL A, V190, P895, DOI 10.1007/s00359-004-0545-0; Herzog E, 2004, NEUROSCIENCE, V123, P983, DOI 10.1016/j.neuroscience.2003.10.039; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Hikida T, 2003, P NATL ACAD SCI USA, V100, P6169, DOI 10.1073/pnas.0631749100; Hikida T, 2001, P NATL ACAD SCI USA, V98, P13351, DOI 10.1073/pnas.231488998; Hioki H, 2004, CEREB CORTEX, V14, P1266, DOI 10.1093/cercor/bhh088; HITZEMANN R, 1993, J PHARMACOL EXP THER, V266, P431; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; Kashani A, 2007, NEUROBIOL AGING, V28, P568, DOI 10.1016/j.neurobiolaging.2006.02.010; KAWAGUCHI Y, 1992, J NEUROPHYSIOL, V67, P1669, DOI 10.1152/jn.1992.67.6.1669; Kawano M, 2006, J COMP NEUROL, V498, P581, DOI 10.1002/cne.21054; KEMEL ML, 1989, P NATL ACAD SCI USA, V86, P9006, DOI 10.1073/pnas.86.22.9006; Kitabatake Y, 2003, P NATL ACAD SCI USA, V100, P7965, DOI 10.1073/pnas.1032899100; Nguyen ML, 1998, BIOCHEMISTRY-US, V37, P13400, DOI 10.1021/bi9802263; Poulin AN, 2006, J COMP NEUROL, V498, P690, DOI 10.1002/cne.21081; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Roseth S, 1998, BIOCHEM PHARMACOL, V56, P1243, DOI 10.1016/S0006-2952(98)00200-7; SCATTON B, 1982, NATURE, V297, P422, DOI 10.1038/297422a0; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; SCHERMAN D, 1980, BIOCHIM BIOPHYS ACTA, V601, P664, DOI 10.1016/0005-2736(80)90567-2; Somogyi J, 2004, EUR J NEUROSCI, V19, P552, DOI 10.1111/j.0953-816X.2003.03091.x; Takamori S, 2002, EMBO REP, V3, P798, DOI 10.1093/embo-reports/kvf159; Tzavara ET, 2006, MOL PSYCHIATR, V11, P187, DOI 10.1038/sj.mp.4001763; Yamaguchi T, 2007, EUR J NEUROSCI, V25, P106, DOI 10.1111/j.1460-9568.2006.05263.x; Zhou FM, 2002, J NEUROBIOL, V53, P590, DOI 10.1002/neu.10150	47	154	160	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					292	300		10.1038/nn2052	http://dx.doi.org/10.1038/nn2052			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18278042				2022-12-17	WOS:000253548300012
J	Banissy, MJ; Ward, J				Banissy, Michael J.; Ward, Jamie			Mirror-touch synesthesia is linked with empathy	NATURE NEUROSCIENCE			English	Editorial Material							AUTISM SPECTRUM DISORDERS; SIMULATION; QUOTIENT; SYSTEM; FMRI; MIND	Watching another person being touched activates a similar neural circuit to actual touch and, for some people with 'mirror-touch' synesthesia, can produce a felt tactile sensation on their own body. In this study, we provide evidence for the existence of this type of synesthesia and show that it correlates with heightened empathic ability. This is consistent with the notion that we empathize with others through a process of simulation.	UCL, Dept Psychol, Bedford WC1H OAP, England	University of London; University College London	Banissy, MJ (corresponding author), UCL, Dept Psychol, 26 Bedford Way, Bedford WC1H OAP, England.	m.banissy@ucl.ac.uk	Ward, Jamie/F-3609-2011	Ward, Jamie/0000-0001-7007-1902				Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Lawrence EJ, 2006, NEUROIMAGE, V29, P1173, DOI 10.1016/j.neuroimage.2005.09.001; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2	14	154	158	1	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					815	816		10.1038/nn1926	http://dx.doi.org/10.1038/nn1926			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17572672				2022-12-17	WOS:000247560200009
J	Hartman, KN; Pal, SK; Burrone, J; Murthy, VN				Hartman, KN; Pal, SK; Burrone, J; Murthy, VN			Activity-dependent regulation of inhibitory synaptic transmission in hippocampal neurons	NATURE NEUROSCIENCE			English	Article							VESICULAR GABA TRANSPORTER; VISUAL-CORTEX; CRITICAL PERIOD; RECEPTOR TRAFFICKING; GABAERGIC SYNAPSES; SLICE CULTURES; MESSENGER-RNA; PLASTICITY; BRAIN; BDNF	Neural activity regulates the number and properties of GABAergic synapses in the brain, but the mechanisms underlying these changes are unclear. We found that blocking spike activity globally in developing hippocampal neurons from rats reduced the density of GABAergic terminals as well as the frequency and amplitude of miniature inhibitory postsynaptic currents (mIPSCs). Chronic inactivity later in development led to a reduction in the mIPSC amplitude, without any change in GABAergic synapse density. By contrast, hyperpolarizing or abolishing spike activity in single neurons did not alter GABAergic synaptic inputs. Suppressing activity in individual presynaptic GABAergic neurons also failed to decrease synaptic output. Our results indicate that GABAergic synapses are regulated by the level of activity in surrounding neurons. Notably, we found that the expression of GABAergic plasticity involves changes in the amount of neurotransmitter in individual vesicles.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Murthy, VN (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	vnmurthy@fas.harvard.edu	Burrone, Juan/C-5654-2009	Murthy, Venkatesh/0000-0003-2443-4252; Burrone, Juan/0000-0003-1233-668X	Medical Research Council [G9900989B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Auger C, 1997, NEURON, V19, P139, DOI 10.1016/S0896-6273(00)80354-2; Barberis A, 2004, EUR J NEUROSCI, V20, P1803, DOI 10.1111/j.1460-9568.2004.03624.x; Barberis A, 2005, MOL PHARMACOL, V67, P1221, DOI 10.1124/mol.104.006437; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENSON DL, 1989, MOL BRAIN RES, V5, P279, DOI 10.1016/0169-328X(89)90062-4; Bolton MM, 2000, J NEUROSCI, V20, P3221, DOI 10.1523/JNEUROSCI.20-09-03221.2000; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Elmariah SB, 2004, J NEUROSCI, V24, P2380, DOI 10.1523/JNEUROSCI.4112-03.2004; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Genoud C, 2004, J NEUROSCI, V24, P2394, DOI 10.1523/JNEUROSCI.4040-03.2004; Gianfranceschi L, 2003, P NATL ACAD SCI USA, V100, P12486, DOI 10.1073/pnas.1934836100; HENDRY SHC, 1988, NEURON, V1, P701, DOI 10.1016/0896-6273(88)90169-9; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Jones MV, 2001, BIOPHYS J, V81, P2660, DOI 10.1016/S0006-3495(01)75909-7; Kanaani J, 2002, J CELL BIOL, V158, P1229, DOI 10.1083/jcb.200205053; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mangan PS, 2005, MOL PHARMACOL, V67, P775, DOI 10.1124/mol.104.007385; Marty S, 2000, J NEUROSCI, V20, P8087; Marty S, 2004, EUR J NEUROSCI, V20, P427, DOI 10.1111/j.1460-9568.2004.03491.x; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Morales B, 2002, J NEUROSCI, V22, P8084; Ohba S, 2005, CEREB CORTEX, V15, P291, DOI 10.1093/cercor/bhh130; OTIS TS, 1994, P NATL ACAD SCI USA, V91, P7698, DOI 10.1073/pnas.91.16.7698; Owens DF, 1996, J NEUROSCI, V16, P6414; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Rosato-Siri M, 2002, EUR J NEUROSCI, V16, P2123, DOI 10.1046/j.1460-9568.2002.02291.x; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Seil FJ, 2000, J NEUROSCI, V20, P5367, DOI 10.1523/JNEUROSCI.20-14-05367.2000; SEIL FJ, 1994, J COMP NEUROL, V342, P366, DOI 10.1002/cne.903420305; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Xu XR, 2005, J NEUROSCI RES, V79, P428, DOI 10.1002/jnr.20378	48	154	158	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					642	649		10.1038/nn1677	http://dx.doi.org/10.1038/nn1677			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16582905				2022-12-17	WOS:000237417200015
J	Long, MA; Jutras, MJ; Connors, BW; Burwell, RD				Long, MA; Jutras, MJ; Connors, BW; Burwell, RD			Electrical synapses coordinate activity in the suprachiasmatic nucleus	NATURE NEUROSCIENCE			English	Article							CIRCADIAN-RHYTHMS; LOCOMOTOR-ACTIVITY; NEURONAL-ACTIVITY; GAP-JUNCTIONS; SYNCHRONIZATION; TRANSMISSION; NETWORKS; TETRODOTOXIN; INTERNEURONS; CHANNELS	In the suprachiasmatic nucleus (SCN), the master circadian pacemaker, neurons show circadian variations in firing frequency. There is also considerable synchrony of spiking across SCN neurons on a scale of milliseconds, but the mechanisms are poorly understood. Using paired whole-cell recordings, we have found that many neurons in the rat SCN communicate via electrical synapses. Spontaneous spiking was often synchronized in pairs of electrically coupled neurons, and the degree of this synchrony could be predicted from the magnitude of coupling. In wild-type mice, as in rats, the SCN contained electrical synapses, but electrical synapses were absent in connexin36-knockout mice. The knockout mice also showed dampened circadian activity rhythms and a delayed onset of activity during transition to constant darkness. We suggest that electrical synapses in the SCN help to synchronize its spiking activity, and that such synchrony is necessary for normal circadian behavior.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA; Brown Univ, Dept Psychol, Providence, RI 02912 USA	Brown University; Brown University	Connors, BW (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	bwc@brown.edu	Connors, Barry/AAX-1975-2020; Burwell, Rebecca D/E-4970-2011	Connors, Barry/0000-0002-3739-3157; Burwell, Rebecca/0000-0002-2063-9616	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012500] Funding Source: NIH RePORTER; NIDA NIH HHS [DA12500] Funding Source: Medline; NIMH NIH HHS [MH60284] Funding Source: Medline; NINDS NIH HHS [NS25983] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Amitai Y, 2002, J NEUROSCI, V22, P4142, DOI 10.1523/JNEUROSCI.22-10-04142.2002; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; BOUSKILA Y, 1993, P NATL ACAD SCI USA, V90, P3207, DOI 10.1073/pnas.90.8.3207; Brandstaetter R, 2004, P NATL ACAD SCI USA, V101, P5699, DOI 10.1073/pnas.0401378101; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; CHRISTIE MJ, 1989, J NEUROSCI, V9, P3584; Chu ZG, 2003, J NEUROSCI, V23, P96; Colwell CS, 2000, J NEUROBIOL, V43, P379, DOI 10.1002/1097-4695(20000615)43:4<379::AID-NEU6>3.0.CO;2-0; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GRACE AA, 1983, NEUROSCIENCE, V10, P333, DOI 10.1016/0306-4522(83)90137-9; GROOS G, 1982, NEUROSCI LETT, V34, P283, DOI 10.1016/0304-3940(82)90189-6; Guldenagel M, 2001, J NEUROSCI, V21, P6036, DOI 10.1523/JNEUROSCI.21-16-06036.2001; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Jiang ZG, 1997, NEUROSCIENCE, V77, P1059, DOI 10.1016/S0306-4522(96)00539-8; Kistler WM, 2002, ANN NY ACAD SCI, V978, P391, DOI 10.1111/j.1749-6632.2002.tb07582.x; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; LeSauter J, 1998, CHRONOBIOL INT, V15, P535, DOI 10.3109/07420529808998706; Long MA, 2004, J NEUROSCI, V24, P341, DOI 10.1523/JNEUROSCI.3358-03.2004; Long MA, 2002, J NEUROSCI, V22, P10898; Lupi D, 1999, NEUROSCIENCE, V89, P363, DOI 10.1016/S0306-4522(98)00353-4; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Pennartz CMA, 1998, J PHYSIOL-LONDON, V506, P775, DOI 10.1111/j.1469-7793.1998.775bv.x; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; PEREZARMENDARIZ M, 1991, BIOPHYS J, V59, P76, DOI 10.1016/S0006-3495(91)82200-7; PROSSER RA, 1989, J NEUROSCI, V9, P1073; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Schaap J, 1999, BRAIN RES, V815, P154, DOI 10.1016/S0006-8993(98)01025-7; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; SCHWARTZ WJ, 1977, SCIENCE, V197, P1089, DOI 10.1126/science.887940; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; SHIBATA S, 1993, BRAIN RES, V606, P259, DOI 10.1016/0006-8993(93)90993-W; Shinohara K, 2001, NEUROSCI LETT, V309, P37, DOI 10.1016/S0304-3940(01)02022-5; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Srinivas M, 1999, J NEUROSCI, V19, P9848; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Strecker GJ, 1997, J NEUROPHYSIOL, V78, P2217, DOI 10.1152/jn.1997.78.4.2217; Teclemariam-Mesbah R, 1999, J COMP NEUROL, V406, P171, DOI 10.1002/(SICI)1096-9861(19990405)406:2<171::AID-CNE3>3.0.CO;2-U; VANDENPOL AN, 1986, NEUROSCIENCE, V17, P643, DOI 10.1016/0306-4522(86)90037-0; Wagner S, 1997, NATURE, V387, P598, DOI 10.1038/42468; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	50	154	158	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					61	66		10.1038/nn1361	http://dx.doi.org/10.1038/nn1361			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15580271				2022-12-17	WOS:000225967600016
J	Rodriguez, I; Del Punta, K; Rothman, A; Ishii, T; Mombaerts, P				Rodriguez, I; Del Punta, K; Rothman, A; Ishii, T; Mombaerts, P			Multiple new and isolated families within the mouse superfamily of V1r vomeronasal receptors	NATURE NEUROSCIENCE			English	Article							PUTATIVE PHEROMONE RECEPTORS; MULTIGENE FAMILY; NEURONS; GENES; LOCALIZATION; ORGANIZATION; PROJECTIONS; EXPRESSION; SELECTION; PUBERTY	Seven-transmembrane-domain proteins encoded by the vomeronasal receptor V1r and V2r gene superfamilies, and expressed by vomeronasal sensory neurons, are believed to be pheromone receptors in rodents. Four V1r gene families have been described in the mouse (V1ra, V1rb, V1rc and V3r). Here we have screened near-complete mouse genomic databases to obtain a first global draft of the mouse V1r repertoire, including 104 new V1r genes. It comprises eight new and extremely isolated families in addition to the four families previously identified. Members of these new families were expressed in vomeronasal sensory neurons. The genome-wide view revealed great sequence diversity within the V1r superfamily. Phylogenetic analyses suggested an ancient original radiation, followed by the isolation, divergence and expansion of families by extensive gene duplications and frequent gene loss. The isolated nature of these gene families probably reflects a specialization of different receptor classes in the detection of specific types of chemicals.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Rodriguez, I (corresponding author), Univ Geneva, CMU, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland.	Ivan.Rodriguez@zoo.unige.ch; peter@rockefeller.edu		rodriguez, ivan/0000-0002-6468-0565				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Berghard A, 1996, J NEUROSCI, V16, P909; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; Cadavid LF, 1997, P NATL ACAD SCI USA, V94, P14536, DOI 10.1073/pnas.94.26.14536; Cao YX, 1998, P NATL ACAD SCI USA, V95, P11987, DOI 10.1073/pnas.95.20.11987; Del Punta K, 2000, GENOME RES, V10, P1958, DOI 10.1101/gr.10.12.1958; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Giorgi D, 2000, GENOME RES, V10, P1979, DOI 10.1101/gr.10.12.1979; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; HIROTA S, 1992, MOL BRAIN RES, V15, P47, DOI 10.1016/0169-328X(92)90150-A; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; Naito T, 1998, P NATL ACAD SCI USA, V95, P5178, DOI 10.1073/pnas.95.9.5178; Norlin EM, 2001, MOL CELL NEUROSCI, V17, P872, DOI 10.1006/mcne.2001.0976; NOVOTNY M, 1986, SCIENCE, V231, P722, DOI 10.1126/science.3945805; NOVOTNY M, 1985, P NATL ACAD SCI USA, V82, P2059, DOI 10.1073/pnas.82.7.2059; Novotny MV, 1999, CHEM BIOL, V6, P377, DOI 10.1016/S1074-5521(99)80049-0; Otaki JM, 2001, J THEOR BIOL, V211, P77, DOI 10.1006/jtbi.2001.2272; Pantages E, 2000, NEURON, V28, P835, DOI 10.1016/S0896-6273(00)00157-4; Rodriguez I, 2000, NAT GENET, V26, P18, DOI 10.1038/79124; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Saito H, 1998, MOL BRAIN RES, V60, P215, DOI 10.1016/S0169-328X(98)00183-1; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Speca DJ, 1999, NEURON, V23, P487, DOI 10.1016/S0896-6273(00)80802-8; STROTMANN J, 1994, CELL TISSUE RES, V278, P11, DOI 10.1007/s004410050189; SWANSON WJ, 1995, P NATL ACAD SCI USA, V92, P4957, DOI 10.1073/pnas.92.11.4957; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Wallace KJ, 2000, BEHAV NEUROSCI, V114, P912, DOI 10.1037//0735-7044.114.5.912; WANG D, 1993, BRAIN BEHAV EVOLUT, V41, P246, DOI 10.1159/000113846; WYSOCKI CJ, 1991, J STEROID BIOCHEM, V39, P661, DOI 10.1016/0960-0760(91)90265-7; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zozulya S, 2001, GENOME BIOL, V2	43	154	167	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					134	140		10.1038/nn795	http://dx.doi.org/10.1038/nn795			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802169				2022-12-17	WOS:000173558400015
J	Ratcliffe, CF; Qu, YS; McCormick, KA; Tibbs, VC; Dixon, JE; Scheuer, T; Catterall, WA				Ratcliffe, CF; Qu, YS; McCormick, KA; Tibbs, VC; Dixon, JE; Scheuer, T; Catterall, WA			A sodium channel signaling complex: modulation by associated receptor protein tyrosine phosphatase beta	NATURE NEUROSCIENCE			English	Article							EXTRACELLULAR-MATRIX; TENASCIN-R; HIPPOCAMPAL-NEURONS; CHONDROITIN SULFATE; NERVOUS-SYSTEM; RPTP-BETA; RAT-BRAIN; KINASE-C; SRC; SUBUNIT	Voltage-gated sodium channels in brain neurons were found to associate with receptor protein tyrosine phosphatase beta (RPTP beta) and its catalytically inactive, secreted isoform phosphacan, and this interaction was regulated during development. Both the extracellular domain and the intracellular catalytic domain of RPTP beta interacted with sodium channels. Sodium channels were tyrosine phosphorylated and were modulated by the associated catalytic domains of RPTP beta. Dephosphorylation slowed sodium channel inactivation, positively shifted its voltage dependence, and increased whole-cell sodium current. Our results define a sodium channel signaling complex containing RPTP beta, which acts to regulate sodium channel modulation by tyrosine phosphorylation.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Mailstop 357280, Seattle, WA 98195 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025704] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM18848] Funding Source: Medline; NINDS NIH HHS [NS25704] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; BARNEA G, 1994, J BIOL CHEM, V269, P14349; BLISKA JB, 1992, J EXP MED, V176, P1625, DOI 10.1084/jem.176.6.1625; Canoll PD, 1996, J NEUROSCI RES, V44, P199, DOI 10.1002/(SICI)1097-4547(19960501)44:3<199::AID-JNR1>3.0.CO;2-B; Cantrell AR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-17-j0003.1999; Cantrell AR, 1997, J NEUROSCI, V17, P7330; Cantrell AR, 1996, NEURON, V16, P1019, DOI 10.1016/S0896-6273(00)80125-7; CATTERALL WA, 1992, PHYSIOL REV, V72, P15; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; EVANS GA, 1994, J BIOL CHEM, V269, P23407; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; GORDON D, 1988, BIOCHEMISTRY-US, V27, P7032, DOI 10.1021/bi00418a054; HARTSHORNE RP, 1984, J BIOL CHEM, V259, P1667; Hilborn MD, 1998, J NEUROSCI, V18, P590; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Hu XQ, 1998, J BIOL CHEM, V273, P5337, DOI 10.1074/jbc.273.9.5337; Isom LL, 1996, NATURE, V383, P307, DOI 10.1038/383307b0; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; KIM JS, 1993, PROTEIN SCI, V2, P348; Kokel M, 1998, GENE DEV, V12, P1425, DOI 10.1101/gad.12.10.1425; LEVY JB, 1993, J BIOL CHEM, V268, P10573; MAUREL P, 1995, DNA SEQUENCE, V5, P323, DOI 10.3109/10425179509030989; MAUREL P, 1994, P NATL ACAD SCI USA, V91, P2512, DOI 10.1073/pnas.91.7.2512; McCormick KA, 1999, J BIOL CHEM, V274, P32638, DOI 10.1074/jbc.274.46.32638; MEYERPUTTLITZ B, 1995, J NEUROCHEM, V65, P2327; Nishiwaki T, 1998, J BIOCHEM-TOKYO, V123, P458; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; QU YS, 1994, P NATL ACAD SCI USA, V91, P3289, DOI 10.1073/pnas.91.8.3289; Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907; Snyder SE, 1996, MOL BRAIN RES, V40, P79; Sobko A, 1998, EMBO J, V17, P4723, DOI 10.1093/emboj/17.16.4723; Srinivasan J, 1998, P NATL ACAD SCI USA, V95, P15753, DOI 10.1073/pnas.95.26.15753; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; Weber P, 1999, J NEUROSCI, V19, P4245, DOI 10.1523/jneurosci.19-11-04245.1999; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Wischmeyer E, 1998, J BIOL CHEM, V273, P34063, DOI 10.1074/jbc.273.51.34063; Xiao ZC, 1999, J BIOL CHEM, V274, P26511, DOI 10.1074/jbc.274.37.26511; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	39	154	154	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					437	444		10.1038/74805	http://dx.doi.org/10.1038/74805			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309DG	10769382				2022-12-17	WOS:000086752000011
J	Chuang, RSI; Jaffe, H; Cribbs, L; Perez-Reyes, E; Swartz, KJ				Chuang, RSI; Jaffe, H; Cribbs, L; Perez-Reyes, E; Swartz, KJ			Inhibition of T-type voltage-gated calcium channels by a new scorpion toxin	NATURE NEUROSCIENCE			English	Article							VERTEBRATE SENSORY NEURONS; HIGH-AFFINITY BINDING; FUNCTIONAL EXPRESSION; SODIUM-CHANNEL; ALPHA-SUBUNIT; BETA-SUBUNIT; CA-CHANNEL; K+ CHANNEL; CELLS; CURRENTS	The biophysical properties of T-type voltage-gated calcium channels are well suited to pacemaking and to supporting calcium flux near the resting membrane potential in both excitable and nonexcitable cells. We have identified a new scorpion toxin (kurtoxin) that binds to the alpha(1G) T-type calcium channel with high affinity and inhibits the channel by modifying voltage-dependent gating. This toxin distinguishes between alpha(1G) T-type calcium channels and other types of voltage-gated calcium channels, including alpha(1A), alpha(1B), alpha(1C) and alpha(1E). Like the other alpha-scorpion toxins to which it is related, kurtoxin also interacts with voltage-gated sodium channels and slows their inactivation. Kurtoxin will facilitate characterization of the subunit composition of T-type calcium channels and help determine their involvement in electrical and biochemical signaling.	NINDS, Mol Physiol & Biophys Unit, NIH, Bethesda, MD 20892 USA; NINDS, Prot Peptide Sequencing Facil, NIH, Bethesda, MD 20892 USA; Loyola Univ, Med Ctr, Dept Physiol, Maywood, IL 60153 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Loyola University Chicago	Swartz, KJ (corresponding author), NINDS, Mol Physiol & Biophys Unit, NIH, Bldg 36,Rm 2CI9,36 Convent Dr,MSC 4066, Bethesda, MD 20892 USA.	kjswartz@codon.nih.gov	Tuluc, Petronel/C-2527-2011		Intramural NIH HHS [ZIA NS002945-13] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ARMSTRONG CM, 1985, SCIENCE, V227, P65, DOI 10.1126/science.2578071; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; Bean BP, 1998, NEURON, V20, P825, DOI 10.1016/S0896-6273(00)80463-8; BEAN BP, 1985, J GEN PHYSIOL, V86, P1, DOI 10.1085/jgp.86.1.1; BEZPROZVANNY L, 1995, MOL PHARMACOL, V48, P540; BOSSU JL, 1985, PFLUG ARCH EUR J PHY, V403, P360, DOI 10.1007/BF00589247; Bourinet E, 1996, J NEUROSCI, V16, P4983; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; CATTERALL WA, 1979, J GEN PHYSIOL, V74, P375, DOI 10.1085/jgp.74.3.375; CHEN CF, 1990, J GEN PHYSIOL, V96, P603, DOI 10.1085/jgp.96.3.603; CHEN CF, 1988, SCIENCE, V239, P1024, DOI 10.1126/science.2449730; COHEN CJ, 1988, P NATL ACAD SCI USA, V85, P2412, DOI 10.1073/pnas.85.7.2412; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; GONOI T, 1987, J GEN PHYSIOL, V89, P253, DOI 10.1085/jgp.89.2.253; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; Jaffe H, 1998, BIOCHEMISTRY-US, V37, P3931, DOI 10.1021/bi972518u; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; KOSTYUK PG, 1988, PFLUGERS ARCH, V411, P611; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P569, DOI 10.1113/jphysiol.1981.sp013764; McDonough SI, 1997, BIOPHYS J, V72, P2117, DOI 10.1016/S0006-3495(97)78854-4; McDonough SI, 1997, MOL PHARMACOL, V52, P1095, DOI 10.1124/mol.52.6.1095; Meir A, 1998, NEURON, V20, P341, DOI 10.1016/S0896-6273(00)80461-4; MEVES H, 1986, ANN NY ACAD SCI, V479, P113, DOI 10.1111/j.1749-6632.1986.tb15565.x; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NILIUS B, 1985, NATURE, V316, P443, DOI 10.1038/316443a0; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; PRAGNELL M, 1991, FEBS LETT, V291, P253, DOI 10.1016/0014-5793(91)81296-K; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Santi CM, 1996, AM J PHYSIOL-CELL PH, V271, pC1583, DOI 10.1152/ajpcell.1996.271.5.C1583; SCHNEIDER T, 1994, RECEPTOR CHANNEL, V2, P255; Seok YJ, 1997, J BIOL CHEM, V272, P26511, DOI 10.1074/jbc.272.42.26511; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; Stone K. L., 1993, PRACTICAL GUIDE PROT, P43; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; WANG GK, 1985, J GEN PHYSIOL, V86, P739, DOI 10.1085/jgp.86.5.739; Wei X, 1996, RECEPTOR CHANNEL, V4, P205; WEI XY, 1991, J BIOL CHEM, V266, P21943	44	154	164	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					668	674		10.1038/3669	http://dx.doi.org/10.1038/3669			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196582				2022-12-17	WOS:000077323400010
J	Bayraktar, OA; Bartels, T; Holmqvist, S; Kleshchevnikov, V; Martirosyan, A; Polioudakis, D; Ben Haim, L; Young, AMH; Batiuk, MY; Prakash, K; Brown, A; Roberts, K; Paredes, MF; Kawaguchi, R; Stockley, JH; Sabeur, K; Chang, SM; Huang, E; Hutchinson, P; Ullian, EM; Hemberg, M; Coppola, G; Holt, MG; Geschwind, DH; Rowitch, DH				Bayraktar, Omer Ali; Bartels, Theresa; Holmqvist, Staffan; Kleshchevnikov, Vitalii; Martirosyan, Araks; Polioudakis, Damon; Ben Haim, Lucile; Young, Adam M. H.; Batiuk, Mykhailo Y.; Prakash, Kirti; Brown, Alexander; Roberts, Kenny; Paredes, Mercedes F.; Kawaguchi, Riki; Stockley, John H.; Sabeur, Khalida; Chang, Sandra M.; Huang, Eric; Hutchinson, Peter; Ullian, Erik M.; Hemberg, Martin; Coppola, Giovanni; Holt, Matthew G.; Geschwind, Daniel H.; Rowitch, David H.			Astrocyte layers in the mammalian cerebral cortex revealed by a single-cell in situ transcriptomic map	NATURE NEUROSCIENCE			English	Article							PROJECTION NEURON IDENTITY; SATB2; GLIA; HYBRIDIZATION; PROTEINS; CALLOSAL	Although the cerebral cortex is organized into six excitatory neuronal layers, it is unclear whether glial cells show distinct layering. In the present study, we developed a high-content pipeline, the large-area spatial transcriptomic (LaST) map, which can quantify single-cell gene expression in situ. Screening 46 candidate genes for astrocyte diversity across the mouse cortex, we identified superficial, mid and deep astrocyte identities in gradient layer patterns that were distinct from those of neurons. Astrocyte layer features, established in the early postnatal cortex, mostly persisted in adult mouse and human cortex. Single-cell RNA sequencing and spatial reconstruction analysis further confirmed the presence of astrocyte layers in the adult cortex. Satb2 and Reeler mutations that shifted neuronal post-mitotic development were sufficient to alter glial layering, indicating an instructive role for neuronal cues. Finally, astrocyte layer patterns diverged between mouse cortical regions. These findings indicate that excitatory neurons and astrocytes are organized into distinct lineage-associated laminae. A new spatial transcriptomic approach reveals astrocyte heterogeneity across layers of the mammalian cerebral cortex. Astrocytes diversify into superficial-, mid- and deep-layer subtypes distinct from neuronal laminae, yet instructed by neuronal cues.	[Bayraktar, Omer Ali; Bartels, Theresa; Holmqvist, Staffan; Ben Haim, Lucile; Prakash, Kirti; Stockley, John H.; Sabeur, Khalida; Chang, Sandra M.; Rowitch, David H.] Univ Cambridge, Wellcome MRC Cambridge Stem Cell Inst, Dept Paediat, Cambridge, England; [Bayraktar, Omer Ali; Paredes, Mercedes F.; Sabeur, Khalida; Chang, Sandra M.; Rowitch, David H.] Univ Calif San Francisco, Dept Pediat, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94115 USA; [Bayraktar, Omer Ali; Paredes, Mercedes F.; Sabeur, Khalida; Chang, Sandra M.; Rowitch, David H.] Univ Calif San Francisco, Dept Neurosurg, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94115 USA; [Bayraktar, Omer Ali; Kleshchevnikov, Vitalii; Roberts, Kenny; Hemberg, Martin] Wellcome Sanger Inst, Hinxton, England; [Martirosyan, Araks; Batiuk, Mykhailo Y.; Holt, Matthew G.] Katholieke Univ Leuven, VIB KU Leuven Ctr Brain & Dis Res, Lab Glia Biol, Dept Neurosci, Leuven, Belgium; [Polioudakis, Damon; Coppola, Giovanni; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Polioudakis, Damon; Coppola, Giovanni; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Polioudakis, Damon; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Ctr Autism Res & Treatment, Los Angeles, CA 90095 USA; [Young, Adam M. H.; Hutchinson, Peter] Univ Cambridge, Div Acad Neurosurg, Dept Clin Neurosci, Cambridge, England; [Brown, Alexander] UCL, Sainsbury Wellcome Ctr, London, England; [Paredes, Mercedes F.; Huang, Eric] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Kawaguchi, Riki; Coppola, Giovanni] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA; [Huang, Eric] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Ullian, Erik M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA	University of Cambridge; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Wellcome Trust Sanger Institute; Flanders Institute for Biotechnology (VIB); KU Leuven; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Cambridge; University of London; University College London; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bayraktar, OA; Rowitch, DH (corresponding author), Univ Cambridge, Wellcome MRC Cambridge Stem Cell Inst, Dept Paediat, Cambridge, England.; Bayraktar, OA; Rowitch, DH (corresponding author), Univ Calif San Francisco, Dept Pediat, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94115 USA.; Bayraktar, OA; Rowitch, DH (corresponding author), Univ Calif San Francisco, Dept Neurosurg, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94115 USA.; Bayraktar, OA (corresponding author), Wellcome Sanger Inst, Hinxton, England.	ob5@sanger.ac.uk; dhr25@medschl.cam.ac.uk	Kawaguchi, Riki/AAV-6090-2020; Prakash, Kirti/AAN-3675-2020; Batiuk, Mykhailo Y./AAY-7125-2021; please delete, please delete/AAY-7192-2021; huang, dezhi/ABC-6566-2021	Prakash, Kirti/0000-0002-0325-9988; Batiuk, Mykhailo Y./0000-0001-6681-4048; Holt, Matthew/0000-0002-8958-4027; Ben Haim, Lucile/0000-0002-3652-5736; Kleshchevnikov, Vitalii/0000-0001-9110-7441; Holmqvist, Staffan/0000-0001-6709-6666; Bartels, Theresa/0000-0003-4100-0608; Roberts, Kenny/0000-0001-6155-0821; Bayraktar, Omer/0000-0001-6055-277X; Stockley, John/0000-0002-7385-8310	Life Sciences Research Fellowship; Howard Hughes Medical Institute; Wellcome Trust; National Institute for Health Research (NIHR) Academic Clinical Fellowship; Stichting Alzheiemer Onderzoek; Paul G. Allen Foundation Distinguished Investigator Program; Loulou Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; BRAIN initiative [1U01 MH105991]; National Institutes of Health [1R01 MH109912, P01NS08351]; NIHR; European Union Seventh Framework; National Institute of Neurological Disorders and Stroke Informatics Center for Neurogenetics and Neurogenomics [P30 NS062691]; European Research Council [281961]; Fonds Wetenschappelijk Onderzoek [G066715N, 1523014N]; Stichting Alzheimer Onderzoek [16025]; VIB Institutional Support; Tech Watch funding; MRC [MC_PC_17230] Funding Source: UKRI	Life Sciences Research Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wellcome Trust(Wellcome Trust); National Institute for Health Research (NIHR) Academic Clinical Fellowship(National Institute for Health Research (NIHR)); Stichting Alzheiemer Onderzoek; Paul G. Allen Foundation Distinguished Investigator Program; Loulou Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; BRAIN initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHR(National Institute for Health Research (NIHR)); European Union Seventh Framework; National Institute of Neurological Disorders and Stroke Informatics Center for Neurogenetics and Neurogenomics; European Research Council(European Research Council (ERC)European Commission); Fonds Wetenschappelijk Onderzoek(FWO); Stichting Alzheimer Onderzoek; VIB Institutional Support; Tech Watch funding; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank B. Barres and S. Teichmann for helpful discussions and comments. We thank B. Lynch and X.-J. Ma for advice on RNAScope, as well as R. Sawkins and J. Hutt for technical support on imaging. We also thank E. Olson (SUNY Upstate University) for providing Reeler mice and R. Marcucio (UCSF) for providing the Satb2-flox mice. The authors were supported by the Life Sciences Research Fellowship and the Howard Hughes Medical Institute (O.A.B.), the Wellcome Trust (T.B.), National Institute for Health Research (NIHR) Academic Clinical Fellowship and a Wellcome Trust PhD for Clinicians Fellowship (A.M.H.Y.) and Stichting Alzheiemer Onderzoek (A.M.). The present study was supported by the Paul G. Allen Foundation Distinguished Investigator Program (E.M.U. and D.H.R.), the Loulou Foundation, the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (D.H.R., D.G. and G. C.), BRAIN initiative (grant no. 1U01 MH105991 to D.G.) and National Institutes of Health (grant nos. 1R01 MH109912 to D.G. and P01NS08351 to D.H.R.), NIHR and the European Union Seventh Framework (to P.H.), National Institute of Neurological Disorders and Stroke Informatics Center for Neurogenetics and Neurogenomics (grant no. P30 NS062691 to G.C.), Wellcome Trust core support (M.H. and O.A.B.), European Research Council (grant no. 281961 to M.G.H.), Fonds Wetenschappelijk Onderzoek (grant nos. G066715N and 1523014N to M.G.H.), Stichting Alzheimer Onderzoek (S no. 16025 to M.G.H.) and VIB Institutional Support and Tech Watch funding (to M.G.H.), Howard Hughes Medical Institute and the Wellcome Trust (to D.H.R.).	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2014, GENOME BIOL, DOI DOI 10.1186/S13059-014-0550-8; Batiuk MY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14198-8; Battich N, 2013, NAT METHODS, V10, P1127, DOI 10.1038/nmeth.2657; Blanco-Suarez E, 2018, NEURON, V100, P1116, DOI 10.1016/j.neuron.2018.09.043; Boisvert MM, 2018, CELL REP, V22, P269, DOI 10.1016/j.celrep.2017.12.039; Boyle MP, 2011, J COMP NEUROL, V519, P2061, DOI 10.1002/cne.22655; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chai H., 2017, NEURON, V548, P396; Champliaud MF, 2000, GENOMICS, V70, P264, DOI 10.1006/geno.2000.6390; Cui YH, 2018, NATURE, V554, P323, DOI 10.1038/nature25752; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Freeman MR, 2013, NEURON, V80, P613, DOI 10.1016/j.neuron.2013.10.034; Ge Woo-Ping, 2012, Nature, V484, P376, DOI 10.1038/nature10959; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gorski JA, 2002, J NEUROSCI, V22, P6309; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Hartfuss E, 2003, DEVELOPMENT, V130, P4597, DOI 10.1242/dev.00654; Karreman MA, 2016, J CELL SCI, V129, P444, DOI 10.1242/jcs.181842; Kelley KW, 2018, NEURON, V98, P306, DOI 10.1016/j.neuron.2018.03.010; KERSTENS HMJ, 1995, J HISTOCHEM CYTOCHEM, V43, P347, DOI 10.1177/43.4.7897179; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kwan KY, 2012, DEVELOPMENT, V139, P1535, DOI 10.1242/dev.069963; Lanjakornsiripan D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03940-3; Lein E, 2017, SCIENCE, V358, P64, DOI 10.1126/science.aan6827; Leone DP, 2015, CEREB CORTEX, V25, P3406, DOI 10.1093/cercor/bhu156; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin CCJ, 2017, NAT NEUROSCI, V20, P396, DOI 10.1038/nn.4493; Lun Aaron T L, 2016, F1000Res, V5, P2122; Marshel JH, 2019, SCIENCE, V365, P558, DOI 10.1126/science.aaw5202; McKenna WL, 2015, P NATL ACAD SCI USA, V112, P11702, DOI 10.1073/pnas.1504144112; Moffitt JR, 2016, P NATL ACAD SCI USA, V113, P14456, DOI 10.1073/pnas.1617699113; Molofsky AV, 2014, NATURE, V509, P189, DOI 10.1038/nature13161; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nakayama N, 2001, DEV BIOL, V232, P372, DOI 10.1006/dbio.2001.0200; Nikouei K, 2016, J CHEM NEUROANAT, V71, P1, DOI 10.1016/j.jchemneu.2015.12.004; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Shah S, 2016, NEURON, V92, P342, DOI 10.1016/j.neuron.2016.10.001; Sosunov AA, 2014, J NEUROSCI, V34, P2285, DOI 10.1523/JNEUROSCI.4037-13.2014; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Vainchtein ID, 2018, SCIENCE, V359, P1269, DOI 10.1126/science.aal3589; Velmeshev D, 2019, SCIENCE, V364, P685, DOI 10.1126/science.aav8130; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang X, 2018, SCIENCE, V361, DOI 10.1126/science.aat5691	47	153	155	8	82	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2020	23	4					500	+		10.1038/s41593-020-0602-1	http://dx.doi.org/10.1038/s41593-020-0602-1		MAR 2020	14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY8DN	32203496	Green Accepted, Green Submitted			2022-12-17	WOS:000519843200003
J	Chikazoe, J; Lee, DH; Kriegeskorte, N; Anderson, AK				Chikazoe, Junichi; Lee, Daniel H.; Kriegeskorte, Nikolaus; Anderson, Adam K.			Population coding of affect across stimuli, modalities and individuals	NATURE NEUROSCIENCE			English	Article							VENTRAL TEMPORAL CORTEX; HUMAN VISUAL-CORTEX; ORBITOFRONTAL CORTEX; HUMAN BRAIN; PREFRONTAL CORTEX; NEURAL EVIDENCE; REPRESENTATIONS; FMRI; INFORMATION; VALENCE	It remains unclear how the brain represents external objective sensory events alongside our internal subjective impressions of them-affect. Representational mapping of population activity evoked by complex scenes and basic tastes in humans revealed a neural code supporting a continuous axis of pleasant-to-unpleasant valence. This valence code was distinct from low-level physical and high-level object properties. Although ventral temporal and anterior insular cortices supported valence codes specific to vision and taste, both the medial and lateral orbitofrontal cortices (OFC) maintained a valence code independent of sensory origin. Furthermore, only the OFC code could classify experienced affect across participants. The entire valence spectrum was represented as a collective pattern in regional neural activity as sensory-specific and abstract codes, whereby the subjective quality of affect can be objectively quantified across stimuli, modalities and people.	[Chikazoe, Junichi; Anderson, Adam K.] Cornell Univ, Coll Human Ecol, Dept Human Dev, Human Neurosci Inst, Ithaca, NY 14850 USA; [Lee, Daniel H.; Anderson, Adam K.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Kriegeskorte, Nikolaus] MRC, Cognit & Brain Sci Unit, Cambridge, England	Cornell University; University of Toronto	Chikazoe, J (corresponding author), Cornell Univ, Coll Human Ecol, Dept Human Dev, Human Neurosci Inst, Ithaca, NY 14850 USA.	j.chikazoe@gmail.com; aka47@cornell.edu		Chikazoe, Junichi/0000-0003-4155-1370	Canadian Institutes of Health Research grants; Japan Society for the Promotion of Science [H23]; MRC [MC_U105597120] Funding Source: UKRI; Medical Research Council [MC_U105597120] Funding Source: researchfish	Canadian Institutes of Health Research grants(Canadian Institutes of Health Research (CIHR)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. Schmitz, M. Taylor, D. Hamilton and K. Gardhouse for technical collaboration and discussion. This work was funded by Canadian Institutes of Health Research grants to A.K.A. J.C. was supported by the Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad (H23).	Alink A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00493; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Brouwer GJ, 2009, J NEUROSCI, V29, P13992, DOI 10.1523/JNEUROSCI.3577-09.2009; Dolcos F, 2004, NEUROIMAGE, V23, P64, DOI 10.1016/j.neuroimage.2004.05.015; Freeman J, 2011, J NEUROSCI, V31, P4792, DOI 10.1523/JNEUROSCI.5160-10.2011; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Grabenhorst F, 2010, NEUROIMAGE, V51, P1265, DOI 10.1016/j.neuroimage.2010.03.043; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Haxby JV, 2011, NEURON, V72, P404, DOI 10.1016/j.neuron.2011.08.026; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2011, ANN NY ACAD SCI, V1224, P9, DOI 10.1111/j.1749-6632.2011.05994.x; Hinton GE, 1986, PARALLEL DISTRIBUTED, P77; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2013, TRENDS COGN SCI, V17, P401, DOI 10.1016/j.tics.2013.06.007; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Kron A, 2013, PSYCHOL SCI, V24, P1503, DOI 10.1177/0956797613475456; Lapid H, 2011, NAT NEUROSCI, V14, P1455, DOI 10.1038/nn.2926; Lazarus RS., 1984, STRESS APPRAISAL COP; Lewis PA, 2007, CEREB CORTEX, V17, P742, DOI 10.1093/cercor/bhk024; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Lim SL, 2013, J NEUROSCI, V33, P8729, DOI 10.1523/JNEUROSCI.4809-12.2013; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; McNamee D, 2013, NAT NEUROSCI, V16, P479, DOI 10.1038/nn.3337; Misaki M, 2010, NEUROIMAGE, V53, P103, DOI 10.1016/j.neuroimage.2010.05.051; Mogami T, 2006, J NEUROSCI, V26, P6761, DOI 10.1523/JNEUROSCI.4924-05.2006; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Osgood C. E., 1975, CROSS CULTURAL UNIVE; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Raizada RDS, 2012, J COGNITIVE NEUROSCI, V24, P868, DOI 10.1162/jocn_a_00189; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sasaki Y, 2006, NEURON, V51, P661, DOI 10.1016/j.neuron.2006.07.021; Shenhav A, 2013, COGN AFFECT BEHAV NE, V13, P46, DOI 10.3758/s13415-012-0128-4; Small DM, 1999, NEUROREPORT, V10, P7, DOI 10.1097/00001756-199901180-00002; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Todd RM, 2012, J NEUROSCI, V32, P11201, DOI 10.1523/JNEUROSCI.0155-12.2012; Wilson-Mendenhall CD, 2013, PSYCHOL SCI, V24, P947, DOI 10.1177/0956797612464242; Wundt W., 1897, GRUNDRIESS PSYCHOL W	49	153	156	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2014	17	8					1114	1122		10.1038/nn.3749	http://dx.doi.org/10.1038/nn.3749			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AM1XA	24952643	Green Accepted			2022-12-17	WOS:000339641400018
J	Woo, J; Kwon, SK; Choi, S; Kim, S; Lee, JR; Dunah, AW; Sheng, M; Kim, E				Woo, Jooyeon; Kwon, Seok-Kyu; Choi, Seungwon; Kim, Seho; Lee, Jae-Ran; Dunah, Anthone W.; Sheng, Morgan; Kim, Eunjoon			Trans-synaptic adhesion between NGL-3 and LAR regulates the formation of excitatory synapses	NATURE NEUROSCIENCE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; LIPRIN-ALPHA; NEURITE OUTGROWTH; NERVOUS-SYSTEM; BETA-NEUREXINS; RECEPTOR; LIGAND; MOLECULES; NETRIN; DIFFERENTIATION	Synaptic adhesion molecules regulate multiple steps of synapse formation and maturation. The great diversity of neuronal synapses predicts the presence of a large number of adhesion molecules that control synapse formation through trans-synaptic and heterophilic adhesion. We identified a previously unknown trans-synaptic interaction between netrin-G ligand-3 (NGL-3), a postsynaptic density (PSD) 95-interacting postsynaptic adhesion molecule, and leukocyte common antigen-related (LAR), a receptor protein tyrosine phosphatase. NGL-3 and LAR expressed in heterologous cells induced pre-and postsynaptic differentiation in contacting axons and dendrites of cocultured rat hippocampal neurons, respectively. Neuronal overexpression of NGL-3 increased presynaptic contacts on dendrites of transfected neurons. Direct aggregation of NGL-3 on dendrites induced coclustering of excitatory postsynaptic proteins. Knockdown of NGL-3 reduced the number and function of excitatory synapses. Competitive inhibition by soluble LAR reduced NGL-3-induced presynaptic differentiation. These results suggest that the trans-synaptic adhesion between NGL-3 and LAR regulates excitatory synapse formation in a bidirectional manner.	[Woo, Jooyeon; Kwon, Seok-Kyu; Choi, Seungwon; Kim, Seho; Lee, Jae-Ran; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Synaptogenis, Taejon 305701, South Korea; [Woo, Jooyeon; Kwon, Seok-Kyu; Choi, Seungwon; Kim, Seho; Lee, Jae-Ran; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Dunah, Anthone W.] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Charlestown, MA USA; [Dunah, Anthone W.] Harvard Univ, Sch Med, Charlestown, MA USA; [Sheng, Morgan] MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Cambridge, MA USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health	Kim, E (corresponding author), Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Synaptogenis, Taejon 305701, South Korea.	kime@kaist.ac.kr	Kim, Eunjoon/C-1566-2011	Sheng, Morgan/0000-0002-8703-5366; Choi, Seungwon/0000-0002-8644-3659; Kwon, Seok-Kyu/0000-0002-7280-9867	Korean Ministry of Science and Technology	Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea)	We would like to thank A. M. Craig for neurexin 1 alpha, 2 alpha, 3 alpha and 1 beta cDNAs, T. Biederer for SynCAM 1, Y.-P. Hsueh for Syndecan-2, P. Maness for NCAM-140, J. Ko for quantitative analysis, J. Nam for SALM4, M.-H. Kim for the mini analysis program, and Y.-G. Oh, M.-S. Baek, M. Ryu and J.-G. Jung for the help with antibody generation. This work was supported by the National Creative Research Initiative Program of the Korean Ministry of Science and Technology (E. K.).	Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Akins MR, 2006, CURR OPIN NEUROBIOL, V16, P83, DOI 10.1016/j.conb.2006.01.009; Aoki-Suzuki M, 2005, BIOL PSYCHIAT, V57, P382, DOI 10.1016/j.biopsych.2004.11.022; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Lin JC, 2003, NAT NEUROSCI, V6, P1270, DOI 10.1038/nn1148; Majeti R, 2001, CHEM REV, V101, P2441, DOI 10.1021/cr000085m; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; Nakashiba T, 2000, J NEUROSCI, V20, P6540, DOI 10.1523/JNEUROSCI.20-17-06540.2000; Nam HJ, 1999, CELL, V97, P449, DOI 10.1016/S0092-8674(00)80755-2; Nishimura-Akiyoshi S, 2007, P NATL ACAD SCI USA, V104, P14801, DOI 10.1073/pnas.0706919104; O'Grady P, 1998, J CELL BIOL, V141, P1675, DOI 10.1083/jcb.141.7.1675; OGRADY P, 1994, J BIOL CHEM, V269, P25193; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Stryker E, 2007, J CELL SCI, V120, P3723, DOI 10.1242/jcs.03491; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yang T, 2003, J NEUROSCI, V23, P3353; Yin Y, 2002, MOL CELL NEUROSCI, V19, P344, DOI 10.1006/mcne.2001.1089; ZHANG JS, 1995, J CELL BIOL, V128, P415, DOI 10.1083/jcb.128.3.415; Zhang JS, 1998, MOL CELL NEUROSCI, V10, P271, DOI 10.1006/mcne.1998.0663; Zhang W, 2008, GENES BRAIN BEHAV, V7, P385, DOI 10.1111/j.1601-183X.2007.00361.x; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	50	153	157	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2009	12	4					428	437		10.1038/nn.2279	http://dx.doi.org/10.1038/nn.2279			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	424JN	19252495				2022-12-17	WOS:000264563100017
J	Zhou, J; Du, WL; Zhou, KC; Tai, YL; Yao, HL; Jia, YC; Ding, YQ; Wang, YZ				Zhou, Jian; Du, Wanlu; Zhou, Kechun; Tai, Yilin; Yao, Hailan; Jia, Yichang; Ding, Yuqiang; Wang, Yizheng			Critical role of TRPC6 channels in the formation of excitatory synapses	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINES; MEMORY; ACTIVATION; BDNF	The transient receptor potential canonical (TRPC) channels are Ca2+-permeable, nonselective cation channels with different biological functions, but their roles in brain are largely unknown. Here we report that TRPC6 was localized to excitatory synapses and promoted their formation via a CaMKIV-CREB-dependent pathway. TRPC6 transgenic mice showed enhancement in spine formation, and spatial learning and memory in Morris water maze. These results reveal a previously unknown role of TRPC6 in synaptic and behavioral plasticity.	[Zhou, Jian; Du, Wanlu; Zhou, Kechun; Tai, Yilin; Yao, Hailan; Jia, Yichang; Ding, Yuqiang; Wang, Yizheng] Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Lab Neural Signal Transduct, Shanghai 200031, Peoples R China; [Zhou, Jian; Du, Wanlu; Zhou, Kechun; Tai, Yilin; Yao, Hailan; Jia, Yichang] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Wang, YZ (corresponding author), Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Lab Neural Signal Transduct, Shanghai 200031, Peoples R China.	yzwang@ion.ac.cn		Du, Wanlu/0000-0003-2612-7846; Ding, Yu-Qiang/0000-0003-1202-4635				Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Pang PT, 2004, AGEING RES REV, V3, P407, DOI 10.1016/j.arr.2004.07.002; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	14	153	161	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					741	743		10.1038/nn.2127	http://dx.doi.org/10.1038/nn.2127			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18516035				2022-12-17	WOS:000257089400007
J	London, SE; Clayton, DF				London, Sarah E.; Clayton, David F.			Functional identification of sensory mechanisms required for developmental song learning	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ADULT ZEBRA FINCHES; ZENK GENE RESPONSE; TAENIOPYGIA-GUTTATA; SYNAPTIC PLASTICITY; NEURAL MECHANISMS; CONSPECIFIC SONG; BIRDSONG MEMORY; FOREBRAIN; EXPRESSION	A young male zebra finch (Taeniopygia guttata) learns to sing by copying the vocalizations of an older tutor in a process that parallels human speech acquisition. Brain pathways that control song production are well defined, but little is known about the sites and mechanisms of tutor song memorization. Here we test the hypothesis that molecular signaling in a sensory brain area outside of the song system is required for developmental song learning. Using controlled tutoring and a pharmacological inhibitor, we transiently suppressed the extracellular signal-regulated kinase signaling pathway in a portion of the auditory forebrain specifically during tutor song exposure. On maturation, treated birds produced poor copies of tutor song, whereas controls copied the tutor song effectively. Thus the foundation of normal song learning, the formation of a sensory memory of tutor song, requires a conserved molecular pathway in a brain area that is distinct from the circuit for song motor control.	[London, Sarah E.; Clayton, David F.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Clayton, David F.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Clayton, David F.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	London, SE (corresponding author), Univ Illinois, Inst Genom Biol, 2500N IGB,MC-195,1206 W Gregory Dr, Urbana, IL 61801 USA.	slondon@igb.uiuc.edu; dclayton@uiuc.edu	Clayton, David/B-2190-2008	Clayton, David/0000-0002-6395-3488; London, Sarah/0000-0002-7839-2644	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045264, R01NS051820, F32NS055413] Funding Source: NIH RePORTER; NINDS NIH HHS [F32 NS055413-01A2, R01 NS051820-13, R01 NS045264, R01 NS051820, NS045264] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adret P, 2004, ANN NY ACAD SCI, V1016, P303, DOI 10.1196/annals.1298.005; Apergis-Schoute AM, 2005, J NEUROSCI, V25, P5730, DOI 10.1523/JNEUROSCI.0096-05.2005; Basham ME, 1996, NEUROBIOL LEARN MEM, V66, P295, DOI 10.1006/nlme.1996.0071; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bolhuis JJ, 2001, EUR J NEUROSCI, V13, P2165, DOI 10.1046/j.0953-816x.2001.01588.x; Bolhuis JJ, 2000, P NATL ACAD SCI USA, V97, P2282, DOI 10.1073/pnas.030539097; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Bozon B, 2003, PHILOS T R SOC B, V358, P805, DOI 10.1098/rstb.2002.1224; Cheng HY, 2004, J NEUROSCI, V24, P7503, DOI 10.1523/JNEUROSCI.1405-04.2004; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; CYNX J, 1992, P NATL ACAD SCI USA, V89, P1368, DOI 10.1073/pnas.89.4.1368; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Doupe AJ, 2004, ANN NY ACAD SCI, V1016, P495, DOI 10.1196/annals.1298.035; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EALES LA, 1987, ANIM BEHAV, V35, P1356, DOI 10.1016/S0003-3472(87)80008-8; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Gahr M, 2000, J COMP NEUROL, V426, P182; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hessler NA, 1999, J NEUROSCI, V19, P10461; Huesmann GR, 2006, NEURON, V52, P1061, DOI 10.1016/j.neuron.2006.10.033; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jin H, 1997, NEURON, V19, P1049, DOI 10.1016/S0896-6273(00)80396-7; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kim JJ, 2006, STRESS, V9, P1, DOI 10.1080/10253890600678004; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Kruse AA, 2004, NEUROBIOL LEARN MEM, V82, P99, DOI 10.1016/j.nlm.2004.05.001; Leonardo A, 2004, P NATL ACAD SCI USA, V101, P16935, DOI 10.1073/pnas.0407870101; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; MELLO C, 1995, J NEUROSCI, V15, P6919; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Park KHJ, 2002, BEHAV BRAIN RES, V136, P185, DOI 10.1016/S0166-4328(02)00129-8; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Roper A, 2006, ETHOLOGY, V112, P458, DOI 10.1111/j.1439-0310.2005.01169.x; Sauro MD, 2003, STRESS, V6, P235, DOI 10.1080/10253890310001616482; Scharff C, 1998, J NEUROBIOL, V36, P81, DOI 10.1002/(SICI)1097-4695(199807)36:1<81::AID-NEU7>3.3.CO;2-8; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Stripling R, 1997, J NEUROSCI, V17, P3883; Sturdy CB, 2001, ANIM BEHAV, V62, P1207, DOI 10.1006/anbe.2001.1864; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Terpstra NJ, 2006, J COMP NEUROL, V494, P784, DOI 10.1002/cne.20831; Terpstra NJ, 2004, J NEUROSCI, V24, P4971, DOI 10.1523/JNEUROSCI.0570-04.2004; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7	49	153	153	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					579	586		10.1038/nn.2103	http://dx.doi.org/10.1038/nn.2103			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18391944	Green Accepted			2022-12-17	WOS:000255327300017
J	Shaban, H; Humeau, Y; Herry, C; Cassasus, G; Shigemoto, R; Ciocchi, S; Barbieri, S; van der Putten, H; Kaupmann, K; Bettler, B; Luthi, A				Shaban, Hamdy; Humeau, Yann; Herry, Cyril; Cassasus, Guillaume; Shigemoto, Ryuichi; Ciocchi, Stephane; Barbieri, Samuel; van der Putten, Herman; Kaupmann, Klemens; Bettler, Bernhard; Luethi, Andreas			Generalization of amygdala LTP and conditioned fear in the absence of presynaptic inhibition	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RAT LATERAL AMYGDALA; GABA(B) RECEPTORS; BASOLATERAL AMYGDALA; STIMULUS-GENERALIZATION; AUDITORY-CORTEX; IN-VITRO; NEURONS; INDUCTION; LOCALIZATION	Pavlovian fear conditioning, a simple form of associative learning, is thought to involve the induction of associative, NMDA receptor dependent long-term potentiation (LTP) in the lateral amygdala. Using a combined genetic and electrophysiological approach, we show here that lack of a specific GABA(B) receptor subtype, GABA(B(1a, 2)), unmasks a nonassociative, NMDA receptor-independent form of presynaptic LTP at cortico-amygdala afferents. Moreover, the level of presynaptic GABA(B(1a, 2)) receptor activation, and hence the balance between associative and nonassociative forms of LTP, can be dynamically modulated by local inhibitory activity. At the behavioral level, genetic loss of GABA(B(1a)) results in a generalization of conditioned fear to nonconditioned stimuli. Our findings indicate that presynaptic inhibition through GABA(B(1a, 2)) receptors serves as an activity-dependent constraint on the induction of homosynaptic plasticity, which may be important to prevent the generalization of conditioned fear.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; CNRS, UMR 7168, F-67084 Strasbourg, France; Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Japan; Univ Basel, Dept Clin Biol Sci, Pharmazentrum, CH-4056 Basel, Switzerland; Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST); University of Basel; Novartis	Luthi, A (corresponding author), Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.	andreas.luthi@fmi.ch	Shaban, Hamdy/ABD-5617-2021; Shigemoto, Ryuichi/E-3628-2013; Herry, Cyril/AAP-9902-2020; shaban, Hamdy/C-1939-2014; bettler, bernhard/AAO-8018-2020	Shaban, Hamdy/0000-0003-3760-6113; Shigemoto, Ryuichi/0000-0001-8761-9444; Herry, Cyril/0000-0003-2973-0843; shaban, Hamdy/0000-0003-3760-6113; Kaupmann, Klemens/0000-0001-8903-2508; Bettler, Bernhard/0000-0003-0842-8207; Ciocchi, Stephane/0000-0002-5701-9250				Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; ASPRODINI EK, 1992, J PHARMACOL EXP THER, V262, P1011; Baldi E, 2004, NEUROBIOL LEARN MEM, V81, P162, DOI 10.1016/j.nlm.2004.02.004; Bauer EP, 2004, J NEUROSCI, V24, P9507, DOI 10.1523/JNEUROSCI.3567-04.2004; Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Billinton A, 1999, BRIT J PHARMACOL, V126, P1387, DOI 10.1038/sj.bjp.0702460; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; Cryan JF, 2005, TRENDS PHARMACOL SCI, V26, P36, DOI 10.1016/j.tips.2004.11.004; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; Dittman JS, 1997, J NEUROSCI, V17, P9048; Fi XF, 1996, SYNAPSE, V24, P115, DOI 10.1002/(SICI)1098-2396(199610)24:2<115::AID-SYN3>3.0.CO;2-I; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; JARRELL TW, 1987, BRAIN RES, V412, P285, DOI 10.1016/0006-8993(87)91135-8; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; Lang EJ, 1997, J NEUROPHYSIOL, V77, P353, DOI 10.1152/jn.1997.77.1.353; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; Laxmi TR, 2003, BEHAV BRAIN RES, V145, P89, DOI 10.1016/S0166-4328(03)00101-3; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; McDonald AJ, 2004, BRAIN RES, V1018, P147, DOI 10.1016/j.brainres.2004.05.053; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Pelletier JG, 2004, BIOL PSYCHIAT, V55, P559, DOI 10.1016/j.biopsych.2003.08.019; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Porter JT, 2004, J NEUROPHYSIOL, V92, P2762, DOI 10.1152/jn.00196.2004; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Schmitz D, 2003, NAT NEUROSCI, V6, P1058, DOI 10.1038/nn1116; SUGITA S, 1993, BRAIN RES, V612, P151, DOI 10.1016/0006-8993(93)91655-C; SUGITA S, 1993, J PHYSIOL-LONDON, V460, P705, DOI 10.1113/jphysiol.1993.sp019495; Szinyei C, 2000, J NEUROSCI, V20, P8909; THOMPSON RF, 1962, J COMP PHYSIOL PSYCH, V55, P279, DOI 10.1037/h0047856; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yamada J, 1999, NEUROPHARMACOLOGY, V38, P1743, DOI 10.1016/S0028-3908(99)00126-4; Zhu PJ, 2005, J NEUROSCI, V25, P6199, DOI 10.1523/JNEUROSCI.1148-05.2005	48	153	156	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1028	1035		10.1038/nn1732	http://dx.doi.org/10.1038/nn1732			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16819521				2022-12-17	WOS:000240080300015
J	Sandberg, M; Kallstrom, M; Muhr, J				Sandberg, M; Kallstrom, M; Muhr, J			Sox21 promotes the progression of vertebrate neurogenesis	NATURE NEUROSCIENCE			English	Article							NEURONAL DIFFERENTIATION; EMBRYONIC-DEVELOPMENT; MAMMALIAN-CELLS; NERVOUS-SYSTEM; STEM-CELLS; EXPRESSION; IDENTITY; PROTEIN; GENES; LOOP	The generation of neurons constitutes the foundation of nervous system development, yet the mechanisms underlying neurogenesis are not well established. The HMG-box transcription factors Sox1, Sox2 and Sox3 ( Sox1 - 3) have previously been shown to suppress neurogenesis by maintaining neural cells in an undifferentiated state. Here we report that another HMG-box protein, Sox21, has the opposite activity and promotes neuronal differentiation. Using genetic studies in the chick embryo, we found that Sox21 mediates this function by counteracting the activity of Sox1 - 3. Accordingly, the balance of Sox21 and Sox1 - 3 activities determines whether neural cells remain as progenitors or commit to differentiation. Proneural basic helix-loop-helix proteins are essential for the establishment of neuronal fates. We now show that proneural proteins promote neurogenesis by upregulating Sox21 expression. These data establish a key role for Sox21 in the progression of neuronal differentiation and indicate that an important role of proneural proteins is their capacity to upregulate the expression of Sox21.	Karolinska Inst, Ludwig Inst Canc Res, SE-17177 Stockholm, Sweden	Karolinska Institutet; Ludwig Institute for Cancer Research	Muhr, J (corresponding author), Karolinska Inst, Ludwig Inst Canc Res, Box 240, SE-17177 Stockholm, Sweden.	jonas.muhr@licr.ki.se		Sandberg, Magnus/0000-0003-0809-0656				Bae SK, 2000, DEVELOPMENT, V127, P2933; Beranger F, 2000, J BIOL CHEM, V275, P16103, DOI 10.1074/jbc.275.21.16103; Berk AJ, 1998, COLD SPRING HARB SYM, V63, P243, DOI 10.1101/sqb.1998.63.243; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; CACCAMO DV, 1989, AM J PATHOL, V135, P801; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Dubreuil W, 2002, DEVELOPMENT, V129, P5241; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HAMBURGER V, 1992, DEV DYNAM, V195, P273, DOI 10.1002/dvdy.1001950405; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kintner C, 2002, J NEUROSCI, V22, P639, DOI 10.1523/JNEUROSCI.22-03-00639.2002; Komatsu T, 2004, MOL ENDOCRINOL, V18, P2451, DOI 10.1210/me.2004-0173; Koyano-Nakagawa N, 2000, DEVELOPMENT, V127, P4203; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Ohba H, 2004, NEUROSCI LETT, V358, P157, DOI 10.1016/j.neulet.2004.01.026; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Rex M, 1997, MECH DEVELOP, V66, P39, DOI 10.1016/S0925-4773(97)00086-5; Roztocil T, 1997, DEVELOPMENT, V124, P3263; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Smith ST, 1996, DEVELOPMENT, V122, P3141; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090	39	153	158	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					995	1001		10.1038/nn1493	http://dx.doi.org/10.1038/nn1493			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	15995704				2022-12-17	WOS:000230760200010
J	Tong, JY; Hannan, F; Zhu, YH; Bernards, A; Zhong, Y				Tong, JY; Hannan, F; Zhu, YH; Bernards, A; Zhong, Y			Neurofibromin regulates G protein-stimulated adenylyl cyclase activity	NATURE NEUROSCIENCE			English	Article							DROSOPHILA NF1; GENE; DEFICITS; MODEL		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11790 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Massachusetts General Hospital	Zhong, Y (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zhongyi@cshl.org		Zhong, Yi/0000-0002-7927-5976; Zhong, Yi/0000-0001-7810-9899; Hannan, Frances/0000-0002-9958-3706	NINDS NIH HHS [NS34779] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034779] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; Costa RM, 2001, NAT GENET, V27, P399, DOI 10.1038/86898; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Fahsold R, 2000, AM J HUM GENET, V66, P790, DOI 10.1086/302809; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; Hsueh YP, 2001, J NEUROSCI, V21, P3764, DOI 10.1523/JNEUROSCI.21-11-03764.2001; Kim HA, 1997, MOL CELL BIOL, V17, P862, DOI 10.1128/MCB.17.2.862; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097	14	153	160	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					95	96		10.1038/nn792	http://dx.doi.org/10.1038/nn792			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11788835				2022-12-17	WOS:000173558400007
J	Li, P; Kerchner, GA; Sala, C; Wei, F; Huettner, JE; Sheng, M; Zhuo, M				Li, P; Kerchner, GA; Sala, C; Wei, F; Huettner, JE; Sheng, M; Zhuo, M			AMPA receptor-PDZ interactions in facilitation of spinal sensory synapses	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; SPINOTHALAMIC TRACT NEURONS; LONG-TERM POTENTIATION; DORSAL HORN; SILENT SYNAPSES; GLUTAMATE RECEPTORS; RAT; CORD; TRANSMISSION; DOMAIN	Silent synapses form between some primary sensory afferents and dorsal horn neurons in the spinal cord. Molecular mechanisms for activation or conversion of silent synapses to conducting synapses are unknown. Serotonin can trigger activation of silent synapses in dorsal horn neurons by recruiting AMPA receptors. AMPA-receptor subunits GluR2 and GluR3 interact via their cytoplasmic C termini with PDZ-domain-containing proteins such as GRIP (glutamate receptor interacting protein), but the functional significance of these interactions is unclear. Here we demonstrate that protein interactions involving the GluR2/3 C terminus are important for serotonin-induced activation of silent synapses in the spinal cord. Furthermore, PKC is a necessary and sufficient trigger for this activation. These results implicate AMPA receptor-PDZ interactions in mechanisms underlying sensory synaptic potentiation and provide insights into the pathogenesis of chronic pain.	Washington Univ, Sch Med, Dept Anesthesiol Anat & Neurobiol, St Louis, MO 63110 USA; Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Washington University (WUSTL)	Zhuo, M (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol Anat & Neurobiol, Campus Box 8054,660 S Euclid Ave, St Louis, MO 63110 USA.		Zhuo, Min/A-2072-2008; Huettner, James E/C-5219-2012; Sala, Carlo/A-2493-2009	Zhuo, Min/0000-0001-9062-3241; Sala, Carlo/0000-0003-0662-9523; Sheng, Morgan/0000-0002-8703-5366	NINDS NIH HHS [R01 NS030888] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030888] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bardoni R, 1998, J NEUROSCI, V18, P6558; Calejesan AA, 1998, BRAIN RES, V798, P46, DOI 10.1016/S0006-8993(98)00394-1; Carlton SM, 1998, NEUROSCI LETT, V242, P21, DOI 10.1016/S0304-3940(98)00036-6; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; GERBER G, 1989, J NEUROSCI, V9, P3606; GOBEL S, 1984, J NEUROSCI, V4, P2281; Harris JA, 1996, NEUROSCIENCE, V74, P7, DOI 10.1016/0306-4522(96)00196-0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hori Y, 1996, J PHYSIOL-LONDON, V492, P867, DOI 10.1113/jphysiol.1996.sp021352; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HOYER D, 1994, PHARMACOL REV, V46, P157; HYLDEN JLK, 1989, PAIN, V37, P229, DOI 10.1016/0304-3959(89)90135-8; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Li P, 1998, NATURE, V393, P695, DOI 10.1038/31496; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lin JW, 1998, NEURON, V21, P267, DOI 10.1016/S0896-6273(00)80534-6; Lin Q, 1996, J NEUROSCI, V16, P3026; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; MENETREY D, 1982, PAIN, V13, P343, DOI 10.1016/0304-3959(82)90003-3; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; PALECEK J, 1992, J NEUROPHYSIOL, V68, P1951, DOI 10.1152/jn.1992.68.6.1951; Perl E, 1996, NEUROBIOLOGY NOCICEP, P5; Popratiloff A, 1996, J NEUROSCI, V16, P3363; Rumpel S, 1998, J NEUROSCI, V18, P8863; Sandkuhler J, 1996, PROG NEUROBIOL, V50, P49; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; TACHIBANA M, 1994, J COMP NEUROL, V344, P431, DOI 10.1002/cne.903440307; Urban MO, 1996, BRAIN RES, V737, P83, DOI 10.1016/0006-8993(96)00631-2; WALL PD, 1977, PHILOS T R SOC B, V278, P361, DOI 10.1098/rstb.1977.0048; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wyszynski M, 1998, NEUROPHARMACOLOGY, V37, P1335, DOI 10.1016/S0028-3908(98)00120-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; YAKSH TL, 1985, EUR J PHARMACOL, V117, P81, DOI 10.1016/0014-2999(85)90474-1; YOSHIMURA M, 1990, J PHYSIOL-LONDON, V430, P315, DOI 10.1113/jphysiol.1990.sp018293; Zhuo M, 1997, J NEUROPHYSIOL, V78, P746, DOI 10.1152/jn.1997.78.2.746; ZHUO M, 1991, PAIN, V46, P211, DOI 10.1016/0304-3959(91)90078-C	46	153	157	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					972	977		10.1038/14771	http://dx.doi.org/10.1038/14771			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526335				2022-12-17	WOS:000083883300013
J	Chance, FS; Nelson, SB; Abbott, LF				Chance, FS; Nelson, SB; Abbott, LF			Complex cells as cortically amplified simple cells	NATURE NEUROSCIENCE			English	Article							CAT STRIATE CORTEX; RECEPTIVE-FIELD PROPERTIES; PRIMARY VISUAL-CORTEX; ORIENTATION SELECTIVITY; SYNAPTIC DEPRESSION; THALAMIC INPUT; AREA 17; ORGANIZATION; AFFERENTS; NEURONS	The majority of synapses in primary visual cortex mediate excitation between nearby neurons, yet the role of local recurrent connections in visual processing remains unclear. We propose that these connections are responsible for the spatial-phase invariance of complex-cell responses. In a network model with selective cortical amplification, neurons exhibit simple-cell responses when recurrent connections are weak and complex-cell responses when they are strong, suggesting that simple and complex cells are the low- and high-gain limits of the same basic cortical circuit. Given the ubiquity of invariant responses in cognitive processing, the recurrent mechanism we propose for complex cells may be widely applicable.	Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Abbott, LF (corresponding author), Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA.			Nelson, Sacha/0000-0002-0108-8599	NEI NIH HHS [EY-11116] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011116] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Braitenberg V, 1991, ANATOMY CORTEX; Chance FS, 1998, J NEUROSCI, V18, P4785; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Debanne D, 1998, J PHYSIOL-LONDON, V508, P523, DOI 10.1111/j.1469-7793.1998.00523.x; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; HAMMOND P, 1977, EXP BRAIN RES, V30, P275; HAMMOND P, 1975, EXP BRAIN RES, V22, P427; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; HOFFMANN KP, 1971, BRAIN RES, V32, P460, DOI 10.1016/0006-8993(71)90340-4; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KISVARDAY ZF, 1986, EXP BRAIN RES, V64, P541, DOI 10.1007/BF00340492; LEVAY S, 1986, J NEUROSCI, V6, P3564; MALPELI JG, 1983, J NEUROPHYSIOL, V49, P595, DOI 10.1152/jn.1983.49.3.595; MALPELI JG, 1986, J NEUROPHYSIOL, V56, P1062, DOI 10.1152/jn.1986.56.4.1062; MCGUIRE BA, 1984, J NEUROSCI, V4, P3021; Mel BW, 1998, J NEUROSCI, V18, P4325; MIGNARD M, 1991, SCIENCE, V251, P1249, DOI 10.1126/science.1848727; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; MOVSHON JA, 1975, J PHYSIOL-LONDON, V249, P445, DOI 10.1113/jphysiol.1975.sp011025; PETERS A, 1994, CEREB CORTEX, V4, P215, DOI 10.1093/cercor/4.3.215; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; POLLEN DA, 1981, SCIENCE, V212, P1409, DOI 10.1126/science.7233231; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SINGER W, 1975, J NEUROPHYSIOL, V38, P1080, DOI 10.1152/jn.1975.38.5.1080; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P202, DOI 10.1152/jn.1981.46.2.202; TREVES A, 1993, NETWORK-COMP NEURAL, V4, P259, DOI 10.1088/0954-898X/4/3/002; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Varela JA, 1997, J NEUROSCI, V17, P7926; White E.L., 1989, CORTICAL CIRCUITS SY	39	153	154	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					277	282		10.1038/6381	http://dx.doi.org/10.1038/6381			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195222				2022-12-17	WOS:000081684500017
J	Pesaran, B; Vinck, M; Einevoll, GT; Sirota, A; Fries, P; Siegel, M; Truccolo, W; Schroeder, CE; Srinivasan, R				Pesaran, Bijan; Vinck, Martin; Einevoll, Gaute T.; Sirota, Anton; Fries, Pascal; Siegel, Markus; Truccolo, Wilson; Schroeder, Charles E.; Srinivasan, Ramesh			Investigating large-scale brain dynamics using field potential recordings: analysis and interpretation	NATURE NEUROSCIENCE			English	Review							GAMMA-BAND SYNCHRONIZATION; VARIABLE COMPONENT ANALYSIS; LATERAL GENICULATE-NUCLEUS; SOURCE-DENSITY ANALYSIS; SINGLE-NEURON SPIKING; GRANGER CAUSALITY; VISUAL-CORTEX; NEOCORTICAL DYNAMICS; SPATIAL ATTENTION; CORTICAL NETWORK	New technologies to record electrical activity from the brain on a massive scale offer tremendous opportunities for discovery. Electrical measurements of large-scale brain dynamics, termed field potentials, are especially important to understanding and treating the human brain. Here, our goal is to provide best practices on how field potential recordings (electroencephalograms, magnetoencephalograms, electrocorticograms and local field potentials) can be analyzed to identify large-scale brain dynamics, and to highlight critical issues and limitations of interpretation in current work. We focus our discussion of analyses around the broad themes of activation, correlation, communication and coding. We provide recommendations for interpreting the data using forward and inverse models. The forward model describes how field potentials are generated by the activity of populations of neurons. The inverse model describes how to infer the activity of populations of neurons from field potential recordings. A recurring theme is the challenge of understanding how field potentials reflect neuronal population activity given the complexity of the underlying brain systems.	[Pesaran, Bijan] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Pesaran, Bijan] NYU, Neurosci Inst, New York Univ Langone Hlth, New York, NY 10003 USA; [Vinck, Martin; Fries, Pascal] Max Planck Gesell, Ernst Strungmann Inst ESI Neurosci Cooperat, Frankfurt, Germany; [Einevoll, Gaute T.] Norwegian Univ Life Sci, Fac Sci & Technol, As, Norway; [Einevoll, Gaute T.] Univ Oslo, Dept Phys, Oslo, Norway; [Sirota, Anton] Ludwig Maximilians Univ Munchen, Fac Med, Munich Cluster Syst Neurol SyNergy, Bernstein Ctr Computat Neurosci Munich, Planegg Martinsried, Germany; [Fries, Pascal] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Siegel, Markus] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany; [Siegel, Markus] Univ Tubingen, MEG Ctr, Tubingen, Germany; [Truccolo, Wilson] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Truccolo, Wilson] Brown Univ, Inst Brain Sci, Providence, RI 02912 USA; [Truccolo, Wilson] US Dept Vet Affairs, Ctr Neurorestorat & Neurotechnol, Providence, RI USA; [Schroeder, Charles E.] Nathan S Kline Inst Psychiat Res, Ctr Biomed Imaging & Neuromodulat, Translat Neurosci Div, Orangeburg, NY USA; [Schroeder, Charles E.] Columbia Coll Phys & Surg, Dept Neurosurg, New York, NY USA; [Srinivasan, Ramesh] Univ Calif Irvine, Dept Biomed Engn, Dept Cognit Sci, Irvine, CA USA	New York University; New York University; Max Planck Society; Norwegian University of Life Sciences; University of Oslo; University of Munich; Radboud University Nijmegen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Brown University; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Nathan Kline Institute for Psychiatric Research; Columbia University; University of California System; University of California Irvine	Pesaran, B (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.; Pesaran, B (corresponding author), NYU, Neurosci Inst, New York Univ Langone Hlth, New York, NY 10003 USA.	bijan@nyu.edu	Vinck, Martin/AAA-6151-2020; Fries, Pascal/E-3196-2010; Siegel, Markus/H-5225-2012	Fries, Pascal/0000-0002-4270-1468; Srinivasan, Ramesh/0000-0002-2090-8257; Pesaran, Bijan/0000-0003-4116-0038; Siegel, Markus/0000-0001-5115-936X; Vinck, Martin/0000-0002-4044-0970	European Union's Horizon 2020 Framework Programme for Research and Innovation [720270]; DFG [SPP 1665, FOR 1847, FR2557/5-1-CORNET]; European Union [FP7-600730-Magnetrodes]; NIH [1U54MH091657-WU-Minn-Consortium-HCP]; LOEWE (NeFF); U.S. Department of Veterans Affairs [RX000668]; Pablo J. Salame ' 88 Goldman Sachs endowed Assistant Professorship of Computational Neuroscience; DoD [W911NF-14-2-0043, N66001-17-C-4002]; BrainCom from EU Horizon 2020 program [732032]; Munich Cluster for Systems Neurology (SyNergy) [EXC 1010]; Deutsche Forschungsgemeinschaft Priority Program; Bundesministerium fur Bildung und Forschung;  [MH111439];  [DC015780];  [NIH-NINDS R01NS079533];  [NEI R01-EY024067];  [NINDS R01-NS104923];  [ARO MURI 68984-CS-MUR];  [NSF BCS 150236]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079533] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000668] Funding Source: NIH RePORTER	European Union's Horizon 2020 Framework Programme for Research and Innovation; DFG(German Research Foundation (DFG)); European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LOEWE (NeFF); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Pablo J. Salame ' 88 Goldman Sachs endowed Assistant Professorship of Computational Neuroscience; DoD(United States Department of Defense); BrainCom from EU Horizon 2020 program; Munich Cluster for Systems Neurology (SyNergy); Deutsche Forschungsgemeinschaft Priority Program(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); ; ; ; ; ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	C.S. acknowledges Y. Kajikawa for contributing figure 4b and for editorial comments. C.S. acknowledges grant support from MH111439 and DC015780. G.E. acknowledges grant support from the European Union's Horizon 2020 Framework Programme for Research and Innovation under the Specific Grant Agreement No. 720270 ( Human Brain Project SGA1). P.F. acknowledges grant support from DFG (SPP 1665, FOR 1847, FR2557/5-1-CORNET), the European Union (FP7-600730-Magnetrodes), NIH (1U54MH091657-WU-Minn-Consortium-HCP), and LOEWE (NeFF). W. T. acknowledges grant support from NIH-NINDS R01NS079533, U.S. Department of Veterans Affairs, Merit Review Award RX000668, and the Pablo J. Salame ' 88 Goldman Sachs endowed Assistant Professorship of Computational Neuroscience. B.P. acknowledges grant support from NEI R01-EY024067, NINDS R01-NS104923, ARO MURI 68984-CS-MUR, NSF BCS 150236, and DoD contracts W911NF-14-2-0043 and N66001-17-C-4002. A.S. acknowledges grant support from BrainCom from EU Horizon 2020 program via grant no. 732032, Munich Cluster for Systems Neurology (SyNergy, EXC 1010), Deutsche Forschungsgemeinschaft Priority Program 1665 and 1392 and Bundesministerium fur Bildung und Forschung via grant	Agarwal G, 2014, SCIENCE, V344, P626, DOI 10.1126/science.1250444; Anastassiou CA, 2015, CURR OPIN NEUROBIOL, V31, P95, DOI 10.1016/j.conb.2014.09.002; Aru J, 2015, CURR OPIN NEUROBIOL, V31, P51, DOI 10.1016/j.conb.2014.08.002; Banerjee A, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00051; Bansal AK, 2012, J NEUROPHYSIOL, V107, P1337, DOI 10.1152/jn.00781.2011; Barnett L, 2014, J NEUROSCI METH, V223, P50, DOI 10.1016/j.jneumeth.2013.10.018; BARTH D S, 1991, Brain Topography, V4, P85, DOI 10.1007/BF01132765; Bastos AM, 2014, J NEUROSCI, V34, P7639, DOI 10.1523/JNEUROSCI.4216-13.2014; Bedard C, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051911; Bedard C, 2009, BIOPHYS J, V96, P2589, DOI 10.1016/j.bpj.2008.12.3951; Berens P, 2008, FRONT NEUROSCI-SWITZ, V2, P199, DOI 10.3389/neuro.01.037.2008; Besserve M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002257; Boes AD, 2015, BRAIN, V138, P3061, DOI 10.1093/brain/awv228; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; Brillinger D.R, 2001, TIME SERIES DATA ANA, DOI [10.1137/1.9780898719246, DOI 10.1137/1.9780898719246]; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Brunet NM, 2014, P NATL ACAD SCI USA, V111, P3626, DOI 10.1073/pnas.1309714111; Burns SP, 2011, J NEUROSCI, V31, P9658, DOI 10.1523/JNEUROSCI.0660-11.2011; Burns SP, 2010, J NEUROSCI, V30, P4033, DOI 10.1523/JNEUROSCI.5319-09.2010; Buzsaki G, 2015, NEURON, V86, P92, DOI 10.1016/j.neuron.2015.01.028; Buzsaki G, 2015, NAT NEUROSCI, V18, P484, DOI 10.1038/nn.3952; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Cannon J, 2014, EUR J NEUROSCI, V39, P705, DOI 10.1111/ejn.12453; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Carlson T, 2013, J VISION, V13, DOI 10.1167/13.10.1; Castelo-Branco M, 1998, J NEUROSCI, V18, P6395; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Cichy RM, 2014, NAT NEUROSCI, V17, P455, DOI 10.1038/nn.3635; Cogan GB, 2014, NATURE, V507, P94, DOI 10.1038/nature12935; CUFFIN BN, 1991, ANN NEUROL, V29, P132, DOI 10.1002/ana.410290204; Dean HL, 2012, NEURON, V73, P829, DOI 10.1016/j.neuron.2011.12.035; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Dowrick T, 2015, PHYSIOL MEAS, V36, P1273, DOI 10.1088/0967-3334/36/6/1273; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; Elbohouty M, 2013, PHYS MED BIOL, V58, P3599, DOI 10.1088/0031-9155/58/11/3599; Feingold J, 2015, P NATL ACAD SCI USA, V112, P13687, DOI 10.1073/pnas.1517629112; Fernandez-Ruiz A, 2013, J NEUROSCI, V33, P15518, DOI 10.1523/JNEUROSCI.0338-13.2013; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Friston KJ, 2014, NEUROIMAGE, V101, P796, DOI 10.1016/j.neuroimage.2014.06.062; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; Gilja V, 2007, NEURON, V55, P684, DOI 10.1016/j.neuron.2007.08.012; Glabska H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105071; Glabska HT, 2016, FRONT NEUROINFORM, V10, DOI 10.3389/fninf.2016.00001; Granger C.W.J., 1974, J EC, V2, P111, DOI [DOI 10.1016/0304-4076(74)90034-7, 10.1016/0304-4076(74)90034-7]; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Gratiy SL, 2017, EUR J NEUROSCI, V45, P1013, DOI 10.1111/ejn.13534; Gunduz A, 2012, NEUROIMAGE, V60, P2285, DOI 10.1016/j.neuroimage.2012.02.017; Haider B, 2016, NEURON, V90, P35, DOI 10.1016/j.neuron.2016.02.034; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Halnes G, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005193; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hamalainen Matti S., 1992, Brain Topography, V5, P95, DOI 10.1007/BF01129036; Hari R, 1999, PHILOS T R SOC B, V354, P1145, DOI 10.1098/rstb.1999.0470; Hastie T., 2009, SPRINGER, V2nd, DOI DOI 10.1007/978-0-387-21606-5; Hawellek DJ, 2016, P NATL ACAD SCI USA, V113, P13492, DOI 10.1073/pnas.1606479113; Hipp JF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00338; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Holt GR, 1999, J COMPUT NEUROSCI, V6, P169, DOI 10.1023/A:1008832702585; Insanally M, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026030; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Kajikawa Y, 2011, NEURON, V72, P847, DOI 10.1016/j.neuron.2011.09.029; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Katz LN, 2016, NATURE, V535, P285, DOI 10.1038/nature18617; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Khodagholy D, 2015, NAT NEUROSCI, V18, P310, DOI 10.1038/nn.3905; Knuth KH, 2006, J NEUROPHYSIOL, V95, P3257, DOI 10.1152/jn.00663.2005; Krings T, 1998, ANN NEUROL, V44, P76, DOI 10.1002/ana.410440114; Lepage KQ, 2013, J NEUROSCI METH, V213, P43, DOI 10.1016/j.jneumeth.2012.10.010; Lepage KQ, 2011, NEURAL COMPUT, V23, P2209, DOI 10.1162/NECO_a_00169; Leski S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003137; LEUNG LS, 1990, NEUROMETHODS, V15, P277; Linden H., 2014, FRONT NEUROINFORM, V7, P41, DOI DOI 10.3389/fninf.2013.00041; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Linden H, 2010, J COMPUT NEUROSCI, V29, P423, DOI 10.1007/s10827-010-0245-4; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Livingstone MS, 1996, J NEUROPHYSIOL, V75, P2467, DOI 10.1152/jn.1996.75.6.2467; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; LORENTE de NO R, 1947, Stud Rockefeller Inst Med Res Repr, V132, P384; Maris E, 2007, J NEUROSCI METH, V163, P161, DOI 10.1016/j.jneumeth.2007.02.011; Maris E, 2013, NEUROIMAGE, V74, P99, DOI 10.1016/j.neuroimage.2013.02.007; Markowitz DA, 2011, J NEUROSCI, V31, P18412, DOI 10.1523/JNEUROSCI.4165-11.2011; Mazzoni A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004584; McGinley MJ, 2015, NEURON, V87, P1143, DOI 10.1016/j.neuron.2015.09.012; McIntyre CC, 2000, ANN BIOMED ENG, V28, P219, DOI 10.1114/1.262; Miceli S, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0291-16.2016; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; Minlebaev M, 2011, SCIENCE, V334, P226, DOI 10.1126/science.1210574; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Myers NE, 2015, ELIFE, V4, DOI 10.7554/eLife.09000; Ness TV, 2016, J PHYSIOL-LONDON, V594, P3809, DOI 10.1113/JP272022; NICHOLSON C, 1975, BRAIN RES, V100, P418, DOI 10.1016/0006-8993(75)90494-1; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez P.L., 2006, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Nunez PL, 1998, IEEE ENG MED BIOL, V17, P110, DOI 10.1109/51.715494; OGATA Y, 1981, IEEE T INFORM THEORY, V27, P23, DOI 10.1109/TIT.1981.1056305; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Pesaran B, 2006, CURR BIOL, V16, pR77, DOI 10.1016/j.cub.2006.01.043; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pesaran B., 2008, NEURAL SIGNAL PROCES, P1; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Pesaran B, 2016, TRENDS NEUROSCI, V39, P642, DOI 10.1016/j.tins.2016.08.008; Pettersen KH, 2008, J COMPUT NEUROSCI, V24, P291, DOI 10.1007/s10827-007-0056-4; Pettersen KH, 2006, J NEUROSCI METH, V154, P116, DOI 10.1016/j.jneumeth.2005.12.005; Pettersen KH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003928; Pettersen KH, 2012, HANDBOOK OF NEURAL ACTIVITY MEASUREMENT, P92; PFURTSCHELLER G, 1975, ELECTROEN CLIN NEURO, V38, P93, DOI 10.1016/0013-4694(75)90215-1; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Potworowski J, 2012, NEURAL COMPUT, V24, P541, DOI 10.1162/NECO_a_00236; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; RANCK JB, 1963, EXP NEUROL, V7, P144, DOI 10.1016/S0014-4886(63)80005-9; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Reimann MW, 2013, NEURON, V79, P375, DOI 10.1016/j.neuron.2013.05.023; Richter CG, 2015, NEUROIMAGE, V114, P57, DOI 10.1016/j.neuroimage.2015.04.040; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; Riera JJ, 2012, J NEUROPHYSIOL, V108, P956, DOI 10.1152/jn.00098.2011; Rule ME, 2017, J NEUROPHYSIOL, V117, P1524, DOI 10.1152/jn.00651.2016; Rule ME, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00089; Salazar RF, 2012, SCIENCE, V338, P1097, DOI 10.1126/science.1224000; Saleem AB, 2017, NEURON, V93, P315, DOI 10.1016/j.neuron.2016.12.028; Samaha J, 2016, J COGNITIVE NEUROSCI, V28, P1090, DOI 10.1162/jocn_a_00955; Scheffer-Teixeira R, 2013, J NEUROSCI, V33, P1535, DOI 10.1523/JNEUROSCI.4217-12.2013; Schoffelen JM, 2008, NEUROIMAGE, V41, P437, DOI 10.1016/j.neuroimage.2008.01.045; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Schomburg EW, 2014, NEURON, V84, P470, DOI 10.1016/j.neuron.2014.08.051; Schomburg EW, 2012, J NEUROSCI, V32, P11798, DOI 10.1523/JNEUROSCI.0656-12.2012; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Siegel M, 2003, J NEUROSCI, V23, P4251; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Srinivasan R, 1998, IEEE T BIO-MED ENG, V45, P814, DOI 10.1109/10.686789; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Steriade M, 1996, J NEUROSCI, V16, P2788; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Swadlow HA, 2002, J NEUROSCI, V22, P7766; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; TENKE CE, 1993, EXP BRAIN RES, V94, P183; Tian L, 2012, PROG BRAIN RES, V196, P79, DOI 10.1016/B978-0-444-59426-6.00005-7; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Truccolo W, 2003, BIOL CYBERN, V89, P426, DOI 10.1007/s00422-003-0433-7; Truccolo WA, 2002, CLIN NEUROPHYSIOL, V113, P206, DOI 10.1016/S1388-2457(01)00739-8; Tuckwell H. C, 1988, INTRO THEORETICAL NE, V1; van Wingerden M, 2012, NEURON, V76, P813, DOI 10.1016/j.neuron.2012.09.039; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vinck M, 2015, NEURON, V86, P740, DOI 10.1016/j.neuron.2015.03.028; Vinck M, 2013, NEURON, V80, P1077, DOI 10.1016/j.neuron.2013.08.019; Vinck M, 2012, J COMPUT NEUROSCI, V33, P53, DOI 10.1007/s10827-011-0374-4; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Vinck M, 2010, NEUROIMAGE, V51, P112, DOI 10.1016/j.neuroimage.2010.01.073; Vinck M, 2010, J NEUROSCI, V30, P1250, DOI 10.1523/JNEUROSCI.1623-09.2010; Wagner T, 2014, NEUROIMAGE, V85, P1048, DOI 10.1016/j.neuroimage.2013.06.079; Waldert S, 2013, J PHYSIOL-LONDON, V591, P5291, DOI 10.1113/jphysiol.2013.258228; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Wang X, 2008, NEUROIMAGE, V41, P767, DOI 10.1016/j.neuroimage.2008.03.025; Welle CG, 2016, J NEUROPHYSIOL, V115, P1821, DOI 10.1152/jn.00137.2015; Wiener N, 1956, MODERN MATH ENG, V58; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Wong YT, 2016, NAT NEUROSCI, V19, P327, DOI 10.1038/nn.4210; Xu LZ, 2009, IEEE T BIO-MED ENG, V56, P111, DOI 10.1109/TBME.2008.2008166; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110; Zanos TP, 2011, J NEUROPHYSIOL, V105, P474, DOI 10.1152/jn.00642.2010; Zeitler M, 2006, NEURAL COMPUT, V18, P2256, DOI 10.1162/neco.2006.18.9.2256	169	152	153	11	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2018	21	7					903	919		10.1038/s41593-018-0171-8	http://dx.doi.org/10.1038/s41593-018-0171-8			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GM3EW	29942039	Green Accepted, Green Submitted			2022-12-17	WOS:000437983900004
J	Ferreira, DG; Temido-Ferreira, M; Miranda, HV; Batalha, VL; Coelho, JE; Szego, EM; Marques-Morgado, I; Vaz, SH; Rhee, JS; Schmitz, M; Zerr, I; Lopes, LV; Outeiro, TF				Ferreira, Diana G.; Temido-Ferreira, Mariana; Miranda, Hugo Vicente; Batalha, Vania L.; Coelho, Joana E.; Szego, Eva M.; Marques-Morgado, Ines; Vaz, Sandra H.; Rhee, Jeong Seop; Schmitz, Matthias; Zerr, Inga; Lopes, Luisa V.; Outeiro, Tiago F.			alpha-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B	NATURE NEUROSCIENCE			English	Article							CELLULAR PRION PROTEIN; ADENOSINE A(2A) RECEPTORS; AMYLOID-BETA OLIGOMERS; LONG-TERM POTENTIATION; POSSIBLE KEY MECHANISM; LEWY BODY DISEASES; PARKINSONS-DISEASE; TYROSINE PHOSPHORYLATION; DEPENDENT MECHANISM; CA2+ SIGNALS	Synucleinopathies, such as Parkinson's disease and dementia with Lewy bodies, are neurodegenerative disorders that are characterized by the accumulation of alpha-synuclein (aSyn) in intracellular inclusions known as Lewy bodies. Prefibrillar soluble aSyn oligomers, rather than larger inclusions, are currently considered to be crucial species underlying synaptic dysfunction. We identified the cellular prion protein (PrPC) as a key mediator in aSyn-induced synaptic impairment. The aSyn-associated impairment of long-term potentiation was blocked in Prnp null mice and rescued following PrPC blockade. We found that extracellular aSyn oligomers formed a complex with PrPC that induced the phosphorylation of Fyn kinase via metabotropic glutamate receptors 5 (mGluR5). aSyn engagement of PrPC and Fyn activated NMDA receptor (NMDAR) and altered calcium homeostasis. Blockade of mGluR5-evoked phosphorylation of NMDAR in aSyn transgenic mice rescued synaptic and cognitive deficits, supporting the hypothesis that a receptor-mediated mechanism, independent of pore formation and membrane leakage, is sufficient to trigger early synaptic damage induced by extracellular aSyn.	[Ferreira, Diana G.; Temido-Ferreira, Mariana; Miranda, Hugo Vicente; Batalha, Vania L.; Coelho, Joana E.; Marques-Morgado, Ines; Vaz, Sandra H.; Lopes, Luisa V.] Univ Lisbon, Fac Med Lisboa, Inst Med Mol, Lisbon, Portugal; [Ferreira, Diana G.; Szego, Eva M.; Outeiro, Tiago F.] Univ Med Ctr Gottingen, Ctr Biostruct Imaging Neurodegenerat, Ctr Nanoscale Microscopy & Mol Physiol Brain, Dept Expt Neurodegenerat, Gottingen, Germany; [Ferreira, Diana G.] Univ Porto, Fac Med, Dept Pharmacol & Therapeut, Oporto, Portugal; [Ferreira, Diana G.] Univ Porto, MedInUP Ctr Drug Discovery & Innovat Med, Oporto, Portugal; [Miranda, Hugo Vicente; Outeiro, Tiago F.] Univ Nova Lisboa, Fac Ciencias Med, NOVA Med Sch, CEDOC,Chron Dis Res Ctr, Lisbon, Portugal; [Rhee, Jeong Seop; Outeiro, Tiago F.] Max Planck Inst Expt Med, Gottingen, Germany; [Schmitz, Matthias; Zerr, Inga] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany; [Schmitz, Matthias; Zerr, Inga] German Ctr Neurodegenerat Dis DZNE Site Gottingen, Gottingen, Germany	Universidade de Lisboa; University of Gottingen; Universidade do Porto; Universidade do Porto; Universidade Nova de Lisboa; Max Planck Society; University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Lopes, LV (corresponding author), Univ Lisbon, Fac Med Lisboa, Inst Med Mol, Lisbon, Portugal.; Outeiro, TF (corresponding author), Univ Med Ctr Gottingen, Ctr Biostruct Imaging Neurodegenerat, Ctr Nanoscale Microscopy & Mol Physiol Brain, Dept Expt Neurodegenerat, Gottingen, Germany.; Outeiro, TF (corresponding author), Univ Nova Lisboa, Fac Ciencias Med, NOVA Med Sch, CEDOC,Chron Dis Res Ctr, Lisbon, Portugal.; Outeiro, TF (corresponding author), Max Planck Inst Expt Med, Gottingen, Germany.	lvlopes@medicina.ulisboa.pt; touteir@gwdg.de	Outeiro, Tiago/M-8106-2019; Coelho, Joana/AAB-5263-2022; Miranda, Hugo Vicente/I-3525-2013; Outeiro, Tiago/L-7351-2019; Outeiro, Tiago F/C-1067-2008; Vaz, Sandra H./L-7393-2015	Coelho, Joana/0000-0002-3964-6197; Miranda, Hugo Vicente/0000-0001-8065-9259; Outeiro, Tiago/0000-0003-1679-1727; Outeiro, Tiago F/0000-0003-1679-1727; Vaz, Sandra H./0000-0003-4258-9397; Marques-Morgado, Ines/0000-0003-3053-2772; Szego, Eva Monika/0000-0002-2629-2131; Lopes, Luisa/0000-0001-8367-3005; Temido Ferreira, Mariana/0000-0002-4356-547X	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/52228/2013, SFRH/BPD/109347/2015, SFRH/BPD/87647/2012]; Fritz Thyssen Stiftung, Germany [Az.10.12.2.165]; iMM Lisboa internal fund (BIG - Breakthrough Idea Grant); DFG Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), Germany; FEDER, POR Lisboa - Programa Operacional Regional de Lisboa [LISBOA-01-0145-FEDER-007391]; Fundacao para a Ciencia e a Tecnologia [LISBOA-01-0145-FEDER-007391]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fritz Thyssen Stiftung, Germany; iMM Lisboa internal fund (BIG - Breakthrough Idea Grant); DFG Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), Germany(German Research Foundation (DFG)); FEDER, POR Lisboa - Programa Operacional Regional de Lisboa; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors thank L. Gros for figure layout design and C. Fahlbusch (University Medical Center Gottingen), A. Margarida Nascimento and J. Rino (Instituto de Medicina Molecular (iMM) Bioimaging facility), I. Moreira and J. Marques (iMM Rodent facility), and the iMM Histology and Comparative Pathology laboratory for technical assistance. M.T.F., H.V.M. and J.E.C. were supported by individual grants from Fundacao para a Ciencia e Tecnologia (FCT) (SFRH/BD/52228/2013; SFRH/BPD/109347/2015; SFRH/BPD/87647/2012); L.V.L. and T.F.O. were supported by a grant from the Fritz Thyssen Stiftung (Az.10.12.2.165), Germany. L.V.L. received an iMM Lisboa internal fund (BIG - Breakthrough Idea Grant) for part of the project. L.V.L. is an Investigator FCT, Portugal. T.F.O. is supported by the DFG Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), Germany. LISBOA-01-0145-FEDER-007391, project co-financed by FEDER, POR Lisboa 2020 - Programa Operacional Regional de Lisboa, from PORTUGAL 2020 and by Fundacao para a Ciencia e a Tecnologia.	Barhoumi R, 2010, NEUROTOXICOL TERATOL, V32, P16, DOI 10.1016/j.ntt.2009.06.002; Batalha VL, 2013, MOL PSYCHIATR, V18, P320, DOI 10.1038/mp.2012.8; Batalha VL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31493; Beraldo FH, 2016, J BIOL CHEM, V291, P21945, DOI 10.1074/jbc.M116.738286; Braak H, 2005, NEUROLOGY, V64, P1404, DOI 10.1212/01.WNL.0000158422.41380.82; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Chesselet MF, 2012, NEUROTHERAPEUTICS, V9, P297, DOI 10.1007/s13311-012-0104-2; Coelho JE, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00067; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Criado JR, 2005, NEUROBIOL DIS, V19, P255, DOI 10.1016/j.nbd.2005.01.001; Curtis J, 2003, NEUROBIOL DIS, V13, P55, DOI 10.1016/S0969-9961(03)00017-2; De Mario A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00416; Di Scala C, 2016, SCI REP-UK, V6, DOI 10.1038/srep28781; Diogenes MJ, 2012, J NEUROSCI, V32, P11750, DOI 10.1523/JNEUROSCI.0234-12.2012; Dungo RT, 2013, DRUGS, V73, P1503, DOI 10.1007/s40265-013-0111-6; Emes RD, 2008, NAT NEUROSCI, V11, P799, DOI 10.1038/nn.2135; Ferreira DG, 2017, CEREB CORTEX, V27, P718, DOI 10.1093/cercor/bhv268; Garman RH, 2011, TOXICOL PATHOL, V39, P22, DOI 10.1177/0192623310389621; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Goldman JG, 2014, MOVEMENT DISORD, V29, P608, DOI 10.1002/mds.25866; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Kachroo A, 2012, ANN NEUROL, V71, P278, DOI 10.1002/ana.22630; Kasai T, 2014, J NEUROL, V261, P1203, DOI 10.1007/s00415-014-7334-7; Katamine S, 1998, CELL MOL NEUROBIOL, V18, P731, DOI 10.1023/A:1020234321879; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Knot HJ, 2005, MOL INTERV, V5, P112, DOI 10.1124/mi.5.2.8; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Laurent C, 2016, MOL PSYCHIATR, V21, P97, DOI 10.1038/mp.2014.151; Lee HJ, 2014, NAT REV NEUROL, V10, P92, DOI 10.1038/nrneurol.2013.275; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Magen I, 2012, EUR J NEUROSCI, V35, P870, DOI 10.1111/j.1460-9568.2012.08012.x; Marques O, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.94; Martin ZS, 2012, J NEUROCHEM, V120, P440, DOI 10.1111/j.1471-4159.2011.07576.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Pedersen WA, 2002, J NEUROSCI, V22, P404, DOI 10.1523/JNEUROSCI.22-02-00404.2002; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sarantis K, 2015, J NEUROCHEM, V135, P714, DOI 10.1111/jnc.13291; Schmitz M, 2014, MOL NEUROBIOL, V50, P923, DOI 10.1007/s12035-014-8655-3; Schulz-Schaeffer WJ, 2010, ACTA NEUROPATHOL, V120, P131, DOI 10.1007/s00401-010-0711-0; Sorgato MC, 2009, BIOCHEM BIOPH RES CO, V379, P171, DOI 10.1016/j.bbrc.2008.12.026; SUZUKI T, 1995, BIOCHEM BIOPH RES CO, V216, P582, DOI 10.1006/bbrc.1995.2662; Tebano MT, 2005, J NEUROCHEM, V95, P1188, DOI 10.1111/j.1471-4159.2005.03455.x; Um JW, 2013, PRION, V7, P37, DOI 10.4161/pri.22212; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Urrea L, 2017, MOL NEUROBIOL; Valadas JS, 2012, J NEUROCHEM, V123, P1030, DOI 10.1111/jnc.12050; Vicente Miranda H, 2013, J NEUROCHEM, V126, P673, DOI 10.1111/jnc.12251; Williamson R, 2008, FASEB J, V22, P1552, DOI 10.1096/fj.07-9766com; Wulf MA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0375-5; Yang M, 2007, N-S ARCH PHARMACOL, V375, P133, DOI 10.1007/s00210-007-0135-0; Yang WW, 2017, CELL MOL LIFE SCI, V74, P1485, DOI 10.1007/s00018-016-2411-y	60	152	154	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2017	20	11					1569	+		10.1038/nn.4648	http://dx.doi.org/10.1038/nn.4648			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL0QV	28945221				2022-12-17	WOS:000413916800018
J	Lim, JHA; Stafford, BK; Nguyen, PL; Lien, BV; Wang, C; Zukor, K; He, ZG; Huberman, AD				Lim, Jung-Hwan A.; Stafford, Benjamin K.; Nguyen, Phong L.; Lien, Brian V.; Wang, Chen; Zukor, Katherine; He, Zhigang; Huberman, Andrew D.			Neural activity promotes long-distance, target-specific regeneration of adult retinal axons	NATURE NEUROSCIENCE			English	Article							OPTIC-NERVE REGENERATION; GANGLION-CELLS; SPINAL-CORD; SUPERIOR COLLICULUS; NOGO-A; MICE; RESPONSES; SYSTEM; RAT; CNS	Axons in the mammalian CNS fail to regenerate after injury. Here we show that if the activity of mouse retinal ganglion cells (RGCs) is increased by visual stimulation or using chemogenetics, their axons regenerate. We also show that if enhancement of neural activity is combined with elevation of the cell-growth-promoting pathway involving mammalian target of rapamycin ( mTOR), RGC axons regenerate long distances and re-innervate the brain. Analysis of genetically labeled RGCs revealed that this regrowth can be target specific: RGC axons navigated back to their correct visual targets and avoided targets incorrect for their function. Moreover, these regenerated connections were successful in partially rescuing a subset of visual behaviors. Our findings indicate that combining neural activity with activation of mTOR can serve as powerful tool for enhancing axon regeneration, and they highlight the remarkable capacity of CNS neurons to re-establish accurate circuit connections in adulthood.	[Lim, Jung-Hwan A.; Lien, Brian V.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Stafford, Benjamin K.; Nguyen, Phong L.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Wang, Chen; He, Zhigang] Harvard Med Sch, Boston Childrens Hosp, Boston, MA USA; [Zukor, Katherine] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Huberman, Andrew D.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Huberman, Andrew D.] Stanford Univ, Sch Med, Dept Ophthalmol, Stanford, CA 94305 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; Harvard Medical School; Utah System of Higher Education; Utah State University; Stanford University; Stanford University	Huberman, AD (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.; Huberman, AD (corresponding author), Stanford Univ, Sch Med, Dept Ophthalmol, Stanford, CA 94305 USA.	adh1@stanford.edu		Lien, Brian/0000-0003-3044-8626	National Institutes of Health National Eye Institute [NIH/NEI R01EY026100]; Pew Biomedical Foundation; McKnight Foundation; Glaucoma Research Foundation Catalyst for a Cure Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY026100] Funding Source: NIH RePORTER	National Institutes of Health National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Pew Biomedical Foundation; McKnight Foundation; Glaucoma Research Foundation Catalyst for a Cure Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors would like to thank T. Seabrook, O. Dhande, R. El-Danaf and other members of the Huberman laboratory for comments on earlier versions of this manuscript. This work was supported by grants from the National Institutes of Health National Eye Institute R01, NIH/NEI R01EY026100 (ADH), The Pew Biomedical Foundation, The McKnight Foundation and The Glaucoma Research Foundation Catalyst for a Cure Initiative.	Barres BA, 1999, J CELL BIOL, V147, P1123, DOI 10.1083/jcb.147.6.1123; Bei FF, 2016, CELL, V164, P219, DOI 10.1016/j.cell.2015.11.036; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chierzi S, 1999, J NEUROSCI, V19, P8367; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; Dhande OS, 2015, ANNU REV VIS SCI, V1, P291, DOI 10.1146/annurev-vision-082114-035502; Duan X, 2015, NEURON, V85, P1244, DOI 10.1016/j.neuron.2015.02.017; Fu L, 2015, GRAEF ARCH CLIN EXP, V253, P171, DOI 10.1007/s00417-014-2889-7; GALLO V, 1987, DEV BIOL, V123, P282, DOI 10.1016/0012-1606(87)90450-7; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Harvey P, 2010, P NATL ACAD SCI USA, V107, P11585, DOI 10.1073/pnas.1003287107; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; King CE, 2003, EXP NEUROL, V183, P593, DOI 10.1016/S0014-4886(03)00211-5; Kwong JMK, 2010, INVEST OPHTH VIS SCI, V51, P1052, DOI 10.1167/iovs.09-4098; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; Leaver SG, 2006, GENE THER, V13, P1328, DOI 10.1038/sj.gt.3302791; Li S, 2016, P NATL ACAD SCI USA, V113, P1937, DOI 10.1073/pnas.1523645113; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Luo XT, 2013, EXP NEUROL, V247, P653, DOI 10.1016/j.expneurol.2013.03.001; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Osterhout JA, 2015, NEURON, V86, P985, DOI 10.1016/j.neuron.2015.04.005; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pasterkamp RJ, 1998, EXP NEUROL, V153, P313, DOI 10.1006/exnr.1998.6886; Pernet V, 2014, TRENDS NEUROSCI, V37, P381, DOI 10.1016/j.tins.2014.05.002; Prusky GT, 2008, J NEUROSCI, V28, P9817, DOI 10.1523/JNEUROSCI.1940-08.2008; Shang CP, 2015, SCIENCE, V348, P1472, DOI 10.1126/science.aaa8694; SHEWAN D, 1995, J NEUROSCI, V15, P2057, DOI 10.1523/JNEUROSCI.15-03-02057.1995; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Sun LO, 2015, NEURON, V86, P971, DOI 10.1016/j.neuron.2015.03.064; Sweeney NT, 2014, J NEUROSCI, V34, P5447, DOI 10.1523/JNEUROSCI.0035-14.2014; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; WATANABE M, 1993, J NEUROSCI, V13, P2105; WICTORIN K, 1990, NATURE, V347, P556, DOI 10.1038/347556a0; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yilmaz M, 2013, CURR BIOL, V23, P2011, DOI 10.1016/j.cub.2013.08.015; Zhao XY, 2014, NEURON, V84, P202, DOI 10.1016/j.neuron.2014.08.037	46	152	153	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2016	19	8					1073	+		10.1038/nn.4340	http://dx.doi.org/10.1038/nn.4340			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DS4TB	27399843	Green Accepted, Green Published, Green Submitted			2022-12-17	WOS:000380773200016
J	Doll, BB; Duncan, KD; Simon, DA; Shohamy, D; Daw, ND				Doll, Bradley B.; Duncan, Katherine D.; Simon, Dylan A.; Shohamy, Daphna; Daw, Nathaniel D.			Model-based choices involve prospective neural activity	NATURE NEUROSCIENCE			English	Article							PREDICTION ERROR; REINFORCEMENT; HIPPOCAMPAL; SYSTEMS; MECHANISMS; CORTEX; REPRESENTATIONS; COMPUTATIONS; ADDICTION; HABITS	Decisions may arise via 'model-free' repetition of previously reinforced actions or by 'model-based' evaluation, which is widely thought to follow from prospective anticipation of action consequences using a learned map or model. While choices and neural correlates of decision variables sometimes reflect knowledge of their consequences, it remains unclear whether this actually arises from prospective evaluation. Using functional magnetic resonance imaging and a sequential reward-learning task in which paths contained decodable object categories, we found that humans' model-based choices were associated with neural signatures of future paths observed at decision time, suggesting a prospective mechanism for choice. Prospection also covaried with the degree of model-based influences on neural correlates of decision variables and was inversely related to prediction error signals thought to underlie model-free learning. These results dissociate separate mechanisms underlying model-based and model-free evaluation and support the hypothesis that model-based influences on choices and neural decision variables result from prospection.	[Doll, Bradley B.; Daw, Nathaniel D.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Doll, Bradley B.; Duncan, Katherine D.; Shohamy, Daphna] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Simon, Dylan A.; Daw, Nathaniel D.] NYU, Dept Psychol, New York, NY 10003 USA; [Shohamy, Daphna] Columbia Univ, Kavli Inst Brain Sci, New York, NY USA	New York University; Columbia University; New York University; Columbia University	Doll, BB (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	bradley.doll@nyu.edu		Shohamy, Daphna/0000-0003-4239-4960; Duncan, Katherine/0000-0003-0456-851X	NINDS [R01NS078784]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078784] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S.M. Fleming and L.Y. Atlas for helpful discussions. This work was supported by NINDS grant R01NS078784.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2020, REINFORCEMENT LEARNI; Badre D, 2010, NEURON, V66, P315, DOI 10.1016/j.neuron.2010.03.025; Barron HC, 2013, NAT NEUROSCI, V16, P1492, DOI 10.1038/nn.3515; Ben Eppinger, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00253; Boorman ED, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001093; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Botvinick M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0480; Botvinick MM, 2009, COGNITION, V113, P262, DOI 10.1016/j.cognition.2008.08.011; Daw N.D., 2011, ATTEN PERFORM, P1; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0478; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; DAYAN P, 1993, NEURAL COMPUT, V5, P613, DOI 10.1162/neco.1993.5.4.613; Dolan RJ, 2013, NEURON, V80, P312, DOI 10.1016/j.neuron.2013.09.007; Doll BB, 2015, NEUROBIOL LEARN MEM, V117, P4, DOI 10.1016/j.nlm.2014.04.014; Doll BB, 2012, CURR OPIN NEUROBIOL, V22, P1075, DOI 10.1016/j.conb.2012.08.003; Doya K, 1999, NEURAL NETWORKS, V12, P961, DOI 10.1016/S0893-6080(99)00046-5; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fermin A, 2010, J MOTOR BEHAV, V42, P371, DOI 10.1080/00222895.2010.526467; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Foerde K, 2006, P NATL ACAD SCI USA, V103, P11778, DOI 10.1073/pnas.0602659103; Garrison J, 2013, NEUROSCI BIOBEHAV R, V37, P1297, DOI 10.1016/j.neubiorev.2013.03.023; Gershman SJ, 2014, J EXP PSYCHOL GEN, V143, P182, DOI 10.1037/a0030844; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; GLUCK MA, 1993, HIPPOCAMPUS, V3, P491, DOI 10.1002/hipo.450030410; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Kurth-Nelson Z, 2015, ELIFE, V4, DOI 10.7554/eLife.04919; Lee SW, 2014, NEURON, V81, P687, DOI 10.1016/j.neuron.2013.11.028; MOORE AW, 1993, MACH LEARN, V13, P103, DOI 10.1007/BF00993104; Otto AR, 2013, PSYCHOL SCI, V24, P751, DOI 10.1177/0956797612463080; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Reddy L, 2006, CURR OPIN NEUROBIOL, V16, P408, DOI 10.1016/j.conb.2006.06.004; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Schapiro AC, 2013, NAT NEUROSCI, V16, P486, DOI 10.1038/nn.3331; Schapiro AC, 2012, CURR BIOL, V22, P1622, DOI 10.1016/j.cub.2012.06.056; Shenhav A, 2014, NAT NEUROSCI, V17, P1249, DOI 10.1038/nn.3771; Shohamy D, 2008, NEURON, V60, P378, DOI 10.1016/j.neuron.2008.09.023; Simon DA, 2011, J NEUROSCI, V31, P5526, DOI 10.1523/JNEUROSCI.4647-10.2011; Sutton R. S., 1990, Machine Learning: Proceedings of the Seventh International Conference (1990), P216; Thorndike E. L., 1911, ANIMAL INTELLIGENCE; Tolman E.C., 1930, PUBLICATIONS PSYCHOL, V4, P257; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Tricomi E, 2009, EUR J NEUROSCI, V29, P2225, DOI 10.1111/j.1460-9568.2009.06796.x; Voon V, 2010, NEURON, V65, P135, DOI 10.1016/j.neuron.2009.12.027; Wimmer GE, 2012, SCIENCE, V338, P270, DOI 10.1126/science.1223252; Wunderlich K, 2012, NAT NEUROSCI, V15, P786, DOI 10.1038/nn.3068; Zeithamova D, 2012, NEURON, V75, P168, DOI 10.1016/j.neuron.2012.05.010	50	152	152	1	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2015	18	5					767	+		10.1038/nn.3981	http://dx.doi.org/10.1038/nn.3981			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG9LN	25799041	Green Accepted			2022-12-17	WOS:000353636900025
